FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Zhang, QR
   Yang, QG
   Phanlavong, P
   Li, YX
   Wang, ZK
   Jiao, TF
   Peng, QM
AF Zhang, Qingrui
   Yang, Qinggang
   Phanlavong, Pikky
   Li, Yixiang
   Wang, Zikang
   Jiao, Tifeng
   Peng, Qiuming
TI Highly Efficient Lead(II) Sequestration Using Size-Controllable
   Polydopamine Microspheres with Superior Application Capability and Rapid
   Capture
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Polydopamine; Heavy metal; Adsorption; Application
ID HEAVY-METAL IONS; MUSSEL-INSPIRED SYNTHESIS; WATER-PURIFICATION;
   PHOSPHATE SEQUESTRATION; MAGNETIC NANOPARTICLES; OXIDE NANOCOMPOSITES;
   SELECTIVE ADSORPTION; REUSABLE ADSORBENTS; AQUEOUS-SOLUTIONS; REMOVAL
AB In this work, we successfully prepared the mussel inspired polydopamine microspheres (PDA-Ms) with controllable sizes, through a facile self-oxidative polymerization method. The prepared PDA-M biomaterial with environmentally benign properties exhibits efficient lead(II) sequestration against high salts of competitive Ca(II), Mg(II), or Na(I) ions. It reveals 30 times greater than the commercial ion-exchanger 001x7 by selectivity evaluation. Kinetic results show that an exceedingly rapid lead(II) uptake can be achieved below 1 min. More attractively, the prepared PDA-Ms further exhibit the distinguished application ability with superior treated capacity of similar to 42000 kg contaminated water/kg sorbent, and the effluents can be reduced from 1000 mu g/L to below 10 mu g/L, reaching the drinking water standard (WHO), which is equal to 200 times greater than commercial ion exchanger resin (similar to 210 kg) and granular activated carbon (similar to 120 kg). In addition, the exhaust PDA-M material can be well regenerated and repeated use using binary 1% HCl + 5% Ca(NO3)(2) solution. X-ray photoelectron spectroscopy (XPS), zeta potential, and FT-IR analysis prove that such satisfactory performances can be ascribed to the following aspects (1) the well-dispersed nanoscale morphology and highly charged property will achieve the rapid adsorption and sufficient sorbent utilization. That is, the negatively-charged PDA sphere can exert the famous Donnan membrane effects for target lead(II) enrichment and diffusion enhancement; (2) the strong amine and carbonyl/hydroxyl group within the matrix can offer sorption selectivity for powerful lead(II) capture. Effective performances as well as environmentally friendly features suggest PDA-M material is a promising lead(II)-removing candidate for water remediation.
C1 [Zhang, Qingrui; Jiao, Tifeng; Peng, Qiuming] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
   [Zhang, Qingrui; Yang, Qinggang; Phanlavong, Pikky; Li, Yixiang; Wang, Zikang; Jiao, Tifeng] Yanshan Univ, Sch Environm & Chem Engn, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
RP Jiao, TF; Peng, QM (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.; Jiao, TF (reprint author), Yanshan Univ, Sch Environm & Chem Engn, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
EM Tfjiao@ysu.edu.cn; pengqiuming@gmail.com
OI Jiao, Tifeng/0000-0003-1238-0277
FU NSFC [51578476, 21473153, 51422105]; NSF of Hebei Province [B2016203056,
   E2015203404]; China Post-doctoral Science Foundation [2015M580214];
   Science and Technology Support Program of Hebei Province [15273626];
   Support Program for the Top Young Talents of Hebei Province
FX This work was financially supported by NSFC (grant Nos. 51578476,
   21473153, 51422105), NSF of Hebei Province (grant No. B2016203056,
   E2015203404,), the China Post-doctoral Science Foundation (No.
   2015M580214), Science and Technology Support Program of Hebei Province
   (No. 15273626), and the Support Program for the Top Young Talents of
   Hebei Province.
CR Ai KL, 2013, ADV MATER, V25, P998, DOI 10.1002/adma.201203923
   Ali I, 2006, NAT PROTOC, V1, P2661, DOI 10.1038/nprot.2006.370
   [Anonymous], 2005, GUID DRINK WAT QUAL, P104
   Awual MR, 2014, SENSOR ACTUAT B-CHEM, V203, P854, DOI 10.1016/j.snb.2014.07.063
   Bolisetty S, 2016, NAT NANOTECHNOL, V11, P365, DOI [10.1038/NNANO.2015.310, 10.1038/nnano.2015.310]
   Bosch X, 2003, SCIENCE, V609, P1
   Cao CY, 2013, CHEM-EUR J, V19, P1558, DOI 10.1002/chem.201203986
   Ceglowski M, 2015, CHEM ENG J, V263, P402, DOI 10.1016/j.cej.2014.11.047
   Chen YL, 2010, ENVIRON SCI TECHNOL, V44, P3508, DOI 10.1021/es100341x
   Donnan FG, 1924, CHEM REV, V1, P73, DOI 10.1021/cr60001a003
   Fu FL, 2012, CHEM ENG J, V189, P283, DOI 10.1016/j.cej.2012.02.073
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Fu JW, 2016, J COLLOID INTERF SCI, V461, P292, DOI 10.1016/j.jcis.2015.09.017
   Fu JW, 2015, CHEM ENG J, V259, P53, DOI 10.1016/j.cej.2014.07.101
   Gao HC, 2013, ACS APPL MATER INTER, V5, P425, DOI 10.1021/am302500v
   Gupta N, 2012, J TAIWAN INST CHEM E, V43, P125, DOI 10.1016/j.jtice.2011.07.009
   Hamza IAA, 2013, PHYS CHEM EARTH, V66, P157, DOI 10.1016/j.pce.2013.08.006
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   Hokkanen S, 2016, WATER RES, V91, P156, DOI 10.1016/j.watres.2016.01.008
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kemper JM, 2009, ENVIRON SCI TECHNOL, V43, P466, DOI 10.1021/es802460n
   Khajeh M, 2013, CHEM REV, V113, P7728, DOI 10.1021/cr400086v
   Khan MA, 2015, IND ENG CHEM RES, V54, P76, DOI 10.1021/ie504148k
   Koley P, 2016, ACS APPL MATER INTER, V8, P2380, DOI 10.1021/acsami.5b11533
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee M, 2012, CHEMPLUSCHEM, V77, P987, DOI 10.1002/cplu.201200209
   Li CY, 2014, RSC ADV, V4, P47848, DOI 10.1039/c4ra08193e
   Li F, 2016, BIORESOURCE TECHNOL, V211, P751, DOI 10.1016/j.biortech.2016.03.169
   Liang HW, 2011, ADV FUNCT MATER, V21, P3851, DOI 10.1002/adfm.201100983
   Liao YA, 2010, MATER CHEM PHYS, V121, P534, DOI 10.1016/j.matchemphys.2010.02.019
   Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288
   Liu SJ, 2016, J ENVIRON MANAGE, V182, P328, DOI 10.1016/j.jenvman.2016.07.086
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Liu YL, 2013, ADV MATER, V25, P1353, DOI 10.1002/adma.201204683
   Mahmud HNME, 2016, RSC ADV, V6, P14778, DOI 10.1039/c5ra24358k
   Office of the Federal Register Department of Health and Human Services, 2010, FED REG
   Palui G, 2015, CHEM SOC REV, V44, P193, DOI 10.1039/c4cs00124a
   Pan BC, 2007, WATER RES, V41, P3103, DOI 10.1016/j.watres.2007.03.004
   Peng QM, 2014, J AM CHEM SOC, V136, P4113, DOI 10.1021/ja500506k
   Qiu H, 2017, CHEM ENG J, V315, P345, DOI 10.1016/j.cej.2017.01.043
   Qiu H, 2015, ACS APPL MATER INTER, V7, P20835, DOI 10.1021/acsami.5b06098
   Qu J, 2012, J MATER CHEM, V22, P3562, DOI 10.1039/c2jm15841h
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Shan C, 2015, WATER RES, V69, P252, DOI 10.1016/j.watres.2014.11.030
   Song Q, 2013, ANAL CHIM ACTA, V787, P64, DOI 10.1016/j.aca.2013.06.010
   Su Q, 2009, SCI TOTAL ENVIRON, V407, P5471, DOI 10.1016/j.scitotenv.2009.06.045
   Sun YB, 2016, ENVIRON SCI TECHNOL, V50, P4459, DOI 10.1021/acs.est.6b00058
   Wan SL, 2016, J HAZARD MATER, V314, P32, DOI 10.1016/j.jhazmat.2016.04.014
   Wang B, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500234
   Wang J, 2016, J MATER CHEM A, V4, P3893, DOI 10.1039/c6ta00269b
   Xing RR, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8050181
   Yang FC, 2014, COLLOID SURFACE A, V463, P101, DOI 10.1016/j.colsurfa.2014.09.022
   Yu SJ, 2016, ENVIRON SCI-NANO, V3, P1361, DOI 10.1039/c6en00297h
   Zhang QR, 2016, NANOSCALE, V8, P7085, DOI 10.1039/c5nr09303a
   Zhang QR, 2015, IND ENG CHEM RES, V54, P2940, DOI 10.1021/ie503943z
   Zhang QR, 2013, ENVIRON SCI TECHNOL, V47, P6536, DOI 10.1021/es400919t
   Zhang RY, 2016, ACS APPL MATER INTER, V8, P13262, DOI 10.1021/acsami.6b02416
   Zhang S, 2013, CHEM ENG J, V234, P33, DOI 10.1016/j.cej.2013.08.102
   Zhang SX, 2014, J HAZARD MATER, V270, P27, DOI 10.1016/j.jhazmat.2014.01.039
   Zhang XL, 2014, APPL SURF SCI, V314, P166, DOI 10.1016/j.apsusc.2014.06.158
   Zhang YP, 2017, SCI TOTAL ENVIRON, V580, P776, DOI 10.1016/j.scitotenv.2016.12.024
   Zhuang Y, 2009, J PHYS CHEM C, V113, P10441, DOI 10.1021/jp9014756
   Zou YD, 2016, ENVIRON POLLUT, V219, P107, DOI 10.1016/j.envpol.2016.10.052
   Zou YD, 2016, ENVIRON SCI TECHNOL, V50, P7290, DOI 10.1021/acs.est.6b01897
   Zou YD, 2016, ENVIRON SCI TECHNOL, V50, P3658, DOI 10.1021/acs.est.6b00255
NR 65
TC 11
Z9 11
U1 16
U2 72
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAY
PY 2017
VL 5
IS 5
BP 4161
EP 4170
DI 10.1021/acssuschemeng.7b00129
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA ET9NT
UT WOS:000400634900067
DA 2018-10-20
ER

PT J
AU Zong, JY
   Cobb, SL
   Cameron, NR
AF Zong, Jingyi
   Cobb, Steven L.
   Cameron, Neil R.
TI Peptide-functionalized gold nanoparticles: versatile biomaterials for
   diagnostic and therapeutic applications
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; BETA-AMYLOID PEPTIDE; IN-VIVO; BIOMEDICAL
   APPLICATIONS; COLORIMETRIC DETECTION; SENSITIVE DETECTION; CLUSTER
   MOLECULES; CELLULAR UPTAKE; GENE DELIVERY; NEUROGENIN3
AB Colloidal gold solutions have been used for centuries in a wide variety of applications including staining glass and in the colouring of ceramics. More recently, gold nanoparticles (GNPs) have been studied extensively due to their interesting size-dependent electronic and optical properties. GNPs can be functionalized easily with biomolecules that contain thiols, amines, or even phosphine moieties. For example, the reaction of thiol-containing peptides with GNPs has been used extensively to prepare novel hybrid materials for biomedical applications. A range of different types of peptides can be used to access biomaterials that are designed to perform a specific role such as cancer cell targeting. In addition, specific peptide sequences that are responsive to external stimuli (e.g. temperature or pH) can be used to stabilise/destabilise the aggregation of colloidal GNPs. Such systems have exciting potential applications in the field of colorimetric sensing (including bio-sensing) and in targeted drug delivery platforms. In this review, we will give an overview of the current methods used for preparing peptide functionalized GNPs, and we will discuss their key properties outlining the various applications of this class of biomaterial. In particular, the potential applications of peptide functionalized GNPs in areas of sensing and targeted drug delivery will be discussed.
C1 [Zong, Jingyi; Cobb, Steven L.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.
   [Cameron, Neil R.] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia.
   [Cameron, Neil R.] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
RP Cameron, NR (reprint author), Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia.; Cameron, NR (reprint author), Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
EM neil.cameron@monash.edu
RI Cobb, Steven/F-3926-2012
OI Cobb, Steven/0000-0002-3790-7023
FU China Scholarship Council
FX We thank the China Scholarship Council for funding (Scholarship to JYZ).
CR Aili D, 2008, NANO LETT, V8, P2473, DOI 10.1021/nl8014796
   Aili D, 2008, J AM CHEM SOC, V130, P5780, DOI 10.1021/ja711330f
   Aili D, 2009, SMALL, V5, P2445, DOI 10.1002/smll.200900530
   Akrami M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31030
   Arosio D, 2011, BIOCONJUGATE CHEM, V22, P664, DOI 10.1021/bc100448r
   Bartczak D, 2012, NANOSCALE, V4, P4470, DOI 10.1039/c2nr31064c
   Bartczak D, 2011, LANGMUIR, V27, P10119, DOI 10.1021/la2022177
   Bhattacharjee RR, 2005, J NANOSCI NANOTECHNO, V5, P1141, DOI 10.1166/jnn.2005.166
   Borghouts C, 2005, J PEPT SCI, V11, P713, DOI 10.1002/psc.717
   Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107
   Chandrawati R, 2014, CHEM COMMUN, V50, P5431, DOI 10.1039/c4cc00572d
   Chen P, 2013, NANOSCALE, V5, P8973, DOI 10.1039/c3nr03006g
   Chen WH, 2013, CHEM COMMUN, V49, P6403, DOI 10.1039/c3cc43283a
   Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6
   Cheng K, 2014, J AM CHEM SOC, V136, P3560, DOI 10.1021/ja412001e
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+
   Dowling MB, 2010, BIOCONJUGATE CHEM, V21, P1968, DOI 10.1021/bc100115m
   Dufort S, 2011, J DRUG TARGET, V19, P582, DOI 10.3109/1061186X.2010.542245
   Dykman LA, 2014, CHEM REV, V114, P1258, DOI 10.1021/cr300441a
   Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Ghosh P, 2010, J AM CHEM SOC, V132, P2642, DOI 10.1021/ja907887z
   Gibson MI, 2013, CHEM SOC REV, V42, P7204, DOI 10.1039/c3cs60035a
   Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607
   Gupta S, 2010, SMALL, V6, P1509, DOI 10.1002/smll.201000099
   Harper B, 2014, NANOMATERIALS-BASEL, V4, P355, DOI 10.3390/nano4020355
   Hosta-Rigau L, 2010, BIOCONJUGATE CHEM, V21, P1070, DOI 10.1021/bc1000164
   Hostetler MJ, 1999, LANGMUIR, V15, P3782, DOI 10.1021/la981598f
   Hur H.-G., 2013, US Pat, Patent No. 20130123466
   Khamehchian S, 2016, J BIOMED MATER RES A, V104, P2693, DOI 10.1002/jbm.a.35806
   Kogan MJ, 2007, NANOMEDICINE-UK, V2, P287, DOI 10.2217/17435889.2.3.287
   Krpetic Z, 2009, BIOCONJUGATE CHEM, V20, P619, DOI 10.1021/bc8003028
   Kumar A, 2014, ACS NANO, V8, P4205, DOI 10.1021/nn500152u
   Kumar A, 2012, BIOMATERIALS, V33, P1180, DOI 10.1016/j.biomaterials.2011.10.058
   Laromaine A, 2007, J AM CHEM SOC, V129, P4156, DOI 10.1021/ja0706504
   Lemieux V, 2010, CHEM COMMUN, V46, P3071, DOI 10.1039/b923280j
   Levine RM, 2013, SOFT MATTER, V9, P985, DOI 10.1039/c2sm26633d
   Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269
   Levy R, 2006, CHEMBIOCHEM, V7, P1141, DOI 10.1002/cbic.200600129
   Li ZJ, 2012, J TRANSL MED, V10, DOI [10.1186/1479-5876-10-S1-S1, 10.4018/jeco.2012070101]
   Li ZM, 2010, MOL PHARMACEUT, V7, P94, DOI 10.1021/mp9001415
   Lin SY, 2004, J PHYS CHEM B, V108, P2134, DOI 10.1021/jp036310w
   Liu YL, 2008, BIOCONJUGATE CHEM, V19, P1009, DOI 10.1021/bc700421u
   Ma XC, 2013, ADV HEALTHC MATER, V2, P1638, DOI 10.1002/adhm.201300037
   Mak WC, 2014, PART PART SYST CHAR, V31, P1127, DOI 10.1002/ppsc.201400082
   Maus L, 2010, ACS NANO, V4, P6617, DOI 10.1021/nn101867w
   Minelli C, 2013, SOFT MATTER, V9, P5119, DOI 10.1039/c3sm50379h
   Morais T, 2012, EUR J PHARM BIOPHARM, V80, P185, DOI 10.1016/j.ejpb.2011.09.005
   Mu CJ, 2010, ACS NANO, V4, P1511, DOI 10.1021/nn9017334
   Muroski ME, 2014, J AM CHEM SOC, V136, P14763, DOI 10.1021/ja505190q
   Nowinski AK, 2014, LANGMUIR, V30, P1864, DOI 10.1021/la404980g
   Patel S, 2014, ACS NANO, V8, P8959, DOI 10.1021/nn501589f
   Peng LH, 2016, BIOMATERIALS, V103, P137, DOI 10.1016/j.biomaterials.2016.06.057
   Pujols-Ayala I, 2003, J AM CHEM SOC, V125, P7536, DOI 10.1021/ja035005l
   Rana S, 2012, ADV DRUG DELIVER REV, V64, P200, DOI 10.1016/j.addr.2011.08.006
   Retout M, 2016, ACS SENSORS, V1, P929, DOI 10.1021/acssensors.6b00229
   Roma-Rodrigues C, 2016, INT J NANOMED, V11, P2633, DOI 10.2147/IJN.S108661
   Saxena VK, 2012, RES VET SCI, V93, P1531, DOI 10.1016/j.rvsc.2012.04.013
   Serizawa T, 2009, LANGMUIR, V25, P12229, DOI 10.1021/la9021799
   Shirazi AN, 2014, MOLECULES, V19, P13319, DOI 10.3390/molecules190913319
   Shukla R, 2008, SOFT MATTER, V4, P2160, DOI 10.1039/b810885d
   Si S, 2008, CHEMPHYSCHEM, V9, P1578, DOI 10.1002/cphc.200800121
   Si S, 2007, J PHYS CHEM C, V111, P1248, DOI 10.1021/jp066303i
   Si S, 2007, LANGMUIR, V23, P190, DOI 10.1021/la061505r
   Silva F, 2016, BIOCONJUGATE CHEM, V27, P1153, DOI 10.1021/acs.bioconjchem.6b00102
   Slocik JM, 2008, SMALL, V4, P548, DOI 10.1002/smll.200700920
   Sun LL, 2008, LANGMUIR, V24, P10293, DOI 10.1021/la8015063
   Tadepalli S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16206
   Takatsuji Y, 2012, SENSORS-BASEL, V12, P4952, DOI 10.3390/s120404952
   Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664
   Thovhogi N, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2904-x
   Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347
   Tiwari PM, 2011, NANOMATERIALS-BASEL, V1, P31, DOI 10.3390/nano1010031
   Tiwari PM, 2014, BIOMATERIALS, V35, P9484, DOI 10.1016/j.biomaterials.2014.07.032
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
   Vericat C, 2010, CHEM SOC REV, V39, P1805, DOI 10.1039/b907301a
   Wang CK, 2012, CHEM COMMUN, V48, P8392, DOI 10.1039/c2cc33568a
   Wang CK, 2010, TALANTA, V80, P1626, DOI 10.1016/j.talanta.2009.09.052
   Wang JH, 2011, SOFT MATTER, V7, P7217, DOI 10.1039/c1sm05242j
   Wang Y, 2016, ANALYST, V141, P3233, DOI 10.1039/c5an02508g
   Wang Y, 2014, CHEM SCI, V5, P2651, DOI 10.1039/c3sc53305k
   Wang Z, 2005, BIOCONJUGATE CHEM, V16, P497, DOI 10.1021/bc0500471
   Wei L, 2014, NANOSCALE, V6, P10207, DOI 10.1039/c4nr02732a
   Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14
   Xie W, 2009, BIOCONJUGATE CHEM, V20, P768, DOI 10.1021/bc800469g
   Yan XH, 2012, ACS NANO, V6, P111, DOI 10.1021/nn202939s
   Yang H, 2011, ANGEW CHEM INT EDIT, V50, P9643, DOI 10.1002/anie.201102911
   Yi Y, 2016, J CONTROL RELEASE, V244, P247, DOI 10.1016/j.jconrel.2016.08.041
   Yin TT, 2016, ACS APPL MATER INTER, V8, P19291, DOI 10.1021/acsami.6b05089
   Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036
   Yuan H, 2016, J BIOPHOTONICS, V9, P406, DOI 10.1002/jbio.201500173
   Yuan Y, 2011, BIOSENS BIOELECTRON, V26, P4245, DOI 10.1016/j.bios.2011.04.021
   Zhang M, 2012, ANALYST, V137, P601, DOI 10.1039/c1an15909g
   Zhen SJ, 2008, TALANTA, V76, P230, DOI 10.1016/j.talanta.2008.02.030
   Zhu DR, 2012, BIOSENS BIOELECTRON, V31, P505, DOI 10.1016/j.bios.2011.11.026
NR 97
TC 12
Z9 12
U1 10
U2 64
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAY 1
PY 2017
VL 5
IS 5
BP 872
EP 886
DI 10.1039/c7bm00006e
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA EU0HH
UT WOS:000400690700002
PM 28304023
DA 2018-10-20
ER

PT J
AU Pereira, LX
   Viana, CTR
   Orellano, LAA
   Almeida, SA
   Vasconcelos, AC
   Goes, AD
   Birbrair, A
   Andrade, SP
   Campos, PP
AF Pereira, Luciana Xavier
   Rodrigues Viana, Celso Tarso
   Ariza Orellano, Laura Alejandra
   Almeida, Simone Aparecida
   Vasconcelos, Anilton Cesar
   Goes, Alfredo de Miranda
   Birbrair, Alexander
   Andrade, Silvia Passos
   Campos, Paula Peixoto
TI Synthetic matrix of polyether-polyurethane as a biological platform for
   pancreatic regeneration
SO LIFE SCIENCES
LA English
DT Article
DE Sponge implant; Diabetes; Scaffold; Biomaterial; Human adipose stem
   cells; Insulin-producing cell
ID MESENCHYMAL STROMAL CELLS; TYPE-1 DIABETES-MELLITUS; STEM-CELLS;
   BONE-MARROW; BETA-CELLS; MICE; ANGIOGENESIS; MODEL; VASCULARIZATION;
   HYPOGLYCEMIA
AB Aims: Several alternative cellular approaches using biomaterials to host insulin-producing cells derived from stem cells have been developed to overcome the limitations of type 1 diabetes treatment (exogenous insulin injection). However, none seem to fulfill all requirements needed to induce pancreatic cells successful colonization of the scaffolds. Here, we report a polymeric platform adherent to the native mice pancreas filled with human adipose stem cells (hASCs) that was able to induce growth of pancreatic parenchyma.
   Main methods: Synthetic polyether-polyurethane discs were placed adjacent to pancreas of normoglycemic and streptozotocin-induced diabetic mice. At day 4 post implantation, 1 x 10(6) hASCs were injected intra-implant in groups of normoglycemic and diabetic mice. Immunohistochemistry analysis of the implants was performed to identify insulin positive cells in the newly formed tissue. In addition, metabolic, inflammatory and angiogenic parameters were carried out in those mice.
   Key findings: This study provides evidence of the ability of a biohybrid device to induce the growth of differentiated pancreas parenchyma in both normoglycemic and streptozotocin-induced diabetic mice as detected by histological analysis. Glucose metabolism and body weight of hyperglycemic mice bearing hASCs implants improved.
   Significance: The synthetic porous scaffold bearing hASC cells placed adjacent to the native animal pancreas exhibits the potential to be exploited in future cell-based type 1 diabetes therapies. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Pereira, Luciana Xavier; Rodrigues Viana, Celso Tarso; Ariza Orellano, Laura Alejandra; Almeida, Simone Aparecida; Vasconcelos, Anilton Cesar; Birbrair, Alexander; Campos, Paula Peixoto] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.
   [Goes, Alfredo de Miranda] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Andrade, Silvia Passos] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.
RP Campos, PP (reprint author), Univ Fed Minas Gerais, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM paulapc@icb.ufmg.br
RI Birbrair, Alexander/H-2497-2012
OI Birbrair, Alexander/0000-0003-1015-2561
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [481659/2012-9]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)
   [APQ-01461/12]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) (481659/2012-9), Fundacao de Amparo a
   Pesquisa de Minas Gerais (FAPEMIG) (APQ-01461/12). The fluorescence
   microscopic data shown in this work was obtained using the microscopes
   and equipment in the Centro de Aquisicao e Processamento de Imagens
   (CAPI-ICB/UFMG) and of Laboratory of multi-user equipment - Department
   of Biochemistry and Immunology, UFMG. The authors would like thank Mrs.
   M.M. Pereira and Mr. B. R. Barrioni for technical assistance in
   analyzing the synthetic matrix by mCT; Mrs. N. B. Pereira and C. C.
   Figueiredo for assistance in fluorescence microscopy technique.
CR Amer LD, 2014, TISSUE ENG PART B-RE, V20, P455, DOI [10.1089/ten.TEB.2013.0462, 10.1089/ten.teb.2013.0462]
   ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Bouwens L, 2013, NAT REV ENDOCRINOL, V9, P598, DOI 10.1038/nrendo.2013.145
   Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263
   Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003
   Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020615
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520
   Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170
   Gao WC, 2011, J CELL MOL MED, V15, P2575, DOI 10.1111/j.1582-4934.2011.01313.x
   Godfrey KJ, 2012, DIABETIC MED, V29, P14, DOI 10.1111/j.1464-5491.2011.03433.x
   Gupta D, 2014, PHYSIOL BEHAV, V129, P73, DOI 10.1016/j.physbeh.2014.02.036
   Haworth R, 2015, REGEN MED, V10, P231, DOI [10.2217/rme.14.50, 10.2217/RME.14.50]
   HAYASHI Y, 2015, CURR STEM CELL RES T, V6, P111, DOI DOI 10.1186/S13287-015-0088-Z
   Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Kim JH, 2015, DIABETES OBES METAB, V17, P161, DOI 10.1111/dom.12408
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu JJ, 2017, MOL IMAGING BIOL, V19, P31, DOI 10.1007/s11307-016-0962-9
   Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011
   Magin CM, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/022001
   Marques SM, 2014, WOUND REPAIR REGEN, V22, P381, DOI 10.1111/wrr.12177
   Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024
   Martin-Timon I, 2015, WORLD J DIABETES, V6, P912, DOI 10.4239/wjd.v6.i7.912
   Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140
   Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149
   Paula ACC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0030-4
   Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017
   Rambhia K.J., 2015, J CONTROL RELEASE, P1
   Rebelo A., 2015, J BIOMED MATER RES B, P1
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Robertson RP, 2015, DIABETES CARE, V38, P1030, DOI 10.2337/dc15-0079
   Salvatori Marcus, 2014, J Diabetes Sci Technol, V8, P159
   Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996
   Stucky EC, 2015, CYTOTHERAPY, V17, P1353, DOI 10.1016/j.jcyt.2015.05.002
   The Diabetes Control and Complications Trial Research Group, 1994, NEW ENGL J MED, V329, P1993
   Tilkorn DJ, 2010, TISSUE ENG PT A, V16, P165, DOI [10.1089/ten.tea.2009.0075, 10.1089/ten.TEA.2009.0075]
   Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010
   Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235
   Xiao N, 2013, CYTOTHERAPY, V15, P1374, DOI 10.1016/j.jcyt.2013.06.013
   Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015
   Zhang L, 2013, STEM CELLS DEV, V22, P3074, DOI 10.1089/scd.2013.0142
NR 53
TC 10
Z9 10
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD MAY 1
PY 2017
VL 176
BP 67
EP 74
DI 10.1016/j.lfs.2017.03.015
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA ET8GR
UT WOS:000400537500008
PM 28336399
DA 2018-10-20
ER

PT J
AU Wang, HB
   Zhu, H
   Fu, WG
   Zhang, YY
   Xu, B
   Gao, F
   Cao, ZQ
   Liu, WG
AF Wang, Hongbo
   Zhu, Hui
   Fu, Weigui
   Zhang, Yinyu
   Xu, Bing
   Gao, Fei
   Cao, Zhiqiang
   Liu, Wenguang
TI A High Strength Self-Healable Antibacterial and Anti-Inflammatory
   Supramolecular Polymer Hydrogel
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE antimicrobial; high strength; self-healing; supramolecular polymer
   hydrogels
ID FOREIGN-BODY RESPONSE; SUBCUTANEOUS IMPLANTS; DERIVATIVES; THICKNESS;
   BASES; MICE
AB There is a significant cost to mitigate the infection and inflammation associated with the implantable medical devices. The development of effective antibacterial and anti-inflammatory biomaterials with novel mechanism of action has become an urgent task. In this study, a supramolecular polymer hydrogel is synthesized by the copolymerization of N-acryloyl glycinamide and 1-vinyl-1,2,4-triazole in the absence of any chemical crosslinker. The hydrogel network is crosslinked through the hydrogen bond interactions between dual amide motifs in the side chain of N-acryloyl glycinamide. The prepared hydrogels demonstrate excellent mechanical propertieshigh tensile strength (approximate to 1.2 MPa), large stretchability (approximate to 1300%), and outstanding compressive strength (approximate to 11 MPa) at swelling equilibrium state. A simulation study elaborates the changes of hydrogen bond interactions when 1-vinyl-1,2,4-triazole is introduced into the gel network. It is demonstrated that the introduction of 1-vinyl-1,2,4-triazole endowes the supramolecular hydrogels with self-repairability, thermoplasticity, and reprocessability over a lower temperature range for 3D printing of different shapes and patterns under simplified thermomelting extrusion condition. In addition, these hydrogels exhibit antimicrobial and anti-inflammatory activities, and in vitro cytotoxicity assay and histological staining following in vivo implantation confirm the biocompatibility of the hydrogel. These hydrogels with integrated multifunctions hold promising potential as an injectable biomaterial for treating degenerated soft supporting tissues.
C1 [Wang, Hongbo; Zhang, Yinyu; Xu, Bing; Gao, Fei; Liu, Wenguang] Tianjin Univ, Sch Mat Sci & Engn, Tianjin Key Lab Composite & Funct Mat, Tianjin 300072, Peoples R China.
   [Zhu, Hui; Cao, Zhiqiang] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
   [Fu, Weigui] Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Hollow Fiber Membrane Mat & Proc, Tianjin 300387, Peoples R China.
RP Liu, WG (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin Key Lab Composite & Funct Mat, Tianjin 300072, Peoples R China.; Cao, ZQ (reprint author), Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
EM zcao@wayne.edu; wgliu@tju.edu.cn
FU National Natural Science Foundation [51325305, 21274105, 51303132];
   National Key Research and Development Program [2016YFC1101301]; Tianjin
   Municipal Natural Science Foundation [15JCZD JC38000]; Juvenile Diabetes
   Research Foundation [1-SRA-2015-41-A-N, 2-PNF-2016-324-S-B]; US National
   Science Foundation [DMR-1410853]; US National Institute of Diabetes And
   Digestive And Kidney Diseases of the National Institutes of Health
   [DP2DK111910]
FX The authors gratefully acknowledge the support for this work from the
   National Natural Science Foundation (Grant Nos. 51325305, 21274105 and
   51303132), National Key Research and Development Program (Grant No.
   2016YFC1101301), Tianjin Municipal Natural Science Foundation (Grant
   Nos. 15JCZD JC38000), the Juvenile Diabetes Research Foundation
   (1-SRA-2015-41-A-N, 2-PNF-2016-324-S-B), US National Science Foundation
   (DMR-1410853) and the US National Institute of Diabetes And Digestive
   And Kidney Diseases of the National Institutes of Health (DP2DK111910).
   We also appreciate Prof. Qigang Wang and Dr. Qingcong Wei of Department
   of Chemistry, Tongji University, for printing hydrogel using their
   device.
CR Almajan GL, 2009, EUR J MED CHEM, V44, P3083, DOI 10.1016/j.ejmech.2008.07.003
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Bayramgil NP, 2012, COLLOID SURFACE B, V97, P182, DOI 10.1016/j.colsurfb.2012.04.026
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Dai XY, 2015, ADV MATER, V27, P3566, DOI 10.1002/adma.201500534
   Ezabadi RR, 2008, BIOORGAN MED CHEM, V16, P1150, DOI 10.1016/j.bmc.2007.10.082
   Gao F, 2016, ACS APPL MATER INTER, V8, P8956, DOI 10.1021/acsami.6b00912
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   JOHNSON EM, 1995, J ANTIMICROB CHEMOTH, V35, P103, DOI 10.1093/jac/35.1.103
   JONES DH, 1965, J MED CHEM, V8, P676, DOI 10.1021/jm00329a026
   Katica C., 2001, MOLECULES, V6, P815
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Nichols SP, 2012, BIOMATERIALS, V33, P6305, DOI 10.1016/j.biomaterials.2012.05.053
   Nonoyama T, 2016, ADV MATER, V28, P6740, DOI 10.1002/adma.201601030
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Seuring J, 2010, MACROMOL CHEM PHYS, V211, P2109, DOI 10.1002/macp.201000147
   Sumrra SH, 2013, J ENZYM INHIB MED CH, V28, P1291, DOI 10.3109/14756366.2012.735666
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Sztanke K, 2008, EUR J MED CHEM, V43, P404, DOI 10.1016/j.ejmech.2007.03.033
   Tang L, 2010, ADV MATER, V22, P2652, DOI 10.1002/adma.200904016
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Vijesh AM, 2013, EUR J MED CHEM, V62, P410, DOI 10.1016/j.ejmech.2012.12.057
   Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xu B, 2015, ACS APPL MATER INTER, V7, P16865, DOI [10.1021/acsami.5b05074, 10.1021/acsami.5605074]
   Xu CS, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604513
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 30
TC 12
Z9 12
U1 48
U2 200
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAY
PY 2017
VL 38
IS 9
AR 1600695
DI 10.1002/marc.201600695
PG 9
WC Polymer Science
SC Polymer Science
GA ET9TO
UT WOS:000400651500001
PM 28272767
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bellefeuille, M
   Peters, DF
   Nolin, M
   Slusarewicz, P
   Telgenhoff, D
AF Bellefeuille, M.
   Peters, D. F.
   Nolin, M.
   Slusarewicz, P.
   Telgenhoff, D.
TI Examination of toxicity and collagen linearity after the administration
   of the protein cross-linker genipin in equine tendon and dermis: a pilot
   study
SO AUSTRALIAN VETERINARY JOURNAL
LA English
DT Article
DE collagen; cross-linking; genipin; histology; horses
ID LINKING REAGENT; MECHANICAL-PROPERTIES; NATURAL BIOMATERIAL; MODEL;
   BIOCOMPATIBILITY; FIXATION
AB ObjectiveCollagen cross-linking is an attractive therapeutic route aimed at supplementing natural collagen stabilisation. In this study the toxicity of the cross-linker genipin (GP) was examined in avascular (tendon) and vascular (dermis) tissue.
   MethodsHigh doses of GP were injected intratendinously into three yearling horses and evaluated at various time points up to 30 days. A second group of three yearlings were injected into the dermis and evaluated at various time points up to 1 year. Metrics used included lameness, circumferential swelling, ultrasound evaluation, microscopic morphology, collagen production and systemic effect on blood parameters.
   ResultsThe tendon injection sites exhibited mild lameness and swelling with no apparent systemic toxicity or stabilisation defects. Treated tendons exhibited increased linear collagen microscopically. Dermal injections showed similar results, with mild swelling at the injection site. Microscopic morphology resulted in a decrease in dermal collagen at 30 days post-injection. Dermis injected at the high dose of 355mmol/L examined 1year post-treatment appeared similar to the untreated biopsies; however, there was an increase in mature collagen.
   Conclusion GP injection appeared to be well tolerated, with transient lameness and mild circumferential swelling when injected into the tendon and local tissue swelling when injected into the dermis. No systemic hypersensitivities or toxicities were observed. Microscopically, GP resulted in increased linear collagen in tendons at 30 days post-injection and overall increased collagen in dermal tissue when evaluated 1 year post-injection.
C1 [Bellefeuille, M.] Equine Sports Med & Surg, Weatherford, TX USA.
   [Peters, D. F.] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA.
   [Nolin, M.; Slusarewicz, P.] Equinext LLC, Lexington, KY USA.
   [Telgenhoff, D.] Tarleton State Univ, Med Lab Sci Dept, 1501 Enderly Pl, Ft Worth, TX 76104 USA.
RP Telgenhoff, D (reprint author), Tarleton State Univ, Med Lab Sci Dept, 1501 Enderly Pl, Ft Worth, TX 76104 USA.
EM telgenhoff@tarleton.edu
FU Equinext LLC
FX The authors thank Equinext LLC for financial support for the conduct of
   the research and preparation of the article.
CR Awang MA, 2014, BIO-MED MATER ENG, V24, P1715, DOI 10.3233/BME-140983
   BAILEY AJ, 1974, NATURE, V251, P105, DOI 10.1038/251105a0
   Boschetti F, 2006, BIORHEOLOGY, V43, P235
   Bou-Akl T, 2013, J BIOMED MATER RES A, V101, P2507, DOI 10.1002/jbm.a.34549
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   Chuang SY, 2007, CLIN BIOMECH, V22, P14, DOI 10.1016/j.clinbiomech.2006.08.001
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048
   Fessel G, 2012, J ORTHOP RES, V30, P973, DOI 10.1002/jor.22014
   Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002
   Gindre J, 2013, J MECH BEHAV BIOMED, V22, P84, DOI 10.1016/j.jmbbm.2013.02.007
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460
   HARADA M, 1974, YAKUGAKU ZASSHI, V94, P157, DOI 10.1248/yakushi1947.94.2_157
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN, V1, P1
   O'Sullivan C. B., 2007, Clinical Techniques in Equine Practice, V6, P189, DOI 10.1053/j.ctep.2007.08.005
   Powers D L, 1988, J Invest Surg, V1, P249, DOI 10.3109/08941938809141090
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wilgenbusch C, 2014, VET COMP ORTHOPAED, V27, P113, DOI 10.3415/VCOT-13-08-0101
   Wisnewski P J, 1988, J Invest Surg, V1, P259, DOI 10.3109/08941938809141091
   Young B, 2014, WHEATERS FUNCTIONAL
NR 27
TC 3
Z9 3
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0005-0423
EI 1751-0813
J9 AUST VET J
JI Aust. Vet. J.
PD MAY
PY 2017
VL 95
IS 5
BP 167
EP 173
DI 10.1111/avj.12583
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA ET3GA
UT WOS:000400164500020
PM 28444753
DA 2018-10-20
ER

PT J
AU Lorenz, J
   Blume, M
   Barbeck, M
   Teiler, A
   Kirkpatrick, CJ
   Sader, RA
   Ghanaati, S
AF Lorenz, Jonas
   Blume, Maximilian
   Barbeck, Mike
   Teiler, Anna
   Kirkpatrick, C. James
   Sader, Robert A.
   Ghanaati, Shahram
TI Expansion of the peri-implant attached gingiva with a three-dimensional
   collagen matrix in head and neck cancer patients-results from a
   prospective clinical and histological study
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Attached gingiva; Collagen matrix; Dental implants; Peri-implant soft
   tissue; Mucograft (R)
ID OUTGROWTH ENDOTHELIAL-CELLS; SOFT-TISSUE AUGMENTATION; KERATINIZED
   TISSUE; CONNECTIVE-TISSUE; DENTAL IMPLANTS; TRIAL; VASCULARIZATION;
   GRAFTS; MUCOSA; REGENERATION
AB Attached peri-implant gingiva has proven to have an influence on the long-term stability of dental implants. In patients with head and neck cancer, a functional peri-implant gingiva is even more of critical importance. The aim of the presented prospective study was to investigate a three-dimensional xenogeneic collagen matrix for augmentation around dental implants in patients with former head and neck cancer.
   Eight patients presenting with insufficient peri-implant gingiva underwent vestibuloplasty on 51 implants using a xenogeneic collagen matrix. The clinical performance and the shrinking tendency of the matrix were analyzed in a cohort study. Furthermore, eight biopsies from the augmented regions were examined histologically to determine the biomaterial-related tissue reaction.
   Initially after vestibuloplasty, a mean width of attached gingiva of 4.4 +/- 0.94 mm could be achieved. At clinical follow up investigation 6 months after vestibuloplasty, a mean width of 3.9 +/- 0.65 mm attached peri-implant gingiva with a mean shrinking tendency of 14 % could be detected. Histological analysis of the biopsies revealed a well integrated collagen22 matrix covered with epithelium. Within the compact layer, mononuclear cells were observed only, while the spongious layer was infiltrated with a cell-rich connective tissue.
   Within its limits, the presented study revealed that the investigated collagen matrix is suitable to enlarge the peri-implant attached gingiva in head and neck cancer patients without adverse reactions or a multinucleated giant cell-triggered tissue reaction.
   The application of the investigated three-dimensional collagen matrix in vestibuloplasty achieved a sufficient amount of peri-implant attached gingiva in head and neck cancer patients. The favorable tissue reaction and the low shrinking tendency make the collagen matrix a promising alternative to autologous tissue grafts.
C1 [Lorenz, Jonas; Blume, Maximilian; Barbeck, Mike; Teiler, Anna; Kirkpatrick, C. James; Sader, Robert A.; Ghanaati, Shahram] Goethe Univ Frankfurt, Clin Maxillofacial & Plast Surg, Frankfurt Oral Regenerat Med, FORM, Frankfurt, Germany.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Clin Maxillofacial & Plast Surg, Frankfurt Oral Regenerat Med, FORM, Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
FU Clinic for Maxillofacial and Plastic Surgery, Johann Wolfgang Goethe
   University in Frankfurt Am Main, Germany
FX The work was supported by the Clinic for Maxillofacial and Plastic
   Surgery, Johann Wolfgang Goethe University in Frankfurt Am Main,
   Germany.
CR Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12
   Askin SB, 2015, CLIN IMPLANT DENT R, V17, P1, DOI 10.1111/cid.12079
   Barbeck M, 2014, J ORAL IMPLANTOL
   Barbeck M, 2014, J ORAL IMPLANTOL
   Basegmez C, 2013, EUR J ORAL IMPLANTOL, V6, P145
   Brito C, 2014, J BIOMED MATER RES B, V102, P643, DOI 10.1002/jbm.b.33042
   Cardaropoli D, 2012, J PERIODONTOL, V83, P321, DOI 10.1902/jop.2011.110215
   De Santis D, 2012, J CRANIOFAC SURG, V23, pE186, DOI 10.1097/SCS.0b013e31824de62c
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Ghanaati S, 2015, J CELL COMMUN
   Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   Herford AS, 2015, J ORAL IMPLANTOL, V41, P196, DOI 10.1563/AAID-JOI-D-12-00218
   Herford AS, 2010, J ORAL MAXIL SURG, V68, P1463, DOI 10.1016/j.joms.2010.02.054
   Javed F, 2010, ORAL ONCOL, V46, P854, DOI 10.1016/j.oraloncology.2010.10.004
   Lee Kang-Ho, 2010, J Periodontal Implant Sci, V40, P96, DOI 10.5051/jpis.2010.40.2.96
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   Lorenz J, 2015, J ORAL IMPLANTOL, V41, pE257, DOI [10.1563/aaid-joi-D-14-00273, 10.1563/AAID-JOI-D-14-00273]
   McGuire MK, 2014, J PERIODONTOL, V85, P1333, DOI 10.1902/jop.2014.130692
   Mohammadi Mohammad, 2011, Acta Med Iran, V49, P319
   Nevins M, 2011, INT J PERIODONT REST, V31, P367
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   PARK SH, 2012, INT J PERIODONT REST, V32, P116
   Reddy VK, 2013, CONTEMP CLIN DENT, V4, P319, DOI 10.4103/0976-237X.118378
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schmitt CM, 2013, J PERIODONTOL, V84, P914, DOI 10.1902/jop.2012.120084
   Schmitt CM, 2015, CLIN ORAL IMPLANTS R
   Simion M, 2012, INT J PERIODONT REST, V32, P273
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x
   Urban IA, 2015, INT J PERIODONT REST, V35, P345, DOI 10.11607/prd.2287
   Zucchelli G, 2010, J CLIN PERIODONTOL, V37, P728, DOI 10.1111/j.1600-051X.2010.01550.x
NR 34
TC 1
Z9 1
U1 2
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAY
PY 2017
VL 21
IS 4
BP 1103
EP 1111
DI 10.1007/s00784-016-1868-2
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ES9OL
UT WOS:000399888600017
PM 27306889
DA 2018-10-20
ER

PT J
AU Kang-Mieler, JJ
   Dosmar, E
   Liu, WQ
   Mieler, WF
AF Kang-Mieler, Jennifer J.
   Dosmar, Emily
   Liu, Wenqiang
   Mieler, William F.
TI Extended ocular drug delivery systems for the anterior and posterior
   segments: biomaterial options and applications
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE Anterior segment delivery; drug delivery; eye; hydrogels; liposomes;
   microspheres; nanospheres; PLGA; posterior segment delivery
ID MICROSPHERE/HYDROGEL COMBINATION SYSTEM; SUBFOVEAL CHOROIDAL
   NEOVASCULARIZATION; CHITIN/PLGA BLEND MICROSPHERES; HYDROGEL
   CONTACT-LENSES; PROTEIN DELIVERY; CONTROLLED-RELEASE; IN-VIVO;
   THERMORESPONSIVE HYDROGELS; BIOMEDICAL APPLICATIONS; INTRAVITREAL
   INJECTION
AB Introduction: The development of new therapies for treating various eye conditions has led to a demand for extended release delivery systems, which would lessen the need for frequent application while still achieving therapeutic drug levels in the target tissues.
   Areas covered: Following an overview of the different ocular drug delivery modalities, this article surveys the biomaterials used to develop sustained release drug delivery systems. Microspheres, nanospheres, liposomes, hydrogels, and composite systems are discussed in terms of their primary materials. The advantages and disadvantages of each drug delivery system are discussed for various applications. Recommendations for modifications and strategies for improvements to these basic systems are also discussed.
   Expert opinion: An ideal sustained release drug delivery system should be able to encapsulate and deliver the necessary drug to the target tissues at a therapeutic level without any detriment to the drug. Drug encapsulation should be as high as possible to minimize loss and unless it is specifically desired, the initial burst of drug release should be kept to a minimum. By modifying various biomaterials, it is possible to achieve sustained drug delivery to both the anterior and posterior segments of the eye.
C1 [Kang-Mieler, Jennifer J.; Dosmar, Emily; Liu, Wenqiang] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Mieler, William F.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.
RP Kang-Mieler, JJ (reprint author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
EM kang-mieler@iit.edu
CR Agrawal AK, 2012, EXPERT OPIN DRUG DEL, V9, P383, DOI 10.1517/17425247.2012.665367
   AHMED I, 1985, INVEST OPHTH VIS SCI, V26, P584
   Ali M, 2009, PHARM RES-DORDR, V26, P714, DOI 10.1007/s11095-008-9818-6
   Allison SD, 2007, J INFUS MURS, V30, P89, DOI 10.1097/01.NAN.0000264712.26219.67
   ALLISON SD, 2007, J INFUS NURS, V30, P120
   Alvarez-Lorenzo C, 2004, J CHROMATOGR B, V804, P231, DOI 10.1016/j.jchromb.2003.12.032
   Alvarez-Lorenzo C, 2006, J CONTROL RELEASE, V113, P236, DOI 10.1016/j.jconrel.2006.05.003
   Balasubramaniam J, 2003, DRUG DELIV, V10, P185, DOI 10.1080/10717540390215609
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI [10.1517/17425247.5.5.567 , 10.1517/17425240802095061]
   Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198
   Brandt JD, 2016, OPHTHALMOLOGY, V123, P1685, DOI 10.1016/j.ophtha.2016.04.026
   Bressler NM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1443
   Bucolo C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00188
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Clearside Biomedical Inc, SAF STUD SUPR TRIAMC
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9
   Davis BM, 2014, SMALL, V10, P1575, DOI 10.1002/smll.201303433
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Drapala PW, 2014, PHARM RES-DORDR, V31, P742, DOI 10.1007/s11095-013-1195-0
   Drapala PW, 2011, J BIOMAT SCI-POLYM E, V22, P59, DOI 10.1163/092050609X12578498952315
   Eljarrat-Binstock E, 2006, J CONTROL RELEASE, V110, P479, DOI 10.1016/j.jconrel.2005.09.049
   Fenton C, 2006, DRUG AGING, V23, P421, DOI 10.2165/00002512-200623050-00006
   Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3
   Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Geroski DH, 2001, ADV DRUG DELIVER REV, V52, P37, DOI 10.1016/S0169-409X(01)00193-4
   Ghassemi AH, 2010, PHARM RES-DORDR, V27, P2008, DOI 10.1007/s11095-010-0205-8
   Guthrie MJ, 2014, MICROVASC RES, V91, P1, DOI 10.1016/j.mvr.2013.11.005
   Hammer N, 2015, MACROMOL BIOSCI, V15, P405, DOI 10.1002/mabi.201400379
   Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1
   Hiratani H, 2005, BIOMATERIALS, V26, P1293, DOI 10.1016/j.biomaterials.2004.04.030
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hu CC, 2014, BIO-MED MATER ENG, V24, P1941, DOI 10.3233/BME-141003
   Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004
   Hughes PM, 2011, U. S. Patent, Patent No. [US20100278898 A1, 20100278898]
   Janssen Research & Development LLC, SAF STUD CNTO 2476 P
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Kang Derwent Jennifer J, 2008, Trans Am Ophthalmol Soc, V106, P206
   Kang-Mieler JJ, 2016, DEV OPHTHALMOL, V55, P104, DOI 10.1159/000434694
   Kang-Mieler JJ, 2014, EXPERT OPIN DRUG DEL, V11, P1647, DOI 10.1517/17425247.2014.935338
   Kang-Mieler JJ, 2011, DRUG DELIVERY POSTER
   Kanjickal D, 2008, J BIOMED MATER RES A, V87A, P608, DOI 10.1002/jbm.a.31811
   Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105
   Kaur IP, 2004, INT J PHARM, V269, P1, DOI 10.1016/j.ijpharm.2003.09.016
   Keles H, 2015, POLYM DEGRAD STABIL, V119, P228, DOI 10.1016/j.polymdegradstab.2015.04.025
   Kirchhof S, 2015, EUR J PHARM BIOPHARM, V95, P227, DOI 10.1016/j.ejpb.2015.05.016
   Klouda L, 2015, EUR J PHARM BIOPHARM, V97, P338, DOI 10.1016/j.ejpb.2015.05.017
   Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305
   Lajavardi L, 2009, J CONTROL RELEASE, V139, P22, DOI 10.1016/j.jconrel.2009.05.033
   Lane SS, 2008, J CATARACT REFR SURG, V34, P1451, DOI 10.1016/j.jcrs.2008.05.034
   Lee J, 2010, PHARM RES-DORDR, V27, P767, DOI 10.1007/s11095-010-0067-0
   Lee J, 2009, MACROMOL BIOSCI, V9, P671, DOI 10.1002/mabi.200800317
   Lee J, 2009, J CONTROL RELEASE, V137, P196, DOI 10.1016/j.jconrel.2009.04.008
   Lee JY, 2012, TISSUE ENG REGEN MED, V9, P249, DOI 10.1007/s13770-012-0355-3
   Lee V H, 1986, J Ocul Pharmacol, V2, P67, DOI 10.1089/jop.1986.2.67
   Lewis RA, 2007, J CATARACT REFR SURG, V33, P1217, DOI 10.1016/j.jcrs.2007.03.051
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Liu Y, 2013, TISSUE ENG PT A, V19, P135, DOI [10.1089/ten.tea.2012.0209, 10.1089/ten.TEA.2012.0209]
   Liu ZD, 2006, INT J PHARM, V315, P12, DOI 10.1016/j.ijpharm.2006.01.029
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Malaekeh-Nikouei B, 2013, CURR DRUG DELIV, V10, P279
   Mamalis N, 2006, J CATARACT REFR SURG, V32, P324, DOI 10.1016/j.jcrs.2006.01.065
   Manoharan C, 2009, J PHARM SCI-US, V98, P529, DOI 10.1002/jps.21445
   Maulvi FA, 2016, J CONTROL RELEASE, V226, P47, DOI 10.1016/j.jconrel.2016.02.012
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Montan PG, 2002, J CATARACT REFR SURG, V28, P977, DOI 10.1016/S0886-3350(01)01269-X
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   MORITERA T, 1991, INVEST OPHTH VIS SCI, V32, P1785
   Musumeci T, 2013, INT J PHARMACEUT, V440, P135, DOI 10.1016/j.ijpharm.2012.10.014
   Myles ME, 2005, ADV DRUG DELIVER REV, V57, P2063, DOI 10.1016/j.addr.2005.08.006d
   Natarajan JV, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S25468
   Navratil T, 2015, ARVO ABSTRACT POSTER
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Olsen TW, 2006, AM J OPHTHALMOL, V142, P777, DOI 10.1016/j.ajo.2006.05.045
   Olsen TW, 2011, INVEST OPHTH VIS SCI, V52, P4749, DOI 10.1167/iovs.10-6291
   Osswald CR, 2015, ANN BIOMED ENG, V43, P2609, DOI 10.1007/s10439-015-1314-7
   Osswald CR, 2016, CURR EYE RES, P1
   Paradiso P, 2014, J BIOMED MATER RES B, V102, P1170, DOI 10.1002/jbm.b.33099
   Patel SR, 2011, PHARM RES-DORDR, V28, P166, DOI 10.1007/s11095-010-0271-y
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peyman GA, 2009, RETINA-J RET VIT DIS, V29, P875, DOI 10.1097/IAE.0b013e3181a94f01
   Rauck BM, 2014, INVEST OPHTH VIS SCI, V55, P469, DOI 10.1167/iovs.13-13120
   Refractive S, 2007, J CATARACT REFR SURG, V33, P978, DOI [10.1016/j.jcrs.2007.02.032, DOI 10.1016/J.JCRS.2007.02.032]
   Ribeiro A, 2011, BIOMACROMOLECULES, V12, P701, DOI 10.1021/bm101562v
   Rieke ER, 2010, J OCUL PHARMACOL TH, V26, P55, DOI 10.1089/jop.2009.0059
   Rizzo S, 2012, RETINA-J RET VIT DIS, V32, P776, DOI 10.1097/IAE.0b013e3182278b0e
   ROZIER A, 1989, INT J PHARM, V57, P163, DOI 10.1016/0378-5173(89)90305-0
   SANZGIRI YD, 1993, J CONTROL RELEASE, V26, P195, DOI 10.1016/0168-3659(93)90186-9
   Schultz C, 2011, CLIN EXP OPTOM, V94, P212, DOI 10.1111/j.1444-0938.2010.00553.x
   Shin SH, 2013, J CONTROL RELEASE, V166, P38, DOI 10.1016/j.jconrel.2012.12.020
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Simoes SMN, 2012, EUR J PHARM BIOPHARM, V80, P103, DOI 10.1016/j.ejpb.2011.09.017
   Sultana Y, 2006, DRUG DELIV, V13, P215, DOI 10.1080/10717540500309164
   Tao Weng, 2006, Expert Opin Biol Ther, V6, P717, DOI 10.1517/14712598.6.7.717
   Tetz M, 2012, OPHTHALMOLOGICA, V227, P183, DOI 10.1159/000336045
   Turturro SB, 2011, BIOMATERIALS, V32, P3620, DOI 10.1016/j.biomaterials.2011.01.058
   Yang L, 2007, INT J PHARM, V340, P163, DOI 10.1016/j.ijpharm.2007.03.028
   Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037
   Zhai P, 2015, MAT SCI ENG C-MATER, V56, P251, DOI 10.1016/j.msec.2015.06.015
   Zheng CH, 2010, DRUG DELIV, V17, P77, DOI 10.3109/10717540903509001
   Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007
   ZIGNANI M, 1995, ADV DRUG DELIVER REV, V16, P51, DOI 10.1016/0169-409X(95)00015-Y
NR 108
TC 7
Z9 8
U1 9
U2 40
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2017
VL 14
IS 5
BP 611
EP 620
DI 10.1080/17425247.2016.1227785
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ES7SK
UT WOS:000399750800004
PM 27551742
DA 2018-10-20
ER

PT J
AU Picchio, ML
   Minari, RJ
   Gugliotta, LM
AF Picchio, Matias L.
   Minari, Roque J.
   Gugliotta, Luis M.
TI Enhancing the coating properties of acrylic/casein latexes with high
   protein content
SO JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH
LA English
DT Article
DE Acrylic/casein latexes; Methacrylated casein; High protein
   incorporation; Water-based binders
ID GRAFT-COPOLYMERIZATION; METHYL-METHACRYLATE; SPECTROPHOTOMETRIC ASSAY;
   ORTHO-PHTHALDIALDEHYDE; CASEIN; FILMS; NANOCOMPOSITE; BARRIER
AB Casein-derived materials are highly attractive as a consequence of their environmental friendliness and excellent film-forming properties. Due to the casein hydrophilicity, films containing a large protein content are highly susceptible to water, thus limiting their use in coating applications. A novel approach for synthesizing waterborne acrylic-casein latexes with large content of protein and high degree of compatibilization between both components is presented. The employed synthesis strategy involves the use of a highly methacrylated casein in an emulsifier-free emulsion polymerization of acrylic monomers with the aim of controlling both the fraction of grafted biomaterial and the amount of acrylic chains linked onto the protein backbone. The performance of the resulting materials was evaluated in a water-based coating application. The used methacrylation approach allowed the maximum compatibilization of 33% of casein in the hybrid polymer. The as-obtained casein-derived films were proven to exhibit superior water resistance, which would open a new possibility for designing biobased coatings in several fields.
C1 [Picchio, Matias L.; Minari, Roque J.; Gugliotta, Luis M.] INTEC Univ Nacl Litoral CONICET, Grp Polymers & Polymerizat Reactors, Guemes 3450, RA-3000 Santa Fe, Argentina.
   [Picchio, Matias L.] Univ Tecnol Nacl, Fac Reg Villa Maria, Ave Univ 450, RA-5900 Villa Maria, Argentina.
   [Minari, Roque J.; Gugliotta, Luis M.] Univ Nacl Litoral, Fac Ingn Quim, Santiago Estero 2829, RA-3000 Santa Fe, Argentina.
RP Gugliotta, LM (reprint author), INTEC Univ Nacl Litoral CONICET, Grp Polymers & Polymerizat Reactors, Guemes 3450, RA-3000 Santa Fe, Argentina.
EM lgug@intec.unl.edu.ar
OI Minari, Roque/0000-0003-3645-5317
FU CONICET (Argentina); ANPCyT (Argentina); Santa Fe State (Argentina);
   Educational Ministry (Argentina)
FX The financial support received from CONICET, ANPCyT, the Secretary of
   Science, Technology and Research of Santa Fe State, and the Secretary of
   University Policies from the Educational Ministry (all of Argentina) is
   gratefully acknowledged. We also acknowledge Prof. Maria Jesus
   Barandiaran (University of the Basque Country) for her help with the
   open time and TEM characterizations.
CR Brun A, 2008, PROG ORG COAT, V61, P181, DOI 10.1016/j.porgcoat.2007.09.041
   Chen H, 2002, PROTEIN-BASED FILMS AND COATINGS, P181
   Eckersley ST, 1997, J COATING TECHNOL, V69, P97, DOI 10.1007/BF02696096
   Fan QQ, 2015, COLLOID SURFACE B, V128, P181, DOI 10.1016/j.colsurfb.2015.02.033
   Gaudin JC, 2009, BIOTECHNOL ADV, V27, P1124, DOI 10.1016/j.biotechadv.2009.05.011
   Gurney RS, 2012, ACS APPL MATER INTER, V4, P5442, DOI 10.1021/am3013642
   Irissin-Mangata J, 2001, EUR POLYM J, V37, P1533, DOI 10.1016/S0014-3057(01)00039-8
   Kiil S, 2006, PROG ORG COAT, V57, P236, DOI 10.1016/j.porgcoat.2006.09.003
   LAUER BH, 1977, CAN J ZOOL, V55, P231, DOI 10.1139/z77-026
   Li P, 2000, MACROMOL SYMP, V151, P605, DOI 10.1002/1521-3900(200002)151:1<605::AID-MASY605>3.0.CO;2-4
   Li P, 2002, LANGMUIR, V18, P8641, DOI 10.1021/la0261343
   Liu YH, 2004, J MACROMOL SCI PURE, VA41, P305, DOI 10.1081/MA-120028209
   Liu YH, 2002, EUR POLYM J, V38, P1619, DOI 10.1016/S0014-3057(02)00035-6
   Ma JZ, 2013, PROG ORG COAT, V76, P1346, DOI 10.1016/j.porgcoat.2013.04.006
   Maldonado-Valderrama J, 2009, STRUCTURE FUNCTIONAL, P219
   Mali S, 2004, CARBOHYD POLYM, V56, P129, DOI 10.1016/j.carbpol.2004.01.004
   Monedero FM, 2009, J FOOD ENG, V91, P509, DOI 10.1016/j.jfoodeng.2008.09.034
   McMahon DJ, 2008, J DAIRY SCI, V91, P1709, DOI 10.3168/jds.2007-0819
   MOHAN D, 1985, J MACROMOL SCI CHEM, VA22, P75, DOI 10.1080/00222338508063298
   MOHAN D, 1990, J APPL POLYM SCI, V39, P1507, DOI 10.1002/app.1990.070390709
   Overbeek A, 2003, PROG ORG COAT, V48, P125, DOI 10.1016/S0300-9440(03)00101-2
   Picchio ML, 2015, PROG ORG COAT, V88, P8, DOI 10.1016/j.porgcoat.2015.06.012
   Picchio ML, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42421
   Picchio ML, 2014, MACROMOL SYMP, V344, P76, DOI 10.1002/masy.201400013
   Qiang XH, 2014, J COAT TECHNOL RES, V11, P923, DOI 10.1007/s11998-014-9599-2
   Shaik A, 2014, J COAT TECHNOL RES, V11, P397, DOI 10.1007/s11998-013-9548-5
   SHECHTER L, 1956, IND ENG CHEM, V48, P94, DOI 10.1021/ie50553a029
   Siyab N, 2016, J COAT TECHNOL RES, V13, P629, DOI 10.1007/s11998-015-9766-0
   SVEDAS VJK, 1980, ANAL BIOCHEM, V101, P188, DOI 10.1016/0003-2697(80)90059-7
   VIGO MS, 1992, FOOD CHEM, V44, P363, DOI 10.1016/0308-8146(92)90269-8
   Xu QN, 2016, PROG ORG COAT, V99, P223, DOI 10.1016/j.porgcoat.2016.05.024
   Xu QN, 2015, PROG ORG COAT, V88, P1, DOI 10.1016/j.porgcoat.2015.06.011
   Xu QN, 2013, CHEM ENG J, V228, P281, DOI 10.1016/j.cej.2013.04.079
   Zhang F, 2016, ACS APPL MATER INTER, V8, P11739, DOI 10.1021/acsami.6b00611
   Zhu JM, 2003, J POLYM SCI POL CHEM, V41, P3346, DOI 10.1002/pola.10920
NR 35
TC 1
Z9 1
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1945-9645
EI 1935-3804
J9 J COAT TECHNOL RES
JI J. Coat. Technol. Res.
PD MAY
PY 2017
VL 14
IS 3
BP 543
EP 553
DI 10.1007/s11998-016-9877-2
PG 11
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA ES8RY
UT WOS:000399825800005
DA 2018-10-20
ER

PT J
AU Onggo, D
   Mulyani, I
   Valverde-Munoz, FJ
   Real, JA
   Molnar, G
AF Onggo, Djulia
   Mulyani, Irma
   Javier Valverde-Munoz, Francisco
   Antonio Real, Jose
   Molnar, Gabor
TI Bistable thermo-chromic and magnetic spin crossover microcrystals
   embedded in nata de coco bacterial cellulose biofilm
SO CELLULOSE
LA English
DT Article
DE Bacterial cellulose; Iron(II) complex; Spin crossover; Composite
   material; Environmental responsive materials
ID LANGMUIR-BLODGETT-FILMS; THERMAL HYSTERESIS; POLYMERIC MATERIAL;
   ROOM-TEMPERATURE; TRANSITION; COMPLEXES; NANOPARTICLES; PERFORMANCE;
   ELECTRONICS; NANOFIBRILS
AB Bacterial cellulose (BC) is a unique biomaterial with interesting physico-chemical properties and potential technological applications (i.e. removal of heavy metals from wastewater, manufacturing electrical and electronic devices, papermaking and biomedical technologies among others). In this work, we describe the growth of well formed micro-crystals of the one-dimensional spin crossover (SCO) compound {[Fe(Htrz)(2)(trz)](BF4)}(n) in a matrix of BC. The thermal dependence of the magnetic, optical, calorimetric and vibrational properties associated with the SCO properties of the resulting composite material have been investigated and compare well with those of the bulk SCO. The SCO-BC composite films display reversible thermomagnetic (diamagnetic <-> paramagnetic) and thermochromic bistability (purple <-> pale-yellow) determined by a well-defined hysteresis in the temperature range ca. 345-380 K where these properties depend on the history of the sample (memory effect).
C1 [Onggo, Djulia; Mulyani, Irma] Inst Teknol Bandung, Fac Math & Nat Sci, Inorgan & Phys Chem Res Grp, Jl Ganesha 10, Bandung 40132, Indonesia.
   [Javier Valverde-Munoz, Francisco; Antonio Real, Jose] Univ Valencia, Inst Ciencia Mol ICMol, C Catedrat Jose Beltran Martinez 2, Valencia 46980, Spain.
   [Molnar, Gabor] CNRS, LCC, 205 Route Narbonne, F-31077 Toulouse, France.
   [Molnar, Gabor] Univ Toulouse, UPS, INP, 205 Route Narbonne, F-31077 Toulouse, France.
RP Onggo, D (reprint author), Inst Teknol Bandung, Fac Math & Nat Sci, Inorgan & Phys Chem Res Grp, Jl Ganesha 10, Bandung 40132, Indonesia.; Real, JA (reprint author), Univ Valencia, Inst Ciencia Mol ICMol, C Catedrat Jose Beltran Martinez 2, Valencia 46980, Spain.
EM djulia@chem.itb.ac.id; jose.a.real@uv.es
RI Molnar, Gabor/Q-6874-2016
OI Molnar, Gabor/0000-0001-6032-6393
FU ITB [254/I.1.C01/PL/2011]; FEDER funds [CTQ2013-46275-P,
   CTQ2016-78341-P]; MINECO
FX D.O. wish to express special thanks to Prof. H. A. Goodwin for giving
   inspiration in exploring SCO and for Research funding ITB No.
   254/I.1.C01/PL/2011. J.A.R. thanks the Spanish Ministerio de Economia y
   Competitividad (MINECO) and FEDER funds (CTQ2013-46275-P and
   CTQ2016-78341-P and Unidad de Excelencia Maria de Maeztu (MDM-2015-0538)
   and Generalitat Valenciana (PROMETEO/2016/147). F.J.V.M. thanks the
   MINECO for a predoctoral FPI fellowship.
CR ARMAND F, 1995, LANGMUIR, V11, P3467, DOI 10.1021/la00009a032
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Chen Y, 2010, CHEM COMMUN, V46, P5073, DOI 10.1039/b927191k
   Dirtu MM, 2010, INORG CHEM, V49, P5723, DOI 10.1021/ic100667f
   Garcia J, 2004, TOP CURR CHEM, V233, P229
   Grondin P, 2010, LANGMUIR, V26, P5184, DOI 10.1021/la903653d
   Grosjean A, 2013, EUR J INORG CHEM, P796, DOI 10.1002/ejic.201201121
   Grosjean A, 2011, CHEM COMMUN, V47, P12382, DOI 10.1039/c1cc14220h
   Guillaume F, 2014, CHEM PHYS LETT, V604, P105, DOI 10.1016/j.cplett.2014.04.024
   Gutlich P., 2004, TOPICS CURRENT CHEM
   Hayami S, 2009, POLYHEDRON, V28, P1722, DOI 10.1016/j.poly.2008.10.059
   Kahn O, 1998, SCIENCE, V279, P44, DOI 10.1126/science.279.5347.44
   KROBER J, 1994, CHEM MATER, V6, P1404
   KROBER J, 1993, J AM CHEM SOC, V115, P9810, DOI 10.1021/ja00074a062
   Kuroiwa K, 2010, CHEM LETT, V39, P790, DOI 10.1246/cl.2010.790
   Kuroiwa K, 2010, CHEM COMMUN, V46, P1229, DOI 10.1039/b920631k
   Lee SW, 2004, SYNTHETIC MET, V142, P243, DOI 10.1016/j.synthmet.2003.09.011
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Moussa NO, 2009, CHEM PHYS LETT, V477, P156, DOI 10.1016/j.cplett.2009.06.065
   Nagy V, 2015, J MATER CHEM C, V3, P7897, DOI 10.1039/c5tc01246e
   Nagy V, 2014, COLLOID SURFACE A, V456, P35, DOI 10.1016/j.colsurfa.2014.05.007
   Naik AD, 2010, SMALL, V6, P2842, DOI 10.1002/smll.201001527
   Nakamoto A, 2003, CHEM LETT, V32, P336, DOI 10.1246/cl.2003.336
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Onggo D, 2011, 23 INT C COORD BIOIN
   Putri O, 2013, THESIS
   Quintero CM, 2012, J MATER CHEM, V22, P3745, DOI 10.1039/c2jm15662h
   Radiman C, 2008, POLYM INT, V57, P502, DOI 10.1002/pi.2374
   Rat S, 2016, CHEM COMMUN, V52, P11267, DOI 10.1039/c6cc06137k
   Roubeau O, 2007, LANGMUIR, V23, P3110, DOI 10.1021/la062207x
   Roubeau O, 2012, CHEM-EUR J, V18, P15230, DOI 10.1002/chem.201201647
   Rubio M, 2011, EUR POLYM J, V47, P52, DOI 10.1016/j.eurpolymj.2010.10.029
   Smit E, 2001, J RAMAN SPECTROSC, V32, P339, DOI 10.1002/jrs.696
   Thibault C, 2010, LANGMUIR, V26, P1557, DOI 10.1021/la904162m
   Tobon YA, 2012, EUR J INORG CHEM, P5837, DOI 10.1002/ejic.201200562
   Urakawa A, 2011, J PHYS CHEM C, V115, P1323, DOI 10.1021/jp107206n
   Walther A, 2011, ADV MATER, V23, P2924, DOI 10.1002/adma.201100580
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Zeng ML, 2014, CELLULOSE, V21, P4455, DOI 10.1007/s10570-014-0408-y
   Zhu HL, 2016, CHEM REV, V116, P9305, DOI 10.1021/acs.chemrev.6b00225
NR 41
TC 2
Z9 2
U1 3
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD MAY
PY 2017
VL 24
IS 5
BP 2205
EP 2213
DI 10.1007/s10570-017-1248-3
PG 9
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA ES0RF
UT WOS:000399233400022
DA 2018-10-20
ER

PT J
AU Willems, N
   Mihov, G
   Grinwis, GCM
   van Dijk, M
   Schumann, D
   Bos, C
   Strijkers, GJ
   Dhert, WJA
   Meij, BP
   Creemers, LB
   Tryfonidou, MA
AF Willems, Nicole
   Mihov, George
   Grinwis, Guy C. M.
   van Dijk, Maarten
   Schumann, Detlef
   Bos, Clemens
   Strijkers, Gustav J.
   Dhert, Wouter J. A.
   Meij, Bjorn P.
   Creemers, Laura B.
   Tryfonidou, Marianna A.
TI Safety of intradiscal injection and biocompatibility of polyester amide
   microspheres in a canine model predisposed to intervertebral disc
   degeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE dog; biomaterial; microspheres; nucleus pulposus; intradiscal delivery
ID CONTROLLED DRUG-DELIVERY; POLY(ESTER AMIDE)S; BIOMEDICAL APPLICATIONS;
   CAVEOLIN-1 EXPRESSION; AMINO-ACID; PUNCTURE; INJURY; REGENERATION;
   HYDROGEL; POLYMERS
AB Repair of degenerated intervertebral discs (IVD) might be established via intradiscal delivery of biologic therapies. Polyester amide polymers (PEA) were evaluated for in vitro cytotoxicity and in vivo biocompatibility, and thereafter intradiscal application of PEA microspheres (PEAMs) in a canine model predisposed to IVD degeneration at long-term (6 months) follow-up. PEA extracts did not induce cytotoxicity in mouse fibroblast cells (microscopy and XTT assay), while a slight foreign body reaction was demonstrated by histopathology after intramuscular implantation in rabbits. Intradiscal injection of a volume of 40 mu L through 26 and 27G needles induced no degenerative changes in acanine model susceptible to IVD disease. Although sham-injected IVDs showed increased CAV1 expression compared with noninjected IVDs, which may indicate increased cell senescence, these findings were not supported by immunohistochemistry, biomolecular analysis of genes related to apoptosis, biochemical and histopathological results. PEAM-injected IVDs showed significantly higher BAX/BCL2 ratio vs sham-injected IVDs suggestive of an anti-apoptotic effect of the PEAMs. These findings were not supported by other analyses (clinical signs, disc height index, T2 values, biomolecular and biochemical analyses, and IVD histopathology). PEAs showed a good cytocompatibility and biocompatibility. PEAMs are considered safe sustained release systems for intradiscal delivery of biological treatments. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 707-714, 2017.
C1 [Willems, Nicole; Dhert, Wouter J. A.; Meij, Bjorn P.; Tryfonidou, Marianna A.] Fac Vet Med Utrecht, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands.
   [Mihov, George; van Dijk, Maarten; Schumann, Detlef] DSM Biomed Mat BV, R&D Orthoped, NL-6167 RA Geleen, Netherlands.
   [Grinwis, Guy C. M.] Fac Vet Med Utrecht, Dept Pathobiol, NL-3508 TD Utrecht, Netherlands.
   [Bos, Clemens] Univ Med Ctr, Imaging Div, NL-3584 CX Utrecht, Netherlands.
   [Strijkers, Gustav J.] AMC, Biomed Engn & Phys, NL-1100 DE Amsterdam, Netherlands.
   [Dhert, Wouter J. A.; Creemers, Laura B.] Univ Med Ctr, Dept Orthopaed, NL-3584 CX Utrecht, Netherlands.
RP Tryfonidou, MA (reprint author), Fac Vet Med Utrecht, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands.
EM m.a.tryfonidou@uu.nl
OI Creemers, Laura/0000-0002-1585-3052
FU BioMedical Materials institute [P2.01 IDiDAS]; Dutch Ministry of
   Economic Affairs, Agriculture and Innovation; Dutch Arthritis Foundation
FX This research forms part of the Project P2.01 IDiDAS of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs, Agriculture and Innovation. The financial
   contribution of the Dutch Arthritis Foundation is gratefully
   acknowledged (IDiDAS, LLP22 and LLP12). We would like to acknowledge
   Toxikon Corporation (Bedford, MA, USA) for performing the
   cytocompatibility tests in vitro, and the biocompatibility tests in
   vivo. Furthermore we would like to express our sincere appreciation to
   Saskia Plomp and Jeannette Wolfswinkel for their assistance in the
   laboratory.
CR Andres-Guerrero V, 2015, J CONTROL RELEASE, V211, P105, DOI 10.1016/j.jconrel.2015.05.279
   [Anonymous], 2009, 1099352009 ISO
   Bergknut N, 2013, VET J, V195, P156, DOI 10.1016/j.tvjl.2012.05.027
   Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665
   DeFife KM, 2009, J BIOMAT SCI-POLYM E, V20, P1495, DOI 10.1163/092050609X12464344572881
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Ghaffar A, 2011, BIOMACROMOLECULES, V12, P3243, DOI 10.1021/bm200709r
   Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290
   Guo K, 2009, J BIOMED MATER RES B, V89B, P491, DOI 10.1002/jbm.b.31239
   Heathfield SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2468
   Ho G, 2008, CONNECT TISSUE RES, V49, P15, DOI 10.1080/03008200701818595
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   Kranenburg HJC, 2013, VET J, V195, P164, DOI 10.1016/j.tvjl.2012.06.001
   Kranenburg HJC, 2012, J BIOMED MATER RES B, V100B, P2148, DOI 10.1002/jbm.b.32780
   KRISTENSEN HK, 1948, STAIN TECHNOL, V23, P151, DOI 10.3109/10520294809106242
   Kropp M, 2014, POLYMERS-BASEL, V6, P243, DOI 10.3390/polym6010243
   Lee SH, 2002, CORONARY ARTERY DIS, V13, P237, DOI 10.1097/00019501-200206000-00006
   Mao HJ, 2011, SPINE, V36, pE1062, DOI 10.1097/BRS.0b013e3182027d42
   Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20
   Mihov G, 2010, J CONTROL RELEASE, V148, pE46, DOI 10.1016/j.jconrel.2010.07.053
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   Rodriguez-Galan A, 2011, POLYMERS-BASEL, V3, P65, DOI 10.3390/polym3010065
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Schechtman H, 2006, J BIOMECH, V39, P1401, DOI 10.1016/j.jbiomech.2005.04.018
   Smolders LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4157
   Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251
   Sun HL, 2011, BIOMACROMOLECULES, V12, P1937, DOI 10.1021/bm200043u
   Wang JL, 2007, SPINE, V32, P1809, DOI 10.1097/BRS.0b013e31811ec282
   Webster M, 2013, EUROINTERVENTION, V9, P46, DOI 10.4244/EIJV9I1A8
   Willems N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0727-x
   Willems N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0625-2
NR 34
TC 1
Z9 1
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2017
VL 105
IS 4
BP 707
EP 714
DI 10.1002/jbm.b.33579
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ES2UI
UT WOS:000399383000001
PM 26687460
OA Bronze
DA 2018-10-20
ER

PT J
AU Park, SH
   Yun, BG
   Won, JY
   Yun, WS
   Shim, JH
   Lim, MH
   Kim, DH
   Baek, SA
   Alahmari, YD
   Jeun, JH
   Hwang, SH
   Kim, SW
AF Park, Sun Hwa
   Yun, Byeong Gon
   Won, Joo Yun
   Yun, Won Soo
   Shim, Jin Hyung
   Lim, Mi Hyun
   Kim, Do Hyun
   Baek, Sang A.
   Alahmari, Yahya Dhafer
   Jeun, Jun Ho
   Hwang, Se Hwan
   Kim, Sung Won
TI New application of three-dimensional printing biomaterial in nasal
   reconstruction
SO LARYNGOSCOPE
LA English
DT Article
DE Polycaprolactone; 3D printing; animal study; rabbit; rhinoplasty; tip
   augmentation
ID AUGMENTATION RHINOPLASTY; MECHANICAL-PROPERTIES; BONE-GRAFTS; MODEL;
   CARTILAGE; IMPLANTS; SCAFFOLDS; REPAIR; RABBIT
AB ObjectivesPolycaprolactone (PCL) is an U.S. Food and Drug Administration-approved synthetic biodegradable polymer and is easily fabricated into three-dimensional (3D) structures. In this study, the 3D-printed PCL implant for nasal augmentation was further evaluated for its suitability for nasal surgeries such as septoplasty and rhinoplasty.
   MethodsTen New Zealand White rabbits were included and divided into study and sham groups (7 and 3, respectively). A lateral incision was made on the nasal dorsum and a pocket formed in the subperichondrial plane between the upper lateral cartilage and nasal septum. Polycaprolactone was fabricated based on 3D printing technology into a 0.8 x 0.8-cm rectangular shape for use as a nasal implant. The material was inserted as a septal extension graft and sutured with alar cartilage for nasal reshaping. The implants were harvested 4, 8, and 12 weeks after implantation and evaluated by gross morphological assessment and histological examination.
   ResultsThe initial shape of the implant was unchanged in all cases, and no definitive postoperative complications were seen over the 3-month period. Gross morphological evaluation confirmed that implants remained in their initial location without migration or extrusion. Histologic evaluations showed that the implant architectures were maintained with excellent fibrovascular ingrowth and minimal inflammatory reactions.
   ConclusionPolycaprolactone can be used for nasal reconstruction such as nasal augmentation. Polycaprolactone is easy to work with and will avoid the increased operative time and morbidity associated with autograft harvesting. Therefore, PCL implants designed by 3D printing can serve as clinically biocompatible materials in craniofacial reconstruction in the future.
   Level of EvidenceNA. Laryngoscope, 127:1036-1043, 2017
C1 [Park, Sun Hwa; Yun, Byeong Gon; Lim, Mi Hyun; Kim, Do Hyun; Baek, Sang A.; Alahmari, Yahya Dhafer; Jeun, Jun Ho; Hwang, Se Hwan; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, 222 Banpo Daero, Seoul 137701, South Korea.
   [Park, Sun Hwa; Yun, Byeong Gon; Lim, Mi Hyun; Baek, Sang A.; Jeun, Jun Ho] Catholic Univ Korea, Dept Biomed Sci, Coll Med, Seoul, South Korea.
   [Won, Joo Yun] T&R Biofab Co Ltd, Seoul, South Korea.
   [Yun, Won Soo; Shim, Jin Hyung] Korea Polytech Univ, Dept Mech Engn, Seoul, South Korea.
RP Kim, SW (reprint author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, 222 Banpo Daero, Seoul 137701, South Korea.; Hwang, SH (reprint author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Bucheon St Marys Hosp, Coll Med, 327 Sosa Ro, Bucheon Si 14647, Gyeonggi Do, South Korea.
EM yellobird@catholic.ac.kr; kswent@catholic.ac.kr
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning [2014R1A2A2A01004325]; Korea Health Industry
   Development Institute - Ministry of Health and Welfare [HI14C3228,
   HI16C0133]; Institute of Clinical Medicine Research of Bucheon St.
   Mary's Hospital, Research Fund; MSIP/COMPA [2014K000163]
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Ministry of Science, ICT and Future Planning
   (No. 2014R1A2A2A01004325) Korea Health Industry Development Institute
   funded by the Ministry of Health and Welfare (HI14C3228, HI16C0133), and
   the Institute of Clinical Medicine Research of Bucheon St. Mary's
   Hospital, Research Fund, 2015 and 2016. This research was also supported
   by the R&D program of MSIP/COMPA (No. 2014K000163). The authors have no
   other funding, financial relationships, or conflicts of interest to
   disclose.
CR Boutry CM, 2012, PHILOS T R SOC A, V370, P2418, DOI 10.1098/rsta.2011.0439
   Chang AA, 2012, OTOLARYNG HEAD NECK, V146, P46, DOI 10.1177/0194599811425141
   Cologlu H, 2006, PLAST RECONSTR SURG, V117, P1851, DOI 10.1097/01.prs.0000221875.24467.2d
   Eskandarlou M, 2014, WORLD J PLAST SURG, V3, P122
   Ferril GR, 2013, CURR OPIN OTOLARYNGO, V21, P372, DOI 10.1097/MOO.0b013e3283628e40
   GLASGOLD MJ, 1988, OTOLARYNG HEAD NECK, V99, P374, DOI 10.1177/019459988809900404
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Kim SW, 2009, LARYNGOSCOPE, V119, P62, DOI 10.1002/lary.20025
   Kim YS, 2015, ANN BIOMED ENG, V43, P2153, DOI 10.1007/s10439-015-1261-3
   Kim YS, 2015, J PLAST RECONSTR AES, V68, P659, DOI 10.1016/j.bjps.2014.12.017
   Lee JS, 2012, J BIOMED MATER RES A, V100A, P1846, DOI 10.1002/jbm.a.34149
   Li SH, 2014, AESTHET PLAST SURG, V38, P817, DOI 10.1007/s00266-014-0324-4
   Li X, 2014, INT J POLYM SCI, V2014, P13, DOI DOI 10.1155/2014/829145
   Lim HC, 2011, J BONE JOINT SURG BR, V93B, P120, DOI 10.1302/0301-620X.93B1.24767
   Mendelson A, 2014, PLAST RECONSTR SURG, V133, P1344, DOI 10.1097/PRS.0000000000000232
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Schantz JT, 2003, TISSUE ENG, V9, pS113, DOI 10.1089/10763270360697021
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107
   Teo L, 2015, ORBIT, V34, P192, DOI 10.3109/01676830.2015.1015263
   Watson Deborah, 2009, Facial Plast Surg Clin North Am, V17, P157, DOI 10.1016/j.fsc.2008.09.010
   WELLING DB, 1988, ARCH OTOLARYNGOL, V114, P291
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yildirim G, 2013, TURK J VET ANIM SCI, V37, P326, DOI 10.3906/vet-1101-694
   Yu MS, 2012, OTOLARYNG HEAD NECK, V147, P239, DOI 10.1177/0194599812444269
   Zhou J, 2014, AESTHET PLAST SURG, V38, P295, DOI 10.1007/s00266-014-0299-1
NR 26
TC 2
Z9 3
U1 2
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD MAY
PY 2017
VL 127
IS 5
BP 1036
EP 1043
DI 10.1002/lary.26400
PG 8
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA ES6DY
UT WOS:000399637800013
PM 28150412
DA 2018-10-20
ER

PT J
AU Hoeyer, K
   Tupasela, A
   Rasmussen, MB
AF Hoeyer, Klaus
   Tupasela, Aaro
   Rasmussen, Malene Bogehus
TI Ethics Policies and Ethics Work in Cross-national Genetic Research and
   Data Sharing: Flows, Nonflows, and Overflows
SO SCIENCE TECHNOLOGY & HUMAN VALUES
LA English
DT Article
DE biobank; collaboration; confidentiality; data sharing; ethics; genetic
   research; open science
ID COLLABORATIONS INVOLVING BIOBANKS; GLOBAL SAMPLE COLLECTION; ELSI
   CHALLENGES; DNA; CONSENT
AB In recent years, cross-national collaboration in medical research has gained increased policy attention. Policies are developed to enhance data sharing, ensure open-access, and harmonize international standards and ethics rules in order to promote access to existing resources and increase scientific output. In tandem with this promotion of data sharing, numerous ethics policies are developed to control data flows and protect privacy and confidentiality. Both sets of policy making, however, pay limited attention to the moral decisions and social ties enacted in the everyday routines of scientific work. This paper takes its point of departure in the practices of a Danish laboratory with great experience in international collaboration regarding genetic research. We focus on a simple query, what makes genetic material and health data flow, and which hopes and concerns travel along with them? We explore what we call the flows, the nonflows, and the overflows of material and information, and we document the work producing the flows of health data and biomaterial. We call this work ethics work and argue that it is crucial for data sharing though it is rarely articulated in ethics policies, remains inadequately funded, and lacks acknowledgment in policies promoting international data sharing.
C1 [Hoeyer, Klaus] Univ Copenhagen, Fac Hlth & Med Sci, Med Sci & Technol Studies, Copenhagen, Denmark.
   [Hoeyer, Klaus] Univ Copenhagen, Fac Hlth & Med Sci, Grad Program Med Culture & Soc, Copenhagen, Denmark.
   [Tupasela, Aaro] Univ Copenhagen, Fac Hlth & Med Sci, Eth Legal & Social Aspects Biobanking, Copenhagen, Denmark.
   [Tupasela, Aaro] Univ Copenhagen, Fac Law, Copenhagen, Denmark.
   [Rasmussen, Malene Bogehus] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.
RP Hoeyer, K (reprint author), Univ Copenhagen, Oster Farimagsgade 5,Room 10-0-09,1014K, Copenhagen, Denmark.
EM klho@sund.ku.dk
OI Rasmussen, Malene Bogehus/0000-0002-2349-538X; Tupasela,
   Aaro/0000-0003-1512-7533
FU University of Copenhagen's Excellence Programme for Interdisciplinary
   Research
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The study
   was supported financially by the University of Copenhagen's Excellence
   Programme for Interdisciplinary Research.
CR Albert M, 2015, Collaboration across Health Research and Medical Care: Healthy Collaboration, P59
   Anderson Warwick, 2008, COLLECTORS LOST SOUL
   APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038
   Arzberger P., 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135
   Bjugn R, 2015, BIOPRESERV BIOBANK, V13, P70, DOI 10.1089/bio.2015.1323
   Blasimme A, 2012, AM J BIOETHICS, V12, P20, DOI 10.1080/15265161.2012.699149
   Bosk CL, 1979, FORGIVE REMEMBER MAN
   Cadigan R Jean, 2013, Life Sci Soc Policy, V9, P1
   Cambliss D. F., 1996, CARING HOSP NURSES S
   Colledge F, 2013, BIOPRESERV BIOBANK, V11, P339, DOI 10.1089/bio.2013.0039
   Cooper Melinda, 2014, CLIN LABOR TISSUE DO
   Cunningham H, 1998, CRIT ANTHROPOL, V18, P205, DOI 10.1177/0308275X9801800205
   Dove ES, 2014, BIOPRESERV BIOBANK, V12, P363, DOI 10.1089/bio.2014.1263
   Evans BJ, 2006, J LEGAL MED, V27, P119, DOI 10.1080/01947640600716366
   Friese C, 2013, CURR ANTHROPOL, V54, pS129, DOI 10.1086/670805
   Geissler PW, 2013, AM ETHNOL, V40, P13, DOI 10.1111/amet.12002
   Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/.j.socscimed.2008.02.004
   General Secretariat of the Council, 2016, 259616 GEN SECR COUN
   Hayden C, 2007, SOC STUD SCI, V37, P729, DOI 10.1177/03063127067078012
   HOCHSCHILD AR, 1979, AM J SOCIOL, V85, P551, DOI 10.1086/227049
   Hoeyer K, 2016, NEW GENET SOC, V35, P351, DOI 10.1080/14636778.2016.1245134
   Kaye J, 2012, ANNU REV GENOM HUM G, V13, P415, DOI 10.1146/annurev-genom-082410-101454
   Keating P, 2003, INSIDE TECHNOL, P1
   Knoppers BM, 2012, ANNU REV GENOM HUM G, V13, P395, DOI 10.1146/annurev-genom-090711-163834
   Kowal E, 2013, SOC STUD SCI, V43, P577, DOI 10.1177/0306312712471739
   Kowal E, 2013, SOC STUD SCI, V43, P465, DOI 10.1177/0306312713490843
   Lauss G., 2012, TRUST IN BIOBANKING, P219
   Leonelli S, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714534395
   Marks Jonathan, 2001, RELATIVE VALUES RECO, P355
   Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197
   Mayrhofer M. T., 2009, INT J RISK ASSESSMEN, V12, P64, DOI [DOI 10.1504/IJRAM.2009.024130, 10.1504/IJRAM.2009.024130]
   McGoey L, 2012, ECON SOC, V41, P1, DOI 10.1080/03085147.2011.637330
   Meijer I, 2012, SCI PUBL POLICY, V39, P491, DOI 10.1093/scipol/scs033
   Mol A., 2008, LOGIC CARE HLTH PROB
   Nielsen J., 1980, TOPICS HUM GENET, V5, P1
   OECD (Organization for Economic Cooperation and Development), 2009, OECD GUID TEST CHEM, P1
   Organisation for Economic Co- operation and Development, 2007, OECD PRINC GUID ACC
   Patra P. K., 2012, TRUST BIOBANKING, P237
   Penders B, 2015, Collaboration across Health Research and Medical Care: Healthy Collaboration, P3
   Proctor R. N., 2008, AGNOTOLOGY MAKING UN, P1
   Reardon J, 2005, IN-FORMATION, P1
   Rose H, 2006, COMMUNITY GENET, V9, P184, DOI 10.1159/000092655
   Sheller M, 2006, ENVIRON PLANN A, V38, P207, DOI 10.1068/a37268
   Sleeboom-Faulkner M, 2011, SOC STUD SCI, V41, P645, DOI 10.1177/0306312711409792
   Star SL, 1996, INFORM SYST RES, V7, P111, DOI 10.1287/isre.7.1.111
   Timmermans S, 2015, SOC STUD SCI, V45, P77, DOI 10.1177/0306312714559323
   Urry John, 2000, SOCIOLOGY SOC MOBILI
NR 47
TC 3
Z9 3
U1 5
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0162-2439
EI 1552-8251
J9 SCI TECHNOL HUM VAL
JI Sci. Technol. Hum. Values
PD MAY
PY 2017
VL 42
IS 3
BP 381
EP 404
DI 10.1177/0162243916674321
PG 24
WC Social Issues
SC Social Issues
GA ER5LH
UT WOS:000398842800002
DA 2018-10-20
ER

PT J
AU Wu, G
   Cao, ZZ
   Luo, XL
   Wang, XX
   Wang, SH
   Wang, DL
AF Wu, Gang
   Cao, Zhi-Zhong
   Luo, Xiao-Long
   Wang, Xing-Xing
   Wang, Shao-Hai
   Wang, Da -Lin
TI Fabrication and Characterization of a PDLSCs/BMP-2-PLGA-NP/RADA Peptide
   Hydrogel Composite for Bone Repair
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE RADA-16 Peptide Hydrogel; rhBMP-2-Loaded PLGA Nanoparticle; PLDSC;
   Osteogenesis; Bone Repair
ID LIGAMENT STEM-CELLS; MORPHOGENETIC PROTEIN-2; PERIODONTAL-LIGAMENT;
   CONTROLLED-RELEASE; IN-VIVO; DELIVERY; REGENERATION; PLGA;
   DIFFERENTIATION; SCAFFOLDS
AB It is of great interest to develop implantable biomaterial with controlled BMP-2 release. This study aimed to construct a composite (BMP-2/PLGA-NP/RADA) containing periodontal ligament stem cells (PDLSCs), rhBMP-2-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles (BMP-2/PLGANP), and self-assembling RADA-16 peptide hydrogel and characterize its osteogenic capacity. PLGA nanoparticles were produced by double-emulsionmethod, which were then incorporated into RADA16 peptide hydrogel with or without PDLSCs. The time course of rhBMP-2 release was measured by ELISA after incubating BMP-2/PLGA-NP and BMP-2/PLGA-NP/RADA in PBS. The osteoinductivity of BMP-2/PLGA-NP and BMP-2/PLGA-NP/RADA in vitro was analyzed by measuring alkaline phosphotase activity and ossification. The in vivo osteogenesis of BMP-2/PLGA-NP/RADA composite was examined by HE and Alizarin Red staining as well as the expression of ALP and OCN genes. The incorporation of PDLSCs and BMP-2/PLGA-NP did not change the appearance of RADA hydrogel whereas BMP-2/PLGA-NP/RADA improved rhBMP-2 release pattern and enhanced osteoinductive ability compared to BMP-2/PLGA-NP. Implantation of BMP-2/PLGA-NP/RADA composite resulted in significant osteogenesis in 4 weeks. These results indicated that stem cells, rhBMP-2loaded PLGA microparticles, and RADA-16 hydrogel composite would be a promising biomaterial for bone repair and regeneration.
C1 [Wu, Gang; Cao, Zhi-Zhong; Luo, Xiao-Long; Wang, Xing-Xing; Wang, Shao-Hai; Wang, Da -Lin] Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai 200082, Peoples R China.
RP Wang, SH; Wang, DL (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai 200082, Peoples R China.
CR Agrawal V, 2017, J BIOMED MATER RES B, V105, P904, DOI 10.1002/jbm.b.33599
   Bigham-Sadegh A, 2015, INT WOUND J, V12, P238, DOI 10.1111/iwj.12231
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Cui HX, 2015, GENET MOL RES, V14, P13511, DOI 10.4238/2015.October.28.12
   Hopkins RB, 2013, OSTEOPOROSIS INT, V24, P581, DOI 10.1007/s00198-012-1997-7
   Iwasaki K, 2014, TISSUE ENG PT A, V20, P693, DOI 10.1089/ten.TEA.2013.0017
   Jung IH, 2014, TISSUE ENG PT A, V20, P2189, DOI [10.1089/ten.tea.2013.0648, 10.1089/ten.TEA.2013.0648]
   Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]
   Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Lee CM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-227
   Lee JH, 2014, J MATER SCI-MATER M, V25, P2141, DOI 10.1007/s10856-014-5250-0
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Liedmann A, 2012, BIORESEARCH OPEN ACC, V1, P16, DOI 10.1089/biores.2012.0209
   Liu WJ, 2014, BBA-GEN SUBJECTS, V1840, P1125, DOI 10.1016/j.bbagen.2013.11.003
   Haber Y, 2013, BIOMED MICRODEVICES, V15, P1055, DOI 10.1007/s10544-013-9797-1
   Ortega-Oller I., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/415289
   Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006
   Pan HT, 2016, COLLOID SURFACE B, V142, P1, DOI 10.1016/j.colsurfb.2016.01.060
   Pan HT, 2013, MAT SCI ENG C-MATER, V33, P3336, DOI 10.1016/j.msec.2013.04.019
   Park SY, 2015, J BIOMED MATER RES A, V103, P38, DOI 10.1002/jbm.a.35145
   Peng Q, 2015, ANN MED, V47, P186, DOI 10.3109/07853890.2015.1007520
   Poon B, 2016, J PHARM PHARMACOL, V68, P139, DOI 10.1111/jphp.12506
   Rodriguez-Evora M, 2013, EUR J PHARM SCI, V49, P873, DOI 10.1016/j.ejps.2013.06.008
   Tang D, 2016, BIOMATERIALS, V83, P363, DOI 10.1016/j.biomaterials.2016.01.024
   Wan F, 2016, INT J PHARMACEUT, V498, P82, DOI 10.1016/j.ijpharm.2015.12.025
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wink JD, 2014, PLAST RECONSTR SURG, V134, P51, DOI 10.1097/PRS.0000000000000287
   Wu M, 2015, BIOMACROMOLECULES, V16, P3112, DOI 10.1021/acs.biomac.5b00493
   Xiong SJ, 2011, BIOTECHNOL J, V6, P501, DOI 10.1002/biot.201000351
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   Zhu WJ, 2015, STEM CELLS INT, DOI 10.1155/2015/972313
   Zou ZW, 2014, J BIOMED MATER RES A, V102, P1286, DOI 10.1002/jbm.a.34804
NR 33
TC 2
Z9 2
U1 7
U2 22
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAY
PY 2017
VL 7
IS 5
BP 379
EP 385
DI 10.1166/jbt.2017.1586
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA ER6PX
UT WOS:000398929400006
DA 2018-10-20
ER

PT J
AU Wei, BG
   Shi, ZJ
   Xiao, J
   Xu, YS
   Lv, L
AF Wei, Baogang
   Shi, Zhanjun
   Xiao, Jun
   Xu, Yongsheng
   Lv, Long
TI In Vivo and In Vitro Antibacterial Effect of Nano-Structured Titanium
   Coating Incorporated with Silver Oxide Nanoparticles
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Titanium Oxide Nanotubes; Silver Oxide Nanoparticles; Antibacterial
   Activity; Biocompatibility; Osteogenic Differentiation
ID ORTHOPEDIC IMPLANTS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ADHESION;
   NANOTUBES; INFECTIONS; MECHANISM; ION
AB Backgrounds: Periprosthetic joint infection (PJI) is one of the most common and devastating complications associated with the implants. Researches have focus on development of a novel biomaterial that could be used for prosthetic coatings, which was expected to possess good antibacterial activity and biocompatibility. Titanium oxide nanotubes (TiO2-NTs) incorporated with silver (Ag) nanoparticles have been proposed to be applied, while cytotoxcity induced by burst release of Ag ion limited its further development. Methods: We prepared TiO2-NTs embedded with silver oxide nanoparticles (Ag2O-TiO2-NTs) by magnetron sputtering and anodization. Viable bacterial count was performed to test antibacterial activity in vitro and in vivo. Potential for cell proliferation was tested by by cytotoxcity assay, and potential for osteogenic differentiation was investigated by ALP, collagen secretion and extracellular mineralization assay. Results: Ag2O-TiO2-NTs could release antibacterial Ag ion in a steady and controllable pattern, without a excessive burst of Ag ion release. Moreover, the antibacterial activity both in vitro and in vivo was satisfactory. Besides, Ag2O-TiO2-NTs manifested good biocompatibility, without significant cytotoxicity or impairment of osteogenic differentiation. Conclusions. Ag2O-TiO2-NTs has the potential to be developed into a promising biomaterial for prosthetic coatings in the prevention and treatment of PJI.
C1 [Wei, Baogang; Shi, Zhanjun; Xiao, Jun] Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou 510515, Guangdong, Peoples R China.
   [Wei, Baogang; Xu, Yongsheng; Lv, Long] Inner Mongolia Peoples Hosp, Dept Orthopaed Surg, Hohhot 010017, Peoples R China.
RP Shi, ZJ; Xiao, J (reprint author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou 510515, Guangdong, Peoples R China.; Xu, YS (reprint author), Inner Mongolia Peoples Hosp, Dept Orthopaed Surg, Hohhot 010017, Peoples R China.
FU Inner Mongolia Science and Technology Department applied technology
   research and development projects [20140149]; Inner Mongolia Natural
   Science Foundation [2014MS08131]
FX This work was supported by Inner Mongolia Science and Technology
   Department applied technology research and development projects (Item
   Number 20140149) and Inner Mongolia Natural Science Foundation (Item
   Number 2014MS08131).
CR Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Crawford GA, 2007, ACTA BIOMATER, V3, P359, DOI 10.1016/j.actbio.2006.08.004
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hajicharalambous CS, 2009, BIOMATERIALS, V30, P4029, DOI 10.1016/j.biomaterials.2009.03.020
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kumar R, 2005, J BIOMED MATER RES B, V75B, P311, DOI 10.1002/jbm.b.30306
   McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Peng ZX, 2013, INT J NANOMED, V8, P3093, DOI 10.2147/IJN.S48084
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Raphel J, 2016, BIOMATERIALS, V84, P301, DOI 10.1016/j.biomaterials.2016.01.016
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
NR 24
TC 3
Z9 3
U1 5
U2 46
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAY
PY 2017
VL 7
IS 5
BP 418
EP 425
DI 10.1166/jbt.2017.1581
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA ER6PX
UT WOS:000398929400012
DA 2018-10-20
ER

PT J
AU Piai, JF
   da Silva, MA
   Martins, A
   Torres, AB
   Faria, S
   Reis, RL
   Muniz, EC
   Neves, NM
AF Piai, Juliana Francis
   da Silva, Marta Alves
   Martins, Albino
   Torres, Ana Bela
   Faria, Susana
   Reis, Rui L.
   Muniz, Edvani Curti
   Neves, Nuno M.
TI Chondroitin sulfate immobilization at the surface of electrospun
   nanofiber meshes for cartilage tissue regeneration approaches
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Chondroitin sulfate; Electrospun nanofiber meshes; Surface
   functionalization; Human articular condrocytes
ID MESENCHYMAL STEM-CELLS; HUMAN ENDOTHELIAL-CELLS; L-LACTIC ACID; II
   COLLAGEN; IN-VITRO; ARTICULAR CHONDROCYTES; POROUS SCAFFOLDS;
   POLYCAPROLACTONE; MEMBRANE; CYTOCOMPATIBILITY
AB Aiming at improving the biocompatibility of biomaterial scaffolds, surface modification presents a way to preserve their mechanical properties and to improve the surface bioactivity. In this work, chondroitin sulfate (CS) was immobilized at the surface of electrospun poly(caprolactone) nanofiber meshes (PCL NFM5), previously functionalized by UV/O-3 exposure and aminolysis. Contact angle, SEM, optical profilometry, FTIR, X-ray photoelectron spectroscopy techniques confirmed the success of CS-immobilization in PCL NFMs. Furthermore, CS-immobilized PCL NFM5 showed lower roughness and higher hydrophilicity than the samples without CS. Human articular chondrocytes (hACs) were cultured on electrospun PCL NFMs with or without CS immobilization. It was observed that hACs proliferated through the entire time course of the experiment in both types of nanofibrous scaffolds, as well as for the production of glycosaminoglycans. Quantitative-PCR results demonstrated over-expression of cartilage-related genes such as Aggrecan, Collagen type II, COMP and Sox9 on both types of nanofibrous scaffolds. Morphological observations from SEM and LSCM revealed that hACs maintained their characteristic round shape and cellular agglomeration exclusively on PCL NFMs with CS immobilization. In conclusion, CS immobilization at the surface of PCL NFMs was achieved successfully and provides a valid platform enabling further surface functionalization methods in scaffolds to be developed for cartilage tissue engineering. (C) 2016 Published by Elsevier B.V.
C1 [Piai, Juliana Francis; da Silva, Marta Alves; Martins, Albino; Torres, Ana Bela; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, AvePk, P-4805017 Barco, Guimaraes, Portugal.
   [Piai, Juliana Francis; da Silva, Marta Alves; Martins, Albino; Torres, Ana Bela; Reis, Rui L.; Neves, Nuno M.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Piai, Juliana Francis; Muniz, Edvani Curti] Univ Estadual Maringa, Dept Quim, GMPC, Ave Colombo 5790, BR-87020900 Maringa, Parana, Brazil.
   [Faria, Susana] Univ Minho, Res Ctr Off Math, Dept Math Sci & Technol, Campus Azurem, P-4800058 Guimaraes, Portugal.
RP Neves, NM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, AvePk, P-4805017 Barco, Guimaraes, Portugal.
EM nuno@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Neves, Nuno/B-4685-2008; Reis, Rui
   L./A-8938-2008; Martins, Albino/C-8432-2012
OI Group, 3Bs/0000-0002-5195-3456; Neves, Nuno/0000-0003-3041-0687; Reis,
   Rui L./0000-0002-4295-6129; Martins, Albino/0000-0003-3868-0251; Muniz,
   Edvani/0000-0001-6685-1519
FU CAPES-Brazil; CNPq-Brazil [201733/2009-9]; Portuguese Foundation for
   Science and Technology (FCT), FCT/MCTES (POCH - Programa Operacional
   Capital Humano, comparticipado pelo Fundo Social Europeu e por fundos
   nacionais do MCTES) [SFRH/BPD/73322/2010, SFRH/BPD/70669/2010]
FX Juliana F. Piai would like to acknowledge CAPES-Brazil and CNPq-Brazil
   for the financial support (Proc. No. 201733/2009-9). Marta Alves da
   Silva and Albino Martins would like to acknowledge the Portuguese
   Foundation for Science and Technology (FCT), FCT/MCTES (POCH - Programa
   Operacional Capital Humano, comparticipado pelo Fundo Social Europeu e
   por fundos nacionais do MCTES) for their post-doctoral grants
   (SFRH/BPD/73322/2010 and SFRH/BPD/70669/2010). Authors would like to
   acknowledge the patients of Hospital de Braga for the kind donation of
   biological samples, as well as the medical and nursing staff, and
   CACTI-UVigo (Spain) for the XPS and Optical Profilometry data analysis.
CR da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   Chahine NO, 2005, BIOPHYS J, V89, P1543, DOI 10.1529/biophysj.104.057315
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chang KY, 2009, ACTA BIOMATER, V5, P1937, DOI 10.1016/j.actbio.2009.02.002
   Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Crawford A., 2004, POLYM SCAFFOLDS METH, P147
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   da Costa DS, 2012, J MATER CHEM, V22, P7172, DOI 10.1039/c2jm15762d
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Darain F, 2011, SOFT MATER, V9, P64, DOI 10.1080/1539445X.2010.520797
   Gao CY, 2003, MACROMOL BIOSCI, V3, P157, DOI 10.1002/mabi.200390020
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Gumusderelioglu M, 2011, J BIOMED MATER RES A, V98A, P461, DOI 10.1002/jbm.a.33143
   Home MK, 2010, STEM CELLS DEV, V19, P843
   Jou CH, 2008, POLYM ADVAN TECHNOL, V19, P377, DOI 10.1002/pat.1020
   Kafienah W, 2004, BIOPOLYMER METHODS T, P217
   Kim TG, 2008, MACROMOL RAPID COMM, V29, P1231, DOI 10.1002/marc.200800094
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koshimizu T, 2012, J BIOL CHEM, V287, P15760, DOI 10.1074/jbc.M111.308072
   Kuo YC, 2008, BIOMACROMOLECULES, V9, P2662, DOI 10.1021/bm800651r
   Lee CT, 2007, BIOMOL ENG, V24, P131, DOI 10.1016/j.bioeng.2006.05.010
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Li SY, 2013, HISTOCHEM CELL BIOL, V139, P59, DOI 10.1007/s00418-012-1017-1
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu YX, 2007, J BIOMED MATER RES A, V81A, P692, DOI 10.1002/jbm.a.31102
   Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Martins A, 2011, MACROMOL BIOSCI, V11, P978, DOI 10.1002/mabi.201100012
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010
   TYLLIANAKIS PE, 1993, APPL BIOCHEM BIOTECH, V38, P15, DOI 10.1007/BF02916409
   Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI 10.1089/ten.TEA.2008.0405
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wang HS, 2009, RECENT PAT NANOTECH, V3, P21, DOI 10.2174/187221009787003285
   Wang LY, 2009, J MACROMOL SCI A, V46, P765, DOI 10.1080/10601320903004517
   WASTESON A, 1971, BIOCHEM J, V122, P477, DOI 10.1042/bj1220477
   Watanabe H, 1998, J BIOCHEM-TOKYO, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166
   Yan YH, 2007, J WUHAN UNIV TECHNOL, V22, P681, DOI 10.1007/s11595-006-4681-y
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
NR 57
TC 3
Z9 3
U1 9
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 1
PY 2017
VL 403
BP 112
EP 125
DI 10.1016/j.apsusc.2016.12.135
PG 14
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EN4BO
UT WOS:000395952800016
DA 2018-10-20
ER

PT J
AU Tarakanova, A
   Huang, W
   Weiss, AS
   Kaplan, DL
   Buehler, MJ
AF Tarakanova, Anna
   Huang, Wenwen
   Weiss, Anthony S.
   Kaplan, David L.
   Buehler, Markus J.
TI Computational smart polymer design based on elastin protein mutability
SO BIOMATERIALS
LA English
DT Article
DE Elastin-like peptide (ELP); Inverse temperature transition;
   Peptide-water interaction; Single-molecule; Protein simulation library
ID INVERSE TEMPERATURE TRANSITION; MOLECULAR-DYNAMICS METHOD; FREE-ENERGY
   TRANSDUCTION; HUMAN TROPOELASTIN; SECONDARY STRUCTURE; CHAIN DYNAMICS;
   PHASE-BEHAVIOR; DRUG-DELIVERY; LCST BEHAVIOR; SOLID-STATE
AB Soluble elastin-like peptides (ELPs) can be engineered into a range of physical forms, from hydrogels and scaffolds to fibers and artificial tissues, finding numerous applications in medicine and engineering as "smart polymers". Elastin-like peptides are attractive candidates as a platform for novel biomaterial design because they exhibit a highly tunable response spectrum, with reversible phase transition capabilities. Here, we report the design of the first virtual library of elastin-like protein models using methods for enhanced sampling to study the effect of peptide chemistry, chain length, and salt concentration on the structural transitions of ELPs, exposing associated molecular mechanisms. We describe the behavior of the local molecular structure under increasing temperatures and the effect of peptide interactions with nearest hydration shell water molecules on peptide mobility and propensity to exhibit structural transitions. Shifts in the magnitude of structural transitions at the single-molecule scale are explained from the perspective of peptide-ion-water interactions in a library of four unique elastin-like peptide systems. Predictions of structural transitions are subsequently validated in experiment. This library is a valuable resource for recombinant protein design and synthesis as it elucidates mechanisms at the single-molecule level, paving a feedback path between simulation and experiment for smart material designs, with applications in biomedicine and diagnostic devices. (C) 2017 Published by Elsevier Ltd.
C1 [Tarakanova, Anna; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Huang, Wenwen; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Weiss, Anthony S.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM mbuehler@mit.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083; WEISS, ANTHONY/0000-0002-8106-4836
FU National Science Foundation [ACI-1053575]; NIH [5U01EB014976, EB014283];
   ONR [N000141612333]; AFOSR [FA9550-11-1-0199]
FX We thank Zhao Qin and Davoud Ebrahimi for fruitful discussions. This
   work used the Extreme Science and Engineering Discovery Environment
   (XSEDE), supported by the National Science Foundation grant number
   ACI-1053575. The authors acknowledge support from the NIH (5U01EB014976
   and EB014283), ONR (N000141612333) and AFOSR (FA9550-11-1-0199).
CR Amiram M, 2013, P NATL ACAD SCI USA, V110, P2792, DOI 10.1073/pnas.1214518110
   Baer M, 2006, J PHYS CHEM B, V110, P3576, DOI 10.1021/jp054805a
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Blanchevoye C, 2013, J BIOL CHEM, V288, P1317, DOI 10.1074/jbc.M112.419929
   Bochicchio B, 2013, RSC ADV, V3, P13273, DOI 10.1039/c3ra41893f
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chang SW, 2012, BIOMATERIALS, V33, P3852, DOI 10.1016/j.biomaterials.2012.02.001
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Christensen T, 2013, BIOMACROMOLECULES, V14, P1514, DOI 10.1021/bm400167h
   Dandurand J, 2015, J THERM ANAL CALORIM, V120, P419, DOI 10.1007/s10973-014-4254-9
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005
   Floquet N, 2004, BIOPOLYMERS, V76, P266, DOI 10.1002/bip.20029
   Gautieri A, 2012, J BIOMECH, V45, P2079, DOI 10.1016/j.jbiomech.2012.05.047
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Girotti A, 2004, MACROMOLECULES, V37, P3396, DOI 10.1021/ma035603k
   Gross PC, 2003, Z NATURFORSCH C, V58, P873
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hong M, 2003, BIOPOLYMERS, V70, P158, DOI 10.1002/bip.10431
   Humphrey W., 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5
   Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kurkova D, 2003, BIOMACROMOLECULES, V4, P589, DOI 10.1021/bm025618a
   Kurzbach D, 2013, J AM CHEM SOC, V135, P11299, DOI 10.1021/ja4047872
   Lee J, 2001, J BIOMAT SCI-POLYM E, V12, P229, DOI 10.1163/156856201750180942
   LELJ F, 1992, BIOPOLYMERS, V32, P161, DOI 10.1002/bip.360320206
   Li B, 2002, STRUCTURE, V10, P989, DOI 10.1016/S0969-2126(02)00792-X
   Li B, 2001, J MOL BIOL, V305, P581, DOI 10.1006/jmbi.2000.4306
   Li G, 2015, ADV HEALTHC MATER, V4, P1134, DOI 10.1002/adhm.201500002
   Li NK, 2014, BIOMACROMOLECULES, V15, P3522, DOI 10.1021/bm500658w
   LUAN CH, 1991, BIOPOLYMERS, V31, P465, DOI 10.1002/bip.360310502
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   MacEwan SR, 2012, NANO LETT, V12, P3322, DOI 10.1021/nl301529p
   MacKay JA, 2010, BIOMACROMOLECULES, V11, P2873, DOI 10.1021/bm100571j
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   McDaniel JR, 2014, NANO LETT, V14, P6590, DOI 10.1021/nl503221p
   McDaniel JR, 2013, BIOMACROMOLECULES, V14, P2866, DOI 10.1021/bm4007166
   McDaniel JR, 2010, ADV DRUG DELIVER REV, V62, P1456, DOI 10.1016/j.addr.2010.05.004
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   Nuhn H, 2008, BIOMACROMOLECULES, V9, P2755, DOI 10.1021/bm800784y
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Reguera J, 2007, BIOMACROMOLECULES, V8, P354, DOI 10.1021/bm060936l
   Ribeiro A, 2009, BIOPHYS J, V97, P312, DOI 10.1016/j.bpj.2009.03.030
   Roberts S, 2015, FEBS LETT, V589, P2477, DOI 10.1016/j.febslet.2015.08.029
   Rodriguez-Cabello JC, 1999, MACROMOL CHEM PHYSIC, V200, P1831, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1831::AID-MACP1831>3.0.CO;2-V
   Rousseau R, 2004, BIOPHYS J, V86, P1393, DOI 10.1016/S0006-3495(04)74210-1
   Samouillan V, 2004, BIOMACROMOLECULES, V5, P958, DOI 10.1021/bm034436t
   Samouillan V, 2001, BIOPOLYMERS, V58, P175, DOI 10.1002/1097-0282(200102)58:2<175::AID-BIP60>3.0.CO;2-K
   Schreiner E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.148101
   Seo M, 2012, J CHEM THEORY COMPUT, V8, P1774, DOI 10.1021/ct200876v
   STRZEGOWSKI LA, 1994, J AM CHEM SOC, V116, P813, DOI 10.1021/ja00081a070
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Sun C, 2011, J PHYS CHEM B, V115, P13935, DOI 10.1021/jp207607r
   Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014
   TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419
   Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t
   Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Ukpebor OT, 2014, SOFT MATTER, V10, P773, DOI 10.1039/c3sm52001c
   Urry D.W., 2006, WHAT SUSTAINS LIFE C
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1988, J PROTEIN CHEM, V7, P81, DOI 10.1007/BF01025240
   URRY DW, 1992, BIOPOLYMERS, V32, P1243, DOI 10.1002/bip.360320913
   URRY DW, 1985, BIOCHEM BIOPH RES CO, V130, P50, DOI 10.1016/0006-291X(85)90380-8
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   URRY DW, 1985, BIOPOLYMERS, V24, P2345, DOI 10.1002/bip.360241212
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   URRY DW, 1985, BIOCHEMISTRY-US, V24, P5182, DOI 10.1021/bi00340a034
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
NR 87
TC 10
Z9 10
U1 13
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2017
VL 127
BP 49
EP 60
DI 10.1016/j.biomaterials.2017.01.041
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ER5VQ
UT WOS:000398872300005
PM 28279921
DA 2018-10-20
ER

PT J
AU Liu, XQ
   Fourel, L
   Dalonneau, F
   Sadir, R
   Leal, S
   Lortat-Jacob, H
   Weidenhaupt, M
   Albiges-Rizo, C
   Picart, C
AF Liu, Xi Qiu
   Fourel, Laure
   Dalonneau, Fabien
   Sadir, Rabia
   Leal, Salome
   Lortat-Jacob, Hugues
   Weidenhaupt, Marianne
   Albiges-Rizo, Corinne
   Picart, Catherine
TI Biomaterial-enabled delivery of SDF-1 alpha at the ventral side of
   breast cancer cells reveals a crosstalk between cell receptors to
   promote the invasive phenotype
SO BIOMATERIALS
LA English
DT Article
DE Chemokines; SDF-1 alpha/CXCL12; Breast cancer cells; Metastasis; Tumoral
   niche; Hyaluronan; Polyelectrolyte multilayer films; CXCR4; CD44
ID POLYELECTROLYTE MULTILAYER FILMS; CHEMOKINE RECEPTOR; HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; PROSTATE-CANCER; BONE-MARROW; BIOMEDICAL
   APPLICATIONS; HYAL1 HYALURONIDASE; SIGNAL-TRANSDUCTION; GUIDANCE
   CHANNELS
AB The SDF-1 alpha chemokine (CXCL12) is a potent bioactive chemoattractant known to be involved in hematopoietic stem cell homing and cancer progression. The associated SDF-1 alpha/CXCR4 receptor signaling is a hallmark of aggressive tumors, which can metastasize to distant sites such as lymph nodes, lung and bone. Here, we engineered a biomimetic tumoral niche made of a thin and soft polyelectrolyte film that can retain SDF-1 alpha to present it, in a spatially-controlled manner, at the ventral side of the breast cancer cells. Matrix-bound SDF-1 alpha but not soluble SDF-1 alpha induced a striking increase in cell spreading and migration in a serum-containing medium, which was associated with the formation of lamellipodia and filopodia in MDA-MB231 cells and specifically mediated by CXCR4. Other Knockdown and inhibition experiments revealed that CD44, the major hyaluronan receptor, acted in concert, via a spatial coincidence, to drive a specific matrix-bound SDF alpha-induced cell response associated with ERK signaling. In contrast, the beta 1 integrin adhesion receptor played only a minor role on cell polarity. The CXCR4/CD44 mediated cellular response to matrix-bound SDF-1 alpha involved the Rac1 RhoGTPase and was sustained solely in the presence of matrix-bound SDF alpha, in contrast with the transient signaling observed in response to soluble SDF-1 alpha. Our results highlight that a biomimetic tumoral niche enables to reveal potent cellular effects and so far hidden molecular mechanisms underlying the breast cancer response to chemokines. These results open new insights for the design of future innovative therapies in metastatic cancers, by inhibiting CXCR4-mediated signaling in the tumoral niche via dual targeting of receptors (CXCR4 and CD44) or of associated signaling molecules (CXCR4 and Rac1). (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Liu, Xi Qiu; Dalonneau, Fabien; Leal, Salome; Weidenhaupt, Marianne; Picart, Catherine] CNRS, UMR 5628, LMGP, 3 Parvis Louis Neel, F-38016 Grenoble, France.
   [Liu, Xi Qiu; Dalonneau, Fabien; Leal, Salome; Weidenhaupt, Marianne; Picart, Catherine] Univ Grenoble Alpes, LMGP, 3 Parvis Louis Neel, F-38016 Grenoble, France.
   [Liu, Xi Qiu] FDN ARC, 9 Rue Guy Moquet, F-94803 Villejuff, France.
   [Liu, Xi Qiu] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China.
   [Fourel, Laure; Albiges-Rizo, Corinne] Univ Grenoble Alpes, Inst Albert Bonniot, INSERM, U1209, Site Sante, F-38042 Grenoble 9, France.
   [Fourel, Laure; Albiges-Rizo, Corinne] CNRS, Inst Albert Bonniot, Inst Adv Biosci, UMR5309, F-38700 La Tronche, France.
   [Sadir, Rabia; Lortat-Jacob, Hugues] Univ Grenoble Alpes, CEA, CNRS, Inst Biol Struct,UMR 5075, F-38027 Grenoble, France.
RP Picart, C (reprint author), CNRS, UMR 5628, LMGP, 3 Parvis Louis Neel, F-38016 Grenoble, France.; Liu, XQ (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China.
EM xiqiuliu@hust.edu.cn; catherine.picart@grenoble-inp.fr
OI Leal, Salome/0000-0002-7243-4997
FU Association Recherche contre le Cancer (ARC) [PDF20121206052]; Agence
   Nationale de la Recherche [ANR-NT05-4-41968-Chemoglycan]; European
   Commission (ERC) [GA 259370]; FRM; Ligue Nationale contre le Cancer for
   Equipe labellisee Ligue
FX This research was supported by the "Association Recherche contre le
   Cancer" via a post-doctoral fellowship to XQL (ARC, PDF20121206052) and
   the Agence Nationale de la Recherche (ANR-NT05-4-41968-Chemoglycan).
   This work was supported by the European Commission in the frame of FP7
   (ERC Starting Grant BIOMIM, GA 259370 to CP), by the FRM (CAR) and by
   the Ligue Nationale contre le Cancer for Equipe labellisee Ligue 2014
   (CAR). CP is a senior member of Institute Universitaire de France, whose
   support is acknowledged. The groups of C.P. and C.A.R. belong to the
   CNRS consortium CellTiss. We thank Thomas Boudou, Franz Bruckert and
   Matt Kutys for fruitful discussions and technical advices. We are also
   grateful to Laurence Lafanechere and Sophie Michallet for providing the
   MCF-7 cells and advices on cell culture.
CR Ablett MP, 2014, ONCOTARGET, V5, P599, DOI 10.18632/oncotarget.1169
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Boudou T, 2009, LANGMUIR, V25, P13809, DOI 10.1021/la9018663
   Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4
   Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865
   Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52
   Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Dalonneau F, 2014, BIOMATERIALS, V35, P4525, DOI 10.1016/j.biomaterials.2014.02.008
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005
   Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fourel L, 2016, J CELL BIOL, V212, P693, DOI 10.1083/jcb.201508018
   Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364
   Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x
   Gribova V, 2013, ACTA BIOMATER, V9, P6468, DOI 10.1016/j.actbio.2012.12.015
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Hesselgesser J, 1998, J IMMUNOL, V160, P877
   Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4
   Kang H, 2005, INT J ONCOL, V26, P1429
   Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153
   Kucia M, 2004, J MOL HISTOL, V35, P233
   Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110
   Lechertier T, 2004, ANTICANCER RES, V24, P4011
   Lefort S., 2016, ONCOGENE, P1
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022
   Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200
   Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003
   Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886
   Meincke M, 2011, CLIN EXP METASTAS, V28, P713, DOI 10.1007/s10585-011-9403-y
   Migliorini E, 2014, BIOMATERIALS, V35, P8903, DOI 10.1016/j.biomaterials.2014.07.017
   Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83
   Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R
   Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.3.CO;2-V
   Mukherjee D, 2013, AM J CANCER RES, V3, P46
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009
   Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113
   Nelson MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-825
   Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peng SB, 2005, MOL CANCER RES, V3, P227
   Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246
   Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299
   Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290
   Salazar N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-198
   Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Sharrocks AD, 2006, CURR BIOL, V16, pR540, DOI 10.1016/j.cub.2006.06.038
   Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013
   Sison EAR, 2011, EXPERT REV HEMATOL, V4, P271, DOI [10.1586/ehm.11.30, 10.1586/EHM.11.30]
   Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844
   So Jae Young, 2012, Mol Cell Pharmacol, V4, P31
   Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088
   Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Xu TP, 2013, CANCER EPIDEMIOL, V37, P725, DOI 10.1016/j.canep.2013.04.017
   Xu X, 2012, BIOMATERIALS, V33, P9049, DOI 10.1016/j.biomaterials.2012.08.061
   YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang ZG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-49
   Zhou LP, 2010, BIOCELL, V34, P91
NR 87
TC 0
Z9 0
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2017
VL 127
BP 61
EP 74
DI 10.1016/j.biomaterials.2017.02.035
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ER5VQ
UT WOS:000398872300006
PM 28279922
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hachim, D
   Wang, N
   Lopresti, ST
   Stahl, EC
   Umeda, YU
   Rege, RD
   Carey, ST
   Mani, D
   Brown, BN
AF Hachim, Daniel
   Wang, Na
   Lopresti, Samuel T.
   Stahl, Elizabeth C.
   Umeda, Yuta U.
   Rege, Rahul D.
   Carey, Sean T.
   Mani, Deepa
   Brown, Bryan N.
TI Effects of aging upon the host response to implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; polarization; host response; aging; implant
ID BIOMATERIAL SURFACE-CHEMISTRY; FOREIGN-BODY REACTION; MACROPHAGE
   ACTIVATION; INFLAMMATORY RESPONSE; IN-VITRO; SUBCUTANEOUS IMPLANTS;
   REGENERATIVE MEDICINE; CARDIAC MACROPHAGES; TISSUE-REPAIR; PORE-SIZE
AB Macrophage polarization during the host response is now a well-accepted predictor of outcomes following material implantation. Immunosenescence, dysregulation of macrophage function, and delayed resolution of immune responses in aged individuals have all been demonstrated, suggesting that host responses to materials in aged individuals should differ from those in younger individuals. However, few studies examining the effects of aging upon the host response have been performed. The present work sought to elucidate the impacts of aging upon the host response to polypropylene mesh implanted into 8-week-old and 18-month-old mice. The results showed that there are significant differences in macrophage surface marker expression, migration, and polarization during the early host macrophage response and delayed resolution of the host response in 18-month-old versus 8-week-old mice. These differences could not be attributed to cell-intrinsic defects alone, suggesting that the host macrophage response to implants is likely also dictated to a significant degree by the local tissue microenvironment. These results raise important questions about the design and testing of materials and devices often intended to treat aged individuals and suggest that an improved understanding of patient- and context-dependent macrophage responses has the potential to improve outcomes in aged individuals. (C) 2017 Wiley Periodicals, Inc.
C1 [Hachim, Daniel; Wang, Na; Lopresti, Samuel T.; Stahl, Elizabeth C.; Mani, Deepa; Brown, Bryan N.] Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
   [Hachim, Daniel; Lopresti, Samuel T.; Umeda, Yuta U.; Rege, Rahul D.; Brown, Bryan N.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15260 USA.
   [Stahl, Elizabeth C.] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.
   [Carey, Sean T.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem Engn, 3700 OHara St, Pittsburgh, PA 15260 USA.
   [Brown, Bryan N.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15213 USA.
RP Brown, BN (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.; Brown, BN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15260 USA.; Brown, BN (reprint author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15213 USA.
EM brownb@upmc.edu
FU National Institutes of Health [K12HD043441, R03AG043606, R21GM107882,
   T32EB001026]
FX Contract grant sponsor: National Institutes of Health; contract grant
   numbers: K12HD043441, R03AG043606, R21GM107882, and T32EB001026
CR Alvarez M. M., 2016, J CONTROL RELEASE
   Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395
   Ashcroft GS, 1998, LAB INVEST, V78, P47
   Blaszykowski C, 2012, CHEM SOC REV, V41, P5599, DOI 10.1039/c2cs35170f
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bruno ME, 2015, J BIOMED MATER RES A, V103, P471, DOI 10.1002/jbm.a.35194
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Campos PP, 2011, HISTOL HISTOPATHOL, V26, P433, DOI 10.14670/HH-26.433
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Finley MJ, 2013, BIOMATERIALS, V34, P8640, DOI 10.1016/j.biomaterials.2013.07.088
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Fleckman P, 2012, J BIOMED MATER RES A, V100A, P1256, DOI 10.1002/jbm.a.34012
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Garash R, 2016, EXP BIOL MED, V241, P1054, DOI 10.1177/1535370216649444
   Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Guo R, 2015, BIOMATERIALS, V73, P85, DOI 10.1016/j.biomaterials.2015.09.005
   Hachim D, 2017, BIOMATERIALS, V112, P95, DOI 10.1016/j.biomaterials.2016.10.019
   Holt DJ, 2012, BIOMATERIALS, V33, P7497, DOI 10.1016/j.biomaterials.2012.06.099
   Hotchkiss KM, 2016, ACTA BIOMATER, V31, P425, DOI 10.1016/j.actbio.2015.12.003
   Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144
   KARP RD, 1973, J NATL CANCER I, V51, P1275, DOI 10.1093/jnci/51.4.1275
   Keeney M, 2013, BIOMATERIALS, V34, P10287, DOI 10.1016/j.biomaterials.2013.09.028
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111
   Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martucci C, 2004, PAIN, V110, P385, DOI 10.1016/j.pain.2004.04.020
   Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810
   Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10
   Miron RJ, 2016, BIOMATERIALS, V82, P1, DOI 10.1016/j.biomaterials.2015.12.017
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Oliva N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1616
   Olivares-Navarrete R, 2012, J BONE MINER RES, V27, P1773, DOI 10.1002/jbmr.1628
   Ortman JM, 2014, AGING NATION OLDER P
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pierce LM, 2009, AM J OBSTET GYNECOL, V200, P546, DOI DOI 10.1016/J.AJ0G.2008.12.040
   Pinto AR, 2014, AGING-US, V6, P399, DOI 10.18632/aging.100669
   Rao ANAMN, 2015, HOST RESPONSE BIOMAT
   Ratner BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5371
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa
   Sebastian C, 2009, HDB IMMUNOSENESCENCE, P919, DOI DOI 10.1007/S11481-011-9312-5
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Stahl EC, 2015, ORGANOGENESIS, V11, P159, DOI 10.1080/15476278.2015.1120046
   Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tengood JE, 2016, EXP BIOL MED, V241, P1033, DOI 10.1177/1535370216647130
   Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125
   Vishwakarma A, 2016, TRENDS BIOTECHNOL, V34, P470, DOI 10.1016/j.tibtech.2016.03.009
   Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 71
TC 4
Z9 4
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1281
EP 1292
DI 10.1002/jbm.a.36013
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300005
PM 28130823
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Xie, CM
   Sun, HL
   Wang, KF
   Zheng, W
   Lu, X
   Ren, FZ
AF Xie, Chaoming
   Sun, Honglong
   Wang, Kefeng
   Zheng, Wei
   Lu, Xiong
   Ren, Fuzeng
TI Graphene oxide nanolayers as nanoparticle anchors on biomaterial
   surfaces with nanostructures and charge balance for bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE graphene oxide; BSA nanoparticle; growth factors; tissue engineering
   scaffold; drug delivery
ID MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS;
   PHOSPHATE SCAFFOLDS; CELL FATE; BMP-2; TITANIUM; IMMOBILIZATION;
   DEGRADATION; STRATEGIES
AB Graphene oxide (GO) is a carbon-based nanomaterial with high surface area and abundant functional groups, providing various sites for binding and immobilization of growth factor vehicles. This study used GO nanolayer as an anchor for the immobilization of bone morphogenetic protein-2 (BMP-2)-encapsulated bovine serum albumin nanoparticles (NPs) on the hydroxyapatite (HA) and tricalcium phosphate (TCP) scaffolds by electrostatic interaction between the positive charges of the NPs and negative charges of GO. GO nanolayers prevented the rapid degradation of TCP scaffolds. Moreover, GO nanolayers promoted NP adsorption on these scaffolds, and realized BMP-2 sustained release. NPs endowed the scaffold surfaces with a nanostructure similar to that of the extracellular matrix (ECM), improving bone marrow stromal cell (BMSC) attachment. Furthermore, the positive charged NPs and negative charged GO nanolayers constructed a charge-balanced surface on the scaffolds, enhancing BMSC proliferation. The nanostructure, charge balance and BMP-2 sustained release capability synergistically improved BMSC differentiation and bone regeneration. In summary, GO is a potential candidate to modify biomaterial surfaces as an anchor for efficient immobilization of growth factor vehicles. (C) 2017 Wiley Periodicals, Inc.
C1 [Xie, Chaoming; Sun, Honglong; Lu, Xiong] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.
   [Wang, Kefeng; Lu, Xiong] Sichuan Univ, Natl Engn Res Ctr Biomat, Genome Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.
   [Zheng, Wei] Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu 610083, Sichuan, Peoples R China.
   [Ren, Fuzeng] South Univ Sci & Technol, Dept Mat Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China.
RP Lu, X (reprint author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.; Lu, X (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Genome Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.; Zheng, W (reprint author), Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu 610083, Sichuan, Peoples R China.
EM luxiong_2004@163.com; zw770880@126.com
RI Ren, Fuzeng/C-3480-2009; Xie, Chaoming/A-4484-2015; LU,
   xiong/B-3092-2010
OI Xie, Chaoming/0000-0002-6916-675X; LU, xiong/0000-0001-6367-430X
FU 863 Program [2015AA034202]; National key research and development
   program of China [2016YFB0700802]; NSFC [81671824]; Open Fund of Key Lab
   of Advanced Technologies of Materials (MOE), Fundamental Research Funds
   for the Central Universities [2682016CX075]; Natural Science Foundation
   of Guangdong Province [2014A030310358]
FX Contract grant sponsor: 863 Program; contract grant number:
   2015AA034202; Contract grant sponsor: National key research and
   development program of China; contract grant number: 2016YFB0700802;
   Contract grant sponsor: NSFC; contract grant number: 81671824; Contract
   grant sponsor: Open Fund of Key Lab of Advanced Technologies of
   Materials (MOE), Fundamental Research Funds for the Central
   Universities; contract grant number: 2682016CX075; Contract grant
   sponsor: Natural Science Foundation of Guangdong Province; contract
   grant number: 2014A030310358
CR Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Bonanni A, 2011, ACS NANO, V5, P2356, DOI 10.1021/nn200091p
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Camci-Unal G, 2013, J TISSUE ENG REGEN M, V7, P337, DOI 10.1002/term.517
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f
   De Luca I, 2016, STEM CELL RES, V17, P248, DOI 10.1016/j.scr.2016.07.005
   Dellinger JG, 2006, J BIOMED MATER RES A, V77A, P563, DOI 10.1002/jbm.a.30658
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c
   Jeon H, 2014, J BIOMED MATER RES B, V102, P1580, DOI 10.1002/jbm.b.33158
   Jiang GD, 2011, CARBON, V49, P2693, DOI 10.1016/j.carbon.2011.02.059
   Jiang L, 2013, J MAT SCI MAT ELECT
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   La WG, 2014, CARBON, V78, P428, DOI 10.1016/j.carbon.2014.07.023
   La WG, 2014, INT J NANOMED, V9, P107, DOI 10.2147/IJN.S50742
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu XL, 2014, CHEM SOC REV, V43, P2385, DOI 10.1039/c3cs60419e
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Ma HS, 2016, ADV FUNCT MATER, V26, P1197, DOI 10.1002/adfm.201504142
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Schuessele A, 2009, J BIOMED MATER RES A, V90A, P959, DOI 10.1002/jbm.a.31745
   Shen XK, 2015, COLLOID SURFACE B, V127, P221, DOI 10.1016/j.colsurfb.2015.01.048
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467
   Tang YW, 2014, J BIOMED MATER RES A, V102, P3803, DOI 10.1002/jbm.a.35050
   Wang HB, 2011, ANGEW CHEM INT EDIT, V50, P7065, DOI 10.1002/anie.201101351
   Wang ZM, 2015, ADV HEALTHC MATER, V4, P927, DOI 10.1002/adhm.201400684
   Wang ZM, 2015, J BIOMED MATER RES A, V103, P1520, DOI 10.1002/jbm.a.35282
   Weaver CL, 2014, ACS NANO, V8, P1834, DOI 10.1021/nn406223e
   Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668
   Wu CT, 2015, CARBON, V93, P116, DOI 10.1016/j.carbon.2015.04.048
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xie CM, 2016, ACS BIOMATER SCI ENG, V2, P920, DOI 10.1021/acsbiomaterials.6b00015
   Xie CM, 2016, ACS APPL MATER INTER, V8, P1707, DOI 10.1021/acsami.5b09232
   Xu C, 2009, SMALL, V5, P2212, DOI 10.1002/smll.200900548
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Zhang SF, 2009, BIOMATERIALS, V30, P5143, DOI 10.1016/j.biomaterials.2009.05.060
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 48
TC 2
Z9 2
U1 3
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1311
EP 1323
DI 10.1002/jbm.a.36010
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300008
PM 28120372
DA 2018-10-20
ER

PT J
AU Lin, STC
   Musson, DS
   Amirapu, S
   Cornish, J
   Bhattacharyya, D
AF Lin, S. T. C.
   Musson, D. S.
   Amirapu, S.
   Cornish, J.
   Bhattacharyya, D.
TI Development of organic solvent-free micro-/nano-porous polymer scaffolds
   for musculoskeletal regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE micro-/nano-fibrillar composite; polymer tissue scaffolds; organic
   solvent-free; osteoblast; tenocyte
ID ROTATOR CUFF TEARS; SYNTHETIC AUGMENTATION; TENDON; REPAIR; TENOMODULIN;
   EXPRESSION; TENOCYTES
AB The use of biomaterial scaffolds has been an enormous field of research in tissue engineering, where the aim is to use graft materials for assisting the human body in recovering lost functions. Currently, there are many ways biomaterial scaffolds can be fabricated; however, many of these techniques involve the use of toxic organic solvents during the process. As biocompatibility is one of the mandatory requirements in designing a successful scaffold, there is an interest in fabricating scaffolds that are completely organic solvent-free. This paper describes the development and characterization of novel micro-/nano-fibrillar composites (MFC/NFC) that can produce scaf-folds which are completely free from organic solvents. In this research, the cytocompatibility of these materials have been tested in vitro using mouse osteoblast-like cells and primary rat tenocytes, where cell numbers increase over the culture period, demonstrating the material viability. Gene expression analysis of primary rat tenocytes on MFC/NFC scaffolds demonstrate tenocytic behavior, and histology studies show an increase in cell formation on NFC scaffolds. This study establishes the potential of using the MFC/NFC technique to produce completely organic solvent-free scaffolds capable of hosting musculoskeletal cells, in the hope of providing a graft material for non-union skeletal fractures and rotator cuff repairs. (C) 2017 Wiley Periodicals, Inc.
C1 [Lin, S. T. C.; Bhattacharyya, D.] Univ Auckland, Dept Mech Engn, Ctr Adv Composite Mat, Auckland, New Zealand.
   [Lin, S. T. C.; Musson, D. S.; Amirapu, S.; Cornish, J.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand.
RP Lin, STC (reprint author), Univ Auckland, Dept Mech Engn, Ctr Adv Composite Mat, Auckland, New Zealand.; Lin, STC (reprint author), Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand.
EM s.lin@auckland.ac.nz
OI Lin, Sandy/0000-0001-9822-3517; Musson, David/0000-0003-2109-8791
FU Ministry of Business, Innovation and Employment [UOAX 1004]; Auckland
   Medical Research Foundation [1311002]; Health Research Council of New
   Zealand; European Union Seventh Framework Programme ske\GEN (FP7)
   [318553]
FX Contract grant sponsor: Ministry of Business, Innovation and Employment;
   contract grant number: UOAX 1004; Contract grant sponsor: Auckland
   Medical Research Foundation; contract grant number: 1311002; Contract
   grant sponsor: Health Research Council of New Zealand; Contract grant
   sponsor: European Union Seventh Framework Programme ske vertical bar GEN
   (FP7/2007-2013); contract grant number: 318553
CR Atala A, 2012, SCI TRANSLAT MED, V4
   Benjamin M, 2000, INT REV CYTOL, V196, P85
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chhana A, 2014, ANN RHEUM DIS, V73, P1737, DOI 10.1136/annrheumdis-2013-204657
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005
   Fakirov S, 2014, INT J POLYM MATER PO, V63, P777, DOI 10.1080/00914037.2014.886214
   Fehringer EV, 2008, J SHOULDER ELB SURG, V17, P881, DOI 10.1016/j.jse.2008.05.039
   Hutmacher D. W., 2006, BIOMATERIALS SILVER, P175
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Kramschuster A, 2010, J BIOMED MATER RES B, V92B, P366, DOI 10.1002/jbm.b.31523
   Le BTN, 2014, AM J SPORT MED, V42, P1134, DOI 10.1177/0363546514525336
   Lin STC, 2014, INT J POLYM MATER PO, V63, P416, DOI 10.1080/00914037.2013.854210
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo UG, 2011, SPORTS MED ARTHROSC, V19, P360, DOI 10.1097/JSA.0b013e318224e359
   Longo UG, 2012, MED SPORT SCI, V57, P168, DOI 10.1159/000328891
   Minagawa H, 2013, J ORTHOP, V10, P8, DOI 10.1016/j.jor.2013.01.008
   Musson DS, 2015, TISSUE ENG PT A, V21, P1539, DOI [10.1089/ten.tea.2014.0128, 10.1089/ten.TEA.2014.0128]
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002
   Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036
   Sun JY, 2010, MACROMOL RAPID COMM, V31, P2077, DOI 10.1002/marc.201000379
   Woo SLY, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P997, DOI 10.1016/B978-0-12-381422-7.10054-9
   Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006
NR 26
TC 1
Z9 1
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1393
EP 1404
DI 10.1002/jbm.a.36023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300016
PM 28160406
DA 2018-10-20
ER

PT J
AU Yang, XY
   Xu, SZ
   Chen, XY
   He, DS
   Ke, XR
   Zhang, L
   Yang, GJ
   Liu, A
   Mou, XZ
   Xia, W
   Gou, ZR
AF Yang, Xianyan
   Xu, Sanzhong
   Chen, Xiaoyi
   He, Dongshuang
   Ke, Xiurong
   Zhang, Lei
   Yang, Guojing
   Liu, An
   Mou, Xiaozhou
   Xia, Wei
   Gou, Zhongru
TI Intra-bone marrow injection of trace elements co-doped calcium phosphate
   microparticles for the treatment of osteoporotic rat
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE antiosteoporosis; trace element; calcium phosphate; local intramarrow
   injection; osteoporotic fracture
ID MESENCHYMAL STEM-CELLS; IN-VIVO; REGENERATIVE MEDICINE; SILICATE
   BIOCERAMICS; OVARIECTOMIZED RATS; SENILE OSTEOPOROSIS; DEFECT REPAIR;
   VITAMIN-D; FRACTURES; PREVENTION
AB Osteoporotic femur fractures are the most common fragility fracture and account for approximately one million injuries per year. Local intervention by intra-marrow injection is potentially a good choice for preventing osteoporotic bone loss when the osteoporotic femoral fracture was treated. Previously, it was shown that trace element co-doped calcium phosphate (teCaP) implants could stimulate osteoporotic bone marrow mesenchymal stem cell activity in vitro and bone regeneration in femoral bone defects in osteoporotic animal models. They hypothesized that local intra-marrow injection of teCaP particles could improve bone function because the teCaP can sustain release of biologically essential inorganic minerals and improve bone remodeling in osteoporosis. The teCaP and CaP particles were synthesized in simulated body fluid with and without adding silicon, zinc and strontium ions. Female rats (8 months) were ovariectomized (OVX) or sham-operated, and then intervened in the femoral marrow space at 12 months old. Groups include: (1) saline water; (2) CaP particles; and (3) teCaP particles. After 2-3 months of intervention, the sham groups showed higher bone mineral density (MBD) in the femur, and teCaP group increased the BMD in the OVX groups. The compressive strength of the OVX-teCaP group was significantly higher than that in the OVX-CaP group. Significant differences between OVX-teCaP and OVX-CaP groups were found for bone mineral microarchitecture, bone mineral density, and trace mineral content, but not for feces composition. These results confirm the teCaP particles could suppress osteoporotic bone loss by local intramarrow injection. Therefore, this biomaterial could be used as a next-generation combination treatment for osteoporotic trauma and osteoporosis itself. (C) 2017 Wiley Periodicals, Inc.
C1 [Yang, Xianyan; Chen, Xiaoyi; He, Dongshuang; Gou, Zhongru] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
   [Xu, Sanzhong] Zhejiang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.
   [Chen, Xiaoyi; Mou, Xiaozhou] Zhejiang Prov Peoples Hosp, Clin Res Inst, Hangzhou 310014, Zhejiang, Peoples R China.
   [Ke, Xiurong; Zhang, Lei; Yang, Guojing] Wenzhou Med Univ, Ruian Peoples Hosp, Ruian 325200, Peoples R China.
   [Ke, Xiurong; Zhang, Lei; Yang, Guojing] Wenzhou Med Univ, Hosp Affiliated 3, Ruian 325200, Peoples R China.
   [Liu, An] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China.
   [Xia, Wei] Uppsala Univ, Angstrom Lab, Dept Engn Sci, Box 534, S-75121 Uppsala, Sweden.
RP Gou, ZR (reprint author), Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.; Xu, SZ (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Orthoped, Qunchun Rd 79, Hangzhou 310009, Zhejiang, Peoples R China.
EM wyhxsz@aliyun.com; zhrgou@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation of China [LY15H180006,
   LY17H180010]; Science and Technology Department of Zhejiang Province
   Foundation [2015C33287, 2014C33202, 2016C33055, 2017C37134]; National
   Science Foundation of China [81301326, 51372218]
FX Contract grant sponsor: Zhejiang Provincial Natural Science Foundation
   of China; contract grant numbers: LY15H180006, LY17H180010; Contract
   grant sponsor: Science and Technology Department of Zhejiang Province
   Foundation; contract grant numbers: 2015C33287, 2014C33202, 2016C33055,
   2017C37134; Contract grant sponsor: National Science Foundation of
   China; contract grant numbers: 81301326, 51372218
CR Arcos D, 2014, ACTA BIOMATER, V10, P1793, DOI 10.1016/j.actbio.2014.01.004
   Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Cao L, 2012, BIOMATERIALS, V33, P5076, DOI 10.1016/j.biomaterials.2012.03.069
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen TL, 2004, BONE, V35, P83, DOI 10.1016/j.bone.2004.03.019
   Chen X, 2013, J NUTR HEALTH AGING, V17, P426, DOI 10.1007/s12603-013-0006-y
   Chen XY, 2013, J MATER CHEM B, V1, P1316, DOI 10.1039/c2tb00138a
   Compston J, 2005, OSTEOPOROSIS INT, V16, pS4, DOI 10.1007/s00198-004-1760-9
   desWinter FR, 1975, CALCIF TISSUE RES, V17, P303
   Egermann M, 2010, J ORTHOP RES, V28, P798, DOI 10.1002/jor.21041
   Fielding GA, 2014, J BIOMED MATER RES A, V102, P2417, DOI 10.1002/jbm.a.34909
   Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249
   Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665
   Gur A, 2002, J BONE MINER METAB, V20, P39, DOI 10.1007/s774-002-8445-y
   He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HOTT M, 1993, CALCIFIED TISSUE INT, V53, P174, DOI 10.1007/BF01321834
   Hulsart-Billstrom G, 2013, J BIOMED MATER RES A, V101, P2322, DOI 10.1002/jbm.a.34526
   Ito H, 2014, CURR OSTEOPOROS REP, V12, P230, DOI 10.1007/s11914-014-0201-8
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   Jee W S, 2001, J Musculoskelet Neuronal Interact, V1, P183
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JC133612
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kwak J, 2013, TISSUE ENG PT A, V19, P426, DOI [10.1089/ten.tea.2012.0042, 10.1089/ten.TEA.2012.0042]
   Li XJJW, 1992, CELLS MATERIALS S, V1, P25
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   Maki K, 2002, AM J ORTHOD DENTOFAC, V122, P410, DOI 10.1067/mod.2002.126152
   Marmor Meir, 2015, J Orthop Trauma, V29 Suppl 12, pS53, DOI 10.1097/BOT.0000000000000469
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Nguyen DT, 2015, J BIOMED MATER RES A, V103, P420, DOI 10.1002/jbm.a.35139
   Nielsen FH, 2000, J TRACE ELEM EXP MED, V13, P113
   Nowson CA, 2010, NUTRIENTS, V2, P975, DOI 10.3390/nu2090975
   Ostuka M, 2008, J PHARM SCI, V97, P421
   Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590
   SCHAPIRA D, 1991, CELLS MATERIALS S, V1, P181
   Shen JH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00067
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Soares AP, 2016, ENVIRON TOXICOL PHAR, V42, P212, DOI 10.1016/j.etap.2016.01.015
   Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2
   Takada K, 2006, STEM CELLS, V24, P399, DOI 10.1634/stemcells.2005-0068
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L
   Tokudome Y, 2009, J BIOMED MATER RES B, V90B, P229, DOI 10.1002/jbm.b.31277
   Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619
   Wu CC, 2015, J BIOMED MATER RES A, V103, P3355, DOI 10.1002/jbm.a.35471
   Xiao Y, 2007, BONE, V40, P700, DOI 10.1016/j.bone.2006.10.021
   Xu SZ, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035002
   Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646
   Yang XY, 2010, J BIOMED MATER RES A, V95A, P1170, DOI 10.1002/jbm.a.32936
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
NR 55
TC 2
Z9 2
U1 5
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1422
EP 1432
DI 10.1002/jbm.a.36027
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300019
PM 28233417
DA 2018-10-20
ER

PT J
AU Jacobs, EE
   Gronowicz, G
   Hurley, MM
   Kuhn, LT
AF Jacobs, E. E.
   Gronowicz, G.
   Hurley, M. M.
   Kuhn, L. T.
TI Biomimetic calcium phosphate/polyelectrolyte multilayer coatings for
   sequential delivery of multiple biological factors
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; multifactor delivery; calcium phosphate; polyelectrolyte
   multilayer films; fibroblast growth factor-2
ID FIBROBLAST GROWTH FACTOR-2; VIVO BONE-FORMATION; DRUG-DELIVERY;
   POLYELECTROLYTE MULTILAYERS; MORPHOGENETIC PROTEIN-2; OSTEOBLASTIC
   CELLS; MC3T3-E1 CELLS; DUAL DELIVERY; FILMS; NANOPARTICLES
AB Combinations of growth factors synergistically enhance tissue regeneration, but typically require sequential, rather than co-delivery from biomaterials for maximum efficacy. Polyelectrolyte multilayer (PEM) coatings can deliver multiple factors without loss of activity; however, sequential delivery from PEM has been limited due to interlayer diffusion that results in co-delivery of the factors. This study shows that addition of a biomimetic calcium phosphate (bCaP) barrier layer to a PEM coating effectively prevents interlayer diffusion and enables sequential delivery of two different biomolecules via direct cell access. A simulated body fluid method was used to deposit a layer of bCaP followed by 30 bilayers of PEM made with poly-l-Lysine (+) and poly l-Glutamic acid (-) (bCaP-PEM). Measurements of MC3T3-E1 proliferation and viability over time on bCaP-PEM were used to demonstrate the sequential delivery kinetics of a proliferative factor [fibroblast growth factor-2 (FGF-2)] followed by a cytotoxic factor (antimycin A, AntiA). FGF-2 and AntiA both retained their bioactivity within bCaP-PEM, yet no release of FGF-2 or AntiA from bCaP-PEM was observed when cells were absent indicating a cell-mediated, local delivery process. This coating technique is useful for a variety of applications that would benefit from highly localized, sequential delivery of multiple biomolecules governed by cell initiated degradation that avoids off-target effects associated with diffusion-based release. (C) 2017 Wiley Periodicals, Inc.
C1 [Jacobs, E. E.; Kuhn, L. T.] Univ Connecticut Hlth, Reconstruct Sci, Farmington, CT 06030 USA.
   [Jacobs, E. E.; Kuhn, L. T.] Univ Connecticut, Biomed Engn, Storrs, CT 06269 USA.
   [Gronowicz, G.] Univ Connecticut Hlth, Dept Surg, Farmington, CT USA.
   [Hurley, M. M.] Univ Connecticut Hlth, Dept Med, Farmington, CT USA.
RP Kuhn, LT (reprint author), Univ Connecticut Hlth, Reconstruct Sci, Farmington, CT 06030 USA.; Kuhn, LT (reprint author), Univ Connecticut, Biomed Engn, Storrs, CT 06269 USA.
EM lkuhn@uchc.edu
FU National Institutes of Health, National Institute of Dental and
   Craniofacial Research (NIDCR) [R01DE021103]
FX Contract grant sponsor: The National Institutes of Health, National
   Institute of Dental and Craniofacial Research (NIDCR); contract grant
   number: R01DE021103
CR Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Charles LF, 2015, EXP GERONTOL, V64, P62, DOI 10.1016/j.exger.2015.02.006
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Choi EM, 2012, INFLAMMATION, V35, P1204, DOI 10.1007/s10753-012-9430-0
   Facca S, 2011, J BIOMED NANOTECHNOL, V7, P482, DOI 10.1166/jbn.2011.1311
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Gerstenfeld L. C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P297
   Gerstenfeld LC, 2003, J MUSCULOSKEL NEURON, V3, P320
   GOHEL AR, 1995, J HISTOCHEM CYTOCHEM, V43, P1085, DOI 10.1177/43.11.7560891
   Goldberg AJ, 2010, J BIOMAT SCI-POLYM E, V21, P1371, DOI 10.1163/092050609X12517190417830
   GRONOWICZ G, 1986, J BONE MINER RES, V1, P441
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005
   KONG W, 1994, J CHEM SOC CHEM COMM, P1297, DOI 10.1039/c39940001297
   Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018
   La WG, 2014, INT J NANOMED, V9, P107, DOI 10.2147/IJN.S50742
   Lee ALZ, 2009, BIOMATERIALS, V30, P919, DOI 10.1016/j.biomaterials.2008.10.062
   Lee JS, 2010, J MATER CHEM, V20, P8894, DOI 10.1039/c0jm01389g
   Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989
   Lim SM, 2010, J MATER SCI-MATER M, V21, P2593, DOI 10.1007/s10856-010-4118-1
   Lukasiewicz S, 2015, LANGMUIR, V31, P6415, DOI 10.1021/acs.langmuir.5b01226
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0
   Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Murshid SA, 2007, J BONE MINER METAB, V25, P151, DOI 10.1007/s00774-006-0745-5
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Ou GM, 2010, J GERONTOL A-BIOL, V65, P1051, DOI 10.1093/gerona/glq114
   Peterson AM, 2014, ACS APPL MATER INTER, V6, P1866, DOI 10.1021/am404849y
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Salama A, 2014, CARBOHYD POLYM, V113, P500, DOI 10.1016/j.carbpol.2014.07.022
   Schade R, 2011, BIOCERAMICS DEV APPL, V1, P1, DOI DOI 10.4303/BDA/D110159
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Su JS, 2013, INT J MOL SCI, V14, P12714, DOI 10.3390/ijms140612714
   Suh KS, 2013, BIOL TRACE ELEM RES, V153, P428, DOI 10.1007/s12011-013-9679-7
   Sundararaj SC, 2013, BIOMATERIALS, V34, P8835, DOI 10.1016/j.biomaterials.2013.07.093
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Vodouhe C, 2006, BIOMATERIALS, V27, P4149, DOI 10.1016/j.biomaterials.2006.03.024
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Zhang S, 2013, HYDROXYAPATITE COATI
NR 47
TC 5
Z9 5
U1 4
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1500
EP 1509
DI 10.1002/jbm.a.35985
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300026
PM 28002652
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bock, RM
   Jones, EN
   Ray, DA
   Bal, BS
   Pezzotti, G
   McEntire, BJ
AF Bock, Ryan M.
   Jones, Erin N.
   Ray, Darin A.
   Bal, B. Sonny
   Pezzotti, Giuseppe
   McEntire, Bryan J.
TI Bacteriostatic behavior of surface modulated silicon nitride in
   comparison to polyetheretherketone and titanium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silicon nitride; anti-infective; surface treatments; titanium;
   polyetheretherketone
ID BACTERIAL ADHESION; BIOFILM FORMATION; ANTIBIOTIC-RESISTANCE; ORTHOPEDIC
   APPLICATIONS; MICROBIAL ADHESION; IMPLANT MATERIALS; ESCHERICHIA-COLI;
   MEDICAL DEVICES; BIOMATERIAL; INFECTION
AB Perioperative and latent infections are leading causes of revision surgery for orthopaedic devices resulting in significant increased patient care, comorbidities, and attendant costs. Identifying biomaterial surfaces that inherently resist biofilm adhesion and bacterial expression is an important emerging strategy in addressing implant-related infections. This in vitro study was designed to compare biofilm formation on three biomaterials commonly employed in spinal fusion surgerysilicon nitride (Si3N4), polyetheretherketone (PEEK), and a titanium alloy (Ti6Al4V-ELI) using one gram-positive and one gram-negative bacterial species. Disc samples from various surface treated Si3N4, PEEK, and Ti6Al4V were inoculated with 10(5) CFU/mm(2)Staphylococcus epidermidis (ATCC (R) 14990 (TM)) or Escherichia coli (ATCC (R) 25922 (TM)) and cultured in PBS, 7% glucose, and 10% human plasma for 24 and 48 h, followed by retrieval and rinsing. Vortexed solutions were diluted, plated, and incubated at 37 degrees C for 24 to 48 h. Colony forming units (CFU/mm(2)) were determined using applicable dilution factors and surface areas. A two-tailed, heteroscedastic Student's t-test (95% confidence) was used to determine statistical significance. The various Si3N4 samples showed the most favorable bacterial resistance for both bacilli tested. The mechanisms for the bacteriostatic behavior of Si3N4 are likely due to multivariate surface effects including submicron-topography, negative charging, and chemical interactions which form peroxynitrite (an oxidative agent). Si3N4 is a new biomaterial with the apparent potential to inhibit biofilm formation. (C) 2017 Wiley Periodicals, Inc.
C1 [Bock, Ryan M.; Jones, Erin N.; Ray, Darin A.; Bal, B. Sonny; McEntire, Bryan J.] Amedica Corp, 1885 W 2100 S, Salt Lake City, UT 84119 USA.
   [Bal, B. Sonny] Univ Missouri, Dept Orthopaed Surg, Coll Med, Columbia, MO 65212 USA.
   [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto, Matsugasaki 6068585, Japan.
RP McEntire, BJ (reprint author), Amedica Corp, 1885 W 2100 S, Salt Lake City, UT 84119 USA.
EM BMcEntire@amedica.com
OI MCENTIRE, BRYAN/0000-0002-7612-9789
FU College of Engineering; Health Sciences Center; Office of the Vice
   President for Research; Utah Science Technology and Research (USTAR)
   initiative of the State of Utah
FX The authors gratefully acknowledge Dr. Brian van Devener of the
   University of Utah for performing XPS measurements and aiding in data
   analyses. Dr. Vinod Radhakrishnan of AntonPaar USA is appreciated for
   performing streaming potential measurements. This work made use of
   University of Utah shared facilities of the Micron Microscopy Suite
   sponsored by the College of Engineering, Health Sciences Center, Office
   of the Vice President for Research, and the Utah Science Technology and
   Research (USTAR) initiative of the State of Utah.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   [Anonymous], 2016, E218007 ASTM
   [Anonymous], 2016, E214913A ASTM
   [Anonymous], 2016, 221962011 ISO
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Bock RM, 2015, ACTA BIOMATER, V26, P318, DOI 10.1016/j.actbio.2015.08.014
   Bordi C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-19
   Bryers JD, 2004, ASM NEWS, V70, P232
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11
   Carvalho I, 2013, MICROBIAL PATHOGENS
   Charville GW, 2008, BIOMATERIALS, V29, P4039, DOI 10.1016/j.biomaterials.2008.07.005
   Cobo J, 2011, EXPERT REV ANTI-INFE, V9, P787, DOI [10.1586/ERI.11.95, 10.1586/eri.11.95]
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   Dante RC, 2012, WEAR, V288, P27, DOI 10.1016/j.wear.2012.03.001
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Delgado AV, 2007, J COLLOID INTERF SCI, V309, P194, DOI 10.1016/j.jcis.2006.12.075
   Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dowsey MM, 2012, RECENT ADV ARTHROPLA, P413
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798
   Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Gomes J, 2013, CHIMIA, V67, P275, DOI 10.2533/chimia.2013.275
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gutowski CJ, 2016, PERIPROSTHETIC JOINT
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hong Y, 2008, LANGMUIR, V24, P5003, DOI 10.1021/la703564q
   Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528
   Izquierdo-Barba I, 2011, ACTA BIOMATER, V7, P2977, DOI 10.1016/j.actbio.2011.03.005
   Jaekel DJ, 2014, PERIPROSTHETIC JOINT, DOI [10.1007/978-1-4614-7928-4_1, DOI 10.1007/978-1-4614-7928-4_1]
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Kelleher SM, 2015, ACS APPL MATER INTER
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Kurtz SM, 2012, J NEUROSURG-SPINE, V17, P342, DOI 10.3171/2012.7.SPINE12203
   Kyomoto M, 2015, ACTA BIOMATER, V24, P24, DOI 10.1016/j.actbio.2015.05.034
   Laarz E, 2000, J AM CERAM SOC, V83, P2394
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lull ME, 2006, ASAIO J, V52, P562, DOI 10.1097/01.mat.0000237694.53808.78
   Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682
   Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   Missirlis YF, 2007, MATERIALWISS WERKST, V38, P983, DOI 10.1002/mawe.200700240
   Moraes MN, 2013, REV MED MINAS GERAIS, V23, P99
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Ozmen Y, 2016, LUBR SCI, V28, P243, DOI 10.1002/ls.1329
   Pezzotti G, 2016, LANGMUIR, V32, P3024, DOI 10.1021/acs.langmuir.6b00393
   Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Rochford ETJ, 2014, COLLOID SURFACE B, V113, P213, DOI 10.1016/j.colsurfb.2013.09.012
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Waser-Althaus J, 2014, J MATER SCI-MATER M, V25, P515, DOI 10.1007/s10856-013-5072-5
   Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8
   Watson GS, 2015, J NANOSCI ADV TECH, V1, P6
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Weidenhammer P, 1996, J COLLOID INTERF SCI, V180, P232, DOI 10.1006/jcis.1996.0294
   Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Yoda I, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0234-2
   Zhang XX, 2013, RSC ADV, V3, P12003, DOI 10.1039/c3ra40497h
   Zhmud BV, 1999, J COLLOID INTERF SCI, V218, P582, DOI 10.1006/jcis.1999.6425
NR 87
TC 7
Z9 7
U1 5
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2017
VL 105
IS 5
BP 1521
EP 1534
DI 10.1002/jbm.a.35987
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ6RR
UT WOS:000398211300028
PM 28000413
DA 2018-10-20
ER

PT J
AU Arahira, T
   Maruta, M
   Matsuya, S
AF Arahira, Takaaki
   Maruta, Michito
   Matsuya, Shigeki
TI Development and characterization of carbonate apatite/beta-tricalcium
   phosphate biphasic cement
SO MATERIALS LETTERS
LA English
DT Article
DE beta-TCP; Carbonate apatite; Biomaterial; Biphasic cement; Bioceramics
ID SCAFFOLDS
AB Biphasic calcium phosphate consisting of carbonate apatite and beta-tricalcium phosphate (beta-TCP) is an excellent bone substitute with controllable bioresorbability. Fabrication of biphasic calcium phosphate with self-setting ability is expected to enhance the potential of applicability as bone substitute. In this study, mixtures of alpha-TCP/beta-TCP powder after carbonation period 1, 3, and 5 h with 1.0 M NaHCO3 were prepared. These powders were mixed with 0.25 M Na2HPO4 at a P/L ratio of 2, and then hardehed at 37 degrees C and 100% RH up to 24 h. XRD patterns and FT-IR spectrum showed that the resulting hardened cement consisted of biphasic carbonate apatite and beta-TCP. Diametral tensile strength of the cement decreased with the carbonation period. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Arahira, Takaaki; Maruta, Michito; Matsuya, Shigeki] Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
RP Arahira, T (reprint author), Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM arahira@college.fdcnet.ac.jp
CR Ahn MK, 2013, CERAM INT, V39, P5879, DOI 10.1016/j.ceramint.2013.01.006
   APFELBAUM F, 1992, J INORG BIOCHEM, V45, P277, DOI 10.1016/0162-0134(92)84016-G
   Arahira T., 2016, MAT SCI E C IN PRESS
   Daitou F, 2010, DENT MATER J, V29, P303, DOI 10.4012/dmj.2009-095
   DRIESSENS FCM, 1983, Z ANORG ALLG CHEM, V504, P195, DOI 10.1002/zaac.19835040925
   FEATHERSTONE JDB, 1984, CARIES RES, V18, P63, DOI 10.1159/000260749
   Gallinetti S, 2014, J AM CERAM SOC, V97, P1065, DOI 10.1111/jace.12861
   Kim JH, 2011, CERAM INT, V37, P2317, DOI 10.1016/j.ceramint.2011.03.023
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3500, DOI 10.1016/j.actbio.2012.05.033
   Matsuya S, 2013, KEY ENG MATER, V529-530, P197, DOI 10.4028/www.scientific.net/KEM.529-530.197
   Nakagawa A, 2007, DENT MATER J, V26, P342, DOI 10.4012/dmj.26.342
   Tiwari Akshay, 2012, J Clin Orthop Trauma, V3, P4, DOI 10.1016/j.jcot.2012.04.004
NR 13
TC 0
Z9 0
U1 3
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD MAY 1
PY 2017
VL 194
BP 205
EP 208
DI 10.1016/j.matlet.2017.02.071
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EP4MD
UT WOS:000397353700053
DA 2018-10-20
ER

PT J
AU Jiao, GL
   Lou, GF
   Mo, YF
   Pan, YQ
   Zhang, ZY
   Guo, R
   Li, ZZ
AF Jiao, Genlong
   Lou, Guofeng
   Mo, Yunfei
   Pan, Yongqin
   Zhang, Ziyong
   Guo, Rui
   Li, Zhizhong
TI A combination of GDNF and hUCMSC transplantation loaded on SF/AGs
   composite scaffolds for spinal cord injury repair
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Alginate microspheres; Silk fibroin; Scaffold; Glial cell-derived
   neurotrophic factor; Human umbilical cord mesenchymal stem cells; Spinal
   cord injury
ID MESENCHYMAL STEM-CELLS; SILK FIBROIN SCAFFOLD; FIBROBLAST-GROWTH-FACTOR;
   FUNCTIONAL RECOVERY; IN-VITRO; REGENERATION; DELIVERY; BIOMATERIAL;
   THERAPIES; MICROSPHERES
AB Spinal cord injury (SCI) is a severe trauma for which no effective treatment is currently available. In this study, a composited treatment system was prepared using a silk fibroin/alginates/glial cell line-derived neurotrophic factor (SF/AGs/GDNF) scaffold seeded with human umbilical cord mesenchymal stem cells (hUCMSCs) and the combined therapeutic effects of the composite scaffold to repair SCI rats were evaluated. The use of SF as a scaffold material could act as a biomimetic platform allowing neurons to properly accommodate and rebuild the target tissue. The SF/AGs/GDNF scaffold had the best sustained-release function and the AGs were the key determining factor in the controlled release of GDNF. After 8 weeks of treatment, the hUCMSCs on SF/AGs/GDNF composite scaffolds could significantly enhance the scar expansion of spinal cord tissue and increased the number of surviving neurons. The combination of GDNF and hUCMSCs transplantation loaded on SF/AGs composite scaffolds exhibited better therapeutic and repair effects to the SCI of rats, compared with the SF/AGs group or GDNF alone on SF/AGs scaffolds. The composite scaffold, GDNF and stem cells could build a bioactive material to form the micro-environment of growth and repair of the neurons. These results may provide a theoretical basis and beneficial exploration for clinical treatment of SCI. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jiao, Genlong; Li, Zhizhong] OfJinan Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510632, Guangdong, Peoples R China.
   [Lou, Guofeng] Jinan Univ, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China.
   [Lou, Guofeng] Jinan Univ, Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China.
   [Mo, Yunfei; Guo, Rui] Jinan Univ, Key Lab Biomat, Guangdong Higher Educ Inst, Guangzhou 510632, Guangdong, Peoples R China.
   [Mo, Yunfei; Guo, Rui] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Pan, Yongqin] Jinan Univ, Affiliated Hosp 1, Dept Surg, Guangzhou 510632, Guangdong, Peoples R China.
   [Zhang, Ziyong] Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
RP Guo, R; Li, ZZ (reprint author), Jinan Univ, 601 Huang Pu Rd West, Guangzhou 510632, Guangdong, Peoples R China.
EM guorui@jnu.edu.cn; lizhizhong1@medmail.com.cn
OI Guo, Rui/0000-0002-7674-073X; Lou, Guofeng/0000-0003-3873-0247
FU Scientific Research Cultivation and Innovation Fund [21615468];
   Administration of Traditional Chinese Medicine of Guangdong Province
   [20141067]; High Level University Construction Funds [88016013032];
   Natural Science Foundation of China [51303064, 31271019]; Ph.D. Programs
   Foundation of the Ministry of Education of China [20124401120015];
   Science and Technology Program of Guangzhou [201601010270]; Science and
   Technology Project of Guangdong [2011B031300006, 2015A010101313,
   2016ZCO050]
FX This study was supported financially by the Scientific Research
   Cultivation and Innovation Fund (21615468), and the Administration of
   Traditional Chinese Medicine of Guangdong Province (20141067), the High
   Level University Construction Funds (88016013032), the Natural Science
   Foundation of China (51303064 and 31271019), the Ph.D. Programs
   Foundation of the Ministry of Education of China (20124401120015), the
   Science and Technology Program of Guangzhou (201601010270), and the
   Science and Technology Project of Guangdong (2011B031300006,
   2015A010101313, 2016ZCO050).
CR Abbott R.D., 2016, ACS APPL MAT INTERFA
   Amr SM, 2014, J SPINAL CORD MED, V37, P54, DOI 10.1179/2045772312Y.0000000069
   Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Chung YG, 2014, BIOMATERIALS, V35, P7452, DOI 10.1016/j.biomaterials.2014.05.044
   DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
   Ding SL, 2015, ANN PLAS SURG, V75, P644, DOI 10.1097/SAP.0000000000000201
   DROST AC, 1993, ANN SURG, V218, P74, DOI 10.1097/00000658-199307000-00012
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Gholipourmalekabadi M, 2015, BIOTECHNOL APPL BIOC, V62, P785, DOI 10.1002/bab.1324
   Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z
   Grulova I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13702
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031
   Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Ji WC, 2013, EXP THER MED, V6, P513, DOI 10.3892/etm.2013.1185
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Khanna O., 2012, J VIS EXP
   Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lan Y, 2014, J BIOMAT SCI-POLYM E, V25, P75, DOI 10.1080/09205063.2013.836951
   Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025
   Li Q, 2013, CELL TISSUE RES, V354, P471, DOI 10.1007/s00441-013-1719-2
   Liu J, 2013, J NEUROL SCI, V325, P127, DOI 10.1016/j.jns.2012.11.022
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Niapour A, 2012, CELL TRANSPLANT, V21, P827, DOI 10.3727/096368911X593163
   Papiez Monika A, 2014, Folia Med Cracov, V54, P71
   Poojari R, 2013, EXPERT OPIN DRUG DEL, V10, P1061, DOI 10.1517/17425247.2013.796361
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253
   Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Snyder EY, 2012, NEW ENGL J MED, V366, P1940, DOI 10.1056/NEJMcibr1200138
   Takenaga M, 2007, CELL TRANSPLANT, V16, P57, DOI 10.3727/000000007783464434
   Tu D.D., 2012, J VIS EXP
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Yang ZY, 2015, P NATL ACAD SCI USA, V112, P13354, DOI 10.1073/pnas.1510194112
   Zhou ZL, 2012, BRAIN RES, V1481, P79, DOI 10.1016/j.brainres.2012.08.051
   Zhu XH, 2008, TISSUE ENG PT A, V14, P1939, DOI 10.1089/ten.tea.2007.0346
   Zuo QH, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/035008
NR 50
TC 2
Z9 2
U1 3
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2017
VL 74
BP 230
EP 237
DI 10.1016/j.msec.2016.12.017
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA EP4NJ
UT WOS:000397356900027
PM 28254289
DA 2018-10-20
ER

PT J
AU Li, WW
   Wang, HY
   Zhang, YQ
AF Li, Wen-Wen
   Wang, Hai-Yan
   Zhang, Yu-Qing
TI A novel chitosan hydrogel membrane by an improved electrophoretic
   deposition and its characteristics in vitro and in vivo
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Chitosan; Electrophoretic deposition; Hydrogel membrane; Medical
   biomaterials
ID FABRICATION; COMPLEX; CHITIN; CELLS; FILMS; GEL
AB Here, we report a novel chitosan hydrogel membrane (CHM) created by an improved electrophoretic deposition. Unlike a traditional CHM by electrophoretic deposition, the CHM was formed on a nanoporous film as a barrier using a homemade device at a high DC voltage.(60 V-Dc). The CHM maximum recovery of 81.7% could be achieved after 1 h of electrophoretic deposition. The transparent CHM with an elongation of 42.46% and swelling index of 538.86% was a mixture of type I and type II crystal structures. SEM revealed that the CHM had an irregular net structure. The CHM was sufficient for L-929 mouse fibroblast cell adhesion and growth. To demonstrate immunocompatibility with host tissues, H&E and TGF-beta were observed and the expressions of TNF-alpha and NE-kappa B were measured up to 3 weeks post-implantation. Although these scaffolds demonstrated an initial pro-inflammatory response, the amount of inflammatory cells and the expressions of TGF-beta 1 returned to baseline control values at 3 weeks. The expressions of TNF-alpha. and NF-kappa B had no significant difference between the experimental and control groups. Animal experiments showed that the CHM did not incite serious inflammatory reactions. Thus, the CHM is a promising medical biomaterial candidate for loading appropriate cells for use as artificial skin or in transplantation.(C) 2016 Elsevier B.V. All rights reserved.
C1 [Li, Wen-Wen; Wang, Hai-Yan; Zhang, Yu-Qing] Soochow Univ, Silk Biotechnol Lab, Sch Biol & Basic Med Sci, Natl Engn Lab Modem Silk, RM702-2303,199 Renai Rd, Suzhou 215123, Peoples R China.
RP Zhang, YQ (reprint author), Soochow Univ, Silk Biotechnol Lab, Sch Biol & Basic Med Sci, Natl Engn Lab Modem Silk, RM702-2303,199 Renai Rd, Suzhou 215123, Peoples R China.
EM sericult@suda.edu.cn
OI Zhang, Yu-Qing/0000-0001-7670-386X
FU earmarked fund for China Agriculture Research System (CARS)
   [CARS-22-ZJ0504]; Priority Academic Program Development (PAPD) of
   Jiangsu Higher Education Institutions, PR China
FX The authors gratefully acknowledge the earmarked fund (CARS-22-ZJ0504)
   for China Agriculture Research System (CARS) and a project funded by the
   Priority Academic Program Development (PAPD) of Jiangsu Higher Education
   Institutions, PR China.
CR Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Chen X, 2000, ACTA CHIM SINICA, V58, P1654
   Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a
   Feng J, 2004, THIN SOLID FILMS, V460, P286, DOI 10.1016/j.tsf.2004.01.082
   Gomes A, 2015, MED CHEM, V11, P560, DOI 10.2174/1573406411666150209114702
   Kaessmann H.J., 1997, USP, Patent No. [US 5597581, 5597581]
   Kastantin MJ, 2003, SENSOR MATER, V15, P295
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu H, 2004, CARBOHYD POLYM, V55, P291, DOI 10.1016/j.carbpol.2003.10.001
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Powers MA, 2005, LAB CHIP, V5, P583, DOI 10.1039/b503112e
   Richardson KE, 2013, CARBOHYD POLYM, V93, P709, DOI 10.1016/j.carbpol.2012.12.054
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Sakiyama T, 1999, J APPL POLYM SCI, V73, P2227, DOI 10.1002/(SICI)1097-4628(19990912)73:11<2227::AID-APP20>3.3.CO;2-W
   Saouels R.J., 1981, J POLYM SCI PP, V19, P1081
   Shacham R, 1999, ADV MATER, V11, P384, DOI 10.1002/(SICI)1521-4095(199903)11:5<384::AID-ADMA384>3.3.CO;2-D
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tanigawa K, 2000, J IMMUNOTHER, V23, P528, DOI 10.1097/00002371-200009000-00003
   Tsai GJ, 2000, J FOOD PROTECT, V63, P747, DOI 10.4315/0362-028X-63.6.747
   URBANCZYK GW, 1994, J APPL POLYM SCI, V51, P2191, DOI 10.1002/app.1994.070511311
   Wang H.Y., 2014, SCI REPORT, P1
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Zhang Z, 2011, J MATER CHEM, V21, P7705, DOI 10.1039/c0jm04164e
NR 28
TC 1
Z9 1
U1 7
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2017
VL 74
BP 287
EP 297
DI 10.1016/j.msec.2016.12.005
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EP4NJ
UT WOS:000397356900034
PM 28254297
DA 2018-10-20
ER

PT J
AU Arahira, T
   Maruta, M
   Matsuya, S
AF Arahira, Takaaki
   Maruta, Michito
   Matsuya, Shigeki
TI Characterization and in vitro evaluation of biphasic alpha-tricalcium
   phosphate/beta-tricalcium phosphate cement
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Biphasic cement; beta-TCP; Biomaterial; Hydroxyapatite
ID MESENCHYMAL STEM-CELLS; BONE REGENERATION; OSTEOGENIC DIFFERENTIATION;
   COMPOSITE SCAFFOLDS; HYDROXYAPATITE; PROLIFERATION; BIOACTIVITY;
   FABRICATION; IMPROVES; SILICATE
AB Biphasic calcium phosphate consisting of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP) is an excellent bone substitute with controllable.bioresorbability. Fabrication of biphasic calcium phosphate with self-setting ability is expected to enhance its potential application as bone substitute. In this study, mixtures of alpha-TCP and beta-TCP with various compositions were prepared through alpha-beta phase transition of alpha-TCP powder at 1000 degrees C for various periods. These powders were mixed with 0.25 M Na2HPO4 at a P/L ratio of 2, and then hardened at 37 degrees C at 100% RH for up to 24h. Material properties of biphasic HA/beta-TCP cement with different alpha-TCP/beta-TCP composition were characterized. These cements were also evaluated with respect to cell response in vitro using MOT3-E1 cell lines. In conclusion, mechanical and biological properties of HA/beta-TCP cement could be controlled by changing the heat treatment time of alpha-TCP powder at 1000 degrees C. In vitro results indicated that cell proliferation and ALP activity increased with increase beta-TCP content. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Arahira, Takaaki; Maruta, Michito; Matsuya, Shigeki] Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
RP Maruta, M (reprint author), Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM maruta@college.fdcnet.ac.jp
FU Japan Society for the Promotion of Science [15K11206]
FX The authors are grateful to Melvin L. Munar for English proofreading.
   This work was supported by a Japan Society for the Promotion of Science
   Grant-in-Aid for Scientific Research (C) Grant Number 15K11206.
CR AbdulQader ST, 2013, CERAM INT, V39, P2375, DOI 10.1016/j.ceramint.2012.08.089
   Abouheif MM, 2010, ARCH ORTHOP TRAUM SU, V130, P231, DOI 10.1007/s00402-009-0998-2
   Ahn MK, 2013, CERAM INT, V39, P5879, DOI 10.1016/j.ceramint.2013.01.006
   Akram M, 2014, J MATER SCI, V49, P1461, DOI 10.1007/s10853-013-7864-x
   Arahira T, 2014, J MECH BEHAV BIOMED, V39, P218, DOI 10.1016/j.jmbbm.2014.07.013
   Capanna R, 2011, CLIN ORTHOP RELAT R, V469, P2905, DOI 10.1007/s11999-011-1882-2
   Correa D, 2015, J BIOMED MATER RES B, V103, P72, DOI 10.1002/jbm.b.33176
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P180
   Fujita M, 2005, TISSUE ENG, V11, P1346, DOI 10.1089/ten.2005.11.1346
   Gallinetti S, 2014, J AM CERAM SOC, V97, P1065, DOI 10.1111/jace.12861
   Gandolfi MG, 2011, MAT SCI ENG C-MATER, V31, P1412, DOI 10.1016/j.msec.2011.05.012
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   Kang YQ, 2012, BIOMATERIALS, V33, P6998, DOI 10.1016/j.biomaterials.2012.06.061
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Link DP, 2007, TISSUE ENG, V13, P493, DOI 10.1089/ten.2006.0015
   Lohfeld S, 2012, ACTA BIOMATER, V8, P3446, DOI 10.1016/j.actbio.2012.05.018
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3500, DOI 10.1016/j.actbio.2012.05.033
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Matsuno T, 2006, DENT MATER J, V25, P138, DOI 10.4012/dmj.25.138
   Matsuo T, 2008, ARCH ORTHOP TRAUM SU, V128, P941, DOI 10.1007/s00402-008-0615-9
   Montufar EB, 2010, ACTA BIOMATER, V6, P876, DOI 10.1016/j.actbio.2009.10.018
   Mori Y, 2014, J HARD TISSUE BIOL, V23, P217, DOI 10.2485/jhtb.23.217
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nikaido T., 2013, KEY ENG MATER, P529
   Oda M, 2008, DENT MATER J, V27, P672, DOI 10.4012/dmj.27.672
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   Poffyn B, 2011, INT ORTHOP, V35, P889, DOI 10.1007/s00264-010-1098-1
   Tamai N, 2010, J ORTHOP SCI, V15, P560, DOI 10.1007/s00776-010-1479-8
   Tiwari Akshay, 2012, J Clin Orthop Trauma, V3, P4, DOI 10.1016/j.jcot.2012.04.004
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Yamauchi D, 2013, J HARD TISSUE BIOL, V22, P473
   Yoshida Y, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-76
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 37
TC 1
Z9 1
U1 6
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2017
VL 74
BP 478
EP 484
DI 10.1016/j.msec.2016.12.049
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EP4NJ
UT WOS:000397356900056
PM 28254321
DA 2018-10-20
ER

PT J
AU Ekdahl, KN
   Soveri, I
   Hilborn, J
   Fellstrom, B
   Nilsson, B
AF Ekdahl, Kristina N.
   Soveri, Inga
   Hilborn, Jons
   Fellstrom, Bengt
   Nilsson, Bo
TI Cardiovascular disease in haemodialysis: role of the intravascular
   innate immune system
SO NATURE REVIEWS NEPHROLOGY
LA English
DT Review
ID CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS
   CIRCUITS; CITRATE-ENRICHED DIALYSATE; PLACEBO-CONTROLLED TRIAL;
   COMPLEMENT COMPONENT C3; STAGE RENAL-DISEASE; ENDOTHELIAL FUNCTION;
   CONTACT ACTIVATION; OXIDATIVE STRESS
AB Haemodialysis is a life-saving renal replacement modality for end-stage renal disease, but this therapy also represents a major challenge to the intravascular innate immune system, which is comprised of the complement, contact and coagulation systems. Chronic inflammation is strongly associated with cardiovascular disease (CVD) in patients on haemodialysis. Biomaterial-induced contact activation of proteins within the plasma cascade systems occurs during haemodialysis and initially leads to local generation of inflammatory mediators on the biomaterial surface. The inflammation is spread by soluble activation products and mediators that are generated during haemodialysis and transported in the extracorporeal circuit back into the patient together with activated leukocytes and platelets. The combined effect is activation of the endothelium of the cardiovascular system, which loses its anti-thrombotic and anti-inflammatory properties, leading to atherogenesis and arteriosclerosis. This concept suggests that maximum suppression of the intravascular innate immune system is needed to minimize the risk of CVD in patients on haemodialysis. A potential approach to achieve this goal is to treat patients with broad-specificity systemic drugs that target more than one of the intravascular cascade systems. Alternatively, 'stealth' biomaterials that cause minimal cascade system activation could be used in haemodialysis circuits.
C1 [Ekdahl, Kristina N.; Nilsson, Bo] Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina N.] Linnaeus Univ, Linnaeus Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Soveri, Inga; Fellstrom, Bengt] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden.
   [Hilborn, Jons] Uppsala Univ, Angstrom Lab, Dept Chem, SE-75121 Uppsala, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
EM bo.nilsson@igp.uu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; European Community
   [602699]; Linnaeus University, Sweden
FX The authors thank Deborah McClellan for editing the manuscript before
   submission and Osama Hamad (Uppsala University, Sweden) for excellent
   help with drafting the figures. The authors' work was supported by grant
   2013-65X-05647-34-4 from the Swedish Research Council (VR), the European
   Community's Seventh Framework Programme under the grant agreement no
   602699 (DIREKT), and faculty grants from the Linnaeus University,
   Sweden.
CR Agharazii M, 2015, AM J HYPERTENS, V28, P746, DOI 10.1093/ajh/hpu225
   Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940
   Almasri J, 2016, J VASC SURG, V64, P236, DOI 10.1016/j.jvs.2016.01.053
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Annuk M, 2005, J NEPHROL, V18, P721
   Annuk M, 2001, J AM SOC NEPHROL, V12, P2747
   Annuk M, 2001, CLIN NEPHROL, V56, P308
   Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3
   Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44
   BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409
   Ceravolo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111117
   Cheng YL, 2011, NEPHROL DIAL TRANSPL, V26, P641, DOI 10.1093/ndt/gfq396
   CHENOWETH DE, 1983, KIDNEY INT, V24, P764, DOI 10.1038/ki.1983.225
   Cobo G, 2016, SEMIN DIALYSIS, V29, P7, DOI 10.1111/sdi.12440
   Cohen SD, 2010, NEPHROL DIAL TRANSPL, V25, P1239, DOI 10.1093/ndt/gfp625
   Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229
   Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130
   Dhondt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128634
   DINARELLO CA, 1985, J CLIN IMMUNOL, V5, P287, DOI 10.1007/BF00918247
   Duchene J, 2009, CURR OPIN PHARMACOL, V9, P125, DOI 10.1016/j.coph.2008.11.011
   Eckardt KU, 2015, KIDNEY INT, V88, P1117, DOI 10.1038/ki.2015.117
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471
   Engberg AE, 2015, BIOMATERIALS, V36, P55, DOI 10.1016/j.biomaterials.2014.09.011
   Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730
   Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177
   Feng WJ, 2016, J GERONTOL A-BIOL, V71, P178, DOI 10.1093/gerona/glu210
   Figueroa CD, 2015, INNATE IMMUN-LONDON, V21, P289, DOI 10.1177/1753425914529169
   Foley RN, 1998, J AM SOC NEPHROL, V9, P267
   Francois K, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-104
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Friedrich B, 2006, KIDNEY INT, V70, P2124, DOI 10.1038/sj.ki.5001865
   Furebring M, 2006, SCAND J IMMUNOL, V63, P208, DOI 10.1111/j.1365-2006.01724.x
   Ghanavatian S, 2014, ANGIOLOGY, V65, P443, DOI 10.1177/0003319713483000
   Ghebrehiwet B, 2016, IMMUNOL REV, V274, P281, DOI 10.1111/imr.12469
   Gillespie IA, 2015, PHARMACOEPIDEM DR S, V24, P414, DOI 10.1002/pds.3755
   Giri S, 2015, THROMB RES, V135, P782, DOI 10.1016/j.thromres.2015.02.013
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Hamad OA, 2012, ADV EXP MED BIOL, V946, P185, DOI 10.1007/978-1-4614-0106-3_11
   Heitsch H, 2003, EXPERT OPIN INV DRUG, V12, P759, DOI 10.1517/13543784.12.5.759
   Hemker HC, 2016, J THROMB HAEMOST, V14, P2329, DOI 10.1111/jth.13555
   Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x
   Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0
   Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014
   Horl WH, 2002, J AM SOC NEPHROL, V13, pS62
   Huang S, 2016, BIOMATERIALS, V77, P111, DOI 10.1016/j.biomaterials.2015.10.067
   Huang ZP, 2009, SEMIN DIALYSIS, V22, P623, DOI 10.1111/j.1525-139X.2009.00658.x
   Hulander M, 2013, COLLOID SURFACE B, V110, P261, DOI 10.1016/j.colsurfb.2013.04.010
   Hung AM, 2011, J AM SOC NEPHROL, V22, P437, DOI 10.1681/ASN.2010070760
   Ishihara K, 2009, J R SOC INTERFACE, V6, pS279, DOI [10.1098/rsif.2008.0335.focus, 10.1098/rsif.2008.0335]
   Ismail G, 2013, INT J NEPHROL, V2013
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2
   Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
   Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926
   Kessler M, 2013, HEMODIAL INT, V17, P282, DOI 10.1111/j.1542-4758.2012.00733.x
   Koch M, 2014, IUBMB LIFE, V66, P735, DOI 10.1002/iub.1333
   Kolafova H., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/694312
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Krummel T, 2013, BLOOD PURIFICAT, V35, P1, DOI 10.1159/000350835
   Larsson M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006804
   Leeb-Lundberg LMF, 2001, J BIOL CHEM, V276, P8785, DOI 10.1074/jbc.M007396200
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451
   Lizama AJ, 2015, INNATE IMMUN-LONDON, V21, P575, DOI 10.1177/1753425914566083
   Manthey HD, 2011, FASEB J, V25, P2447, DOI 10.1096/fj.10-174284
   Mares J, 2010, PROTEOM CLIN APPL, V4, P829, DOI 10.1002/prca.201000031
   Marney AM, 2009, J AM SOC NEPHROL, V20, P2246, DOI 10.1681/ASN.2009050505
   Merchant AA, 2015, CURR OPIN NEPHROL HY, V24, P276, DOI 10.1097/MNH.0000000000000114
   Molnar MZ, 2012, NAT REV NEPHROL, V8, P284, DOI 10.1038/nrneph.2012.36
   Nakano A, 2011, CONTRIB NEPHROL, V173, P164, DOI 10.1159/000329056
   Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Olsson C, 2000, SCAND CARDIOVASC J, V34, P33
   Papageorgiou PC, 2014, J HYPERTENS, V32, P1523, DOI 10.1097/HJH.0000000000000192
   Persona P, 2015, INT J ARTIF ORGANS, V38, P343, DOI 10.5301/ijao.5000421
   Peters SAE, 2016, NEPHROL DIAL TRANSPL, V31, P978, DOI 10.1093/ndt/gfv349
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Rogacev KS, 2009, NEPHROL DIAL TRANSPL, V24, P3480, DOI 10.1093/ndt/gfp287
   Saito A., 2011, HIGH PERFORMANCE MEM, P137
   Sakai K, 2011, CONTRIB NEPHROL, V173, P11, DOI 10.1159/000328940
   Schoorl M, 2011, SCAND J CLIN LAB INV, V71, P240, DOI 10.3109/00365513.2011.558106
   Soveri I, 2007, NEPHRON CLIN PRACT, V106, P180, DOI 10.1159/000104429
   Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x
   Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015
   Taal MW, 2014, CURR OPIN NEPHROL HY, V23, P169, DOI 10.1097/01.mnh.0000441153.40072.e0
   Takemoto Y, 2011, CONTRIB NEPHROL, V168, P139, DOI 10.1159/000321753
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   Terzuoli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084358
   The Cholesterol Treatment Trialists' (CTT) Collaboration, 2016, LANCET DIABETES ENDO, V4, P829
   Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085
   Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972
   Trouw LA, 2011, IMMUNOL LETT, V138, P35, DOI 10.1016/j.imlet.2011.02.014
   Varela MP, 2001, BLOOD PURIFICAT, V19, P370, DOI 10.1159/000046967
   Verschoor A, 2016, IMMUNOL REV, V274, P112, DOI 10.1111/imr.12473
   Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545
   Wanner C, 2016, LANCET, V388, P276, DOI 10.1016/S0140-6736(16)30508-6
   Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194
   Wezel A, 2014, J CELL MOL MED, V18, P2020, DOI 10.1111/jcmm.12357
   Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014
   Yang Guang, 2010, J Cardiovasc Dis Res, V1, P59, DOI 10.4103/0975-3583.64432
   Zhang W, 2013, J NEPHROL, V26, P243, DOI 10.5301/jn.5000169
   Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910
   Zweigert C, 2013, COMPREHENSIVE MEMBRA, P351
NR 112
TC 9
Z9 9
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5061
EI 1759-507X
J9 NAT REV NEPHROL
JI Nat. Rev. Nephrol.
PD MAY
PY 2017
VL 13
IS 5
BP 285
EP 296
DI 10.1038/nrneph.2017.17
PG 12
WC Urology & Nephrology
SC Urology & Nephrology
GA ER7OR
UT WOS:000399003200005
PM 28239169
DA 2018-10-20
ER

PT J
AU Rico, JL
   Hargreaves, JSJ
AF Rico, J. L.
   Hargreaves, J. S. J.
TI Synthesis and characterization of iron and iron nitride microtubes
   obtained from biogenic iron oxide
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID CATALYST
AB With the aim to obtain iron tubular microstructures attractive for various applications, we have used a natural biogenic iron ochre as a raw material and explore various procedures and experimental conditions to achieve our goal. Our experiments included reduction, nitridation and characterization of microtubes derived from biogenic iron ochre. Various temperatures of reduction under streams of H-2/N-2 or NH3 were tested. Our results show that the tubular structure is maintained after reduction of the natural material under H-2/N-2. In addition, ammonia was not produced under our experimental conditions, and as expected, hydrogen reduced the material. However, the treatment under NH3 reduces the material and allows the incorporation of nitrogen into the structure of the solid yielding iron nitride microtubes. Reduced and nitrided microstructures were successfully obtained from natural biogenic iron ochre. A temperature of 500 A degrees C seems to be suitable to expose the calcined biogenic iron ochre under H-2/N-2 for 4 h or under ammonia for 8 h to obtain reduced or nitrided microtubes, respectively. The stability of the tubular structure during reduction/reduction-nitridation is maintained under both treatments. Further interesting applications of this natural biomaterial could be envisaged.
C1 [Rico, J. L.] Univ Michoacana, Fac Ingn Quim, Lab Catalisis, Edificio V1, Morelia 58060, Michoacan, Mexico.
   [Hargreaves, J. S. J.] Univ Glasgow, Sch Chem, WestCHEM, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
RP Hargreaves, JSJ (reprint author), Univ Glasgow, Sch Chem, WestCHEM, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM jlrico@umich.mx; Justin.Hargreaves@glasgow.ac.uk
FU CONACyT
FX The authors thank Mr. Gangi Reddy Ubarra for CHN analysis, and James and
   Christopher Hargreaves for collecting the iron ochre. In addition, JLR
   thanks CONACyT for the financial support received during his sabbatical
   period at the University of Glasgow, Scotland, UK.
CR Alharthi A, 2014, J CHEM TECHNOL BIOT, V89, P1317, DOI 10.1002/jctb.4434
   Darken L, 1953, PHYS CHEM METALS, V1953, P374
   Ema T, 2013, GREEN CHEM, V15, P2485, DOI 10.1039/c3gc41055b
   Ema T, 2011, GREEN CHEM, V13, P3187, DOI 10.1039/c1gc15877e
   Ferris FG, 2000, APPL GEOCHEM, V15, P1035, DOI 10.1016/S0883-2927(99)00093-1
   Hargreaves JSJ, 2016, J CHEM TECHNOL BIOT, V91, P296, DOI 10.1002/jctb.4847
   Hashimoto H, 2015, MATER CHEM PHYS, V155, P67, DOI 10.1016/j.matchemphys.2015.01.067
   Hashimoto H, 2013, ACS APPL MATER INTER, V5, P518, DOI 10.1021/am302837p
   Jozwiak WK, 2007, APPL CATAL A-GEN, V326, P17, DOI 10.1016/j.apcata.2007.03.021
   Mandai K, 2012, TETRAHEDRON LETT, V53, P329, DOI 10.1016/j.tetlet.2011.11.044
   Nishimaki K, 1999, NANOSTRUCT MATER, V12, P527, DOI 10.1016/S0965-9773(99)00175-0
   Rentz J, 2010, PHOSPHORUS REMOVAL P
   Shopska M, 2016, REACT KINET MECH CAT, V118, P179, DOI 10.1007/s11144-016-0989-6
   Shopska MG, 2015, BULG CHEM COMMUN, V47, P79
   Shopska MG, 2014, CROAT CHEM ACTA, V87, P161, DOI 10.5562/cca2374
   VOLPE L, 1985, J SOLID STATE CHEM, V59, P332, DOI 10.1016/0022-4596(85)90301-9
NR 16
TC 1
Z9 1
U1 1
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY
PY 2017
VL 52
IS 9
BP 5188
EP 5193
DI 10.1007/s10853-017-0759-5
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA EM1VP
UT WOS:000395105500037
DA 2018-10-20
ER

PT J
AU Bonifacio, MA
   Gentile, P
   Ferreira, AM
   Cometa, S
   De Giglio, E
AF Bonifacio, Maria A.
   Gentile, Piergiorgio
   Ferreira, Ana M.
   Cometa, Stefania
   De Giglio, Elvira
TI Insight into halloysite nanotubes-loaded gellan gum hydrogels for soft
   tissue engineering applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Gellan gum; Halloysite nanotubes (HNT); Hydrogel; Human fibroblasts;
   Tissue engineering
ID SPONGY-LIKE HYDROGELS; STEM-CELL FATE; MECHANICAL-PROPERTIES; COMPOSITE
   SCAFFOLDS; REGENERATIVE MEDICINE; CLAY NANOTUBES; BONE TISSUE;
   NANOCOMPOSITES; POLYMER; DESIGN
AB A tri-component hydrogel, based on gellan gum (GG), glycerol (Gly) and halloysite nanotubes (HNT), is proposed in this work for soft tissue engineering applications. The FDA-approved GG polysaccharide has been recently exploited as biomaterial because its biomimetic features. Gly is added as molecular spacer to improve hydrogel viscosity and mechanical properties. HNT incorporation within the hydro gel offers the versatility to improve the GG-Gly biocompatibility with potential incorporation of target biomolecules. In this work, hydrogels with different composition ratios are physically crosslinked for tuning physico-mechanical properties. An accurate physico-chemical characterization is reported. HNT addition leads to a water uptake decrease of 30-35% and tuneable mechanical properties with a compressive Young's modulus ranging between 20 and 75 kPa. Finally, in vitro study with human fibroblasts on GG-Gly hydrogels loaded with 25% HNT offered the higher metabolic activities and cell survival up to 7 days of incubation. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Bonifacio, Maria A.; De Giglio, Elvira] Univ Bari Aldo Moro, Dept Chem, Via E Orabona 4, I-70126 Bari, Italy.
   [Gentile, Piergiorgio; Ferreira, Ana M.] Newcastle Univ, Sch Mech & Syst Engn, Stephenson Bldg,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Cometa, Stefania] Jaber Innovat Srl, Via Calcutta 8, I-00144 Rome, Italy.
RP De Giglio, E (reprint author), Univ Bari Aldo Moro, Dept Chem, Via E Orabona 4, I-70126 Bari, Italy.
EM maria.bonifacio@uniba.it; piergiorgio.gentile@newcastle.ac.uk;
   ana.ferreira-duarte@newcastle.ac.uk; stefania.cometa@virgilio.it;
   elvira.degiglio@uniba.it
OI Ferreira-Duarte, Ana/0000-0002-7728-1619; Gentile,
   Piergiorgio/0000-0002-3036-6594; Bonifacio, Maria
   Addolorata/0000-0002-9923-8267; De Giglio, Elvira/0000-0001-9387-6201
FU University degli Studi di Bari Aldo Moro
FX This work was supported by University degli Studi di Bari Aldo Moro. The
   authors would like to thank the Bioimaging Unit at Newcastle University
   for supporting the confocal analysis. Dr Vincenzo Schiavo is greatly
   acknowledged for his valuable support in TGA measurements. The authors
   would also like to thank Mr Michael Foster for his helpful advice on
   SEM/EDX analysis, Mr Stephen Moore for the kind support during the
   freeze-drying procedure and Mr Alex Boote for his helpful contribution
   in mechanical test.
CR Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Balakrishnan B, 2014, ACTA BIOMATER, V10, P3650, DOI 10.1016/j.actbio.2014.04.031
   Barbucci R., 2009, HYDROGELS BIOL PROPE, P84
   Barrett DG, 2009, MOLECULES, V14, P4022, DOI 10.3390/molecules14104022
   Bottino MC, 2015, J TISSUE ENG REGEN M, V9, pE116, DOI 10.1002/term.1712
   Cerqueira MT, 2014, ACS APPL MATER INTER, V6, P19668, DOI 10.1021/am504520j
   Chalasani R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03498
   Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]
   Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   da Silva LP, 2014, ACTA BIOMATER, V10, P4787, DOI 10.1016/j.actbio.2014.07.009
   Dawson JI, 2013, ADV MATER, V25, P4069, DOI 10.1002/adma.201301034
   De Giglio E, 2011, ACTA BIOMATER, V7, P882, DOI 10.1016/j.actbio.2010.07.030
   de Souza FS, 2016, CARBOHYD POLYM, V148, P309, DOI 10.1016/j.carbpol.2016.04.019
   Du ML, 2008, POLYMER, V49, P4871, DOI 10.1016/j.polymer.2008.08.042
   Du ML, 2010, POLYM INT, V59, P574, DOI 10.1002/pi.2754
   Fernandez-Diaz MD, 2001, FOOD CHEM, V74, P161, DOI 10.1016/S0308-8146(01)00110-8
   Gentile P, 2012, J BIOMED MATER RES A, V100A, P2654, DOI 10.1002/jbm.a.34205
   Giavasis I, 2000, CRIT REV BIOTECHNOL, V20, P177, DOI 10.1080/07388550008984169
   Goponenko AV, 2016, POLYMER, V101, P415, DOI 10.1016/j.polymer.2016.08.068
   Gorodzha S., 2016, J BIOMEDICAL MAT R A, V104, P1294
   Gupta NV, 2010, DARU, V18, P200
   Huang B, 2017, MAT SCI ENG C-MATER, V70, P303, DOI 10.1016/j.msec.2016.09.001
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hughes AD, 2015, LANGMUIR, V31, P13553, DOI 10.1021/acs.langmuir.5b03288
   Jia ZX, 2009, POLYM-PLAST TECHNOL, V48, P607, DOI 10.1080/03602550902824440
   Kaklamani G, 2014, J MECH BEHAV BIOMED, V36, P135, DOI 10.1016/j.jmbbm.2014.04.013
   Kamble R., 2012, J ADV SCI RES, V3, P25, DOI DOI 10.1002/PI.2754
   Kang D, 2015, CARBON, V91, P445, DOI 10.1016/j.carbon.2015.05.021
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kommireddy DS, 2005, J BIOMED NANOTECHNOL, V1, P286, DOI 10.1166/jbn.2005.046
   Liu HH, 2011, CARBOHYD POLYM, V83, P1591, DOI 10.1016/j.carbpol.2010.10.018
   Liu MX, 2015, MAT SCI ENG C-MATER, V49, P700, DOI 10.1016/j.msec.2015.01.037
   Liu MX, 2013, J MATER CHEM B, V1, P2078, DOI 10.1039/c3tb20084a
   Liu MX, 2012, INT J BIOL MACROMOL, V51, P566, DOI 10.1016/j.ijbiomac.2012.06.022
   Lopes AC, 2014, PROG SURF SCI, V89, P239, DOI 10.1016/j.progsurf.2014.08.002
   Lugao AB, 2002, RADIAT PHYS CHEM, V63, P543, DOI 10.1016/S0969-806X(01)00551-5
   Lvov Y, 2016, ADV MATER, V28, P1227, DOI 10.1002/adma.201502341
   Mattioli-Belmonte M., 2015, J TISSUE ENG REGENER
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Naumenko EA, 2016, NANOSCALE, V8, P7257, DOI 10.1039/c6nr00641h
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Oliveira MB, 2016, ACTA BIOMATER, V41, P119, DOI 10.1016/j.actbio.2016.05.033
   Osmalek T, 2014, INT J PHARMACEUT, V466, P328, DOI 10.1016/j.ijpharm.2014.03.038
   Pasqui D, 2012, POLYMERS-BASEL, V4, P1517, DOI 10.3390/polym4031517
   Payen S., 2007, INTEGRATION HYDROGEL, P37
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pfeiffer E, 2008, OSTEOARTHR CARTILAGE, V16, P1237, DOI 10.1016/j.joca.2008.02.014
   Prajapati VD, 2013, CARBOHYD POLYM, V93, P670, DOI 10.1016/j.carbpol.2013.01.030
   Santhanam S, 2016, ACTA BIOMATER, V43, P327, DOI 10.1016/j.actbio.2016.07.051
   Shah D, 2005, ADV MATER, V17, P525, DOI 10.1002/adma.200400984
   Shin HH, 2014, J MATER CHEM B, V2, P2508, DOI 10.1039/c3tb20984a
   Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vergaro V, 2010, BIOMACROMOLECULES, V11, P820, DOI 10.1021/bm9014446
   Wagenseil JE, 2003, J BIOMECH ENG-T ASME, V125, P719, DOI 10.1115/1.1614818
   Wang CM, 2008, ACTA BIOMATER, V4, P1226, DOI 10.1016/j.actbio.2008.03.008
   White RD, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065705
   Yuan P, 2015, APPL CLAY SCI, V112, P75, DOI 10.1016/j.clay.2015.05.001
   Zhang Y, 2016, APPL CLAY SCI, V119, P8, DOI 10.1016/j.clay.2015.06.034
   Zhao S, 2014, BIOMACROMOLECULES, V15, P2521, DOI 10.1021/bm500388m
   Zhao X., 2010, J APPL PHYS, V107
   Zhou WY, 2010, J BIOMED MATER RES A, V93A, P1574, DOI 10.1002/jbm.a.32656
NR 65
TC 13
Z9 13
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 1
PY 2017
VL 163
BP 280
EP 291
DI 10.1016/j.carbpol.2017.01.064
PG 12
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA EO8QS
UT WOS:000396955500032
PM 28267508
DA 2018-10-20
ER

PT J
AU Kang, DH
   Choi, H
   Yoo, YJ
   Kim, JH
   Park, YB
   Moon, HS
AF Kang, Doo-Hwa
   Choi, Hyunmin
   Yoo, Yun-Jung
   Kim, Jae-Hong
   Park, Young-Bum
   Moon, Hong-Seok
TI Effect of polishing method on surface roughness and bacterial adhesion
   of zirconia-porcelain veneer
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Bacterial adhesion; Zirconia; Surface roughness; Sreptococcus mitis;
   Scanning electron microscopy; LIVE/DEAD staining
ID IN-VITRO; RESTORATIVE MATERIALS; STREPTOCOCCUS-MUTANS; ORAL
   STREPTOCOCCI; DENTAL CERAMICS; BIOFILM; CORE; BIOMATERIAL; ADHERENCE;
   STRENGTH
AB The purpose of this study was to evaluate the effect of various polishing methods on surface roughness of zirconia-porcelain veneer and to correlate the findings with early bacterial adhesion. The study specimens were glazed (control group), glazed after fine polishing (glazed group) and polished with Exa Cerapol (Cerapol group) or with Shofu porcelain adjustment kit (Shofu group) (n =20). Surface roughness was then measured using profilometer and scanning electron microscope (SEM). After artificial saliva coating, the specimens were incubated in Streptococcus mitis suspension for 4 h at 37 degrees C. Adherent bacteria were quantified from SEM images. Streptococcal viability was assessed by LIVE/DEAD staining kit and fluorescent microscope. There were significant differences in surface roughness according to polishing method and surface material. Relatively smoother surfaces were found in zirconia surfaces and glazed porcelain surfaces. There were also significant differences in bacterial adhesion according to polishing method and surface material. Cerapol group showed minimal bacterial adhesion with more dead cells when compared to other groups. A positive correlation between surface roughness and bacterial adhesion was found in glazed porcelain surface and a negative correlation in zirconia surface of Cerapol group, both with no statistical significance. Within the limitations of in vitro study, surface roughness and bacteria adhesion were significantly influenced by polishing method and surface material. Also, there was a positive correlation and negative correlation between surface roughness and bacterial adhesion in glazed porcelain surface and in zirconia surface of Cerapol group, respectively.
C1 [Kang, Doo-Hwa; Choi, Hyunmin; Park, Young-Bum; Moon, Hong-Seok] Yonsei Univ, Coll Dent, Oral Sci Res Ctr, Dept Prosthodont, Seoul, South Korea.
   [Yoo, Yun-Jung] Yonsei Univ, Coll Dent, Res Ctr Orofacial Hard Tissue Regenerat, Dept Oral Biol, Seoul, South Korea.
   [Kim, Jae-Hong] Kyungdong Univ, Sch Med & Publ Hlth, Dept Dent Technol, Wonju, Gangwondo, South Korea.
   [Park, Young-Bum] Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea.
   [Moon, Hong-Seok] Yonsei Univ, Coll Dent, Dept Prosthodont, 50 Yonsei Ro, Seoul 120752, South Korea.
RP Park, YB; Moon, HS (reprint author), Yonsei Univ, Coll Dent, Oral Sci Res Ctr, Dept Prosthodont, Seoul, South Korea.; Park, YB (reprint author), Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea.
EM drybpark@yuhs.ac; hsm5@yuhs.ac
FU Institute for Information & communications Technology Promotion (IITP) -
   Korea government (MSIP) [R0190-15-1113]
FX This work was supported by Institute for Information & communications
   Technology Promotion (IITP) grant funded by the Korea government (MSIP)
   (No. R0190-15-1113, Developing digital dentistry system for implant
   surgical guide and prosthetic design).
CR Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Allion A, 2006, BIOFOULING, V22, P269, DOI 10.1080/08927010600902789
   BESSING C, 1983, SCAND J DENT RES, V91, P482
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Eick S, 2004, J ORAL REHABIL, V31, P278, DOI 10.1046/j.0305-182X.2003.01233.x
   Grivet M, 2000, J MATER SCI-MATER M, V11, P637, DOI 10.1023/A:1008913915399
   Guazzato M, 2004, DENT MATER, V20, P449, DOI 10.1016/j.dental.2003.05.002
   Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Johansson A, 1996, APMIS, V104, P367, DOI 10.1111/j.1699-0463.1996.tb00729.x
   Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002
   Kou W, 2006, J ORAL REHABIL, V33, P117, DOI 10.1111/j.1365-2842.2006.01546.x
   Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x
   Meier R, 2008, J MATER SCI-MATER M, V19, P3249, DOI 10.1007/s10856-008-3457-7
   Messer RLW, 2003, J PROSTHET DENT, V90, P452, DOI 10.1016/S0022-3913(03)00533-X
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Rosentritt M, 2008, J BIOMED MATER RES B, V86B, P36, DOI 10.1002/jbm.b.30985
   Rosentritt M, 2009, J BIOMED MATER RES B, V91B, P257, DOI 10.1002/jbm.b.31397
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
NR 21
TC 5
Z9 5
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY
PY 2017
VL 43
IS 7
BP 5382
EP 5387
DI 10.1016/j.ceramint.2016.11.036
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA EP0KJ
UT WOS:000397075900003
DA 2018-10-20
ER

PT J
AU Zhukova, Y
   Ulasevich, SA
   Dunlop, JWC
   Fratzl, P
   Mohwald, H
   Skorb, EV
AF Zhukova, Yulia
   Ulasevich, Sviatlana A.
   Dunlop, John W. C.
   Fratzl, Peter
   Moehwald, Helmuth
   Skorb, Ekaterina V.
TI Ultrasound-driven titanium modification with formation of titania based
   nanofoam surfaces
SO ULTRASONICS SONOCHEMISTRY
LA English
DT Article
DE Ultrasound; Cavitation; Titanium; TiO2; Nanotopography; Roughness
ID BIOCOMPATIBLE IMPLANT SURFACES; CAPSULES; RELEASE; ANTIBACTERIAL;
   CAVITATION; ADHESION; WATER; HEAT
AB Titanium has been widely used as biomaterial for various medical applications because of its mechanical strength and inertness. This on the other hand makes it difficult to structure it. Nanostructuring can improve its performance for advanced applications such as implantation and lab-on-chip systems. In this study we show that a titania nanofoam on titanium can be formed under high intensity ultrasound (HIUS) treatment in alkaline solution. The physicochemical properties and morphology of the titania nanofoam are investigated in order to find optimal preparation conditions for producing surfaces with high wettability for cell culture studies and drug delivery applications. AFM and contact angle measurements reveal, that surface roughness and wettability of the surfaces depend nonmonotonously on ultrasound intensity and duration of treatment, indicating a competition between HIUS induced roughening and smoothening mechanisms. We finally demonstrate that superhydrophilic bio-and cytocompatible surfaces can be fabricated with short time ultrasonic treatment. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhukova, Yulia; Ulasevich, Sviatlana A.; Dunlop, John W. C.; Fratzl, Peter; Moehwald, Helmuth; Skorb, Ekaterina V.] Max Planck Inst Colloids & Interfaces, Muhlenberg 1, D-14476 Golm, Germany.
RP Zhukova, Y (reprint author), Max Planck Inst Colloids & Interfaces, Muhlenberg 1, D-14476 Golm, Germany.
EM yulia.zhukova@mpikg.mpg.de
RI Skorb, Ekaterina/J-1554-2017; Fratzl, Peter/H-9095-2012
OI Skorb, Ekaterina/0000-0003-0888-1693; Fratzl, Peter/0000-0003-4437-7830
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Andreeva DV, 2012, SMALL, V8, P820, DOI 10.1002/smll.201102365
   [Anonymous], 2014, CAV NOV EN EFF TECHN
   Baidukova O, 2015, CHEM COMMUN, V51, P7606, DOI 10.1039/c4cc10026c
   Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cherepanov PV, 2015, GREEN CHEM, V17, P2745, DOI 10.1039/c5gc00047e
   Cherepanov PV, 2015, ULTRASON SONOCHEM, V26, P9, DOI 10.1016/j.ultsonch.2015.03.002
   De Geest BG, 2007, SMALL, V3, P804, DOI 10.1002/smll.200600441
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   Drelich J, 2011, SOFT MATTER, V7, P9804, DOI 10.1039/c1sm05849e
   Dulle J, 2012, ADV FUNCT MATER, V22, P3128, DOI 10.1002/adfm.201200437
   Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239
   Ferraris S, 2014, APPL SURF SCI, V311, P279, DOI 10.1016/j.apsusc.2014.05.056
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Karpitschka S, 2010, LANGMUIR, V26, P11823, DOI 10.1021/la1007457
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Necula BS, 2013, APPL SURF SCI, V273, P310, DOI 10.1016/j.apsusc.2013.02.036
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001
   Skirtach AG, 2007, J MATER CHEM, V17, P1050, DOI 10.1039/b609934c
   Skorb EV, 2013, ADV MATER, V25, P5029, DOI 10.1002/adma.201302142
   Skorb EV, 2012, ANGEW CHEM INT EDIT, V51, P5138, DOI 10.1002/anie.201105084
   Skorb EV, 2011, NANOSCALE, V3, P985, DOI 10.1039/c0nr00635a
   Skorb EV, 2010, NANOSCALE, V2, P722, DOI 10.1039/c0nr00074d
   Skorb EV, 2012, J MATER CHEM, V22, P13841, DOI 10.1039/c2jm30768e
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   Suslick KS, 1999, ANNU REV MATER SCI, V29, P295, DOI 10.1146/annurev.matsci.29.1.295
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Virot M, 2012, J PHYS CHEM C, V116, P15493, DOI 10.1021/jp305375r
   Virot M, 2010, J PHYS CHEM C, V114, P13083, DOI 10.1021/jp1046276
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   ZIEMNIAK SE, 1993, J SOLUTION CHEM, V22, P601, DOI 10.1007/BF00646781
NR 38
TC 4
Z9 4
U1 1
U2 69
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4177
EI 1873-2828
J9 ULTRASON SONOCHEM
JI Ultrason. Sonochem.
PD MAY
PY 2017
VL 36
BP 146
EP 154
DI 10.1016/j.ultsonch.2016.11.014
PG 9
WC Acoustics; Chemistry, Multidisciplinary
SC Acoustics; Chemistry
GA EI8PP
UT WOS:000392770100018
PM 28069194
DA 2018-10-20
ER

PT J
AU Wang, XY
   Chen, W
   Liu, QQ
   Gao, K
   Wang, G
   Gao, L
   Liu, L
AF Wang, Xiaoyan
   Chen, Wei
   Liu, Qianqian
   Gao, Kai
   Wang, Gan
   Gao, Li
   Liu, Long
TI Function and mechanism of mesoporous bioactive glass adsorbed epidermal
   growth factor for accelerating bone tissue regeneration
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE MBG; EGF; osteoblast differentiation; ERK; bone tissue engineering
ID SIGNAL-REGULATED KINASE; ENHANCES OSTEOGENIC DIFFERENTIATION; IN-VITRO
   BIOACTIVITY; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; DELIVERY;
   SCAFFOLDS; RELEASE; DRUG; GEL
AB Mesoporous bioactive glass (MBG) has been demonstrated to play a vital role in bone tissue engineering due to its bioactivity, biocompatibility, and osteoinduction properties. Here, we report that MBG grafted with an amino group (MBG-NH2) and MBG-NH2 adsorbed epidermal growth factor (EGF) (MBG-NH2/EGF) sustained-release EGF, and MBG-NH2/EGF could accelerate osteoblast differentiation and mineralization in MC3T3-E1 cells. We found that MBG-NH2 could promote bone-like deposit formation and Ca deposition in vitro. Intriguingly, we observed that MBGNH(2)/EGF enhanced MC3T3-E1 cell adhesion. We also showed that extracellular signal-regulated kinase 1/2 (ERK1/2) was phosphorylated when MC3T3-E1 cells were cultured on MBG-NH2/EGF. Interestingly, the transcription factor Runx2, important for osteoblast differentiation, was also activated when MC3T3-E1 cells were cultured onMBG-NH2/EGF. We showed that MC3T3-E1 cells cultured onMBG-NH2/EGF activating Runx2 was through ERK1/2 phosphorylation. Consistent with this survey, we observed that MC3T3-E1 cells cultured onMBG-NH2/EGF accelerated osteoblastic marker gene expressions, including osteopontin (Opn) and osteocalcin (Ocn). Taken together, we conclude that the osteoblast differentiation and mineralization were accelerated in MC3T3-E1 cells cultured onMBG-NH2/EGF through ERK-activated Runx2 pathway. These findings support the idea thatMBG-NH2/EGF is a potential biomaterial for bone tissue repair in bone defectrelated diseases.
C1 [Wang, Xiaoyan; Gao, Kai; Wang, Gan; Liu, Long] Natl Univ Def Technol, Dept Chem & Biol, Coll Sci, Changsha 410073, Hunan, Peoples R China.
   [Chen, Wei] Hunan Normal Univ, Dept Life Sci, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.
   [Liu, Qianqian] Cent S Univ, Sch Life Sci, Dept Biochem, Changsha 410013, Hunan, Peoples R China.
   [Gao, Li] Hebei Normal Univ, Coll Life Sci, Shijiazhuang 050016, Peoples R China.
RP Wang, XY (reprint author), Natl Univ Def Technol, Dept Chem & Biol, Coll Sci, Changsha 410073, Hunan, Peoples R China.
EM wangxiaoyan0511@163.com; hnsdcw712@126.com; qianqianhn@163.com;
   gaokaikd@163.com; wanggan@nudt.edu.cn; gaoli@mail.hebtu.edu.cn;
   llbio@126.com
FU Research Program of the National University of Defense Technology
   [ZK16-03-15]
FX We thank Dr RT Franceschi for kindly providing 1.3 kb mOG2-Luc plasmids.
   This work was supported by the Research Program of the National
   University of Defense Technology (ZK16-03-15).
CR Andersson J, 2005, BIOMATERIALS, V26, P6827, DOI 10.1016/j.biomaterials.2005.05.002
   Atefyekta S, 2016, INT J NANOMED, V11, P977, DOI 10.2147/IJN.S95375
   Baino F, 2016, ACTA BIOMATER, V42, P18, DOI 10.1016/j.actbio.2016.06.033
   Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339
   Dai CL, 2011, BIOMATERIALS, V32, P8506, DOI 10.1016/j.biomaterials.2011.07.090
   Del Angel-Mosqueda C, 2015, HEAD FACE MED, V11, DOI 10.1186/s13005-015-0086-5
   El-Fiqi A, 2015, ACS APPL MATER INTER, V7, P1140, DOI 10.1021/am5077759
   Fiorilli S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5346-6
   Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046
   Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980
   Gentile P, 2015, RSC ADV, V5, P80039, DOI 10.1039/c5ra15579g
   Gentile P, 2017, ADV HEALTHC MAT
   Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Li Y, 2016, J CELL PHYSL
   Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574
   Li Y, 2010, J BONE MINER RES, V25, P154, DOI 10.1359/jbmr.090705
   Lin HM, 2012, J MATER SCI-MATER M, V23, P2619, DOI 10.1007/s10856-012-4734-z
   Liu YH, 2013, POLYM ENG SCI, V53, P507, DOI 10.1002/pen.23279
   Ma J, 2014, MAT SCI ENG C-MATER, V39, P21, DOI 10.1016/j.msec.2014.01.060
   Mahapatra C, 2016, ACS APPL MATER INTER, V8, P27573, DOI 10.1021/acsami.6b09769
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Perez RA, 2014, ACTA BIOMATER, V10, P520, DOI 10.1016/j.actbio.2013.09.042
   Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Sanui T, 2015, J CELL BIOCHEM, V116, P628, DOI 10.1002/jcb.25014
   Song WH, 2015, INT J NANOMED, V10, P1715, DOI 10.2147/IJN.S70934
   Vaid C, 2013, MAT SCI ENG C-MATER, V33, P959, DOI 10.1016/j.msec.2012.11.028
   Wang XY, 2011, J BONE MINER RES, V26, P1964, DOI 10.1002/jbmr.394
   Wang XY, 2010, BIOL PHARM BULL, V33, P1891, DOI 10.1248/bpb.33.1891
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2013, J BIOMATER APPL, V28, P367, DOI 10.1177/0885328212453635
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhang X, 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0141513
   Zhang XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19361
   Zhang YH, 2005, SPECTROSC SPECT ANAL, V25, P2034
NR 42
TC 2
Z9 2
U1 1
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR 28
PY 2017
VL 12
IS 2
AR 025020
DI 10.1088/1748-605X/aa65d8
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET7CG
UT WOS:000400450500001
PM 28452332
DA 2018-10-20
ER

PT J
AU Landry, MJ
   Applegate, MB
   Bushuyev, OS
   Omenetto, FG
   Kaplan, DL
   Cronin-Golomb, M
   Barrett, CJ
AF Landry, Michael J.
   Applegate, Matthew B.
   Bushuyev, Oleksandr S.
   Omenetto, Fiorenzo G.
   Kaplan, David L.
   Cronin-Golomb, Mark
   Barrett, Christopher J.
TI Photo-induced structural modification of silk gels containing azobenzene
   side groups
SO SOFT MATTER
LA English
DT Article
ID FIBROIN FILMS; BIOMATERIALS; COMPOSITE; SCAFFOLDS; HYDROGELS; GROWTH;
   CELLS; FIBER
AB Azobenzene modification of Bombyx mori silkworm silk creates a photo-responsive 'azosilk' biomaterial, allowing for 3D laser patterning. Written regions fluoresce, and become fluid-filled raised 'micro-blisters' with a 10=fold photo-softening effect of the modulus. Patterning is facile and versatile, with potential applications as soft tunable materials for dynamic cell guidance and microfluidics.
C1 [Landry, Michael J.; Bushuyev, Oleksandr S.; Cronin-Golomb, Mark; Barrett, Christopher J.] McGill Univ, Dept Chem, 801 Sherbrooke St West, Montreal, PQ H3A 0B8, Canada.
   [Applegate, Matthew B.; Omenetto, Fiorenzo G.; Kaplan, David L.; Cronin-Golomb, Mark] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
RP Cronin-Golomb, M; Barrett, CJ (reprint author), McGill Univ, Dept Chem, 801 Sherbrooke St West, Montreal, PQ H3A 0B8, Canada.; Cronin-Golomb, M (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM mark.cronin-golomb@tufts.edu; christopher.barrett@mcgill.ca
OI Cronin-Golomb, Mark/0000-0002-8936-4358
FU AFOSR (Tufts); NSERC Canada (McGill); FQRNT Quebec Canada
FX Images were collected, processed, and analyzed for this manuscript in
   the McGill University Life Sciences Complex Advanced BioImaging Facility
   (ABIF). We thank the AFOSR (Tufts) and NSERC Canada (McGill) for support
   of this work. CJB and MCG are grateful for funding from FQRNT Quebec
   Canada, which assisted a sabbatical stay at McGill University's Centre
   for Self-Assembled Chemical Structures. CJB is grateful to the Artisans
   d'Angkor and Kolbe Foundations for enabling a visit to Bombyx Mori
   silkworm farms and silk harvesting facilities in Cambodia, with in-kind
   supply of silk cocoons.
CR Applegate MB, 2015, P NATL ACAD SCI USA, V112, P12052, DOI 10.1073/pnas.1509405112
   Audorff H, 2010, ADV POLYM SCI, V228, P59, DOI 10.1007/12_2009_35
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Cronin-Golomb M, 2012, J POLYM SCI POL PHYS, V50, P257, DOI 10.1002/polb.23003
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   Ding GZ, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1194-7
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Harms G., 1997, J FLUORESC, V7, P283, DOI DOI 10.1023/A:1022525909128
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Krasnov I, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913912
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Li ZH, 2013, FRONT MATER SCI, V7, P237, DOI 10.1007/s11706-013-0214-8
   Liu JQ, 2004, J APPL POLYM SCI, V91, P2028, DOI 10.1002/app.13389
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Priimagi A, 2014, J MATER CHEM C, V2, P7155, DOI 10.1039/c4tc01236d
   Sakakibara K, 2011, SMALL, V7, P1288, DOI 10.1002/smll.201002350
   Satzger H, 2003, CHEM PHYS LETT, V372, P216, DOI 10.1016/S0009-2614(03)00364-6
   Shishido A, 2010, POLYM J, V42, P525, DOI 10.1038/pj.2010.45
   Tomba C, 2015, MICROELECTRON ENG, V132, P176, DOI 10.1016/j.mee.2014.10.007
   Ude AU, 2014, MATER DESIGN, V57, P298, DOI 10.1016/j.matdes.2013.12.052
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Ye XJ, 2014, OPT COMMUN, V312, P210, DOI 10.1016/j.optcom.2013.09.040
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
   Zhao RY, 2013, POLYM CHEM-UK, V4, P5382, DOI 10.1039/c3py00770g
NR 32
TC 3
Z9 3
U1 6
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PD APR 28
PY 2017
VL 13
IS 16
BP 2903
EP 2906
DI 10.1039/c7sm00446j
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA ES9KX
UT WOS:000399877400001
PM 28368427
DA 2018-10-20
ER

PT J
AU Douglas, TEL
   Sobczyk, K
   Lapa, A
   Wlodarczyk, K
   Brackman, G
   Vidiasheva, I
   Reczynska, K
   Pietryga, K
   Schaubroeck, D
   Bliznuk, V
   Van der Voort, P
   Declercq, HA
   Van den Bulcke, J
   Samal, SK
   Khalenkow, D
   Parakhonskiy, BV
   Van Acker, J
   Coenye, T
   Lewandowska-Szumiel, M
   Pamula, E
   Skirtach, AG
AF Douglas, Timothy E. L.
   Sobczyk, Katarzyna
   Lapa, Agata
   Wlodarczyk, Katarzyna
   Brackman, Gilles
   Vidiasheva, Irina
   Reczynska, Katarzyna
   Pietryga, Krzysztof
   Schaubroeck, David
   Bliznuk, Vitaliy
   Van der Voort, Pascal
   Declercq, Heidi A.
   Van den Bulcke, Jan
   Samal, Sangram Keshari
   Khalenkow, Dmitry
   Parakhonskiy, Bogdan V.
   Van Acker, Joris
   Coenye, Tom
   Lewandowska-Szumiel, Malgorzata
   Pamula, Elzbieta
   Skirtach, Andre G.
TI Ca: Mg: Zn: CO3 and Ca: Mg: CO3-tri- and bi-elemental carbonate
   microparticles for novel injectable self-gelling hydrogel-microparticle
   composites for tissue regeneration
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hydrogel; composite; injectable; zinc; magnesium; gellan gum; carbonate
ID CRYSTALLINE CALCIUM-CARBONATE; GELATION; PARTICLES; DELIVERY;
   PHOTOSENSITIZER; HYDROXYAPATITE; REFINEMENT; DOLOMITE; PH
AB Injectable composites for tissue regeneration can be developed by dispersion of inorganic microparticles and cells in a hydrogel phase. In this study, multifunctional carbonate microparticles containing different amounts of calcium, magnesium and zinc were mixed with solutions of gellan gum (GG), an anionic polysaccharide, to form injectable hydrogel-microparticle composites, containing Zn, Ca and Mg. Zn and Ca were incorporated into microparticle preparations to a greater extent than Mg. Microparticle groups were heterogeneous and contained microparticles of differing shape and elemental composition. Zn-rich microparticles were 'star shaped' and appeared to consist of small crystallites, while Zn-poor, Ca-and Mg-rich microparticles were irregular in shape and appeared to contain lager crystallites. Zn-free microparticle groups exhibited the best cytocompatibility and, unexpectedly, Zn-free composites showed the highest antibacterial activity towards methicilin-resistant Staphylococcus aureus. Composites containing Zn-free microparticles were cytocompatible and therefore appear most suitable for applications as an injectable biomaterial. This study proves the principle of creating bi-and tri-elemental microparticles to induce the gelation of GG to create injectable hydrogel-microparticle composites.
C1 [Douglas, Timothy E. L.; Khalenkow, Dmitry; Skirtach, Andre G.] Univ Ghent, Dept Mol Biotechol, Coupure Links 653, B-9000 Ghent, Belgium.
   [Douglas, Timothy E. L.] Univ Lancaster, Dept Engn, Lancaster LA1 4YW, England.
   [Sobczyk, Katarzyna; Lapa, Agata; Reczynska, Katarzyna; Pietryga, Krzysztof; Pamula, Elzbieta] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Al Mickiewicza 30, PL-30059 Krakow, Poland.
   [Wlodarczyk, Katarzyna; Lewandowska-Szumiel, Malgorzata] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, Warsaw, Poland.
   [Wlodarczyk, Katarzyna] Ctr Preclin Res & Technol, Warsaw, Poland.
   [Wlodarczyk, Katarzyna] Med Univ Warsaw, Lab Cell Res & Applicat, Warsaw, Poland.
   [Brackman, Gilles; Coenye, Tom] Univ Ghent, Dept Pharmaceut Anal, LPM, Ghent, Belgium.
   [Vidiasheva, Irina] Saratov NG Chernyshevskii State Univ, Inst Nanostruct & Biosyst, Cell Engn Dept, Saratov, Russia.
   [Schaubroeck, David] Imec & Ghent Univ, CMST, Technol Pk 914a, B-9052 Ghent, Belgium.
   [Bliznuk, Vitaliy] Dept Mat Sci Engn, Tech Lane Ghent Sci Park Campus A, B-9052 Zwijnaarde, Belgium.
   [Van der Voort, Pascal] Univ Ghent, Dept Inorgan Chem, COMOC, Krijgslaan 281, B-9000 Ghent, Belgium.
   [Declercq, Heidi A.] Univ Ghent, Dept Basic Med Sci Tissue Engn Grp, Pintelaan 185, B-9000 Ghent, Belgium.
   [Van den Bulcke, Jan; Van Acker, Joris] Univ Ghent, Dept Forest & Water Management, UGCT Woodlab Lab Wood Technol, Ghent, Belgium.
   [Samal, Sangram Keshari] Univ Ghent, Lab Gen Biochem & Phys Pharm, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.
   [Samal, Sangram Keshari] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium.
   [Parakhonskiy, Bogdan V.] RAS, Shubnikov Inst Crystallog, Moscow, Russia.
RP Douglas, TEL (reprint author), Univ Ghent, Dept Mol Biotechol, Coupure Links 653, B-9000 Ghent, Belgium.; Douglas, TEL (reprint author), Univ Lancaster, Dept Engn, Lancaster LA1 4YW, England.
EM t.douglas@lancaster.ac.uk
RI Van Der Voort, Pascal/D-3800-2012; Parakhonskiy, Bogdan/E-8956-2012
OI Van Der Voort, Pascal/0000-0002-1248-479X; Parakhonskiy,
   Bogdan/0000-0002-6481-3700; Bliznuk, Vitaliy/0000-0002-6402-4066;
   Schaubroeck, David/0000-0001-9576-3091; Lewandowska-Szumiel,
   Malgorzata/0000-0002-7140-0541; Douglas, Timothy/0000-0002-6661-3120
FU Research Foundation Flanders (FWO); FWO; BOF UGent; ERA-Net Rus Plus
   project 'Fabrication and investigation of new hybrid scaffolds with the
   controlled porous hierarchy for bone tissue engineering' (Intelbiocomp);
   Polish Academy of Sciences (PAN)
FX TELD, BVP and AGS acknowledge the Research Foundation Flanders (FWO) for
   support in the framework of a postdoctoral fellowship. Tom Planckaert,
   Danny Vandeput, and Joanna Aernoudt are thanked for excellent technical
   assistance. Prof Kevin Braeckmans and Dr Bart Lucas are thanked for
   enabling rheometrical measurements to be performed. AGS also
   acknowledges the support of FWO and BOF UGent. The ERA-Net Rus Plus
   project 'Fabrication and investigation of new hybrid scaffolds with the
   controlled porous hierarchy for bone tissue engineering' (Intelbiocomp)
   is thanked for support. TELD, KW and ML-S acknowledge the FWO and Polish
   Academy of Sciences (PAN) for support in the framework of the joint
   project 'Biomimetic three-phase biomaterials for regeneration of
   mineralized and unmineralized tissues'.
CR ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018
   BISCHOFF WD, 1985, AM MINERAL, V70, P581
   Brauer DS, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045007
   Chan LW, 2002, INT J PHARM, V242, P259, DOI 10.1016/S0378-5173(02)00170-9
   Donatan S, 2016, ACS APPL MATER INTER, V8, P14284, DOI 10.1021/acsami.6b03492
   Douglas TEL, 2014, J TISSUE ENG REGEN M, V8, P906, DOI 10.1002/term.1616
   Douglas T. E. L., 2016, BIOMED MATER, V11
   Douglas T E L, 2015, J TISS ENG REGEN MED
   Douglas TEL, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/4/045015
   Douglas TEL, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045014
   Douglas TEL, 2016, J TISSUE ENG REGEN M, V10, P938, DOI 10.1002/term.1875
   FOLK RL, 1974, J SEDIMENT PETROL, V44, P40
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Gorodzha S, 2016, J BIOMED MATER RES A, V104, P1194, DOI 10.1002/jbm.a.35642
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Gubler M, 2008, INT ENDOD J, V41, P670, DOI 10.1111/j.1365-2591.2008.01413.x
   Hollingbery LA, 2010, THERMOCHIM ACTA, V509, P1, DOI 10.1016/j.tca.2010.06.012
   Ihli J, 2013, CHEM COMMUN, V49, P3134, DOI 10.1039/c3cc40807h
   JAROSCH D, 1986, TSCHER MINER PETROG, V35, P127, DOI 10.1007/BF01140844
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Landi E, 2006, J EUR CERAM SOC, V26, P2593, DOI 10.1016/j.jeurceramsoc.2005.06.040
   Le Bail A, 2011, POWDER DIFFR, V26, P16, DOI 10.1154/1.3552994
   Moreira HR, 2014, CARBOHYD POLYM, V103, P339, DOI 10.1016/j.carbpol.2013.12.057
   NEUMAN WF, 1971, CALC TISS RES, V7, P133, DOI 10.1007/BF02062601
   Parakhonskiy BV, 2013, BIOMATER SCI-UK, V1, P1273, DOI 10.1039/c3bm60141b
   Raz S, 2002, BIOL BULL, V203, P269, DOI 10.2307/1543569
   REEDER RJ, 1986, AM MINERAL, V71, P795
   Savelyeva MS, 2017, J BIOMED MATER RES A, V105, P94, DOI 10.1002/jbm.a.35870
   Sawai J, 2005, SOIL BIOL BIOCHEM, V37, P1484, DOI 10.1016/j.soilbio.2005.01.011
   Sitepu H, 2009, POWDER DIFFR, V24, P315, DOI 10.1154/1.3257906
   STRELTSOV VA, 1988, KRISTALLOGRAFIYA+, V33, P90
   Svenskaya YI, 2016, COLLOID SURFACE B, V146, P171, DOI 10.1016/j.colsurfb.2016.05.090
   Svenskaya Y, 2013, BIOPHYS CHEM, V182, P11, DOI 10.1016/j.bpc.2013.07.006
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Viateau V, 2016, J TISSUE ENG REGEN M, V10, pE177, DOI 10.1002/term.1782
   Yamamoto O, 2008, TANSO, V232, P77
   Zhao S F, 2012, CLIN ORAL IMPLANT SA, V100, P34
NR 37
TC 2
Z9 2
U1 4
U2 33
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR 28
PY 2017
VL 12
IS 2
AR 025015
DI 10.1088/1748-605X/aa6200
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EP7BJ
UT WOS:000397532300009
PM 28223552
DA 2018-10-20
ER

PT J
AU Wrobel, MR
   Sundararaghavan, HG
AF Wrobel, Melissa R.
   Sundararaghavan, Harini G.
TI Positive and negative cues for modulating neurite dynamics and receptor
   expression
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE flow cytometry; chondroitin sulfate; syndecans; time lapse imaging;
   neurite outgrowth behavior
ID CHONDROITIN SULFATE PROTEOGLYCAN; PERIPHERAL-NERVE INJURY;
   EXTRACELLULAR-MATRIX; HYALURONIC-ACID; GROWTH CONES; IN-VITRO; AXONAL
   DEGENERATION; PATTERNED SUBSTRATA; GLIAL SCAR; OUTGROWTH
AB Many current peripheral nerve repair strategies focus on delivering positive, growth promoting cues (e. g. extracellular matrix, ECM) while eliminating negative, growth inhibiting cues (e. g. chondroitin sulfate proteoglycans, CSPGs) at the injury site. Wehypothesized that recapitulating the positive and negative cues of the peripheral nerve injury microenvironment would improve regeneration. First, we tested the effects of a characteristic CSPG, chondroitin sulfate A (CSA) on neurite dynamics of dissociated chick embryo dorsal root ganglion (DRG) neurons using time lapse video microscopy. DRGgrowth was recorded on different adhesive substrates, including a novel, porcine-derived spinal cord matrix (SCM). TheSCMsignificantly increased frequency of neurite extension coordinated by a significant reduction in the neurites' time spent stalled. TheSCMalso mitigated inhibitory effects of CSA, producing longer neurites than the controls without CSA treatment. Next we aimed to elucidate receptors involved in mediating this behavior by testing the ability of CSA to upregulate cell-substrate binding receptors using flow cytometry. Our results showed a significant increase in syndecan-3 receptor expression in neurons treated with CSA. Furthermore, syndecans would most likely bind to the sulfated glycosaminoglycans measured in the SCM. Finally, we evaluated neurite growth on biomaterial scaffolds featuring CSA andSCMcues. Our results showed significantly increased neurite outgrowth on electrospun hyaluronic acid fibers withSCMand low levels of CSA. Higher incorporation of CSA maintained its inhibitory properties. Future work will evaluate coupling CSPGs with growth-permissiveECMto assess the combined effect on neurite outgrowth.
C1 [Wrobel, Melissa R.; Sundararaghavan, Harini G.] Wayne State Univ, Dept Biomed Engn, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
RP Sundararaghavan, HG (reprint author), Wayne State Univ, Dept Biomed Engn, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
EM melissa.wrobel@wayne.edu; hsundara@wayne.edu
FU Thomas C Rumble Graduate Fellowship; US Department of Defense Grant
   [W81XWH-16-1-0102]
FX This research was supported in part by the Thomas C Rumble Graduate
   Fellowship and a US Department of Defense Grant (W81XWH-16-1-0102). The
   authors thank Dr Olivia Merkel (Wayne State University Department of
   Pharmaceutical Sciences) and Steve Jones for assistance with flow
   cytometry.
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Agius E, 1996, NEUROSCIENCE, V71, P773, DOI 10.1016/0306-4522(95)00447-5
   Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0
   Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060
   Bao F, 2011, J NEUROTRAUM, V28, P269, DOI 10.1089/neu.2010.1618
   Beller JA, 2013, EXP NEUROL, V247, P143, DOI 10.1016/j.expneurol.2013.02.012
   Bockelmann J, 2011, TISSUE ENG PT A, V17, P475, DOI [10.1089/ten.tea.2010.0369, 10.1089/ten.TEA.2010.0369]
   Brattain K, 2012, ANAL PERIPHERAL NERV, P1
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   BUETTNER HM, 1991, DEV BIOL, V145, P266, DOI 10.1016/0012-1606(91)90125-M
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Carey DJ, 1997, BIOCHEM J, V327, P1
   Castro C, 2006, EXP NEUROL, V200, P19, DOI 10.1016/j.expneurol.2006.02.001
   Chan CCM, 2008, J NEUROSCI RES, V86, P581, DOI 10.1002/jnr.21522
   Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011
   Chung H, 2016, FEBS LETT, V590, P2408, DOI 10.1002/1873-3468.12280
   Coburn J, 2011, SMART STRUCT SYST, V7, P213, DOI 10.12989/sss.2011.7.3.213
   Coulson-Thomas V, 2014, BIOPROTOCOL, V4, pe1236
   Derakhshan ZH, 2015, INT J POLYM MATER PO, V64, P919, DOI 10.1080/00914037.2015.1030662
   Dou CL, 1995, J NEUROSCI, V15, P8053
   Fuentes EO, 2008, J BRACHIAL PLEXUS PE, V3, pe58
   Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1
   Gopalakrishnan SM, 2008, J NEUROSCI RES, V86, P2214, DOI 10.1002/jnr.21671
   GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5
   Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5
   Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x
   Hodgkinson GN, 2012, BIOMATERIALS, V33, P4288, DOI 10.1016/j.biomaterials.2012.02.046
   Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212
   Ifkovits J L, 2009, JOVE-J VIS EXP, V32, pe1589
   Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930
   Jayakumar R, 2012, BIOMEDICAL APPL POLY
   Jiang T, 2013, MAT SCI ENG C-MATER, V33, P3514, DOI 10.1016/j.msec.2013.04.046
   Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349
   Lanza R, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001
   Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002
   Man AJ, 2014, ANN BIOMED ENG, V42, P1271, DOI 10.1007/s10439-014-0991-y
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003
   Ozturk G, 2013, NEUROPATH APPL NEURO, V39, P362, DOI 10.1111/j.1365-2990.2012.01295.x
   Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272
   Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995
   Schmalfeldt M, 2000, J CELL SCI, V113, P807
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   Snow DM, 1996, INT J DEV NEUROSCI, V14, P331, DOI 10.1016/0736-5748(96)00017-2
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Swarup Vimal P, 2013, Biomol Concepts, V4, P233, DOI 10.1515/bmc-2012-0042
   Walwyn W, 2005, MOL PHARMACOL, V68, P1688, DOI 10.1124/mol.105.014829
   Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007
   Wang TW, 2006, ARTIF ORGANS, V30, P141, DOI 10.1111/j.1525-1594.2006.00200.x
   Wen XX, 2015, TISSUE ENG PT A, V21, P1095, DOI [10.1089/ten.tea.2014.0173, 10.1089/ten.TEA.2014.0173]
   Whitehead TJ, 2014, JOVE-J VIS EXP, V90
   Wrobel MR, 2014, TISSUE ENG PART B-RE, V20, P93, DOI [10.1089/ten.teb.2013.0233, 10.1089/ten.TEB.2013.0233]
   Yegiyants S, 2010, J CRANIOFAC SURG, V21, P998, DOI 10.1097/SCS.0b013e3181e17aef
   Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.0.CO;2-C
NR 60
TC 1
Z9 1
U1 4
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR 28
PY 2017
VL 12
IS 2
AR 025016
DI 10.1088/1748-605X/aa61d1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EP7BJ
UT WOS:000397532300010
PM 28221164
DA 2018-10-20
ER

PT J
AU Utomo, L
   Boersema, GSA
   Bayon, Y
   Lange, JF
   van Osch, GJVM
   Bastiaansen-Jenniskens, YM
AF Utomo, Lizette
   Boersema, Geesien S. A.
   Bayon, Yves
   Lange, Johan F.
   van Osch, Gerjo J. V. M.
   Bastiaansen-Jenniskens, Yvonne M.
TI In vitro modulation of the behavior of adhering macrophages by
   medications is biomaterial-dependent
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE macrophages; inflammation; foreign body reaction; polyethylene
   terephthalate; polypropylene; polylactic acid; biomaterials
ID TOTAL HIP-ARTHROPLASTY; NITRIC-OXIDE; POLARIZATION; INFLAMMATION;
   EXPRESSION; ACTIVATION; CYTOKINES; CORTICOSTEROIDS; OSTEOARTHRITIS;
   ATORVASTATIN
AB After implantation of a biomaterial, an inflammatory response involving macrophages is induced. The behavior of macrophages depends on their phenotype, and by directing macrophage polarization. unwanted effects may be avoided. In this study, the possibility to modulate the behavior of macrophages activated by biomaterials. was assessed in an in vitro model. Primary human monocytes were seeded on polyethylene terephthalate, polypropylene and polylactic acid yarns, and treated with medications frequently used by patients: rapamycin, dexamethasone, celecoxib or pravastatin. Modulation of the adhering macrophages with rapamycin resulted in a generally pro-inflammatory effect. Dexamethasone caused an overall anti-inflammatory effect on the macrophages cultured on either material, while celecoxib only affected macrophages adhering to polyethylene terephthalate and polylactic acid. Pravastatin increased the. pro-inflammatory genes of macrophages cultured on polypropylene and polylactic acid. Pairwise comparison revealed that macrophages adhering to polylactic acid seemed to be more susceptible to phenotype modulation than when adhering to polypropylene or polyethylene terephthalate. The. data show. that macrophages activated by the biomaterials can be modulated, yet the degree of the modulatory capacity depends on the type of material. Combined, this model provides insights into the possibility of using a medication in combination with a biomaterial to direct macrophage behavior and thereby possibly avoid. unwanted effects after implantation.
C1 [Utomo, Lizette; Boersema, Geesien S. A.; van Osch, Gerjo J. V. M.; Bastiaansen-Jenniskens, Yvonne M.] Erasmus MC, Dept Orthopaed, Univ Med Ctr, Rotterdam, Netherlands.
   [Boersema, Geesien S. A.; Lange, Johan F.] Erasmus MC, Dept Surg, Univ Med Ctr, Rotterdam, Netherlands.
   [Bayon, Yves] Medtronic Sofradim Prod, 116 Ave Formans, F-01600 Trevoux, France.
   [van Osch, Gerjo J. V. M.] Erasmus MC, Dept Otorhinolaryngol, Univ Med Ctr, Rotterdam, Netherlands.
RP Bastiaansen-Jenniskens, YM (reprint author), Erasmus MC, Dept Orthopaed, Univ Med Ctr, Rotterdam, Netherlands.
EM y.bastiaansen@erasmusmc.nl
OI Bastiaansen-Jenniskens, Yvonne/0000-0002-2921-1237; Utomo,
   Lizette/0000-0003-2214-2344
FU Technology Foundation STW (Veni grant); Dutch Arthritis Foundation
   [LLP11, 13-3302]
FX This study was financially supported by Technology Foundation STW (Veni
   grant) and by the Dutch Arthritis Foundation, grant numbers LLP11 and
   13-3302. This research was conducted within the postgraduate school
   Molecular Medicine, Erasmus MC, University Medical Center, the
   Netherlands.
CR Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192
   Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5
   Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736
   Boersema GSA, 2016, BIOMATERIALS, V109, P32, DOI 10.1016/j.biomaterials.2016.09.009
   Boersema GSA, 2016, BIORESEARCH OPEN ACC, V5, P6, DOI 10.1089/biores.2015.0041
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220
   Bygd HC, 2015, BIOMATERIALS, V56, P187, DOI 10.1016/j.biomaterials.2015.03.042
   Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834
   Centre N, 2015, 12 ANN REP
   Chedid M, 1996, ENDOCRINOLOGY, V137, P2232, DOI 10.1210/en.137.6.2232
   Dave M, 2013, IMMUNOL LETT, V152, P47, DOI 10.1016/j.imlet.2013.04.002
   Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Grotenhuis N, 2013, BIOCHEM BIOPH RES CO, V433, P115, DOI 10.1016/j.bbrc.2013.02.054
   Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540
   Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011
   Haynes JA, 2016, J ARTHROPLASTY, V31, P622, DOI 10.1016/j.arth.2015.09.026
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   Jamsen E, 2014, J ORTHOP RES, V32, P1241, DOI 10.1002/jor.22658
   Jiang JH, 2016, AM J PATHOL, V186, P57, DOI 10.1016/j.ajpath.2015.09.006
   Lee DK, 2012, CELL PHYSIOL BIOCHEM, V30, P499, DOI 10.1159/000341433
   Lopa S, 2015, OSTEOARTHR CARTILAGE, V23, P1853, DOI 10.1016/j.joca.2015.06.003
   Ma WS, 2014, BIOCHEM PHARMACOL, V89, P99, DOI 10.1016/j.bcp.2014.02.014
   Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002
   Mambo G, 2003, INT IMMUNOPHARMACOL, V3, P513, DOI 10.1016/S1567-5769(03)00022-5
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126
   Mihos CG, 2014, PHARMACOL RES, V88, P12, DOI 10.1016/j.phrs.2014.02.009
   Minardi S, 2016, ANN BIOMED ENG, V44, P2008, DOI 10.1007/s10439-016-1580-z
   Moojen DJF, 2010, ACTA ORTHOP, V81, P667, DOI 10.3109/17453674.2010.525201
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Nakamura Y, 1996, EUR RESPIR J, V9, P301, DOI 10.1183/09031936.96.09020301
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Ren PG, 2011, CLIN ORTHOP RELAT R, V469, P113, DOI 10.1007/s11999-010-1645-5
   Shappley RK, 2014, INT J INFLAM, V2014
   Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P2162, DOI 10.1016/j.joca.2016.07.018
   Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P1629, DOI 10.1016/j.joca.2016.04.013
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845
   Wang AS, 2013, AM J SURG, V206, P410, DOI 10.1016/j.amjsurg.2012.11.018
   Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106
   Zanette DL, 2014, HUM IMMUNOL, V75, P10, DOI 10.1016/j.humimm.2013.09.016
   Zhang J, 2013, CYTOKINE, V61, P540, DOI 10.1016/j.cyto.2012.12.006
   Zhang O, 2015, INT IMMUNOPHARMACOL, V26, P58, DOI 10.1016/j.intimp.2015.03.005
NR 52
TC 0
Z9 0
U1 3
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR 28
PY 2017
VL 12
IS 2
AR 025006
DI 10.1088/1748-605X/aa5cbc
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN7RU
UT WOS:000396200700002
PM 28267684
DA 2018-10-20
ER

PT J
AU Gerhard, EM
   Wang, W
   Li, CY
   Guo, JS
   Ozbolat, IT
   Rahn, KM
   Armstrong, AD
   Xia, JF
   Qian, GY
   Yang, J
AF Gerhard, Ethan Michael
   Wang, Wei
   Li, Caiyan
   Guo, Jinshan
   Ozbolat, Ibrahim Tarik
   Rahn, Kevin Michael
   Armstrong, April Dawn
   Xia, Jingfen
   Qian, Guoying
   Yang, Jian
TI Design strategies and applications of nacre-based biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterials; Nacre; Pearl powder; Pearl; Bone; Orthopedic; Tissue
   engineering
ID OYSTER PINCTADA-FUCATA; SOLUBLE MATRIX-FRACTION; OSTEOBLASTS MAINTAINED
   INVITRO; MOLECULAR-WEIGHT MOLECULES; PHOSPHATE BUFFER SOLUTION;
   HALIOTIS-LAEVIGATA NACRE; TERNARY ARTIFICIAL NACRE; MESENCHYMAL
   STEM-CELLS; IN-SITU HYBRIDIZATION; WATER PEARL MUSSEL
AB The field of tissue engineering and regenerative medicine relies heavily on materials capable of implantation without significant foreign body reactions and with the ability to promote tissue differentiation and regeneration. The field of bone tissue engineering in particular requires materials capable of providing enhanced mechanical properties and promoting osteogenic cell lineage commitment. While bone repair has long relied almost exclusively on inorganic, calcium phosphate ceramics such as hydroxyapatite and their composites or on non-degradable metals, the organically derived shell and pearl nacre generated by mollusks has emerged as a promising alternative. Nacre is a naturally occurring composite material composed of inorganic, calcium carbonate plates connected by a framework of organic molecules. Similar to mammalian bone, the highly organized microstructure of nacre endows the composite with superior mechanical properties while the organic phase contributes to significant bioactivity. Studies, both in vitro and in vivo, have demonstrated nacre's biocompatibility, biodegradability, and osteogenic potential, which are superior to pure inorganic minerals such as hydroxyapatite or non-degradable metals. Nacre can be used directly as a bulk implant or as part of a composite material when combined with polymers or other ceramics. While nacre has demonstrated its effectiveness in multiple cell culture and animal models, it remains a relatively underexplored biomaterial. This review introduces the formation, structure, and characteristics of nacre, and discusses the present and future uses of this biologically-derived material as a novel biomaterial for orthopedic and other tissue engineering applications.
   Statement of Significance
   Mussel derived nacre, a biological composite composed of mineralized calcium carbonate platelets and interplatelet protein components, has recently gained interest as a potential alternative ceramic material in orthopedic biomaterials, combining the integration and mechanical capabilities of calcium phosphates with increased bioactivity derived from proteins and biomolecules; however, there is limited awareness of this material's potential. Herein, we present, to our knowledge, the first comprehensive review of nacre as a biomaterial. Nacre is a highly promising yet overlooked biomaterial for orthopedic tissue engineering with great potential in a wide variety of material systems. It is our hope that publication of this article will lead to increased community awareness of the potential of nacre as a versatile, bioactive ceramic capable of improving bone tissue regeneration and will elicit increased research effort and innovation utilizing nacre. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Gerhard, Ethan Michael; Guo, Jinshan; Ozbolat, Ibrahim Tarik; Rahn, Kevin Michael; Yang, Jian] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Biomed Engn, University Pk, PA 16802 USA.
   [Wang, Wei; Li, Caiyan; Xia, Jingfen; Qian, Guoying] Zhejiang Wanli Univ, Coll Biol & Environm Sci, Zhejiang Prov Top Key Discipline Bioengn, South Qianhu Rd 8, Ningbo 315100, Zhejiang, Peoples R China.
   [Ozbolat, Ibrahim Tarik] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Engn Sci & Mech Dept, University Pk, PA 16802 USA.
   [Armstrong, April Dawn] Penn State Univ, Coll Med, Dept Orthopaed & Rehabil, Hershey, PA 17033 USA.
RP Yang, J (reprint author), Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Biomed Engn, University Pk, PA 16802 USA.; Qian, GY (reprint author), Zhejiang Wanli Univ, Coll Biol & Environm Sci, Zhejiang Prov Top Key Discipline Bioengn, South Qianhu Rd 8, Ningbo 315100, Zhejiang, Peoples R China.
EM qiangy@zwu.edu.cn; jxy30@psu.edu
RI Yang, Jian/N-1291-2014
OI Yang, Jian/0000-0003-0695-828X; Armstrong, April/0000-0003-3729-9811
FU National Institutes of Health [CA182670, HL118498]; National Science
   Foundation (NSF) [CMMI 1537008]
FX This work was supported in part by National Institutes of Health awards
   (CA182670, HL118498) and National Science Foundation (NSF) award (CMMI
   1537008).
CR Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980
   Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#
   Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r
   Asvanund P, 2011, IMPLANT DENT, V20, P32, DOI 10.1097/ID.0b013e3182061be1
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bahar H, 2003, J PERIODONTOL, V74, P366, DOI 10.1902/jop.2003.74.3.366
   Bai H, 2016, ADV MATER, V28, P50, DOI 10.1002/adma.201504313
   Bai JJ, 2015, PROG NAT SCI-MATER, V25, P327, DOI 10.1016/j.pnsc.2015.07.004
   Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Bezares J, 2008, J STRUCT BIOL, V163, P61, DOI 10.1016/j.jsb.2008.04.009
   Bezares J, 2010, J STRUCT BIOL, V170, P484, DOI 10.1016/j.jsb.2010.01.006
   Bogatov VV, 2012, BIOL BULL+, V39, P672, DOI 10.1134/S1062359012080031
   Bolotov IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122408
   Brion A, 2015, J STRUCT BIOL, V192, P500, DOI 10.1016/j.jsb.2015.10.012
   Brown AH, 2014, BIOMACROMOLECULES, V15, P4467, DOI 10.1021/bm501263s
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   Chakraborty M, 2012, BRIT J NUTR, V108, P1346, DOI 10.1017/S0007114511006805
   Chaturvedi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084584
   Checa AG, 2005, BIOMATERIALS, V26, P1071, DOI 10.1016/j.biomaterials.2004.04.007
   Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011
   Checa AG, 2009, NATURWISSENSCHAFTEN, V96, P111, DOI 10.1007/s00114-008-0461-1
   Chen K, 2015, ACS NANO, V9, P8165, DOI 10.1021/acsnano.5b02333
   Currey JD, 2001, P ROY SOC B-BIOL SCI, V268, P107, DOI 10.1098/rspb.2000.1337
   Dai JM, 2015, ADV ENG MATER, V17, P1691, DOI 10.1002/adem.201500144
   Das P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6967
   Dashkovskiy S, 2007, COMP MATER SCI, V41, P96, DOI 10.1016/j.commatsci.2007.03.015
   Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z
   Dauphin Y, 2006, ZOOLOGY, V109, P85, DOI 10.1016/j.zool.2005.08.005
   Delattre O., 1997, EUR J ORTHOP SURG TR, V7, P143
   Deng YH, 2015, BIO-MED MATER ENG, V26, pS27, DOI 10.3233/BME-151286
   Denkena B, 2010, J MATER PROCESS TECH, V210, P1827, DOI 10.1016/j.jmatprotec.2010.06.014
   Duan JL, 2016, ACS APPL MATER INTER, V8, P10545, DOI 10.1021/acsami.6b02156
   Duplat D, 2007, BIOMATERIALS, V28, P2155, DOI 10.1016/j.biomaterials.2007.01.015
   Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594
   Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629
   Fricain J.C., 2005, KEY ENG MAT T TECH P, P965
   Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v
   Gao HY, 2008, FOOD CHEM, V109, P493, DOI 10.1016/j.foodchem.2007.12.052
   Gilbert PUPA, 2008, J AM CHEM SOC, V130, P17519, DOI 10.1021/ja8065495
   GINZBURG EL, 1973, TSITOLOGIYA+, V15, P1085
   Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009
   Green DW, 2015, MOL CELLS, V38, P267, DOI 10.14348/molcells.2015.2315
   GREGOIRE C, 1957, J BIOPHYS BIOCHEM CY, V3, P797, DOI 10.1083/jcb.3.5.797
   Guenther J, 2006, BIOFOULING, V22, P163, DOI 10.1080/08927010600691929
   Guo YP, 2008, J BIOMED MATER RES A, V86A, P510, DOI 10.1002/jbm.a.31541
   Hao WT, 2016, RSC ADV, V6, P1415, DOI 10.1039/c5ra21580c
   Hao WT, 2015, RSC ADV, V5, P86861, DOI 10.1039/c5ra15570c
   He SH, 2013, FISH SHELLFISH IMMUN, V34, P865, DOI 10.1016/j.fsi.2012.12.021
   Heinemann F, 2011, BIOPHYS CHEM, V153, P126, DOI 10.1016/j.bpc.2010.11.003
   Hu X., 2013, SCI REP, P3
   Huang YC, 2014, PROTEIN EXPRES PURIF, V100, P26, DOI 10.1016/j.pep.2014.05.002
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099
   Jin-Jin M., 2015, ZOOL RES, V36, P34
   Kadar E, 2008, J COMP PHYSIOL B, V178, P123, DOI 10.1007/s00360-007-0178-z
   Kim YW, 2002, BIOMATERIALS, V23, P2089, DOI 10.1016/S0142-9612(01)00340-4
   Klishko O., 1850, BIOL BULL, V41, P434
   Kobayashi S., 2012, MAT SCI FORUM T TECH, P526
   Kroger N, 2009, SCIENCE, V325, P1351, DOI 10.1126/science.1177055
   Kwan M., 2013, KEY ENG MAT T TECH P, P255
   Lamghari M, 1999, BIOMATERIALS, V20, P2107, DOI 10.1016/S0142-9612(99)00113-1
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Lee JH, 2012, MITOCHONDR DNA, V23, P39, DOI 10.3109/19401736.2011.643882
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Li J, 2015, CRYSTENGCOMM, V17, P520, DOI 10.1039/c4ce01632g
   Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012
   Li X, 2013, CRYSTENGCOMM, V15, P4351, DOI 10.1039/c3ce26947g
   Li YC, 2013, PHARM BIOL, V51, P289, DOI 10.3109/13880209.2012.721130
   Li-Qin Z., 2008, PROG BIOCHEM BIOPHYS, V35, P671
   Lian M, 2015, CARBON, V89, P279, DOI 10.1016/j.carbon.2015.03.045
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Liu XJ, 2015, GENE, V555, P217, DOI 10.1016/j.gene.2014.11.006
   Liu YS, 2014, MAT SCI ENG C-MATER, V38, P227, DOI 10.1016/j.msec.2014.02.007
   Liu YS, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500206
   Liu YM, 2013, WEAR, V300, P44, DOI 10.1016/j.wear.2013.01.102
   Liu YS, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065001
   Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x
   Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636
   Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159
   Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x
   Marie B, 2012, AMINO ACIDS, V42, P2009, DOI 10.1007/s00726-011-0932-0
   Marie B, 2011, FEBS J, V278, P2117, DOI 10.1111/j.1742-4658.2011.08129.x
   Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009
   Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8
   Meifeng H., 2016, J ALLOY COMPD, V663, P156
   Meng X.H., 2010, INT FOR BIOM TEXT MA, P124
   Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010
   MIYOSHI T, 1987, JPN J APPL PHYS 1, V26, P578, DOI 10.1143/JJAP.26.578
   Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Naganuma T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112326
   Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f
   Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338
   Oliveira D.V., 2012, SCI WORLD J, V2012
   Osuna-Mascaro AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122934
   Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027
   Perovic I, 2014, BIOCHEMISTRY-US, V53, P7259, DOI 10.1021/bi5008854
   Perovic I, 2014, BIOCHEMISTRY-US, V53, P2739, DOI 10.1021/bi401721z
   Pourang N, 2014, ENVIRON MONIT ASSESS, V186, P2465, DOI 10.1007/s10661-013-3553-0
   Ramos-Silva P, 2012, CHEMBIOCHEM, V13, P1067, DOI 10.1002/cbic.201100708
   REIMANN BEF, 1965, J CELL BIOL, V24, P39, DOI 10.1083/jcb.24.1.39
   RICHARDS CS, 1972, J INVERTEBR PATHOL, V20, P37, DOI 10.1016/0022-2011(72)90078-X
   Rousseau M, 2005, J STRUCT BIOL, V149, P149, DOI 10.1016/j.jsb.2004.09.005
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
   Rousseau M, 2012, BIO-MED MATER ENG, V22, P227, DOI 10.3233/BME-2012-0712
   Rousseau M, 2009, J STRUCT BIOL, V165, P190, DOI 10.1016/j.jsb.2008.11.011
   Sarikaya M., 1992, STRUCTURE CELLULAR S, P1
   Sarin S, 2016, RSC ADV, V6, P33501, DOI 10.1039/c6ra02996e
   Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052372
   Schmieden DT, 2016, MRS ADV, V1, P559, DOI 10.1557/adv.2016.150
   Shao DZ, 2010, J COSMET SCI, V61, P133
   Shao Y, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1016
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088
   Shono M, 2008, BIOSCI BIOTECH BIOCH, V72, P2761, DOI 10.1271/bbb.80267
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166
   Sumitomo T, 2011, J STRUCT BIOL, V174, P31, DOI 10.1016/j.jsb.2011.01.001
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Takahashi K, 2004, CHEM COMMUN, P996, DOI 10.1039/b315478e
   Tan ZB, 2015, ACS APPL MATER INTER, V7, P15010, DOI 10.1021/acsami.5b04093
   Tao J, 1998, Guang Pu Xue Yu Guang Pu Fen Xi, V18, P307
   Tao L., 2008, CN 100427150C, Patent No. 100427150
   Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108
   Vannarattanarat S, 2014, ANIM GENET, V45, P235, DOI 10.1111/age.12115
   Vecchio KS, 2007, ACTA BIOMATER, V3, P910, DOI 10.1016/j.actbio.2007.06.003
   Voet VSD, 2015, MACROMOL RAPID COMM, V36, P1756, DOI 10.1002/marc.201500301
   Wan SJ, 2015, ACS NANO, V9, P9830, DOI 10.1021/acsnano.5b02902
   Wan SJ, 2015, ACS NANO, V9, P708, DOI 10.1021/nn506148w
   Wang GL, 2013, MITOCHONDR DNA, V24, P513, DOI 10.3109/19401736.2013.770508
   Wang SN, 2013, J STRUCT BIOL, V183, P404, DOI 10.1016/j.jsb.2013.07.013
   Wang XY, 2006, INT FED INFO PROC, V207, P743
   Wang XX, 2005, BIOMATERIALS, V26, P6229, DOI 10.1016/j.biomaterials.2005.03.029
   WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6
   WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Weiss IM, 2001, BIOCHEM BIOPH RES CO, V285, P244, DOI 10.1006/bbrc.2001.5170
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WISE SW, 1970, SCIENCE, V167, P1486, DOI 10.1126/science.167.3924.1486
   Wu SC, 2011, MATER CHARACT, V62, P1180, DOI 10.1016/j.matchar.2011.09.009
   Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086
   Xiao WD, 2012, SAUDI MED J, V33, P601
   Xie L, 2010, J STRUCT BIOL, V169, P89, DOI 10.1016/j.jsb.2009.09.002
   Xu LP, 2013, ACS NANO, V7, P5077, DOI 10.1021/nn400650f
   Xu MG, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025002
   Yan L, 2015, ADV ENG MATER, V17, P523, DOI 10.1002/adem.201400237
   Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494
   Yang YL, 2014, BIO-MED MATER ENG, V24, P979, DOI 10.3233/BME-130893
   Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172
   Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042
   Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1
   Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6
   Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P43, DOI 10.1016/S1096-4959(03)00050-2
   Zhu LQ, 2011, AFR J BIOTECHNOL, V10, P15387, DOI 10.5897/AJB11.996
   Ziuganov V V, 2004, Adv Gerontol, V14, P21
   Zuykov M, 2011, CHEMOSPHERE, V84, P701, DOI 10.1016/j.chemosphere.2011.03.021
NR 174
TC 5
Z9 5
U1 10
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 21
EP 34
DI 10.1016/j.actbio.2017.03.003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400002
PM 28274766
DA 2018-10-20
ER

PT J
AU Zhang, XQ
   Battiston, KG
   Labow, RS
   Simmons, CA
   Santerre, JP
AF Zhang, Xiaoqing
   Battiston, Kyle G.
   Labow, Rosalind S.
   Simmons, Craig A.
   Santerre, J. Paul
TI Generating favorable growth factor and protease release profiles to
   enable extracellular matrix accumulation within an in vitro tissue
   engineering environment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Matrix metalloproteinase; Co-culture; Underlying
   mechanisms; Biomaterial
ID SMOOTH-MUSCLE-CELLS; MESENCHYMAL STEM-CELLS; COCULTURE SYSTEMS;
   MECHANICAL-PROPERTIES; CULTURE-SYSTEMS; DRUG DISCOVERY; BLOOD-VESSELS;
   EXPRESSION; DIFFERENTIATION; SCAFFOLD
AB Tissue engineering (particularly for the case of load-bearing cardiovascular and connective tissues) requires the ability to promote the production and accumulation of extracellular matrix (ECM) components (e.g., collagen, glycosaminoglycan and elastin). Although different approaches have been attempted in order to enhance ECM accumulation in tissue engineered constructs, studies of underlying signalling mechanisms that influence ECM deposition and degradation during tissue remodelling and regeneration in multi-cellular culture systems have been limited. The current study investigated vascular smooth muscle cell (VSMC)-monocyte co-culture systems using different VSMC:monocyte ratios, within a degradable polyurethane scaffold, to assess their influence on ECM generation and degradation processes, and to elucidate relevant signalling molecules involved in this in vitro vascular tissue engineering system. It was found that a desired release profile of growth factors (e.g. insulin growth factor-1 (IGF-1)) and hydrolytic proteases (e.g. matrix-metalloproteinases 2, 9,13 and 14 (MMP2, MMP9, MMP13 and MMP14)), could be achieved in co-culture systems, yielding an accumulation of ECM (specifically for 2:1 and 4:1 VSMC:monocyte culture systems). This study has significant implications for the tissue engineering field (including vascular tissue engineering), not only because it identified important cytokines and proteases that control ECM accumulation/degradation within synthetic tissue engineering scaffolds, but also because the established culture systems could be applied to improve the development of different types of tissue constructs.
   Statement of Significance
   Sufficient extracellular matrix accumulation within cardiovascular and connective tissue engineered constructs is a prerequisite for their appropriate function in vivo. This study established co-culture systems with tissue specific cells (vascular smooth muscle cells (VSMCs)) and defined ratios of immune cells (monocytes) to investigate extracellular matrix (ECM) generation and degradation processes, revealing important mechanisms underlying ECM turnover during vascular tissue regeneration/remodelling. A specific growth factor (IGF-1), as well as hydrolytic proteases (e.g. MMP2, MMP9, MMP13 and MMP14), were identified as playing important roles in these processes. ECM accumulation was found to be dependent on achieving a desired release profile of these ECM-promoting and ECM-degrading factors within the multi-cellular microenvironment. The findings enhance our understanding of ECM deposition and degradation during in vitro tissue engineering and would be applicable to the repair or regeneration of a variety of tissues. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiaoqing; Battiston, Kyle G.; Simmons, Craig A.; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Simmons, Craig A.; Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [Zhang, Xiaoqing; Battiston, Kyle G.; Simmons, Craig A.; Santerre, J. Paul] Univ Toronto, Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, 661 Univ Ave,14th Floor,Room 1435, Toronto, ON M5G 1M1, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, 661 Univ Ave,14th Floor,Room 1435, Toronto, ON M5G 1M1, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU Canadian Institutes of Health Research [230762]; Canada Graduate
   Scholarship (CGS-M)
FX This study was funded by a Canadian Institutes of Health Research
   operating grant #230762. Xiaoqing Zhang was funded by a Canada Graduate
   Scholarship (CGS-M). Special thanks to Feryal Sarraf for preparation of
   histology samples and staining.
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Battiston KG, 2015, ACTA BIOMATER, V24, P74, DOI 10.1016/j.actbio.2015.05.038
   Battiston KG, 2014, ACTA BIOMATER, V10, P1146, DOI 10.1016/j.actbio.2013.12.022
   Battiston KG, 2014, BIOMATERIALS, V35, P4465, DOI 10.1016/j.biomaterials.2014.02.023
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Berg EL, 2014, ADV DRUG DELIVER REV, V69, P190, DOI 10.1016/j.addr.2014.01.013
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Chen JL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-88
   Cooke ME, 2011, OSTEOARTHR CARTILAGE, V19, P1210, DOI 10.1016/j.joca.2011.07.005
   Dahl SLM, 2007, ANN BIOMED ENG, V35, P348, DOI 10.1007/s10439-006-9226-1
   Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09
   Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441
   Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102
   Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006
   Jacobsen JA, 2010, BBA-MOL CELL RES, V1803, P72, DOI 10.1016/j.bbamcr.2009.08.006
   JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679
   Kaji H, 2011, BBA-GEN SUBJECTS, V1810, P239, DOI 10.1016/j.bbagen.2010.07.002
   Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322
   Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1006/jsre.2002.6561
   Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108
   Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042
   Morhayim J., 2016, CURR MOL BIOL REP, V2, P48
   Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902
   Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022
   Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405
   Neuzil P, 2012, NAT REV DRUG DISCOV, V11, P620, DOI 10.1038/nrd3799
   Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Nguyen TV, 2015, DRUG METAB DISPOS, V43, P774, DOI [10.1124/dmd.114.06137, 10.1124/dmd.114.061317]
   Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871
   Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279
   Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683
   Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x
   Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001
   Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537
   Song Y, 2016, CARBOHYD POLYM, V153, P652, DOI 10.1016/j.carbpol.2016.07.058
   Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66
   Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951
   Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85
   Xu ZY, 2013, BIOMATERIALS, V34, P4109, DOI 10.1016/j.biomaterials.2013.02.045
   Yan GL, 2015, INT J MOL MED, V36, P1001, DOI 10.3892/ijmm.2015.2320
   Yi Y, 2011, CURR GENE THER, V11, P218
   Zachos C, 2014, J ORTHOP RES, V32, P1264, DOI 10.1002/jor.22663
   Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751
NR 63
TC 0
Z9 0
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 81
EP 94
DI 10.1016/j.actbio.2017.02.041
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400007
PM 28242454
DA 2018-10-20
ER

PT J
AU Li, KJ
   Zhong, XF
   Yang, SJ
   Luo, ZM
   Li, K
   Liu, Y
   Cai, S
   Gu, HY
   Lu, ST
   Zhang, HJ
   Wei, YT
   Zhuang, J
   Zhuo, YH
   Fan, ZG
   Ge, J
AF Li, Kangjun
   Zhong, Xiufeng
   Yang, Sijing
   Luo, Ziming
   Li, Kang
   Liu, Ying
   Cai, Song
   Gu, Huaiyu
   Lu, Shoutao
   Zhang, Haijun
   Wei, Yantao
   Zhuang, Jing
   Zhuo, Yehong
   Fan, Zhigang
   Ge, Jian
TI HiPSC-derived retinal ganglion cells grow dendritic arbors and
   functional axons on a tissue-engineered scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Retinal ganglion cells (RGCs); Human-induced pluripotent stem cells
   (hiPSCs); Retina; Biomaterials; Tissue engineering
ID PLURIPOTENT STEM-CELLS; DRUG-DELIVERY; MESSENGER-RNA; CHOLERA-TOXIN;
   MOUSE RETINA; SUBUNIT-B; DIFFERENTIATION; NEURONS; TRANSPLANTATION;
   GENERATION
AB Numerous therapeutic procedures in modern medical research rely on the use of tissue engineering for the treatment of retinal diseases. However, the cell source and the transplantation method are still a limitation. Previously, it was reported that a self-organizing three-dimensional neural retina can be induced from human-induced pluripotent stem cells (hiPSCs). In this study, we disclose the generation of retinal ganglion cells (RGCs) from the neural retina and their seeding on a biodegradable poly (lactic-co-glycolic acid) (PLGA) scaffold to create an engineered RGC-scaffold biomaterial. Moreover, we explored the dendritic arbor, branching point, functional axon and action potential of the biomaterial. Finally, the cell scaffold was transplanted into the intraocular environment of rabbits and rhesus monkeys.
   Statement of Significance
   As a part of the mammalian central nervous system (CNS), the retinal ganglion cell (RGC) shows little regenerative capacity. With the use of medical biomaterial for cells seeding and deliver, a new domain is now emerging that uses tissue engineering therapy for retinal disease. However, previous studies utilized RGCs from rodent model, which has limitations for human disease treatment. In the present study, we generated RGCs from hiPSCs-3D neural retina and then seeded these RGCs on PLGA scaffold to create an engineered RGC-scaffold biomaterial. Moreover, we assessed the transplantation method for biomaterial in vivo. Our study provides a technique to produce the engineered human RGC-scaffold biomaterial. (C) 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.
C1 [Li, Kangjun; Zhong, Xiufeng; Yang, Sijing; Luo, Ziming; Li, Kang; Liu, Ying; Wei, Yantao; Zhuang, Jing; Zhuo, Yehong; Fan, Zhigang; Ge, Jian] Sun Yet Sen Univ, Key Lab Ophthalmol & Visual Sci, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlienan RD, Guangzhou, Guangdong, Peoples R China.
   [Cai, Song; Gu, Huaiyu] Yet Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou, Guangdong, Peoples R China.
   [Lu, Shoutao; Zhang, Haijun] Bai Duoan Med Equipment Co, Qihe, Shandong, Peoples R China.
RP Ge, J (reprint author), Sun Yet Sen Univ, Key Lab Ophthalmol & Visual Sci, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlienan RD, Guangzhou, Guangdong, Peoples R China.
EM gejian@mail.sysu.edu.cn
RI Li, Kang/Q-4855-2017
OI Li, Kang/0000-0003-0355-4255
FU National Natural Science Foundation of China [81430009, 81570874];
   Fundamental Research Funds of the State Key Laboratory of Ophthalmology
   [2012IP02]; Science and Technology Program of Guangzhou, China
   [15570001, 2014A020211008, 2015A020212011]
FX The authors thank Prof. Linzhao Cheng (Johns Hopkins University) and
   Prof. Tian Xue (University of Science and Technology of China) for the
   gift of BC1 hiPSC line labeled with GFP used in this study. We
   gratefully acknowledge support from the National Natural Science
   Foundation of China (81430009 and 81570874) and Fundamental Research
   Funds of the State Key Laboratory of Ophthalmology (2012IP02) and
   partial funding by the Science and Technology Program of Guangzhou,
   China (15570001, 2014A020211008 and 2015A020212011). We would like to
   acknowledge the Zhongshan Ophthalmic Center for assistance with the
   transplantation studies. We would like to acknowledge the Zhongshan
   Medicine School of China for assistance with electron microscopy. We
   would like to acknowledge the Bai Duoan medical equipment company for
   their donation of medical-grade biomaterials. We would like to thank Mr.
   Ummear from East Tennessee State University in the USA for reviewing and
   editing this manuscript.
CR Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102
   Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7
   Argaw A, 2008, EXP NEUROL, V211, P494, DOI 10.1016/j.expneurol.2008.02.014
   Bertram JP, 2009, J MICROENCAPSUL, V26, P18, DOI 10.1080/02652040802095250
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Borooah S, 2013, PROG RETIN EYE RES, V37, P163, DOI 10.1016/j.preteyeres.2013.09.002
   Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152
   Chen J, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0264-1
   Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504
   Chen YX, 2013, INT J NANOMED, V8, P4315, DOI 10.2147/IJN.S51629
   Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079
   Deng F, 2016, MOL VIS, V22, P536
   Desmet AS, 2014, NEUROGASTROENT MOTIL, V26, P1131, DOI 10.1111/nmo.12371
   Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008
   Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011
   Fang X, 2002, J NEUROSCI, V22, P7425
   Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125
   Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003
   Harrison RR, 2015, J NEUROPHYSIOL, V113, P1275, DOI 10.1152/jn.00629.2014
   Haverkamp S, 2000, J COMP NEUROL, V424, P1
   Hein LRO, 2013, SCANNING, V35, P196, DOI 10.1002/sca.21048
   Herrero-Vanrell R, 2014, PROG RETIN EYE RES, V42, P27, DOI 10.1016/j.preteyeres.2014.04.002
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Huang CL, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.26
   Huang W, 2006, CURR EYE RES, V31, P265, DOI 10.1080/02713680500545671
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Ivanova E, 2013, JOVE-J VIS EXP, DOI 10.3791/51018
   Jeong JH, 2003, J BIOMAT SCI-POLYM E, V14, P1, DOI 10.1163/15685620360511100
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Kador KE, 2016, TISSUE ENG PT A, V22, P286, DOI [10.1089/ten.TEA.2015.0373, 10.1089/ten.tea.2015.0373]
   Kador KE, 2014, ACTA BIOMATER, V10, P4939, DOI 10.1016/j.actbio.2014.08.032
   Kador KE, 2013, BIOMATERIALS, V34, P4242, DOI 10.1016/j.biomaterials.2013.02.027
   Kaihara S, 2007, NAT PROTOC, V2, P2767, DOI 10.1038/nprot.2007.391
   Kaneko Y, 2007, NEUROSCI LETT, V424, P83, DOI 10.1016/j.neulet.2007.07.023
   Kovacs G, 2016, STEM CELLS INT, V2016
   Kundu J, 2014, DEV OPHTHALMOL, V53, P143, DOI 10.1159/000357369
   Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183
   Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Maity B, 2012, METHOD CELL BIOL, V113, P81, DOI 10.1016/B978-0-12-407239-8.00005-7
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x
   McKernan DP, 2007, INVEST OPHTH VIS SCI, V48, P5420, DOI 10.1167/iovs.07-0287
   McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083
   MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8
   MIKKELSEN JD, 1992, BRAIN RES BULL, V28, P619, DOI 10.1016/0361-9230(92)90112-B
   Nafissi-Varcheh N, 2011, IRAN J PHARM RES, V10, P203
   Ng XW, 2015, DRUG DELIV TRANSL RE, V5, P469, DOI 10.1007/s13346-015-0240-4
   Nseir N, 2013, TISSUE ENG PART C-ME, V19, P257, DOI [10.1089/ten.tec.2012.0118, 10.1089/ten.TEC.2012.0118]
   Nuschke AC, 2015, EXP EYE RES, V141, P111, DOI 10.1016/j.exer.2015.06.006
   Ohlemacher SK, 2016, STEM CELLS, V34, P1553, DOI 10.1002/stem.2356
   Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Parameswaran S, 2010, STEM CELLS, V28, P695, DOI 10.1002/stem.320
   Roozafzoon R, 2015, BIOCHEM BIOPH RES CO, V457, P154, DOI 10.1016/j.bbrc.2014.12.069
   Russo R, 2015, MOL VIS, V21
   Santos RCC, 2001, BRAZ J MED BIOL RES, V34, P1585, DOI 10.1590/S0100-879X2001001200011
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmitz C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00027
   Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3
   Seiler MJ, 2012, PROG RETIN EYE RES, V31, P661, DOI 10.1016/j.preteyeres.2012.06.003
   Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595
   Song YY, 2013, NEURON, V78, P109, DOI 10.1016/j.neuron.2013.01.036
   Sridhar A, 2016, STEM CELL TRANSL MED, V5, P417, DOI 10.5966/sctm.2015-0093
   Sun JN, 2015, STEM CELLS, V33, P1543, DOI 10.1002/stem.1960
   Tanaka T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08344
   Teotia P, 2017, STEM CELLS, V35, P572, DOI 10.1002/stem.2513
   TOHYAMA T, 1992, LAB INVEST, V66, P303
   Tomita M, 2006, STEM CELLS, V24, P2270, DOI 10.1634/stemcells.2005-0507
   Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472
   Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912
   Wang GF, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.019
   Wang Y, 2004, BIOMATERIALS, V25, P4279, DOI 10.1016/j.biomaterials.2003.10.075
   Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192
   Wu L, 2002, NEUROREPORT, V13, P2547, DOI 10.1097/01.wnr.0000052322.62862.a5
   Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729
   Zhang XM, 2010, MOL VIS, V16, P2867
   Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047
   Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07
   Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688
NR 80
TC 7
Z9 8
U1 5
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 117
EP 127
DI 10.1016/j.actbio.2017.02.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400010
PM 28216299
DA 2018-10-20
ER

PT J
AU Zhou, X
   Wang, H
   Zhang, JM
   Li, XM
   Wu, YF
   Wei, YZ
   Ji, SL
   Kong, DL
   Zhao, Q
AF Zhou, Xin
   Wang, He
   Zhang, Jimin
   Li, Xuemei
   Wu, Yifan
   Wei, Yongzhen
   Ji, Shenglu
   Kong, Deling
   Zhao, Qiang
TI Functional poly(epsilon-caprolactone)/chitosan dressings with nitric
   oxide releasing property improve wound healing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nitric oxide; Wound dressing; Angiogenesis; Immunomodulation
ID SKIN; REPAIR; ANGIOGENESIS; BIOMATERIALS; ACTIVATION; MECHANISMS;
   CYTOKINES; HYDROGEL; DELIVERY; MODEL
AB Wound healing dressings are increasingly needed clinically due to the large number of skin damage annually. Nitric oxide (NO) plays a key role in promoting wound healing, thus biomaterials with NO releasing property receive increasing attention as ideal wound dressing. In present study, we prepared a novel functional wound dressing by combining electrospun poly(epsilon-caprolactone) (PCL) nonwoven mat with chitosan-based NO-releasing biomaterials (CS-NO). As-prepared PCL/CS-NO dressing released NO sustainably under the physiological conditions, which was controlled by the catalysis of beta-galactosidase. In vivo wound healing characteristics were further evaluated on full-thickness cutaneous wounds in mice. Results showed that PCL/CS-NO wound dressings remarkably accelerated wound healing process through enhancing re-epithelialization and granulation formation and effectively improved the organization of regenerated tissues including epidermal-dermal junction, which could be ascribed to the pro-angiogenesis, immunomodulation, and enhanced collagen synthesis provided by the sustained release of NO. Therefore, PCL/CS-NO may be a promising candidate for wound dressings, especially for the chronic wound caused by the ischemia.
   Statement of significance
   Serious skin damage caused by trauma, surgery, burn or chronic disease has become one of the most serious clinical problems. Therefore, there is an increasing demand for ideal wound dressing that can improve wound healing. Due to the vital role of nitric oxide (NO), we developed a novel functional wound dressing by combining electrospun polycaprolactone (PCL) mat with NO-releasing biomaterial (CS-NO). The sustained release of NO from PCL/CS-NO demonstrated positive effects on wound healing, including pro-angiogenesis, immunomodulation, and enhanced collagen synthesis. Hence, wound healing process was remarkably accelerated and the organization of regenerated tissues was effectively improved as well. Taken together, PCL/CS-NO dressing may be a promising candidate for wound treatment, especially for the chronic wound caused by the ischemia. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, Xin; Wang, He; Zhang, Jimin; Wu, Yifan; Wei, Yongzhen; Ji, Shenglu; Kong, Deling; Zhao, Qiang] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin 300071, Peoples R China.
   [Li, Xuemei] Tianjin Med Univ, Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Minist Hlth,Tianjin Metab Dis Hosp, Tianjin 300070, Peoples R China.
   [Li, Xuemei] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin 300070, Peoples R China.
RP Kong, DL; Zhao, Q (reprint author), Nankai Univ, Inst Mol Biol, Tianjin 300071, Peoples R China.
EM kongdeling@nankai.edu.cn; qiangzhao@nankai.edu.cn
FU NSFC [81522023, 81530059, 91639113, 81371699]; Program for Changjiang
   Scholars and Innovative Research Team in University [IRT13023]
FX The work was financially supported by NSFC projects (No. 81522023,
   81530059, 91639113, and 81371699), Program for Changjiang Scholars and
   Innovative Research Team in University (No. IRT13023).
CR Bai MY, 2013, MAT SCI ENG C-MATER, V33, P224, DOI 10.1016/j.msec.2012.08.034
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009
   Charernsriwilaiwat N, 2012, INT J PHARMACEUT, V427, P379, DOI 10.1016/j.ijpharm.2012.02.010
   DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Epstein FH, 1999, NEW ENGL J MED, V341, P738, DOI DOI 10.1056/NEJM199909023411006.PMID:10471461
   Frank S, 2002, KIDNEY INT, V61, P882, DOI 10.1046/j.1523-1755.2002.00237.x
   Gao J, 2013, CHEM COMMUN, V49, P9173, DOI 10.1039/c3cc45666h
   Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003
   Ghaffari A, 2005, NITRIC OXIDE-BIOL CH, V12, P129, DOI 10.1016/j.niox.2005.01.006
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   Kim SE, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044106
   KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X
   Kutner A., 2013, EXPERT REV DERMATOL, V8, P451
   Lowe A, 2015, ACTA BIOMATER, V13, P121, DOI 10.1016/j.actbio.2014.11.032
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Miller CC, 2004, J CUTAN MED SURG, V8, P233, DOI 10.1007/s10227-004-0106-8
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mu LX, 2014, FASEB J, V28, P3919, DOI 10.1096/fj.13-248476
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Schaffer MR, 1997, SURGERY, V121, P513, DOI 10.1016/S0039-6060(97)90105-7
   Schaffer MR, 1997, J IMMUNOL, V158, P2375
   Schanuel FS, 2015, COLLOID SURFACE B, V130, P182, DOI 10.1016/j.colsurfb.2015.04.007
   Schwentker A, 2002, NITRIC OXIDE-BIOL CH, V7, P1, DOI 10.1016/S1089-8603(02)00002-2
   Seabra AB, 2012, CURR NANOSCI, V8, P520
   Shekhter AB, 2005, NITRIC OXIDE-BIOL CH, V12, P210, DOI 10.1016/j.niox.2005.03.004
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Thornton FJ, 1998, BIOCHEM BIOPH RES CO, V246, P654, DOI 10.1006/bbrc.1998.8681
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Torpy Janet M, 2009, JAMA, V302, P1828, DOI 10.1001/jama.302.16.1828
   Varga T, 2016, IMMUNITY, V45, P1038, DOI 10.1016/j.immuni.2016.10.016
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002
   Witte Maria B., 1997, Surgical Forum, V48, P665
   Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1
   Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2
   Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhao Q, 2013, BIOMATERIALS, V34, P8450, DOI 10.1016/j.biomaterials.2013.07.045
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zhou X, 2016, CURR MED CHEM, V23, P2579, DOI 10.2174/0929867323666160729104647
NR 51
TC 7
Z9 7
U1 24
U2 69
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 128
EP 137
DI 10.1016/j.actbio.2017.03.11
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400011
PM 28285076
DA 2018-10-20
ER

PT J
AU Abdallah, MN
   Tran, SD
   Abughanam, G
   Laurenti, M
   Zuanazzi, D
   Mezour, MA
   Xiao, YZ
   Cerruti, M
   Siqueira, WL
   Tamimi, F
AF Abdallah, Mohamed-Nur
   Tran, Simon D.
   Abughanam, Ghada
   Laurenti, Marco
   Zuanazzi, David
   Mezour, Mohamed A.
   Xiao, Yizhi
   Cerruti, Marta
   Siqueira, Walter L.
   Tamimi, Faleh
TI Biomaterial surface proteomic signature determines interaction with
   epithelial cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Proteomics; Percutaneous devices; Surface characterization; Proteins
   adsorption; Cell interactions
ID BASEMENT-MEMBRANES; SOFT-TISSUE; IN-VITRO; JUNCTIONAL EPITHELIUM;
   PERCUTANEOUS IMPLANTS; SUBSTRATE STIFFNESS; PROTEIN ADSORPTION; TITANIUM
   SURFACES; ADSORBED PROTEINS; SKIN
AB Cells interact with biomaterials indirectly through extracellular matrix (ECM) proteins adsorbed onto their surface. Accordingly, it could be hypothesized that the surface proteomic signature of a biomaterial might determine its interaction with cells. Here, we present a surface proteomic approach to test this hypothesis in the specific case of biomaterial-epithelial cell interactions. In particular, we determined the surface proteomic signature of different biomaterials exposed to the ECM of epithelial cells (basal lamina). We revealed that the biomaterial surface chemistry determines the surface proteomic profile, and subsequently the interaction with epithelial cells. In addition, we found that biomaterials with surface chemistries closer to that of percutaneous tissues, such as aminated PMMA and aminated PDLLA, promoted higher selective adsorption of key basal lamina proteins (laminins, nidogen-1) and subsequently improved their interactions with epithelial cells. These findings suggest that mimicking the surface chemistry of natural percutaneous tissues can improve biomaterial-epithelial integration, and thus provide a rationale for the design of improved biomaterial surfaces for skin regeneration and percutaneous medical devices.
   Statement of Significance
   Failure of most biomaterials originates from the inability to predict and control the influence of their surface properties on biological phenomena, particularly protein adsorption, and cellular behaviour, which subsequently results in unfavourable host response. Here, we introduce a surface-proteomic screening approach using a label-free mass spectrometry technique to decipher the adsorption profile of extracellular matrix (ECM) proteins on different biomaterials, and correlate it with cellular behaviour. We demonstrated that the way a biomaterial selectively interacts with specific ECM proteins of a given tissue seems to determine the interactions between the cells of that tissue and biomaterials. Accordingly, this approach can potentially revolutionize the screening methods for investigating the protein-cell-biomaterial interactions and pave the way for deeper understanding of these interactions. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Abdallah, Mohamed-Nur; Tran, Simon D.; Abughanam, Ghada; Laurenti, Marco; Mezour, Mohamed A.; Tamimi, Faleh] McGill Univ, Fac Dent, Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 0C7, Canada.
   [Tran, Simon D.; Abughanam, Ghada] McGill Univ, Craniofacia Stem Cells & Tissue Engn Lab, Montreal, PQ, Canada.
   [Abughanam, Ghada] Univ Jordan, Fac Med, Amman, Jordan.
   [Zuanazzi, David; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Dent, London, ON, Canada.
   [Zuanazzi, David; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Dept Biochem, London, ON, Canada.
   [Cerruti, Marta] McGill Univ, Dept Min & Mat Engn, Montreal, PQ, Canada.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 0C7, Canada.
EM faleh.tamimimarino@mcgill.ca
RI Laurenti, Marco/M-3529-2015
OI Laurenti, Marco/0000-0002-0273-7423; Abdallah,
   Mohamed-Nur/0000-0003-1179-6270
FU Fondation de I'Ordre des dentists du Quebec (FODQ), Le Reseau de
   recherch en sante buccodentaire et ossseuse (RSBO); Fonds de Recherche
   du Quebec - Nature et Technologies (FRQNT); Canadian Foundation for
   Innovation (CFI); NSRC; Canada Research Chair; University of Jordan
FX The authors would like to acknowledge the financial support from the
   following agencies: Fondation de I'Ordre des dentists du Quebec (FODQ),
   Le Reseau de recherch en sante buccodentaire et ossseuse (RSBO) (M.N.
   Abdallah, M. Laurenti), the Fonds de Recherche du Quebec - Nature et
   Technologies (FRQNT) (M.N. Abdallah), Canadian Foundation for Innovation
   (CFI, F. Tamimi), NSRC-Discovery (F. Tamimi, M. Cerruti), Canada
   Research Chair (F. Tamimi, M.Cerruti), the University of Jordan (G.
   Abughanam). We kindly acknowledge Ms. L. Harrison for her technical
   support.
CR Abdallah M. N., 2014, J DENT, V14
   Abdallah MN, 2016, ACTA BIOMATER, V37, P174, DOI 10.1016/j.actbio.2016.04.005
   Affeld K, 2012, EXPERT REV MED DEVIC, V9, P389, DOI [10.1586/ERD.12.25, 10.1586/erd.12.25]
   Alageel O, 2015, DENT MATER, V31, P105, DOI 10.1016/j.dental.2014.11.002
   Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   An N, 2012, DENT MATER, V28, P1207, DOI 10.1016/j.dental.2012.08.007
   AOKI H, 1987, MED PROG TECHNOL, V12, P213
   Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033
   Atsuta I, 2012, CLIN ORAL IMPLAN RES, V23, P459, DOI 10.1111/j.1600-0501.2011.02163.x
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   de Berker D. A. R., 2007, International Journal of Cosmetic Science, V29, P241, DOI 10.1111/j.1467-2494.2007.00372.x
   Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garric X, 2005, J BIOMED MATER RES A, V72A, P180, DOI 10.1002/jbm.a.30216
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Gordon DJ, 2010, J BIOMED MATER RES A, V94A, P586, DOI 10.1002/jbm.a.32735
   Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007
   Hammad M, 2016, BIOMATER SCI-UK, V4, P1381, DOI 10.1039/c6bm00214e
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lei HQ, 1999, BIOL REPROD, V60, P176, DOI 10.1095/biolreprod60.1.176
   LEMPERLE G, 1995, PLAST RECONSTR SURG, V96, P627, DOI 10.1097/00006534-199509000-00015
   Mahjoubi H, 2014, ACS APPL MATER INTER, V6, P9975, DOI 10.1021/am502752j
   Mao AS, 2016, BIOMATERIALS, V98, P184, DOI 10.1016/j.biomaterials.2016.05.004
   McCann MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117807
   Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0
   Park JC, 1998, INT J ORAL MAX IMPL, V13, P826
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Saito M, 2015, J DERMATOL SCI, V79, P187, DOI 10.1016/j.jdermsci.2015.04.011
   Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627
   Silva-Boghossian CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075898
   SINCLAIR RD, 1994, BRIT J DERMATOL, V131, P499
   Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204
   Sittampalam GS, 2004, ASSAY GUIDANCE MANUA
   Slotnick MJ, 2006, ENVIRON RES, V102, P125, DOI 10.1016/j.envres.2005.12.001
   Tihan TG, 2009, MATER CHEM PHYS, V118, P265, DOI 10.1016/j.matchemphys.2009.03.019
   Trescher K, 2012, CLIN HEMORHEOL MICRO, V52, P391, DOI 10.3233/CH-2012-1613
   Tsikandylakis G., 2014, CLIN ORTHOP RELAT R, V31, P31
   Unadkat HV, 2013, BIOMATERIALS, V34, P1498, DOI 10.1016/j.biomaterials.2012.10.035
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vanea E, 2011, APPL SURF SCI, V257, P2346, DOI 10.1016/j.apsusc.2010.09.101
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Viel P, 2008, J MATER CHEM, V18, P5913, DOI 10.1039/b811299a
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 67
TC 5
Z9 5
U1 3
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 150
EP 163
DI 10.1016/j.actbio.2017.02.044
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400013
PM 28259836
DA 2018-10-20
ER

PT J
AU Oliveira, H
   Catros, S
   Castano, O
   Rey, S
   Siadous, R
   Clift, D
   Marti-Munoz, J
   Batista, M
   Bareille, R
   Planell, J
   Engel, E
   Amedee, J
AF Oliveira, Hugo
   Catros, Sylvain
   Castano, Oscar
   Rey, Sylvie
   Siadous, Robin
   Clift, Douglas
   Marti-Munoz, Joan
   Batista, Marc
   Bareille, Reine
   Planell, Josep
   Engel, Elisabeth
   Amedee, Joelle
TI The proangiogenic potential of a novel calcium releasing composite
   biomaterial: Orthotopic in vivo evaluation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Angiogenesis; Bone regeneration; Calcium phosphate ormoglasses
ID ANGIOGENIC GROWTH-FACTORS; EXTRACELLULAR CALCIUM; BONE REGENERATION;
   SENSING RECEPTOR; BIOACTIVE GLASS; TISSUE; CELLS; SUBSTITUTES; VITRO;
   ENVIRONMENT
AB Insufficient angiogenesis remains a major hurdle in current bone tissue engineering strategies. An extensive body of work has focused on the use of angiogenic factors or endothelial progenitor cells. However, these approaches are inherently complex, in terms of regulatory and methodologic implementation, and present a high cost. We have recently demonstrate the potential of electrospun poly(lactic acid) (PLA) fiber-based membranes, containing calcium phosphate (CaP) ormoglass particles, to elicit angiogenesis in vivo, in a subcutaneous model in mice. Here we have devised an injectable composite, containing CaP glass-ceramic particles, dispersed within a (Hydroxypropyl)methyl cellulose (HPMC) matrix, with the capacity to release calcium in a more sustained fashion. We show that by tuning the release of calcium in vivo, in a rat bone defect model, we could improve both bone formation and increase angiogenesis. The bone regeneration kinetics was dependent on the Ca2+ release rate, with the faster Ca2+ release composite gel showing improved bone repair at 3 weeks, in relation to control. In the same line, improved angiogenesis could be observed for the same gel formulation at 6 weeks post implantation. This methodology allows to integrate two fundamental processes for bone tissue regeneration while using a simple, cost effective, and safe approach.
   Statement of Significance
   In current bone tissue engineering approaches the achievement of sufficient angiogenesis, during tissue regeneration, is a major limitation in order to attain full tissue functionality. Recently, we have shown that calcium ions, released by the degradation of calcium phosphate ormoglasses (CaP), are effective angiogenic promoters, in both in vitro and in a subcutaneous implantation model. Here, we devised an injectable composite, containing CaP glass-ceramic particles, dispersed within a HPMC matrix, enabling the release of calcium in a more sustained fashion. We show that by tuning the release of calcium in vivo, in a rat bone defect model, we could improve both bone formation and increase angiogenesis. This simple and cost effective approach holds great promise to translate to the clinics. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oliveira, Hugo; Catros, Sylvain; Rey, Sylvie; Siadous, Robin; Bareille, Reine; Amedee, Joelle] Univ Bordeaux, Tissue Bioengn, U1026, F-33076 Bordeaux, France.
   [Oliveira, Hugo; Catros, Sylvain; Rey, Sylvie; Siadous, Robin; Bareille, Reine; Amedee, Joelle] INSERM, Tissue Bioengn, U1026, F-33076 Bordeaux, France.
   [Catros, Sylvain] CHU Bordeaux, Serv Odontol & Sante Buccale, F-33076 Bordeaux, France.
   [Castano, Oscar; Clift, Douglas; Marti-Munoz, Joan; Batista, Marc; Planell, Josep; Engel, Elisabeth] Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies, Barcelona, Spain.
   [Castano, Oscar; Clift, Douglas; Marti-Munoz, Joan; Batista, Marc; Planell, Josep; Engel, Elisabeth] CIBER BBN, Zaragoza 50018, Spain.
   [Engel, Elisabeth] Univ Politecn Cataluna, Mat Sci & Met Engn, Barcelona, Spain.
   [Planell, Josep] Univ Barcelona, Mat Sci & Phys Chem, Barcelona, Spain.
RP Oliveira, H (reprint author), INSERM, Biotis U1026, Bat 4a,2eme Etage,146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM hugo.de-oliveira@inserm.fr
RI Castano, Oscar/F-6725-2012
OI Castano, Oscar/0000-0001-9212-784X; Oliveira, Hugo/0000-0002-9715-8052
CR Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Brown EM, 2001, PHYSIOL REV, V81, P239
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Castano O, 2014, ACS APPL MATER INTER, V6, P7512, DOI 10.1021/am500885v
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Ebraheim N A, 2001, J Am Acad Orthop Surg, V9, P210
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee GH, 2011, INT J BIOCHEM CELL B, V43, P1305, DOI 10.1016/j.biocel.2011.05.004
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Oliveira H, 2016, ACTA BIOMATER, V29, P435, DOI 10.1016/j.actbio.2015.10.003
   Pickup DM, 2008, J MATER SCI-MATER M, V19, P1681, DOI 10.1007/s10856-007-3342-9
   Pickup DM, 2007, J MATER CHEM, V17, P4777, DOI 10.1039/b709955j
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Thebaud NB, 2010, J TISSUE ENG REGEN M, V4, P473, DOI 10.1002/term.261
   Tommila M, 2009, J R SOC INTERFACE, V6, P873, DOI 10.1098/rsif.2009.0020
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Woodruff MA, 2012, MATER TODAY, V15, P430, DOI 10.1016/S1369-7021(12)70194-3
NR 34
TC 1
Z9 1
U1 10
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 24
PY 2017
VL 54
BP 377
EP 385
DI 10.1016/j.actbio.2017.02.039
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EW2QZ
UT WOS:000402342400032
PM 28242456
DA 2018-10-20
ER

PT J
AU Nunez-Toldra, R
   Martinez-Sarra, E
   Gil-Recio, C
   Carrasco, MA
   Al Madhoun, A
   Montori, S
   Atari, M
AF Nunez-Toldra, Raquel
   Martinez-Sarra, Ester
   Gil-Recio, Carlos
   Carrasco, Miguel Angel
   Al Madhoun, Ashraf
   Montori, Sheyla
   Atari, Maher
TI Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell
   population with chromosomal stability and osteogenic capacity for
   biomaterials evaluation
SO BMC CELL BIOLOGY
LA English
DT Article
DE Dental pulp; Stem cells; Pluripotency; Genetic stability; Osteogenic
   differentiation; Biomaterials
ID 3RD MOLAR; COLLAGEN; OSTEOBLAST; CULTURE; BONE; DIFFERENTIATION;
   PROLIFERATION; INSTABILITY; SCAFFOLDS; THERAPY
AB Background: Biomaterials are widely used to regenerate or substitute bone tissue. In order to evaluate their potential use for clinical applications, these need to be tested and evaluated in vitro with cell culture models. Frequently, immortalized osteoblastic cell lines are used in these studies. However, their uncontrolled proliferation rate, phenotypic changes or aberrations in mitotic processes limits their use in long-term investigations. Recently, we described a new pluripotent-like subpopulation of dental pulp stem cells derived from the third molars (DPPSC) that shows genetic stability and shares some pluripotent characteristics with embryonic stem cells. In this study we aim to describe the use of DPPSC to test biomaterials, since we believe that the biomaterial cues will be more critical in order to enhance the differentiation of pluripotent stem cells.
   Methods: The capacity of DPPSC to differentiate into osteogenic lineage was compared with human sarcoma osteogenic cell line (SAOS-2). Collagen and titanium were used to assess the cell behavior in commonly used biomaterials. The analyses were performed by flow cytometry, alkaline phosphatase and mineralization stains, RT-PCR, immunohistochemistry, scanning electron microscopy, Western blot and enzymatic activity. Moreover, the genetic stability was evaluated and compared before and after differentiation by short-comparative genomic hybridization (sCGH).
   Results: DPPSC showed excellent differentiation into osteogenic lineages expressing bone-related markers similar to SAOS-2. When cells were cultured on biomaterials, DPPSC showed higher initial adhesion levels. Nevertheless, their osteogenic differentiation showed similar trend among both cell types. Interestingly, only DPPSC maintained a normal chromosomal dosage before and after differentiation on 2D monolayer and on biomaterials.
   Conclusions: Taken together, these results promote the use of DPPSC as a new pluripotent-like cell model to evaluate the biocompatibility and the differentiation capacity of biomaterials used in bone regeneration.
C1 [Nunez-Toldra, Raquel; Martinez-Sarra, Ester; Gil-Recio, Carlos; Montori, Sheyla; Atari, Maher] Univ Int Catalunya, Regenerat Med Res Inst, Barcelona, Spain.
   [Nunez-Toldra, Raquel; Martinez-Sarra, Ester; Gil-Recio, Carlos; Montori, Sheyla; Atari, Maher] Chair Regenerat Implantol MIS UIC, Barcelona, Spain.
   [Carrasco, Miguel Angel] Univ Int Catalunya, Area Pathol, Barcelona, Spain.
   [Al Madhoun, Ashraf] Dasman Diabet Inst, Div Res, Dasman, Kuwait.
   [Atari, Maher] Univ Int Catalunya, Surg & Oral Implantol Dept, Barcelona, Spain.
RP Atari, M (reprint author), Univ Int Catalunya, Regenerat Med Res Inst, Barcelona, Spain.; Atari, M (reprint author), Chair Regenerat Implantol MIS UIC, Barcelona, Spain.
EM matari@uic.es
FU Universitat International de Catalunya (UIC); Agencia de Gestio d'ajuts
   Universitaris i de Recerca; Generalitat de Catalunya (SGR) [1060]; Obra
   Social La Caixa; UIC; Kuwait Foundation for the Advancement of Sciences
   (KFAS) [RA-2013-009]
FX This study was funded by the Universitat International de Catalunya
   (UIC) and the Agencia de Gestio d'ajuts Universitaris i de Recerca,
   Generalitat de Catalunya (SGR 2014; No 1060). The authors R.
   Nunez-Toldra, E. Martinez-Sarra and C. Gil-Recio were funded by the
   predoctoral grant Junior Faculty awarded by the Obra Social La Caixa and
   the UIC. A. Al Madhoun was funded by Kuwait Foundation for the
   Advancement of Sciences (KFAS) (project number RA-2013-009).
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Atari M, 2012, BONE, V50, P930, DOI 10.1016/j.bone.2012.01.005
   Atari M, 2011, HISTOL HISTOPATHOL, V26, P1057, DOI 10.14670/HH-26.1057
   Atari M, 2012, J CELL SCI, V125, P3343, DOI 10.1242/jcs.096537
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   Chen XL, 2010, STEM CELLS DEV, V19, P1781, DOI 10.1089/scd.2010.0077
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Covani U, 2007, J BIOMED MATER RES A, V82A, P723, DOI 10.1002/jbm.a.31055
   Czekanska EM, 2014, J BIOMED MATER RES A, V102, P2636, DOI 10.1002/jbm.a.34937
   Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Griffin DK, 1998, J MED GENET, V35, P37, DOI 10.1136/jmg.35.1.37
   Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Jacobs K, 2016, STEM CELL REP, V6, P330, DOI 10.1016/j.stemcr.2016.01.015
   Karner E, 2009, BBA-GEN SUBJECTS, V1790, P110, DOI 10.1016/j.bbagen.2008.10.004
   Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Micol LA, 2011, BIOMATERIALS, V32, P1543, DOI 10.1016/j.biomaterials.2010.10.028
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Nothdurft FP, 2015, CLIN IMPLANT DENT R, V17, P1237, DOI 10.1111/cid.12253
   Perez RA, 2016, PROG MATER SCI, V82, P234, DOI 10.1016/j.pmatsci.2016.05.003
   Perez RA, 2015, MATER TODAY, V18, P573, DOI 10.1016/j.mattod.2015.06.011
   Rius M, 2010, HUM REPROD, V25, P1824, DOI 10.1093/humrep/deq118
   RODAN SB, 1987, CANCER RES, V47, P4961
   Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.tec.2011.0201, 10.1089/ten.TEC.2011.0201]
   Vandrovcova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100475
   Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846
   Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
NR 40
TC 2
Z9 2
U1 5
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2121
J9 BMC CELL BIOL
JI BMC Cell Biol.
PD APR 21
PY 2017
VL 18
AR 21
DI 10.1186/s12860-017-0137-9
PG 15
WC Cell Biology
SC Cell Biology
GA EU2XU
UT WOS:000400894000001
PM 28427322
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liu, YW
   Xia, T
   Wei, JJ
   Liu, QJ
   Li, XH
AF Liu, Yaowen
   Xia, Tian
   Wei, Jiaojun
   Liu, Qingjie
   Li, Xiaohong
TI Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for
   predictive screening of drug cardiotoxicities
SO NANOSCALE
LA English
DT Article
ID ENGINEERED HEART-TISSUE; CELL-DERIVED CARDIOMYOCYTES; PLURIPOTENT
   STEM-CELLS; IN-VITRO; VENTRICULAR MYOCYTES; DE-POINTES; MUSCLE; FIBERS;
   PLATFORM; BIOMATERIAL
AB The spatial arrangement of cardiac myocytes (CMs) and other non-myocytes scaffolds, closely resembling native tissue, is essential to control the CM morphology and function for cardiac tissue regeneration. In the current study, micropatterned fibrous scaffolds were developed to establish a CM co-culture system with cardiac fibroblasts (CFs) and endothelial cells (ECs) as a potential in vitro drug screening model. To pursue a biomimetic approach to influence CM behaviors, strip, oval and wave-patterned mats were constructed by deposition of electrospun fibers on lithographic collectors, followed by precise stacking for cell co-cultures. CMs, CFs, and ECs were located on the patterned scaffolds with controlled cellular distribution in the respective regions and no across condition was found. Compared with those after strip and oval-patterned co-culture, CMs co-cultured on wave-patterned scaffolds displayed significantly greater cell viabilities, larger cell elongation ratios, stronger expressions of cardiac-specific Troponin I, connexin 43 and sarcomeric a-actinin and higher beating rates during 15 days of incubation. The responses of co-cultured CMs to quinidine, erythromycin and sotalol show good correlations with clinical observations in the beating rate and the prolongation of the contraction and relaxation time. The in vivo safety data reflected well with the concentrations for 50% of maximal effect (EC50) after drug treatment on cocultured CMs, which was determined from the changes in the corrected field potential duration (FPDc) against the drug concentrations. During 15 days of patterned co-culture, the interbeat intervals and fluctuations of the CMs indicated quick changes in response to haloperidol treatment and sufficient restoration of the original beating profiles after drug removal. This study demonstrates the capabilities of micropatterned co-culture of CMs to establish the cardiac function as a reproducible and reliable platform for screening cardiac side effects of drugs.
C1 [Liu, Yaowen; Wei, Jiaojun; Liu, Qingjie; Li, Xiaohong] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
   [Liu, Yaowen] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China.
   [Xia, Tian] Peoples Liberat Army, Hosp 452, Dept Pathol, Chengdu 610021, Peoples R China.
RP Li, XH (reprint author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM xhli@swjtu.edu.cn
OI Li, Xiaohong/0000-0003-1312-0215
FU National Natural Science Foundation of China [31470922, 21274117];
   Fundamental Research Funds for the Central Universities [2682016YXZT08]
FX This work was supported by National Natural Science Foundation of China
   (31470922 and 21274117) and Fundamental Research Funds for the Central
   Universities (2682016YXZT08).
CR Antzelevitch C, 1996, J AM COLL CARDIOL, V28, P1836, DOI 10.1016/S0735-1097(96)00377-4
   Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001
   Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.
   Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.tea.2011.0341, 10.1089/ten.TEA.2011.0341]
   Cai PQ, 2016, ADV MATER, V28, P3102, DOI 10.1002/adma.201505300
   Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]
   Carlsson L, 2006, J INTERN MED, V259, P70, DOI 10.1111/j.1365-2/-96.2005.01590.x
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen A, 2014, BIOMATERIALS, V35, P675, DOI 10.1016/j.biomaterials.2013.10.007
   Chen PH, 2015, RSC ADV, V5, P6932, DOI 10.1039/c4ra12486c
   Cimetta E, 2013, CURR OPIN BIOTECH, V24, P926, DOI 10.1016/j.copbio.2013.07.002
   Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008
   Dhir V, 2009, BIOTECHNOL PROGR, V25, P594, DOI [10.1021/bp.150, 10.1002/btpr.150]
   Eder A, 2016, ADV DRUG DELIVER REV, V96, P214, DOI 10.1016/j.addr.2015.05.010
   Fleischer S, 2013, BIOMATERIALS, V34, P8599, DOI 10.1016/j.biomaterials.2013.07.054
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Gao Q., 2014, STEM CELLS INT, V291
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458
   Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.tea.2012.0181, 10.1089/ten.TEA.2012.0181]
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Kaneko T, 2007, ANALYST, V132, P892, DOI 10.1039/b704961g
   Kharaziha M, 2014, BIOMATERIALS, V35, P7346, DOI 10.1016/j.biomaterials.2014.05.014
   Kharaziha M, 2013, BIOMATERIALS, V34, P6355, DOI 10.1016/j.biomaterials.2013.04.045
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Korinek J, 2007, J AM SOC ECHOCARDIOG, V20, P1407, DOI 10.1016/j.echo.2007.04.010
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   KRIWISKY M, 1990, CHEST, V98, P482, DOI 10.1378/chest.98.2.482
   Lamore SD, 2013, TOXICOL SCI, V135, P402, DOI 10.1093/toxsci/kft167
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051
   Lichter JG, 2014, J MOL CELL CARDIOL, V72, P186, DOI 10.1016/j.yjmcc.2014.03.012
   Liu YW, 2016, MAT SCI ENG C-MATER, V69, P865, DOI 10.1016/j.msec.2016.07.069
   Liu YW, 2014, BIOMACROMOLECULES, V15, P1044, DOI 10.1021/bm401926k
   Liu YW, 2012, LANGMUIR, V28, P17134, DOI 10.1021/la303490x
   Mandenius CF, 2011, J APPL TOXICOL, V31, P191, DOI 10.1002/jat.1663
   Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s
   Pratt CM, 1998, AM J CARDIOL, V81, P869, DOI 10.1016/S0002-9149(98)00006-X
   Pugsley MK, 2005, CLIN EXP PHARMACOL P, V32, P60, DOI 10.1111/j.1440-1681.2005.04149.x
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Reppel M, 2005, J ELECTROCARDIOL, V38, P166, DOI 10.1016/j.jelectrocard.2005.06.029
   ROBINSON TF, 1988, CIRC RES, V63, P577, DOI 10.1161/01.RES.63.3.577
   RODEN DM, 1987, J PHARMACOL EXP THER, V243, P1218
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Su WF, 2016, INT J POLYM MATER PO, V65, P703, DOI 10.1080/00914037.2016.1157802
   Tay CY, 2015, NPG ASIA MATER, V7, DOI 10.1038/am.2015.66
   Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Waldhauser KM, 2006, J PHARMACOL EXP THER, V319, P1413, DOI 10.1124/jpet.106.108993
   Wang JX, 2005, J BIOL CHEM, V280, P7273, DOI 10.1074/jbc.M410819200
   Wilson A, 2014, CELL MOL LIFE SCI, V71, P165, DOI 10.1007/s00018-013-1374-5
   Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 56
TC 0
Z9 0
U1 2
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PD APR 21
PY 2017
VL 9
IS 15
BP 4950
EP 4962
DI 10.1039/c7nr00001d
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA ES3KZ
UT WOS:000399429800012
PM 28382363
DA 2018-10-20
ER

PT J
AU Alves, AC
   Wenger, F
   Ponthiaux, P
   Celis, JP
   Pinto, AM
   Rocha, LA
   Fernandes, JCS
AF Alves, A. C.
   Wenger, F.
   Ponthiaux, P.
   Celis, J. -P.
   Pinto, A. M.
   Rocha, L. A.
   Fernandes, J. C. S.
TI Corrosion mechanisms in titanium oxide-based films produced by anodic
   treatment
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Titanium; Biomaterial; Anodic treatment; Corrosion; EIS
ID MICRO-ARC OXIDATION; COMMERCIALLY PURE TITANIUM; PLASMA ELECTROLYTIC
   OXIDATION; SURFACE CHARACTERISTICS; BIOMEDICAL APPLICATIONS;
   ELECTROCHEMICAL-BEHAVIOR; HYDROTHERMAL TREATMENT; ARTIFICIAL SALIVA;
   CALCIUM-ION; CP TI
AB Thanks to its excellent corrosion resistance, good mechanical properties and biocompatibility, titanium has been widely used as dental implant material. A passive oxide film formed on titanium surface is responsible for its high corrosion resistance. This study has evaluated the surface characteristics of oxide layers formed on commercially pure titanium samples by anodic treatment and the effect of anodic treatment on their corrosion behaviour. FEG-SEM and XRD were used to evaluate the micromorphology and crystalline structure of these oxide films. Their corrosion resistance was evaluated using electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization curves. EIS was performed for different times of immersion and a new equivalent electrical circuit (EEC) is proposed to fit the experimental data of the anodic oxide films. It was concluded that the morphology, composition, and structure of the outer porous layer of the anodic layer determine the corrosion protection of the material. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Alves, A. C.; Pinto, A. M.; Rocha, L. A.] Univ Minho, CMEMS UMinho Ctr MicroElectroMech Syst, P-4800058 Azurem, Guimaraes, Portugal.
   [Wenger, F.; Ponthiaux, P.] Ecole Cent Paris, LGPM, Paris, France.
   [Celis, J. -P.] KULeuven, MTM Mat Engn, Leuven, Belgium.
   [Pinto, A. M.] Univ Minho, Dept Mech Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
   [Rocha, L. A.] UNESP Univ Estadual Paulista, Fac Ciencias Bauru, Dept Phys, Sao Paulo, SP, Brazil.
   [Rocha, L. A.] IBTN Br Brazilian Branch Inst Biomat Tribocorros, Bauru, Brazil.
   [Fernandes, J. C. S.] Univ Lisbon, CQE DEQ Inst Super Tecn, Lisbon, Portugal.
RP Alves, AC (reprint author), Univ Minho, Dept Mech Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM alexandra@dem.uminho.pt
RI Rocha, Luis/A-8592-2008; Fernandes, Joao/B-2748-2013
OI Rocha, Luis/0000-0002-7219-1518; Fernandes, Joao/0000-0002-3017-2626;
   Alves, Alexandra C./0000-0001-5054-9083; Pinto, Ana/0000-0002-1155-9972
FU FCT [UID/EEA/04436/2013, UID/QUI/00100/2013]; FEDER funds through the
   COMPETE Programa Operacional Competitividade e Internacionalizacao
   (POCI) [POCI-01-0145-FEDER-006941]; FWO-Flanders [WO.039.14N]; EU [COST
   MP1407]
FX This work is supported by FCT with the reference project
   UID/EEA/04436/2013, by FEDER funds through the COMPETE 2020 Programa
   Operacional Competitividade e Internacionalizacao (POCI) with the
   reference project POCI-01-0145-FEDER-006941. Part of this work was done
   within the Scientific Community on Surface Modification of Materials
   funded by FWO-Flanders (grant number WO.039.14N), and within the scope
   of the EU-funded COST MP1407 "E-MINDS. CQE is financed by FCT under
   contract UID/QUI/00100/2013.
CR Abbasi S, 2013, MAT SCI ENG C-MATER, V33, P2555, DOI 10.1016/j.msec.2013.02.018
   Alves AC, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/40/404001
   Alves S., 2015, J BIO TRIBO CORROS, V1, P1
   Alves SA, 2014, LUBR SCI, V26, P500, DOI 10.1002/ls.1234
   Banakh O, 2016, APPL SURF SCI, V378, P207, DOI 10.1016/j.apsusc.2016.03.161
   Chang P.-C., 2007, J BIOMED MATER RES A, V80, P283
   Chen YJ, 2009, MATER LETT, V63, P2659, DOI 10.1016/j.matlet.2009.09.029
   Cui WF, 2013, MAT SCI ENG C-MATER, V33, P3775, DOI 10.1016/j.msec.2013.05.011
   Deng FL, 2010, MAT SCI ENG C-MATER, V30, P141, DOI 10.1016/j.msec.2009.09.010
   Dheda SS, 2013, J MATER SCI-MATER M, V24, P1239, DOI 10.1007/s10856-013-4889-2
   ELAGLI K, 1993, ELECTROCHIM ACTA, V38, P1769, DOI 10.1016/0013-4686(93)85075-A
   Fadl-Allah SA, 2010, APPL SURF SCI, V256, P5849, DOI 10.1016/j.apsusc.2010.03.058
   Fazel M, 2015, APPL SURF SCI, V324, P751, DOI 10.1016/j.apsusc.2014.11.030
   Felgueiras HP, 2015, J BIOMED MATER RES B, V103, P661, DOI 10.1002/jbm.b.33236
   GRAHAME DC, 1952, J ELECTROCHEM SOC, V99, pC370, DOI 10.1149/1.2779638
   Han I, 2007, SURF COAT TECH, V201, P5533, DOI 10.1016/j.surfcoat.2006.07.102
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   He G, 2013, SURF COAT TECH, V228, P201, DOI 10.1016/j.surfcoat.2013.04.030
   Hsu CH, 2001, CORROSION, V57, P747, DOI 10.5006/1.3280607
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Ishizawa H, 1999, J MATER SCI, V34, P5893, DOI 10.1023/A:1004739108534
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Ishizawa H, 1997, J BIOMED MATER RES, V35, P199
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kim Kyo-Han, 2006, J Oral Implantol, V32, P8, DOI 10.1563/741.1
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Le Guehennec L, 2007, DENT MATER, V3, P844
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lundstrom J., 1999, 12 IEEE INT, P10
   Matykina E, 2016, SURF COAT TECH, V307, P1255, DOI 10.1016/j.surfcoat.2016.08.018
   Matykina E., 2013, J MATER SCI-MATER M, P37
   Mohedano M., 2013, DENT MATER, V30, pe28
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Ni YX, 2011, APPL SURF SCI, V257, P9287, DOI 10.1016/j.apsusc.2011.05.007
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Ohtsuka T, 1997, CORROS SCI, V39, P1253, DOI 10.1016/S0010-938X(97)00025-5
   Oliveira FG, 2015, APPL SURF SCI, V341, P1, DOI 10.1016/j.apsusc.2015.02.163
   Orazem ME, 2008, ELECTROCHEMICAL IMPE
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Park IS, 2007, ELECTROCHIM ACTA, V53, P863, DOI 10.1016/j.electacta.2007.07.067
   Park IS, 2006, MET MATER-INT, V12, P399, DOI 10.1007/BF03027706
   Pham MT, 2000, THIN SOLID FILMS, V379, P50, DOI 10.1016/S0040-6090(00)01553-4
   Quintero D, 2014, SURF COAT TECH, V258, P1223, DOI 10.1016/j.surfcoat.2014.06.058
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Ribeiro AR, 2015, MAT SCI ENG C-MATER, V54, P196, DOI 10.1016/j.msec.2015.05.012
   Roach MD, 2016, MAT SCI ENG C-MATER, V58, P213, DOI 10.1016/j.msec.2015.08.028
   Shokouhfar M, 2012, APPL SURF SCI, V258, P2416, DOI 10.1016/j.apsusc.2011.10.064
   Song HJ, 2007, SURF COAT TECH, V201, P8738, DOI 10.1016/j.surfcoat.2006.11.022
   Souza MEP, 2007, SURF COAT TECH, V201, P7775, DOI 10.1016/j.surfcoat.2007.03.005
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Szesz EM, 2013, THIN SOLID FILMS, V528, P163, DOI 10.1016/j.tsf.2012.09.096
   Venkateswarlu K, 2013, CERAM INT, V39, P801, DOI 10.1016/j.ceramint.2012.07.001
   Venkateswarlu K, 2012, APPL SURF SCI, V258, P6853, DOI 10.1016/j.apsusc.2012.03.118
   Vercaigne S, 1998, BIOMATERIALS, V19, P1093, DOI 10.1016/S0142-9612(98)00039-8
   Veys-Renaux D, 2016, SURF COAT TECH, V285, P214, DOI 10.1016/j.surfcoat.2015.11.028
   Wang YH, 2006, MATER LETT, V60, P474, DOI 10.1016/j.matlet.2005.09.015
   Williamson RS, 2013, J MATER SCI-MATER M, V24, P2327, DOI 10.1007/s10856-013-4985-3
   Wu SD, 2015, APPL SURF SCI, V329, P347, DOI 10.1016/j.apsusc.2014.12.039
   Wypych A, 2014, J NANOMATER, DOI 10.1155/2014/124814
   Yang YZ, 2002, MAT SCI ENG C-BIO S, V20, P117, DOI 10.1016/S0928-4931(02)00021-8
   Yu SR, 2007, J BIOMED MATER RES B, V83B, P623, DOI 10.1002/jbm.b.30836
NR 64
TC 15
Z9 16
U1 5
U2 45
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 20
PY 2017
VL 234
BP 16
EP 27
DI 10.1016/j.electacta.2017.03.011
PG 12
WC Electrochemistry
SC Electrochemistry
GA EQ8IS
UT WOS:000398328800003
DA 2018-10-20
ER

PT J
AU Casdorff, K
   Keplinger, T
   Bellanger, H
   Michen, B
   Schon, S
   Burgert, I
AF Casdorff, Kirstin
   Keplinger, Tobias
   Bellanger, Herve
   Michen, Benjamin
   Schon, Silke
   Burgert, Ingo
TI High-Resolution Adhesion Mapping of the Odd-Even Effect on a
   Layer-by-Layer Coated Biomaterial by Atomic-Force-Microscopy
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE LbL; ARM; wood; quartz; quantitative imaging
ID POLYELECTROLYTE CHARGE-DENSITY; IN-SITU; MULTILAYERS; SURFACE; AFM;
   CONTACT; GROWTH; WOOD; MECHANISMS; ADSORPTION
AB The adhesion behavior of polyelectrolyte multilayers consisting of poly(diallyldimethylammoniurn chloride), PDDA, and poly(styrenesulfonate), PSS, toward a silicon AFM tip was studied during their build-up on wood, a chemically heterogeneous, micrometer rough biomaterial and compared with a nanometer rough substrate, namely quartz. The atomic force microscopy-based force mapping approach generated high-resolution topography,, and adhesion maps within the first bilayers, which point toward a homogeneous layer-by-layer build-up on the biomaterial surface, and therefore,3 indicate an even charge distribution. By analyzing the force-distance curves in every pixel of the mapping, new insights into the specific interactions of the polyelectrolyte multilayers at the surface were achieved. The characteristic odd-even effect of polyelectrolyte multilayers cannot only be determined on quartz, but also on the biomaterial wood, however, only after an offset of two bilayers. This is potentially due to the specific roughness and charge of wood in comparison to commonly used quartz.
C1 [Casdorff, Kirstin; Keplinger, Tobias; Bellanger, Herve; Michen, Benjamin; Burgert, Ingo] Swiss Fed Inst Technol, Inst Bldg Mat, Wood Mat Sci, Stefano Franscini Pl 3, CH-8093 Zurich, Switzerland.
   [Casdorff, Kirstin; Keplinger, Tobias; Bellanger, Herve; Michen, Benjamin; Burgert, Ingo] EMPA Swiss Fed Labs Mat Sci & Technol, Appl Wood Mat, Uberlandstr 129, CH-8600 Dubendorf, Switzerland.
   [Schon, Silke] Swiss Fed Inst Technol, Lab 1, CH-8093 Zurich, Switzerland.
RP Burgert, I (reprint author), Swiss Fed Inst Technol, Inst Bldg Mat, Wood Mat Sci, Stefano Franscini Pl 3, CH-8093 Zurich, Switzerland.; Burgert, I (reprint author), EMPA Swiss Fed Labs Mat Sci & Technol, Appl Wood Mat, Uberlandstr 129, CH-8600 Dubendorf, Switzerland.
EM iburgert@ethz.ch
FU EIT Climate-KIC;  [SNFNRP66]
FX This work was supported by EIT Climate-KIC, BTA (Building Technology
   Accelerator) and in the framework of the SNFNRP66 project: Improved wood
   materials for structures and interior applications.
CR Ankerfors C, 2012, SOFT MATTER, V8, P8298, DOI 10.1039/c2sm26096d
   Bellanger H., 2017, J COLLOID I IN PRESS, DOI [10.1016/j.jcis.2017.02.048, DOI 10.1016/J.JCIS.2017.02.048]
   Bhushan B, 2003, J VAC SCI TECHNOL B, V21, P2262, DOI 10.1116/1.1627336
   Boudou T, 2009, LANGMUIR, V25, P13809, DOI 10.1021/la9018663
   Braithwaite GJC, 1996, LANGMUIR, V12, P4224, DOI 10.1021/la960154l
   Brandstrom J, 2001, IAWA J, V22, P333
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Chopinet L, 2013, MICRON, V48, P26, DOI 10.1016/j.micron.2013.02.003
   Criado M, 2017, BIOMACROMOLECULES, V18, P169, DOI 10.1021/acs.biomac.6b01449
   de Villiers MM, 2011, ADV DRUG DELIVER REV, V63, P701, DOI 10.1016/j.addr.2011.05.011
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 2003, MULTILAYER THIN FILM
   DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   Fengel D, 1984, WOOD CHEM ULTRASTRUC
   Ghostine RA, 2013, LANGMUIR, V29, P11742, DOI 10.1021/la401632x
   Ghostine RA, 2013, J AM CHEM SOC, V135, P7636, DOI 10.1021/ja401318m
   Glinel K, 2002, LANGMUIR, V18, P1408, DOI 10.1021/la0113670
   Gong HF, 2005, LANGMUIR, V21, P7545, DOI 10.1021/la051045m
   Johansson E, 2009, LANGMUIR, V25, P2887, DOI 10.1021/la803628w
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7
   Klitzing V., 2006, PHYS CHEM CHEM PHYS, V8, P5012
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lehaf AM, 2012, LANGMUIR, V28, P6348, DOI 10.1021/la300482x
   Lingstrom R, 2007, J COLLOID INTERF SCI, V314, P1, DOI 10.1016/j.jcis.2007.04.046
   Lozhechnikova A, 2017, APPL SURF SCI, V396, P1273, DOI 10.1016/j.apsusc.2016.11.132
   Lu X, 2016, BIORESOURCES, V11, P4605
   Notley SM, 2005, J COLLOID INTERF SCI, V292, P29, DOI 10.1016/j.jcis.2005.05.057
   Priya DN, 2009, ACS APPL MATER INTER, V1, P2684, DOI 10.1021/am900566n
   Rao X, 2016, HOLZFORSCHUNG, V70, P361, DOI 10.1515/hf-2015-0047
   Renneckar S, 2009, ACS APPL MATER INTER, V1, P559, DOI 10.1021/am800119q
   Schoeler B, 2002, MACROMOLECULES, V35, P889, DOI 10.1021/ma011349p
   Sneddon N., 1965, INT J ENG SCI, V3, P47
   Tsukruk VV, 1997, MACROMOLECULES, V30, P6615, DOI 10.1021/ma961897g
   Tsukruk VV, 2012, SCANNING PROBE MICROSCOPY OF SOFT MATTER: FUNDAMENTALS AND PRACTICES, P1
   Voigt U, 2003, J PHYS CHEM B, V107, P5273, DOI 10.1021/jp0256488
   Volodkin D, 2014, CURR OPIN COLLOID IN, V19, P25, DOI 10.1016/j.cocis.2014.01.001
   Zerball M, 2015, J PHYS CHEM B, V119, P11879, DOI 10.1021/acs.jpcb.5b04350
NR 39
TC 3
Z9 3
U1 3
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 19
PY 2017
VL 9
IS 15
BP 13793
EP 13800
DI 10.1021/acsami.7b02564
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA ET0PK
UT WOS:000399965700097
PM 28345851
DA 2018-10-20
ER

PT J
AU Fontana, G
   Gershlak, J
   Adamski, M
   Lee, JS
   Matsumoto, S
   Le, HD
   Binder, B
   Wirth, J
   Gaudette, G
   Murphy, WL
AF Fontana, Gianluca
   Gershlak, Joshua
   Adamski, Michal
   Lee, Jae-Sung
   Matsumoto, Shion
   Le, Hau D.
   Binder, Bernard
   Wirth, John
   Gaudette, Glenn
   Murphy, William L.
TI Biofunctionalized Plants as Diverse Biomaterials for Human Cell Culture
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biofunctionalization; biomaterials; cell expansion; decellularized
   scaffolds; plants
ID BACTERIAL CELLULOSE; IN-VIVO; MINERAL COATINGS; VASCULAR PLANTS; WATER
   TRANSPORT; BIOCOMPATIBILITY; STRATEGIES; RELEASE; DESIGN; GROWTH
AB The commercial success of tissue engineering products requires efficacy, cost effectiveness, and the possibility of scaleup. Advances in tissue engineering require increased sophistication in the design of biomaterials, often challenging the current manufacturing techniques. Interestingly, several of the properties that are desirable for biomaterial design are embodied in the structure and function of plants. This study demonstrates that decellularized plant tissues can be used as adaptable scaffolds for culture of human cells. With simple biofunctionalization technique, it is possible to enable adhesion of human cells on a diverse set of plant tissues. The elevated hydrophilicity and excellent water transport abilities of plant tissues allow cell expansion over prolonged periods of culture. Moreover, cells are able to conform to the microstructure of the plant frameworks, resulting in cell alignment and pattern registration. In conclusion, the current study shows that it is feasible to use plant tissues as an alternative feedstock of scaffolds for mammalian cells.
C1 [Fontana, Gianluca; Lee, Jae-Sung] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI 53705 USA.
   [Gershlak, Joshua; Matsumoto, Shion; Gaudette, Glenn] Worcester Polytech Inst, Biomed Engn, Worcester, MA 01609 USA.
   [Adamski, Michal; Le, Hau D.; Binder, Bernard] Univ Wisconsin, Sch Med, Dept Surg, Madison, WI 53705 USA.
   [Wirth, John] Olbrich Bot Gardens, Madison, WI 53704 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Surg, Dept Orthoped & Rehabil, Biomed Engn,Mat Sci & Engn, Madison, WI 53705 USA.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Surg, Dept Orthoped & Rehabil, Biomed Engn,Mat Sci & Engn, Madison, WI 53705 USA.
EM wlmurphy@ortho.wisc.edu
FU Environmental Protection Agency (STAR) [83573701]; National Institutes
   of Health [R01HL093282-01A1, UH3TR000506]; National Science Foundation
   [IGERT DGE1144804]
FX The authors thank Bradley Herrick and the University of Wisconsin
   Arboretum (Madison, Wisconsin) for allowing to collect plant samples;
   all the staff in the Olbrich Botanical Gardens (Madison, Wisconsin) for
   their assistance regarding collection of tropical plants; and Ellen
   Leiferman (University of Wisconsin-Madison) for her help with the
   faxitron images. This work was supported by the Environmental Protection
   Agency (STAR grant no. 83573701), the National Institutes of Health
   (R01HL093282-01A1 and UH3TR000506), and the National Science Foundation
   (IGERT DGE1144804).
CR Ball P, 2002, NANOTECHNOLOGY, V13, pR15, DOI 10.1088/0957-4484/13/5/201
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Burgert I, 2006, AM J BOT, V93, P1391, DOI 10.3732/ajb.93.10.1391
   Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003
   Choi S, 2010, ACTA BIOMATER, V6, P3426, DOI 10.1016/j.actbio.2010.03.020
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341
   Gu Bon Kang, 2016, Biomater Res, V20, P12, DOI 10.1186/s40824-016-0058-2
   Guyette JP, 2014, NAT PROTOC, V9, P1451, DOI 10.1038/nprot.2014.097
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45
   Hoshiba T, 2016, STEM CELLS INT, V2016
   Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS
   Kim HK, 2014, J EXP BOT, V65, P1895, DOI 10.1093/jxb/eru075
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Lenting HBM, 2001, J BIOTECHNOL, V89, P217, DOI 10.1016/S0168-1656(01)00300-5
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444
   Mehdizadeh M, 2013, MACROMOL BIOSCI, V13, P271, DOI 10.1002/mabi.201200332
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Modulevsky DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157894
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Paulsen SJ, 2015, DEV DYNAM, V244, P629, DOI 10.1002/dvdy.24254
   Petit G, 2009, J THEOR BIOL, V259, P1, DOI 10.1016/j.jtbi.2009.03.007
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Raven PH, 2005, BIOL PLANTS
   REESE ET, 1956, APPL MICROBIOL, V4, P39
   Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tyree M. T., 2013, XYLEM STRUCTURE ASCE
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Wertz J. -L., 2010, CELLULOSE SCI TECHNO
   Wilker JJ, 2014, NAT MATER, V13, P849, DOI 10.1038/nmat4070
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791
NR 41
TC 0
Z9 0
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 19
PY 2017
VL 6
IS 8
AR UNSP 1601225
DI 10.1002/adhm.201601225
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA ES7HO
UT WOS:000399720700007
PM 28319334
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Ta, VD
   Caixeiro, S
   Fernandes, FM
   Sapienza, R
AF Van Duong Ta
   Caixeiro, Soraya
   Fernandes, Francisco M.
   Sapienza, Riccardo
TI Microsphere Solid-State Biolasers
SO ADVANCED OPTICAL MATERIALS
LA English
DT Article
DE biomaterial; lasers; protein; polysaccharides; whispering gallery mode
ID DISTRIBUTED-FEEDBACK LASER; LABEL-FREE; OPTICAL MICRORESONATORS;
   FLUORESCENT PROTEIN; BONE TISSUE; MICROLASERS; MICROCAVITIES;
   NANOPARTICLES; CELLULOSE
AB Biolasers obtained from biomaterials are attracting a wealth of interest for their potential as future biosensors with enhanced sensitivity, and advanced cell tracking. Here, miniature biolasers are reported, which are formed by bovine serum albumin (BSA) protein and biosourced polysaccharides derived from land plants such as cellulose and pectin. Using a green processing route aided by simple emulsions, solid-state microspheres with diameters of 15-100 mu m are fabricated and utilized as whispering gallery mode lasers with thresholds of a few mu J mm(-2) and quality factors of up to 3000. Furthermore, BSA microlasers are found to be compatible with cell growth and resistant to the aqueous environment of cell culture media. This environmentally friendly and biocompatible design shows promise for future implantable biosensing devices opening a path between laser science and medicine.
C1 [Van Duong Ta; Caixeiro, Soraya; Sapienza, Riccardo] Kings Coll London, Dept Phys, London WC2R 2LS, England.
   [Fernandes, Francisco M.] Univ Paris 06, Lab Chim Mat Condensee Paris, Sorbonne Univ, UMR7574, 4 Pl Jussieu, F-75005 Paris, France.
RP Ta, VD (reprint author), Kings Coll London, Dept Phys, London WC2R 2LS, England.
EM van_duong.ta@kcl.ac.uk
RI Fernandes, Francisco/F-8688-2010; Ta, Duong/C-5591-2018
OI Fernandes, Francisco/0000-0002-6697-1470; Ta, Duong/0000-0003-3961-714X
FU Engineering and Physical Sciences Research Council (EPSRC)
   [EP/M027961/1]; Leverhulme Trust [RPG-2014-238]; Royal Society
   [RG140457]
FX This work was funded by the Engineering and Physical Sciences Research
   Council (EPSRC) under grant EP/M027961/1, the Leverhulme Trust
   (RPG-2014-238), and the Royal Society (RG140457).
CR Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   Caixeiro S, 2016, ADV OPT MATER, V4, P998, DOI 10.1002/adom.201600185
   Chen R, 2011, ADV MATER, V23, P2199, DOI 10.1002/adma.201100423
   Choi Y, 2015, LAB CHIP, V15, P642, DOI 10.1039/c4lc01171f
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y
   dos Santos MV, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866686
   Dumanli AG, 2014, ADV OPT MATER, V2, P646, DOI 10.1002/adom.201400112
   Gather MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6722
   Gather MC, 2011, OPT LETT, V36, P3299, DOI 10.1364/OL.36.003299
   Gather MC, 2011, NAT PHOTONICS, V5, P406, DOI [10.1038/nphoton.2011.99, 10.1038/NPHOTON.2011.99]
   He LN, 2013, LASER PHOTONICS REV, V7, P60, DOI 10.1002/lpor.201100032
   He LN, 2011, NAT NANOTECHNOL, V6, P428, DOI [10.1038/nnano.2011.99, 10.1038/NNANO.2011.99]
   Humar M, 2009, NAT PHOTONICS, V3, P595, DOI 10.1038/NPHOTON.2009.170
   Humar M, 2017, NANOPHOTONICS-BERLIN, V6, P414, DOI 10.1515/nanoph-2016-0003
   Humar M, 2015, NAT PHOTONICS, V9, P572, DOI [10.1038/NPHOTON.2015.129, 10.1038/nphoton.2015.129]
   Jayakumar GC, 2014, RSC ADV, V4, P42846, DOI 10.1039/c4ra07683d
   Jiang XF, 2016, LASER PHOTONICS REV, V10, P40, DOI 10.1002/lpor.201500163
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Lahoz F, 2015, LASER PHYS LETT, V12, DOI 10.1088/1612-2011/12/4/045805
   LAM CC, 1992, J OPT SOC AM B, V9, P1585, DOI 10.1364/JOSAB.9.001585
   Li JJ, 2011, CARBOHYD POLYM, V85, P885, DOI 10.1016/j.carbpol.2011.04.015
   LIN HB, 1986, OPT LETT, V11, P614, DOI 10.1364/OL.11.000614
   Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006
   Nizamoglu S, 2015, ADV OPT MATER, V3, P1197, DOI 10.1002/adom.201500144
   Nizamoglu S, 2013, ADV MATER, V25, P5943, DOI 10.1002/adma201300818
   Oxborrow M, 2007, IEEE T MICROW THEORY, V55, P1209, DOI 10.1109/TMTT.2007.897850
   Polson RC, 2004, APPL PHYS LETT, V85, P1289, DOI 10.1063/1.1782259
   Schubert M, 2015, NANO LETT, V15, P5647, DOI 10.1021/acs.nanolett.5b02491
   Song QH, 2010, OPT LETT, V35, P1425, DOI 10.1364/OL.35.001425
   Spillane SM, 2002, NATURE, V415, P621, DOI 10.1038/415621a
   Sun YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12852
   Sun YL, 2012, ANGEW CHEM INT EDIT, V51, P1558, DOI 10.1002/anie.201105925
   Ta V. D., 2013, SCI REP, V3, P1362
   Toffanin S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748120
   Ta VD, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4936628
   Ta VD, 2013, LASER PHOTONICS REV, V7, P133, DOI 10.1002/lpor.201200074
   Vannahme C, 2013, LAB CHIP, V13, P2675, DOI 10.1039/c3lc50140j
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Ward J, 2011, LASER PHOTONICS REV, V5, P553, DOI 10.1002/lpor.201000025
   Wei YH, 2017, ACS NANO, V11, P597, DOI 10.1021/acsnano.6b06772
   Wu X, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807837
NR 43
TC 2
Z9 2
U1 16
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2195-1071
J9 ADV OPT MATER
JI Adv. Opt. Mater.
PD APR 18
PY 2017
VL 5
IS 8
AR UNSP 1601022
DI 10.1002/adom.201601022
PG 6
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA ES6TT
UT WOS:000399683300008
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Al-Kaabi, Z
   Pradhan, RR
   Thevathasan, N
   Chiang, YW
   Gordon, A
   Dutta, A
AF Al-Kaabi, Zainab
   Pradhan, Ranjan R.
   Thevathasan, Naresh
   Chiang, Yi Wai
   Gordon, Andrew
   Dutta, Animesh
TI Potential value added applications of black liquor generated at paper
   manufacturing industry using recycled fibers
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Black liquor; Recycled paper; Pulp; Biopolymer
ID HYDROTHERMAL CARBONIZATION; LIGNIN; FUEL; PULP
AB Characterization of neutral sulphite semi-chemical black liquor (NSSCBL), sampled from paper manufacturing process that uses recycled fibers as primary feedstock, was carried out for potential bioenergy and biomaterial applications. Physico-chemical characteristics including inorganic elements content, thermogravimetric analysis, GC/MS, and FT-IR are presented. The black liquor of the recycled fibers in the manufacturing process revealed unique characteristics in terms of chemical composition profile compared to the black liquor originating from regular pulp and paper industries. The major findings include the presence of chemical compounds, from a non-plant origin, such as derivatives of hexanedioic acid in significant quantities. The favorable biofuel characteristics of this black liquor are: neutral pH, a higher volatile content, and HHV. The recycled paper NSSCBL can be a good candidate for biomaterial and biofuel applications. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Al-Kaabi, Zainab; Thevathasan, Naresh; Gordon, Andrew] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.
   [Pradhan, Ranjan R.; Chiang, Yi Wai; Dutta, Animesh] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Dutta, A (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
EM adutta@uoguelph.ca
OI Dutta, Animesh/0000-0002-9995-807X; Chiang, Yi Wai/0000-0002-7798-9166
FU Ministry of Higher Education and Scientific Research, Baghdad, Iraq
FX This research work was supported by Ministry of Higher Education and
   Scientific Research, Baghdad, Iraq. The authors, also would like to
   thank Cascade Inc., Canada, Tembec pulp and paper, Canada, and
   Alberta-Pacific Forest industries Inc., Canada for supplying the black
   liquor samples.
CR ALEN R, 1995, J ANAL APPL PYROL, V31, P1, DOI 10.1016/0165-2370(94)00811-E
   Andelin J., 1989, TECHNOLOGIES REDUCIN, P17
   Bajpai P., 2014, BIOL ODOUR TREATMENT, P9
   Bajpai P, 2012, BIOTECHNOLOGY FOR PULP AND PAPER PROCESSING, P7, DOI 10.1007/978-1-4614-1409-4_2
   Cadogan D. F., 1992, ULLMANNS ENCY IND CH, VA20
   Cadogan DF, 1996, KIRK OTHMER ENCY CHE, V19, P258
   Cao C., 2010, ENERGY, V78, P161
   Davis D. D., 1991, KIRKOTHMER ENCY CHEM, V1, P466
   Foulet A, 2015, J CLEAN PROD, V91, P180, DOI 10.1016/j.jclepro.2014.12.035
   Friedl A, 2005, ANAL CHIM ACTA, V544, P191, DOI 10.1016/j.aca.2005.01.041
   Froass PM, 1996, J WOOD CHEM TECHNOL, V16, P347, DOI 10.1080/02773819608545820
   Gamgoum R, 2016, ENERGIES, V9, DOI 10.3390/en9060435
   GU P, 1992, J ANAL APPL PYROL, V24, P147, DOI 10.1016/0165-2370(92)85026-H
   Jonsson J, 2011, APPL THERM ENG, V31, P2107, DOI 10.1016/j.applthermaleng.2011.03.001
   Kambo HS, 2014, APPL ENERG, V135, P182, DOI 10.1016/j.apenergy.2014.08.094
   Kang SM, 2012, BIORESOURCE TECHNOL, V110, P715, DOI 10.1016/j.biortech.2012.01.093
   Kong LB, 2016, J CLEAN PROD, V122, P5, DOI 10.1016/j.jclepro.2015.12.116
   Ksibi M, 2003, J PHOTOCH PHOTOBIO A, V154, P211, DOI 10.1016/S1010-6030(02)00316-7
   Lin S. Y., 1992, METHODS LIGNIN CHEM
   Patt R., 2005, PAPER PULP ULLMANNS
   Radoykova T., 2013, J CHEM TECHNOLOGY ME, V48, P524
   Ramesh S., 2013, INT J CHEM ENG APPL, V4
   REIMER RA, 1994, ENVIRON PROG, V13, P134, DOI 10.1002/ep.670130217
   Sjostrom E., 1993, WOOD CHEM FUNDAMENTA
   Smook G. A., 1992, HDB PULP PAPER TECHN, P419
   Sommersacher P, 2012, ENERG FUEL, V26, P380, DOI 10.1021/ef201282y
   Song XF, 2015, BIORESOURCES, V10, P137
   Wag K., 1996, THESIS
   Wallberg O, 2006, DESALINATION, V199, P413, DOI 10.1016/j.desal.2006.03.094
   Yuan TQ, 2011, BIORESOURCES, V6, P414
   Zhao Y, 2010, ENERG SOURCE PART A, V32, P962, DOI 10.1080/15567030802578815
NR 31
TC 1
Z9 1
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD APR 15
PY 2017
VL 149
BP 156
EP 163
DI 10.1016/j.jclepro.2017.02.074
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA EX6CO
UT WOS:000403330200014
DA 2018-10-20
ER

PT J
AU Bouler, JM
   Pilet, P
   Gauthier, O
   Verron, E
AF Bouler, J. M.
   Pilet, P.
   Gauthier, O.
   Verron, E.
TI Biphasic calcium phosphate ceramics for bone reconstruction: A review of
   biological response
SO ACTA BIOMATERIALIA
LA English
DT Review
DE BCP; Bone biomaterial; Bone regeneration; Porosity; Osteoconduction;
   Osteoinduction; In vitro; In vivo
ID BETA-TRICALCIUM PHOSPHATE; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS;
   3-YEAR FOLLOW-UP; IN-VITRO; INJECTABLE BONE; OSTEOBLAST DIFFERENTIATION;
   DIFFERENT HYDROXYAPATITE; SUBSTITUTE BIOMATERIALS; SYNTHESIS PARAMETERS
AB Autologous bone graft is considered as the gold standard in bone reconstructive surgery. However, the quantity of bone available is limited and the harvesting procedure requires a second surgical site resulting in severe complications. Due to these limits, scientists and clinicians have considered alternatives to autologous bone graft. Calcium phosphates (CaPs) biomaterials including biphasic calcium phosphate (BCP) ceramics have proven efficacy in numerous clinical indications. Their specific physicochemical properties (HA/TCP ratio, dual porosity and subsequent interconnected architecture) control (regulate/condition) the progressive resorption and the bone substitution process.
   By describing the most significant biological responses reported in the last 30 years, we review the main events that made their clinical success. We also discuss about their exciting future applications as osteoconductive scaffold for delivering various bioactive molecules or bone cells in bone tissue engineering and regenerative medicine.
   Statement of Significance
   Nowadays, BCPs are definitely considered as the gold standard of bone substitutes in bone reconstructive surgery. Among the numerous clinical studies in literature demonstrating the performance of BCP, Passuti et al. and Randsford et al. studies largely contributed to the emergence of the BCPs. It could be interesting to come back to the main events that made their success and could explain their large adhesion from scientists to clinicians. This paper aims to review the most significant biological responses reported in the last 30 years, of these BCP-based materials. We also discuss about their exciting future applications as osteoconductive scaffold for delivering various bioactive molecules or bone cells in bone tissue engineering and regenerative medicine. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bouler, J. M.] Univ Nantes, CNRS, UMR 6230, CEISAM, 2 Rue Houssiniere,BP 92208, F-44322 Nantes 2, France.
   [Pilet, P.; Gauthier, O.; Verron, E.] Univ Nantes, INSERM, UMR 1229, RMeS, BP 84215, F-44042 Nantes 1, France.
   [Gauthier, O.] ONIRIS Nantes Atlantic Coll Vet Med Food Sci & En, Ctr Res & Preclin Invest, Nantes, France.
RP Verron, E (reprint author), Univ Nantes, INSERM, UMR 1229, RMeS, BP 84215, F-44042 Nantes 1, France.
EM elise.verron@univ-nantes.fr
OI BOULER, Jean-Michel/0000-0001-9784-5584
CR AbdulQader ST, 2016, J BIOMATER APPL, V30, P1300, DOI 10.1177/0885328215625759
   Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200
   Alam MI, 2001, BIOMATERIALS, V22, P1643
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Anuta DA, 1985, T ANN M SOC BIOM CON, V8, P62
   Badran Z, 2012, J MATER SCI-MATER M, V23, P797, DOI 10.1007/s10856-011-4534-x
   Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Bara J.J., 2016, J TISSUE ENG REGENER
   Barbieri D, 2010, EUR CELLS MATER, V19, P252, DOI 10.22203/eCM.v019a24
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Basha RY, 2015, MAT SCI ENG C-MATER, V57, P452, DOI 10.1016/j.msec.2015.07.016
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Bernstein A, 2013, ACTA BIOMATER, V9, P7490, DOI 10.1016/j.actbio.2013.03.021
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Blery P, 2014, J MATER SCI-MATER M, V25, P2711, DOI 10.1007/s10856-014-5282-5
   Bodic F, 2002, J MATER SCI-MATER M, V13, P953, DOI 10.1023/A:1019808613046
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Brennan MA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt504
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Chan O, 2012, ACTA BIOMATER, V8, P2788, DOI 10.1016/j.actbio.2012.03.038
   Cho DY, 2005, SURG NEUROL, V63, P497, DOI 10.1016/j.surneu.2004.10.016
   Chouteau J, 2003, REV CHIR ORTHOP, V89, P44
   Claase MB, 2007, J MATER SCI-MATER M, V18, P1299, DOI 10.1007/s10856-006-0077-y
   Coathup MJ, 2012, J BIOMED MATER RES A, V100A, P1550, DOI 10.1002/jbm.a.34094
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Dai LY, 2008, SPINE, V33, P1299, DOI 10.1097/BRS.0b013e3181732a8e
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Detsch R, 2011, J BIOMATER APPL, V26, P359, DOI 10.1177/0885328210373285
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Ellinger R F, 1986, Int J Periodontics Restorative Dent, V6, P22
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Frenken J.W., CLIN ORAL IMPLANTS R, V21, P201
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Gauthier O, 1999, BONE, V25, p71S, DOI 10.1016/S8756-3282(99)00137-4
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GLOWACKI J, 1995, J ORAL MAXIL SURG, V53, P922, DOI 10.1016/0278-2391(95)90282-1
   Gouin F, 2010, ORTHOP TRAUMATOL-SUR, V96, P637, DOI 10.1016/j.otsr.2010.03.022
   Guicheux J, 1998, J BIOMED MATER RES, V40, P560, DOI 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hasegawa S, 2007, J BIOMED MATER RES A, V81A, P930, DOI 10.1002/jbm.a.31109
   Heymann D, 2001, HISTOL HISTOPATHOL, V16, P37, DOI 10.14670/HH-16.37
   Isaac J, 2008, J BIOMED MATER RES A, V86A, P386, DOI 10.1002/jbm.a.31644
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jegoux F, 2010, ARCH OTOLARYNGOL, V136, P971, DOI 10.1001/archoto.2010.173
   Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002
   Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z
   KLEIN CPAT, 1986, BIOMATERIALS, V7, P144
   Lapczyna H, 2014, EUR CELLS MATER, V28, P299, DOI 10.22203/eCM.v028a21
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Laursen MB, 2007, INT ORTHOP, V31, P199, DOI 10.1007/s00264-006-0148-1
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lee EU, 2016, CLIN ORAL IMPLAN RES, V27, pe91, DOI 10.1111/clr.12568
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R. Z, 1992, BIOMECHANICS ORTHOPE, P147
   LeGeros R. Z., 1991, MONOGR ORAL SCI, V15
   Lerner T, 2009, EUR SPINE J, V18, P170, DOI 10.1007/s00586-008-0844-1
   Lerouxel E, 2006, BIOMATERIALS, V27, P4566, DOI 10.1016/j.biomaterials.2006.04.027
   Levengood SKL, 2010, BIOMATERIALS, V31, P3552, DOI 10.1016/j.biomaterials.2010.01.052
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   Linton JL, 2002, CLEFT PALATE-CRAN J, V39, P197, DOI 10.1597/1545-1569(2002)039<0197:EOCPCB>2.0.CO;2
   Lu JX, 2004, J MATER SCI-MATER M, V15, P361, DOI 10.1023/B:JMSM.0000021102.68509.65
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Marques CF, 2017, J EUR CERAM SOC, V37, P359, DOI 10.1016/j.jeurceramsoc.2016.08.018
   Minier K, 2014, VET COMP ORTHOPAED, V27, P411, DOI 10.3415/VCOT-14-03-0036
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Moore DC, 1985, T ANN M SOC BIOM CON, V8, P160
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   NERY EB, 1990, J PERIODONTOL, V61, P737, DOI 10.1902/jop.1990.61.12.737
   NEWESELY H, 1963, EXPERIENTIA, V19, P458
   Nilen RWN, 2008, J MATER SCI-MATER M, V19, P1693, DOI 10.1007/s10856-007-3252-x
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Pecqueux F, 2010, J EUR CERAM SOC, V30, P819, DOI 10.1016/j.jeurceramsoc.2009.09.017
   Polak SJ, 2013, ACTA BIOMATER, V9, P7977, DOI 10.1016/j.actbio.2013.04.040
   Polak SJ, 2011, ACTA BIOMATER, V7, P1760, DOI 10.1016/j.actbio.2010.12.030
   POLLICK S, 1995, J ORAL MAXIL SURG, V53, P915, DOI 10.1016/0278-2391(95)90281-3
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037
   Ripamonti U, 2009, BIOMATERIALS, V30, P1428, DOI 10.1016/j.biomaterials.2008.10.065
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Rouahi M, 2006, J BIOMED MATER RES A, V78A, P222, DOI 10.1002/jbm.a.30682
   Rustom LE, 2016, ACTA BIOMATER, V44, P144, DOI 10.1016/j.actbio.2016.08.025
   Saffarzadeh A, 2009, CLIN ORAL IMPLAN RES, V20, P1133, DOI 10.1111/j.1600-0501.2009.01738.x
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   Santori FS, 2001, ORTHOPEDICS, V24, P1147
   Silva SN, 2003, J BIOMED MATER RES A, V65A, P475, DOI 10.1002/jbm.a.10544
   Struillou X, 2011, J MATER SCI-MATER M, V22, P1707, DOI 10.1007/s10856-011-4344-1
   Tang XH, 2016, CERAM INT, V42, P15311, DOI 10.1016/j.ceramint.2016.06.172
   Titorencu I, 2007, CYTOTHERAPY, V9, P682, DOI 10.1080/14653240701561329
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   Verron E, 2012, ACTA BIOMATER, V8, P3541, DOI 10.1016/j.actbio.2012.06.022
   Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Werntz JR, 1996, J ORTHOP RES, V14, P85, DOI 10.1002/jor.1100140115
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang L. G., 2014, TISSUE ORGAN REGENER
NR 136
TC 27
Z9 27
U1 18
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 1
EP 12
DI 10.1016/j.actbio.2017.01.076
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100001
PM 28159720
DA 2018-10-20
ER

PT J
AU Julier, Z
   Park, AJ
   Briquez, PS
   Martino, MM
AF Julier, Ziad
   Park, Anthony J.
   Briquez, Priscilla S.
   Martino, Mikael M.
TI Promoting tissue regeneration by modulating the immune system
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Regenerative medicine; Immune system; Biomaterials; Drug delivery
   systems; Cytokines; Inflammation; Scarring; Fibrosis; Macrophages; T
   cells
ID MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; PATTERN-RECOGNITION
   RECEPTORS; MACROPHAGE RECRUITMENT AGENT; TOLL-LIKE RECEPTORS; TNF-ALPHA;
   EXTRACELLULAR VESICLES; TGF-BETA; FACTOR-I; INFLAMMATORY RESPONSE
AB The immune system plays a central role in tissue repair and regeneration. Indeed, the immune response to tissue injury is crucial in determining the speed and the outcome of the healing process, including the extent of scarring and the restoration of organ function. Therefore, controlling immune components via biomaterials and drug delivery systems is becoming an attractive approach in regenerative medicine, since therapies based on stem cells and growth factors have not yet proven to be broadly effective in the clinic. To integrate the immune system into regenerative strategies, one of the first challenges is to understand the precise functions of the different immune components during the tissue healing process. While remarkable progress has been made, the immune mechanisms involved are still elusive, and there is indication for both negative and positive roles depending on the tissue type or organ and life stage. It is well recognized that the innate immune response comprising danger signals, neutrophils and macrophages modulates tissue healing. In addition, it is becoming evident that the adaptive immune response, in particular T cell subset activities, plays a critical role. In this review, we first present an overview of the basic immune mechanisms involved in tissue repair and regeneration. Then, we highlight various approaches based on biomaterials and drug delivery systems that aim at modulating these mechanisms to limit fibrosis and promote regeneration. We propose that the next generation of regenerative therapies may evolve from typical biomaterial-, stem cell-, or growth factor-centric approaches to an immune centric approach.
   Statement of Significance
   Most regenerative strategies have not yet proven to be safe or reasonably efficient in the clinic. In addition to stem cells and growth factors, the immune system plays a crucial role in the tissue healing process. Here, we propose that controlling the immune-mediated mechanisms of tissue repair and regeneration may support existing regenerative strategies or could be an alternative to using stem cells and growth factors. The first part of this review we highlight key immune mechanisms involved in the tissue healing process and marks them as potential target for designing regenerative strategies. In the second part, we discuss various approaches using biomaterials and drug delivery systems that aim at modulating the components of the immune system to promote tissue regeneration. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd.
C1 [Julier, Ziad; Park, Anthony J.; Martino, Mikael M.] Monash Univ, European Mol Biol Lab Australia, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.
   [Briquez, Priscilla S.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
RP Martino, MM (reprint author), Australian Regenerat Med Inst, Martino Lab, 15 Innovat Walk,Bldg 75,Level 1, Clayton, Vic 3800, Australia.
EM mikael.martino@monash.edu
OI Julier, Ziad/0000-0001-7707-3804; Martino, Mikael/0000-0002-5012-4605
FU Astellas Foundation for Research on Metabolic Disorders
FX This work was supported in part by the research grant of Astellas
   Foundation for Research on Metabolic Disorders to M.M.M.
CR Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005
   Aggarwal NR, 2010, PHYSIOL GENOMICS, V41, P109, DOI 10.1152/physiolgenomics.00131.2009
   Alvarez M. M., 2016, J CONTROL RELEASE
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Andaloussi SEL, 2013, NAT REV DRUG DISCOV, V12, P347, DOI DOI 10.1038/NRD3978
   Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126
   Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392
   Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Arnold L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9972
   Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021
   Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Banerjee J., 2013, MICRORNA PROTOCOLS, P343
   Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010
   Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bhattacharyya S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008264
   Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Browne Shane, 2015, Front Bioeng Biotechnol, V3, P67, DOI 10.3389/fbioe.2015.00067
   Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974
   Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054
   Canton I, 2010, BIOTECHNOL BIOENG, V105, P396, DOI 10.1002/bit.22530
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004
   Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110
   Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954
   Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603
   Chen L, 2012, J INVEST DERMATOL
   Chen WCW, 2015, BIOMATERIALS, V72, P138, DOI 10.1016/j.biomaterials.2015.08.050
   Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660
   Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315
   Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539
   Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   DeOliveira C.P, 2016, COCHRANE DB SYST REV, V2
   Dietmar M W Zaiss, 2013, IMMUNITY, V38, P275
   Ding J, 2011, WOUND REPAIR REGEN, V19, P568, DOI 10.1111/j.1524-475X.2011.00724.x
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Dziki JL, 2017, J BIOMED MATER RES A, V105, P138, DOI 10.1002/jbm.a.35894
   Essandoh K, 2016, SHOCK, V46, P122, DOI 10.1097/SHK.0000000000000604
   Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015
   Ferguson MWJ, 2009, LANCET, V373, P1264, DOI 10.1016/S0140-6736(09)60322-6
   Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653
   Friedrich EE, 2014, J BIOMED MATER RES A, V102, P1527, DOI 10.1002/jbm.a.34829
   Frith JE, 2014, STEM CELL TRANSL MED, V3, P969, DOI 10.5966/sctm.2014-0032
   Gandolfo MT, 2010, TRANSPL IMMUNOL, V23, P45, DOI 10.1016/j.trim.2010.04.002
   Gao N, 2011, AM J PATHOL, V179, P2243, DOI 10.1016/j.ajpath.2011.07.050
   Garibaldi BT, 2013, AM J RESP CELL MOL, V48, P35, DOI 10.1165/rcmb.2012-0198OC
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Glowacki AJ, 2015, ANN BIOMED ENG, V43, P593, DOI 10.1007/s10439-014-1125-2
   Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Gori M, 2015, EXPERT OPIN BIOL TH, V15, P1601, DOI 10.1517/14712598.2015.1071349
   Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733
   Hirsiger S, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/315941
   Hong S, 2014, AM J PHYSIOL-CELL PH, V307, pC1058, DOI 10.1152/ajpcell.00270.2014
   Horckmans M., 2016, EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHW002
   Huleihel L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600502
   Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054
   Hyun J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14135
   Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569
   Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598
   Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514
   Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639
   JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037
   Je JY, 2006, BIOORGAN MED CHEM, V14, P5989, DOI 10.1016/j.bmc.2006.05.016
   Johnston CJC, 2016, CELL IMMUNOL, V299, P14, DOI 10.1016/j.cellimm.2015.10.006
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   JULIER Z, 2015, SCI REP, V5
   Kalinski P, 1997, J IMMUNOL, V159, P28
   Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151
   KATAMURA K, 1995, J IMMUNOL, V155, P4604
   Katare R, 2011, CIRC RES, V109, P894, DOI 10.1161/CIRCRESAHA.111.251546
   Kato N, 2007, J CELL BIOCHEM, V101, P1063, DOI 10.1002/jcb.21160
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kim YH, 2016, J BIOMED MATER RES A, V104, P942, DOI 10.1002/jbm.a.35635
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Kim YS, 2009, FRONT BIOSCI-LANDMRK, V14, P2845, DOI 10.2741/3417
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   King A, 2014, ADV WOUND CARE, V3, P614, DOI 10.1089/wound.2013.0497
   Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Kono H, 2014, CURR OPIN IMMUNOL, V26, P147, DOI 10.1016/j.coi.2013.12.004
   Kovalchin JT, 2006, WOUND REPAIR REGEN, V14, P129, DOI 10.1111/j.1743-6109.2006.00102.x
   Kucia M, 2004, J MOL HISTOL, V35, P233
   Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021
   Kumar P, 2013, J CANCER, V4, P57, DOI 10.7150/jca.5048
   Lai LW, 2012, KIDNEY INT, V81, P983, DOI 10.1038/ki.2011.412
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173
   Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184
   Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989
   Li DQ, 2015, J CLIN INVEST, V125, P3008, DOI 10.1172/JCI79052
   Li JB, 2014, CHEM COMMUN, V50, P3722, DOI 10.1039/c4cc00156g
   Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008
   Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395
   Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200
   Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008
   Marote A, 2016, FRONT PHARMACOL, V7, DOI [10.3389/fphar2016.00231, 10.3389/fphar.2016.00231]
   Martino MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11051
   Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40
   Meng X, 2016, NAT REV CARDIOL, V13, P167, DOI 10.1038/nrcardio.2015.169
   Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469
   Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Morishita Y, 2015, INT J NANOMED, V10, P3475, DOI 10.2147/IJN.S82587
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   Mountziaris PM, 2012, ACTA BIOMATER, V8, P3552, DOI 10.1016/j.actbio.2012.06.031
   Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079
   Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.bioce1.2010.10.013
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x
   Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x
   Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72
   Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174
   Noguchi K, 2007, PERIODONTOL 2000, V43, P85, DOI 10.1111/j.1600-0757.2006.00170.x
   Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139
   Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708
   Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84
   Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Penn JW, 2012, INT J BURNS TRAUMA, V2, P18
   Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727
   Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459
   Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472
   Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429
   Projahn D, 2014, J CELL MOL MED, V18, P790, DOI 10.1111/jcmm.12225
   Qin YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21961
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Ramirez K, 2015, CELL IMMUNOL, V296, P57, DOI 10.1016/j.cellimm.2015.04.003
   Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486
   Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754
   Rigamonti E., 2014, BIOMED RES INT, V2014
   Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272
   Sager HB, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1435
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877
   Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004
   Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479
   Sethi Apoorva, 2013, Frontiers in Genetics, V4, P8, DOI 10.3389/fgene.2013.00008
   SHAPIRA L, 1994, J PERIODONTOL, V65, P139, DOI 10.1902/jop.1994.65.2.139
   Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749
   Silva A.M., 2016, EUR J PHARM SCI
   Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061
   Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875
   Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170
   Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271
   Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477
   Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009
   Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104
   Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684
   Teixeira JH, 2016, TRANSFUS APHER SCI, V55, P53, DOI 10.1016/j.transci.2016.07.015
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765
   To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21
   Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185
   Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787
   Toyoda H, 2005, BONE, V37, P555, DOI 10.1016/j.bone.2005.04.042
   Trujillo G, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-18
   Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614
   Turner NJ, 2015, ADV WOUND CARE, V4, P490, DOI 10.1089/wound.2014.0604
   van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983
   Varatharajan L., 2015, PHLEBOLOGY
   Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Vasconcelos DP, 2013, BIOMATERIALS, V34, P9952, DOI 10.1016/j.biomaterials.2013.09.012
   Vinish M., 2016, WOUND REPAIR REGENER
   Wang Q, 2015, J CONTROL RELEASE, V206, P232, DOI 10.1016/j.jconrel.2015.03.019
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887
   Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008
   Wu XQ, 2016, IMMUNOLOGY, V148, P237, DOI 10.1111/imm.12608
   Wulff BC, 2013, EXP DERMATOL, V22, P507, DOI 10.1111/exd.12169
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Yamamoto M, 2011, BIOMATERIALS, V32, P4238, DOI 10.1016/j.biomaterials.2011.02.043
   Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   Zemans RL, 2011, P NATL ACAD SCI USA, V108, P15990, DOI 10.1073/pnas.1110144108
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
   Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090
NR 215
TC 22
Z9 25
U1 10
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 13
EP 28
DI 10.1016/j.actbio.2017.01.056
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100002
PM 28119112
OA Other Gold
DA 2018-10-20
ER

PT J
AU Shah, SB
   Singh, A
AF Shah, Shivem B.
   Singh, Ankur
TI Cellular self-assembly and biomaterials-based organoid models of
   development and diseases
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomimetic; Biomaterials; Immune; Spatio-temporal; Self assembly; Brain;
   Gut; Intestine
ID PLURIPOTENT STEM-CELLS; IN-VITRO EXPANSION; FUNCTIONAL HUMAN LIVER;
   GROWTH-FACTOR ACTIVITY; INTESTINAL ORGANOIDS; GERMINAL-CENTER;
   3-DIMENSIONAL CULTURE; EXTRACELLULAR-MATRIX; CEREBRAL ORGANOIDS;
   HIGH-THROUGHPUT
AB Organogenesis and morphogenesis have informed our understanding of physiology, pathophysiology, and avenues to create new curative and regenerative therapies. Thus far, this understanding has been hindered by the lack of a physiologically relevant yet accessible model that affords biological control. Recently, three-dimensional ex vivo cellular cultures created through cellular self-assembly under natural extracellular matrix cues or through biomaterial-based directed assembly have been shown to physically resemble and recapture some functionality of target organs. These "organoids" have garnered momentum for their applications in modeling human development and disease, drug screening, and future therapy design or even organ replacement. This review first discusses the self-organizing organoids as materials with emergent properties and their advantages and limitations. We subsequently describe biomaterials-based strategies used to afford more control of the organoid's microenvironment and ensuing cellular composition and organization. In this review, we also offer our perspective on how multifunctional biomaterials with precise spatial and temporal control could ultimately bridge the gap between in vitro organoid platforms and their in vivo counterparts.
   Statement of Significance
   Several notable reviews have highlighted PSC-derived organoids and 3D aggregates, including embryoid bodies, from a development and cellular assembly perspective. The focus of this review is to highlight the materials-based approaches that cells, including PSCs and others, adopt for self-assembly and the controlled development of complex tissues, such as that of the brain, gut, and immune system. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shah, Shivem B.; Singh, Ankur] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
   [Singh, Ankur] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Singh, A (reprint author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.; Singh, A (reprint author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
EM as2833@cornell.edu
RI Singh, Ankur/K-5585-2014
OI Singh, Ankur/0000-0002-3501-2277
FU United States National Science Foundation CAREER [DMR-1554275]; Cornell
   University's Presidential Life Sciences Fellowship
FX The authors acknowledge financial support from the United States
   National Science Foundation CAREER award (DMR-1554275 (A.S)) and
   academic scholarship support from Cornell University's Presidential Life
   Sciences Fellowship (S.B.S.). The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the funding agencies.
CR Aihara E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17185
   Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009
   Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Astashkina AI, 2012, BIOMATERIALS, V33, P4700, DOI 10.1016/j.biomaterials.2012.02.063
   Au SH, 2014, LAB CHIP, V14, P3290, DOI 10.1039/c4lc00531g
   Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9
   Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Bershteyn M, 2013, CELL, V155, P19, DOI 10.1016/j.cell.2013.09.010
   Bertaux-Skeirik N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004663
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Brugmann SA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt362
   Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020
   CAMPANA D, 1985, J IMMUNOL, V134, P1524
   Cayrol F, 2015, BLOOD, V125, P841, DOI 10.1182/blood-2014-07-587337
   Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13708
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Clevers H, 2015, NATURE, V521, pS15, DOI 10.1038/521S15a
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027
   DiMarco RL, 2015, BIOMATER SCI-UK, V3, P1376, DOI 10.1039/c5bm00108k
   DiMarco RL, 2014, INTEGR BIOL-UK, V6, P127, DOI 10.1039/c3ib40188j
   Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415
   Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002
   Durdu S, 2014, NATURE, V515, P120, DOI 10.1038/nature13852
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fan Y, 2015, MOL THER, V23, P1262, DOI 10.1038/mt.2015.77
   Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15
   Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Garcez P. P., 2016, PEERJ PREPRINTS
   Gjorevski N, 2016, NATURE, V539, P359, DOI 10.1038/nature20168
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508
   Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643
   Gravelle P, 2014, AM J PATHOL, V184, P282, DOI 10.1016/j.ajpath.2013.09.018
   Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026
   Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628
   Hisha H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03224
   Hounnou G, 2002, SURG RADIOL ANAT, V24, P290, DOI 10.1007/s00276-002-0057-y
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Jabaji Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107814
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017
   Keung AJ, 2012, INTEGR BIOL-UK, V4, P1049, DOI 10.1039/c2ib20083j
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Kim HY, 2015, DEV CELL, V34, P719, DOI 10.1016/j.devcel.2015.08.012
   Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100
   Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298
   Kuo YC, 2012, BIOMATERIALS, V33, P5672, DOI 10.1016/j.biomaterials.2012.04.046
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lee JS, 2011, ADV MATER, V23, P4279, DOI 10.1002/adma.201100060
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lindborg BA, 2016, STEM CELL TRANSL MED, V5, P970, DOI 10.5966/sctm.2015-0305
   Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460
   LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0
   Lu HF, 2012, BIOMATERIALS, V33, P9179, DOI 10.1016/j.biomaterials.2012.09.006
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410
   McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128
   Mondrinos MJ, 2014, TISSUE ENG PT A, V20, P2892, DOI [10.1089/ten.TEA.2014.0085, 10.1089/ten.tea.2014.0085]
   Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Mustata RC, 2013, CELL REP, V5, P421, DOI 10.1016/j.celrep.2013.09.005
   Nadauld L.D., 2014, GENOME BIOL
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   Noguchi TK, 2015, NAT CELL BIOL, V17, P984, DOI 10.1038/ncb3200
   Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475
   Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Purwada A., 2017, ACS BIOMATER SCI ENG
   Purwada A, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.157
   Purwada A, 2015, BIOMATERIALS, V63, P24, DOI 10.1016/j.biomaterials.2015.06.002
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Raghavan S, 2013, BIOMATERIALS, V34, P6649, DOI 10.1016/j.biomaterials.2013.05.023
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Ranga A, 2012, CURR OPIN CELL BIOL, V24, P236, DOI 10.1016/j.ceb.2012.01.006
   Rao JN, 2010, REGULATION GASTROINT
   Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rodansky ES, 2015, EXP MOL PATHOL, V98, P346, DOI 10.1016/j.yexmp.2015.03.033
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275
   Sart S, 2014, TISSUE ENG PT A, V20, P54, DOI [10.1089/ten.tea.2012.0690, 10.1089/ten.TEA.2012.0690]
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schepers A, 2016, LAB CHIP, V16, P2644, DOI 10.1039/c6lc00598e
   Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070
   Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949
   Schumacher MA, 2015, J PHYSIOL-LONDON, V593, P1809, DOI 10.1113/jphysiol.2014.283028
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573
   Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Seto SP, 2012, CELL TISSUE RES, V347, P589, DOI 10.1007/s00441-011-1265-8
   Shao Y., 2016, NAT MAT
   Shen SS, 2009, ARCH PATHOL LAB MED, V133, P781, DOI 10.1043/1543-2165-133.5.781
   Shroyer NF, 2016, CELL STEM CELL, V18, P686, DOI 10.1016/j.stem.2016.05.020
   Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680
   Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/NMETH.2437, 10.1038/nmeth.2437]
   Sokol ES, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0677-5
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008
   STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Suzuki IK, 2015, DEVELOPMENT, V142, P3138, DOI 10.1242/dev.120568
   Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067
   Takasato Minoru, 2016, Nature, V536, P238, DOI 10.1038/nature17982
   Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695
   Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tang H, 2016, CELL STEM CELL
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tian YF, 2015, BIOMATERIALS, V73, P110, DOI 10.1016/j.biomaterials.2015.09.007
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649
   Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Vrij EJ, 2016, LAB CHIP, V16, P734, DOI 10.1039/c5lc01499a
   VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q
   Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737
   Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386
   Willenbring H, 2013, CELL STEM CELL, V13, P139, DOI 10.1016/j.stem.2013.07.014
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wilson SS, 2015, MUCOSAL IMMUNOL, V8, P352, DOI 10.1038/mi.2014.72
   Wroblewski LE, 2015, GUT, V64, P720, DOI 10.1136/gutjnl-2014-307650
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695
   Zhang Y. G., 2014, PHYSL REP, V2
   Zietek T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16831
NR 180
TC 10
Z9 10
U1 7
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 29
EP 45
DI 10.1016/j.actbio.2017.01.075
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100003
PM 28159716
DA 2018-10-20
ER

PT J
AU Sok, MCP
   Tria, MC
   Olingy, CE
   Emeterio, CLS
   Botchwey, EA
AF Sok, Mary Caitlin P.
   Tria, Maxianne C.
   Olingy, Claire E.
   Emeterio, Cheryl L. San
   Botchwey, Edward A.
TI Aspirin-Triggered Resolvin D1-modified materials promote the
   accumulation of pro-regenerative immune cell subsets and enhance
   vascular remodeling
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Resolvin; Immunomodulation; Innate immunity; Vascular remodeling
ID PRORESOLVING LIPID MEDIATORS; ACUTE KIDNEY INJURY; MONONUCLEAR
   PHAGOCYTES; ANTIINFLAMMATORY MONOCYTES; MACROPHAGE POLARIZATION;
   INFLAMMATION-RESOLUTION; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS;
   ACCESSORY CELLS; NEUTROPHILS
AB Many goals in tissue engineering rely on modulating cellular localization and polarization of cell signaling, including the inhibition of inflammatory infiltrate, facilitation of inflammatory cell egress, and clearance of apoptotic cells. Omega-3 polyunsaturated fatty acid-derived resolvins are gaining increasing recognition for their essential roles in inhibition of neutrophil invasion into inflamed tissue and promotion of macrophage phagocytosis of cellular debris as well as their egress to the lymphatics. Biomaterial-based release of lipid mediators is a largely under-explored approach that provides a method to manipulate local lipid signaling gradients in vivo and direct the recruitment and/or polarization of anti-inflammatory cell subsets to suppress inflammatory signaling and enhance angiogenesis and tissue regeneration. The goal of this study was to encapsulate Aspirin-Triggered Resolvin D1 (AT-RvD1) into a degradable biomaterial in order to elucidate the effects of sustained, localized delivery in a model of sterile inflammation. Flow cytometric and imaging analysis at both 1 and 3 days after injury showed that localized AT-RvD1 delivery was able significantly increase the accumulation of anti-inflammatory monocytes and M2 macrophages while limiting the infiltration of neutrophils. Additionally, cytokine profiling and longitudinal vascular analysis revealed a shift towards a pro-angiogenic profile with increased concentrations of VEGF and SDF-1 alpha, and increased arteriolar diameter and tortuosity. These results demonstrate the ability of locally-delivered AT-RvD1 to increase pro-regenerative immune subpopulations and promote vascular remodeling.
   Statement of Significance
   This work is motivated by our efforts to explore the underlying mechanisms of inflammation resolution after injury and to develop biomaterial-based approaches to amplify endogenous mechanisms of resolution and repair. Though specific lipid mediators have been identified that actively promote the resolution of inflammation, biomaterial-based localized delivery of these mediators has been largely unexplored. We loaded Aspirin-Triggered Resolvin D1 into a PLGA scaffold and examined the effects of sustained, localized delivery on the innate immune response. We found that biomaterial delivery of resolvin was able to enhance the accumulation of pro-regenerative populations of immune cells, including anti-inflammatory monocytes, population that has never before been shown to respond to resolvin treatment, and also enhance vascular remodeling in response to tissue injury. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Botchwey, EA (reprint author), Georgia Inst Technol, Dept Biomed Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM edward.botchwey@bme.gatech.edu
FU National Institutes of Health [K01AR052352-01A1, R01AR056445-01A2,
   R01DE019935-01]
FX Sources of support for this study include the National Institutes of
   Health grants K01AR052352-01A1, R01AR056445-01A2, and R01DE019935-01 to
   Dr. Botchwey.
CR Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariel A., 2012, FRONT IMMUNOL, V3
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Bajwa A, 2009, CURR DRUG TARGETS, V10, P1196, DOI 10.2174/138945009789753174
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JC134431
   Bekler A, 2015, PAK J MED SCI, V31, P159, DOI 10.12669/pjms.311.5967
   Benson DD, 2010, J GASTROINTEST SURG, V14, P1560, DOI 10.1007/s11605-010-1329-1
   Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x
   Bruce A.C., 2014, ARTERIOSCLER THROMB, V34
   Carbone F, 2013, THROMB HAEMOSTASIS, V110, P501, DOI 10.1160/TH13-03-0211
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen J, 2014, TOXICOL APPL PHARM, V277, P118, DOI 10.1016/j.taap.2014.03.017
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483
   Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hasegawa S, 2016, ONCOL LETT, V11, P1560, DOI 10.3892/ol.2015.4057
   Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082
   Hsu CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131643
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110
   Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677
   Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045
   Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107
   Lance KD, 2017, J BIOMED MATER RES A, V105, P31, DOI 10.1002/jbm.a.35861
   Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915
   Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001
   Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003
   Liehn EA, 2011, J AM COLL CARDIOL, V58, P2415, DOI 10.1016/j.jacc.2011.08.033
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Massena S, 2015, BLOOD, V126, P2016, DOI 10.1182/blood-2015-03-631572
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380
   Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615
   Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murakami M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00323
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nathan C., 2002, NATURE
   Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865
   Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293
   Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007
   Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382
   Ozdemir Y, 2014, ASIAN PAC J CANCER P, V15, P2647, DOI 10.7314/APJCP.2014.15.6.2647
   Poludasu Shyam, 2009, Clin Cardiol, V32, pE6, DOI 10.1002/clc.20503
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311
   Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665
   Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]
   Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008
   Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647
   Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c
   Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006
   Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.006
   Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200
   Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124
   Tiwari G, 2012, INT J PHARM INVESTIG, V2, P2, DOI 10.4103/2230-973X.96920
   Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Vasconcelos DP, 2015, BIOMATERIALS, V53, P566, DOI 10.1016/j.biomaterials.2015.02.120
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011
   Wieghaus KA, 2006, TISSUE ENG, V12, P1903, DOI 10.1089/ten.2006.12.1903
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887
   Wu B, 2017, J VASC SURG, V65, P207, DOI 10.1016/j.jvs.2016.01.030
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
   Zhang MJ, 2016, CIRCULATION, V134, P666, DOI 10.1161/CIRCULATIONAHA.116.021894
NR 90
TC 6
Z9 6
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 109
EP 122
DI 10.1016/j.actbio.2017.02.020
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100010
PM 28213094
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Crispim, J
   Fernandes, HAM
   Fu, SC
   Lee, YW
   Jonkheijm, P
   Saris, DBF
AF Crispim, J.
   Fernandes, H. A. M.
   Fu, S. C.
   Lee, Y. W.
   Jonkheijm, P.
   Saris, D. B. F.
TI TGF-beta 1 activation in human hamstring cells through growth factor
   binding peptides on polycaprolactone surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tendon/Ligament; TGF-beta 1; Growth factor binding peptide;
   Vascularization; Inflammation
ID ANTERIOR CRUCIATE LIGAMENT; TGF-BETA; GENE-EXPRESSION; TENDON; COLLAGEN;
   RECONSTRUCTION; REGENERATION; ENHANCEMENT; FIBROBLASTS; STRATEGIES
AB The administration of soluble growth factors (GFs) to injured tendons and ligaments (T/L) is known to promote and enhance the healing process. However, the administration of GFs is a complex, expensive and heavily-regulated process and only achieved by employing supraphysiological GF concentrations. In addition, for proper healing, specific and spatial immobilization of the GFs (s) is critical. We hypothesized that biomaterials functionalized with GF-binding peptides can be employed to capture endogenous GFs in a spatially-controlled manner, thus overcoming the need for the exogenous administration of supraphysiological doses of GFs. Here we demonstrate that the modification of films of polycaprolactone (PCL) with transforming growth factor beta 1 (TGF-(beta 1)-binding peptides allows GFs to be captured and presented to the target cells. Moreover, using a TGF-beta reporter cell line and immunocytochemistry, we show that the GFs retained their biological activity. In human primary tendon cells, the immobilized TGF-beta 1 activated TGF-beta target genes ultimately lead to a 2.5-fold increase in total collagen matrix production. In vivo implantation in rats clearly shows an accumulation of TGF-beta 1 on the polymer films functionalized with the TGF-beta 1-binding peptide when compared with the native films. This accumulation leads to an increase in the recruitment of inflammatory cells at day 3 and an increase in the fibrogenic response and vascularization around the implant at day 7. The results herein presented will endow current and future medical devices with novel biological properties and by doing so will accelerate T/L healing.
   Statement of Significance
   Our study describes the possibility to deliver hTGF-beta 1 to human derived hamstring cells using a non covalent bioactive strategy. The significance of our results in vivo with our functionalized biomaterial with TGF-beta 1-binding peptides lies in the fact that these materials can now be employed to capture endogenous TGF-beta 1 in a spatially-controlled manner, overcoming the need for exogenous administration of supra-physiological TGF-beta 1 doses. Our method is different from current solutions that rely on global TGF-beta 1 administration, soaking the devices with TGF-beta 1, etc. Therefore we believe that our method is a significant change from current state-of-the-art in the types of devices that are used for ligament/tendon repair and that following our method can endow current and future medical devices with TGF-beta 1 binding properties. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Crispim, J.; Saris, D. B. F.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev Bioengn, Drienerlolaan 5, NL-7500 AE Enschede, Netherlands.
   [Crispim, J.; Jonkheijm, P.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Bioinspired Mol Engn Lab, Hallenweg 15, NL-7522 NB Enschede, Netherlands.
   [Fernandes, H. A. M.] Univ Coimbra, Ctr Neurosci & Cell Biol Stem Cells & Drug Screen, Fac Med, Rua Larga,Polo 1,1st Floor, P-3004504 Coimbra, Portugal.
   [Fu, S. C.; Lee, Y. W.] Chinese Univ Hong Kong, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Fu, S. C.; Lee, Y. W.] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China.
   [Jonkheijm, P.] Univ Twente, MESA Inst Nanotechnol, Mol Nanofabricat Grp, Hallenweg 15, NL-7522 NB Enschede, Netherlands.
   [Saris, D. B. F.] Univ Med Ctr Utrecht, Dept Orthopaed, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.
   [Fu, S. C.] Prince Wales Hosp, Rm 74034,5-F Lui Che Woo Clin Sci Bldg, Shatin, Hong Kong, Peoples R China.
RP Jonkheijm, P (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Bioinspired Mol Engn Lab, Hallenweg 15, NL-7522 NB Enschede, Netherlands.; Saris, DBF (reprint author), Univ Med Ctr Utrecht, Dept Orthopaed, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.
EM pjonkheijm@utwente.nl; d.b.f.saris@utwente.nl
RI Fu, Sai Chuen/L-1202-2018
OI Fu, Sai Chuen/0000-0001-5865-6801
FU SmithNephew
FX We would like to acknowledge Smith&Nephew for providing financial
   support, and Dr. Bruma Fu and Angel Lee from the University of Hong Kong
   for their collaboration in the in vivo experiments. We would also like
   to acknowledge Joyce Mulder for her contribution to the laboratory work.
CR ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Cabanas-Danes J, 2014, J MATER CHEM B, V2, P2381, DOI 10.1039/c3tb20853b
   Chen CH, 2008, J HAND SURG-AM, V33A, P1834, DOI 10.1016/j.jhsa.2008.07.003
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   DesRosiers EA, 1996, J ORTHOPAED RES, V14, P200, DOI 10.1002/jor.1100140206
   Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Ghebes C.A., 2015, J TISSUE ENG REGEN M
   Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005
   Granan LP, 2008, AM J SPORT MED, V36, P308, DOI 10.1177/0363546507308939
   Granan LP, 2009, ACTA ORTHOP, V80, P563, DOI 10.3109/17453670903350107
   Haider SK, 2005, NEOPLASIA, V7, P509
   HARDY MA, 1989, PHYS THER, V69, P1014, DOI 10.1093/ptj/69.12.1014
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Janssen KW, 2012, SCAND J MED SCI SPOR, V22, P495, DOI 10.1111/j.1600-0838.2010.01253.x
   Jokinen V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3673251
   Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011
   Katsura T, 2006, J BIOMECH, V39, P2566, DOI 10.1016/j.jbiomech.2005.09.001
   Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772
   Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004
   Kutz SM, 2001, J CELL SCI, V114, P3905
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3
   LIU SH, 1995, CLIN ORTHOP RELAT R, P265
   Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811
   Mall NA, 2014, AM J SPORT MED, V42, P2363, DOI 10.1177/0363546514542796
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Natsu-ume T, 1997, J ORTHOPAED RES, V15, P837, DOI 10.1002/jor.1100150608
   Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406
   Penn JW, 2012, INT J BURNS TRAUMA, V2, P18
   REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Singhal MC, 2007, ARTHROSCOPY, V23, P469, DOI 10.1016/j.arthro.2006.12.010
   Solchaga L.A., 2012, J TISSUE ENG, V3
   Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399
   Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004
   Wilson CG, 2009, TISSUE ENG PT A, V15, P1513, DOI 10.1089/ten.tea.2008.0106
   Wurth JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099157
   Yamazaki S, 2005, ARTHROSCOPY, V21, P1034, DOI 10.1016/j.arthro.2005.05.011
   Yuan Ting, 2013, Muscles Ligaments Tendons J, V3, P139
   Zander NE, 2010, BIOINTERPHASES, V5, P149, DOI 10.1116/1.3526140
NR 47
TC 5
Z9 5
U1 4
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 165
EP 178
DI 10.1016/j.actbio.2017.01.066
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100014
PM 28132919
DA 2018-10-20
ER

PT J
AU Maulvi, FA
   Shaikh, AA
   Lakdawala, DH
   Desai, AR
   Pandya, MM
   Singhania, SS
   Vaidya, RJ
   Ranch, KM
   Vyas, BA
   Shah, DO
AF Maulvi, Furgan A.
   Shaikh, Anjum A.
   Lakdawala, Dhara H.
   Desai, Ankita R.
   Pandya, Mihir M.
   Singhania, Sulabh S.
   Vaidya, Rutvi J.
   Ranch, Ketan M.
   Vyas, Bhavin A.
   Shah, Dinesh O.
TI Design and optimization of a novel implantation technology in contact
   lenses for the treatment of dry eye syndrome: In vitro and in vivo
   evaluation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronic acid; Contact lenses; Implantation; Optimization;
   Pharmacokinetic study; In vivo efficacy study
ID OPHTHALMIC DRUG-DELIVERY; BENZALKONIUM CHLORIDE; HYALURONIC-ACID;
   GLAUCOMA THERAPY; SODIUM HYALURONATE; EXTENDED-RELEASE; HYDROGEL;
   TRANSPORT; CORNEAL; DAMAGE
AB Contact lenses are widely used for ophthalmic drug delivery, but incorporation of drug or formulation in the contact lenses affects its optical and physical property. In the present study, we have designed a novel hyaluronic acid (HA)-laden ring implant contact lenses (modified cast moulding method), to circumvent the changes in critical lens property. The objective was to improve the ocular residence time of HA, by providing sustained ocular HA delivery through implant contact lenses for the treatment of dry eye syndrome. Optimization of HA-implant was carried out using 3(2) factorial design by tailoring the amount of cross linker and thickness of implant, to achieve sustained HA release with constraint on effective ion diffusivity. The in vivo pharmacokinetic study in rabbit tear fluid showed sustained HA release up to 15 days, by fabricating implant (80 mu g HA loading) with 78.4 mu m thickness (total thickness of lens = 100 mu m) using 0.925% of cross linker, with effective ion diffusivity > 1.5 x 10(-6) mm(2)/min. In vivo efficacy study in benzalkonium chloride induced dry eye syndrome rabbits showed faster healing with implant contact lenses in comparison to positive control group. The study demonstrated the promising potential of implantation technology to deliver hyaluronic acid without compromising optical and physical properties of contact lens.
   Statement of Significance
   The limitation of contact lenses to be used as therapeutic device for controlled drug delivery is focused in this study. Incorporation of drug or formulation in the biomaterial affects the optical and physical property of contact lenses. The significance of project was to design a novel hyaluronic acid-laden ring implant contact lenses, to by-pass the changes in critical property of biomaterial. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Maulvi, Furgan A.; Shaikh, Anjum A.; Lakdawala, Dhara H.; Desai, Ankita R.; Pandya, Mihir M.; Singhania, Sulabh S.; Vaidya, Rutvi J.; Ranch, Ketan M.; Vyas, Bhavin A.] Uka Tarsadia Univ, Maliba Pharm Coll, Surat 394350, India.
   [Shah, Dinesh O.] Dharmsinh Desai Univ, Shah Schulman Ctr Surface Sci & Nanotechnol, Nadiad 387001, India.
   [Shah, Dinesh O.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   [Shah, Dinesh O.] Univ Florida, Dept Anaesthesiol, Gainesville, FL 32611 USA.
   [Shah, Dinesh O.] Columbia Univ, Sch Earth & Environm Sci, New York, NY USA.
RP Maulvi, FA (reprint author), Uka Tarsadia Univ, Maliba Pharm Coll, Surat 394350, India.
EM furganmpc@gmail.com
FU 'Maliba Pharmacy College' of Uka Tarsadia University
   [UTU/RPS/2015-16/1759-7]
FX We acknowledge the sponsor of this project 'Maliba Pharmacy College'
   which has been approved under Research Promotion Scheme
   (UTU/RPS/2015-16/1759-7) of Uka Tarsadia University.
CR Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069
   Ali M, 2009, PHARM RES-DORDR, V26, P714, DOI 10.1007/s11095-008-9818-6
   BOWMAN FW, 1969, J PHARM SCI-US, V58, P1301, DOI 10.1002/jps.2600581102
   Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008
   Carvalho IM, 2015, J CONTROL RELEASE, V202, P76, DOI 10.1016/j.jconrel.2015.01.023
   Dixon P, 2015, EXPERT OPIN THER PAT, V25, P1117, DOI 10.1517/13543776.2015.1057501
   Gulsen D, 2004, INVEST OPHTH VIS SCI, V45, P2342, DOI 10.1167/iovs.03-0959
   Hamano T, 1996, JPN J OPHTHALMOL, V40, P62
   Hsu KH, 2015, EUR J PHARM BIOPHARM, V94, P312, DOI 10.1016/j.ejpb.2015.06.001
   Jung HJ, 2013, J CONTROL RELEASE, V165, P82, DOI 10.1016/j.jconrel.2012.10.010
   Jung HJ, 2012, BIOMATERIALS, V33, P2289, DOI 10.1016/j.biomaterials.2011.10.076
   Kapoor Y, 2008, J COLLOID INTERF SCI, V322, P624, DOI 10.1016/j.jcis.2008.02.028
   Kearns VR, 2009, EXPERT REV MED DEVIC, V6, P277, DOI [10.1586/erd.09.4, 10.1586/ERD.09.4]
   Kim J, 2008, INT J PHARMACEUT, V353, P205, DOI 10.1016/j.ijpharm.2007.11.049
   Kyada C, 2014, J DRUG DELIV SCI TEC, V24, P61, DOI 10.1016/S1773-2247(14)50009-3
   LEVY G, 1964, ARCH INT PHARMACOD T, V152, P59
   Li CC, 2006, IND ENG CHEM RES, V45, P3718, DOI 10.1021/ie0507934
   Lin ZR, 2011, MOL VIS, V17, P257
   Liu X, 2015, CHINESE MED J-PEKING, V128, P2444, DOI 10.4103/0366-6999.164927
   Maulvi F.A., 2016, DRUG DELIV, P1
   Maulvi F.A., 2015, OPEN PHARM SCI J, V1, P1
   Maulvi F.A., 2016, J MATER SCI, V27, P1
   Maulvi F.A., 2015, J PHARM APPL SCI, V2, P11
   Maulvi FA, 2014, J PHARM APPL SCI, V1, P17
   Maulvi FA, 2016, J CONTROL RELEASE, V226, P47, DOI 10.1016/j.jconrel.2016.02.012
   Maulvi FA, 2015, J BIOMAT SCI-POLYM E, V26, P1035, DOI 10.1080/09205063.2015.1072902
   Maulvi FA, 2014, CURR DRUG DELIV, V11, P380, DOI 10.2174/1567201811666140311103425
   Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060
   Novack GD, 2009, CLIN PHARMACOL THER, V85, P539, DOI 10.1038/clpt.2008.297
   Peng CC, 2012, J CONTROL RELEASE, V162, P152, DOI 10.1016/j.jconrel.2012.06.017
   Peng CC, 2012, J MEMBRANE SCI, V399, P95, DOI 10.1016/j.memsci.2012.01.039
   Pozuelo J, 2014, J MEMBRANE SCI, V452, P62, DOI 10.1016/j.memsci.2013.10.010
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Sankalia JM, 2008, J CONTROL RELEASE, V129, P49, DOI 10.1016/j.jconrel.2008.03.016
   Sasaki Hitoshi, 1997, Acta Medica Nagasakiensia, V42, P45
   Van Beek M, 2008, BIOMATERIALS, V29, P780, DOI 10.1016/j.biomaterials.2007.10.039
   Venkatesh S, 2008, EUR J PHARM BIOPHARM, V69, P852, DOI 10.1016/j.ejpb.2008.01.036
   Weeks A, 2012, J BIOMED MATER RES A, V100A, P1972, DOI 10.1002/jbm.a.33269
   Wu H, 2011, MOL VIS, V17, P3364
   Yu FF, 2013, INVEST OPHTH VIS SCI, V54, P3385, DOI 10.1167/iovs.12-11181
NR 40
TC 8
Z9 9
U1 4
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 211
EP 221
DI 10.1016/j.actbio.2017.01.063
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100018
PM 28131945
DA 2018-10-20
ER

PT J
AU Meng, QY
   Hu, XQ
   Huang, HJ
   Liu, ZL
   Yuan, L
   Shao, ZX
   Jiang, YF
   Zhang, JY
   Fu, X
   Duan, XN
   Ao, YF
AF Meng, Qingyang
   Hu, Xiaoqing
   Huang, Hongjie
   Liu, Zhenlong
   Yuan, Lan
   Shao, Zhenxing
   Jiang, Yanfang
   Zhang, Jiying
   Fu, Xin
   Duan, Xiaoning
   Ao, Yingfang
TI Microfracture combined with functional pig peritoneum-derived acellular
   matrix for cartilage repair in rabbit models
SO ACTA BIOMATERIALIA
LA English
DT Article
DE MSC affinity peptide; Acellular peritoneum matrix; Functional
   modification; Cartilage tissue engineering
ID MESENCHYMAL STEM-CELLS; MSC AFFINITY PEPTIDE; ARTICULAR-CARTILAGE;
   BONE-MARROW; IN-VIVO; CHONDROGENIC DIFFERENTIATION; OSTEOCHONDRAL
   DEFECTS; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; REGENERATION
AB Due to avascular and hypocellular nature of cartilage, repair of articular cartilage defects within synovial joints still poses a significant clinical challenge. To promote neocartilage properties, we established a functional scaffold named APM-E7 by conjugating a bone marrow-derived mesenchymal stem cell (BM-MSC) affinity peptide (E7) onto the acellular peritoneum matrix (APM). During in vitro culture, the APM-E7 scaffold can support better proliferation as well as better differentiation into chondrocytes of BM-MSCs. After implanting into cartilage defects in rabbits for 24 weeks, compared with microfracture and APM groups, the APM-E7 scaffolds exhibited superior quality of neocartilage without transplant rejection, according to general observations, histological assessment, synovial fluid analysis, magnetic resonance imaging (MRI) and nanomechanical properties. This APM-E7 scaffold provided a scaffold for cell attachment, which was crucial for cartilage regeneration. Overall, the APM-E7 is a promising biomaterial with low immunogenicity for one-step cartilage repair by promoting autologous connective tissue progenitor (CTP) attachment.
   Statement of Significance
   We report the one-step transplantation of functional acellular peritoneum matrix (APM-E7) with specific mesenchymal stem cell recruitment to repair rabbit cartilage injury. The experimental results illustrated that the APM-E7 scaffold was successfully fabricated, which could specifically recruit MSCs and fill the cartilage defects in the femoral trochlear of rabbits at 24 weeks post-surgery. The repaired tissue was hyaline cartilage, which exhibited ideal mechanical stability. The APM-E7 biomaterial could provide scaffold for MSCs and improve cell homing, which are two key factors required for cartilage tissue engineering, thereby providing new insights into cartilage tissue engineering. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Meng, Qingyang; Hu, Xiaoqing; Huang, Hongjie; Liu, Zhenlong; Shao, Zhenxing; Jiang, Yanfang; Zhang, Jiying; Fu, Xin; Duan, Xiaoning; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing Key Lab Sports Injuries, 49 North Garden Rd, Beijing 100191, Peoples R China.
   [Yuan, Lan] Peking Univ, Med & Hlth Anal Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Hosp 3, Inst Sports Med, Beijing Key Lab Sports Injuries, 49 North Garden Rd, Beijing 100191, Peoples R China.
EM aoyingfang@163.com
OI liu, zhenlong/0000-0001-5541-5535; ao, yingfang/0000-0002-8909-2022
FU National Natural Science Foundation of China [81330040, 81401778,
   81301539]; Beijing Natural Science Foundation [7154248]; Beijing
   New-star Plan of Science and Technology [xx2014003(A)]
FX This work This project was supported by the National Natural Science
   Foundation of China (Grant Nos. 81330040, 81401778, 81301539), Beijing
   Natural Science Foundation (Grant No. 7154248) and Beijing New-star Plan
   of Science and Technology (Grant No. xx2014003(A)). We would like to
   thank Dr. Qiang Zhao for the technical assistance on the MRI scanning.
CR Anderson JA, 2014, AM J SPORT MED, V42, P2253, DOI 10.1177/0363546513508744
   Anraku Y, 2008, OSTEOARTHR CARTILAGE, V16, P961, DOI 10.1016/j.joca.2007.12.009
   Asik M, 2008, ARTHROSCOPY, V24, P1214, DOI 10.1016/j.arthro.2008.06.015
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Beitzel K, 2014, ARTHROSCOPY, V30, P289, DOI 10.1016/j.arthro.2013.11.020
   Caralla T, 2013, TISSUE ENG PT A, V19, P125, DOI 10.1089/ten.tea.2011.0622
   Dai LH, 2014, AM J SPORT MED, V42, P583, DOI 10.1177/0363546513518415
   Enea D, 2015, KNEE, V22, P30, DOI 10.1016/j.knee.2014.10.003
   Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986
   Evans SF, 2013, BIOMATERIALS, V34, P1878, DOI 10.1016/j.biomaterials.2012.09.024
   Fan W, 2013, J BIOMATER APPL, V27, P979, DOI 10.1177/0885328211431310
   Farrell MJ, 2015, OSTEOARTHR CARTILAGE, V23, P134, DOI 10.1016/j.joca.2014.09.012
   Fermor HL, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5517-0
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Ge Y, 2016, TISSUE ENG PART B-RE, V22, P114, DOI [10.1089/ten.teb.2015.0189, 10.1089/ten.TEB.2015.0189]
   Gomoll AH, 2014, WOUND REPAIR REGEN, V22, P30, DOI 10.1111/wrr.12166
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Guillen-Garcia P, 2014, CARTILAGE, V5, P114, DOI 10.1177/1947603513515903
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Huang HJ, 2014, BIOMATERIALS, V35, P9608, DOI 10.1016/j.biomaterials.2014.08.020
   Huang HJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035008
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Koh YG, 2013, ARTHROSCOPY, V29, P748, DOI 10.1016/j.arthro.2012.11.017
   Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234
   Levato R, 2015, ACTA BIOMATER, V18, P59, DOI 10.1016/j.actbio.2015.02.008
   Li S, 2008, J BIOMAT SCI-POLYM E, V19, P245, DOI 10.1163/156856208783432499
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Luangphakdy V, 2016, TISSUE ENG PT A, V22, P17, DOI [10.1089/ten.tea.2014.0663, 10.1089/ten.TEA.2014.0663]
   Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270
   Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x
   Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031
   McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001
   Mehranjani MS, 2014, CELL J, V16, P195
   Melrose J., 2016, MATRIX BIOL
   Meng QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17802
   Mundi R, 2015, AM J SPORTS MED
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Nishimori M, 2006, J BONE JOINT SURG BR, V88B, P1236, DOI 10.1302/0301-620X.88B9.17810
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Pi YB, 2011, BIOMATERIALS, V32, P6324, DOI 10.1016/j.biomaterials.2011.05.017
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Tsai PC, 2016, TISSUE ENG PT A, V22, P111, DOI [10.1089/ten.tea.2015.0209, 10.1089/ten.TEA.2015.0209]
   Tuan RS, 2006, ARTHRITIS RHEUM, V54, P3075, DOI 10.1002/art.22148
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
   Wang XM, 2015, CELL PHYSIOL BIOCHEM, V37, P1914, DOI 10.1159/000438552
   Wang ZH, 2008, ACTA PHARMACOL SIN, V29, P1215, DOI 10.1111/j.1745-7254.2008.00856.x
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681
   Ye K, 2015, NANO LETT, V15, P4720, DOI 10.1021/acs.nanolett.5b01619
   Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
   Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017
NR 62
TC 1
Z9 1
U1 9
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 279
EP 292
DI 10.1016/j.actbio.2017.01.055
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100025
PM 28115294
DA 2018-10-20
ER

PT J
AU Feng, Q
   Lin, S
   Zhang, KY
   Dong, CQ
   Wu, TY
   Huang, HQ
   Yan, XH
   Zhang, L
   Li, G
   Bian, LM
AF Feng, Qian
   Lin, Sien
   Zhang, Kunyu
   Dong, Chaoqun
   Wu, Tianyi
   Huang, Heqin
   Yan, Xiaohui
   Zhang, Li
   Li, Gang
   Bian, Liming
TI Sulfated hyaluronic acid hydrogels with retarded degradation and
   enhanced growth factor retention promote hMSC chondrogenesis and
   articular cartilage integrity with reduced hypertrophy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Sulfation; Hyaluronic acid; Degradation; Chondrogenesis; Hypertrophy
ID STEM-CELL CHONDROGENESIS; IN-VIVO; MSC CHONDROGENESIS; TISSUE; REPAIR;
   SCAFFOLDS; OSTEOARTHRITIS; AUGMENTATION; REGENERATION; HYALGAN(R)
AB Recently, hyaluronic acid (HA) hydrogels have been extensively researched for delivering cells and drugs to repair damaged tissues, particularly articular cartilage. However, the in vivo degradation of HA is fast, thus limiting the clinical translation of HA hydrogels. Furthermore, HA cannot bind proteins with high affinity because of the lack of negatively charged sulfate groups. In this study, we conjugated tunable amount of sulfate groups to HA. The sulfated HA exhibits significantly slower degradation by hyaluronidase compared to the wild type HA. We hypothesize that the sulfation reduces the available HA octasaccharide substrate needed for the effective catalytic action of hyaluronidase. Moreover, the sulfated HA hydrogels significantly improve the protein sequestration, thereby effectively extending the availability of the proteinaceous drugs in the hydrogels. In the following in vitro study, we demonstrate that the HA hydrogel sulfation exerts no negative effect on the viability of encapsulated human mesenchymal stem cells (hMSCs). Furthermore, the sulfated HA hydrogels promote the chondrogenesis and suppresses the hypertrophy of encapsulated hMSCs both in vitro and in vivo. Moreover, intra-articular injections of the sulfated HA hydrogels avert the cartilage abrasion and hypertrophy in the animal osteoarthritic joints. Collectively, our findings demonstrate that the sulfated HA is a promising biomaterial for the delivery of therapeutic agents to aid the regeneration of injured or diseased tissues and organs.
   Statement of Significance
   In this paper, we conjugated sulfate groups to hyaluronic acid (HA) and demonstrated the slow degradation and growth factor delivery of sulfated HA. Furthermore, the in vitro and in vivo culture of hMSCs laden HA hydrogels proved that the sulfation of HA hydrogels not only promotes the chondrogenesis of hMSCs but also suppresses hypertrophic differentiation of the chondrogenically induced hMSCs. The animal OA model study showed that the injected sulfated HA hydrogels significantly reduced the cartilage abrasion and hypertrophy in the animal OA joints. We believe that this study will provide important insights into the design and optimization of the HA-based hydrogels as the scaffold materials for cartilage regeneration and OA treatment in clinical setting. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Feng, Qian; Lin, Sien; Zhang, Kunyu; Dong, Chaoqun; Wu, Tianyi; Huang, Heqin; Bian, Liming] Chinese Univ Hong Kong, Div Biomed Engn, Shatin 999077, Hong Kong, Peoples R China.
   [Feng, Qian; Zhang, Kunyu; Dong, Chaoqun; Huang, Heqin; Yan, Xiaohui; Zhang, Li; Bian, Liming] Chinese Univ Hong Kong, Dept Mech & Automat Engn, Shatin 999077, Hong Kong, Peoples R China.
   [Bian, Liming] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Shatin 999077, Hong Kong, Peoples R China.
   [Bian, Liming] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China.
   [Bian, Liming] China Orthoped Regenerat Med Grp CORMed, Hangzhou, Zhejiang, Peoples R China.
   [Lin, Sien; Wu, Tianyi] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Hong Kong 999077, Hong Kong, Peoples R China.
   [Bian, Liming] Chinese Univ Hong Kong, Ctr Novel Biomat, Shatin 999077, Hong Kong, Peoples R China.
RP Bian, LM (reprint author), Chinese Univ Hong Kong, Div Biomed Engn, Shatin 999077, Hong Kong, Peoples R China.
EM lbian@mae.cuhk.edu.hk
RI Li, Gang/J-7830-2018; Lin, Sien/J-7773-2018; Zhang, Li/G-7384-2012
OI Li, Gang/0000-0002-3981-2239; Lin, Sien/0000-0002-7292-7062; Zhang,
   Li/0000-0003-1152-8962; Bian, Liming/0000-0003-4739-0918; Feng,
   Qian/0000-0003-3196-0840
FU National Natural Science Foundation of China [31300796]; Shun Hing
   Institute of Advanced Engineering, The Chinese University of Hong Kong
   [BME-p3-15]; Innovation Technology Fund (ITF), Hong Kong [ITS/218/13];
   Research Grants Council of Hong Kong [439913]; Chow Yuk Ho Technology
   Centre for Innovative Medicine, The Chinese University of Hong Kong;
   Health and Medical Research Fund; Food and Health Bureau; Government of
   the Hong Kong Special Administrative Region [03140056]
FX Project 31300796 is supported by the National Natural Science Foundation
   of China. This research is also supported by project BME-p3-15 of the
   Shun Hing Institute of Advanced Engineering, The Chinese University of
   Hong Kong. This research is supported by an Innovation Technology Fund
   (ITF, Tier 3, ITS/218/13), Hong Kong. This work was supported by an
   Early Career Scheme grant from the Research Grants Council of Hong Kong
   (Project No. 439913). This research is supported by the Chow Yuk Ho
   Technology Centre for Innovative Medicine, The Chinese University of
   Hong Kong. This work is supported by the Health and Medical Research
   Fund, the Food and Health Bureau, the Government of the Hong Kong
   Special Administrative Region (reference no.: 03140056).
CR Akar B, 2015, BIOMATERIALS, V72, P61, DOI 10.1016/j.biomaterials.2015.08.049
   Albro MB, 2016, BIOMATERIALS, V77, P173, DOI 10.1016/j.biomaterials.2015.10.018
   Altgarde N, 2013, ACTA BIOMATER, V9, P8158, DOI 10.1016/j.actbio.2013.05.031
   Barry F, 2013, NAT REV RHEUMATOL, V9, P584, DOI 10.1038/nrrheum.2013.109
   Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Blum MM, 2013, MAT SCI ENG C-MATER, V33, P4377, DOI 10.1016/j.msec.2013.06.035
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cohen MM, 2008, FOOT ANKLE INT, V29, P657, DOI 10.3113/FAI.2008.0657
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Feng Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099587
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157
   Kim DW, 2011, J PLAST RECONSTR AES, V64, P1590, DOI 10.1016/j.bjps.2011.07.013
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim JJ, 2003, INT J IMPOT RES, V15, P439, DOI 10.1038/sj.ijir.3901044
   Lee F, 2015, ACS MACRO LETT, V4, P957, DOI 10.1021/acsmacrolett.5b00544
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   McNary SM, 2012, TISSUE ENG PART B-RE, V18, P88, DOI [10.1089/ten.TEB.2011.0394, 10.1089/ten.teb.2011.0394]
   Moller S, 2012, CARBOHYD POLYM, V90, P608, DOI 10.1016/j.carbpol.2012.05.085
   Nakai T, 2012, MACROMOL BIOSCI, V12, P475, DOI 10.1002/mabi.201100352
   Narcisi R, 2015, STEM CELL REP, V4, P459, DOI 10.1016/j.stemcr.2015.01.017
   Neustadt DH, 2003, CLIN EXP RHEUMATOL, V21, P307
   Orth P, 2012, TISSUE ENG PART C-ME, V18, P329, DOI [10.1089/ten.TEC.2011.0462, 10.1089/ten.tec.2011.0462]
   Park H, 2013, ACTA BIOMATER, V9, P4779, DOI 10.1016/j.actbio.2012.08.033
   Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817
   Purcell BP, 2014, BIOMATER SCI-UK, V2, P693, DOI 10.1039/c3bm60227c
   Robinson DE, 2012, BIOMATERIALS, V33, P1007, DOI 10.1016/j.biomaterials.2011.10.042
   Rodell CB, 2015, ACS BIOMATER SCI ENG, V1, P277, DOI 10.1021/ab5001673
   Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Vilela CA, 2015, ACS BIOMATER SCI ENG, V1, P726, DOI 10.1021/acsbiomaterials.5b00245
   Wei Z, 2015, ADV FUNCT MATER, V25, P1352, DOI 10.1002/adfm.201401502
   Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   Yamashita A, 2015, STEM CELL REP, V4, P404, DOI 10.1016/j.stemcr.2015.01.016
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Zhang TT, 2015, BIOMATERIALS, V38, P72, DOI 10.1016/j.biomaterials.2014.10.010
   Zhang W, 2013, BIOMATERIALS, V34, P713, DOI 10.1016/j.biomaterials.2012.10.027
   Zhu ML, 2016, BIOMATERIALS, V77, P44, DOI 10.1016/j.biomaterials.2015.10.072
   Zhu ML, 2014, ACTA BIOMATER, V10, P1333, DOI 10.1016/j.actbio.2013.12.015
NR 42
TC 10
Z9 10
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 329
EP 342
DI 10.1016/j.actbio.2017.02.015
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100029
PM 28193542
DA 2018-10-20
ER

PT J
AU Balakrishnan, B
   Soman, D
   Payanam, U
   Laurent, A
   Labarre, D
   Jayakrishnan, A
AF Balakrishnan, Biji
   Soman, Dawlee
   Payanam, Umashanker
   Laurent, Alexandre
   Labarre, Denis
   Jayakrishnan, Athipettah
TI A novel injectable tissue adhesive based on oxidized dextran and
   chitosan
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue adhesive; Injectable; Hemostat; Dextran; Chitosan
ID IN-VITRO; POLY(L-GLUTAMIC ACID); SURGICAL ADHESIVES; BIOLOGICAL GLUE;
   GELATIN; GLUTARALDEHYDE; BIOADHESIVES; HYDROGELS; SEALANTS; SURGERY
AB A surgical adhesive that can be used in different surgical situations with or without sutures is a surgeons' dream and yet none has been able to fulfill many such demanding requirements. It was therefore a major challenge to develop an adhesive biomaterial that stops bleeding and bond tissues well, which at the same time is non-toxic, biocompatible and yet biodegradable, economically viable and appealing to the surgeon in terms of the simplicity of application in complex surgical situations. With this aim, we developed an in situ setting adhesive based on biopolymers such as chitosan and dextran. Dextran was oxidized using periodate to generate aldehyde functions on the biopolymer and then reacted with chitosan hydrochloride. Gelation occurred instantaneously upon mixing these components and the resulting gel showed good tissue adhesive properties with negligible cytotoxicity and minimal swelling in phosphate buffered saline (PBS). Rheology analysis confirmed the gelation process by demonstrating storage modulus having value higher than loss modulus. Adhesive strength was in the range 200-400 gf/cm(2) which is about 4-5 times more than that of fibrin glue at comparable setting times. The adhesive showed burst strength in the range of 400-410 mm of Hg which should make the same suitable as a sealant for controlling bleeding in many surgical situations even at high blood pressure. Efficacy of the adhesive as a hemostat was demonstrated in a rabbit liver injury model. Histological features after two weeks were comparable to that of commercially available BioGlue (R). The adhesive also demonstrated its efficacy as a drug delivery vehicle. The present adhesive could function without the many toxicity and biocompatibility issues associated with such products.
   Statement of Significance
   Though there are many tissue adhesives available in market, none are free of shortcomings. The newly developed surgical adhesive is a 2-component adhesive system based on time-tested, naturally occurring polysaccharides such as chitosan and dextran which are both biocompatible and biodegradable. Simple polymer modification has been carried out on both polysaccharides so that when aqueous solutions of both are mixed, the solutions gel in less than 10 s and forms an adhesive that seals a variety of incisions. The strength of the adhesive is over 5-times the strength of commercially available Fibrin glue and is more tissue compliant than BioGlue. This adhesive biomaterial showed excellent tissue bonding, was hemostatic, biocompatible and biodegradable. The significance of this work lies on the features of the developed tissue adhesive that it stops bleeding, bond the tissues well, can act as a drug delivery vehicle and would appeal to the surgeon in terms of the simplicity of application in complex surgical situations. There is no need for special delivery systems for application of this adhesive. The two-component adhesive can be applied one over the other using syringes. There is also no need for light curing with UV or visible light and the gelation between the two components spontaneously takes place on application leading to excellent tissue bonding. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jayakrishnan, Athipettah] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Biomat Lab, Madras 600036, Tamil Nadu, India.
   [Balakrishnan, Biji] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Soman, Dawlee; Payanam, Umashanker] Sree Chitra Tirunal Inst Med Sci & Technol, In Vivo Models & Testing Div, BMT Wing, Thiruvananthapuram 695012, Kerala, India.
   [Laurent, Alexandre] INRA, Ctr Rech Imagerie Intervent Cr2i APHP, Batiment 402, F-78352 Jouy En Josas, France.
   [Labarre, Denis] Univ Paris Sud, UMR CNRS 8612, Ctr Etud Pharmaceut, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.
RP Jayakrishnan, A (reprint author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Biomat Lab, Madras 600036, Tamil Nadu, India.
EM ajk@iitm.ac.in
OI Athipettah, Jayakrishnan/0000-0003-2738-6161
FU Indo-French Centre of Advanced Research (IFCPAR), New Delhi [2603-2]
FX Financial support from Indo-French Centre of Advanced Research (IFCPAR
   PROJECT No. 2603-2), New Delhi is gratefully acknowledged.
CR Annabi N, 2015, EUR J PHARM BIOPHARM, V95, P27, DOI 10.1016/j.ejpb.2015.05.022
   Annabi N, 2014, NANO TODAY, V9, P574, DOI 10.1016/j.nantod.2014.09.006
   Artzi N, 2009, MACROMOL BIOSCI, V9, P754, DOI 10.1002/mabi.200800355
   Austin P. R., 1986, CHITIN NATURE TECHNO, P279
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Balakrishnan B, 2014, ACTA BIOMATER, V10, P3650, DOI 10.1016/j.actbio.2014.04.031
   Bassett J., 1978, VOGELS TXB QUANTITAT, P370
   Bochynska AI, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5790-6
   Chao HH, 2003, J CARDIAC SURG, V18, P500, DOI 10.1046/j.0886-0440.2003.00304.x
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Farrar DF, 2012, INT J ADHES ADHES, V33, P89, DOI 10.1016/j.ijadhadh.2011.11.009
   Fernandez-Gutierrez M, 2016, MACROMOL BIOSCI, V16, P1803, DOI 10.1002/mabi.201600246
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gilbert TW, 2013, J PLAST RECONSTR AES, V66, P414, DOI 10.1016/j.bjps.2012.09.029
   Grillet A.M., 2012, RHEOLOGY, P59, DOI DOI 10.5772/2065
   Harris J. M. E., 1992, POLYETHYLENE GLYCOL, P385
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Krauland AH, 2005, DRUG DEV IND PHARM, V31, P885, DOI 10.1080/03639040590405002791985
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Leithner K., 2012, CHITOSAN BASED SYSTE, P159
   LeMaire SA, 2002, ANN THORAC SURG, V73, P1500, DOI 10.1016/S0003-4975(02)03512-9
   Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001
   Marchioni Michele, 2015, Surg Technol Int, V27, P45
   Matsumoto T., 1972, TISSUE ADHESIVES SUR, P154
   Mehdizadeh M, 2013, MACROMOL BIOSCI, V13, P271, DOI 10.1002/mabi.201200332
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Meng H, 2017, ACTA BIOMATER, V48, P144, DOI 10.1016/j.actbio.2016.10.016
   Miller MA, 2010, LANGMUIR, V26, P1067, DOI 10.1021/la9023426
   Mizrahi B, 2011, ACTA BIOMATER, V7, P3150, DOI 10.1016/j.actbio.2011.04.022
   Mo XM, 2010, J BIOMED MATER RES A, V94A, P326, DOI 10.1002/jbm.a.32788
   Nomori H, 1999, ANN THORAC SURG, V67, P212, DOI 10.1016/S0003-4975(98)01184-9
   OLEARY RK, 1969, J PHARM SCI, V58, P1007, DOI 10.1002/jps.2600580824
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Prior JJ, 1999, ANN THORAC SURG, V68, P479, DOI 10.1016/S0003-4975(99)00552-4
   Quinn J.V., 2005, TISSUE ADHESIVES CLI, P14
   Ryu JH, 2015, ACTA BIOMATER, V27, P101, DOI 10.1016/j.actbio.2015.08.043
   Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149
   Shaffer MP, 2000, CONTACT DERMATITIS, V43, P150, DOI 10.1034/j.1600-0536.2000.043003150.x
   Shafiq Z, 2012, ANGEW CHEM INT EDIT, V51, P4332, DOI 10.1002/anie.201108629
   Shivamurthy D M, 2010, Natl J Maxillofac Surg, V1, P15, DOI 10.4103/0975-5950.69151
   SIEDENTOP K H, 1980, American Journal of Otology, V2, P77
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Toriumi DM, 2016, OTOLARYNG CLIN N AM, V49, P585, DOI 10.1016/j.otc.2016.02.012
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Weng LH, 2007, BIOMACROMOLECULES, V8, P1109, DOI 10.1021/bm0610065
   Wheat JC, 2009, UROL CLIN N AM, V36, P265, DOI 10.1016/j.ucl.2009.02.002
   Zhang H, 2014, BIOMATERIALS, V35, P711, DOI 10.1016/j.biomaterials.2013.10.017
NR 52
TC 9
Z9 9
U1 21
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 343
EP 354
DI 10.1016/j.actbio.2017.01.065
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100030
PM 28131944
DA 2018-10-20
ER

PT J
AU Tan, RP
   Lee, BSL
   Chan, AHP
   Yuen, SCG
   Hung, JC
   Wise, SG
   Ng, MKC
AF Tan, Richard P.
   Lee, Bob S. L.
   Chan, Alex H. P.
   Yuen, Sui Ching G.
   Hung, Juichien
   Wise, Steven G.
   Ng, Martin K. C.
TI Non-invasive tracking of injected bone marrow mononuclear cells to
   injury and implanted biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone marrow mononuclear cells; Subcutaneous implant; Bioluminescence;
   Tissue regeneration
ID ENGINEERED VASCULAR GRAFTS; EXTRACELLULAR-MATRIX; ISCHEMIC-MYOCARDIUM;
   STEM-CELLS; INTRACORONARY INJECTION; SCAFFOLDS; INFLAMMATION;
   TRANSPLANTATION; ANGIOGENESIS; MACROPHAGES
AB Biomaterial scaffolds enhancing the engraftment of transplanted bone-marrow mononuclear cells (BM-MNC) have enormous potential for tissue regeneration applications. However, development of appropriate materials is challenging given the precise microenvironments required to support BM-MNC engraftment and function. In this study, we have developed a non-invasive, real-time tracking model of injected BM-MNC engraftment to wounds and implanted biomaterial scaffolds. BM-MNCs, encoded with firefly luciferase and enhanced GFP reporter genes, were tail vein injected into subcutaneously wounded mice. Luciferase-dependent cell bioluminescence curves revealed our injected BM-MNCs homed to and engrafted within subcutaneous wound sites over the course of 21 days. Further immunohistochemical characterization showed that these engrafted cells drove functional changes by increasing the number of immune cells present at early time points and remodelling cell phenotypes at later time points. Using this model, we subcutaneously implanted electrospun polycaprolactone (PCL) and PCL/Collagen scaffolds, to determine differences in exogenous BM-MNC response to these materials. Following BM-MNC injection, immunohistochemical analysis revealed a high exogenous BM-MNC density around the periphery of PCL scaffolds consistent with a classical foreign body response. In contrast, transplanted BM-MNCs engrafted throughout PCL/Collagen scaffolds indicating an improved biological response. Importantly, these differences were closely correlated with the real-time bioluminescence curves, with PCL/Collagen scaffolds exhibiting a 2-fold increase in maximum bioluminescence compared with PCL scaffolds. Collectively, these results demonstrate a new longitudinal cell tracking model that can non-invasively determine transplanted BM-MNC homing and engraftment to biomaterials, providing a valuable tool to inform the design scaffolds that help augment current BM-MNC tissue engineering strategies.
   Statement of Significance
   Tracking the dynamic behaviour of transplanted bone-marrow mononuclear cells (BM-MNCs) is a longstanding research goal. Conventional methods involving contrast and tracer agents interfere with cellular function while also yielding false signals. The use of bioluminescence addresses these shortcomings while allowing for real-time non-invasive tracking in vivo. Given the failures of transplanted BM-MNCs to engraft into injured tissue, biomaterial scaffolds capable of attracting and enhancing BM-MNC engraftment at sites of injury are highly sought in numerous tissue engineering applications. To this end, the results from this study demonstrate a new longitudinal tracking model that can non-invasively determine exogenous BM-MNC homing and engraftment to biomaterials, providing a valuable tool to inform the design of scaffolds with implications for countless tissue engineering applications. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tan, Richard P.; Lee, Bob S. L.; Chan, Alex H. P.; Yuen, Sui Ching G.; Hung, Juichien; Wise, Steven G.; Ng, Martin K. C.] Heart Res Inst, Sydney, NSW 2042, Australia.
   [Tan, Richard P.; Chan, Alex H. P.; Wise, Steven G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Wise, Steven G.; Ng, Martin K. C.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.
   [Ng, Martin K. C.] Royal Prince Alfred Hosp, Sydney, NSW 2042, Australia.
RP Wise, SG (reprint author), Heart Res Inst, Appl Mat Grp, Sydney, NSW 2042, Australia.; Ng, MKC (reprint author), Univ Sydney, Royal Prince Alfred Hosp, Dept Cardiol, Missenden Rd, Camperdown, NSW 2050, Australia.
EM Steve.Wise@hri.org.au; mkcng@med.usyd.edu.au
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; Chan, Alex Ho Pang/0000-0002-1244-7673
FU National Health and Medical Research Council [APP1066174]; Australian
   Postgraduate Scholarship
FX This work was supported by a grant from the National Health and Medical
   Research Council (APP1066174; MKCN). R.P.T is the recipient of an
   Australian Postgraduate Scholarship. We have no competing interests.
CR Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763
   Assmus B, 2016, EUR HEART J, V37, P1659, DOI 10.1093/eurheartj/ehv559
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Bainbridge P, 2013, J WOUND CARE, V22, P407
   Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327
   Caraco C, 2000, J BIOL CHEM, V275, P18489, DOI 10.1074/jbc.M908096199
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c
   Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623
   de Almeida PE, 2011, AM J PHYSIOL-HEART C, V301, pH663, DOI 10.1152/ajpheart.00337.2011
   Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Henrich D., 2015, BIOMED RES INT, V2015
   Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585
   Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kurobe H., 2012, STEM CELLS TRANSL ME, V1, P566
   Leblond AL, 2009, STEM CELLS CLONING, V2, P11, DOI 10.2147/SCCAA.S6210
   Li Chong-jian, 2008, Chinese Medical Sciences Journal, V23, P234
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Liu HJ, 2014, BIOMATERIALS, V35, P5138, DOI 10.1016/j.biomaterials.2014.03.024
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Connell-Rodwell CE, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904665
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Scott M. K., 2014, JOVE-J VIS EXP, V91
   Sheikh AY, 2012, ARTERIOSCL THROM VAS, V32, P92, DOI 10.1161/ATVBAHA.111.238618
   Sohni A, 2013, STEM CELLS INT, V2013, P8, DOI DOI 10.1155/2013/130763
   Steinstraesser L, 2010, LASER SURG MED, V42, P141, DOI 10.1002/lsm.20901
   Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035
   Teodori L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00218
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tse HF, 2007, EUR J HEART FAIL, V9, P747, DOI 10.1016/j.ejheart.2007.03.008
   van der Bogt KEA, 2012, JACC-CARDIOVASC IMAG, V5, P46, DOI 10.1016/j.jcmg.2011.07.011
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   Wilmink GJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2992594
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood2004-11-4418
   Zhang HK, 2008, ANN VASC SURG, V22, P238, DOI 10.1016/j.avsg.2007.07.037
   Zhao YB, 2013, METHODS MOL BIOL, V1052, P57, DOI 10.1007/7651_2013_28
NR 44
TC 3
Z9 3
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 378
EP 388
DI 10.1016/j.actbio.2017.02.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100033
PM 28167301
DA 2018-10-20
ER

PT J
AU Xing, JC
   Mei, TN
   Luo, KY
   Li, ZQ
   Yang, AJ
   Li, ZL
   Xie, Z
   Zhang, ZH
   Dong, SW
   Hou, TY
   Xu, JZ
   Luo, F
AF Xing, Junchao
   Mei, Tieniu
   Luo, Keyu
   Li, Zhiqiang
   Yang, Aijun
   Li, Zhilin
   Xie, Zhao
   Zhang, Zehua
   Dong, Shiwu
   Hou, Tianyong
   Xu, Jianzhong
   Luo, Fei
TI A nano-scaled and multi-layered recombinant fibronectin/cadherin chimera
   composite selectively concentrates osteogenesis-related cells and
   factors to aid bone repair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Selective cell retention; Mesenchymal stem cells; Bone repair;
   Layer-by-layer self-assembly technique; Nanoscale biomaterial
ID MESENCHYMAL STEM-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; PROGENITOR
   CELLS; MARROW; DIFFERENTIATION; OSTEOBLAST; ADHESION; CADHERIN; INTEGRIN
AB Easily accessible and effective bone grafts are in urgent need in clinic. The selective cell retention (SCR) strategy, by which osteogenesis-related cells and factors are enriched from bone marrow into bio-scaffolds, holds great promise. However, the retention efficacy is limited by the relatively low densities of osteogenesis-related cells and factors in marrow; in addition, a lack of satisfactory surface modifiers for scaffolds further exacerbates the dilemma. To address this issue, a multi-layered construct consisting of a recombinant fibronectin/cadherin chimera was established via a layer-by-layer self-assembly technique (LBL-rFN/CDH) and used to modify demineralised bone matrix (DBM) scaffolds. The modification was proven stable and effective. By the mechanisms of physical interception and more importantly, chemical recognition (fibronectin/integrins), the LBL-rFN/CDH modification significantly improved the retention efficacy and selectivity for osteogenesis-related cells, e.g., monocytes, mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs), and bioactive factors, e.g., bFGF, BMP-2 and SDF-1 alpha. Moreover, the resulting composite (designated as DBM-LBL-rFN/CDH) not only exhibited a strong MSC-recruiting capacity after SCR, but also provided favourable microenvironments for the proliferation and osteogenic differentiation of MSCs. Eventually, bone repair was evidently improved. Collectively, DBM-LBL-rFN/CDH presented a suitable biomaterial for SCR and a promising solution for tremendous need for bone grafts.
   Statement of Significance
   There is an urgent need for effective bone grafts. With the potential of integrating osteogenicity, osteoinductivity and osteoconductivity, selective cell retention (SCR) technology brings hope for developing ideal grafts. However, it is constrained by low efficacy and selectivity. Thus, we modified demineralized bone matrix with nano-scaled and multi-layered recombinant fibronectin/cadherin chimera (DBM-rFN/CDH-LBL), and evaluate its effects on SCR and bone repair. DBM-rFN/CDH-LBL significantly improved the efficacy and selectivity of SCR via physical interception and chemical recognition. The post enriched DBM-rFN/CDH-LBL provided favourable microenvironments to facilitate the migration, proliferation and osteogenic differentiation of MSCs, thus accelerating bone repair. Conclusively, DBM-rFN/CDH-LBL presents a novel biomaterial with advantages including high cost-effectiveness, more convenience for storage and transport and can be rapidly constructed intraoperatively. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xing, Junchao; Mei, Tieniu; Luo, Keyu; Li, Zhiqiang; Yang, Aijun; Li, Zhilin; Xie, Zhao; Zhang, Zehua; Dong, Shiwu; Hou, Tianyong; Xu, Jianzhong; Luo, Fei] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Natl & Reg United Engn Lab Tissue Engn, Chongqing, Peoples R China.
   [Xing, Junchao; Mei, Tieniu; Luo, Keyu; Li, Zhiqiang; Yang, Aijun; Li, Zhilin; Xie, Zhao; Zhang, Zehua; Dong, Shiwu; Hou, Tianyong; Xu, Jianzhong; Luo, Fei] Ctr Regenerat & Reconstruct Engn Technol Chongqin, Chongqing, Peoples R China.
   [Xing, Junchao; Mei, Tieniu; Luo, Keyu; Li, Zhiqiang; Yang, Aijun; Li, Zhilin; Xie, Zhao; Zhang, Zehua; Dong, Shiwu; Hou, Tianyong; Xu, Jianzhong; Luo, Fei] Tissue Engn Lab Chongqing City, Chongqing, Peoples R China.
   [Dong, Shiwu] Third Mil Med Univ, Dept Biomed Mat Sci, Coll Biomed Engn, Chongqing, Peoples R China.
   [Li, Zhilin] Lanzhou Gen Hosp, Lanzhou Command CPLA, Dept Spine, Lanzhou 730050, Peoples R China.
RP Xu, JZ; Luo, F (reprint author), 29 Gaotanyan St, Chongqing 400038, Peoples R China.
EM prof_jianzhongxu@163.com; luofly1009@hotmail.com
FU National Natural Science Foundation of China [31100694, 81472059];
   Medical Scientific Research Projects of PLA [CLZBJ002]
FX This work was supported by the National Natural Science Foundation of
   China (31100694 & 81472059) and Medical Scientific Research Projects of
   PLA (CLZBJ002).
CR Bachman H, 2015, ADV WOUND CARE, V4, P501, DOI 10.1089/wound.2014.0621
   Barati D, 2016, J CONTROL RELEASE, V223, P126, DOI 10.1016/j.jconrel.2015.12.031
   Bi XP, 2014, ACTA BIOMATER, V10, P2814, DOI 10.1016/j.actbio.2014.02.018
   Bonda DJ, 2015, NEUROSURGERY, V77, P814, DOI 10.1227/NEU.0000000000000899
   Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080
   Brodke D, 2006, J ORTHOP RES, V24, P857, DOI 10.1002/jor.20094
   Chan KH, 2015, INT J MED SCI, V12, P701, DOI 10.7150/ijms.12658
   Chang YC, 2016, BIOMED RES INT, V2016
   Curry AS, 2016, MATRIX BIOL, V52-54, P397, DOI 10.1016/j.matbio.2016.02.011
   Dallalio G, 2007, J INVEST MED, V55, P69, DOI 10.2310/6650.2007.06029
   Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001
   Di Benedetto A, 2015, STEM CELL RES, V15, P618, DOI 10.1016/j.scr.2015.09.011
   Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777
   GARG NK, 1995, J BONE JOINT SURG BR, V77, P830
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Herrmann Marietta, 2015, Front Bioeng Biotechnol, V3, P79, DOI 10.3389/fbioe.2015.00079
   Hou TY, 2014, BIOMATERIALS, V35, P5689, DOI 10.1016/j.biomaterials.2014.03.079
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   Ito H, 2011, MOD RHEUMATOL, V21, P113, DOI 10.1007/s10165-010-0357-8
   Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420
   Kong Y, 2016, INT J NANOMED, V11, P2543, DOI 10.2147/IJN.S102861
   Lee K, 2009, J ARTHROPLASTY, V24, P43, DOI 10.1016/j.arth.2008.01.133
   Leong JCY, 1996, J BONE JOINT SURG BR, V78B, P683
   Li ZQ, 2015, TISSUE ENG PT A, V21, P1398, DOI [10.1089/ten.tea.2014.0294, 10.1089/ten.TEA.2014.0294]
   Li ZQ, 2014, INT ORTHOP, V38, P2391, DOI 10.1007/s00264-014-2388-9
   Marie PJ, 2014, TRENDS ENDOCRIN MET, V25, P567, DOI 10.1016/j.tem.2014.06.009
   Marie PJ, 2014, CALCIFIED TISSUE INT, V94, P46, DOI 10.1007/s00223-013-9733-7
   Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/561098
   Marx Robert E, 2014, Int J Oral Maxillofac Implants, V29, pe201, DOI 10.11607/jomi.te56
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149
   Pang H, 2013, INT ORTHOP, V37, P753, DOI 10.1007/s00264-012-1751-y
   Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Shanbhag S, 2015, CLIN IMPLANT DENT R, V17, pE17, DOI 10.1111/cid.12103
   Stanovici J, 2016, CURR RES TRANSL MED, V64, P83, DOI 10.1016/j.retram.2016.04.006
   Takemoto RC, 2010, J ORTHOP TRAUMA, V24, P564, DOI 10.1097/BOT.0b013e3181ed29a6
   Wei Q, 2015, BEILSTEIN J ORG CHEM, V11, P773, DOI 10.3762/bjoc.11.87
   Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72
   Xing JC, 2014, J SURG RES, V192, P454, DOI 10.1016/j.jss.2014.05.037
   Zankovych S, 2013, ACTA BIOMATER, V9, P4926, DOI 10.1016/j.actbio.2012.08.013
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang Y, 2012, BIOMATERIALS, V33, P7468, DOI 10.1016/j.biomaterials.2012.06.095
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
   Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187
NR 47
TC 3
Z9 4
U1 7
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 470
EP 482
DI 10.1016/j.actbio.2017.02.016
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100041
PM 28193541
DA 2018-10-20
ER

PT J
AU Biesiekierski, A
   Ping, DH
   Li, YC
   Lin, JX
   Muni, KS
   Yamabe-Mitarai, Y
   Wen, C
AF Biesiekierski, Arne
   Ping, Dehai
   Li, Yuncang
   Lin, Jixing
   Muni, Khurram S.
   Yamabe-Mitarai, Yoko
   Wen, Cuie
TI Extraordinary high strength Ti-Zr-Ta alloys through nanoscaled,
   dual-cubic spinodal reinforcement
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Titanium alloy; Transmission electron microscopy (TEM); Nano-structure;
   Spinodal decomposition; Biomedical
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; NB
   ALLOYS; DECOMPOSITION; ALPHA; FE; INDENTATION; IMPROVEMENT; EVOLUTION
AB While titanium alloys represent the current state-of-the-art for orthopedic biomaterials, concerns still remain over their modulus. Circumventing this via increased porosity requires high elastic admissible strains, yet also limits traditional thermomechanical strengthening techniques. To this end, a novel beta-type Ti-Zr-Ta alloy system, comprised of Ti-45Zr-10Ta, Ti-40Zr-14Ta, Ti-35Zr-18Ta and Ti-30Zr-22Ta, was designed and characterized mechanically and microstructurally. As-cast, this system displayed extremely high yield strengths and elastic admissible strains, up to 1.4 GPa and potentially 1.48%, respectively. This strength was attributed to a nanoscaled, cuboidal structure of semi-coherent, dual body centered cubic (BCC) phases, arising from the thermodynamics of interaction between Ta and Zr; this morphology occurring with dual BCC-phases is heretofore unreported in Ti-based alloys. Further, cell proliferation investigated by MTS assay suggests this was achieved without sacrificing biocompatibility, with no significant difference to either empty-well or commercially-pure Ti controls noted.
   Statement of Significance
   The current research details microstructural, mechanical, and biological investigations into four novel biomedical alloys in a hitherto uninvestigated region of the Ti-Zr-Ta alloy system; Ti-45Zr-10Ta, Ti-40Zr-14Ta, Ti-35Zr-18Ta and Ti-30Zr-22Ta. We find that the investigated alloys display 0.2% yield strengths of up to 1.40 GPa and elastic admissible strains of up to 1.48%, along with biological properties comparable to that seen in the conventional metallic biomaterial ASTM Grade-2 CP-Ti, achieved in the complete absence of traditional thermomechanical processing techniques. This is attributed to the presence of a dual-BCC cuboidal nanostructure, achieved via spinodal decomposition; while similar structures have been reported in e.g. Ni-based superalloys, we believe this is the first such structure investigated in a Ti-based material. As such, this work is felt to be of great interest in aiding the design and manufacture of highly-biocompatible, porous, metallic biomaterials for orthopedic application. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Biesiekierski, Arne; Li, Yuncang; Muni, Khurram S.; Wen, Cuie] RMIT Univ, Sch Engn, Melbourne, Vic 3001, Australia.
   [Biesiekierski, Arne; Wen, Cuie] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
   [Ping, Dehai; Yamabe-Mitarai, Yoko] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
   [Lin, Jixing] Jilin Univ, Coll Mat Sci & Engn, Changchun 130025, Jilin, Peoples R China.
RP Wen, C (reprint author), RMIT Univ, Sch Engn, Melbourne, Vic 3001, Australia.; Wen, C (reprint author), Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
EM cuie.wen@rmit.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772; Munir, Khurram
   Shahzad/0000-0003-4761-4811
FU National Health and Medical Research Council (NHMRC), Australia
   [GNT1087290]
FX The authors acknowledge financial support for this research by the
   National Health and Medical Research Council (NHMRC), Australia, through
   grant GNT1087290, and additionally acknowledge the facility, and the
   scientific and technical assistance of RMIT University's Microscopy and
   Microanalysis facility.
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Abkowitz S., 2007, POTENTIAL TITANIUM T, P124
   Baker H., 1992, ASM HDB, V3
   Baldan A, 2002, J MATER SCI, V37, P2379, DOI 10.1023/A:1015408116016
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Biesiekierski A, 2012, ACTA BIOMATER, V8, P1661, DOI 10.1016/j.actbio.2012.01.018
   CAHN JW, 1962, ACTA METALL MATER, V10, P179, DOI 10.1016/0001-6160(62)90114-1
   CAHN JW, 1963, ACTA METALL MATER, V11, P1275
   CAHN JW, 1961, ACTA METALL MATER, V9, P795, DOI 10.1016/0001-6160(61)90182-1
   Capdevila C, 2016, ACTA MATER, V107, P27, DOI 10.1016/j.actamat.2016.01.039
   Collings E., 1994, TITANIUM ALLOYS
   Cui CY, 2009, J ALLOY COMPD, V471, P248, DOI 10.1016/j.jallcom.2008.03.057
   DAHLGREN SD, 1977, METALL TRANS A, V8, P347, DOI 10.1007/BF02661649
   Findik F, 2002, CAN METALL QUART, V41, P337
   FINDIK F, 1993, MATER SCI TECH SER, V9, P408, DOI 10.1179/mst.1993.9.5.408
   Findik F., 2013, PERIOD ENG NAT SCI, V1, P47
   Findik F, 2012, MATER DESIGN, V42, P131, DOI 10.1016/j.matdes.2012.05.039
   Gibson L. J., 1997, CELLULAR SOLIDS
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Hu QM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988270
   Kim MU, 2009, MET MATER INT, V15, P193, DOI 10.1007/s12540-009-0193-6
   Ko LM, 2016, J BONE JOINT SURG AM, V98, P1400, DOI 10.2106/JBJS.15.00914
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KUBO K, 1985, METALL TRANS B, V16, P359, DOI 10.1007/BF02679728
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Levashov EA, 2013, MAT SCI ENG A-STRUCT, V570, P51, DOI 10.1016/j.msea.2013.01.034
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Min XH, 2012, MATER SCI TECH-LOND, V28, P342, DOI 10.1179/1743284711Y.0000000052
   MOFFAT DL, 1988, METALL TRANS A, V19, P1687, DOI 10.1007/BF02645136
   Narayan R. J., 2012, MAT MED DEVICES
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Nishimoto SK, 2008, INT J ORAL MAX IMPL, V23, P675
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pelleg J., 2012, MECH PROPERTIES MAT
   Peradze T, 2006, INT J APPL ELECTROM, V23, P39
   Ping DH, 2014, ACTA METALL SIN-ENGL, V27, P1, DOI 10.1007/s40195-013-0014-2
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Robin A, 2012, INT J REFRACT MET H, V35, P90, DOI 10.1016/j.ijrmhm.2012.04.008
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Shackelford J F, 2001, CRC MAT SCI ENG HDB
   WELSCH G, 1982, METALL TRANS A, V13, P889, DOI 10.1007/BF02642403
   Yasi JA, 2010, ACTA MATER, V58, P5704, DOI 10.1016/j.actamat.2010.06.045
   Zheng X.H., 2016, SCRIPTA MATER, V68, P1008
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 48
TC 3
Z9 3
U1 5
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2017
VL 53
BP 549
EP 558
DI 10.1016/j.actbio.2017.01.085
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV3SJ
UT WOS:000401679100048
PM 28163238
DA 2018-10-20
ER

PT J
AU Nasirpouri, F
   Yousefi, I
   Moslehifard, E
   Khalil-Allafi, J
AF Nasirpouri, Farzad
   Yousefi, Iman
   Moslehifard, Elnaz
   Khalil-Allafi, Jafar
TI Tuning surface morphology and crystallinity of anodic TiO2 nanotubes and
   their response to biomimetic bone growth for implant applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE TiO2 nanotube; Anodising; Self-organizing; SBF
ID TITANIUM-OXIDE NANOTUBES; SIMULATED BODY-FLUID; HYDROXYAPATITE;
   ELECTROLYTES; APATITE; ARRAYS; BIOACTIVITY; FABRICATION; DEPOSITION;
   OXIDATION
AB The geometry and dimensions of TiO2 nanotubes anodised under different voltages and temperatures in an organic electrolyte were manipulated to investigate the morphological, crystalline microstrcture and their response to soaking in simulated body fluid (SBF) for biomaterial implant applications. It was observed that high anodisation voltages up to 120 V increase the internal pore diameter. Hexagonally arranged nanotubes were achieved by anodisation of Ti in a lower temperature of 0 degrees C, while the geometry of nanotubes becomes circular at a higher temperature of 30 degrees C. For biomaterial application in particular the bone cell/implant biomaterial interaction, we found that the nanotubes anodised at a voltage of 120 V and a temperature of 0 degrees C exhibited a better mineralisation than those obtained under other anodising conditions. This was mainly due to the rougher and sharper tube walls which provide more suitable places for the nucleation of bio-sediments. On the other hand, annealing of the nanotubes results in the formation of crystalline sediments the amount of which was decreased compared to the as-anodised nanotubes.(C) 2017 Elsevier B.V. All rights reserved.
C1 [Nasirpouri, Farzad; Yousefi, Iman; Khalil-Allafi, Jafar] Sahand Univ Technol, Fac Mat Engn, Tabriz, Iran.
   [Moslehifard, Elnaz] Tabriz Univ Med Sci, Dept Prosthodont, Fac Dent, Tabriz, Iran.
RP Moslehifard, E (reprint author), Tabriz Univ Med Sci, Dept Prosthodont, Fac Dent, Tabriz, Iran.
EM elnaz_moslehi@yahoo.com
CR Albu SP, 2008, ADV MATER, V20, P4135, DOI 10.1002/adma.200801189
   Albu SP, 2007, PHYS STATUS SOLIDI-R, V1, pR65, DOI 10.1002/pssr.200600069
   Allam NK, 2008, SOL ENERG MAT SOL C, V92, P1468, DOI 10.1016/j.solmat.2008.06.007
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Drnovsek N, 2012, SURF COAT TECH, V209, P177, DOI 10.1016/j.surfcoat.2012.08.037
   Elias CN, 2008, JOM-US, V60, P46, DOI 10.1007/s11837-008-0031-1
   Feng B, 2010, J POROUS MAT, V17, P453, DOI 10.1007/s10934-009-9307-2
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Grimes C. A., 2009, SYNTHESIS PROPERTIES
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kant K, 2009, PHYS STATUS SOLIDI-R, V3, P139, DOI 10.1002/pssr.200903087
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Kodama A, 2009, ACTA BIOMATER, V5, P2322, DOI 10.1016/j.actbio.2009.02.032
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Li MO, 2008, APPL SURF SCI, V255, P365, DOI 10.1016/j.apsusc.2008.06.108
   Liang YQ, 2010, CURR NANOSCI, V6, P256, DOI 10.2174/157341310791171144
   Ma QQ, 2008, MATER LETT, V62, P3035, DOI 10.1016/j.matlet.2008.01.121
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Macak JM, 2007, PHYS STATUS SOLIDI-R, V1, P181, DOI 10.1002/pssr.200701148
   Macak JM, 2006, ELECTROCHIM ACTA, V52, P1258, DOI 10.1016/j.electacta.2006.07.021
   Macak JM, 2005, ELECTROCHEM COMMUN, V7, P1133, DOI 10.1016/j.elecom.2005.08.013
   Mills A, 2003, J PHOTOCH PHOTOBIO A, V160, P185, DOI 10.1016/S1010-6030(03)00206-5
   Nasirpouri F, 2013, IONICS, V19, P535, DOI 10.1007/s11581-012-0774-0
   Neupane MP, 2012, MATER CHEM PHYS, V134, P536, DOI 10.1016/j.matchemphys.2012.03.029
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Paulose M, 2006, NANOTECHNOLOGY, V17, P398, DOI 10.1088/0957-4484/17/2/009
   Peighambardoust NS, 2013, SURF COAT TECH, V235, P727, DOI 10.1016/j.surfcoat.2013.08.058
   Raja KS, 2007, ELECTROCHEM COMMUN, V9, P1069, DOI 10.1016/j.elecom.2006.12.024
   Raja KS, 2005, MATER LETT, V59, P2137, DOI 10.1016/j.matlet.2005.01.084
   Rohanizadeh R, 2004, J BIOMED MATER RES A, V71A, P343, DOI 10.1002/jbm.a.30171
   Roy S. B. Poulomi, 2011, ANGEW CHEM INT EDIT, V50, P2904
   Ruan CM, 2005, J PHYS CHEM B, V109, P15754, DOI 10.1021/jp052736u
   Seunghan Oh., 2006, MAT SCI ENG C, V26, P1301
   Takadama H, 2001, SCI TECHNOL ADV MAT, V2, P389, DOI 10.1016/S1468-6996(01)00007-9
   Taveira LV, 2005, J ELECTROCHEM SOC, V152, pB405, DOI 10.1149/1.2008980
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yasuda K, 2007, ELECTROCHIM ACTA, V52, P4053, DOI 10.1016/j.electacta.2006.11.023
   Yu Wang, 2014, J BIOMED MATER RES A, V102, P743
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 48
TC 5
Z9 5
U1 2
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 15
PY 2017
VL 315
BP 163
EP 171
DI 10.1016/j.surfcoat.2017.02.006
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ES1DM
UT WOS:000399268100018
DA 2018-10-20
ER

PT J
AU Park, H
   Lee, HJ
   An, H
   Lee, KY
AF Park, Honghyun
   Lee, Hyun Ji
   An, Hyoseok
   Lee, Kuen Yong
TI Alginate hydrogels modified with low molecular weight hyaluronate for
   cartilage regeneration
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Alginate; Hyaluronate; Hydrogel; Cartilage; Tissue engineering
ID COLLAGEN GENE; S-100 PROTEIN; TISSUE; CHONDROCYTES; CD44; SOX9; ACID;
   DIFFERENTIATION; TRANSPLANTATION; MICROCAPSULES
AB Alginate is a typical biomaterial that forms hydrogels in the presence of calcium ions and has often been utilized in tissue engineering approaches. However, it lacks biofunctionality in the form of interactions with cells and proteins. Hyaluronate, a main component of glycosaminoglycans, provides CD44-specific interactions with chondrocytes but typically requires chemical cross-linking agents to fabricate hydro gels, which may cause unexpected side effects in the body. In this study, we propose the design and fabrication of a hybrid structure of alginate and hyaluronate useful for cartilage regeneration. Alginate was used as a backbone, and hyaluronate with a low molecular weight was introduced to the backbone to fabricate alginate-hyaluronate hybrid coupled by ethylenediamine. We hypothesized that alginate-hyaluronate hybrid (AH) could maintain its ability to form gels in the presence of calcium ions and could be useful for cartilage regeneration as an injectable system. Characteristics of AH hydrogels containing various composition ratios of hyaluronate to alginate were investigated, and the chondrogenic potential of ATDC5 cells encapsulated within AH hydrogels was evaluated in vitro. Consequently, AH hydrogels having a defined polymer composition and mechanical stiffness were useful to successfully regulate chondrogenic differentiation and to maintain the chondrocytic cell phenotype, which may lead to many useful applications in cartilage regeneration. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Park, Honghyun; Lee, Hyun Ji; An, Hyoseok; Lee, Kuen Yong] Hanyang Univ, Dept Bioengn, 222 Wangsimni Ro, Seoul 04763, South Korea.
   [Lee, Kuen Yong] Hanyang Univ, Inst Nanosci & Technol, Seoul 04763, South Korea.
RP Lee, KY (reprint author), Hanyang Univ, Dept Bioengn, 222 Wangsimni Ro, Seoul 04763, South Korea.
EM leeky@hanyang.ac.kr
OI Lee, Kuen Yong/0000-0002-5759-5952
FU Commercializations Promotion Agency for R&D Outcomes (COMPA) - Ministry
   of Science, ICT, & Future Planning [2016K000144]
FX This research was supported by the Commercializations Promotion Agency
   for R&D Outcomes (COMPA) funded by the Ministry of Science, ICT, &
   Future Planning (2016K000144).
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   LaPrade RF, 2004, ARTHROSCOPY, V20, DOI 10.1016/j.arthro.2004.06.022
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Park H, 2014, J CONTROL RELEASE, V196, P146, DOI 10.1016/j.jconrel.2014.10.008
   Park H, 2011, CARBOHYD POLYM, V86, P1107, DOI 10.1016/j.carbpol.2011.05.032
   Park H, 2009, MACROMOL BIOSCI, V9, P895, DOI 10.1002/mabi.200800376
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   STEFANSSON K, 1982, NATURE, V295, P63, DOI 10.1038/295063a0
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Tatman PD, 2015, TISSUE ENG PART B-RE, V21, P543, DOI [10.1089/ten.teb.2015.0142, 10.1089/ten.TEB.2015.0142]
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   Wirth CJ, 1996, ARTHROSCOPY, V12, P300, DOI 10.1016/S0749-8063(96)90062-6
   WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106
   Woo E, 2014, MACROMOL BIOSCI, V14, P740, DOI 10.1002/mabi.201300365
NR 37
TC 14
Z9 14
U1 3
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 15
PY 2017
VL 162
BP 100
EP 107
DI 10.1016/j.carbpol.2017.01.045
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA EP4UZ
UT WOS:000397376700013
PM 28224886
DA 2018-10-20
ER

PT J
AU Lin, DJ
   Hung, FY
   Jakfar, S
   Yeh, ML
AF Lin, Da-Jun
   Hung, Fei-Yi
   Jakfar, Subhaini
   Yeh, Ming-Long
TI Corrigendum to "Tailored coating chemistry and interfacial properties
   for construction of bioactive ceramic coatings on magnesium biomaterial"
   (Vol 89, pg 235, 2016)
SO MATERIALS & DESIGN
LA English
DT Correction
C1 [Lin, Da-Jun; Hung, Fei-Yi] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
   [Jakfar, Subhaini; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Jakfar, Subhaini] Syiah Kuala Univ, Fac Dent, Dept Dent Mat, Darussalam, Indonesia.
   [Hung, Fei-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
RP Hung, FY (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.; Yeh, ML (reprint author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.; Yeh, ML (reprint author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
EM fyhung@mail.ncku.edu.tw; mlyeh@mail.ncku.edu.tw
CR Lin DJ, 2016, MATER DESIGN, V89, P235, DOI 10.1016/j.matdes.2015.09.144
NR 1
TC 0
Z9 0
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-1275
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD APR 15
PY 2017
VL 120
BP 404
EP 405
DI 10.1016/j.matdes.2017.02.050
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA EP4QM
UT WOS:000397365000042
DA 2018-10-20
ER

PT J
AU de Oliveira, JP
   Bruni, GP
   Lima, KO
   El Halal, SLM
   da Rosa, GS
   Dias, ARG
   Zavareze, ED
AF de Oliveira, Jean Paulo
   Bruni, Graziella Pinheiro
   Lima, Karina Oliveira
   Lisie Mello El Halal, Shanise
   da Rosa, Gabriela Silveira
   Guerra Dias, Alvaro Renato
   Zavareze, Elessandra da Rosa
TI Cellulose fibers extracted from rice and oat husks and their application
   in hydrogel
SO FOOD CHEMISTRY
LA English
DT Article
DE Cellulose; Fibers; Hydrogel; Oat; Rice
ID VINEYARD PRUNING WASTE; POLY(VINYL ALCOHOL); LIGNOCELLULOSIC FIBERS;
   THERMAL-DECOMPOSITION; MECHANICAL-PROPERTIES; CRYSTALLITE SIZE; DYE
   REMOVAL; NANOFIBERS; NANOCELLULOSE; PULP
AB The commercial cellulose fibers and cellulose fibers extracted from rice and oat husks were analyzed by chemical composition, morphology, functional groups, crystallinity and thermal properties. The cellulose fibers from rice and oat husks were used to produce hydrogels with poly (vinyl alcohol). The fibers presented different structural, crystallinity, and thermal properties, depending on the cellulose source. The hydrogel from rice cellulose fibers had a network structure with a similar agglomeration sponge, with more homogeneous pores compared to the hydrogel from oat cellulose fibers. The hydrogels prepared from the cellulose extracted from rice and oat husks showed water absorption capacity of 141.6-392.1% and high opacity. The highest water absorption capacity and maximum stress the compression were presented by rice cellulose hydrogel at 25 degrees C. These results show that the use of agro-industrial residues is promising for the biomaterial field, especially in the preparation of hydrogels. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [de Oliveira, Jean Paulo; Bruni, Graziella Pinheiro; Lisie Mello El Halal, Shanise; Guerra Dias, Alvaro Renato; Zavareze, Elessandra da Rosa] Univ Fed Pelotas, Dept Agroind Sci & Technol, BR-96010900 Pelotas, Brazil.
   [Lima, Karina Oliveira] Fed Univ Rio Grande, Coll Chem & Food Engn, BR-96201900 Rio Grande, Brazil.
   [da Rosa, Gabriela Silveira] Fed Univ Pampa, Dept Chem Engn, BR-96413170 Bage, Brazil.
RP Zavareze, ED (reprint author), Univ Fed Pelotas, Dept Agroind Sci & Technol, BR-96010900 Pelotas, Brazil.
EM jeanoliveira.alimentos@yahoo.com.br; graziellabruni@yahoo.com.br;
   karinah_ol@hotmail.com; shanisemell@hotmail.com; gabysrosa@gmail.com;
   alvaro.guerradias@gmail.com; elessandrad@yahoo.com.br
OI Oliveira Lima, Karina/0000-0001-5834-957X
CR Abe K, 2011, CARBOHYD POLYM, V85, P733, DOI 10.1016/j.carbpol.2011.03.028
   Abraham E, 2011, CARBOHYD POLYM, V86, P1468, DOI 10.1016/j.carbpol.2011.06.034
   Ahrem H, 2014, ACTA BIOMATER, V10, P1341, DOI 10.1016/j.actbio.2013.12.004
   Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   AOAC, 2006, OFFICIAL METHODS ANA
   Brasileiro LB, 2001, QUIM NOVA, V24, P819, DOI 10.1590/S0100-40422001000600020
   Buyanov AL, 2013, POLYM SCI SER A+, V55, P302, DOI 10.1134/S0965545X13050027
   Chandrasekhar S, 2003, J MATER SCI, V38, P3159, DOI 10.1023/A:1025157114800
   Chang CY, 2010, CARBOHYD POLYM, V82, P122, DOI 10.1016/j.carbpol.2010.04.033
   Chang YW, 2007, POLYM ADVAN TECHNOL, V18, P535, DOI 10.1002/pat.913
   Demitri C, 2013, INT J POLYM SCI, DOI 10.1155/2013/435073
   Food and Agriculture Organization of the United Nations-FAO, 2011, STAT DIV
   Food and Agriculture Organization of the United Nations-FAO, 2013, STAT DIV
   Fuqua MA, 2012, POLYM REV, V52, P259, DOI 10.1080/15583724.2012.705409
   Guerrini Lilia M., 2006, Polímeros, V16, P286, DOI 10.1590/S0104-14282006000400007
   Hacker MC, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P587, DOI 10.1016/B978-0-12-381422-7.10033-1
   Halal S. L. M., 2015, CARBOHYD POLYM, V133, P644
   Hassan ML, 2010, WOOD FIBER SCI, V42, P362
   Hebeish A, 2014, CARBOHYD POLYM, V102, P159, DOI 10.1016/j.carbpol.2013.10.054
   Holland BJ, 2001, POLYMER, V42, P6775, DOI 10.1016/S0032-3861(01)00166-5
   Johar N, 2012, BIORESOURCES, V7, P5469
   Johar N, 2012, IND CROP PROD, V37, P93, DOI 10.1016/j.indcrop.2011.12.016
   John MJ, 2008, CARBOHYD POLYM, V71, P343, DOI 10.1016/j.carbpol.2007.05.040
   Kayalvizhy E, 2016, INT J BIOL MACROMOL, V86, P721, DOI 10.1016/j.ijbiomac.2016.01.047
   Kim UJ, 2010, POLYM DEGRAD STABIL, V95, P778, DOI 10.1016/j.polymdegradstab.2010.02.009
   Liu DG, 2013, CELLULOSE, V20, P2981, DOI 10.1007/s10570-013-0073-6
   Mandal A, 2014, J IND ENG CHEM, V20, P462, DOI 10.1016/j.jiec.2013.05.003
   Poletto M, 2012, BIORESOURCE TECHNOL, V109, P148, DOI 10.1016/j.biortech.2011.11.122
   Rabek J., 1980, EXPT METHODS POLYM C
   Rosa SML, 2012, CARBOHYD POLYM, V87, P1131, DOI 10.1016/j.carbpol.2011.08.084
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Silva R, 2009, QUIM NOVA, V32, P661, DOI 10.1590/S0100-40422009000300010
   TAPPI, 1991, T13M54 TAPPI
   TAPPI, 1954, T19M54 TAPPI
   Thomas PS, 2001, J THERM ANAL CALORIM, V64, P501, DOI 10.1023/A:1011578514047
   Tibolla H, 2014, LWT-FOOD SCI TECHNOL, V59, P1311, DOI 10.1016/j.lwt.2014.04.011
   Vecino X, 2015, CARBOHYD POLYM, V115, P129, DOI 10.1016/j.carbpol.2014.08.088
   Vecino X, 2015, J ENVIRON SCI-CHINA, V38, P158, DOI 10.1016/j.jes.2015.05.032
   Vila C, 2011, BIORESOURCE TECHNOL, V102, P6554, DOI 10.1016/j.biortech.2011.03.068
   Wang J, 2013, CARBOHYD POLYM, V94, P749, DOI 10.1016/j.carbpol.2013.01.036
   Zhang XF, 2014, CARBOHYD POLYM, V114, P166, DOI 10.1016/j.carbpol.2014.08.012
   Zuluaga R, 2009, CARBOHYD POLYM, V76, P51, DOI 10.1016/j.carbpol.2008.09.024
NR 42
TC 9
Z9 10
U1 6
U2 182
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD APR 15
PY 2017
VL 221
BP 153
EP 160
DI 10.1016/j.foodchem.2016.10.048
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA EE8XD
UT WOS:000389909100022
PM 27979125
DA 2018-10-20
ER

PT J
AU Park, SH
   Kang, BK
   Lee, JE
   Chun, SW
   Jang, K
   Kim, YH
   Jeong, MA
   Kim, Y
   Kang, K
   Lee, NK
   Choi, D
   Kim, HJ
AF Park, Suk-Hee
   Kang, Bo-Kyeong
   Lee, Ji Eun
   Chun, Seung Woo
   Jang, Kiseok
   Kim, Youn Hwan
   Jeong, Mi Ae
   Kim, Yohan
   Kang, Kyojin
   Lee, Nak Kyu
   Choi, Dongho
   Kim, Han Joon
TI Design and Fabrication of a Thin-Walled Free-Form Scaffold on the Basis
   of Medical Image Data and a 3D Printed Template: Its Potential Use in
   Bile Duct Regeneration
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE 3D printing; dip coating; medical imaging; customized scaffold; bile
   duct reconstruction
ID RAPID PROTOTYPING TECHNIQUES; TISSUE; DEPOSITION; POLYMER;
   STEREOLITHOGRAPHY
AB Three-dimensional (3D) printing, combined with medical imaging technologies, such as computed tomography and magnetic resonance imaging (MRI), has shown a great potential in patient-specific tissue regeneration. Here, we successfully fabricated an ultrathin tubular free-form structure with a wall thickness of several tens of micrometers that is capable of providing sufficient mechanical flexibility. Such a thin geometry cannot easily be achieved by 3D printing alone; therefore, it was realized through a serial combination of processes, including the 3D printing of a sacrificial template, the dip coating of the biomaterial, and the removal of the inner template. We demonstrated the feasibility of this novel tissue engineering construct by conducting bile duct surgery on rabbits. Moving from a rational design based on MRI data to a successful surgical procedure for reconstruction, we confirmed that the presented method of fabricating scaffolds has the potential for use in customized bile duct regeneration. In addition to the specific application presented here, the developed process and scaffold are expected to have universal applicability in other soft-tissue engineering fields, particularly those involving vascular, airway, and abdominal tubular tissues.
C1 [Park, Suk-Hee; Lee, Ji Eun; Chun, Seung Woo; Lee, Nak Kyu] Korea Inst Ind Technol, Micro Nano Scale Mfg R&D Grp, Ansan 426910, Gyeonggi Do, South Korea.
   [Kang, Bo-Kyeong] Hanyang Univ, Coll Med, Dept Radiol, 222 Wangsimri Ro, Seoul 04763, South Korea.
   [Jang, Kiseok] Hanyang Univ, Coll Med, Dept Pathol, 222 Wangsimri Ro, Seoul 04763, South Korea.
   [Kim, Youn Hwan] Hanyang Univ, Coll Med, Dept Plast & Reconstruct Surg, 222 Wangsimri Ro, Seoul 04763, South Korea.
   [Jeong, Mi Ae] Hanyang Univ, Coll Med, Dept Anesthesiol & Pain Med, 222 Wangsimri Ro, Seoul 04763, South Korea.
   [Kim, Yohan; Kang, Kyojin; Choi, Dongho; Kim, Han Joon] Hanyang Univ, Coll Med, Dept Surg, 222 Wangsimri Ro, Seoul 04763, South Korea.
RP Choi, D; Kim, HJ (reprint author), Hanyang Univ, Coll Med, Dept Surg, 222 Wangsimri Ro, Seoul 04763, South Korea.
EM crane87@hanyang.ac.kr; thicknyh@gmail.com
FU Industrial Fundamental Technology Development - Ministry of Trade,
   Industry and Energy (MOTIE) of Korea [10051680]; KITECH (Korea Institute
   of Industrial Technology); Technology Innovation Program or Industrial
   Strategic Technology Development Program - MOTIE [10063334]
FX This work was supported by the Industrial Fundamental Technology
   Development Program funded by the Ministry of Trade, Industry and Energy
   (MOTIE) of Korea (10051680, Development of high strength and
   environmental friendly polymer for 3D printing), a KITECH (Korea
   Institute of Industrial Technology) internal project, and the Technology
   Innovation Program or Industrial Strategic Technology Development
   Program (10063334, Vascularized 3D tissue (liver/heart, cancer) chip for
   evaluation of drug efficacy and toxicity) funded by the MOTIE.
CR Aikawa M, 2012, J GASTROINTEST SURG, V16, P529, DOI 10.1007/s11605-011-1801-6
   Aikawa M, 2010, SURGERY, V147, P575, DOI 10.1016/j.surg.2009.10.049
   Azam A, 2011, BIOMED MICRODEVICES, V13, P51, DOI 10.1007/s10544-010-9470-x
   Bassik N, 2008, ADV MATER, V20, P4760, DOI 10.1002/adma.200801759
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Dai KR, 2007, J ARTHROPLASTY, V22, P981, DOI 10.1016/j.arth.2007.05.002
   Giacomo G., 2005, J PERIODONTOL, V76, P503
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUNT DR, 1989, GASTROENTEROLOGY, V97, P1485, DOI 10.1016/0016-5085(89)90393-4
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Kang TY, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015007
   Kim HN, 2012, ANN BIOMED ENG, V40, P1339, DOI 10.1007/s10439-012-0510-y
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Li Q, 2012, BIOMATERIALS, V33, P4298, DOI 10.1016/j.biomaterials.2012.03.003
   McGurk M, 1997, ANN ROY COLL SURG, V79, P169
   MEULENBROEK B, 2003, PHYS REV LETT, V90
   Miyazawa M, 2005, AM J TRANSPLANT, V5, P1541, DOI 10.1111/j.1600-6143.2005.00845.x
   Miyazawa M, 2012, J ARTIF ORGANS, V15, P26, DOI 10.1007/s10047-011-0590-8
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Pati F, 2016, ANGEW CHEM INT EDIT, V55, P4650, DOI 10.1002/anie.201505062
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Thrimurthulu K, 2004, INT J MACH TOOL MANU, V44, P585, DOI 10.1016/j.ijmachtools.2003.12.004
   Tocchi A, 2001, ANN SURG, V234, P210, DOI 10.1097/00000658-200108000-00011
   Trachtenberg JE, 2014, J BIOMED MATER RES A, V102, P4326, DOI 10.1002/jbm.a.35108
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Wang S, 2005, ADV MATER, V17, P1182, DOI 10.1002/adma.200401117
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yimsiri P, 2006, CHEM ENG SCI, V61, P3496, DOI 10.1016/j.ces.2005.12.018
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zong C., 2015, J TISSUE ENG REGEN M, V3, P579
NR 34
TC 3
Z9 3
U1 2
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 12
PY 2017
VL 9
IS 14
BP 12290
EP 12298
DI 10.1021/acsami.7b00849
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA ES2JJ
UT WOS:000399354100015
PM 28322040
DA 2018-10-20
ER

PT J
AU Baumann, B
   Jungst, T
   Stichler, S
   Feineis, S
   Wiltschka, O
   Kuhlmann, M
   Linden, M
   Groll, J
AF Baumann, Bernhard
   Jungst, Tomasz
   Stichler, Simone
   Feineis, Susanne
   Wiltschka, Oliver
   Kuhlmann, Matthias
   Linden, Mika
   Groll, Juergen
TI Control of Nanoparticle Release Kinetics from 3D Printed Hydrogel
   Scaffolds
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biofabrication; charge interaction; controlled release; gold
   nanoparticles; mesoporous silica nanoparticles
ID SILICA NANOPARTICLES; CANCER-CELLS; CONSTRUCTS; TISSUES
AB The convergence of biofabrication with nanotechnology is largely unexplored but enables geometrical control of cell-biomaterial arrangement combined with controlled drug delivery and release. As a step towards integration of these two fields of research, this study demonstrates that modulation of electrostatic nanoparticle-polymer and nanoparticle-nanoparticle interactions can be used for tuning nanoparticle release kinetics from 3D printed hydrogel scaffolds. This generic strategy can be used for spatiotemporal control of the release kinetics of nanoparticulate drug vectors in biofabricated constructs.
C1 [Baumann, Bernhard; Wiltschka, Oliver; Linden, Mika] Univ Ulm, Inst Inorgan Chem 2, Albert Einstein Allee 11, D-89081 Ulm, Germany.
   [Jungst, Tomasz; Stichler, Simone; Feineis, Susanne; Kuhlmann, Matthias; Groll, Juergen] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Jungst, Tomasz; Stichler, Simone; Feineis, Susanne; Kuhlmann, Matthias; Groll, Juergen] Univ Wurzburg, BPI, D-97070 Wurzburg, Germany.
RP Linden, M (reprint author), Univ Ulm, Inst Inorgan Chem 2, Albert Einstein Allee 11, D-89081 Ulm, Germany.; Groll, J (reprint author), Univ Wurzburg, BPI, D-97070 Wurzburg, Germany.
EM mika.linden@uni-ulm.de; juergen.groll@fmz.uni-wuerzburg.de
RI Groll, Jurgen/F-4202-2012
OI Groll, Jurgen/0000-0003-3167-8466
FU European Community's 7th Framework Programme [309962]; European Research
   Council [617989]
FX This work was financially supported by the European Community's 7th
   Framework Programme under grant agreement 309962 (HydroZONES) and the
   European Research Council under grant agreement 617989 (Design2Heal).
   The biological division at ILM Ulm and the department for tissue
   engineering and regenerative medicine at the University of Wurzburg are
   thanked for providing access to the confocal laser microscopes and for
   excellent technical assistance. We thank Daimon Hall (CGI,
   carbonandneon.com) for support with the illustrations.
CR [Anonymous], 2015, ANGEW CHEM, V127, P2858
   [Anonymous], 2013, ANGEW CHEM, V125, P1194
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Bocking D, 2014, NANOSCALE, V6, P1490, DOI 10.1039/c3nr04022d
   Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006
   Colosi C, 2016, ADV MATER, V28, P677, DOI 10.1002/adma.201503310
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Groll J, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/013001
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Jungst T, 2016, CHEM REV, V116, P1496, DOI 10.1021/acs.chemrev.5b00303
   Kehr NS, 2013, ANGEW CHEM INT EDIT, V52, P1156, DOI 10.1002/anie.201206951
   Malda J., 2013, ADV MATER, V25, P581
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r
   Rosenholm JM, 2016, NANOMEDICINE-UK, V11, P391, DOI 10.2217/nnm.15.212
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Shokry H, 2015, NANOSCALE, V7, P14434, DOI 10.1039/c5nr03983e
   Silveira CP, 2016, ACS BIOMATER SCI ENG, V2, P1190, DOI 10.1021/acsbiomaterials.6b00241
   Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943
   Stichler S, 2017, ANN BIOMED ENG, V45, P273, DOI 10.1007/s10439-016-1633-3
   von Haartman E, 2016, EUR J PHARM SCI, V95, P17, DOI 10.1016/j.ejps.2016.06.001
   Zehnder T, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/2/025001
NR 22
TC 13
Z9 13
U1 17
U2 107
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD APR 10
PY 2017
VL 56
IS 16
BP 4623
EP 4628
DI 10.1002/ange.201700153
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA EQ5WP
UT WOS:000398154000041
PM 28328084
OA Other Gold
DA 2018-10-20
ER

PT J
AU Long, J
   Kim, H
   Kim, D
   Lee, JB
   Kim, DH
AF Long, Joseph
   Kim, Hyejin
   Kim, Dajeong
   Lee, Jong Bum
   Kim, Deok-Ho
TI A biomaterial approach to cell reprogramming and differentiation
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; NANOPARTICLE-MEDIATED DELIVERY; SUBSTRATE
   STIFFNESS; MESSENGER-RNA; GENE DELIVERY; IPS CELLS; IN-VITRO; TISSUE
   REGENERATION; TOPOGRAPHICAL CUES; GOLD NANOPARTICLES
AB The cell reprogramming of somatic cells into pluripotent states and subsequent differentiation into certain phenotypes has helped progress regenerative medicine research and other medical applications. Recent research has used viral vectors to induce this reprogramming; however, limitations include low efficiency and safety concerns. In this review, we discuss how biomaterial methods offer potential avenues for either increasing viability and downstream applicability of viral methods, or providing a safer alternative. The use of non-viral delivery systems, such as electroporation, micro/nanoparticles, nucleic acids and the modulation of culture substrate topography and stiffness, has generated valuable insights regarding cell reprogramming.
C1 [Long, Joseph; Kim, Deok-Ho] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Long, Joseph; Kim, Deok-Ho] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98109 USA.
   [Kim, Hyejin; Kim, Dajeong; Lee, Jong Bum] Univ Seoul, Dept Chem Engn, Seoul 02504, South Korea.
RP Kim, DH (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Kim, DH (reprint author), Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98109 USA.; Lee, JB (reprint author), Univ Seoul, Dept Chem Engn, Seoul 02504, South Korea.
EM jblee@uos.ac.kr; deokho@uw.edu
RI Long, Joseph/R-6100-2016; Kim, Hyejin/K-8782-2018
OI Long, Joseph/0000-0002-9531-7232; Kim, Hyejin/0000-0002-7937-2733; Kim,
   Deok-Ho/0000-0002-6989-6074; Lee, Jong Bum/0000-0002-8319-5055
FU National Institute of Health [R21EB02013201, R01HL135143,
   R01NS09438801]; Bio & Medical Technology Development Program of the
   National Research Foundation of Korea (NRF) - Korean Government
   [NRF2016M3A9C6917402]
FX This work was supported by the National Institute of Health
   R21EB02013201, R01HL135143, and R01NS09438801 (to D.-H. K.). This work
   was also supported by the Bio & Medical Technology Development Program
   of the National Research Foundation of Korea (NRF) funded by the Korean
   Government (NRF2016M3A9C6917402).
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Ali MY, 2014, SOFT MATTER, V10, P8829, DOI 10.1039/c4sm01602e
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Anderson Hilary J., 2016, Frontiers in Bioengineering and Biotechnology, V4, P38, DOI 10.3389/fbioe.2016.00038
   Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884
   Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Boroujeni SM, 2016, J BIOMED MATER RES A, V104, P1610, DOI 10.1002/jbm.a.35686
   Caiazzo M, 2016, NAT MATER, V15, P344, DOI [10.1038/NMAT4536, 10.1038/nmat4536]
   Cao X, 2013, ADV FUNCT MATER, V23, P5403, DOI 10.1002/adfm.201203646
   Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862
   Carson D, 2016, ACS APPL MATER INTER, V8, P21923, DOI 10.1021/acsami.5b11671
   Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264
   Chen W, 2013, ACS NANO, V7, P8423, DOI 10.1021/nn401418n
   Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561
   Choi B, 2016, MACROMOL BIOSCI, V16, P199, DOI 10.1002/mabi.201500273
   Coombs KE, 2017, J BIOMED MATER RES A, V105, P51, DOI 10.1002/jbm.a.35864
   Deng WW, 2015, ACS APPL MATER INTER, V7, P18957, DOI 10.1021/acsami.5b06768
   Deng XY, 2015, CURR STEM CELL RES T, V10, P153, DOI 10.2174/1574888X09666140923101914
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Drews K, 2012, BIOMATERIALS, V33, P4059, DOI 10.1016/j.biomaterials.2012.02.025
   Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164
   Engler A. J, 2014, NAT MATER, V13, p[547, 756]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gu SR, 2017, J BIOSCI BIOENG, V123, P252, DOI 10.1016/j.jbiosc.2016.07.020
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111
   Higuchi A, 2017, PROG POLYM SCI, V65, P83, DOI 10.1016/j.progpolymsci.2016.09.002
   Higuchi A, 2015, J MATER CHEM B, V3, P8032, DOI 10.1039/c5tb01276g
   Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi S, 2014, J BIOSCI BIOENG, V117, P749, DOI 10.1016/j.jbiosc.2013.11.011
   Hubbi K. M. E., 2012, SCI SIGNAL, V5
   Hussein SMI, 2015, NATURE, V523, P626, DOI 10.1038/nature14606
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x
   Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035
   Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]
   Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043
   Khan M, 2013, BIOMATERIALS, V34, P5336, DOI 10.1016/j.biomaterials.2013.03.072
   Kim J, 2014, BIOMATERIALS, V35, P9058, DOI 10.1016/j.biomaterials.2014.07.036
   Kim JH, 2016, ACS NANO, V10, P3342, DOI 10.1021/acsnano.5b06985
   Klymov A, 2015, ACTA BIOMATER, V16, P117, DOI 10.1016/j.actbio.2015.01.016
   Kong LD, 2015, ACS APPL MATER INTER, V7, P4833, DOI 10.1021/am508760w
   Kulangara K, 2014, BIOMATERIALS, V35, P5327, DOI 10.1016/j.biomaterials.2014.03.034
   Lee CH, 2011, BIOMATERIALS, V32, P6683, DOI 10.1016/j.biomaterials.2011.05.070
   Lee ES, 2016, J BIOMED MATER RES B, V104, P686, DOI 10.1002/jbm.b.33601
   Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170
   Li JJ, 2015, BIOMATERIALS, V54, P226, DOI 10.1016/j.biomaterials.2015.03.001
   Liang X, 2016, STEM CELL TRANSL MED, V5, P960, DOI 10.5966/sctm.2015-0274
   Lim H, 2013, BIOMACROMOLECULES, V14, P240, DOI 10.1021/bm301669e
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Macadangdang J, 2015, CELL MOL BIOENG, V8, P320, DOI 10.1007/s12195-015-0413-8
   Macri-Pellizzeri L, 2015, TISSUE ENG PT A, V21, P1633, DOI [10.1089/ten.tea.2014.0251, 10.1089/ten.TEA.2014.0251]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Mengsteab PY, 2016, BIOMATERIALS, V86, P1, DOI 10.1016/j.biomaterials.2016.01.062
   Morez C, 2015, BIOMATERIALS, V70, P94, DOI 10.1016/j.biomaterials.2015.07.063
   Muthiah M, 2013, EXPERT OPIN DRUG DEL, V10, P1259, DOI 10.1517/17425247.2013.798640
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466
   O'Doherty R, 2013, BIOMED RES INT, DOI 10.1155/2013/705902
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250
   Park S, 2015, J BIOMED MATER RES A, V103, P1238, DOI 10.1002/jbm.a.35236
   Patel S, 2015, ANGEW CHEM INT EDIT, V54, P11983, DOI 10.1002/anie.201504902
   Peng CH, 2011, BIOMATERIALS, V32, P9077, DOI 10.1016/j.biomaterials.2011.08.008
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Pioner JM, 2016, STEM CELL REP, V6, P885, DOI 10.1016/j.stemcr.2016.04.006
   Plews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014397
   Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382
   Qin TW, 2015, BIOMATERIALS, V51, P43, DOI 10.1016/j.biomaterials.2015.01.070
   Rippon HJ, 2004, CELL PROLIFERAT, V37, P23, DOI 10.1111/j.1365-2184.2004.00298.x
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Sciancalepore AG, 2016, BIOMATERIALS, V94, P57, DOI 10.1016/j.biomaterials.2016.03.042
   Sia JR, 2016, BIOMATERIALS, V103, P1, DOI 10.1016/j.biomaterials.2016.06.034
   Smith AST, 2017, BIOTECHNOL ADV, V35, P77, DOI 10.1016/j.biotechadv.2016.12.002
   Smith AST, 2016, DRUG DISCOV TODAY, V21, P1387, DOI 10.1016/j.drudis.2016.04.013
   Smith AW, 2013, BIOMATERIALS, V34, P6559, DOI 10.1016/j.biomaterials.2013.05.050
   Sohn YD, 2013, BIOMATERIALS, V34, P4235, DOI 10.1016/j.biomaterials.2013.02.005
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Su GN, 2013, BIOMATERIALS, V34, P3215, DOI 10.1016/j.biomaterials.2013.01.044
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tammam S, 2016, ONCOTARGET, V7, P37728, DOI 10.18632/oncotarget.9276
   Tanabe S, 2015, WORLD J STEM CELLS, V7, P992, DOI 10.4252/wjsc.v7.i7.992
   Tavernier G, 2012, BIOMATERIALS, V33, P412, DOI 10.1016/j.biomaterials.2011.09.062
   Tong ZX, 2015, EMBO J, V34, P987, DOI 10.15252/embj.201490756
   Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Uto K, 2017, PROG POLYM SCI, V65, P53, DOI 10.1016/j.progpolymsci.2016.09.004
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vertelov G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33411
   Wang L, 2015, ACS APPL MATER INTER, V7, P15088, DOI 10.1021/acsami.5b04450
   Wang Q, 2016, BIOTECHNOL BIOENG, V113, P2191, DOI 10.1002/bit.25981
   Wang ZY, 2014, J BIOMED MATER RES A, V102, P2197, DOI 10.1002/jbm.a.34899
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Wasik AM, 2014, INT REV CEL MOL BIO, V308, P167, DOI 10.1016/B978-0-12-800097-7.00005-1
   Williford JM, 2014, ANNU REV BIOMED ENG, V16, P347, DOI 10.1146/annurev-bioeng-071813-105119
   Wu SM, 2011, NAT CELL BIOL, V13, P734, DOI 10.1038/ncb0611-734b
   Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016
   Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622
   Ye K, 2015, NANO LETT, V15, P4720, DOI 10.1021/acs.nanolett.5b01619
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yoo J, 2015, BIOMATERIALS, V45, P36, DOI 10.1016/j.biomaterials.2014.12.049
   Yoo J, 2014, BIOMATERIALS, V35, P8321, DOI 10.1016/j.biomaterials.2014.05.096
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan HH, 2016, ACTA BIOMATER, V42, P247, DOI 10.1016/j.actbio.2016.06.034
   Zhang DH, 2015, BIOSCIENCE, V65, P468, DOI 10.1093/biosci/biv016
   Zhao W, 2014, MAT SCI ENG C-MATER, V40, P316, DOI 10.1016/j.msec.2014.03.048
NR 109
TC 0
Z9 0
U1 10
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD APR 7
PY 2017
VL 5
IS 13
BP 2375
EP 2389
DI 10.1039/c6tb03130g
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA EQ3HH
UT WOS:000397961800001
PM 28966790
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chen, JJ
   Zhu, YC
   Song, YC
   Wang, L
   Zhan, JZ
   He, JC
   Zheng, J
   Zhong, CT
   Shi, XT
   Liu, S
   Ren, L
   Wang, YJ
AF Chen, Junjian
   Zhu, Yuchen
   Song, Yancheng
   Wang, Lin
   Zhan, Jiezhao
   He, Jingcai
   Zheng, Jian
   Zhong, Chunting
   Shi, Xuetao
   Liu, Sa
   Ren, Li
   Wang, Yingjun
TI Preparation of an antimicrobial surface by direct assembly of
   antimicrobial peptide with its surface binding activity
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; IMPLANT-ASSOCIATED INFECTIONS; SILVER
   NANOPARTICLES; CALCIUM-PHOSPHATE; BACTERIAL ADHESION;
   CONTROLLED-RELEASE; IN-VIVO; TITANIUM; BONE; TOXICITY
AB Antimicrobial peptides (AMPs) are a broad prospect for clinical application against bacterial infections of biomaterials. However, a bottleneck exists as there is a lack of simple technology to prepare AMPs on biomaterials with sufficient activity, as the activity of AMP is dependent on the correct orientation on the biomaterial. In the present study, based on the conventional AMP (Tet213: KRWWKWWRRC) and surface binding peptide (SKHKGGKHKGGKHKG), we designed an Anchor-AMP that could be directly assembled onto the surface of the biomaterial and also showed excellent antimicrobial activity. By characterizing the surface using a quartz crystal microbalance with dissipation (QCM-D), contact angle, atom force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS), we found that Anchor-AMP could adsorb onto the titanium surface with a strong affinity. Different from Tet213 peptide, Anchor-AMP exhibits excellent antimicrobial activity on the titanium surface being able to inhibit 95.33% of Escherichia coli and 96.67% of Staphylococcus aureus after 2.5 h. The improved antimicrobial activity is a result of improved orientation of Anchor-AMP on the biomaterial compared to that of the Tet213 peptide. In addition, the antimicrobial activity of Anchor-AMP was active for more than 24 h. The CCK-8 assay illustrated that the modified titanium surface showed negligible cytotoxicity to bone marrow mesenchymal stem cells. The in vivo results showed that it exhibited excellent antimicrobial activity after 5 and 7 days, inhibiting 89.32% and 99.78% of S. aureus, respectively. We also demonstrated that Anchor-AMP could be applied on a variety of surfaces including gold (Au), polymethyl methacrylate (PMMA) and hydroxyapatite (HA) with strong affinity and good antimicrobial activity.
C1 [Chen, Junjian; Shi, Xuetao; Wang, Yingjun] South China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Zhu, Yuchen; Zhan, Jiezhao; Zheng, Jian; Liu, Sa; Ren, Li] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
   [Song, Yancheng] Southern Med Univ, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
   [Wang, Lin; He, Jingcai; Zhong, Chunting] South China Univ Technol, Guangdong Prov Key Lab Biomed Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Wang, YJ (reprint author), South China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.; Ren, L (reprint author), Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.; Wang, L (reprint author), South China Univ Technol, Guangdong Prov Key Lab Biomed Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM wanglin3@scut.edu.cn; psrenli@163.com; imwangyj@163.com
RI ren, li/L-2454-2017
FU National Natural Science Foundation of China [51232002, 51302088,
   51273072]; Guangdong Scientific and Technological Project
   [2014B090907004]; Guangdong Natural Science Funds for Distinguished
   Young Scholar [2016A030306018]
FX The authors gratefully acknowledge the financial support of the National
   Natural Science Foundation of China (Grant 51232002, 51302088 and
   51273072), the Guangdong Scientific and Technological Project
   (2014B090907004), and Guangdong Natural Science Funds for Distinguished
   Young Scholar (2016A030306018).
CR Ash A, 2014, COLLOID SURFACE B, V116, P603, DOI 10.1016/j.colsurfb.2013.10.024
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06
   Benito D, 2014, INT J MED MICROBIOL, V304, P1226, DOI 10.1016/j.ijmm.2014.09.004
   Brown MF, 2011, MEDCHEMCOMM, V2, P735, DOI 10.1039/c1md00095k
   Chen JJ, 2014, RSC ADV, V4, P27630, DOI 10.1039/c4ra01983k
   Choi JE, 2010, AQUAT TOXICOL, V100, P151, DOI 10.1016/j.aquatox.2009.12.012
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Costa FMTA, 2015, BIOMATERIALS, V52, P531, DOI 10.1016/j.biomaterials.2015.02.049
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009
   de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365
   Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x
   Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Harrasser N, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1005-z
   Hequet A, 2011, COLLOID SURFACE B, V84, P301, DOI 10.1016/j.colsurfb.2011.01.012
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hindi KM, 2009, BIOMATERIALS, V30, P3771, DOI 10.1016/j.biomaterials.2009.03.044
   Ishi T, 2007, BIOMACROMOLECULES, V8, P3340, DOI 10.1021/bm070420h
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Khoo X, 2010, BIOMATERIALS, V31, P9285, DOI 10.1016/j.biomaterials.2010.08.031
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Korani M, 2013, IRAN J PHARM RES, V12, P511
   Ma LM, 2016, BIOMATERIALS, V87, P32, DOI 10.1016/j.biomaterials.2016.02.011
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   Micksch T, 2015, ACTA BIOMATER, V12, P290, DOI 10.1016/j.actbio.2014.10.020
   Milic M, 2015, J APPL TOXICOL, V35, P581, DOI 10.1002/jat.3081
   Paithankar D, 2015, J CONTROL RELEASE, V206, P30, DOI 10.1016/j.jconrel.2015.03.004
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Pazos E, 2016, J AM CHEM SOC, V138, P5507, DOI 10.1021/jacs.6b01570
   Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010
   Pridmore A, 2011, VET MICROBIOL, V151, P409, DOI 10.1016/j.vetmic.2011.03.016
   Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004
   Sahariah P, 2015, CHEM COMMUN, V51, P11611, DOI 10.1039/c5cc04010h
   Salahinejad E, 2013, J BIOMED NANOTECHNOL, V9, P1327, DOI 10.1166/jbn.2013.1619
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Senay C, 1997, MOL PHARMACOL, V51, P406
   Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276
   Shi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16336
   Silva EC, 2012, ARQ BRAS MED VET ZOO, V64, P873, DOI 10.1590/S0102-09352012000400013
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Sung WS, 2008, BIOL PHARM BULL, V31, P1614, DOI 10.1248/bpb.31.1614
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Voicu G, 2013, INT J PHARMACEUT, V446, P63, DOI 10.1016/j.ijpharm.2013.02.011
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wang L, 2015, J MATER CHEM B, V3, P30, DOI 10.1039/c4tb01318b
   Wang L, 2014, CHEM COMMUN, V50, P975, DOI 10.1039/c3cc47922f
   Wronska MA, 2016, ADV MATER, V28, P5485, DOI 10.1002/adma.201504310
   Xie JQ, 2014, J PEPT SCI, V20, P876, DOI 10.1002/psc.2679
   Xue YY, 2016, J APPL TOXICOL, V36, P352, DOI 10.1002/jat.3199
   Yala JF, 2011, APPL MICROBIOL BIOT, V89, P623, DOI 10.1007/s00253-010-2930-7
   Yang H, 2014, J MATER CHEM B, V2, P4703, DOI 10.1039/c4tb00424h
   Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yu HY, 2013, BBA-BIOMEMBRANES, V1828, P2720, DOI 10.1016/j.bbamem.2013.07.020
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhan JZ, 2015, ACS APPL MATER INTER, V7, P13876, DOI 10.1021/acsami.5b02262
NR 63
TC 3
Z9 3
U1 24
U2 92
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD APR 7
PY 2017
VL 5
IS 13
BP 2407
EP 2415
DI 10.1039/c6tb03337g
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EQ3HH
UT WOS:000397961800005
DA 2018-10-20
ER

PT J
AU Friedemann, M
   Kalbitzer, L
   Franz, S
   Moeller, S
   Schnabelrauch, M
   Simon, JC
   Pompe, T
   Franke, K
AF Friedemann, Markus
   Kalbitzer, Liv
   Franz, Sandra
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Simon, Jan-Christoph
   Pompe, Tilo
   Franke, Katja
TI Instructing Human Macrophage Polarization by Stiffness and
   Glycosaminoglycan Functionalization in 3D Collagen Networks
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; IN-VITRO; CROSS-LINKING; CELL-CULTURE; WOUND
   REPAIR; TISSUE; BIOMATERIALS; HYDROGELS; ACTIVATION; SCAFFOLD
AB Dynamic alterations of composition and mechanics of the extracellular matrix are suggested to modulate cellular behavior including plasticity of macrophages (MPhs) during wound healing. In this study, engineered 3D fibrillar matrices based on naturally occurring biopolymers (collagen I, glycosaminoglycans (GAGs)) are used to mimic matrix stiffening as well as modification by sulfated and nonsulfated GAGs at different stages of wound healing. Human MPhs are found to sensitively respond to these micro-environmental cues in terms of polarization toward proinflammatory or wound healing phenotypes over 6 days in vitro. MPhs exhibit a wound healing phenotype in stiffer matrices as determined by protein and gene expression of relevant cytokines (IL10, IL12, and TNF alpha). Presence of sulfated and nonsulfated GAGs inhibits this polarization effect. Furthermore, control experiments on 2D matrices stress the relevance of using stiffness-controlled 3D matrices, as MPhs show a reciprocal polarization behavior depending on GAG presence. Hence, the results indicate a strong influence of dimensionality, stiffness, and GAG presence of the biomaterial scaffold on MPh polarization and emphasize the need for matrices closely mimicking the 3D in vivo context with a variable stiffness and GAG composition in in vitro studies.
C1 [Friedemann, Markus; Kalbitzer, Liv; Pompe, Tilo; Franke, Katja] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany.
   [Franz, Sandra; Simon, Jan-Christoph] Univ Klinikum Leipzig, Dept Dermatol Venerol & Allergol, D-04103 Leipzig, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT EV, Biomat Dept, D-07745 Jena, Germany.
RP Franke, K (reprint author), Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany.
EM katja.franke@uni-leipzig.de
OI Franz, Sandra/0000-0002-3449-2723
FU EFRE; Free State of Saxony (SAB) [100144684, 100146227]; Deutsche
   Forschungsgemeinschaft (DFG) [SFB-TRR67/B3,B10,Z3, INST 268/293-1 FUGG];
   Core Unit Fluorescence-Technologies of the Faculty of Medicine of the
   University of Leipzig
FX The authors acknowledge the support of grants from EFRE and Free State
   of Saxony (SAB, Grant Nos. 100144684 and 100146227), from Deutsche
   Forschungsgemeinschaft (DFG, Grant Nos. SFB-TRR67/B3,B10,Z3 and INST
   268/293-1 FUGG). This work was supported by the Core Unit
   Fluorescence-Technologies of the Faculty of Medicine of the University
   of Leipzig. Stimulating discussions with Colin Logie (Radboud Institute
   for Molecular Life Sciences) and Ronald Weiss (Institute for Clinical
   Immunology, Universitat Leipzig) are gratefully acknowledged.
CR Ansorge M, 2016, J CONTROL RELEASE, V224, P59, DOI 10.1016/j.jconrel.2015.12.053
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Choi YC, 2012, TISSUE ENG PART C-ME, V18, P866, DOI [10.1089/ten.tec.2012.0009, 10.1089/ten.TEC.2012.0009]
   Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Franke K, 2014, ACTA BIOMATER, V10, P2693, DOI 10.1016/j.actbio.2014.02.036
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Harris JR, 2013, MICRON, V49, P60, DOI 10.1016/j.micron.2013.03.004
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Hwang YJ, 2012, ACS APPL MATER INTER, V4, P261, DOI 10.1021/am2013147
   Hynes RO, 2014, NAT REV MOL CELL BIO, V15, P761, DOI 10.1038/nrm3908
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kalbitzer L, 2015, J MATER CHEM B, V3, P8902, DOI 10.1039/c5tb01737h
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Rohani MG, 2015, J INVEST DERMATOL, V135, P2377, DOI 10.1038/jid.2015.167
   Salek-Ardakani S, 2000, BLOOD, V96, P1879
   Sapudom J, 2015, BIOMATERIALS, V52, P367, DOI 10.1016/j.biomaterials.2015.02.022
   Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155
   Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101
   Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2
   Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005
   Zidek J, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5717-2
NR 48
TC 11
Z9 11
U1 3
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 5
PY 2017
VL 6
IS 7
AR UNSP 1600967
DI 10.1002/adhm.201600967
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA ES7HG
UT WOS:000399719900003
PM 28135049
DA 2018-10-20
ER

PT J
AU Jacobsen, MM
   Li, D
   Rim, NG
   Backman, D
   Smith, ML
   Wong, JY
AF Jacobsen, Matthew M.
   Li, David
   Rim, Nae Gyune
   Backman, Daniel
   Smith, Michael L.
   Wong, Joyce Y.
TI Silk-fibronectin protein alloy fibres support cell adhesion and
   viability as a high strength, matrix fibre analogue
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BOMBYX-MORI SILK; SPIDER SILK; MECHANICAL-PROPERTIES;
   POLYACRYLAMIDE-GELS; FIBROIN SCAFFOLDS; COLLAGEN; BINDING; BIOMATERIALS;
   FABRICATION; HYDROGELS
AB Silk is a natural polymer with broad utility in biomedical applications because it exhibits general biocompatibility and high tensile material properties. While mechanical integrity is important for most biomaterial applications, proper function and integration also requires biomaterial incorporation into complex surrounding tissues for many physiologically relevant processes such as wound healing. In this study, we spin silk fibroin into a protein alloy fibre with whole fibronectin using wet spinning approaches in order to synergize their respective strength and cell interaction capabilities. Results demonstrate that silk fibroin alone is a poor adhesive surface for fibroblasts, endothelial cells, and vascular smooth muscle cells in the absence of serum. However, significantly improved cell attachment is observed to silk-fibronectin alloy fibres without serum present while not compromising the fibres' mechanical integrity. Additionally, cell viability is improved up to six fold on alloy fibres when serum is present while migration and spreading generally increase as well. These findings demonstrate the utility of composite protein alloys as inexpensive and effective means to create durable, biologically active biomaterials.
C1 [Jacobsen, Matthew M.; Li, David; Rim, Nae Gyune; Backman, Daniel; Smith, Michael L.; Wong, Joyce Y.] Boston Univ, Dept Biomed Engn, 44 Cummington Mall, Boston, MA 02215 USA.
   [Li, David] Carnegie Mellon Univ, Dept Biomed Engn, 2100 Doherty Hall, Pittsburgh, PA 15213 USA.
RP Smith, ML; Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington Mall, Boston, MA 02215 USA.
EM msmith@bu.edu; jywong@bu.edu
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381; Jacobsen, Matthew/0000-0002-0368-3439
FU NIH [5T32EB006359-05]; College of Engineering Distinguished Fellowship;
   Beckman Foundation; Boston University UROP program
FX M.M.J. acknowledges support from NIH 5T32EB006359-05. This work was
   supported by a College of Engineering Distinguished Fellowship to J.Y.W.
   Special thanks to Shannon Anderson, Anthony Maita, Nicholas Hall, and
   Allison Durkan who contributed to the preparation of microfluidic
   devices, the spinning and testing of fibres, and cell culture and
   maintenance for this study. We thank the Beckman Foundation and the
   Boston University UROP program for sponsoring undergraduate research
   that contributed to this manuscript. We thank Carmen Preda of the Kaplan
   laboratory at Tufts University for providing the silk solutions used in
   this project.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Asakura T, 2011, BIOMACROMOLECULES, V12, P3910, DOI 10.1021/bm2011196
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Backman D. E., 2016, J BIOMECH, DOI [10.1016/j.jbiomech.2016.11.065, DOI 10.1016/J.JBIOMECH.2016.11.065(2016]
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Borkner CB, 2014, ACS APPL MATER INTER, V6, P15611, DOI 10.1021/am5008479
   Bornschlogl T, 2016, P NATL ACAD SCI USA, V113, P5940, DOI 10.1073/pnas.1520302113
   Breslauer DN, 2009, BIOMACROMOLECULES, V10, P49, DOI 10.1021/bm800752x
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Chen FJ, 2012, ACTA BIOMATER, V8, P2620, DOI 10.1016/j.actbio.2012.03.043
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Chen X, 2012, APPL SPECTROSC, V66, P696, DOI 10.1366/11-06551
   ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673
   Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hubbard B, 2016, J CELL PHYSIOL, V231, P1728, DOI 10.1002/jcp.25271
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Lin YN, 2015, NANOMEDICINE-UK, V10, P803, DOI [10.2217/NNM.14.230, 10.2217/nnm.14.230]
   Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003
   Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   Maghdouri-White Y, 2014, MAT SCI ENG C-MATER, V43, P37, DOI 10.1016/j.msec.2014.06.037
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Porter D, 2013, ADV MATER, V25, P1275, DOI 10.1002/adma.201204158
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saeidi N, 2011, ACTA BIOMATER, V7, P2437, DOI 10.1016/j.actbio.2011.02.038
   SCHNAAR RL, 1978, J BIOL CHEM, V253, P7940
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shapiro M, 2014, MAT SCI ENG C-MATER, V39, P100, DOI 10.1016/j.msec.2014.02.032
   Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Um IC, 2004, INT J BIOL MACROMOL, V34, P107, DOI 10.1016/j.ijbiomac.2004.03.011
   Wang GL, 2011, IN VITRO CELL DEV-AN, V47, P234, DOI 10.1007/s11626-010-9381-4
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   WEIGEL PH, 1982, METHOD ENZYMOL, V83, P294
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Widhe M, 2016, BIOMATERIALS, V74, P256, DOI 10.1016/j.biomaterials.2015.10.013
   Wlodarczyk-Biegun MK, 2014, ACTA BIOMATER, V10, P3620, DOI 10.1016/j.actbio.2014.05.006
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Yan JP, 2010, BIOMACROMOLECULES, V11, P1, DOI 10.1021/bm900840h
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Yang YJ, 2014, BIOMACROMOLECULES, V15, P1390, DOI 10.1021/bm500001n
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhang Q, 2015, MATER LETT, V161, P576, DOI 10.1016/j.matlet.2015.09.031
NR 60
TC 2
Z9 2
U1 5
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 5
PY 2017
VL 7
AR 45653
DI 10.1038/srep45653
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ9BE
UT WOS:000398378400001
PM 28378749
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Luan, YF
   Li, D
   Wei, T
   Wang, MMM
   Tang, ZC
   Brash, JL
   Chen, H
AF Luan, Yafei
   Li, Dan
   Wei, Ting
   Wang, Mengmeng
   Tang, Zengchao
   Brash, John L.
   Chen, Hong
TI "Hearing Loss" in QCM Measurement of Protein Adsorption to Protein
   Resistant Polymer Brush Layers
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; QUARTZ-CRYSTAL MICROBALANCE; PLATELET
   ACTIVATION; FIBRINOGEN; FILMS; INTERFACES; BIOSENSOR; COATINGS;
   ADHESION; GLYCOL)
AB Accurate quantification of nonspecific protein adsorption on biomaterial surfaces is essential for evaluation of their antifouling properties. The quartz crystal microbalance (QCM) is an acoustic sensor widely used for the measurement of protein adsorption. However, although the QCM is highly sensitive, it does have performance limitations when working with surfaces modified with thick viscous layers. In the case of polymer brush surfaces, factors such as the thickness and viscosity of the brush may bring such limitations. In the present work, three types of antifouling molecules were used to explore the applicability of QCM for the evaluation of the protein resistance of hydrophilic polymer brush surfaces. Adsorption was also measured by surface plasmon resonance (SPR) as a reference. It was shown that the detection of adsorbed protein requires that protein be located within a critical distance from the QCM chip surface, determined by the viscosity of polymer brush. For larger proteins like fibrinogen, adsorption is expected to occur mainly "on top" of the polymer brush, and brush thickness determines whether protein is located in the "detectable zone". For smaller proteins like lysozyme, adsorption is expected to occur mainly at the chip surface and within the polymer brush layer and to be detectable by QCM. However, the quantity of adsorbed lysozyme may be underestimated when secondary adsorption also occurred. It is concluded that QCM data suggesting very low protein adsorption on polymer brush surfaces should take account of these considerations and should be treated generally with caution.
C1 [Luan, Yafei; Li, Dan; Wei, Ting; Wang, Mengmeng; Tang, Zengchao; Brash, John L.; Chen, Hong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, State & Local Joint Engn Lab Novel Funct Polymer, 199 Renai Rd, Suzhou 215123, Peoples R China.
   [Brash, John L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
   [Brash, John L.] McMaster Univ, Dept Chem Engn, Hamilton, ON, Canada.
RP Li, D; Chen, H (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, State & Local Joint Engn Lab Novel Funct Polymer, 199 Renai Rd, Suzhou 215123, Peoples R China.
EM lidan@suda.edu.cn; chenh@suda.edu.cn
FU National Natural Science Foundation of China [21334004, 21574093];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); Jiangsu Clinical Research Center for Cardiovascular
   Surgery; Natural Sciences and Engineering Research Council of Canada
FX This work was supported by the National Natural Science Foundation of
   China (21334004 and 21574093), the Priority Academic Program Development
   of Jiangsu Higher Education Institutions (PAPD), Jiangsu Clinical
   Research Center for Cardiovascular Surgery and the Natural Sciences and
   Engineering Research Council of Canada.
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Benhabbour SR, 2008, MACROMOLECULES, V41, P4817, DOI 10.1021/ma8004586
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   Kitano K, 2009, COLLOID SURFACE B, V74, P350, DOI 10.1016/j.colsurfb.2009.08.004
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Li X, 2013, LANGMUIR, V29, P1122, DOI 10.1021/la3044472
   Liu XL, 2014, J MATER CHEM B, V2, P5718, DOI 10.1039/c4tb00881b
   Luan YF, 2014, LANGMUIR, V30, P1029, DOI 10.1021/la403498w
   Ma HW, 2006, ADV FUNCT MATER, V16, P640, DOI 10.1002/adfm.200500426
   Maehashi K, 2007, ANAL CHEM, V79, P782, DOI 10.1021/ac060830g
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   McClung WG, 2003, J BIOMED MATER RES A, V66A, P795, DOI 10.1002/jdm.a.10017
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAI H, 1993, THROMB RES, V71, P467, DOI 10.1016/0049-3848(93)90120-D
   PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   Rowe CA, 1999, ANAL CHEM, V71, P3846, DOI 10.1021/ac981425v
   Tang ZC, 2015, CHEM COMMUN, V51, P14263, DOI 10.1039/c5cc05652g
   Tang ZC, 2013, POLYM CHEM-UK, V4, P5597, DOI 10.1039/c3py00710c
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   Vermette P, 2003, COLLOID SURFACE B, V28, P153, DOI 10.1016/S0927-7765(02)00160-1
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wei Q, 2014, BIOMACROMOLECULES, V15, P3061, DOI 10.1021/bm500673u
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Wu ZQ, 2009, MACROMOL BIOSCI, V9, P1165, DOI 10.1002/mabi.200900221
   Zhang YX, 2013, ANAL CHEM, V85, P1106, DOI 10.1021/ac302874s
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zhao HC, 2013, ACS APPL MATER INTER, V5, P4536, DOI 10.1021/am400135c
   Zhou GY, 2011, POLYM CHEM-UK, V2, P1409, DOI 10.1039/c1py00016k
NR 33
TC 1
Z9 1
U1 8
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD APR 4
PY 2017
VL 89
IS 7
BP 4184
EP 4191
DI 10.1021/acs.analchem.7b00198
PG 8
WC Chemistry, Analytical
SC Chemistry
GA ER2SY
UT WOS:000398645300053
PM 28276243
DA 2018-10-20
ER

PT J
AU Zhu, XL
   Gojgini, S
   Chen, TH
   Fei, P
   Dong, SY
   Ho, CM
   Segura, T
AF Zhu, Xiaolu
   Gojgini, Shiva
   Chen, Ting-Hsuan
   Fei, Peng
   Dong, Siyan
   Ho, Chih-Ming
   Segura, Tatiana
TI Directing three-dimensional multicellular morphogenesis by
   self-organization of vascular mesenchymal cells in hyaluronic acid
   hydrogels
SO JOURNAL OF BIOLOGICAL ENGINEERING
LA English
DT Article
DE Self-organization; Hyaluronic acid; Turing mechanism; Mesenchymal stem
   cell
ID TISSUE MORPHOGENESIS; PATTERN-FORMATION; STEM-CELLS; PROTEIN 4; 3D;
   CULTURE; NOGGIN; DIFFERENTIATION; MIGRATION; STIFFNESS
AB Background: Physical scaffolds are useful for supporting cells to form three-dimensional (3D) tissue. However, it is non-trivial to develop a scheme that can robustly guide cells to self-organize into a tissue with the desired 3D spatial structures. To achieve this goal, the rational regulation of cellular self-organization in 3D extracellular matrix (ECM) such as hydrogel is needed.
   Results: In this study, we integrated the Turing reaction-diffusion mechanism with the self-organization process of cells and produced multicellular 3D structures with the desired configurations in a rational manner. By optimizing the components of the hydrogel and applying exogenous morphogens, a variety of multicellular 3D architectures composed of multipotent vascular mesenchymal cells (VMCs) were formed inside hyaluronic acid (HA) hydrogels. These 3D architectures could mimic the features of trabecular bones and multicellular nodules. Based on the Turing reaction-diffusion instability of morphogens and cells, a theoretical model was proposed to predict the variations observed in 3D multicellular structures in response to exogenous factors. It enabled the feasibility to obtain diverse types of 3D multicellular structures by addition of Noggin and/or BMP2.
   Conclusions: The morphological consistency between the simulation prediction and experimental results probably revealed a Turing-type mechanism underlying the 3D self-organization of VMCs in HA hydrogels. Our study has provided new ways to create a variety of self-organized 3D multicellular architectures for regenerating biomaterial and tissues in a Turing mechanism-based approach.
C1 [Zhu, Xiaolu] Hohai Univ, Coll Mech & Elect Engn, Changzhou 213022, Jiangsu, Peoples R China.
   [Zhu, Xiaolu; Fei, Peng; Dong, Siyan; Ho, Chih-Ming] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.
   [Gojgini, Shiva; Segura, Tatiana] Univ Calif Los Angeles, Chem & Biomol Engn Dept, Los Angeles, CA 90095 USA.
   [Chen, Ting-Hsuan] City Univ Hong Kong, Dept Mech & Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
   [Ho, Chih-Ming] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Zhu, XL (reprint author), Hohai Univ, Coll Mech & Elect Engn, Changzhou 213022, Jiangsu, Peoples R China.; Segura, T (reprint author), Univ Calif Los Angeles, Chem & Biomol Engn Dept, Los Angeles, CA 90095 USA.
EM zhuxiaolu@hhu.edu.cn; tsegura@ucla.edu
OI Ho, Chih-Ming/0000-0001-7369-5446
FU National Natural Science Foundation of China [51505127]; Natural Science
   Foundation of Jiangsu Province [BK20161197]; Changzhou SciTech Program
   [CE20165029]; Fundamental Research Funds for the Central Universities of
   China [2015B04414]; National Science Foundation of the United States
   [SINAM 00006047]
FX This research was supported by grants from the National Natural Science
   Foundation of China (Grant No. 51505127), the Natural Science Foundation
   of Jiangsu Province (Grant No. BK20161197), the Changzhou Sci&Tech
   Program (Grant No. CE20165029), the Fundamental Research Funds for the
   Central Universities of China (Grant No. 2015B04414), and the National
   Science Foundation (SINAM 00006047) of the United States.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12
   Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]
   Bansagi T, 2011, SCIENCE, V331, P1309, DOI 10.1126/science.1200815
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257
   Bhatia SN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3005975
   Bostrom K, J CLIN INVEST
   Cam C, 2014, ACTA BIOMATER, V10, P205, DOI 10.1016/j.actbio.2013.10.002
   Chen TH, 2012, BIOMATERIALS, V33, P9019, DOI 10.1016/j.biomaterials.2012.08.067
   Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927
   Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003
   Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580
   Franzdottir SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-162
   Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002
   Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101
   Garzon-Alvarado DA, 2013, COMPUT METH PROG BIO, V112, P655, DOI 10.1016/j.cmpb.2013.07.027
   Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507
   Griffin DR, 2014, CHEMBIOCHEM, V15, P233, DOI 10.1002/cbic.201300687
   Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245
   Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108
   Hagiwara M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08054
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1
   Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b60203d
   Hsiai TK, 2001, ARTERIOSCL THROM VAS, V21, P1770, DOI 10.1161/hq1001.097104
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047
   La Rosa I, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-18
   Lam J, 2014, ACTA BIOMATER, V10, P1571, DOI 10.1016/j.actbio.2013.07.025
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Lorda-Diez Cl, 2013, PLOS ONE, V8
   Mihailescu M, 2016, J MATER SCI, V51, P4262, DOI 10.1007/s10853-016-9723-z
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Morizane R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064843
   Murphy KC, 2014, CELL TISSUE RES, V357, P91, DOI 10.1007/s00441-014-1830-z
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132
   Rizzoti K, 2011, NATURE, V480, P44, DOI 10.1038/480044a
   Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   Tompkins N, 2014, P NATL ACAD SCI USA, V111, P4397, DOI 10.1073/pnas.1322005111
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yao Y, 2007, J BIOL CHEM, V282, P30131, DOI 10.1074/jbc.M704297200
   Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.tea.2010.0481, 10.1089/ten.TEA.2010.0481]
   Zhu XL, 2016, BIOMED PHARMACOTHER, V83, P1203, DOI 10.1016/j.biopha.2016.08.018
   Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6
NR 63
TC 6
Z9 6
U1 5
U2 28
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1754-1611
J9 J BIOL ENG
JI J. Biol. Eng.
PD APR 3
PY 2017
VL 11
AR 12
DI 10.1186/s13036-017-0055-6
PG 12
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA ET7YK
UT WOS:000400515200001
PM 28392831
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jones, O
   Gilbert, J
AF Jones, Owen
   Gilbert, Jay
TI Improved stability of whey protein fibrils and utility for biomaterial
   application
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Jones, Owen; Gilbert, Jay] Purdue Univ, Nelsen Hall, W Lafayette, IN 47907 USA.
EM joneso@purdue.edu; gilber26@purdue.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 216
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568500217
DA 2018-10-20
ER

PT J
AU Pan, L
AF Pan, Long
TI Water soluble cationic zinc lysine hydrochloride compound for
   spontaneous coating of znO on biomaterial surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Pan, Long] Colgate Palmol Co, Piscataway, NJ USA.
EM long_pan@colpal.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 1332
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TH
UT WOS:000430569104007
DA 2018-10-20
ER

PT J
AU Tayeb, P
   Pal, L
   Tayeb, A
AF Tayeb, Pegah
   Pal, Lokendra
   Tayeb, Ali
TI Biomaterial polymer blends for material extrusion 3D printing
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Tayeb, Pegah; Pal, Lokendra; Tayeb, Ali] North Carolina State Univ, Forest Biomat, Raleigh, NC USA.
EM shajimi2@ncsu.edu
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 162
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568503124
DA 2018-10-20
ER

PT J
AU Yao, Y
AF Yao, Yuan
TI Dendrimer-like biopolymers: A new arena for biomaterial development
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Yao, Yuan] Purdue Univ, W Lafayette, IN 47907 USA.
EM yao1@purdue.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 360
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568503319
DA 2018-10-20
ER

PT J
AU Wang, F
   Zhou, WJ
   Monje, A
   Huang, W
   Wang, YP
   Wu, YQ
AF Wang, Feng
   Zhou, Wenjie
   Monje, Alberto
   Huang, Wei
   Wang, Yueping
   Wu, Yiqun
TI Influence of Healing Period Upon Bone Turn Over on Maxillary Sinus Floor
   Augmentation Grafted Solely with Deproteinized Bovine Bone Mineral: A
   Prospective Human Histological and Clinical Trial
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE deproteinized bovine bone mineral; histological analyses; implant
   survival rate; maxillary sinus floor augmentation
ID PLATELET-RICH PLASMA; SCHNEIDERIAN MEMBRANE; AUTOGENOUS BONE; ELEVATION;
   IMPLANTS; HYDROXYAPATITE; SUBSTITUTES; SURVIVAL; OUTCOMES; MONKEYS
AB Purpose To investigate the influence of maturation timing upon histological, histomorphometric and clinical outcomes when deproteinized bovine bone mineral (DBBM) was used as a sole biomaterial for staged maxillary sinus floor augmentation (MSFA).
   Materials and methods Patients with a posterior edentulous maxillary situation and a vertical bone height4 mm were included in this study. A staged MSFA was carried out. After MSFA with DBBM as a sole grafting material, biopsy cores were harvested with simultaneous implant placement followed by a healing period of 5, 8, and 11 months, respectively. Micro-CT, histologic and histomorphometric analyses were performed.
   Results Forty-one patients were enrolled and 38 bone core biopsies were harvested. Significantly greater BV/TV was observed between 5- and 8-month healing from micro-CT analysis. Histomorphometric analyses showed the ratio of mineralized newly formed bone increased slightly from 5 to 11 months; however, no statistically significant difference was reached (p=.409). Residual bone substitute decreased from 37.35.04% to 20.6 +/- 7.45%, achieving a statistical significant difference from of 5 up to 11 months (p<.01). Moreover, no implant failure, biological or technical complication occurred after 12-month follow-up of functional loading.
   Conclusion DBBM utilized as sole grafting material in staged MSFA demonstrated to be clinically effective regardless of the healing period. Histomorphometrical and micro-CT assessments revealed that at later stages of healing (8 and 11 months) there is a higher proportion of newly-bone formation compared to earlier stages (5 months). Moreover, the longer the maturation period, the substantially lesser remaining biomaterial could be expected. Even though, these facts did not seem to negatively impact on the implant prognosis 1-year after loading.
C1 [Wang, Feng; Huang, Wei; Wu, Yiqun] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Oral Implantol,Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Zhou, Wenjie; Wang, Yueping] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dent Clin 2,Sch Med, 280 Mohe Rd, Shanghai 200011, Peoples R China.
   [Monje, Alberto] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
RP Wu, YQ (reprint author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Oral Implantol,Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Wang, YP (reprint author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dent Clin 2,Sch Med, 280 Mohe Rd, Shanghai 200011, Peoples R China.
EM wangyueping309@hotmail.com; yiqunwu@hotmail.com
FU project of the Combined Engineering and Medical Project of Shanghai Jiao
   Tong University [YG2014QN01]; National Natural Science Foundation of
   China [81371190]
FX This study was supported by the project of the Combined Engineering and
   Medical Project of Shanghai Jiao Tong University (YG2014QN01) and the
   National Natural Science Foundation of China (81371190).
CR Bassil J, 2013, J ORAL IMPLANTOL, V39, P73, DOI 10.1563/AAID-JOI-D-11-00012
   Caneva M, 2017, CLIN ORAL IMPLAN RES, V28, pe21, DOI 10.1111/clr.12850
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Chao YL, 2010, J CLIN PERIODONTOL, V37, P456, DOI 10.1111/j.1600-051X.2010.01555.x
   De Santis E, 2017, CLIN ORAL IMPLAN RES, V28, P503, DOI 10.1111/clr.12825
   Esposito M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008397.pub2
   Favero V, 2016, CLIN ORAL IMPLAN RES, V27, P233, DOI 10.1111/clr.12576
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   Galindo-Moreno P, 2014, CLIN ORAL IMPLAN RES, V25, P366, DOI 10.1111/clr.12112
   Galindo-Moreno P, 2011, CLIN ORAL IMPLAN RES, V22, P857, DOI 10.1111/j.1600-0501.2010.02073.x
   Gruber R, 2004, CLIN ORAL IMPLAN RES, V15, P575, DOI 10.1111/j.1600-0501.2004.01062.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Jensen T, 2012, INT J ORAL MAX SURG, V41, P114, DOI 10.1016/j.ijom.2011.08.010
   Jungner M, 2015, CLIN IMPLANT DENT R, V17, P1092, DOI 10.1111/cid.12218
   Lee DZ, 2012, CLIN ORAL IMPLAN RES, V23, P918, DOI 10.1111/j.1600-0501.2011.02239.x
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   Mombelli A, 1994, Periodontol 2000, V4, P81, DOI 10.1111/j.1600-0757.1994.tb00008.x
   Monje A, 2016, INT J ORAL MAXILLOFA, DOI 10.11607/jomi.4801
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Palmer W, 2008, W INDIAN MED J, V57, P490
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Roldan JC, 2008, CLIN ORAL IMPLAN RES, V19, P373, DOI 10.1111/j.1600-0501.2007.01465.x
   Rong Q, 2015, BRIT J ORAL MAX SURG, V53, P607, DOI 10.1016/j.bjoms.2015.02.010
   Scala A, 2012, CLIN ORAL IMPLAN RES, V23, P175, DOI 10.1111/j.1600-0501.2011.02227.x
   Scala A, 2010, CLIN ORAL IMPLAN RES, V21, P1320, DOI 10.1111/j.1600-0501.2010.01964.x
   Sohn DS, 2010, IMPLANT DENT, V19, P259, DOI 10.1097/ID.0b013e3181df1406
   Srouji S, 2010, INT J ORAL MAX SURG, V39, P793, DOI 10.1016/j.ijom.2010.03.009
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Srouji S, 2013, CLIN ORAL IMPLAN RES, V24, P1288, DOI 10.1111/j.1600-0501.2012.02571.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
NR 34
TC 3
Z9 3
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD APR
PY 2017
VL 19
IS 2
BP 341
EP 350
DI 10.1111/cid.12463
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ER1GX
UT WOS:000398539300013
PM 27862924
DA 2018-10-20
ER

PT J
AU Carreno-De Leon, MC
   Rios, MJS
   Cosme-Torres, I
   Hernandez-Berriel, MC
   Flores-Alamo, N
AF Carreno-De Leon, M. C.
   Solache Rios, M. J.
   Cosme-Torres, I.
   Hernandez-Berriel, M. C.
   Flores-Alamo, N.
TI ADSORPTION OF Cr(VI) BY Zea mays RACHIS
SO REVISTA MEXICANA DE INGENIERIA QUIMICA
LA English
DT Article
DE adsoption; Cr(VI); Zea mays; adsorption; aqueous solutions
ID AQUEOUS-SOLUTIONS; ORANGE PEEL; KINETICS; REMOVAL; EQUILIBRIUM;
   BIOSORPTION; CHITOSAN; CR(III); IONS; ZINC
AB Removal of Cr(VI) from aqueous solutions by Zea mays rachis (ZMR) was studied. The BET surface area of the Zea Mays Material was 1.25 +/- 0.01 m(2)g(-1), with an average pore size of 4.71 nm. Experimental data show a 100% of Cr(VI) is removed in a period of 4 hours at pH between 1 and 3. A pH value of 3 was chosen for the adsorption studies, with a maximum adsorption capacity of 2 mg g(-1) and a Cr(VI) adsorption percentage onto ZMR of 98.6%. The Freundlich model represented the equilibrium of the adsorption process better than Langmuir model. The adsorption kinetics of Cr(VI) onto, ZMR were well defined using the pseudo-second order model. The results showed that ZMR is a potential biomaterial for Cr(VI) removal and pH has an important effect on metal adsorption capacity. The Cr(VI) reduction to Cr(III) was observed during the adsorption process.
C1 [Carreno-De Leon, M. C.; Cosme-Torres, I.; Hernandez-Berriel, M. C.; Flores-Alamo, N.] Inst Tecnol Toluca, Ave Inst Tecnol S-N,Colonia Agr Bellavista, Metepec 52149, Estado De Mexic, Mexico.
   [Solache Rios, M. J.] Inst Nacl Invest Nucl, Dept Quim, Apdo Postal 18-1027, Mexico City 11801, DF, Mexico.
RP Flores-Alamo, N (reprint author), Inst Tecnol Toluca, Ave Inst Tecnol S-N,Colonia Agr Bellavista, Metepec 52149, Estado De Mexic, Mexico.
EM alamofn@gmail.com
OI Flores-Alamo, Nicolas/0000-0003-2281-610X
FU Tecnologico Nacional de Mexico [ITTOL-PTC-006]
FX The authors are grateful to Tecnologico Nacional de Mexico for financial
   support (ITTOL-PTC-006 project).
CR Barrera-Diaz C. E, 2012, J HAZARD MATER, V1-12, P224
   Garcia-Reyes RB, 2010, BIORESOURCE TECHNOL, V101, P8099, DOI 10.1016/j.biortech.2010.06.020
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Dai J, 2012, INT J ENV RES PUB HE, V9, P1757, DOI 10.3390/ijerph9051757
   Demirbas E, 2004, WATER SA, V30, P533
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Flores-Alamo N, 2015, REV MEX ING QUIM, V14, P801
   Garcia-Gonzalez R, 2016, REV MEX ING QUIM, V15, P311
   Garcia-Rosales G, 2010, J ENVIRON MANAGE, V91, P2079, DOI 10.1016/j.jenvman.2010.06.004
   Gregg S.J., 1982, ADSORPTION SURFACE A, P111
   Gun'ko VM, 2013, ADV COLLOID INTERFAC, V187, P1, DOI 10.1016/j.cis.2012.11.001
   Hasan SH, 2008, J HAZARD MATER, V152, P356, DOI 10.1016/j.jhazmat.2007.07.006
   Li X, 2008, COLLOID SURFACE A, V317, P512, DOI 10.1016/j.colsurfa.2007.11.031
   Lugo-Lugo V, 2012, J ENVIRON MANAGE, V112, P120, DOI 10.1016/j.jenvman.2012.07.009
   Navarro B. S., 2013, QUIMICA AGRICOLA SUE, P15
   Pandey PK, 2010, INT J ENVIRON SCI TE, V7, P395, DOI 10.1007/BF03326149
   Ramos-Ramirez E, 2015, REV MEX ING QUIM, V14, P711
   Showkat AM, 2007, B KOREAN CHEM SOC, V28, P1985
   Tan GQ, 2010, J HAZARD MATER, V174, P740, DOI 10.1016/j.jhazmat.2009.09.114
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Zvinowanda CM, 2009, J APPL POLYM SCI, V111, P1923, DOI 10.1002/app.29213
NR 21
TC 0
Z9 0
U1 0
U2 0
PU UNIV AUTONOMA METROPOLITANA-IZTAPALAPA
PI MEXICO
PA C/O DR JAIME VERNON-CARTER, SAN RAFAEL ATLIXCO NO 186, COL VICENTINA,
   DELEGACION IZTAPALAPA, MEXICO, 09340, MEXICO
SN 1665-2738
J9 REV MEX ING QUIM
JI Rev. Mex. Ing. Quim.
PD APR
PY 2017
VL 16
IS 1
BP 261
EP 269
PG 9
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA FQ2SW
UT WOS:000418209300025
DA 2018-10-20
ER

PT J
AU De Oliveira, DP
   Ottria, L
   Gargari, M
   Candotto, V
   Silvestre, FJ
   Lauritano, D
AF De Oliveira, D. Pedreira
   Ottria, L.
   Gargari, M.
   Candotto, V.
   Silvestre, F. J.
   Lauritano, D.
TI SURFACE MODIFICATION OF TITANIUM ALLOYS FOR BIOMEDICAL APPLICATION: FROM
   MACRO TO NANO SCALE
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE titanium; surface; modification; cell; alloy
ID SEVERE PLASTIC-DEFORMATION; OSTEOBLAST-LIKE CELLS; IN-VIVO EVALUATION;
   IMPLANT SURFACES; STEM-CELLS; MECHANICAL-PROPERTIES; CHRONIC
   PERIODONTITIS; FATIGUE PERFORMANCE; BONE REGENERATION; TISSUE FORMATION
AB Bone is a complexly structured tissue and hierarchically organized from macro to nano levels of dimensions. Biomaterial devices developed to replace and interact with bone tissues have been designed from the macro to nano perspective to provide suitable performance in acquiring primary and biological stability. Macro level designed features provide mechanical interlock and primary stability to implants inside the bone. Surface micro and nano structures influence cells behavior to promote the secondary or biological stability, reaching succesfull osseointegration.
C1 [De Oliveira, D. Pedreira] Univ Fed Sao Carlos, Dept Mat Engn, Sao Carlos, SP, Brazil.
   [Ottria, L.] Tor Vergata Univ, Dent Sch, Rome, Italy.
   [Gargari, M.] Univ Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.
   [Candotto, V.] Univ Valencia, Dr Peset Univ Hospita, Dept Stomatol, Stomatol & Oral Surg, Valencia, Spain.
   [Silvestre, F. J.] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy.
   [Lauritano, D.] Univ Milano Bicocca, Dept Med & Surg, Via Cadore 48, I-20052 Monza, Italy.
RP Lauritano, D (reprint author), Univ Milano Bicocca, Dept Med & Surg, Via Cadore 48, I-20052 Monza, Italy.
EM dorina.lauritano@unimib.it
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Antonialli AIS, 2013, FED U SAO CARL
   Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P765, DOI 10.1002/jbm.a.34379
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Banerjee R, 2005, MAT SCI ENG C-BIO S, V25, P282, DOI 10.1016/j.msec.2004.12.010
   Barfeie A, 2015, BRIT DENT J, V218, DOI 10.1038/sj.bdj.2015.171
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   Bilezikian J, 2002, PRINCIPLES BONE BIOL
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Caccianiga G, 2016, J BIOL REG HOMEOS AG, V30, P87
   Campanelli LC, 2017, J MECH BEHAV BIOMED, V65, P542, DOI 10.1016/j.jmbbm.2016.09.015
   Campanelli LC, 2014, MATER DESIGN, V64, P393, DOI 10.1016/j.matdes.2014.07.074
   Carinci F, 2016, J BIOL REG HOMEOS AG, V30, P69
   Checchi L, 2016, J BIOL REG HOMEOS AG, V30, P199
   Chug A, 2013, J ORAL MAX SURG MED, V25, P1, DOI 10.1016/j.ajoms.2012.01.008
   Cimpean A, 2012, MAT SCI ENG C-MATER, V32, P1554, DOI 10.1016/j.msec.2012.04.042
   Cordeiro JM, 2017, MAT SCI ENG C-MATER, V71, P1201, DOI 10.1016/j.msec.2016.10.025
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239
   El Haddad E, 2016, Oral Implantol (Rome), V9, P76, DOI 10.11138/orl/2016.9.2.076
   Elias C. N., 2013, J MATER RES TECHNOL, V2, P340, DOI DOI 10.1016/J.JMRT.2013.07.003
   Claros CAE, 2016, MAT SCI ENG C-MATER, V67, P425, DOI 10.1016/j.msec.2016.04.099
   Felgueiras HP, 2015, ACTA BIOMATER, V28, P225, DOI 10.1016/j.actbio.2015.09.030
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Grandfield K, 2012, PHILOS T R SOC A, V370, P1337, DOI 10.1098/rsta.2011.0253
   Griffin MF, 2015, WORLD J STEM CELLS, V7, P37, DOI 10.4252/wjsc.v7.i1.37
   Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0
   Havlikova J, 2014, MAT SCI ENG C-MATER, V39, P371, DOI 10.1016/j.msec.2014.03.024
   He HD, 2016, SURF COAT TECH, V307, P898, DOI 10.1016/j.surfcoat.2016.10.033
   Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897
   Kaivosoja E, 2013, J BIOMED MATER RES A, V101, P842, DOI 10.1002/jbm.a.34378
   Khan WS, 2012, STEM CELLS INT, V2012
   Kirby TJ, 2016, NAT MATER, V15, P1227, DOI 10.1038/nmat4809
   Kirmanidou Y, 2016, BIOMED RES INT, DOI 10.1155/2016/2908570
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Lai M, 2013, J BIOMED MATER RES A, V101, P653, DOI 10.1002/jbm.a.34371
   Lauritano D, 2016, J BIOL REG HOMEOS AG, V30, P123
   Lauritano D, 2016, J BIOL REG HOMEOS AG, V30, P149
   Lauritano D, 2016, J BIOL REG HOMEOS AG, V30, P155
   Lee JM, 2010, APPL SURF SCI, V256, P3086, DOI 10.1016/j.apsusc.2009.11.078
   Lee JW, 2011, ANAL SCI, V27, P369, DOI 10.2116/analsci.27.369
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012
   Li Y, 2014, NEW DEV TI BASED ALL
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   LODISH HB, 2000, MOL CELL BIOL
   Maekawa K, 2008, CLIN ORAL IMPLAN RES, V19, P320, DOI 10.1111/j.1600-0501.2007.01477.x
   Majumdar P, 2015, MAT SCI ENG C-MATER, V46, P62, DOI 10.1016/j.msec.2014.10.012
   Mancini G E, 2016, Oral Implantol (Rome), V9, P99, DOI 10.11138/orl/2016.9.3.099
   McKee MD, 2005, CELLS TISSUES ORGANS, V181, P176, DOI 10.1159/000091379
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018
   Meynardi F, 2016, J BIOL REG HOMEOS AG, V30, P115
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Osathanon T, 2006, J MATER SCI-MATER M, V17, P619, DOI 10.1007/s10856-006-9224-8
   Park JW, 2007, BIOMATERIALS, V28, P3306, DOI 10.1016/j.biomaterials.2007.04.007
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Park JW, 2009, ACTA BIOMATER, V5, P2311, DOI 10.1016/j.actbio.2009.02.026
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Perrotti V, 2013, ODONTOLOGY, V101, P133, DOI 10.1007/s10266-012-0067-0
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   Polyakov AV, 2015, RECENT ADV PROCESSIN, V12, P1869
   Polyakova V, 2011, MATER SCI FORUM, V667-669, P943, DOI 10.4028/www.scientific.net/MSF.667-669.943
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Qu CJ, 2013, MAT SCI ENG C-MATER, V33, P1676, DOI 10.1016/j.msec.2012.12.078
   Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434
   Ramazanoglu M, 2011, CLIN ORAL IMPLAN RES, V22, P1433, DOI 10.1111/j.1600-0501.2010.02133.x
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Ribeiro SM, 2007, FACULDADE ENGENHARIA
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Rupp F, 2014, ACTA BIOMATER, V10, P2894, DOI 10.1016/j.actbio.2014.02.040
   Ryu HS, 2014, J ADV PROSTHODONT, V6, P547, DOI 10.4047/jap.2014.6.6.547
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014
   Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Tavares MG, 2007, CLIN ORAL IMPLAN RES, V18, P452, DOI 10.1111/j.1600-0501.2007.01344.x
   Valiev RZ, 2008, ADV ENG MATER, V10, pB15, DOI 10.1002/adem.200800026
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yoo Chae-Kyung, 2016, Maxillofac Plast Reconstr Surg, V38, P17, DOI 10.1186/s40902-016-0062-4
   Yoon BJV, 2016, SPINE J, V16, P1238, DOI 10.1016/j.spinee.2016.05.017
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 114
TC 0
Z9 0
U1 4
U2 9
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD APR-JUN
PY 2017
VL 31
IS 2
SU S
BP 221
EP 232
PG 12
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA FH5BX
UT WOS:000411179400030
PM 28691477
DA 2018-10-20
ER

PT J
AU Kusuma, MH
   Putra, N
   Antariksawan, AR
   Susyadi
   Imawan, FA
AF Kusuma, Mukhsinun Hadi
   Putra, Nandy
   Antariksawan, Anhar Riza
   Susyadi
   Imawan, Ficky Augusta
TI Investigation of the Thermal Performance of a Vertical Two-Phase Closed
   Thermosyphon as a Passive Cooling System for a Nuclear Reactor Spent
   Fuel Storage Pool
SO NUCLEAR ENGINEERING AND TECHNOLOGY
LA English
DT Article
DE Heat Pipe; Passive Cooling System; Spent Fuel Storage Pool; Two-Phase
   Closed Thermosyphon
ID LOOP HEAT-PIPE; BIOMATERIAL WICK; NANOFLUIDS; SIMULATION; DESIGN
AB The decay heat that is produced by nuclear reactor spent fuel must be cooled in a spent fuel storage pool. A wickless heat pipe or a vertical two-phase closed thermosyphon (TPCT) is used to remove this decay heat. The objective of this research is to investigate the thermal performance of a prototype model for a large-scale vertical TPCT as a passive cooling system for a nuclear research reactor spent fuel storage pool. An experimental investigation and numerical simulation using RELAP5/MOD 3.2 were used to investigate the TPCT thermal performance. The effects of the initial pressure, filling ratio, and heat load were analyzed. Demineralized water was used as the TPCT working fluid. The cooled water was circulated in the water jacket as a cooling system. The experimental results show that the best thermal performance was obtained at a thermal resistance of 0.22 degrees C/W, the lowest initial pressure, a filling ratio of 60%, and a high evaporator heat load. The simulation model that was experimentally validated showed a pattern and trend line similar to those of the experiment and can be used to predict the heat transfer phenomena of TPCT with varying inputs. Copyright (C) 2016, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.
C1 [Kusuma, Mukhsinun Hadi; Putra, Nandy; Imawan, Ficky Augusta] Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus UI, Depok 16424, Indonesia.
   [Kusuma, Mukhsinun Hadi; Antariksawan, Anhar Riza; Susyadi] Natl Nucl Energy Agcy Indonesia BATAN, Ctr Nucl Reactor Safety & Technol, Kawasan Puspiptek Serpong, Tangerang Selatan 15314, Indonesia.
RP Putra, N (reprint author), Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus UI, Depok 16424, Indonesia.
EM nandyputra@eng.ui.ac.id
CR Alizadehdakhel A, 2010, INT COMMUN HEAT MASS, V37, P312, DOI 10.1016/j.icheatmasstransfer.2009.09.002
   Anjakar P.G., 2012, INT J EMERGING TECHN, V2, P494
   Bergman T. L., 2011, FUNDAMENTALS HEAT MA
   Byon C, 2012, INT J HEAT MASS TRAN, V55, P4096, DOI 10.1016/j.ijheatmasstransfer.2012.03.051
   Fu W, 2015, ANN NUCL ENERGY, V85, P346, DOI 10.1016/j.anucene.2015.05.026
   Jackel BS, 2015, NUCL ENG DES, V283, P2, DOI 10.1016/j.nucengdes.2014.07.007
   Kafeel K, 2013, HEAT MASS TRANSFER, V49, P1089, DOI 10.1007/s00231-013-1155-6
   Kusuma M. Hadi, 2016, Applied Mechanics and Materials, V819, P122, DOI 10.4028/www.scientific.net/AMM.819.122
   Li Y, 2013, APPL THERM ENG, V50, P342, DOI 10.1016/j.applthermaleng.2012.07.042
   Noie SH, 2009, INT J HEAT FLUID FL, V30, P700, DOI 10.1016/j.ijheatfluidflow.2009.03.001
   Noie SH, 2005, APPL THERM ENG, V25, P495, DOI 10.1016/j.applthermaleng.2004.06.019
   Ognerubov V, 2014, ANN NUCL ENERGY, V72, P497, DOI 10.1016/j.anucene.2014.06.021
   Putra N, 2013, ADV MAT RES, V651, P728
   Putra N, 2014, ADV MATER RES-SWITZ, V875-877, P356, DOI 10.4028/www.scientific.net/AMR.875-877.356
   Putra N, 2014, INT J THERM SCI, V76, P128, DOI 10.1016/j.ijthermalsci.2013.08.020
   Putra N, 2012, EXP THERM FLUID SCI, V40, P10, DOI 10.1016/j.expthermflusci.2012.01.007
   Reay D., 2013, HEAT PIPES ORY DE
   Sailor V.L., 1987, SEVERE ACCIDENTS SPE
   THROM ED, 1991, NUCL ENG DES, V126, P333, DOI 10.1016/0029-5493(91)90024-C
   Tung YH, 2014, NUCL ENG DES, V275, P80, DOI 10.1016/j.nucengdes.2014.04.012
   Wang DD, 2014, EXP THERM FLUID SCI, V57, P157, DOI 10.1016/j.expthermflusci.2014.04.017
   Wu XL, 2014, ANN NUCL ENERGY, V72, P198, DOI 10.1016/j.anucene.2014.05.030
   Xiong ZQ, 2015, ANN NUCL ENERGY, V83, P258, DOI 10.1016/j.anucene.2015.03.045
   Ye C, 2013, ANN NUCL ENERGY, V58, P124, DOI 10.1016/j.anucene.2013.03.007
NR 24
TC 5
Z9 5
U1 3
U2 14
PU KOREAN NUCLEAR SOC
PI DAEJEON
PA NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA
SN 1738-5733
J9 NUCL ENG TECHNOL
JI Nucl. Eng. Technol.
PD APR
PY 2017
VL 49
IS 3
BP 476
EP 483
DI 10.1016/j.net.2016.10.008
PG 8
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA EZ4EK
UT WOS:000404665000003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Nishizaki, M
   Komasa, S
   Taguchi, Y
   Nishizaki, H
   Okazaki, J
AF Nishizaki, Mariko
   Komasa, Satoshi
   Taguchi, Yoichiro
   Nishizaki, Hiroshi
   Okazaki, Joji
TI Bioactivity of NANOZR Induced by Alkali Treatment
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE zirconia/alumina nano-composite; bioactivity; alkali treatment
ID SURFACE-PROPERTIES; IN-VITRO; TITANIUM SURFACES; ZIRCONIA CERAMICS;
   PROTEIN-SYNTHESIS; GENE-EXPRESSION; IMPLANT; DIFFERENTIATION;
   BIOMATERIAL; ADHESION
AB In recent years, zirconia has been a recognized implant material in clinical dentistry. In the present study, we investigated the performance of an alkali-modified ceria-stabilized tetragonal ZrO2 polycrystalline ceramic-based nanostructured zirconia/alumina composite (NANOZR) implant by assessing surface morphology and composition, wettability, bovine serum albumin adsorption rate, rat bone marrow (RBM) cell attachment, and capacity for inducing bone differentiation. NANOZR surfaces without and with alkali treatment served as the control and test groups, respectively. RBM cells were seeded in a microplate with the implant and cultured in osteogenic differentiation medium, and their differentiation was evaluated by measuring alkaline phosphatase (ALP) activity, osteocalcin (OCN) production, calcium deposition, and osteogenic gene expression. The alkali-treated NANOZR surface increased ALP activity, OCN production, calcium deposition, and osteogenesis-related gene expression in attached RBM cells. These data suggest that alkali treatment enhances the osteogenesis-inducing capacity of NANOZR implants and may therefore improve their biointegration into alveolar bone.
C1 [Nishizaki, Mariko; Komasa, Satoshi; Nishizaki, Hiroshi; Okazaki, Joji] Osaka Dent Univ, Dept Removable Prosthodont & Occlus, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.
   [Taguchi, Yoichiro] Osaka Dent Univ, Dept Periodotol, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.
RP Nishizaki, M (reprint author), Osaka Dent Univ, Dept Removable Prosthodont & Occlus, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.
EM nishizaki-m@cc.osaka-dent.ac.jp; komasa-s@cc.osaka-dent.ac.jp;
   taguchi@cc.osaka-dent.ac.jp; nisizaki@cc.osaka-dent.ac.jp;
   joji@cc.osaka-dent.ac.jp
OI komasa, satoshi/0000-0001-5400-8479; OKAZAKI, Joji/0000-0001-5406-7823;
   Nishizaki, Hiroshi/0000-0001-6778-6915; Nishizaki,
   Mariko/0000-0002-5376-179X
FU Japan Society for Promotion of Science [16K20524]; Osaka Dental
   University [17-08, 16-02]
FX The authors thank Tohru Sekino from Osaka University for preparing the
   nanosheets and for helpful suggestions. The authors also thank Satsuki
   Yamamoto from Osaka Dental University for helpful suggestions. We are
   also grateful to the members of the Department of Removable
   Prosthodontics and Occlusion and the Department of Periodontology for
   their advice and assistance. This work was supported by the grants from
   Japan Society for Promotion of Science (16K20524), a Research Promotion
   Grant of Osaka Dental University (17-08) and Oral Implant Research Grant
   of Osaka Dental University (16-02).
CR Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Endo K., 1988, J JAPANESE SOC DENT, V7, P184
   Fujino T, 2014, J HARD TISSUE BIOL, V23, P63, DOI 10.2485/jhtb.23.63
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Hao L, 2004, J BIOMATER APPL, V19, P81, DOI 10.1177/0885328204043546
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   Komasa S, 2012, J PROSTHODONT RES, V56, P170, DOI 10.1016/j.jpor.2011.12.002
   Li P., 1992, J BIOMED MATER RES A, V28, P7
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Nawa M, 1998, J EUR CERAM SOC, V18, P209, DOI 10.1016/S0955-2219(97)00116-7
   Nishizaki M., 2016, P 30 JAP ASS OR REH
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rosa MB, 2012, J APPL ORAL SCI, V20, P550, DOI 10.1590/S1678-77572012000500010
   SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Wadamoto M, 1996, J PROSTHET DENT, V76, P170, DOI 10.1016/S0022-3913(96)90302-9
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
   Xing HL, 2014, INT J NANOMED, V9, P1741, DOI 10.2147/IJN.S58502
   Yildirim M, 2000, INT J PERIODONT REST, V20, P81
NR 39
TC 2
Z9 2
U1 0
U2 8
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2017
VL 18
IS 4
AR 780
DI 10.3390/ijms18040780
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EW6SA
UT WOS:000402639400104
PM 28383491
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Schilder, AGM
   Marom, T
   Bhutta, MF
   Casselbrant, ML
   Coates, H
   Gisselsson-Solen, M
   Hall, AJ
   Marchisio, P
   Ruohola, A
   Venekamp, RP
   Mandel, EM
AF Schilder, Anne G. M.
   Marom, Tal
   Bhutta, Mahmood F.
   Casselbrant, Margaretha L.
   Coates, Harvey
   Gisselsson-Solen, Marie
   Hall, Amanda J.
   Marchisio, Paola
   Ruohola, Aino
   Venekamp, Roderick P.
   Mandel, Ellen M.
TI Panel 7: Otitis Media: Treatment and Complications
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Review
DE otitis; otitis media; otorrhea; tympanostomy tube; adenoidectomy;
   perforation; guidelines; mastoiditis
ID LATERAL SINUS THROMBOSIS; TYMPANOSTOMY TUBE PLACEMENT;
   PLACEBO-CONTROLLED TRIAL; TYMPANIC MEMBRANE PERFORATION;
   CLINICAL-PRACTICE GUIDELINES; PEDIATRIC ACUTE MASTOIDITIS; CONJUGATE
   VACCINE ERA; INTRACRANIAL COMPLICATIONS; CLEFT-PALATE; LONG-TERM
AB Objective. We aimed to summarize key articles published between 2011 and 2015 on the treatment of (recurrent) acute otitis media, otitis media with effusion, tympanostomy tube otorrhea, chronic suppurative otitis media and complications of otitis media, and their implications for clinical practice.
   Data Sources. PubMed, Ovid Medline, the Cochrane Library, and Clinical Evidence (BMJ Publishing).
   Review Methods. All types of articles related to otitis media treatment and complications between June 2011 and March 2015 were identified. A total of 1122 potential related articles were reviewed by the panel members; 118 relevant articles were ultimately included in this summary.
   Conclusions. Recent literature and guidelines emphasize accurate diagnosis of acute otitis media and optimal management of ear pain. Watchful waiting is optional in mild to moderate acute otitis media; antibiotics do shorten symptoms and duration of middle ear effusion. The additive benefit of adenoidectomy to tympanostomy tubes in recurrent acute otitis media and otitis media with effusion is controversial and age dependent. Topical antibiotic is the treatment of choice in acute tube otorrhea. Symptomatic hearing loss due to persistent otitis media with effusion is best treated with tympanostomy tubes. Novel molecular and biomaterial treatments as adjuvants to surgical closure of eardrum perforations seem promising. There is insufficient evidence to support the use of complementary and alternative treatments.
   Implications for Practice. Emphasis on accurate diagnosis of otitis media, in its various forms, is important to reduce over-diagnosis, overtreatment, and antibiotic resistance. Children at risk for otitis media and its complications deserve special attention.
C1 [Schilder, Anne G. M.] UCL, Ear Inst, EvidENT, London, England.
   [Schilder, Anne G. M.; Venekamp, Roderick P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Marom, Tal] Tel Aviv Univ, Assaf Harofeh Med Ctr, Fac Med, Dept Otolaryngol Head & Neck Surg, Zerifin, Israel.
   [Bhutta, Mahmood F.] Royal Natl Throat Nose & Ear Hosp, London, England.
   [Casselbrant, Margaretha L.; Mandel, Ellen M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Otolaryngol,UPMC, Pittsburgh, PA USA.
   [Coates, Harvey] Univ Western Australia, Sch Paediat & Child Hlth, Dept Otolaryngol, Nedlands, WA, Australia.
   [Gisselsson-Solen, Marie] Lund Univ Hosp, Div Otorhinolaryngol Head & Neck Surg, Dept Clin Sci, Lund, Sweden.
   [Hall, Amanda J.] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England.
   [Hall, Amanda J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.
   [Marchisio, Paola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.
   Univ Turku, Dept Pediat, Turku, Finland.
RP Mandel, EM (reprint author), UPMC, Childrens Hosp Pittsburgh, ENT Dept, 4401 Penn Ave, Pittsburgh, PA 15224 USA.
EM mandele@pitt.edu
OI Hall, Amanda/0000-0001-8520-6005
CR Ackerman S, 2012, J DEV BEHAV PEDIATR, V33, P252, DOI 10.1097/DBP.0b013e31824b9f57
   Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190
   Amir AZ, 2014, SCAND J INFECT DIS, V46, P9, DOI 10.3109/00365548.2013.849814
   Anthonsen K, 2013, PEDIATR INFECT DIS J, V32, P436, DOI 10.1097/INF.0b013e31828abd13
   Arguedas A, 2011, INT J INFECT DIS, V15, pE240, DOI 10.1016/j.ijid.2010.12.003
   Au JK, 2013, AM J OTOLARYNG, V34, P145, DOI 10.1016/j.amjoto.2012.09.011
   Baik G, 2015, OTOLARYNG HEAD NECK, V152, P1000, DOI 10.1177/0194599814566594
   Barati Behrouz, 2012, Iran J Otorhinolaryngol, V24, P181
   Berkman ND, 2013, AHRQ PUBLICATION
   Bhargava R, 2014, AM J OTOLARYNG, V35, P766, DOI 10.1016/j.amjoto.2014.06.006
   Bidarian-Moniri A, 2014, INT J PEDIATR OTORHI, V78, P1298, DOI 10.1016/j.ijporl.2014.05.015
   Boonacker CWB, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18050
   Califano L, MINERVA PEDIAT
   Casey JR, 2012, DRUGS, V72, P1991, DOI 10.2165/11590320-000000000-00000
   Celind J, 2014, INT J PEDIATR OTORHI, V78, P1128, DOI 10.1016/j.ijporl.2014.04.029
   Chen KT, 2013, AURIS NASUS LARYNX, V40, P46, DOI 10.1016/j.anl.2012.05.008
   Cheng J, 2012, INT J PEDIATR OTORHI, V76, P1795, DOI 10.1016/j.ijporl.2012.09.003
   Cheong KH, 2012, J LARYNGOL OTOL, V126, P874, DOI 10.1017/S0022215112001338
   Chesney J, 2014, LARYNGOSCOPE, V124, P1057, DOI 10.1002/lary.24306
   Chien JH, 2012, J MICROBIOL IMMUNOL, V45, P377, DOI 10.1016/j.jmii.2011.12.008
   Cohen R, 2013, PEDIATR INFECT DIS J, V32, P810, DOI 10.1097/INF.0b013e31828df4f3
   Coutinho J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002005, 10.1002/14651858.CD002005.pub2]
   Csakanyi Z, 2013, EUR ARCH OTO-RHINO-L, V270, P1991, DOI 10.1007/s00405-012-2258-2
   Damoiseaux Roger A M J, 2012, Ned Tijdschr Geneeskd, V156, pA3795
   Daniel M, 2013, J LARYNGOL OTOL, V127, pS30, DOI 10.1017/S0022215112002654
   Danish Health and Medicines Authority, NAT CLIN GUID MAN OT
   Del Castillo Martin F, 2012, AN PEDIAT BARC, V77
   Dinleyici EC, 2013, INT J PEDIATR OTORHI, V77, P756, DOI 10.1016/j.ijporl.2013.02.004
   Erdoglija M, 2012, VOJNOSANIT PREGL, V69, P409, DOI 10.2298/VSP1205409E
   Ertugay CK, 2013, ACTA OTO-LARYNGOL, V133, P1266, DOI 10.3109/00016489.2013.824113
   Fixsen A, 2013, HOMEOPATHY, V102, P145, DOI 10.1016/j.homp.2013.01.004
   Forrest CB, 2013, PEDIATRICS, V131, pE1071, DOI 10.1542/peds.2012-1988
   Giannakopoulos P, 2014, PEDIATR INFECT DIS J, V33, P111, DOI 10.1097/INF.0b013e3182a6adb7
   Glatstein M, AM J THER
   Gleinser DM, 2011, INT J PEDIATR OTORHI, V75, P1247, DOI 10.1016/j.ijporl.2011.06.023
   Gorphe P, 2012, EUR ARCH OTO-RHINO-L, V269, P455, DOI 10.1007/s00405-011-1667-y
   Griffin G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003423.pub3
   Grossman Z, 2013, ACTA PAEDIATR, V102, pe29, DOI 10.1111/apa.12051
   Groth A, 2011, INT J PEDIATR OTORHI, V75, P1496, DOI 10.1016/j.ijporl.2011.08.015
   Gulani A, 2014, COCHRANE DB SYST REV, V6
   Haggard MP, 2012, CLIN OTOLARYNGOL, V37, P107, DOI 10.1111/j.1749-4486.2012.02469.x
   Halgrimson WR, 2014, PEDIATR INFECT DIS J, V33, P453, DOI 10.1097/INF.0000000000000138
   Hawker JI, 2014, J ANTIMICROB CHEMOTH, V69, P3423, DOI 10.1093/jac/dku291
   Hellstrom S, 2011, OTOLARYNG HEAD NECK, V145, P383, DOI 10.1177/0194599811409862
   Hong HR, 2014, INT J PEDIATR OTORHI, V78, P938, DOI 10.1016/j.ijporl.2014.03.019
   Hong P, 2013, INT J PEDIATR OTORHI, V77, P3, DOI 10.1016/j.ijporl.2012.09.022
   Iacovou E, 2013, EUR ARCH OTO-RHINO-L, V270, P2803, DOI 10.1007/s00405-012-2329-4
   Jensen RG, 2012, PEDIATR INFECT DIS J, V31, P139, DOI 10.1097/INF.0b013e318238c0a4
   Kanemaru SI, 2011, OTOL NEUROTOL, V32, P1218, DOI 10.1097/MAO.0b013e31822e0e53
   Khodaverdi M, 2013, INT J PEDIATR OTORHI, V77, P241, DOI 10.1016/j.ijporl.2012.11.008
   Kitamura K, 2015, AURIS NASUS LARYNX, V42, P99, DOI 10.1016/j.anl.2014.09.006
   Kontorinis G, 2012, J LARYNGOL OTOL, V126, P244, DOI 10.1017/S0022215111002921
   Kordeluk S, 2014, INT J PEDIATR OTORHI, V78, P1599, DOI 10.1016/j.ijporl.2014.07.003
   Kujala T, 2012, PEDIATR INFECT DIS J, V31, P565, DOI 10.1097/INF.0b013e318255ddde
   Kuo CL, 2014, PEDIATRICS, V134, P983, DOI 10.1542/peds.2014-0323
   Lakic Dragana, 2014, Med Pregl, V67, P282
   Laulajainen-Hongisto A, 2014, INT J PEDIATR OTORHI, V78, P2072, DOI 10.1016/j.ijporl.2014.09.007
   Lebas A, 2012, EUR J PAEDIATR NEURO, V16, P219, DOI 10.1016/j.ejpn.2012.02.005
   Lee HJ, 2012, J KOREAN MED SCI, V27, P835, DOI 10.3346/jkms.2012.27.8.835
   Levy C, 2014, MED MALADIES INFECT, V44, P102, DOI [10.1016/j.medma1.2014.01.005, 10.1016/j.medmal.2014.01.005]
   Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488
   Lildal TK, 2014, DAN MED J, V61
   Lous J, 2011, INT J PEDIATR OTORHI, V75, P1058, DOI 10.1016/j.ijporl.2011.05.009
   Luntz M, 2012, LARYNGOSCOPE, V122, P2813, DOI 10.1002/lary.22193
   Maltezou HC, 2014, MINERVA PEDIATR, V66, P209
   Marchica CL, 2013, INT J PEDIATR OTORHI, V77, P252, DOI 10.1016/j.ijporl.2012.11.010
   Marchisio P, 2014, EXPERT REV ANTI-INFE, V12, P1541, DOI 10.1586/14787210.2014.982093
   Marchisio P, 2014, EXPERT REV ANTI-INFE, V12, P1159, DOI 10.1586/14787210.2014.944503
   Marchisio P, 2013, PEDIATR INFECT DIS J, V32, P1055, DOI 10.1097/INF.0b013e31829be0b0
   Marchisio P, 2013, OTOLARYNG HEAD NECK, V148, pE102, DOI 10.1177/0194599812465397
   Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924
   Mattos JL, 2014, INT J PEDIATR OTORHI, V78, P2161, DOI 10.1016/j.ijporl.2014.09.032
   Mikals SJ, 2014, JAMA OTOLARYNGOL, V140, P95, DOI 10.1001/jamaoto.2013.5842
   Miller BJ, 2013, CLIN OTOLARYNGOL, V38, P525, DOI 10.1111/coa.12195
   Mohamad SH, 2012, OTOL NEUROTOL, V33, P699, DOI 10.1097/MAO.0b013e318254fbc2
   Mohiuddin S, 2015, EUR J HEALTH ECON, V16, P573, DOI 10.1007/s10198-014-0610-8
   Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226
   Morris P., 2012, BMJ CLIN EVID
   Novoa E, 2013, INT J PEDIATR OTORHI, V77, P996, DOI 10.1016/j.ijporl.2013.03.030
   Palma S, 2014, EUR ARCH OTO-RHINO-L, V271, P925, DOI 10.1007/s00405-013-2454-8
   Park Kye Hoon, 2012, Korean J Audiol, V16, P130, DOI 10.7874/kja.2012.16.3.130
   Paulson LM, 2014, INT J PEDIATR OTORHI, V78, P223, DOI 10.1016/j.ijporl.2013.10.062
   Perera R, 2013, COCHRANE DB SYST REV, V5
   Pichichero ME, 2013, PEDIATR INFECT DIS J, V32, P473, DOI 10.1097/INF.0b013e3182862b57
   Principi N, 2013, EUR J CLIN MICROBIOL, V32, P151, DOI 10.1007/s10096-012-1747-y
   Pritchett CV, 2012, ARCH OTOLARYNGOL, V138, P451, DOI 10.1001/archoto.2012.269
   Psarommatis I, 2012, J LARYNGOL OTOL, V126, P1204, DOI 10.1017/S0022215112002332
   Psarommatis IM, 2012, INT J PEDIATR OTORHI, V76, P791, DOI 10.1016/j.ijporl.2012.02.042
   Qureishi A, 2014, J LARYNGOL OTOL, V128, P972, DOI 10.1017/S0022215114002163
   Ropposch T, 2012, INT J PEDIATR OTORHI, V76, P1023, DOI 10.1016/j.ijporl.2012.03.024
   Rosdy B, 2014, INT J PEDIATR OTORHI, V78, P1253, DOI 10.1016/j.ijporl.2014.05.001
   Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813487302
   Ryborg CT, 2013, ISRN FAMILY MED, V2013
   Saki Nader, 2012, Iran J Otorhinolaryngol, V24, P15
   Shviro-Roseman N, 2014, BRAZ J INFECT DIS, V18, P355, DOI 10.1016/j.bjid.2013.11.007
   Sinha MN, 2012, HOMEOPATHY, V101, P5, DOI 10.1016/j.homp.2011.08.003
   Smillie I, 2014, JAMA OTOLARYNGOL, V140, P940, DOI 10.1001/jamaoto.2014.1657
   Smith NSP, 2013, INT J PEDIATR OTORHI, V77, P873, DOI 10.1016/j.ijporl.2013.03.006
   Stenfeldt K, 2014, INT J PEDIATR OTORHI, V78, P1119, DOI 10.1016/j.ijporl.2014.04.027
   Stephen ATN, 2013, MED J AUSTRALIA, V199, P51, DOI 10.5694/mja13.10533
   Sun JQ, 2014, EUR ARCH OTO-RHINO-L, V271, P2923, DOI 10.1007/s00405-013-2778-4
   Syed MI, 2013, COCHRANE DB SYST REV, V4
   Takahashi H, 2012, AURIS NASUS LARYNX, V39, P1, DOI 10.1016/j.anl.2011.09.008
   Tamir SO, 2014, CLIN VACCINE IMMUNOL, V21, P1189, DOI 10.1128/CVI.00289-14
   Tapiainen T, 2014, JAMA PEDIATR, V168, P635, DOI 10.1001/jamapediatrics.2013.5311
   Thanaviratananich S, 2013, COCHRANE DB SYST REV, V12
   Tierney S, 2013, INT J PEDIATR OTORHI, V77, P1742, DOI 10.1016/j.ijporl.2013.08.006
   Ulanovski D, 2014, INT J PEDIATR OTORHI, V78, P930, DOI 10.1016/j.ijporl.2014.03.016
   van Dongen TMA, 2015, PEDIATRICS, V135, pE1182, DOI 10.1542/peds.2014-3141
   van Dongen TMA, 2014, NEW ENGL J MED, V370, P723, DOI 10.1056/NEJMoa1301630
   van Dongen TMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069062
   Van Zon A, 2012, COCHRANE DB SYST REV, V9
   Venekamp RP, 2015, COCHRANE DB SYST REV, V6
   Venekamp RP, 2014, HUISARTS WET, V57, P649
   Venekamp RP, 2014, BMJ CLIN EVID, V2014
   Vernacchio L, 2014, PEDIATRICS, V133, P289, DOI 10.1542/peds.2013-2373
   Walls A, 2015, OTOLARYNG HEAD NECK, V152, P336, DOI 10.1177/0194599814557777
   Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101175
   Wood DN, 2012, INT J PEDIATR OTORHI, V76, P1229, DOI [10.1016/j.ijporl.2012.05.022, 10.1016/j.ijpor1.2012.05.022]
   Wu JF, 2012, ACTA OTO-LARYNGOL, V132, P261, DOI 10.3109/00016489.2011.643239
   Yang FL, 2014, OTOL NEUROTOL, V35, P629, DOI 10.1097/MAO.0000000000000212
   Zangari P, 2012, BLOOD COAGUL FIBRIN, V23, P158, DOI 10.1097/MBC.0b013e328349cafb
NR 122
TC 7
Z9 8
U1 4
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD APR
PY 2017
VL 156
SU 4
BP S88
EP S105
DI 10.1177/0194599816633697
PG 18
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA EW9QE
UT WOS:000402853500007
PM 28372534
DA 2018-10-20
ER

PT J
AU Lee, H
   Jang, TS
   Song, J
   Kim, HE
   Jung, HD
AF Lee, Hyun
   Jang, Tae-Sik
   Song, Juha
   Kim, Hyoun-Ee
   Jung, Hyun-Do
TI The Production of Porous Hydroxyapatite Scaffolds with Graded Porosity
   by Sequential Freeze-Casting
SO MATERIALS
LA English
DT Article
DE freeze-casting; porous materials; porosity; graded structure;
   compressive strengths
ID BONE-GRAFT SUBSTITUTE; MICRO-ARC OXIDATION; MECHANICAL-PROPERTIES; PORE
   CHANNELS; FABRICATION; RECONSTRUCTION; CEMENT; BIOCERAMICS;
   BIOCOMPATIBILITY; BIOMATERIAL
AB Porous hydroxyapatite (HA) scaffolds with porosity-graded structures were fabricated by sequential freeze-casting. The pore structures, compressive strengths, and biocompatibilities of the fabricated porous HA scaffolds were evaluated. The porosities of the inner and outer layers of the graded HA scaffolds were controlled by adjusting the initial HA contents of the casting slurries. The interface between the dense and porous parts was compact and tightly adherent. The porosity and compressive strengths of the scaffold were controlled by the relative thicknesses of the dense/porous parts. In addition, the porous HA scaffolds showed good biocompatibility in terms of preosteoblast cell attachment and proliferation. The results suggest that porous HA scaffolds with load-bearing parts have potential as bone grafts in hard-tissue engineering.
C1 [Lee, Hyun; Jang, Tae-Sik; Kim, Hyoun-Ee] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Jang, Tae-Sik; Song, Juha] Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
   [Kim, Hyoun-Ee] Adv Inst Convergence Technol, Biomed Implant Convergence Res Ctr, Suwon 443270, South Korea.
   [Jung, Hyun-Do] Korea Inst Ind Technol, Liquid Proc & Casting Technol R&D Grp, Incheon 406840, South Korea.
RP Jung, HD (reprint author), Korea Inst Ind Technol, Liquid Proc & Casting Technol R&D Grp, Incheon 406840, South Korea.
EM akusaya@snu.ac.kr; cgamja@snu.ac.kr; songjuha@ntu.edu.sg;
   kimhe@snu.ac.kr; jhd1357@kitech.re.kr
RI Song, Juha/P-1927-2017
OI Song, Juha/0000-0002-3503-680X; Jung, Hyun-Do/0000-0001-8632-7431
FU Basic Science Research Program through the National Research Foundation
   of Korea and Technology Innovation Program - Ministry of Education
   [2015R1D1A1A01057311, 10037915]; Ministry of Trade, Industry Energy
FX This research was supported by Basic Science Research Program (No.
   2015R1D1A1A01057311) through the National Research Foundation of Korea
   and Technology Innovation Program (10037915, WPM Biomedical
   Materials-Implant Materials) funded by the Ministry of Education and the
   Ministry of Trade, Industry & Energy.
CR BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Diez M., 2016, J MATER SCI-MATER M, V27, P1
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Fu Q, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025005
   Goldstein SA, 1987, BIOMECHANICS, V20, P1055, DOI DOI 10.1016/0021-9290(87)90023-6
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jo IH, 2009, MATER LETT, V63, P1702, DOI 10.1016/j.matlet.2009.05.017
   Jung H.D., 2015, JOVE-J VIS EXP, V106
   Jung HD, 2015, BIOMATERIALS, V37, P49, DOI 10.1016/j.biomaterials.2014.10.027
   Jung HD, 2009, MATER LETT, V63, P1545, DOI 10.1016/j.matlet.2009.04.012
   Kang MH, 2016, MAT SCI ENG C-MATER, V62, P634, DOI 10.1016/j.msec.2016.01.085
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   Kim J, 2011, INT J PRECIS ENG MAN, V12, P695, DOI 10.1007/s12541-011-0090-z
   Kim M., 2009, KOR J MAT RES, V19, P680
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Koh YH, 2006, J AM CERAM SOC, V89, P3646, DOI 10.1111/j.1551-2916.2006.01311.x
   KVETON JF, 1995, AM J OTOL, V16, P465
   Lee EJ, 2007, MATER LETT, V61, P2270, DOI 10.1016/j.matlet.2006.08.065
   Lee H, 2016, MATER LETT, V185, P21, DOI 10.1016/j.matlet.2016.08.075
   Lee SH, 2008, J AM CERAM SOC, V91, P1912, DOI 10.1111/j.1551-2916.2008.02359.x
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Liu F.H., 2011, WORLD ACAD SCI ENG T, V76, P214
   Miao XG, 2010, MATERIALS, V3, P26, DOI 10.3390/ma3010026
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Pavon JJ, 2015, J MATER SCI, V50, P6103, DOI 10.1007/s10853-015-9163-1
   Rabiee SM, 2010, J MOL STRUCT, V969, P172, DOI 10.1016/j.molstruc.2010.01.068
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Redondo LM, 1995, INT J ORAL MAX SURG, V24, P445, DOI 10.1016/S0901-5027(05)80475-8
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   Suk MJ, 2003, MET MATER-INT, V9, P599, DOI 10.1007/BF03027261
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   Yook SW, 2012, ACTA BIOMATER, V8, P2401, DOI 10.1016/j.actbio.2012.03.020
   Zhang RB, 2016, CERAM INT, V42, P6046, DOI 10.1016/j.ceramint.2015.12.161
NR 46
TC 3
Z9 3
U1 3
U2 24
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2017
VL 10
IS 4
AR 367
DI 10.3390/ma10040367
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA EW9ML
UT WOS:000402843800042
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rabadan-Ros, R
   Aznar-Cervantes, S
   Mazon, P
   Ros-Tarraga, P
   De Aza, PN
   Meseguer-Olmo, L
AF Rabadan-Ros, Ruben
   Aznar-Cervantes, Salvador
   Mazon, Patricia
   Ros-Tarraga, Patricia
   De Aza, Piedad N.
   Meseguer-Olmo, Luis
TI Nurse's A-Phase Material Enhance Adhesion, Growth and Differentiation of
   Human Bone Marrow-Derived Stromal Mesenchymal Stem Cells
SO MATERIALS
LA English
DT Article
DE TCP-C2S Nurse's A-phase ceramic; biomaterials; adult human mesenchymal
   stem cells; solid state reaction; biomedical applications
ID CURRENT TRENDS; IN-VITRO; PROLIFERATION; BIOMATERIALS; PERSPECTIVE;
   KINETICS; SCAFFOLD
AB The purpose of this study was to evaluate the bioactivity and cell response of a well-characterized Nurse's A-phase (7CaO center dot P2O5 center dot 2SiO(2)) ceramic and its effect compared to a control (tissue culture polystyrene-TCPS) on the adhesion, viability, proliferation, and osteogenic differentiation of ahMSCs in vitro. Cell proliferation (Alamar Blue Assay), Alizarin Red-S (AR-s) staining, alkaline phosphatase (ALP) activity, osteocalcin (OCN), and collagen I (Col I) were evaluated. Also, field emission scanning electron microscopy (FESEM) images were acquired in order to visualise the cells and the topography of the material. The proliferation of cells growing in a direct contact with the material was slower at early stages of the study because of the new environmental conditions. However, the entire surface was colonized after 28 days of culture in growth medium (GM). Osteoblastic differentiation markers were significantly enhanced in cells growing on Nurse's A phase ceramic and cultured with osteogenic medium (OM), probably due to the role of silica to stimulate the differentiation of ahMSCs. Moreover, calcium nodules were formed under the influence of ceramic material. Therefore, it is predicted that Nurse's A-phase ceramic would present high biocompatibility and osteoinductive properties and would be a good candidate to be used as a biomaterial for bone tissue engineering.
C1 [Rabadan-Ros, Ruben; Ros-Tarraga, Patricia; Meseguer-Olmo, Luis] Univ Catolica San Antonio Murcia UCAM, Grp Regenerac & Reparac Tejidos Ortobiol Biomat &, Murcia 30107, Spain.
   [Aznar-Cervantes, Salvador] Inst Murciano Invest & Desarrollo Agr & Alimentar, Dept Biotechnol, Murcia 30150, Spain.
   [Mazon, Patricia] Univ Miguel Hernandez, Dept Mat Opt & Tecnol Elect, Avda Univ S-N, Alicante 03202, Spain.
   [De Aza, Piedad N.] Univ Miguel Hernandez, Inst Bioingn, Avda Univ S-N, Alicante 03202, Spain.
   [Meseguer-Olmo, Luis] Hosp Clin Univ Virgen de la Arrixaca, Serv Cirugia Ortoped & Traumatol, Murcia 30120, Spain.
RP Rabadan-Ros, R (reprint author), Univ Catolica San Antonio Murcia UCAM, Grp Regenerac & Reparac Tejidos Ortobiol Biomat &, Murcia 30107, Spain.
EM rubenrabadanros@gmail.com; sdac1@um.es; pmazon@umh.es;
   p.ros.tarraga@gmail.com; piedad@umh.es; lmeseguer.doc@gmail.com
RI De Aza, Piedad/A-7621-2015; Ros Tarraga, Patricia/R-5661-2018; Patricia,
   Mazon Canales/P-5067-2015
OI De Aza, Piedad/0000-0001-9316-4407; Ros Tarraga,
   Patricia/0000-0002-8643-4090; Patricia, Mazon
   Canales/0000-0001-7704-7577; Rabadan-Ros, Ruben/0000-0003-2990-4620;
   AZNAR CERVANTES, SALVADOR/0000-0001-9809-7215; Meseguer-Olmo,
   Luis/0000-0003-3858-8148
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [MAT2013-48426-C2-2-R]
FX Part of this work was supported by the Spanish Ministry of Economy and
   Competitiveness (MINECO) contract grant number: MAT2013-48426-C2-2-R.
CR Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   De Aza PN, 2016, CLIN ORAL IMPLAN RES, V27, P1368, DOI 10.1111/clr.12745
   De Aza PN, 2013, MAT SCI ENG C-MATER, V33, P4009, DOI 10.1016/j.msec.2013.05.043
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dong M, 2016, BIOL TRACE ELEM RES, V173, P306, DOI 10.1007/s12011-016-0686-3
   Garcia-Paez IH, 2014, J MECH BEHAV BIOMED, V30, P1, DOI 10.1016/j.jmbbm.2013.10.011
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002
   Hild N, 2011, NANOSCALE, V3, P401, DOI 10.1039/c0nr00615g
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Kular J. K., 2014, J TISS ENG, V5
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lugo GJ, 2015, J EUR CERAM SOC, V35, P3693, DOI 10.1016/j.jeurceramsoc.2015.04.036
   Lugo GJ, 2016, CERAM INT, V42, P673, DOI 10.1016/j.ceramint.2015.08.164
   Lugo GJ, 2015, J AM CERAM SOC, V98, P3042, DOI 10.1111/jace.13747
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rabadan-Ros R., 2016, MATERIALS, V9
   Ros-Tarraga P., 2016, MATERIALS, P9
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Taherkhani S, 2016, J SOL-GEL SCI TECHN, V78, P539, DOI 10.1007/s10971-016-3995-2
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
NR 32
TC 2
Z9 2
U1 2
U2 7
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2017
VL 10
IS 4
AR 347
DI 10.3390/ma10040347
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA EW9ML
UT WOS:000402843800022
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ling, SJ
   Qin, Z
   Huang, WW
   Cao, SF
   Kaplan, DL
   Buehler, MJ
AF Ling, Shengjie
   Qin, Zhao
   Huang, Wenwen
   Cao, Sufeng
   Kaplan, David L.
   Buehler, Markus J.
TI Design and function of biomimetic multilayer water purification
   membranes
SO SCIENCE ADVANCES
LA English
DT Article
ID MULTIWALLED CARBON NANOTUBES; HEAVY-METAL IONS; AQUEOUS-SOLUTION;
   POLYELECTROLYTE MEMBRANES; MOLECULE SEPARATION; WASTE-WATER; ADSORPTION;
   REMOVAL; COMPOSITES; TRANSPORT
AB Multilayer architectures in water purification membranes enable increased water throughput, high filter efficiency, and high molecular loading capacity. However, the preparation of membranes with well-organized multilayer structures, starting from the nanoscale to maximize filtration efficiency, remains a challenge. We report a complete strategy to fully realize a novel biomaterial-based multilayer nanoporous membrane via the integration of computational simulation and experimental fabrication. Our comparative computational simulations, based on coarsegrained models of protein nanofibrils and mineral plates, reveal that the multilayer structure can only form with weak interactions between nanofibrils and mineral plates. We demonstrate experimentally that silk nanofibril (SNF) and hydroxyapatite (HAP) can be used to fabricate highly ordered multilayer membranes with nanoporous features by combining protein self-assembly and in situ biomineralization. The production is optimized to be a simple and highly repeatable process that does not require sophisticated equipment and is suitable for scaled production of low-cost water purification membranes. These membranes not only show ultrafast water penetration but also exhibit broad utility and high efficiency of removal and even reuse (in some cases) of contaminants, including heavy metal ions, dyes, proteins, and other nanoparticles in water. Our biomimetic design and synthesis of these functional SNF/HAP materials have established a paradigm that could lead to the large-scale, low-cost production of multilayer materials with broad spectrum and efficiency for water purification, with applications in wastewater treatment, biomedicine, food industry, and the life sciences.
C1 [Ling, Shengjie; Qin, Zhao; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Ling, Shengjie; Huang, Wenwen; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Cao, Sufeng] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; mbuehler@mit.edu
RI Huang, Wenwen/H-5352-2018; Qin, Zhao/B-4667-2010
OI Huang, Wenwen/0000-0001-8175-9083; Qin, Zhao/0000-0001-5696-8553
FU NSF [1541959]; NIH [U01 EB014976]; Office of Naval Research
   [N00014-16-1-2333]; Air Force Office of Scientific Research
   [FA9550-11-1-0199]
FX We acknowledge the Harvard University Center for Nanoscale Systems (CNS)
   for providing AFM and SEM measurements. The CNS is a member of the
   National Nanotechnology Coordinated Infrastructure Network, which is
   supported by the NSF under award no. 1541959. Funding: This work was
   supported by NIH (U01 EB014976). Additional support was provided by the
   Office of Naval Research (N00014-16-1-2333) and Air Force Office of
   Scientific Research (FA9550-11-1-0199).
CR Afkhami A, 2010, J HAZARD MATER, V181, P836, DOI 10.1016/j.jhazmat.2010.05.089
   Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1
   Baker R. W., 2012, MEMBRANE TECHNOLOGY
   Balachandra AM, 2002, MACROMOLECULES, V35, P3171, DOI 10.1021/ma0116349
   Banerjee IA, 2003, P NATL ACAD SCI USA, V100, P14678, DOI 10.1073/pnas.2433456100
   Bertaud J, 2009, J STRAIN ANAL ENG, V44, P517, DOI 10.1243/03093247JSA533
   Bolisetty S, 2016, NAT NANOTECHNOL, V11, P365, DOI [10.1038/NNANO.2015.310, 10.1038/nnano.2015.310]
   Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v
   Braeken L, 2006, J PHYS CHEM B, V110, P2957, DOI 10.1021/jp0534333
   Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758
   Cao CY, 2010, J PHYS CHEM C, V114, P9865, DOI 10.1021/jp101553x
   Chen CL, 2006, IND ENG CHEM RES, V45, P9144, DOI 10.1021/ie060791z
   Chen CL, 2009, J HAZARD MATER, V164, P923, DOI 10.1016/j.jhazmat.2008.08.089
   Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001
   Chen YH, 2010, J COLLOID INTERF SCI, V347, P277, DOI 10.1016/j.jcis.2010.03.050
   Chen Z, 2008, J HAZARD MATER, V155, P327, DOI 10.1016/j.jhazmat.2007.11.064
   Cheng C, 2013, LANGMUIR, V29, P1885, DOI 10.1021/la304574e
   Choi H, 2006, ADV FUNCT MATER, V16, P1067, DOI 10.1002/adfm.200500658
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Deng C, 2013, NANOSCALE, V5, P11028, DOI 10.1039/c3nr03362g
   Eguizabal A, 2014, J MEMBRANE SCI, V454, P243, DOI 10.1016/j.memsci.2013.12.006
   Fang GQ, 2016, MAT SCI ENG C-MATER, V64, P376, DOI 10.1016/j.msec.2016.03.113
   Farhat TR, 2003, J AM CHEM SOC, V125, P4627, DOI 10.1021/ja021448y
   Fei X, 2013, BIOMACROMOLECULES, V14, P4483, DOI 10.1021/bm4014149
   Fei X, 2013, NANOSCALE, V5, P7991, DOI 10.1039/c3nr01872e
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Gao SJ, 2015, J MATER CHEM A, V3, P6649, DOI 10.1039/c5ta00366k
   GLAVEE GN, 1994, LANGMUIR, V10, P4726, DOI 10.1021/la00024a055
   He JB, 2011, NANO LETT, V11, P2430, DOI 10.1021/nl200841a
   Hirota M, 2009, CELLULOSE, V16, P841, DOI 10.1007/s10570-009-9296-y
   Hokkanen S, 2016, WATER RES, V91, P156, DOI 10.1016/j.watres.2016.01.008
   Hokkanen S, 2013, CHEM ENG J, V223, P40, DOI 10.1016/j.cej.2013.02.054
   Hu J, 2005, WATER RES, V39, P4528, DOI 10.1016/j.watres.2005.05.051
   Hu J, 2006, J ENVIRON ENG-ASCE, V132, P709, DOI 10.1061/(ASCE)0733-9372(2006)132:7(709)
   Hu XJ, 2013, SEP PURIF TECHNOL, V108, P189, DOI 10.1016/j.seppur.2013.02.011
   Huang HB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3979
   International Agency for Research on Cancer, 2012, AG CLASS IARC MON, V87
   International Agency for Research on Cancer, 2012, AG CLASS IARC MON, V49
   Isobe N, 2013, J HAZARD MATER, V260, P195, DOI 10.1016/j.jhazmat.2013.05.024
   Joseph N, 2014, POLYM CHEM-UK, V5, P1817, DOI 10.1039/c3py01262j
   Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711
   Jung JM, 2010, LANGMUIR, V26, P504, DOI 10.1021/la9021432
   Kabbashi NA, 2009, J ENVIRON SCI-CHINA, V21, P539, DOI 10.1016/S1001-0742(08)62305-0
   Karan S, 2013, J MEMBRANE SCI, V448, P270, DOI 10.1016/j.memsci.2013.07.068
   Karan S, 2012, SCIENCE, V335, P444, DOI 10.1126/science.1212101
   Koivula R, 2009, SEP PURIF TECHNOL, V70, P53, DOI 10.1016/j.seppur.2009.08.014
   Koley P, 2016, RSC ADV, V6, P86607, DOI 10.1039/c6ra12818a
   Kowshik M, 2002, ADV MATER, V14, P815, DOI 10.1002/1521-4095(20020605)14:11<815::AID-ADMA815>3.0.CO;2-K
   Krieg E, 2011, NAT NANOTECHNOL, V6, P141, DOI 10.1038/NNANO.2010.274
   Lee YM, 2014, ADV MATER, V26, P3899, DOI 10.1002/adma.201305862
   Li CX, 2014, ADV MATER, V26, P3207, DOI 10.1002/adma.201306198
   Li Y, 2012, CHEM SOC REV, V41, P5998, DOI 10.1039/c2cs35107b
   Li YH, 2003, CARBON, V41, P2787, DOI 10.1016/S0008-6223(03)00392-0
   Li YH, 2002, CHEM PHYS LETT, V357, P263, DOI 10.1016/S0009-2614(02)00502-X
   Li YH, 2003, CARBON, V41, P1057, DOI 10.1016/S0008-6223(02)00440-2
   Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004
   Liang HW, 2010, ADV MATER, V22, P4691, DOI 10.1002/adma.201001863
   Liang P, 2004, J ANAL ATOM SPECTROM, V19, P1489, DOI 10.1039/b409619c
   Lin TJ, 2016, J PHYS CHEM C, V120, P4975, DOI 10.1021/acs.jpcc.5b12504
   Ling SJ, 2016, ADV MATER, V28, P7783, DOI 10.1002/adma.201601783
   Ling SJ, 2016, NANO LETT, V16, P3795, DOI 10.1021/acs.nanolett.6b01195
   Ling SJ, 2014, ADV MATER, V26, P4569, DOI 10.1002/adma.201400730
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Liu XY, 2004, CHEM MATER, V16, P351, DOI 10.1021/cm034559k
   Lu CY, 2006, J CHEM TECHNOL BIOT, V81, P1932, DOI 10.1002/jctb.1626
   Lu CY, 2006, CHEM ENG SCI, V61, P1138, DOI 10.1016/j.ces.2005.08.007
   Lu YY, 2007, CHEM MATER, V19, P3194, DOI 10.1021/cm070200a
   Matsumoto T, 2002, BIOMATERIALS, V23, P2241, DOI 10.1016/S0142-9612(01)00358-1
   Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752
   Mourhatch R, 2010, J MEMBRANE SCI, V356, P138, DOI 10.1016/j.memsci.2010.03.045
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Pakarinen J, 2010, J HAZARD MATER, V180, P234, DOI 10.1016/j.jhazmat.2010.04.019
   Pakarinen J, 2009, SEPAR SCI TECHNOL, V44, P3045, DOI 10.1080/01496390903183329
   Peng XS, 2007, ADV FUNCT MATER, V17, P1849, DOI 10.1002/adfm.200600911
   Peng XS, 2009, NAT NANOTECHNOL, V4, P353, DOI [10.1038/nnano.2009.90, 10.1038/NNANO.2009.90]
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Pu XL, 2004, J ANAL ATOM SPECTROM, V19, P984, DOI 10.1039/b403389b
   Qin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3187
   Qu XL, 2013, ACCOUNTS CHEM RES, V46, P834, DOI 10.1021/ar300029v
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P3630, DOI 10.1002/app.33059
   Reichert J, 1996, J MATER SCI, V31, P1231, DOI 10.1007/BF00353102
   Richardson JJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2491
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   Smuleac V, 2006, LANGMUIR, V22, P10118, DOI 10.1021/la061124d
   Striemer CC, 2007, NATURE, V445, P749, DOI 10.1038/nature05532
   Sun LW, 2014, ACS NANO, V8, P6304, DOI 10.1021/nn501786m
   Sun LW, 2013, CHEM COMMUN, V49, P10718, DOI 10.1039/c3cc46136j
   Tao JH, 2007, J PHYS CHEM B, V111, P13410, DOI 10.1021/jp0732918
   Vandezande P, 2008, CHEM SOC REV, V37, P365, DOI 10.1039/b610848m
   Vankelecom I. F. J., 2005, NANOFILTRATION PRINC
   Wang HJ, 2007, J COLLOID INTERF SCI, V316, P277, DOI 10.1016/j.jcis.2007.07.075
   Wang JS, 2011, CARBOHYD POLYM, V84, P1169, DOI 10.1016/j.carbpol.2011.01.007
   Wang QF, 2011, ADV MATER, V23, P2004, DOI 10.1002/adma.201100475
   Wang XB, 2010, J MATER CHEM, V20, P8582, DOI 10.1039/c0jm01024c
   Werber J. R., 2016, NAT REV MAT
   World Health Organization, 2011, GUID DRINK WAT QUAL
   Yu XL, 2013, J ENVIRON SCI-CHINA, V25, P933, DOI 10.1016/S1001-0742(12)60145-4
   Zhang HG, 2005, CHEM LETT, V34, P788, DOI 10.1246/cl.2005.788
   Zhang Qiliang, 2011, MODERN ED TECHNOLOGY, V21, P2011
   Zhang QG, 2016, ADV FUNCT MATER, V26, P792, DOI 10.1002/adfm.201503858
   Zhao GX, 2011, ENVIRON SCI TECHNOL, V45, P10454, DOI 10.1021/es203439v
   Zhou Y, 2001, CHEM COMMUN, P2518, DOI 10.1039/b108013j
NR 102
TC 19
Z9 19
U1 36
U2 117
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD APR
PY 2017
VL 3
IS 4
AR e1601939
DI 10.1126/sciadv.1601939
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV7KR
UT WOS:000401954800015
PM 28435877
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Geelhoed, WJ
   Moroni, L
   Rotmans, JI
AF Geelhoed, Wouter J.
   Moroni, Lorenzo
   Rotmans, Joris I.
TI Utilizing the Foreign Body Response to Grow Tissue Engineered Blood
   Vessels in Vivo
SO JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
LA English
DT Article
DE Vascular tissue engineering; Tissue engineering; In vivo tissue
   engineering; Graft; Vascular graft; Vasculature; Vascular access; Animal
   models; Translational; Graft patency; Foreign body response
ID ACUTE INFLAMMATORY RESPONSES; BIOTUBE VASCULAR GRAFTS; GIANT-CELL
   FORMATION; EXTRACELLULAR-MATRIX; SPARKS-MANDRIL; COMPLEMENT ACTIVATION;
   MOLECULAR-BASIS; ELASTIC FIBER; FOLLOW-UP; BIOMATERIALS
AB It is well known that the number of patients requiring a vascular grafts for use as vessel replacement in cardiovascular diseases, or as vascular access site for hemodialysis is ever increasing. The development of tissue engineered blood vessels (TEBV's) is a promising method to meet this increasing demand vascular grafts, without having to rely on poorly performing synthetic options such as polytetrafluoroethylene (PTFE) or Dacron. The generation of in vivo TEBV's involves utilizing the host reaction to an implanted biomaterial for the generation of completely autologous tissues. Essentially this approach to the development of TEBV's makes use of the foreign body response to biomaterials for the construction of the entire vascular replacement tissue within the patient's own body. In this review we will discuss the method of developing in vivo TEBV's, and debate the approaches of several research groups that have implemented this method.
C1 [Geelhoed, Wouter J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands.
   [Geelhoed, Wouter J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Eindhoven Lab Expt Vasc Med, Leiden, Netherlands.
   [Moroni, Lorenzo] Maastricht Univ, Complex Tissue Regenerat, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Netherlands.
RP Rotmans, JI (reprint author), Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands.; Rotmans, JI (reprint author), Leiden Univ, Med Ctr, Eindhoven Lab Expt Vasc Med, Leiden, Netherlands.
EM j.i.rotmans@lumc.nl
OI Moroni, Lorenzo/0000-0003-1298-6025
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aslam S, 2014, J AM SOC NEPHROL, V25, P2927, DOI 10.1681/ASN.2013091009
   Bambrah RK, 2013, THER ADV CHRONIC DIS, V4, P302, DOI 10.1177/2040622313494987
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Brouty-Boye D, 2000, EUR J IMMUNOL, V30, P914, DOI 10.1002/1521-4141(200003)30:3<914::AID-IMMU914>3.0.CO;2-D
   Byrom MJ, 2010, J VASC SURG, V52, P176, DOI 10.1016/j.jvs.2009.10.080
   Campbell GR, 2007, CURR PHARM BIOTECHNO, V8, P43, DOI 10.2174/138920107779941426
   Campbell JH, 1999, CIRC RES, V85, P1173
   Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003
   Cummings I, 2012, EUR J CARDIO-THORAC, V41, P167, DOI 10.1016/j.ejcts.2011.02.077
   Damanik FFR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06325
   Dao H, 2007, GENDER MED, V4, P308
   Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930
   Farndale RW, 2004, J THROMB HAEMOST, V2, P561, DOI 10.1111/j.1538-7836.2004.00665.x
   Furukoshi M, 2016, J ARTIF ORGANS, V19, P54, DOI 10.1007/s10047-015-0859-4
   Gemmiti CV, 2009, BIOTECHNOL BIOENG, V104, P809, DOI 10.1002/bit.22440
   Ghosh AK, 2002, J EXP MED, V195, P973, DOI 10.1084/jem.20011782
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GUIDOIN R, 1984, J MAL VASCUL, V9, P277
   Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731
   HALLIN RW, 1975, AM SURGEON, V41, P550
   HALLIN RW, 1976, AM J SURG, V132, P221, DOI 10.1016/0002-9610(76)90051-9
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hirsh SL, 2013, COLLOID SURFACE B, V103, P395, DOI 10.1016/j.colsurfb.2012.10.039
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jadlowiec CC, 2015, ANN VASC SURG, V29, P1642, DOI 10.1016/j.avsg.2015.07.009
   Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749
   Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kainz A, 2015, NEPHROL DIAL TRANSPL, V30, P113, DOI 10.1093/ndt/gfv073
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Knapp J, 2016, MIL MED, V181, P240, DOI 10.7205/MILMED-D-15-00154
   Kourtzelis I, 2013, FASEB J, V27, P2768, DOI 10.1096/fj.12-225888
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Lawson JH, 2016, LANCET, V387, P2026, DOI 10.1016/S0140-6736(16)00557-2
   Lindner D, 2012, BIOCHEM RES INT, DOI 10.1155/2012/875742
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Maroz Natallia, 2013, J Am Coll Clin Wound Spec, V5, P2, DOI 10.1016/j.jccw.2014.05.002
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828
   Nakayama Y, 2014, J BIOMED MATER RES B, V102, P231, DOI 10.1002/jbm.b.32999
   Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345
   Oie T, 2010, J ARTIF ORGANS, V13, P235, DOI 10.1007/s10047-010-0517-9
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Pashneh-Tala S, 2016, TISSUE ENG PART B-RE, V22, P68, DOI 10.1089/ten.teb.2015.0100
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   PEIRCE EC, 1953, SURGERY, V33, P648
   Petersen E, 2002, EUR J VASC ENDOVASC, V24, P440, DOI 10.1053/ejvs.2002.1750
   Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   ROBERTS PN, 1977, BRIT MED J, V2, P1190, DOI 10.1136/bmj.2.6096.1190-a
   ROSE JR, 1993, FASEB J, V7, pA1208
   Rothuizen TC, 2016, TISSUE ENG PART C-ME, V22, P923, DOI [10.1089/ten.tec.2016.0173, 10.1089/ten.TEC.2016.0173]
   Rothuizen TC, 2016, BIOMATERIALS, V75, P82, DOI 10.1016/j.biomaterials.2015.10.023
   Rothuizen TC, 2015, TISSUE ENG PART C-ME, V21, P436, DOI [10.1089/ten.tec.2014.0264, 10.1089/ten.TEC.2014.0264]
   Rotmans J. I., 2014, OPEN UROLOGY NEPHROL, V7
   Rotmans JI, 2005, J NEPHROL, V18, P9
   Rotmans JI, 2006, CAN J CARDIOL, V22, P1113, DOI 10.1016/S0828-282X(06)70946-1
   Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.0590062325.x
   Sakai O, 2009, J BIOMED MATER RES B, V90B, P412, DOI 10.1002/jbm.b.31300
   Sato M, 2002, ASAIO J, V48, P360, DOI 10.1097/00002480-200207000-00006
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Shah A, 2011, J TISSUE ENG REGEN M, V5, P301, DOI 10.1002/term.316
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Sparks C H, 1969, Ann Thorac Surg, V8, P104
   SPARKS CH, 1973, ANN SURG, V177, P293, DOI 10.1097/00000658-197303000-00009
   Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041
   Strang AC, 2014, J VASC ACCESS, V15, P95, DOI 10.5301/jva.5000166
   Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Teirstein PS, 2000, CIRCULATION, V101, P360, DOI 10.1161/01.CIR.101.4.360
   Tsukagoshi T, 1999, J RECONSTR MICROSURG, V15, P127, DOI 10.1055/s-2007-1000083
   Tzoulaki I, 2016, CIRCULATION, V133, P2314, DOI 10.1161/CIRCULATIONAHA.115.008718
   Verhagen HJM, 1996, BRIT J HAEMATOL, V95, P542, DOI 10.1046/j.1365-2141.1996.d01-1935.x
   Vouyouka AG, 2001, J VASC SURG, V33, P1263, DOI 10.1067/mva.2001.113579
   WALLACE DG, 1992, J BIOMED MATER RES, V26, P1517, DOI 10.1002/jbm.820261110
   Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841
   Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510
   Weigand A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-192
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Yamanami M, 2013, J ARTIF ORGANS, V16, P59, DOI 10.1007/s10047-012-0676-y
   Yates CC, 2012, BIRTH DEFECTS RES C, V96, P325, DOI 10.1002/bdrc.21024
NR 100
TC 3
Z9 2
U1 4
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1937-5387
EI 1937-5395
J9 J CARDIOVASC TRANSL
JI J. Cardiovasc. Transl. Res.
PD APR
PY 2017
VL 10
IS 2
SI SI
BP 167
EP 179
DI 10.1007/s12265-017-9731-7
PG 13
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental
SC Cardiovascular System & Cardiology; Research & Experimental Medicine
GA EV4IP
UT WOS:000401723000008
PM 28205013
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Tam, H
   Zhang, W
   Infante, D
   Parchment, N
   Sacks, M
   Vyavahare, N
AF Tam, H.
   Zhang, W.
   Infante, D.
   Parchment, N.
   Sacks, M.
   Vyavahare, N.
TI Fixation of Bovine Pericardium-Based Tissue Biomaterial with
   Irreversible Chemistry Improves Biochemical and Biomechanical Properties
SO JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
LA English
DT Article
DE Cardiovascular biomaterial durability; Soft tissue biomechanics;
   Permanent set; Extracellular matrix stabilization; Structural
   degradation
ID BIOPROSTHETIC HEART-VALVES; AORTIC-WALL CALCIFICATION; CROSS-LINKING;
   SOFT-TISSUE; SHEEP MODEL; GLUTARALDEHYDE FIXATION; ELASTIN; COLLAGEN;
   MECHANISMS; CUSP
AB Bioprosthetic heart valves (BHVs), derived from glutaraldehyde crosslinked (GLUT) porcine aortic valve leaflets or bovine pericardium (BP), are used to replace defective heart valves. However, valve failure can occur within 12-15 years due to calcification and/or progressive structural degeneration. We present a novel fabrication method that utilizes carbodiimide, neomycin trisulfate, and pentagalloyl glucose crosslinking chemistry (TRI) to better stabilize the extracellular matrix of BP. We demonstrate that TRI-treated BP is more compliant than GLUT-treated BP. GLUT-treated BP exhibited permanent geometric deformation and complete alteration of apparent mechanical properties when subjected to induced static strain. TRI BP, on the other hand, did not exhibit such permanent geometric deformations or significant alterations of apparent mechanical properties. TRI BP also exhibited better resistance to enzymatic degradation in vitro and calcification in vivo when implanted subcutaneously in juvenile rats for up to 30 days.
C1 [Tam, H.; Infante, D.; Parchment, N.; Vyavahare, N.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Zhang, W.; Sacks, M.] Univ Texas Austin, Dept Biomed Engn, Austin, TX USA.
RP Vyavahare, N (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
EM narenv@clemson.edu
FU National Institutes of Health [R01HL108330, P20GM103444]; Hunter
   Endowment
FX This work was supported by the National Institutes of Health
   (R01HL108330 and P20GM103444) and Hunter Endowment to NRV.
CR Aslam AK, 2007, INT J CARDIOL, V122, P99, DOI 10.1016/j.ijcard.2006.12.037
   Bezuidenhout D, 2009, BIOTECHNOL APPL BIOC, V54, P133, DOI 10.1042/BA20090101
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Butany J., 2013, ISRN BIOMATER, P1, DOI DOI 10.5402/2013/728791
   Chiang YTP, 2014, JAMA-J AM MED ASSOC, V312, P1323, DOI 10.1001/jama.2014.12679
   Chow JP, 2013, BIOMATERIALS, V34, P685, DOI 10.1016/j.biomaterials.2012.09.081
   Christian AJ, 2014, BIOMATERIALS, V35, P2097, DOI 10.1016/j.biomaterials.2013.11.045
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   Gott JP, 1997, ANN THORAC SURG, V64, P50, DOI 10.1016/S0003-4975(97)00118-5
   Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]
   Gratzer PF, 2001, J BIOMED MATER RES, V58, P172, DOI 10.1002/1097-4636(2001)58:2<172::AID-JBM1004>3.0.CO;2-9
   Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016
   Lee TC, 2001, J BIOMECH, V34, P203, DOI 10.1016/S0021-9290(00)00187-1
   Levy RJ, 2003, J HEART VALVE DIS, V12, P209
   Manji RA, 2012, AM HEART J, V164, P177, DOI 10.1016/j.ahj.2012.05.011
   Martin C, 2013, BIOMECH MODEL MECHAN, V12, P645, DOI 10.1007/s10237-012-0431-6
   Mohammadi H, 2011, MED ENG PHYS, V33, P131, DOI 10.1016/j.medengphy.2010.09.017
   Nashef A, 2003, J HEART VALVE DIS, V12, P100
   Nimni M. E., 1989, CALCIFICATION CARDIO
   Ogle MF, 2003, ANN THORAC SURG, V75, P1267, DOI 10.1016/S0003-4975(02)04489-2
   Perrotta I, 2011, HISTOPATHOLOGY, V59, P504, DOI 10.1111/j.1365-2559.2011.03977.x
   Rucker R B, 1974, Adv Exp Med Biol, V48, P185
   Sacks M S, 2001, J Long Term Eff Med Implants, V11, P231
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911
   SCOTT M, 1995, ANN THORAC SURG, V60, pS391, DOI 10.1016/0003-4975(95)00263-K
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Shang H, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5829-8
   Siddiqui RF, 2009, HISTOPATHOLOGY, V55, P135, DOI 10.1111/j.1365-2559.2008.03190.x
   Smith DB, 1997, J HEART VALVE DIS, V6, P424
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Takkenberg J. J., 2002, EUR J CARDIO-THORAC, V21, P691
   Takkenberg JJM, 2002, EUR J CARDIO-THORAC, V21, P683, DOI 10.1016/S1010-7940(02)00025-8
   Tam H, 2015, BIOMATERIALS, V66, P83, DOI 10.1016/j.biomaterials.2015.07.011
   Trantina-Yates A, 2001, ANN THORAC SURG, V71, pS422, DOI 10.1016/S0003-4975(01)02502-4
   Trantina-Yates AE, 2003, J HEART VALVE DIS, V12, P93
   Tripi DR, 2014, J BIOMATER APPL, V28, P757, DOI 10.1177/0885328213479047
   Vesely I, 1998, J BIOMECH, V31, P115
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Vyavahare N, 1997, CIRCULATION, V95, P479
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wright G, 2015, J HEART VALVE DIS, V24, P386
   Yang B, 2015, BIOMED OPT EXPRESS, V6, P1520, DOI 10.1364/BOE.6.001520
   Zhang W, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029266
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
   Zilla P, 2001, J CARDIAC SURG, V16, P467, DOI 10.1111/j.1540-8191.2001.tb00551.x
   Zilla P, 2001, J BIOMED MATER RES, V56, P56, DOI 10.1002/1097-4636(200107)56:1<56::AID-JBM1068>3.0.CO;2-3
   Zilla P, 2008, BIOMATERIALS, V29, P385, DOI 10.1016/j.biomaterials.2007.09.033
NR 53
TC 2
Z9 2
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1937-5387
EI 1937-5395
J9 J CARDIOVASC TRANSL
JI J. Cardiovasc. Transl. Res.
PD APR
PY 2017
VL 10
IS 2
SI SI
BP 194
EP 205
DI 10.1007/s12265-017-9733-5
PG 12
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental
SC Cardiovascular System & Cardiology; Research & Experimental Medicine
GA EV4IP
UT WOS:000401723000010
PM 28213846
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Brady, AJ
   Laverty, G
   Gilpin, DF
   Kearney, P
   Tunney, M
AF Brady, Aaron J.
   Laverty, Garry
   Gilpin, Deirdre F.
   Kearney, Patricia
   Tunney, Michael
TI Antibiotic susceptibility of planktonic-and biofilm-grown staphylococci
   isolated from implant-associated infections: should MBEC and nature of
   biofilm formation replace MIC?
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE antibiotic susceptibility; antibiotic resistance; biofilms;
   biomaterials; indwelling devices
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   INDEPENDENT BIOFILM; ANTIMICROBIAL AGENTS; ICA LOCUS; EPIDERMIDIS;
   AUREUS; EXPRESSION; RESISTANCE; PATHOGENESIS
AB Purpose. The purpose of this study was to develop an alternative, more clinically relevant approach to susceptibility reporting for implant-associated infections. Using 20 staphylococcal isolates, isolated from clinical implant infections, the majority (85 %) demonstrated biofilm-forming capabilities. A significantly increased minimum biofilm eradication concentration (MBEC) compared to minimum inhibitory concentration (MIC) breakpoint was obtained, with MBEC values greater than 256 mu g ml(-1) for the majority of bacteria. Such a vast increase was also demonstrated for isolates defined as negligible biofilm formers via crystal violet staining, likely due to the high protein content of biofilms, as confirmed by proteinase-K treatment.
   Methodology. This study employed a variety of techniques to assess MIC and MBEC of the isolates tested. In addition, the nature of bacterial biofilm across a range of clinical isolates was investigated using crystal violet staining, sodium metaperiodate and proteinase-K treatment, and PCR analysis.
   Results/Key findings. Infection of medical implants is associated with increased rates of infection and increased bacterial tolerance to antibiotic strategies. Clinical significance is due to the presence of pathogens attached to biomaterial surfaces enclosed in an extracellular polymeric matrix termed the biofilm. This article highlights the importance of defining the clinical susceptibility of implant-associated infections in vitro using methods that are relevant to the biofilm phenotype in vivo, and highlights how current planktonic-based antimicrobial susceptibility tests are often misleading.
   Conclusion. The use of biofilm-relevant susceptibility tests would improve patient outcomes by enabling correct antimicrobial regimens to be rapidly identified, reducing treatment failure and halting the spread of antimicrobial-resistant strains.
C1 [Brady, Aaron J.; Laverty, Garry; Gilpin, Deirdre F.; Tunney, Michael] Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
   [Kearney, Patricia] United Hosp Trust, Antrim Area Lab, Belfast BT41, Antrim, North Ireland.
RP Brady, AJ (reprint author), Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM aaron.brady@qub.ac.uk
OI Laverty, Garry/0000-0002-1435-2942; TUNNEY, MICHAEL/0000-0002-7433-7074
FU European Social Fund Grant
FX A. B. was funded by a European Social Fund Grant.
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Andrews JM, 2007, J ANTIMICROB CHEMOTH, V60, P20, DOI 10.1093/jac/dkm110
   Blahova J, 2007, J CHEMOTHERAPY, V19, P665, DOI 10.1179/joc.2007.19.6.665
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bordi C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-19
   Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217
   Clinical and Laboratory Standards Institute, 2015, METHODS DILUTION ANT
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, METHOD ENZYMOL, V336, P239, DOI 10.1016/S0076-6879(01)36593-X
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cunningham CD, 2004, OTOLARYNG HEAD NECK, V131, P109, DOI 10.1016/j.othons.2004.02.011
   DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005
   Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06
   Gatermann SG, 2007, CLIN MICROBIOL INFEC, V13, P777, DOI 10.1111/j.1469-0691.2007.01749.x
   GORMAN SP, 1994, EPIDEMIOL INFECT, V112, P551, DOI 10.1017/S0950268800051256
   Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001
   Hola V, 2004, Epidemiol Mikrobiol Imunol, V53, P66
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Isiklar ZU, 1996, CLIN ORTHOP RELAT R, P184
   Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004
   Laverty G, 2014, SOJ MICROBIOL INFECT, V2, P1
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   MacGowan AP, 2001, J ANTIMICROB CHEMOTH, V48, P17, DOI 10.1093/jac/48.suppl_1.17
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   O'Neill J., 2016, REV ANTIMICROBIAL RE
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Sandoe JAT, 2006, J ANTIMICROB CHEMOTH, V57, P767, DOI 10.1093/jac/dkl013
   Scott R. D., 2009, DIRECT MED COSTS HEA
   Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005
   Soroush S, 2016, MICROB PATHOGENESIS, V93, P126, DOI 10.1016/j.micpath.2016.01.018
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Talsma Silke S, 2007, Home Healthc Nurse, V25, P589, DOI 10.1097/01.NHH.0000296117.87061.14
   Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 49
TC 2
Z9 2
U1 1
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD APR
PY 2017
VL 66
IS 4
BP 461
EP 469
DI 10.1099/jmm.0.000466
PG 9
WC Microbiology
SC Microbiology
GA EV7TL
UT WOS:000401984400010
PM 28463662
OA Green Published
DA 2018-10-20
ER

PT J
AU Rijal, G
   Shin, HI
AF Rijal, Girdhari
   Shin, Hong-In
TI Human tooth-derived biomaterial as a graft substitute for hard tissue
   regeneration
SO REGENERATIVE MEDICINE
LA English
DT Article
DE augmentation; BFR; bone thickness; demineralized; dentine graft; MAR;
   mineralized; tetracycline; TRAP; Villanueva
ID DEMINERALIZED BONE-MATRIX; HUMAN DENTIN-MATRIX; MORPHOGENETIC PROTEIN;
   EXTRACELLULAR-MATRIX; INDUCED OSTEOGENESIS; RIDGE PRESERVATION;
   EXPERIMENTAL-MODEL; GROWTH-FACTORS; IN-VITRO; RATS
AB Aim: The present study was conducted to evaluate the efficacy of human dentine grafts for new bone augmentation. Materials & methods: Dentine grafts (demineralized dentine matrix [DDM] and mineralized dentine matrix [MDM]) were prepared and implanted in rats. Tetracycline was administered twice. Paraffin and resin sections were prepared from the harvested grafts and stained respectively with hematoxylin and eosin (in addition to tartrate acid phosphatase for osteoclasts) and Villanueva. The new bone formation (bone thickness, mineral apposition rate and the bone formation rate) was analyzed in tetracycline- labeled resin sections. Results & conclusion: DDM grafts implanted in bone were better able to augment the bone compared to MDM grafts. However, both MDM and DDM failed to induce new bone in ectopic site, they could be considered as alternative autograft substitutes after protocol optimization.
C1 [Rijal, Girdhari; Shin, Hong-In] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, Taegu 704412, South Korea.
   [Rijal, Girdhari] Washington State Univ, Elson S Floyd Coll Med, Dept Biomed Sci, Spokane, WA 99210 USA.
RP Shin, HI (reprint author), Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, Taegu 704412, South Korea.
EM hishin@knu.ac.kr
OI Rijal, Girdhari/0000-0001-8933-5111
CR Andersson L, 2009, DENT TRAUMATOL, V25, P78, DOI 10.1111/j.1600-9657.2008.00703.x
   BANG G, 1973, SCAND J DENT RES, V81, P240
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   BESSHO K, 1991, J DENT RES, V70, P171, DOI 10.1177/00220345910700030301
   BUTLER WT, 1995, INT J DEV BIOL, V39, P169
   Castro-Govea Y, 2012, J CRANIOFAC SURG, V23, P392, DOI 10.1097/SCS.0b013e318240fe9b
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Cook DC, 2013, J PERIODONTOL, V84, P585, DOI 10.1902/jop.2012.120219
   Figueiredo M, 2011, CHEM ENG RES DES, V89, P116, DOI 10.1016/j.cherd.2010.04.013
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Hilroyuki Kanzak MC, 2002, J BONE MINER RES, V17, P210
   Honsawek S, 2011, GENET MOL RES, V10, P2093, DOI 10.4238/vol10-3gmr1329
   HOSNY M, 1985, J ORAL MAXIL SURG, V43, P925, DOI 10.1016/0278-2391(85)90004-7
   HUGGINS C, 1970, J EXP MED, V132, P1250, DOI 10.1084/jem.132.6.1250
   INOUE T, 1986, J DENT RES, V65, P12, DOI 10.1177/00220345860650010101
   Iwata H, 2002, CLIN ORTHOP RELAT R, P99
   Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014
   Kim SG, 2001, J CRANIO MAXILL SURG, V29, P282, DOI 10.1054/jcms.2001.0236
   이지영, 2011, [Journal of Dental Rehabilitation and Applied Science, 구강회복응용과학지], V27, P141
   이정훈, 2011, Maxillofacial Plastic Reconstructive Surgery, V33, P144
   Kim Y, 2013, PROCEEDINGS OF 2013 TWENTIETH INTERNATIONAL WORKSHOP ON ACTIVE-MATRIX FLATPANEL DISPLAYS AND DEVICES (AM-FPD 13): TFT TECHNOLOGIES AND FPD MATERIALS, P103
   Kim YK, 2011, J KOR ASSOC ORAL MAX, V37, P142, DOI 10.5125/jkaoms.2011.37.2.142
   Kolerman R, 2012, J ORAL MAXIL SURG, V70, P1835, DOI 10.1016/j.joms.2012.04.034
   Li R, 2011, BIOMATERIALS, V32, P4525, DOI 10.1016/j.biomaterials.2011.03.008
   MacKelvie KJ, 2002, BRIT J SPORT MED, V36, P250, DOI 10.1136/bjsm.36.4.250
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Margonar R, 2010, J CRANIOFAC SURG, V21, P1894, DOI 10.1097/SCS.0b013e3181f4af65
   Meningaud JP, 2012, REV STOMATOL CHIR, V113, P350, DOI 10.1016/j.stomax.2012.06.005
   Mordenfeld A, 2011, DENT TRAUMATOL, V27, P446, DOI 10.1111/j.1600-9657.2011.01026.x
   Murata M, 2005, J HARD TISSUE BIOL, V14, P80
   Nakao K, 2004, BIOCHEM BIOPH RES CO, V325, P1052, DOI 10.1016/j.bbrc.2004.10.136
   Park JH, 2012, AM J ORTHOD DENTOFAC, V141, P641, DOI 10.1016/j.ajodo.2010.07.030
   Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3
   Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545
   Schmidt Samuel K, 2012, Northwest Dent, V91, P29
   Schmidt-Schultz TH, 2005, BIOL CHEM, V386, P767, DOI 10.1515/BC.2005.090
   Seifi Massoud, 2012, Dent Res J (Isfahan), V9, P203
   Silva TA, 2004, ORAL DIS, V10, P63, DOI 10.1111/j.1601-0825.2004.00992.x
   Sousa Simone Maria Galvão, 2005, Braz. oral res., V19, P188, DOI 10.1590/S1806-83242005000300006
   Stockmann P, 2012, J CRANIO MAXILL SURG, V40, P310, DOI 10.1016/j.jcms.2011.05.004
   Takeshi Moriishi RF, 2012, PLOS ONE, V7, P20
   TAM CS, 1978, METABOLISM, V27, P143, DOI 10.1016/0026-0495(78)90160-9
   TAM CS, 1980, CALCIFIED TISSUE INT, V30, P121, DOI 10.1007/BF02408616
   Tazaki J, 2010, J CERAM SOC JPN, V118, P442, DOI 10.2109/jcersj2.118.442
   Togari K, 2012, J HARD TISSUE BIOL, V21, P25, DOI 10.2485/jhtb.21.25
   TURNER CH, 1995, J BONE MINER RES, V10, P1544
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P156, DOI 10.1007/s002239900676
   Wang Y, 2012, J DENT RES, V91, P690, DOI 10.1177/0022034512448660
   Yanko C-V, J CRANIOFAC SURG, V23, P392
   YEOMANS JD, 1967, ARCH ORAL BIOL, V12, P999, DOI 10.1016/0003-9969(67)90095-7
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
NR 52
TC 1
Z9 1
U1 1
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD APR
PY 2017
VL 12
IS 3
BP 263
EP 273
DI 10.2217/rme-2016-0147
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA EV6SB
UT WOS:000401901900006
PM 28350271
DA 2018-10-20
ER

PT J
AU Mithieux, SM
   Weiss, AS
AF Mithieux, Suzanne M.
   Weiss, Anthony S.
TI Design of an elastin-layered dermal regeneration template
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 9th European Elastin Meeting (EEM)
CY JUN 17-19, 2016
CL Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, GERMANY
HO Fraunhofer Inst Interfacial Engn & Biotechnol
DE Elastin; Elastic fiber; Tropoelastin; Deep dermis; Integra
ID EXTRACELLULAR-MATRIX; FIBER FORMATION; HUMAN TROPOELASTIN; BINDING;
   CELLS; COACERVATION; MICROFIBRILS; EXPRESSION; LONGEVITY; PROTEINS
AB We demonstrate a novel approach for the production of tunable quantities of elastic fibers. We also show that exogenous tropoelastin is rate-limiting for elastin synthesis regardless of the age of the dermal fibroblast donor. Additionally, we provide a strategy to further enhance synthesis by older cells through the application of conditioned media. We show that this approach delivers an elastin layer on one side of the leading dermal repair template for contact with the deep dermis in order to deliver prefabricated elastic fibers to a physiologically appropriate site during subsequent surgery. This system is attractive because it provides for the first time a viable path for sufficient, histologically detectable levels of patient elastin into full-thickness wound sites that have until now lacked this elastic underlayer.
   Statement of Significance
   The scars of full thickness wounds typically lack elasticity. Elastin is essential for skin elasticity and is enriched in the deep dermis. This paper is significant because it shows that: (1) we can generate elastic fibers in tunable quantities, (2) tropoelastin is the rate-limiting component in elastin synthesis in vitro, (3) we can generate elastin fibers regardless of donor age, (4) we describe a novel approach to further increase the numbers and thickness of elastic fibers for older donors, (5) we improve on Integra Dermal Regeneration Template and generate a new hybrid biomaterial intended to subsequently surgically deliver these elastic fibers, (6) the elastic fiber layer is presented on the side of Integra that is intended for delivery into its physiologically appropriate site i.e. the deep dermis. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd.
C1 [Mithieux, Suzanne M.; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Mithieux, Suzanne M.; Weiss, Anthony S.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
OI Mithieux, Suzanne/0000-0001-6160-9352; WEISS,
   ANTHONY/0000-0002-8106-4836
FU Australian Research Council; National Health and Medical Research
   Council; Wellcome Trust
FX We acknowledge funding from the Australian Research Council, National
   Health and Medical Research Council and Wellcome Trust.
CR Baldwin AK, 2014, J CELL SCI, V127, P158, DOI 10.1242/jcs.134270
   Calabro N.E., 2014, BIOCHIM BIOPHYS ACTA, V8, P15
   Charbonneau NL, 2010, J BIOL CHEM, V285, P20242, DOI 10.1074/jbc.M109.087031
   Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573
   Di Vito A, 2015, EUR J HISTOCHEM, V59, P51, DOI 10.4081/ejh.2015.2459
   Dong XR, 2012, ARTERIOSCL THROM VAS, V32, P548, DOI 10.1161/ATVBAHA.111.242412
   Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001
   Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026
   Hirt-Burri N., 2011, ISRN DERMATOL
   Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3
   Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164
   Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153
   Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004
   Langton A. K., 2010, International Journal of Cosmetic Science, V32, P330, DOI 10.1111/j.1468-2494.2010.00574.x
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Muiznieks LD, 2016, BIOPOLYMERS, V105, P267, DOI 10.1002/bip.22804
   Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004
   Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775
   Raghunath M, 1998, J INVEST DERMATOL, V111, P559, DOI 10.1046/j.1523-1747.1998.00339.x
   Rasband WS, 1997, IMAGEJ
   Rnjak J, 2011, TISSUE ENG PART B-RE, V17, P81, DOI [10.1089/ten.teb.2010.0452, 10.1089/ten.TEB.2010.0452]
   Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005
   Sabatier L, 2014, FEBS LETT, V588, P2890, DOI 10.1016/j.febslet.2014.06.061
   Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9
   SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204
   Sherratt MJ, 2009, AGE, V31, P305, DOI 10.1007/s11357-009-9103-6
   Sivan SS, 2012, BBA-GEN SUBJECTS, V1820, P1671, DOI 10.1016/j.bbagen.2012.06.010
   Tu Y, 2010, MATRIX BIOL, V29, P152, DOI 10.1016/j.matbio.2009.10.003
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Wang YW, 2015, ADV HEALTHC MATER, V4, P577, DOI 10.1002/adhm.201400571
   Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Yeo GC, 2014, J BIOL CHEM, V289, P34815, DOI 10.1074/jbc.M114.606772
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
   ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165
   Zhang MC, 1999, MOL CELL BIOL, V19, P7314
NR 44
TC 4
Z9 4
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2017
VL 52
BP 33
EP 40
DI 10.1016/j.actbio.2016.11.054
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EU5AD
UT WOS:000401043100005
PM 27903444
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ahadian, S
   Huyer, LD
   Estili, M
   Yee, B
   Smith, N
   Xu, ZS
   Sun, Y
   Radisic, M
AF Ahadian, Samad
   Huyer, Locke Davenport
   Estili, Mehdi
   Yee, Bess
   Smith, Nathaniel
   Xu, Zhensong
   Sun, Yu
   Radisic, Milica
TI Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac
   tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 9th European Elastin Meeting (EEM)
CY JUN 17-19, 2016
CL Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, GERMANY
HO Fraunhofer Inst Interfacial Engn & Biotechnol
DE Carbon nanotubes; Scaffold; Cardiac tissue engineering; Elastomer;
   Electrical conductivity; Maturation
ID CELL-DERIVED CARDIOMYOCYTES; ELECTRICAL-CONDUCTIVITY; HYBRID HYDROGELS;
   EMBRYOID BODIES; MUSCLE; DIFFERENTIATION; STIMULATION; FABRICATION;
   REGENERATION; CONSTRUCTS
AB Polymer biomaterials are used to construct scaffolds in tissue engineering applications to assist in mechanical support, organization, and maturation of tissues. Given the flexibility, electrical conductance, and contractility of native cardiac tissues, it is desirable that polymeric scaffolds for cardiac tissue regeneration exhibit elasticity and high electrical conductivity. Herein, we developed a facile approach to introduce carbon nanotubes (CNTs) into poly(octamethylene maleate (anhydride) 1,2,4-butanetricarboxylate) (124 polymer), and developed an elastomeric scaffold for cardiac tissue engineering that provides electrical conductivity and structural integrity to 124 polymer. 124 polymer-CNT materials were developed by first dispersing CNTs in poly(ethylene glycol) dimethyl ether porogen and mixing with 124 prepolymer for molding into shapes and crosslinking under ultraviolet light. 124 polymers with 0.5% and 0.1% CNT content (wt) exhibited improved conductivity against pristine 124 polymer. With increasing the CNT content, surface moduli of hybrid polymers were increased, while their bulk moduli were decreased. Furthermore, increased swelling of hybrid 124 polymer-CNT materials was observed, suggesting their improved structural support in an aqueous environment. Finally, functional characterization of engineered cardiac tissues using the 124 polymer-CNT scaffolds demonstrated improved excitation threshold in materials with 0.5% CNT content (3.6 +/- 0.8 V/cm) compared to materials with 0% (5.1 +/- 0.8 V/cm) and 0.1% (5.0 +/- 0.7 V/cm), suggesting greater tissue maturity. 124 polymer-CNT materials build on the advantages of 124 polymer elastomer to give a versatile biomaterial for cardiac tissue engineering applications.
   Statement of Significance
   Achieving a high elasticity and a high conductivity in a single cardiac tissue engineering material remains a challenge. We report the use of CNTs in making electrically conductive and mechanically strong polymeric scaffolds in cardiac tissue regeneration. CNTs were incorporated in elastomeric polymers in a facile and reproducible approach. Polymer-CNT materials were able to construct complicated scaffold structures by injecting the prepolymer into a mold and crosslinking the prepolymer under ultraviolet light. CNTs enhanced electrical conductivity and structural support of elastomeric polymers. Hybrid polymeric scaffolds containing 0.5 wt% CNTs increased the maturation of cardiac tissues fabricated on them compared to pure polymeric scaffolds. The cardiac tissues on hybrid polymer-CNT scaffolds showed earlier beating than those on pure polymer scaffolds. In the future, fabricated polymer-CNT scaffolds could also be used to fabricate other electro-active tissues, such neural and skeletal muscle tissues. In the future, fabricated polymer-CNT scaffolds could also be used to fabricate other electro-active tissues, such as neural and skeletal muscle tissues. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ahadian, Samad; Huyer, Locke Davenport; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Huyer, Locke Davenport; Yee, Bess; Smith, Nathaniel; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Estili, Mehdi] Natl Inst Mat Sci, Funct Mat Res Ctr, Ceram Proc Grp, Tsukuba, Ibaraki, Japan.
   [Xu, Zhensong; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Adv Micro & Nanosyst Lab, Toronto, ON, Canada.
RP Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
EM m.radisic@utoronto.ca
OI Sun, Yu/0000-0001-7895-0741
FU CIHR Canada Graduate Scholarships-Masters; CIHR Vanier Canada Graduate
   Scholarships; NSERC; Canadian Institutes of Health Research (CIHR);
   NSERC [RGPIN 326982-10]; McLean Award;  [MOP-126027];  [MOP-137107]
FX The authors would like to thank Dr. Boyang Zhang (University of Toronto,
   Canada) for guidance on in vitro cardiac patch seeding and confocal
   microscopy. L.D.H is supported by CIHR Canada Graduate
   Scholarships-Masters and CIHR Vanier Canada Graduate Scholarships. This
   work is funded by the NSERC Steacie Fellowship to M.R., Canadian
   Institutes of Health Research (CIHR) Operating Grants (MOP-126027 and
   MOP-137107), NSERC Discovery Grant (RGPIN 326982-10) and McLean Award.
CR Ahadian S, 2016, J NANOSCI NANOTECHNO, V16, P8862, DOI 10.1166/jnn.2016.12729
   Ahadian S, 2016, NANOSCALE, V8, P7075, DOI 10.1039/c5nr07059g
   Ahadian S, 2016, ACTA BIOMATER, V31, P134, DOI 10.1016/j.actbio.2015.11.047
   Ahadian S, 2015, BIOMATER SCI-UK, V3, P1449, DOI 10.1039/c5bm00215j
   Ahadian S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04271
   Ahadian S, 2013, ORGANOGENESIS, V9, P87, DOI 10.4161/org.25121
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Annabi N, 2016, ADV MATER, V28, P40, DOI 10.1002/adma.201503255
   Beese AM, 2013, ACS NANO, V7, P3434, DOI 10.1021/nn400346r
   Braunwald E, 2015, LANCET, V385, P812, DOI 10.1016/S0140-6736(14)61889-4
   Casalini R, 2012, POLYMER, V53, P1282, DOI 10.1016/j.polymer.2012.01.034
   Chen ZX, 2012, J MATER CHEM, V22, P12479, DOI 10.1039/c2jm30517h
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012
   Ding XL, 2015, ADV HEALTHC MATER, V4, P1451, DOI 10.1002/adhm.201500203
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Estili M, 2012, ADV MATER, V24, P4322, DOI 10.1002/adma.201201134
   Gao ZH, 2016, BIOMATER SCI-UK, V4, P230, DOI 10.1039/c5bm00134j
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Hoshi RA, 2009, ADV MATER, V21, P188, DOI 10.1002/adma.200801132
   Huyer LD, 2016, ACS BIOMATER SCI ENG, V2, P780, DOI 10.1021/acsbiomaterials.5b00525
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Kharaziha M, 2014, BIOMATERIALS, V35, P7346, DOI 10.1016/j.biomaterials.2014.05.014
   Li ZL, 2016, POLYMER, V85, P67, DOI 10.1016/j.polymer.2016.01.025
   Liaw NY, 2016, ADV DRUG DELIVER REV, V96, P156, DOI 10.1016/j.addr.2015.09.001
   Liu HJ, 2014, CELL BIOCHEM BIOPHYS, V68, P241, DOI 10.1007/s12013-013-9702-9
   Liu YW, 2016, MAT SCI ENG C-MATER, V69, P865, DOI 10.1016/j.msec.2016.07.069
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Marchesan S, 2016, NANO TODAY, V11, P398, DOI 10.1016/j.nantod.2015.11.007
   Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Mozaffarian D., 2015, CIRCULATION, V132
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Pahnke A, 2016, BIOCHEM BIOPH RES CO, V473, P698, DOI 10.1016/j.bbrc.2015.11.060
   Pok S, 2013, ACTA BIOMATER, V9, P5630, DOI 10.1016/j.actbio.2012.10.032
   Putz KW, 2004, J POLYM SCI POL PHYS, V42, P2286, DOI 10.1002/polb.20073
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Ramon-Azcon J, 2014, J BIOMED NANOTECHNOL, V10, P2539, DOI 10.1166/jbn.2014.1899
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Rosellini E, 2009, J BIOMED MATER RES A, V91A, P447, DOI 10.1002/jbm.a.32216
   Saito N, 2014, CHEM REV, V114, P6040, DOI 10.1021/cr400341h
   Seyedin MZ, 2014, ADV FUNCT MATER, V24, P2957, DOI 10.1002/adfm.201303905
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shin SR, 2016, SMALL, V12, P3677, DOI 10.1002/smll.201600178
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Skrifvars M, 2004, J APPL POLYM SCI, V93, P1285, DOI 10.1002/app.20584
   Stout DA, 2015, CURR PHARM DESIGN, V21, P2037, DOI 10.2174/1381612821666150302153406
   Stout DA, 2011, ACTA BIOMATER, V7, P3101, DOI 10.1016/j.actbio.2011.04.028
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Zhang BY, 2016, NAT MATER, V15, P669, DOI [10.1038/NMAT4570, 10.1038/nmat4570]
   Zhang BY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500423
NR 57
TC 7
Z9 7
U1 3
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2017
VL 52
BP 81
EP 91
DI 10.1016/j.actbio.2016.12.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EU5AD
UT WOS:000401043100010
PM 27940161
DA 2018-10-20
ER

PT J
AU Francis, MP
   Breathwaite, E
   Bulysheva, AA
   Varghese, F
   Rodriguez, RU
   Dutta, S
   Semenov, I
   Ogle, R
   Huber, A
   Tichy, AM
   Chen, S
   Zemlin, C
AF Francis, Michael P.
   Breathwaite, Erick
   Bulysheva, Anna A.
   Varghese, Frency
   Rodriguez, Rudy U.
   Dutta, Sucharita
   Semenov, Iurii
   Ogle, Rebecca
   Huber, Alexander
   Tichy, Alexandra-Madelaine
   Chen, Silvia
   Zemlin, Christian
TI Human placenta hydrogel reduces scarring in a rat model of cardiac
   ischemia and enhances cardiomyocyte and stem cell cultures
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 9th European Elastin Meeting (EEM)
CY JUN 17-19, 2016
CL Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, GERMANY
HO Fraunhofer Inst Interfacial Engn & Biotechnol
DE Placenta; Extracellular matrix; Ischemia; Cardiomyocyte culture;
   Hydrogel; Decellularized
ID AMNIOTIC MEMBRANE; HEART; ANGIOGENESIS; MECHANISMS; EXPRESSION;
   INFARCTION; DELIVERY; SCAFFOLD; CORNEAL; MATRIX
AB Introduction: Xenogeneic extracellular matrix (ECM) hydrogels have shown promise in remediating cardiac ischemia damage in animal models, yet analogous human ECM hydrogels have not been well development. An original human placenta-derived hydrogel (hpECM) preparation was thus generated for assessment in cardiomyocyte cell culture and therapeutic cardiac injection applications. Methods and results: Hybrid orbitrap-quadrupole mass spectrometry and ELISAs showed hpECM to be rich in collagens, basement membrane proteins, and regenerative growth factors (e.g. VEGF-B, HGF). Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes synchronized and electrically coupled on hpECM faster than on conventional cell culture environments, as validated by intracellular calcium measurements. In vivo, injections using biotin-labeled hpECM confirmed its spatially discrete localization to the myocardium proximal to the injection site. hpECM was injected into rat myocardium following an acute myocardium infarction induced by left anterior descending artery ligation. Compared to sham treated animals, which exhibited aberrant electrical activity and larger myocardial scars, hpECM injected rat hearts showed a significant reduction in scar volume along with normal electrical activity of the surviving tissue, as determined by optical mapping. Conclusion: Placental matrix and growth factors can be extracted as a hydrogel that effectively supports cardiomyocytes in vitro, and in vivo reduces scar formation while maintaining electrophysiological activity when injected into ischemic myocardium.
   Statement of Significance
   This is the first report of an original extracellular matrix hydrogel preparation isolated from human placentas (hpECM). hpECM is rich in collagens, laminin, fibronectin, glycoproteins, and growth factors, including known pro-regenerative, pro-angiogenic, anti-scarring, anti-inflammatory, and stem cell recruiting factors. hpECM supports the culture of cardiomyocytes, stem cells and blood vessels assembly from endothelial cells. In a rat model of myocardial infarction, hpECM injections were safely deliverable to the ischemic myocardium. hpECM injections repaired the myocardium, resulting in a significant reduction in infarct size, more viable myocardium, and a normal electrophysiological contraction profile. hpECM thus has potential in therapeutic cardiovascular applications, in cellular therapies (as a delivery vehicle), and is a promising biomaterial for advancing basic cell-based research and regenerative medicine applications. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Francis, Michael P.; Breathwaite, Erick; Rodriguez, Rudy U.; Ogle, Rebecca; Huber, Alexander; Chen, Silvia] LifeNet Hlth Inst Regenerat Med, Virginia Beach, VA USA.
   [Francis, Michael P.; Dutta, Sucharita] Eastern Virginia Med Sch, Norfolk, VA 23501 USA.
   [Bulysheva, Anna A.; Varghese, Frency; Semenov, Iurii; Zemlin, Christian] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA.
   [Varghese, Frency; Zemlin, Christian] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA.
   [Tichy, Alexandra-Madelaine] FH Campus Wien, Appl Life Sci, Vienna, Austria.
RP Francis, MP (reprint author), 700 West Olney Rd, Norfolk, VA 23507 USA.
EM mpf3b@virginia.edu; erick_breathwaite@lifenethealth.org;
   abulyshe@odu.edu; fvarg001@odu.edu; rudy_rodriguez@lifenethealth.org;
   duttasm@evms.edu; Rebecca_ogle@lifenethealth.org;
   alexander_huber@lifenethealth.org; czemlin@odu.edu
FU LifeNet Health
FX This work was supported by the non-profit, LifeNet Health. Authors: MF,
   EB, RR, RO, SC and AH are or were previously employed by LifeNet Health.
   All studies were designed by MF, except for optical mapping studies (by
   CZ, FV and MF), and mass spectrometry studies (by SD and MF), with data
   collected, analyzed, and interpreted by all authors, and the manuscript
   composed by MF. The authors have no direct financial interest in the
   publication of this work.
CR Bellamy V, 2015, J HEART LUNG TRANSPL, V34, P1198, DOI 10.1016/j.healun.2014.10.008
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Chiu YW, 2014, NANOMED-NANOTECHNOL, V10, P1065, DOI 10.1016/j.nano.2014.01.005
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35
   Gallina C, 2015, STEM CELLS INT, DOI 10.1155/2015/765846
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454
   Litwiniuk M, 2014, WOUND REPAIR REGEN, V22, P451, DOI 10.1111/wrr.12188
   Liu ML, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001101
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   McGregor CGA, 2013, J HEART VALVE DIS, V22, P383
   Mills WR, 2006, AM J PHYSIOL-HEART C, V290, pH1298, DOI 10.1152/ajpheart.00437.2005
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Narita T, 2013, MOL THER, V21, P860, DOI 10.1038/mt.2013.9
   O'Connor DM, 2015, PHYSL REP, V3, DOI 10.14814/phy2.12351
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Pampaloni Francesco, 2009, Recent Pat Biotechnol, V3, P103
   Perea-Gil I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0237-4
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Rufaihah A.J., 2015, ADV DRUG DELIV REV
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Semenov I, 2013, BBA-BIOMEMBRANES, V1828, P981, DOI 10.1016/j.bbamem.2012.11.032
   Silini A, 2013, CURR STEM CELL RES T, V8, P6, DOI 10.2174/1574888X11308010003
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Vogel R, 2015, EXPERT REV CARDIOVAS, V13, P75, DOI 10.1586/14779072.2015.988142
   Wilhite T, 2012, XENOTRANSPLANTATION, V19, P56, DOI 10.1111/j.1399-3089.2011.00691.x
   WIT AL, 1983, AM HEART J, V106, P798, DOI 10.1016/0002-8703(83)90003-0
   Yang LF, 2015, ONCOTARGET, V6, P43743, DOI 10.18632/oncotarget.6193
NR 37
TC 7
Z9 7
U1 8
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2017
VL 52
BP 92
EP 104
DI 10.1016/j.actbio.2016.12.027
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EU5AD
UT WOS:000401043100011
PM 27965171
DA 2018-10-20
ER

PT J
AU Ruff, SM
   Keller, S
   Wieland, DE
   Wittmann, V
   Tovar, GEM
   Bach, M
   Kluger, PJ
AF Ruff, S. M.
   Keller, S.
   Wieland, D. E.
   Wittmann, V.
   Tovar, G. E. M.
   Bach, M.
   Kluger, P. J.
TI clickECM: Development of a cell-derived extracellular matrix with azide
   functionalities
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 9th European Elastin Meeting (EEM)
CY JUN 17-19, 2016
CL Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, GERMANY
HO Fraunhofer Inst Interfacial Engn & Biotechnol
DE Cell-derived extracellular matrix; Metabolic oligosaccharide
   engineering; Biorthogonal click chemistry; Surface modification; Tissue
   engineering
ID O-LINKED GLYCOSYLATION; LIVING ANIMALS; REGENERATIVE MEDICINE; TISSUE;
   CHEMISTRY; COLLAGEN; HYDROGELS; SCAFFOLD; DIFFERENTIATION; SYSTEMS
AB In vitro cultured cells produce a complex extracellular matrix (ECM) that remains intact after decellularization. The biological complexity derived from the variety of distinct ECM molecules makes these matrices ideal candidates for biomaterials. Biomaterials with the ability to guide cell function are a topic of high interest in biomaterial development. However, these matrices lack specific addressable functional groups, which are often required for their use as a biomaterial. Due to the biological complexity of the cell-derived ECM, it is a challenge to incorporate such functional groups without affecting the integrity of the biomolecules within the ECM. The azide-alkyne cycloaddition (click reaction, Huisgen-reaction) is an efficient and specific ligation reaction that is known to be biocompatible when strained alkynes are used to avoid the use of copper (I) as a catalyst. In our work, the ubiquitous modification of a fibroblast cell-derived ECM with azides was achieved through metabolic oligosaccharide engineering by adding the azide-modified monosaccharide Ac(4)GalNAz (1,3,4,6-tetra-O-acetyl-N-azidoacetylgalactosamine) to the cell culture medium. The resulting azide-modified network remained intact after removing the cells by lysis and the molecular structure of the ECM proteins was unimpaired after a gentle homogenization process. The biological composition was characterized in order to show that the functionalization does not impair the complexity and integrity of the ECM. The azides within this "clickECM" could be accessed by small molecules (such as an alkyne-modified fluorophore) or by surface-bound cyclooctynes to achieve a covalent coating with clickECM.
   Statement of Significance
   The clickECM was produced by the incorporation of azide-functionalized sugar analogues into the extra cellular glycans of fibroblast cell cultures by metabolic oligosaccharide engineering. By introducing these azide groups into the glycan structures, we enabled this cell-derived ECM for bioorthogonal click reactions. Click chemistry provides extremely specific reactions with high efficiency, high selectivity, and high reaction yields. We could show that the azide functionalities within the clickECM are chemically accessible. Based on our here described clickECM technique it will be possible to create and investigate new clickECM materials with tunable bioactive properties and additional functionalities, which offers a promising approach for basic and applied research in the field of biomaterial science, biomedical applications, and tissue engineering. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ruff, S. M.; Keller, S.; Tovar, G. E. M.; Bach, M.] Univ Stuttgart, Inst Interfacial Proc Engn & Plasma Technol, Nobelstr 12, D-70569 Stuttgart, Germany.
   [Tovar, G. E. M.; Bach, M.; Kluger, P. J.] Fraunhofer Inst Interfacial Engn & Biotechnol, Nobelstr 12, D-70569 Stuttgart, Germany.
   [Wieland, D. E.; Wittmann, V.] Univ Konstanz, Dept Chem, Univ Str 10, D-78457 Constance, Germany.
   [Wieland, D. E.; Wittmann, V.] Univ Konstanz, Konstanz Res Sch Chem Biol, Univ Str 10, D-78457 Constance, Germany.
   [Kluger, P. J.] Reutlingen Univ, Sch Appl Chem, Alteburgstr 150, D-72762 Reutlingen, Germany.
RP Kluger, PJ (reprint author), Fraunhofer Inst Interfacial Engn & Biotechnol, Dept Cell & Tissue Engn, Nobelstr 12, D-70569 Stuttgart, Germany.
EM petra.kluger@igb.fraunhofer.de
OI Wittmann, Valentin/0000-0003-4043-6813
FU Baden-Wurttemberg Stiftung [P-BWS-Glyko/09]; Fraunhofer Internal
   Programs [Discover 828 335]
FX The authors kindly thank Shannon L. Layland (Fraunhofer IGB Stuttgart)
   and Vanessa Albernaz (IGVP University of Stuttgart) for proof reading
   the article. This work was supported by contract research
   (Glycobiology/Glycomics, Grant number: P-BWS-Glyko/09) of the
   Baden-Wurttemberg Stiftung and by the Fraunhofer Internal Programs under
   Grant No. Discover 828 335.
CR Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029
   Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja0449981
   Aich U., 2008, GLYCOSCIENCE, P2133, DOI DOI 10.1007/978-3-540-30429-6_55
   Almaraz RT, 2012, BIOTECHNOL BIOENG, V109, P992, DOI 10.1002/bit.24363
   Ao H., 2013, J R SOC INTERFACE, V10
   Baskin JM, 2007, QSAR COMB SCI, V26, P1211, DOI 10.1002/qsar.200740086
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107
   Chuh KN, 2014, J AM CHEM SOC, V136, P12283, DOI 10.1021/ja504063c
   Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031
   Debets MF, 2010, CHEMBIOCHEM, V11, P1168, DOI 10.1002/cbic.201000064
   Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.TEA.2011.0677, 10.1089/ten.tea.2011.0677]
   Decaris ML, 2012, ACTA BIOMATER, V8, P744, DOI 10.1016/j.actbio.2011.10.035
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115
   Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103
   Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006
   Everitt EA, 1996, J LEUKOCYTE BIOL, V60, P199
   Fitzpatrick LE, 2015, BIOMATER SCI-UK, V3, P12, DOI [10.1039/c4bm00246f, 10.1039/C4BM00246F]
   Friscourt F, 2012, J AM CHEM SOC, V134, P18809, DOI 10.1021/ja309000s
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Grefte S, 2016, ACTA BIOMATER, V30, P265, DOI 10.1016/j.actbio.2015.11.009
   Hagel V, 2013, SCI REP-UK, V3, DOI 10.1038/srep02043
   Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100
   Hinderer S, 2016, ADV DRUG DELIVER REV, V97, P260, DOI 10.1016/j.addr.2015.11.019
   Hinderer S, 2012, BIOMATERIALS, V33, P5259, DOI 10.1016/j.biomaterials.2012.03.075
   Horisawa K, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00457
   Hsu SH, 2013, ACTA BIOMATER, V9, P6606, DOI 10.1016/j.actbio.2013.01.025
   Huber B, 2016, TISSUE ENG PART C-ME, V22, P756, DOI [10.1089/ten.tec.2016.0141, 10.1089/ten.TEC.2016.0141]
   Huber B, 2016, J BIOMATER APPL, V30, P699, DOI 10.1177/0885328215587450
   Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b
   Hynes R.O., 2012, COLD SPRING HARB PER, V4, P16
   Jabbari E, 2016, MATER TODAY, V19, P190, DOI 10.1016/j.mattod.2015.10.005
   Jang S, 2012, BIOCONJUGATE CHEM, V23, P2256, DOI 10.1021/bc300364z
   Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R
   Kim IG, 2015, BIOMATERIALS, V50, P75, DOI 10.1016/j.biomaterials.2015.01.054
   Kleinhans C, 2015, J BIOTECHNOL, V205, P101, DOI 10.1016/j.jbiotec.2014.11.039
   Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106
   Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6
   Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Lv SS, 2013, ACTA BIOMATER, V9, P6481, DOI 10.1016/j.actbio.2013.01.002
   Moller H, 2011, J CARBOHYD CHEM, V30, P334, DOI 10.1080/07328303.2011.608140
   Morra M, 2006, J BIOMED MATER RES A, V78A, P449, DOI 10.1002/jbm.a.30783
   Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Nwe K, 2009, CANCER BIOTHER RADIO, V24, P289, DOI 10.1089/cbr.2008.0626
   Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13
   Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791
   Pudlas M, 2011, TISSUE ENG PART C-ME, V17, P1027, DOI 10.1089/ten.tec.2011.0082
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rentsch C, 2014, BIOMED RES INT, DOI 10.1155/2014/217078
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Sart S, 2016, ACTA BIOMATER, V30, P222, DOI 10.1016/j.actbio.2015.11.016
   Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033
   Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   TETI A, 1992, J AM SOC NEPHROL, V2, pS83
   Tian Y, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9083-8
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Uchida N, 2016, J BIOMED MATER RES A, V104, P94, DOI 10.1002/jbm.a.35544
   Visser J, 2015, TISSUE ENG PT A, V21, P1195, DOI [10.1089/ten.tea.2014.0362, 10.1089/ten.TEA.2014.0362]
   Wang L, 2014, ACS APPL MATER INTER, V6, P8401, DOI 10.1021/am501309d
   Wolchok JC, 2010, BIOMATERIALS, V31, P9595, DOI 10.1016/j.biomaterials.2010.08.072
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 69
TC 4
Z9 4
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2017
VL 52
BP 159
EP 170
DI 10.1016/j.actbio.2016.12.022
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EU5AD
UT WOS:000401043100016
PM 27965173
DA 2018-10-20
ER

PT J
AU Rasoulianboroujeni, M
   Yazdimamaghani, M
   Khoshkenar, P
   Pothineni, VR
   Kim, KM
   Murray, TA
   Rajadas, J
   Mills, DK
   Vashaee, D
   Moharamzadeh, K
   Tayebi, L
AF Rasoulianboroujeni, Morteza
   Yazdimamaghani, Mostafa
   Khoshkenar, Payam
   Pothineni, Venkata Raveendra
   Kim, Kwang Min
   Murray, Teresa A.
   Rajadas, Jayakumar
   Mills, David K.
   Vashaee, Daryoosh
   Moharamzadeh, Keyvan
   Tayebi, Lobat
TI From solvent-free microspheres to bioactive gradient scaffolds
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Tissue engineering scaffold; Pore size gradient; Solvent-free method;
   Microsphere sintering; Mineralization; Bone-like apatite
ID AMORPHOUS CALCIUM-PHOSPHATE; SIMULATED BODY-FLUID; PORE-SIZE GRADIENT;
   IN-VITRO; OCTACALCIUM PHOSPHATE; OSTEOBLAST ADHESION; TIO2
   NANOPARTICLES; APATITE FORMATION; TREATED TITANIUM; TISSUE
AB A solvent-free microsphere sintering technique was developed to fabricate scaffolds with pore size gradient for tissue engineering applications. Poly(D, L-Lactide) microspheres were fabricated through an emulsification method where TiO2 nanoparticles were employed both as particulate emulsifier in the preparation procedure and as surface modification agent to improve bioactivity of the scaffolds. A finetunable pore size gradient was achieved with a pore volume of 30 +/- 2.6%. SEM, EDX, XRD and FTIR analyses all confirmed the formation of bone-like apatite at the 14th day of immersion in Simulated Body Fluid (SBF) implying the ability of our scaffolds to bond to living bone tissue. In vitro examination of the scaffolds showed progressive activity of the osteoblasts on the scaffold with evidence of increase in its mineral content. The bioactive scaffold developed in this study has the potential to be used as a suitable biomaterial for bone tissue engineering and hard tissue regeneration. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Rasoulianboroujeni, Morteza; Tayebi, Lobat] Marquette Univ, Sch Dent, Milwaukee, WI 53233 USA.
   [Rasoulianboroujeni, Morteza; Yazdimamaghani, Mostafa; Tayebi, Lobat] Oklahoma State Univ, Helmerich Adv Technol Res Ctr, Tulsa, OK USA.
   [Khoshkenar, Payam] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Khoshkenar, Payam; Murray, Teresa A.; Mills, David K.] Louisiana Tech Univ, Biomed Engn Dept, Ruston, LA 71270 USA.
   [Pothineni, Venkata Raveendra; Kim, Kwang Min; Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Palo Alto, CA 94304 USA.
   [Rajadas, Jayakumar] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.
   [Rajadas, Jayakumar] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA.
   [Vashaee, Daryoosh] North Carolina State Univ, Elect & Comp Engn Dept, Raleigh, NC 27695 USA.
   [Moharamzadeh, Keyvan] Univ Sheffield, Sch Clin Dent, Claremont Crescent, Sheffield, S Yorkshire, England.
RP Tayebi, L (reprint author), Marquette Univ, Sch Dent, Milwaukee, WI 53233 USA.
EM lobat.tayebi@marquette.edu
OI Murray, Teresa/0000-0002-8857-154X; Moharamzadeh,
   Keyvan/0000-0002-8842-4638; Yazdimamaghani, Mostafa/0000-0001-5090-9528
FU National Science Foundation (NSF) [CMMI-1363485]; Marquette University
   Strategic Innovation Fund
FX The authors are thankful of the support from National Science Foundation
   (NSF, Grant no. CMMI-1363485) and Marquette University Strategic
   Innovation Fund.
CR Abdelaal O. M., 2013, CHARACTERIZATION DEV, V29, P33
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   BADDIEL CB, 1966, SPECTROCHIM ACTA, V22, P1407, DOI 10.1016/0371-1951(66)80133-9
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123
   BLUMENTH.NC, 1972, MATER RES BULL, V7, P1181, DOI 10.1016/0025-5408(72)90097-9
   Borden M, 2002, J BIOMED MATER RES, V61, P421, DOI 10.1002/jbm.10201
   BOSKEY AL, 1974, MATER RES BULL, V9, P907, DOI 10.1016/0025-5408(74)90169-X
   Chen LX, 1997, J PHYS CHEM B, V101, P10688, DOI 10.1021/jp971930g
   Chen XC, 2002, J MATER SCI LETT, V21, P1637, DOI 10.1023/A:1020871830587
   Choi SY, 2012, J MATER CHEM, V22, P25288, DOI 10.1039/c2jm33354f
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Drouet C., 2013, BIOMED RES INT, V2013
   Eanes E.D., 1998, CALCIUM PHOSPHATES B, P21
   Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012
   Finkle P, 1923, J AM CHEM SOC, V45, P2780, DOI 10.1021/ja01665a002
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gemelli E, 2010, J MATER SCI-MATER M, V21, P2035, DOI 10.1007/s10856-010-4074-9
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   HARTER RD, 1977, SOIL SCI SOC AM J, V41, P1077, DOI 10.2136/sssaj1977.03615995004100060012x
   HEUGHEBAERT JC, 1984, J PHYS CHEM-US, V88, P2478, DOI 10.1021/j150656a012
   Hu XX, 2014, APPL SURF SCI, V292, P764, DOI 10.1016/j.apsusc.2013.12.045
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2007, J EUR CERAM SOC, V27, P1553, DOI 10.1016/j.jeurceramsoc.2006.04.015
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Liu HN, 2005, NANOTECHNOLOGY, V16, pS601, DOI 10.1088/0957-4484/16/7/038
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Nakayama N, 2008, COLLOID SURFACE A, V317, P543, DOI 10.1016/j.colsurfa.2007.11.036
   Nakayama N, 2007, POLYM DEGRAD STABIL, V92, P1255, DOI 10.1016/j.polymdegradstab.2007.03.026
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Rabadjieva D, 2010, J MATER SCI-MATER M, V21, P2501, DOI 10.1007/s10856-010-4103-8
   Silva SN, 2003, J BIOMED MATER RES A, V65A, P475, DOI 10.1002/jbm.a.10544
   Singh M, 2010, ACTA BIOMATER, V6, P137, DOI 10.1016/j.actbio.2009.07.042
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Takadama H, 2001, SCI TECHNOL ADV MAT, V2, P389, DOI 10.1016/S1468-6996(01)00007-9
   Tamayo A, 2008, J EUR CERAM SOC, V28, P1871, DOI 10.1016/j.jeurceramsoc.2007.12.026
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Wang YJ, 2010, J BIOMAT SCI-POLYM E, V21, P1227, DOI 10.1163/092050609X12481751806259
   Wang YJ, 2010, J BIOMED MATER RES B, V93B, P84, DOI 10.1002/jbm.b.31561
   Wang YJ, 2009, MAT SCI ENG C-MATER, V29, P2502, DOI 10.1016/j.msec.2009.07.018
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Wu H, 2008, MATER LETT, V62, P2733, DOI 10.1016/j.matlet.2008.01.029
   Xie Y., 2006, SURF SCI, V600, P651
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 59
TC 5
Z9 5
U1 3
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD APR
PY 2017
VL 13
IS 3
BP 1157
EP 1169
DI 10.1016/j.nano.2016.10.008
PG 13
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA EU5QX
UT WOS:000401089100037
PM 27793788
OA Green Published
DA 2018-10-20
ER

PT J
AU Tihan, GT
   Sereanu, V
   Meghea, A
   Voicu, G
   Albu, MG
   Mitran, V
   Cimpean, A
   Zgarian, RG
AF Tihan, Gratiela Teodora
   Sereanu, Viviana
   Meghea, Aurelia
   Voicu, Georgeta
   Albu, Madalina Georgiana
   Mitran, Valentina
   Cimpean, Anisoara
   Zgarian, Roxana Gabriela
TI Innovative methodology for developing a bone grafting composite
   biomaterial starting from the seashell of Rapana thomasiana
SO COMPTES RENDUS CHIMIE
LA English
DT Article
DE Collagen gel; Rapana thomasiana shell; Hydroxyapatite; Composite
   biomaterial; Bone regeneration
ID HYDROXYAPATITE; SCAFFOLDS; DELIVERY
AB Bone grafts are used in a wide array of clinical settings to augment bone repair and regeneration. This article reports a new method for the elaboration of a hybrid biomaterial in the form of sponge based on collagen gel, CaCO3 from recycled Rapana thomasiana seashell, and Na2HPO4 center dot 2H(2)O. Practically, collagen acts as a matrix through which calcium and phosphate ions are diffusing during in situ hydroxyapatite synthesis. The organiceinorganic interactions among biomaterial components have been studied by infrared spectroscopy, and the surface morphology was investigated by scanning electron microscopy technique. Moreover, the developed biomaterials were studied for in vitro biocompatibility with MG63 human osteoblasts. The results obtained demonstrated that the developed hybrid material does not exhibit a significant cytotoxicity and supports cell proliferation. Consequently, it holds great promise for applications in bone tissue engineering. (C) 2016 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.
C1 [Tihan, Gratiela Teodora; Sereanu, Viviana; Meghea, Aurelia; Voicu, Georgeta; Zgarian, Roxana Gabriela] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu St 1, Bucharest 011061, Romania.
   [Albu, Madalina Georgiana] Natl Res & Dev Inst Text & Leather, Bucharest, Romania.
   [Mitran, Valentina; Cimpean, Anisoara] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest, Romania.
RP Zgarian, RG (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu St 1, Bucharest 011061, Romania.
EM zgirianroxana@yahoo.com
RI Cimpean, Anisoara/C-2101-2011
OI Cimpean, Anisoara/0000-0002-5833-3110; Voicu,
   Georgeta/0000-0001-7155-7138; Sereanu, Viviana/0000-0002-5826-9710
CR Andronescu E, 2013, TECHNOL CANCER RES T, V12, P275, DOI 10.7785/tcrt.2012.500331
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003
   Green DW, 2010, PAN ST SER BIOM NANO, V1, P821
   Gunduz O. J., 2014, AUST CERAM SOC, V50, P52
   Ivanova EP, 2014, WOODH PUBL SER BIOM, V67, P71, DOI 10.1533/9781782422662.71
   Ivanova EP, 2014, WOODH PUBL SER BIOM, V67, P187, DOI 10.1533/9781782422662.187
   Ivanova EP, 2014, WOODH PUBL SER BIOM, V67, P1, DOI 10.1533/9781782422662.1
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Lee SW, 2014, TISSUE ENG REGEN MED, V11, P113, DOI 10.1007/s13770-014-0056-1
   LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6
   Mann R., 2004, ICES ALIEN SPECIES A, P14
   Mitran V, 2015, PROG NAT SCI-MATER, V25, P122, DOI 10.1016/j.pnsc.2015.03.008
   Paluszkiewicz C, 2006, J MOL STRUCT, V792, P176, DOI 10.1016/j.molstruc.2006.01.066
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Popescu RG, 2009, MATER PLAST, V46, P140
   Qingrong W., 2015, NANOTECHNOLOGY, V26
   Sereanu V, 2014, INT MULTI SCI GEOCO, P531
   Tihan TG, 2009, MATER CHEM PHYS, V118, P265, DOI 10.1016/j.matchemphys.2009.03.019
   Ungureanu C, 2015, J BRAZIL CHEM SOC, V26, P458, DOI 10.5935/0103-5053.20150298
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   Wu SC, 2011, MATER CHARACT, V62, P1180, DOI 10.1016/j.matchar.2011.09.009
   Zhao QF, 2012, J NON-CRYST SOLIDS, V358, P229, DOI 10.1016/j.jnoncrysol.2011.09.020
NR 25
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0748
EI 1878-1543
J9 CR CHIM
JI C. R. Chim.
PD APR
PY 2017
VL 20
IS 4
BP 440
EP 445
DI 10.1016/j.crci.2016.11.003
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA ET9VE
UT WOS:000400656200014
DA 2018-10-20
ER

PT J
AU Fischer, M
   Gebhard, F
   Hammer, T
   Zurek, C
   Meurer, G
   Marquardt, C
   Hoefer, D
AF Fischer, Melissa
   Gebhard, Florian
   Hammer, Timo
   Zurek, Christian
   Meurer, Guido
   Marquardt, Christoph
   Hoefer, Dirk
TI Microbial alginate dressings show improved binding capacity for
   pathophysiological factors in chronic wounds compared to commercial
   alginate dressings of marine origin
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Alginate; wound dressing; microbial; pathophysiology; wound material;
   specific advantages; wound biomaterial importance
ID NECROSIS-FACTOR-ALPHA; VENOUS LEG ULCERS; AZOTOBACTER-VINELANDII; MATRIX
   METALLOPROTEINASES; PSEUDOMONAS-AERUGINOSA; O-ACETYLATION; IN-VITRO;
   OXYGEN; ELASTASE; FIBERS
AB Marine alginates are well established in wound management. Compared with different modern wound dressings, marine alginates cannot prove superior effects on wound healing. Alginates from bacteria have never been studied for medical applications so far, although the microbial polymer raises expectations for improved binding of wound factors because of its unique O-acetylation. Due to its possible positive effects on wound healing, alginates from bacteria might be a superior future medical product for clinical use. To prove the binding capacity of microbial alginates to pathophysiological factors in chronic wounds, we processed microbial alginate fibres, produced from fermentation of the soil bacterium Azotobacter vinelandii ATCC 9046, into needle web dressings and compared them with commercial dressings made of marine alginate. Four dressings were assessed: Marine alginate dressings containing either ionic silver or zinc/manganese/calcium, and microbial alginate dressings with and without nanosilver. All dressings were tested in an invitro approach for influence on chronic wound parameters such as elastase, matrix metalloproteases-2, tumour necrosis factor-, interleukin-8, and free radical formation. Despite the alginate origin or addition of antimicrobials, all dressings were able to reduce the concentration of the proinflammatory cytokines TNF- and IL-8. However, microbial alginate was found to bind considerable larger amounts of elastase and matrix metalloproteases-2 in contrast to the marine alginate dressings. The incorporation of zinc, silver or nanosilver into alginate fibres did not improve their binding capacity for proteases or cytokines. The addition of nanosilver slightly enhanced the antioxidant capacity of microbial alginate dressings, whereas the marine alginate dressing containing zinc/manganese/calcium was unable to inhibit the formation of free radicals. The enhanced binding affinity by microbial alginate of Azotobacter vinelandii to pathophysiological factors may be interesting to support optimal conditions for wound healing.
C1 [Fischer, Melissa; Gebhard, Florian] Albert Einstein Univ, Dept Trauma Hand Plast & Reconstruct Surg, Ulm, Germany.
   [Hammer, Timo] Xenios AG, Heilbronn, Germany.
   [Zurek, Christian; Meurer, Guido] BRAIN AG, Darmstadter Str 34-36, Zwingenberg, Germany.
   [Marquardt, Christoph] Klinikum Ludwigsburg, Dept Gen & Visceral Surg, Ludwigsburg, Germany.
   [Hoefer, Dirk] Hohenstein Inst, Dept Hyg Environm & Med, Schlosssteige 1, D-74357 Bonnigheim, Germany.
RP Hoefer, D (reprint author), Hohenstein Inst, Dept Hyg Environm & Med, Schlosssteige 1, D-74357 Bonnigheim, Germany.
EM d.hoefer@hohenstein.de
FU German Federal Ministry of Education and Research as part of a programme
   [BMBF 031A126A]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was funded by a grant promoted by the German Federal Ministry of
   Education and Research as part of a programme to support the joint
   industrial research and development (grant no. BMBF 031A126A).
CR Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x
   Castillo T, 2013, PROCESS BIOCHEM, V48, P995, DOI 10.1016/j.procbio.2013.04.014
   Chrisman CA, 2010, INT WOUND J, V7, P214, DOI 10.1111/j.1742-481X.2010.00682.x
   Dumville JC, 2015, COCHRANE DB SYST REV, V21, P1
   Edwards JV, 2007, J BIOMED MATER RES A, V83A, P446, DOI 10.1002/jbm.a.31171
   Eisenbud David, 2003, Ostomy Wound Manage, V49, P52
   Eming S, 2008, BIOMATERIALS, V29, P2932, DOI 10.1016/j.biomaterials.2008.03.029
   Eming SA, 2006, J INVEST DERMATOL, V126, P2731, DOI 10.1038/sj.jid.5700474
   Flores C, 2013, ENZYME MICROB TECH, V53, P85, DOI 10.1016/j.enzmictec.2013.04.010
   Harris I R, 1995, Exp Dermatol, V4, P342, DOI 10.1111/j.1600-0625.1995.tb00058.x
   Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076
   He CF, 1999, WOUND REPAIR REGEN, V7, P97, DOI 10.1046/j.1524-475X.1999.00097.x
   Herrick S, 1997, LAB INVEST, V77, P281
   Hoefer D, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5492-5
   James TJ, 2003, WOUND REPAIR REGEN, V11, P172, DOI 10.1046/j.1524-475X.2003.11304.x
   Kirsner RS, 2001, WOUNDS, V13, P4
   Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x
   Mahsood R, 2014, J WOUND CARE, V23, P153, DOI 10.12968/jowc.2014.23.3.153
   Moral CK, 2015, APPL BIOCHEM BIOTECH, V176, P875, DOI 10.1007/s12010-015-1617-z
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001
   Opasanon S, 2012, ASKINA CALGITROL MAD
   Pena C, 2006, LETT APPL MICROBIOL, V43, P200, DOI 10.1111/j.1472-765X.2006.01925.x
   Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001
   Qin Y, 1996, Med Device Technol, V7, P32
   Rostan EF, 2002, INT J DERMATOL, V41, P606, DOI 10.1046/j.1365-4362.2002.01567.x
   Saco M., 2016, DERMATOL ONLINE J, V22
   SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239
   Sweeney IR, 2014, CARBOHYD POLYM, V102, P920, DOI 10.1016/j.carbpol.2013.10.053
   Sweeney IR, 2012, INT WOUND J, V9, P601, DOI 10.1111/j.1742-481X.2011.00923.x
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Thomas S, 2000, J Wound Care, V9, P56
   Thomas S, 2000, J Wound Care, V9, P163
   Thomas S, 2000, J Wound Care, V9, P115
   Thomas S., 2010, SURG DRESSINGS WOUND, P58
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Walker M, 2007, OSTOMY WOUND MANAG, V53, P18
   Wallace HJ, 1998, J INVEST DERMATOL, V110, P292, DOI 10.1046/j.1523-1747.1998.00113.x
   Warriner Robert, 2005, Adv Skin Wound Care, V18 Suppl 1, P2, DOI 10.1097/00129334-200510001-00001
   Wiegand C, 2011, J MATER SCI-MATER M, V22, P2583, DOI 10.1007/s10856-011-4423-3
   Wiegand C, 2009, WOUND REPAIR REGEN, V17, P511, DOI 10.1111/j.1524-475X.2009.00503.x
   WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Yager Dorne R., 1997, Wound Repair and Regeneration, V5, P23, DOI 10.1046/j.1524-475X.1997.50108.x
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
NR 45
TC 3
Z9 3
U1 8
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2017
VL 31
IS 9
BP 1267
EP 1276
DI 10.1177/0885328217702173
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET8BQ
UT WOS:000400523600003
PM 28355974
DA 2018-10-20
ER

PT J
AU Masuda, T
   Maruyama, H
   Arai, F
   Anada, T
   Tsuchiya, K
   Fukuda, T
   Suzuki, O
AF Masuda, Taisuke
   Maruyama, Hisataka
   Arai, Fumihito
   Anada, Takahisa
   Tsuchiya, Kaori
   Fukuda, Toshio
   Suzuki, Osamu
TI Application of an indicator-immobilized-gel-sheet for measuring the pH
   surrounding a calcium phosphate-based biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Octacalcium phosphate; pH measurement; biomaterials; conversion;
   microenvironment
ID SYNTHETIC OCTACALCIUM PHOSPHATE; BETA-TRICALCIUM PHOSPHATE; BOVINE
   SERUM-ALBUMIN; SINTERED HYDROXYAPATITE; OPTICAL TWEEZERS; EXTRACELLULAR
   PH; BONE-FORMATION; HYDROLYSIS; FLUORIDE; APATITE
AB The present study was designed to investigate the local microenvironment of octacalcium phosphate in a granule form upon biomolecules adsorption utilizing an indicator-immobilized-gel-sheet for measuring pH. We previously showed that octacalcium phosphate enhances bone regeneration during its progressive hydrolysis into hydroxyapatite if implanted in bone defects. The gel-sheet was made from a photocrosslinkable prepolymer solution, which can easily immobilize a pH indicator (bromothymol blue; BTB) in the hydrogel. The indicator-immobilized-gel-sheet was mounted on a biochip which was made of polydimethylsiloxane (PDMS) with a flow channel. The pH value was calculated by detecting the color changes in the gel-sheet and displayed as the pH distribution. After pre-adsorption of bovine albumin, -lactoglobuline or cytochrome C onto octacalcium phosphate granules, the granules with the gel-sheet were further incubated in Tris-HCl buffer solution in the absence or presence of fluoride, known as an accelerator of octacalcium phosphate hydrolysis. pH values of the gel-sheet surrounding octacalcium phosphate granules showed a decrease from pH 7.4 to 6.6 in relation to the proteins adsorbed. Overall, the proposed pH-sensitive gel can be used to detect the pH around octacalcium phosphate granules with a high spatial resolution.
C1 [Masuda, Taisuke; Maruyama, Hisataka; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi, Japan.
   [Anada, Takahisa; Tsuchiya, Kaori; Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
   [Fukuda, Toshio] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi, Japan.
RP Suzuki, O (reprint author), Tohoku Univ, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM suzuki-o@m.tohoku.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [23106010, 26293417, 15K15720]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by Grants-in Aid (grant nos 23106010, 26293417 and
   15K15720) from the Ministry of Education, Culture, Sports, Science and
   Technology, Japan.
CR BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   Chow LC, 2009, DENT MATER J, V28, P1
   Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   Hirayama B, 2016, RSC ADV, V6, pS7475, DOI 10.1039/c6ra10834b
   Honda Y, 2007, J BIOMED MATER RES B, V80B, P281, DOI 10.1002/jbm.b.30595
   Hwang EY, 2004, BIOMED MICRODEVICES, V6, P241, DOI 10.1023/B:BMMD.0000042054.02940.b6
   Iijima M, 1996, CALCIFIED TISSUE INT, V59, P377, DOI 10.1007/s002239900143
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Kaneko H, 2011, ANAL BIOCHEM, V418, P276, DOI 10.1016/j.ab.2011.07.022
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kirchhof K, 2011, LAB CHIP, V11, P3326, DOI 10.1039/c1lc20408d
   Klauke N, 2006, LAB CHIP, V6, P788, DOI 10.1039/b517237c
   Lee WK, 2002, J COLLOID INTERF SCI, V246, P70, DOI 10.1006/jcis.2001.8026
   Li CY, 2006, ANALYST, V131, P388, DOI 10.1039/b514510d
   Maruyama H, 2008, LAB CHIP, V8, P346, DOI 10.1039/b712566f
   Maruyama H, 2009, MICROFLUID NANOFLUID, V6, P383, DOI 10.1007/s10404-008-0401-6
   MCKENZIE HA, 1967, NATURE, V214, P1101, DOI 10.1038/2141101a0
   Miyatake N, 2009, BIOMATERIALS, V30, P1005, DOI 10.1016/j.biomaterials.2008.10.058
   Monfoulet LE, 2014, TISSUE ENG PT A, V20, P1827, DOI [10.1089/ten.TEA.2013.0500, 10.1089/ten.tea.2013.0500]
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Nishikawa R, 2014, DENT MATER J, V33, P242, DOI 10.4012/dmj.2013-226
   Nomura S, 1997, ANAL CHEM, V69, P977, DOI 10.1021/ac960909t
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Pooler PM, 1998, ANAL BIOCHEM, V256, P238, DOI 10.1006/abio.1997.2508
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   Sakai S, 2016, DENT MATER J, V35, P216, DOI 10.4012/dmj.2015-255
   Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shiwaku Y, 2012, ACTA BIOMATER, V8, P4417, DOI 10.1016/j.actbio.2012.07.041
   Shiwaku Y, 2010, J CERAM SOC JPN, V118, P402, DOI 10.2109/jcersj2.118.402
   SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050
   Stern H, 2005, IMAGE VISION COMPUT, V23, P353, DOI 10.1016/j.imavis.2004.09.005
   Suge T, 2012, AM J DENT, V25, P299
   SUZUKI O, 1993, BONE MINER, V20, P151, DOI 10.1016/S0169-6009(08)80024-4
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   SUZUKI O, 1995, CELL MATER, V5, P45
   Suzuki O, 2013, JPN DENT SCI REV, V49, P58, DOI 10.1016/j.jdsr.2013.01.001
   Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065
   TOYA H, 2001, T MAT RES SOC JPN, V26, P1247
   TUNG MS, 1992, ARCH ORAL BIOL, V37, P585, DOI 10.1016/0003-9969(92)90142-U
   Waldman SD, 2004, TISSUE ENG, V10, P1633, DOI 10.1089/ten.2004.10.1633
   Wang XG, 2015, J TISSUE ENG REGEN M, V9, P1310, DOI 10.1002/term.1669
   Wen HB, 1999, J BIOMED MATER RES, V46, P245, DOI 10.1002/(SICI)1097-4636(199908)46:2<245::AID-JBM14>3.0.CO;2-A
   Wu MH, 2009, BIOMED MICRODEVICES, V11, P265, DOI 10.1007/s10544-008-9233-0
NR 49
TC 1
Z9 1
U1 3
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2017
VL 31
IS 9
BP 1296
EP 1304
DI 10.1177/0885328217699108
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET8BQ
UT WOS:000400523600005
PM 28447546
DA 2018-10-20
ER

PT J
AU Liu, MY
   Wu, KM
   Zhao, LZ
   Zhang, YM
AF Liu, Mengyuan
   Wu, Kaimin
   Zhao, Lingzhou
   Zhang, Yumei
TI Foreign Body Reaction to Biomaterial Nanotubular Surface and the
   Influence of Silver Loading
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Foreign Body Reaction; Nanotopography; Silver; Macrophages;
   Biocompatibility
ID HUMAN GINGIVAL FIBROBLASTS; OSTEOBLAST ADHESION; TIO2 NANOTUBES; TISSUE;
   IMPLANTS; MACROPHAGES; ROUGHNESS; RESPONSES; TOPOGRAPHY; COATINGS
AB The impacts of biomaterial surface properties (i.e., surface nanotopography) and dopants (i.e., silver (Ag)) on the biomaterial-associated foreign body reaction (FBR) remain unclear. In this study, an in vivo FBR that was induced by a titania nanotube array (NT) on titanium was examined with and without Ag loading. An NT with an 80 nm diameter that was fabricated by anodization, and the NT samples that were loaded with two Ag concentrations (NT-AgH and NT-AgL) and formed by electrodeposition exhibited high hydrophilicities. A relatively rapid initial Ag+ release with a subsequent gradual reduction was observed for NT-AgH and NT-AgL; the Ag+ release was higher for NT-AgH than for NT-AgL. We found that the NT decreased the biomaterial-associated FBR, evidenced by a decreased fibrous capsule thickness and a number of recruited macrophages. The effect of Ag loading on the FBR was considered acceptable because the FBR induced by the NT-Ag samples was still less severe than that of the PT control. Additionally, the temporary increases in the blood, brain, liver and kidney Ag+ concentrations did not produce general side effects and were considered to be in the safe range. This study demonstrates the ability of nanotopography to alleviate the biomaterial-associated FBR and provides further evidence for future clinical applications of biomaterials with nanostructures and Ag loading.
C1 [Liu, Mengyuan; Zhang, Yumei] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.
   [Zhao, Lingzhou] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.
   [Wu, Kaimin] 401 Mil Hosp, Dept Stomatol, Qingdao 266071, Peoples R China.
   [Liu, Mengyuan] Qingdao Municipal Hosp, Oral Res Ctr, Qingdao 266071, Peoples R China.
RP Zhang, YM (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.; Zhao, LZ (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.
EM zhaolingzhou1983@hotmail.com; wqtzym@fmmu.edu.cn
FU National Natural Science Foundation of China [31200716, 81070862,
   31170915]; National Excellent Doctoral Dissertation of PR China (FANEDD)
   [201483]; National High Technology Research and Development Program of
   China [SS2015AA020921]; Self-Selected Topic Project of State Key
   Laboratory of Military Stomatology [2014ZB04]; Program for Changjiang
   Scholars and Innovative Research Team in University [IRT13051]; School
   of Stomatology
FX The authors appreciate the grants from the National Natural Science
   Foundation of China (31200716, 81070862 and 31170915), A Foundation for
   the Author of National Excellent Doctoral Dissertation of PR China
   (FANEDD, No. 201483), the National High Technology Research and
   Development Program of China (SS2015AA020921), Self-Selected Topic
   Project of State Key Laboratory of Military Stomatology (2014ZB04),
   Program for Changjiang Scholars and Innovative Research Team in
   University IRT13051, and the financial support from the School of
   Stomatology, The Fourth Military Medical University to L. Z. Zhao.
CR Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Benvenuto P, 2009, J ELECTROANAL CHEM, V627, P76, DOI 10.1016/j.jelechem.2008.12.022
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Chun YW, 2011, CARBON, V49, P2092, DOI 10.1016/j.carbon.2011.01.044
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004
   Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7
   Khang D, 2009, ACTA BIOMATER, V5, P1425, DOI 10.1016/j.actbio.2009.01.031
   Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028
   Ma QL, 2011, J BIOMED MATER RES A, V98A, P274, DOI 10.1002/jbm.a.33111
   Mendez-Vilas A, 2007, ULTRAMICROSCOPY, V107, P617, DOI 10.1016/j.ultramic.2006.12.002
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   SCHEDLE A, 1995, J DENT RES, V74, P1513, DOI 10.1177/00220345950740081301
   Smith GC, 2011, ACTA BIOMATER, V7, P3209, DOI 10.1016/j.actbio.2011.05.003
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wang Y, 2013, J CONTROL RELEASE, V169, P341, DOI 10.1016/j.jconrel.2012.12.028
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 41
TC 5
Z9 5
U1 3
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2017
VL 13
IS 4
BP 381
EP 392
DI 10.1166/jbn.2017.2354
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA ET8RM
UT WOS:000400568400003
PM 29384602
DA 2018-10-20
ER

PT J
AU Soon, G
   Pingguan-Murphy, B
   Akbar, SA
AF Soon, Ginny
   Pingguan-Murphy, Belinda
   Akbar, Sheikh Ali
TI Modulation of osteoblast behavior on nanopatterned yttria-stabilized
   zirconia surfaces
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Nanostructure; Osteoblast; Zirconia; Cell behaviour; Self-assembly
ID TITANIUM SURFACES; CELL BEHAVIOR; ROUGHNESS; PROLIFERATION; WETTABILITY;
   BIOMATERIAL; ELECTROSPUN; ATTACHMENT; STRATEGIES; INTERFACE
AB This study utilizes the technique of self-assembly to fabricate arrays of nanoislands on (001)-oriented yttria-stabilized zirconia single crystal substrates with miscut of 10 degrees toward < 110 > direction. These self-assembled nanostructures were annealed at 1100 degrees C for 5 h upon doping with 10 mol% gadolinium-doped ceria (GDC) by powder-suspension based. method. X-Ray diffraction result showed that the miscut substrate after doping GDC was in the cubic phase. Energy dispersive X-ray (EDX) illustrates that the nanopatterned material contains all the elements from the GDC source and yttria-stabilized zirconia (YSZ) substrate. It also demonstrates a higher surface roughness and a more hydrophilic surface. The nanostructured materials were subsequently used for an in vitro study using a human fetal osteoblastic cell line (hFOB). An improved spreading, enhanced cell proliferation and up-regulated alkaline phosphatase activity (ALP) were observed on the nanopatterned substrates compared to the control substrates. Calcium deposits, which were stained positively by Alizarin Red S, appeared to be more abundant on the nanopatterned surfaces on day 7. The overall findings suggest that post fabrication treatment with surface modification such as creating a nanostructure (e.g. nanopatterns) can improve biocompatibility.
C1 [Soon, Ginny; Pingguan-Murphy, Belinda] Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Akbar, Sheikh Ali] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM bpingguan@um.edu.my
RI Pingguan-Murphy, Belinda/B-8332-2010
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141
FU University of Malaya [RP040A-15HTM];  [PG122-2015A]
FX This research is supported by the University of Malaya - Grant number
   RP040A-15HTM and Postgraduate Research Grant (PG122-2015A).
CR An J, 2013, NANOMEDICINE-UK, V8, P591, DOI [10.2217/NNM.13.46, 10.2217/nnm.13.46]
   Ansari HM, 2013, NANO LETT, V13, P2116, DOI 10.1021/nl4005282
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Choi JS, 2014, MACROMOL BIOSCI, V14, P270, DOI 10.1002/mabi.201300281
   Davidson PM, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4927556
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Frandsen CJ, 2011, MAT SCI ENG C-MATER, V31, P1716, DOI 10.1016/j.msec.2011.07.016
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Jalaja K, 2014, CARBOHYD POLYM, V114, P467, DOI 10.1016/j.carbpol.2014.08.023
   Keller John C, 2003, Implant Dent, V12, P175
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kulkarni M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062002
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Ni SY, 2014, J BIOMED MATER RES B, V102, P1297, DOI 10.1002/jbm.b.33127
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Richardson JJ, 2011, J MATER CHEM, V21, P14417, DOI 10.1039/c1jm13167b
   Rolandi M, 2014, ADV COLLOID INTERFAC, V207, P216, DOI 10.1016/j.cis.2014.01.019
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Sjostrom T, 2011, APPL SURF SCI, V257, P4552, DOI 10.1016/j.apsusc.2010.11.064
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun QQ, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/11/115602
   Sun X., 2015, B AM PHYS SOC, V60
   Tarlani A, 2015, BIOSENS BIOELECTRON, V67, P601, DOI 10.1016/j.bios.2014.09.063
   Turner LA, 2014, BIOMATER SCI-UK, V2, P1574, DOI 10.1039/c4bm00155a
   Zamani M, 2013, INT J NANOMED, V8, P2997, DOI 10.2147/IJN.S43575
   Zhu M, 2011, NANOSCALE, V3, P2723, DOI 10.1039/c1nr00015b
   Zimmerman L.B., 2009, NANOTECHNOLOGY, V21
NR 40
TC 1
Z9 1
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2017
VL 68
BP 26
EP 31
DI 10.1016/j.jmbbm.2017.01.028
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET4DI
UT WOS:000400229100004
PM 28135639
DA 2018-10-20
ER

PT J
AU Heath, DE
AF Heath, Daniel E.
TI Promoting Endothelialization of Polymeric Cardiovascular Biomaterials
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE blood outgrowth endothelial cell; endothelial cell; endothelial
   progenitor cell; small diameter vascular graft; thrombus
ID ELECTROSPUN SCAFFOLD TOPOGRAPHY; CELL-SPECIFIC PEPTIDE; SHEAR-STRESS;
   PROGENITOR CELLS; VASCULAR GRAFTS; BLOOD COMPATIBILITY; TERPOLYMER
   BIOMATERIALS; ADHESION PEPTIDES; RE-ENDOTHELIALIZATION;
   EXTRACELLULAR-MATRIX
AB The lack of a blood compatible synthetic interface is one of the largest unaddressed challenges in the field of biomaterials science. This technological shortcoming hinders the successful clinical application of small diameter vascular grafts and other cardiovascular devices such as stents and artificial heart valves. Therefore, intensive research activities are ongoing to develop polymer materials with improved blood compatibility. One attractive strategy to improve the blood compatibility of an interface is to design surfaces that promote the development of an endothelium, the monolayer of endothelial cells that line our native vasculature and is responsible for blood compatibility. This article describes the recent strategies that have been used to generate polymeric materials that promote the development of an endothelium, discusses shortcomings in the field, and proposes future directions of research that can be undertaken to design next generation polymeric biomaterial that promote endothelialization.
C1 [Heath, Daniel E.] Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia.
RP Heath, DE (reprint author), Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia.
EM daniel.heath@unimelb.edu.au
FU University of Melbourne; Therapeutic Technologies Research Initiative;
   Equity Trustees
FX The author would like to acknowledge the University of Melbourne, the
   Therapeutic Technologies Research Initiative, and Equity Trustees for
   financial support.
CR AlKhaffaf H, 1996, J VASC SURG, V23, P686, DOI 10.1016/S0741-5214(96)80050-4
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Ballyk PD, 1998, J BIOMECH, V31, P229
   Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423
   Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129
   Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038
   Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603
   Brown T. D., 2015, PROG POLYM SCI, V7, P373
   Byron A, 2010, CURR BIOL, V20, pR1063, DOI 10.1016/j.cub.2010.10.059
   Chiu JJ, 2009, ANN MED, V41, P19, DOI 10.1080/07853890802186921
   Chollet C, 2012, MACROMOL BIOSCI, V12, P1648, DOI 10.1002/mabi.201200167
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5
   Cucina A, 1998, SURGERY, V123, P212, DOI 10.1067/msy.1998.83187
   Dardik A, 1999, J VASC SURG, V29, P157, DOI 10.1016/S0741-5214(99)70357-5
   Ding YH, 2015, ACTA BIOMATER, V15, P150, DOI 10.1016/j.actbio.2014.12.014
   Duarte ARC, 2009, ACTA BIOMATER, V5, P2054, DOI 10.1016/j.actbio.2009.01.047
   Dudash LA, 2014, J BIOMED MATER RES A, V102, P2857, DOI 10.1002/jbm.a.34960
   Farrar DJ, 2000, HEART SURG FORUM, V3, P36
   Franco D, 2011, SOFT MATTER, V7, P7313, DOI 10.1039/c1sm05191a
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Garin G, 2006, ENDOTHELIUM-J ENDOTH, V13, P375, DOI 10.1080/10623320601061599
   Gloe T, 2002, J BIOL CHEM, V277, P23453, DOI 10.1074/jbc.M203889200
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Habib Anwer, 2016, Interv Cardiol Clin, V5, P321, DOI 10.1016/j.iccl.2016.02.002
   Hadjizadeh A, 2013, J BIOMED NANOTECHNOL, V9, P1195, DOI 10.1166/jbn.2013.1622
   Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Heath DE, 2013, TISSUE ENG PT A, V19, P79, DOI [10.1089/ten.tea.2011.0655, 10.1089/ten.TEA.2011.0655]
   Heath DE, 2012, ACTA BIOMATER, V8, P2899, DOI 10.1016/j.actbio.2012.03.052
   Heath DE, 2010, J BIOMED MATER RES A, V94A, P1294, DOI 10.1002/jbm.a.32811
   Heath DE, 2010, J BIOMED MATER RES A, V94A, P1195, DOI 10.1002/jbm.a.32802
   Heath DE, 2010, J BIOMED MATER RES B, V92B, P289, DOI 10.1002/jbm.b.31514
   Henderson TMA, 2015, J BIOMAT SCI-POLYM E, V26, P881, DOI 10.1080/09205063.2015.1065597
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hill SM, 1998, ANAT REC, V253, P42, DOI 10.1002/(SICI)1097-0185(199804)253:2<42::AID-AR7>3.0.CO;2-G
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Hu ZJ, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-115
   Huang YJ, 2013, COLLOID SURFACE B, V101, P361, DOI 10.1016/j.colsurfb.2012.06.034
   Human M. C. Yoder, 2012, COLD SPRING HARB PER, V2, P1
   Ino JM, 2013, J BIOMED MATER RES B, V101, P1549, DOI 10.1002/jbm.b.32977
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Jeon H, 2015, ACS APPL MATER INTER, V7, P4525, DOI 10.1021/acsami.5b00554
   Jeschke MG, 1999, J VASC SURG, V29, P168, DOI 10.1016/S0741-5214(99)70358-7
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kelly BS, 2002, KIDNEY INT, V62, P2272, DOI 10.1046/j.1523-1755.2002.00684.x
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Ko YG, 2016, TISSUE ENG REGEN MED, V13, P343, DOI 10.1007/s13770-016-0053-7
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Konradi R, 2012, MACROMOL RAPID COMM, V33, P1663, DOI 10.1002/marc.201200422
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kraitzer A, 2012, ADV ENG MATER, V14, pB294, DOI 10.1002/adem.201180088
   LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004
   Le Saux G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021869
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   Li Q, 2013, MAT SCI ENG C-MATER, V33, P1646, DOI 10.1016/j.msec.2012.12.074
   Lichtenberg A, 2006, J HEART VALVE DIS, V15, P287
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Lord MS, 2009, BIOMATERIALS, V30, P4898, DOI 10.1016/j.biomaterials.2009.05.063
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lv Q, 2013, CLIN ORTHOP RELAT R, V471, P2422, DOI 10.1007/s11999-013-2859-0
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Mecham R. P., 2012, CURR PROTOC CELL BIO, V57
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   MOORADIAN DL, 1993, INVEST OPHTH VIS SCI, V34, P153
   Niu BL, 2012, PROTEIN EXPRES PURIF, V83, P92, DOI 10.1016/j.pep.2012.03.004
   Paszkowiak Jacek J, 2003, Vasc Endovascular Surg, V37, P47, DOI 10.1177/153857440303700107
   Pennel T, 2013, J VASC SURG, V58, P1053, DOI 10.1016/j.jvs.2012.11.093
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Potthoff E, 2014, NANO LETT, V14, P1069, DOI 10.1021/nl4047398
   Pratumvinit B., 2013, BIOMED RES INT, V2013
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P241
   Ratner B.D., 2001, BIOMATERIALS SCI INT, P35
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Rayatpisheh S, 2014, BIOMATERIALS, V35, P2713, DOI 10.1016/j.biomaterials.2013.12.035
   Reid B, 2015, J TISSUE ENG REGEN M, V9, P315, DOI 10.1002/term.1688
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SEEGER JM, 1985, J SURG RES, V38, P641, DOI 10.1016/0022-4804(85)90087-3
   Seto Y, 2010, BIOMATERIALS, V31, P2209, DOI 10.1016/j.biomaterials.2009.11.104
   Sgarioto M, 2012, CR BIOL, V335, P520, DOI 10.1016/j.crvi.2012.07.003
   Shemesh D, 2015, J VASC SURG, V62, P115, DOI 10.1016/j.jvs.2015.01.056
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shirbin S. J., 2016, BIOMACROMOLECULES
   Sims FH, 2000, PATHOLOGY, V32, P171
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tsai MY, 2014, ADV FUNCT MATER, V24, P2281, DOI 10.1002/adfm.201303050
   Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639
   Urbich C, 2002, ARTERIOSCL THROM VAS, V22, P69, DOI 10.1161/hq0102.101518
   Veleva AN, 2009, J BIOMED MATER RES A, V91A, P1131, DOI 10.1002/jbm.a.32276
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Wang X, 2013, TISSUE ENG PT A, V19, P1113, DOI [10.1089/ten.tea.2011.0653, 10.1089/ten.TEA.2011.0653]
   Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026
   Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546
   Whited BM, 2014, BIOTECHNOL BIOENG, V111, P184, DOI 10.1002/bit.24995
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Williams SK, 2011, J BIOMED MATER RES A, V99A, P67, DOI 10.1002/jbm.a.33138
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yang BH, 2013, CELL MOL BIOENG, V6, P346, DOI 10.1007/s12195-013-0276-9
   Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x
   Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab
   Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484
NR 123
TC 4
Z9 4
U1 4
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1352
EI 1521-3935
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD APR
PY 2017
VL 218
IS 8
AR UNSP 1600574
DI 10.1002/macp.201600574
PG 10
WC Polymer Science
SC Polymer Science
GA ET9DP
UT WOS:000400607100007
DA 2018-10-20
ER

PT J
AU Rao, N
   Agmon, G
   Tierney, MT
   Ungerleider, JL
   Braden, RL
   Sacco, A
   Christman, KL
AF Rao, Nikhil
   Agmon, Gillie
   Tierney, Matthew T.
   Ungerleider, Jessica L.
   Braden, Rebecca L.
   Sacco, Alessandra
   Christman, Karen L.
TI Engineering an Injectable Muscle-Specific Microenvironment for Improved
   Cell Delivery Using a Nanofibrous Extracellular Matrix Hydrogel
SO ACS NANO
LA English
DT Article
DE biomaterial; muscle; myoblast; peripheral artery disease; cell delivery;
   cell microenvironment; injectable
ID SKELETAL-MUSCLE; STEM-CELLS; GROWTH-FACTOR; ISCHEMIA; MYOBLAST; TISSUE;
   ARTERIOGENESIS; ANGIOGENESIS; THERAPY; MODEL
AB Injection of skeletal muscle progenitors has the potential to be a minimally invasive treatment for a number of diseases that negatively affect vasculature and skeletal muscle, including peripheral artery disease. However, success with this approach has been limited because of poor transplant cell survival. This is primarily attributed to cell death due to extensional flow through the needle, the harsh ischemic environment of the host tissue, a deleterious immune cell response, and a lack of biophysical cues supporting exogenous cell viability. We show that engineering a muscle-specific microenvironment, using a nanofibrous decellularized skeletal muscle extracellular matrix hydrogel and skeletal muscle fibroblasts, improves myoblast viability and maturation in vitro. In vivo, this translates to improved cell survival and engraftment and increased perfusion as a result of increased vascularization. Our results indicate that a combinatorial delivery system, which more fully recapitulates the tissue microenvironment, can improve cell delivery to skeletal muscle.
C1 [Rao, Nikhil; Agmon, Gillie; Ungerleider, Jessica L.; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA.
   [Rao, Nikhil; Agmon, Gillie; Ungerleider, Jessica L.; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
   [Tierney, Matthew T.] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, La Jolla, CA 92037 USA.
   [Tierney, Matthew T.; Sacco, Alessandra] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA.; Christman, KL (reprint author), Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
OI Agmon, Gillie/0000-0002-3451-3694
FU NIH [R01HL113468, P30 AR06130303, R01 AR064873, T32 EB009380, T32
   HL105373, F31 AR065923]
FX This work was supported by NIH grants R01HL113468 (K.L.C.), P30
   AR06130303 and R01 AR064873 (A.S.). N.R. acknowledges the Training
   Program in Multi-Scale Analysis of Biological Structure and Function
   (Interfaces Graduate Training Program, NIH T32 EB009380) and the
   Training Program in Integrative Bioengineering of Heart, Vessels and
   Blood (NIH T32 HL105373), and M.T.T. acknowledges NIH fellowship F31
   AR065923 for support.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Buschmann I, 1999, NEWS PHYSIOL SCI, V14, P121
   Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]
   Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Eschenhagen T, 2006, CIRC RES, V98, P573, DOI 10.1161/01.RES.0000215627.13049.5d
   Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Menasche P, 2005, CORONARY ARTERY DIS, V16, P105, DOI 10.1097/00019501-200503000-00005
   Niagara MI, 2004, J VASC SURG, V40, P774, DOI 10.1016/j.jvs.2004.07.027
   Norgren L, 2010, EUR J VASC ENDOVASC, V40, P375, DOI 10.1016/j.ejvs.2010.05.005
   Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180
   Quevedo HC, 2014, J INVASIVE CARDIOL, V26, P22
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rao N, 2013, BIOMED MICRODEVICES, V15, P161, DOI 10.1007/s10544-012-9709-9
   Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200
   Ruan J, 2012, THERANOSTICS, V2, P618, DOI 10.7150/thno.4561
   Sacco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137139
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Somanchi SS, 2012, BLOOD, V119, P5164, DOI 10.1182/blood-2011-11-389924
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Ungerleider JL, 2015, METHODS, V84, P53, DOI 10.1016/j.ymeth.2015.03.024
   Ungerleider Jessica L, 2016, JACC Basic Transl Sci, V1, P32
   Yoshikawa HY, 2013, J PHYS CHEM B, V117, P4081, DOI 10.1021/jp4008224
NR 31
TC 6
Z9 6
U1 7
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD APR
PY 2017
VL 11
IS 4
BP 3851
EP 3859
DI 10.1021/acsnano.7b00093
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA ET4EX
UT WOS:000400233200043
PM 28323411
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pedron, S
   Pritchard, AM
   Vincil, GA
   Andrade, B
   Zimmerman, SC
   Harley, BAC
AF Pedron, Sara
   Pritchard, Amanda M.
   Vincil, Gretchen A.
   Andrade, Brenda
   Zimmerman, Steven C.
   Harley, Brendan A. C.
TI Patterning Three-Dimensional Hydrogel Microenvironments Using
   Hyperbranched Polyglycerols for Independent Control of Mesh Size and
   Stiffness
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; STEM-CELL FATE; FLUORESCENCE RECOVERY;
   MECHANICAL-PROPERTIES; CLICK REACTIONS; POLYMER; DIFFERENTIATION;
   CHEMISTRY; BIOACTIVITY; PHENOTYPE
AB The extracellular matrix is an environment rich with structural, mechanical, and molecular signals that can impact cell biology. Traditional approaches in hydrogel biomaterial design often rely on modifying the concentration of cross-linking groups to adjust mechanical properties. However, this strategy provides limited capacity to control additional important parameters in 3D cell culture such as microstructure and molecular diffusivity. Here we describe the use of multifunctional hyperbranched polyglycerols (HPGs) to manipulate the mechanical properties of polyethylene glycol (PEG) hydrogels while not altering biomolecule diffusion. This strategy also provides the ability to separately regulate spatial and temporal distribution of biomolecules tethered within the hydrogel. The functionalized HPGs used here can also react through a copper-free click chemistry, allowing for the encapsulation of cells and covalently tethered biomolecules within the hydrogel. Because of the hyperbranched architecture and unique properties of HPGs, their addition into PEG hydrogels affords opportunities to locally alter hydrogel cross-linking density with minimal effects on global network architecture. Additionally, photocoupling chemistry allows micropatterning of bioactive cues within the three-dimensional gel structure. This approach therefore enables us to tailor mechanical and diffusive properties independently while further allowing for local modulation of biomolecular cues to create increasingly complex cell culture microenvironments.
C1 [Pedron, Sara; Pritchard, Amanda M.; Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, 1206 West Gregory Dr, Urbana, IL 61801 USA.
   [Vincil, Gretchen A.; Andrade, Brenda; Zimmerman, Steven C.] Univ Illinois, Dept Chem, 505 South Mathews Ave, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, 110 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, 1206 West Gregory Dr, Urbana, IL 61801 USA.; Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, 110 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Pedron, Sara/E-6404-2015
OI Zimmerman, Steven C./0000-0002-5333-3437; Harley,
   Brendan/0000-0001-5458-154X
FU National Science Foundation [CBET-1254738, CHE-1307404]; National
   Institute of Diabetes and Digestive and Kidney Diseases of the National
   Institutes of Health [R01 DK099528]; Illini; Department of Chemical and
   Biomolecular Engineering; Carl R Woese Institute for Genomic Biology at
   the University of Illinois at Urbana-Champaign
FX The authors acknowledge Carl R. Woese Institute for Genomic Biology Core
   Facilities for assistance with fluorescence imaging, Dr. Matthew Wheeler
   (University of Illinois) for the gift of porcine adipose derived stem
   cells, and Professor Hyunjoon Kong (University of Illinois) for access
   to equipment to analyze mechanical properties of hydrogels. This
   material is based upon work supported by the National Science Foundation
   under Grant CBET-1254738 (B.A.C.H.) and CHE-1307404 (S.C.Z.). Research
   reported in this publication was supported by the National Institute of
   Diabetes and Digestive and Kidney Diseases of the National Institutes of
   Health under Award Number R01 DK099528 (B.A.C.H). The authors are
   grateful for additional funding provided by the Illini 4000, as well as
   the Department of Chemical and Biomolecular Engineering and the Carl R
   Woese Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign.
CR Andrzejewska E, 2001, PROG POLYM SCI, V26, P605, DOI 10.1016/S0079-6700(01)00004-1
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Banks JM, 2015, ACS BIOMATER SCI ENG, V1, P718, DOI 10.1021/acsbiomaterials.5b00196
   Banks JM, 2014, BIOMATERIALS, V35, P8951, DOI 10.1016/j.biomaterials.2014.07.012
   Bionaz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137644
   Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9
   Browning MB, 2011, J BIOMED MATER RES A, V98A, P268, DOI 10.1002/jbm.a.33109
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Caliari SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21387
   Costa P, 2014, ACTA BIOMATER, V10, P2415, DOI 10.1016/j.actbio.2014.01.029
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Frey H., 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   Hensarling RM, 2009, J AM CHEM SOC, V131, P14673, DOI 10.1021/ja9071157
   Hoyle CE, 2010, CHEM SOC REV, V39, P1355, DOI 10.1039/b901979k
   Keys KB, 1998, MACROMOLECULES, V31, P8149, DOI 10.1021/ma980999z
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917
   Liao HM, 2008, ACTA BIOMATER, V4, P1161, DOI 10.1016/j.actbio.2008.04.013
   Lowe AB, 2014, POLYMER, V55, P5517, DOI 10.1016/j.polymer.2014.08.015
   Lowe AB, 2010, POLYM CHEM-UK, V1, P17, DOI 10.1039/b9py00216b
   Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138
   Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481
   Monaco E, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt7
   Mozdzen LC, 2016, ACTA BIOMATER, V33, P25, DOI 10.1016/j.actbio.2016.02.004
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Oudshoorn MHM, 2007, LANGMUIR, V23, P11819, DOI 10.1021/la701910d
   Oudshoorn MHM, 2006, BIOMATERIALS, V27, P5471, DOI 10.1016/j.biomaterials.2006.06.030
   Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Pedron S, 2010, ACTA BIOMATER, V6, P4189, DOI 10.1016/j.actbio.2010.06.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615
   Steinhilber D, 2011, BIOMATERIALS, V32, P1311, DOI 10.1016/j.biomaterials.2010.10.010
   Voit BI, 2009, CHEM REV, V109, P5924, DOI 10.1021/cr900068q
   Wang DK, 2012, J POLYM SCI POL CHEM, V50, P1143, DOI 10.1002/pola.25874
   Weisgerber DW, 2016, J MECH BEHAV BIOMED, V61, P318, DOI 10.1016/j.jmbbm.2016.03.032
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang HB, 2013, BIOMACROMOLECULES, V14, P1299, DOI 10.1021/bm301825q
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zill A, 2011, CHEM COMMUN, V47, P1279, DOI 10.1039/c0cc04096g
NR 45
TC 2
Z9 2
U1 8
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2017
VL 18
IS 4
BP 1393
EP 1400
DI 10.1021/acs.biomac.7b00118
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA ER8HU
UT WOS:000399061100035
PM 28245360
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dogan, S
   Caglar, M
   Caglar, B
   Cirak, C
   Zeytun, E
AF Dogan, Salih
   Caglar, Mustafa
   Caglar, Bulent
   Cirak, Cagri
   Zeytun, Erhan
TI Structural characterization of the silk of two-spotted spider mite
   Tetranychus urticae Koch (Acari: Tetranychidae)
SO SYSTEMATIC AND APPLIED ACAROLOGY
LA English
DT Article
DE Tetranychus urticae; silk; characterization; chemical composition; AFM;
   ATR-FTIR; EDX
ID SPINNING BEHAVIOR; ACARIFORMES HYDRACHNIDIA; SPECTROSCOPY; MORPHOLOGY
AB The present investigation was undertaken to obtain information about the structural and morphological properties of the silk of two-spotted spider mite Tetranychus urticae Koch (Acari: Tetranychidae) by means of the atomic force microscope (AFM), scanning electron microscope (SEM), energy dispersive X-ray spectrophotometer (EDX) and attenuated total reflection Fourier transmission infrared spectroscopy (ATR-FTIR) techniques. AFM images show that the shapes of silken threads produced by both female and male mites are similar and have non-uniform cylindrical structure. In general, the appearance of silks produced by female mites is smoother than those of the male mites. In addition, it is determined that the silk threads produced by both female and male individuals have single and double stranded structure. There were differences in the thread dimensions of female and male which could depend on the body size of the mites. However, there is no statistically significant correlation between the body size of the mites and their thread dimensions. The silk material was found to consist predominantly of C, N and O elements and minor fractions of Al, P, Cl and K. The ATR-FTIR spectrum of the silk of two-spotted spider mite exhibited characteristic vibrational modes originating from amid groups, which were attributed to random coil and a-sheet molecular conformation in the protein structure of the silk of two-spotted spider mite. Understanding the features of the two-spotted spider mite silks may be of practical importance for the future studies related to biomaterial and material science.
C1 [Dogan, Salih; Caglar, Mustafa; Zeytun, Erhan] Erzincan Univ, Arts & Sci Fac, Dept Biol, Erzincan, Turkey.
   [Caglar, Bulent] Erzincan Univ, Arts & Sci Fac, Dept Chem, Erzincan, Turkey.
   [Cirak, Cagri] Erzincan Univ, Arts & Sci Fac, Dept Phys, Erzincan, Turkey.
RP Dogan, S (reprint author), Erzincan Univ, Arts & Sci Fac, Dept Biol, Erzincan, Turkey.
EM salihdogan@erzincan.edu.tr
OI Dogan, Salih/0000-0001-5030-0544; Cirak, Cagri/0000-0002-4717-8602
FU Erzincan University Scientific Research Projects Coordinatorship
   [FOA-2016-372]
FX This study is based on M. Caglar's MSc thesis and was supported by
   Erzincan University Scientific Research Projects Coordinatorship,
   research project number FOA-2016-372. The experimental preliminary study
   of this work was presented as a seminar in University of Amsterdam, the
   Netherlands by the first author. The senior author is very grateful to
   Dr Maurice W. Sabelis (+), Dr Farid Faraji and all other colleagues in
   MITOX/ Eurofins and Population Biology group, Institute of Biodiversity
   and Ecosystem Dynamics (IBED), University of Amsterdam, the Netherlands
   for their critical review and valuable suggestions during the
   presentation.
CR Asakura T, 2013, PROG NUCL MAG RES SP, V69, P23, DOI 10.1016/j.pnmrs.2012.08.001
   Clotuche G, 2009, MICROSC RES TECHNIQ, V72, P659, DOI 10.1002/jemt.20712
   Clotuche G, 2014, EXP APPL ACAROL, V63, P377, DOI 10.1007/s10493-014-9779-x
   Clotuche G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077573
   Clotuche G, 2013, CR BIOL, V336, P93, DOI 10.1016/j.crvi.2013.02.006
   Clotuche G, 2012, EXP APPL ACAROL, V56, P345, DOI 10.1007/s10493-012-9520-6
   Clotuche G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018854
   DENNY M, 1976, J EXP BIOL, V65, P483
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Grbic M., 2013, United States Patent No, Patent No. [US008501913B2, 008501913]
   Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640
   Hudson SD, 2013, J APPL PHYS, V113, DOI 10.1063/1.4800865
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Koperska MA, 2014, POLYM DEGRAD STABIL, V105, P185, DOI 10.1016/j.polymdegradstab.2014.04.008
   Le Goff G., 2011, THESIS
   Le Goff GJ, 2012, J ETHOL, V30, P125, DOI 10.1007/s10164-011-0305-x
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   MCGREGOR EA, 1950, AM MIDL NAT, V44, P257, DOI 10.2307/2421963
   Migeon A., 2013, SPIDER MITES WEB COM
   NAPPO, 2014, MORPH ID SPID MIT TE
   Ray HA, 2014, INT J ACAROL, V40, P577, DOI 10.1080/01647954.2014.963668
   Sabelis M. W., 1985, THEIR BIOL NATURAL E, P103
   SABELIS MW, 1992, EXP APPL ACAROL, V16, P203, DOI 10.1007/BF01193804
   SAITO Y, 1979, JPN J APPL ENTOMOL Z, V23, P82
   SAITO Y, 1977, JPN J APPL ENTOMOL Z, V21, P150
   SAITO Y, 1977, JPN J APPL ENTOMOL Z, V21, P27
   SAITO Y, 1983, ACAROLOGIA, V24, P377
   Seeman OD, 2011, ZOOTAXA, P1
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Shatrov A., 2016, 8 S EUR ASS AC EURAA, P33
   Shatrov AB, 2016, J NAT HIST, V50, P2199, DOI 10.1080/00222933.2016.1193643
   Shatrov A. B., 2014, Acarina, V22, P133
   Shatrov A. B., 2014, MICROSCOPY ADV SCI R, P538
   Siri S, 2010, INT J BIOL MACROMOL, V46, P529, DOI [10.1016/j.fibiomac.2010.03.002, 10.1016/j.ijbiomac.2010.03.002]
   Tien NSH, 2009, EVOL ECOL RES, V11, P1271
   Tsukada M, 2010, INT J BIOL MACROMOL, V46, P54, DOI 10.1016/j.ijbiomac.2009.10.003
   Van Nimmen E, 2008, VIB SPECTROSC, V46, P63, DOI 10.1016/j.vibspec.2007.10.003
   Yano S, 2008, ANN ENTOMOL SOC AM, V101, P247, DOI 10.1603/0013-8746(2008)101[247:CASBOT]2.0.CO;2
   Zhang Z.-Q., 2002, LAND CARE RESEARCH C
   Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3703.1.1
NR 40
TC 0
Z9 0
U1 4
U2 16
PU SYSTEMATIC & APPLIED ACAROLOGY SOC LONDON, NATURAL HISTORY MUSEUM
PI LONDON
PA DEPT ENTOMOLOGY, LONDON, SW7 5BD, ENGLAND
SN 1362-1971
J9 SYST APPL ACAROL-UK
JI Syst. Appl. Acarol.
PD APR
PY 2017
VL 22
IS 4
BP 572
EP 583
DI 10.11158/saa.22.4.11
PG 12
WC Entomology
SC Entomology
GA ES6NU
UT WOS:000399666100011
DA 2018-10-20
ER

PT J
AU Freeman, FE
   McNamara, LM
AF Freeman, Fiona E.
   McNamara, Laoise M.
TI Endochondral Priming: A Developmental Engineering Strategy for Bone
   Tissue Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
DE 3D cell culture; bone; mesenchymal stem cells; tissue development and
   growth
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; CYCLIC
   HYDROSTATIC-PRESSURE; COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLD; VASCULAR
   ENDOTHELIAL-CELLS; DIFFERENTIATION IN-VITRO; COMPOSITE SCAFFOLDS; ADULT
   HUMAN; POROUS HYDROXYAPATITE; CHONDROGENIC DIFFERENTIATION
AB Tissue engineering and regenerative medicine have significant potential to treat bone pathologies by exploiting the capacity for bone progenitors to grow and produce tissue constituents under specific biochemical and physical conditions. However, conventional tissue engineering approaches, which combine stem cells with biomaterial scaffolds, are limited as the constructs often degrade, due to a lack of vascularization, and lack the mechanical integrity to fulfill load bearing functions, and as such are not yet widely used for clinical treatment of large bone defects. Recent studies have proposed that in vitro tissue engineering approaches should strive to simulate in vivo bone developmental processes and, thereby, imitate natural factors governing cell differentiation and matrix production, following the paradigm recently defined as "developmental engineering.'' Although developmental engineering strategies have been recently developed that mimic specific aspects of the endochondral ossification bone formation process, these findings are not widely understood. Moreover, a critical comparison of these approaches to standard biomaterial-based bone tissue engineering has not yet been undertaken. For that reason, this article presents noteworthy experimental findings from researchers focusing on developing an endochondral-based developmental engineering strategy for bone tissue regeneration. These studies have established that in vitro approaches, which mimic certain aspects of the endochondral ossification process, namely the formation of the cartilage template and the vascularization of the cartilage template, can promote mineralization and vascularization to a certain extent both in vitro and in vivo. Finally, this article outlines specific experimental challenges that must be overcome to further exploit the biology of endochondral ossification and provide a tissue engineering construct for clinical treatment of large bone/nonunion defects and obviate the need for bone tissue graft.
C1 [Freeman, Fiona E.; McNamara, Laoise M.] Natl Univ Ireland Galway, Coll Engn & Informat, Ctr Biomech Res BMEC, Biomed Engn, Galway, Ireland.
RP McNamara, LM (reprint author), Natl Univ Ireland Galway, Coll Engn & Informat, Ctr Biomech Res BMEC, Biomed Engn, Galway, Ireland.
EM laoise.mcnamara@nuigalway.ie
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   BLENMAN PR, 1989, J ORTHOPAED RES, V7, P398, DOI 10.1002/jor.1100070312
   Bonfield W, 2006, PHILOS T ROY SOC A, V364, P227, DOI 10.1098/rsta.2005.1692
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carlevaro MF, 2000, J CELL SCI, V113, P59
   Carter D.R., 1987, CLIN ORTHOP RELAT R, V219, P237
   CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604
   Casabona F, 1998, PLAST RECONSTR SURG, V101, P577, DOI 10.1097/00006534-199803000-00003
   CHAPMAN PG, 1992, J BONE JOINT SURG BR, V74, P398
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Claes LE, 1998, CLIN ORTHOP RELAT R, pS132
   Correia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028352
   COVENTRY MB, 1972, J BONE JOINT SURG AM, VA 54, P83, DOI 10.2106/00004623-197254010-00008
   Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   DICK HM, 1994, CLIN ORTHOP RELAT R, P46
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Elsinger E C, 1996, J Foot Ankle Surg, V35, P396
   ENNEKING WF, 1980, J BONE JOINT SURG AM, V62, P1039, DOI 10.2106/00004623-198062070-00001
   Farrell E, 2007, Technol Health Care, V15, P19
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297
   Fell HB, 1934, BIOCHEM J, V28, P2243, DOI 10.1042/bj0282243
   Fell HB, 1929, BIOCHEM J, V23, P767, DOI 10.1042/bj0230767
   Finger AR, 2007, TISSUE ENG, V13, P1151, DOI 10.1089/ten.2006.0290
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Freeman FE, 2016, J TISSUE ENG REGEN M, V10, pE250, DOI 10.1002/term.1793
   Freeman FE, 2016, TISSUE ENG PT A, V22, P1176, DOI 10.1089/ten.tea.2015.0339
   Freeman FE, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0210-2
   Freeman FE, 2015, TISSUE ENG PT A, V21, P1320, DOI [10.1089/ten.tea.2014.0249, 10.1089/ten.TEA.2014.0249]
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P208, DOI [10.1089/ten.tea.2010.0731, 10.1089/ten.TEA.2010.0731]
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Ghanaati S, 2011, J TISSUE ENG REGEN M, V5, pE136, DOI 10.1002/term.373
   Giovannini S, 2010, EUR CELLS MATER, V20, P245
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HALL BK, 1987, CLIN ORTHOP RELAT R, P255
   Harada N, 2014, BIOMATERIALS, V35, P7800, DOI 10.1016/j.biomaterials.2014.05.052
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   HEISE U, 1990, INT ORTHOP, V14, P329
   Hibi H, 2006, INT J ORAL MAX SURG, V35, P551, DOI 10.1016/j.ijom.2005.12.007
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hunziker EB, 1989, PHYSIOLOGY, V414, P55
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Krecic-Stres H, 2007, IFMBE PROC, V16, P253
   Krishnan L, 2015, CLIN ORTHOP RELAT R, V473, P2885, DOI 10.1007/s11999-015-4312-z
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Kruyt MC, 2004, J BIOMED MATER RES B, V69B, P113, DOI 10.1002/jbm.b.10073
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690
   LEBOY PS, 1989, J BIOL CHEM, V264, P17281
   Lee J, 2010, J ORAL MAXIL SURG, V68, P188, DOI 10.1016/j.joms.2009.08.031
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P395, DOI [10.1089/ten.teb.2009.0461, 10.1089/ten.TEB.2009.0461]
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI [10.1089/ten.teb.2008.0575, 10.1089/ten.TEB.2008.0575]
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Luo ZJ, 2007, P I MECH ENG H, V221, P499, DOI 10.1243/09544119JEIM199
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Martin I, 2014, TISSUE ENG PT A, V20, P1132, DOI 10.1089/ten.tea.2013.0772
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102
   McFadden TM, 2013, ACTA BIOMATER, V9, P9303, DOI 10.1016/j.actbio.2013.08.014
   McNamara L. M, 2011, COMPREHENSIVE BIOMAT, P169
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Merz E, 2004, ULTRASOUND OBSTET GY
   Meyer EG, 2011, J MECH BEHAV BIOMED, V4, P1257, DOI 10.1016/j.jmbbm.2011.04.012
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253
   Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Nakaoka R, 2006, TISSUE ENG, V12, P2425, DOI 10.1089/ten.2006.12.2425
   Narayan D, 2008, J BIOMED MATER RES A, V87A, P710, DOI 10.1002/jbm.a.31749
   Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031
   Nowlan NC, 2007, ANN NY ACAD SCI, V1101, P389, DOI 10.1196/annals.1389.003
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pedersen TO, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt202
   Pelissier P, 2003, PLAST RECONSTR SURG, V111, P1932, DOI 10.1097/01.PRS.0000055044.14093.EA
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Prestwich GD, 2002, ANN NY ACAD SCI, V961, P106, DOI 10.1111/j.1749-6632.2002.tb03058.x
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Reddi AH, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P117, DOI 10.1016/B978-012370615-7/50013-5
   REID RL, 1968, J BONE JOINT SURG AM, VA 50, P757, DOI 10.2106/00004623-196850040-00012
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Rizzo Marco, 2008, Semin Plast Surg, V22, P213, DOI 10.1055/s-2008-1081404
   ROACH HI, 1992, BONE MINER, V19, P1, DOI 10.1016/0169-6009(92)90840-A
   Roach HI, 1997, J BONE MINER RES, V12, P795, DOI 10.1359/jbmr.1997.12.5.795
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Saleh F A, 2011, Eur Cell Mater, V22, P242
   Sartoris D., 1991, J FOOT ANKLE SURG, V31, P301
   Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124
   Scheufler O, 2008, J CELL MOL MED, V12, P1238, DOI [10.1111/j.1582-4934.2008.00137.x, 10.1111/j.1582-4934.2007.00137.x]
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Sheehy EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090716
   Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Smith A., 1968, THE BODY
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   SOWA DT, 1987, ORTHOP CLIN N AM, V18, P257
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   TAYLOR GI, 1983, CLIN PLAST SURG, V10, P185
   Thompson EM, 2016, TISSUE ENG PT A, V22, P556, DOI [10.1089/ten.TEA.2015.0457, 10.1089/ten.tea.2015.0457]
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Tsai TL, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0065-6
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   van der Stok J, 2014, EUR CELLS MATER, V27, P137, DOI 10.22203/eCM.v027a11
   Verseijden F, 2010, TISSUE ENG PT A, V16, P101, DOI [10.1089/ten.tea.2009.0106, 10.1089/ten.TEA.2009.0106]
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09
   Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Webster S, 2012, EMBRYOLOGY GLANCE
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WEILAND AJ, 1983, CLIN ORTHOP RELAT R, P87
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   WONG M, 1990, BONE, V11, P127, DOI 10.1016/8756-3282(90)90060-C
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   WONG M, 1990, ANAT EMBRYOL, V181, P523
   Yang WX, 2015, ACTA BIOMATER, V13, P254, DOI 10.1016/j.actbio.2014.11.029
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yoshida K, 1999, J DENT RES, V78, P1505, DOI 10.1177/00220345990780090401
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zamiri B, 2013, J CRANIOFAC SURG, V24, P1292, DOI 10.1097/SCS.0b013e318294288a
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhao X, 2012, ANN PLAS SURG, V69, P91, DOI 10.1097/SAP.0b013e3182583eb9
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
   Zomorodian E., 2012, STEM CELLS INT, V2012
NR 200
TC 4
Z9 4
U1 2
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD APR
PY 2017
VL 23
IS 2
BP 128
EP 141
DI 10.1089/ten.teb.2016.0197
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA ES2AB
UT WOS:000399327000003
PM 27758156
DA 2018-10-20
ER

PT J
AU Addi, C
   Murschel, F
   De Crescenzo, G
AF Addi, Cyril
   Murschel, Frederic
   De Crescenzo, Gregory
TI Design and Use of Chimeric Proteins Containing a Collagen-Binding Domain
   for Wound Healing and Bone Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
DE biomedical engineering; wound healing; growth factors; extracellular
   matrix; bone; collagen
ID VON-WILLEBRAND-FACTOR; ENDOTHELIAL GROWTH-FACTOR; FACTOR FUSION PROTEIN;
   CLOSTRIDIUM-HISTOLYTICUM COLLAGENASE; TARGETING PARATHYROID-HORMONE;
   SURFACE-PLASMON RESONANCE; MESENCHYMAL STEM-CELLS; RAT FLAP MODELS;
   VONWILLEBRAND-FACTOR; GELATIN-BINDING
AB Collagen-based biomaterials are widely used in the field of tissue engineering; they can be loaded with biomolecules such as growth factors (GFs) to modulate the biological response of the host and thus improve its potential for regeneration. Recombinant chimeric GFs fused to a collagen-binding domain (CBD) have been reported to improve their bioavailability and the host response, especially when combined with an appropriate collagen-based biomaterial. This review first provides an extensive description of the various CBDs that have been fused to proteins, with a focus on the need for accurate characterization of their interaction with collagen. The second part of the review highlights the benefits of various CBD/GF fusion proteins that have been designed for wound healing and bone regeneration.
C1 [Addi, Cyril; Murschel, Frederic; De Crescenzo, Gregory] Ecole Polytech Montreal, Dept Chem Engn, Bio Res Unit P2, Biomed Sci & Technol Res Grp, POB 6079,Succ Ctr Ville, Montreal, PQ H3C 3A7, Canada.
RP De Crescenzo, G (reprint author), Ecole Polytech Montreal, Dept Chem Engn, Bio Res Unit P2, Biomed Sci & Technol Res Grp, POB 6079,Succ Ctr Ville, Montreal, PQ H3C 3A7, Canada.
EM gregory.decrescenzo@polymtl.ca
OI Murschel, Frederic/0000-0002-6735-8934
FU Canada Research Chair on Protein-Enhanced Biomaterials; Natural Sciences
   and Engineering Research Council of Canada; MEDITIS training program
FX We apologize to authors whose relevant articles were not cited due to
   space limitations. This work was supported by the Canada Research Chair
   on Protein-Enhanced Biomaterials, by the Natural Sciences and
   Engineering Research Council of Canada, and by the MEDITIS training
   program.
CR Akimoto M, 2013, PLAST RECONSTR SURG, V131, P717, DOI 10.1097/PRS.0b013e3182818b34
   An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013
   An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808
   Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932
   Andrades JA, 2001, GROWTH FACTORS, V18, P261, DOI 10.3109/08977190109029115
   Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Becerra J, 2006, REGEN MED, V1, P267, DOI 10.2217/17460751.1.2.267
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4
   BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250
   BOCKENSTEDT P, 1986, J CLIN INVEST, V78, P551, DOI 10.1172/JCI112608
   Boucher C, 2009, BIOCONJUGATE CHEM, V20, P1569, DOI 10.1021/bc9001147
   Boucher C, 2008, TISSUE ENG PT A, V14, P2069, DOI 10.1089/ten.tea.2008.0037
   Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2
   Brewster LP, 2008, BIOMATERIALS, V29, P327, DOI 10.1016/j.biomaterials.2007.09.034
   BROWN GL, 1991, PLAST RECONSTR SURG, V88, P189, DOI 10.1097/00006534-199108000-00001
   BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chan TR, 2011, ADV FUNCT MATER, V21, P4252, DOI 10.1002/adfm.201101163
   Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen W, 2010, J UROLOGY, V183, P2432, DOI 10.1016/j.juro.2010.02.042
   Citarella F, 2000, THROMB HAEMOSTASIS, V84, P1057
   Claros S, 2014, INT J MOL SCI, V15, P11255, DOI 10.3390/ijms150711255
   CRUZ MA, 1993, J BIOL CHEM, V268, P21238
   CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   DELANNOY P, 1989, FEBS LETT, V247, P25, DOI 10.1016/0014-5793(89)81232-3
   DESOUZA SJ, 1992, J BIOL CHEM, V267, P13763
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Du MC, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044104
   Du MC, 2014, COLLOID SURFACE B, V114, P316, DOI 10.1016/j.colsurfb.2013.10.001
   Eckhard U, 2013, J BIOL CHEM, V288, P20184, DOI 10.1074/jbc.M112.448548
   El-Jawhari JJ, 2016, J ORTHOP RES, V34, P597, DOI 10.1002/jor.23070
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Fang TL, 2014, J RECONSTR MICROSURG, V30, P1, DOI 10.1055/s-0033-1345429
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Flood VH, 2012, J THROMB HAEMOST, V10, P1417, DOI 10.1111/j.1538-7836.2012.04746.x
   Flood VH, 2015, BLOOD, V125, P2297, DOI 10.1182/blood-2014-11-610824
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fukata Y, 2014, BBA-GEN SUBJECTS, V1840, P1892, DOI 10.1016/j.bbagen.2014.01.019
   Gao J, 2011, TISSUE ENG PT A, V17, P2739, DOI [10.1089/ten.tea.2011.0105, 10.1089/ten.TEA.2011.0105]
   Graiani G, 2004, DIABETOLOGIA, V47, P1047, DOI 10.1007/s00125-004-1414-7
   Hall FL, 2000, INT J MOL MED, V6, P635
   Han B, 2002, J ORTHOPAED RES, V20, P747, DOI 10.1016/S0736-0266(01)00157-7
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008
   HAUSER S, 1993, GROWTH FACTORS, V9, P259, DOI 10.3109/08977199308991586
   Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002
   Hiraoka M, 2009, BIOCONJUGATE CHEM, V20, P976, DOI 10.1021/bc9000068
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hoylaerts MF, 1997, BIOCHEM J, V324, P185, DOI 10.1042/bj3240185
   INGHAM KC, 1989, J BIOL CHEM, V264, P16977
   Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X
   INGHAM KC, 1988, J BIOL CHEM, V263, P4624
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Ishikawa T, 2006, ARTERIOSCL THROM VAS, V26, P1998, DOI 10.1161/01.ATV.0000233359.74484.77
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Jia WS, 2015, BIOMATERIALS, V69, P45, DOI 10.1016/j.biomaterials.2015.08.009
   Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200
   Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007
   Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200
   Kato K, 2007, BIOCONJUGATE CHEM, V18, P2137, DOI 10.1021/bc700259g
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kim DG, 2015, J MICROBIOL BIOTECHN, V25, P119, DOI 10.4014/jmb.1405.05073
   Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Kitajima T, 2007, BIOMATERIALS, V28, P1989, DOI 10.1016/j.biomaterials.2006.12.022
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013
   Kumra H, 2016, ADV DRUG DELIVER REV, V97, P101, DOI 10.1016/j.addr.2015.11.014
   Lai CH, 2013, J PERIODONTOL, V84, P950, DOI 10.1902/jop.2012.120415
   Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JH, 2005, FEBS LETT, V579, P2507, DOI 10.1016/j.febslet.2005.03.062
   Lee JH, 2003, FEMS MICROBIOL LETT, V223, P293, DOI 10.1016/S0378-1097(03)00401-4
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Lequoy P, 2016, ACTA BIOMATER, V29, P239, DOI 10.1016/j.actbio.2015.10.026
   Li F, 2002, ANN BIOMED ENG, V30, P1107, DOI 10.1114/1.1521931
   Li Q, 2012, BIOMATERIALS, V33, P4298, DOI 10.1016/j.biomaterials.2012.03.003
   Li XA, 2011, BIOMATERIALS, V32, P8172, DOI 10.1016/j.biomaterials.2011.07.050
   Li X, 2016, ACTA BIOMATER, V30, P233, DOI 10.1016/j.actbio.2015.11.023
   Liang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18205
   Liang H, 2015, J CONTROL RELEASE, V209, P101, DOI 10.1016/j.jconrel.2015.04.029
   Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Lin NC, 2012, BIOMATERIALS, V33, P1801, DOI 10.1016/j.biomaterials.2011.11.038
   Lineaweaver WC, 2014, PLAST RECONSTR SURG, V133, p423E, DOI 10.1097/01.prs.0000438450.63153.25
   Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965
   Lu HX, 2012, BIOMATERIALS, V33, P6140, DOI 10.1016/j.biomaterials.2012.05.038
   Martino MM, 2015, ADV DRUG DELIVER REV, V94, P41, DOI 10.1016/j.addr.2015.04.007
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Matsuno H, 2002, BLOOD, V100, P2487, DOI 10.1182/blood-2002-12-0251
   Matsushita O, 1999, J BACTERIOL, V181, P923
   Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200
   Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643
   Mazaki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04457
   Millard C.J., 2007, THESIS
   Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082
   Miyagawa S, 2002, CIRCULATION, V105, P2556, DOI 10.1161/01.CIR.0000016722.37138.F2
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Miyazaki H, 2008, BIOCONJUGATE CHEM, V19, P1119, DOI 10.1021/bc700470v
   Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x
   MORTON LF, 1983, THROMB RES, V32, P545, DOI 10.1016/0049-3848(83)90056-7
   Motulsky H., 2004, FITTING MODELS BIOL
   Muniruzzaman M, 1998, J BIOMAT SCI-POLYM E, V9, P459, DOI 10.1163/156856298X00569
   Murschel F, 2013, ACTA BIOMATER, V9, P6806, DOI 10.1016/j.actbio.2013.02.032
   Nakaji-Hirabayashi T, 2013, BIOCONJUGATE CHEM, V24, P1798, DOI 10.1021/bc400005m
   Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027
   Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x
   Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Ohkawara N, 2007, J ATHEROSCLER THROMB, V14, P185, DOI 10.5551/jat.E503
   Okiyama N, 2011, J DERMATOL SCI, V61, P215, DOI 10.1016/j.jdermsci.2011.01.001
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   Pang YG, 2010, J INVEST MED, V58, P845, DOI 10.231/JIM.0b013e3181ee81f7
   PARETI FI, 1986, J BIOL CHEM, V261, P15310
   Parsons P, 2011, J BIOL CHEM, V286, P34986, DOI 10.1074/jbc.M111.238188
   Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519
   Ponnapakkam T, 2014, DRUG DISCOV TODAY, V19, P204, DOI 10.1016/j.drudis.2013.07.015
   Ponnapakkam T, 2011, J ENDOCRINOL INVEST, V34, pE392, DOI 10.3275/7864
   Ponnapakkam T, 2011, CALCIFIED TISSUE INT, V88, P511, DOI 10.1007/s00223-011-9485-1
   Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906
   Robson MC, 1998, AM J SURG, V176, p80S, DOI 10.1016/S0002-9610(98)00186-X
   Rohatgi A, 2015, WEBPLOTDIGITIZER VER
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395
   Saito W, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0201-0
   Saito W, 2014, J BIOMED MATER RES A, V102, P3049, DOI 10.1002/jbm.a.34974
   Samorezov JE, 2015, ADV DRUG DELIVER REV, V84, P45, DOI 10.1016/j.addr.2014.11.018
   Sekiguchi H, 2016, J BIOMED MATER RES A, V104, P1372, DOI 10.1002/jbm.a.35670
   SEPHEL GC, 1989, DEV NEUROSCI-BASEL, V11, P313, DOI 10.1159/000111909
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   Shiozaki Y, 2013, INT J NANOMED, V8, P1349, DOI 10.2147/IJN.S44124
   Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226
   Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038
   Sistiabudi R, 2008, LANGMUIR, V24, P1591, DOI 10.1021/la703561d
   Sistiabudi R, 2009, BIOTECHNOL BIOENG, V102, P1723, DOI 10.1002/bit.22215
   SIXMA JJ, 1991, EUR J BIOCHEM, V196, P369, DOI 10.1111/j.1432-1033.1991.tb15826.x
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   STEENFOS HH, 1994, SCAND J PLAST RECONS, V28, P95, DOI 10.3109/02844319409071186
   Steffensen B, 2002, MATRIX BIOL, V21, P399, DOI 10.1016/S0945-053X(02)00032-X
   Sun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26683
   Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1
   Tada S, 2012, INT J MOL SCI, V13, P6053, DOI 10.3390/ijms13056053
   TAKAGI J, 1992, BIOCHEMISTRY-US, V31, P8530, DOI 10.1021/bi00151a021
   TAKAGI J, 1991, J BIOL CHEM, V266, P5575
   Tan H., 2016, J DRUG TARGET, V1
   Tan Q, 2014, J TISSUE ENG REGEN M, V8, P195, DOI 10.1002/term.1513
   Toyoshima T, 2001, CONNECT TISSUE RES, V42, P281, DOI 10.3109/03008200109016842
   Tuan TL, 1996, CONNECT TISSUE RES, V34, P1, DOI 10.3109/03008209609028888
   Uchida K, 2017, J TISSUE ENG REGEN M, V11, P1165, DOI 10.1002/term.2019
   Uchida K, 2014, J BIOMED MATER RES A, V102, P1737, DOI 10.1002/jbm.a.34841
   Ueno M, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035014
   UNDERWOOD PA, 1993, J IMMUNOL METHODS, V164, P119, DOI 10.1016/0022-1759(93)90282-C
   van der Plas RM, 2000, THROMB HAEMOSTASIS, V84, P1005
   Van Vlierberghe S, 2009, MACROMOL BIOSCI, V9, P1105, DOI 10.1002/mabi.200900043
   Vanhoorelbeke K, 2000, THROMB HAEMOSTASIS, V84, P621
   Visser R, 2014, TISSUE ENG PT A, V20, P34, DOI [10.1089/ten.TEA.2012.0610, 10.1089/ten.tea.2012.0610]
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Wahyudi H, 2016, J CONTROL RELEASE, V240, P323, DOI 10.1016/j.jconrel.2016.01.007
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang AY, 2008, BIOMACROMOLECULES, V9, P1755, DOI 10.1021/bm701378k
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Won JE, 2015, BIOMATERIALS, V56, P46, DOI 10.1016/j.biomaterials.2015.03.022
   Wu XC, 2013, INT J MOL MED, V31, P430, DOI 10.3892/ijmm.2012.1219
   Xu F, 2001, INT J MOL MED, V8, P19
   Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yang J, 2014, FOOD SCI HUMAN WELLN, V3, P127, DOI DOI 10.1016/J.FSHW.2014.12.002
   Yang YF, 2009, TISSUE ENG PT A, V15, P3589, DOI [10.1089/ten.tea.2008.0648, 10.1089/ten.TEA.2008.0648]
   Yano K, 2013, BIOMATERIALS, V34, P3165, DOI 10.1016/j.biomaterials.2013.01.048
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
   Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565
   Zhao WX, 2007, J BIOMED MATER RES A, V82A, P630, DOI 10.1002/bjm.a.31179
   Zhao YN, 2009, J BIOMED MATER RES A, V88A, P725, DOI 10.1002/jbm.a.31928
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 200
TC 2
Z9 2
U1 12
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD APR
PY 2017
VL 23
IS 2
BP 163
EP +
DI 10.1089/ten.teb.2016.0280
PG 21
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA ES2AB
UT WOS:000399327000006
PM 27824290
DA 2018-10-20
ER

PT J
AU Staruch, RMT
   Glass, GE
   Rickard, R
   Hettiaratchy, SP
   Butler, PEM
AF Staruch, Robert M. T.
   Glass, Graeme E.
   Rickard, Rory
   Hettiaratchy, Shehan P.
   Butler, Peter E. M.
TI Injectable Pore-Forming Hydrogel Scaffolds for Complex Wound Tissue
   Engineering: Designing and Controlling Their Porosity and Mechanical
   Properties
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
DE injectable; hydrogel; scaffolds; wound; mechanotransduction; NPWT
ID SUPERCRITICAL CARBON-DIOXIDE; POLY(ETHYLENE GLYCOL) HYDROGELS;
   CALCIUM-PHOSPHATE CEMENTS; VACUUM-ASSISTED CLOSURE; MESENCHYMAL
   STEM-CELL; NEGATIVE-PRESSURE; IN-VITRO; SUBSTRATE STIFFNESS; MICROSCALE
   TECHNOLOGIES; REGENERATIVE MEDICINE
AB Traumatic soft tissue wounds present a significant reconstructive challenge. The adoption of closed-circuit negative pressure wound therapy (NPWT) has enabled surgeons to temporize these wounds before reconstruction. Such systems use porous synthetic foam scaffolds as wound fillers at the interface between the negative pressure system and the wound bed. The idea of using a bespoke porous biomaterial that enhances wound healing, as filler for an NPWT system, is attractive as it circumvents concerns regarding reconstructive delay and the need for dressing changes that are features of the current systems. Porous foam biomaterials are mechanically robust and able to synthesize in situ. Hence, they exhibit potential to fulfill the niche for such a functionalized injectable material. Injectable scaffolds are currently in use for minimally invasive surgery, but the design parameters for large-volume expansive foams remain unclear. Potential platforms include hydrogel systems, (particularly superabsorbent, superporous, and nanocomposite systems), polyurethane-based moisture-cured foams, and high internal phase emulsion polymer systems. The aim of this review is to discuss the design parameters for such future biomaterials and review potential candidate materials for further research into this up and coming field.
C1 [Staruch, Robert M. T.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Glass, Graeme E.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
   [Rickard, Rory] Acad Dept Mil Surg & Trauma, ICT Business Pk, Birmingham, W Midlands, England.
   [Hettiaratchy, Shehan P.] St Marys Hosp, London, England.
   [Hettiaratchy, Shehan P.] Imperial Coll NHS Trust, London, England.
   [Butler, Peter E. M.] UCL, Royal Free Hosp, Dept Surg & Intervent Sci, London, England.
RP Staruch, RMT (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM robmtstaruch@doctors.org.uk
OI Butler, Peter/0000-0001-7419-1493
FU Academy of Medical Sciences (AMS) [AMS-SGCL6-Glass]
CR Adolph EJ, 2012, J BIOMED MATER RES A, V100A, P450, DOI 10.1002/jbm.a.33266
   Ahearne M, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0038
   Aimetti AA, 2009, BIOMACROMOLECULES, V10, P1484, DOI 10.1021/bm9000926
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barry JJA, 2006, PHILOS T ROY SOC A, V364, P249, DOI [10.1098/rsta.2005.1687, 10.1098/rsta.2000.1687]
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   Bellas E, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400506
   Bencherif SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8556
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Bradley M, 1999, Health Technol Assess, V3, P1
   Brown KV, 2011, J ROY ARMY MED CORPS, V157, pS315, DOI 10.1136/jramc-157-03s-11
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Caykara T, 2007, POLYM INT, V56, P532, DOI 10.1002/pi.2166
   Chaby G, 2007, ARCH DERMATOL, V143, P1297, DOI 10.1001/archderm.143.10.1297
   Charles-de-Sa L, 2015, AESTHET SURG J, V35, P334, DOI 10.1093/asj/sju047
   Chattopadhyay DK, 2005, PROG ORG COAT, V54, P296, DOI 10.1016/j.porgcoat.2005.07.004
   Chau M, 2016, CHEM MATER, V28, P3406, DOI 10.1021/acs.chemmater.6b00792
   Chen CF, 2006, IND ENG CHEM RES, V45, P3400, DOI 10.1021/ie0507169
   Chen YH, 2012, BIOMATERIALS, V33, P1336, DOI 10.1016/j.biomaterials.2011.10.048
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   d'Agostino MC, 2015, INT J SURG, V24, P147, DOI 10.1016/j.ijsu.2015.11.030
   da Silva R, 2007, POLYMER, V48, P4114, DOI 10.1016/j.polymer.2007.05.010
   DALY CH, 1982, J INVEST DERMATOL, V79, pS17, DOI 10.1111/1523-1747.ep12544620
   Darby IA, 2014, CLIN COSMET INVESTI, V7, P301, DOI 10.2147/CCID.S50046
   Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048
   Du H, 2016, POLYM CHEM-UK, V7, P5620, DOI 10.1039/c6py01346e
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Evriviades D, 2011, PHILOS T R SOC B, V366, P219, DOI 10.1098/rstb.2010.0237
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Geffers M, 2015, ACTA BIOMATER, V11, P467, DOI 10.1016/j.actbio.2014.09.036
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Glass GE, 2014, BRIT J SURG, V101, P1627, DOI 10.1002/bjs.9636
   Gong CY, 2013, BIOMATERIALS, V34, P6377, DOI 10.1016/j.biomaterials.2013.05.005
   Griffin DR, 2015, NAT MATER, V14, P737, DOI [10.1038/nmat4294, 10.1038/NMAT4294]
   Guelcher SA, 2006, TISSUE ENG, V12, P1247, DOI 10.1089/ten.2006.12.1247
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Guyver PM, 2013, ANN ROY COLL SURG, V95, P226, DOI 10.1308/003588413X13511609958532f
   Habraken WJEM, 2008, J BIOMED MATER RES A, V87A, P643, DOI 10.1002/jbm.a.31703
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hashmi B, 2014, ADV MATER, V26, P3253, DOI 10.1002/adma.201304995
   Hermann CD, 2014, BIOMATERIALS, V35, P9698, DOI 10.1016/j.biomaterials.2014.07.065
   Higham AK, 2014, SOFT MATTER, V10, P4990, DOI 10.1039/c4sm00411f
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Huang CY, 2014, CURR PROB SURG, V51, P301, DOI 10.1067/j.cpsurg.2014.04.001
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Huh KM, 2005, J BIOACT COMPAT POL, V20, P231, DOI 10.1177/0883911505053378
   Ingber DE, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046603
   Ishii S, 2016, BIOMATERIALS, V84, P210, DOI 10.1016/j.biomaterials.2016.01.029
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jackson PC, 2014, INJURY, V45, P44, DOI 10.1016/j.injury.2012.08.036
   Januszyk M, 2014, ORGANOGENESIS, V10, P186, DOI 10.4161/org.28818
   Jeffery S.L., 2012, J WOUND CARE S, V21, pS3
   Jerrell RJ, 2016, BIOMATERIALS, V84, P119, DOI 10.1016/j.biomaterials.2016.01.028
   Jones A, 2005, J ORTHOP NURS, V9, pS1, DOI DOI 10.1016/S1361-3111(05)80001-9)
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   Kaigler D, 2013, J PERIODONTOL, V84, P230, DOI 10.1902/jop.2012.110684
   Kairinos N, 2014, PLAST RECONSTR SURG, V133, P1178, DOI 10.1097/PRS.0000000000000130
   Kairinos N, 2013, PLAST RECONSTR SURG, V132, P978, DOI 10.1097/PRS.0b013e31829f4ad9
   Kairinos N, 2009, PLAST RECONSTR SURG, V123, P601, DOI 10.1097/PRS.0b013e318196b97b
   Karr JC, 2011, J AM PODIAT MED ASSN, V101, P146, DOI 10.7547/1010146
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khademhosseini A, 2006, J BIOMAT SCI-POLYM E, V17, P1221, DOI 10.1163/156856206778667488
   Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99
   Kim HS, 2013, J NANOSCI NANOTECHNO, V13, P2068, DOI 10.1166/jnn.2013.6906
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Knapik DM, 2014, ANTIOXID REDOX SIGN, V20, P970, DOI 10.1089/ars.2013.5467
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Kumashiro Y, 2010, ANN BIOMED ENG, V38, P1977, DOI 10.1007/s10439-010-0035-1
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2004, BIOMATERIALS, V25, P2461, DOI 10.1016/j.biomaterials.2003.09.030
   Lei N, 2012, NANOSCALE, V4, P5686, DOI [10.1039/c2nr30731f, 10.1039/c2nr30731]
   Li HY, 2016, BIOMATERIALS, V84, P64, DOI 10.1016/j.biomaterials.2016.01.033
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li XY, 2012, INT J PHARMACEUT, V437, P110, DOI 10.1016/j.ijpharm.2012.08.001
   Li Z, 2016, BIOMATERIALS, V84, P196, DOI 10.1016/j.biomaterials.2016.01.040
   Lin DL, 2004, J ORTHOP TRAUMA, V18, pS48, DOI 10.1097/00005131-200409001-00008
   Lips PAM, 2005, POLYMER, V46, P9396, DOI 10.1016/j.polymer.2005.07.052
   Liu CS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034111
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Magnenat-Thalmann N, 2002, IEEE T INF TECHNOL B, V6, P317, DOI 10.1109/TITB.2002.806097
   Malmsjo M, 2009, WOUND REPAIR REGEN, V17, P200, DOI 10.1111/j.1524-475X.2009.00461.x
   Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005
   Mammoto T, 2013, ANNU REV CELL DEV BI, V29, P27, DOI 10.1146/annurev-cellbio-101512-122340
   Marelli B, 2015, BIOMATERIALS, V37, P183, DOI 10.1016/j.biomaterials.2014.10.019
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Marsich E, 2011, COLLOID SURFACE B, V83, P331, DOI 10.1016/j.colsurfb.2010.12.002
   McManus J, 2007, PREHOSP EMERG CARE, V11, P67, DOI 10.1080/10903120601021176
   McNulty AK, 2007, WOUND REPAIR REGEN, V15, P838, DOI 10.1111/j.1524-475X.2007.00287.x
   Mi FL, 2003, POLYMER, V44, P6521, DOI 10.1016/S0032-3861(03)00620-7
   MIYAZAKI K, 1993, DENT MATER, V9, P46, DOI 10.1016/0109-5641(93)90105-Y
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mrowka P, 2010, J BIOMED MATER RES A, V94A, P71, DOI 10.1002/jbm.a.32699
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Oh BHL, 2015, MACROMOL RAPID COMM, V36, P364, DOI 10.1002/marc.201400524
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Park JS, 2009, LANGMUIR, V25, P451, DOI 10.1021/la8025683
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Partap S, 2006, ADV MATER, V18, P501, DOI 10.1002/adma.200501423
   Peev MP, 2014, J TRAUMA ACUTE CARE, V76, P619, DOI 10.1097/TA.0000000000000126
   Penn-Barwell JG, 2011, INJURY, V42, P1474, DOI 10.1016/j.injury.2011.07.005
   Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111
   Prieto EM, 2014, WIRES NANOMED NANOBI, V6, P136, DOI 10.1002/wnan.1248
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Santhanam S, 2016, ACTA BIOMATER, V43, P327, DOI 10.1016/j.actbio.2016.07.051
   Sanz-Ramos P, 2013, CONNECT TISSUE RES, V54, P159, DOI 10.3109/03008207.2012.762360
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Staruch R.M.T., 2015, MECH ANAL NANOCOMPOS
   Sterley M, 2012, J APPL POLYM SCI, V126, pE296, DOI 10.1002/app.36895
   Stulajterova R, 2008, COLLOID SURFACE A, V316, P104, DOI 10.1016/j.colsurfa.2007.08.036
   Swioklo S, 2016, STEM CELL TRANSL MED, V5, P339, DOI 10.5966/sctm.2015-0131
   Tai H, 2007, BIOCHEM SOC T, V35, P516, DOI 10.1042/BST0350516
   Tan B, 2007, MACROMOLECULES, V40, P1945, DOI 10.1021/ma062518e
   Taylor C J, 2009, J R Army Med Corps, V155, P302
   Thoniyot P, 2015, ADV SCI, V2, DOI 10.1002/advs.201400010
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   TOONEY NM, 1983, J CELL BIOL, V97, P1686, DOI 10.1083/jcb.97.6.1686
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsao CT, 2015, MACROMOL RAPID COMM, V36, P332, DOI 10.1002/marc.201400586
   Verbeke CS, 2015, ADV HEALTHC MATER, V4, P2677, DOI 10.1002/adhm.201500618
   Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Walker D, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2877
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Wang X., 2015, J NANOMATER, V8, P2015, DOI DOI 10.1016/J.SCIT0TENV.2015.08.026
   Webster J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009261.pub2
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010
   Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212
   Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026
   Yamaki K, 2009, BIOMATERIALS, V30, P1421, DOI 10.1016/j.biomaterials.2008.11.036
   Yannas IV, 2011, PLAST RECONSTR SURG, V127, p60S, DOI 10.1097/PRS.0b013e318200a44d
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yashima S, 2014, SOFT MATTER, V10, P3192, DOI 10.1039/c3sm52883a
   Yeh HY, 2008, J BIOMAT SCI-POLYM E, V19, P291, DOI 10.1163/156856208783720985
   Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014
   Yom-Tov O, 2014, ACTA BIOMATER, V10, P4236, DOI 10.1016/j.actbio.2014.07.006
   Yu YX, 2011, J BIOMED MATER RES A, V99A, P316, DOI 10.1002/jbm.a.33199
   Yuk H, 2016, NAT MATER, V15, P190, DOI [10.1038/NMAT4463, 10.1038/nmat4463]
   Zeng QY, 2015, J MATER CHEM B, V3, P8856, DOI 10.1039/c5tb01758k
   Zhang XD, 2012, BIOMATERIALS, V33, P4628, DOI 10.1016/j.biomaterials.2012.03.020
   Zhao YH, 2015, STEM CELL RES, V14, P283, DOI 10.1016/j.scr.2015.02.006
   Zhou SZ, 2012, MACROMOL RAPID COMM, V33, P1833, DOI 10.1002/marc.201200336
   Zhu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107339
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 160
TC 3
Z9 3
U1 17
U2 66
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD APR
PY 2017
VL 23
IS 2
BP 183
EP 198
DI 10.1089/ten.teb.2016.0305
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA ES2AB
UT WOS:000399327000007
PM 27824295
DA 2018-10-20
ER

PT J
AU Lullove, EJ
AF Lullove, Eric J.
TI Use of Ovine-based Collagen Extracellular Matrix and Gentian
   Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve
   Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort
   Study
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE antibacterial foam dressings; collagen extracellular matrix dressing;
   gentian violet/methylene blue; MMP reduction; ovine-based
ID DIABETIC FOOT ULCERS; VENOUS LEG ULCERS; FORESTOMACH MATRIX; CARE;
   BIOMATERIAL; MANAGEMENT; BURDEN
AB Dressings that provide broad spectrum metalloprotease reduction along with inherent aspects of an extracellular matrix may contribute to improved wound healing outcomes and shorter treatment times. Objective. The author performed a retrospective case series analysis to determine the clinical outcomes of regular debridement with the use of ovine-based collagen extracellular matrix dressings and gentian violet/methylene blue polyurethane antibacterial foam dressings in treating 53 patients with 53 chronic lower extremity wounds (diabetic foot ulcers [DFUs], venous leg ulcers, and heel pressure ulcers). Materials and Methods. Patients were treated twice weekly in an outpatient clinic for the first 4 weeks and weekly thereafter until closure. Results. Average body mass index (BMI) for the study population was 28.3, and the average patient age was 75.9 years. Mean percent wound surface area reduction at 4, 8, and 12 weeks was 38.5%, 73.3%, and 91.3%, respectively. Average time to closure for all wounds was 10.6 weeks (range, 5-24 weeks). All wounds were 100% reepithelialized by week 20 except 1 DFU that reepithelialized at week 24. The average cost of care for a single wound episode (from presentation to closure) was $2749.49. Conclusion. Results of this analysis showed that the healing of chronic wounds in this series could be achieved at a reasonable cost with regular debridement and a collagen matrix dressing regimen, even in patients of advanced age and above average BMI as well as in wounds that did not achieve > 40% wound surface area reduction at 4 weeks.
C1 [Lullove, Eric J.] West Boca Ctr Wound Healing, 2900 N Mil Trail,Suite 316, Boca Raton, FL 33431 USA.
RP Lullove, EJ (reprint author), West Boca Ctr Wound Healing, 2900 N Mil Trail,Suite 316, Boca Raton, FL 33431 USA.
EM drlullove@drlullove.com
FU Hollister Wound Care, Inc
FX Dr. Lullove is a speaker and consultant for Hollister Wound Care, Inc
   (Libertyville, IL) and received an unrestricted grant to perform this
   study from Hollister Wound Care, Inc.
CR Anderson K, 2014, J AM COLL CLIN WOUND, V4, P84
   Bohn GA, 2014, ADV SKIN WOUND CARE
   Bohn G, 2016, ADV WOUND CARE, V5, P1, DOI 10.1089/wound.2015.0660
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Brett D, 2008, WOUNDS, V20, P347
   Brownrigg JRW, 2013, EUR J VASC ENDOVASC, V45, P673, DOI 10.1016/j.ejvs.2013.02.014
   Edwards K, 2016, ADV WOUND CARE, V5, P11, DOI 10.1089/wound.2014.0593
   Fife CE, 2012, WOUNDS, V24, P10
   Hankin Cheryl S, 2012, J Manag Care Pharm, V18, P375
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Liden BA, 2013, ADV SKIN WOUND CARE, V26, P164, DOI 10.1097/01.ASW.0000428862.34294.d4
   Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   Negron L, 2014, INT WOUND J, V11, P392, DOI 10.1111/j.1742-481X.2012.01106.x
   Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x
   Rice J Bradford, 2014, J Med Econ, V17, P347, DOI 10.3111/13696998.2014.903258
   Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Simcock JW, 2013, J WOUND CARE, V22, P383, DOI 10.12968/jowc.2013.22.7.383
   Warriner RA, 2012, ADV SKIN WOUND CARE, V25, P494, DOI 10.1097/01.ASW.0000422629.03053.06
   Woo Kevin, 2007, Adv Skin Wound Care, V20, P99, DOI 10.1097/00129334-200702000-00009
NR 23
TC 0
Z9 0
U1 4
U2 4
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD APR
PY 2017
VL 29
IS 4
BP 107
EP 114
PG 8
WC Dermatology; Surgery
SC Dermatology; Surgery
GA ET3US
UT WOS:000400205600004
PM 28448264
DA 2018-10-20
ER

PT J
AU Huang, WW
   Ebrahimi, D
   Dinjaski, N
   Tarakanova, A
   Buehler, MJ
   Wong, JY
   Kaplan, DL
AF Huang, Wenwen
   Ebrahimi, Davoud
   Dinjaski, Nina
   Tarakanova, Anna
   Buehler, Markus J.
   Wong, Joyce Y.
   Kaplan, David L.
TI Synergistic Integration of Experimental and Simulation Approaches for
   the de Novo Design of Silk-Based Materials
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID SPIDER SILK; PROPERTY RELATIONSHIPS; PROTEIN BIOMATERIALS; BINDING
   PEPTIDES; BLOCK-COPOLYMERS; DRUG-DELIVERY; ELASTIN; FIBROIN; WATER;
   NANOPARTICLES
AB Tailored biornaterials with tunable functional properties are crucial for a variety of task-specific applications ranging from healthcare to sustainable, novel bio nanodevices. To generate polymeric materials with predictive functional outcomes, exploiting designs from nature while morphing them toward non-natural systems offers an important strategy. Silks are Nature's building blocks and are produced by arthropods for a variety of uses that are essential for their survival. Due to the genetic control of encoded protein sequence, mechanical properties, biocompatibility, and biodegradability, silk proteins have been selected as prototype models to emulate for the tunable designs of biomaterial systems.
   The bottom up strategy of material design opens important opportunities to create predictive functional outcomes, following the exquisite polymeric templates inspired by silks. Recombinant DNA technology provides a systematic approach to recapitulate, vary, and evaluate the core structure peptide motifs in silks and then biosynthesize silk-based polymers by design. Post-biosynthesis processing allows for another dimension of material design by controlled or assisted assembly. Multiscale modeling, from the theoretical prospective, provides strategies to explore interactions at different length scales, leading to selective material properties. Synergy among experimental and modeling approaches can provide new and more rapid insights into the most appropriate structure function relationships to pursue while also furthering our understanding in terms of the range of silk-based systems that can be generated. This approach utilizes nature as a blueprint for initial polymer designs with useful functions (e.g., silk fibers) but also employs modeling-guided experiments to expand the initial polymer designs into new domains of functional materials that do not exist in nature. The overall path to these new functional outcomes is greatly accelerated via the integration of modeling with experiment.
   In this Account, we summarize recent advances in understanding and functionalization of silk-based protein systems, with a focus on the integration of simulation and experiment for biopolymer design. Spider silk was. selected as an exemplary protein to address the fundamental challenges in polymer designs, including specific insights into the role of molecular weight, hydrophobic/hydrophilic partitioning, and shear stress for silk fiber formation. To expand current silk designs toward biointerfaces and stimuli responsive materials, peptide modules from other natural proteins were added to silk designs to introduce new functions, exploiting the modular nature of silk proteins and fibrous proteins in general. The integrated approaches explored suggest that protein folding, silk volume fraction, and protein amino acid sequence changes (e.g., mutations) are critical factors for functional biomaterial designs.
   In summary, the integrated modeling experimental approach described in this Account suggests a more rationally directed and more rapid method for the design of polymeric materials. It is expected that this combined use of experimental and computational approaches has a broad applicability not only for silk-based systems, but also for other polymer and composite materials.
C1 [Huang, Wenwen; Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Ebrahimi, Davoud; Tarakanova, Anna; Buehler, Markus J.] MIT, LAMM, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Wong, Joyce Y.] Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018; Wong, Joyce/F-3732-2011
OI Huang, Wenwen/0000-0001-8175-9083; Wong, Joyce/0000-0002-3526-6381;
   Buehler, Markus/0000-0002-4173-9659
FU NIH [U01 EB014976]; Tissue Engineering Resource Center [NIH P41
   EB002520]; ONR [N00014-16-1-2333]; AFOSR [FA9550-11-1-0199]
FX The authors acknowledge the financial support of the NIH (Grant U01
   EB014976), Tissue Engineering Resource Center (Grant NIH P41 EB002520),
   ONR (Grant N00014-16-1-2333), and AFOSR (Grant FA9550-11-1-0199).
CR Addison WN, 2010, BIOMATERIALS, V31, P9422, DOI 10.1016/j.biomaterials.2010.08.064
   Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00782
   Buehler MJ, 2013, MRS BULL, V38, P169, DOI 10.1557/mrs.2013.26
   CHANG DK, 1988, CHEM PHYS LETT, V147, P395, DOI 10.1016/0009-2614(88)80255-0
   Dinjaski N, 2017, ACS BIOMATER SCI ENG, V3, P2877, DOI 10.1021/acsbiomaterials.6b00236
   Ebrahimi D, 2015, ACS BIOMATER SCI ENG, V1, P864, DOI 10.1021/acsbiomaterials.5b00152
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang WW, 2016, ADV FUNCT MATER, V26, P4113, DOI 10.1002/adfm.201600236
   Huang WW, 2015, EXPERT OPIN DRUG DEL, V12, P779, DOI 10.1517/17425247.2015.989830
   Huang WW, 2014, MACROMOLECULES, V47, P8107, DOI 10.1021/ma5016227
   Huang WW, 2014, MACROMOLECULES, V47, P8098, DOI 10.1021/ma5016215
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Jose RR, 2015, ACS BIOMATER SCI ENG, V1, P780, DOI 10.1021/acsbiomaterials.5b00160
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270
   Krishnaji ST, 2011, LANGMUIR, V27, P1000, DOI 10.1021/la102638j
   Krishnaji ST, 2014, MACROMOL CHEM PHYS, V215, P1230, DOI 10.1002/macp.201400135
   Krishnaji ST, 2013, ADV FUNCT MATER, V23, P241, DOI 10.1002/adfm.201200510
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   Lin SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7892
   Lin YA, 2014, LANGMUIR, V30, P4406, DOI 10.1021/la403559t
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Plowright R, 2016, RSC ADV, V6, P21776, DOI 10.1039/c6ra03706b
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Su I, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/30/302001
   Sun ZY, 2013, J AM CHEM SOC, V135, P3675, DOI 10.1021/ja312647n
   Tarakanova A, 2017, BIOMATERIALS, V127, P49, DOI 10.1016/j.biomaterials.2017.01.041
   Tarakanova A, 2012, JOM-US, V64, P214, DOI 10.1007/s11837-012-0250-3
   Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103
   Tokareva OS, 2014, J STRUCT BIOL, V186, P412, DOI 10.1016/j.jsb.2014.03.004
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang LL, 2011, J PHYS CHEM B, V115, P9431, DOI 10.1021/jp204407d
   Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wong JY, 2012, NANO TODAY, V7, P488, DOI 10.1016/j.nantod.2012.09.001
   Xia XX, 2014, BIOMACROMOLECULES, V15, P908, DOI 10.1021/bm4017594
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Yeo GC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501145
   Yigit S, 2014, MACROMOL BIOSCI, V14, P1291, DOI 10.1002/mabi.201400113
   Zhou S, 2015, ACTA BIOMATER, V15, P173, DOI 10.1016/j.actbio.2014.10.040
   Zhu JX, 2016, MATERIALS, V9, DOI 10.3390/ma9040221
NR 52
TC 10
Z9 10
U1 15
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
EI 1520-4898
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD APR
PY 2017
VL 50
IS 4
BP 866
EP 876
DI 10.1021/acs.accounts.6b00616
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA ES9EV
UT WOS:000399859800023
PM 28191922
DA 2018-10-20
ER

PT J
AU Jia, XT
   Wang, CY
   Ranganathan, V
   Napier, B
   Yu, CC
   Chao, YF
   Forsyth, M
   Omenetto, FG
   MacFarlane, DR
   Wallace, GG
AF Jia, Xiaoteng
   Wang, Caiyun
   Ranganathan, Vijayaraghavan
   Napier, Bradley
   Yu, Changchun
   Chao, Yunfeng
   Forsyth, Maria
   Omenetto, Fiorenzo G.
   MacFarlane, Douglas R.
   Wallace, Gordon G.
TI A Biodegradable Thin-Film Magnesium Primary Battery Using Silk
   Fibroin-Ionic Liquid Polymer Electrolyte
SO ACS ENERGY LETTERS
LA English
DT Article
ID BOMBYX-MORI SILK; AIR BATTERIES; DEVICES; OPPORTUNITIES; BIOMATERIAL;
   ELECTRONICS
AB Transient implantable medical bionics offer great promise in the field of smart controlled release and tissue regeneration. On-board energy storage is the ideal power system to drive them. In this work, a critical component of such a device, a biodegradable polymer electrolyte (silk fibroin choline nitrate) has been developed. The efficiency of this electrolyte is demonstrated when deployed in a biodegradable thin-film magnesium battery. The battery, encapsulated in silk, offers a specific capacity of 0.06 mAh cm(-2). The enzymatic degradation of the whole device occurs over 45 days in the buffered protease XIV solution. A programmed battery lifetime can be achieved using silk protection layers. This battery system provides a new avenue for an on-board biodegradable power source for next-generation transient medical bionics.
C1 [Jia, Xiaoteng; Wang, Caiyun; Yu, Changchun; Chao, Yunfeng; Wallace, Gordon G.] Univ Wollongong, AIIM Facil, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia.
   [Ranganathan, Vijayaraghavan; MacFarlane, Douglas R.] Monash Univ, Sch Chem, ARC Ctr Excellence Electromat Sci, Clayton, Vic 3800, Australia.
   [Napier, Bradley; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Silklab, Medford, MA 02155 USA.
   [Forsyth, Maria] Deakin Univ, Inst Frontier Mat, ARC Ctr Excellence Electromat Sci, Burwood, Vic 3125, Australia.
RP Wang, CY; Wallace, GG (reprint author), Univ Wollongong, AIIM Facil, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia.
EM caiyun@uow.edu.au; gwallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273
FU Australian Research Council Centre of Excellence Scheme [CE 140100012];
   ARC under the Australian Laureate Fellowship scheme [FL110100196,
   FL110100013, FL120100019]; Office of Naval Research [N00014-13-1-0596]
FX Funding from the Australian Research Council Centre of Excellence Scheme
   (Project Number CE 140100012) is gratefully acknowledged. G.G.W., M.F.,
   and D.R.M. are grateful to the ARC for support under the Australian
   Laureate Fellowship scheme FL110100196, FL110100013, and FL120100019
   respectively. The authors thank the Australian National Fabrication
   Facility (ANFF)-Materials Node and the UoW Electron Microscopy Centre
   for equipment use. F.G.O. acknowledges funding from the Office of Naval
   Research (N00014-13-1-0596).
CR Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bharmoria P, 2015, PHYS CHEM CHEM PHYS, V17, P10189, DOI 10.1039/c4cp06044j
   Boutry CM, 2012, PHILOS T R SOC A, V370, P2418, DOI 10.1098/rsta.2011.0439
   Brenckle MA, 2016, ADV FUNCT MATER, V26, P44, DOI 10.1002/adfm.201502819
   Brenckle MA, 2015, ACS APPL MATER INTER, V7, P19870, DOI 10.1021/acsami.5b06059
   Brenckle MA, 2013, BIOMACROMOLECULES, V14, P2189, DOI 10.1021/bm400305r
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Heller A, 2006, ANAL BIOANAL CHEM, V385, P469, DOI 10.1007/s00216-006-0326-4
   Hwang SW, 2015, ADV MATER, V27, P47, DOI 10.1002/adma.201403051
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Jia XT, 2014, ACS APPL MATER INTER, V6, P21110, DOI 10.1021/am505985z
   Kim YJ, 2014, ADV MATER, V26, P6572, DOI 10.1002/adma.201402295
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Kong Y, 2012, SYNTHETIC MET, V162, P584, DOI 10.1016/j.synthmet.2012.01.021
   Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P229, DOI 10.1109/JSSC.2012.2221233
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Lu JM, 2009, PROG POLYM SCI, V34, P431, DOI 10.1016/j.progpolymsci.2008.12.001
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MacFarlane DR, 2014, ENERG ENVIRON SCI, V7, P232, DOI 10.1039/c3ee42099j
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pereira RFP, 2016, CHEMELECTROCHEM, V3, P1084, DOI 10.1002/celc.201600095
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Rahman MA, 2013, J ELECTROCHEM SOC, V160, pA1759, DOI 10.1149/2.062310jes
   Susan MA, 2005, J AM CHEM SOC, V127, P4976, DOI 10.1021/ja045155b
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Ueki T, 2008, MACROMOLECULES, V41, P3739, DOI 10.1021/ma800171k
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang B, 2005, J POWER SOURCES, V152, P1, DOI 10.1016/j.jpowsour.2005.05.098
   Weaver KD, 2010, GREEN CHEM, V12, P507, DOI 10.1039/b918726j
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yin L, 2014, ADV MATER, V26, P3879, DOI 10.1002/adma.201306304
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
NR 36
TC 12
Z9 13
U1 21
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2380-8195
J9 ACS ENERGY LETT
JI ACS Energy Lett.
PD APR
PY 2017
VL 2
IS 4
BP 831
EP 836
DI 10.1021/acsenergylett.7b00012
PG 6
WC Chemistry, Physical; Electrochemistry; Energy & Fuels; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Electrochemistry; Energy & Fuels; Science & Technology -
   Other Topics; Materials Science
GA ES6DM
UT WOS:000399636600015
DA 2018-10-20
ER

PT J
AU Putra, N
   Septiadi, WN
AF Putra, Nandy
   Septiadi, Wayan Nata
TI Improvement of heat pipe performance through integration of a coral
   biomaterial wick structure into the heat pipe of a CPU cooling system
SO HEAT AND MASS TRANSFER
LA English
DT Article
ID COPPER METAL FOAMS; THERMAL PERFORMANCE; BIPOROUS WICKS; MASS-TRANSFER;
   LOOP; CAPILLARY; EVAPORATION; NANOFLUIDS; MANAGEMENT; VISUALIZATION
AB The very high heat flux dissipated by a Central Processing Unit (CPU) can no longer be handled by a conventional, single-phased cooling system. Thermal management of a CPU is now moving towards two-phase systems to maintain CPUs below their maximum temperature. A heat pipe is one of the emerging cooling systems to address this issue because of its superior efficiency and energy input independence. The goal of this research is to improve the performance of a heat pipe by integrating a biomaterial as the wick structure. In this work, the heat pipe was made from copper pipe and the biomaterial wick structure was made from tabulate coral with a mean pore diameter of 52.95 mu m. For comparison purposes, the wick structure was fabricated from sintered Cu-powder with a mean pore diameter of 58.57 A mu m. The working fluid for this experiment was water. The experiment was conducted using a processor as the heat source and a plate simulator to measure the heat flux. The utilization of coral as the wick structure can improve the performance of a heat pipe and can decrease the temperature of a simulator plate by as much as 38.6 % at the maximum heat load compared to a conventional copper heat sink. This method also decreased the temperature of the simulator plate by as much as 44.25 A degrees C compared to a heat pipe composed of a sintered Cu-powder wick.
C1 [Putra, Nandy] Univ Indonesia, Dept Mech Engn, Appl Heat Transfer Res Grp, Heat Transfer Lab, Kampus UI Depok, Depok 16424, Indonesia.
   [Septiadi, Wayan Nata] Univ Udayana, Dept Mech Engn, Kampus Bukit Jimbaran, Bali, Indonesia.
RP Putra, N (reprint author), Univ Indonesia, Dept Mech Engn, Appl Heat Transfer Res Grp, Heat Transfer Lab, Kampus UI Depok, Depok 16424, Indonesia.
EM nandyputra@eng.ui.ac.id
OI Septiadi, Wayan Nata/0000-0003-3121-9542
FU DRPM University of Indonesia
FX The authors would like to thank the DRPM University of Indonesia for
   funding this research.
CR Ahmed YMZ, 2007, POWDER TECHNOL, V175, P48, DOI 10.1016/j.powtec.2007.01.027
   Amon CH, 2001, EXP THERM FLUID SCI, V25, P231, DOI 10.1016/S0894-1777(01)00071-1
   [Anonymous], 2003, KARAKTERISTIK BIOL K
   Bodla KK, 2013, INT J HEAT MASS TRAN, V61, P729, DOI 10.1016/j.ijheatmasstransfer.2013.02.038
   Canti G, 1998, REV GEN THERM, V37, P5, DOI 10.1016/S0035-3159(97)82462-2
   Chein R, 2004, APPL THERM ENG, V24, P2207, DOI 10.1016/j.applthermaleng.2004.03.001
   Deng DX, 2013, EXP THERM FLUID SCI, V50, P1, DOI 10.1016/j.expthermflusci.2013.04.014
   Espinosa FAD, 2012, INT J HEAT MASS TRAN, V55, P7471, DOI 10.1016/j.ijheatmasstransfer.2012.07.037
   Gurses AC, 1991, RENEW ENERG, V1, P667
   Harris JM, 2008, THESIS
   Holley B, 2006, APPL THERM ENG, V26, P448, DOI 10.1016/j.applthermaleng.2005.05.023
   Hung YM, 2011, INT J HEAT MASS TRAN, V54, P1198, DOI 10.1016/j.ijheatmasstransfer.2010.09.070
   Kaya T, 2006, INT J HEAT MASS TRAN, V49, P3211, DOI 10.1016/j.ijheatmasstransfer.2006.01.028
   Kaya T, 2009, INT J HEAT MASS TRAN, V52, P5731, DOI 10.1016/j.ijheatmasstransfer.2009.08.015
   Kempers R, 2008, INT J HEAT MASS TRAN, V51, P6039, DOI 10.1016/j.ijheatmasstransfer.2008.04.001
   Kiseev VM, 2010, APPL THERM ENG, V30, P1312, DOI 10.1016/j.applthermaleng.2010.02.010
   Lago M, 2011, J COLLOID INTERF SCI, V234, P35
   Leong KC, 1997, J POROUS MAT, V4, P303, DOI 10.1023/A:1009685508557
   Li JW, 2010, EXP THERM FLUID SCI, V34, P1403, DOI 10.1016/j.expthermflusci.2010.06.016
   Lips S, 2009, INT J THERM SCI, V48, P1273, DOI 10.1016/j.ijthermalsci.2008.11.011
   Mihai IC, 2009, ADV TOPICS OPTOELECT, VIV
   Mishra DK, 2010, ADV POWDER TECHNOL, V21, P658, DOI 10.1016/j.apt.2010.07.011
   Mudawar I, 2001, IEEE T COMPON PACK T, V24, P122, DOI 10.1109/6144.926375
   OLIVER DR, 1968, CHEM ENG SCI, V23, P525, DOI 10.1016/0009-2509(68)89001-3
   Putra N, 2013, ADV MAT RES, V651, P728
   Putra N, 2014, ADV MATER RES-SWITZ, V875-877, P356, DOI 10.4028/www.scientific.net/AMR.875-877.356
   Putra N, 2014, INT J THERM SCI, V76, P128, DOI 10.1016/j.ijthermalsci.2013.08.020
   Putra N, 2012, EXP THERM FLUID SCI, V40, P10, DOI 10.1016/j.expthermflusci.2012.01.007
   Reay D, 2006, HEAT PIPE THEORY DES
   Ren C, 2011, INT J HEAT MASS TRAN, V54, P3987, DOI 10.1016/j.ijheatmasstransfer.2011.04.026
   Sadeghinezhad E, 2016, APPL THERM ENG, V100, P775, DOI 10.1016/j.applthermaleng.2016.02.071
   Semenic T, 2008, APPL THERM ENG, V28, P278, DOI 10.1016/j.applthermaleng.2006.02.030
   Septiadi WN, 2013, AT INDONES, V39, P24, DOI 10.17146/aij.2013.220
   Shirazy MRS, 2013, INT J HEAT MASS TRAN, V58, P282, DOI 10.1016/j.ijheatmasstransfer.2012.11.031
   Shirazy MRS, 2012, APPL SURF SCI, V258, P6416, DOI 10.1016/j.apsusc.2012.03.052
   Solomon AB, 2012, APPL THERM ENG, V36, P106, DOI 10.1016/j.applthermaleng.2011.12.004
   Tang Y, 2010, EXP THERM FLUID SCI, V34, P190, DOI 10.1016/j.expthermflusci.2009.10.016
   Vasiliev LL, 2005, APPL THERM ENG, V25, P1, DOI 10.1016/j.applthermaleng.2003.12.004
   Weibel JA, 2012, INT J HEAT MASS TRAN, V55, P3498, DOI 10.1016/j.ijheatmasstransfer.2012.03.021
   Weibel JA, 2010, INT J HEAT MASS TRAN, V53, P4204, DOI 10.1016/j.ijheatmasstransfer.2010.05.043
   Wong SC, 2012, INT J HEAT MASS TRAN, V55, P2229, DOI 10.1016/j.ijheatmasstransfer.2012.01.045
   Yeh CC, 2009, INT J HEAT MASS TRAN, V52, P4426, DOI 10.1016/j.ijheatmasstransfer.2009.03.059
NR 42
TC 2
Z9 3
U1 6
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-7411
EI 1432-1181
J9 HEAT MASS TRANSFER
JI Heat Mass Transf.
PD APR
PY 2017
VL 53
IS 4
BP 1163
EP 1174
DI 10.1007/s00231-016-1890-6
PG 12
WC Thermodynamics; Mechanics
SC Thermodynamics; Mechanics
GA ER6BH
UT WOS:000398889200004
DA 2018-10-20
ER

PT J
AU Muthukumar, H
   Gire, A
   Kumari, M
   Manickam, M
AF Muthukumar, Harshiny
   Gire, Ashish
   Kumari, Meena
   Manickam, Matheswaran
TI Biogenic synthesis of nano-biomaterial for toxic naphthalene
   photocatalytic degradation optimization and kinetics studies
SO INTERNATIONAL BIODETERIORATION & BIODEGRADATION
LA English
DT Article
DE Bio-reduction; Fe-doped ZnO; Characterization; Photocatalytic;
   Naphthalene; Degradation
ID POLYCYCLIC AROMATIC-HYDROCARBONS; MAGNETIC-PROPERTIES;
   OPTICAL-PROPERTIES; LIGHT IRRADIATION; METHYLENE-BLUE; LEAF EXTRACT;
   ZNO; NANOPARTICLES; ADSORPTION; EXPOSURE
AB Zinc Oxide (ZnO) and Iron (Fe x)-Zn1-x O (x = 0, 0.5, 1 and 2 wt%) doped ZnO nanoparticles were synthesized using Amaranthus dubius aqueous leaf extract as a reducing agent. The physicochemical properties of the nanoparticles such size, shape, surface area and band energy were determined by analytical techniques. The characterization confirmed that Fe-ZnO were spherical shape with wurtzite phase structure, smaller size, and large surface with less aggregation. The photocatalytic efficiency of ZnO and Fe-ZnO were evaluated by degradation of naphthalene. The effects of various operating parameters including solution pH, photocatalyst and naphthalene concentration on the degradation efficiency and the rate of degradation were investigated. The degradation efficiency and rate of degradation of Fe-ZnO was higher than ZnO photocatalyst. The results confirmed the degradation rate of naphthalene follows the pseudo-first order kinetics. From experimental results, Fe-ZnO can be effectively used in environmental safe applications for pollutant treatment. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Muthukumar, Harshiny; Gire, Ashish; Kumari, Meena; Manickam, Matheswaran] Natl Inst Technol, Dept Chem Engn, Tiruchchirappalli 620015, Tamil Nadu, India.
RP Manickam, M (reprint author), Natl Inst Technol, Dept Chem Engn, Tiruchchirappalli 620015, Tamil Nadu, India.
EM math.chem95@gmail.com
FU Department of Science and Technology [SB/FT/CS-047/2012]; Department of
   Biotechnology Government of India [BT/PR6080/GBD/27/503/2013]
FX The author M.M are grateful to Department of Science and Technology (NO
   . SB/FT/CS-047/2012) and the authors M.M, M.H thankfull to Department of
   Biotechnology (BT/PR6080/GBD/27/503/2013) Government of India for the
   financial assistance. Also authors sincerely thank Division of
   Nanotechnology. Periyar Maniammai University for SEM analysis.
CR Amin M.T., 2014, ADV MATER SCI ENG, V2014, DOI DOI 10.1155/2014/825910
   Amzad Hossain M., 2009, AS J ENERGY ENV, V10, P230
   Antoine Lair, 2008, J PHOTOCH PHOTOBIO A, V193, P193
   Ba-Abbad MM, 2013, CHEMOSPHERE, V91, P1604, DOI 10.1016/j.chemosphere.2012.12.055
   Behera AK, 2014, J NANOSCI NANOTECHNO, V14, P3667, DOI 10.1166/jnn.2014.7917
   Behrooz K., 2015, J ENV HLTH SCI ENG, V13, P26
   Benhebal H, 2013, ALEX ENG J, V52, P517, DOI 10.1016/j.aej.2013.04.005
   Dong SY, 2015, RSC ADV, V5, P14610, DOI 10.1039/c4ra13734e
   Elangovan SV, 2015, SUPERLATTICE MICROST, V85, P901, DOI 10.1016/j.spmi.2015.07.004
   Ferradji FZ, 2014, INT BIODETER BIODEGR, V86, P300, DOI 10.1016/j.ibiod.2013.10.003
   George S, 2010, ACS NANO, V4, P15, DOI 10.1021/nn901503q
   Griego FY, 2008, REGUL TOXICOL PHARM, V51, pS22, DOI 10.1016/j.yrtph.2008.02.003
   Harshiny M., 2015, SUSTAIN CHEM ENG, V3, P3149
   Harshiny M, 2015, POWDER TECHNOL, V286, P744, DOI 10.1016/j.powtec.2015.09.021
   Hassan MM, 2014, J LUMIN, V145, P160, DOI 10.1016/j.jlumin.2013.06.024
   Ho LN, 2012, J ENVIRON SCI-CHINA, V24, P1142, DOI 10.1016/S1001-0742(11)60872-3
   Innocent U.K., 2013, MAT SCI SEMICON PROC, V16, P2070
   Jia CR, 2010, INT J ENV RES PUB HE, V7, P2903, DOI 10.3390/ijerph7072903
   Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016
   Kaviya S, 2015, RSC ADV, V5, P17179, DOI 10.1039/c4ra15293j
   Kumar K, 2014, J ALLOY COMPD, V588, P681, DOI 10.1016/j.jallcom.2013.11.127
   Law J.B.K., 2006, APPL PHYS LETT, V881, P33114
   Liu DD, 2016, J ALLOY COMPD, V676, P489, DOI 10.1016/j.jallcom.2016.03.124
   Liu DD, 2016, J TAIWAN INST CHEM E, V59, P563, DOI 10.1016/j.jtice.2015.09.001
   Lupan O, 2010, MATER RES BULL, V45, P1026, DOI 10.1016/j.materresbull.2010.03.027
   Ma B, 2016, ECOTOX ENVIRON SAFE, V125, P55, DOI 10.1016/j.ecoenv.2015.11.032
   Niranjan Bala, 2015, RSC ADV, V5, P4993
   Qu XL, 2013, WATER RES, V47, P3931, DOI 10.1016/j.watres.2012.09.058
   Raja K, 2014, SPECTROCHIM ACTA A, V131, P183, DOI 10.1016/j.saa.2014.03.047
   Rajamanickam D., 2012, ARAB J CHEM IN PRESS
   Rengarajan Thamaraiselvan, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P182, DOI 10.1016/S2221-1691(15)30003-4
   Rubio-Clemente A, 2014, SCI TOTAL ENVIRON, V478, P201, DOI 10.1016/j.scitotenv.2013.12.126
   Saber A, 2011, WATER AIR SOIL POLL, V215, P3
   Samadi M, 2016, THIN SOLID FILMS, V605, P2, DOI 10.1016/j.tsf.2015.12.064
   Sangeetha G, 2011, MATER RES BULL, V46, P2560, DOI 10.1016/j.materresbull.2011.07.046
   Vahid Mahmoodi, 2014, DESALIN WATER TREAT, V52, P6664
   Vela N, 2012, J PHOTOCH PHOTOBIO A, V232, P32, DOI 10.1016/j.jphotochem.2012.02.003
   Wang J, 2008, ULTRASON SONOCHEM, V15, P768, DOI 10.1016/j.ultsonch.2008.02.002
   Wu Xiaojuan, 2014, J NANOMATER, V2014, P6
   Xiaojun W., 2014, CERAM INT, V40, P14635
   Xuemin X., 2015, J TAIWAN INST CHEM E, P1
   Yu XH, 2014, J MATER SCI-MATER EL, V25, P3920, DOI 10.1007/s10854-014-2107-8
   Zhang J, 2015, MATER RES BULL, V70, P358, DOI 10.1016/j.materresbull.2015.04.060
   Zhang Y, 2013, CURR MOL MED, V13, P1633, DOI 10.2174/1566524013666131111130058
   Zhou Aijuan, 2012, INT J PHOTOENERGY, V3, P0
NR 45
TC 2
Z9 2
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-8305
EI 1879-0208
J9 INT BIODETER BIODEGR
JI Int. Biodeterior. Biodegrad.
PD APR
PY 2017
VL 119
SI SI
BP 587
EP 594
DI 10.1016/j.ibiod.2016.10.036
PG 8
WC Biotechnology & Applied Microbiology; Environmental Sciences
SC Biotechnology & Applied Microbiology; Environmental Sciences & Ecology
GA ES4NJ
UT WOS:000399511700060
DA 2018-10-20
ER

PT J
AU Shandhi, MMH
   Leber, M
   Hogan, AL
   Warren, DJ
   Bhandari, R
   Negi, S
AF Shandhi, Md. Mobashir Hasan
   Leber, Moritz
   Hogan, Alexander L.
   Warren, David J.
   Bhandari, Rajmohan
   Negi, Sandeep
TI Reusable High Aspect Ratio 3-D Nickel Shadow Mask
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE 3-D shadow mask; stencil; high aspect ratio; microneedle; neural
   electrodes
ID STENCIL LITHOGRAPHY; FABRICATION; RESOLUTION; SURFACES; DEVICES
AB Shadow mask technology has been used over the years for resistless patterning and to pattern on unconventional surfaces, fragile substrate, and biomaterial. In this paper, we are presenting a novel method to fabricate high aspect ratio (15: 1) 3-D nickel (Ni) shadow mask with vertical pattern length and width of 1.2 mm and 40 mu m, respectively. The Ni shadow mask is 1.5 mm tall and 100 mu m wide at the base. The aspect ratio of the shadow mask is 15. Ni shadow mask is mechanically robust and, hence, easy to handle. It is also reusable and used to pattern the sidewalls of unconventional and complex 3-D geometries, such as microneedles or neural electrodes (such as the Utah array). The standard Utah array has 100 active sites at the tip of the shaft. Using the proposed high aspect ratio Ni shadow mask, the Utah array can accommodate 300 active sites, 200 of which will be along and around the shaft. The robust Ni shadow mask is fabricated using laser patterning and electroplating techniques. The use of Ni 3-D shadow mask will lower the fabrication cost, complexity, and time for patterning out-of-plane structures.
C1 [Shandhi, Md. Mobashir Hasan; Leber, Moritz; Negi, Sandeep] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.
   [Hogan, Alexander L.; Bhandari, Rajmohan; Negi, Sandeep] Blackrock Microsyst, Salt Lake City, UT 84108 USA.
   [Warren, David J.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Shandhi, MMH (reprint author), Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.
FU College of Engineering, Health Sciences Center, Office of the Vice
   President for Research; Utah Science Technology and Research (USTAR)
   initiative of the State of Utah
FX The authors appreciate the support of the staff and facilities that made
   this work possible. This work made use of University of Utah shared
   facilities of the Micron Technology Foundation Inc. Microscopy Suite
   sponsored by the College of Engineering, Health Sciences Center, Office
   of the Vice President for Research, and the Utah Science Technology and
   Research (USTAR) initiative of the State of Utah.
CR ALIX EC, 1969, J CHEM EDUC, V46, P863, DOI 10.1021/ed046p863
   Barz F, 2014, IEEE ENG MED BIO, P3977, DOI 10.1109/EMBC.2014.6944495
   Barz F., 2013, TRANSD JUN, P884
   Brugger J, 1999, SENSOR ACTUAT A-PHYS, V76, P329, DOI 10.1016/S0924-4247(98)00286-6
   Brugger J, 2000, MICROELECTRON ENG, V53, P403, DOI 10.1016/S0167-9317(00)00343-9
   Burger GJ, 1996, SENSOR ACTUAT A-PHYS, V54, P669, DOI 10.1016/S0924-4247(97)80035-0
   CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588
   Champagne AR, 2003, APPL PHYS LETT, V82, P1111, DOI 10.1063/1.1554483
   Cheng MY, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/12/125010
   Choi JH, 2011, INT J PRECIS ENG MAN, V12, P165, DOI 10.1007/s12541-011-0023-x
   Choi S.O., 2006, SOL STAT SENS ACT MI
   Choi Y, 2005, Transducers '05, Digest of Technical Papers, Vols 1 and 2, P1469
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   del Campo A, 2008, CHEM REV, V108, P911, DOI 10.1021/cr050018y
   DUNKLEBERGER LN, 1978, J VAC SCI TECHNOL, V15, P88, DOI 10.1116/1.569443
   Fekete Z, 2015, SENSOR ACTUAT B-CHEM, V215, P300, DOI 10.1016/j.snb.2015.03.055
   INGLE FW, 1974, REV SCI INSTRUM, V45, P1460, DOI 10.1063/1.1686529
   Kang GH, 2006, INT J MOD PHYS B, V20, P4493, DOI 10.1142/S0217979206041574
   NGUYEN HB, 1980, IEEE T ELECTRON DEV, V27, P1303, DOI 10.1109/T-ED.1980.20027
   Perlin GE, 2008, IEEE ENG MED BIO, P5806, DOI 10.1109/IEMBS.2008.4650534
   Shandhi MMH, 2015, 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P1759, DOI 10.1109/TRANSDUCERS.2015.7181286
   Shandhi M. M. H., FABRICATION IN PRESS
   Vazquez-Mena O, 2015, MICROELECTRON ENG, V132, P236, DOI 10.1016/j.mee.2014.08.003
   Villanueva G., 2009, MEMS JAN
NR 24
TC 2
Z9 2
U1 2
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1057-7157
EI 1941-0158
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD APR
PY 2017
VL 26
IS 2
BP 376
EP 384
DI 10.1109/JMEMS.2017.2654126
PG 9
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA ES2CQ
UT WOS:000399333800010
PM 29056835
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schrama, D
   Ritter, C
   Becker, JC
AF Schrama, David
   Ritter, Cathrin
   Becker, Juergen C.
TI T cell receptor repertoire usage in cancer as a surrogate marker for
   immune responses
SO SEMINARS IN IMMUNOPATHOLOGY
LA English
DT Review
ID TUMOR-INFILTRATING LYMPHOCYTES; MALIGNANT-MELANOMA; INTRATUMOR
   HETEROGENEITY; DONOR TRANSMISSION; PERIPHERAL-BLOOD; DENDRITIC CELLS;
   DIVERSITY; TCR; ANTIGEN; IDENTIFICATION
AB Characterizing the interaction of cancer cells with the host adaptive immune system is critical for understanding tumor immunology and the modus operandi of immunotherapeutic interventions to treat cancer. As the key cellular effectors of adaptive immunity, T cells are endowed with specialized receptors (the T cell receptor; TCR), to recognize and to eliminate cancer cells. The diversity of the TCR repertoire results from specialized genetic diversification mechanisms that generate an incredible variability allowing recognizing extensive collections of antigens. Based on the attainment and function of the TCR, the TCR repertoire is a mirror of the human immune response, and the dynamic changes of its usage can be assumed as a promising biomarker to monitor immunomodulatory therapies. Recent advances in multiplexed PCR amplification and massive parallel sequencing technologies have facilitated the characterization of TCR repertoires at high resolution even when only biomaterial of limited quantity and quality, such as formalin-fixed paraffin-embedded (FFPE) archived tissues, is available. Here, we review the concept framework and current experimental approaches to characterize the TCR repertoire usage in cancer including inherent technical and biological challenges.
C1 [Schrama, David] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany.
   [Ritter, Cathrin; Becker, Juergen C.] Univ Hosp Essen, Dept Translat Skin Canc Res, Essen, Germany.
   [Ritter, Cathrin; Becker, Juergen C.] German Canc Consortium DKTK, Essen, Germany.
   [Ritter, Cathrin; Becker, Juergen C.] German Canc Res Ctr, Heidelberg, Germany.
RP Becker, JC (reprint author), Univ Hosp Essen, Dept Translat Skin Canc Res, Essen, Germany.; Becker, JC (reprint author), German Canc Consortium DKTK, Essen, Germany.; Becker, JC (reprint author), German Canc Res Ctr, Heidelberg, Germany.
EM j.becker@dkfz.de
CR Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606
   Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614
   Bai XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13664
   Bajaj NS, 2010, TRANSPL INT, V23, pe26, DOI 10.1111/j.1432-2277.2010.01090.x
   Bentzen AK, 2016, NAT BIOTECHNOL, V34, P1037, DOI 10.1038/nbt.3662
   Boyle J., 2008, BIOCH MOL BIOL ED, V36, P317, DOI DOI 10.1002/BMB.20192
   Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158
   BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1
   Busch W., 1868, BERL KLIN WOCHENSCHR, V5, P137
   Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211
   CHALLIS GB, 1990, ACTA ONCOL, V29, P545, DOI 10.3109/02841869009090048
   Chen ZC, 2016, J PATHOL, V239, P450, DOI 10.1002/path.4742
   COCHET M, 1992, EUR J IMMUNOL, V22, P2639, DOI 10.1002/eji.1830221025
   COLEY WB, 1893, AM J MED SCI, V105, P487, DOI DOI 10.1097/00000441-189305000-00001
   Cooper ZA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26615
   DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0
   Del Mar Valenzuela-Membrives M, 2016, ONCOTARGET
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006
   EHRLICH P, 1909, NED TIJDSCHR GENEES, V5, P273
   Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260
   Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Funt SCA, 2016, J CLIN ONCOL
   Galon J, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1029-z
   Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139
   Gerlinger M, 2013, J PATHOL, V231, P424, DOI 10.1002/path.4284
   Giraldo NA, 2014, CURR OPIN IMMUNOL, V27, P8, DOI 10.1016/j.coi.2014.01.001
   GODFREY DI, 1993, J IMMUNOL, V150, P4244
   Goldinger SM, 2016, J CLIN ONCOL
   Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051
   Grupp SA, 2012, CLIN CANCER RES, V18, P6732, DOI 10.1158/1078-0432.CCR-12-1432
   Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016
   Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173
   Hanson WM, 2016, J AM CHEM SOC, V138, P11073, DOI 10.1021/jacs.6b04465
   Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281
   Hayashi T, 2006, CANCER RES, V66, P563, DOI 10.1158/0008-5472.CAN-05-2776
   Hebeisen M, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00582
   HERMASZEWSKI RA, 1993, Q J MED, V86, P31
   Hishii M, 1997, P NATL ACAD SCI USA, V94, P1378, DOI 10.1073/pnas.94.4.1378
   Howie B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5624
   Iannello Alexandre, 2013, Cold Spring Harb Symp Quant Biol, V78, P249, DOI 10.1101/sqb.2013.78.020255
   Jang M, 2015, ONCOIMMUNOLOGY, V4, DOI DOI 10.1080/2162402X.2015.1030561
   Kim JK, 2009, CLIN TRANSPLANT, V23, P571, DOI 10.1111/j.1399-0012.2008.00928.x
   Klarenbeek PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140815
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Klinger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141561
   Klinger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074231
   Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309
   Kohrt HE, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0118-0
   Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918
   Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851
   Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601
   Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581
   Li HM, 2016, J LEUKOCYTE BIOL, V99, P505, DOI 10.1189/jlb.6A0215-071RR
   Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333
   Li Yangqiu, 2015, Stem Cell Investig, V2, P17, DOI 10.3978/j.issn.2306-9759.2015.09.01
   Linnemann C, 2014, IMMUNOL REV, V257, P72, DOI 10.1111/imr.12140
   Liu Q, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-776
   Livak F, 1999, J IMMUNOL, V162, P2575
   LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1
   Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112
   Manuel M, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19545
   Menon S, 2016, CANCERS, V8, DOI 10.3390/cancers8120106
   Munson DJ, 2016, P NATL ACAD SCI USA, V113, P8272, DOI 10.1073/pnas.1606994113
   Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1
   Nie J, 2016, ONCOTARGET, V7, P37882, DOI 10.18632/oncotarget.9352
   PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0
   Pasero C, 2016, CANCER RES, V76, P2153, DOI 10.1158/0008-5472.CAN-15-1965
   Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001
   Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011
   Poschke I, 2016, J PATHOL, V240, P384, DOI 10.1002/path.4800
   Postow MA, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0070-4
   Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111
   Redmond D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0335-7
   Robbins HA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju503
   Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648
   Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017
   Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033
   Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971
   Shang W, 2016, MOL CLIN ONCOL, V5, P315, DOI [10.3892/mco.2016.952, DOI 10.3892/MCO.2016.952]
   Sheikh N, 2016, CANCER RES, V76, P3711, DOI 10.1158/0008-5472.CAN-15-3173
   Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2
   Sims JS, 2016, P NATL ACAD SCI USA, V113, pE3529, DOI 10.1073/pnas.1601012113
   Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416
   Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681
   Staal FJT, 2001, STEM CELLS, V19, P165, DOI 10.1634/stemcells.19-3-165
   Straten P, 1996, J CLIN INVEST, V98, P279
   Straten PT, 2006, CANCER IMMUNOL IMMUN, V55, P495, DOI 10.1007/s00262-005-0023-8
   Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110
   Topalian SL, 2015, CELL, V161, P185
   Trolle T, 2016, J IMMUNOL, V196, P1480, DOI 10.4049/jimmunol.1501721
   Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954
   Turchaninova MA, 2013, EUR J IMMUNOL, V43, P2507, DOI 10.1002/eji.201343453
   VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703
   Vanhanen R, 2016, MOL IMMUNOL, V76, P116, DOI 10.1016/j.molimm.2016.07.002
   Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110
   Willhauck M, 1996, CLIN CANCER RES, V2, P767
   Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017
   Yang XB, 2015, P NATL ACAD SCI USA, V112, P8166, DOI 10.1073/pnas.1510127112
   Yao X, 2014, CLIN CANCER RES, V20, P3401, DOI [10.1158/1078-0432, DOI 10.1158/1078-0432]
   Zhang SQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1278
   Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007
NR 103
TC 3
Z9 3
U1 3
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1863-2297
EI 1863-2300
J9 SEMIN IMMUNOPATHOL
JI Semin. Immunopathol.
PD APR
PY 2017
VL 39
IS 3
BP 255
EP 268
DI 10.1007/s00281-016-0614-9
PG 14
WC Immunology; Pathology
SC Immunology; Pathology
GA ER6PR
UT WOS:000398928500003
PM 28074285
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
TI COMPARATIVE SEM AND EDX ANALYSIS OF SURFACE COATINGS CREATED ON NIOBIUM
   AND TITANIUM ALLOYS AFTER PLASMA ELECTROLYTIC OXIDATION (PEO)
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE Plasma Electrolytic Oxidation (PEO); Micro Arc Oxidation (MAO); SEM; EDS
   Analysis; Niobium; TNZ (Ti-Nb-Zr); NiTi; Ti6Al4V
ID AISI 316L SS; SILICATE SOLUTIONS; TI-13NB-13ZR ALLOY; STAINLESS-STEELS;
   XPS; LAYERS; ANTIBACTERIAL; BIOMATERIAL; CORROSION; NANOINDENTATION
AB In the paper, the SEM and EDS study results of the surface coatings formed on the niobium and titanium alloys (TNZ, NiTi, Ti6Al4V) after the Plasma Electrolytic Oxidation (PEO), also known as Micro Arc Oxidation (MAO), are described. For the experiment of the PEO treatment, a non-conventional electrolyte, based on the concentrated orthophosphoric acid, was used. Copper-enriched surface coatings on the biomaterials after the PEO were obtained and studied. General surface characteristics, regarding the metallic biomaterials after the PEO treatment, with the significant differences of the results, have been displayed and statistically developed.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
RP Rokosz, K (reprint author), Koszalin Univ Technol, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl
RI Hryniewicz, Tadeusz/N-3520-2018
CR Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2014, INT LETT CHEM PHYS A, V4, P98, DOI DOI 10.18052/WWW.SCIPRESS.COM/ILCPA.23.98
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicza T, 2014, ADV MATER SCI, V14, P34, DOI 10.2478/adms-2014-0014
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Kusnerova M, 2013, MEAS SCI REV, V13, P1, DOI 10.2478/msr-2013-0007
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokicki R, 2015, J MATER ENG PERFORM, V24, P1634, DOI 10.1007/s11665-015-1429-x
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Rokosz Krzysztof, 2015, Solid State Phenomena, V227, P155, DOI 10.4028/www.scientific.net/SSP.227.155
   Rokosz K., 2012, MONOGRAPH, V219
   Rokosz K, 2017, SURF INTERFACE ANAL, V49, P303, DOI 10.1002/sia.6136
   Rokosz K, 2016, INT J ADV MANUF TECH, V85, P2425, DOI 10.1007/s00170-015-8086-y
   Rokosz K, 2015, SURF COAT TECH, V276, P516, DOI 10.1016/j.surfcoat.2015.06.022
   Rokosz K, 2015, TEH VJESN, V22, P415, DOI 10.17559/TV-20140722110711
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P643, DOI 10.1002/sia.5758
   Rokosz K, 2015, TEH VJESN, V22, P125, DOI 10.17559/TV-20140211130812
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Simka W, 2013, APPL SURF SCI, V279, P317, DOI 10.1016/j.apsusc.2013.04.091
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Sowa M, 2015, MAT SCI ENG C-MATER, V49, P159, DOI 10.1016/j.msec.2014.12.073
   Sowa M, 2014, J SOLID STATE ELECTR, V18, P3129, DOI 10.1007/s10008-013-2341-7
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
NR 40
TC 10
Z9 10
U1 6
U2 29
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD APR
PY 2017
VL 24
IS 2
BP 465
EP 472
DI 10.17559/TV-20151105101443
PG 8
WC Engineering, Multidisciplinary
SC Engineering
GA ES5FL
UT WOS:000399563100019
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Anitha, A
   Joseph, J
   Menon, D
   Nair, SV
   Nair, MB
AF Anitha, A.
   Joseph, John
   Menon, Deepthy
   Nair, Shantikumar V.
   Nair, Manitha B.
TI Electrospun Yarn Reinforced NanoHA Composite Matrix as a Potential Bone
   Substitute for Enhanced Regeneration of Segmental Defects
SO TISSUE ENGINEERING PART A
LA English
DT Article
DE bone tissue engineering; composite scaffold; fiber reinforcement;
   electrospinning; segmental defect
ID CALCIUM-PHOSPHATE CEMENT; CERAMIC-COATED HYDROXYAPATITE; MESENCHYMAL
   STEM-CELLS; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; IN-VITRO
   DEGRADATION; OSTEOGENIC DIFFERENTIATION; MECHANICAL-PROPERTIES; FIBER
   REINFORCEMENT; SCAFFOLDS
AB Nanohydroxyapatite (nanoHA) is a well-established synthetic bone substitute with excellent osteoconduction and osteointegration. However, brittleness coupled with slow degradation curtails its load-bearing and bone regeneration potential, respectively. To address these limitations, nanoHA composite matrix reinforced with electrospun fibrous yarns was fabricated and tested in vitro and in vivo. Different weight percentages (5, 10, 15wt%) and varying lengths (short and continuous) of poly(l-lactic acid) yarns were randomly dispersed in a gelatinous matrix containing nanoHA. This significantly improved the compressive strength as well as work of fracture, especially for continuous yarns at high weight percentages (10 and 15wt%). Incorporation of yarns did not adversely affect the pore size (50-350 mu m) or porosity of the scaffolds as well as the in vitro cellular response. Finally, when tested in a critical-sized femoral segmental defect in rat, the nanocomposite scaffolds induced osteoblast cell infiltration at 2 months that subsequently underwent increased mature lamellar bone formation at 4 months, in both the mid and peripheral defect regions. Histomorphometric analysis demonstrated that new bone formation and biomaterial degradation were significantly enhanced in the composite scaffold when compared to commercially available HA. Overall, the composite matrix reinforced with electrospun yarns proved to be a potential bone substitute having an appropriate balance between mechanical strength, porosity, biodegradation, and bone regeneration ability.
C1 [Anitha, A.; Joseph, John; Menon, Deepthy; Nair, Shantikumar V.; Nair, Manitha B.] Amrita Vishwa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Ctr Nanosci & Mol Med, Cochin, Kerala, India.
RP Nair, SV; Nair, MB (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Ctr Nanosci & Mol Med, Cochin, Kerala, India.
EM shantinair@aims.amrita.edu; manithanair@aims.amrita.edu
FU Department of Science & Technology, Government of India, through a
   Thematic Unit of Excellence [SR/NM/NS-07/2011]
FX The authors acknowledge the funding received from the Department of
   Science & Technology, Government of India, through a Thematic Unit of
   Excellence (SR/NM/NS-07/2011), and are grateful to Amrita
   Vishwavidyapeetham for all infrastructural support. Mr. Sajin P Ravi,
   Mr. Sharath S, Mr. Dennis Mathew, and Dr. Anusha Ashokan are duly
   acknowledged for their technical help; Dr. A.K.K. Unni, Dr. P. Reshmi,
   P. Dr. Renjith, and Mr. Amit G. Krishnan for animal surgical
   experiments.
CR Agrawal A, 2015, INT J BIOMATER, DOI 10.1155/2015/434876
   Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014
   Bao CY, 2011, ACTA BIOMATER, V7, P4037, DOI 10.1016/j.actbio.2011.06.046
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   BIRCHALL JD, 1986, CIBA F SYMP, V121, P140
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Gorst NJS, 2006, ACTA BIOMATER, V2, P95, DOI 10.1016/j.actbio.2005.09.001
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Jager M, 2005, ANN BIOMED ENG, V33, P1319, DOI 10.1007/s10439-005-5889-2
   John A, 2008, INT J APPL CERAM TEC, V5, P11, DOI 10.1111/j.1744-7402.2008.02191.x
   Joseph J, 2015, NANO LETT, V15, P5420, DOI 10.1021/acs.nanolett.5b01815
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kruger R, 2012, BIOMATERIALS, V33, P5887, DOI 10.1016/j.biomaterials.2012.04.053
   Kumar Prasanna, 2013, J Pharm Bioallied Sci, V5, pS125, DOI 10.4103/0975-7406.113312
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Loiselle AE, 2013, TISSUE ENG PT A, V19, P1704, DOI [10.1089/ten.TEA.2012.0560, 10.1089/ten.tea.2012.0560]
   Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619
   Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720
   Nair MB, 2010, TISSUE ENG PT A, V16, P385, DOI [10.1089/ten.tea.2009.0207, 10.1089/ten.TEA.2009.0207]
   Nair MB, 2009, ACTA BIOMATER, V5, P1742, DOI 10.1016/j.actbio.2009.01.009
   Nair MB, 2009, TISSUE ENG PT A, V15, P1619, DOI 10.1089/ten.tea.2008.0229
   Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Pegoretti A, 1997, J APPL POLYM SCI, V64, P213, DOI 10.1002/(SICI)1097-4628(19970411)64:2<213::AID-APP2>3.0.CO;2-U
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Pietak AM, 2006, BIOMATERIALS, V27, P3, DOI 10.1016/j.biomaterials.2005.05.093
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   Singh RK, 2014, J AM CERAM SOC, V97, P3071, DOI 10.1111/jace.13075
   Xu HHK, 2001, J BIOMED MATER RES, V57, P457, DOI 10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X
   Xu HHK, 2001, J MATER SCI-MATER M, V12, P57, DOI 10.1023/A:1026753020208
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
   Xu HHK, 2000, J BIOMED MATER RES, V52, P107, DOI 10.1002/1097-4636(200010)52:1<107::AID-JBM13>3.0.CO;2-0
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Yang BY, 2016, INT J NANOMED, V11, P163, DOI 10.2147/IJN.S91596
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
   Zuo Y, 2010, ACTA BIOMATER, V6, P1238, DOI 10.1016/j.actbio.2009.10.036
NR 39
TC 5
Z9 5
U1 4
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2017
VL 23
IS 7-8
BP 345
EP 358
DI 10.1089/ten.tea.2016.0337
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA ES3HC
UT WOS:000399419400009
PM 28093043
DA 2018-10-20
ER

PT J
AU Cipriano, AF
   Sallee, A
   Guan, RG
   Lin, A
   Liu, HN
AF Cipriano, Aaron F.
   Sallee, Amy
   Guan, Ren-Guo
   Lin, Alan
   Liu, Huinan
TI A Comparison Study on the Degradation and Cytocompatibility of
   Mg-4Zn-xSr Alloys in Direct Culture
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biodegradable magnesium zinc strontium alloys; Mg-Zn-Sr alloys;
   degradation; bone marrow derived mesenchymal stem cells (BMSCs);
   cytocompatibility; in vitro direct culture method
ID ZINC-STRONTIUM ALLOYS; EMBRYONIC STEM-CELLS; IN-VIVO CORROSION;
   MAGNESIUM DEGRADATION; ENDOTHELIAL-CELLS; VITRO; BIODEGRADATION;
   IMPLANTS; ADHESION; BIOMATERIALS
AB This article reports the behaviors of bone marrow -derived mesenchymal stem cells (BMSCs) in the direct culture with four Mg-4Zn-xSr alloys (x = 0.15, 0.5, 1.0, 1.5 wt %), designated as ZSr41A, B, C, and D, respectively; and a systematic comparison on the degradation of the ZSr41 alloys and their biological impact in the direct culture with different cell types in their respective media. The direct culture method, in which cells are seeded directly onto the surface of the sample, was used to investigate cellular responses at the cell-biomaterial interface in vitro. The results showed that BMSCs adhered and remained viable on the surfaces of all ZSr41 alloys, but the faster degrading ZSr41A and ZSr41B alloys showed a significantly lower amount of viable BMSCs adhered to their surfaces. Moreover, BMSCs adhered to the culture plate surrounding the samples were unaffected by the solubilized degradation products from the ZSr41 alloys. The results from the comparison study showed that the in vitro degradation rates of Mg-based biomaterials in different culture systems might be mostly affected by media buffer capacity (i.e., HCO3- concentration), and to a lesser extent, (D)-glucose concentration. The comparison study also indicated that BMSCs were more robust than H9 human embryonic stem cells and human umbilical vein endothelial cells for screening the cytocompatibility of Mg-based biomaterials. In general, the adhesion and viability of BMSCs at the cell -material interface were inversely proportional to the alloy degradation rates. This study presented a clinically relevant in vitro culture system for screening bioresorbable alloys in direct culture, and provided valuable guidelines for determining the degradation rates of Mg-based biomaterials.
C1 [Cipriano, Aaron F.; Sallee, Amy; Lin, Alan; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
   [Cipriano, Aaron F.; Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA.
   [Guan, Ren-Guo] Northeastern Univ, Sch Mat Sci & Engn, Shenyang 110819, Peoples R China.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.; Liu, HN (reprint author), Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.; Liu, HN (reprint author), Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.; Liu, HN (reprint author), Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU U.S. National Institute of Arthritis and Musculoskeletal and Skin
   Diseases (NIAMS) of the National Institutes of Health [1R03AR069373-01];
   Hellman Faculty Fellowship; University of California Regents Faculty
   Fellowship; U.S. Department of Education for Hispanic Service
   Institutions Undergraduate Research program [P031C110131]; California
   Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research
   program; National Natural Science Foundation of China [51674077,
   51474063]
FX The authors thank the U.S. National Institute of Arthritis and
   Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of
   Health (Award Number 1R03AR069373-01), Hellman Faculty Fellowship
   (H.L.), and the University of California Regents Faculty Fellowship
   (H.L.) for financial support. The authors thank U.S. Department of
   Education for Hispanic Service Institutions Undergraduate Research
   program (Award Number P031C110131) and California Institute for
   Regenerative Medicine (CIRM) Bridges to Stem Cell Research program for
   supporting the undergraduate student researchers (A.L. and A.S.,
   respectively). The authors also thank National Natural Science
   Foundation of China (Grants 51674077 and 51474063) for financial
   support. The authors thank the Central Facility for Advanced Microscopy
   and Microanalysis (CFAMM) at the University of California, Riverside.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Agha NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157874
   Amini Ami R, 2011, J Long Term Eff Med Implants, V21, P93
   Cipriano AF, 2017, ACTA BIOMATER, V48, P499, DOI 10.1016/j.actbio.2016.10.020
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P660, DOI 10.1166/jbn.2014.1760
   Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1
   Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P1773, DOI 10.1016/j.mseb.2011.06.002
   Guan RG, 2013, MAT SCI ENG C-MATER, V33, P3661, DOI 10.1016/j.msec.2013.04.054
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290
   Kannan MB, 2015, COLLOID SURFACE B, V126, P603, DOI 10.1016/j.colsurfb.2015.01.015
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2012, J MATER SCI-MATER M, V23, P283, DOI 10.1007/s10856-011-4517-y
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KNEDLER A, 1987, IN VITRO CELL DEV B, V23, P481
   LASCHINSKI G, 1991, REPROD TOXICOL, V5, P57, DOI 10.1016/0890-6238(91)90111-R
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Nguyen TY, 2015, J BIOMED MATER RES A, V103, P2974, DOI 10.1002/jbm.a.35429
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Rusin O, 2004, J FLUORESC, V14, P611, DOI 10.1023/B:JOFL.0000039348.74270.03
   Sands JM, 2009, SEMIN NEPHROL, V29, P178, DOI 10.1016/j.semnephrol.2009.03.008
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Talbot P, 2011, CURR TOP MED CHEM, V11, P1638
   Nguyen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076547
   Walker J, 2012, J BIOMED MATER RES B, V100B, P1134, DOI 10.1002/jbm.b.32680
   Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042
   Witecka A, 2017, COLLOID SURFACE B, V150, P288, DOI 10.1016/j.colsurfb.2016.10.041
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Zhang J, 2016, J BIOMED MATER RES A, V104, P2476, DOI 10.1002/jbm.a.35788
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 35
TC 6
Z9 6
U1 6
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2017
VL 3
IS 4
BP 540
EP 550
DI 10.1021/acsbiomaterials.6b00684
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA ER8KV
UT WOS:000399069300006
DA 2018-10-20
ER

PT J
AU Williams, PA
   Campbell, KT
   Gharaviram, H
   Madrigal, JL
   Silva, EA
AF Williams, Priscilla A.
   Campbell, Kevin T.
   Gharaviram, Hessam
   Madrigal, Justin L.
   Silva, Eduardo A.
TI Alginate-Chitosan Hydrogels Provide a Sustained Gradient of
   Sphingosine-1-Phosphate for Therapeutic Angiogenesis
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Composite hydrogel; Controlled release; Lipid; Outgrowth endothelial
   cell; Homing; Proangiogenic factors; Sphingosine-1-phosphate (S1P)
ID ENDOTHELIAL PROGENITOR CELLS; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTOR;
   IN-VIVO; BIOMEDICAL APPLICATIONS; DELIVERY; RELEASE; BEADS; DRUG;
   SCAFFOLDS
AB Sphingosine-1-phosphate (S1P), a bioactive lipid, is a potent candidate for treatment of ischemic vascular disease. However, designing biomaterial systems for the controlled release of S1P to achieve therapeutic angiogenesis presents both biological and engineering challenges. Thus, the objective of this study was to design a hydrogel system that provides controlled and sustained release of S1P to establish local concentration gradients that promote neovascularization. Alginate hydrogels have been extensively studied and characterized for delivery of proangiogenic factors. We sought to explore if chitosan (0, 0.1, 0.5, or 1%) incorporation could be used as a means to control S1P release from alginate hydrogels. With increasing chitosan incorporation, hydrogels exhibited significantly denser pore structure and stiffer material properties. While 0.1 and 0.5% chitosan gels demonstrated slower respective release of S1P, release from 1% chitosan gels was similar to alginate gels alone. Furthermore, 0.5% chitosan gels induced greater sprouting and directed migration of outgrowth endothelial cells (OECs) in response to released S1P under hypoxia in vitro. Overall, this report presents a platform for a novel alginate-chitosan hydrogel of controlled composition and in situ gelation properties that can be used to control lipid release for therapeutic applications.
C1 [Williams, Priscilla A.; Campbell, Kevin T.; Gharaviram, Hessam; Madrigal, Justin L.; Silva, Eduardo A.] Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.
RP Silva, EA (reprint author), Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.
EM esilva@ucdavis.edu
RI Silva, Eduardo/M-2711-2015
OI Silva, Eduardo/0000-0003-3173-7622
FU American Heart Association [15BGIA25730057, 15PRE22930044]; Hellman
   Family
FX We thank the American Heart Association (15BGIA25730057 and
   15PRE22930044) and the Hellman Family for the funding support for this
   work. We also acknowledge Dr. J. Kent Leach and Dr. Scott Simon for the
   use of their equipment in acquiring this data. We thank Fred Hayes and
   the UC Davis Advanced Materials Characterization and Testing (AM-CAT)
   facility for guidance with SEM imaging.
CR Anderson EM, 2015, J VASC RES, V52, P62, DOI 10.1159/000382129
   Baysal K, 2013, INT J BIOL MACROMOL, V59, P342, DOI 10.1016/j.ijbiomac.2013.04.073
   Bencherif SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8556
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Binder BYK, 2015, TISSUE ENG PART B-RE, V21, P531, DOI [10.1089/ten.teb.2015.0107, 10.1089/ten.TEB.2015.0107]
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104
   Das RK, 2010, NANOMED-NANOTECHNOL, V6, P153, DOI 10.1016/j.nano.2009.05.009
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Huguet ML, 1996, PROCESS BIOCHEM, V31, P745, DOI 10.1016/S0032-9592(96)00032-5
   Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee BH, 2012, ACTA BIOMATER, V8, P1693, DOI 10.1016/j.actbio.2012.01.012
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Liu Jingjing, 2011, World J Biol Chem, V2, P1, DOI 10.4331/wjbc.v2.i1.1
   Madan M, 2009, INDIAN J PHARM SCI, V71, P242, DOI 10.4103/0250-474X.56015
   MAGHAMI GG, 1988, MAKROMOL CHEM, V189, P2239
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Meng X, 2010, J MATER SCI-MATER M, V21, P1751, DOI 10.1007/s10856-010-3996-6
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Naor MM, 2007, J MOL GRAPH MODEL, V26, P519, DOI 10.1016/j.jmgm.2007.03.004
   Neves SC, 2015, J MATER CHEM B, V3, P2096, DOI 10.1039/c4tb00885e
   Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007
   Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sezer AD, 1999, J MICROENCAPSUL, V16, P687
   Sibaja B, 2015, CARBOHYD POLYM, V134, P598, DOI 10.1016/j.carbpol.2015.07.076
   Silva CM, 2005, AAPS J, V7, pE903, DOI 10.1208/aapsj070488
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010
   Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Khong TT, 2013, BIOMACROMOLECULES, V14, P2765, DOI 10.1021/bm400610b
   Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013
   Venkatesan J, 2014, MAR DRUGS, V12, P300, DOI 10.3390/md12010300
   Wacker BK, 2006, BIOMACROMOLECULES, V7, P1335, DOI 10.1021/bm050948r
   Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70
   Williams PA, 2015, ANN BIOMED ENG, V43, P2301, DOI 10.1007/s10439-015-1400-x
   Williams PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123437
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
NR 49
TC 5
Z9 5
U1 5
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD APR
PY 2017
VL 45
IS 4
BP 1003
EP 1014
DI 10.1007/s10439-016-1768-2
PG 12
WC Engineering, Biomedical
SC Engineering
GA ER3YV
UT WOS:000398737100013
PM 27904998
DA 2018-10-20
ER

PT J
AU Chuah, YJ
   Peck, Y
   Lau, JEJ
   Heec, HT
   Wang, DA
AF Chuah, Yon Jin
   Peck, Yvonne
   Lau, Jia En Josias
   Heec, Hwan Tak
   Wang, Dong-An
TI Hydrogel based cartilaginous tissue regeneration: recent insights and
   technologies
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   INTERVERTEBRAL DISC REGENERATION; RANDOMIZED CONTROLLED-TRIAL;
   LOW-BACK-PAIN; INTERPENETRATING-NETWORK HYDROGEL; NUCLEUS PULPOSUS
   REGENERATION; ASSEMBLING PEPTIDE HYDROGEL; IN-VITRO CHARACTERIZATION;
   ANNULUS FIBROSUS REPAIR
AB Hydrogels have been extensively employed as an attractive biomaterial to address numerous existing challenges in the fields of regenerative medicine and research because of their unique properties such as the capability to encapsulate cells, high water content, ease of modification, low toxicity, injectability, in situ spatial fit and biocompatibility. These inherent properties have created many opportunities for hydrogels as a scaffold or a cell/drug carrier in tissue regeneration, especially in the field of cartilaginous tissue such as articular cartilage and intervertebral discs. A concise overview of the anatomy/physiology of these cartilaginous tissues and their pathophysiology, epidemiology and existing clinical treatments will be briefly described. This review article will discuss the current state-of-the-art of various polymers and developing strategies that are explored in establishing different technologies for cartilaginous tissue regeneration. In particular, an innovative approach to generate scaffold-free cartilaginous tissue via a transient hydrogel scaffolding system for disease modeling to pre-clinical trials will be examined. Following that, the article reviews numerous hydrogel-based medical implants used in clinical treatment of osteoarthritis and degenerated discs. Last but not least, the challenges and future directions of hydrogel based medical implants in the regeneration of cartilaginous tissue are also discussed.
C1 [Chuah, Yon Jin; Peck, Yvonne; Wang, Dong-An] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
   [Lau, Jia En Josias] Singapore Polytech, Sch Chem & Life Sci, 500 Dover Rd, Singapore 139651, Singapore.
   [Heec, Hwan Tak] Nanyang Technol Univ, Lee Kong Chian Sch Med, 59 Nanyang Dr, Singapore 636921, Singapore.
   [Heec, Hwan Tak] Mt Elizabeth Med Ctr, Pinnacle Spine & Scoliosis Ctr, 3 Mt Elizabeth, Singapore 228510, Singapore.
RP Wang, DA (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
EM YCHUAH001@e.ntu.edu.sg; DAWang@ntu.edu.sg
RI Wang, Dong-an/G-6195-2010
OI Chuah, Yon Jin/0000-0003-0579-6370
FU Ministry of Education of Singapore [RG37/14]
FX This work was financially supported by the Tier 1 Academic Research Fund
   from the Ministry of Education of Singapore (RG37/14). The authors thank
   Ms Wee Mei Ling for assisting in the preparation of the figures and Ms
   Tan Jing Shi's effort at proofreading this article.
CR Abella V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20356
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Albers G. H., 2009, 55 ANN M ORTH RES SO
   Almeida HV, 2016, ACTA BIOMATER, V36, P55, DOI 10.1016/j.actbio.2016.03.008
   Altman RD, 2009, SEMIN ARTHRITIS RHEU, V39, P1, DOI 10.1016/j.semarthrit.2009.04.001
   Andereya S, 2006, Z ORTHOP GRENZGEB, V144, P272, DOI 10.1055/s-2006-933445
   Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133
   Andersson GBJ, 1998, ACTA ORTHOP SCAND, V69, P28, DOI 10.1080/17453674.1998.11744790
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Balakrishnan B, 2014, ACTA BIOMATER, V10, P3650, DOI 10.1016/j.actbio.2014.04.031
   Balakrishnan B, 2013, J MATER CHEM B, V1, P5564, DOI 10.1039/c3tb21056a
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Barrick WT, 2000, SPINE, V25, P853, DOI 10.1097/00007632-200004010-00014
   Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb
   Berlemann U., 2016, J SPINE NEUROSURG, V5, P2
   Berlemann U., 2006, EUR CELLS MATER, V11, P24
   Berlemann U, 2009, EUR SPINE J, V18, P1706, DOI 10.1007/s00586-009-1136-0
   Bertagnoli R, 2002, EUR SPINE J, V11, pS143, DOI 10.1007/s00586-002-0424-8
   BERTHETCOLOMINAS C, 1982, BIOCHIM BIOPHYS ACTA, V706, P50, DOI 10.1016/0167-4838(82)90374-0
   Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Bian SQ, 2016, COLLOID SURFACE B, V140, P392, DOI 10.1016/j.colsurfb.2016.01.008
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   Borde B, 2015, J BIOMED MATER RES A, V103, P2571, DOI 10.1002/jbm.a.35388
   Borenstein DG, 2001, CURR OPIN RHEUMATOL, V13, P128, DOI 10.1097/00002281-200103000-00006
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Camci-Unal G, 2013, BIOMACROMOLECULES, V14, P1085, DOI 10.1021/bm3019856
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Choi B, 2014, ACS APPL MATER INTER, V6, P20110, DOI 10.1021/am505723k
   Chuah Y, 2015, TISSUE ENG PT A, V21, pS327
   Chuah Y. J., 2014, SPIN J M, P79
   Chuah YF, 2015, EXP CELL RES, V331, P176, DOI 10.1016/j.yexcr.2014.09.022
   Chuah YJ, 2015, ACTA BIOMATER, V23, P52, DOI 10.1016/j.actbio.2015.05.023
   Clave A, 2016, J ORTHOP RES, V34, P658, DOI 10.1002/jor.23152
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   Colombier P, 2014, TRENDS BIOTECHNOL, V32, P433, DOI 10.1016/j.tibtech.2014.05.006
   Cubukcu D, 2005, CLIN RHEUMATOL, V24, P336, DOI 10.1007/s10067-004-1043-z
   Daly AC, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045002
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Di Martino A, 2005, SPINE, V30, pS16, DOI 10.1097/01.brs.0000174530.88585.32
   Dillon CF, 2006, J RHEUMATOL, V33, P2271
   Ding J, 2011, WOUND REPAIR REGEN, V19, P568, DOI 10.1111/j.1524-475X.2011.00724.x
   DuRaine G. D., 2014, ANN BIOMED ENG, V21, P21
   Durdag E, 2014, TURK NEUROSURG, V24, P602, DOI 10.5137/1019-5149.JTN.9328-13.1
   Eaton Charles B, 2004, Med Health R I, V87, P201
   Efe T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-283
   Ehlicke F, 2010, INT J ARTIF ORGANS, V33, P244
   Eslahi N, 2016, BIOMACROMOLECULES, V17, P3441, DOI 10.1021/acs.biomac.6b01235
   Eyre DR, 2002, BIOCHEM SOC T, V30, P844
   EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267
   Eysel P, 1999, ACTA NEUROCHIR, V141, P1083, DOI 10.1007/s007010050486
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396
   Fu JY, 2016, ANN BIOMED ENG, V44, P2957, DOI 10.1007/s10439-016-1615-5
   Giannoni P, 2016, BIOMATER SCI-UK, V4, P1691, DOI 10.1039/c6bm00478d
   Gong YH, 2010, TISSUE ENG PT A, V16, P3611, DOI [10.1089/ten.tea.2010.0219, 10.1089/ten.TEA.2010.0219]
   Grasslober M., 2006, 6 CENTR EUR ORTH C G
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guerin HAL, 2006, J BIOMECH, V39, P1410, DOI 10.1016/j.jbiomech.2005.04.007
   Guiot BH, 2000, NEUROSURGERY, V47, P1034, DOI 10.1097/00006123-200011000-00003
   Han FX, 2015, J BIOMED MATER RES B, V103, P1344, DOI 10.1002/jbm.b.33314
   Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1
   Hee HT, 2010, J BONE JOINT SURG BR, V92B, P726, DOI 10.1302/0301-620X.92B5.23015
   Hee HT, 2011, SPINE, V36, P505, DOI 10.1097/BRS.0b013e3181d32410
   Heidari B, 2011, CASP J INTERN MED, V2, P205
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Ho STB, 2010, BIOMATERIALS, V31, P38, DOI 10.1016/j.biomaterials.2009.09.021
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2015, AM J SPORT MED, V43, P2469, DOI 10.1177/0363546515593943
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601
   Huang TL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-221
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Hunt JA, 2014, J MATER CHEM B, V2, P5319, DOI 10.1039/c4tb00775a
   Hwang NS, 2007, FEBS LETT, V581, P4172, DOI 10.1016/j.febslet.2007.07.049
   Jin DD, 2003, J SPINAL DISORD TECH, V16, P331, DOI 10.1097/00024720-200308000-00004
   Jordan JM, 2007, J RHEUMATOL, V34, P172
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KELLGREN JH, 1977, RHEUMATOL REHABIL, V16, P3, DOI 10.1093/rheumatology/16.1.3
   Kim J, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0212-x
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Kim YS, 2015, AM J SPORT MED, V43, P176, DOI 10.1177/0363546514554190
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEIN JA, 1982, BIOCHIM BIOPHYS ACTA, V719, P98, DOI 10.1016/0304-4165(82)90312-9
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Ko CY, 2013, RSC ADV, V3, P25769, DOI 10.1039/c3ra42406e
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Koh YG, 2016, ARTHROSCOPY, V32, P97, DOI 10.1016/j.arthro.2015.09.010
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Kubota K, 2004, COLLOID SURFACE B, V38, P103, DOI 10.1016/j.colsurfb.2004.02.017
   KUSLICH SD, 1991, ORTHOP CLIN N AM, V22, P181
   Lange J, 2006, UNFALLCHIRURG, V109, P193, DOI 10.1007/s00113-005-1025-x
   Lau TT, 2016, J BIOMED MATER RES A, V104, P2968, DOI 10.1002/jbm.a.35845
   Lau TT, 2012, BIOMATERIALS, V33, P8406, DOI 10.1016/j.biomaterials.2012.08.025
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee M, 2010, TISSUE ENG PT A, V16, P1791, DOI 10.1089/ten.TEA.2009.0384
   Leyland KM, 2012, ARTHRITIS RHEUM-US, V64, P2243, DOI 10.1002/art.34415
   Li JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085373
   Li Yuting, 2015, ScientificWorldJournal, V2015, P685690, DOI 10.1155/2015/685690
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Lin H, 2014, TISSUE ENG PT A, V20, P2402, DOI [10.1089/ten.tea.2013.0642, 10.1089/ten.TEA.2013.0642]
   Lindley EM, 2010, SPINE, V35, pE1241, DOI 10.1097/BRS.0b013e3181dfbc78
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Lu ZF, 2008, J CELL MOL MED, V12, P2812, DOI 10.1111/j.1582-4934.2008.00278.x
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]
   Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157
   Maldonado M, 2013, BIOMED RES INT, DOI 10.1155/2013/284873
   Menze M., ELDERLY SPINE PATIEN
   Methot S, 2016, CARTILAGE, V7, P16, DOI 10.1177/1947603515595837
   Meyer C, 2005, UNFALLCHIRURG, V108, P163, DOI 10.1007/s00113-004-0798-7
   Miles DE, 2016, J MATER CHEM B, V4, P3225, DOI 10.1039/c6tb00121a
   Miller Y, 2015, J PHYS CHEM B, V119, P482, DOI 10.1021/jp511485n
   Mishra A, 2011, NANO TODAY, V6, P232, DOI 10.1016/j.nantod.2011.05.001
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mobbs RJ, 2001, J CLIN NEUROSCI, V8, P10, DOI 10.1054/jocn.1999.0682
   Muller-Rath R, 2007, INT J ARTIF ORGANS, V30, P1057
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61728-0
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y
   Neame P J, 1994, EXS, V70, P53
   Ng KFJ, 2002, CLIN J PAIN, V18, P275, DOI 10.1097/00002508-200209000-00001
   Nie X., 2016, POLYM BIOMATERIALS T, P57, DOI [10.1007/978-981-10-2293-7_3, DOI 10.1007/978-981-10-2293-7_3]
   O'Connell GD, 2015, BIORESEARCH OPEN ACC, V4, P431, DOI 10.1089/biores.2015.0034
   Omlor GW, 2012, EUR SPINE J, V21, P1700, DOI 10.1007/s00586-012-2291-2
   Paglia DN, 2016, SPINE, V41, pE449, DOI 10.1097/BRS.0000000000001336
   Pavelka K, 2011, OSTEOARTHR CARTILAGE, V19, P1294, DOI 10.1016/j.joca.2011.07.016
   PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206
   Peck Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16225
   Peck Y, 2014, MOL PHARMACEUT, V11, P1997, DOI 10.1021/mp500026x
   Peck Y, 2013, EXPERT OPIN DRUG DEL, V10, P369, DOI 10.1517/17425247.2013.751096
   Rackwitz L, 2012, ORTHOPADE, V41, P268, DOI 10.1007/s00132-011-1853-z
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ray CD, 2002, EUR SPINE J, V11, pS137, DOI 10.1007/s00586-002-0425-7
   Reppel L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0263-2
   Rey-Rico A, 2016, BIOMED RES INT, DOI 10.1155/2016/1215263
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   ROBERTS S, 1991, ANN RHEUM DIS, V50, P787, DOI 10.1136/ard.50.11.787
   Roelofs AJ, 2013, OSTEOARTHR CARTILAGE, V21, P892, DOI 10.1016/j.joca.2013.04.008
   Roessler PP, 2015, INT ORTHOP, V39, P2473, DOI 10.1007/s00264-015-2695-9
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   ROUGHLEY PJ, 1994, MICROSC RES TECHNIQ, V28, P385, DOI 10.1002/jemt.1070280505
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Santo VE, 2015, ACTA BIOMATER, V19, P56, DOI 10.1016/j.actbio.2015.03.015
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   Seliktar D., 2007, OSTEOARTHR CARTILAGE, V15, pB123
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Selviaridis P, 2010, HIPPOKRATIA, V14, P176
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Shim CS, 2003, J SPINAL DISORD TECH, V16, P324, DOI 10.1097/00024720-200308000-00003
   Shive MS, 2015, CARTILAGE, V6, P62, DOI 10.1177/1947603514562064
   Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019
   Singh YP, 2016, ACS APPL MATER INTER, V8, P21236, DOI 10.1021/acsami.6b08285
   Smeriglio P., 2015, JOVE-J VIS EXP, V7, P53085
   Smith LJ, 2014, TISSUE ENG PT A, V20, P1841, DOI [10.1089/ten.tea.2013.0516, 10.1089/ten.TEA.2013.0516]
   Snyder TN, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-10
   Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345
   Steinwachs MR, 2014, ARTHROSC TEC, V3, pE399, DOI 10.1016/j.eats.2014.02.011
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Su K, 2012, ADV FUNCT MATER, V22, P972, DOI 10.1002/adfm.201102884
   Subhan RA, 2014, SCI WORLD J, DOI 10.1155/2014/818502
   Suk KS, 2001, SPINE, V26, P672, DOI 10.1097/00007632-200103150-00024
   Teixeira LSM, 2012, BIOMATERIALS, V33, P3164, DOI 10.1016/j.biomaterials.2012.01.001
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Tsaryk R, 2015, ACTA BIOMATER, V20, P10, DOI 10.1016/j.actbio.2015.03.041
   Tschugg A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1239-y
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Vynios DH, 2001, BIOCHIMIE, V83, P899, DOI 10.1016/S0300-9084(01)01332-3
   Wada Y, 2009, TISSUE ENG PT A, V15, P3765, DOI [10.1089/ten.tea.2009.0078, 10.1089/ten.TEA.2009.0078]
   Walkenhorst J., 2004, INT M ADV SPIN TECHN
   Wan S, 2016, ACTA BIOMATER, V46, P29, DOI 10.1016/j.actbio.2016.09.033
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang QG, 2010, EUR CELLS MATER, V19, P86, DOI 10.22203/eCM.v019a09
   Wang R, 2014, POLYM ADVAN TECHNOL, V25, P568, DOI 10.1002/pat.3286
   Wang TY, 2016, TISSUE ENG PT A, V22, P1348, DOI 10.1089/ten.tea.2016.0306
   Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50
   Wennink JWH, 2011, MACROMOL SYMP, V309-310, P213, DOI 10.1002/masy.201100032
   Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x
   Wu YH, 2016, ARTIF ORGANS, V40, pE112, DOI 10.1111/aor.12694
   Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343
   Yamaoka H, 2010, J BIOMED MATER RES A, V93A, P123, DOI 10.1002/jbm.a.32509
   Yan SF, 2016, J MATER CHEM B, V4, P947, DOI 10.1039/c5tb01488c
   Yan SF, 2014, BIOMACROMOLECULES, V15, P4495, DOI 10.1021/bm501313t
   Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111
   Yeo SN, 2009, ANN ACAD MED SINGAP, V38, P937
   Ylarinne JH, 2016, OSTEOARTHR CARTILAGE, V24, pS466
   Yoon DM, 2009, TISSUE ENG PT A, V15, P3449, DOI [10.1089/ten.tea.2009.0069, 10.1089/ten.TEA.2009.0069]
   Yue JJ, 2016, MED DEVICES-EVID RES, V9, P75, DOI 10.2147/MDER.S102949
   Yue JJ, 2011, EUROPEAN MUSCULOSKEL, V6, P184
   Zhang F, 2013, TISSUE ENG PT A, V19, P1091, DOI [10.1089/ten.TEA.2012.0441, 10.1089/ten.tea.2012.0441]
   Zhang HW, 2011, BIOMATERIALS, V32, P890, DOI 10.1016/j.biomaterials.2010.09.053
   Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI 10.1016/j.cger.2010.03.001
   Zhao X, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1100-1
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 226
TC 16
Z9 16
U1 19
U2 66
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD APR 1
PY 2017
VL 5
IS 4
BP 613
EP 631
DI 10.1039/c6bm00863a
PG 19
WC Materials Science, Biomaterials
SC Materials Science
GA ER7OI
UT WOS:000399002000001
PM 28233881
DA 2018-10-20
ER

PT J
AU He, XY
   Qu, Y
   Peng, JR
   Peng, T
   Qian, ZY
AF He, Xinye
   Qu, Ying
   Peng, Jinrong
   Peng, Tao
   Qian, Zhiyong
TI A novel botryoidal aramid fiber reinforcement of a PMMA resin for a
   restorative biomaterial
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID DENTURE BASE RESIN; MECHANICAL-PROPERTIES; BONE CEMENTS; GLASS-FIBERS;
   STRENGTH; NANOCOMPOSITES; COMPOSITES
AB Poly(methyl methacrylate) (PMMA) resin is widely used as a prosthetic and restorative biomaterial, such as in bone cement, denture base resin, etc. The flexural and compressive strength of a PMMA resin is of great concern and many approaches have been made to improve the flexural resistance and compressive strength of PMMA. To strengthen PMMA via high-performance (HP) fibers is a feasible way; however, the HP fibers are not very satisfactory in practice, with a complex handling process and esthetic concerns. The aim of this study is to investigate the preparation of a novel botryoidal PMMA microsphere-grafted aramid fiber system, which has never been reported before, and the flexural and compression behavior of the PMMA/aramid composite, and evaluate the cytotoxic effects of the PMMA/aramid composite. As a result, the addition of a microsphere-grafted aramid fiber to an acrylic resin, with the esthetic problem of the aramid fiber minimized, simultaneously improves the mechanical properties and the safety of the PMMA/aramid composite in vitro is proven acceptable, suggesting that the novel composite has great potential in the field of restorative materials in clinical applications where high mechanical properties are required such as hard tissue repairing.
C1 [He, Xinye; Qu, Ying; Peng, Jinrong; Qian, Zhiyong] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   [He, Xinye; Qu, Ying; Peng, Jinrong; Qian, Zhiyong] Sichuan Univ, Canc Ctr, West China Hosp, Chengdu 610041, Peoples R China.
   [He, Xinye; Qu, Ying; Peng, Jinrong; Qian, Zhiyong] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.
   [He, Xinye; Peng, Tao] China Blue Star Chengrand Res & Design Inst Chem, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Qian, ZY (reprint author), Sichuan Univ, Canc Ctr, West China Hosp, Chengdu 610041, Peoples R China.; Qian, ZY (reprint author), Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com
RI yang, xueqin/K-1830-2017
FU National Natural Science Foundation of China [NSFC31525009,
   NSFC31271021]; National 863 project [2015AA020316]; Sichuan Innovative
   Research Team Program for Young Scientists [2016TD0004]; Distinguished
   Young Scholars of Sichuan University [2011SCU04B18]
FX This work was financially supported by the National Natural Science
   Foundation of China (NSFC31525009 and NSFC31271021), the National 863
   project (2015AA020316), the Sichuan Innovative Research Team Program for
   Young Scientists (2016TD0004), and the Distinguished Young Scholars of
   Sichuan University (2011SCU04B18). We would like to offer many thanks to
   Wang Hui (Analytical & Testing Center, Sichuan University) for her great
   help in SEM analysis.
CR Arash B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06479
   Berrong J M, 1990, Int J Prosthodont, V3, P391
   Brown JR, 1997, J MATER SCI, V32, P2599, DOI 10.1023/A:1018654501851
   Chen SY, 2001, J BIOMED MATER RES, V58, P203
   Farrar DF, 2001, BIOMATERIALS, V22, P3005, DOI 10.1016/S0142-9612(01)00047-3
   Goguta L., 2006, TEMPOROMANDIBULAR JO, V1, P88
   Grave A M, 1985, Dent Mater, V1, P185, DOI 10.1016/S0109-5641(85)80015-4
   HENDERSON JD, 1987, J BIOMED MATER RES, V21, P59, DOI 10.1002/jbm.820210110
   Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002
   Jagger DC, 1999, J ORAL REHABIL, V26, P185, DOI 10.1046/j.1365-2842.1999.00375.x
   Jee AY, 2011, J NANOSCI NANOTECHNO, V11, P533, DOI 10.1166/jnn.2011.3290
   John J, 2001, J PROSTHET DENT, V86, P424, DOI 10.1067/mpr.2001.118564
   Kanie T, 2000, DENT MATER, V16, P150, DOI 10.1016/S0109-5641(99)00097-4
   Kristina O., 1998, J APPL POLYM SCI, V67, P1503
   Liu L, 2001, J APPL POLYM SCI, V81, P2764, DOI 10.1002/app.1722
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Nakamura M, 2007, DENT MATER J, V26, P733, DOI 10.4012/dmj.26.733
   Ozen J, 2006, TURKISH J MEDICAL SC, V36, P121
   Ramanathan T, 2008, NAT NANOTECHNOL, V3, P327, DOI 10.1038/nnano.2008.96
   Saygili G, 2003, OPER DENT, V28, P80
   Valles C, 2013, COMPOS SCI TECHNOL, V88, P158, DOI 10.1016/j.compscitech.2013.08.030
   Vallittu P K, 1997, Quintessence Int, V28, P39
   Vallittu P. K., 1996, J PROSTHODONT, V4, P270
   Wening J V, 1989, Unfallchirurgie, V15, P215
   Wiskott H W, 1995, Int J Prosthodont, V8, P105
   Yang H. H, 1993, KEVLAR ARAMID FIBER
   YAZDANIE N, 1985, J PROSTHET DENT, V54, P543, DOI 10.1016/0022-3913(85)90431-7
   Zhang XY, 2014, DENT MATER J, V33, P141, DOI 10.4012/dmj.2013-054
   Zywicka Boguslawa, 2004, Polim Med, V34, P3
NR 29
TC 0
Z9 0
U1 10
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD APR 1
PY 2017
VL 5
IS 4
BP 808
EP 816
DI 10.1039/c6bm00939e
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA ER7OI
UT WOS:000399002000020
PM 28275764
DA 2018-10-20
ER

PT J
AU Sevcikova, J
   Goldbergova, MP
AF Sevcikova, Jana
   Goldbergova, Monika Pavkova
TI Biocompatibility of NiTi alloys in the cell behaviour
SO BIOMETALS
LA English
DT Review
DE Alloy; Biomaterial; NiTi; Cell; Biocompatibility
ID SHAPE-MEMORY ALLOYS; NICKEL-TITANIUM ALLOY; SMOOTH-MUSCLE-CELLS;
   IN-VITRO; CORROSION BEHAVIOR; TI ALLOYS; MOLECULAR-MECHANISM; VASCULAR
   IMPLANTS; SURFACE-TREATMENT; ION RELEASE
AB Metallic biomaterial alloys composed of nickel and titanium have unique thermal shape memory, superelastic, and high damping properties, which are widely used in the medicine. The major parameter evaluated in the studies regarding the behaviour of the material in the contact with organism or cells is biocompatibility. The aim of the studies is to clarify the differences in the proliferation, growth, and morphology especially in the cell cultures. The cytotoxicity is affected among other by release of the metal ions in the presence of the metal alloy, which is further dependent on the possible treatments of the material and the corrosive properties. To evaluate the cytotoxicity, wide range of tests including the Sulforhodamine B assay and MTT tests, expression profiles, cell survival tests such as apoptotic test are used. The review compares the cell behaviour in contact with the material alloys composed of nickel and titanium with respect to different materials composition and different surface treatment that affects the ion release. Even though the results published so far are controversial, almost all data suggest sufficient biocompatibility in medical use.
C1 [Sevcikova, Jana; Goldbergova, Monika Pavkova] Masaryk Univ, Inst Pathol Physiol, Med Fac, Kamenice 5, Brno 62500, Czech Republic.
RP Goldbergova, MP (reprint author), Masaryk Univ, Inst Pathol Physiol, Med Fac, Kamenice 5, Brno 62500, Czech Republic.
EM goldberg@med.muni.cz
FU Grant agency of the Czech republic [GA15-16336S]
FX This work was supported by the research project GA15-16336S of Grant
   agency of the Czech republic.
CR Armitage DA, 2003, J BIOMED MATER RES A, V66A, P129, DOI 10.1002/jbm.a.10549
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Banasiak D, 1999, RADIAT ONCOL INVESTI, V7, P77, DOI 10.1002/(SICI)1520-6823(1999)7:2<77::AID-ROI3>3.0.CO;2-M
   BENSIMON J, 1974, CR ACAD SCI D NAT, V278, P345
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Carroll WM, 2003, J BIOMED MATER RES A, V67A, P1123, DOI 10.1002/jbm.a.10099
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   Clarke B, 2006, J BIOMED MATER RES A, V79A, P61, DOI 10.1002/jbm.a.30720
   CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Es-Souni M, 2001, BIOMATERIALS, V22, P2153, DOI 10.1016/S0142-9612(00)00406-3
   EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Gill P, 2015, MAT SCI ENG C-MATER, V50, P37, DOI 10.1016/j.msec.2015.01.009
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Haider W, 2011, J MATER ENG PERFORM, V20, P816, DOI 10.1007/s11665-011-9884-5
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hillen U, 2002, CONTACT DERMATITIS, V47, P353, DOI 10.1034/j.1600-0536.2002.470607.x
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   KAWAHARA H, 1983, INT DENT J, V33, P350
   Ke QD, 2007, TOXICOL APPL PHARM, V219, P18, DOI 10.1016/j.taap.2006.08.013
   Kobayashi S, 2005, DIAM RELAT MATER, V14, P1094, DOI 10.1016/j.diamond.2004.11.036
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Li Q, 2009, TOXICOL APPL PHARM, V235, P191, DOI 10.1016/j.taap.2008.12.005
   Lifeng Z, 2011, BIOMED MATER, V6, DOI [10.1088/1748-6041/6/2/025012, DOI 10.1088/1748-6041/6/2/025012]
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Manceur A, 2003, J BIOMED MATER RES A, V67A, P641, DOI 10.1002/jbm.a.10134
   O'Brien B, 2002, BIOMATERIALS, V23, P1739, DOI 10.1016/S0142-9612(01)00299-X
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   Pulletikurthi C, 2011, J MATER ENG PERFORM, V20, P824, DOI 10.1007/s11665-011-9930-3
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Ries MW, 2003, AM HEART J, V145, P737, DOI 10.1067/mhj.2003.7
   Rokicki R, 2013, U.S. Patent, Patent No. [8,377,237, 8377237]
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J., 1999, BIOCOMPATIBILITY EVA
   Shabalovskaya S, 2004, J BIOMED MATER RES B, V69B, P223, DOI 10.1002/jbm.b.30006
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P468, DOI 10.1016/j.biomaterials.2008.10.014
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Strauss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051264
   Sui JH, 2006, DIAM RELAT MATER, V15, P1720, DOI 10.1016/j.diamond.2006.03.004
   SUNDERMAN FW, 1978, FED PROC, V37, P40
   SWIERENG.SH, 1968, LAB INVEST, V19, P663
   Van Humbeeck J, 1998, WIL SER BIOM SCI ENG, P73
   Wataha JC, 2001, J BIOMED MATER RES, V58, P537, DOI 10.1002/jbm.1052.abs
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1133, DOI 10.1002/jbm.820250907
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WEBB M, 1972, BRIT J CANCER, V26, P292, DOI 10.1038/bjc.1972.39
   Weinandy S, 2012, TISSUE ENG PT A, V18, P1818, DOI [10.1089/ten.tea.2011.0648, 10.1089/ten.TEA.2011.0648]
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Winn B, 2011, METALLOMICS, V3, P934, DOI 10.1039/c1mt00035g
   Yang DY, 2014, BIOMATERIALS, V35, P6195, DOI 10.1016/j.biomaterials.2014.04.069
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Yeung KWK, 2005, J BIOMED MATER RES A, V72A, P238, DOI 10.1002/jbm.a.30201
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 62
TC 3
Z9 3
U1 7
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0966-0844
EI 1572-8773
J9 BIOMETALS
JI Biometals
PD APR
PY 2017
VL 30
IS 2
BP 163
EP 169
DI 10.1007/s10534-017-0002-5
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ER3PI
UT WOS:000398709100002
PM 28190193
DA 2018-10-20
ER

PT J
AU Okada, T
   Kanai, T
   Tachikawa, N
   Munakata, M
   Kasugai, S
AF Okada, Tsuneji
   Kanai, Toru
   Tachikawa, Noriko
   Munakata, Motohiro
   Kasugai, Shohei
TI Histological and Histomorphometrical Determination of the Biogradation
   of -Tricalcium Phosphate Granules in Maxillary Sinus Floor Augmentation:
   A Prospective Observational Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE calcium phosphate; biopsy; biomaterial resorption; CBCT
ID AUTOGENOUS BONE; RESORPTION; ELEVATION; TISSUE; GRAFT
AB Introduction:We have recently used highly pure -TCP (beta-tricalcium phosphate) as the bone grafting material to avoid highly invasive autogenous bone grafting. We evaluated the osseoconduction potential of highly pure -TCP in sinus augmentation surgery treatment.Materials and Methods:The study group comprised 13 patients who underwent maxillary sinus floor augmentation with -TCP alone. Seven patients underwent sinus augmentation and implant placement simultaneously. Six patients were treated with a staged approach. Six months after surgery, specimens were obtained from 7 patients (for lateral biopsy) and 6 patients (for vertical biopsy).Results:Histological and histomorphometrical analysis showed a mean bone proportion of 30.8% (vertical) and 12.0% (lateral) for new bone formation and good integration of the -TCP. New bone formation was lower in the lateral biopsy specimens than in the vertical.Conclusion:Highly pure -TCP is a safe bone-grafting material with superior osteoconductive properties. Histologic and radiographic examinations indicate that -TCP is slowly resorbed, which results in unresorbed graft material remaining even 6 months after the procedure, and that new bone replacement occurs slowly for approximately 1 year.
C1 [Okada, Tsuneji; Kanai, Toru; Tachikawa, Noriko; Kasugai, Shohei] Tokyo Med & Dent Univ, Dent Hosp, Clin Implant Dent, Tokyo, Japan.
   [Munakata, Motohiro] Kanagawa Dent Univ, Dept Oral & Maxillofacial Rehabil, Removable Prosthet, Yokosuka, Kanagawa, Japan.
RP Okada, T (reprint author), Tokyo Med & Dent Univ, Dent Hosp, Clin Implant Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM okatune@masaka-dental.com
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Avila-Ortiz G, 2012, INT J ORAL MAX IMPL, V27, P1230
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Matsunaga A, 2015, CYTOTECHNOLOGY, V67, P727, DOI 10.1007/s10616-015-9854-0
   MISCH CE, 1993, CONT IMPLANT DENT, P545
   Okada T, 2016, INT J IMPLANT DENT, V2, DOI 10.1186/s40729-016-0042-6
   Ozawa M, 1995, J JPN SOC BIOMATER, V13, P167
   OZAWA M, 2000, J E JPN ORTHOP TRAUM, V12, P409
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   Suba Z, 2006, CLIN ORAL IMPLAN RES, V17, P102, DOI 10.1111/j.1600-0501.2005.01166.x
   Szabo G, 2005, INT J ORAL MAX IMPL, V20, P371
   TORIYAMA M, 1986, NIPPON SERAM KYO GAK, V94, P1004
   Witfang J, 2005, INT J ORAL MAXILLOF, V34, P885
   Wood R M, 1988, Int J Oral Maxillofac Implants, V3, P209
   Yokoyama N, 1989, Nihon Shishubyo Gakkai Kaishi, V31, P213
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
   Zijderveld SA, 2009, CLIN ORAL IMPLAN RES, V20, P691, DOI [10.1111/j.1600-0501.2008.01697.x, 10.1111/j.1600-0501.2009.01697.x]
NR 25
TC 1
Z9 1
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2017
VL 26
IS 2
BP 275
EP 283
DI 10.1097/ID.0000000000000577
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ER4WK
UT WOS:000398802400016
PM 28301385
DA 2018-10-20
ER

PT J
AU Maciel, J
   Momesso, GAC
   Ramalho-Ferreira, G
   Consolaro, RB
   de Carvalho, PSP
   Faverani, LP
   Bassi, APF
AF Maciel, Juceleia
   Correa Momesso, Gustavo Antonio
   Ramalho-Ferreira, Gabriel
   Consolaro, Renata Bianco
   Perri de Carvalho, Paulo Sergio
   Faverani, Leonardo Perez
   Farnezi Bassi, Ana Paula
TI Bone Healing Evaluation in Critical-Size Defects Treated With Xenogenous
   Bone Plus Porcine Collagen
SO IMPLANT DENTISTRY
LA English
DT Article
DE biomaterials; critical defects; new bone formation; calvaria;
   histomorphometric
ID BIO-OSS COLLAGEN; BIO-OSS(R) COLLAGEN; EXTRACTION SOCKETS; REGENERATION;
   AUGMENTATION; BIOMATERIALS; IMMEDIATE; IMPLANTS; CALVARIA; THERAPY
AB Purpose:This study aimed to evaluate the osteoconductive features of Bio-Oss Collagen in large critical-size defects (8 mm).Materials and Methods:Thirty-six adult Wistar Albinus male adult rats were carried out a critical-size defect with a trephine bur of 8 mm in the calvaria. Groups were divided depending on the filling biomaterial as follows: group BO: Bio-Oss (n = 18); group BOC: Bio-Oss Collagen (n = 18). After 7, 30, and 60 days, 6 rats of each group were euthanized with anesthetic overdose. Specimens were laboratory processed for histomorphometric analysis. Histomorphometric data were statistically analyzed by analysis of variance and post-Tukey test (P < 0.05).Results:Statistical differences were found in new bone formation just in the intragroup comparison among periods after 7 and 60 postoperative days, indicating more new bone formation after 60 days (Tukey test, P = 0.029).Conclusion:Under the limitation of this research, it could be concluded that Bio-Oss and Bio-Oss Collagen in this experimental model did not show osteoconductive features.
C1 [Maciel, Juceleia; Correa Momesso, Gustavo Antonio; Ramalho-Ferreira, Gabriel; Perri de Carvalho, Paulo Sergio; Faverani, Leonardo Perez; Farnezi Bassi, Ana Paula] Univ Estadual Paulista UNESP, Aracatuba Dent Sch, Dept Surg & Integrated Clin, Rua Jose Bonifacio 1193, BR-16015050 Sao Paulo, Brazil.
   [Consolaro, Renata Bianco; Perri de Carvalho, Paulo Sergio] Fac Adamantinenses Integradas, Dept Oral Pathol, Sao Paulo, Brazil.
RP Momesso, GAC (reprint author), Univ Estadual Paulista UNESP, Aracatuba Dent Sch, Dept Surg & Integrated Clin, Rua Jose Bonifacio 1193, BR-16015050 Sao Paulo, Brazil.
EM gustavomomesso@gmail.com
OI Faverani, Leonardo/0000-0003-2249-3048
FU Foundation "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo"
   (FAPESP) [2013/06805-0, 2013/18339-4]; UNESP Foundation for Development
   (FUNDUNESP) (PROPE/FUNDUNESP) [2342-00214]
FX The authors thank the Foundation "Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo" (FAPESP) for funding this study through the
   scientific initiation scholarship (process number 2013/06805-0) and the
   regular aid in research (process number 2013/18339-4). They also thank
   the UNESP Foundation for Development (FUNDUNESP) for financial support
   (PROPE/FUNDUNESP process 2342-00214).
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Arias-Gallo J, 2013, J CRANIOFAC SURG, V24, P1, DOI 10.1097/SCS.0b013e31828f2469
   Borie E, 2011, ANN ANAT, V193, P412, DOI 10.1016/j.aanat.2011.06.003
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   de Avila ED, 2014, J PERIODONTAL IMPLAN, V44, P33, DOI 10.5051/jpis.2014.44.1.33
   DeNicolo PJ, 2015, J ORAL IMPLANTOL, V41, P543, DOI 10.1563/AAID-JOI-D-12-00075
   deOliveira E, 2012, INT J BIOMATER, V2012
   Furlaneto FAC, 2007, CLIN ORAL IMPLAN RES, V18, P311, DOI 10.1111/j.1600-0501.2006.01331.x
   Gokhale Shankar T, 2012, J Indian Soc Periodontol, V16, P247, DOI 10.4103/0972-124X.99270
   Handschel J, 2009, J BIOMATER APPL, V23, P549, DOI 10.1177/0885328208094305
   Heinemann F, 2012, ANN ANAT, V194, P508, DOI 10.1016/j.aanat.2011.11.012
   Kato E, 2014, CLIN IMPLANT DENT R, V16, P202, DOI 10.1111/j.1708-8208.2012.00467.x
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Kruger J, 1992, Zentralbl Neurochir, V53, P33
   Liu Jie, 2014, Open Dent J, V8, P56, DOI 10.2174/1874210601408010056
   Lundgren S, 1996, Int J Oral Maxillofac Implants, V11, P760
   Nagata MJH, 2013, J PHOTOCH PHOTOBIO B, V121, P6, DOI 10.1016/j.jphotobiol.2013.01.013
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Penarrocha-Oltra D, 2012, INT J ORAL MAX IMPL, V27, P604
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Rohner D, 2013, INT J ORAL MAX SURG, V42, P585, DOI 10.1016/j.ijom.2012.10.024
   Tovar N, 2014, INT J ORAL MAX SURG, V43, P251, DOI 10.1016/j.ijom.2013.07.005
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Twardowski T, 2007, CURR PHARM DESIGN, V13, P3608, DOI 10.2174/138161207782794176
   Vahabi Surena, 2012, Chang Gung Med J, V35, P28
NR 27
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2017
VL 26
IS 2
BP 296
EP 302
DI 10.1097/ID.0000000000000572
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ER4WK
UT WOS:000398802400019
PM 28288022
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
   Chapon, P
   Prima, F
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steinar
   Chapon, Patrick
   Prima, Frederic
TI Development of copper-enriched porous coatings on ternary Ti-Nb-Zr alloy
   by plasma electrolytic oxidation
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE Plasma electrolytic oxidation (PEO); Micro arc oxidation (MAO); Titanium
   ternary Ti-Nb-Zr alloy; SEM; XPS; GDOES; Porous coating
ID AISI 316L SS; NANOCRYSTALLINE TITANIA FILMS; OXIDE COATINGS; SURFACE
   MODIFICATION; CORROSION BEHAVIOR; SILICATE SOLUTIONS; ZIRCONIUM ALLOY;
   TI-6AL-4V ALLOY; XPS ANALYSIS; ALUMINUM
AB In this paper, a preparation method and characteristics of porous coatings enriched in copper distributed in the whole volume on a ternary Ti-Nb-Zr alloy biomaterial obtained by plasma electrolytic oxidation (PEO) in an electrolyte containing H3PO4 within Cu(NO3)(2) at potentials of 180 and 450 V are presented. It has been shown that the PEO potential has impact on the thickness of the coatings, i.e., the higher the potential used, the thicker the coating obtained. Using XPS study, it was shown that copper inside the coating appears as Cu+ and Cu2+ ions, while titanium, niobium, and zirconium appear as Ti4+, Nb5+, and Zrx+ (x <= 2), respectively. It was also found that the roughness of PEO coating formed at 450 V is higher than the one obtained at 180 V, and it is well correlated with bigger pores after the PEO treatment. Additionally, in this paper two PEO coating models composed of three sub-layers are presented. The thickness of the outer top porous sub-layer obtained after PEO oxidation at both 180 and 450 V equals to about 2 mu m, while the semi-porous as well as transition sub-layers are thicker after PEO processing at 450 V (5 mu m) than those obtained at 180 V (4 mu m thick). The creation of the top porous and transition compact sub-layer of PEO coating may be explained by switch-on and switch-off of the PEO potential, while the middle and semi-porous sub-layers are most likely formed during the stable voltage conditions of PEO treatment.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Dept Engn & Informat Syst, Div Bioengn & Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] Norwegian Univ Sci & Technol NTNU, Dept Phys, Realfagbygget E3-124 Hogskoleringen 5, NO-7491 Trondheim, Norway.
   [Chapon, Patrick] HORIBA Jobin Yvon SAS, 16-18,Rue Canal, F-91165 Longjumeau, France.
   [Prima, Frederic] PSL Res Univ, Chim ParisTech CNRS, Inst Rech Chim Paris, F-75005 Paris, France.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Dept Engn & Informat Syst, Div Bioengn & Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   steinar.raaen@ntnu.no; patrick.chapon@horiba.com;
   frederic.prima@chimie-paristech.fr
RI Hryniewicz, Tadeusz/N-3520-2018
CR [Anonymous], 42871999 EN ISO
   [Anonymous], 4768 DIN
   BABU U, 1990, J NUTR, V120, P1692
   Bajat JB, 2014, ACTA CHIM SLOV, V61, P308
   Bellows CG, 1999, CALCIFIED TISSUE INT, V65, P59, DOI 10.1007/s002239900658
   Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086
   Boffa AB, 1994, THESIS
   Casa Software Ltd, 2009, CASAXPS PROC SOFTW X
   Chen YP, 2009, FLUID PHASE EQUILIBR, V275, P33, DOI 10.1016/j.fluid.2008.09.009
   Cheng YL, 2013, ELECTROCHIM ACTA, V107, P358, DOI 10.1016/j.electacta.2013.06.022
   Curran JA, 2011, T I MET FINISH, V89, P295, DOI 10.1179/174591911X13188464808830
   Dehnavi V., 2014, THESIS
   Dehnavi V, 2014, SURF COAT TECH, V251, P106, DOI 10.1016/j.surfcoat.2014.04.010
   Dehnavi V, 2013, SURF COAT TECH, V226, P100, DOI 10.1016/j.surfcoat.2013.03.041
   DOLLWET H., 2012, TRACE ELEM MED, V2, P80
   Han Y, 2002, SURF COAT TECH, V154, P314, DOI 10.1016/S0257-8972(02)00036-1
   Han Y, 2002, MATER LETT, V56, P744, DOI 10.1016/S0167-577X(02)00606-7
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2008, MATER LETT, V62, P3073, DOI 10.1016/j.matlet.2008.01.130
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   HRYNIEWICZ T, 1994, SURF COAT TECH, V64, P75, DOI 10.1016/S0257-8972(09)90006-8
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2007, SURFACE TREATMENT ME
   Hryniewicz T, 2013, INT LETT CHEM PHYS A, V23, P98, DOI 10.18052/www.scipress.com/ILCPA.23.98
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hussein RO, 2012, MATER CHEM PHYS, V134, P484, DOI 10.1016/j.matchemphys.2012.03.020
   Hussein R.O., 2014, MAT SCI APPL, V5, P124
   Hussein R.O., 2013, CORROS MAT, V38, P55
   Ismail M, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-45
   KLAPKIV MD, 1994, MATER SCI+, V30, P333
   Krzakala A, 2014, ARCH METALL MATER, V59, P199, DOI 10.2478/amm-2014-0032
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Kusnerova M, 2013, MEAS SCI REV, V13, P1, DOI 10.2478/msr-2013-0007
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1137, DOI 10.1016/j.msec.2010.06.011
   Liang J, 2009, ELECTROCHIM ACTA, V54, P3842, DOI 10.1016/j.electacta.2009.02.004
   Matykina E, 2010, SURF COAT TECH, V204, P2142, DOI 10.1016/j.surfcoat.2009.11.042
   Norlin A, 2005, Porous niobium oxide as electrode material and manufacturing process, Patent No. [US 20090292346:A1, 20090292346]
   Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953
   Petkovic M, 2011, APPL SURF SCI, V257, P10590, DOI 10.1016/j.apsusc.2011.07.055
   Petkovic M., 2012, SERB J ELECT ENG, V9, P81
   Pulsed RF Glow Discharge Optical Emission Spectrometry-Ultra Fast Elemental Depth Profiling, 2014, GLOW DISCHARGE OPTIC
   Rodenbucher CH, 2014, THESIS AACHEN U, P79
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Rokosz K, 2015, ADV MATER SCI, V15, P21, DOI 10.1515/adms-2015-0004
   Rokosz K., 2015, MECHANIK, V12, P15, DOI DOI 10.17814/MECHANIK.2015.12.530
   Rokosz K., 2012, ELECTROCHEMICAL POLI
   Rokosz K., 2016, WORLD SCI NEWS, V35, P44
   Rokosz K, 2016, INT J ADV MANUF TECH, V87, P3497, DOI 10.1007/s00170-016-8692-3
   Rokosz K, 2016, J NANOSCI NANOTECHNO, V16, P7814, DOI 10.1166/jnn.2016.12558
   Rokosz K, 2016, INT J ADV MANUF TECH, V85, P2425, DOI 10.1007/s00170-015-8086-y
   Rokosz K, 2015, SURF COAT TECH, V276, P516, DOI 10.1016/j.surfcoat.2015.06.022
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Rokosz R, 2015, TEH VJESN, V22, P415, DOI 10.17559/TV-20140722110711
   Simka W., 2013, HABILITATION SUMMARY, P1
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Soutourina O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000894
   Sowa M, 2014, J SOLID STATE ELECTR, V18, P3129, DOI 10.1007/s10008-013-2341-7
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   StatSoft Inc, 2014, STAT DAT AN SOFTW SY
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Valicek J, 2012, MEAS SCI REV, V12, P184, DOI 10.2478/v10048-012-0028-3
   Wagner C.D., 2003, NIST STANDARD REFERE
   Walsh FC, 2009, T I MET FINISH, V87, P122, DOI 10.1179/174591908X372482
   Wang CC, 2016, APPL SURF SCI, V361, P190, DOI 10.1016/j.apsusc.2015.11.133
   Wang YM, 2005, MATER CHEM PHYS, V90, P128, DOI 10.1016/j.matchemphys.2004.10.025
   White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201
   WINSHIP KA, 1988, ADVERSE DRUG REACT T, V7, P19
   Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108
   Xue WB, 2010, MATER CHEM PHYS, V120, P656, DOI 10.1016/j.matchemphys.2009.12.012
   Yang H, 2009, CERAM INT, V35, P1595, DOI 10.1016/j.ceramint.2008.09.012
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Zhang JY, 2013, MAT SCI ENG A-STRUCT, V563, P78, DOI 10.1016/j.msea.2012.11.045
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
   Zhu W, 2013, J MATER SCI TECHNOL, V29, P237, DOI 10.1016/j.jmst.2012.12.015
NR 86
TC 8
Z9 8
U1 7
U2 39
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-3768
EI 1433-3015
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD APR
PY 2017
VL 89
IS 9-12
BP 2953
EP 2965
DI 10.1007/s00170-016-9206-z
PG 13
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA ER6NT
UT WOS:000398922700035
OA Other Gold
DA 2018-10-20
ER

PT J
AU Haase, T
   Krost, A
   Sauter, T
   Kratz, K
   Peter, J
   Kamann, S
   Jung, F
   Lendlein, A
   Zohlnhofer, D
   Ruder, C
AF Haase, Tobias
   Krost, Annalena
   Sauter, Tilman
   Kratz, Karl
   Peter, Jan
   Kamann, Stefanie
   Jung, Friedrich
   Lendlein, Andreas
   Zohlnhoefer, Dietlind
   Rueder, Constantin
TI In vivo biocompatibility assessment of poly (ether imide) electrospun
   scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE poly(ether imide); in vivo study; electrospun scaffold; capsule
   formation; foreign body giant cells; vascularization
ID FOREIGN-BODY REACTION; ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX;
   HOLLOW-FIBER; MEMBRANES; TISSUE; VIABILITY; ADHESION; VITRO;
   POLYETHERIMIDE
AB Poly(ether imide) (PEI), which can be chemically functionalized with biologically active ligands, has emerged as a potential biomaterial for medical implants. Electrospun PEI scaffolds have shown advantageous properties, such as enhanced endothelial cell adherence, proliferation and low platelet adhesion in in vitro experiments. In this study, the in vivo behaviour of electrospun PEI scaffolds and PEI films was examined in a murine subcutaneous implantation model. Electrospun PEI scaffolds and films were surgically implanted subcutaneously in the dorsae of mice. The surrounding subcutaneous tissue response was examined via histopathological examination at 7 and 28days after implantation. No serious adverse events were observed for both types of PEI implants. The presence of macrophages or foreign body giant cells in the vicinity of the implants and the formation of a fibrous capsule indicated a normal foreign body reaction towards PEI films and scaffolds. Capsule thickness and inflammatory infiltration cells significantly decreased for PEI scaffolds during days 7-28 while remaining unchanged for PEI films. The infiltration of cells into the implant was observed for PEI scaffolds 7days after implantation and remained stable until 28days of implantation. Additionally some, but not all, PEI scaffold implants induced the formation of functional blood vessels in the vicinity of the implants. Conclusively, this study demonstrates the in vivo biocompatibility of PEI implants, with favourable properties of electrospun PEI scaffolds regarding tissue integration and wound healing. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Haase, Tobias; Krost, Annalena; Sauter, Tilman; Kratz, Karl; Peter, Jan; Kamann, Stefanie; Jung, Friedrich; Lendlein, Andreas; Zohlnhoefer, Dietlind; Rueder, Constantin] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Sauter, Tilman; Kratz, Karl; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Haase, Tobias; Kamann, Stefanie; Zohlnhoefer, Dietlind; Rueder, Constantin] Charite, Campus Virchow Klinikum, Dept Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Sauter, Tilman; Lendlein, Andreas] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.
RP Haase, T (reprint author), Charite, Campus Virchow Klinikum, Dept Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM tobias_haase@hotmail.com
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670
FU Berlin-Brandenburg School for Regenerative Therapies [DFG-GSC 203]
FX We are grateful to Y. Pieper for acquisition of the SEM images and to M.
   Heister and C. Heide for analysis of the PEI scaffolds, R. Jeziorski for
   the preparation of PEI films and M. Keller for surface analysis of the
   PEI scaffolds and films. The animal trial number, as approved by the
   Landesamt fur Gesundheit und Soziales (LaGeSo), was G 0175_10. T. Sauter
   is grateful to Berlin-Brandenburg School for Regenerative Therapies for
   a fellowship (Grant No. DFG-GSC 203).
CR Albrecht W, 2007, J MEMBRANE SCI, V292, P145, DOI 10.1016/j.memsci.2007.01.027
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P225, DOI 10.1007/978-0-387-98161-1_11
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   Bat E, 2013, MACROMOL BIOSCI, V13, P573, DOI 10.1002/mabi.201200373
   Bosetti M, 2012, J TISSUE ENG REGEN M, V6, P205, DOI 10.1002/term.416
   Braune S, 2013, CLIN HEMORHEOL MICRO, V54, P235, DOI 10.3233/CH-131729
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Burugapalli K, 2014, MACROMOL BIOSCI, V14, P244, DOI 10.1002/mabi.201300195
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   Collet G, 2014, MOL CANCER THER, V13, P165, DOI 10.1158/1535-7163.MCT-13-0637
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Dimitrievska S, 2011, MACROMOL BIOSCI, V11, P13, DOI 10.1002/mabi.201000268
   Ercolani E, 2015, J TISSUE ENG REGEN M, V9, P861, DOI 10.1002/term.1697
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Kawakami H, 1997, ASAIO J, V43, pM490
   Kim SB, 2013, J BIOMED MATER RES A, V101, P1708, DOI 10.1002/jbm.a.34474
   KNEIFEL K, 1992, J MEMBRANE SCI, V65, P295, DOI 10.1016/0376-7388(92)87030-2
   Kratz K, 2011, INT J ARTIF ORGANS, V34, P225, DOI 10.5301/IJAO.2011.6404
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Neffe AT, 2013, MACROMOL BIOSCI, V13, P1720, DOI 10.1002/mabi.201300309
   Peinemann KV, 1998, POLYMER, V39, P3411, DOI 10.1016/S0032-3861(97)10067-2
   PELUSO G, 1994, J MATER SCI-MATER M, V5, P738, DOI 10.1007/BF00120367
   Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Rizvi MS, 2012, ACTA BIOMATER, V8, P4111, DOI 10.1016/j.actbio.2012.07.025
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Ruder C, 2012, CLIN HEMORHEOL MICRO, V50, P101, DOI 10.3233/CH-2011-1447
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Scharnagl N, 2012, CLIN HEMORHEOL MICRO, V52, P295, DOI 10.3233/CH-2012-1606
   Schneider T, 2012, CLIN HEMORHEOL MICRO, V52, P325, DOI 10.3233/CH-2012-1608
   Schulz C, 2012, CLIN HEMORHEOL MICRO, V52, P267, DOI 10.3233/CH-2012-1604
   Seifert B, 2002, ARTIF ORGANS, V26, P189, DOI 10.1046/j.1525-1594.2002.06876.x
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stieglitz T, 1999, Med Device Technol, V10, P28
   Sundararaghavan HG, 2010, MACROMOL BIOSCI, V10, P265, DOI 10.1002/mabi.200900363
   Tzoneva R, 2008, J MATER SCI-MATER M, V19, P3203, DOI 10.1007/s10856-008-3456-8
   Tzoneva R, 2008, J BIOMAT SCI-POLYM E, V19, P837, DOI 10.1163/156856208784613523
   Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
NR 53
TC 4
Z9 4
U1 4
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2017
VL 11
IS 4
BP 1034
EP 1044
DI 10.1002/term.2002
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA ER5BC
UT WOS:000398815300008
PM 25712330
DA 2018-10-20
ER

PT J
AU Gabbai-Armelin, PR
   Souza, MT
   Kido, HW
   Tim, CR
   Bossini, PS
   Fernandes, KR
   Magri, AMP
   Parizotto, NA
   Fernandes, KPS
   Mesquita-Ferrari, RA
   Ribeiro, DA
   Zanotto, ED
   Peitl, O
   Renno, ACM
AF Gabbai-Armelin, P. R.
   Souza, M. T.
   Kido, H. W.
   Tim, C. R.
   Bossini, P. S.
   Fernandes, K. R.
   Magri, A. M. P.
   Parizotto, N. A.
   Fernandes, K. P. S.
   Mesquita-Ferrari, R. A.
   Ribeiro, D. A.
   Zanotto, E. D.
   Peitl, O.
   Renno, A. C. M.
TI Characterization and biocompatibility of a fibrous glassy scaffold
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biocompatibility; biomaterial; bioactive glass; fibrous scaffold; bone
   repair; cytotoxicity
ID BIOACTIVE GLASS; IN-VITRO; CERAMIC SCAFFOLDS; CALCIUM-PHOSPHATE; BLOOD
   PERMEABILITY; FIBROBLAST CELLS; GROWTH; VIVO; GENOTOXICITY; COMPOSITES
AB Bioactive glasses (BGs) are known for their ability to bond to living bone and cartilage. In general, they are readily available in powder and monolithic forms, which are not ideal for the optimal filling of bone defects with irregular shapes. In this context, the development of BG-based scaffolds containing flexible fibres is a relevant approach to improve the performance of BGs. This study is aimed at characterizing a new, highly porous, fibrous glassy scaffold and evaluating its in vitro and in vivo biocompatibility. The developed scaffolds were characterized in terms of porosity, mineralization and morphological features. Additionally, fibroblast and osteoblast cells were seeded in contact with extracts of the scaffolds to assess cell proliferation and genotoxicity after 24, 72 and 144 h. Finally, scaffolds were placed subcutaneously in rats for 15, 30 and 60 days. The scaffolds presented interconnected porous structures, and the precursor bioglass could mineralize a hydroxyapatite (HCA) layer in simulated body fluid (SBF) after only 12 h. The biomaterial elicited increased fibroblast and osteoblast cell proliferation, and no DNA damage was observed. The in vivo experiment showed degradation of the biomaterial over time, with soft tissue ingrowth into the degraded area and the presence of multinucleated giant cells around the implant. At day 60, the scaffolds were almost completely degraded and an organized granulation tissue filled the area. The results highlight the potential of this fibrous, glassy material for bone regeneration, due to its bioactive properties, non-cytotoxicity and biocompatibility. Future investigations should focus on translating these findings to orthotopic applications. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.] Fed Univ Sao Carlos UFSCar, Postgrad Programme Biotechnol, Sao Carlos, SP, Brazil.
   [Souza, M. T.; Zanotto, E. D.; Peitl, O.] Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab LaMaV, Dept Mat Engn, Sao Carlos, SP, Brazil.
   [Bossini, P. S.; Fernandes, K. R.; Magri, A. M. P.; Ribeiro, D. A.; Renno, A. C. M.] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Ave Ana Costa 95, BR-11050240 Santos, SP, Brazil.
   [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.; Parizotto, N. A.] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Sao Carlos, SP, Brazil.
   [Fernandes, K. P. S.; Mesquita-Ferrari, R. A.] Nove de Julho Univ UNINOVE, Dept Rehabil Sci & Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil.
RP Renno, ACM (reprint author), Fed Univ Sao Paulo UNIFESP, Dept Biosci, Ave Ana Costa 95, BR-11050240 Santos, SP, Brazil.
EM a.renno@unifesp.br
RI Zanotto, Edgar/A-7992-2011; CerTEV, CeRTEV/J-6817-2015
OI Zanotto, Edgar/0000-0003-4931-4505; Tim, Carla/0000-0002-4745-9375;
   Kido, Hueliton/0000-0001-8554-432X
FU CAPES; CNPq [303662/2012-3]; FAPESP, the Sao Paulo Research Funding
   Agency; Centre for Research Technology and Education in Vitreous
   Materials (CeRTEV) [2013/07793-6]; FAPESP [2011/22937-9]
FX The authors are indebted to CAPES, CNPq (Grant No. 303662/2012-3),
   FAPESP, the Sao Paulo Research Funding Agency, the Centre for Research
   Technology (Grant No. 2013/07793-6) and Education in Vitreous Materials
   (CeRTEV) for funding this research work. M.T.S. thanks FAPESP for
   student Grant No. 2011/22937-9.
CR Akazawa T, 2006, J BIOMED MATER RES A, V76A, P44, DOI 10.1002/jbm.a.30439
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0
   Baino F, 2014, MATER LETT, V118, P27, DOI 10.1016/j.matlet.2013.12.037
   Bretcanu O, 2014, J BIOMATER APPL, V28, P1287, DOI 10.1177/0885328213506759
   Brown RF, 2008, ACTA BIOMATER, V4, P387, DOI 10.1016/j.actbio.2007.07.006
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Claes L, 2007, PROG BIOPHYS MOL BIO, V93, P384, DOI 10.1016/j.pbiomolbio.2006.07.021
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Franca R, 2014, J COLLOID INTERF SCI, V420, P182, DOI 10.1016/j.jcis.2013.12.055
   Gautier E, 2003, INJURY, V34, P63, DOI 10.1016/j.injury.2003.09.026
   Ghasemi-Mobarakeh L, 2007, J APPL POLYM SCI, V106, P2536, DOI 10.1002/app.26949
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hench L.L., 2013, INTRO BIOCERAMICS, V620
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hubbell J.A., 1998, CURR OPIN SOLID ST M, V3, P4
   ISO IOFS, 2003, BIOL EV MED DEV 3, P10993
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kido HW, 2013, J BIOMED MATER RES A, V101, P667, DOI 10.1002/jbm.a.34360
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lacroix J, 2014, CHEM ENG J, V256, P9, DOI 10.1016/j.cej.2014.06.022
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Liu WN, 2012, J BIOMATER APPL, V27, P171, DOI 10.1177/0885328211398507
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Mirhadi SM, 2014, J ALLOY COMPD, V610, P399, DOI 10.1016/j.jallcom.2014.05.032
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Moimas L, 2006, ACTA BIOMATER, V2, P191, DOI 10.1016/j.actbio.2005.09.006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Murata M, 2007, J BIOMED MATER RES B, V81B, P469, DOI 10.1002/jbm.b.30686
   Naghavi N, 2014, DENT MATER J, V33, P64, DOI 10.4012/dmj.2013-123
   Narayan R., 2009, SCANNING ELECT MICRO
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Pelaez A, 2005, KEY ENG MAT, V284-286, P593, DOI 10.4028/www.scientific.net/KEM.284-286.593
   Radetzki F, 2011, BIO-MED MATER ENG, V21, P307, DOI 10.3233/BME-2012-0678
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Renno ACM, 2013, ACTA BIOMATER, V9, P5728, DOI 10.1016/j.actbio.2012.11.009
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Serrano MC, 2008, TISSUE ENG PT A, V14, P617, DOI 10.1089/tea.2007.0205
   Souza MT, 2013, Patent Application, Patent No. [BR 10 2013 020961 9, 1020130209619]
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P135, DOI 10.1177/088391103033857
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Xie ZP, 2009, J BIOMED MATER RES B, V90B, P195, DOI 10.1002/jbm.b.31273
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang JZ, 2014, INT J APPL CERAM TEC, V11, P22, DOI 10.1111/ijac.12024
NR 56
TC 4
Z9 4
U1 5
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2017
VL 11
IS 4
BP 1141
EP 1151
DI 10.1002/term.2017
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA ER5BC
UT WOS:000398815300018
PM 25712803
DA 2018-10-20
ER

PT J
AU Chameettachal, S
   Murab, S
   Vaid, R
   Midha, S
   Ghosh, S
AF Chameettachal, Shibu
   Murab, Sumit
   Vaid, Radhika
   Midha, Swati
   Ghosh, Sourabh
TI Effect of visco-elastic silk-chitosan microcomposite scaffolds on matrix
   deposition and biomechanical functionality for cartilage tissue
   engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE silk; chitosan; cartilage; tissue engineering; visco-elastic;
   extracellular matrix
ID MESENCHYMAL STEM-CELLS; INFRARED-SPECTROSCOPY; MECHANICAL-PROPERTIES;
   ARTICULAR-CARTILAGE; IN-VITRO; FIBROIN; CHONDROCYTES; CONSTRUCTS;
   DIFFERENTIATION; BIOMATERIALS
AB Commonly used polymer-based scaffolds often lack visco-elastic properties to serve as a replacement for cartilage tissue. This study explores the effect of reinforcement of silk matrix with chitosan microparticles to create a visco-elastic matrix that could support the redifferentiation of expanded chondrocytes. Goat chondrocytes produced collagen type II and glycosaminoglycan (GAG)-enriched matrix on all the scaffolds (silk:chitosan 1:1, 1:2 and 2:1). The control group of silk-only constructs suffered from leaching out of GAG molecules into the medium. Chitosan-reinforced scaffolds retained a statistically significant (p<0.02) higher amount of GAG, which in turn significantly increased (p<0.005) the aggregate modulus (as compared to silk-only controls) of the construct akin to that of native tissue. Furthermore, the microcomposite constructs demonstrated highly pronounced hysteresis at 4% strain up to 400cycles, mimicking the visco-elastic properties of native cartilage tissue. These results demonstrated a step towards optimizing the design of biomaterial scaffolds used for cartilage tissue engineering. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Chameettachal, Shibu; Murab, Sumit; Vaid, Radhika; Midha, Swati; Ghosh, Sourabh] Indian Inst Technol, Dept Text Technol, Delhi, India.
RP Ghosh, S (reprint author), Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
EM sghosh08@textile.iitd.ac.in
OI /0000-0003-0295-5356
FU Department of Biotechnology, Government of India
   [BT/PR/10662/MED/32/26/2008]
FX This study was supported by the Department of Biotechnology, Government
   of India (BT/PR/10662/MED/32/26/2008).
CR da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Augst A, 2008, J R SOC INTERFACE, V5, P929, DOI 10.1098/rsif.2007.1302
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhattacharjee M, 2015, ADV DRUG DELIVER REV, V84, P107, DOI 10.1016/j.addr.2014.08.010
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]
   Das S, 2013, BIOMACROMOLECULES, V14, P311, DOI 10.1021/bm301193t
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   Edelsten L, 2010, SOFT MATTER, V6, P5206, DOI 10.1039/c0sm00097c
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fernandez JG, 2012, ADV MATER, V24, P480, DOI 10.1002/adma.201104051
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   KWAN MK, 1984, ANN BIOMED ENG, V12, P537, DOI 10.1007/BF02371448
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LARK MW, 1995, J BIOL CHEM, V270, P2550, DOI 10.1074/jbc.270.6.2550
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Ma GP, 2008, CARBOHYD POLYM, V74, P121, DOI 10.1016/j.carbpol.2008.01.028
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Maurstad G, 2007, BIOMACROMOLECULES, V8, P1124, DOI 10.1021/bm0610119
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Moulharat N, 2004, OSTEOARTHR CARTILAGE, V12, P296, DOI 10.1016/j.joca.2003.11.009
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Murab S, 2013, TISSUE ENG PT A, V19, P1733, DOI [10.1089/ten.TEA.2012.0385, 10.1089/ten.tea.2012.0385]
   Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005
   Niamsa N, 2009, CARBOHYD POLYM, V78, P60, DOI 10.1016/j.carbpol.2009.04.003
   Park S, 2008, ANN BIOMED ENG, V36, P425, DOI 10.1007/s10439-007-9431-6
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Skaalure SC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024111
   SUH JK, 1995, J BIOMECH, V28, P357, DOI 10.1016/0021-9290(94)00103-B
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sztrolovics R, 2002, BIOCHEM J, V362, P465, DOI 10.1042/0264-6021:3620465
   Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Varga F, 2007, PHYSIOL RES, V56, pS61
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yan LP, 2015, ACTA BIOMATER, V12, P227, DOI 10.1016/j.actbio.2014.10.021
   Yang J, 2013, ACS APPL MATER INTER, V5, P3199, DOI 10.1021/am4001997
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
NR 57
TC 4
Z9 4
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2017
VL 11
IS 4
BP 1212
EP 1229
DI 10.1002/term.2024
PG 18
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA ER5BC
UT WOS:000398815300024
PM 25846347
DA 2018-10-20
ER

PT J
AU Pinheiro, ALB
   Soares, LGP
   Marques, AMC
   Cangussu, MCT
   Pacheco, MTT
   Silveira, L
AF Barbosa Pinheiro, Antonio Luiz
   Pinheiro Soares, Luiz Guilherme
   Cordeiro Marques, Aparecida Maria
   Teixeira Cangussu, Maria Cristina
   Tavares Pacheco, Marcos Tadeu
   Silveira, Landulfo, Jr.
TI Biochemical changes on the repair of surgical bone defects grafted with
   biphasic synthetic micro-granular HA plus beta-tricalcium phosphate
   induced by laser and LED phototherapies and assessed by Raman
   spectroscopy
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; Laser and LED phototherapy; Biochemical assay;
   Raman spectroscopy
ID MORPHOGENETIC PROTEINS; RODENT MODEL; IN-VIVO; LAMBDA-850 NM;
   REGENERATION; LIGHT; RATS; PHOTOBIOMODULATION; HYDROXYAPATITE; TISSUES
AB This work aimed the assessment of biochemical changes induced by laser or LED irradiation during mineralization of a bone defect in an animal model using a spectral model based on Raman spectroscopy. Six groups were studied: clot, laser (lambda = 780 nm; 70 mW), LED (lambda = 850 +/- 10 nm; 150 mW), biomaterial (biphasic synthetic micro-granular hydroxyapatite (HA) + beta-tricalcium phosphate), biomaterial + laser, and biomaterial + LED. When indicated, defects were further irradiated at a 48-h interval during 2 weeks (20 J/cm(2) per session). At the 15th and 30th days, femurs were dissected and spectra of the defects were collected. Raman spectra were submitted to a model to estimate the relative amount of collagen, phosphate HA, and carbonate HA by using the spectra of pure collagen and biomaterials composed of phosphate and carbonate HA, respectively. The use of the biomaterial associated to phototherapy did not change the collagen formation at both 15 and 30 days. The amount of carbonate HA was not different in all groups at the 15th day. However, at the 30th day, there was a significant difference (ANOVA, p = 0.01), with lower carbonate HA for the group biomaterial + LED compared to biomaterial (p < 0.05). The phosphate HA was higher in the groups that received biomaterial grafts at the 15th day compared to clot (significant for the biomaterial; p < 0.01). At the 30th day, the phosphate HA was higher for the group biomaterial + laser, while this was lower for all the other groups. These results indicated that the use of laser phototherapy improved the repair of bone defects grafted with the biomaterial by increasing the deposition of phosphate HA.
C1 [Barbosa Pinheiro, Antonio Luiz; Pinheiro Soares, Luiz Guilherme; Cordeiro Marques, Aparecida Maria; Teixeira Cangussu, Maria Cristina] Fed Univ Bahia UFBA, Sch Dent, Ctr Biophoton, Ave Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
   [Barbosa Pinheiro, Antonio Luiz; Cordeiro Marques, Aparecida Maria] Univ Sao Paulo, Phys Inst Sao Carlos, Natl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.
   [Barbosa Pinheiro, Antonio Luiz; Tavares Pacheco, Marcos Tadeu; Silveira, Landulfo, Jr.] UAM, CITE, Parque Tecnol Sao Jose dos Campos, BR-12247016 Sao Jose Dos Campos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Fed Univ Bahia UFBA, Sch Dent, Ctr Biophoton, Ave Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.; Pinheiro, ALB (reprint author), Univ Sao Paulo, Phys Inst Sao Carlos, Natl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.; Pinheiro, ALB (reprint author), UAM, CITE, Parque Tecnol Sao Jose dos Campos, BR-12247016 Sao Jose Dos Campos, SP, Brazil.
EM albp@ufba.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; Silveira,
   Landulfo/I-2474-2012; Pacheco, Marcos/B-7991-2012
OI Silveira, Landulfo/0000-0002-6616-3334; Pacheco,
   Marcos/0000-0002-1725-4803
FU CNPq (Brazilian National Counsel of Technological and Scientific
   Development); FAPESP (Sao Paulo Research Foundation) [2009/01788-5,
   2015/24040-7]
FX The authors would like to thank the CNPq (Brazilian National Counsel of
   Technological and Scientific Development) and FAPESP (Sao Paulo Research
   Foundation-nos. 2009/01788-5 and 2015/24040-7) for the financial support
   that allowed this research.
CR Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Boivin G, 2003, OSTEOPOROSIS INT, V14, pS19, DOI 10.1007/s00198-002-1347-2
   Brennan JF, 1997, CIRCULATION, V96, P99
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho FB, 2011, P SOC PHOTO-OPT INS, V7887, DOI DOI 10.1117/12.874288
   Aciole JMD, 2014, LASER MED SCI, V29, P1269, DOI 10.1007/s10103-013-1509-9
   Haka AS, 2006, CANCER RES, V66, P3317, DOI 10.1158/0008-5472.CAn-05-2815
   Hanlon B, 2000, PHYS MED BIOL, V45, pR1
   Kalfas HI, 2001, NEUROSURG FOCUS, V10
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Krafft EC, 2012, J BIOMED OPT, V17
   LeGeros RZ, 1991, MONOGRAPHS ORAL SCI, V15, P82
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Moler C. B., 2008, NUMERICAL COMPUTING
   Moreira LM, 2008, SPECTROSC-INT J, V22, P1, DOI 10.3233/SPE-2008-0326
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Okagbare PI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090502
   Pence I, 2016, CHEM SOC REV, V45, P1958, DOI 10.1039/c5cs00581g
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 2003, DENT MED PROBL, V40, P37
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   PINHEIRO ALB, 2001, LASER THER, V13, P73
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2014, J PHOTOCH PHOTOBIO B, V138, P146, DOI 10.1016/j.jphotobiol.2014.05.022
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Silveira L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077003
   Soares Luiz Guilherme P., 2015, Braz. Dent. J., V26, P19, DOI 10.1590/0103-6440201300055
   Soares LGP, 2014, LASER MED SCI, V29, P1927, DOI 10.1007/s10103-014-1601-9
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Stone N, 2007, ANAL BIOANAL CHEM, V387, P1657, DOI 10.1007/s00216-006-0937-9
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   de Castro ICV, 2014, LASER MED SCI, V29, P1607, DOI 10.1007/s10103-014-1562-z
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Yamada K, 1991, J JPN ORTHOP ASSOC, V65, P101
NR 45
TC 3
Z9 3
U1 2
U2 6
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD APR
PY 2017
VL 32
IS 3
BP 663
EP 672
DI 10.1007/s10103-017-2165-2
PG 10
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA ER3RU
UT WOS:000398716200021
PM 28188497
DA 2018-10-20
ER

PT J
AU Sjollema, J
   Keul, H
   van der Mei, H
   Dijkstra, R
   Rustema-Abbing, M
   de Vries, J
   Loontjens, T
   Dirks, T
   Busscher, H
AF Sjollema, Jelmer
   Keul, Heidrun
   van der Mei, Henny
   Dijkstra, Rene
   Rustema-Abbing, Minie
   de Vries, Joop
   Loontjens, Ton
   Dirks, Ton
   Busscher, Henk
TI A Trifunctional, Modular Biomaterial Coating: Nonadhesive to Bacteria,
   Chlorhexidine-Releasing and Tissue-Integrating
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE antimicrobial; biomaterial; coating; infection; polymer brush; release;
   tissue integration
ID PROTEIN ADSORPTION; CELL-ADHESION; IN-VITRO; SURFACES; ANTIBIOTICS;
   INFECTIONS; IMPLANTS; ANTISEPTICS; STRATEGIES; INTEGRINS
AB Various potential anti-infection strategies can be thought of for biomaterial implants and devices. Permanent, tissue-integrated implants such as artificial joint prostheses require a different anti-infection strategy than, for instance, removable urinary catheters. The different requirements set to biomaterials implants and devices in different clinical applications call for tailor-made strategies. Here, a modular coating-concept for biomaterials is reported, which in its full, trifunctional form comprises nonadhesiveness to bacteria and antimicrobial release, combined with enhanced tissue integration characteristics. Nonadhesiveness to proteins and bacteria is accomplished by a hydrophilic brush coating (Vitrostealth). The antimicrobial release module is constituted by a chlorhexidine releasing poly(ethylene glycol) diacrylamide based-coating that continues to release its antimicrobial content also when underneath the nonadhesive top-coating. The third module, enhancing tissue integration, is realized by the incorporation of the penta-peptide Glycine-Arginine-Glycine-Aspartic acid-Serine (GRGDS) within the nonadhesive top-coating. Modules function in concert or independently of each other. Specifically, tissue integration by the GRGDS-module does not affect the nonadhesiveness of the Vitrostealth-module toward bovine serum albumin and Staphylococcus aureus, while the antimicrobial release module does not affect tissue-integration by the GRGDS-module. Uniquely, using this modular system, tailor-made anti-infection strategies can thus readily be made for biomaterials in different clinical applications.
C1 [Sjollema, Jelmer; van der Mei, Henny; Dijkstra, Rene; Rustema-Abbing, Minie; de Vries, Joop; Busscher, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   [Sjollema, Jelmer; van der Mei, Henny; Dijkstra, Rene; Rustema-Abbing, Minie; de Vries, Joop; Busscher, Henk] Univ Groningen, Univ Med Ctr Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   [Keul, Heidrun; Loontjens, Ton] DSM Res & Patents, POB 18, NL-6160 MD Geleen, Netherlands.
   [Loontjens, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
   [Dirks, Ton] Trobas Gelatine BV, Steenstr 9, NL-5107 NE Dongen, Netherlands.
RP Sjollema, J (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.; Sjollema, J (reprint author), Univ Groningen, Univ Med Ctr Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM j.sjollema@umcg.nl
FU NANTICO of the research program of the BioMedical Materials institute
   [P4.01]; Dutch Ministry of Economic Affairs
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Materials institute, cofunded by the Dutch
   Ministry of Economic Affairs. H.B. is also director of a consulting
   company SASA BV. Opinions and assertions contained herein are those of
   the authors and are not construed as necessarily representing views of
   the funding organization or their respective employer(s).
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Banks MK, 1992, BIOFOULING, V6, P81
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Domingues JFD, 2015, ACTA BIOMATER, V18, P1, DOI 10.1016/j.actbio.2015.02.028
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Geurts JAP, 2013, ACTA ORTHOP, V84, P509, DOI 10.3109/17453674.2013.858288
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   Gon S, 2012, MACROMOLECULES, V45, P8373, DOI 10.1021/ma300981r
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holmes PF, 2009, J BIOMED MATER RES A, V91A, P824, DOI 10.1002/jbm.a.32285
   Holmes P. F., 2005, POLYM PREPR, V46, P6
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   Kempf M, 2011, BURNS, V37, P994, DOI 10.1016/j.burns.2011.03.017
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Moriarty TF, 2014, EUR CELLS MATER, V28, P112, DOI 10.22203/eCM.v028a09
   Muszanska AK, 2012, ANTIMICROB AGENTS CH, V56, P4961, DOI 10.1128/AAC.00431-12
   Pavlukhina S, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.63
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
NR 33
TC 4
Z9 4
U1 6
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2017
VL 17
IS 4
AR 1600336
DI 10.1002/mabi.201600336
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA ER6CB
UT WOS:000398891200018
PM 27759333
DA 2018-10-20
ER

PT J
AU Stoll, H
   Steinle, H
   Stang, K
   Kunnakattu, S
   Scheideler, L
   Neumann, B
   Kurz, J
   Degenkolbe, I
   Perle, N
   Schlensak, C
   Wendel, HP
   Avci-Adali, M
AF Stoll, Heidi
   Steinle, Heidrun
   Stang, Katharina
   Kunnakattu, Silju
   Scheideler, Lutz
   Neumann, Bernd
   Kurz, Julia
   Degenkolbe, Ilka
   Perle, Nadja
   Schlensak, Christian
   Wendel, Hans Peter
   Avci-Adali, Meltem
TI Generation of Large-Scale DNA Hydrogels with Excellent Blood and Cell
   Compatibility
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE cytocompatibility; DNA hydrogel; hemocompatibility; tissue engineering
ID ROLLING CIRCLE AMPLIFICATION; GROWTH-FACTOR; IN-VIVO; MORPHOLOGY;
   SCAFFOLD; DELIVERY; RELEASE; MATRIX; ACID
AB Hemocompatibility and cytocompatibility of biomaterials codetermine the success of tissue engineering applications. DNA, the natural component of our cells, is an auspicious biomaterial for the generation of designable scaffolds with tailorable characteristics. In this study, a combination of rolling circle amplification and multiprimed chain amplification is used to generate hydrogels at centimeter scale consisting solely of DNA. Using an in vitro rotation model and fresh human blood, the reaction of the hemostatic system on DNA hydrogels is analyzed. The measurements of hemolysis, platelets activation, and the activation of the complement, coagulation, and neutrophils using enzyme-linked immunosorbent assays demonstrate excellent hemocompatibility. In addition, the cytocompatibility of the DNA hydrogels is tested by indirect contact (agar diffusion tests) and material extract experiments with L929 murine fibroblasts according to the ISO 10993-5 specifications and no negative impact on the cell viability is detected. These results indicate the promising potential of DNA hydrogels as biomaterials for versatile applications in the field of regenerative medicine.
C1 [Stoll, Heidi; Steinle, Heidrun; Stang, Katharina; Kunnakattu, Silju; Neumann, Bernd; Kurz, Julia; Degenkolbe, Ilka; Perle, Nadja; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem] Univ Hosp Tuebingen, Dept Thorac & Cardiovasc Surg, Calwerstr 7-1, D-72076 Tubingen, Germany.
   [Scheideler, Lutz] Univ Hosp Tuebingen, Dept Thorac & Cardiovasc Surg, Sect Med Mat Sci & Technol, Osianderstr 2-8, D-72076 Tubingen, Germany.
RP Avci-Adali, M (reprint author), Univ Hosp Tuebingen, Dept Thorac & Cardiovasc Surg, Calwerstr 7-1, D-72076 Tubingen, Germany.
EM meltem.avci-adali@uni-tuebingen.de
FU European Social Funds in Baden-Wuerttemberg, Germany; MWK-BW, Germany;
   Baden-Wurttemberg Stiftung [BioMatS-05]
FX The authors would like to thank Professor Dan Luo and Dr. Songming Peng
   for the supportive information concerning DNA hydrogel optimization.
   Cornelia Fuger and Evi Kimmerle-Muller are appreciated for laboratory
   support. Furthermore, the authors thank Professor Andreas Marx and
   Professor Christof M. Niemeyer for providing expertise. For SEM-EDX
   analyses, the authors would like to thank Professor Ulrich Schraermeyer
   and Dr. Antje Biesemeier (Core Facility for Electron Microscopy at the
   Center for Ophthalmology, University Hospital Tubingen,) and Professor
   Oliver Eibl (Institute of Applied Physics, University of Tubingen).
   Furthermore, the authors thank Professor Thilo Stehle and Joana Tavares
   Macedo (Interfaculty Institute of Biochemistry, University of Tubingen)
   for performing CD spectroscopy analyses. This study was funded by the
   European Social Funds in Baden-Wuerttemberg, Germany, the MWK-BW,
   Germany, and the Baden-Wurttemberg Stiftung BioMatS-05.
CR Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971
   [Anonymous], 2002, BIOL EVALUATION ME 4
   [Anonymous], 2009, BIOL EVALUATION ME 5
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   Calo E, 2015, EUR POLYM J, V65, P252, DOI 10.1016/j.eurpolymj.2014.11.024
   Cheng EJ, 2011, CHEM COMMUN, V47, P5545, DOI 10.1039/c1cc11028d
   Cheng EJ, 2009, ANGEW CHEM INT EDIT, V48, P7660, DOI 10.1002/anie.200902538
   Crassous JJ, 2005, J RHEOL, V49, P851, DOI 10.1122/1.1917843
   Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501
   Floren M, 2016, ACTA BIOMATER, V31, P156, DOI 10.1016/j.actbio.2015.11.051
   Jaiswal MK, 2015, COLLOID SURFACE B, V136, P625, DOI 10.1016/j.colsurfb.2015.09.058
   Jin J, 2013, ADV MATER, V25, P4714, DOI 10.1002/adma.201301175
   Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Klar AS, 2016, PEDIATR SURG INT, V32, P17, DOI 10.1007/s00383-015-3808-7
   Kowalczewski CJ, 2015, ACTA BIOMATER, V25, P109, DOI 10.1016/j.actbio.2015.07.045
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7
   Lee JB, 2009, NAT NANOTECHNOL, V4, P430, DOI [10.1038/nnano.2009.93, 10.1038/NNANO.2009.93]
   Li C, 2015, ADV MATER, V27, P3298, DOI 10.1002/adma.201501102
   Li C, 2015, ANGEW CHEM INT EDIT, V54, P3957, DOI 10.1002/anie.201411383
   Li C, 2015, SMALL, V11, P1138, DOI 10.1002/smll.201401906
   Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s
   Meng QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17802
   Mori H, 2016, J BIOSCI BIOENG, V121, P584, DOI 10.1016/j.jbiosc.2015.09.010
   Nakajima K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133308
   Ni YL, 2015, INT J BIOL MACROMOL, V74, P367, DOI 10.1016/j.ijbiomac.2014.10.058
   Nishikawa M, 2014, J CONTROL RELEASE, V180, P25, DOI 10.1016/j.jconrel.2014.02.001
   Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046
   Previtera M. L., 2014, JOVE-J VIS EXP, P51323
   Reppel L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0263-2
   Roh YH, 2011, CHEM SOC REV, V40, P5730, DOI 10.1039/c1cs15162b
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Shen YI, 2015, J INVEST DERMATOL, V135, P2519, DOI 10.1038/jid.2015.182
   Sridharan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141479
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Thankam FG, 2014, CARBOHYD POLYM, V112, P235, DOI 10.1016/j.carbpol.2014.05.083
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   Umeki Y, 2015, ADV FUNCT MATER, V25, P5758, DOI 10.1002/adfm.201502139
   Van Hove AH, 2015, J CONTROL RELEASE, V217, P191, DOI 10.1016/j.jconrel.2015.09.005
   van Oeveren W, 2013, SCIENTIFICA, V2013
   Wang ZG, 2013, ADV MATER, V25, P3905, DOI 10.1002/adma.201301450
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Wu YZ, 2014, CHEM COMMUN, V50, P14620, DOI 10.1039/c4cc07144a
   Xiang J, 2015, MAT SCI ENG C-MATER, V50, P274, DOI 10.1016/j.msec.2015.01.089
   Xiong XL, 2013, MACROMOL RAPID COMM, V34, P1271, DOI 10.1002/marc.201300411
   Yang DY, 2014, ACCOUNTS CHEM RES, V47, P1902, DOI 10.1021/ar5001082
   Yang DY, 2010, WIRES NANOMED NANOBI, V2, P648, DOI 10.1002/wnan.111
   Yata T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14979
   Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274
   Zhou X, 2016, CHEM COMMUN, V52, P10668, DOI 10.1039/c6cc04724f
NR 51
TC 2
Z9 3
U1 3
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2017
VL 17
IS 4
AR 1600252
DI 10.1002/mabi.201600252
PG 13
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA ER6CB
UT WOS:000398891200019
PM 27758025
DA 2018-10-20
ER

PT J
AU Zhang, PF
   Liu, G
   Chen, XY
AF Zhang, Pengfei
   Liu, Gang
   Chen, Xiaoyuan
TI Nanobiotechnology: Cell membrane-based delivery systems
SO NANO TODAY
LA English
DT Article
DE Nanobiotechnology; Nanovesicles; Biomaterial; Bio-inspired synthesis;
   Cell membrane
ID DRUG-DELIVERY; MIMETIC NANOVESICLES; NANOPARTICLES; VACCINATION;
   PLATFORM; CARRIERS
AB The increasingly rapid pace of research in the field of bioinspired drug delivery systems is revealing the promise of cell membrane-based nanovesicles for biomedical applications. Those cell membrane-based nanoparticles combine the natural functionalities of cell plasma membranes and the bioengineering flexibility of synthetic nanomaterials, and such versatility provides a means of designing exciting new drug formulations for personalized treatment in future nanomedicine. Published by Elsevier Ltd.
C1 [Zhang, Pengfei; Liu, Gang] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China.
   [Zhang, Pengfei; Liu, Gang] Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361102, Peoples R China.
   [Liu, Gang] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Biol, Sch Life Sci, Xiamen 361102, Peoples R China.
   [Liu, Gang] Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China.
   [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA.
RP Liu, G; Chen, XY (reprint author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China.; Liu, G; Chen, XY (reprint author), Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361102, Peoples R China.
EM gangliu.cmitm@xmu.edu.cn; Shawn.Chen@nih.gov
FU MOST of China [2014CB744503, 2013CB733802]; NSFC [81422023, 81371596,
   51273165, U1505221]; Program for New Century Excellent Talents in
   University [NCET-13-0502]; Fundamental Research Funds for the Central
   Universities, China [20720150206, 20720150141]; Intramural Research
   Program, National Institute of Biomedical Imaging and Bioengineering,
   National Institutes of Health
FX This work was supported by the MOST of China (2014CB744503 and
   2013CB733802), the NSFC under Grant No. 81422023, 81371596, 51273165,
   and U1505221, the Program for New Century Excellent Talents in
   University (NCET-13-0502), the Fundamental Research Funds for the
   Central Universities, China (20720150206 and 20720150141), and the
   Intramural Research Program, National Institute of Biomedical Imaging
   and Bioengineering, National Institutes of Health.
CR Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u
   Furman NET, 2013, NANO LETT, V13, P3248, DOI 10.1021/nl401376w
   Grinthal A, 2012, NANO TODAY, V7, P35, DOI 10.1016/j.nantod.2011.12.005
   Hildebrand A, 2002, LANGMUIR, V18, P2836, DOI 10.1021/la011421c
   Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Jang SC, 2013, ACS NANO, V7, P7698, DOI 10.1021/nn402232g
   Lu Y, 2012, NANO TODAY, V7, P297, DOI 10.1016/j.nantod.2012.06.011
   Meyer RA, 2015, TRENDS BIOTECHNOL, V33, P514, DOI 10.1016/j.tibtech.2015.07.001
   Sealy C, 2006, NANO TODAY, V1, P1
   Shi JH, 2014, P NATL ACAD SCI USA, V111, P10131, DOI 10.1073/pnas.1409861111
   Somiya M, 2015, ADV DRUG DELIVER REV, V95, P77, DOI 10.1016/j.addr.2015.10.003
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Zhang PF, 2015, P NATL ACAD SCI USA, V112, pE6129, DOI 10.1073/pnas.1505799112
NR 16
TC 15
Z9 15
U1 9
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-0132
EI 1878-044X
J9 NANO TODAY
JI Nano Today
PD APR
PY 2017
VL 13
BP 7
EP 9
DI 10.1016/j.nantod.2016.10.008
PG 3
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA ES3QZ
UT WOS:000399445400006
PM 28435439
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Seghier, A
   Hadjel, M
   Benderdouche, N
AF Seghier, A.
   Hadjel, M.
   Benderdouche, N.
TI Adsorption Study of Heavy Metal and Acid Dye on an Amphoteric
   Biomaterial Using Barbary Fig Skin
SO ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING
LA English
DT Article
DE Adsorption; Amphoteric biomaterial; Heavy metals; Dye; Wastewater
ID ACTIVATED CARBON; CONGO RED; AQUEOUS-SOLUTION; CHEMICAL ACTIVATION;
   NATURAL ZEOLITE; REMOVAL; SORPTION; WATER; COPPER; WASTE
AB In this paper, Barbary fig skin was used which is a natural adsorbent and is low cost, without any chemical or physical activation that causes loss of energy and mass and use of large amount of water for rinsing. The product was characterized by SEM, energy-dispersive X-ray, (NMRC)-C-13, and FTIR spectroscopy. In addition, physicochemical parameters to know the iodine value, pH((ZPC)), and distribution of functional groups on the surface were determined. The material obtained was then used for the treatment of water contaminated by zinc released by zinc plating industrial activities and by an acid red dye (CR) from the textile industry. The results obtained after the study of kinetics, sorption isotherms, the effect of pH, mass and thermodynamic quantities show good efficiency in view of the large sorption capacity to the two treated pollutants (Q(max-Zn) = 129.87 mg g(-1), Q(max-CR) = 151.51 mg g(-1)). The results found in the course of this study show that the surface of the prepared material has an amphoteric character with the presence of cavities. Freundlich parameters confirm that the adsorption of both pollutants was favorable. The sorption capacity results were compared with those of other adsorbents cited in the literature.
C1 [Seghier, A.; Hadjel, M.] Univ Sci & Technol Mohamed BOUDIAF Oran, Fac Sci, Dept Chim Organ Ind, Lab Sci Technol & Genie Procedes, BP 1505,El Mnaouar, Oran 31000, Algeria.
   [Seghier, A.] Ctr Univ Ahmed ZABANA, Inst Sci Exactes & Sci Vie, BP 48000, Relizane, Algeria.
   [Benderdouche, N.] Univ Mostaganem, BP 227, Mostaganem, Algeria.
RP Seghier, A (reprint author), Univ Sci & Technol Mohamed BOUDIAF Oran, Fac Sci, Dept Chim Organ Ind, Lab Sci Technol & Genie Procedes, BP 1505,El Mnaouar, Oran 31000, Algeria.; Seghier, A (reprint author), Ctr Univ Ahmed ZABANA, Inst Sci Exactes & Sci Vie, BP 48000, Relizane, Algeria.
EM krimouvert@yahoo.fr
CR Aguayo-Villarreal IA, 2011, CHEM ENG J, V167, P67, DOI 10.1016/j.cej.2010.11.107
   Amran Muhammad Bachri, 2010, International Journal of Environmental Studies, V67, P911, DOI 10.1080/00207233.2010.528256
   Annadurai G, 2003, WATER SCI TECHNOL, V47, P185
   Aziz A, 2009, J HAZARD MATER, V163, P441, DOI 10.1016/j.jhazmat.2008.06.117
   Barka N, 2013, J TAIWAN INST CHEM E, V44, P52, DOI 10.1016/j.jtice.2012.09.007
   Belaroui K, 2014, DESALIN WATER TREAT, V52, P1422, DOI 10.1080/19443994.2013.789404
   Binupriya AR, 2008, BIORESOURCE TECHNOL, V99, P1080, DOI 10.1016/j.biortech.2007.02.022
   Boehm H. P., 1966, ADV CATAL, V16, P179, DOI DOI 10.1016/S0360-0564(08)60354-5
   Booth SC, 2011, METALLOMICS, V3, P1142, DOI 10.1039/c1mt00070e
   Chatterjee S, 2009, BIORESOURCE TECHNOL, V100, P2803, DOI 10.1016/j.biortech.2008.12.035
   Chen H, 2009, ADSORPTION, V15, P381, DOI 10.1007/s10450-009-9155-z
   Daoud M., 2014, REV ENERGIES RENOUVE, V14, P155
   Esmi CF, 2014, J ENVIRON CHEM ENG, V2, P1705, DOI 10.1016/j.jece.2014.06.009
   Farinella NV, 2007, BIORESOURCE TECHNOL, V98, P1940, DOI 10.1016/j.biortech.2006.07.043
   Galiatsatou P, 2002, J HAZARD MATER, V91, P187, DOI 10.1016/S0304-3894(02)00008-0
   Gouda AA, 2016, FOOD CHEM, V202, P409, DOI 10.1016/j.foodchem.2016.02.006
   Haddad M. E., 2013, J ASS ARAB U BASIC A, V14, P51
   Hasar H, 2003, ADSORPT SCI TECHNOL, V21, P799, DOI 10.1260/02636170360744056
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   IBARRA JV, 1991, J ANAL APPL PYROL, V20, P171, DOI 10.1016/0165-2370(91)80071-F
   Ihsanullah, 2016, SEP PURIF TECHNOL, V157, P141, DOI 10.1016/j.seppur.2015.11.039
   Issabayeva G., 2011, WORLD ACAD SCI ENG T, V5, P279
   Jayaraj RP, 2011, J CHEM PHARM RES, V3, P389
   Kalyani G., 2009, ARPN J ENG APPL SCI, V4, P39
   Khan MN, 2007, J HAZARD MATER, V141, P237, DOI 10.1016/j.jhazmat.2006.06.119
   Khare P, 2016, CHEM ENG J, V293, P44, DOI 10.1016/j.cej.2016.02.049
   Khormaei M, 2007, J HAZARD MATER, V149, P269, DOI 10.1016/j.jhazmat.2007.03.074
   Larous S, 2012, ENRGY PROCED, V18, P915, DOI 10.1016/j.egypro.2012.05.106
   Li FT, 2007, CHINESE CHEM LETT, V18, P325, DOI 10.1016/j.cclet.2007.01.034
   Liu C, 2011, TALANTA, V84, P766, DOI 10.1016/j.talanta.2011.02.006
   Liu C, 2009, ANAL CHIM ACTA, V641, P59, DOI 10.1016/j.aca.2009.03.027
   Liu H, 2013, J ANAL APPL PYROL, V102, P7, DOI 10.1016/j.jaap.2013.04.010
   Liu H, 2013, J ANAL APPL PYROL, V101, P156, DOI 10.1016/j.jaap.2013.01.016
   Liu H, 2012, CHEM ENG J, V209, P155, DOI 10.1016/j.cej.2012.07.132
   Lu CY, 2006, CHEM ENG SCI, V61, P1138, DOI 10.1016/j.ces.2005.08.007
   Mahmoodi NM, 2011, DESALINATION, V272, P187, DOI 10.1016/j.desal.2011.01.023
   Markovska LT, 2006, J SERB CHEM SOC, V71, P957, DOI 10.2298/JSC0609957M
   MCKAY G, 1982, J CHEM TECHNOL BIOT, V32, P759
   MCKAY G, 1979, AM DYEST REP, V68, P29
   Memon GZ, 2008, CHEM ENG J, V138, P616, DOI 10.1016/j.cej.2007.09.027
   Monday M., 2011, REP OPIN, V3, P41
   Morais SAL, 1999, J BRAZIL CHEM SOC, V10, P447, DOI 10.1590/S0103-50531999000600005
   Morris K, 2005, AUST J CHEM, V58, P237, DOI 10.1071/CH05038
   Mumin MA, 2007, INT J ENVIRON SCI TE, V4, P525, DOI 10.1007/BF03325990
   Namane A, 2005, J HAZARD MATER, V119, P189, DOI 10.1016/j.jhazmat.2004.12.006
   Namasivayam C, 2002, DYES PIGMENTS, V54, P47, DOI 10.1016/S0143-7208(02)00025-6
   Nowicki P, 2015, POWDER TECHNOL, V269, P312, DOI 10.1016/j.powtec.2014.09.023
   Pasco N, 2004, BIOSENS BIOELECTRON, V20, P524, DOI 10.1016/j.bios.2004.02.016
   Pasco N, 2001, BIOMARKERS, V6, P83, DOI 10.1080/135475001452832
   Pasco N, 2008, INT J ENVIRON AN CH, V88, P1063, DOI 10.1080/03067310802248028
   Patil A. K., 2010, International Journal of ChemTech Research, V2, P842
   Peric J, 2004, WATER RES, V38, P1893, DOI 10.1016/j.watres.2003.12.035
   Rengaraj S, 2002, J HAZARD MATER, V92, P185, DOI 10.1016/S0304-3894(02)00018-3
   Sakr F., 2015, J MAT ENV SCI, V6, P397
   Shrestha S, 2013, CHEMOSPHERE, V92, P1053, DOI 10.1016/j.chemosphere.2013.02.068
   Smaranda C, 2011, INT J ENVIRON RES, V5, P177
   Tizzard A, 2004, ANAL CHIM ACTA, V522, P197, DOI 10.1016/j.aca.2004.05.010
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Wang L, 2008, J HAZARD MATER, V160, P173, DOI 10.1016/j.jhazmat.2008.02.104
   Yong DM, 2011, ANAL CHIM ACTA, V701, P164, DOI 10.1016/j.aca.2011.06.044
   Yong DM, 2011, TALANTA, V84, P7, DOI 10.1016/j.talanta.2010.11.012
   Zhang ZY, 2011, CHEM ENG J, V178, P122, DOI 10.1016/j.cej.2011.10.024
   Zhao X, 2002, WATER RES, V36, P851, DOI 10.1016/S0043-1354(01)00289-5
   Zhu JZ, 2009, CARBON, V47, P2014, DOI 10.1016/j.carbon.2009.03.047
   Zulfikar M. A., 2013, International Journal of ChemTech Research, V5, P1532
NR 65
TC 2
Z9 2
U1 1
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2193-567X
EI 2191-4281
J9 ARAB J SCI ENG
JI Arab. J. Sci. Eng.
PD APR
PY 2017
VL 42
IS 4
BP 1487
EP 1496
DI 10.1007/s13369-016-2360-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ1CO
UT WOS:000397807100013
DA 2018-10-20
ER

PT J
AU Westphal, I
   Jedelhauser, C
   Liebsch, G
   Wilhelmi, A
   Aszodi, A
   Schieker, M
AF Westphal, Ines
   Jedelhauser, Claudia
   Liebsch, Gregor
   Wilhelmi, Arnd
   Aszodi, Attila
   Schieker, Matthias
TI Oxygen mapping: Probing a novel seeding strategy for bone tissue
   engineering
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE bone tissue engineering; mesenchymal stem cells; 3D scaffolds; oxygen
   measurement; time point of harvest; cell density
ID MARROW STROMAL CELLS; LONG-TERM CULTURES; STEM-CELLS; OSTEOGENIC
   DIFFERENTIATION; PERFUSION BIOREACTOR; FUTURE-DIRECTIONS; CONSUMPTION;
   SENESCENCE; SYSTEMS; HYPOXIA
AB Bone tissue engineering (BTE) utilizing biomaterial scaffolds and human mesenchymal stem cells (hMSCs) is a promising approach for the treatment of bone defects. The quality of engineered tissue is crucially affected by numerous parameters including cell density and the oxygen supply. In this study, a novel oxygen-imaging sensor was introduced to monitor the oxygen distribution in three dimensional (3D) scaffolds in order to analyze a new cell-seeding strategy. Immortalized hMSCs, pre-cultured in a monolayer for 30-40% or 70-80% confluence, were used to seed demineralized bone matrix (DBM) scaffolds. Real-time measurements of oxygen consumption in vitro were simultaneously performed by the novel planar sensor and a conventional needle-type sensor over 24h. Recorded oxygen maps of the novel planar sensor revealed that scaffolds, seeded with hMSCs harvested at lower densities (30-40% confluence), exhibited rapid exponential oxygen consumption profile. In contrast, harvesting cells at higher densities (70-80% confluence) resulted in a very slow, almost linear, oxygen decrease due to gradual achieving the stationary growth phase. In conclusion, it could be shown that not only the seeding density on a scaffold, but also the cell density at the time point of harvest is of major importance for BTE. The new cell seeding strategy of harvested MSCs at low density during its log phase could be a useful strategy for an early in vivo implantation of cell-seeded scaffolds after a shorter in vitro culture period. Furthermore, the novel oxygen imaging sensor enables a continuous, two-dimensional, quick and convenient to handle oxygen mapping for the development and optimization of tissue engineered scaffolds. Biotechnol. Bioeng. 2017;114: 894-902. (c) 2016 Wiley Periodicals, Inc.
C1 [Westphal, Ines; Jedelhauser, Claudia; Aszodi, Attila; Schieker, Matthias] Ludwig Maximillians Univ Munich, Expt Surg & Regenerat Med, Dept Gen Trauma & Reconstruct Surg, Nussbaumstr 20, D-80336 Munich, Germany.
   [Westphal, Ines; Schieker, Matthias] LivImplant GmbH, Starnberg, Germany.
   [Liebsch, Gregor] PreSens Precis Sensing GmbH, Regensburg, Germany.
   [Wilhelmi, Arnd] Tutogen Med GmbH, Neunkirchen, Germany.
RP Westphal, I; Schieker, M (reprint author), Ludwig Maximillians Univ Munich, Expt Surg & Regenerat Med, Dept Gen Trauma & Reconstruct Surg, Nussbaumstr 20, D-80336 Munich, Germany.; Westphal, I; Schieker, M (reprint author), LivImplant GmbH, Starnberg, Germany.
EM ines.westphal@med.uni-muenchen.de; matthias.schieker@med.uni-muenchen.de
OI Schieker, Matthias/0000-0002-1230-3653
FU Bayerische Forschungsstiftung
FX Contract grant sponsor: Bayerische Forschungsstiftung
CR Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Balint R, 2015, J TISSUE ENG REGEN M, V9, P1200, DOI 10.1002/term.2051
   Benjamin S, 2013, TISSUE ENG PT A, V19, P748, DOI [10.1089/ten.tea.2012.0298, 10.1089/ten.TEA.2012.0298]
   Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Ceccarelli Gabriele, 2013, Recent Pat Drug Deliv Formul, V7, P29
   Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI [10.1055/s-0029-1215875.ISSN1943-3875, 10.1055/s-0029-1215875]
   Fayaz HC, 2011, INT ORTHOP, V35, P1587, DOI 10.1007/s00264-011-1338-z
   Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700
   Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072
   Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1
   Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI [10.3727/0963689109X546562, 10.3727/096368910X546562]
   Hofmann J, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/4/045002
   Janssen FW, 2006, J BIOMED MATER RES A, V79A, P338, DOI 10.1002/jbm.a.30794
   Janssen FW, 2010, J TISSUE ENG REGEN M, V4, P12, DOI 10.1002/term.197
   Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556
   Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363
   Kim M, 2012, MECH AGEING DEV, V133, P215, DOI 10.1016/j.mad.2012.03.014
   Korompilias AV, 2011, MICROSURG, V31, P223, DOI 10.1002/micr.20837
   Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005
   Meier JK, 2012, CLIN HEMORHEOL MICRO, V50, P13, DOI 10.3233/CH-2011-1439
   Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Ochs CJ, 2014, LAB CHIP, V14, P459, DOI 10.1039/c3lc51160j
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Pederson WC, 2007, ORTHOP CLIN N AM, V38, P23, DOI 10.1016/j.ocl.2006.10.006
   Polzer H, 2014, TISSUE ENG PART C-ME, V20, P11, DOI [10.1089/ten.tec.2012.0740, 10.1089/ten.TEC.2012.0740]
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630
   Santoro R, 2012, J TISSUE ENG REGEN M, V6, P696, DOI 10.1002/term.473
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Tschiersch H., 2011, MICROSENSORS, P281
   Tschiersch H, 2012, NEW PHYTOL, V196, P926, DOI 10.1111/j.1469-8137.2012.04295.x
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Volkmer E, 2010, TISSUE ENG PT A, V16, P153, DOI 10.1089/ten.TEA.2009.0021
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   Woertgen C, 2009, ADV EXP MED BIOL, V645, P167, DOI 10.1007/978-0-387-85998-9_26
   Xing Z, 2011, INT J ARTIF ORGANS, V34, P432, DOI 10.5301/IJAO.2011.8319
   YAMADA K, 1990, BIOTECHNOL BIOENG, V36, P759, DOI 10.1002/bit.260360715
   Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007
NR 44
TC 3
Z9 3
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD APR
PY 2017
VL 114
IS 4
BP 894
EP 902
DI 10.1002/bit.26202
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EM9SE
UT WOS:000395650600017
PM 27748516
OA Bronze
DA 2018-10-20
ER

PT J
AU Osmond, M
   Bernier, SM
   Pantcheva, MB
   Krebs, MD
AF Osmond, Matthew
   Bernier, Sarah M.
   Pantcheva, Mina B.
   Krebs, Melissa D.
TI Collagen and collagen-chondroitin sulfate scaffolds with uniaxially
   aligned pores for the biomimetic, three dimensional culture of
   trabecular meshwork cells
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE biomaterial; trabecular meshwork; in vitro model; glaucoma; collagen;
   scaffold
ID OUTFLOW PHYSIOLOGY; CROSS-LINKING; INNER WALL; GLAUCOMA; MYOCILIN;
   BIOLOGY; MATRIX; MODEL
AB Glaucoma is a disease in which damage to the optic nerve leads to progressive, irreversible vision loss. The intraocular pressure (IOP) is the only modifiable risk factor for glaucoma and its lowering is considered a useful strategy for preventing or slowing down the progression of glaucomatous neuropathy. Elevated intraocular pressure associated with glaucoma is due to increased aqueous humor outflow resistance, primarily through the trabecular meshwork (TM) of the eye. Current in vitro models of the trabecular meshwork are oversimplified and do not capture the organized and complex three-dimensional nature of this tissue that consists primarily of collagen and glycoasaminoglycans. In this work, collagen and collagen-chondroitin sulfate (CS) scaffolds were fabricated via unidirectional freezing and lyophilization to induce the formation of aligned pores. Scaffolds were characterized by scanning electron microscopy, dynamic mechanical analysis, and a chondroitin sulfate quantification assay. Scaffold characterization confirmed the formation of aligned pores, and also that the CS was leaching out of the scaffolds over time. Primary porcine trabecular meshwork (TM) cells were seeded onto the surface of scaffolds and their gene expression, proliferation, viability, migration into the scaffolds, and morphology were examined. The TM cells were viable and proliferated 2 weeks after seeding. The cells migrated down into the internal scaffold structure and their morphology reflected the topography and alignment of the scaffold structure. This work is a promising step toward the development of a three dimensional in vitro model of the TM that can be used for testing of glaucoma pharmacological agents in future experimentation and to better our understanding of the trabecular meshwork and its complex physiology. Biotechnol. Bioeng. 2017;114: 915-923. (c) 2016 Wiley Periodicals, Inc.
C1 [Osmond, Matthew; Bernier, Sarah M.; Krebs, Melissa D.] Colorado Sch Mines, Dept Chem & Biol Engn, 1613 Illinois St,431 Alderson Hall, Golden, CO 80401 USA.
   [Pantcheva, Mina B.] Univ Colorado Denver, Dept Ophthalmol, 1675 Aurora Court, Aurora, CO 80045 USA.
RP Krebs, MD (reprint author), Colorado Sch Mines, Dept Chem & Biol Engn, 1613 Illinois St,431 Alderson Hall, Golden, CO 80401 USA.; Pantcheva, MB (reprint author), Univ Colorado Denver, Dept Ophthalmol, 1675 Aurora Court, Aurora, CO 80045 USA.
EM mina.pantcheva@ucdenver.edu; mdkrebs@mines.edu
RI Krebs, Melissa/L-4878-2015
OI Krebs, Melissa/0000-0002-5170-7116
FU Colorado School of Mines; University of Colorado Denver
FX Contract grant sponsor: Colorado School of Mines and University of
   Colorado Denver
CR Abelson MB, 2013, REV OPHTHALMOL
   Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013
   Beidoe G, 2012, CLIN OPHTHALMOL, V6, P1699, DOI 10.2147/OPTH.S32933
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Camras LJ, 2012, INVEST OPHTH VIS SCI, V53, P5242, DOI [10.1167/iovs.12-9825a, 10.1167/iovs.12-9825]
   Choy ATH, 2013, ACTA BIOMATER, V9, P4661, DOI 10.1016/j.actbio.2012.09.016
   Chu ER, 2014, J OCUL PHARMACOL TH, V30, P191, DOI 10.1089/jop.2013.0190
   COLLINS JS, 1981, J HISTOCHEM CYTOCHEM, V29, P411, DOI 10.1177/29.3.6787116
   Dautriche CN, 2015, BIOMATERIALS, V65, P86, DOI 10.1016/j.biomaterials.2015.06.034
   Dautriche CN, 2014, BIOTECHNOL ADV, V32, P971, DOI 10.1016/j.biotechadv.2014.04.012
   Ellis Diane L, 1999, CONCISE POLYM MAT EN, P1415
   Gonzalez JM, 2013, INVEST OPHTH VIS SCI, V54, P1039, DOI 10.1167/iovs.12-10479
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117
   Johnson DH, 1996, INVEST OPHTH VIS SCI, V37, P1204
   Kim B, 2011, 15 INT C MIN SYST CH, P801
   Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360
   Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342
   Llobet A, 2003, NEWS PHYSIOL SCI, V18, P205, DOI 10.1152/nips.01443.2003
   Mckee CT, 2011, BIOMATERIALS, V32, P2417, DOI 10.1016/j.biomaterials.2010.11.071
   National Eye Institute, 2010, 2010 GLAUC OP ANGL
   Obazawa M, 2004, INVEST OPHTH VIS SCI, V45, P2652, DOI 10.1167/iovs.03-0572
   Overby DR, 2009, EXP EYE RES, V88, P656, DOI 10.1016/j.exer.2008.11.033
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224
   Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   SPENCER WH, 1968, INVEST OPHTH VISUAL, V7, P651
   Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P668
   Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007
   Torrejon KY, 2013, BIOTECHNOL BIOENG, V110, P3205, DOI 10.1002/bit.24977
   Trattler B, 2012, REV OPHTHALMOLOGY, P252
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Wood JA, 2011, INVEST OPHTH VIS SCI, V52, P9298, DOI 10.1167/iovs.11-7857
   YUE BYJT, 1984, EXP EYE RES, V38, P35, DOI 10.1016/0014-4835(84)90136-2
NR 38
TC 5
Z9 6
U1 2
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD APR
PY 2017
VL 114
IS 4
BP 915
EP 923
DI 10.1002/bit.26206
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EM9SE
UT WOS:000395650600019
PM 27775151
DA 2018-10-20
ER

PT J
AU Rodrigues, APH
   Pereira, IM
   de Souza, SD
   Gil, CSB
   Machado, G
   Carvalho, SM
   Pereira, FV
   Paiva, PRP
   de Oliveira, LCA
   Patricio, PSD
AF Rodrigues, Ana P. H.
   Pereira, Iaci M.
   de Souza, Samara D.
   Brey Gil, Camila S.
   Machado, Giovanna
   Carvalho, Sandhra M.
   Pereira, Fabiano V.
   Paiva, Paulo R. P.
   de Oliveira, Luiz C. A.
   Patricio, Patricia S. de O.
TI Control of properties of nanocomposites bio-based collagen and cellulose
   nanocrystals
SO CELLULOSE
LA English
DT Article
DE Cellulose nanocrystals; Collagen; Hydrophilicity; SAXS
ID CROSS-LINKING; COMPOSITES; FILMS; TRANSGLUTAMINASE; BIOCOMPATIBILITY;
   NANOWHISKERS; STABILITY; CHITOSAN
AB Collagen is an important biomaterial because it has many applications in the biomedical sector. However, the high hydrophilicity of collagen (COL) leads to easy swelling. Thus, controlling this property is highly desirable. In this work, cellulose nanocrystals (CNCs) dispersed in glycerol (GLI) were incorporated in the matrix collagen to tailor the hydrophilicity and mechanical properties. Study of the hydrophilicity of the bio-based nanocomposite was evaluated by contact angle measurement and thermo-gravimetric analysis. Mechanical analyses showed that CNCs are excellent reinforcing fillers to the collagen matrix. Synchrotron small-angle X-ray scattering was employed to investigate the nanostructures of COL/GLI/CNC nanocomposites and CNC water dispersion. CNC in concentrations up to 1 wt% presents an intermediate shape between a rod and a plane with a 9.34-nm radius of gyration (R-g). Biobased nanocomposites present two different structural levels with two types of particles with very different R(g)s. At the intermediate power-law regime, a large-scale mass fractal aggregate is observed. In the high-power-law regime, it is observed scattering from primary particles smaller than 1 nm. As the CNC concentration increases, the original particle distorts from a rod to a plate. The cytotoxicity assay indicates that the collagen and nanocomposites did not affect the cell viability of rat calvarial cells in vitro.
C1 [Rodrigues, Ana P. H.; Pereira, Fabiano V.; de Oliveira, Luiz C. A.] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
   [Pereira, Iaci M.] Brazilian Army Technol Ctr, Rio De Janeiro, Brazil.
   [de Souza, Samara D.; Patricio, Patricia S. de O.] Ctr Fed Educ Tecnol Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
   [Brey Gil, Camila S.; Carvalho, Sandhra M.] Univ Fed Minas Gerais, Dept Met Mat & Mines Engn, Belo Horizonte, MG, Brazil.
   [Machado, Giovanna] Ctr Tecnol Estrateg Nordeste Microscopia Eletron, Recife, PE, Brazil.
   [Paiva, Paulo R. P.] Ctr Fed Educ Tecnol Minas Gerais, Dept Mat Engn, Belo Horizonte, MG, Brazil.
RP Patricio, PSD (reprint author), Ctr Fed Educ Tecnol Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
EM patriciapatricio@des.cefetmg.br
RI Pereira, Iaci/J-2641-2014; Patricio, Patricia/I-3111-2013; Oliveira,
   Luiz Carlos/E-8376-2017; MACHADO, GIOVANNA/N-1217-2014
OI Pereira, Iaci/0000-0001-9595-1084; Oliveira, Luiz
   Carlos/0000-0003-4595-2753; MACHADO, GIOVANNA/0000-0002-9058-3056
CR Vieira MGA, 2011, EUR POLYM J, V47, P254, DOI 10.1016/j.eurpolymj.2010.12.011
   Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y
   Benhamou K, 2015, CARBOHYD POLYM, V122, P202, DOI 10.1016/j.carbpol.2014.12.081
   Borges JG, 2016, INT J BIOL MACROMOL, V86, P907, DOI 10.1016/j.ijbiomac.2016.01.089
   Caetano BL, 2011, J PHYS CHEM C, V115, P4404, DOI 10.1021/jp109585t
   de Mesquita JP, 2012, CARBOHYD POLYM, V90, P210, DOI 10.1016/j.carbpol.2012.05.025
   de Mesquita JP, 2011, SOFT MATTER, V7, P4405, DOI 10.1039/c0sm01168a
   Farrell HM, 2001, FOOD HYDROCOLLOID, V15, P341, DOI 10.1016/S0268-005X(01)00080-7
   Moraes PRFD, 2016, MATER RES-IBERO-AM J, V19, P106, DOI 10.1590/1980-5373-MR-2015-0249
   Fortunati E, 2013, J APPL POLYM SCI, V128, P3220, DOI 10.1002/app.38524
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Hirata E, 2011, CARBON, V49, P3284, DOI 10.1016/j.carbon.2011.04.002
   Homenick CM, 2010, J MATER CHEM, V20, P2887, DOI 10.1039/b925799c
   Hyeon-Lee J, 1998, LANGMUIR, V14, P5751, DOI 10.1021/la980308s
   Khan A, 2012, CARBOHYD POLYM, V90, P1601, DOI 10.1016/j.carbpol.2012.07.037
   Kluver E, 2013, J APPL POLYM SCI, V128, P4201, DOI 10.1002/app.38644
   KO YC, 1981, J COLLOID INTERF SCI, V82, P25, DOI 10.1016/0021-9797(81)90120-X
   Li N, 2016, COLLOID SURFACE B, V140, P287, DOI 10.1016/j.colsurfb.2015.12.005
   Li WC, 2014, J BIOMED MATER RES A, V102, P1131, DOI 10.1002/jbm.a.34792
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Nagalakshmaiah M, 2016, ACS APPL MATER INTER, V8, P8755, DOI 10.1021/acsami.6b01650
   OLMO N, 1987, BIOMATERIALS, V8, P67, DOI 10.1016/0142-9612(87)90033-0
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Pajot-augy E, 1992, EFFECT ORGANIC CRYOS, P179
   Pastorino L, 2011, J COLLOID INTERF SCI, V357, P56, DOI 10.1016/j.jcis.2011.02.010
   Patricio PSDO, 2013, J APPL POLYM SCI, V127, P3613, DOI 10.1002/app.37811
   Pereira IM, 2010, POLYMER, V51, P1744, DOI 10.1016/j.polymer.2010.02.037
   Pereira IM, 2011, MACROMOL SYMP, V299-300, P190, DOI 10.1002/masy.200900080
   Plepis AG, 1996, POLYM ENG SCI, V3, P3, DOI [10.1002/pen.10694, DOI 10.1002/PEN.10694]
   Ramachandran R, 2008, MACROMOLECULES, V41, P9802, DOI 10.1021/ma801775n
   Ramanen P, 2012, CELLULOSE, V19, P901, DOI 10.1007/s10570-012-9695-3
   Rivadeneira J, 2014, J APPL MICROBIOL, V116, P1438, DOI 10.1111/jam.12476
   Singh M, 2011, J NANOPART RES, V13, P69, DOI 10.1007/s11051-010-0001-8
   Stachel I, 2010, BIOMACROMOLECULES, V11, P698, DOI 10.1021/bm901284x
   Su DH, 2012, APPL CLAY SCI, V62-63, P41, DOI 10.1016/j.clay.2012.04.017
   Ten E, 2010, POLYMER, V51, P2652, DOI 10.1016/j.polymer.2010.04.007
   Wei WB, 2014, BIORESOURCES, V9, P6087
   Yang J, 2014, MACROMOLECULES, V47, P4077, DOI 10.1021/ma500729q
   Yousefi M, 2017, FOOD HYDROCOLLOID, V63, P372, DOI 10.1016/j.foodhyd.2016.09.029
NR 40
TC 1
Z9 1
U1 4
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD APR
PY 2017
VL 24
IS 4
BP 1731
EP 1744
DI 10.1007/s10570-017-1218-9
PG 14
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA EO6GD
UT WOS:000396789100011
DA 2018-10-20
ER

PT J
AU Stanton, J
   Xue, Y
   Waters, JC
   Lewis, A
   Cowan, D
   Hu, X
   la Cruz, DSD
AF Stanton, John
   Xue, Ye
   Waters, Joshua C.
   Lewis, Ashley
   Cowan, Darrel
   Hu, Xiao
   la Cruz, David Salas-de
TI Structure-property relationships of blended polysaccharide and protein
   biomaterials in ionic liquid
SO CELLULOSE
LA English
DT Article
DE Cellulose; Silk; X-ray scattering; Microfibril; beta-Sheets; Morphology
ID CELLULOSE CRYSTALLINE-STRUCTURE; REGENERATED SILK FIBROIN;
   X-RAY-SCATTERING; RHEOLOGICAL PROPERTIES; MECHANICAL-PROPERTIES; SPRUCE
   WOOD; FILMS; DISSOLUTION; MICROFIBRILS; PRETREATMENT
AB Cellulose and silk blended biomaterial films were regenerated from ionic liquid solution and investigated to characterize and understand the effect of inter- and intra-molecular interactions upon the morphology and thermal properties. The blended films were dissolved in 1-allyl-3-methylimidazolium chloride ionic liquid, coagulated and regenerated with water. Various characterization techniques were implemented to characterize structural, morphological and thermal properties: FTIR, SEM, TGA, DSC and X-ray scattering. The results showed that the cellulose microcrystalline structure and beta-sheets from the silk can be disrupted by inter- and intra-molecular hydrogen bonds forming intermediate semicrystalline or amorphous structures. The SEM showed morphological effects of such interactions that cause varying thermal degradation and glass transition temperature. The X-ray scattering confirms such findings at the molecular level, demonstrating that the cellulose microfibril diameter decreases as the silk content increases. It also shows that the beta-sheets size increases as the cellulose content increases. These various techniques provide evidence that suggest the hydrogen bonds between the beta-sheets and the glucose units in the cellulose chains control the thermal and structural properties of the blended films, changing the morphology and physicochemical properties.
C1 [Stanton, John; Cowan, Darrel; la Cruz, David Salas-de] Rutgers Univ Camden, Dept Chem, 315 Penn St, Camden, NJ 08102 USA.
   [Xue, Ye; Hu, Xiao] Rowan Univ, Dept Phys & Astron, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA.
   [Waters, Joshua C.; Lewis, Ashley] Rutgers Univ Camden, Dept Biol, 315 Penn St, Camden, NJ 08102 USA.
   [la Cruz, David Salas-de] Rutgers Univ Camden, Ctr Computat & Integrat Biol, 315 Penn St, Camden, NJ 08102 USA.
RP la Cruz, DSD (reprint author), Rutgers Univ Camden, Dept Chem, 315 Penn St, Camden, NJ 08102 USA.
EM david.salas@camden.rutgers.edu
OI Hu, Xiao/0000-0002-2579-2820
FU Rutgers University-Camden Laboratory Start-up funds; State of New Jersey
   ELF Grant; Rowan University Start-up Grants; NSF-MRI Program
   [DMR-1338014]; New Jersey Space Grant Consortium
FX We would like to acknowledge the funding provided by the Rutgers
   University-Camden Laboratory Start-up funds, and State of New Jersey ELF
   Grant to Rutgers-Chemistry. We would like to thank The LRSM at the
   University of Pennsylvania for allowing us to use the X-Ray Scattering
   equipment. Finally, we would like to thank Mr. Robert Kristin and Ms.
   Michel Ntiri for their assistant in preparing the films. The authors
   would like to thank Fang Wang for her initial support and assistance
   with DSC analysis. This study was also supported by the Rowan University
   Start-up Grants, NSF-MRI Program (DMR-1338014) and New Jersey Space
   Grant Consortium.
CR Abdul Khalil H. P. S., 2015, HDB POLYM NANOCOMPOS, P475, DOI [DOI 10.1007/978-3-642-45232-1_72, 10.1007/978-3-642-45232-1_72]
   Abdul KHP, 2014, CARBOHYD POLYM, V99, P649, DOI DOI 10.1016/J.CARBP0L.2013.08.069
   Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z
   Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5<521::AID-BIP1027>3.0.CO;2-T
   Asakura T, 2015, MACROMOLECULES, V48, P2345, DOI 10.1021/acs.macromol.5b00160
   ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575
   Cheng G, 2012, J PHYS CHEM B, V116, P10049, DOI 10.1021/jp304538v
   Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z
   Dammstrom S, 2009, BIORESOURCES, V4, P3
   Eyley S, 2014, NANOSCALE, V6, P7764, DOI 10.1039/c4nr01756k
   Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   French AD, 2014, CELLULOSE, V21, P885, DOI 10.1007/s10570-013-0030-4
   Fukushima T., 2005, ANGEW CHEM, V117, P2462, DOI DOI 10.1002/ANGE.200462318
   Gong ZG, 2009, CHEM COMMUN, P7506, DOI 10.1039/b914218e
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Helbert W, 1998, J STRUCT BIOL, V124, P42, DOI 10.1006/jsbi.1998.4045
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03428
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Ibbett R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-33
   Isogai A, 1998, CELLULOSE, V5, P309, DOI 10.1023/A:1009272632367
   Johnson KE, 2007, ELECTROCHEM SOC INTE, V16, P38
   Kamel S, 2007, EXPRESS POLYM LETT, V1, P546, DOI 10.3144/expresspolymlett.2007.78
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Levy I, 2002, CELLULOSE, V9, P91, DOI 10.1023/A:1015848701029
   Lewis A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121989
   Liu XM, 2014, IDEAS HIST MOD CHINA, V8, P3, DOI 10.1163/9789004265356_002
   Liu Z, 2011, MATER CHEM PHYS, V128, P220, DOI 10.1016/j.matchemphys.2011.02.062
   Loelovich M, 2011, J SCI ISR TECHNOL AD, V13, P4
   Metzke M, 2008, BIOMACROMOLECULES, V9, P208, DOI 10.1021/bm701013y
   NIEDUSZY.I, 1970, NATURE, V225, P273, DOI 10.1038/225273a0
   Saitoh H, 2004, INT J BIOL MACROMOL, V34, P317, DOI [10.1016/j.ijbiomac.2004.09.003, 10.1016/j.ijbiomat.2004.09.003]
   Samayam IP, 2011, BIOMACROMOLECULES, V12, P3091, DOI 10.1021/bm200736a
   Scherrer P., 1918, BESTIMMUNG GRSLIE IN
   Su JF, 2010, CARBOHYD POLYM, V79, P145, DOI 10.1016/j.carbpol.2009.07.035
   Sundberg J, 2015, CELLULOSE, V22, P1943, DOI 10.1007/s10570-015-0606-2
   Szczesniak L, 2008, CELLULOSE, V15, P445, DOI 10.1007/s10570-007-9192-2
   Tang JB, 2005, J POLYM SCI POL CHEM, V43, P5477, DOI 10.1002/pola.21031
   Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030
   Thomas LH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0538-x
   Tomczynska-Mleko M, 2015, FOOD HYDROCOLLOID, V49, P232, DOI 10.1016/j.foodhyd.2015.03.027
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Utracki LA, 2002, CAN J CHEM ENG, V80, P1008, DOI 10.1002/cjce.5450800601
   Vainio U, 2004, LANGMUIR, V20, P9736, DOI 10.1021/la048407v
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Wang Q, 2013, BIOMACROMOLECULES, V14, P285, DOI 10.1021/bm301741q
   Wang Q, 2012, BIOMACROMOLECULES, V13, P1875, DOI 10.1021/bm300387z
   Wang XJ, 2011, BIORESOURCE TECHNOL, V102, P7959, DOI 10.1016/j.biortech.2011.05.064
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Yin JH, 2016, REGEN BIOMATER, V3, P129, DOI 10.1093/rb/rbw008
   Yoshizawa M, 2004, CHEM COMMUN, P1828, DOI 10.1039/b404137b
   Yuan XM, 2015, PHYS CHEM CHEM PHYS, V17, P31592, DOI 10.1039/c5cp05744b
   Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676
   Zhou L, 2013, POLYMER, V54, P5035, DOI 10.1016/j.polymer.2013.07.002
NR 56
TC 1
Z9 1
U1 6
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD APR
PY 2017
VL 24
IS 4
BP 1775
EP 1789
DI 10.1007/s10570-017-1208-y
PG 15
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA EO6GD
UT WOS:000396789100014
DA 2018-10-20
ER

PT J
AU Satue, M
   Monjo, M
   Ronold, HJ
   Lyngstadaas, SP
   Ramis, JM
AF Satue, Maria
   Monjo, Marta
   Jacob Ronold, Hans
   Petter Lyngstadaas, Staale
   Ramis, Joana M.
TI Titanium implants coated with UV-irradiated vitamin D precursor and
   vitamin E: in vivo performance and coating stability
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE 7-Dehydrocholesterol; bone formation; coating stability; dental implant;
   invivo; titanium; vitamin D; vitamin E
ID DENTAL IMPLANTS; SHAPED IMPLANTS; BONE-FORMATION; OSSEOINTEGRATION;
   SURFACE; OSTEOPOROSIS; BIOMATERIAL; STORAGE; DISEASE; DIFFERENTIATION
AB Objectives This study aimed at evaluating the biological response of titanium implants coated with UV-irradiated 7-dehydrocholesterol (7-DHC) and vitamin E (VitE) invivo and analyzing the effects of aging on their stability and bioactivity invitro.
   Material and methods Titanium surfaces were coated with 7-DHC and VitE, UV-irradiated and incubated for 48h at 23 degrees C to allow cholecalciferol synthesis. The invivo biological response was tested using a rabbit tibia model after 8weeks of healing by analyzing the wound fluid and the mRNA levels of several markers at the bone-implant interface (N=8). The stability of the coating after storage up to 12weeks was determined using HPLC analysis, and the bioactivity of the stored modified implants was studied by an invitro study with MC3T3-E1 cells (N=6).
   Results A significant increase in gene expression levels of osteocalcin was found in the bone tissue attached to implants coated with the low dose of 7-DHC and VitE, together with a higher ALP activity in the wound fluid. Implants treated with the high dose of 7-DHC and VitE showed increased tissue necrosis and inflammation. Regarding the aging effects, coated implants were stable and bioactive up to 12weeks when stored at 4 degrees C and avoiding oxygen, light and moisture.
   Conclusion This study demonstrates that Ti implants coated with UV-irradiated 7-DHC and VitE promote invivo gene expression of bone formation markers and ALP activity, while they keep their osteopromotive potential invitro and composition when stored up to 12weeks at 4 degrees C.
C1 [Satue, Maria; Monjo, Marta; Ramis, Joana M.] Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain.
   [Monjo, Marta; Ramis, Joana M.] Inst Invest Sanitaria Palma, Palma De Mallorca, Spain.
   [Jacob Ronold, Hans] Univ Oslo, Inst Clin Dent, Dept Prosthet & Oral Funct, Oslo, Norway.
   [Petter Lyngstadaas, Staale] Univ Oslo, Inst Clin Dent, Dept Biomat, Oslo, Norway.
RP Monjo, M; Ramis, JM (reprint author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Ctra Valldemossa,Km 7-5, E-07122 Palma De Mallorca, Spain.
EM marta.monjo@uib.es; joana.ramis@uib.es
OI Ramis, Joana Maria/0000-0001-9109-8362; Monjo, Marta/0000-0002-2731-9527
FU Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes
   Balears; European Social Fund; NILS Science and Sustainability Programme
   (ES07 EEA) [013-Abel-CM-2013]
FX This work was supported by the Conselleria d'Educacio, Cultura i
   Universitats del Govern de les Illes Balears and the European Social
   Fund (contract to JMR) and NILS Science and Sustainability Programme
   (ES07 EEA Grants; 013-Abel-CM-2013).
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Amano Yusuke, 2009, J Oral Sci, V51, P11
   Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Baker SE, 2008, LANGMUIR, V24, P14254, DOI 10.1021/la802804z
   Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.200095
   Chen TC, 2000, J NUTR BIOCHEM, V11, P267, DOI 10.1016/S0955-2863(00)00077-2
   Cho YJ, 2011, INT J ORAL MAX IMPL, V26, P1225
   Davies John E, 2003, J Dent Educ, V67, P932
   Dong WY, 2006, J CONTROL RELEASE, V115, P158, DOI 10.1016/j.jconrel.2006.07.013
   Dvorak G, 2012, CLIN ORAL IMPLAN RES, V23, P1308, DOI 10.1111/j.1600-0501.2011.02346.x
   Ellingsen J. E., 2015, DEV NOVEL FLUORIDE M
   Feldman D., 2013, OSTEOPOROSIS
   Ferraris S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054102
   Garcia MN, 2014, J EVID-BASED DENT PR, V14, P39, DOI 10.1016/j.jebdp.2014.01.010
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Guillot R, 2013, BIOMATERIALS, V34, P5737, DOI 10.1016/j.biomaterials.2013.03.067
   Haham M, 2012, FOOD FUNCT, V3, P737, DOI 10.1039/c2fo10249h
   Haugen HJ, 2013, ACTA BIOMATER, V9, P5390, DOI 10.1016/j.actbio.2012.09.009
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Joddar B, 2011, J MATER CHEM, V21, P13737, DOI 10.1039/c1jm10984g
   Kaushik R, 2014, LWT-FOOD SCI TECHNOL, V56, P421, DOI 10.1016/j.lwt.2013.11.029
   Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x
   Kloss FR, 2013, HEAD NECK-J SCI SPEC, V35, P235, DOI 10.1002/hed.22958
   Kubodera N, 2009, MINI-REV MED CHEM, V9, P1416, DOI 10.2174/138955709789957486
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lehmann B, 2003, RECENT RESULTS CANC, V164, P135
   Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002
   Liu W., 2014, PLOS ONE, V9, P3
   Lu HB, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055002
   Martelli FS, 2014, CLIN CASES MINER BON, V11, P15, DOI 10.11138/ccmbm/2014.11.1.015
   Mengatto CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015848
   Mohl S, 2006, PHARM DEV TECHNOL, V11, P103, DOI 10.1080/10837450500464230
   Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001
   Monjo M, 2013, CLIN ORAL IMPLAN RES, V24, P1035, DOI 10.1111/j.1600-0501.2012.02496.x
   Monjo M, 2010, ACTA BIOMATER, V6, P1405, DOI 10.1016/j.actbio.2009.09.027
   Naito Y., 2014, J ORAL MAXILLOFACIA, V5, P1
   Nishii Y, 2002, J BONE MINER METAB, V20, P57, DOI 10.1007/s007740200008
   Novaes Jr Arthur Belém, 2010, Braz. Dent. J., V21, P471, DOI 10.1590/S0103-64402010000600001
   Ogawa T, 2014, INT J ORAL MAX IMPL, V29, pE95, DOI 10.11607/jomi.te47
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Petzold C., 2012, INT J ORAL MAXILLOF, V28, pe547
   Petzold C, 2011, J BIOMED MATER RES A, V96A, P83, DOI 10.1002/jbm.a.32960
   Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Satue M, 2013, ACTA BIOMATER, V9, P5759, DOI 10.1016/j.actbio.2012.11.021
   Satue M., 2014, J BIOMEDICAL MAT R A, V103, P2280
   Satue M, 2016, J BIOMATER APPL, V30, P770, DOI 10.1177/0885328215582324
   Scharnweber D, 2010, J MATER SCI-MATER M, V21, P525, DOI 10.1007/s10856-009-3908-9
   Slaets E, 2006, J PERIODONTOL, V77, P1015, DOI 10.1902/jop.2006.050196
   St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Suzuki T, 2009, TISSUE ENG PT A, V15, P3679, DOI 10.1089/ten.TEA.2008.0568
   Tian Y, 2002, DRUG DEV IND PHARM, V28, P897, DOI 10.1081/DDC-120006422
   TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601
   Ueno T, 2012, J BIOMED MATER RES B, V100B, P2279, DOI 10.1002/jbm.b.32799
   Wang Heng, 2013, Zhonghua Kou Qiang Yi Xue Za Zhi, V48, P294, DOI 10.3760/cma.j.issn.1002-0098.2013.05.009
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005
   Yamaguchi M, 2012, INT J MOL MED, V29, P934, DOI 10.3892/ijmm.2012.900
NR 66
TC 2
Z9 2
U1 4
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2017
VL 28
IS 4
BP 424
EP 431
DI 10.1111/clr.12815
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA ER1YL
UT WOS:000398591000007
PM 26926140
DA 2018-10-20
ER

PT J
AU Zhou, J
   Guo, XD
   Zheng, QX
   Wu, YC
   Cui, FZ
   Wu, B
AF Zhou, Jing
   Guo, Xiaodong
   Zheng, Qixin
   Wu, Yongchao
   Cui, Fuzai
   Wu, Bin
TI Improving osteogenesis of three-dimensional porous scaffold based on
   mineralized recombinant human-like collagen via mussel-inspired
   polydopamine and effective immobilization of BMP-2-derived peptide
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE BMP2-related peptide; Surface modification; Osteogenesis; Polydopamine
ID BONE REGENERATION; IN-VITRO; SURFACE; VIVO; HYDROXYAPATITE; MATRIX;
   REPAIR; CONJUGATION; COMPOSITES; STRATEGIES
AB An ideal bone substitute should be biocompatible, biodegradable, osteoinductive and osteoconductive. In our previous work, we fabricated a three-dimensional porous scaffold based on mineralized recombinant human-like collagen, nano-hydroxyapatite/recombinant human-like collagen/poly(lactic acid) (nHA/RHLC/PLA). Like other HA/collagen scaffolds, the nHA/RHLC/PLA scaffold lacked osteoinductive bioactivity. The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. The immobilization efficiency and release kinetics of P24, and in vitro osteoinductive activity of the nHA/RHLC/PLA-pDA-P24 scaffold were examined. The in vivo osteoinductive activity of the scaffold was evaluated usinga rat criticalsize calvarial defect model. Our results showed that pDA-assisted surface modification could more efficiently mediate the immobilization of P24 peptide onto the scaffold surfaces than physical adsorption. The in vitro release study showed that the P24 peptide was released slowly and steadily from the nHA/RHLC/PLA-pDA-P24 scaffold in a sustained manner, with a short initial burst release only during the first day, while the physisorbed nHA/RHLC/PLA-P24 group showed a sharp burst P24 release followed by a plateau phase. In vitro osteogenesis assay, the ALP activitiy and mRNA expression of osteo-specific markers of rat-derived mesenchymal stem cells (rMSCs) in the nHA/RHLC/PLA-pDA-P24 group were significantly higher than those of the nHA/RHLC/PLA-P24 and non-P24-loaded nHA/RHLC/PLA groups. In vivo, three-dimensional CT evaluation and histological examination demonstrated the nHA/RHLC/PLA-pDA-P24 scaffolds significantly enhanced bone regeneration of rat cranial defects to a much greater extent than physisorbed nHA/RHLC/PLA-P24 and non-P24-loaded nHA/RHLC/PLA scaffolds. Our findings indicated that the pDA-assisted surface modification method could significantly improve the osteogenesis activity of the nHA/RHLC/PLA scaffold and the new nHA/RHLC/PLA-pDA-P24 scaffold was a promising scaffold biomaterial for bone tissue regeneration. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Zhou, Jing] Huazhong Univ Sci & Technol, Union Hosp, Dept Breast & Thyroid Surg, Tongji Med Coll, Wuhan 430022, Peoples R China.
   [Guo, Xiaodong; Zheng, Qixin; Wu, Yongchao; Wu, Bin] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthopaed, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
   [Cui, Fuzai] Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
RP Wu, B (reprint author), Huazhong Univ Sci & Technol, Union Hosp, Dept Orthopaed, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
EM bin_wu@hust.edu.cn
FU National Natural Science Foundation of China [81000520, 81471271,
   30900292]
FX This research was supported by the National Natural Science Foundation
   of China (81000520, 81471271, 30900292).
CR BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Duan ZX, 2007, J HUAZHONG UNIV SCI, V27, P179, DOI 10.1007/s11596-007-0219-6
   Duan Zhixia, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1118
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Garai S, 2014, COLLOID SURFACE B, V115, P182, DOI 10.1016/j.colsurfb.2013.11.042
   Ho CC, 2014, J BIOMED NANOTECHNOL, V10, P3063, DOI 10.1166/jbn.2014.1888
   Ho MH, 2006, MACROMOL BIOSCI, V6, P90, DOI 10.1002/mabi.200500130
   Jal PK, 2004, TALANTA, V62, P1005, DOI 10.1016/j.talanta.2003.10.028
   Kang SM, 2010, COLLOID SURFACE B, V75, P385, DOI 10.1016/j.colsurfb.2009.08.039
   Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim JH, 2014, ANGEW CHEM INT EDIT, V53, P6364, DOI 10.1002/anie.201402608
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Li JF, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035005
   Liao S, 2005, J BIOMED MATER RES B, V74B, P817, DOI 10.1002/jbm.b.30315
   Lin XH, 2005, J BONE MINER RES, V20, P693, DOI 10.1359/JBMR.041104
   Lin XH, 2006, J ORTHOP RES, V24, P2051, DOI 10.1002/jor.20215
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Liu YH, 2013, BIOMATERIALS, V34, P9998, DOI 10.1016/j.biomaterials.2013.09.040
   Liu ZM, 2009, J MATER SCI-MATER M, V20, P2317, DOI 10.1007/s10856-009-3806-1
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Muhonen V, 2016, J ORTHOP RES, V34, P745, DOI 10.1002/jor.23099
   Nielsen SR, 2013, PHYS CHEM CHEM PHYS, V15, P17029, DOI 10.1039/c3cp52651h
   Pan HT, 2016, COLLOID SURFACE B, V142, P1, DOI 10.1016/j.colsurfb.2016.01.060
   Pan HT, 2014, J BIOMED MATER RES A, V102, P2864, DOI 10.1002/jbm.a.34961
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Que R, 2014, BIOMACROMOLECULES, V15, P3540, DOI [10.1021/bm500735, 10.1021/bm500735d]
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Shegarfi Hamid, 2009, J Orthop Surg (Hong Kong), V17, P206
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239
   Thorwarth M, 2005, BIOCHEM BIOPH RES CO, V329, P789, DOI 10.1016/j.bbrc.2005.01.157
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984
   Wu B, 2010, J HUAZHONG U SCI-MED, V30, P178, DOI 10.1007/s11596-010-0209-y
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 43
TC 7
Z9 7
U1 4
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2017
VL 152
BP 124
EP 132
DI 10.1016/j.colsurfb.2016.12.041
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EQ4AC
UT WOS:000398014100015
PM 28103529
DA 2018-10-20
ER

PT J
AU Ansari, NF
   Annuar, MSM
   Murphy, BP
AF Ansari, Nor Faezah
   Annuar, M. Suffian M.
   Murphy, Belinda Pingguan
TI A porous medium-chain-length poly(3-hydroxyalkanoates)/hydroxyapatite
   composite as scaffold for bone tissue engineering
SO ENGINEERING IN LIFE SCIENCES
LA English
DT Article
DE Bone scaffold; Composite; Hydroxyapatite (30%); mcl-PHA; Porous
   biomaterial
ID MECHANICAL-PROPERTIES; POLYHYDROXYALKANOATES; HYDROXYAPATITE;
   CRYSTALLIZATION; PARTICLES; BLENDS; PHAS; FTIR
AB Polyhydroxyalkanoates (PHA) are hydrophobic biopolymers with huge potential for biomedical applications due to their biocompatibility, excellent mechanical properties and biodegradability. A porous composite scaffold made of mediumchain-length poly(3-hydroxyalkanoates) (mcl-PHA) and hydroxyapatite (HA) was fabricated using particulate leaching technique and NaCl as a porogen. Different percentages of HA loading was investigated that would support the growth of osteoblast cells. Ultrasonic irradiation was applied to facilitate the dispersion of HA particles into the mcl-PHA matrix. The different P(3HO-co-3HHX)/HA composites were investigated using field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD) and energy dispersive X-ray analysis (EDXA). The scaffolds were found to be highly porous with interconnecting pore structures and the HA particles were homogeneously dispersed in the polymer matrix. The scaffolds biocompatibility and osteoconductivity were also assessed following the proliferation and differentiation of osteoblast cells on the scaffolds. From the results, it is clear that scaffolds made from P( 3HO-co-3HHX)/HA composites are viable candidate materials for bone tissue engineering applications.
C1 [Ansari, Nor Faezah; Annuar, M. Suffian M.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
   [Ansari, Nor Faezah] Int Islamic Univ Malaysia, Kuliyyah Sci, Dept Biotechnol, Kuantan, Pahang, Malaysia.
   [Annuar, M. Suffian M.] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.
   [Murphy, Belinda Pingguan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.
RP Annuar, MSM (reprint author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
EM suffian_annuar@um.edu.my
RI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010
OI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/0000-0003-3387-0160
FU University of Malaya [PG043-2014A, RP031C-15AET]
FX The authors acknowledged University of Malaya for research grants
   PG043-2014A and RP031C-15AET.
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Baei M. S., 2011, MIDDLE E J, V7, P46
   Baek J. -Y., 2012, J NANOMATER, V2012, DOI DOI 10.1155/2012/171804
   Chardron S, 2010, POLYM TEST, V29, P966, DOI 10.1016/j.polymertesting.2010.08.009
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen W, 2005, APPL SURF SCI, V252, P1404, DOI 10.1016/j.apsusc.2005.02.138
   Doi Y., 1990, MICROBIAL POLYESTERS
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   Gumel A., 2014, J NANOMATER, V2014
   Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214
   Huang J, 2007, J MATER SCI-MATER M, V18, P2151, DOI 10.1007/s10856-007-3201-8
   Jack KS, 2009, ACTA BIOMATER, V5, P2657, DOI 10.1016/j.actbio.2009.03.017
   Kansiz M, 2007, ANAL BIOANAL CHEM, V388, P1207, DOI 10.1007/s00216-007-1337-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kuo YC, 2006, BIOTECHNOL PROGR, V22, P1664, DOI 10.1021/bp0602303
   Meischel M, 2016, J MECH BEHAV BIOMED, V53, P104, DOI 10.1016/j.jmbbm.2015.08.004
   Moradi A, 2013, MATER DESIGN, V50, P446, DOI 10.1016/j.matdes.2013.03.026
   Muhr A, 2013, REACT FUNCT POLYM, V73, P1391, DOI 10.1016/j.reactfunctpolym.2012.12.009
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Pramanik N, 2009, INT J BIOMATER, DOI 10.1155/2009/512417
   Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002
   Razaif-Mazinah MRM, 2016, BIOTECHNOL APPL BIOC, V63, P92, DOI 10.1002/bab.1354
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Saadat A, 2013, BIOTECHNOL BIOPROC E, V18, P587, DOI 10.1007/s12257-012-0744-4
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sultana N, 2008, J EXP NANOSCI, V3, P121, DOI 10.1080/17458080701867429
   Sultana N., 2012, J NANOMATER, V2012
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Xi J, 2008, J BIOMATER APPL, V22, P293, DOI 10.1177/0885328207075425
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 33
TC 0
Z9 0
U1 4
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1618-0240
EI 1618-2863
J9 ENG LIFE SCI
JI Eng. Life Sci.
PD APR
PY 2017
VL 17
IS 4
BP 420
EP 429
DI 10.1002/elsc.201600084
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA ER1JA
UT WOS:000398545000008
DA 2018-10-20
ER

PT J
AU Dozza, B
   Lesci, IG
   Duchi, S
   Della Bella, E
   Martini, L
   Salamanna, F
   Falconi, M
   Cinotti, S
   Fini, M
   Lucarelli, E
   Donati, D
AF Dozza, B.
   Lesci, I. G.
   Duchi, S.
   Della Bella, E.
   Martini, L.
   Salamanna, F.
   Falconi, M.
   Cinotti, S.
   Fini, M.
   Lucarelli, E.
   Donati, D.
TI When size matters: differences in demineralized bone matrix particles
   affect collagen structure, mesenchymal stem cell behavior, and
   osteogenic potential
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE demineralized bone matrix; particle size; collagen structure;
   osteoinduction; mesenchymal stem cells
ID EXTRACELLULAR-MATRIX; GRAFT SUBSTITUTES; STROMAL CELLS; SCAFFOLDS;
   DIFFERENTIATION; OSTEOINDUCTIVITY; BIOMATERIALS; ADHESION; GROWTH;
   REPAIR
AB Demineralized bone matrix (DBM) is a natural, collagen-based, osteoinductive biomaterial. Nevertheless, there are conflicting reports on the efficacy of this product. The purpose of this study was to evaluate whether DBM collagen structure is affected by particle size and can influence DBM cytocompatibility and osteoinductivity. Sheep cortical bone was ground and particles were divided in three fractions with different sizes, defined as large (L, 1-2 mm), medium (M, 0.5-1 mm), and small (S, <0.5 mm). After demineralization, the chemical-physical analysis clearly showed a particle size-dependent alteration in collagen structure, with DBM-M being altered but not as much as DBM-S. DBM-M displayed a preferable trend in almost all biological characteristics tested, although all DBM particles revealed an optimal cytocompatibility. Subcutaneous implantation of DBM particles into immunocompromised mice resulted in bone induction only for DBM-M. When sheep MSC were seeded onto particles before implantation, all DBM particles were able to induce new bone formation with the best incidence for DBM-M and DBM-S. In conclusion, the collagen alteration in DBM-M is likely the best condition to promote bone induction in vivo. Furthermore, the choice of 0.5-1 mm particles may enable to obtain more efficient and consistent results among different research groups in bone tissue-engineering applications. (C) 2017 Wiley Periodicals, Inc.
C1 [Dozza, B.; Duchi, S.; Donati, D.] Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin Prevalently Oncol 3, Osteoarticolar Regenerat Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
   [Dozza, B.; Donati, D.] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Via G C Pupilli 1, I-40136 Bologna, Italy.
   [Lesci, I. G.] WAPH Technol Corp, 1920 N Commerce Pkwy, Weston, FL 33326 USA.
   [Della Bella, E.; Martini, L.; Salamanna, F.; Fini, M.] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, Via Barbiano 1-10, I-40136 Bologna, Italy.
   [Della Bella, E.] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via G Massarenti 9, I-40138 Bologna, Italy.
   [Falconi, M.] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Div Human Anat, Via Irnerio 48, I-40126 Bologna, Italy.
   [Cinotti, S.] Cell Culture Ctr, Ist Zooprofilattico Sperimentale Lombardia & Emil, Via Bianchi 9, I-25124 Brescia, Italy.
RP Dozza, B (reprint author), Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin Prevalently Oncol 3, Osteoarticolar Regenerat Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.; Dozza, B (reprint author), Osteoarticular Regenerat Lab, Bologna, Italy.; Dozza, B (reprint author), Rizzoli Orthopaed Inst, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM barbara.dozza@ior.it
OI Duchi, Serena/0000-0002-6418-3323; DONATI, DAVIDE
   MARIA/0000-0002-9170-0576; Della Bella, Elena/0000-0001-5151-7390;
   Dozza, Barbara/0000-0002-7604-0039
FU Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia
   Romagna "Bruno Ubertini" (IZSLER), Brescia, Italy
FX Research reported in this publication was supported by Istituto
   Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna
   "Bruno Ubertini" (IZSLER), Brescia, Italy. The authors wish to thank Dr.
   Marco Gambarotti for his precious help on histological analysis, Dr.
   Gabriella Teti for her assistance with scanning electron microscopy,
   Charlotte Mcilwaine Story and Emily Aharon for editorial assistance.
CR Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   Chen YT, 2011, TISSUE ENG PART C-ME, V17, P1211, DOI 10.1089/ten.tec.2011.0092
   DesLong WG, 2007, J BONE JOINT SURG AM, V89, P649
   Dozza B, 2017, J BIOMED MATER RES A, V105, P1019, DOI 10.1002/jbm.a.35975
   Dozza B, 2011, J ORTHOP RES, V29, P961, DOI 10.1002/jor.21333
   El-Jawhari JJ, 2016, J ORTHOP RES, V34, P597, DOI 10.1002/jor.23070
   Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841
   Figueiredo M, 2011, CHEM ENG RES DES, V89, P116, DOI 10.1016/j.cherd.2010.04.013
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Glowacki Julie, 2005, Cell and Tissue Banking, V6, P3, DOI 10.1007/s10561-005-4252-z
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Han B, 2005, J ORTHOP RES, V23, P855, DOI 10.1016/j.orthres.2004.11.007
   Iafisco M, 2010, COLLOID SURFACE B, V81, P274, DOI 10.1016/j.colsurfb.2010.07.022
   Impens S, 2010, TISSUE ENG PART C-ME, V16, P1575, DOI 10.1089/ten.TEC.2010.0069
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maddox E, 2000, TISSUE ENG, V6, P441, DOI 10.1089/107632700418146
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   Pietrzak WS, 2012, CELL TISSUE BANK, V13, P653, DOI 10.1007/s10561-011-9286-9
   Pietrzak WS, 2011, CELL TISSUE BANK, V12, P81, DOI 10.1007/s10561-009-9168-6
   Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   Supronowicz P, 2016, J TISSUE ENG REGEN M, V10, P275, DOI 10.1002/term.1706
   Supronowicz P, 2011, TISSUE ENG PT A, V17, P789, DOI 10.1089/ten.TEA.2010.0357
   SYFTESTAD G, 1979, CLIN ORTHOP RELAT R, P281
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhou XH, 2013, TISSUE ENG PART C-ME, V19, P720, DOI [10.1089/ten.TEC.2012.0601, 10.1089/ten.tec.2012.0601]
   Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046
NR 43
TC 7
Z9 7
U1 3
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1019
EP 1033
DI 10.1002/jbm.a.35975
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300007
PM 27943619
DA 2018-10-20
ER

PT J
AU Martinez, C
   Fernandez, C
   Prado, M
   Ozols, A
   Olmedo, DG
AF Martinez, Cristian
   Fernandez, Carlos
   Prado, Miguel
   Ozols, Andres
   Olmedo, Daniel G.
TI Synthesis and characterization of a novel scaffold for bone tissue
   engineering based on Wharton's jelly
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocomposite; biomaterial; Wharton's jelly; bone regeneration;
   biomimetic material
ID HYDROXYAPATITE SCAFFOLDS; INFRARED-SPECTROSCOPY; MECHANICAL-PROPERTIES;
   COMPOSITE SCAFFOLDS; COLLAGEN-FIBERS; TEMPERATURE; REGENERATION;
   BIOGLASS; GROWTH; BIOACTIVITY
AB A composite is a material made of more than one component, and the bond between the components is on a scale larger than the atomic scale. The objective of the present study was to synthesize and perform the structural characterization and biological evaluation of a new biocomposite (BCO) based on a novel combination of an organic and an inorganic phase, for bone tissue engineering applications. The organic phase consisted of Wharton's jelly (WJ), which was obtained from embryonic tissue following a protocol developed by our laboratory. The inorganic phase consisted of bioceramic particles (BC), produced by sintering hydroxyapatite (HA) with - tricalcium phosphate (-TCP), and bioactive glass particles (BG). Each phase of the BCO was fully characterized by SEM, EDS, XRD, and FTIR. Biocompatibility was evaluated in vivo in the tibiae of Wistar rats (n=40). Histological evaluation was performed at 0, 1, 7, 14, 30, and 60 days. XRD showed the phases corresponding to HA and -TCP, whereas diffractogram of BG showed it to have an amorphous structure. EDS showed mainly Si and Na, Ca, P in BG, and Ca and P in HA and -TCP. FTIR identified bonds between the organic and inorganic phases. From a mechanical viewpoint, the composite showed high flexural strength of 40.3 +/- 0.8 MPa. The synthesized BCO exhibited adequate biocompatibility as shown by formation of lamellar type bone linked by BG and BC particles. The biomaterial presented here showed excellent mechanical and biocompatibility properties for its potential clinical use. (C) 2017 Wiley Periodicals, Inc.
C1 [Martinez, Cristian; Fernandez, Carlos; Ozols, Andres] Univ Buenos Aires, Sch Engn, Inst Biomed Engn, Dept Oral Pathol, Av Paseo Col 850, RA-C1063ACV Buenos Aires, DF, Argentina.
   [Martinez, Cristian; Olmedo, Daniel G.] Univ Buenos Aires, Sch Dent, Dept Oral Pathol, Lab Study Biomat, MT Alvear 2142,28 A,, RA-C1122AAH Buenos Aires, DF, Argentina.
   [Martinez, Cristian] Natl Univ Cuyo, Sch Dent, Biomat Grp, Gen San Martin Pk, RA-M5502JMA Mendoza, Argentina.
   [Prado, Miguel] Bariloche Atom Ctr GMN CAB, Natl Atom Energy Commiss, Nucl Mat Grp, Bustillo 9500, RA-R8402AGP San Carlos De Bariloche, Rio Negro, Argentina.
   [Olmedo, Daniel G.] Natl Res Council CONICET, RA-C1122AAH Buenos Aires, DF, Argentina.
RP Martinez, C (reprint author), Univ Buenos Aires, Sch Engn, Inst Biomed Engn, Dept Oral Pathol, Av Paseo Col 850, RA-C1063ACV Buenos Aires, DF, Argentina.
EM yo.cristian.martinez@gmail.com
FU UBACyT (University of Buenos Aires, Argentina) [20020150100032BA,
   0020130100332BA]; PIP (National Council for Scientific and Technological
   Research, Argentina) [11220130100091]
FX Contract grant sponsor: UBACyT (University of Buenos Aires, Argentina);
   contract grant number: 20020150100032BA and 0020130100332BA; Contract
   grant sponsor: PIP (National Council for Scientific and Technological
   Research, Argentina); contract grant number: 11220130100091
CR Aniket, 2015, J BIOMED MATER RES A, V103, P1961, DOI 10.1002/jbm.a.35326
   Aniket, 2012, J BIOMED MATER RES A, V100A, P3314, DOI 10.1002/jbm.a.34280
   Bakhtiari L, 2010, CERAM INT, V36, P2421, DOI 10.1016/j.ceramint.2010.07.012
   Barbeck M, 2014, Ann Maxillofac Surg, V4, P150, DOI 10.4103/2231-0746.147106
   Boryskina OP, 2007, J MOL STRUCT, V827, P1, DOI 10.1016/j.molstruc.2006.05.002
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Carlton A, 1987, ORTHOP CLIN N AM, V18, P323
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014
   Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077
   El-Ghannam A, 2006, J BIOMED MATER RES A, V76A, P386, DOI 10.1002/jbm.a.30517
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Fong CY, 2010, REP BIOMED, V21, P331
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041
   Guo XJ, 2013, ADV POWDER TECHNOL, V24, P1034, DOI 10.1016/j.apt.2013.03.002
   Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL., 2004, BIOMATERIALS SCI INT, P73
   Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kandamchira A, 2013, MAT SCI ENG C-MATER, V33, P4985, DOI 10.1016/j.msec.2013.08.018
   Katti DR, 2010, J BIOMECH, V43, P1723, DOI 10.1016/j.jbiomech.2010.02.027
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kim HL, 2015, MAT SCI ENG C-MATER, V54, P20, DOI 10.1016/j.msec.2015.04.033
   Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015
   Klein P, 2003, J ORTHOPAED RES, V21, P662, DOI 10.1016/S0736-0266(02)00259-0
   Lee DSH, 2013, MATER LETT, V102, P76, DOI 10.1016/j.matlet.2013.03.116
   Letaief N, 2014, J NON-CRYST SOLIDS, V402, P194, DOI 10.1016/j.jnoncrysol.2014.06.005
   Leu JK., 2008, PHARM RES, V25, P1222
   Li HY, 2013, ACTA BIOMATER, V9, P5379, DOI 10.1016/j.actbio.2012.10.019
   Li JS, 2010, ACTA BIOMATER, V6, P2013, DOI 10.1016/j.actbio.2009.12.008
   Li L, 2010, MAT SCI ENG C, V30, P1272
   Libonati F, 2014, MECH RES COMMUN, V58, P17, DOI 10.1016/j.mechrescom.2013.08.008
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   Liu A., 2015, SERIES BIOMATERIALS, P211
   Ma J, 2010, CERAM INT, V36, P1911, DOI 10.1016/j.ceramint.2010.03.017
   MacDuff E, 2009, SURGERY, V27, P55
   Martinez C, 2017, J BIOMED MATER RES A, V105, P1034, DOI 10.1002/jbm.a.35976
   Meng ZJ, 2012, INT J BIOL MACROMOL, V51, P440, DOI 10.1016/j.ijbiomac.2012.05.030
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Plewinski M, 2013, DENT MATER, V29, P1256, DOI 10.1016/j.dental.2013.09.016
   Qian JM, 2009, MAT SCI ENG C-BIO S, V29, P1361, DOI 10.1016/j.msec.2008.11.004
   Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salma-Ancane K, 2015, CERAM INT, V41, P4996, DOI 10.1016/j.ceramint.2014.12.065
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Scalera F, 2013, CERAM INT, V39, P4839, DOI 10.1016/j.ceramint.2012.11.076
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schwarz F, 2007, INT J ORAL MAX SURG, V36, P1198, DOI 10.1016/j.ijom.2007.07.014
   Sha L, 2011, MATER CHEM PHYS, V129, P1138, DOI 10.1016/j.matchemphys.2011.05.075
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Singh BR., 2000, AM CHEM SOC SERIES, V750
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P483, DOI 10.1016/j.ijbiomac.2010.07.002
   Sobolewski K, 2005, PLACENTA, V26, P747, DOI 10.1016/j.placenta.2004.10.008
   Taghizadeh RR, 2011, PLACENTA, V32, pS311, DOI 10.1016/j.placenta.2011.06.010
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   TWARDOWSKI J, 1994, RAMAN IR SPECTROSCOP
   Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010
   Xu Z, 2010, MAT SCI ENG C-MATER, V30, P822, DOI 10.1016/j.msec.2010.03.014
   Zhang L, 2010, ACTA BIOMATER, V6, P2189, DOI 10.1016/j.actbio.2009.12.042
NR 73
TC 3
Z9 3
U1 4
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1034
EP 1045
DI 10.1002/jbm.a.35976
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300008
PM 27977894
DA 2018-10-20
ER

PT J
AU Dewi, AH
   Ana, ID
   Jansen, J
AF Dewi, Anne Handrini
   Ana, Ika Dewi
   Jansen, John
TI Preparation of a calcium carbonate-based bone substitute with
   cinnamaldehyde crosslinking agent with potential anti-inflammatory
   properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE POP; hydrogel CaCO3; cinnamaldehyde; controlled release manner;
   inflammatory control
ID CONTROLLED-RELEASE; CINNAMOMUM-OSMOPHLOEUM; GELATIN HYDROGELS; CHITOSAN
   FILMS; ESSENTIAL OIL; SCAFFOLDS; DELIVERY; INFLAMMATION; BEHAVIOR
AB Calcium sulfate (CS), also known as POP (Plaster of Paris) is a self-setting, biocompatible, and osteoconductive biomaterial with a long history for the treatment of skeletal defects. However, CS cements show a too fast resorption rate and are unable to provide a long-term 3D framework during the osteogenesis process. In our previous studies, it was found that the incorporation of CaCO3 and CaCO3 hydrogel provided enhanced mechanical and degradation properties of POP composites. Furthermore, it was also found that the use of cinnamaldehyde to crosslink CaCO3 hydrogel may have some advantages, for example to crosslink the hydrogel and to act as anti-inflammatory control agent. The objective of the current study was to evaluate the effect of adding cinnamaldehyde crosslinked CaCO3 hydrogel into POP on the diametral tensile strength, weight loss, age swelling, degradation, cinnamaldehyde release, and porosity. The following composites were prepared: POP/HCin-025 (25% addition of hydrogel microsphere) and POP/HCin-050 (50% addition of hydrogel microsphere). The composites were assessed on their diametral tensile strength, weight loss of the POP composite, age swelling, degradation of the hydrogel CaCO3, cinnamaldehyde release, and porosity, as well as XRD-patterns and FT-IR spectra. It was confirmed from the study that incorporation of cinnamaldehyde into CaCO3 hydrogel system significantly increased the mechanical strength of the POP composite. Weight loss, swelling ratio in both acid to neutral pH, and biodegradability of the POP composites were controllable by the addition of cinnamaldehyde-CaCO3 hydrogel. Moreover, the cinnamaldehyde incorporated into the hydrogel was proven to be released in a controlled manner. (C) 2017 Wiley Periodicals, Inc.
C1 [Dewi, Anne Handrini; Ana, Ika Dewi] Gadjah Mada Univ, Fac Dent, Dept Dent Biomed Sci, Yogyakarta 55281, Indonesia.
   [Jansen, John] Radboud Univ Nijmegen Med Ctr, Dept Biomaterials, NL-6500 HB Nijmegen, Netherlands.
   [Jansen, John] Radboud Univ Nijmegen Med Ctr, Dept Biomaterials, THK 309, Box 9101, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, J (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Biomaterials, THK 309, Box 9101, NL-6500 HB Nijmegen, Netherlands.
EM john.jansen@radboudumc.nl
FU Ministry of Research, Technology and Higher Education of the Republic of
   Indonesia
FX This study was supported by Ministry of Research, Technology and Higher
   Education of the Republic of Indonesia.
CR Babu VN, 2012, INT J BIOL MACROMOL, V51, P1103, DOI 10.1016/j.ijbiomac.2012.08.038
   Bilbao-Sainz C, 2013, J AM OIL CHEM SOC, V90, P233, DOI 10.1007/s11746-012-2164-1
   Bundela H, 2008, EXPRESS POLYM LETT, V2, P201, DOI 10.3144/expresspolymlett.2008.25
   Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u
   Cirotteau Y., 2001, EUR J ORTHOP SURG TR, V11, P149
   Dewi AH, 2017, J BIOMED MATER RES A, V105, P1055, DOI 10.1002/jbm.a.35990
   Dewi AH, 2016, J BIOMED MATER RES A, V104, P768, DOI 10.1002/jbm.a.35571
   Dewi AH, 2015, J BIOMED MATER RES A, V103, P3273, DOI 10.1002/jbm.a.35460
   Dewi AH, 2013, J BIOMED MATER RES A, V101, P2143, DOI 10.1002/jbm.a.34513
   Elsinger E C, 1996, J Foot Ankle Surg, V35, P396
   Engineer C, 2011, TRENDS BIOMATER ARTI, V25, P79
   Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004
   Gomes C, 2011, J FOOD SCI, V76
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Higueras L, 2015, FOOD BIOPROCESS TECH, V8, P526, DOI 10.1007/s11947-014-1421-8
   Jakhetia V., 2010, J ADV SCI RES, V1, P19
   Jamali A, 2002, CALCIFIED TISSUE INT, V71, P172, DOI 10.1007/s00223-001-1087-x
   Kim BH, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/529359
   Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Mazor Z, 2011, J ORAL IMPLANTOL, V37, P287, DOI 10.1563/AAID-JOI-D-10-00006.1
   Narbat Mehdi Kazemzadeh, 2006, Iranian Journal of Biotechnology, V4, P54
   Ojagh SM, 2010, FOOD CHEM, V122, P161, DOI 10.1016/j.foodchem.2010.02.033
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Park SI, 2004, J AGR FOOD CHEM, V52, P1933, DOI 10.1021/jf034612p
   Peng Y, 2014, FOOD HYDROCOLLOID, V36, P287, DOI 10.1016/j.foodhyd.2013.10.013
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Puspitasari T, 2012, PROCEDIA CHEM, V21, P1803
   Qiao CD, 2012, POLYM POLYM COMPOS, V20, P53, DOI 10.1177/0967391112020001-210
   Ratanavaraporn J, 2006, J METALS MAT MINERAL, V16, P31
   Saito T, 2012, ACTA BIOMATER, V8, P646, DOI 10.1016/j.actbio.2011.10.025
   Singh A, 2006, B MATER SCI, V29, P233, DOI 10.1007/BF02706490
   Soundrapandian C, 2009, AAPS PHARMSCITECH, V10, P1158, DOI 10.1208/s12249-009-9308-0
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Tung YT, 2008, BIORESOURCE TECHNOL, V99, P3908, DOI 10.1016/j.biortech.2007.07.050
   Wolke J, 2004, J BIOMED MATER RES A, V28, P1477
   Youn HS, 2008, BIOCHEM PHARMACOL, V75, P494, DOI 10.1016/j.bcp.2007.08.033
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   ZAIKA LL, 1988, J FOOD SAFETY, V9, P97
NR 39
TC 4
Z9 4
U1 7
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1055
EP 1062
DI 10.1002/jbm.a.35990
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300010
PM 28028917
DA 2018-10-20
ER

PT J
AU Zhang, Q
   Chen, XH
   Geng, SN
   Wei, LF
   Miron, RJ
   Zhao, YB
   Zhang, YF
AF Zhang, Qiao
   Chen, Xiaohui
   Geng, Shinan
   Wei, Lingfei
   Miron, Richard J.
   Zhao, Yanbing
   Zhang, Yufeng
TI Nanogel-based scaffolds fabricated for bone regeneration with mesoporous
   bioactive glass and strontium: In vitro and in vivo characterization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE strontium; mesoporous bioactive glass; osteoinductive; nanogel;
   osteoporosis
ID METHYLACRYLATE) NANOGEL; DIFFERENTIATION; RANELATE; DEFECTS;
   HYDROXYAPATITE; PROLIFERATION; FORMULATIONS; EXPRESSION; HYDROGELS;
   CELLS
AB The delivery of novel bioactive scaffolds for the repair of bone defects remains a prominent challenge worldwide. Currently osteoporosis, a disease caused by low bone mineral density affects over 200 million people worldwide with up to half of this population experiencing at least one fracture within their lifetime. Recently temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogel (PIB nanogel) scaffolds have emerged as biomaterial candidate for regenerative therapies. It has the advantage of being injected from syringes as a soluble gel form(capable of delivering growth and/or living progenitor cells) yet hardens once it reaches body temperatures. Although this material demonstrates optimal clinical delivery of scaffolds, its main drawback is its low osteoconductivity and bioactivity. Recently we have demonstrated that mesoporous bioactive glass (MBG) loaded with strontium was able to regenerate osteoporotic defects in vivo and enhance osteoblast differentiation in vitro. The aim of this study was to combine the advantages of these two therapies and prepare PIB-nanogel scaffolds containing Sr-MBG and investigate their ability to regenerate femur defects created in ovarectamized rats. The results demonstrate that groups containing Sr-MBG within the nanogel formulation had significantly higher new bone formation when compared with other modalities. We further demonstrate that although nanogel demonstrated poor osteogenic ability, the addition of osteoblasts worked synergistically with Sr-MBG particles to enhance the regeneration of the created femur defects in osteoporotic animals. In conclusion, PIB nanogel scaffolds are a viable treatment modality for bone tissue engineering and may serve as a carrier-scaffold for osteogenic cells and/or bioactive scaffolds such as Sr-MBG. (C) 2017 Wiley Periodicals, Inc.
C1 [Zhang, Qiao; Chen, Xiaohui; Wei, Lingfei; Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.
   [Zhang, Qiao; Chen, Xiaohui; Wei, Lingfei; Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomedicine Minist Educ, Wuhan, Peoples R China.
   [Zhang, Qiao; Chen, Xiaohui; Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Dept Dent Implantol, Wuhan, Peoples R China.
   [Geng, Shinan; Zhao, Yanbing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomedicine, Wuhan, Peoples R China.
   [Miron, Richard J.] Nova Southeastern Univ, Coll Dent Med, Dept Periodontol, Ft Lauderdale, FL USA.
RP Zhang, YF (reprint author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.; Zhang, YF (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomedicine Minist Educ, Wuhan, Peoples R China.; Zhang, YF (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Dept Dent Implantol, Wuhan, Peoples R China.; Zhao, YB (reprint author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomedicine, Wuhan, Peoples R China.
EM zhaoyanb@hust.edu.cn; zyf@whu.edu.cn
FU Youth Chenguang Project of Science and Technology of Wuhan City of China
   [2016070204010147]; National Natural Science Foundation of China
   [81570954]
FX Contract grant sponsor: The Youth Chenguang Project of Science and
   Technology of Wuhan City of China; contract grant number:
   2016070204010147; Contract grant sponsor: National Natural Science
   Foundation of China; contract grant number: 81570954 (to Y.F.Z.)
CR Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607
   Callens C, 2003, EUR J PHARM BIOPHARM, V55, P323, DOI 10.1016/S0939-6411(03)00024-9
   Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y
   Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Dong YX, 2012, MACROMOL RAPID COMM, V33, P120, DOI 10.1002/marc.201100534
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   Li YF, 2010, J ORTHOP RES, V28, P578, DOI 10.1002/jor.21050
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Ng KW, 2014, CURR OPIN PHARMACOL, V16, P58, DOI 10.1016/j.coph.2014.03.004
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Wei L, 2014, OSTEOPOROSIS INT, V25, P2089, DOI 10.1007/s00198-014-2735-0
   Wu CT, 2012, ACTA BIOMATER, V8, P3805, DOI 10.1016/j.actbio.2012.06.023
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Zhang Q, 2017, J BIOMED MATER RES A, V105, P1175, DOI 10.1002/jbm.a.35980
   Zhang YF, 2016, J TISSUE ENG REGEN M, V10, pE372, DOI 10.1002/term.1825
   Zhang YF, 2015, J BONE MINER RES, V30, P286, DOI 10.1002/jbmr.2322
   Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104527
   Zhang YF, 2013, J MATER CHEM B, V1, P5711, DOI 10.1039/c3tb21047b
   Zhao H, 2013, AM J NEURORADIOL, V34, P169, DOI 10.3174/ajnr.A3177
   Zhao YB, 2011, ADV FUNCT MATER, V21, P2035, DOI 10.1002/adfm.201002510
   Zhou ZY, 2009, J BIOACT COMPAT POL, V24, P405, DOI 10.1177/0883911509341774
NR 26
TC 5
Z9 5
U1 9
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1175
EP 1183
DI 10.1002/jbm.a.35980
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300023
PM 27998017
DA 2018-10-20
ER

PT J
AU Pajarinen, J
   Lin, Th
   Nabeshima, A
   Jamsen, E
   Lu, L
   Nathan, K
   Yao, Z
   Goodman, SB
AF Pajarinen, Jukka
   Lin, Tzu-hua
   Nabeshima, Akira
   Jamsen, Eemeli
   Lu, Laura
   Nathan, Karthik
   Yao, Zhenyu
   Goodman, Stuart B.
TI Mesenchymal stem cells in the aseptic loosening of total joint
   replacements
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE total joint replacement; peri-prosthetic osteolysis; aseptic loosening;
   mesenchymal stem cells; macrophages
ID TOTAL HIP-ARTHROPLASTY; TOLL-LIKE RECEPTORS; REVISION TOTAL HIP;
   NF-KAPPA-B; ORTHOPEDIC WEAR PARTICLES; MARROW STROMAL CELLS;
   BONE-MARROW; IN-VITRO; OSTEOGENIC DIFFERENTIATION; TNF-ALPHA
AB Peri-prosthetic osteolysis remains as the main long-term complication of total joint replacement surgery. Research over four decades has established implant wear as the main culprit for chronic inflammation in the peri-implant tissues and macrophages as the key cells mediating the host reaction to implant-derived wear particles. Wear debris activated macrophages secrete inflammatory mediators that stimulate bone resorbing osteoclasts; thus bone loss in the peri-implant tissues is increased. However, the balance of bone turnover is not only dictated by osteoclast-mediated bone resorption but also by the formation of new bone by osteoblasts; under physiological conditions these two processes are tightly coupled. Increasing interest has been placed on the effects of wear debris on the cells of the bone-forming lineage. These cells are derived primarily from multipotent mesenchymal stem cells (MSCs) residing in bone marrow and the walls of the microvasculature. Accumulating evidence indicates that wear debris significantly impairs MSC-to-osteoblast differentiation and subsequent bone formation. In this review, we summarize the current understanding of the effects of biomaterial implant wear debris on MSCs. Emerging treatment options to improve initial implant integration and treat developing osteolytic lesions by utilizing or targeting MSCs are also discussed. (C) 2017 Wiley Periodicals, Inc.
C1 [Pajarinen, Jukka; Lin, Tzu-hua; Nabeshima, Akira; Jamsen, Eemeli; Lu, Laura; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Stanford, CA 94305 USA.
   [Jamsen, Eemeli] Univ Helsinki, Dept Med Clinicum, Helsinki, Finland.
   [Jamsen, Eemeli] Helsinki Univ Hosp, Dept Med Clinicum, Helsinki, Finland.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
OI Nathan, Karthik/0000-0002-6322-9959
FU NIH [2R01AR055650, 1R01AR063717]; Ellenburg Chair in Surgery at Stanford
   University; Jane and Aatos Erkko foundation
FX Contract grant sponsor: NIH; contract grant number: 2R01AR055650,
   1R01AR063717; Contract grant sponsor: The Ellenburg Chair in Surgery at
   Stanford University; Contract grant sponsor: Jane and Aatos Erkko
   foundation (J.P.)
CR Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Aspenberg P, 1998, ACTA ORTHOP SCAND, V69, P1, DOI 10.3109/17453679809002344
   Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44
   Bechtel CP, 2016, J BONE JOINT SURG AM, V98, P285, DOI 10.2106/JBJS.O.00736
   Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Blaber EA, 2014, STEM CELL RES, V13, P181, DOI 10.1016/j.scr.2014.05.005
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826
   CDC/NCHS National Hospital Discharge Survey, 2010, NUMB ALL LIST PROC D
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chiu R, 2006, J BIOMED MATER RES A, V77A, P850, DOI 10.1002/jbm.a.30697
   Chiu R, 2007, J ORTHOP RES, V25, P450, DOI 10.1002/jor.20328
   Chiu R, 2009, J BIOMED MATER RES A, V89A, P242, DOI 10.1002/jbm.a.32001
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024
   Ciavarella Carmen, 2016, Methods Mol Biol, V1516, P309, DOI 10.1007/7651_2016_350
   Clohisy JC, 2003, J ORTHOPAED RES, V21, P202, DOI 10.1016/S0736-0266(02)00133-X
   Coathup MJ, 2013, J BIOMED MATER RES A, V101, P2210, DOI 10.1002/jbm.a.34536
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Croes M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132781
   Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949
   Delaine-Smith Robin M, 2012, Muscles Ligaments Tendons J, V2, P169
   DelaRosa O, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/865601
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dozza B, 2011, J ORTHOP RES, V29, P961, DOI 10.1002/jor.21333
   Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779
   Gao C, 2012, J ORTHOP RES, V30, P1183, DOI 10.1002/jor.22028
   Gibon E, 2012, BIOMATERIALS, V33, P3632, DOI 10.1016/j.biomaterials.2012.02.003
   Gill HS, 2012, TRENDS MOL MED, V18, P145, DOI 10.1016/j.molmed.2011.12.002
   GOODMAN SB, 1994, ACTA ORTHOP SCAND, V65, P1
   Goodman SB, 2006, BIOMATERIALS, V27, P6096, DOI 10.1016/j.biomaterials.2006.08.023
   Goodman Stuart B, 2013, Instr Course Lect, V62, P201
   Goodman SB, 2010, BIOMATERIALS, V31, P5045, DOI 10.1016/j.biomaterials.2010.03.046
   Greenfield EM, 2008, J AM ACAD ORTHOP SUR, V16, pS56, DOI 10.5435/00124635-200800001-00012
   Greenfield EM, 2014, CLIN ORTHOP RELAT R, V472, P3709, DOI 10.1007/s11999-014-3786-4
   Greenfield EM, 2010, J BIOL CHEM, V285, P32378, DOI 10.1074/jbc.M110.136895
   Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040
   Haleem-Smith H, 2012, J ORTHOP RES, V30, P853, DOI 10.1002/jor.22002
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hernigou P, 2014, INT ORTHOP, V38, P1913, DOI 10.1007/s00264-014-2285-2
   Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Hsu SH, 2013, STEM CELLS, V31, P2779, DOI 10.1002/stem.1441
   Huang ZN, 2010, J BIOMED MATER RES A, V94A, P1264, DOI 10.1002/jbm.a.32803
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Jager M, 2006, Int J Biomed Sci, V2, P187
   Jamsen E, 2016, J BIOMED A IN PRESS
   Jamsen E, 2014, J ORTHOP RES, V32, P1241, DOI 10.1002/jor.22658
   Jiang YP, 2013, J BIOMED MATER RES A, V101, P2817, DOI 10.1002/jbm.a.34595
   Kalia P, 2006, TISSUE ENG, V12, P1617, DOI 10.1089/ten.2006.12.1617
   Kann S, 2010, J BIOMED MATER RES A, V94A, P485, DOI 10.1002/jbm.a.32712
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Korda M, 2006, TISSUE ENG, V12, P625, DOI 10.1089/ten.2006.12.625
   Korda M, 2008, J ORTHOP RES, V26, P880, DOI 10.1002/jor.20598
   Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979
   Lassus J, 2000, ARCH ORTHOP TRAUM SU, V120, P328, DOI 10.1007/s004020050475
   Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Lee HG, 2013, AM J PHYSIOL-CELL PH, V304, pC431, DOI 10.1152/ajpcell.00202.2012
   Lee HG, 2011, BIOMATERIALS, V32, P9197, DOI 10.1016/j.biomaterials.2011.08.059
   Lee SS, 2012, BIOMATERIALS, V33, P4251, DOI 10.1016/j.biomaterials.2012.03.005
   Lepperdinger G, 2011, CURR OPIN IMMUNOL, V23, P518, DOI 10.1016/j.coi.2011.05.007
   Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287
   Lin TH, 2017, J ORTHOP RES, V35, P281, DOI 10.1002/jor.23270
   Lin TH, 2016, ACTA BIOMATER, V41, P273, DOI 10.1016/j.actbio.2016.05.038
   Lin TH, 2015, TISSUE ENG PT A, V21, P875, DOI [10.1089/ten.tea.2014.0144, 10.1089/ten.TEA.2014.0144]
   Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034
   Loi F, 2016, BONE, V86, P119, DOI [10.1016/j.bone.2016.02.0208756-3282, 10.1016/j.bone.2016.02.020]
   Loi F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0276-5
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Looney RJ, 2006, CURR OPIN RHEUMATOL, V18, P80, DOI 10.1097/01.bor.0000198004.88568.96
   Lu ZF, 2013, J CELL PHYSIOL, V228, P1737, DOI 10.1002/jcp.24330
   Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589
   Mafi R, 2011, Open Orthop J, V5 Suppl 2, P242, DOI 10.2174/1874325001105010242
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Margulies BS, 2015, J ORTHOP RES, V33, P615, DOI 10.1002/jor.22790
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mountziaris PM, 2013, J BIOMAT SCI-POLYM E, V24, P1794, DOI 10.1080/09205063.2013.803455
   Mountziaris PM, 2010, BIOMATERIALS, V31, P1666, DOI 10.1016/j.biomaterials.2009.11.058
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   O'Neill SC, 2013, BONE JOINT J, V95B, P1022, DOI 10.1302/0301-620X.95B8.31229
   OECD, 2011, HIP KNEE REPL HLTH G, P92
   Ogawa M, 2012, INT J MOL SCI, V13, P5528, DOI 10.3390/ijms13055528
   Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075
   Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048
   Pajarinen J, 2014, J MATER CHEM B, V2, P7094, DOI [10.1039/c4tb01005a, 10.1039/C4TB01005A]
   Pajarinen J, 2017, J BIOMED MATER RES A, V105, P1195, DOI 10.1002/jbm.a.35978
   Pearl JI, 2011, BIOMATERIALS, V32, P5535, DOI 10.1016/j.biomaterials.2011.04.046
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Rakow A, 2016, BIOMATERIALS, V98, P31, DOI 10.1016/j.biomaterials.2016.04.023
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142
   Ritchlin C. T., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P276
   Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452
   Samelko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067127
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Schofer MD, 2008, BIO-MED MATER ENG, V18, P395, DOI 10.3233/BME-2008-0556
   Schrock K, 2015, J ORTHOP RES, V33, P325, DOI 10.1002/jor.22765
   Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622
   Steward AJ, 2015, J ANAT, V227, P717, DOI 10.1111/joa.12243
   Stuart B, 2012, RECENT ADV ARTHROPLA, P319
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Tamaki Y, 2009, J RHEUMATOL, V36, P598, DOI 10.3899/jrheum.080390
   Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3
   Vaananen HK, 2005, ANN MED, V37, P469, DOI 10.1080/07853890500371957
   Vulcano E, 2013, EUR REV MED PHARMACO, V17, P2240
   Wang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23827
   Wang ML, 2003, J ORTHOPAED RES, V21, P697, DOI 10.1016/S0736-0266(02)00241-3
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50
   Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008
   Zhou JH, 2016, ACTA BIOMATER, V43, P358, DOI 10.1016/j.actbio.2016.07.045
NR 138
TC 8
Z9 9
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1195
EP 1207
DI 10.1002/jbm.a.35978
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300025
PM 27977880
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Andorko, JI
   Pineault, KG
   Jewell, CM
AF Andorko, James I.
   Pineault, Kevin G.
   Jewell, Christopher M.
TI Impact of molecular weight on the intrinsic immunogenic activity of
   poly(beta amino esters)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(beta amino ester); dendritic cell and lymphocyte; nanoparticle and
   microparticle; degradable biomaterial; immunology and vaccine
ID PARTICULATE VACCINE ADJUVANTS; DENDRITIC CELL MATURATION;
   POLYELECTROLYTE MULTILAYERS; IMMUNE-RESPONSE; IN-VIVO; POLYMERIC
   NANOPARTICLES; GENE DELIVERY; SHAPE; ACTIVATION; DNA
AB Polymeric carriers are ubiquitously studied in vaccine and drug delivery to control the encapsulation, kinetics, and targeting of cargo. Recent research reveals many polymers can cause immunostimulatory and inflammatory responses, even in the absence of other immune signals. However, the extent to which this intrinsic immunogenicity evolves during degradation is understudied. Here we synthesized a small library of poly(beta amino esters) (PBAEs) that exhibit different starting molecular weights (MWs), but with similar and rapid degradation rates. Primary dendritic cells (DCs) treated with free PBAEs, either intact or degraded to form low MW fragments, were not activated. In contrast particles formed from PBAEs at different extents of degradation caused differential expression of classical DC activation markers (for example, CD40, CD80, CD86, MHCII), as well as antigen presentation. During degradation, activation levels changed with changing physicochemical properties (for example, MW, concentration, size, charge). Of note, irrespective of starting MW, immunogenicity peaked when the MW of degrading PBAEs decreased to a range of similar to 1500-3000 Da. These findings could help inform design of future carriers that exploit the dynamic interactions with the immune system as materials degrade, leading to carriers that deliver cargo but also help direct the immune responses to vaccine or immunotherapy cargo. (C) 2017 Wiley Periodicals, Inc.
C1 [Andorko, James I.; Pineault, Kevin G.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD USA.
   [Jewell, Christopher M.] Univ Maryland Med Sch, Dept Microbiol & Immunol, Baltimore, MD USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
   [Jewell, Christopher M.] US Dept Vet Affairs, Biomed Lab Res & Dev, Baltimore, MD USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD USA.; Jewell, CM (reprint author), Univ Maryland Med Sch, Dept Microbiol & Immunol, Baltimore, MD USA.; Jewell, CM (reprint author), Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.; Jewell, CM (reprint author), US Dept Vet Affairs, Biomed Lab Res & Dev, Baltimore, MD USA.
EM cmjewell@umd.edu
FU American Association of Pharmaceutical Scientists; National Science
   Foundation CAREER Award [CAREER 1351688]; Alliance for Cancer Gene
   Therapy [15051543]; Damon Runyon Foundation [DRR3415]; Melanoma Research
   Alliance [348963]; Alex's Lemonade Stand Foundation for Childhood Cancer
   [27120]; National Multiple Sclerosis Society [RG-1501-02968]
FX Contract grant sponsors: American Association of Pharmaceutical
   Scientists; Contract grant sponsor: National Science Foundation CAREER
   Award; contract grant number: CAREER 1351688; Contract grant sponsor:
   Alliance for Cancer Gene Therapy; contract grant number: 15051543;
   Contract grant sponsor: Damon Runyon Foundation; contract grant number:
   DRR3415; Contract grant sponsor: Melanoma Research Alliance; contract
   grant number: 348963; Contract grant sponsor: Alex's Lemonade Stand
   Foundation for Childhood Cancer; contract grant number: 27120; Contract
   grant sponsor: National Multiple Sclerosis Society; contract grant
   number: RG-1501-02968
CR Andorko J. I., 2014, AAPS J, P1
   Andorko JI, 2017, J BIOMED MATER RES A, V105, P1219, DOI 10.1002/jbm.a.35970
   Andorko JI, 2016, ACTA BIOMATER, V32, P24, DOI 10.1016/j.actbio.2015.12.026
   Anselmo AC, 2014, ACS NANO, V8, P11243, DOI 10.1021/nn503732m
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banerjee A, 2016, J CONTROL RELEASE, V238, P176, DOI 10.1016/j.jconrel.2016.07.051
   Bechler SL, 2011, J POLYM SCI POL CHEM, V49, P1572, DOI 10.1002/pola.24578
   Benne N, 2016, J CONTROL RELEASE, V234, P124, DOI 10.1016/j.jconrel.2016.05.033
   Cai XQ, 2016, COLLOID SURFACE B, V142, P114, DOI 10.1016/j.colsurfb.2016.02.033
   Chiu YC, 2016, ACS APPL MATER INTER, V8, P18722, DOI 10.1021/acsami.6b06275
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   Gallorini S, 2007, J IMMUNOL, V179, P8208, DOI 10.4049/jimmunol.179.12.8208
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Joshi VB, 2014, AAPS J, V16, P975, DOI 10.1208/s12248-014-9624-5
   Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d
   Kozielski KL, 2014, ACS NANO, V8, P3232, DOI 10.1021/nn500704t
   Kumar S, 2015, J CONTROL RELEASE, V220, P141, DOI 10.1016/j.jconrel.2015.09.069
   Li WA, 2016, BIOMATERIALS, V83, P249, DOI 10.1016/j.biomaterials.2016.01.026
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Lynn DM, 2001, ANGEW CHEM INT EDIT, V40, P1707, DOI 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.3.CO;2-6
   Lynn GM, 2015, NAT BIOTECHNOL, V33, P1201, DOI 10.1038/nbt.3371
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Neumann S, 2014, IMMUNOL CELL BIOL, V92, P535, DOI 10.1038/icb.2014.21
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181
   Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Swartz M. A., 2012, SCI TRANSL MED, V4
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   Tostanoski LH, 2016, ACS NANO, V10, P9334, DOI 10.1021/acsnano.6b04001
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Zhang PP, 2017, BIOTECHNOL BIOENG, V114, P423, DOI 10.1002/bit.26083
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
   Zhou DZ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600102
NR 58
TC 8
Z9 9
U1 2
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2017
VL 105
IS 4
BP 1219
EP 1229
DI 10.1002/jbm.a.35970
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM0KX
UT WOS:000395008300027
PM 27977902
OA Bronze
DA 2018-10-20
ER

PT J
AU Muhamed, J
   Rajan, A
   Surendran, A
   Jaleel, A
   Anilkumar, TV
AF Muhamed, Jaseer
   Rajan, Akhila
   Surendran, Arun
   Jaleel, Abdul
   Anilkumar, Thapasimuthu V.
TI Comparative profiling of extractable proteins in extracellular matrices
   of porcine cholecyst and jejunum intended for preparation of tissue
   engineering scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE xenograft; extracellular matrix; cholecyst; scaffold; protein profile
ID SMALL-INTESTINAL SUBMUCOSA; BIOMATERIAL; ANGIOGENESIS; ANTIGENS;
   EFFICACY; BLADDER; SIS
AB Scaffolds prepared from cholecyst and jejunum have differential immunological potential, despite similar biocompatibility, when used as subcutaneous grafts. The reason for differential immunogenicity is probably due to differences in the nature of protein composition and biomolecules in the extracellular matrices (ECMs) of source organs that are used for preparation of the scaffolds. Against this background, the present study aims to identify the extractable proteins of ECMs derived from porcine cholecyst and jejunum. The proteins were extracted and identified through a conventional database search following sodium dodecyl sulfate-polyacrylamide gel-electrophoresis separation and mass spectroscopy. The resultant protein profile was analyzed and at least 154 proteins in cholecyst-derived extracellular matrix (CDE) and 186 proteins in jejunum-derived extracellular matrix (JDE) were identified. Both the matrices contained several extracelluar proteins including fibronectin, nidogen, decorin, and lumican that are known to participate in wound healing responses. However, the CDE had fewer cellular proteins than JDE, especially the latter contained class-I and class-II histocompatibility antigens which are incriminated as potent immunogens responsible for graft rejection. The results of the study suggested that the ECMs used for the scaffold preparation need not be acellular and differences in the protein composition of the ECMs might have caused the differential wound healing responses. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 489-496, 2017.
C1 [Muhamed, Jaseer; Rajan, Akhila; Anilkumar, Thapasimuthu V.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Expt Pathol, Thiruvananthapuram, Kerala, India.
   [Surendran, Arun; Jaleel, Abdul] Rajiv Gandhi Ctr Biotechnol, Dept Cardiovasc & Diabet Dis Biol, Thiruvananthapuram, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Expt Pathol, Thiruvananthapuram, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Muhamed, Jaseer/0000-0001-5046-9438
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/167/2011]
FX Mr. Jaseer is senior research fellow of Indian Council of Medical
   Research. The authors thank the financial support from the Department of
   Biotechnology, Government of India (BT/PR15461/MED/32/167/2011). The
   authors thank the Director, Meat Products of India, Edayar, Kerala,
   India for granting permission to collect and use porcine organs/tissues
   for research purposes.
CR Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200
   Burugapalli K, 2008, OBES SURG, V18, P1418, DOI 10.1007/s11695-008-9518-7
   Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476
   Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim HJ, 2009, BLOOD, V114, P5206, DOI 10.1182/blood-2009-03-212415
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   McDonald JF, 1997, BIOCHEMISTRY-US, V36, P7464, DOI 10.1021/bi962895r
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Muhamed J, 2015, J BIOMED MATER RES B, V103, P1302, DOI 10.1002/jbm.b.33296
   Muhamed J, 2015, TOXICOL PATHOL, V43, P536, DOI 10.1177/0192623314550722
   MURRAY AG, 1994, IMMUNITY, V1, P57, DOI 10.1016/1074-7613(94)90009-4
   Naziruddin B, 1998, TRANSPLANTATION, V66, P1074, DOI 10.1097/00007890-199810270-00018
   NCBI, SUS SCROF DAT
   Nischt R, 2007, J INVEST DERMATOL, V127, P545, DOI 10.1038/sj.jid.5700562
   Olack B, 2000, J IMMUNOL, V165, P1294, DOI 10.4049/jimmunol.165.3.1294
   Revi D, 2013, J TISSUE ENG, V4
   Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607
   Sakai T, 2007, AM J PATHOL, V171, P1659, DOI 10.2353/ajpath.2007.070146
   Sinno H, 2013, J DERMATOL TREAT, V24, P141, DOI 10.3109/09546634.2011.631977
   Siracusano S, 2011, EUR J OBSTET GYN R B, V158, P350, DOI 10.1016/j.ejogrb.2011.06.012
   To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21
   WANG Xiao, 2010, CONTROL THEORY, V8, P8
   Zhang WQ, 2005, BLOOD, V106, P1621, DOI 10.1182/blood-2005-02-0547
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 35
TC 1
Z9 2
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 489
EP 496
DI 10.1002/jbm.b.33567
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100003
PM 26546090
DA 2018-10-20
ER

PT J
AU Durham, JW
   Allen, MJ
   Rabiei, A
AF Durham, John W., III
   Allen, Matthew J.
   Rabiei, Afsaneh
TI Preparation, characterization and in vitro response of bioactive
   coatings on polyether ether ketone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioactive coatings; hydroxyapatite; PEEK; physical vapor deposition;
   crystallinity
ID CALCIUM-PHOSPHATE COATINGS; HYDROXYAPATITE-COATED PEEK; MC3T3-E1 CELLS;
   TEMPERATURE; IMPLANTS; POLYETHERETHERKETONE; DIFFERENTIATION;
   CRYSTALLINITY; BIOMATERIAL; DEPOSITION
AB Polyether ether ketone (PEEK) is a highly heat-resistant thermoplastic with excellent strength and elastic modulus similar to human bone, making it an attractive material for orthopedic implants. However, the hydrophobic surface of PEEK implants induces fibrous encapsulation which is unfavorable for stable implant anchorage. In this study, PEEK was coated via ion-beam-assisted deposition (IBAD) using a two-layer design of yttria-stabilized zirconia (YSZ) as a heat-protection layer, and hydroxyapatite (HA) as a top layer to improve osseointegration. Microstructural analysis of the coatings showed a dense, uniform columnar grain structure in the YSZ layer and no delamination from the substrate. The HA layer was found to be amorphous and free of porosities in its as-deposited state. Subsequent heat treatment via microwave energy followed by autoclaving crystallized the HA layer, confirmed by SEM and XRD analysis. An in vitro study using MC3T3 preosteoblast cells showed improved bioactivity in heat-treated sample groups. Cell proliferation, differentiation, and mineralization were analyzed by MTT assay and DNA content, osteocalcin expression, and Alizarin Red S (AR-S) content, respectively. Initial cell growth was increased, and osteogenic maturation and mineralization were accelerated most on coatings that underwent a combined microwave and autoclave heat treatment process as compared to uncoated PEEK and amorphous HA surfaces. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 560-567, 2017.
C1 [Durham, John W., III; Rabiei, Afsaneh] North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
   [Allen, Matthew J.] Univ Cambridge, Dept Vet Med, Cambridge, England.
RP Rabiei, A (reprint author), North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
EM arabiei@ncsu.edu
FU National Institute of Dental and Craniofacial Research of the National
   Institutes of Health [R21DE022925]
FX Contract grant sponsor: National Institute of Dental and Craniofacial
   Research of the National Institutes of Health; contract grant number:
   R21DE022925
CR Almasi D, 2014, APPL SURF SCI, V314, P1034, DOI 10.1016/j.apsusc.2014.06.074
   Bai X, 2009, ACTA BIOMATER, V5, P3563, DOI 10.1016/j.actbio.2009.05.013
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Blalock T, 2007, SURF COAT TECH, V201, P5850, DOI 10.1016/j.surfcoat.2006.10.039
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Eschbach L, 2000, INJURY, V31, pS22
   Ferguson SJ, 2006, EUR SPINE J, V15, P149, DOI 10.1007/s00586-005-0915-5
   Godara A, 2007, ACTA BIOMATER, V3, P209, DOI 10.1016/j.actbio.2006.11.005
   Hahn BD, 2013, APPL SURF SCI, V283, P6, DOI 10.1016/j.apsusc.2013.05.073
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Li N, 2014, ACS APPL MATER INTER, V6, P17134, DOI 10.1021/am5047944
   Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Ozeki K, 2010, APPL SURF SCI, V256, P7027, DOI 10.1016/j.apsusc.2010.05.018
   Rabiei A., 2012, PROCESSING BIOCOMPAT
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Wang JW, 2009, J BIOMED MATER RES A, V90A, P664, DOI 10.1002/jbm.a.32128
   Wu CY, 2015, BIO-MED MATER ENG, V26, pS155, DOI 10.3233/BME-151301
   Yang YZ, 2003, BIOMATERIALS, V24, P5131, DOI 10.1016/S0142-9612(03)00459-9
NR 24
TC 1
Z9 1
U1 9
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 560
EP 567
DI 10.1002/jbm.b.33578
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100010
PM 26613207
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Agenor, A
   Dvoracek, L
   Leu, A
   Hunter, DA
   Newton, P
   Yan, Y
   Johnson, PJ
   Mackinnon, SE
   Moore, AM
   Wood, MD
AF Agenor, Aouod
   Dvoracek, Lucas
   Leu, Ann
   Hunter, Daniel A.
   Newton, Piyaraj
   Yan, Ying
   Johnson, Philip J.
   Mackinnon, Susan E.
   Moore, Amy M.
   Wood, Matthew D.
TI Hyaluronic acid/carboxymethyl cellulose directly applied to transected
   nerve decreases axonal outgrowth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE axon growth; hyaluronate; hyaluronic acid; neuroma; peripheral nerve
ID PERIPHERAL-NERVE; SCIATIC-NERVE; NEUROTROPHIC FACTOR; NEUROMA FORMATION;
   DELIVERY-SYSTEMS; FIBRIN MATRICES; REGENERATION; ADHESION; MODEL; RAT
AB Neuroma management is an unresolved problem. Biomaterials to limit unwanted axonal growth could be a tool to manage neuroma. Hyaluronic acid/carboxymethyl cellulose (HA/CMC) is an antiadhesive, biodegradable material that is nontoxic to nerve. The purpose of this study was to evaluate the efficacy of this biomaterial to limit axonal growth. Rats received a sciatic nerve transection and repair with a short conduit (5 mm) containing HA/CMC, fibrin, or nothing (empty conduit). In another study, nerve was transected and either left undisturbed or wrapped with HA/CMC around the proximal and distal ends. In a final study, nerve was transected and repaired with an HA/CMC wrap. Four weeks following the procedures, nerves were harvested and assessed using histomorphometry to measure axonal regeneration. Axonal regeneration following transection was significantly inhibited by direct axonal contact with HA/CMC, whether within a conduit or wrapped around the transected proximal nerve end. Axonal regeneration following epineurial repair was not affected by HA/CMC wrapped around nerve, demonstrating axonal growth inhibition due to direct contact of regenerating axons with HA/CMC. These studies demonstrate the efficacy of HA/CMC to limit axonal outgrowth by contact with regenerating axons. HA/CMC barriers may prove to be a tool to prevent neuroma formation by inhibiting axonal growth. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 568-574, 2017.
C1 [Agenor, Aouod; Dvoracek, Lucas; Leu, Ann; Hunter, Daniel A.; Newton, Piyaraj; Yan, Ying; Johnson, Philip J.; Mackinnon, Susan E.; Moore, Amy M.; Wood, Matthew D.] Washington Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.
RP Moore, AM; Wood, MD (reprint author), Washington Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.
EM woodm@wudosis.wustl.edu; mooream@wudosis.wustl.edu
OI Wood, Matthew/0000-0001-8132-6827
FU Foundation for Barnes-Jewish Hospital
FX This work was supported in part by the The Foundation for Barnes-Jewish
   Hospital.
CR Adanali G, 2003, J RECONSTR MICROSURG, V19, P29, DOI 10.1055/s-2003-37188
   Beck DE, 1997, EUR J SURG, V163, P49
   Bora F W Jr, 1976, J Hand Surg Am, V1, P138
   Burns JW, 1997, EUR J SURG, V163, P40
   DELLON AL, 1984, ANN PLAS SURG, V12, P30, DOI 10.1097/00000637-198401000-00006
   DELLON AL, 1986, PLAST RECONSTR SURG, V77, P427, DOI 10.1097/00006534-198603000-00016
   Diamond MP, 2010, SURG INNOV, V17, P183, DOI 10.1177/1553350610379869
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   Dorsi MJ, 2008, PAIN, V134, P320, DOI 10.1016/j.pain.2007.06.030
   Fox DJ, 1999, RESTOR NEUROL NEUROS, V15, P319
   Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018
   LANE JM, 1978, J BONE JOINT SURG AM, V60, P197, DOI 10.2106/00004623-197860020-00010
   Lee M, 2000, MUSCLE NERVE, V23, P633, DOI 10.1002/(SICI)1097-4598(200004)23:4<633::AID-MUS24>3.0.CO;2-Q
   MACKINNON S E, 1988, Microsurgery, V9, P95, DOI 10.1002/micr.1920090208
   Mackinnon S E, 1997, Tech Hand Up Extrem Surg, V1, P195, DOI 10.1097/00130911-199709000-00007
   MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P384, DOI 10.1097/00006534-198503000-00014
   MACKINNON SE, 1985, PLAST RECONSTR SURG, V76, P345, DOI 10.1097/00006534-198509000-00001
   MACKINNON SE, 1985, ANN PLAS SURG, V14, P428, DOI 10.1097/00000637-198505000-00005
   Magill CK, 2009, J RECONSTR MICROSURG, V25, P345, DOI 10.1055/s-0029-1215526
   MEYER RA, 1985, BRAIN RES, V325, P255, DOI 10.1016/0006-8993(85)90321-X
   MIDHA R, 1994, J NEUROPATH EXP NEUR, V53, P316, DOI 10.1097/00005072-199405000-00013
   Midha R, 1997, J NEUROPATH EXP NEUR, V56, P421, DOI 10.1097/00005072-199704000-00011
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Sanders Richard J, 2007, Hand (N Y), V2, P179, DOI 10.1007/s11552-007-9044-4
   Sikkink Cornelis J J M, 2007, Surg Technol Int, V16, P19
   Suresh A, 2011, SURG ENDOSC, V25, P2661, DOI 10.1007/s00464-011-1624-2
   Tintle SM, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00197
   Tintle SM, 2014, J ORTHOP TRAUMA, V28, P232, DOI 10.1097/BOT.0b013e3182a53130
   Tintle SM, 2012, J ORTHOP TRAUMA, V26, P123, DOI 10.1097/BOT.0b013e318214fd7b
   Vernadakis AJ, 2003, CLIN PLAST SURG, V30, P247, DOI 10.1016/S0094-1298(02)00104-9
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2010, J BIOMAT SCI-POLYM E, V21, P771, DOI 10.1163/156856209X445285
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Zawaneh PN, 2008, TISSUE ENG PART B-RE, V14, P377, DOI 10.1089/ten.teb.2008.0226
NR 34
TC 1
Z9 1
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 568
EP 574
DI 10.1002/jbm.b.33576
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100011
PM 26621079
DA 2018-10-20
ER

PT J
AU Weiss, R
   Eichhorn, T
   Spittler, A
   Micusik, M
   Fischer, MB
   Weber, V
AF Weiss, Rene
   Eichhorn, Tanja
   Spittler, Andreas
   Micusik, Matej
   Fischer, Michael B.
   Weber, Viktoria
TI Release and cellular origin of extracellular vesicles during circulation
   of whole blood over adsorbent polymers for lipid apheresis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adsorption; lipid apheresis; polymers; microvesicles; hemocompatibility
ID LOW-DENSITY-LIPOPROTEIN; PROTEIN ADSORPTION; CYTOKINE PATTERN;
   LDL-APHERESIS; IN-VITRO; PLATELETS; MICROPARTICLES; COMPATIBILITY;
   ATHEROSCLEROSIS; MICROVESICLES
AB Whole blood lipid apheresis is clinically applied in patients with familial hypercholesterolemia to reduce low density lipoprotein and other apolipoprotein B 100 containing lipoproteins. Here, the hemocompatibility of two polyacrylate-coated polyacrylamide-based polymers for lipid apheresis by evaluating the adhesion of blood cells to the adsorbent polymers, their respective activation, as well as the release of microvesicles during circulation of whole blood over the polymers was studied. Characterization of the adsorbents by scanning electron microscopy, atomic force microscopy, and X-ray photoelectron spectroscopy revealed differences with respect to their surface morphology and their surface chemical composition. Despite these differences, equivalent amounts of leukocytes and platelets adhered to both polymers during circulation of whole blood over the adsorbent columns. The release of phosphatidylserine-exposing microvesicles, in contrast, increased significantly with increasing surface roughness and with the amount of polyacrylate groups at the adsorbent surface. The majority of microvesicles generated during blood-material contact were platelet-derived, and their release was associated with enhanced thrombin generation. Microvesicles were present in free and in cell-bound form, and 75% of all monocytes, but only 0.2% and 2.3% of red blood cells and platelets, respectively, were associated with microvesicles, pointing to a role of monocytes in the clearance of released microvesicles. Taken together, microvesicles are sensitive indicators for biomaterial-induced activation of blood cells in apheresis. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 636-646, 2017.
C1 [Weiss, Rene; Eichhorn, Tanja; Fischer, Michael B.; Weber, Viktoria] Danube Univ Krems, Dept Hlth Sci & Biomed, Christian Doppler Lab Innovat Therapy Approaches, Krems, Austria.
   [Spittler, Andreas] Med Univ Vienna, Core Facil Flow Cytometry Surg Res Labs, Vienna, Austria.
   [Micusik, Matej] Slovak Acad Sci, Inst Polymer, Bratislava, Slovakia.
   [Fischer, Michael B.] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria.
RP Weber, V (reprint author), Danube Univ Krems, Dept Hlth Sci & Biomed, Christian Doppler Lab Innovat Therapy Approaches, Krems, Austria.
EM viktoria.weber@donau-uni.ac.at
FU Christian Doppler Society (Christian Doppler Laboratory for Innovative
   Therapy Approaches in Sepsis)
FX Contract grant sponsor: The Christian Doppler Society (Christian Doppler
   Laboratory for Innovative Therapy Approaches in Sepsis)
CR Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554
   Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919
   Badrnya S, 2012, THROMB HAEMOSTASIS, V108, P719, DOI 10.1160/TH12-03-0206
   Bosch T, 2000, ARTIF ORGANS, V24, P81, DOI 10.1046/j.1525-1594.2000.06476.x
   Connolly KD, 2014, J LIPID RES, V55, P2064, DOI 10.1194/jlr.M049726
   Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644
   Danesh A, 2014, BLOOD, V123, P687, DOI 10.1182/blood-2013-10-530469
   Dihazi H, 2008, NEPHROL DIAL TRANSPL, V23, P2925, DOI 10.1093/ndt/gfn127
   Drager LJ, 1998, EUR J CLIN INVEST, V28, P994
   Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   Key NS, 2010, THROMB RES, V125, pS42, DOI 10.1016/j.thromres.2010.01.035
   Kopprasch S, 2009, ATHEROSCLEROSIS SUPP, V10, P34, DOI 10.1016/S1567-5688(09)71807-0
   Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x
   Luciani N, 2010, BIOMATERIALS, V31, P7061, DOI 10.1016/j.biomaterials.2010.05.062
   Maiolino G, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/714653
   Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875
   Neumann CL, 2013, ATHEROSCLEROSIS SUPP, V14, P29, DOI 10.1016/j.atherosclerosissup.2012.10.017
   Nielsen MH, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.20795
   Ono S, 2004, AM J SURG, V188, P150, DOI 10.1016/j.amjsurg.2003.12.067
   Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056
   Peng ZY, 2012, KIDNEY INT, V81, P363, DOI 10.1038/ki.2011.320
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Rimmele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12587
   Sadallah S, 2011, J IMMUNOL, V186, P6543, DOI 10.4049/jimmunol.1002788
   Schildberger A, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/697972
   Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313
   Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804
   Spronk HMH, 2014, THROMB RES, V133, pS54, DOI 10.1016/j.thromres.2014.03.022
   Stefanutti C, 2011, CYTOKINE, V56, P842, DOI 10.1016/j.cyto.2011.08.027
   Stefanutti C, 2011, CYTOKINE, V56, P835, DOI 10.1016/j.cyto.2011.08.024
   Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890
   Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878
   Weber V, 2008, BIOMACROMOLECULES, V9, P1322, DOI 10.1021/bm701396n
   Weiss R, 2014, BIOMACROMOLECULES, V15, P2648, DOI 10.1021/bm500492r
   Winters JL, 2011, J CLIN APHERESIS, V26, P269, DOI 10.1002/jca.20299
   Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 38
TC 5
Z9 5
U1 3
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 636
EP 646
DI 10.1002/jbm.b.33588
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100018
PM 26671881
DA 2018-10-20
ER

PT J
AU Horst, M
   Milleret, V
   Noetzli, S
   Gobet, R
   Sulser, T
   Eberli, D
AF Horst, Maya
   Milleret, Vincent
   Noetzli, Sarah
   Gobet, Rita
   Sulser, Tullio
   Eberli, Daniel
TI Polyesterurethane and acellular matrix based hybrid biomaterial for
   bladder engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE urinary bladder; tissue engineering; polyesterurethane; acellular
   matrix; hybrid scaffold
ID MESENCHYMAL-EPITHELIAL INTERACTIONS; SMALL-INTESTINAL SUBMUCOSA;
   SMOOTH-MUSCLE DEVELOPMENT; TENDON RUPTURE REPAIR; IN-VITRO;
   MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS; TISSUE REGENERATION;
   INCREASED POROSITY; CELLULAR-RESPONSE
AB Poly(lactic-co-glycolic acid) (PLGA) based biomaterials for soft tissue engineering have inherent disadvantages, such as a relative rigidity and a limited variability in the mechanical properties and degradation rates. In this study, a novel electrospun biomaterial based on degradable polyesterurethane (PEU) (DegraPol((R))) was investigated for potential use for bladder engineering in vitro and in vivo. Hybrid microfibrous PEU and PLGA scaffolds were produced by direct electrospinning of the polymer onto a bladder acellular matrix. The scaffold morphology of the scaffold was analyzed, and the biological performance was tested in vitro and in vivo using a rat cystoplasty model. Anatomical and functional outcomes after implantation were analyzed macroscopically, histologically and by cystometry, respectively. Scanning electron microscopy analysis showed that PEU samples had a lower porosity (p<0.001) and were slightly thinner (p=0.009) than the PGLA samples. Proliferation and survival of the seeded smooth muscle cells in vitro were comparable on PEU and PLGA scaffolds. After 8 weeks in vivo, the PEU scaffolds exhibited no shrinkage. However, cystometry of the reconstructed bladders exhibited a slightly greater functional bladder capacity in the PLGA group. Morphometric analyses revealed significantly better tissue healing (p<0.05) and, in particular, better smooth muscle regeneration, as well as a lower rate of inflammatory responses at 8 weeks in the PEU group. Collectively, the results indicated that PEU-hybrid scaffolds promote bladder tissue formation with excellent tissue integration and a low inflammatory reaction in vivo. PEU is a promising biomaterial, particularly with regard to functional tissue engineering of the bladder and other hollow organs. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 658-667, 2017.
C1 [Horst, Maya; Noetzli, Sarah; Sulser, Tullio; Eberli, Daniel] Univ Zurich Hosp, Dept Urol, Lab Tissue Engn & Stem Cell Therapy, Zurich, Switzerland.
   [Horst, Maya; Gobet, Rita] Univ Childrens Hosp, Div Pediat Urol, Zurich, Switzerland.
   [Milleret, Vincent] Univ Zurich Hosp, Dept Obstet, Lab Cell & Tissue Engn, Zurich, Switzerland.
RP Eberli, D (reprint author), Univ Zurich Hosp, Dept Urol, Lab Tissue Engn & Stem Cell Therapy, Zurich, Switzerland.
EM daniel.eberli@usz.ch
CR Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Baskin L, 2001, J UROLOGY, V165, P1283, DOI 10.1016/S0022-5347(05)66514-7
   Buschmann J, 2015, J TISSUE ENG REGEN M, V9, P584, DOI 10.1002/term.1624
   Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI [10.1089/ten.tea.2010.0278, 10.1089/ten.TEA.2010.0278]
   Buschmann J, 2013, J TISSUE ENG REGEN M, V7, P413, DOI 10.1002/term.538
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Chen W, 2010, J UROLOGY, V183, P2432, DOI 10.1016/j.juro.2010.02.042
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026
   DiSandro MJ, 1998, J UROLOGY, V160, P1040, DOI 10.1016/S0022-5347(01)62694-6
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Heise RL, 2009, TISSUE ENG PT A, V15, P3951, DOI [10.1089/ten.tea.2009.0044, 10.1089/ten.TEA.2009.0044]
   Horst M, 2014, J BIOMED MATER RES A, V102, P2116, DOI 10.1002/jbm.a.34889
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Krynauw H, 2011, J BIOMED MATER RES B, V99B, P359, DOI 10.1002/jbm.b.31907
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Milleret V, 2011, EUR CELLS MATER, V21, P286, DOI 10.22203/eCM.v021a22
   Milleret V, 2009, J BIOMED MATER RES B, V91B, P109, DOI 10.1002/jbm.b.31379
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Rohman G, 2007, BIOMATERIALS, V28, P2264, DOI 10.1016/j.biomaterials.2007.01.032
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   Simonet M, 2007, POLYM ENG SCI, V47, P2020, DOI 10.1002/pen.20914
   Stoll C, 2011, BIOMATERIALS, V32, P4806, DOI 10.1016/j.biomaterials.2011.03.026
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 37
TC 1
Z9 2
U1 4
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 658
EP 667
DI 10.1002/jbm.b.33591
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100020
PM 26669507
DA 2018-10-20
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Protein adsorption, platelet adhesion, and bacterial adhesion to
   polyethylene-glycol-textured polyurethane biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE protein adsorption; platelet adhesion; bacterial adhesion; PEG; textured
ID GRAFTED POLY(ETHYLENE GLYCOL); VENTRICULAR ASSIST DEVICE;
   STAPHYLOCOCCUS-EPIDERMIDIS; FIBRINOGEN ADSORPTION; BIOFILM FORMATION;
   VASCULAR GRAFTS; GLOW-DISCHARGE; CELL BEHAVIOR; OXIDE); BIOCOMPATIBILITY
AB Traditional strategies for surface modification to enhance the biocompatibility of biomaterials often focus on a single route utilizing either chemical or physical approaches. This study combines the chemical and physical treatments as applied to poly(urethane urea) (PUU) biomaterials to enhance biocompatibility at the interface for inhibiting platelet-related thrombosis or bacterial adhesion-induced microbial infections. PUU films were first textured with submicron patterns by a soft lithography two-stage replication process, and then were grafted with polyethylene glycol (PEG). A series of biological response experiments including protein adsorption, platelet adhesion/activation, and bacterial adhesion/biofilm formation showed that PEG-grafted submicron textured biomaterial surfaces were resistant to protein adsorption, and greatly increased the efficiency in reducing both platelet adhesion/activation and bacterial adhesion/biofilm formation due to the additive effects of physical topography and grafted PEG. Results suggest that a combination of chemical modification and surface texturing will be more efficient in preventing biomaterial-associated thrombosis and infection of biomaterials. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 668-678, 2017.
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Bioengn, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Xu, LC (reprint author), Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Hershey, PA 17033 USA.
EM lxx5@psu.edu
FU Surgery Feasibility Grant of Penn State College of Medicine
FX Contract grant sponsor: Surgery Feasibility Grant of Penn State College
   of Medicine
CR Aksoy EA, 2008, J BIOACT COMPAT POL, V23, P505, DOI 10.1177/0883911508097422
   Alibeik S, 2010, COLLOID SURFACE B, V81, P389, DOI 10.1016/j.colsurfb.2010.07.024
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Amiji M.M., 1995, ENCY HDB BIOMATERIAL
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Ayres N, 2010, POLYM CHEM-UK, V1, P769, DOI 10.1039/b9py00246d
   Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2008, COLLOID SURFACE B, V61, P237, DOI 10.1016/j.colsurfb.2007.08.012
   Chong DST, 2014, EUR J VASC ENDOVASC, V47, P566, DOI 10.1016/j.ejvs.2014.02.007
   Clauser J, 2014, J BIOMAT SCI-POLYM E, V25, P504, DOI 10.1080/09205063.2013.879561
   Du YJ, 2007, J BIOMED MATER RES A, V80, P216
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   Garcia A., 2008, PRINCIPLES REGENERAT, P656
   Geer CB, 2007, ACTA BIOMATER, V3, P663, DOI 10.1016/j.actbio.2007.03.004
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Guney A, 2013, BIOMATERIALS SURFACE SCIENCE, P89
   Hantgan RR, 1994, HEMOSTASIS THROMBOSI, P277
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/ERD.12.82, 10.1586/erd.12.82]
   Hsu SH, 2005, MACROMOL BIOSCI, V5, P246, DOI 10.1002/mabi.200400163
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   Josefsson E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002206
   Kanyanta V, 2010, J MECH BEHAV BIOMED, V3, P51, DOI 10.1016/j.jmbbm.2009.03.005
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Linnes JC, 2012, J BIOMED MATER RES A, V100A, P1990, DOI 10.1002/jbm.a.34036
   Lorenzetti M, 2015, ACS APPL MATER INTER, V7, P1644, DOI 10.1021/am507148n
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Milner KR, 2005, ASAIO J, V51, P578, DOI 10.1097/01.mat.0000171594.44974.89
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Nonckreman CJ, 2010, COLLOID SURFACE B, V77, P139, DOI 10.1016/j.colsurfb.2010.01.014
   Oliveira SM, 2011, SOFT MATTER, V7, P8932, DOI 10.1039/c1sm05943b
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Pereda D, 2011, CARDIOL CLIN, V29, P515, DOI 10.1016/j.ccl.2011.08.004
   Perera-Costa D, 2014, LANGMUIR, V30, P4633, DOI 10.1021/la5001057
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611
   Ren ZC, 2013, J APPL POLYM SCI, V127, P308, DOI 10.1002/app.37885
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Salim M, 2007, LAB CHIP, V7, P64, DOI 10.1039/b612521m
   Sanchis MR, 2007, J APPL POLYM SCI, V105, P1077, DOI 10.1002/app.26250
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   Shenkman B, 2000, J LAB CLIN MED, V135, P43, DOI 10.1016/S0022-2143(00)70019-9
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Vasudevan R, 2014, COLLOID SURFACE B, V117, P225, DOI 10.1016/j.colsurfb.2014.02.037
   Xu L.-C., 2012, J BIOMATER NANOBIOTE, V3, P487
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xu LC, 2015, RSC SMART MATER, V10, P365
   Xu LC, 2014, COLLOID SURFACE B, V124, P49, DOI 10.1016/j.colsurfb.2014.09.040
   Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 73
TC 6
Z9 6
U1 4
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2017
VL 105
IS 3
BP 668
EP 678
DI 10.1002/jbm.b.33592
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN5DF
UT WOS:000396025100021
PM 26669615
DA 2018-10-20
ER

PT J
AU Opell, BD
   Buccella, KE
   Godwin, MK
   Rivas, MX
   Hendricks, ML
AF Opell, Brent D.
   Buccella, Katrina E.
   Godwin, Meaghan K.
   Rivas, Malik X.
   Hendricks, Mary L.
TI Humidity-mediated changes in an orb spider's glycoprotein adhesive
   impact prey retention time
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Adhesion; Araneus marmoreus; Biomaterial; Extended phenotypic
   plasticity; Orb web; Viscous capture thread
ID CAPTURE THREADS SPUN; WEAVING SPIDERS; VISCOUS THREAD; WEB; DROPLETS;
   GLUE; EVOLUTION; PERFORMANCE; VOLUME; RARE
AB Properties of the viscous prey capture threads of araneoid orb spiders change in response to their environment. Relative humidity (RH) affects the performance of the thread's hygroscopic droplets by altering the viscoelasticity of each droplet's adhesive glycoprotein core. Studies that have characterized this performance used smooth glass and steel surfaces and uniform forces. In this study, we tested the hypothesis that these changes in performance translate into differences in prey retention times. We first characterized the glycoprotein contact surface areas and maximum extension lengths of Araneus marmoreus droplets at 20%, 37%, 55%, 72% and 90% RH and then modeled the relative work required to initiate pull-off of a 4 mm thread span, concluding that this species' droplets and threads performed optimally at 72% RH. Next, we evaluated the ability of three equally spaced capture thread strands to retain a house fly at 37%, 55% and 72% RH. Each fly's struggle was captured in a video and bouts of active escape behavior were summed. House flies were retained 11 s longer at 72% RH than at 37% and 55% RH. This difference is ecologically significant because the short time after an insect strikes a web and before a spider begins wrapping it is an insect's only opportunity to escape from the web. Moreover, these results validate the mechanism by which natural selection can tune the performance of an orb spider's capture threads to the humidity of its habitat.
C1 [Opell, Brent D.; Buccella, Katrina E.; Rivas, Malik X.; Hendricks, Mary L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
   [Godwin, Meaghan K.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.
RP Opell, BD (reprint author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
EM bopell@vt.edu
FU National Science Foundation [IOS-1257719]
FX National Science Foundation grant IOS-1257719 supported this study.
CR Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003
   Amarpuri G, 2015, ACS NANO, V9, P11472, DOI 10.1021/acsnano.5b05658
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blamires SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26383
   Blamires SJ, 2010, J EXP BIOL, V213, P3207, DOI 10.1242/jeb.045583
   Boutry C., 2013, SPIDERS MORPHOLOGY B, P1
   Boutry C, 2013, J EXP BIOL, V216, P3606, DOI 10.1242/jeb.084236
   Bradley R. A., 2013, COMMON SPIDERS N AM
   Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29
   Dawkins R., 1982, EXTENDED PHENOTYPE L
   Eberhard W.G., 1989, Bulletin of the British Arachnological Society, V8, P45
   Eberhard WG, 2013, J ARACHNOL, V41, P76, DOI 10.1636/B12-34.1
   EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055
   FASOLA M, 1995, B ZOOL, V62, P159, DOI 10.1080/11250009509356064
   Herberstein Marie E., 2011, P57
   JENNINGS DT, 2007, SPIDERS ARACHNIDA AR
   Liao CP, 2015, J ARACHNOL, V43, P97, DOI 10.1636/M14-50.1
   Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952
   Opell BD, 2015, J ARACHNOL, V43, P152
   Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822
   Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996
   Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064
   Sahni V, 2014, BIOL INSPIR SYST, V5, P203, DOI 10.1007/978-94-007-7119-2_11
   Sahni V, 2014, BIOMACROMOLECULES, V15, P1225, DOI 10.1021/bm401800y
   Sahni V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00041
   Scharf I, 2011, BIOL REV, V86, P626, DOI 10.1111/j.1469-185X.2010.00163.x
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   Stellwagen SD, 2015, J EXP BIOL, V218, P2675, DOI 10.1242/jeb.123067
   Stellwagen SD, 2014, J EXP BIOL, V217, P1563, DOI 10.1242/jeb.097816
   Townley M. A., 2013, SPIDER ECOPHYSIOLOGY, P283
   Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147
   TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203
   TOWNLEY MA, 1988, J ARACHNOL, V16, P303
   Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   Wu CC, 2013, J EXP BIOL, V216, P3342, DOI 10.1242/jeb.083618
   Zschokke S, 2015, BIOL J LINN SOC, V114, P659, DOI 10.1111/bij.12456
NR 38
TC 3
Z9 3
U1 0
U2 9
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD APR 1
PY 2017
VL 220
IS 7
BP 1313
EP 1321
DI 10.1242/jeb.148080
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EP8IW
UT WOS:000397620100026
PM 28356367
OA Bronze
DA 2018-10-20
ER

PT J
AU Yoo, F
   Wang, MB
   Bergsneider, M
   Suh, JD
AF Yoo, Frederick
   Wang, Marilene B.
   Bergsneider, Marvin
   Suh, Jeffrey D.
TI Single Layer Repair of Large Anterior Skull Base Defects without
   Vascularized Mucosal Flap
SO JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE
LA English
DT Article
DE anterior cranial fossa; skull base; skull base neoplasm; paranasal sinus
   neoplasms; reconstructive surgical procedures; biocompatible materials
ID ENDOSCOPIC RECONSTRUCTION; RESECTION; OUTCOMES; MALIGNANCIES; SURGERY;
   TUMORS
AB Objectives Bilateral anterior skull base (ASB) defects following endoscopic endonasal tumor resection are most commonly repaired utilizing multilayered reconstruction with a vascularized mucosal flap. Single-layer closure of large ASB defects has been described in the literature but this technique has yet to gain a widespread use. We report our experience with a series of patients who underwent reconstruction of large ASB defects using a single-layer intradural graft, without nasoseptal flaps. We also compared the use of acellular dermal matrix (AlloDerm, LifeCell, Branchburg, New Jersey, United States) or collagen matrix xenograft (Duramatrix, Stryker, Kalamazoo, Michigan, United States) as the graft biomaterial.
   Design A retrospective case series.
   Setting Tertiary academic medical center.
   Main Outcome Measures Postoperative cerebrospinal fluid leak, the number of postoperative debridements, the number of postoperative infections, and time to remucosalization.
   Results Two patients were reconstructed with AlloDerm and three with Duramatrix, with all patients receiving postoperative external beam radiation. There were no postoperative cerebrospinal fluid leaks identified in these patients during follow-up. The AlloDerm group showed increased postsurgical crusting, the number of clinically apparent postoperative infections, and an increased time to remucosalization.
   Conclusions Single-layer repair without a vascularized mucosal flap is a viable method of skull base repair for large ASB defects. We found repair with Duramatrix was superior, with less graft crusting and infection, requiring fewer debridements.
C1 [Yoo, Frederick; Wang, Marilene B.; Suh, Jeffrey D.] UCLA David Geffen Sch Med, Dept Head & Neck Surg, 10833 Le Conte Ave 62-132 CHS, Los Angeles, CA 90095 USA.
   [Bergsneider, Marvin] UCLA David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.
RP Yoo, F (reprint author), UCLA David Geffen Sch Med, Dept Head & Neck Surg, 10833 Le Conte Ave 62-132 CHS, Los Angeles, CA 90095 USA.
EM fyoo@mednet.ucla.edu
CR Battaglia P, 2015, NEUROSURGERY, V11, P462
   Battaglia P, 2015, OPER NEUROSURG, V11, P457, DOI 10.1227/NEU.0000000000000859
   Bernal-Sprekelsen M, 2014, BIOMED RES INT, V2014
   Chin D, 2013, ADV OTO-RHINO-LARYNG, V74, P104, DOI 10.1159/000342285
   Clavenna MJ, 2015, CURR OPIN OTOLARYNGO, V23, P71, DOI 10.1097/MOO.0000000000000115
   Eloy JA, 2013, INT FORUM ALLERGY RH, V3, P204, DOI 10.1002/alr.21089
   Eloy JA, 2012, LARYNGOSCOPE, V122, P2652, DOI 10.1002/lary.23539
   Germani RM, 2007, AM J RHINOL, V21, P615, DOI 10.2500/ajr.2007.21.3080
   Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.c4
   Hanson M, 2015, J LARYNGOL OTOL, V129, pS41, DOI 10.1017/S002221511500047X
   Harvey RJ, 2012, LARYNGOSCOPE, V122, P452, DOI 10.1002/lary.22475
   Pant H, 2010, SKULL BASE-INTERD AP, V20, P35, DOI 10.1055/s-0029-1242983
   Patel MR, 2014, LARYNGOSCOPE, V124, P846, DOI 10.1002/lary.24319
   Patel MR, 2010, SKULL BASE-INTERD AP, V20, P397, DOI 10.1055/s-0030-1253573
   Suh JD, 2013, ANN OTO RHINOL LARYN, V122, P54, DOI 10.1177/000348941312200110
   Zanation AM, 2009, LARYNGOSCOPE, V119, P13, DOI 10.1002/lary.20022
   Zuniga MG, 2016, CURR OPIN OTOLARYNGO, V24, P75, DOI 10.1097/MOO.0000000000000223
NR 17
TC 1
Z9 1
U1 0
U2 2
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 2193-6331
EI 2193-634X
J9 J NEUROL SURG PART B
JI Journal of Neurol. Surg. Part B
PD APR
PY 2017
VL 78
IS 2
BP 139
EP 144
DI 10.1055/s-0036-1593438
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA ER0HK
UT WOS:000398468700007
PM 28321377
OA Green Published
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
   Chapon, P
   Dudek, L
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steinar
   Chapon, Patrick
   Dudek, Lukasz
TI GDOES, XPS, and SEM with EDS analysis of porous coatings obtained on
   titanium after plasma electrolytic oxidation
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE glow discharge optical emission spectroscopy (GDOES); plasma
   electrolytic oxidation (PEO); porous coatings; titanium; X-ray
   photoelectron spectroscopy (XPS)
ID COPPER; LAYERS; ALLOY; FILMS; ANTIBACTERIAL; TI; BIOMATERIAL;
   PASSIVATION; DEPOSITION; LASER
AB In the paper, the glow discharge optical emission spectroscopy, X-ray photoelectron spectroscopy, scanning electron microscopy, and energy-dispersive X-ray spectroscopy results of a commercial purity titanium grade 2 after plasma electrolytic oxidation (PEO), also known as micro arc oxidation (MAO), are presented. The PEO treatment was performed in the electrolyte containing concentrated (85%) phosphoric acid with copper nitrate at the voltage of 45010V for 1min. For the electrolyte, copper nitrate addition from 300 to 600g/l was used. Porous coatings of specific properties were obtained. The measurements results allow to state that the copper and nitrogen ions can be introduced into the surface layer formed on pure titanium by the plasma electrolytic oxidation. The distributions of these elements were detected to depend on the electrolyte composition, with the highest amounts revealed in the coating created in the electrolyte containing 600g Cu(NO3)(2) in 1l H3PO4. Three sub-layers of the coating, displayed in this work by two models, were developed in the study. The analysis performed shows that under the PEO treatment in each of the electrolytes used, the formation of coating with the top sub-layers always enriched in copper compounds was found. Copyright (c) 2016 John Wiley & Sons, Ltd.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Dudek, Lukasz] Koszalin Univ Technol, Dept Engn & Informat Syst, Div Bioengn & Surface Elect, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] Norwegian Univ Sci & Technol, Dept Phys, Realfagbygget E3-124 Hogskoleringen 5, NO-7491 Trondheim, Norway.
   [Chapon, Patrick] HORIBA Jobin Yvon SAS, 16-18 Rue Canal, F-91165 Longjumeau, France.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Dept Engn & Informat Syst, Div Bioengn & Surface Elect, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
RI Hryniewicz, Tadeusz/N-3520-2018
CR [Anonymous], 1999, 42871999 EN ISO
   [Anonymous], 4768 DIN
   Bai B, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5600-6
   Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086
   Casa Software Ltd, CASAXPS PROC SOFTW X
   Fernandez AM, 2008, BOL SOC ESP CERAM V, V47, P259, DOI 10.3989/cyv.2008.v47.i5.164
   Fuge GM, 2003, DIAM RELAT MATER, V12, P1049, DOI 10.1016/S0925-9635(02)00357-6
   Gandikota S, 2000, MICROELECTRON ENG, V50, P547, DOI 10.1016/S0167-9317(99)00326-3
   Hatano Y, 2012, FUSION ENG DES, V87, P1091, DOI 10.1016/j.fusengdes.2012.02.078
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T., 2008, SURFACE COATINGS TEC, V203, P1508, DOI DOI 10.1016/J.SURFC0AT.2008.11.028
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Jin FY, 2006, MATER CHEM PHYS, V100, P31, DOI 10.1016/j.matchemphys.2005.12.001
   Lee JY, 2009, J R SOC INTERFACE, V6, P801, DOI 10.1098/rsif.2008.0403
   Lee SY, 2006, SOLID STATE PHENOMEN, V116-117, P84, DOI 10.4028/www.scientific.net/SSP.116-117.84
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Nelis T., 2004, GLOW DISCHARGE OPTIC, P197
   Parajulee S., 2009, PLASMA FUSION RES LE, V4, DOI DOI 10.1585/PFR.4.055
   Payling R, 1997, GLOW DISCHARGE OPTICAL EMISSION SPECTROMETRY, P20
   Piszczek P, 2013, CHEM VAPOR DEPOS, V19, P251, DOI 10.1002/cvde.201207049
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokosz K., 2016, WORLD SCI NEWS, V35, P44
   Rokosz K, 2016, INT J ADV MANUF TECH, V87, P3497, DOI 10.1007/s00170-016-8692-3
   Rokosz K, 2016, J NANOSCI NANOTECHNO, V16, P7814, DOI 10.1166/jnn.2016.12558
   Rokosz K, 2016, MATERIALS, V9, DOI 10.3390/ma9050318
   Rokosz K, 2016, INT J ADV MANUF TECH, V85, P2425, DOI 10.1007/s00170-015-8086-y
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   StatSoft Inc, 2011, STATISTICA DAT AN SO
   Suzuki S., 2005, J SURF ANAL, V12, P174
   Toh BHW, 2005, J MATER SCI-MATER EL, V16, P437, DOI 10.1007/s10854-005-2311-7
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Vidal CV, 2012, J ELECTROCHEM SOC, V159, pC233, DOI 10.1149/2.090205jes
   Wagner C. D., 2003, NIST STANDARD REFERE, V20
   Weiss K, 2000, MICROELECTRON ENG, V50, P433, DOI 10.1016/S0167-9317(99)00312-3
   Wienecke M., 2013, SCHLUSSBERICHT ZUM V, P1
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
   Zhu W, 2013, J MATER SCI TECHNOL, V29, P237, DOI 10.1016/j.jmst.2012.12.015
NR 46
TC 8
Z9 8
U1 13
U2 45
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD APR
PY 2017
VL 49
IS 4
BP 303
EP 315
DI 10.1002/sia.6136
PG 13
WC Chemistry, Physical
SC Chemistry
GA EP6NS
UT WOS:000397496800010
DA 2018-10-20
ER

PT J
AU Shchukarev, A
   Ramstedt, M
AF Shchukarev, Andrey
   Ramstedt, Madeleine
TI Cryo-XPS: probing intact interfaces in nature and life
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE cryogenic XPS; solid-aqueous solution interface; electrical double
   layer; cell wall composition
ID RAY-PHOTOELECTRON-SPECTROSCOPY; FROZEN HEMATITE COLLOIDS; MANGANITE
   GAMMA-MNOOH; BACILLUS-SUBTILIS; SURFACE SCIENCE; AQUEOUS-SOLUTIONS;
   COORDINATION CHEMISTRY; ESCA INVESTIGATIONS; CHLORIDE-IONS; LIQUIDS
AB Experimental studies of solid-aqueous solution interfaces are of great importance for reaching a better chemical understanding of interfacial phenomena at the molecular level. This perspective article presents a recently developed approach for investigation of intact interfaces, based on fast freezing of centrifuged wet pastes followed by traditional XPS measurements at liquid nitrogen temperatures. Sample preparation and handling protocols, applicable to any suspension or gel, are discussed in detail. For mineral suspensions, cryogenic XPS is an important complement to traditional analyses of supernatant solutions and dry solids that is capable of revealing novel insights of the electrical double layer in terms of structure and composition. It can be used to study changes in the biochemistry of bacterial cell walls as influenced by external stimuli, and interfacial features related to biocompatibility of implant materials. Herein we review how the technique has been applied to minerals in electrolyte solutions, intact bacterial surfaces, and biomaterial interfaces in biologically relevant media, and highlight some future requirements for development of interface analysis methodologies. Copyright (c) 2016 John Wiley & Sons, Ltd.
C1 [Shchukarev, Andrey; Ramstedt, Madeleine] Umea Univ, Dept Chem, S-90187 Umea, Sweden.
RP Shchukarev, A (reprint author), Umea Univ, Dept Chem, S-90187 Umea, Sweden.
EM andrey.shchukarev@umu.se
OI Ramstedt, Madeleine/0000-0003-2646-8501; Shchukarev,
   Andrey/0000-0002-4766-2672
FU Umea University
FX Funding from the strong research area at Umea University, 'The
   Environment's Chemistry-from molecule to ecosystem', is gratefully
   acknowledged.
CR Bengtsson A, 2009, LANGMUIR, V25, P2355, DOI 10.1021/la803137u
   Bengtsson A, 2009, GEOCHIM COSMOCHIM AC, V73, P257, DOI 10.1016/j.gca.2008.09.034
   Boily JF, 2010, J PHYS CHEM C, V114, P2613, DOI 10.1021/jp908197f
   Brown MA, 2013, NANO LETT, V13, P5403, DOI 10.1021/nl402957y
   BURGER K, 1975, J INORG NUCL CHEM, V37, P55, DOI 10.1016/0022-1902(75)80124-2
   BURGER K, 1978, J ELECTRON SPECTROSC, V14, P405, DOI 10.1016/0368-2048(78)80013-9
   BURGER K, 1974, INORG NUCL CHEM LETT, V10, P171, DOI 10.1016/0020-1650(74)80162-5
   BURGER K, 1977, J ELECTRON SPECTROSC, V10, P461, DOI 10.1016/0368-2048(77)85042-1
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Delcroix MF, 2012, SURF INTERFACE ANAL, V44, P175, DOI 10.1002/sia.3793
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   FELLNERFELDEGG H, 1975, J ELECTRON SPECTROSC, V7, P421, DOI 10.1016/0368-2048(75)85006-7
   Grassian VH, 2008, SURF SCI, V602, P2955, DOI 10.1016/j.susc.2008.07.039
   Hakobyan S., 2016, J INORGANIC IN PRESS
   HANSEN WN, 1983, J ELECTROANAL CHEM, V150, P133, DOI 10.1016/S0022-0728(83)80197-1
   Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6
   Kallay N, 2008, J COLLOID INTERF SCI, V318, P290, DOI 10.1016/j.jcis.2007.09.090
   Kolb DM, 2001, ANGEW CHEM INT EDIT, V40, P1162, DOI 10.1002/1521-3773(20010401)40:7<1162::AID-ANIE1162>3.0.CO;2-F
   Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184
   Leone L, 2007, ENVIRON SCI TECHNOL, V41, P6465, DOI 10.1021/es070996e
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e
   LUKAS J, 1995, J COLLOID INTERF SCI, V174, P421, DOI 10.1006/jcis.1995.1410
   McArthur SL, 2006, SURF INTERFACE ANAL, V38, P1380, DOI 10.1002/sia.2498
   MIKSCHE G, 1977, J ELECTRON SPECTROSC, V10, P423, DOI 10.1016/0368-2048(77)85038-X
   Mladenovic Z, 2010, SURF INTERFACE ANAL, V42, P452, DOI 10.1002/sia.3337
   Ramstedt M, 2004, SURF INTERFACE ANAL, V36, P1074, DOI 10.1002/sia.1844
   Ramstedt M, 2004, LANGMUIR, V20, P8224, DOI 10.1021/la0496338
   Ramstedt M, 2002, SURF INTERFACE ANAL, V34, P632, DOI 10.1002/sia.1376
   Ramstedt M, 2014, LANGMUIR, V30, P4367, DOI 10.1021/la5002573
   Ramstedt M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209536
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   Rouxhet PG, 2011, SURF INTERFACE ANAL, V43, P1453, DOI 10.1002/sia.3831
   Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001
   Seidel R, 2011, J PHYS CHEM LETT, V2, P633, DOI 10.1021/jz101636y
   Shchukarev A, 2006, ADV COLLOID INTERFAC, V122, P149, DOI 10.1016/j.cis.2006.06.015
   Shchukarev A, 2006, SURF INTERFACE ANAL, V38, P682, DOI 10.1002/sia.2162
   Shchukarev A, 2005, SURF SCI, V584, P106, DOI 10.1016/j.susc.2005.01.060
   Shchukarev A, 2004, J ELECTRON SPECTROSC, V137, P171, DOI 10.1016/j.elspec.2004.02.095
   Shchukarev A, 2012, SURF INTERFACE ANAL, V44, P919, DOI 10.1002/sia.5012
   Shchukarev A., 2015, 16 EUR C APPL SURF I, P226
   Shchukarev AV, 2007, COLLOID J+, V69, P514, DOI 10.1134/S1061933X0704014X
   Shchukarev A, 2007, J PHYS CHEM C, V111, P18307, DOI 10.1021/jp075321c
   Shchukarev A, 2008, SURF INTERFACE ANAL, V40, P354, DOI 10.1002/sia.2704
   Shchukarev A, 2010, J ELECTRON SPECTROSC, V176, P13, DOI 10.1016/j.elspec.2009.03.020
   Shimizu K, 2013, LANGMUIR, V29, P2623, DOI 10.1021/la3039973
   Shimizu K, 2012, SURF SCI, V606, P1005, DOI 10.1016/j.susc.2012.02.018
   Shimizu K, 2011, J PHYS CHEM C, V115, P6796, DOI 10.1021/jp2002035
   SIEGBAHN H, 1975, J ELECTRON SPECTROSC, V7, P411, DOI 10.1016/0368-2048(75)85005-5
   SIEGBAHN H, 1985, J PHYS CHEM-US, V89, P897, DOI 10.1021/j100252a005
   Siegbahn H., 1973, Journal of Electron Spectroscopy and Related Phenomena, V2, P319, DOI 10.1016/0368-2048(73)80023-4
   SIEGBAHN H, 1974, J ELECTRON SPECTROSC, V5, P1059, DOI 10.1016/0368-2048(74)85065-6
   SIEGBAHN H, 1981, J ELECTRON SPECTROSC, V24, P205, DOI 10.1016/0368-2048(81)80007-2
   Soderstrom J, 2011, J ELECTRON SPECTROSC, V184, P375, DOI 10.1016/j.elspec.2011.02.006
   van der Mei HC, 2000, SURF SCI REP, V39, P3
   Viipsi K, 2012, APPL GEOCHEM, V27, P15, DOI 10.1016/j.apgeochem.2011.08.010
   Winter B, 2006, CHEM REV, V106, P1176, DOI 10.1021/cr040381p
NR 61
TC 2
Z9 2
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD APR
PY 2017
VL 49
IS 4
BP 349
EP 356
DI 10.1002/sia.6025
PG 8
WC Chemistry, Physical
SC Chemistry
GA EP6NS
UT WOS:000397496800016
DA 2018-10-20
ER

PT J
AU Perez-Tanoira, R
   Aarnisalo, AA
   Eklund, KK
   Han, X
   Soininen, A
   Tiainen, VM
   Esteban, J
   Kinnari, TJ
AF Perez-Tanoira, Ramon
   Aarnisalo, Antti A.
   Eklund, Kari K.
   Han, Xia
   Soininen, Antti
   Tiainen, Veli-Matti
   Esteban, Jaime
   Kinnari, Teemu J.
TI Prevention of Biomaterial Infection by Pre-Operative Incubation with
   Human Cells
SO SURGICAL INFECTIONS
LA English
DT Article
DE bacterial adherence; biofilm; biomaterial; pre-operative incubation;
   race for the surface
ID ORTHOPEDIC IMPLANTS; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS;
   ANTIBIOTIC-RESISTANCE; TISSUE INTEGRATION; ADHESION; SURFACES;
   EPIDERMIDIS; BACTERIA; COATINGS
AB Background: Cells of tissues and biofilm forming bacteria compete for the living space on the surface of an implant. We hypothesized the incubation of the implant (titanium, polydimethylsiloxane, and polystyrene surface) with human cells before implantation as a strategy to prevent bacterial adhesion and biofilm formation.
   Methods: After 24 hours of incubation with human osteogenic sarcoma SaOS-2 cells (1x10(5) cells/mL), the materials were incubated for 4.5 hours or two days with Staphylococcus aureus in serial 1:10 dilutions of 10(8) colony-forming units/mL. The bacterial adherence and biofilm biomass on materials pre-incubated with SaOS-2 cells were compared with our previous results on materials incubated only with bacteria or in simultaneous co-culture of SaOS-2 cells and S. aureus. Fluorescent microscopy and crystal violet stain were used. The number of viable SaOS-2 and bacterial cells present was tested using colorimetric methods (MTT, LDH) and drop plate method, respectively.
   Results: The pre-treatment with human cells was associated with a reduction of bacterial colonization of the biomaterial at 4.5 hours and 48 hours compared with the non-pre-treated materials. The presence of bacteria decreased the number of viable human cells on all materials. (Supplementary Fig. 1; see online supplementary materials at www.liebertpub.com/sur).
   Conclusions: These results suggest that the pre-operative incubation of prostheses with host cells could prevent infection of biomaterials.
C1 [Perez-Tanoira, Ramon; Aarnisalo, Antti A.; Kinnari, Teemu J.] Helsinki Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Haartmaninkatu 4 E,POB 263, Helsinki 00029, Finland.
   [Perez-Tanoira, Ramon; Aarnisalo, Antti A.; Eklund, Kari K.; Kinnari, Teemu J.] Univ Helsinki, Haartmaninkatu 4 E,POB 263, Helsinki 00029, Finland.
   [Eklund, Kari K.; Han, Xia] Univ Helsinki, Clin, Helsinki, Finland.
   [Soininen, Antti; Tiainen, Veli-Matti] ORTON Res Inst, Helsinki, Finland.
   [Soininen, Antti; Tiainen, Veli-Matti] ORTON Orthoped Hosp, Helsinki, Finland.
   [Eklund, Kari K.] Helsinki Univ Hosp, Dept Rheumatol, Helsinki, Finland.
   [Esteban, Jaime] IIS Fdn Jimenez Diaz, Clin Microbiol, Madrid, Spain.
RP Perez-Tanoira, R (reprint author), Helsinki Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Haartmaninkatu 4 E,POB 263, Helsinki 00029, Finland.; Perez-Tanoira, R (reprint author), Univ Helsinki, Haartmaninkatu 4 E,POB 263, Helsinki 00029, Finland.
EM ramontanoira@hotmail.com
RI Esteban, Jaime/S-6554-2018
OI Esteban, Jaime/0000-0002-8971-3167
FU Department of Otorhinolaryngology - Head and Neck Surgery of Helsinki
   University Hospital; University of Helsinki
FX This work was supported by the Department of Otorhinolaryngology - Head
   and Neck Surgery of Helsinki University Hospital and University of
   Helsinki.
CR Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Kobayashi N, 2007, CLIN ORTHOP RELAT R, P210, DOI 10.1097/BLO.0b013e3180312042
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Metsemakers WJ, 2016, INJURY, V47, P595, DOI 10.1016/j.injury.2016.01.019
   Perez-Jorge C, 2012, J BIOMED MATER RES A, V100A, P1696, DOI 10.1002/jbm.a.34118
   Perez-Tanoira R, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5569-1
   Perez-Tanoira R, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5568-2
   Perez-Tanoira R, 2017, J BIOMED MATER RES A, V105, P62, DOI 10.1002/jbm.a.35863
   Perez-Tanoira R, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5625-x
   Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4
   Raphel J, 2016, BIOMATERIALS, V84, P301, DOI 10.1016/j.biomaterials.2016.01.016
   de Viteri VS, 2016, J MECH BEHAV BIOMED, V55, P75, DOI 10.1016/j.jmbbm.2015.10.020
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Sun JD, 2016, ACTA BIOMATER, V45, P387, DOI 10.1016/j.actbio.2016.09.007
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
NR 37
TC 0
Z9 0
U1 2
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD APR
PY 2017
VL 18
IS 3
BP 336
EP 344
DI 10.1089/sur.2016.263
PG 9
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA ER7YS
UT WOS:000399032400013
PM 28267427
DA 2018-10-20
ER

PT J
AU Hajarian, H
   Aghaz, F
   Shabankareh, HK
AF Hajarian, H.
   Aghaz, F.
   Shabankareh, H. Karami
TI Replacement of serum with sericin in in vitro maturation and culture
   media: Effects on embryonic developmental competence of Sanjabi sheep
   embryo during breeding season
SO THERIOGENOLOGY
LA English
DT Article
DE In vitro embryo production; Sericin; Free serum media; Sheep
ID SILK PROTEIN SERICIN; BOVINE EMBRYOS; OXIDATIVE STRESS; SUPPLEMENTATION;
   OOCYTES; FERTILIZATION; PARAMETERS; MOUSE; EWES; SKIN
AB Sericin is a water-soluble component of silk and has been used as a biomaterial due to its antibacterial and ultraviolet radiation-resistant properties. This study was designed to evaluate the effect of sericin supplementation, as a serum replacement, in maturation and culture media on the meiotic competence of oocytes or in vitro culture of ovine embryos. In experiment 1, oocytes were matured in the presence of 10% fetal ovine serum (FOS), 0.1% polyvinyl alcohol (PVA) and different concentrations of sericin (0.1, 0.5, 1 and 2.5%), for 24 h. The addition of 0.5% sericin to maturation medium increased the rates of maturation to metaphase II of oocytes compared with those in cultures with 0.1% PVA. Following fertilization, blastocyst development was higher for oocytes matured with 0.5% of sericin compared with 0.1% PVA. However, the rates of nuclear maturation of oocytes and blastocyst development under FOS and 0.5% sericin were not significantly different. In experiment 2, presumptive zygotes were cultured in the presence of 10% FOS, 0.1% PVA and different concentrations of sericin (0.1, 0.5, 1 and 2.5%), for 7-8 days. The addition of 0.5% sericin to culture medium increased the blastocyst rate compared with those in cultures without sericin or addition of 0.1% PVA and 10% FOS. These results indicate the feasibility of sericin as an alternative protein supplement for IVM and IVC in ovine oocytes and zygotes. (C) 2016 Published by Elsevier Inc.
C1 [Hajarian, H.; Aghaz, F.; Shabankareh, H. Karami] Razi Univ, IVF Lab, Dept Anim Sci, Fac Agr, Kermanshah, Iran.
   [Aghaz, F.] Kermanshah Univ Med Sci, Fertil & Infertil Res Ctr, Kermanshah, Iran.
RP Hajarian, H (reprint author), Razi Univ, IVF Lab, Dept Anim Sci, Fac Agr, Kermanshah, Iran.
EM h.hajarian@razi.ac.ir
CR Aghaz F, 2016, SMALL RUMINANT RES, V136, P257, DOI 10.1016/j.smallrumres.2016.01.019
   Aghaz F, 2015, THERIOGENOLOGY, V84, P1631, DOI 10.1016/j.theriogenology.2015.08.013
   Aghaz F, 2016, REPROD BIOL, V16, P87, DOI 10.1016/j.repbio.2015.11.001
   Aramwit P, 2010, INT J MOL SCI, V11, P2200, DOI 10.3390/ijms11052200
   Cho KY, 2003, INT J BIOL MACROMOL, V32, P36, DOI 10.1016/S0141-8130(03)00023-0
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   De AK, 2011, SMALL RUMINANT RES, V96, P185, DOI 10.1016/j.smallrumres.2011.01.001
   Di Francesco S, 2011, ANIM REPROD SCI, V123, P48, DOI 10.1016/j.anireprosci.2010.11.009
   Tetzner TAD, 2011, REV BRAS ZOOTECN, V40, P2135, DOI 10.1590/S1516-35982011001000010
   Ghaffarilaleh V, 2014, THERIOGENOLOGY, V82, P686, DOI 10.1016/j.theriogenology.2014.05.027
   Grazu-Bilska AT, 2006, ANIM REPROD SCI, V92, P268, DOI 10.1016/j.anireprosci.2005.06.013
   Hosoe M, 2014, J REPROD DEVELOP, V60, P268, DOI 10.1262/jrd.2013-110
   Isobe T, 2012, THERIOGENOLOGY, V78, P747, DOI 10.1016/j.theriogenology.2012.03.021
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Marei WFA, 2013, MOL HUM REPROD, V19, P590, DOI 10.1093/molehr/gat032
   MASTROIANNI L, 1965, J REPROD FERTIL, V9, P99
   Miyamoto Y, 2012, CELL TRANSPLANT, V21, P617, DOI 10.3727/096368911X605556
   Moore K, 2007, THERIOGENOLOGY, V68, P1316, DOI 10.1016/j.theriogenology.2007.08.034
   NATSUYAMA S, 1993, THERIOGENOLOGY, V40, P149, DOI 10.1016/0093-691X(93)90348-9
   Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057
   Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Shabankareh HK, 2010, FERTIL STERIL, V94, P335, DOI 10.1016/j.fertnstert.2009.01.160
   Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005
   Tao W, 2005, MACROMOL MATER ENG, V290, P188, DOI 10.1002/mame.200400306
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Terada S, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P397, DOI 10.1007/978-1-4020-5476-1_66
   Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x
   van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016
   Yasmin C, 2015, ACTA VET HUNG, V63, P110, DOI 10.1556/AVet.2015.009
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
NR 32
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD APR 1
PY 2017
VL 92
BP 144
EP 148
DI 10.1016/j.theriogenology.2016.12.027
PG 5
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA EN4FU
UT WOS:000395964200021
PM 28237330
DA 2018-10-20
ER

PT J
AU Yanga, JH
   Dingb, CC
   Huanga, LL
   Zhanga, M
   Chen, LH
AF Yanga, Junhui
   Dingb, Cuicui
   Huanga, Liulian
   Zhanga, Min
   Chen, Lihui
TI The preparation of poly(gamma-glutamic acid)-NHS ester as a natural
   cross-linking agent of collagen
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Poly(gamma-glutamic acid); Thermal stability
ID ACTIVATED ADIPIC ACID; N-HYDROXYSUCCINIMIDE; ALGINATE DIALDEHYDE;
   IN-VITRO; BIOCHEMICAL-PROPERTIES; LINKED COLLAGEN; SCAFFOLDS;
   BIOMATERIAL; HYDROGELS; MEMBRANE
AB gamma-PGA-NHS ester, which was prepared using poly(gamma-glutamic acid) (gamma-PGA) and N-hydroxysuccinimide (NHS) as the raw materials, was synthesized to be a novel cross-linker of collagen. Fourier transform infrared spectra analysis suggested that the products displayed the characteristic absorption peak of ester. Results from nuclear magnetic resonance analysis indicated that the esterification degree of gamma-PGA-NHS ester was increased with the increase of NHS. Modified collagen was prepared and characterized. The results of circular dichroism analysis indicated modified collagen retained the triple helix structure of natural collagen. Sodium dodecyl sulphate polyacrylamide gel electrophoresis revealed that the molecular weight of collagen was increased after cross-linking. Peptide mapping of collagen suggested that cross-linked collagen possessed an enhanced resistance to trypsin degradation. Differential scanning calorimeter results showed that the denaturation temperature of collagen was improved from 68.1 +/- 0.4 to 91.2 +/- 0.5 degrees C (p < 0.05). Dynamic viscoelastic measurements demonstrated the improvement of thermal stability and reflected the exponential increase in eta*. The cross-linked collagen retained porous structure and the pore size became larger as observed by scanning electron microscopy. The investigation results provided useful information to produce collagen with improved physicochemical properties, particularly the thermal stability via the use of gamma-PGA-NHS ester as a biomacromolecule-based cross-linker. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yanga, Junhui; Huanga, Liulian; Zhanga, Min; Chen, Lihui] Fujian Agr & Forestry Univ, Coll Mat Engn, Fuzhou 350002, Peoples R China.
   [Dingb, Cuicui] Fujian Univ Technol, Coll Ecol Environm & Urban Construct, Fuzhou 350108, Peoples R China.
RP Zhanga, M; Chen, LH (reprint author), Fujian Agr & Forestry Univ, Coll Mat Engn, Fuzhou 350002, Peoples R China.
EM zhangmin_860820@163.com; fafuclh@163.com
FU National Natural Science Foundation of China [21306024, 21606046];
   National Science Foundation of Fujian Province [2016J01208]; Foundation
   of Distinguished Young Scholars of Fujian Agriculture and Forestry
   University [XJQ201212]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grant Nos. 21306024 and 21606046), the National
   Science Foundation of Fujian Province (Grant No. 2016J01208), and the
   Foundation of Distinguished Young Scholars of Fujian Agriculture and
   Forestry University (Grant No. XJQ201212).
CR Ahn JI, 2013, ACTA BIOMATER, V9, P7796, DOI 10.1016/j.actbio.2013.04.014
   ANDERSON GW, 1964, J AM CHEM SOC, V86, P1839, DOI 10.1021/ja01063a037
   Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039
   Ding CC, 2016, CONNECT TISSUE RES, V57, P270, DOI 10.3109/03008207.2016.1149170
   Ding CC, 2015, CARBOHYD POLYM, V119, P194, DOI 10.1016/j.carbpol.2014.11.057
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8
   Hidetoshi K., 1993, BIOSCI BIOTECH BIOCH, V57, P1212
   Hu Y, 2014, CARBOHYD POLYM, V102, P324, DOI 10.1016/j.carbpol.2013.11.050
   Huang GP, 2015, J BIOMED MATER RES A, V103, P762, DOI 10.1002/jbm.a.35222
   Huang X, 2009, J HAZARD MATER, V170, P1141, DOI 10.1016/j.jhazmat.2009.05.086
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Kajiyama T, 2004, MAT SCI ENG C-BIO S, V24, P815, DOI 10.1016/j.msec.2004.08.023
   Kolodziejska I, 1999, FOOD CHEM, V66, P153, DOI 10.1016/S0308-8146(98)00251-9
   Kozlowska J, 2015, INT J BIOL MACROMOL, V74, P397, DOI 10.1016/j.ijbiomac.2014.12.023
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu X, 2014, J COLLOID INTERF SCI, V426, P117, DOI 10.1016/j.jcis.2014.04.007
   Liu XH, 2016, INT J BIOL MACROMOL, V88, P179, DOI 10.1016/j.ijbiomac.2016.03.066
   Liu XH, 2015, RSC ADV, V5, P52079, DOI 10.1039/c5ra08992a
   Mao H, 2011, J MOL CATAL A-CHEM, V341, P51, DOI 10.1016/j.molcata.2011.03.023
   Mu CD, 2010, MACROMOL MATER ENG, V295, P100, DOI 10.1002/mame.200900292
   Ogawa M, 2004, FOOD CHEM, V88, P495, DOI 10.1016/j.foodchem.2004.02.006
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Saeko M., 2006, BIOMACROMOLECULES, V7, P2122
   Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522
   SCHNAAR RL, 1975, BIOCHEMISTRY-US, V14, P1535, DOI 10.1021/bi00678a030
   Shi L, 2015, MAT SCI ENG C-MATER, V48, P533, DOI 10.1016/j.msec.2014.12.047
   Tambe N, 2015, J BIOMED MATER RES B, V103, P1188, DOI 10.1002/jbm.b.33285
   Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034
   Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Vidal CMP, 2014, LANGMUIR, V30, P14887, DOI 10.1021/la5034383
   WALLACE DG, 1989, J BIOMED MATER RES, V23, P931, DOI 10.1002/jbm.820230809
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   Xu YT, 2013, CARBOHYD POLYM, V95, P148, DOI 10.1016/j.carbpol.2013.03.021
   Xu YT, 2012, CARBOHYD POLYM, V87, P1589, DOI 10.1016/j.carbpol.2011.09.059
   Yu X., 2016, CURR ORG CHEM, V20, P1
   Zeugolis DI, 2010, POLYM INT, V59, P1403, DOI 10.1002/pi.2882
   Zhang M, 2013, FOOD HYDROCOLLOID, V30, P504, DOI 10.1016/j.foodhyd.2012.07.015
   Zhang M, 2011, INT J BIOL MACROMOL, V49, P847, DOI 10.1016/j.ijbiomac.2011.08.007
   Zhang X, 2014, ACS SUSTAIN CHEM ENG, V2, P1318, DOI 10.1021/sc500154t
NR 48
TC 5
Z9 5
U1 5
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2017
VL 97
BP 1
EP 7
DI 10.1016/j.ijbiomac.2016.12.070
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EM3KK
UT WOS:000395213400001
PM 28057575
DA 2018-10-20
ER

PT J
AU Shao, Y
   Taniguchi, K
   Gurdziel, K
   Townshend, RF
   Xue, XF
   Yong, KMA
   Sang, JM
   Spence, JR
   Gumucio, DL
   Fu, JP
AF Shao, Yue
   Taniguchi, Kenichiro
   Gurdziel, Katherine
   Townshend, Ryan F.
   Xue, Xufeng
   Yong, Koh Meng Aw
   Sang, Jianming
   Spence, Jason R.
   Gumucio, Deborah L.
   Fu, Jianping
TI Self-organized amniogenesis by human pluripotent stem cells in a
   biomimetic implantation-like niche
SO NATURE MATERIALS
LA English
DT Article
ID GENE-EXPRESSION DATA; RHESUS-MONKEY; HUMAN EMBRYOS; AMNION; FATE;
   DIFFERENTIATION; TROPHOBLAST; MODEL; MICE
AB Amniogenesis-the development of amnion-is a critical developmental milestone for early human embryogenesis and successful pregnancy(1,2). However, human amniogenesis is poorly understood due to limited accessibility to peri-implantation embryos and a lack of in vitro models. Here we report an efficient biomaterial system to generate human amnion-like tissue in vitro through self-organized development of human pluripotent stem cells (hPSCs) in a bioengineered niche mimicking the in vivo implantation environment. We show that biophysical niche factors act as a switch to toggle hPSC self-renewal versus amniogenesis under self-renewal-permissive biochemical conditions. We identify a unique molecular signature of hPSC-derived amnion-like cells and show that endogenously activated BMP-SMAD signalling is required for the amnion-like tissue development by hPSCs. This study unveils the self-organizing and mechanosensitive nature of human amniogenesis and establishes the first hPSC-based model for investigating peri-implantation human amnion development, thereby helping advance human embryology and reproductive medicine.
C1 [Shao, Yue; Xue, Xufeng; Yong, Koh Meng Aw; Sang, Jianming; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Taniguchi, Kenichiro; Townshend, Ryan F.; Spence, Jason R.; Gumucio, Deborah L.; Fu, Jianping] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.
   [Gurdziel, Katherine] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.
   [Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Fu, JP (reprint author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Gumucio, DL; Fu, JP (reprint author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.; Fu, JP (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM dgumucio@med.umich.edu; jpfu@umich.edu
RI Fu, Jianping/C-9605-2009
OI Fu, Jianping/0000-0001-9629-6739; Aw Yong, Koh Meng/0000-0001-6295-9645;
   Shao, Yue/0000-0001-7548-3551
FU National Science Foundation [CMMI 1129611, CBET 1149401]; National
   Institutes of Health [R21 EB017078, R01 EB019436, R01 DK089933];
   American Heart Association [12SDG12180025]; University of Michigan
   Rackham Predoctoral Fellowship
FX We thank K. S. O'Shea, S. Kalantry, T. Miki and W. Shawlot for comments
   on the manuscript. We are grateful to M. Czerwinski for help with
   bioinformatics. We thank G. D. Smith at the University of Michigan MStem
   Cell Laboratories for providing the UM63-1 hESC line and the University
   of Michigan Pluripotent Stem Cell Core and the Steven Schwartzberg
   Memorial Fund for the derivation of the 1196a hiPSC line. This work is
   supported by the National Science Foundation (CMMI 1129611 and CBET
   1149401, J.F.), the National Institutes of Health (R21 EB017078 and R01
   EB019436, J.F.; R01 DK089933, D.L.G.), and the American Heart
   Association (12SDG12180025, J.F.). Y.S. is also partially supported by
   the University of Michigan Rackham Predoctoral Fellowship. The Lurie
   Nanofabrication Facility at the University of Michigan, a member of the
   National Nanotechnology Infrastructure Network (NNIN) funded by the
   National Science Foundation, is acknowledged for support in
   microfabrication.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Ben-David U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2992
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12
   Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dobreva M. P., 2012, STEM CELLS INT, V2012
   Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   ENDERS AC, 1986, AM J ANAT, V177, P161
   Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029
   Fischer RS, 2012, NAT PROTOC, V7, P2056, DOI 10.1038/nprot.2012.127
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084
   Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Koschwanez JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004572
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee CQE, 2016, STEM CELL REP, V6, P257, DOI 10.1016/j.stemcr.2016.01.006
   Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUCKETT WP, 1975, AM J ANAT, V144, P149, DOI 10.1002/aja.1001440204
   Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002
   Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006
   Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0
   Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096
   O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135
   Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48
   REGAUER S, 1985, J CELL BIOL, V100, P997, DOI 10.1083/jcb.100.4.997
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Sasaki K, 2016, DEV CELL, V39, P169, DOI 10.1016/j.devcel.2016.09.007
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347
   Shao Y, 2014, INTEGR BIOL-UK, V6, P300, DOI 10.1039/c3ib40223a
   Slieker R.C, 2015, STEM CELLS INT, V11
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Taniguchi K, 2015, STEM CELL REP, V5, P954, DOI 10.1016/j.stemcr.2015.10.015
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Tse Justin R, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1016s47
   Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Weng SN, 2011, BIOMATERIALS, V32, P9584, DOI 10.1016/j.biomaterials.2011.09.006
   Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017
NR 45
TC 17
Z9 17
U1 5
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD APR
PY 2017
VL 16
IS 4
BP 419
EP +
DI 10.1038/NMAT4829
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EP8BI
UT WOS:000397600500011
PM 27941807
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lo, SC
   Li, KC
   Chang, YH
   Hsu, MN
   Sung, LY
   Vu, TA
   Hu, YC
AF Lo, Shih-Chun
   Li, Kuei-Chang
   Chang, Yu-Han
   Hsu, Mu-Nung
   Sung, Li-Yu
   Truong Anh Vu
   Hu, Yu-Chen
TI Enhanced critical-size calvarial bone healing by ASCs engineered with
   Cre/loxP-based hybrid baculovirus
SO BIOMATERIALS
LA English
DT Article
DE Adipose-derived stem cells; Baculovirus; BMP-2; Calvarial bone healing;
   Cre/loxP; SDF-1
ID MESENCHYMAL STEM-CELLS; GENE DELIVERY; OSTEOBLAST DIFFERENTIATION;
   OSTEOGENIC DIFFERENTIATION; DEFECTS; BMP-2; REPAIR; REGENERATION;
   VECTOR; SDF-1
AB Calvarial bone repair remains challenging for adults. Although adipose-derived stem cells (ASCs) hold promise to heal bone defects, use of ASCs for critical-size calvarial bone repair is ineffective. Stromal cell derived factor 1 (SDF-1) is a chemokine capable of triggering stem cell migration. Although recombinant SDF-1 protein is co-delivered with other molecules including BMP-2 to facilitate calvarial bone repair, these approaches did not yield satisfactory healing. This study aimed to exploit a newly developed Cre/loxP-based hybrid baculovirus for efficient gene delivery and prolonged transgene expression in ASCs. We demonstrated that transduction of rat ASCs with the hybrid Cre/loxP-based baculovirus enabled robust and sustained expression of functional BMP-2 and SDF-1. Expression of BMP-2 or SDF-1 alone failed to effectively induce rat ASCs osteogenesis and healing of critical-size calvarial bone defects. Nonetheless, prolonged BMP-2/SDF-1 co-expression in ASCs synergistically activated both Smad and ERK1/2 pathways and hence potentiated the osteogenesis. Consequently, transplantation of the hybrid baculovirus-engineered, BMP-2/SDF-1-expressing ASCs/scaffold constructs potently healed the critical size (6 mm) calvarial bone defects (filling approximate to 70% of defect volume), which considerably outperformed the calvarial bone repair using BMP-2/SDF-1 delivered with biomaterial-based scaffolds. These data implicated the potential of CrefioxP-based hybrid baculovirus vector for ASCs engineering and calvarial bone healing. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Lo, Shih-Chun; Li, Kuei-Chang; Hsu, Mu-Nung; Sung, Li-Yu; Truong Anh Vu; Hu, Yu-Chen] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
   [Chang, Yu-Han] Chang Gang Mem Hosp, Ctr Tissue Engn, Taoyuan 333, Taiwan.
   [Chang, Yu-Han] Chang Gang Mem Hosp, Dept Orthopaed, Taoyuan 333, Taiwan.
RP Hu, YC (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
EM ychu@mx.nthu.edu.tw
FU National Tsing Hua University (Toward World-Class University)
   [104N2050E1, 105N526CE1]; CGMH Intramural Project [CRRPG3E0172,
   CMRPG3E0441, CMRPG3E0061, CMRPG3B1542, CMRPG3B1541]; Ministry of Science
   and Technology, Taiwan [MOST 104-2221-E-007-088-MY3,
   103-2221-E-007-093-MY3, 101-2628-E-007-009-MY3]
FX This work was supported by the National Tsing Hua University (Toward
   World-Class University Project 104N2050E1 and 105N526CE1), CGMH
   Intramural Project (CRRPG3E0172, CMRPG3E0441, CMRPG3E0061, CMRPG3B1542,
   CMRPG3B1541), and Ministry of Science and Technology (MOST
   104-2221-E-007-088-MY3, 103-2221-E-007-093-MY3, 101-2628-E-007-009-MY3),
   Taiwan.
CR Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286
   Chandler RJ, 2016, MOL THER, V24, P198, DOI 10.1038/mt.2016.17
   Chen CY, 2010, VACCINE, V28, P7644, DOI 10.1016/j.vaccine.2010.09.048
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Chen X, 2015, BIOMATERIALS, V53, P239, DOI 10.1016/j.biomaterials.2015.02.071
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980
   Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59
   Herberg S, 2014, BONE, V67, P95, DOI 10.1016/j.bone.2014.07.007
   Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]
   Higashino K, 2011, TISSUE ENG PT A, V17, P523, DOI 10.1089/ten.tea.2010.0168
   Holloway JL, 2015, MACROMOL BIOSCI, V15, P1218, DOI 10.1002/mabi.201500178
   Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020
   Hwang HD, 2015, TISSUE ENG PT A, V21, P2125, DOI [10.1089/ten.tea.2014.0571, 10.1089/ten.TEA.2014.0571]
   Jin QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097035
   Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307
   Kelly AM, 2016, MOL THER, V24, P331, DOI 10.1038/mt.2015.195
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Lee CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120051
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   Li KC, 2016, BIOMATERIALS, V74, P155, DOI 10.1016/j.biomaterials.2015.09.046
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lin CY, 2015, BIOMATERIALS, V50, P98, DOI 10.1016/j.biomaterials.2015.01.052
   Lin CY, 2012, BIOMATERIALS, V33, P3682, DOI 10.1016/j.biomaterials.2012.02.007
   Lin CY, 2011, BIOMATERIALS, V32, P6505, DOI 10.1016/j.biomaterials.2011.05.059
   Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z
   Liu YS, 2014, BIOMATERIALS, V35, P4489, DOI 10.1016/j.biomaterials.2014.02.025
   Lu CH, 2014, MOL THER, V22, P186, DOI 10.1038/mt.2013.165
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Luo WY, 2013, J VIROL, V87, P4965, DOI 10.1128/JVI.03510-12
   Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08
   Mizrahi O, 2013, GENE THER, V20, P370, DOI 10.1038/gt.2012.45
   Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515
   Penn MS, 2012, GENE THER, V19, P583, DOI 10.1038/gt.2012.32
   Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6
   Raisin S, 2016, BIOMATERIALS, V104, P223, DOI 10.1016/j.biomaterials.2016.07.017
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Sung LY, 2014, NAT PROTOC, V9, P1882, DOI 10.1038/nprot.2014.130
   Sung LY, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt442
   Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346
   Walia JS, 2015, MOL THER, V23, P414, DOI 10.1038/mt.2014.240
   Xie Q, 2016, BIOMATERIALS, V75, P279, DOI 10.1016/j.biomaterials.2015.10.042
   Yeh TS, 2014, BIOMATERIALS, V35, P174, DOI 10.1016/j.biomaterials.2013.09.080
   Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200
   Zwingenberger S, 2014, TISSUE ENG PT A, V20, P810, DOI 10.1089/ten.TEA.2013.0222
NR 52
TC 7
Z9 7
U1 5
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2017
VL 124
BP 1
EP 11
DI 10.1016/j.biomaterials.2017.01.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CS
UT WOS:000395956000001
PM 28182872
DA 2018-10-20
ER

PT J
AU Zhu, W
   Qu, X
   Zhu, J
   Ma, XY
   Patel, S
   Liu, J
   Wang, PR
   Lai, CSE
   Gou, ML
   Xu, Y
   Zhang, K
   Chen, SC
AF Zhu, Wei
   Qu, Xin
   Zhu, Jie
   Ma, Xuanyi
   Patel, Sherrina
   Liu, Justin
   Wang, Pengrui
   Lai, Cheuk Sun Edwin
   Gou, Maling
   Xu, Yang
   Zhang, Kang
   Chen, Shaochen
TI Direct 3D bioprinting of prevascularized tissue constructs with complex
   microarchitecture
SO BIOMATERIALS
LA English
DT Article
DE 3D bioprinting; Vasculature; Tissue engineering; Complex
   microarchitecture; Biomaterials
ID STIFFNESS GRADIENT STRENGTH; CELL DUROTAXIS DEPENDS; ON-A-CHIP;
   STEM-CELLS; VASCULAR NETWORKS; BLOOD-VESSELS; HYDROGELS; MUSCLE;
   STEREOLITHOGRAPHY; ANASTOMOSIS
AB Living tissues rely heavily on vascular networks to transport nutrients, oxygen and metabolic waste. However, there still remains a need for a simple and efficient approach to engineer vascularized tissues. Here, we created prevascularized tissues with complex three-dimensional (3D) microarchitectures using a rapid bioprinting method microscale continuous optical bioprinting (40B). Multiple cell types mimicking the native vascular cell composition were encapsulated directly into hydrogels with precisely controlled distribution without the need of sacrificial materials or perfusion. With regionally controlled biomaterial properties the endothelial cells formed lumen-like structures spontaneously in vitro. In vivo implantation demonstrated the survival and progressive formation of the endothelial network in the prevascularized tissue. Anastomosis between the bioprinted endothelial network and host circulation was observed with functional blood vessels featuring red blood cells. With the superior bioprinting speed, flexibility and scalability, this new prevascularization approach can be broadly applicable to the engineering and translation of various functional tissues. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Zhu, Wei; Qu, Xin; Lai, Cheuk Sun Edwin; Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
   [Zhu, Jie; Patel, Sherrina; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.
   [Ma, Xuanyi; Chen, Shaochen] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Liu, Justin; Wang, Pengrui; Chen, Shaochen] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA.
   [Gou, Maling] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan Provinc, Peoples R China.
   [Gou, Maling] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Sichuan Provinc, Peoples R China.
   [Gou, Maling] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan Provinc, Peoples R China.
   [Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.
RP Chen, SC (reprint author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
EM chen168@eng.ucsd.edu
RI Zhu, Wei/V-8424-2017
OI Zhu, Wei/0000-0002-2524-0866
FU California Institute for Regenerative Medicine [RT3-07899]; National
   Institutes of Health [R01EB021857]; National Science Foundation
   [CMMI-1332681, CMMI-1644967];  [P30 (NS047101)]
FX The work was supported in part by grants from the California Institute
   for Regenerative Medicine (RT3-07899), National Institutes of Health
   (R01EB021857) and National Science Foundation (CMMI-1332681 and
   CMMI-1644967). The UCSD Neuroscience Microscopy Shared Facility was
   supported by Grant P30 (NS047101). We thank Dr. Shu Chien of UC San
   Diego for providing HUVECs as a gift and we thank Shangting You for his
   assistance.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Choi YS, 2012, BIOMATERIALS, V33, P6943, DOI 10.1016/j.biomaterials.2012.06.057
   Debbage PL, 2001, HISTOCHEM CELL BIOL, V116, P349, DOI 10.1007/s004180100328
   Debbage PL, 1998, J HISTOCHEM CYTOCHEM, V46, P627, DOI 10.1177/002215549804600508
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Gou ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4774
   Hribar KC, 2014, ADV FUNCT MATER, V24, P4922, DOI 10.1002/adfm.201400274
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   Jia WT, 2016, BIOMATERIALS, V106, P58, DOI 10.1016/j.biomaterials.2016.07.038
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee KY, 2000, NATURE, V408, P998
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Ma XY, 2016, P NATL ACAD SCI USA, V113, P2206, DOI 10.1073/pnas.1524510113
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sahota PS, 2004, WOUND REPAIR REGEN, V12, P635, DOI 10.1111/j.1067-1927.2004.12608.x
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Smith CM, 2007, TISSUE ENG, V13, P373, DOI 10.1089/ten.2006.0101
   Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9
   Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397
   Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhang BY, 2016, NAT MATER, V15, P669, DOI [10.1038/NMAT4570, 10.1038/nmat4570]
   Zhang YS, 2016, BIOMATERIALS, V110, P45, DOI 10.1016/j.biomaterials.2016.09.003
   Zhu W, 2015, ADV MATER, V27, P4411, DOI 10.1002/adma.201501372
NR 41
TC 41
Z9 40
U1 56
U2 200
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2017
VL 124
BP 106
EP 115
DI 10.1016/j.biomaterials.2017.01.042
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CS
UT WOS:000395956000010
PM 28192772
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Knabe, C
   Mele, A
   Kann, PH
   Peleska, B
   Adel-Khattab, D
   Renz, H
   Reuss, A
   Bohner, M
   Stiller, M
AF Knabe, Christine
   Mele, Aynur
   Kann, Peter Herbert
   Peleska, Barbara
   Adel-Khattab, Doaa
   Renz, Harald
   Reuss, Alexander
   Bohner, Marc
   Stiller, Michael
TI Effect of sex-hormone levels, sex, body mass index and other host
   factors on human craniofacial bone regeneration with bioactive
   tricalcium phosphate grafts
SO BIOMATERIALS
LA English
DT Article
DE Craniofacial bone regeneration; Tricalcium phosphate; Sinus floor
   augmentation; Body mass index; Sex-hormone levels; Host factors;
   Estradiol; Testosterone; Smoking
ID SINUS FLOOR AUGMENTATION; CORONARY-ARTERY-DISEASE; MINERAL DENSITY;
   POSTMENOPAUSAL WOMEN; BINDING GLOBULIN; OBESITY PARADOX; OSTEOPOROTIC
   FRACTURES; PHYSICAL-ACTIVITY; DISTRACTION OSTEOGENESIS; VERTEBRAL
   FRACTURES
AB Little is known regarding the associations between sex-hormone levels, sex, body mass index (BMI), age, other host factors and biomaterial stimulated bone regeneration in the human craniofacial skeleton. The aim of this study was to elucidate the associations between these factors and bone formation after sinus floor augmentation procedures (SFA) utilizing a bioactive tricalcium phosphate (TCP) bone grafting material. We conducted a prospective study in a human population in which 60 male and 60 female participants underwent SFA and dental implant placement using a staged approach. BMI as well as levels of serum estradiol (E2), total testosterone (TT), and the free androgen index (FAI) were measured by radioimmunoassay and electrochemoluminescent-immunoassay. At implant placement, 6 months after SFA, bone biopsy specimens were harvested for hard tissue histology, the amount of bone formation was evaluated by histomorphometry and immunohistochemical analysis of osteogenic marker expression. The Wilcoxon rank-sum U test, Spearman correlations and linear regression analysis were used to explore the association between bone formation and BMI, hormonal and other host factors. BMI and log E2 were significantly positively associated with bone formation in male individuals (p < 0.05). Histomorphometry revealed trends toward greater bone formation and osteogenic marker expression with non-smokers compared to smokers. In male patients, higher E2 levels and higher BMI enhanced TCP stimulated craniofacial i.e. intramembranous bone repair. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Knabe, Christine; Mele, Aynur; Adel-Khattab, Doaa; Stiller, Michael] Univ Marburg, Dept Expt Orofa Med, D-35039 Marburg, Germany.
   [Kann, Peter Herbert] Univ Marburg, Dept Endocrinol & Diabet, D-35033 Marburg, Germany.
   [Peleska, Barbara] Univ Marburg, Dept Prosthodont, D-35039 Marburg, Germany.
   [Adel-Khattab, Doaa; Stiller, Michael] Ain Shams Univ, Dept Periodontol, Cairo, Egypt.
   [Renz, Harald] Univ Marburg, Inst Lab Med & Pathobiochem, D-35032 Marburg, Germany.
   [Reuss, Alexander] Univ Marburg, Coordinating Ctr Clin Trails, D-35043 Marburg, Germany.
   [Bohner, Marc] RMS Fdn, CH-2544 Battlach, Switzerland.
   [Stiller, Michael] ECDI, D-14193 Berlin, Germany.
RP Knabe, C; Mele, A (reprint author), Univ Marburg, Dept Expt Orofa Med, D-35039 Marburg, Germany.
EM knabec@med.uni-marburg.de
OI Bohner, Marc/0000-0002-5079-3286
FU RMS Foundation [P08_0016E I CaP-Hormone]
FX This work was partially supported by a grant from the RMS Foundation
   (grant no. P08_0016E I CaP-Hormone). The authors would like to thank Ms.
   A. Kopp for her excellent technical assistance.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215
   Arazi H, 2016, J CLIN DENSITOM, V19, P382, DOI 10.1016/j.jocd.2016.01.005
   Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099
   Bahney CS, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00004
   Basques BA, 2015, CLIN ORTHOP RELAT R, V473, P1133, DOI 10.1007/s11999-014-4005-z
   Bednarek A., 2011, THESIS
   Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Bouillon R, 2004, J CLIN ENDOCR METAB, V89, P6025, DOI 10.1210/jc.2004-0602
   Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429
   Callreus M, 2013, CALCIFIED TISSUE INT, V93, P517, DOI 10.1007/s00223-013-9785-8
   Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282
   Cauley JA, 2010, J CLIN ENDOCR METAB, V95, P4314, DOI 10.1210/jc.2009-2635
   Chang VW, 2010, JAMA-J AM MED ASSOC, V303, P1274, DOI 10.1001/jama.2010.339
   Chrcanovic BR, 2014, J DENT RES, V93, P859, DOI 10.1177/0022034514538820
   Clapauch R, 2009, ARQ BRAS ENDOCRINOL, V53, P1020, DOI 10.1590/S0004-27302009000800017
   Cuenin MF, 1997, MIL MED, V162, P582
   Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4
   Davis SR, 2014, J STEROID BIOCHEM, V142, P107, DOI 10.1016/j.jsbmb.2013.05.006
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Edman K, 2015, INT J DENT HYG, V13, P283, DOI 10.1111/idh.12164
   Erdogan O, 2015, CLIN ORAL IMPLAN RES, V26, P1267, DOI 10.1111/clr.12450
   Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239
   Evans SF, 2002, CALCIFIED TISSUE INT, V70, P9, DOI 10.1007/s00223-001-2018-6
   Farhadieh RD, 2004, J CRANIOFAC SURG, V15, P714, DOI 10.1097/00001665-200409000-00003
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   Flegal KM, 2013, OBESITY, V21, P1744, DOI 10.1002/oby.20588
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Fleming LE, 2008, MENOPAUSE, V15, P1103, DOI 10.1097/gme.0b013e3181706292
   Rodriguez-Argueta OF, 2011, J ORAL MAXIL SURG, V69, P2152, DOI 10.1016/j.joms.2011.02.082
   Fritz J, 2016, ACTA PAEDIATR, V105, P1216, DOI 10.1111/apa.13440
   Galindo-Moreno P, 2012, IMPLANT DENT, V21, P433, DOI 10.1097/ID.0b013e3182691959
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gerstenfeld LC, 2005, J BONE MINER RES, V20, P1715, DOI 10.1359/JBMR.050702
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Giuca MR, 2013, EUR J PAEDIATR DENT, V14, P175
   Glaser R, 2013, MATURITAS, V74, P230, DOI 10.1016/j.maturitas.2013.01.003
   Gonnelli S, 2014, CLIN CASES MINER BON, V11, P9, DOI 10.11138/ccmbm/2014.11.1.009
   Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317
   Hillam RA, 2015, J BIOMECH, V48, P3292, DOI 10.1016/j.jbiomech.2015.06.021
   Ho-Pham LT, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-366
   Hoppe E, 2010, JOINT BONE SPINE, V77, P306, DOI 10.1016/j.jbspin.2010.03.011
   Hsu YH, 2006, AM J CLIN NUTR, V83, P146
   Kaing L, 2011, AUST DENT J, V56, P406, DOI 10.1111/j.1834-7819.2011.01369.x
   Kalk WWI, 1996, J ORAL MAXIL SURG, V54, P1424, DOI 10.1016/S0278-2391(96)90257-8
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P399, DOI 10.1007/s00198-008-0560-z
   Kanis JA, 2005, OSTEOPOROSIS INT, V16, P155, DOI 10.1007/s00198-004-1640-3
   Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115
   Kelsey J L, 1989, Public Health Rep, V104 Suppl, P14
   Khosla S, 1996, J BONE MINER RES, V11, P857
   Kim CJ, 2009, CLIN ENDOCRINOL, V71, P18, DOI 10.1111/j.1365-2265.2008.03452.x
   Kim HJ, 1998, DEVELOPMENT, V125, P1241
   Knabe C, 2006, BIOTECH HISTOCHEM, V81, P31, DOI 10.1080/10520290600725474
   Knabe C., 2011, COMPREHENSIVE BIOMAT, V1, P245
   Knabe C., 2011, COMPREHENSIVE BIOMAT, V6, P305
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5
   Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841
   Lee JS, 2008, J CLIN ENDOCR METAB, V93, P1796, DOI 10.1210/jc.2007-2358
   Legrand E, 2001, BONE, V29, P90, DOI 10.1016/S8756-3282(01)00478-1
   Morgan EF, 2014, METHODS MOL BIOL, V1130, P13, DOI 10.1007/978-1-62703-989-5_2
   Nguyen TV, 2000, J BONE MINER RES, V15, P322, DOI 10.1359/jbmr.2000.15.2.322
   Olesen UK, 2015, INT ORTHOP, V39, P1159, DOI 10.1007/s00264-015-2712-z
   Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288
   Palinkas M, 2010, ARCH ORAL BIOL, V55, P797, DOI 10.1016/j.archoralbio.2010.06.016
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Razzouk Sleiman, 2013, N Y State Dent J, V79, P27
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x
   Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763
   Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9
   Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535
   Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019
   Stiller M, 2014, BIOMATERIALS, V35, P3154, DOI 10.1016/j.biomaterials.2013.12.068
   Suba Zsuzsanna, 2006, Fogorv Sz, V99, P21
   Szulc P, 2001, J CLIN ENDOCR METAB, V86, P192, DOI 10.1210/jc.86.1.192
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tavakoli K, 1999, BRIT J PLAST SURG, V52, P434, DOI 10.1054/bjps.1999.3157
   Tuck SP, 2008, BONE, V43, P999, DOI 10.1016/j.bone.2008.08.123
   Verdonk R, 2015, ARTHROSCOPY, V31, P715, DOI 10.1016/j.arthro.2014.11.045
   Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832
   Weber TJ, 2016, J CLIN INVEST, V126, P829, DOI 10.1172/JCI85006
   Wei SY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-288
   Westgeest J, 2016, J ORTHOP TRAUMA, V30, P149, DOI 10.1097/BOT.0000000000000488
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   Wolf M, 2014, INT J ORAL MAX IMPL, V29, P976, DOI 10.11607/jomi.3525
   WOODSIDE DG, 1983, AM J ORTHOD DENTOFAC, V83, P460, DOI 10.1016/S0002-9416(83)90244-0
   Wright Erik, 2016, Instr Course Lect, V65, P509
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
   Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x
   Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4
   Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI [10.1359/jbmr.070813, 10.1359/JBMR.070813]
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
   Zijderveld SA, 2009, CLIN ORAL IMPLAN RES, V20, P691, DOI [10.1111/j.1600-0501.2008.01697.x, 10.1111/j.1600-0501.2009.01697.x]
NR 96
TC 1
Z9 1
U1 4
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2017
VL 123
BP 48
EP 62
DI 10.1016/j.biomaterials.2017.01.035
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EM8YO
UT WOS:000395597800005
PM 28160669
DA 2018-10-20
ER

PT J
AU Baskar, K
   Anusuya, T
   Venkatasubbu, GD
AF Baskar, K.
   Anusuya, T.
   Venkatasubbu, G. Devanand
TI Mechanistic investigation on microbial toxicity of nano hydroxyapatite
   on implant associated pathogens
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Osteomyelitis; Implant; Lactate dehydrogenase; Cytotoxicity
ID ESCHERICHIA-COLI; SILVER NANOPARTICLES; CYTOTOXICITY; SIZES
AB The use of atomic scale inorganic nanoparticles (NPs) to fight against pathogenic microorganisms is a recent trend in biomedical area which overcomes the limitations of organic compounds in terms of stability, shelf life and bioactivity. One such Calcium phosphate based biomaterial is hydroxyapatite (HA), considered as potential bioactive compound with excellent biocompatibility, osteointegrity and biodegradability. Osteomyelitis, the implant associated infection, is the major problem worldwide responsible for the majority of implant failure cases. Since HA is used as a coating material of implants, only few reports were available on its antimicrobial activity and cytotoxicity whereas no reports on its possible antimicrobial mechanism. In this present study, the HA-NPs were synthesized by wet chemical precipitation and were characterized using X-ray diffraction (XRD), Transmission Electron Microscopy (TEM) and Fourier transform infrared spectroscopy (FTIR). The synthesized HA-NPs were evaluated for antimicrobial activity against implant associated bacterial pathogens. The study also explores the mechanistic action of HA-NPs in killing of bacteria by determining the reactive oxygen species (ROS) generation, DNA fragmentation, Lactate dehydrogenase (LDH) leakage and cellular interaction. In addition the cytotoxicity of HA-NPs was determined by MIT assay and Fluorescence Microscopic analysis. The results revealed that, the synthesized HA-NPs showed good antibacterial activity for tested bacterial species and the possible antibacterial mechanism were due to the lack of membrane integrity and cytotoxic studies shows the concentration dependent changes in cell viability. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Baskar, K.] Univ Madras, Dept Biotechnol, Guindy Campus, Chennai, Tamil Nadu, India.
   [Anusuya, T.; Venkatasubbu, G. Devanand] SRM Univ, Dept Nanotechnol, Kattankulathur 603203, Tamil Nadu, India.
RP Venkatasubbu, GD (reprint author), SRM Univ, Dept Nanotechnol, Kattankulathur 603203, Tamil Nadu, India.
EM gdevanandvenkatasubbu@gmail.com
CR Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004
   Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467
   Deepa C, 2013, NANOSYST-PHYS CHEM M, V4, P370
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Dumas EM, 2009, IEEE T NANOBIOSCI, V8, P58, DOI 10.1109/TNB.2009.2017313
   He YT, 2008, J NANOPART RES, V10, P321, DOI 10.1007/s11051-007-9255-1
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kim YS, 2003, ENZYME MICROB TECH, V33, P460, DOI 10.1016/S0141-0229(03)00148-0
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Li TT, 1998, J MATER SCI-MATER M, V9, P631, DOI 10.1023/A:1008979424395
   Lin YG, 2007, J RARE EARTH, V25, P452, DOI 10.1016/S1002-0721(07)60455-4
   Loo SCJ, 2008, J MATER SCI-MATER M, V19, P1389, DOI 10.1007/s10856-007-3261-9
   Magdalena M., 2012, POLYMER, V53, P2818
   Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695
   Mitamura S, 1998, BIOCHEM BIOPH RES CO, V243, P480, DOI 10.1006/bbrc.1998.8122
   Moghaddam AB, 2008, INT J ELECTROCHEM SC, V3, P291
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Rockenfeller P, 2008, EXP GERONTOL, V43, P876, DOI 10.1016/j.exger.2008.08.044
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Tin-Oo MM, 2007, ARCH OROFAC SCI, V2, P41
   Venkatasubbu GD, 2013, BIOMED MICRODEVICES, V15, P711, DOI 10.1007/s10544-013-9767-7
NR 28
TC 4
Z9 4
U1 0
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 8
EP 14
DI 10.1016/j.msec.2016.12.060
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800002
PM 28183675
DA 2018-10-20
ER

PT J
AU Radha, G
   Balakumar, S
   Venkatesan, B
   Vellaichamy, E
AF Radha, G.
   Balakumar, S.
   Venkatesan, Balaji
   Vellaichamy, Elangovan
TI A novel nano-hydroxyapatite - PMMA hybrid scaffolds adopted by
   conjugated thermal induced phase separation (TIPS) and wet-chemical
   approach: Analysis of its mechanical and biological properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE PMMA Nano-hydroxyapatite; In vitro bioactivity; Porosity; Mechanical
   strength and Hemocompatibility
ID POLY(METHYL METHACRYLATE); BONE-CEMENT; COMPOSITE SCAFFOLDS; POROUS
   SCAFFOLDS; BIOCOMPATIBILITY; BIOMATERIAL; NANOCOMPOSITES; FABRICATION;
   RAMAN
AB In this study, we report the preparation of nano-hydroxyapatite (nHAp) incorporated poly(methyl methacrylate) (PMMA) scaffolds by conjugated thermal induced phase separation (TIPS) and wet -chemical approach, which essentially facilitates the enhancement of both mechanical as well as biological properties of the scaffolds. The dissolution of PMMA was accomplished by acetone (Ace scaffold), ethanol-water (E-W scaffold) and isopropanolwater (I-W scaffold) mixtures as solvents. The existence of nHAp in PMMA matrix was investigated systematically. The porosity of similar to 57.89% was achieved from Ace scaffold that was higher degree compared to both I-W and E-W scaffolds. On the other hand, the dense porous architecture of I-W scaffold exhibited superior hardness of similar to 65.6 HR 'D' than that of the Ace and E-W scaffolds. All the fabricated samples demonstrated enhanced in vitro bioactivity with respect to increasing immersion period as a result of flower-like in vitro apatite layer formation. The MTT assay was carried out for 1 day and 3 day culture using Saos-2 osteoblast-like cells, which showed better cell proliferation with increasing culture period owing to the interconnected pore architecture of scaffolds and the rational hemocompatibility as per the ASTM standard F756-00. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Radha, G.; Balakumar, S.] Univ Madras, Natl Ctr Nanosci & Nanotechnol, Guindy Campus, Madras 600025, Tamil Nadu, India.
   [Venkatesan, Balaji; Vellaichamy, Elangovan] Univ Madras, Dept Biochem, Guindy Campus, Madras 600025, Tamil Nadu, India.
RP Balakumar, S (reprint author), Univ Madras, Natl Ctr Nanosci & Nanotechnol, Guindy Campus, Madras 600025, Tamil Nadu, India.
EM balasuga@yahoo.com
FU UGC - Rajiv Gandhi National Fellowship
FX The author, G. Radha would like to acknowledge UGC - Rajiv Gandhi
   National Fellowship for providing funding and National Centre for
   Nanoscience and Nanotechnology (NCNSNT), University of Madras, for
   providing necessary facilities to carry out this study. I would like to
   express my gratitude to Dr. M. Sakar (NCNSNT) for his valuable
   discussion.
CR Ahuja S., 2003, CHROMATOGRAPHY SEPAR, V4
   Akbarzadeh R, 2014, J BIOMED MATER RES B, V102, P1304, DOI 10.1002/jbm.b.33101
   Arabmotlagh M, 2014, J BIOMED MATER RES B, V102, P1613, DOI 10.1002/jbm.b.33140
   Ashok M, 2003, MATER LETT, V57, P2066, DOI 10.1016/S0167-577X(02)01140-0
   Bellucci D, 2011, MATERIALS, V4, P339, DOI 10.3390/ma4020339
   Chavan PN, 2010, MATER SCI ENG B-ADV, V168, P224, DOI 10.1016/j.mseb.2009.11.012
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Cho JS, 2014, PHYS CHEM CHEM PHYS, V16, P16962, DOI 10.1039/c4cp01808g
   Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9
   Deng XL, 2007, J BIOMAT SCI-POLYM E, V18, P117, DOI 10.1163/156856207779146123
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gong YH, 2006, J APPL POLYM SCI, V101, P3336, DOI 10.1002/app.23931
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Ji CD, 2012, ACTA BIOMATER, V8, P570, DOI 10.1016/j.actbio.2011.09.028
   Kang BH, 2012, J CERAM PROCESS RES, V13, P791
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HM, 2004, J ROY SOC INTERFACE, V1, P17, DOI 10.1098/rsif.2004.0003
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Li L, 2014, RSC ADV, V4, P52973, DOI 10.1039/c4ra05385k
   Lv Y, 2015, ACS APPL MATER INTER, V7, P11280, DOI 10.1021/acsami.5b01447
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Mehrabanian M, 2011, INT J NANOMED, V6, P1651, DOI 10.2147/IJN.S21203
   MEYER PR, 1973, J BONE JOINT SURG AM, VA 55, P149, DOI 10.2106/00004623-197355010-00015
   Miyazaki T, 2003, J BIOMED MATER RES A, V67A, P1417, DOI 10.1002/jbm.a.20042
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Mul D.F., 1988, J RAMAN SPECTROSC, V19, P13
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Nordborg A, 2009, ANAL BIOANAL CHEM, V394, P71, DOI 10.1007/s00216-009-2636-9
   Oh SH, 2011, J BIOMAT SCI-POLYM E, V22, P225, DOI 10.1163/092050609X12597621891620
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Radha G, 2015, MAT SCI ENG C-MATER, V50, P143, DOI 10.1016/j.msec.2015.01.054
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Singh M.K., 2008, ADV FUNCT MATER, V9999, P1
   Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5
   Sun XX, 2014, COLLOID POLYM SCI, V292, P1073, DOI 10.1007/s00396-013-3155-y
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tihan TG, 2009, MATER CHEM PHYS, V118, P265, DOI 10.1016/j.matchemphys.2009.03.019
   Vazquez B, 1997, J BIOMED MATER RES, V34, P129
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   WILLIS HA, 1969, POLYMER, V10, P737, DOI 10.1016/0032-3861(69)90101-3
   Xin YR, 2012, POLYMER, V53, P2847, DOI 10.1016/j.polymer.2012.04.029
   Xingsheng X, 2002, J OPT A-PURE APPL OP, V4, P237
   Yaghmaie A., 2011, J NANOSTRUCT CHEM, V2, P29
   Yoneda S, 2014, POLYMER, V55, P3212, DOI 10.1016/j.polymer.2014.05.031
   Zhang JC, 2008, APPL SURF SCI, V255, P328, DOI 10.1016/j.apsusc.2008.06.127
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 53
TC 4
Z9 4
U1 4
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 164
EP 172
DI 10.1016/j.msec.2016.11.098
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800019
DA 2018-10-20
ER

PT J
AU Chen, SS
   Yang, QB
   Brow, RK
   Liu, K
   Brow, KA
   Ma, YF
   Shi, HL
AF Chen, Sisi
   Yang, Qingbo
   Brow, Richard K.
   Liu, Kun
   Brow, Katherine A.
   Ma, Yinfa
   Shi, Honglan
TI In vitro stimulation of vascular endothelial growth factor by
   borate-based glass fibers under dynamic flow conditions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bioactive borate glass nano-/micro-fibers; Copper/zinc (Cu/Zn) doped
   glass fibers; Vascular endothelial growth factor (VEGF); Dynamic flow
   culturing module; Wound healing
ID BIOACTIVE GLASS; BONE REGENERATION; MC3T3-E1 CELLS; ANGIOGENESIS;
   TISSUE; PROLIFERATION; SCAFFOLDS; HYDROXYAPATITE; BIOMATERIAL;
   CONVERSION
AB Bioactive borate glass has been recognized to have both hard and soft tissue repair and regeneration capabilities through stimulating both osteogenesis and angiogenesis. However, the underlying biochemical and cellular mechanisms remain unclear. In this study, dynamic flow culturing modules were designed to simulate the micro-environment near the vascular depletion and hyperplasia area in wound-healing regions, thus to better investigate the mechanisms underlying the biocompatibility and functionality of borate-based glass materials. Glass fibers were dosed either upstream or in contact with the pre-seeded cells in the dynamic flow module. Two types of borate glasses, doped with (1605) or without (13-93B3) CuO and ZnO, were studied along with the silicate-based glass, 45S5. Substantial fiber dissolution in cell culture medium was observed, leading to the release of ions (boron, sodium and potassium) and the deposition of a calcium phosphate phase. Different levels of vascular endothelial growth factor secretion were observed from cells exposed to these three glass fibers, and the copper/zinc containing borate 1605 fibers exhibited the most positive influence. These results indicate that dynamic studies of in vitro bioactivity provide useful information to understand the in vivo response to bioactive borate glasses. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Chen, Sisi; Yang, Qingbo; Liu, Kun; Brow, Katherine A.; Ma, Yinfa; Shi, Honglan] Missouri Univ Sci & Technol, Dept Chem, 400 West 11th St, Rolla, MO 65409 USA.
   [Brow, Richard K.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
   [Chen, Sisi; Yang, Qingbo; Brow, Richard K.; Ma, Yinfa; Shi, Honglan] Missouri Univ Sci & Technol, Ctr Biomed Sci & Engn, Rolla, MO 65409 USA.
   [Yang, Qingbo; Liu, Kun; Ma, Yinfa; Shi, Honglan] Missouri Univ Sci & Technol, Ctr Single Nanoparticle Single Cell & Single Mol, Rolla, MO 65409 USA.
RP Shi, HL (reprint author), Missouri Univ Sci & Technol, Dept Chem, 400 West 11th St, Rolla, MO 65409 USA.
EM honglan@mst.edu
FU Center for Biomedical Science and Engineering (CBSE) at Missouri
   University of Science and Technology
FX This project was supported by the Center for Biomedical Science and
   Engineering (CBSE) at Missouri University of Science and Technology. The
   authors would like to thank Clarissa A. Wisner, Qingzhi Chen and Jessica
   Terbush for their assistance with the SEM imaging and the XRD analysis.
   The technical support from the Center for Single Nanoparticle, Single
   Cell, and Single Molecule Monitoring (CS<SUP>3</SUP>M) at Missburi
   University of Science and Technology is also appreciated. Finally, the
   authors thank Dr. Steve Jung (Mo-Sci, Inc.) for providing the glass
   fibers used in this study.
CR Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   COWLES AL, 1971, ANESTHESIOLOGY, V35, P523, DOI 10.1097/00000542-197111000-00013
   Day DE, 2003, GLASS TECHNOL, V44, P75
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Epstein FH, 1999, NEW ENGL J MED, V341, P738, DOI DOI 10.1056/NEJM199909023411006.PMID:10471461
   Erol MM, 2012, ACTA BIOMATER, V8, P792, DOI 10.1016/j.actbio.2011.10.013
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Hoppe A., 2014, BIOACTIVE GLASS DERI
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jung S.B., 2010, BORATE BASED BIOACTI
   Jung S.B., 2012, ADV BIOCERAM POROUS, VV, P65
   Jung SB, 2009, PHYS CHEM GLASSES-B, V50, P85
   Kabu Mustafa, 2013, REV ENVIRON CONTAM T, P57
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Li QF, 2014, J NUTR BIOCHEM, V25, P44, DOI 10.1016/j.jnutbio.2013.08.013
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Lin WS, 2006, INT J TOXICOL, V25, P451, DOI 10.1080/10915810600959543
   Lin YN, 2016, MAT SCI ENG C-MATER, V67, P440, DOI 10.1016/j.msec.2016.05.073
   Liu X, 2013, ACTA BIOMATER, V9, P7506, DOI 10.1016/j.actbio.2013.03.039
   Liu X, 2010, J MATER SCI-MATER M, V21, P575, DOI 10.1007/s10856-009-3897-8
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   MCGEE GS, 1988, J SURG RES, V45, P145, DOI 10.1016/0022-4804(88)90034-0
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Milkovic L, 2014, J BIOMED MATER RES A, V102, P3556, DOI 10.1002/jbm.a.35032
   Modglin VC, 2013, J MATER SCI-MATER M, V24, P1191, DOI 10.1007/s10856-013-4875-8
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2
   Rahaman M.N., 2015, ADV BIOCERAM POROU 8, V36, P3
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001
   Seo HJ, 2010, NUTR RES PRACT, V4, P356, DOI 10.4162/nrp.2010.4.5.356
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   Wang H, 2016, MAT SCI ENG C-MATER, V58, P194, DOI 10.1016/j.msec.2015.08.027
   Watters R.J., 2015, BIOMED GLASS, V1
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu XW, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3600902
   Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119
   Yang QB, 2015, MAT SCI ENG C-MATER, V55, P105, DOI 10.1016/j.msec.2015.05.049
   Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566
   Zhao SC, 2015, BIOMATERIALS, V53, P379, DOI 10.1016/j.biomaterials.2015.02.112
   Zhou J, 2016, MAT SCI ENG C-MATER, V60, P437, DOI 10.1016/j.msec.2015.11.068
NR 56
TC 6
Z9 6
U1 5
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 447
EP 455
DI 10.1016/j.msec.2016.12.099
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800053
PM 28183631
DA 2018-10-20
ER

PT J
AU Li, Q
   Xing, DM
   Ma, L
   Gao, CY
AF Li, Qian
   Xing, Dongming
   Ma, Lie
   Gao, Changyou
TI Synthesis of E7 peptide-modified biodegradable polyester with the
   improving affinity to mesenchymal stem cells
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Maleimide; Biodegradable polyester; E7 peptide; Affinity; BMSCs
ID SURFACE-MODIFICATION; BONE-MARROW; FUNCTIONAL-GROUPS; ADHESION;
   SCAFFOLDS; RAT; FILMS; DIFFERENTIATION; PROLIFERATION; BIOMATERIALS
AB As the most promising stem cell, bone marrow-derived mesenchymal stem cells (BMSCs) has attracted many attentions and applied widely in regenerative medicine. A biodegradable polyester with tunable affinity to BMSCs plays critical role in determining the properties of the BMSCs-based constructs. In this study, maleimide functionalized biodegradable polyester (P(MTMC-LA)) was synthesized through ring-opening copolymerization between c-lactide (LA) and furan-maleinlide functionalized trimethylene carbonate (FIVITMC) and a subsequent retro Diels-Alder reaction. P(MTMC-LA) was modified by different amounts of BMSCs specific affinity peptide (EPLQLKM, E7) through click-chemistry to investigate the effect on BMSCs. The E7 peptide modified P(MTMC-LA) was casted into films on glass slides and BMSCs were seeded onto the films. In vitro study showed that E7 peptide modified P(MTIVIC-LA) films supported BMSCs adhesion and proliferation compared to unmodified P(MTMC-LA) film. Besides, the adhesion and proliferation were enhanced by the increasing peptide grafting ratio. These results indicated that the novel biodegradable polyester can serve as a biomaterial with great potential application in tissue engineering and regenerative medicine. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Li, Qian; Xing, Dongming; Ma, Lie; Gao, Changyou] Zhejiang Univ, Dept Polymer Sci & Engn, MOE Key Lab Macromol Synth & Functionalizat, Hangzhou 310027, Zhejiang, Peoples R China.
RP Ma, L (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, MOE Key Lab Macromol Synth & Functionalizat, Hangzhou 310027, Zhejiang, Peoples R China.
EM liema@zju.edu.cn
FU Key Science Technology Innovation Team of Zhejiang Province [2013TD02];
   Natural Science Foundation of China [51322302, 51673167, 20934003];
   National Key Research Program of China [2016YFC1101001]
FX We acknowledge financial support by the Key Science Technology
   Innovation Team of Zhejiang Province (2013TD02), the Natural Science
   Foundation of China (51322302, 51673167, 20934003) and the National Key
   Research Program of China (2016YFC1101001).
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bayramoglu G, 2013, MAT SCI ENG C-MATER, V33, P801, DOI 10.1016/j.msec.2012.11.004
   Bi XP, 2014, ACTA BIOMATER, V10, P2814, DOI 10.1016/j.actbio.2014.02.018
   Cai WY, 2011, BIOMATERIALS, V32, P7774, DOI 10.1016/j.biomaterials.2011.06.075
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Coulembier O, 2006, PROG POLYM SCI, V31, P723, DOI 10.1016/j.progpolymsci.2006.08.004
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Gustafsson Y, 2012, BIOMATERIALS, V33, P8094, DOI 10.1016/j.biomaterials.2012.07.060
   Hvilsted S, 2012, POLYM INT, V61, P485, DOI 10.1002/pi.4135
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Lai YK, 2013, ADV MATER, V25, P1682, DOI 10.1002/adma.201203797
   Li B, 2014, TISSUE ENG PT A, V20, P1, DOI [10.1089/ten.tea.2013.0065, 10.1089/ten.TEA.2013.0065]
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Philipp A, 2011, REACT FUNCT POLYM, V71, P288, DOI 10.1016/j.reactfunctpolym.2010.10.003
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Russo V, 2016, MAT SCI ENG C-MATER, V69, P321, DOI 10.1016/j.msec.2016.06.092
   Salerno A, 2016, MAT SCI ENG C-MATER, V63, P512, DOI 10.1016/j.msec.2016.03.018
   Seo CH, 2013, BIOMATERIALS, V34, P1764, DOI 10.1016/j.biomaterials.2012.11.031
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   SPANGLER LL, 1990, POLYM ENG SCI, V30, P644, DOI 10.1002/pen.760301104
   Sun YX, 2013, ACS APPL MATER INTER, V5, P4597, DOI 10.1021/am401088w
   Wang HL, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.143623
   Wang R, 2011, MACROMOLECULES, V44, P6009, DOI 10.1021/ma200824k
   Xing DM, 2014, MACROMOL BIOSCI, V14, P1429, DOI 10.1002/mabi.201400186
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhu Y, 2013, BIOMACROMOLECULES, V14, P342, DOI 10.1021/bm301523p
NR 36
TC 3
Z9 3
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 562
EP 568
DI 10.1016/j.msec.2016.12.088
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800066
PM 28183645
DA 2018-10-20
ER

PT J
AU Cui, X
   Huang, WH
   Zhang, YD
   Huang, CC
   Yu, ZX
   Wang, L
   Liu, WL
   Wang, T
   Zhou, J
   Wang, H
   Zhou, N
   Wang, DP
   Pan, HB
   Rahaman, MN
AF Cui, Xu
   Huang, Wenhai
   Zhang, Yadong
   Huang, Chengcheng
   Yu, Zunxiong
   Wang, Lei
   Liu, Wenlong
   Wang, Ting
   Zhou, Jie
   Wang, Hui
   Zhou, Nai
   Wang, Deping
   Pan, Haobo
   Rahaman, Mohamed N.
TI Evaluation of an injectable bioactive borate glass cement to heal bone
   defects in a rabbit femoral condyle model
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Injectable bioactive glass cement; Bone cement; Bioactive borate glass;
   Bone repair; Rabbit femoral condyle model
ID CALCIUM-PHOSPHATE CEMENT; PHYSICOCHEMICAL PROPERTIES; LOCAL-DELIVERY;
   DRUG-DELIVERY; DIETARY BORON; SCAFFOLDS; SILICATE; HYDROXYAPATITE;
   BEHAVIOR
AB There is a need for synthetic biomaterials to heal bone defects using minimal invasive surgery. In the present study, an injectable cement composed of bioactive borate glass particles and a chitosan bonding solution was developed and evaluated for its capacity to heal bone defects in a rabbit femoral condyle model. The injectability and setting time of the cement in vitro decreased but the compressive strength increased (8 +/- 2 MPa to 31 +/- 2 MPa) as the ratio of glass particles to chitosan solution increased (from 1.0 g ml(-1) to 2.5 g ml(-1)). Upon immersing the cement in phosphate -buffered saline, the glass particles reacted and converted to hydroxyapatite, imparting bioactivity to the cement Osteoblastic MC3T3-E1 cells showed enhanced proliferation and alkaline phosphatase activity when incubated in media containing the soluble ionic product of the cement The bioactive glass cement showed a better capacity to stimulate bone formation in rabbit femoral condyle defects at 12 weeks postimplantation when compared to a commercial calcium sulfate cement The injectable bioactive borate glass cement developed in this study could provide a promising biomaterial to heal bone defects by minimal invasive surgery. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Cui, Xu; Huang, Wenhai; Zhou, Jie; Wang, Hui; Zhou, Nai; Wang, Deping] Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.
   [Cui, Xu; Huang, Chengcheng; Yu, Zunxiong; Wang, Lei; Liu, Wenlong; Wang, Ting; Pan, Haobo] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissues & Organs Degenerat, Shenzhen 518055, Peoples R China.
   [Zhang, Yadong; Rahaman, Mohamed N.] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Spine Surg, Shanghai 200120, Peoples R China.
   [Rahaman, Mohamed N.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
RP Pan, HB (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissues & Organs Degenerat, Shenzhen 518055, Peoples R China.; Zhang, YD; Rahaman, MN (reprint author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Spine Surg, Shanghai 200120, Peoples R China.; Rahaman, MN (reprint author), Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
EM zhangyadong6@126.com; hb.pan@siat.ac.cn; rahaman@mst.edu
FU National Natural Science Foundation of China [51072133, 51372170,
   81201377, 81371938, 81201384, 81572105, 51672191, 51272274]; Shenzhen
   Key Laboratory of Marine Biomedical Materials [ZDSY 20130401165820356];
   Shenzhen Peacock Innovation Team [110811003586331]; Shanghai Science
   Committee [12JC1408500]
FX This work was supported by the National Natural Science Foundation of
   China through projects 51072133, 51372170, 81201377, 81371938, 81201384,
   81572105, 51672191 and 51272274, Shenzhen Key Laboratory of Marine
   Biomedical Materials (ZDSY 20130401165820356), the Shenzhen Peacock
   Innovation Team through the project 110811003586331, and by the Shanghai
   Science Committee through project 12JC1408500.
CR Bohner M, 2010, EUR CELLS MATER, V20, P1
   Cui X, 2016, J NON-CRYST SOLIDS, V432, P150, DOI 10.1016/j.jnoncrysol.2015.06.001
   Cui X, 2014, J MATER SCI-MATER M, V25, P733, DOI 10.1007/s10856-013-5122-z
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   Devirian TA, 2003, CRIT REV FOOD SCI, V43, P219, DOI 10.1080/10408690390826491
   Doadrio JC, 2004, BIOMATERIALS, V25, P2629, DOI 10.1016/j.biomaterials.2003.09.037
   French LL, 2006, J MATER SCI-MATER M, V17, P967
   Fu Q, 2013, ADV FUNCT MATER, V23, P5461, DOI 10.1002/adfm.201301121
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Huang WH, 2006, PHYS CHEM GLASSES-B, V47, P647
   Hunt CD, 1998, BIOL TRACE ELEM RES, V66, P205, DOI 10.1007/BF02783139
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jung S. B., 2012, BIOGLASSES INTRO, P77
   Kai D, 2009, J MATER SCI-MATER M, V20, P1595, DOI 10.1007/s10856-009-3728-y
   Khairoun I., 2008, J MATER SCI-MATER M, V9, P425
   Klijn RJ, 2012, TISSUE ENG PT A, V18, P1171, DOI [10.1089/ten.TEA.2011.0444, 10.1089/ten.tea.2011.0444]
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuang GM, 2012, J BIOMED MATER RES B, V100B, P778, DOI 10.1002/jbm.b.32511
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   Liu CS, 2004, J BIOMED MATER RES B, V69B, P73, DOI 10.1002/jbm.b.20032
   Liu X, 2010, J BIOMED MATER RES B, V94B, P72, DOI 10.1002/jbm.b.31625
   Liu X, 2013, J MATER SCI-MATER M, V24, P583, DOI 10.1007/s10856-012-4831-z
   Lopez-Heredia MA, 2011, BIOMATERIALS, V32, P5411, DOI 10.1016/j.biomaterials.2011.04.010
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   QIANG FU, 2011, J BIOMED MATER RES A, V95, P164
   Rahaman MN, 2014, MAT SCI ENG C-MATER, V41, P224, DOI 10.1016/j.msec.2014.04.055
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047
   Shie MY, 2008, ACTA BIOMATER, V4, P646, DOI 10.1016/j.actbio.2007.10.011
   Su CC, 2014, MAT SCI ENG C-MATER, V37, P156, DOI 10.1016/j.msec.2014.01.010
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yamamuro T, 1998, BIOMATERIALS, V19, P1479, DOI 10.1016/S0142-9612(98)00062-3
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x
   Zhang YD, 2015, ACS APPL MATER INTER, V7, P2393, DOI 10.1021/am507008z
   Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017
NR 40
TC 5
Z9 5
U1 9
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 585
EP 595
DI 10.1016/j.msec.2016.12.101
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800069
PM 28183648
DA 2018-10-20
ER

PT J
AU Sun, JP
   Zheng, XY
   Li, H
   Fan, DD
   Song, ZP
   Ma, HX
   Hua, XF
   Hui, JF
AF Sun, Jianpeng
   Zheng, Xiaoyan
   Li, Hui
   Fan, Daidi
   Song, Zhanping
   Ma, Haixia
   Hua, Xiufu
   Hui, Junfeng
TI Monodisperse selenium-substituted hydroxyapatite: Controllable synthesis
   and biocompatibility
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Selenium; Controllable synthesis; Biocompatibility
ID BIOMEDICAL APPLICATIONS; ANTIBACTERIAL PROPERTIES; IN-VITRO; BONE; CO;
   NANOPARTICLES; NANOPOWDERS; ANTICANCER; CALCITE; VIVO
AB Hydroxyapatite (HA) is the major inorganic component of natural bone tissue. As an essential trace element, selenium involves in antioxidation and anticancer of human body. So far, ion-doped hydroxyapatites (HAs) are widely investigated owing to their great applications in field of biomaterial, biological labeling. In this paper, series of monodisperse HA doped with SeO32- (SeHA) was successfully synthesized based on the liquid-solid-solution (LSS) strategy. The obtained samples were characterized by transmission electron microscopy (TEM), Xray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR) and energy-dispersive spectrometer (EDS). The results indicated that the SeO32- doping level of the Se/(P + Se) molar ratio of 0-0.4 can be requisitely controlled, and the morphology of SeHA nanoparticles varied from nanorods to nanoneedles with increasing Se/(P + Se) molar ratio. Significantly, the as-synthesized SeHA nanocrystals exhibit a low cytotoxicity for osteoblastic cells, showing exciting potentials for application in artificial scaffold materials inhibiting of tumor growth in bone. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Sun, Jianpeng; Song, Zhanping] Xian Univ Architecture & Technol, Sch Civil Engn, Xian 710055, Shaanxi, Peoples R China.
   [Sun, Jianpeng; Zheng, Xiaoyan; Li, Hui; Fan, Daidi; Ma, Haixia; Hui, Junfeng] Northwest Univ Xian, Sch Chem & Engn, Shaanxi R&D Ctr Biomat & Fermentat Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Peoples R China.
   [Hua, Xiufu] Tsinghua Univ, Dept Sci Res & Dev, Beijing 100084, Peoples R China.
RP Hui, JF (reprint author), Northwest Univ Xian, Sch Chem & Engn, Shaanxi R&D Ctr Biomat & Fermentat Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Peoples R China.; Hua, XF (reprint author), Tsinghua Univ, Dept Sci Res & Dev, Beijing 100084, Peoples R China.
EM hua_xiufu@163.com; huijunfeng@126.com
RI Fan, daidi/J-1128-2017
FU National Natural Science Foundation of China [21376190, 21676215,
   51578447, 51408453]; National High Technology Research and Development
   Program of China [2014AA022108, 2012BA17B02]; Specialized Research Fund
   for the Doctoral Program of Higher Education [20136120120022]; China
   Postdoctoral Science Foundation [2013M542378, 2014T70933]; Shaanxi
   Provincial Postdoctoral Science Special Foundation [2014907]; Shaanxi
   Provincial Natural Science Foundation [2016JQ5075]; Northwest University
   Science Foundation [YZZ14045]
FX This work was supported by National Natural Science Foundation of China
   (21376190, 21676215, 51578447, 51408453), National High Technology
   Research and Development Program of China (2014AA022108, 2012BA17B02),
   Specialized Research Fund for the Doctoral Program of Higher Education
   (20136120120022), China Postdoctoral Science Foundation (2013M542378,
   2014T70933), Shaanxi Provincial Postdoctoral Science Special Foundation
   (Grant No. 2014907), Shaanxi Provincial Natural Science Foundation
   (2016JQ5075), and Northwest University Science Foundation (YZZ14045).
CR Thang CX, 2015, MATER SCI ENG B-ADV, V197, P18, DOI 10.1016/j.mseb.2015.02.014
   Chen XY, 2013, COLLOID SURFACE B, V103, P149, DOI 10.1016/j.colsurfb.2012.10.022
   Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a
   del Rio JAG, 2004, J ENVIRON MANAGE, V71, P169, DOI 10.1016/j.jenvman.2004.02.004
   ELDER RC, 1978, INORG CHEM, V17, P870, DOI 10.1021/ic50182a015
   Epple M, 2010, J MATER CHEM, V20, P18, DOI 10.1039/b910885h
   Eslami H, 2009, MAT SCI ENG C-BIO S, V29, P1387, DOI 10.1016/j.msec.2008.10.033
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Huang SP, 2012, MATER RES BULL, V47, P24, DOI 10.1016/j.materresbull.2011.10.013
   Hui J., 2009, INORG CHEM, V48, P10222
   Hui JF, 2012, CHEM-EUR J, V18, P13702, DOI 10.1002/chem.201201277
   Kheradmandfard M, 2010, J ALLOY COMPD, V504, P141, DOI 10.1016/j.jallcom.2010.05.073
   Kolmas J, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0989-x
   Kolmas J, 2014, MAT SCI ENG C-MATER, V39, P134, DOI 10.1016/j.msec.2014.02.018
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   LEGEROS RZ, 1996, BIOCERAMICS, V9, P7
   Ma J, 2013, MAT SCI ENG C-MATER, V33, P440, DOI 10.1016/j.msec.2012.09.011
   Ma MY, 2008, J MATER CHEM, V18, P2722, DOI 10.1039/b800389k
   Matsuya T, 2016, MAT SCI ENG C-MATER, V58, P127, DOI 10.1016/j.msec.2015.08.020
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012
   Perla V, 2005, J BIOMED MATER RES A, V75A, P356, DOI 10.1002/jbm.a.30423
   Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354
   Pon-On W, 2013, MATER CHEM PHYS, V141, P850, DOI 10.1016/j.matchemphys.2013.06.014
   Renard F, 2013, CHEM GEOL, V340, P151, DOI 10.1016/j.chemgeo.2012.12.017
   Rodriguez-Valencia C, 2013, J BIOMED MATER RES A, V101, P853, DOI 10.1002/jbm.a.34387
   Stanic V, 2014, APPL SURF SCI, V290, P346, DOI 10.1016/j.apsusc.2013.11.081
   Su CM, 2000, SOIL SCI SOC AM J, V64, P101, DOI 10.2136/sssaj2000.641101x
   Sun YX, 2011, CERAM INT, V37, P2917, DOI 10.1016/j.ceramint.2011.03.030
   Tran PA, 2010, J BIOMED MATER RES A, V93A, P1417, DOI 10.1002/jbm.a.32631
   VAUGHEY JT, 1994, INORG CHEM, V33, P4370, DOI 10.1021/ic00097a027
   Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008
   Wang YH, 2016, COLLOID SURFACE B, V140, P297, DOI 10.1016/j.colsurfb.2015.12.056
   Wang YH, 2012, INTERFACE FOCUS, V2, P378, DOI 10.1098/rsfs.2012.0002
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Xie YF, 2016, ACS APPL MATER INTER, V8, P10212, DOI 10.1021/acsami.6b01814
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang WD, 2016, ADV POWDER TECHNOL, V27, P1857, DOI 10.1016/j.apt.2016.03.026
   Zhang WD, 2014, MATER LETT, V134, P123, DOI 10.1016/j.matlet.2014.07.072
   Zhu CH, 2014, MAT SCI ENG C-MATER, V34, P393, DOI 10.1016/j.msec.2013.09.044
NR 41
TC 8
Z9 8
U1 9
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2017
VL 73
BP 596
EP 602
DI 10.1016/j.msec.2016.12.106
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EK6VT
UT WOS:000394064800070
PM 28183650
DA 2018-10-20
ER

PT J
AU Patutina, OA
   Bichenkova, EV
   Miroshnichenko, SK
   Mironova, NL
   Trivoluzzi, LT
   Burusco, KK
   Bryce, RA
   Vlassov, VV
   Zenkova, MA
AF Patutina, Olga A.
   Bichenkova, Elena V.
   Miroshnichenko, Svetlana K.
   Mironova, Nadezhda L.
   Trivoluzzi, Linda T.
   Burusco, Kepa K.
   Bryce, Richard A.
   Vlassov, Valentin V.
   Zenkova, Marina A.
TI miRNases: Novel peptide-oligonucleotide bioconjugates that silence
   miR-21 in lymphosarcoma cells
SO BIOMATERIALS
LA English
DT Article
DE Peptide-oligonucleotide conjugates; RNA cleavage; Antisense
   oligonucleotides; Anti-miRNA therapy; Oncogenic miRNA; miR-21
ID ANTISENSE OLIGONUCLEOTIDES; ARTIFICIAL RIBONUCLEASES; BREAST-CANCER;
   IN-VITRO; MICRORNA SPONGES; PROSTATE-CANCER; RT-PCR; RNA; CLEAVAGE; GENE
AB MicroRNAs (miRNAs) are active regulators in malignant growth and constitute potential targets for anticancer therapy. Consequently, considerable effort has focused on identifying effective ways to modulate aberrant miRNA expression. Here we introduce and assess a novel type of chemically engineered biomaterial capable of cleaving specific miRNA sequences, i.e. miRNA-specific artificial ribonucleases (hereafter 'miRNase'). The miRNase template presented here consists of the catalytic peptide Acetyl-[(LeuArg)(2)Gly](2) covalently attached to a miRNA-targeting oligonucleotide, which can be linear or hairpin. The peptide C-terminus is conjugated to an aminohexyl linker located at either the 3'- or 5'-end of the oligonucleotide. The cleavage efficacy, structural aspects of cleavage and biological relevance of a set of these designed miRNases was assayed with respect to highly oncogenic miR-21. Several miRNases demonstrated effective site-selective cleavage of miR-21 exclusively at G-X bonds. One of the most efficient miRNase was shown to specifically inhibit miR-21 in lymphosarcoma cells and lead to a reduction in their proliferative activity. This report provides the first experimental evidence that metallo-independent peptide-oligonucleotide chemical ribonucleases are able to effectively and selectively down-regulate oncogenic miRNA in tumour cells, thus suggesting their potential in development of novel therapeutics aimed at overcoming overexpression of disease-related miRNAs. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Patutina, Olga A.; Miroshnichenko, Svetlana K.; Mironova, Nadezhda L.; Vlassov, Valentin V.; Zenkova, Marina A.] RAS, SB, Inst Chem Biol & Fundamental Med, Lab Nucle Acids Biochem, Lavrentiev Ave 8, Novosibirsk 630090, Russia.
   [Bichenkova, Elena V.; Trivoluzzi, Linda T.; Burusco, Kepa K.; Bryce, Richard A.] Univ Manchester, Sch Hlth Sci, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England.
RP Zenkova, MA (reprint author), RAS, SB, Inst Chem Biol & Fundamental Med, Lab Nucle Acids Biochem, Lavrentiev Ave 8, Novosibirsk 630090, Russia.; Bichenkova, EV (reprint author), Univ Manchester, Sch Hlth Sci, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM elena.v.bichenkova@manchester.ac.uk; marzen@niboch.nsc.ru
RI Patutina, Olga/F-9159-2013; Zenkova, Marina/G-5088-2013
OI Bryce, Richard/0000-0002-8145-2345; Mironova,
   Nadezhda/0000-0003-4375-0269; Bichenkova, Elena/0000-0002-8186-9757;
   Burusco-Goni, Kepa Koldo/0000-0003-1546-3086
FU Russian Science Foundation [14-44-00068]; BBCRC [BB/K012622/1]; EPSRC
   [EP/E003400/1]; Biotechnology and Biological Sciences Research Council
   [1354357]; Engineering and Physical Sciences Research Council
   [EP/E003400/1]
FX This research has been supported by the Russian Science Foundation
   (Grant No. 14-44-00068), BBCRC (Grant No. BB/K012622/1) and EPSRC (Grant
   No. EP/E003400/1). The authors would like to thank Dr. Aled Williams for
   synthesis of 3'-conjugates, and Dr. Maria I. Meschaninova for synthesis
   of miR-21. The authors would like to thank Prof. David J. Clarke for
   fruitful discussions and manuscript editing. The authors are grateful to
   the EPSRC UK National Mass Spectrometry Facility at Swansea University
   for MS analysis of the peptide and peptide-oligonucleotide conjugate
   samples.
CR Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043
   Aiba Y, 2011, CHEM-ASIAN J, V6, P2407, DOI 10.1002/asia.201100238
   Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856
   Baker BF, 1999, NUCLEIC ACIDS RES, V27, P1547, DOI 10.1093/nar/27.6.1547
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bekris LM, 2015, NEURODEGENER DIS MAN, V5, P61, DOI [10.2217/nmt.14.52, 10.2217/NMT.14.52]
   Beloglazova N. G., 2011, J NUCL ACIDS, V2011
   Beloglazova NG, 2000, FEBS LETT, V481, P277, DOI 10.1016/S0014-5793(00)02029-9
   Beloglazova NG, 2004, NUCLEIC ACIDS RES, V32, P3887, DOI 10.1093/nar/gkh702
   Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688
   Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880
   Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707
   Brognara E, 2016, INT J ONCOL, V48, P1029, DOI 10.3892/ijo.2015.3308
   Burke B, 2008, BBA-PROTEINS PROTEOM, V1784, P1222, DOI 10.1016/j.bbapap.2008.04.027
   Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371
   Canaple L, 2002, BIOCONJUGATE CHEM, V13, P945, DOI 10.1021/bc0200024
   Case DA, 2015, AMBER 2015
   Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178
   Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535
   Danneberg F, 2015, BEILSTEIN J ORG CHEM, V11, P493, DOI 10.3762/bjoc.11.55
   DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527
   Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079
   Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110
   Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160
   Gaglione M, 2011, MOL BIOSYST, V7, P2490, DOI 10.1039/c1mb05131h
   Gao SQ, 2015, ACTA BIOMATER, V25, P184, DOI 10.1016/j.actbio.2015.07.020
   Garo LP, 2016, CELL MOL LIFE SCI, V73, P2041, DOI 10.1007/s00018-016-2167-4
   Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179
   Geney R, 2006, J CHEM THEORY COMPUT, V2, P115, DOI 10.1021/ct0501831
   Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555
   Hu HY, 2010, LEUKEMIA LYMPHOMA, V51, P694, DOI 10.3109/10428191003596835
   Huang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0376-8
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Inoue H., 2000, NUCL ACIDS S SER, V44, P279
   Jung J, 2015, ONCOTARGET, V6, P20370, DOI 10.18632/oncotarget.4827
   Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055
   Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021
   Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154
   Kuzuya A., 2002, NUCL ACIDS RES S2, V2, P129
   Lee JE, 2008, J MOL BIOL, V375, P165, DOI 10.1016/j.jmb.2007.09.089
   Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100
   Li S, 2012, MOL CELL BIOCHEM, V360, P147, DOI 10.1007/s11010-011-1052-6
   Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077
   Liang AL, 2016, ONCOL REP, V35, P1950, DOI 10.3892/or.2016.4596
   Lonnberg H, 2011, ORG BIOMOL CHEM, V9, P1687, DOI 10.1039/c0ob00486c
   Loughlin FE, 2009, P NATL ACAD SCI USA, V106, P5581, DOI 10.1073/pnas.0802466106
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72
   Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888
   Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453
   Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4
   Mironova NL, 2007, NUCLEIC ACIDS RES, V35, P2356, DOI 10.1093/nar/gkm143
   Mironova N, 2006, ANN NY ACAD SCI, V1091, P490, DOI 10.1196/annals.1378.090
   Mironova N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083482
   Mironova NL, 2006, J BIOMOL STRUCT DYN, V23, P591, DOI 10.1080/07391102.2006.10507084
   Mironova NL, 2002, RUSS CHEM B+, V51, P1177, DOI 10.1023/A:1020932009136
   Molecular Operating Environment (MOE), 2014, 201409 MOE CHEM COMP
   Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485
   Niittymaki T, 2006, ORG BIOMOL CHEM, V4, P15, DOI 10.1039/b509022a
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033
   Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14
   PARK JG, 1987, CANCER RES, V47, P5875
   Patutina OA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-204
   Regulus Therapeutics Inc, 2016, CLIN PIP RG 101
   Romero-Cordoba SL, 2014, CANCER BIOL THER, V15, P1444, DOI 10.4161/15384047.2014.955442
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Santini GPH, 2009, J PHYS CHEM B, V113, P6881, DOI 10.1021/jp8100656
   Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918
   Silberklang F., 1979, METHOD ENZYMOL, V59, P58
   Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891
   Staroseletz Y, 2017, BIOMATERIALS, V112, P44, DOI 10.1016/j.biomaterials.2016.09.033
   Sunami T, 2004, ACTA CRYSTALLOGR D, V60, P90, DOI 10.1107/S0907444903024703
   Takayama H., 2007, NUCL ACIDS S SER OXF, V51, P203
   Tao YJ, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0228-7
   Ushijima K, 2001, BIOORGAN MED CHEM, V9, P2165, DOI 10.1016/S0968-0896(01)00126-2
   Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12
   Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495
   Vlasov AV, 1996, DOKL AKAD NAUK+, V349, P411
   Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang ZG, 2011, METHODS MOL BIOL, V676, P43, DOI 10.1007/978-1-60761-863-8_3
   Williams A, 2015, BIOCONJUGATE CHEM, V26, P1129, DOI 10.1021/acs.bioconjchem.5b00193
   Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062
   Zenkova M. A., 2004, NUCL ACIDS MOL BIOL, V13
   Zhang TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19346
   Zhao X., 2013, NANO, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0056395
   Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200
NR 92
TC 6
Z9 6
U1 6
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2017
VL 122
BP 163
EP 178
DI 10.1016/j.biomaterials.2017.01.018
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EL2TG
UT WOS:000394472500015
PM 28126663
DA 2018-10-20
ER

PT J
AU Khamhaengpol, A
   Siri, S
AF Khamhaengpol, Arunrat
   Siri, Sineenat
TI Green synthesis of silver nanoparticles using tissue extract of weaver
   ant larvae
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Green synthesis; Nanoparticles; Silver; Weaver ant
ID ANTIBACTERIAL ACTIVITY; IN-VITRO; CYTOTOXICITY
AB Green synthesis of silver nanoparticles (AgNPs) has gained widespread interest as the alternative method to use natural, non-toxic substances to facilitate the formation of AgNPs. This work reported on the alternative source of reducing and stabilizing agents from tissue extract of weaver ant (Oecophylla smaragdina) larvae. The formation of AgNPs in the reaction containing silver nitrate, the tissue extract, and glucose at 60 degrees C was indicated by the surface plasmon resonance at 428 nm. Transmission electron microscopy images revealed spherical AgNPs with the average diameter of 67.4 nm. The synthesized AgNPs exhibited potent antibacterial activity against both Staphylococcus aureus and Escherichia coli with the minimum bactericidal concentrations equally at 16 mu g/mL. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Khamhaengpol, Arunrat] Khon Kaen Univ, Dept Biochem, Khon Kaen 40002, Thailand.
   [Siri, Sineenat] Suranaree Univ Technol, Sch Biol, Nakhon Ratchasima 30000, Thailand.
RP Siri, S (reprint author), Suranaree Univ Technol, Sch Biol, Nakhon Ratchasima 30000, Thailand.
EM ssinee@sut.ac.th
FU Suranaree University of Technology-Thailand [SUT1-104-57-24-20]
FX This work is supported by Suranaree University of Technology-Thailand
   [SUT1-104-57-24-20].
CR Ahmed KBR, 2017, TOXICOL IN VITRO, V38, P179, DOI 10.1016/j.tiv.2016.10.012
   Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007
   Archana D, 2015, INT J BIOL MACROMOL, V73, P49, DOI 10.1016/j.ijbiomac.2014.10.055
   Bahadur NM, 2011, J COLLOID INTERF SCI, V355, P312, DOI 10.1016/j.jcis.2010.12.016
   Bastus NG, 2014, CHEM MATER, V26, P2836, DOI 10.1021/cm500316k
   Cushen M, 2012, TRENDS FOOD SCI TECH, V24, P30, DOI 10.1016/j.tifs.2011.10.006
   Daengsakul S, 2009, APPL PHYS A-MATER, V96, P691, DOI 10.1007/s00339-009-5151-0
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kavita K, 2014, MICROBIOL RES, V169, P301, DOI 10.1016/j.micres.2013.07.002
   Khamhaengpol A, 2016, J PHOTOCH PHOTOBIO B, V163, P337, DOI 10.1016/j.jphotobiol.2016.09.003
   Khan MAM, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-434
   Kshirsagar P, 2011, COLLOID SURFACE A, V392, P264, DOI 10.1016/j.colsurfa.2011.10.003
   Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32
   Ravichandran V, 2016, MATER LETT, V180, P264, DOI 10.1016/j.matlet.2016.05.172
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Vidhu VV, 2015, CURR SCI INDIA, V109, P572
   Walser T, 2011, ENVIRON SCI TECHNOL, V45, P4570, DOI 10.1021/es2001248
   Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010
   Zhang YT, 2013, J INORG BIOCHEM, V118, P59, DOI 10.1016/j.jinorgbio.2012.07.025
NR 19
TC 8
Z9 8
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 1
PY 2017
VL 192
BP 72
EP 75
DI 10.1016/j.matlet.2017.01.076
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EK6VQ
UT WOS:000394064500019
DA 2018-10-20
ER

PT J
AU Ma, XX
   Zhang, L
   Fan, DD
   Xue, WJ
   Zhu, CH
   Li, X
   Liu, YN
   Liu, W
   Ma, P
   Wang, Y
AF Ma, Xiaoxuan
   Zhang, Le
   Fan, Daidi
   Xue, Wenjiao
   Zhu, Chenhui
   Li, Xian
   Liu, Yannan
   Liu, Wan
   Ma, Pei
   Wang, Ya
TI Physicochemical properties and biological behavior of injectable
   crosslinked hydrogels composed of pullulan and recombinant human-like
   collagen
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID BONE TISSUE REGENERATION; BIOMEDICAL APPLICATIONS; SCAFFOLDS; HEMOLYSIS;
   GROWTH; DRUG
AB Injectable hydrogels have become a hot topic of research in tissue engineering field, with broad application prospects. In this paper, recombinant human-like collagen (HLC) and three different kinds of high molecular weight pullulan (P), crosslinked with 1,2,7,8-diepoxyoctane (DEO), were synthesized in a water bath. Pullulan/1,2,7,8-diepoxyoctane (PD) and pullulan human-like collagen/1,2,7,8-diepoxyoctane (PHD) hydrogels, with high crosslinking density, injectability, thermal stability, and biocompatibility were synthesized. According to hypothesis, the biocompatibility and biodegradability of PHD hydrogels was better than PD hydrogels and PHD hydrogels served as ideal filler biomaterials in tissue engineering. Physicochemical properties such as swelling ratio, elastic modulus, thermal stability, porosity, and rheological features of these hydrogels were studied. Results showed that an increase in the molecular weight of pullulan and the amount of added HLC enhanced its mechanical properties. However, it showed little influence on its thermal stability, since pullulan and HLC themselves were thermally stable. Acute toxicity test, hemolysis test, and L929 cell 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide assay (MTT) were employed for testing the toxicity and cytocompatibility. The cell attachment in vitro and biocompatibility in vivo were also investigated. The MTT and live/dead cell viability staining results demonstrated that PDH was less cytotoxic than PD due to the promotion of the L929 proliferation. In vitro degradation results indicated that the hydrogels had prolonged degradation times and excellent anti-enzymatic abilities. Subcutaneous injection of PDH hydrogel in rabbit showed a lower inflammatory response after 1, 2, and 8 weeks, and the hydrogels showed almost no obvious degradation in two months. Thus, the hydrogel had a great potential to be used as ideal filler biomaterial in tissue engineering.
C1 [Ma, Xiaoxuan; Zhang, Le; Fan, Daidi; Zhu, Chenhui; Li, Xian; Liu, Yannan; Liu, Wan; Ma, Pei; Wang, Ya] Northwest Univ, Shaanxi Key Lab Degradable Biomed Mat, Sch Chem Engn, 229 North Taibai Rd, Xian 710069, Shaanxi, Peoples R China.
   [Ma, Xiaoxuan; Zhang, Le; Fan, Daidi; Zhu, Chenhui; Li, Xian; Liu, Yannan; Liu, Wan; Ma, Pei; Wang, Ya] Northwest Univ, Shaanxi R&D Ctr Biomat & Fermentat Engn, Sch Chem Engn, 229 North Taibai Rd, Xian 710069, Shaanxi, Peoples R China.
   [Xue, Wenjiao; Zhu, Chenhui; Li, Xian] Shaanxi Prov Inst Microbiol, Xian 710043, Peoples R China.
RP Fan, DD (reprint author), Northwest Univ, Shaanxi Key Lab Degradable Biomed Mat, Sch Chem Engn, 229 North Taibai Rd, Xian 710069, Shaanxi, Peoples R China.; Fan, DD (reprint author), Northwest Univ, Shaanxi R&D Ctr Biomat & Fermentat Engn, Sch Chem Engn, 229 North Taibai Rd, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
OI xue, wenjiao/0000-0002-8867-1575
FU National Natural Science Foundation of China [21476182, 21576223,
   21606179]; Natural Science Basic Research Plan in Shaanxi Province of
   China [2014JM2-2015]; Scientific and Technologic Research Program of
   Shaanxi Province Academy of Sciences, China [2014k-01]; Shaanxi Key
   Laboratory of Degradable Biomedical Materials Program [2014SZS07-K04,
   2014SZS07-P05, 15JS106, 2014SZS07-Z01, 2014SZS07-K03]; Shaanxi R&D
   Center of Biomaterials and Fermentation Engineering Program
   [2015HBGC-04]; NWU Graduate Innovation and Creativity Funds [YZZ14006]
FX This study was financially supported by the National Natural Science
   Foundation of China (21476182, 21576223, 21606179); Natural Science
   Basic Research Plan in Shaanxi Province of China (2014JM2-2015);
   Scientific and Technologic Research Program of Shaanxi Province Academy
   of Sciences, China (2014k-01); Shaanxi Key Laboratory of Degradable
   Biomedical Materials Program (2014SZS07-K04, 2014SZS07-P05, 15JS106,
   2014SZS07-Z01, 2014SZS07-K03); Shaanxi R&D Center of Biomaterials and
   Fermentation Engineering Program (2015HBGC-04), and the NWU Graduate
   Innovation and Creativity Funds (No. YZZ14006).
CR Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Alijotas-Reig J, 2013, SEMIN ARTHRITIS RHEU, V43, P241, DOI 10.1016/j.semarthrit.2013.02.001
   Aydogdu H, 2016, MAT SCI ENG C-MATER, V63, P439, DOI 10.1016/j.msec.2016.03.002
   Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Bang S, 2016, INT J BIOL MACROMOL, V87, P155, DOI 10.1016/j.ijbiomac.2016.02.026
   Chen JP, 2009, POLYMER, V50, P107, DOI 10.1016/j.polymer.2008.10.045
   Christensen L, 1991, BACTERIAL INFECT LIK, P188
   Cui N, 2015, CARBOHYD POLYM, V126, P192, DOI 10.1016/j.carbpol.2015.03.013
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008
   Jatariu AN, 2011, J BIOMED MATER RES A, V98A, P342, DOI 10.1002/jbm.a.33122
   Jia LP, 2013, MAT SCI ENG C-MATER, V33, P727, DOI 10.1016/j.msec.2012.10.025
   Kimoto T, 1997, FOOD CHEM TOXICOL, V35, P323, DOI 10.1016/S0278-6915(97)00001-X
   Kurisawa M., 2005, CHEMICAL COMMUNICATI, V34, P4312
   Lack S, 2004, POLYM BULL, V52, P429, DOI 10.1007/s00289-004-0299-4
   Li WC, 2016, COMPOS SCI TECHNOL, V128, P58, DOI 10.1016/j.compscitech.2016.03.013
   LI X, 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089856
   Malheiros SVP, 1998, BBA-BIOMEMBRANES, V1373, P332
   Mocanu G, 2012, CARBOHYD POLYM, V87, P1440, DOI 10.1016/j.carbpol.2011.09.037
   Priya VS, 2016, WOUND MED, V14, P1
   Ranjha N. M., 2014, INT J PHARM PHARM SC, V6, P400
   Raza A, 2013, BIOMATERIALS, V34, P5117, DOI 10.1016/j.biomaterials.2013.03.086
   Rekha MR, 2009, BIOMATERIALS, V30, P6655, DOI 10.1016/j.biomaterials.2009.08.029
   Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003
   Singh RS, 2015, CARBOHYD POLYM, V123, P190, DOI 10.1016/j.carbpol.2015.01.032
   Strassner M, 2004, Use of surfactants with a ratio of hemolysis value to denaturation index of greater than or equal to 1 for obtaining or increasing the selectivity of cleansing preparations, Patent No. [EP1432401, 1432401]
   Terada Mizuho, 2014, Tokai J Exp Clin Med, V39, P122
   Wang JP, 2009, J EUR CERAM SOC, V29, P3091, DOI 10.1016/j.jeurceramsoc.2009.04.036
   [王晓军 Wang Xiaojun], 2005, [高校化学工程学报, Journal of Chemical Engineering of Chinese Universities], V19, P410
   Wolffsohn J, 2015, CONTACT LENS ANTERIO, V38, P339, DOI 10.1016/j.clae.2015.03.010
   Yang XC, 2014, BIOMATERIALS, V35, P3873, DOI 10.1016/j.biomaterials.2014.01.036
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhai YG, 2015, MACROMOL MATER ENG, V300, P1290, DOI 10.1002/mame.201500215
   Zhang JJ, 2014, MAT SCI ENG C-MATER, V43, P547, DOI 10.1016/j.msec.2014.07.058
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 37
TC 7
Z9 7
U1 5
U2 84
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD APR
PY 2017
VL 52
IS 7
BP 3771
EP 3785
DI 10.1007/s10853-016-0577-1
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA EI4YO
UT WOS:000392500200018
DA 2018-10-20
ER

PT J
AU Liang, WQ
   Wang, JT
   Zang, XH
   Dong, WH
   Wang, C
   Wang, Z
AF Liang, Weiqian
   Wang, Juntao
   Zang, Xiaohuan
   Dong, Wenhuan
   Wang, Chun
   Wang, Zhi
TI Barley husk carbon as the fiber coating for the solid-phase
   microextraction of twelve pesticides in vegetables prior to gas
   chromatography-mass spectrometric detection
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE Barley husk biomaterial carbon; Solid-phase microextraction; Gas
   chromatography-mass spectrometry; Pesticides; Tomato and cucumber
ID POLYCYCLIC AROMATIC-HYDROCARBONS; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ELECTRON-CAPTURE DETECTION; CARBAMATE PESTICIDES; ACTIVATED CARBONS;
   CHEMICAL ACTIVATION; WATER SAMPLES; COCONUT SHELL; COATED FIBER;
   EXTRACTION
AB In this work, a barley husk biomaterial was successfully carbonized by hydrothermal method. The carbon had a high specific surface area and good stability. It was coated onto a stainless steel wire through sol-gel technique to prepare a solid-phase microextraction fiber for the extraction of trace levels of twelve pesticides (tsumacide, fenobucarb, indoxacarb, diethofencarb, thimet, terbufos, malathion, thiamethoxam, imidacloprid, buprofezin, acetamiprid, thiamethoxam) from vegetable samples prior to gas chromatography-mass spectrometric (GC-MS) detection. The main experimental parameters that could influence the extraction efficiency such as extraction time, extraction temperature, sample pH, sample salinity, stirring rate, desorption temperature and desorption time, were investigated. Under the optimized conditions, the linearity was observed in the range of 0.2-75.0 mu gkg(-1) for tomato samples, and 0.3-60.0 mu gkg(-1) for cucumber samples, with the correlation coefficients (r) ranging from 0.9959 to 0.9983. The limits of detection of the method were 0.01-0.05 mu gkg(-1) for tomato samples, and 0.03-0.10 mu gkg(-1) for cucumber samples. The recoveries of the analytes for the method from spiked samples were in the range of 76%-104%, and the precision, expressed as the relative standard deviations, was less than 12%. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Liang, Weiqian; Wang, Juntao; Zang, Xiaohuan; Dong, Wenhuan; Wang, Chun; Wang, Zhi] Hebei Agr Univ, Coll Sci, Baoding 071001, Hebei, Peoples R China.
RP Zang, XH; Wang, Z (reprint author), Hebei Agr Univ, Coll Sci, Baoding 071001, Hebei, Peoples R China.
EM zangxiaohuan@hebau.edu.cn; zhiwang2013@aliyun.com
FU National Natural Science Foundation of China [31571925, 31471643,
   31671930]; Hebei "Double First Class Discipline" Construction Foundation
   for the Discipline of Food Science and Engineering of Hebei Agricultural
   University [2016SPGCA18]; Natural Science Foundation of Hebei Province
   [B2016204136, B2016204146]; Innovation Talents Research Foundation of
   Hebei Agricultural University; Natural Science Foundation of Hebei
   Agricultural University [ZD201507, LG201607]
FX Financial supports from the National Natural Science Foundation of China
   (No. 31571925, 31471643, 31671930), the Hebei "Double First Class
   Discipline" Construction Foundation for the Discipline of Food Science
   and Engineering of Hebei Agricultural University (2016SPGCA18), the
   Natural Science Foundation of Hebei Province (B2016204136, B2016204146),
   the Innovation Talents Research Foundation of Hebei Agricultural
   University, and the Natural Science Foundation of Hebei Agricultural
   University (ZD201507, LG201607) are gratefully acknowledged.
CR Ash B, 2006, J SCI IND RES INDIA, V65, P1008
   Carabias-Martinez R, 2005, J SEP SCI, V28, P2130, DOI 10.1002/jssc.200400047
   Chen H, 2010, J CHROMATOGR A, V1217, P1244, DOI 10.1016/j.chroma.2009.12.062
   Daud WMAW, 2000, CARBON, V38, P1925, DOI 10.1016/S0008-6223(00)00028-2
   Deng H, 2009, J HAZARD MATER, V166, P1514, DOI 10.1016/j.jhazmat.2008.12.080
   Dias AN, 2015, TALANTA, V134, P409, DOI 10.1016/j.talanta.2014.11.045
   Gou YN, 2000, J CHROMATOGR A, V873, P137, DOI 10.1016/S0021-9673(99)01125-5
   Guo YP, 2006, CARBON, V44, P1464, DOI 10.1016/j.carbon.2005.12.002
   Hayashi J, 2000, CARBON, V38, P1873, DOI 10.1016/S0008-6223(00)00027-0
   Hu ZH, 1999, MICROPOR MESOPOR MAT, V27, P11, DOI 10.1016/S1387-1811(98)00183-8
   Koseoglu E, 2015, ADV POWDER TECHNOL, V26, P811, DOI 10.1016/j.apt.2015.02.006
   Krawczyk H, 2008, FOOD BIOPROD PROCESS, V86, P31, DOI 10.1016/j.fbp.2007.10.018
   Lillo-Rodenas MA, 2003, CARBON, V41, P267, DOI 10.1016/S0008-6223(02)00279-8
   Liu ZM, 2012, INT J ENVIRON AN CH, V92, P571, DOI 10.1080/03067311003628638
   Luo YB, 2012, J CHROMATOGR A, V1268, P9, DOI 10.1016/j.chroma.2012.10.035
   MOORE KM, 1995, WATER RES, V29, P1225, DOI 10.1016/0043-1354(94)00321-W
   Phan NH, 2006, CARBON, V44, P2569, DOI 10.1016/j.carbon.2006.05.048
   Qu YQ, 2013, J SEP SCI, V36, P3889, DOI 10.1002/jssc.201300694
   Rastkari N, 2010, FOOD ADDIT CONTAM A, V27, P1460, DOI 10.1080/19440049.2010.495730
   Rastkari N, 2010, ANAL CHIM ACTA, V662, P90, DOI 10.1016/j.aca.2009.12.035
   Shi Z., 2014, J CHROMATOGR A, V1355
   Stavropoulos GG, 2005, MICROPOR MESOPOR MAT, V82, P79, DOI 10.1016/j.micromeso.2005.03.009
   Suarez-Garcia F, 2002, J ANAL APPL PYROL, V63, P283, DOI 10.1016/S0165-2370(01)00160-7
   Sugumaran P, 2009, J SCI IND RES INDIA, V68, P719
   Sun M, 2013, J SEP SCI, V36, P1478, DOI 10.1002/jssc.201201036
   Tonucci MC, 2015, IND CROP PROD, V74, P111, DOI 10.1016/j.indcrop.2015.05.003
   Tsai WT, 1997, CARBON, V35, P1198, DOI 10.1016/S0008-6223(97)84654-4
   Wu QH, 2011, J CHROMATOGR A, V1218, P7936, DOI 10.1016/j.chroma.2011.09.027
   Xu LL, 2012, J SEP SCI, V35, P93, DOI 10.1002/jssc.201100612
   Zhang GJ, 2014, TALANTA, V129, P600, DOI 10.1016/j.talanta.2014.06.013
   Zhang SL, 2011, ANAL CHEM, V83, P7531, DOI 10.1021/ac201864f
   Zhang X, 2015, MICROCHIM ACTA, V182, P2353, DOI 10.1007/s00604-015-1566-9
   Zou J, 2011, J SEP SCI, V34, P2765, DOI 10.1002/jssc.201100303
NR 33
TC 3
Z9 3
U1 4
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
EI 1873-3778
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD MAR 31
PY 2017
VL 1491
BP 9
EP 15
DI 10.1016/j.chroma.2017.02.034
PG 7
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA EP4UP
UT WOS:000397375700002
PM 28237260
DA 2018-10-20
ER

PT J
AU Zhi, ZL
   Su, YJ
   Xi, YW
   Tian, L
   Xu, M
   Wang, QQ
   Padidan, S
   Li, P
   Huang, W
AF Zhi, Zelun
   Su, Yajuan
   Xi, Yuewei
   Tian, Liang
   Xu, Miao
   Wang, Qjanqian
   Padidan, Sara
   Li, Peng
   Huang, Wei
TI Dual-Functional Polyethylene Glycol-b-polyhexanide Surface Coating with
   in Vitro and in Vivo Antimicrobial and Antifouling Activities
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE antimicrobial; antibiofilm; antifouling polyhexamethylene biguanide
   (PHMB); surface coating
ID POLYHEXAMETHYLENE BIGUANIDE; POLYMER BRUSH; ANTIBIOFILM ACTIVITY;
   BROAD-SPECTRUM; ANTIBACTERIAL; PEPTIDE; GUANIDINE; PROTEINS; PLASMA;
   WATER
AB In recent years, microbial colonization on the surface of biomedical implants/devices has become a severe threat to human health. Herein, surface immobilized guanidine derivative block copolymers create an antimicrobial and antifouling dual-functional coating. We report the preparation of an antimicrobial and antifouling block copolymer by the conjugation of polyhexanide (PHMB) with either ally glycidyl ether or allyloxy polyethylene glycol (APEG; MW 1200 and 2400): The allyl glycidyl ether modified PHMB (A-PHMB) and allyloxy polyethylene glycol(1200/2400) modified PHMB (APEG(1200/2400)-PHMB) copolymers were grafted onto a silicone rubber surface as a bottlebrush-like coating, respectively, using a plasma-UV-assisted surface-initiated polymerization. Both A-PHMB and APEG(1200/2400)-PHMB coatings exhibited excellent broad-spectrum antimicrobial properties against Gram-negative/positive bacteria and fungi. The APEG(2400)-PHMB coating displayed an improved antibiofilrn as well as antifouling properties and a long reusable cycle, compared with two other coatings, due to its abundant PEG blocks among those copolymers. Also, the APEG(2400)-PHMB-coated silicone coupons were biocompatible toward mammalian cells, as revealed by in vitro hemocompatibile and cytotoxic assays. An in vivo study showed a significant decline of Escherichia coli colonies with a 5-log reduction, indicating the APEG(2400)-PHMB coating surface worked effectively in the rodent subcutaneous infection model. This PHMB-based block copolymer coating is believed to be an effective strategy to prevent biomaterial-associated infections.
C1 [Zhi, Zelun; Tian, Liang; Xu, Miao; Wang, Qjanqian; Li, Peng; Huang, Wei] Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Key Lab Flexible Elect KLOFE, Nanjing 211816, Jiangsu, Peoples R China.
   [Zhi, Zelun; Tian, Liang; Xu, Miao; Wang, Qjanqian; Li, Peng; Huang, Wei] Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Inst Adv Mat IAM, Nanjing 211816, Jiangsu, Peoples R China.
   [Zhi, Zelun; Padidan, Sara] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem & Phys, Melbourne, Vic 3086, Australia.
   [Su, Yajuan; Xi, Yuewei] Xi An Jiao Tong Univ, Ctr Biomed Engn & Regenerat Med, Frontier Inst Sci & Technol, Xian 710049, Peoples R China.
RP Li, P (reprint author), Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Key Lab Flexible Elect KLOFE, Nanjing 211816, Jiangsu, Peoples R China.; Li, P (reprint author), Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Inst Adv Mat IAM, Nanjing 211816, Jiangsu, Peoples R China.
EM iampli@njtech.edu.cn
RI Li, Peng/G-9033-2012; Huang, Wei/A-4461-2009
OI Li, Peng/0000-0002-5876-2177; Huang, Wei/0000-0001-7004-6408
FU Natural Science Foundation of China [51403173]; Natural Science Basic
   Research Plan in Shannxi Province of China [2015JQ5139]; Fundamental
   Research Funds for the Central Universities of China
FX This work was funded and supported by the Natural Science Foundation of
   China (No. 51403173), the Natural Science Basic Research Plan in Shannxi
   Province of China (No. 2015JQ5139), and the Fundamental Research Funds
   for the Central Universities of China.
CR Allen MJ, 2004, BIOCHEM BIOPH RES CO, V318, P397, DOI 10.1016/j.bbrc.2004.04.043
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Buchberger T, 2013, J CHROMATOGR A, V1318, P22, DOI 10.1016/j.chroma.2013.10.005
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chadeau E, 2012, CAN J MICROBIOL, V58, P1353, DOI 10.1139/w2012-113
   Chindera K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23121
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001
   Ehrenfreund-Kleinman T, 2004, BIOMATERIALS, V25, P3049, DOI 10.1016/j.biomaterials.2003.09.080
   Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012
   Gao Q, 2017, ACTA BIOMATER, V51, P112, DOI 10.1016/j.actbio.2017.01.061
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   Gilliver S, 2009, J WOUND CARE, P9
   Godoy-Gallardo M, 2015, BIOMACROMOLECULES, V16, P483, DOI 10.1021/bm501528x
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gour N, 2014, MACROMOL MATER ENG, V299, P648, DOI 10.1002/mame.201300285
   Gu J, 2017, ACS APPL MATER INTER, V9, P198, DOI 10.1021/acsami.6b13552
   Hartleb W, 2016, MACROMOL CHEM PHYS, V217, P225, DOI 10.1002/macp.201500266
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Horner IJ, 2015, J PHYS CHEM B, V119, P10531, DOI 10.1021/acs.jpcb.5b07162
   Huang YJ, 2016, BIOMATERIALS, V106, P134, DOI 10.1016/j.biomaterials.2016.08.025
   Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P17, DOI 10.1159/000318264
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   Kamaruzzaman NF, 2016, J ANTIMICROB CHEMOTH, V71, P1252, DOI 10.1093/jac/dkv474
   Li P, 2012, ADV MATER, V24, P4130, DOI 10.1002/adma.201104186
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Li X, 2014, ACTA BIOMATER, V10, P258, DOI 10.1016/j.actbio.2013.09.009
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   Lu Y, 2015, FRONT CHEM SCI ENG, V9, P324, DOI 10.1007/s11705-015-1529-z
   Mi L, 2014, ANGEW CHEM INT EDIT, V53, P1746, DOI 10.1002/anie.201304060
   Mitrano DM, 2014, ACS NANO, V8, P7208, DOI 10.1021/nn502228w
   Peng XL, 2013, ACS APPL MATER INTER, V5, P1017, DOI 10.1021/am3027019
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Pranantyo D, 2015, BIOMACROMOLECULES, V16, P723, DOI 10.1021/bm501623c
   Qin GT, 2015, BIOMATER SCI-UK, V3, P771, DOI 10.1039/c5bm00055f
   Rayatpisheh S, 2012, MACROMOL BIOSCI, V12, P937, DOI 10.1002/mabi.201100477
   Regev-Shoshani G, 2010, ANTIMICROB AGENTS CH, V54, P273, DOI 10.1128/AAC.00511-09
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Shi XH, 2013, J APPL POLYM SCI, V128, P1995, DOI 10.1002/app.38403
   Souza AL, 2015, COLLOID SURFACE B, V132, P117, DOI 10.1016/j.colsurfb.2015.05.018
   Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047
   Voo ZX, 2016, POLYM CHEM-UK, V7, P656, DOI 10.1039/c5py01718a
   Voo ZX, 2015, MACROMOLECULES, V48, P1055, DOI 10.1021/ma5022488
   Wang YL, 2015, ACS NANO, V9, P10142, DOI 10.1021/acsnano.5b03763
   Wei DF, 2013, J APPL POLYM SCI, V127, P666, DOI 10.1002/app.37849
   Wessels S, 2013, REGUL TOXICOL PHARM, V67, P456, DOI 10.1016/j.yrtph.2013.09.006
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
   Wu C, 2014, CHINESE J POLYM SCI, V32, P1575, DOI 10.1007/s10118-014-1539-1
   Xi YJ, 2016, BIOMACROMOLECULES, V17, P3922, DOI 10.1021/acs.biomac.6b01285
   Yang C, 2014, ADV MATER, V26, P7346, DOI 10.1002/adma.201402059
   Yu K, 2015, ACS APPL MATER INTER, V7, P28591, DOI 10.1021/acsami.5b10074
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Zhang YM, 1999, POLYMER, V40, P6189, DOI 10.1016/S0032-3861(98)00828-3
   Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155
   Zhou ZX, 2010, J APPL MICROBIOL, V108, P898, DOI 10.1111/j.1365-2672.2009.04482.x
NR 60
TC 30
Z9 30
U1 35
U2 161
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 29
PY 2017
VL 9
IS 12
BP 10383
EP 10397
DI 10.1021/acsami.6b12979
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EQ7EQ
UT WOS:000398246900010
PM 28263055
DA 2018-10-20
ER

PT J
AU Moerke, C
   Rebl, H
   Finke, B
   Dubs, M
   Nestler, P
   Airoudj, A
   Roucoules, V
   Schnabelrauch, M
   Koertge, A
   Anselme, K
   Helm, CA
   Nebe, JB
AF Moerke, Caroline
   Rebl, Henrike
   Finke, Birgit
   Dubs, Manuela
   Nestler, Peter
   Airoudj, Aissam
   Roucoules, Vincent
   Schnabelrauch, Matthias
   Koertge, Andreas
   Anselme, Karine
   Helm, Christiane A.
   Nebe, J. Barbara
TI Abrogated Cell Contact Guidance on Amino-Functionalized Microgrooves
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE geometric microgrooves; RGD; physical plasma; water contact angle; zeta
   potential; contact guidance; actin cytoskeleton; correlative microscopy
ID OSTEOBLAST-LIKE CELLS; SURFACE-CHEMISTRY; TITANIUM SURFACES; PLASMA
   POLYMERIZATION; MODEL SURFACES; ADHESION; TOPOGRAPHY; PROLIFERATION;
   FIBROBLASTS; MODULATION
AB Topographical and chemical features of biomaterial surfaces affect the cell physiology at the interface and are promising tools for the improvement of implants. The dominance of the surface topography on cell behavior is often accentuated. Striated surfaces induce an alignment of cells and their intracellular adhesion-mediated components. Recently, it could be demonstrated that a chemical modification via plasma polymerized allylamine was not only able to boost osteoblast cell adhesion and spreading but also override the cell alignment on stochastically machined titanium. In order to discern what kind of chemical surface modifications let the cell forget the underlying surface structure, we used an approach on geometric microgrooves produced by deep reactive ion etching (DRIE). In this study, we systematically investigated the surface modification by (i) methyl-, carboxyl-, and amino functionalization created via plasma polymerization processes, (ii) coating with the extracellular matrix protein collagen-I or immobilization of the integrin adhesion peptide sequence Arg-Gly-Asp (RGD), and (iii) treatment with an atmospheric pressure plasma jet operating with argon/oxygen gas (Ar/O-2). Interestingly, only the amino functionalization, which presented positive charges at the surface, was able to chemically disguise the microgrooves and therefore to interrupt the microtopography induced contact guidance of the osteoblastic cells MG-63. However, the RGD peptide coating revealed enhanced cell spreading as well, with fine, actin-containing protrusions. The Ar/O-2-functionalization demonstrated the best topography handling, e.g. cells closely attached even to features such as the sidewalls of the groove steps. In the end, the amino functionalization is unique in abrogating the cell contact guidance
C1 [Moerke, Caroline; Rebl, Henrike; Nebe, J. Barbara] Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
   [Finke, Birgit] Leibniz Inst Plasma Sci & Technol INP, Felix Hausdorff Str 2, D-17489 Greifswald, Germany.
   [Dubs, Manuela; Schnabelrauch, Matthias] INNOVENT eV, Biomaterials Dept, Pruessingstr 27B, D-07745 Jena, Germany.
   [Nestler, Peter] Ernst Moritz Arndt Univ Greifswald, Inst Phys, Felix Hausdorff Str 6, D-17487 Greifswald, Germany.
   [Airoudj, Aissam; Roucoules, Vincent; Anselme, Karine] CNRS UMR7361, Inst Mat Sci Mulhouse IS2M, 15 Rue Jean Starcky,BP2488, F-68057 Mulhouse, France.
   [Koertge, Andreas] Univ Rostock, Inst Elect Appliances & Circuits, Albert Einstein Str 2, D-18059 Rostock, Germany.
RP Nebe, JB (reprint author), Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
RI Helm, Christiane/C-5000-2015
OI Helm, Christiane/0000-0001-5181-1688; Anselme,
   Karine/0000-0002-6669-205X; Finke, Birgit/0000-0002-5941-0376
FU German Research Foundation (DFG) graduate school welisa [1505/2];
   Federal Ministry of Education and Research in Germany (BMBF) [I3N11183,
   13N11188]; Innovative Regional Growth Core BASIS [03WKCBO1F]; Women
   Professors Programme [01FP13064F]
FX This work was supported by the German Research Foundation (DFG) graduate
   school welisa 1505/2 as well as by the Federal Ministry of Education and
   Research in Germany (BMBF, Campus PlasmaMed Grants I3N11183, 13N11188,
   Innovative Regional Growth Core BASIS Grant 03WKCBO1F, and Women
   Professors Programme Grant 01FP13064F).
CR Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cools P, 2014, PLASMA CHEM PLASMA P, V34, P917, DOI 10.1007/s11090-014-9552-2
   D'Sa RA, 2016, ACS APPL MATER INTER, V8, P14920, DOI 10.1021/acsami.5b08073
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   DEVORE JR, 1951, J OPT SOC AM, V41, P416, DOI 10.1364/JOSA.41.000416
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Dvoranova D, 2014, MOLECULES, V19, P17279, DOI 10.3390/molecules191117279
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Finke B, 2014, LANGMUIR, V30, P13914, DOI 10.1021/la5019778
   Gabler C, 2014, INT J MOL SCI, V15, P2454, DOI 10.3390/ijms15022454
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106
   Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271
   Rebl H, 2016, MAT SCI ENG C-MATER, V69, P1116, DOI 10.1016/j.msec.2016.08.016
   Rebl H, 2012, ACTA BIOMATER, V8, P3840, DOI 10.1016/j.actbio.2012.06.015
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shahabi S, 2015, ACS APPL MATER INTER, V7, P13821, DOI 10.1021/acsami.5b01900
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Soppera O, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/39/395304
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Vasudev MC, 2013, ACS APPL MATER INTER, V5, P3983, DOI 10.1021/am302989x
   Vogelsang A, 2010, PLASMA PROCESS POLYM, V7, P16, DOI 10.1002/ppap.200900091
   Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 37
TC 6
Z9 6
U1 2
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 29
PY 2017
VL 9
IS 12
BP 10461
EP 10471
DI 10.1021/acsami.6b16430
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EQ7EQ
UT WOS:000398246900018
PM 28296389
DA 2018-10-20
ER

PT J
AU Cork, J
   Whittaker, AK
   Cooper-White, JJ
   Grondahl, L
AF Cork, Jorja
   Whittaker, Andrew K.
   Cooper-White, Justin J.
   Grondahl, Lisbeth
TI Electrospinning and mechanical properties of P(TMC-co-LLA) elastomers
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VITRO DEGRADATION; TISSUE ENGINEERING APPLICATIONS; CARDIOVASCULAR
   STENT MATERIAL; TRIMETHYLENE CARBONATE; 1,3-TRIMETHYLENE CARBONATE;
   L-LACTIDE; EPSILON-CAPROLACTONE; MOLECULAR-WEIGHT; POLY(TRIMETHYLENE
   CARBONATE-CO-L-LACTIDE); MICROSTRUCTURAL CHARACTERIZATION
AB P(TMC-co-LLA) elastomers have shown great potential for various biomaterial and tissue engineering applications. This study systematically investigated properties key to such applications. Three P(TMC-coLLA) copolymers with 9 to 32 mol% TMC were synthesised and processed into 3D fibrous scaffolds using solution electrospinning. A range of fiber diameters (0.5-5.9 mu m) and pore sizes (3.5-19.8 mu m) were achieved simply by adjusting the voltage, collector distance and feed rate during electrospinning. The morphological features of the electrospun scaffolds were affected by the copolymer composition such that the average fiber diameters decreased in the order of P(TMC20-co-LLA80) 4 P(TMC32-co-LLA68) 4 P(TMC9-co-LLA91), which suggests inherent properties of the copolymers influence the electrospinning process. In addition, the specific parameter combinations applied during electrospinning did not affect the thermal properties of the scaffolds, however, it was confirmed that rapid solidification of the fibers occurred during electrospinning which lowered the inherent crystallinity and caused deviations of the thermodynamic state from equilibrium. Mechanical testing revealed that the Young's modulus and ultimate tensile strength were dependent on the morphology of the fibrous scaffolds, while in contrast, the ductility and toughness were strongly composition dependent with P(TMC20-co-LLA80) scaffolds displaying lower ductility and toughness than P(TMC32-co-LLA68) scaffolds.
C1 [Cork, Jorja; Grondahl, Lisbeth] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
   [Cork, Jorja; Whittaker, Andrew K.; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Whittaker, Andrew K.] ARC Ctr Excellence Convergent Bionano Sci & Techn, Brisbane, Qld, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
   [Cooper-White, Justin J.] CSIRO, Mfg Flagship, Clayton, Vic 3169, Australia.
RP Grondahl, L (reprint author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.; Cooper-White, JJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.; Cooper-White, JJ (reprint author), Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.; Cooper-White, JJ (reprint author), CSIRO, Mfg Flagship, Clayton, Vic 3169, Australia.
EM j.cooperwhite@uq.edu.au; l.grondahl@uq.edu.au
OI Cooper-White, Justin/0000-0002-1920-8229
FU Queensland State Government, under the National and International
   Research Alliance Scheme; Australian Research Council [DP0987407,
   DP110104299, LE0775684, LE0668517, LE0882357]; Australian government
FX Funding for the International Biomaterials Research Alliance was
   provided by the Queensland State Government, under the National and
   International Research Alliance Scheme. This work was carried out in
   part at the Centre for Microscopy and Microanalysis, The University of
   Queensland node of the Australian Microscopy and Microanalysis Research
   Facility (AMMRF). Access to equipment of the Queensland node of the
   Australian National Fabrication Facility, a company established under
   the National Collaborative Research Infrastructure Strategy to provide
   nano- and microfabrication facilities for Australia's researchers, is
   also acknowledged. J. Cork wishes to thank the Australian government for
   an Australian Postgraduate Award. The authors acknowledge the Australian
   Research Council (DP0987407, DP110104299, LE0775684, LE0668517, and
   LE0882357) for support of this research.
CR Agarwal S, 2005, POLYM INT, V54, P1422, DOI 10.1002/pi.1865
   ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Chen F, 2014, BIOMACROMOLECULES, V15, P1593, DOI 10.1021/bm401813j
   Cork J, 2015, J MATER CHEM B, V3, P4406, DOI 10.1039/c5tb00202h
   Darensbourg DJ, 2007, MACROMOLECULES, V40, P3521, DOI 10.1021/ma062780n
   Dargaville BL, 2013, ACTA BIOMATER, V9, P6885, DOI 10.1016/j.actbio.2013.02.009
   Dargaville BL, 2011, BIOMACROMOLECULES, V12, P3856, DOI 10.1021/bm201291e
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GRIJPMA DW, 1992, POLYM BULL, V29, P571, DOI 10.1007/BF00296720
   Guo QK, 2011, ACTA BIOCH BIOPH SIN, V43, P433, DOI 10.1093/abbs/gmr034
   Han YR, 2012, POLYM ENG SCI, V52, P741, DOI 10.1002/pen.22137
   Han YR, 2012, MACROMOL MATER ENG, V297, P128, DOI 10.1002/mame.201100113
   Hua JJ, 2009, J POLYM SCI POL CHEM, V47, P3869, DOI 10.1002/pola.23453
   Huang G, 2012, POLYM DEGRAD STABIL, V97, P1067, DOI 10.1016/j.polymdegradstab.2012.02.004
   Ji LJ, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045009
   Jia YT, 2006, J APPL POLYM SCI, V99, P1462, DOI 10.1002/app.22633
   Joziasse CAP, 1998, POLYMER, V39, P467, DOI 10.1016/S0032-3861(97)00293-0
   Kasperczyk J., 2001, J CONTROL RELEASE, V152, pe1
   Kim G, 2007, J BIOMED MATER RES B, V81B, P104, DOI 10.1002/jbm.b.30642
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   Li YL, 2013, CHINESE J POLYM SCI, V31, P966, DOI 10.1007/s10118-013-1299-3
   Matsumura S, 1999, INT J BIOL MACROMOL, V25, P161, DOI 10.1016/S0141-8130(99)00030-6
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Mukherjee S, 2011, J MATER SCI-MATER M, V22, P1689, DOI 10.1007/s10856-011-4351-2
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ruckenstein E, 1998, J APPL POLYM SCI, V69, P1429, DOI 10.1002/(SICI)1097-4628(19980815)69:7<1429::AID-APP18>3.0.CO;2-O
   Song Y, 2010, ACTA BIOMATER, V6, P1269, DOI 10.1016/j.actbio.2009.10.002
   Stefani I, 2016, ACTA BIOMATER, V36, P231, DOI 10.1016/j.actbio.2016.03.013
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Thomas V, 2011, ACTA BIOMATER, V7, P2070, DOI 10.1016/j.actbio.2011.01.008
   Truong V., 2008, POLYM PREPR AM CHEM, V49, P1097
   Tsutsumi C, 2002, MACROMOL BIOSCI, V2, P223, DOI 10.1002/1616-5195(200206)2:5<223::AID-MABI223>3.0.CO;2-D
   Vaquette C, 2008, J BIOMED MATER RES B, V86B, P9, DOI 10.1002/jbm.b.30982
   Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036
   Wang JH, 2011, CARBOHYD POLYM, V86, P226, DOI 10.1016/j.carbpol.2011.04.037
   Yang JA, 2010, J BIOMED MATER RES A, V94A, P396, DOI 10.1002/jbm.a.32677
   Yang JY, 2013, INT J BIOL MACROMOL, V62, P411, DOI 10.1016/j.ijbiomac.2013.09.055
   Zhang Z, 2004, J MATER SCI-MATER M, V15, P381, DOI 10.1023/B:JMSM.0000021105.02301.ff
   Zuideveld M, 2006, POLYMER, V47, P3740, DOI 10.1016/j.polymer.2006.03.034
NR 52
TC 1
Z9 1
U1 3
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 28
PY 2017
VL 5
IS 12
BP 2263
EP 2272
DI 10.1039/c7tb00137a
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EQ3GQ
UT WOS:000397960100006
DA 2018-10-20
ER

PT J
AU Bedoui, F
   Murthy, NS
   Kohn, J
AF Bedoui, F.
   Murthy, N. S.
   Kohn, J.
TI Structure and Thermal Transitions in a Biomedically Relevant Liquid
   Crystalline Poly(ester amide)
SO MACROMOLECULES
LA English
DT Article
ID STRUCTURE-PROPERTY RELATIONSHIPS; ERODABLE POLYMERIC BIOMATERIALS; POLY
   DESAMINOTYROSYL ARYLATES; X-RAY-SCATTERING; SEMICRYSTALLINE POLYMERS;
   SMECTIC-F; FIBERS; RECONSTRUCTION; COPOLYMERS; PHASE
AB There is still a need to develop bioresorbable polymers with high strength and high modulus for load-bearing biomedical applications. Here we investigate the liquid crystalline structural features of poly(desaminotyrosyl-tyrosine dodecyl dodecanedioate), poly(DTD DD), a new bioresorbable poly(ester amide) that is currently studied in vivo as a slow-degrading implantable biomaterial for load bearing applications. Thermally induced structural changes in poly(DTD DD) were studied using simultaneously differential scanning calorimetry (DSC) and X-ray scattering. The hexatic SmB organization of the polymer chains that exists at room temperature becomes progressively disordered upon heating, changing into a SmF phase and then into a smectic C phase at 60 degrees C before turning into a free -flowing melt at 130 C. X-ray scattering data and thermal analysis indicate the presence of a 2D ordered structure in the polymer melt. A structural model with an interesting 3 fold symmetry in the packing of the side chains around the rigid aromatic main chain, and the packing of these chains into fibrils, is proposed. The liquid crystalline behavior of poly(DTD DD) makes it possible to melt process it at low temperatures without thermal degradation. This is a noteworthy advantage for the use of poly(DTD DD) as a high strength, readily processable, yet biodegradable polymer.
C1 [Bedoui, F.; Murthy, N. S.] Univ Technol Compiegne, Sorbonne Univ, Lab Roberval UMR CNRS 7337, F-60203 Compiegne, France.
   [Bedoui, F.] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.
   [Murthy, N. S.; Kohn, J.] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
EM kohn@rutgers.edu
FU RESBIO (Integrated Technology Resource for Polymeric Biomaterials) -
   National Institutes of Health (NIBIB) [P41 EB001046]; MAPS (Means for
   Making Polymer Materials Smart) - IDEX-SUPER Sorbonne Universites
   [SU-15-R-EMR-06-1]; NSF [DMR-9304725]; State of Illinois [IBHE HECA NWU
   96]; DOE [W-31-109-ENG-38]; New Jersey Center for Biomaterials at
   Rutgers University; RESBIO (Integrated Technology Resource for Polymeric
   Biomaterials) - National Institutes of Health (NCMHD) [P41 EB001046]
FX This work was supported by RESBIO (Integrated Technology Resource for
   Polymeric Biomaterials) funded by the National Institutes of Health
   (NIBIB and NCMHD) under Grant P41 EB001046 and MAPS (Means for Making
   Polymer Materials Smart) funded by IDEX-SUPER Sorbonne Universites under
   Grant SU-15-R-EMR-06-1. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH, NIBIB, or NCMHD. The authors thank Dr. Steven Weigand at the
   DND-CAT (supported by NSF Grant DMR-9304725, and the State of Illinois
   IBHE HECA NWU 96) at the Advanced Photon Source (supported by DOE
   Contract No. W-31-109-ENG-38), Argonne, IL, for enabling the collection
   of X-ray scattering data. The authors are grateful to Prof. William A.
   Goddard III for enabling the molecular simulations in the Materials
   Process and Simulation Center, California Institute of Technology,
   Pasadena, CA. The work was also supported by the New Jersey Center for
   Biomaterials at Rutgers University.
CR AHARONI SM, 1989, MACROMOLECULES, V22, P1137, DOI 10.1021/ma00193a023
   [Anonymous], 2016, SCHR REL 2016 1 MAES
   Asin L, 2001, J POLYM SCI POL CHEM, V39, P4283, DOI 10.1002/pola.10082
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Collins G, 2007, POLYMER, V48, P975, DOI 10.1016/j.polymer.2006.11.049
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FLORY PJ, 1984, ADV POLYM SCI, V59, P1
   FOLDA T, 1988, NATURE, V333, P55, DOI 10.1038/333055a0
   GAYMANS RJ, 1993, POLYMER, V34, P4360, DOI 10.1016/0032-3861(93)90202-L
   Guo Q., 2016, POLYM MORPHOLOGY PRI
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Jackson WJ, 1980, BR POLYM J, V12, P154
   Jaffe M, 2002, POLYM ADVAN TECHNOL, V13, P926, DOI 10.1002/pat.278
   Jaffe M, 2003, THERMOCHIM ACTA, V396, P141, DOI 10.1016/S0040-6031(02)00524-5
   Jaffe M, 2003, POLYMER, V44, P6033, DOI 10.1016/S0032-3861(03)00559-7
   Jones R. G., 2009, COMPENDIUM POLYM TER
   KHAN AH, 1983, POLYMER, V24, P1610, DOI 10.1016/0032-3861(83)90180-5
   KOSTROMIN SG, 1982, MAKROMOL CHEM-RAPID, V3, P809
   KUMAR S, 1983, J PHYS-PARIS, V44, P123, DOI 10.1051/jphys:01983004401012300
   LENZ J, 1988, J APPL POLYM SCI, V35, P1987, DOI 10.1002/app.1988.070350801
   Mark J. E, 2007, PHYS PROPERTIES POLY, V1076
   McIntyre J. E., 1981, British Polymer Journal, V13, P5, DOI 10.1002/pi.4980130103
   MURTHY NS, 1990, J APPL POLYM SCI, V40, P249, DOI 10.1002/app.1990.070400120
   MURTHY NS, 1990, POLYMER, V31, P996, DOI 10.1016/0032-3861(90)90243-R
   Murthy NS, 1996, J POLYM SCI POL PHYS, V34, P821, DOI 10.1002/(SICI)1099-0488(19960415)34:5<821::AID-POLB1>3.0.CO;2-P
   Murthy NS, 1998, MACROMOLECULES, V31, P142, DOI 10.1021/ma9707603
   MURTHY NS, 1992, MACROMOLECULES, V25, P1177, DOI 10.1021/ma00029a026
   MURTHY NS, 1984, BIOPOLYMERS, V23, P1261, DOI 10.1002/bip.360230710
   Pelzl G., 1994, LIQUID CRYSTALS DARM, P51
   RAJA VN, 1992, PHYS REV A, V46, pR726, DOI 10.1103/PhysRevA.46.R726
   Roby M. S., 1999, Patent No. [US 5,902,875 A, 5902875]
   Rodriguez-Galan A, 2011, POLYMERS-BASEL, V3, P65, DOI 10.3390/polym3010065
   Sato N, 1998, MACROMOLECULES, V31, P2673, DOI 10.1021/ma971176x
   Sava I, 2009, REV ROUM CHIM, V54, P381
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Sudha JD, 2000, J POLYM SCI POL CHEM, V38, P2469, DOI 10.1002/1099-0518(20000701)38:13<2469::AID-POLA190>3.0.CO;2-J
   TINH NH, 1986, J PHYS-PARIS, V47, P553
   Tovar N, 2012, J BIOMED MATER RES A, V100A, P2913, DOI 10.1002/jbm.a.34229
   Tovar N, 2010, J BIOMED MATER RES A, V93A, P738, DOI 10.1002/jbm.a.32567
   UNGAR G, 1993, POLYMER, V34, P2050, DOI 10.1016/0032-3861(93)90730-X
   Wang ZG, 2000, J APPL CRYSTALLOGR, V33, P690, DOI 10.1107/S0021889899014193
NR 44
TC 1
Z9 1
U1 5
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD MAR 28
PY 2017
VL 50
IS 6
BP 2257
EP 2266
DI 10.1021/acs.macromol.6b02473
PG 10
WC Polymer Science
SC Polymer Science
GA EQ4AJ
UT WOS:000398014800002
DA 2018-10-20
ER

PT J
AU Huang, HN
   Pan, CY
   Wu, HY
   Chen, JY
AF Huang, Han-Ning
   Pan, Chieh-Yu
   Wu, Hung-Yi
   Chen, Jyh-Yih
TI Antimicrobial peptide Epinecidin-1 promotes complete skin regeneration
   of methicillin-resistant Staphylococcus aureus infected burn wounds in a
   swine model
SO ONCOTARGET
LA English
DT Article
DE antimicrobial peptide; Epinecidin-1; methicillin-resistant
   Staphylococcus aureus
ID DENUDED AMNIOTIC MEMBRANE; ANIMAL-MODELS; EPINEPHELUS-COIOIDES; PIG
   MODEL; EXPRESSION; LIMBAL; PROLIFERATION; CELLS; FISH; MICE
AB This report shows that the antimicrobial peptide ( AMP) Epinecidin-1 (Epi-1) efficiently heals MRSA-infected heat burn injuries and provides protection from infection in a pig model. The presence of an optimal level of Epi-1 induces cell proliferation by promoting cell cycle progression through an increase in S-phase cells. Epi-1 also induces proliferation to cover the wounded region in an in vitro cell proliferation assay using immortalized human epithelial HaCaT cells. Next, the in vivo wound healing efficiency of Epi-1 was tested in heat- burned pig skin infected with MRSA under in vivo conditions. Treatment of the injury with Epi-1 for 1 h at six hours post-infection completely healed the wound within 25 days. Conversely, the injury in the untreated control was not healed 25 days post-infection. Histological staining of wound sections with H& E showed that Epi-1 enhanced vascularization and increased epithelial activities in the wound region. Neutrophil recruitment to the wounded region in the Epi-1-treated sections was visualized by Giemsa staining. Additionally, Masson's trichrome staining of wound sections confirmed that Epi-1 enhanced extracellular collagen compound formation. The induction of sepsisassociated blood C-reactive protein (CRP) and the pro-inflammatory cytokine IL-6 in response to MRSA infection was also suppressed in pigs that received Epi-1. Taken together, the results demonstrate that the biomaterial Epi-1 heals wounds through increasing epithelial cell proliferation, vascularization, and the formation of collagen and controls MRSA infection-mediated sepsis in pigs.
C1 [Huang, Han-Ning; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan.
   [Pan, Chieh-Yu] Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan.
   [Wu, Hung-Yi] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Coll Vet Med, Neipu, Taiwan.
RP Chen, JY (reprint author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan.; Wu, HY (reprint author), Natl Pingtung Univ Sci & Technol, Dept Vet Med, Coll Vet Med, Neipu, Taiwan.
EM wuhy@mail.npust.edu.tw; zoocjy@gate.sinica.edu.tw
FU Marine Research Station, Institute of Cellular and Organismic Biology,
   Academia Sinica, Jiaushi, Ilan, Taiwan
FX Research funding was obtained from the Marine Research Station,
   Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi,
   Ilan, Taiwan. We thank the Department of Veterinary Medicine, College of
   Veterinary Medicine, National Pingtung University of Science and
   Technology and Dr. Hung-Yi Wu for technical support with the animal
   studies.
CR Alcaraz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135324
   Arrecubieta C, 2006, J INFECT DIS, V193, P1109, DOI 10.1086/501366
   Bartlett A, 2016, EXP THER MED, V12, P33, DOI 10.3892/etm.2016.3263
   Birch M, 2005, METH MOLEC MED, V117, P223
   BJORNSON AB, 1984, J TRAUMA, V24, P106, DOI 10.1097/00005373-198402000-00003
   Byers DK, 2008, DM-DIS MON, V54, P756, DOI 10.1016/j.disamonth.2008.09.005
   Dai TH, 2011, VIRULENCE, V2, P296, DOI 10.4161/viru.2.4.16840
   Daum RS, 1998, PEDIATR INFECT DIS J, V17, P745, DOI 10.1097/00006454-199808000-00015
   Demling Robert H, 2007, J Burns Wounds, V7, pe8
   Dryden M, 2008, SURG INFECT, V9, pS3, DOI 10.1089/sur.2008.066.supp
   Garau J, 2009, CLIN MICROBIOL INFEC, V15, P125, DOI 10.1111/j.1469-0691.2009.02701.x
   Grueterich M, 2003, INVEST OPHTH VIS SCI, V44, P4230, DOI 10.1167/iovs.02-0943
   Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63
   Huang HN, 2013, BIOMATERIALS, V34, P10319, DOI 10.1016/j.biomaterials.2013.09.037
   Huang Hui, 2011, Advanced Technology of Electrical Engineering and Energy, V30, P32
   Jacobsen F, 2011, ANTIMICROB AGENTS CH, V55, P2325, DOI 10.1128/AAC.01071-10
   Lin WJ, 2009, PEPTIDES, V30, P283, DOI 10.1016/j.peptides.2008.10.007
   Marra Andrea, 2014, Methods Mol Biol, V1085, P333, DOI 10.1007/978-1-62703-664-1_18
   Martinez-Olondris P, 2010, EUR RESPIR J, V35, P198, DOI 10.1183/09031936.00113908
   Neely AN, 2009, J BURN CARE RES, V30, P19, DOI 10.1097/BCR.0b013e3181921eed
   Nielsen OL, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-14
   Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564
   Pan CY, 2012, DEV COMP IMMUNOL, V36, P166, DOI 10.1016/j.dci.2011.06.013
   Pan CY, 2010, PEPTIDES, V31, P1449, DOI 10.1016/j.peptides.2010.05.011
   Peng Y, 2016, GROWTH FACTORS, P1
   Promprasit D, 2015, CURR EYE RES, V40, P274, DOI 10.3109/02713683.2014.917191
   Schaden W, 2007, J SURG RES, V143, P1, DOI 10.1016/j.jss.2007.01.009
   Tammelin A, 1998, J Wound Care, V7, P435
   Teo T SY, 2016, J PHARM SCI
   Turunen A, 2014, APMIS, V122, P781, DOI 10.1111/apm.12227
NR 30
TC 3
Z9 3
U1 1
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAR 28
PY 2017
VL 8
IS 13
BP 21067
EP 21080
DI 10.18632/oncotarget.15042
PG 14
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EP8RL
UT WOS:000397642400047
PM 28177877
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Yu, HY
   Zhi, ZZ
   Zhang, CX
   Yang, HZ
AF Yu, Huiyan
   Zhi, Zhuangzhi
   Zhang, Chunxia
   Yang, Huazhe
TI Research on literature involving zirconia-based on Pubmed database: a
   bibliometric analysis
SO CURRENT SCIENCE
LA English
DT Article
DE Bibliometrics; biomedicine; Pubmed; zirconia
ID FIXED DENTAL PROSTHESES; LOW-TEMPERATURE DEGRADATION; FOLLOW-UP;
   STRENGTH; TZP; CERAMICS; RESTORATIONS; BIOMATERIAL; IMPLANTS; ALUMINA
AB Zirconia is an important material for both medical science and chemical industry, and numerous studies on zirconia have been published. It is of great importance to summarize the study trend of zirconia for further studies. In the present paper, articles published during five years, i.e. from April 2009 to April 2014, were collected from the Pubmed database for statistical analysis, and the current situation and research advances of zirconia are summarized and analysed. It is found that an increasing number of articles concerning zirconia have been published every year especially in zirconia as dental materials. Authors are mainly from developed countries and regions, and a developing country such as China is playing an increasing role in this field.
C1 [Yu, Huiyan; Yang, Huazhe] China Med Univ, Sch Fundamental Sci, Dept Biophys, Shenyang 110001, Peoples R China.
   [Zhi, Zhuangzhi] Shenyang Pharmaceut Univ, Sch Med Devices, Dept Biomed Engn, Shenyang 110016, Peoples R China.
   [Zhang, Chunxia] Fuzhou Gen Hosp Nanjing Mil Dist, Dept Ophthalmol, Fuzhou 350025, Fujian, Peoples R China.
RP Yang, HZ (reprint author), China Med Univ, Sch Fundamental Sci, Dept Biophys, Shenyang 110001, Peoples R China.
EM hzyang@mail.cmu.edu.cn
FU National Natural Science Foundation of China [81500897]; China
   Scholarship Council [201408210385]; Foundation of the Education
   Department of Liaoning Province [L2013285]; Science and Technology
   Planning Project of Shenyang City [F11-262-9-16]
FX The work was supported by the National Natural Science Foundation of
   China (No. 81500897), China Scholarship Council (No. 201408210385),
   Foundation of the Education Department of Liaoning Province (No.
   L2013285) and Science and Technology Planning Project of Shenyang City
   (No. F11-262-9-16).
CR Alhashim A, 2012, J PROSTHET DENT, V108, P138, DOI 10.1016/S0022-3913(12)00120-5
   Ambre MJ, 2013, J PROSTHODONT, V22, P377, DOI 10.1111/jopr.12003
   Asmussen E, 1999, J DENT, V27, P275, DOI 10.1016/S0300-5712(98)00066-9
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Guess PC, 2012, CLIN IMPLANT DENT R, V14, P633, DOI 10.1111/j.1708-8208.2010.00317.x
   Hallmann L, 2012, J EUR CERAM SOC, V32, P4091, DOI 10.1016/j.jeurceramsoc.2012.07.032
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Ji Y, 2013, REV ADV MATER SCI, V34, P72
   Ji Y, 2014, J MATER SCI TECHNOL, V30, P692, DOI 10.1016/j.jmst.2014.03.016
   JONES DW, 1985, DENT CLIN N AM, V29, P621
   Kasuga H, 2009, KEY ENG MATER, V404, P69, DOI 10.4028/www.scientific.net/KEM.404.69
   Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6
   Chintapalli RK, 2014, J MECH BEHAV BIOMED, V29, P126, DOI 10.1016/j.jmbbm.2013.09.004
   Koenig V, 2013, J DENT, V41, P1164, DOI 10.1016/j.jdent.2013.10.009
   Marchi J, 2010, INT J APPL CERAM TEC, V7, P139, DOI 10.1111/j.1744-7402.2009.02388.x
   Mitov G, 2012, DENT MATER, V28, P909, DOI 10.1016/j.dental.2012.04.010
   Moradabadi A, 2014, MAT SCI ENG C-MATER, V34, P311, DOI 10.1016/j.msec.2013.09.015
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Pelaez J, 2012, INT J PROSTHODONT, V25, P451
   [任永国 Ren Yongguo], 2008, [中国陶瓷, China's Ceramics], V44, P44
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Rosenblum MA, 1997, J AM DENT ASSOC, V128, P297, DOI 10.14219/jada.archive.1997.0193
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   Shijo Y, 2009, DENT MATER J, V28, P352, DOI 10.4012/dmj.28.352
   Tholey MJ, 2009, DENT MATER, V25, P857, DOI 10.1016/j.dental.2009.01.006
   van Brakel R, 2011, CLIN ORAL IMPLAN RES, V22, P571, DOI 10.1111/j.1600-0501.2010.02005.x
   Yang HZ, 2016, J MATER SCI TECHNOL, V32, P593, DOI 10.1016/j.jmst.2016.05.005
   Yoshida H, 2012, J AM CERAM SOC, V95, P1701, DOI 10.1111/j.1551-2916.2012.05150.x
   Zhao J, 2013, CERAM INT, V39, P9277, DOI 10.1016/j.ceramint.2013.05.036
NR 30
TC 2
Z9 2
U1 1
U2 14
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD MAR 25
PY 2017
VL 112
IS 6
BP 1134
EP 1137
DI 10.18520/cs/v112/i06/1134-1137
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6FX
UT WOS:000400387700030
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Verbeke, CS
   Gordo, S
   Schubert, DA
   Lewin, SA
   Desai, RM
   Dobbins, J
   Wucherpfennig, KW
   Mooney, DJ
AF Verbeke, Catia S.
   Gordo, Susana
   Schubert, David A.
   Lewin, Sarah A.
   Desai, Rajiv M.
   Dobbins, Jessica
   Wucherpfennig, Kai W.
   Mooney, David J.
TI Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic
   Immune Modulation
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NONOBESE
   DIABETIC MICE; DENDRITIC CELLS; NOD MICE; IN-VIVO; FORMING HYDROGELS;
   SELF-TOLERANCE; INDUCTION; PEPTIDE
AB Biomaterial scaffolds that enrich and modulate immune cells in situ can form the basis for potent immunotherapies to elicit immunity or reestablish tolerance. Here, the authors explore the potential of an injectable, porous hydrogel to induce a regulatory T cell (Treg) response by delivering a peptide antigen to dendritic cells in a noninflammatory context. Two methods are described for delivering the BDC peptide from pore-forming alginate gels in the nonobese diabetic mouse model of type 1 diabetes: encapsulation in poly(lactide-co-glycolide) (PLG) microparticles, or direct conjugation to the alginate polymer. While particle-based delivery leads to antigen-specific T cells responses in vivo, PLG particles alter the phenotype of the cells infiltrating the gels. Following gel-based peptide delivery, transient expansion of endogenous antigen-specific T cells is observed in the draining lymph nodes. Antigen-specific T cells accumulate in the gels, and, strikingly, approximate to 60% of the antigen-specific CD4(+) T cells in the gels are Tregs. Antigen-specific T cells are also enriched in the pancreatic islets, and administration of peptide-loaded gels does not accelerate diabetes. This work demonstrates that a noninflammatory biomaterial system can generate antigen-specific Tregs in vivo, which may enable the development of new therapies for the treatment of transplant rejection or autoimmune diseases.
C1 [Verbeke, Catia S.; Desai, Rajiv M.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Verbeke, Catia S.; Lewin, Sarah A.; Desai, Rajiv M.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Gordo, Susana; Schubert, David A.; Dobbins, Jessica; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Boston, MA 02215 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Mooney, DJ (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
EM mooneyd@seas.harvard.edu
FU Juvenile Diabetes Research Foundation (JDRF) [5-2011-434]; National
   Institutes of Health (NIH) [1R01DE019917]
FX This work was supported by the Juvenile Diabetes Research Foundation
   (JDRF) (5-2011-434) and the National Institutes of Health (NIH)
   (1R01DE019917). The authors thank the NIH tetramer core facility for
   providing mouse MHC Class II tetramers.
CR Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002
   Baker RL, 2016, J IMMUNOL, V196, P39, DOI 10.4049/jimmunol.1501190
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Campbell DJ, 2015, J IMMUNOL, V195, P2507, DOI 10.4049/jimmunol.1500801
   Coppieters KT, 2013, CLIN IMMUNOL, V149, P345, DOI 10.1016/j.clim.2013.02.002
   Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574
   Doycheva I, 2016, MED CLIN N AM, V100, P551, DOI 10.1016/j.mcna.2016.01.006
   Fehervari Z, 2004, J CLIN INVEST, V114, P1209, DOI 10.1172/JCI200434495
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999
   Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6
   HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000
   HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Int Veld P., 2014, SEMIN IMMUNOPATHOL, V36, P569
   Jaeckel E, 2005, DIABETES, V54, P306, DOI 10.2337/diabetes.54.2.306
   Jang MH, 2003, J IMMUNOL, V171, P4175, DOI 10.4049/jimmunol.171.8.4175
   KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E
   Kishimoto TK, 2016, NAT NANOTECHNOL, V11, P890, DOI [10.1038/NNANO.2016.135, 10.1038/nnano.2016.135]
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26
   Long SA, 2011, J IMMUNOL, V187, P3511, DOI 10.4049/jimmunol.1003880
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153
   Mueller R, 1997, IMMUNITY, V7, P411, DOI 10.1016/S1074-7613(00)80362-3
   Muixi L, 2011, GENES IMMUN, V12, P504, DOI 10.1038/gene.2011.26
   Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394
   Overacre AE, 2016, CURR OPIN IMMUNOL, V39, P39, DOI 10.1016/j.coi.2015.12.009
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Prasad Suchitra, 2012, Rev Diabet Stud, V9, P319, DOI 10.1900/RDS.2012.9.319
   Robbins HA, 2015, J INVEST DERMATOL, V135, P2657, DOI 10.1038/jid.2015.312
   Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x
   Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8
   Smarr CB, 2016, P NATL ACAD SCI USA, V113, P5059, DOI 10.1073/pnas.1505782113
   Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844
   Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631
   Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459
   Verbeke CS, 2015, ADV HEALTHC MATER, V4, P2677, DOI 10.1002/adhm.201500618
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025
   Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001
NR 50
TC 6
Z9 6
U1 10
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 22
PY 2017
VL 6
IS 6
AR UNSP 1600773
DI 10.1002/adhm.201600773
PG 15
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA ES7GL
UT WOS:000399717800001
PM 28116870
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rother, S
   Samsonov, SA
   Moeller, S
   Schnablrauch, M
   Rademann, J
   Blaszkiewicz, J
   Kohling, S
   Waltenberger, J
   Pisabarro, MT
   Scharnweber, D
   Hintze, V
AF Rother, Sandra
   Samsonov, Serty A.
   Moeller, Stephanie
   Schnablrauch, Matthias
   Rademann, Joerg
   Blaszkiewicz, Joanna
   Koehling, Sebastian
   Waltenberger, Johannes
   Pisabarro, M. Teresa
   Scharnweber, Dieter
   Hintze, Vera
TI Sulfated Hyaluronan Alters Endothelial Cell Activation in Vitro by
   Controlling the Biological Activity of the Angiogenic Factors Vascular
   Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hyaluronan/sulfated hyaluronan; tissue inhibitor of metalloproteinase-3;
   vascular endothelial growth factor-A; glycosaminoglycans; endothelial
   cells
ID HEPARIN-BINDING DOMAIN; EXTRACELLULAR-MATRIX; FUNCTIONAL INSIGHTS; VEGF
   BINDING; RECEPTORS; GLYCOSAMINOGLYCANS; VASCULOGENESIS; VEGF(165);
   INTERACT; AFFINITY
AB Several pathologic conditions such as rheumatoid arthritis, ocular neovascularization, cancer, or atherosclerosis are often associated with abnormal angiogenesis, which requires innovative biomaterial-based treatment options to control the activity of angiogenic factors. Here, we studied how sulfated hyaluronan (sHA) and oversulfated chondroitin sulfate derivatives as potential components of functional biomaterials modulate vascular endothelial growth factor-A (VEGF-A) signaling and endothelial cell activity in vitro. Tissue inhibitor of metalloproteinase-3 (TIMP-3), an effective angiogenesis inhibitor, exerts its activity by competing with VEGF-A for binding to VEGF receptor-2 (VEGFR-2). However, even though TIMP-3 and VEGF-A are known to interact with glycosaminoglycans (GAGs), the potential role and mechanism by which GAGs alter the VEGF-A/TIMP-3 regulated VEGFR-2 signaling remains unclear. Combining surface plasmon resonance, immunobiochemical analysis, and molecular modeling, we demonstrate the simultaneous binding of VEGF-A and TIMP-3 to sHA-coated surfaces and identified a novel mechanism by which sulfated. GAG derivatives control angiogenesis: GAG derivatives block the binding of VEGF-A and TIMP-3 to VEGFR-2 thereby reducing their biological activity in a defined, sulfation-dependent manner. This effect was stronger for sulfated GAG derivatives than for native GAGs. The simultaneous formation of TIMP-3/sHA complexes partially rescues the sHA inhibited VEGF-A/VEGFR-2 signaling and endothelial cell activation. These results provide novel insights into the regulation of angiogenic factors by GAG derivatives and highlight the potential of sHA derivatives for the treatment of diseases associated with increased VEGF-A and VEGFR-2 levels.
C1 [Rother, Sandra; Scharnweber, Dieter; Hintze, Vera] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Samsonov, Serty A.; Waltenberger, Johannes] BIOTEC Tech Univ Dresden, Struct Bioinformat, Tatzberg 47-51, D-01307 Dresden, Germany.
   [Moeller, Stephanie; Schnablrauch, Matthias] INNOVENT, Biomat Dept, D-07745 Jena, Germany.
   [Rademann, Joerg; Blaszkiewicz, Joanna; Koehling, Sebastian] Free Univ Berlin, Inst Pharm Inst Chem & Biochem, Konigin Luise Str 2, D-14195 Berlin, Germany.
   [Rademann, Joerg; Blaszkiewicz, Joanna; Koehling, Sebastian] Univ Leipzig, Inste Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.
   [Waltenberger, Johannes] Univ Munster, Dept Cardiovasc Med, Albert Schweitzer Campus 1, D-48149 Munster, Germany.
RP Hintze, V (reprint author), Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
EM Vera.Hintze@tu-dresden.de
RI Pisabarro, M. Teresa/D-4270-2012; Rademann, Jorg/F-4893-2017
OI Rademann, Jorg/0000-0001-6678-3165; Rother, Sandra/0000-0003-0631-752X
FU DFG [TRR 67 A2, TRR 67 A3, TRR 67 A7, TRR 67 A8, TRR 67 Z3]
FX We gratefully acknowledge financial support by the DFG [TRR 67 A2, A3,
   A7, A8, Z3].
CR Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   Case DA, 2015, AMBER 14
   Cochran S, 2003, J MED CHEM, V46, P4601, DOI 10.1021/jm030180y
   Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354
   Di Benedetto M, 2008, BBA-GEN SUBJECTS, V1780, P723, DOI 10.1016/j.bbagen.2008.01.015
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003
   Hamilton JL, 2016, J BONE MINER RES, V31, P911, DOI 10.1002/jbmr.2828
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   Kiselyov A, 2007, EXPERT OPIN INV DRUG, V16, P83, DOI 10.1517/13543784.16.1.83
   Kohling S, 2016, CHEM-EUR J, V22, P5563, DOI 10.1002/chem.201504459
   Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200
   Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201
   Martino Mikael M, 2015, Front Bioeng Biotechnol, V3, P45, DOI 10.3389/fbioe.2015.00045
   MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9
   Molecular Operating Environment (MOE), 2013, MOL OP ENV MOE
   Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233
   Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3
   Neufeld G, 1999, FASEB J, V13, P9
   Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846
   Qi JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055667
   QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533
   Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3
   Rother S, 2016, ACTA BIOMATER, V45, P143, DOI 10.1016/j.actbio.2016.08.030
   Rother S, 2016, BIOMACROMOLECULES, V17, P3252, DOI 10.1021/acs.biomac.6b00980
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Salbach-Hirsch J, 2015, BIOMATERIALS, V67, P335, DOI 10.1016/j.biomaterials.2015.07.021
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Shibuya M, 2014, BIOMOL THER, V22, P1, DOI 10.4062/biomolther.2013.113
   Teran M, 2015, J BIOL CHEM, V290, P16451, DOI 10.1074/jbc.M114.627372
   TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2
   Troeberg L, 2014, CHEM BIOL, V21, P1300, DOI 10.1016/j.chembiol.2014.07.014
   van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200
   Zhang FM, 2015, BIOSENSORS-BASEL, V5, P500, DOI 10.3390/bios5030500
NR 46
TC 3
Z9 3
U1 4
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 22
PY 2017
VL 9
IS 11
BP 9539
EP 9550
DI 10.1021/acsami.7b01300
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EP6HC
UT WOS:000397478100035
PM 28248081
DA 2018-10-20
ER

PT J
AU Wan, J
   Jiang, F
   Zhang, J
   Xu, QS
   Chen, DW
   Yu, B
   Mao, XB
   Yu, J
   Luo, YH
   He, J
AF Wan, Jin
   Jiang, Fei
   Zhang, Jiao
   Xu, Qingsong
   Chen, Daiwen
   Yu, Bing
   Mao, Xiangbing
   Yu, Jie
   Luo, Yuheng
   He, Jun
TI Amniotic fluid metabolomics and biochemistry analysis provides novel
   insights into the diet-regulated foetal growth in a pig model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHITOSAN OLIGOSACCHARIDE; AMINO-ACIDS; INTESTINAL DEVELOPMENT;
   BIOLOGICAL-ACTIVITIES; ANTIOXIDANT CAPACITY; GESTATIONAL-AGE; SUCKLING
   RATS; WEANED PIGS; PERFORMANCE; SPERMINE
AB Foetal loss and intrauterine growth restriction are major problems in mammals, but there are few effective ways in preventing it. Intriguingly, chitosan oligosaccharide (COS), a biomaterial derived from chitosan, can promote foetal survival and growth. Therefore, we have investigated how COS affects foetal survival and growth in a pig model. Fifty-two sows were divided into two treatment groups (n = 26) and fed either solely a control diet or a control diet that includes 100 mg/kg COS. Amniotic fluid and foetus samples from six sows that were of average body weight in each group were collected on gestation day 35. We applied a H-1 NMR-based metabolomics approach combined with biochemistry analysis to track the changes that occurred in the amniotic fluid of pregnant sows after COS intervention. Maternal COS inclusion had enhanced (P < 0.05) the foetal survival rate and size at 35 days. COS supplementation had both increased (P < 0.05) SOD, CAT and T-AOC activities and elevated (P < 0.05) IL-10, IgG and IgM concentrations in the amniotic fluid. Moreover, COS had affected (P < 0.05) the amniotic fluid's lysine, citrate, glucose and hypoxanthine levels. Overall, COS inclusion induced amniotic fluid antioxidant status and metabolic profiles modifications characterising improvements in foetal survival and growth in a pig model.
C1 [Wan, Jin; Jiang, Fei; Zhang, Jiao; Chen, Daiwen; Yu, Bing; Mao, Xiangbing; Yu, Jie; Luo, Yuheng; He, Jun] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.
   [Xu, Qingsong] Dalian Ocean Univ, Coll Fisheries & Life Sci, Dalian 116023, Peoples R China.
RP He, J (reprint author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.
EM hejun8067@163.com
FU Special Fund for Agro-scientific Research in the Public Interest
   [201403047]; Fok Ying-Tung Education Foundation [141027]; National
   Natural Science Foundation of China [31372347]
FX We would like to express our gratitude to Kaiyun Yang, Huifen Wang and
   Quyuan Wang for their ongoing contributions during experiments, and we
   would like to acknowledge Likun Cheng, Heng Yin and Yuguang Du's
   contribution in providing the COS. This work was supported by the
   Special Fund for Agro-scientific Research in the Public Interest
   (201403047), the Fok Ying-Tung Education Foundation (141027) and the
   National Natural Science Foundation of China (31372347).
CR Athanasiadis AP, 2011, J MATERN-FETAL NEO M, V24, P1033, DOI 10.3109/14767058.2010.545909
   BOCK JL, 1994, CLIN CHEM, V40, P56
   Briese V, 1999, Z GEBURTSH NEONATOL, V203, P63
   Cao W, 2015, RSC ADV, V5, P76607, DOI 10.1039/c5ra15793e
   CHAOUAT G, 1995, J IMMUNOL, V154, P4261
   Cheng LK, 2015, LIVEST SCI, V174, P74, DOI 10.1016/j.livsci.2015.02.003
   Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025
   Fang TT, 2016, RSC ADV, V6, P31323, DOI 10.1039/c6ra05361k
   Fanos V, 2013, BIOMED RES INT, DOI 10.1155/2013/720514
   Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8
   Graca G, 2013, ANAL CHIM ACTA, V764, P24, DOI 10.1016/j.aca.2012.12.023
   Huang B, 2016, J AGR FOOD CHEM, V64, P245, DOI 10.1021/acs.jafc.5b05195
   Jacobino SR, 2016, J ALLERGY CLIN IMMUN, V138, P1477, DOI 10.1016/j.jaci.2016.06.001
   Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x
   Krastanov A, 2010, BIOTECHNOL BIOTEC EQ, V24, P1537, DOI 10.2478/V10133-010-0001-Y
   Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494
   Lane M D, 1981, Curr Top Cell Regul, V18, P221
   LEVY HL, 1969, PEDIATR RES, V3, P113, DOI 10.1203/00006450-196903000-00002
   Li XL, 2014, AMINO ACIDS, V46, P375, DOI 10.1007/s00726-013-1626-6
   Li XL, 2010, J NUTR, V140, P1111, DOI 10.3945/jn.110.121350
   LIN H, 1993, J IMMUNOL, V151, P4562
   Liu GM, 2015, RSC ADV, V5, P48769, DOI 10.1039/c5ra01507c
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LIVINGSTONE DR, 1990, FUNCT ECOL, V4, P415, DOI 10.2307/2389604
   Menon R, 2014, REPROD SCI, V21, P791, DOI 10.1177/1933719113518987
   Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t
   Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013
   NATIONAL RESEARCH COUNCIL, 2012, NUTR REQ SWIN
   Orczyk-Pawilowicz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152740
   Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200
   Ozmen B, 2002, CLIN BIOCHEM, V35, P69, DOI 10.1016/S0009-9120(01)00284-3
   Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a
   Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618
   Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1
   Tea I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029947
   Thadathil N, 2014, FOOD CHEM, V150, P392, DOI 10.1016/j.foodchem.2013.10.083
   Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039
   Wan J, 2017, RSC ADV, V7, P9669, DOI 10.1039/c7ra00142h
   Wan J, 2016, RSC ADV, V6, P87026, DOI 10.1039/c6ra18135j
   Wan J, 2016, RSC ADV, V6, P70715, DOI 10.1039/c6ra13294d
   Wan J, 2016, ANIM FEED SCI TECH, V211, P216, DOI 10.1016/j.anifeedsci.2015.12.003
   Wu GY, 2010, ADV NUTR, V1, P31, DOI 10.3945/an.110.1008
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Xie CY, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0872-8
   Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277
   Zhang C, 2015, J FUNCT FOODS, V14, P590, DOI 10.1016/j.jff.2015.02.039
   Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P1807, DOI 10.1016/j.bbadis.2012.08.001
   Zou TD, 2016, EUR J NUTR, V55, P1777, DOI 10.1007/s00394-015-0996-9
NR 50
TC 4
Z9 4
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 16
PY 2017
VL 7
AR 44782
DI 10.1038/srep44782
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO2OH
UT WOS:000396535300001
PM 28300194
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xu, LC
   Wo, Y
   Meyerhoff, ME
   Siedlecki, CA
AF Xu, Li-Chong
   Wo, Yaqi
   Meyerhoff, Mark E.
   Siedlecki, Christopher A.
TI Inhibition of bacterial adhesion and biofilm formation by dual
   functional textured and nitric oxide releasing surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Texturing; Nitric oxide release; Bacterial adhesion; Biofilm;
   S-Nitroso-N-acetylpenicillamine (SNAP); Antimicrobial infection
ID INFECTION-RESISTANT SURFACES; CARE-ASSOCIATED INFECTIONS;
   STAPHYLOCOCCUS-AUREUS; PLATELET-ADHESION; MEDICAL DEVICES; IN-VITRO;
   BIOMATERIALS; NITROSOTHIOLS; STABILITY; REDUCTION
AB In separate prior studies, physical topographic surface modification or nitric oxide (NO) release has been demonstrated to each be an effective approach to inhibit and control bacterial adhesion and biofilm formation on polymeric surfaces. Such approaches can prevent biomaterial-associated infection without causing the antibiotic resistance of the strain. In this work, both techniques were successfully integrated and applied to a polyurethane (PU) biomaterial surface that bears ordered pillar topographies (400/400 nm and 500/500 nm patterns) at the top surface and a S-nitroso-N-acetylpenicillamine (SNAP, NO donor) doped sub-layer in the middle, via a soft lithography two-stage replication process. Upon placing the SNAP textured PU films into PBS at 37 degrees C, the decomposition of SNAP within polymer film initiates NO release with a lifetime of up to 10 days at flux levels >0.5 x 10(-10) mol min(-1) cm(-2) for a textured polyurethane layer containing 15 wt% SNAP. The textured surface reduces the accessible surface area and the opportunity of bacteria-surface interaction, while the NO release from the same surface further inhibits bacterial growth and biofilm formation. Such dual functionality surfaces are shown to provide a synergistic effect on inhibition of Staphylococcus epidermidis bacterial adhesion that is significantly greater than the inhibition of bacterial adhesion achieved by either single treatment approach alone. Longer term experiments to observe biofilm formation demonstrate that the SNAP doped-textured PU surface can inhibit the biofilm formation for >28 d and provide a practical approach to improve the biocompatibility of current biomimetic biomaterials and thereby reduce the risk of pathogenic infection.
   Statement of Significance
   Microbial infection remains a significant barrier to development and implementation of advanced blood contacting medical devices. Clearly, determining how to design and control material properties that can reduce microbial infection is a central question to biomaterial researchers. In separate prior studies, physical topographic surface modification or nitric oxide (NO) release has been demonstrated to each be an effective approach to inhibit and control bacterial adhesion and biofilm formation on polymeric surfaces. Such approaches can prevent biomaterial-associated infection without causing antibiotic resistance of the bacterial strain. However, efficiency of antimicrobial properties of each approach is still limited and far from sufficient for widespread clinical use. This work successfully integrates both techniques and applies them to a polyurethane (PU) biomaterial surface that bears dual functions, surface topographic modification and NO release. The former reduces the surface contact area and changes surface wettability, resulting in reduction of bacterial adhesion, and NO release further inhibits bacteria growth. Such dual functionalized surfaces provide a synergistic effect on inhibition of Staphylococcus epidermidis bacterial adhesion that is significantly greater than the inhibition of bacterial adhesion achieved by either single treatment approach alone. Furthermore, longer-term experiments demonstrate that the dual functionalized surfaces can inhibit biofilm formation for >28 days. The success of this work provides a practical approach to improve the biocompatibility of current biomaterials and thereby reduce the risk of pathogenic infection. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   [Wo, Yaqi; Meyerhoff, Mark E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
RP Xu, LC (reprint author), Penn State Univ, Coll Med, Mail Code H151,500 Univ Dr, Hershey, PA 17033 USA.
EM lxx5@psu.edu
FU National Institutes of Health, United States [HL-128337]; Surgery
   Feasibility Grant of Penn State College of Medicine (PA, United States)
FX This study is partially supported from National Institutes of Health,
   United States (HL-128337) and Surgery Feasibility Grant of Penn State
   College of Medicine (PA, United States).
CR Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Brisbois EJ, 2015, J MATER CHEM B, V3, P1639, DOI 10.1039/c4tb01839g
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Cai WY, 2012, BIOMATERIALS, V33, P7933, DOI 10.1016/j.biomaterials.2012.07.027
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Colletta A, 2015, ACS BIOMATER SCI ENG, V1, P416, DOI 10.1021/acsbiomaterials.5b00032
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Estrela AB, 2009, CURR MED CHEM, V16, P1512, DOI 10.2174/092986709787909640
   Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   Handa H, 2013, J MATER CHEM B, V1, P3578, DOI 10.1039/c3tb20277a
   Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Laver JR, 2013, ANTIOXID REDOX SIGN, V18, P309, DOI 10.1089/ars.2012.4767
   Lin CE, 2006, TETRAHEDRON, V62, P8410, DOI 10.1016/j.tet.2006.06.019
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004
   Park J, 2013, BIOMATERIALS, V34, P8766, DOI 10.1016/j.biomaterials.2013.07.064
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Privett BJ, 2012, NITRIC OXIDE-BIOL CH, V26, P169, DOI 10.1016/j.niox.2012.02.002
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611
   Ren H, 2014, ACS APPL MATER INTER, V6, P3779, DOI 10.1021/am406066a
   Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936
   Scardino AJ, 2009, BIOFOULING, V25, P83, DOI 10.1080/08927010802538480
   Seabra AB, 2010, ARTIF ORGANS, V34, pE204, DOI 10.1111/j.1525-1594.2010.00998.x
   Shin S, 2016, MATERIALS, V9, DOI 10.3390/ma9020116
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Wenzel RP, 2007, CLIN INFECT DIS, V45, P85, DOI 10.1086/518136
   Wo YQ, 2016, BIOMATER SCI-UK, V4, P1161, DOI 10.1039/c6bm00271d
   Wo YQ, 2015, ACS APPL MATER INTER, V7, P22218, DOI 10.1021/acsami.5b07501
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
   Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Zhang L, 2011, INT J ANTIMICROB AG, V38, P9, DOI 10.1016/j.ijantimicag.2011.01.020
NR 50
TC 10
Z9 10
U1 12
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2017
VL 51
BP 53
EP 65
DI 10.1016/j.actbio.2017.01.030
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ4AB
UT WOS:000398014000003
PM 28087484
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Parmar, PA
   St-Pierre, JP
   Chow, LW
   Spicer, CD
   Stoichevska, V
   Peng, YY
   Werkmeister, JA
   Ramshaw, JAM
   Stevens, MM
AF Parmar, Paresh A.
   St-Pierre, Jean-Philippe
   Chow, Lesley W.
   Spicer, Christopher D.
   Stoichevska, Violet
   Peng, Yong Y.
   Werkmeister, Jerome A.
   Ramshaw, John A. M.
   Stevens, Molly M.
TI Enhanced articular cartilage by human mesenchymal stem cells in
   enzymatically mediated transiently RGDS-functionalized collagen mimetic
   hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Mesenchymal stem cell; Biodegradation; RGDS; Biomimetic
   material; Cartilage tissue engineering
ID IN-VITRO CHONDROGENESIS; OSTEOARTHRITIC CARTILAGE;
   STREPTOCOCCUS-PYOGENES; MECHANICAL-PROPERTIES; BACTERIAL COLLAGEN;
   PEPTIDE; DIFFERENTIATION; FIBRONECTIN; SCAFFOLDS; PROTEIN
AB Recapitulation of the articular cartilage microenvironment for regenerative medicine applications faces significant challenges due to the complex and dynamic biochemical and biomechanical nature of native tissue. Towards the goal of biomaterial designs that enable the temporal presentation of bioactive sequences, recombinant bacterial collagens such as Streptococcal collagen-like 2 (Sc12) proteins can be employed to incorporate multiple specific bioactive and biodegradable peptide motifs into a single construct. Here, we first modified the backbone of Sc12 with glycosaminoglycan-binding peptides and cross linked the modified Sc12 into hydrogels via matrix metalloproteinase 7 (MMP7)-cleavable or non cleavable scrambled peptides. The cross-linkers were further functionalized with a tethered RGDS peptide creating a system whereby the release from an MMP7-cleavable hydrogel could be compared to a system where release is not possible. The release of the RGDS peptide from the degradable hydrogels led to significantly enhanced expression of collagen type II (3.9-fold increase), aggrecan (7.6-fold increase), and SOX9 (5.2-fold increase) by human mesenchymal stem cells (hMSCs) undergoing chondrogenesis, as well as greater extracellular matrix accumulation compared to non-degradable hydrogels (collagen type II; 3.2-fold increase, aggrecan; 4-fold increase, SOX9; 2.8-fold increase). Hydrogels containing a low concentration of the RGDS peptide displayed significantly decreased collagen type I and X gene expression profiles, suggesting a major advantage over either hydrogels functionalized with a higher RGDS peptide concentration, or non-degradable hydrogels, in promoting an articular cartilage phenotype. These highly versatile Sc12 hydrogels can be further manipulated to improve specific elements of the chondrogenic response by hMSCs, through the introduction of additional bioactive and/or biodegradable motifs. As such, these hydrogels have the possibility to be used for other applications in tissue engineering.
   Statement of Significance
   Recapitulating aspects of the native tissue biochemical microenvironment faces significant challenges in regenerative medicine and tissue engineering due to the complex and dynamic nature of the tissue. The ability to take advantage of, mimic, and modulate cell-mediated processes within novel naturally-derived hydrogels is of great interest in the field of biomaterials to generate constructs that more closely resemble the biochemical microenvironment and functions of native biological tissues such as articular cartilage. Towards this goal, the temporal presentation of bioactive sequences such as RGDS on the chondrogenic differentiation of human mesenchymal stem cells is considered important as it has been shown to influence the chondrogenic phenotype. Here, a novel and versatile platform to recreate a high
C1 [Parmar, Paresh A.; St-Pierre, Jean-Philippe; Chow, Lesley W.; Spicer, Christopher D.; Stevens, Molly M.] Imperial Coll London, Dept Mat, Exhibition Rd, London SW7 2AZ, England.
   [Parmar, Paresh A.; St-Pierre, Jean-Philippe; Chow, Lesley W.; Spicer, Christopher D.; Stevens, Molly M.] Imperial Coll London, Dept Bioengn, Exhibition Rd, London SW7 2AZ, England.
   [Parmar, Paresh A.; St-Pierre, Jean-Philippe; Chow, Lesley W.; Spicer, Christopher D.; Stevens, Molly M.] Imperial Coll London, Inst Biomed Engn, Exhibition Rd, London SW7 2AZ, England.
   [Parmar, Paresh A.; Stoichevska, Violet; Peng, Yong Y.; Werkmeister, Jerome A.; Ramshaw, John A. M.] CSIRO Mfg, Bayview Ave, Clayton, Vic, Australia.
   [Parmar, Paresh A.; Stevens, Molly M.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biomat & Regenerat Med, Scheeles Vag 2, S-17177 Stockholm, Sweden.
   [Chow, Lesley W.] Lehigh Univ, Dept Mat Sci & Engn & Bioengn Program, Bethlehem, PA 18015 USA.
RP Stevens, MM (reprint author), Imperial Coll London, Dept Mat, Exhibition Rd, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
OI Spicer, Christopher/0000-0001-8787-578X
FU Australia's Commonwealth Scientific and Industrial Research Organisation
   (CSIRO) in the Manufacturing Business Unit; Medical Engineering
   Solutions in Osteoarthritis Centre of Excellence - Wellcome Trust
   [088844]; Wellcome Trust Institutional Strategic Support Fund
   [097816/Z/11/A]; Wellcome Trust [104931/Z/14/Z]
FX P.A.P.'s studentship was funded by Australia's Commonwealth Scientific
   and Industrial Research Organisation (CSIRO) in the Manufacturing
   Business Unit. J.P.S., L.W.C., and M.M.S. were supported by the Medical
   Engineering Solutions in Osteoarthritis Centre of Excellence funded by
   the Wellcome Trust (088844). L.W.C. and J.P.S. would like to acknowledge
   the Value in People Award from the Wellcome Trust Institutional
   Strategic Support Fund (097816/Z/11/A). The authors would also like to
   acknowledge the Harvey Flower Microstructural Characterization Suite.
   MP-SHG imaging was performed in the Facility for Imaging by Light
   Microscopy (FILM), part supported by funding from the Wellcome Trust
   (104931/Z/14/Z). The authors would also like to thank L. Mekul for help
   with the schematic in Fig. 1.
CR Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Bergholt M.S., 2016, ACS CENTRAL SCI, P2374
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   CALIN A, 1989, J RHEUMATOL, V16, P43
   Rodriguez-Merchan EC, 2013, RHEUMATOL INT, V33, P837, DOI 10.1007/s00296-012-2601-3
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Decker RS, 2015, CURR OSTEOPOROS REP, V13, P407, DOI 10.1007/s11914-015-0290-z
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Fujioka R, 2013, OSTEOARTHR CARTILAGE, V21, P1092, DOI 10.1016/j.joca.2013.04.021
   Hangody L, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P262, DOI 10.1007/s001670050061
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Liu SQ, 2010, MACROMOL RAPID COMM, V31, P1148, DOI 10.1002/marc.200900818
   Martin JA, 1998, J ORTHOPAED RES, V16, P752, DOI 10.1002/jor.1100160618
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005
   NIEDERMANN B, 1985, ACTA ORTHOP SCAND, V56, P457, DOI 10.3109/17453678508993034
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Parmar PA, 2016, ADV HEALTHC MATER, V5, P1656, DOI 10.1002/adhm.201600136
   Parmar PA, 2016, BIOMATERIALS, V99, P56, DOI 10.1016/j.biomaterials.2016.05.011
   Parmar PA, 2015, BIOMATERIALS, V54, P213, DOI 10.1016/j.biomaterials.2015.02.079
   Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007
   Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898
   Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pfander D, 1999, J RHEUMATOL, V26, P386
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Roberts JJ, 2011, J BIOMED MATER RES B, V99B, P158, DOI 10.1002/jbm.b.31883
   Rutgers M, 2013, TISSUE ENG PT A, V19, P59, DOI [10.1089/ten.tea.2011.0416, 10.1089/ten.TEA.2011.0416]
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Salinas CN, 2009, J BIOMED MATER RES A, V90A, P456, DOI 10.1002/jbm.a.32112
   SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022
   Steadman JR, 1999, ORTHOPADE, V28, P26, DOI 10.1007/PL00003545
   Tavella S, 1997, J CELL SCI, V110, P2261
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715
   Zhang C, 2014, J BIOMED MATER RES A, V102, P170, DOI 10.1002/jbm.a.34687
   Zhang JJ, 2013, TISSUE ENG PT A, V19, P2166, DOI [10.1089/ten.tea.2012.0393, 10.1089/ten.TEA.2012.0393]
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 59
TC 7
Z9 8
U1 8
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2017
VL 51
BP 75
EP 88
DI 10.1016/j.actbio.2017.01.028
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ4AB
UT WOS:000398014000005
PM 28087486
OA Green Accepted, Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Muller, BM
   Loth, R
   Hoffmeister, PG
   Zuhl, F
   Kalbitzer, L
   Hacker, MC
   Schulz-Siegmund, M
AF Muller, Benno M.
   Loth, Rudi
   Hoffmeister, Peter-Georg
   Zuehl, Friederike
   Kalbitzer, Liv
   Hacker, Michael C.
   Schulz-Siegmund, Michaela
TI Surface modification of copolymerized films from three-armed
   biodegradable macromers - An analytical platform for modified tissue
   engineering scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macromer Polymer film; Cell adhesion; Analyte density; Surface
   topography; Swelling properties; Surface functionalization
ID MARROW STROMAL CELLS; CYCLIC RGD PEPTIDES; PROTEIN ADSORPTION;
   POLY(ETHYLENE GLYCOL)S; OSTEOBLAST ADHESION; DIBLOCK COPOLYMERS;
   MOLECULAR-WEIGHT; POLYMER-FILMS; PEG; DENSITY
AB The concept of macromers allows for a broad adjustment of biomaterial properties by macromer chemistry or copolymerization. Copolymerization strategies can also be used to introduce reactive sites for subsequent surface modification. Control over surface features enables adjustment of cellular reactions with regard to site and object of implantation. We designed macromer-derived polymer films which function as non-implantable analytical substrates for the investigation of surface properties of equally composed scaffolds for bone tissue engineering. To this end, a toolbox of nine different biodegradable, three-armed macromers was thermally cross-copolymerized with poly(ethylene glycol)-methacrylate (PEG-MA) to films. Subsequent activation of PEG-hydroxyl groups with succinic anhydride and Nhydroxysuccinimid allowed for covalent surface modification. We quantified the capacity to immobilize analytes of low (amino-unctionalized fluorescent dye, Fcad, and RGD-peptides) and high (alkaline phosphatase, ALP) molecular weight. Fcad grafting level was controlled by macromer chemistry, content and molecular weight of PEG-MA, but also the solvent used for film synthesis. Fcad molar amount per surface area was twentyfive times higher on high-swelling compared to low-swelling films, but differences became smaller when large ALP (appr. 2:1) were employed. Similarly, small differences were observed on RGD peptide functionalized films that were investigated by cell adhesion studies. Presentation of PEG-derivatives on surfaces was visualized by atomic force microscopy (AFM) which unraveled composition-dependent domain formation influencing fluorescent dye immobilization. Surface wetting characteristics were investigated via static water contact angle. We conclude that macromer ethoxylation and lactic acid content determined film swelling, PEG domain formation and eventually efficiency of surface decoration.
   Statement of Significance
   Surfaces of implantable biomaterials are the site of interaction with a host tissue. Accordingly, modifications in the composition of the surface will determine cellular response towards the material which is crucial for the success of innovations and control of tissue regeneration. We employed a macromer approach which is most flexible for the design of biomaterials with a broad spectrum of physicochemical characteristics. For ideal analytical accessibility of the material platform, we cross-copolymerized films on solid supports. Films allowed for the covalent immobilization of fluorescent labels, peptides and enzymes and thorough analytical characterization revealed that macromer hydrophilicity is the most relevant design parameter for surface analyte presentation in these materials. All analytical results were combined in a model describing PEG linker domain formation and ligand presentation. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Muller, Benno M.; Loth, Rudi; Hoffmeister, Peter-Georg; Zuehl, Friederike; Hacker, Michael C.; Schulz-Siegmund, Michaela] Univ Leipzig, Inst Pharm, Pharmaceut Technol, Eilenburger Str 15a, D-04317 Leipzig, Germany.
   [Kalbitzer, Liv] Univ Leipzig, Inst Biochem, Biophys Chem, Johannisallee 21, D-04103 Leipzig, Germany.
RP Schulz-Siegmund, M (reprint author), Univ Leipzig, Inst Pharm, Pharmaceut Technol, Eilenburger Str 15a, D-04317 Leipzig, Germany.
EM benno.mueller@uni-leipzig.de; loth.rudi@gmail.com;
   petergeorg.hoffmeister@uni-leipzig.de; friederike.zuehl@yahoo.de;
   liv.kalbitzer@uni-leipzig.de; mhacker@uni-leipzig.de;
   schulz@rz.uni-leipzig.de
OI Schulz-Siegmund, Michaela/0000-0003-1340-1850
FU German Research Council (DFG, SFB/Transregio) [67]
FX German Research Council (DFG, SFB/Transregio 67).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Burdick JA, 2001, J BIOMAT SCI-POLYM E, V12, P1253, DOI 10.1163/156856201753395789
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2008, COLLOID SURFACE B, V61, P237, DOI 10.1016/j.colsurfb.2007.08.012
   Chen JX, 1998, MACROMOLECULES, V31, P9328, DOI 10.1021/ma980639b
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   de Jonge LT, 2009, ACTA BIOMATER, V5, P2773, DOI 10.1016/j.actbio.2009.03.019
   De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1
   DRUMHELLER PD, 1994, J POLYM SCI POL CHEM, V32, P2715, DOI 10.1002/pola.1994.080321412
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Even MA, 2006, MACROMOLECULES, V39, P9396, DOI 10.1021/ma061785h
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Hacker MC, 2008, BIOMACROMOLECULES, V9, P1558, DOI 10.1021/bm8000414
   Hacker MC, 2015, INT J MOL SCI, V16, P27677, DOI 10.3390/ijms161126056
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Heitz J, 2003, J BIOMED MATER RES A, V67A, P130, DOI 10.1002/jbm.a.10043
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jansen J, 2010, J CONTROL RELEASE, V147, P54, DOI 10.1016/j.jconrel.2010.06.031
   Jin Y, 2005, ELECTROCHEM SOLID ST, V8, pC6, DOI 10.1149/1.1830371
   Jin Y, 2012, ELECTROCHIM ACTA, V78, P459, DOI 10.1016/j.electacta.2012.06.039
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Kim K, 2000, J BIOMED MATER RES, V52, P836, DOI 10.1002/1097-4636(20001215)52:4<836::AID-JBM30>3.3.CO;2-W
   Kronberg B, 2014, SURFACE CHEMISTRY OF SURFACTANTS AND POLYMERS, P1, DOI 10.1002/9781118695968
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Loth R, 2015, ACTA BIOMATER, V26, P82, DOI 10.1016/j.actbio.2015.08.008
   Loth T, 2013, REACT FUNCT POLYM, V73, P1480, DOI 10.1016/j.reactfunctpolym.2013.08.002
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McIlhenny SE, 2010, TISSUE ENG PT A, V16, P245, DOI 10.1089/ten.TEA.2009.0238
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Oortgiesen Daniel A.W., 2012, J CLIN PERIODONTOL, V39, P546
   Osathanon T, 2009, BIOMATERIALS, V30, P4513, DOI 10.1016/j.biomaterials.2009.05.022
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Raquel M.F., 2013, ACTA BIOMATER, V9, P8773
   Ricoult SG, 2014, BIOMATERIALS, V35, P727, DOI 10.1016/j.biomaterials.2013.10.023
   Satomi T, 2007, LANGMUIR, V23, P6698, DOI 10.1021/la0624384
   Schneider H, 2014, TISSUE ENG PT A, V20, P335, DOI [10.1089/ten.tea.2012.0563, 10.1089/ten.TEA.2012.0563]
   Sharma S, 2004, BIOSENS BIOELECTRON, V20, P227, DOI 10.1016/j.bios.2004.01.034
   Steinhagen M, 2014, ACS APPL MATER INTER, V6, P5891, DOI 10.1021/am500794q
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Teramura Y, 2016, ACTA BIOMATER, V30, P135, DOI 10.1016/j.actbio.2015.11.003
   TIMMONS CO, 1966, J COLLOID INTERF SCI, V22, P165, DOI 10.1016/0021-9797(66)90080-4
   Wu JD, 2012, BIOMATERIALS, V33, P810, DOI 10.1016/j.biomaterials.2011.10.022
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 52
TC 0
Z9 0
U1 7
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2017
VL 51
BP 148
EP 160
DI 10.1016/j.actbio.2017.01.018
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ4AB
UT WOS:000398014000011
PM 28069495
DA 2018-10-20
ER

PT J
AU Guerra, AD
   Rose, WE
   Hematti, P
   Kao, WJ
AF Guerra, Alberto Daniel
   Rose, Warren E.
   Hematti, Peiman
   Kao, W. John
TI Minocycline enhances the mesenchymal stromal/stem cell pro-healing
   phenotype in triple antimicrobial-loaded hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mesenchymal stromal/stem cells; Hydrogel Minocycline; Staphylococcus
   aureus; Wound healing
ID MINIMUM INHIBITORY CONCENTRATION; DRUG-RELEASE KINETICS; STEM-CELLS;
   STAPHYLOCOCCUS-AUREUS; BONE-MARROW; IN-VITRO; ENDOTHELIAL-CELLS;
   GENE-EXPRESSION; GROWTH-FACTOR; EXTRACELLULAR-MATRIX
AB Mesenchymal stromal/stem cells (MSCs) have demonstrated pro-healing properties including an antiinflammatory cytokine profile and the promotion of angiogenesis via expression of growth factors in pre-clinical models. MSCs encapsulated in poly(ethylene glycol) diacrylate (PEGdA) and thiolated gelatin poly(ethylene glycol) (Gel-PEG-Cys) crosslinked hydrogels have led to controlled cellular presentation at wound sites with favorable wound healing outcomes. However, the therapeutic potential of MSC-loaded hydrogels may be limited by non-specific protein adsorption on the delivery matrix that could facilitate the initial adhesion of microorganisms and subsequent virulent biofilm formation. Antimicrobials loaded concurrently in the hydrogels with MSCs could reduce microbial bioburden and promote healing, but the antimicrobial effect on the MSC wound healing capacity and the antibacterial efficacy of the hydrogels is unknown. We demonstrate that minocycline specifically induces a favorable change in MSC migration capacity, proliferation, gene expression, extracellular matrix (ECM) attachment, and adhesion molecule and growth factor release with subsequent increased angiogenesis. We then demonstrate that hydrogels loaded with MSCs, minocycline, vancomycin, and linezolid can significantly decrease bacterial bioburden. Our study suggests that minocycline can serve as a dual mechanism for the regenerative capacity of MSCs and the reduction of bioburden in triple antimicrobial-loaded hydrogels.
   Statement of Significance
   Wound healing is a complex biological process that can be hindered by bacterial infection, excessive inflammation, and inadequate microvasculature. In this study, we develop a new formulation of poly (ethylene glycol) diacrylate and thiolated gelatin poly(ethylene glycol) crosslinked hydrogels loaded with minocycline, vancomycin, linezolid, and mesenchymal stromal/stem cells that induces a favorable wound healing phenotype in mesenchymal stromal/stem cells and prevents bacterial bioburden on the hydrogel. This combinatorial approach to biomaterial development has the potential to impact wound healing for contaminated full thickness cutaneous wounds. (c) 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.
C1 [Guerra, Alberto Daniel; Rose, Warren E.; Kao, W. John] Univ Wisconsin Madison, Sch Pharm, Div Pharmaceut Sci, Pharm Practice Div, 777 Highland Ave, Madison, WI 53705 USA.
   [Hematti, Peiman] Univ Wisconsin Madison, Wisconsin Carbone Canc Ctr, Sch Med & Publ Hlth, Dept Med, 1685 Highland Ave, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin Madison, Coll Engn, Dept Biomed Engn, 1415 Engn Dr, Madison, WI 53706 USA.
   [Kao, W. John] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Surg, 1685 Highland Ave, Madison, WI 53705 USA.
   [Kao, W. John] 10 F Knowles Bldg,Pokfulam, Hong Kong, Peoples R China.
RP Kao, WJ (reprint author), 777 Highland Ave,7123 Rennebohm Hall, Madison, WI 53705 USA.
EM aguerra@wisc.edu; warren.rose@wisc.edu; pxh@medicine.wisc.edu;
   WJKao@wisc.edu
FU University of Wisconsin-Madison School of Pharmacy; National Institutes
   of Health [R21HL115482, HL115482]; University of Wisconsin Carbone
   Cancer Center Cancer Support Center [P30CA014520]; University of
   Wisconsin Science and Medicine Graduate Research Scholars Fellowship
FX The authors would like that thank Dr. Jaehyup Kim for the derivation of
   human and rat MSC5. This work was supported in part by the University of
   Wisconsin-Madison School of Pharmacy, the National Institutes of Health
   [grant numbers R21HL115482, HL115482], the University of Wisconsin
   Carbone Cancer Center Cancer Support Center [grant number P30CA014520],
   and the University of Wisconsin Science and Medicine Graduate Research
   Scholars Fellowship.
CR Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068
   Antti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056971
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arsalan M, 2013, INNOVATIONS, V8, P433, DOI 10.1097/IMI.0000000000000004
   Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273
   Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081
   Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578
   Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247
   Brown JM, 2011, CLIN EXP ALLERGY, V41, P526, DOI 10.1111/j.1365-2222.2010.03685.x
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Cao XK, 2016, BIOMED PHARMACOTHER, V78, P156, DOI 10.1016/j.biopha.2016.01.007
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chen QH, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0025-1
   Chew SA, 2016, J BIOMED MATER RES A, V104, P1202, DOI 10.1002/jbm.a.35657
   Choi S, 2013, NUTR RES PRACT, V7, P9, DOI 10.4162/nrp.2013.7.1.9
   Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106
   Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003
   Copland IB, 2013, BIOMATERIALS, V34, P7840, DOI 10.1016/j.biomaterials.2013.06.050
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Egydio FM, 2015, INT BRAZ J UROL, V41, P990, DOI 10.1590/S1677-5538.IBJU.2014.0422
   Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010
   Fehring TK, 2013, CLIN ORTHOP RELAT R, V471, P250, DOI 10.1007/s11999-012-2373-9
   Flegg JA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00262
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Fu Y, 2010, EXPERT OPIN DRUG DEL, V7, P429, DOI 10.1517/17425241003602259
   Gasparian A, 2015, ANAL BIOCHEM, V484, P1, DOI 10.1016/j.ab.2015.05.002
   Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684
   Ghosh S, 2016, ACS APPL MATER INTER, V8, P7691, DOI 10.1021/acsami.6b01160
   Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896
   Guerra AD, 2015, AAPS J, V17, P620, DOI 10.1208/s12248-015-9728-6
   Gustafsson E, 2004, J MOL MICROB BIOTECH, V8, P232, DOI 10.1159/000086704
   Guthrie KM, 2012, ANN SURG, V256, P371, DOI 10.1097/SLA.0b013e318256ff99
   HAMMES WP, 1974, ANTIMICROB AGENTS CH, V6, P722, DOI 10.1128/AAC.6.6.722
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Jeon YK, 2010, WOUND REPAIR REGEN, V18, P655, DOI 10.1111/j.1524-475X.2010.00636.x
   Jung JP, 2016, BIORESEARCH OPEN ACC, V5, P37, DOI 10.1089/biores.2015.0044
   Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573
   Kalil AC, 2014, JAMA-J AM MED ASSOC, V312, P1552, DOI 10.1001/jama.2014.6364
   Kalomoiris S., 2016, J CELL BIOCH
   Khan A.A., 2014, J SIGNAL TRANSDUCT, V2014, DOI DOI 10.1155/2014/17302625371820
   Khosrotehrani K, 2013, EXP DERMATOL, V22, P307, DOI 10.1111/exd.12141
   Kiran MD, 2008, INT J ARTIF ORGANS, V31, P761
   Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164
   Kleinbeck KR, 2009, J BURN CARE RES, V30, P98, DOI 10.1097/BCR.0b013e3181921ed9
   Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134
   Li C, 2016, J BIOSCI BIOENG, V121, P213, DOI 10.1016/j.jbiosc.2015.05.017
   Lis E, 2012, J FOOD PROTECT, V75, P238, DOI 10.4315/0362-028X.JFP-11-336
   Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108
   Martella E, 2014, CYTOTHERAPY, V16, P1476, DOI 10.1016/j.jcyt.2014.05.005
   Metcalf D, 1999, BLOOD, V93, P1579
   Miyazaki M, 2014, BIOL PHARM BULL, V37, P679, DOI 10.1248/bpb.b13-00670
   Nan WB, 2015, WOUNDS, V27, P134
   Oliveira L, 2012, J DAIRY SCI, V95, P1913, DOI 10.3168/jds.2011-4938
   Peters E.B., 2015, OPEN ACCESS, V4, P75
   Pichereau S, 2012, ANTIMICROB AGENTS CH, V56, P140, DOI 10.1128/AAC.05113-11
   REITAMO S, 1994, BIOCHEM J, V302, P331, DOI 10.1042/bj3020331
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023
   Renault MA, 2009, CIRC RES, V105, P818, DOI 10.1161/CIRCRESAHA.109.206706
   Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005
   Roubelakis MG, 2014, STEM CELL REV REP, V10, P417, DOI 10.1007/s12015-013-9494-8
   Seeger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137419
   Sengstock C, 2014, BEILSTEIN J NANOTECH, V5, P2058, DOI 10.3762/bjnano.5.214
   Serra R, 2015, EXPERT REV ANTI-INFE, V13, P605, DOI 10.1586/14787210.2015.1023291
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC
   Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Skripkin E, 2008, ANTIMICROB AGENTS CH, V52, P3550, DOI 10.1128/AAC.01193-07
   Tammaro L, 2015, INT J PHARMACEUT, V490, P32, DOI 10.1016/j.ijpharm.2015.04.070
   Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100
   Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007
   Waldeck H, 2012, J BIOMAT SCI-POLYM E, V23, P1595, DOI 10.1163/092050611X587547
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006
   Ward CL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0412-x
   Xu KD, 2013, ACTA BIOMATER, V9, P8802, DOI 10.1016/j.actbio.2013.06.021
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Yi T, 2012, GENE, V497, P131, DOI 10.1016/j.gene.2012.01.073
NR 83
TC 3
Z9 4
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2017
VL 51
BP 184
EP 196
DI 10.1016/jactbio.2017.01.021
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ4AB
UT WOS:000398014000014
PM 28069512
DA 2018-10-20
ER

PT J
AU Wang, J
   Liu, D
   Guo, B
   Yang, X
   Chen, XN
   Zhu, XD
   Fan, YJ
   Zhang, XD
AF Wang, Jing
   Liu, Dan
   Guo, Bo
   Yang, Xiao
   Chen, Xuening
   Zhu, Xiangdong
   Fan, Yujiang
   Zhang, Xingdong
TI Role of biphasic calcium phosphate ceramic-mediated secretion of
   signaling molecules by macrophages in migration and osteoblastic
   differentiation of MSCs
SO ACTA BIOMATERIALIA
LA English
DT Article
DE BCP ceramic; Macrophages; Signaling molecules; MSCs; Migration;
   Osteoblastic differentiation
ID MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; FOREIGN-BODY
   REACTION; IN-VITRO; TISSUE-REPAIR; OSTEOGENIC DIFFERENTIATION;
   TNF-ALPHA; BIOMATERIALS; VIVO; ACTIVATION
AB The inflammatory reaction initiates fracture healing and could play a role in the osteoinductive effect of calcium phosphate (CaP) ceramics, which has been widely confirmed; however, the underlying mechanism has not been fully elucidated. In this study, various signaling molecules from macrophages under the stimulation of osteoinductive biphasic calcium phosphate (BCP) ceramic and its degradation products were examined and evaluated for their influence on the migration and osteoblastic differentiation of mesenchymal stem cells (MSCs). The results of cellular experiments confirmed that the gene expression of most inflammatory factors (IL-1, IL-6 and MCP-1) and growth factors (VEGF, PDGF and EGF) by macrophages were up-regulated to varying degrees by BCP ceramic and its degradation products. Cell migration tests demonstrated that the conditioned media (CMs), which contained abundant signaling molecules secreted by macrophages cultured on BCP ceramic and its degradation products, promoted the migration of MSCs. qRT-PCR analysis indicated that CMs promoted the gene expression of osteogenic markers (ALP, COL-I, OSX, BSP and OPN) in MSCs. ALP activity and mineralization staining further confirmed that CMs promoted the osteoblastic differentiation of MSCs. The present study confirmed the correlation between the inflammatory reaction and osteoinductive capacity of BCP ceramic. The ceramic itself and its degradation products can induce macrophages to express and secrete various signaling molecules, which then recruit and promote the MSCs to differentiate into osteoblasts. Compared with BCP conditioned media, degradation particles played a more substantial role in this process. Thus, inflammation initiated by BCP ceramic and its degradation products could be necessary for osteoinduction by the ceramic.
   Statement of Significance
   It is known that the inflammatory reaction initiates fracture healing. The aim of this study was to examine whether osteoinductive BCP ceramics could cause macrophages to change their secretion patterns and whether the secreted cytokines could affect migration and osteoblastic differentiation of MSCs. Moreover, the duration of inflammation could be influenced by the local ionic environment and the degradation products of the implant. Our experimental results revealed the correlation between the inflammatory reaction and osteoinductive capacity of BCP ceramic. The ceramic itself and its degradation products can induce macrophages to express and secrete various signaling molecules, which then recruit and promote the MSCs to differentiate into osteoblasts. Compared with ionic microenvironment, degradation particles played a more substantial role in this process. Therefore, the appropriate inflammation initiated by BCP ceramic and its degradation products could be essential for osteoinduction by the ceramic. We believe that the present study improves the understanding of the effect of biomaterial-mediated inflammation on MSC migration and differentiation and established a preliminary correlation between the immune system and osteoinduction by biomaterials. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Jing; Liu, Dan; Yang, Xiao; Chen, Xuening; Zhu, Xiangdong; Fan, Yujiang; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Guo, Bo] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu 610041, Peoples R China.
RP Zhu, XD (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.; Guo, B (reprint author), Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu 610041, Peoples R China.
EM guobohx@163.com; zxd7303@163.com
FU National Natural Science Foundation of China [31370973, 81190131,
   31400819]; National Key Research and Development Program of China
   [2016YFC1102000]; "111" Project of China [B16033]
FX This work was supported by National Natural Science Foundation of China
   (31370973, 81190131 and 31400819), National Key Research and Development
   Program of China (2016YFC1102000), and the "111" Project of China
   (B16033).
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Chung E, 2014, TISSUE ENG REGEN MED, V11, P431, DOI 10.1007/s13770-014-0072-1
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Garrido CA, 2011, INT J BIOMATER, DOI 10.1155/2011/129727
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hamlet S, 2011, ACTA BIOMATER, V7, P2345, DOI 10.1016/j.actbio.2011.01.032
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Kim YK, 2016, J MATER CHEM B, V4, P1600, DOI 10.1039/c5tb01605c
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee JH, 2015, J TISSUE ENG REGEN M, V9, P447, DOI 10.1002/term.1900
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lin CY, 2015, CELL TRANSPLANT, V24, P2011, DOI 10.3727/096368914X685258
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031
   Marupanthorn Kulisara, 2015, Journal of the Medical Association of Thailand, V98, pS34
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293
   Olivares-Navarrete R, 2015, BONE, V73, P208, DOI 10.1016/j.bone.2014.12.057
   Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sheikh Z, 2015, MATERIALS, V8, P5671, DOI 10.3390/ma8095269
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274
   Visser R, 2016, J BIOMED MATER RES A, V104, P178, DOI 10.1002/jbm.a.35546
   Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102
   Wang L, 2015, J BIOMED MATER RES A, V103, P1919, DOI 10.1002/jbm.a.35325
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xiao Q, 2012, CELL BIOCHEM BIOPHYS, V62, P409, DOI 10.1007/s12013-011-9317-y
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Zhang JW, 2015, J BIOMED MATER RES A, V103, P1188, DOI 10.1002/jbm.a.35272
   Zhang JW, 2014, ACTA BIOMATER, V10, P3254, DOI 10.1016/j.actbio.2014.03.021
   Zhang X., 1991, BIOCERAMICS HUMAN BO, P692
   Zhang Y, 2012, GROWTH FACTORS, V30, P333, DOI 10.3109/08977194.2012.720574
NR 53
TC 13
Z9 14
U1 10
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2017
VL 51
BP 447
EP 460
DI 10.1016/j.actbio.2017.01.059
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EQ4AB
UT WOS:000398014000035
PM 28126596
DA 2018-10-20
ER

PT J
AU Knight, RC
   Thomson, DG
   Danielski, A
AF Knight, Rebekah C.
   Thomson, David G.
   Danielski, Alan
TI Surgical management of pivot-shift phenomenon in a dog
SO JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
LA English
DT Article
ID PLATEAU-LEVELING OSTEOTOMY; ANTERIOR CRUCIATE LIGAMENT; KNEE-JOINT
   MUSCULATURE; IN-VITRO; DEFICIENT-STIFLE; EXTRACAPSULAR STABILIZATION;
   CANINE STIFLE; FUNCTIONAL-ANALYSIS; TIBIAL TRANSLATION; KINEMATICS
AB CASE DESCRIPTION A 6.8-year-old neutered male Labrador Retriever-Poodle mix was evaluated because of continued left pelvic limb lameness unresponsive to conservative management 1 year after undergoing tibial plateau leveling osteotomy (TPLO).
   CLINICAL FINDINGS A jerking lateral movement of the left stifle joint was detected during walking. Orthopedic examination revealed a pivot-shift phenomenon (PSP). Palpation elicited no signs of discomfort over the TPLO plate or caudomedial aspect of the stifle joint. Radiography revealed complete bone fusion at the osteotomy site and only mild joint effusion.
   TREATMENT AND OUTCOME Arthrotomy was performed at the medial aspect of the stifle joint, revealing no meniscal tears. The previously applied plate was removed, and an extracapsular, synthetic, ligament-like biomaterial was placed to counteract internal tibial rotation, thereby eliminating the PSP. Six weeks later, lameness had improved considerably with no evidence of PSP; 8 weeks after surgery, the dog was assessed for sudden-onset lameness in the right pelvic limb. Cranial cruciate ligament rupture was suspected, and TPLO was performed. The PSP was identified intraoperatively, so an extracapsular implant was placed. Six weeks later, the dog had only mild lameness and no evidence of PSP in either pelvic limb. In a follow-up telephone conversation 1 year later, the owner reported no obvious lameness or gait abnormalities.
   CLINICAL RELEVANCE Use of an extracapsular implant effectively eliminated the PSP following TPLO in the dog of this report and can be considered as an intra- or postoperative option for dogs with PSP that responds poorly to conservative management.
C1 [Knight, Rebekah C.; Thomson, David G.; Danielski, Alan] Davies Vet Specialists, Manor Farm Business Pk, Higham Gobion SG5 3HR, Herts, England.
RP Danielski, A (reprint author), Davies Vet Specialists, Manor Farm Business Pk, Higham Gobion SG5 3HR, Herts, England.
EM Alan.Danielski@vetspecialists.co.uk
OI Knight, Rebekah/0000-0003-1925-4265
CR ARNOCZKY SP, 1977, AM J VET RES, V38, P1807
   Arthrex Vet Systems, TIGHTROPE CCL SURG T
   Aulakh KS, 2013, VET COMP ORTHOPAED, V26, P208, DOI 10.3415/VCOT-12-04-0051
   BACH BR, 1988, AM J SPORT MED, V16, P571, DOI 10.1177/036354658801600603
   Bergh MS, 2012, VET COMP ORTHOPAED, V25, P349, DOI 10.3415/VCOT-11-09-0122
   Biskup JJ, 2014, VET SURG, V43, P959, DOI 10.1111/j.1532-950X.2014.12111.x
   Boudrieau RJ, 2009, VET SURG, V38, P1, DOI 10.1111/j.1532-950X.2008.00439.x
   Chailleux N, 2007, CAN J VET RES, V71, P175
   Choate CJ, 2013, VET SURG, V42, P853, DOI 10.1111/j.1532-950X.2013.12049.x
   Choate CJ, 2012, AM J VET RES, V73, P1519, DOI 10.2460/ajvr.73.10.1519
   Cook JL, 2010, VET SURG, V39, P315, DOI 10.1111/j.1532-950X.2010.00658.x
   D'Amico LL, 2013, VET COMP ORTHOPAED, V26, P271, DOI 10.3415/VCOT-12-04-0055
   Fitzpatrick N, 2010, VET SURG, V39, P460, DOI 10.1111/j.1532-950X.2010.00663.x
   GALWAY HR, 1980, CLIN ORTHOP RELAT R, P45
   Gatineau M, 2011, VET COMP ORTHOPAED, V24, P333, DOI 10.3415/VCOT-10-07-0109
   Harper TAM, 2004, VET SURG, V33, P531, DOI [10.1111/j.1532-950X.2004.04075.x, 10.1111/j.1532-950X.2004.04.04075.x]
   Kim SE, 2012, VET SURG, V41, P465, DOI 10.1111/j.1532-950X.2012.00973.x
   Kim SE, 2009, VET SURG, V38, P23, DOI 10.1111/j.1532-950X.2008.00470.x
   KORVICK DL, 1994, J BIOMECH, V27, P77, DOI 10.1016/0021-9290(94)90034-5
   Leitze Z, 2005, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000160026.14363.22
   LIMBIRD TJ, 1988, J ORTHOPAED RES, V6, P630, DOI 10.1002/jor.1100060503
   Pozzi A, 2006, VET SURG, V35, P486, DOI 10.1111/j.1542-950X.2006.0018.x
   Sakai H, 2006, KNEE SURG SPORT TR A, V14, P2, DOI 10.1007/s00167-005-0630-0
   Schulz K., 2007, SMALL ANIMAL SURG, P1254
   SHIAVI R, 1991, J ELECTROMYOGR KINES, V1, P49, DOI 10.1016/1050-6411(91)90026-2
   SLOCUM B, 1993, VET CLIN N AM-SMALL, V23, P777, DOI 10.1016/S0195-5616(93)50082-7
   Snow LA, 2010, VET SURG, V39, P195, DOI 10.1111/j.1532-950X.2009.00635.x
   SOLOMONOW M, 1987, AM J SPORT MED, V15, P207, DOI 10.1177/036354658701500302
   VASSEUR PB, 1981, AM J VET RES, V42, P1133
   Warzee CC, 2001, VET SURG, V30, P278, DOI 10.1053/jvet.2001.21400
   Wheeler JL, 2003, VET SURG, V32, P371, DOI 10.1053/jvet.2003.50038
NR 31
TC 1
Z9 1
U1 0
U2 8
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0003-1488
EI 1943-569X
J9 JAVMA-J AM VET MED A
JI JAVMA-J. Am. Vet. Med. Assoc.
PD MAR 15
PY 2017
VL 250
IS 6
BP 676
EP 680
DI 10.2460/javma.250.6.676
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA EP1QS
UT WOS:000397160000030
PM 28263119
DA 2018-10-20
ER

PT J
AU Kandhasamy, S
   Perumal, S
   Madhan, B
   Umamaheswari, N
   Banday, JA
   Perumal, PT
   Santhanakrishnan, VP
AF Kandhasamy, Subramani
   Perumal, Sathiamurthi
   Madhan, Balaraman
   Umamaheswari, Narayanan
   Banday, Javid Ahmad
   Perumal, Paramasivan Thirumalai
   Santhanakrishnan, Vichangal Pridiuldi
TI Synthesis and Fabrication of Collagen-Coated Ostholamide Electrospun
   Nanofiber Scaffold for Wound Healing
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE ostholamide; collagen; wound healing; fibroblast; electrospun nanofibers
ID TISSUE ENGINEERING APPLICATIONS; GROWTH-FACTOR; BIOLOGICAL EVALUATION;
   COMPOSITE SCAFFOLD; NATURAL-PRODUCTS; FIBER DIAMETER; DERIVATIVES;
   DRESSINGS; GELATIN; CELLS
AB A novel scaffold for effective wound healing treatment was developed utilizing natural product bearing collagen based biocompatible electrospun nanofibers. Initially, ostholamide (OSA) was synthesized from osthole (a natural coumarin), characterized by H-1, C-13, DEPT-135 NMR, ESI-MS, and FT-IR spectroscopy analysis. OSA was incorporated into polyhydroxybutyrate (PHB) and gelatin (GEL), which serve as templates for electrospun nanofibers. The coating of OSA-PHB-GEL nanofibers with collagen resulted in PHB-GEL-OSA-COL nanofibrous scaffold which mimics extracellular matrix and serves as an effective biomaterial for tissue engineering applications, especially for wound healing. PHB-GEL-OSA-COL, along with PHB-GEL-OSA and collagen film (COLF), was characterized in vitro and in vivo to determine its efficacy. The developed PHB-GEL-OSA-COL nanofibers posed an impressive mechanical stability, an essential requirement for wound healing. The presence of OSA had contributed to antimicrobial efficacy. These scaffolds exhibited efficient antibacterial activity against common wound pathogens, Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S. aureus). The zones of inhibition were observed to be 14 22 and 10 2 mm, respectively. It was observed that nanofibrous scaffold had the ability to release OSA in a controlled manner, and hence, OSA would be present at the site of application and exhibit bioactivity in a sustained manner. PHB-GEL-OSA-COL nanofiber was determined to be stable against enzymatic degradation, which is the most important parameter for promoting proliferation of cells contributing to repair and remodeling of tissues during wound healing applications. As hypothesized, PHB-GEL-OSA-COL was observed to imbibe excellent cytocompatibility, which was determined using NIH 3T3 fibroblast cell proliferation studies. PHB-GEL-OSA-COL exhibited excellent wound healing efficacy which was confirmed using full thickness excision wound model in Wistar rats. The rats treated with PHB-GEL-OSA-COL nanofibrous scaffold displayed enhanced healing when compared to untreated control. Both in vitro and in vivo analysis of PHB-GEL-OSA-COL presents a strong case of therapeutic biomaterial suiting wound repair and regeneration.
C1 [Kandhasamy, Subramani; Umamaheswari, Narayanan; Perumal, Paramasivan Thirumalai] CSIR Cent Leather Res Inst, Organ Chem Div, Chennai 600020, Tamil Nadu, India.
   [Perumal, Sathiamurthi; Madhan, Balaraman] CSIR Cent Leather Res Inst, CHORD, AcSIR, Chennai 600020, Tamil Nadu, India.
   [Banday, Javid Ahmad] Natl Inst Technol, Dept Chem, Srinagar, Jammu & Kashmir, India.
   [Santhanakrishnan, Vichangal Pridiuldi] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Dept Plant Biotechnol, Coimbatore, Tamil Nadu, India.
RP Santhanakrishnan, VP (reprint author), Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Dept Plant Biotechnol, Coimbatore, Tamil Nadu, India.
EM kandhasks@gmail.com; santhan_r@yahoo.co.uk
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452; , Kandhasamy/0000-0001-9821-7694;
   Perumal, P T/0000-0003-2057-6368
FU Department of Biotechnology, Government of India
   [BT/PR6274/GBD/27/497/2013]
FX The authors are thankful to the Department of Biotechnology, Government
   of India (BT/PR6274/GBD/27/497/2013), for the financial support to carry
   out this project. S.K.S. acknowledges the CSIR-CLRI for providing
   infrastructure to carry out this research work.
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Bishi DK, 2013, J MATER CHEM B, V1, P3972, DOI 10.1039/c3tb20241k
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chang CC, 2010, OPT EXPRESS, V18, pA174, DOI 10.1364/OE.18.00A174
   Farooq S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108713
   Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048
   Giriprasath R., 2016, RSC ADV, V6, P7914
   Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Hu QH, 2005, FOOD CHEM, V91, P85, DOI 10.1016/j.foodchem.2004.05.052
   Huang WJ, 2011, EUR J MED CHEM, V46, P4042, DOI 10.1016/j.ejmech.2011.06.002
   Jin GR, 2013, BIOMATERIALS, V34, P724, DOI 10.1016/j.biomaterials.2012.10.026
   Jing X, 2014, IND ENG CHEM RES, V53, P9391, DOI 10.1021/ie500762z
   Jithendra P, 2013, ACS APPL MATER INTER, V5, P7291, DOI 10.1021/am401637c
   Kandhasamy S, 2015, RSC ADV, V5, P55075, DOI 10.1039/c5ra07133j
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   Khandalavala K., 2015, JOVE-J VIS EXP, V98
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Kogure K, 2004, PHYTOMEDICINE, V11, P645, DOI 10.1016/j.phymed.2003.09.004
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li DW, 2014, ACS APPL MATER INTER, V6, P9402, DOI 10.1021/am5017792
   Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243
   Lin VCH, 2010, J AGR FOOD CHEM, V58, P4786, DOI 10.1021/jf100352c
   Liu CY, 2015, ACS BIOMATER SCI ENG, V1, P639, DOI 10.1021/acsbiomaterials.5b00015
   Liu CY, 2014, RSC ADV, V4, P46141, DOI 10.1039/c4ra09085c
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Maenthaisong R, 2007, BURNS, V33, P713, DOI 10.1016/j.burns.2006.10.384
   Mavi A, 2004, BIOL PHARM BULL, V27, P702, DOI 10.1248/bpb.27.702
   Merkle VM, 2015, ACS APPL MATER INTER, V7, P8302, DOI 10.1021/acsami.5b01671
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nagiah N, 2013, POLYM BULL, V70, P2337, DOI 10.1007/s00289-013-0956-6
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   Nguyen T.-H., 2010, J BIOMED SCI ENG, V3, P1117, DOI DOI 10.4236/JBISE.2010.312145
   Niamlang P, 2017, J DRUG DELIV SCI TEC, V38, P36, DOI 10.1016/jjddst.2016.12.006
   Park JH, 2010, ADV MATER, V22, P496, DOI 10.1002/adma.200902465
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   Ramadass SK, 2014, ACS APPL MATER INTER, V6, P15015, DOI 10.1021/am502948g
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Renuka N, 2013, BIOORG MED CHEM LETT, V23, P6406, DOI 10.1016/j.bmcl.2013.09.053
   Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Shalumon KT, 2011, INT J BIOL MACROMOL, V49, P247, DOI 10.1016/j.ijbiomac.2011.04.005
   Sivakumar S., 2016, J MATER CHEM B, V4, P3982
   Sivakumar S., 2015, MATER LETT, V152, P90
   Sun LM, 2016, ACS APPL MATER INTER, V8, P2423, DOI 10.1021/acsami.5b11811
   Sweeney IR, 2012, INT WOUND J, V9, P601, DOI 10.1111/j.1742-481X.2011.00923.x
   Tada Y, 2002, PHYTOCHEMISTRY, V59, P649, DOI 10.1016/S0031-9422(02)00023-7
   Tanaka A, 2005, J VET MED SCI, V67, P909, DOI 10.1292/jvms.67.909
   Thuong PT, 2010, PHYTOTHER RES, V24, P101, DOI 10.1002/ptr.2890
   Tombe S, 2013, NEW J CHEM, V37, P679, DOI 10.1039/c2nj40984d
   WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090
   You LS, 2010, BIOORG MED CHEM LETT, V20, P7426, DOI 10.1016/j.bmcl.2010.10.027
   Yu HF, 2016, ACS APPL MATER INTER, V8, P703, DOI 10.1021/acsami.5b09853
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang MZ, 2016, EUR J MED CHEM, V124, P10, DOI 10.1016/j.ejmech.2016.08.012
NR 60
TC 4
Z9 4
U1 7
U2 70
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 15
PY 2017
VL 9
IS 10
BP 8556
EP 8568
DI 10.1021/acsami.6b16488
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EO6KM
UT WOS:000396801200015
PM 28221758
DA 2018-10-20
ER

PT J
AU Hernandez-Gonzalez, M
   Berumen, CMP
   Ruiz, HS
   Salazar, CVR
   Paz, JFH
   Olivas-Armendariz, I
   Martel-Estrada, SA
   Gonzalez, CAR
AF Hernandez-Gonzalez, M.
   Perez Berumen, C. M.
   Sanchez Ruiz, H.
   Ruiz Salazar, C. V.
   Hernandez Paz, J. F.
   Olivas-Armendariz, I.
   Martel-Estrada, S. A.
   Rodriguez Gonzalez, C. A.
TI Polysuccinimide functionalized with oregano's essential oil extracts, an
   antimicrobial extended release bio-material
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; FTIR; Polysuccinimide; Oregano's essential oil;
   Antimicrobial activity
ID CARVACROL; THYMOL; FILMS
AB The use of biobased active packing materials is a trend on the food industry especially when natural additives are incorporated. Polysuccinimide is an environmentally friendly biomaterial with no mutagenic effect. The aim of this work is to study the antimicrobial capacity of polysuccinimide functionalized with Oregano's essential oil and its components migration. Polysuccinimide was obtained by self condensation thermal reaction of aspartic acid and further functionalization with extracts of oregano's essential oil. The biomaterial was characterized by Fourier transform infrared spectroscopy, antibacterial activity and migration analysis. The material functionalized at 3% showed antimicrobial efficiency against Escherichia coli and Staphylococcus aureus, with inhibitory halos of 4.00 cm. No migration of thymol and carvacrol was detected which is associated to prolonged release. This is widely sought in materials for biomedical and food fields. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Hernandez-Gonzalez, M.; Hernandez Paz, J. F.; Olivas-Armendariz, I.; Rodriguez Gonzalez, C. A.] Univ Autonoma Ciudad Juarez, Inst Ingn & Tecnol, Ave Del Charro 610, Cd Juarez 32310, Chihuahua, Mexico.
   [Perez Berumen, C. M.] Univ Autonoma Coahuila, Dept Organ Chem, Blvd V Carranza & J Cardenas, Saltillo 25280, Coahuila, Mexico.
   [Hernandez-Gonzalez, M.; Sanchez Ruiz, H.] Univ Autonoma Agr Antonio Narro, Calzada Antonio Narro 1923, Saltillo 25315, Coahuila, Mexico.
   [Ruiz Salazar, C. V.] Univ Tecnol Coahuila, Ind 2001, Ramos Arizpe 25900, Coahuila, Mexico.
   [Martel-Estrada, S. A.] Univ Autonoma Ciudad Juarez, Inst Arquitectura Diseno & Arte, Ave Del Charro 450, Cd Juarez 32310, Chihuahua, Mexico.
RP Hernandez-Gonzalez, M (reprint author), Univ Autonoma Agr Antonio Narro, Calzada Antonio Narro 1923, Saltillo 25315, Coahuila, Mexico.
EM maryhg12@yahoo.com
OI Martel-Estrada, Santos-Adriana/0000-0002-8803-9406; Hernandez Paz, Juan
   Francisco/0000-0002-1621-835X
FU PRODEP Project [DSA/103.5/15/9620]
FX Acknowledges to PRODEP Project DSA/103.5/15/9620 for supporting this
   work.
CR Bernal M.R., 1984, BIOMEDICA, V4, P112
   Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x
   Emiroglu ZK, 2010, MEAT SCI, V86, P283, DOI 10.1016/j.meatsci.2010.04.016
   Friedman M, 2006, ADV MICROBIAL FOOD S, P167
   Galotto M.J., INOCUIDAD ENVASES PL, P1
   Iturbe L.C., 2004, REV IBEROAMERICANA P, V5, P111
   Li PH, 2012, ULTRASON SONOCHEM, V19, P192, DOI 10.1016/j.ultsonch.2011.05.017
   Lucera A., 2012, FRONT MICROBIOL, V3
   Martin P. Perez de los Bueis, 2012, CARACTERIZACION LIBE
   Navia D.P., 2014, INTERACCIONES EMPAQU, V13
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   Olabisi M.T., 1986, PURE APPL CHEM, V58, P1553
   Pagacz J, 2010, MOL CRYST LIQ CRYST, V523, P50, DOI 10.1080/15421401003719787
   Ramos M, 2012, J FOOD ENG, V109, P513, DOI 10.1016/j.jfoodeng.2011.10.031
   Realini CE, 2014, MEAT SCI, V98, P404, DOI 10.1016/j.meatsci.2014.06.031
   Rodriguez IC, 2000, ARS PHARM, V1, P115
   Sung SY, 2013, TRENDS FOOD SCI TECH, V33, P110, DOI 10.1016/j.tifs.2013.08.001
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tudorachi N, 2011, POLYM TEST, V30, P397, DOI 10.1016/j.polymertesting.2011.02.007
   van Tuil R., 2000, J FOOD SCI TECHNOL, V5, P69
   Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x
NR 21
TC 2
Z9 2
U1 4
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD MAR 15
PY 2017
VL 191
BP 73
EP 76
DI 10.1016/j.matlet.2017.01.035
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EL1TD
UT WOS:000394403000019
DA 2018-10-20
ER

PT J
AU Kumar, R
   Oves, M
   Almeelbi, T
   Al-Makishah, NH
   Barakat, MA
AF Kumar, Rajeev
   Oves, Mohammad
   Almeelbi, Talal
   Al-Makishah, Naief H.
   Barakat, M. A.
TI Hybrid chitosani/polyaniline-polypyrrole biomaterial for enhanced
   adsorption and antimicrobial activity
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Hybrid biomaterial; Adsorption; Kinetics; Thermodynamics; Antimicrobial
   activity
ID AQUEOUS-SOLUTIONS; CHITOSAN DERIVATIVES; SIMULTANEOUS REMOVAL; GRAFTED
   CHITOSAN; PB(II) IONS; ZINC II; NANOPARTICLES; ZN(II); CU(II);
   ANTIBACTERIAL
AB In this work, chitosan (CS) functionalized polyaniline-polypyrrole (Pani-Ppy) copolymer (CS/Pani-Ppy) was synthesized applying a facile one pot method for the enhanced adsorption of Zn(II) and antimicrobial activity for E. coli and E. agglomerans. The synthesized materials were characterized using scanning electron microscopy, energy dispersive X-ray spectroscopy, Fourier transform inferred spectroscopy and X-ray photoelectron spectroscopy. The adsorption of the Zn(II) on the synthesized materials was highly dependent on the pH of the solution, the initial metal ion concentration, and temperature. The adsorption of Zn(II) on the studied materials was as follows: CS/Pani-Ppy > Pani-Ppy > Ppy > Pani > CS. The results reveal that adsorption of Zn(II) follows the Langmuir adsorption isotherm, and that chemisorption occurs through pendant and bridging interactions, with active adsorbent sites. Thermodynamic results show the adsorption is spontaneous and exothermic in nature. The synthesized materials show excellent antimicrobial activity against E. coli and E. agglomerans bacterial organisms, and an approximately 100% decline in the viability of both strains was observed with CS/Pani-Ppy and Pani-Ppy. The order of antimicrobial activity for the synthesized materials was as follows: CS/Ppy-Pani > Ppy-Pani > Ppy > Pani > CS. The results show that the greater activity of CS/Ppy-Pani resulted from the electrostatic interaction between positively charged amine groups and negatively charged bacteria. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Kumar, Rajeev; Almeelbi, Talal; Al-Makishah, Naief H.; Barakat, M. A.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Environm Sci, Jeddah 21589, Saudi Arabia.
   [Oves, Mohammad; Almeelbi, Talal] King Abdulaziz Univ, CEES, Jeddah, Saudi Arabia.
   [Barakat, M. A.] Cent Met R&D Inst, Cairo 11421, Egypt.
RP Barakat, MA (reprint author), King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Environm Sci, Jeddah 21589, Saudi Arabia.
EM mabarakat@gmail.com
RI Oves, Mohammad/J-8804-2015; Barakat, Mohamed/H-7499-2012; Kumar,
   Rajeev/I-6895-2013
OI Oves, Mohammad/0000-0002-8513-6155; Barakat,
   Mohamed/0000-0001-6244-8394; Kumar, Rajeev/0000-0002-0303-4383
CR Afroze S, 2016, PROCESS SAF ENVIRON, V102, P336, DOI 10.1016/j.psep.2016.04.009
   Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   Angeletti S, 2016, TRAVEL MED INFECT DI, V14, P115, DOI 10.1016/j.tmaid.2016.03.005
   Babu KF, 2012, CARBOHYD POLYM, V90, P1557, DOI 10.1016/j.carbpol.2012.07.030
   Balintova M, 2011, CHEM ENGINEER TRANS, V25, P345, DOI 10.3303/CET1125058
   Bhaumik M, 2014, J COLLOID INTERF SCI, V425, P75, DOI 10.1016/j.jcis.2014.03.031
   Bhaumik M, 2013, CHEM ENG J, V228, P506, DOI 10.1016/j.cej.2013.05.026
   Cabuk M, 2014, APPL SURF SCI, V318, P168, DOI 10.1016/j.apsusc.2014.02.180
   Chaluvaraju B.V., 2015, INT J MACROMOL SCI, V5, P1
   Chen AH, 2008, J HAZARD MATER, V154, P184, DOI 10.1016/j.jhazmat.2007.10.009
   Choi M, 2008, J COLLOID INTERF SCI, V325, P287, DOI 10.1016/j.jcis.2008.05.047
   Darabpour E, 2016, PHOTODIAGN PHOTODYN, V14, P211, DOI 10.1016/j.pdpdt.2016.04.009
   Ding P, 2006, INT J BIOL MACROMOL, V39, P222, DOI 10.1016/j.ijbiomac.2006.03.029
   Fan LL, 2011, COLLOID SURFACE B, V88, P574, DOI 10.1016/j.colsurfb.2011.07.038
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gedam AH, 2015, RSC ADV, V5, P54188, DOI 10.1039/c5ra09899h
   Jiang SS, 2016, CHEMOSPHERE, V142, P64, DOI 10.1016/j.chemosphere.2015.06.079
   Karthik R, 2015, CHEM ENG J, V263, P168, DOI 10.1016/j.cej.2014.11.015
   Kerr TA, 1996, CHEM MATER, V8, P2005, DOI 10.1021/cm960071q
   KNOCKE WR, 1981, WATER RES, V15, P275, DOI 10.1016/0043-1354(81)90121-4
   Kouakou U., 2013, J ENV CHEM ECOTOXICO, V5, P168
   Kucekova Z, 2014, COLLOID SURFACE B, V116, P411, DOI 10.1016/j.colsurfb.2014.01.027
   Kumar R, 2013, CHEM ENG J, V218, P32, DOI 10.1016/j.cej.2012.12.029
   Kyzas GZ, 2015, CHEM ENG J, V259, P438, DOI 10.1016/j.cej.2014.08.019
   Kyzas GZ, 2009, CHEM ENG J, V152, P440, DOI 10.1016/j.cej.2009.05.005
   Lai P, 2014, COLLOID SURFACE B, V118, P154, DOI 10.1016/j.colsurfb.2014.03.017
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li R, 2016, CHEMOSPHERE, V154, P310, DOI 10.1016/j.chemosphere.2016.03.100
   Maheshwari U, 2015, PROCESS SAF ENVIRON, V98, P198, DOI 10.1016/j.psep.2015.07.010
   Matthes W, 1999, CLAY CLAY MINER, V47, P617, DOI 10.1346/CCMN.1999.0470508
   Mendez G., 2016, INT J EXP PATHOL
   Miyazaki A, 2003, GEOCHIM COSMOCHIM AC, V67, P3833, DOI 10.1016/S0016-7037(03)00373-9
   Salahi S, 2014, SYNTHETIC MET, V197, P154, DOI 10.1016/j.synthmet.2014.09.009
   Sun CM, 2012, CHEM ENG J, V200, P291, DOI 10.1016/j.cej.2012.06.007
   Tao Y, 2014, CHEM COMMUN, V50, P3030, DOI 10.1039/c4cc00328d
   Thakur VK, 2016, CARBOHYD POLYM, V146, P148, DOI 10.1016/j.carbpol.2016.03.030
   Ungureanu C, 2014, MAT SCI ENG C-MATER, V42, P726, DOI 10.1016/j.msec.2014.06.020
   Upadhyay J, 2015, MAT SCI ENG C-MATER, V54, P8, DOI 10.1016/j.msec.2015.04.027
   Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022
   Wang TQ, 2015, J COLLOID INTERF SCI, V443, P65, DOI 10.1016/j.jcis.2014.11.046
   Wang XH, 2014, COLLOID SURFACE A, V441, P51, DOI 10.1016/j.colsurfa.2013.08.068
   Zhang L, 2016, J MOL LIQ, V214, P175, DOI 10.1016/j.molliq.2015.12.013
   Zhang X, 2003, LANGMUIR, V19, P10703, DOI 10.1021/la034893v
   Zhu YH, 2012, J HAZARD MATER, V221, P155, DOI 10.1016/j.jhazmat.2012.04.026
NR 44
TC 12
Z9 12
U1 14
U2 79
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAR 15
PY 2017
VL 490
BP 488
EP 496
DI 10.1016/j.jcis.2016.11.082
PG 9
WC Chemistry, Physical
SC Chemistry
GA EJ3YJ
UT WOS:000393148300055
PM 27918986
DA 2018-10-20
ER

PT J
AU Wei, CK
   Ding, SJ
AF Wei, Chung-Kai
   Ding, Shinn-Jyh
TI Dual-functional bone implants with antibacterial ability and osteogenic
   activitys
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VITRO; PHYSICOCHEMICAL PROPERTIES; STAPHYLOCOCCUS-AUREUS; SILVER
   NANOPARTICLES; OSTEOBLAST FUNCTIONS; ORTHOPEDIC IMPLANTS; ANTIMICROBIAL
   AGENT; BACTERIAL ADHESION; TITANIUM SURFACES; EXTERNAL FIXATION
AB A growing number of biomaterial-associated infections cause bone implant failures in early and long-term applications. In this regard, a calcium silicate-gelatine composite bone implant with high strength and superior osteogenic activity was coated with a layer of Ag, chitosan polysaccharide (CS) or water-soluble chitosan oligosaccharide (COS) as a bactericidal agent. The influences of surface modifications to the bone implants on phase composition, microstructure, antibacterial effectiveness, and osteogenic activity in vitro were evaluated. Experimental results revealed the presence of the coating on the implant surface using a simple deposition technique. The in vitro antibacterial evaluation indicated that the antimicrobial effectiveness of the Ag coating against Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) was inferior to the 0.4% CS coating, but comparable to those of 0.2% CS and 0.4% COS coatings after 48 h of culture. CS presented a greater bactericidal effect than COS, which was bacteria-independent. CS and COS coatings had no significant cytotoxicity towards L929 cells at coating concentrations of 0.1%, 0.2%, and 0.4%, except for the cells exposed to the 0.4% CS coating, while the 0.004% Ag coating remarkably produced cytotoxicity. The assays of cell functions consistently showed significantly higher osteogenic activity of MG63 cells grown on CS and COS-coated surfaces by increased attachment, proliferation, alkaline phosphatase, osteocalcin, and calcium deposits production, except for the 0.4% CS coating, in comparison with those on the Ag coated surface. It was concluded that, taking antibacterial ability and osteogenic activity into account, 0.2% CS-coated and 0.4% COS-coated calcium silicate-gelatine composite bone implants had a large potential to be used in bone grafts and fracture fixation devices.
C1 [Wei, Chung-Kai; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Stomatol, Taichung 402, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.; Ding, SJ (reprint author), Chung Shan Med Univ Hosp, Dept Stomatol, Taichung 402, Taiwan.
EM sjding@csmu.edu.tw
CR AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen CC, 2015, CERAM INT, V41, P5445, DOI 10.1016/j.ceramint.2014.12.112
   Chen CJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071161
   Chiang TY, 2013, INT ENDOD J, V46, P234, DOI 10.1111/j.1365-2591.2012.02112.x
   Chiang TY, 2010, MATER CHEM PHYS, V120, P282, DOI 10.1016/j.matchemphys.2009.11.007
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ding SJ, 2007, J NON-CRYST SOLIDS, V353, P2367, DOI 10.1016/j.jnoncrysol.2007.04.020
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Ho CC, 2016, CERAM INT, V42, P9183, DOI 10.1016/j.ceramint.2016.03.013
   Ho CC, 2016, J MATER CHEM B, V4, P505, DOI 10.1039/c5tb02401c
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang SC, 2015, J MATER CHEM B, V3, P570, DOI 10.1039/c4tb01617c
   Jeon YJ, 2001, CARBOHYD POLYM, V44, P71, DOI 10.1016/S0144-8617(00)00200-9
   Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126
   Jiravova J, 2016, FOOD CHEM TOXICOL, V96, P50, DOI 10.1016/j.fct.2016.07.015
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Li M, 2015, J MATER CHEM B, V3, P8796, DOI 10.1039/c5tb01597a
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Qi LF, 2005, WORLD J GASTROENTERO, V11, P5136
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Raphel J, 2016, BIOMATERIALS, V84, P301, DOI 10.1016/j.biomaterials.2016.01.016
   Samiezadeh S, 2015, J MECH BEHAV BIOMED, V42, P138, DOI 10.1016/j.jmbbm.2014.11.015
   Seong HS, 2000, J APPL POLYM SCI, V76, P2009, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2009::AID-APP3>3.0.CO;2-W
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Wang CW, 2014, J MATER SCI-MATER M, V25, P2193, DOI 10.1007/s10856-014-5258-5
   Wei CK, 2016, J MECH BEHAV BIOMED, V62, P366, DOI 10.1016/j.jmbbm.2016.05.019
   Wu BC, 2015, INT ENDOD J, V48, P268, DOI 10.1111/iej.12310
   Wu CC, 2015, MATERIALS, V8, P684, DOI 10.3390/ma8020684
   YOSHINO H, 1990, J NON-CRYST SOLIDS, V126, P68, DOI 10.1016/0022-3093(90)91024-L
   Yu L, 2014, J MATER CHEM B, V2, P5397, DOI 10.1039/c4tb00594e
   Zhang F, 2008, BIOMATERIALS, V29, P4751, DOI 10.1016/j.biomaterials.2008.08.043
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
   Zlowodzki M, 2007, INT ORTHOP, V31, P409, DOI 10.1007/s00264-006-0187-7
NR 44
TC 5
Z9 5
U1 4
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 14
PY 2017
VL 5
IS 10
BP 1943
EP 1953
DI 10.1039/c7tb00173h
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EN6ZX
UT WOS:000396153000007
DA 2018-10-20
ER

PT J
AU Groen, N
   Yuan, HP
   Hebels, DGAJ
   Kocer, G
   Mbuyi, F
   LaPointe, V
   Truckenmuller, R
   van Blitterswijk, CA
   Habibovic, P
   de Boer, J
AF Groen, Nathalie
   Yuan, Huipin
   Hebels, Dennie G. A. J.
   Kocer, Gulistan
   Mbuyi, Faustin
   LaPointe, Vanessa
   Truckenmuller, Roman
   van Blitterswijk, Clemens A.
   Habibovic, Pamela
   de Boer, Jan
TI Linking the Transcriptional Landscape of Bone Induction to Biomaterial
   Design Parameters
SO ADVANCED MATERIALS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; MESENCHYMAL STROMAL CELLS; OSTEOGENIC
   DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; STEM-CELLS; PHASE-COMPOSITION;
   TISSUE; OSTEOINDUCTION; DISCOVERY; PATHWAY
AB New engineering possibilities allow biomaterials to serve as active orchestrators of the molecular and cellular events of tissue regeneration. Here, the molecular control of tissue regeneration for calcium phosphate (CaP)-based materials is established by defining the parameters critical for tissue induction and those are linked to the molecular circuitry controlling cell physiology. The material properties (microporosity, ion composition, protein adsorption) of a set of synthesized osteoinductive and noninductive CaP ceramics are parameterized and these properties are correlated to a transcriptomics profile of osteogenic cells grown on the materials in vitro. Using these data, a genetic network controlling biomaterial-induced bone formation is built. By isolating the complex material properties into single-parameter test conditions, it is verified that a subset of these genes is indeed controlled by surface topography and ions released from the ceramics, respectively. The gene network points to a decisive role for extracellular matrix deposition in osteoinduction by genes such as tenascin C and hyaluronic acid synthase 2, which are controlled by calcium and phosphate ions as well as surface topography. This work provides insight into the biomaterial composition and material engineering aspects of bone void filling and can be used as a strategy to explore the interface between biomaterials and tissue regeneration.
C1 [Groen, Nathalie; Kocer, Gulistan; Mbuyi, Faustin; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Yuan, Huipin; Hebels, Dennie G. A. J.; LaPointe, Vanessa; Truckenmuller, Roman; van Blitterswijk, Clemens A.; Habibovic, Pamela; de Boer, Jan] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
   [Yuan, Huipin] Xpand Biotechnol BV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
RP de Boer, J (reprint author), Univ Twente, Dept Tissue Regenerat, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.; de Boer, J (reprint author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
EM jan.deboer@maastrichtuniversity.nl
OI LaPointe, Vanessa/0000-0002-0887-7443; Kocer,
   Gulistan/0000-0003-3449-7388
CR Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P5696, DOI 10.1016/j.biomaterials.2012.04.021
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111
   Bolomsky A, 2013, BLOOD, V122
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Brunner M, 2013, INT REV CEL MOL BIO, V305, P1, DOI 10.1016/B978-0-12-407695-2.00001-9
   Celiz AD, 2014, NAT MATER, V13, P570, DOI [10.1038/NMAT3972, 10.1038/nmat3972]
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Consortium EP, 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Danoux Charlene B, 2014, Biomatter, V4, pe27664, DOI 10.4161/biom.27664
   Davison NL, 2015, EUR CELLS MATER, V29, P314, DOI 10.22203/eCM.v029a24
   de Boer J., 2013, MATERIOMICS HIGH THR
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan L, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/239356
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Groen N, 2013, BIOMATERIALS, V34, P5552, DOI 10.1016/j.biomaterials.2013.04.001
   Habraken W, 2016, MATER TODAY, V19, P69, DOI 10.1016/j.mattod.2015.10.008
   Hyzy SL, 2012, J CELL BIOCHEM, V113, P3236, DOI 10.1002/jcb.24201
   Jung YJ, 2015, BIOCHEM BIOPH RES CO, V466, P339, DOI 10.1016/j.bbrc.2015.09.023
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055
   Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160
   Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Magennis EP, 2016, ACTA BIOMATER, V34, P84, DOI 10.1016/j.actbio.2015.11.008
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Midgley AC, 2015, J BIOL CHEM, V290, P11218, DOI 10.1074/jbc.M114.625939
   Moenning A, 2009, MOL CELL BIOL, V29, P881, DOI 10.1128/MCB.00885-08
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Pastorino D, 2015, ACTA BIOMATER, V28, P205, DOI 10.1016/j.actbio.2015.09.017
   Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037
   Ripamonti U, 2009, BIOMATERIALS, V30, P1428, DOI 10.1016/j.biomaterials.2008.10.065
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Sen D, 2011, SCI REP-UK, V1, DOI 10.1038/srep00035
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   van Leeuwen J P, 1996, Biochim Biophys Acta, V1312, P54
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105
   Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102
   Wang J, 2013, J BIOMED MATER RES B, V101B, P1069, DOI 10.1002/jbm.b.32917
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24
   Zhang JW, 2014, ACTA BIOMATER, V10, P3254, DOI 10.1016/j.actbio.2014.03.021
NR 63
TC 4
Z9 4
U1 8
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 14
PY 2017
VL 29
IS 10
AR UNSP 1603259
DI 10.1002/adma.201603259
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EN7FF
UT WOS:000396166800004
PM 27991696
DA 2018-10-20
ER

PT J
AU An, YH
   Yu, SJ
   Kim, IS
   Kim, SH
   Moon, JM
   Kim, SL
   Choi, YH
   Choi, JS
   Im, SG
   Lee, KE
   Hwang, NS
AF An, Young-Hyeon
   Yu, Seung Jung
   Kim, In Seon
   Kim, Su-Hwan
   Moon, Jeong-Mi
   Kim, Seunghyun L.
   Choi, Young Hwan
   Choi, Joon Sig
   Im, Sung Gap
   Lee, Kyung Eun
   Hwang, Nathaniel S.
TI Hydrogel Functionalized Janus Membrane for Skin Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID WOUND DRESSING APPLICATIONS; GROWTH-FACTORS; IN-VIVO; CHITOSAN;
   BIOMATERIALS; DELIVERY; FABRICS; CELLS; ANGIOGENESIS; INFECTION
AB In this study, a hydrogel functionalized Janus membrane is developed and its capacity is examined as a wound dressing biomaterial. A hydrophobic fluoropolymer, poly(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl methacrylate) (PHFDMA), is uniformly coated onto macroporous polyester membrane through initiated chemical vapor deposition process on both sides. PHFDMA-coated macroporous membrane exhibits antibacterial property, allows air permeation, and inhibits water penetration. Janus membrane property is obtained by exposing one side of PHFDMA coated membrane with 1 m KOH solution, which allows PHFDMA cleavage resulting in carboxylic acid residue. This carboxylic acid residue is then further functionalized with gelatin methacrylate-based photocrosslinkable hydrogel for moisture retention and growth factor release. When applied to full thickness dorsal skin defect model, functionalized hydrogel allows moisture retention and hydrophobic surface prevents exudate leaks via water repellence. Furthermore, hydrogel functionalized Janus membrane enhances the wound healing rate and induces thick epidermal layer formation. In conclusion, the multifunctional Janus membrane with hydrophobic outer surface and immobilized hydrogel on the other surface is fabricated for an innovative strategy for wound healing.
C1 [An, Young-Hyeon; Kim, In Seon; Choi, Young Hwan; Hwang, Nathaniel S.] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 152742, South Korea.
   [Yu, Seung Jung; Im, Sung Gap] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Daejeon 305701, South Korea.
   [Kim, Su-Hwan; Kim, Seunghyun L.] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul 151742, South Korea.
   [Moon, Jeong-Mi] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon 305764, South Korea.
   [Choi, Joon Sig] Chungnam Natl Univ, Dept Biochem, Daejeon 305764, South Korea.
   [Lee, Kyung Eun] Chungbuk Natl Univ, Coll Pharm, Chongju 362763, South Korea.
RP Hwang, NS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 152742, South Korea.; Lee, KE (reprint author), Chungbuk Natl Univ, Coll Pharm, Chongju 362763, South Korea.
EM kaylee@chungbuk.ac.kr; nshwang@snu.ac.kr
RI Im, Sung Gap/C-1823-2011
OI Im, Sung Gap/0000-0002-2802-6398
FU National Research Foundation of Korea (NRF) - Ministry of Education,
   Science and Technology [NRF-2012M3A9C6050102]; Ministry of Science, ICT
   & Future Planning [NRF-2016R1E1A1A01943393]; NRF grant - Korea
   government (MSIP) [MRC-2008-0062275]; Brain Fusion Grant of Seoul
   National University
FX This research was supported by the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education, Science and Technology (Grant
   No. NRF-2012M3A9C6050102); the Ministry of Science, ICT & Future
   Planning (Grant No. NRF-2016R1E1A1A01943393) and by the NRF grant funded
   by the Korea government (MSIP) (Grant No. MRC-2008-0062275). This work
   was also supported in part by Brain Fusion Grant of Seoul National
   University.
CR Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Branski LK, 2012, CHIRURG, V83, P831, DOI 10.1007/s00104-011-2243-0
   Brett DW, 2006, J WOUND OSTOMY CONT, V33, pS9, DOI 10.1097/01.WON.0000278582.47856.92
   Brinkman WT, 2003, BIOMACROMOLECULES, V4, P890, DOI 10.1021/bm0257412
   Camci-Unal G, 2013, BIOMACROMOLECULES, V14, P1085, DOI 10.1021/bm3019856
   Camci-Unal G, 2010, SOFT MATTER, V6, P5120, DOI 10.1039/c0sm00508h
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Castleberry SA, 2016, ADV MATER, V28, P1809, DOI 10.1002/adma.201503565
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414
   Eaglstein WH, 2001, DERMATOL SURG, V27, P175, DOI 10.1046/j.1524-4725.2001.00299.x
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Gilmartin DJ, 2013, ADV HEALTHC MATER, V2, P1151, DOI 10.1002/adhm.201200357
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Han F, 2014, INT J PHARMACEUT, V476, P124, DOI 10.1016/j.ijpharm.2014.09.036
   Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578
   Hook AL, 2014, NAT BIOTECHNOL, V32, P592, DOI 10.1038/nbt0614-592c
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   Kaewsaneha C, 2013, ACS APPL MATER INTER, V5, P1857, DOI 10.1021/am302528g
   Kim SH, 2015, P NATL ACAD SCI USA, V112, P15426, DOI 10.1073/pnas.1504745112
   Lee S, 1999, TEXT RES J, V69, P104, DOI 10.1177/004051759906900205
   Lee YAL, 2016, ADV HEALTHC MATER, V5, P1141, DOI 10.1002/adhm.201501036
   Li JY, 2016, ACTA BIOMATER, V36, P254, DOI 10.1016/j.actbio.2016.03.011
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   Okan Denis, 2007, Adv Skin Wound Care, V20, P39, DOI 10.1097/00129334-200701000-00013
   Oliveira RN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0049
   Ozeki M, 2003, BIOMATERIALS, V24, P2387, DOI 10.1016/S0142-9612(03)00045-0
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x
   Skaat H, 2011, BIOCONJUGATE CHEM, V22, P2600, DOI 10.1021/bc200454k
   Tejeda-Montes E, 2014, BIOMATERIALS, V35, P8339, DOI 10.1016/j.biomaterials.2014.05.095
   Tomsic B, 2008, J SOL-GEL SCI TECHN, V47, P44, DOI 10.1007/s10971-008-1732-1
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Unnithan AR, 2014, CARBOHYD POLYM, V102, P884, DOI 10.1016/j.carbpol.2013.10.070
   Vilcnik A, 2009, LANGMUIR, V25, P5869, DOI 10.1021/la803742c
   Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t
   Wang P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/34/345303
   Wittaya-areekul S, 2006, INT J PHARM, V313, P123, DOI 10.1016/j.ijpharm.2006.01.027
   Yang YQ, 2016, IEEE PHOTONIC TECH L, V28, P2724, DOI 10.1109/LPT.2016.2615471
   Yoo Y, 2013, POLYM CHEM-UK, V4, P1664, DOI [10.1039/C2PY20963B, 10.1039/c2py20963b]
   You JB, 2015, ADV HEALTHC MATER, V4, P2229, DOI 10.1002/adhm.201500416
   You JB, 2014, ACS APPL MATER INTER, V6, P4005, DOI 10.1021/am4054354
   Yucedag F, 2010, J APPL POLYM SCI, V115, P1347, DOI 10.1002/app.30788
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhao X, 2016, ADV HEALTHC MATER, V5, P108, DOI 10.1002/adhm.201500005
NR 47
TC 3
Z9 3
U1 20
U2 82
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 8
PY 2017
VL 6
IS 5
AR UNSP 1600795
DI 10.1002/adhm.201600795
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA ES7FX
UT WOS:000399716300003
PM 27995759
DA 2018-10-20
ER

PT J
AU Lee, JS
   Kim, K
   Park, JP
   Cho, SW
   Lee, H
AF Lee, Jung Seung
   Kim, Kyuri
   Park, Joseph P.
   Cho, Seung-Woo
   Lee, Haeshin
TI Role of Pyridoxal 5 '-Phosphate at the Titanium Implant Interface In
   Vivo: Increased Hemophilicity, Inactive Platelet Adhesion, and
   Osteointegration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID PHOSPHONIC ACID MONOLAYERS; RICH PLASMA; BONE-FORMATION; SERUM-ALBUMIN;
   GROWTH-FACTOR; PROTEIN ADSORPTION; BIOMIMETIC APATITE; DENTAL IMPLANTS;
   OXIDE SURFACES; PHOSPHATE
AB Titanium is the most biocompatible inorganic biomaterial with a long history of use in orthopedic and dental implants. However, promoting rapid and effective bone formation and integration onto etched, rough TiO2 surfaces has been a challenging topic. Here, 21 commercially available molecules are examined that met the following criteria: (1) contain phosphonic acid for stable immobilization onto TiO2 surfaces and (2) have a molecular weight less than 500 Da for negligible coating thickness. Of these molecules, the surface immobilization of pyridoxal 5'-phosphate (PLP), an active form of vitamin B-6, dramatically increases the hemophilic property of the surface and accelerated osteointegration in vivo. Analysis shows that PLP promotes surface binding of serum albumin and other plasma proteins by Schiff-base formations via its aldehyde group, providing a platform suitable for osteoblast adhesion. PLP also retards blood coagulation more than the widely used citric acid at the TiO2 surface. As PLP is capable of maintaining an inactivated status of surface-adsorbed platelets, delayed coagulation at the implant-blood interface allows for sufficient supply of growth factors from blood plasma and migration of osteoblasts. The results suggest that PLP can be widely applicable as a biocompatible, effective coating compound to promote osteointegration of titanium-based implants.
C1 [Lee, Jung Seung; Cho, Seung-Woo] Yonsei Univ, Dept Biotechnol, 50 Yonsei Ro, Seoul 120749, South Korea.
   [Kim, Kyuri] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, 291 Univ Rd, Daejeon 305701, South Korea.
   [Park, Joseph P.; Lee, Haeshin] Korea Adv Inst Sci & Technol, Dept Chem, 291 Univ Rd, Daejeon 305701, South Korea.
RP Cho, SW (reprint author), Yonsei Univ, Dept Biotechnol, 50 Yonsei Ro, Seoul 120749, South Korea.; Lee, H (reprint author), Korea Adv Inst Sci & Technol, Dept Chem, 291 Univ Rd, Daejeon 305701, South Korea.
EM seungwoocho@yonsei.ac.kr; haeshin@kaist.ac.kr
RI Lee, Haeshin/C-1720-2011
OI Lee, Haeshin/0000-0003-3961-9727
FU Ministry of Science, ICT & Future Planning [NRF-2016M3C1B5906481];
   National Research Foundation, Republic of Korea [2015R1A2A1A15053771];
   National R&D Program for Cancer Control, Ministry for Health and
   Welfare, Republic of Korea [1631060]; Translational Research Center for
   Protein Function Control - Ministry of Science, ICT and Future Planning,
   Republic of Korea [2016R1A5A1004694]
FX J.S.L. and K.K. contributed equally to this work. This study was
   supported by the Ministry of Science, ICT & Future Planning in the
   program for Convergence R&D for Traditional Culture and Current
   Technology (NRF-2016M3C1B5906481, H.L.) and a grant from the National
   Research Foundation, Republic of Korea to S.-W.C. (Grant No.
   2015R1A2A1A15053771). This study was also supported by grants from the
   National R&D Program for Cancer Control, Ministry for Health and
   Welfare, Republic of Korea to H.L. (Grant No. 1631060) and the
   Translational Research Center for Protein Function Control funded by the
   Ministry of Science, ICT and Future Planning, Republic of Korea to
   S.-W.C (Grant No. 2016R1A5A1004694).
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421
   BOHNEY JP, 1992, FEBS LETT, V298, P266, DOI 10.1016/0014-5793(92)80073-P
   Brodard-Severac F, 2008, CHEM MATER, V20, P5191, DOI 10.1021/cm8012683
   Burnouf T, 2016, BIOMATERIALS, V76, P371, DOI 10.1016/j.biomaterials.2015.10.065
   Byun HY, 2008, INT J PERIODONT REST, V28, P83
   Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462
   CHEAL EJ, 1987, J BIOMECH, V20, P1121, DOI 10.1016/0021-9290(87)90029-7
   Chen C, 2010, ACTA BIOMATER, V6, P2274, DOI 10.1016/j.actbio.2009.11.033
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Davies John E, 2003, J Dent Educ, V67, P932
   Djellouli R, 2013, J MATH BIOL, V67, P833, DOI 10.1007/s00285-012-0566-1
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51
   Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9
   Funato A, 2013, INT J ORAL MAX IMPL, V28, P1261, DOI 10.11607/jomi.3263
   Skaliczki G, 2013, INT ORTHOP, V37, P741, DOI 10.1007/s00264-012-1770-8
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Guerrero G, 2001, CHEM MATER, V13, P4367, DOI 10.1021/cm001253u
   Heldin CH, 1999, PHYSIOL REV, V79, P1283
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Horvathy DB, 2016, J BIOMED MATER RES B, V104, P126, DOI 10.1002/jbm.b.33359
   Kawase T, 2003, J PERIODONTOL, V74, P858, DOI 10.1902/jop.2003.74.6.858
   Kobayashi N, 2004, WOUND REPAIR REGEN, V12, P109, DOI 10.1111/j.1524-475X.2004.tb00002.x
   KORNECKI E, 1980, AM J PHYSIOL, V238, pH54
   Kourkoumelis N, 2012, J BIOL PHYS, V38, P279, DOI 10.1007/s10867-011-9247-3
   KRISHNAMURTHI S, 1982, THROMB HAEMOSTASIS, V48, P136
   Krout A, 2005, J BIOMED MATER RES A, V73A, P377, DOI 10.1002/jbm.a.30310
   Kulkarni M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062002
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee JS, 2015, ADV FUNCT MATER, V25, P4754, DOI 10.1002/adfm.201501471
   Liu HB, 2008, CHEMPHYSCHEM, V9, P1979, DOI 10.1002/cphc.200800381
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037
   Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025
   MATSUO Y, 1957, J AM CHEM SOC, V79, P2011, DOI 10.1021/ja01565a068
   Milleret V, 2015, ACTA BIOMATER, V24, P343, DOI 10.1016/j.actbio.2015.06.020
   Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Singh I., 2008, ANATOMY PHYSL NURSES
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   SUBBARAO K, 1978, THROMB RES, V13, P1017, DOI 10.1016/0049-3848(78)90230-X
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Tzaphlidou M, 2008, J BIOL PHYS, V34, P39, DOI 10.1007/s10867-008-9115-y
   Vandamme K, 2011, BIOMATERIALS, V32, P3547, DOI 10.1016/j.biomaterials.2011.01.056
   Wang HC, 1998, P NATL ACAD SCI USA, V95, P14429, DOI 10.1073/pnas.95.24.14429
   Wennerberg A, 2014, CLIN ORAL IMPLAN RES, V25, P1041, DOI 10.1111/clr.12213
   Wong HM, 2013, BIOMATERIALS, V34, P9863, DOI 10.1016/j.biomaterials.2013.08.052
   Wu SL, 2014, ADV FUNCT MATER, V24, P5464, DOI 10.1002/adfm.201400706
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
   Zaidi TN, 1996, BLOOD, V88, P2967
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 61
TC 2
Z9 2
U1 2
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 8
PY 2017
VL 6
IS 5
AR UNSP 1600962
DI 10.1002/adhm.201600962
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA ES7FX
UT WOS:000399716300004
PM 28081293
DA 2018-10-20
ER

PT J
AU Silvani, L
   Vrchotova, B
   Kastanek, P
   Demnerova, K
   Pettiti, I
   Papini, MP
AF Silvani, Ludovica
   Vrchotova, Blanka
   Kastanek, Petr
   Demnerova, Katerina
   Pettiti, Ida
   Papini, Marco Petrangeli
TI Characterizing Biochar as Alternative Sorbent for Oil Spill Remediation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACTIVATED CARBON; AQUEOUS-SOLUTIONS; ADSORPTION; SURFACE; AREA; SOIL;
   REMOVAL; HYDROCARBONS; AMENDMENTS; NITROGEN
AB Biochar (BC) was characterized as a new carbonaceous material for the adsorption of toluene from water. The tested BC was produced from pine wood gasification, and its sorption ability was compared with that of more common carbonaceous materials such as activated carbon (AC). Both materials were characterized in terms of textural features and sorption abilities by kinetic and equilibrium tests. AC and BC showed high toluene removal from water. Kinetic tests demonstrated that BC is characterized by faster toluene removal than AC is. Textural features demonstrated that the porosity of AC is double that of BC. Nevertheless, equilibrium tests demonstrated that the sorption ability of BC is comparable with that of AC, so the materials' porosity is not the only parameter that drives toluene adsorption. The specific adsorption ability (mg sorbed m(-2) of surface) of the BC is higher than that of AC: toluene is more highly sorbed onto the biochar surface. Biochar is furthermore obtained from biomaterial thermally treated for making energy; this also makes the use of BC economically and environmentally convenient compared with AC, which, as a manufactured material, must be obtained in selected conditions for this type of application.
C1 [Silvani, Ludovica; Pettiti, Ida; Papini, Marco Petrangeli] Univ Roma La Sapienza, Dept Chem, I-00100 Rome, Italy.
   [Vrchotova, Blanka; Demnerova, Katerina] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic.
   [Kastanek, Petr] Ecofuel, Ecofuel Labs, Prague, Czech Republic.
RP Papini, MP (reprint author), Univ Roma La Sapienza, Dept Chem, I-00100 Rome, Italy.
EM marco.petrangelipapini@uniroma1.it
OI Petrangeli Papini, Marco/0000-0002-8698-675X
FU European Union [312139]
FX The authors wish to acknowledge Dr. Francesco Mura and Centro di Ricerca
   per le Nanotecnologie Applicate all'Ingegneria-CNIS of Universtia degli
   Studi di Roma "La Sapienza". Project co-funding by the European Union
   within the 7<SUP>th</SUP> Framework Programme under Grant Agreement No.
   312139 (Kill Spill) and Universita degli Studi di Roma "La Sapienza",
   Grandi Progetti Universitari Anno 2015, "Development and
   characterization of reactive materials for groundwater remediation".
CR Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071
   Al-Wabel MI, 2013, BIORESOURCE TECHNOL, V131, P374, DOI 10.1016/j.biortech.2012.12.165
   Aygun A, 2003, MICROPOR MESOPOR MAT, V66, P189, DOI 10.1016/j.micromeso.2003.08.028
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Beesley, 2011, ENVIRON POLLUT, V59, P3269, DOI [10.1016/j.envpol.2011.07.023, DOI 10.1016/J.ENVPOL.2011.07.023]
   Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003
   Brennan A, 2014, ENVIRON POLLUT, V193, P79, DOI 10.1016/j.envpol.2014.06.016
   Camilli, 2010, SCI, V330, P201
   Carmody O, 2007, J COLLOID INTERF SCI, V305, P17, DOI 10.1016/j.jcis.2006.09.032
   Carrier M, 2012, J ANAL APPL PYROL, V96, P24, DOI 10.1016/j.jaap.2012.02.016
   Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036
   Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109
   Chen XC, 2011, BIORESOURCE TECHNOL, V102, P8877, DOI 10.1016/j.biortech.2011.06.078
   Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010
   Cho, 2009, ENVIRON SCI TECHNOL, V43, P3815, DOI [10.1021/es802931c, DOI 10.1021/ES802931C]
   Cho, 2007, MAR ENVIRON RES, V64, P541, DOI [10.1016/j.marenvres.2007.04.006, DOI 10.1016/J.MARENVRES.2007.04.006]
   Cornelissen G, 2011, ENVIRON SCI TECHNOL, V45, P6110, DOI 10.1021/es2011397
   Daifullah AAM, 2003, COLLOID SURFACE A, V214, P181, DOI 10.1016/S0927-7757(02)00392-8
   Das R, 2014, DESALINATION, V354, P160, DOI 10.1016/j.desal.2014.09.032
   Doumer ME, 2016, ENVIRON SCI POLLUT R, V23, P2684, DOI 10.1007/s11356-015-5486-3
   Fingas M., 2012, BASIC OIL SPILL CLEA, P1, DOI DOI 10.1201/B13686-2
   Gregg S. J., 1982, ADSORPTION SURFACE A, P42
   Gurvich L., 1915, J PHYS CHEM SOC RUSS, V47, P805
   Haghseresht F, 1998, ENERG FUEL, V12, P1100, DOI 10.1021/ef9801165
   Hale SE, 2012, CHEMOSPHERE, V87, P177, DOI 10.1016/j.chemosphere.2011.12.015
   Hale SE, 2011, ENVIRON SCI TECHNOL, V45, P10445, DOI 10.1021/es202970x
   Harkins WD, 1944, J AM CHEM SOC, V66, P1366, DOI 10.1021/ja01236a048
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P332, DOI 10.1205/095758298529696
   HORVATH G, 1983, J CHEM ENG JPN, V16, P470, DOI 10.1252/jcej.16.470
   Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003
   Khan AR, 1997, WATER RES, V31, P2102, DOI 10.1016/S0043-1354(97)00043-2
   Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383
   LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6
   Maretto M, 2015, MICROPOR MESOPOR MAT, V203, P139, DOI 10.1016/j.micromeso.2014.10.021
   Maretto M, 2014, J CLEAN PROD, V77, P22, DOI 10.1016/j.jclepro.2013.12.070
   Namasivayam C, 2002, DYES PIGMENTS, V54, P47, DOI 10.1016/S0143-7208(02)00025-6
   Otowa T, 1997, CARBON, V35, P1315, DOI 10.1016/S0008-6223(97)00076-6
   Peterson, 2003, SCI, V302, P2082
   Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108
   Silvani L, 2017, DESALIN WATER TREAT, V60, P218, DOI 10.5004/dwt.2017.0839
   Smebye A, 2016, CHEMOSPHERE, V142, P100, DOI 10.1016/j.chemosphere.2015.04.087
   Tan IAW, 2008, J HAZARD MATER, V154, P337, DOI 10.1016/j.jhazmat.2007.10.031
   Xu XY, 2016, J COLLOID INTERF SCI, V463, P55, DOI 10.1016/j.jcis.2015.10.003
   Zabihi M, 2010, J HAZARD MATER, V174, P251, DOI 10.1016/j.jhazmat.2009.09.044
   Zhou JH, 2007, CARBON, V45, P785, DOI 10.1016/j.carbon.2006.11.019
NR 45
TC 2
Z9 2
U1 2
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 8
PY 2017
VL 7
AR 43912
DI 10.1038/srep43912
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN1IK
UT WOS:000395763500001
PM 28272482
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Felgueiras, HP
   Wang, LM
   Ren, KF
   Querido, MM
   Jin, Q
   Barbosa, MA
   Ji, J
   Martins, MCL
AF Felgueiras, Helena P.
   Wang, L. M.
   Ren, K. F.
   Querido, M. M.
   Jin, Q.
   Barbosa, M. A.
   Ji, J.
   Martins, M. C. L.
TI Octadecyl Chains Immobilized onto Hyaluronic Acid Coatings by Thiol-ene
   "Click Chemistry" Increase the Surface Antimicrobial Properties and
   Prevent Platelet Adhesion and Activation to Polyurethane
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE polyurethane; C18 alkyl chains; hyaluronic acid; click chemistry;
   albumin; antimicrobial; hemocompatible; biomaterial
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; STAPHYLOCOCCUS-AUREUS;
   FIBRINOGEN ADSORPTION; SOLID-SURFACES; CONTACT-ANGLE; ATR-FTIR; ALBUMIN;
   BIOMATERIALS; HEMOCOMPATIBILITY
AB Infection and thrombus formation are still the biggest challenges for the success of blood contact medical devices. This work aims the development of an antimicrobial and hemocompatible biomaterial coating through which selective binding of albumin (passivant protein) from the bloodstream is promoted and, thus, adsorption of other proteins responsible for bacterial adhesion and thrombus formation can be prevented. Polyurethane (PU) films were coated with hyaluronic acid, an antifouling agent, that was previously modified with thiol groups (HA-SH), using polydopamine as the binding agent. Octadecyl acrylate (C18) was used to attract albumin since it resembles the circulating free fatty acids and albumin is a fatty acid transporter. Thiol ene "click chemistry" was explored for C18 immobilization on HA-SH through a covalent bond between the thiol groups from the HA and the alkene groups from the C18 chains. Surfaces were prepared with different C18 concentrations (0, 5, 10, and 20%) and successful immobilization was demonstrated by scanning electron microscopy (SEM), water contact angle determinations, X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FTIR). The ability of surfaces to bind albumin selectively was determined by quartz crystal microbalance with dissipation (QCM-D). Albumin adsorption increased in response to the hydrophobic nature of the surfaces, which augmented with C18 saturation. HA-SH coating reduced albumin adsorption to PU. C18 immobilized onto HA-SH at 5% promoted selective binding of albumin, decreased Staphylococcus aureus adhesion and prevented platelet adhesion and activation to PU in the presence of human plasma. C18/HA-SH coating was established as an innovative and promising strategy to improve the antimicrobial properties and hemocompatibility of any blood contact medical device.
C1 [Felgueiras, Helena P.; Querido, M. M.; Barbosa, M. A.; Martins, M. C. L.] I3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Felgueiras, Helena P.; Querido, M. M.; Barbosa, M. A.; Martins, M. C. L.] Inst Engn Biomed, INEB, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Querido, M. M.; Martins, M. C. L.] Univ Porto, Fac Engn, FEUP, Oporto, Portugal.
   [Barbosa, M. A.] Univ Porto, ICBAS, Oporto, Portugal.
   [Wang, L. M.; Ren, K. F.; Jin, Q.; Ji, J.] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Martins, MCL (reprint author), I3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Martins, MCL (reprint author), Inst Engn Biomed, INEB, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Martins, MCL (reprint author), Univ Porto, Fac Engn, FEUP, Oporto, Portugal.
EM cmartins@ineb.up.pt
RI Felgueiras, Helena/H-4323-2017; Barbosa, Mario/F-5964-2011
OI Felgueiras, Helena/0000-0002-4354-0256; Barbosa,
   Mario/0000-0003-3568-7482; Martins, M. Cristina/0000-0002-6574-4794
FU FEDER funds through COMPETE 2020 (POCI), Portugal; FCT/MCTES
   [POCI-01-0145-FEDER-007274]; "Portugal-China joint Innovation Centre for
   Advanced Materials (JICAM2013)";  [NORTE-01-0145-FEDER-000012]
FX This work was financed by FEDER funds through COMPETE 2020 (POCI),
   Portugal 2020 and FCT/MCTES through POCI-01-0145-FEDER-007274;
   NORTE-01-0145-FEDER-000012 and "Portugal-China joint Innovation Centre
   for Advanced Materials (JICAM2013)". The authors would like to thank
   Centro Hospitalar de Sao Joao, Porto, Portugal for kindly donating of
   human plasma and intermediary platelet units (IPUs).
CR ABUSALIM G, 2013, LIFE SCI J, V10, P981
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BANDEKAR J, 1995, J BIOMAT SCI-POLYM E, V7, P485, DOI 10.1163/156856295X00553
   Bernsmann F, 2011, LANGMUIR, V27, P2819, DOI 10.1021/la104981s
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BUSSCHER HJ, 1983, J COLLOID INTERF SCI, V95, P23, DOI 10.1016/0021-9797(83)90067-X
   Chick H, 1914, BIOCHEM J, V8, P59, DOI 10.1042/bj0080059
   Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010
   Cipriani E, 2013, POLYM DEGRAD STABIL, V98, P1225, DOI 10.1016/j.polymdegradstab.2013.03.005
   Ferreira L, 2005, POLYMER, V46, P9840, DOI 10.1016/j.polymer.2005.08.033
   Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204
   Fischer M, 2012, BIOMATERIALS, V33, P7677, DOI 10.1016/j.biomaterials.2012.07.007
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2011, J MATER SCI-MATER M, V22, P2053, DOI 10.1007/s10856-011-4381-9
   Goncalves IC, 2009, BIOMATERIALS, V30, P5541, DOI 10.1016/j.biomaterials.2009.06.025
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HORBETT TA, 1984, J THROMB HAEMOST, V51, P174
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Kazarian SG, 2013, ANALYST, V138, P1940, DOI 10.1039/c3an36865c
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lee H, 2006, MACROMOLECULES, V39, P23, DOI 10.1021/ma051929c
   Liu X, 2014, ACS APPL MATER INTER, V6, P13034, DOI 10.1021/am502921z
   Lowe AB, 2014, POLYM CHEM-UK, V5, P4820, DOI 10.1039/c4py00339j
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Mecea VM, 1996, SENSOR ACTUAT A-PHYS, V53, P371, DOI 10.1016/0924-4247(96)80161-0
   Mohammed-Ziegler I, 2003, POLYM ADVAN TECHNOL, V14, P790, DOI 10.1002/pat.396
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Neto AI, 2014, SMALL, V10, P2459, DOI 10.1002/smll.201303568
   O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257
   PETERS T, 1995, ALL ALBUMIN BIOCH GE
   Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   Ramadan MH, 2014, LANGMUIR, V30, P7485, DOI 10.1021/la500918p
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Ruiz A, 2014, J MATER SCI-MATER M, V25, P487, DOI 10.1007/s10856-013-5092-1
   Schuster S, 2014, INT J MED MICROBIOL, V304, P949, DOI 10.1016/j.ijmm.2014.05.012
   Shah Harshal, 2013, Neurohospitalist, V3, P144, DOI 10.1177/1941874413476043
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WATTS JF, 1994, VACUUM, V45, P653, DOI 10.1016/0042-207X(94)90107-4
   Xu L.-C., 2012, J BIOMATER NANOBIOTE, V3, P487
   Xu LC, 2014, COLLOID SURFACE B, V124, P49, DOI 10.1016/j.colsurfb.2014.09.040
   Zhou P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113087
NR 57
TC 8
Z9 8
U1 17
U2 110
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 8
PY 2017
VL 9
IS 9
BP 7979
EP 7989
DI 10.1021/acsami.6b16415
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EN7MD
UT WOS:000396186000013
PM 28165702
DA 2018-10-20
ER

PT J
AU Okhrimenko, DV
   Budi, A
   Ceccato, M
   Cardenas, M
   Johansson, DB
   Lybye, D
   Bechgaard, K
   Andersson, MP
   Stipp, SLS
AF Okhrimenko, Denis V.
   Budi, Akin
   Ceccato, Marcel
   Cardenas, Marite
   Johansson, Dorte B.
   Lybye, Dorthe
   Bechgaard, Klaus
   Andersson, Martin P.
   Stipp, Susan L. S.
TI Hydrolytic Stability of 3-Aminopropylsilane Coupling Agent on Silica and
   Silicate Surfaces at Elevated Temperatures
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE adhesion; surface treatment; aminosilane; coatings; material stability;
   mineral wool; fibers
ID E-GLASS-FIBER; GENERALIZED GRADIENT APPROXIMATION; AMINO PROPYL
   TRIETHOXYSILANE; GAMMA-AMINOPROPYLTRIETHOXYSILANE;
   CONDENSATION-REACTIONS; FUNCTIONALIZED SILICA; SILANOL CONDENSATION;
   NEXAFS SPECTROSCOPY; ORGANIC FILMS; TOF-SIMS
AB 3-Aminopropylsilane (APS) coupling agent is widely used in industrial, biomaterial, and medical applications to improve adhesion of polymers to inorganic materials. However, during exposure to elevated humidity and temperature, the deposited APS layers can decompose, leading to reduction in coupling efficiency, thus decreasing the product quality and the mechanical strength of the polymer inorganic material interface. Therefore, a better understanding of the chemical state and stability of APS on inorganic surfaces is needed. In this work, we investigated APS adhesion on silica wafers and compared its properties with those on complex silicate surfaces such as those used by industry (mineral fibers and fiber melt wafers). The APS was deposited from aqueous and organic (toluene) solutions and studied with surface sensitive techniques, including X-ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM), streaming potential, contact angle, and spectroscopic ellipsometry. APS configuration on a model silica surface at a range of coverages was simulated using density functional theory (DFT). We also studied the stability of adsorbed APS during aging at high humidity and elevated temperature. Our results demonstrated that APS layer formation depends on the choice of solvent and substrate used for deposition. On silica surfaces in toluene, APS formed unstable multilayers, while from aqueous solutions, thinner and more stable APS layers were produced. The chemical composition and substrate roughness influence the amount of deposited APS. More APS was deposited and its layers were more stable on fiber melt than on silica wafers. The changes in the amount of adsorbed APS can be successfully monitored by streaming potential. These results will aid in improving industrial- and laboratory-scale APS deposition methods and increasing adhesion and stability, thus increasing the quality and effectiveness of materials where APS is used as a coupling agent.
C1 [Okhrimenko, Denis V.; Budi, Akin; Ceccato, Marcel; Cardenas, Marite; Bechgaard, Klaus; Andersson, Martin P.; Stipp, Susan L. S.] Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen OE, Denmark.
   [Cardenas, Marite] Malmoe Univ, Dept Biomed Sci, S-20500 Malmo, Sweden.
   [Cardenas, Marite] Malmoe Univ, Biofilm Res Ctr Biointerfaces Hlth & Soc, S-20500 Malmo, Sweden.
   [Johansson, Dorte B.; Lybye, Dorthe] ROCKWOOL Int AS, Hovedgaden 584, DK-2640 Hedehusene, Denmark.
RP Okhrimenko, DV (reprint author), Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen OE, Denmark.
EM denisokr@nano.ku.dk
RI Ceccato, Marcel/P-8469-2016; Andersson, Martin/F-9598-2010; Cardenas,
   Marite/O-4669-2014; Budi, Akin/B-4855-2008
OI Ceccato, Marcel/0000-0002-6653-836X; Andersson,
   Martin/0000-0002-4921-1461; Cardenas, Marite/0000-0003-0392-3540; Budi,
   Akin/0000-0002-9929-1279
FU Innovation Foundation, Denmark; ROCKWOOL International A/S
FX Funding was provided by the Innovation Foundation, Denmark and ROCKWOOL
   International A/S.
CR Abel ML, 1998, INT J ADHES ADHES, V18, P179, DOI 10.1016/S0143-7496(97)00059-6
   Andrzejewska A, 2004, DYES PIGMENTS, V62, P121, DOI 10.1016/j.dyepig.2003.11.014
   ARMISTEAD CG, 1969, J PHYS CHEM-US, V73, P3947, DOI 10.1021/j100845a065
   Basarir F, 2009, J COLLOID INTERF SCI, V336, P393, DOI 10.1016/j.jcis.2009.04.041
   Bazzan G, 2008, LANGMUIR, V24, P3244, DOI [10.1021/la7031658, 10.1021/1a7031658]
   Bellmann C, 2013, COMPOS INTERFACE, V20, P279, DOI 10.1080/15685543.2013.795756
   Bohmler J, 2011, J PHYS CHEM C, V115, P11102, DOI 10.1021/jp201377n
   BOERIO FJ, 1978, J APPL POLYM SCI, V22, P203, DOI 10.1002/app.1978.070220114
   Chauhan AK, 2008, APPL PHYS A-MATER, V90, P581, DOI 10.1007/s00339-007-4336-7
   CHIANG CH, 1980, J COLLOID INTERF SCI, V74, P396, DOI 10.1016/0021-9797(80)90209-X
   CHIANG CH, 1982, J COLLOID INTERF SCI, V86, P26, DOI 10.1016/0021-9797(82)90037-6
   CULLER SR, 1986, J COLLOID INTERF SCI, V109, P1, DOI 10.1016/0021-9797(86)90275-4
   Cuoq F, 2013, APPL SURF SCI, V266, P155, DOI 10.1016/j.apsusc.2012.11.120
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452
   Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015
   Denoyel R, 2002, COLLOID SURFACE A, V197, P213, DOI 10.1016/S0927-7757(01)00904-9
   DWIGHT DW, 1990, J ADHES SCI TECHNOL, V4, P619, DOI 10.1163/156856190X00568
   Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035
   Etienne M, 2003, TALANTA, V59, P1173, DOI 10.1016/S0039-9140(03)00024-9
   Graf N, 2008, SURF INTERFACE ANAL, V40, P180, DOI 10.1002/sia.2621
   Graf N, 2009, SURF SCI, V603, P2849, DOI 10.1016/j.susc.2009.07.029
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   Herbelin A. L, 1999, FITEQL 4 0
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Impens NREN, 1999, MICROPOR MESOPOR MAT, V28, P217, DOI 10.1016/S1387-1811(98)00239-X
   Jesionowski T, 2003, COLLOID SURFACE A, V222, P87, DOI 10.1016/S0927-7757(03)00237-1
   Jesionowski T, 2002, DYES PIGMENTS, V55, P133, DOI 10.1016/S0143-7208(02)00105-5
   Jesionowski T, 2014, ADSORPTION, V20, P801, DOI 10.1007/s10450-014-9623-y
   Juvaste H, 1999, J ORGANOMET CHEM, V587, P38, DOI 10.1016/S0022-328X(99)00264-8
   Kamisetty NK, 2006, ANAL BIOANAL CHEM, V386, P1649, DOI 10.1007/s00216-006-0741-6
   Kim J, 2008, SURF SCI, V602, P3323, DOI 10.1016/j.susc.2008.09.001
   Kim JY, 2009, J COLLOID INTERF SCI, V329, P114, DOI 10.1016/j.jcis.2008.09.031
   Kowalczyk D, 1996, INT J ADHES ADHES, V16, P227, DOI 10.1016/0143-7496(95)00052-6
   Krasnoslobodtsev AV, 2002, LANGMUIR, V18, P3181, DOI 10.1021/la015628h
   KURTH DG, 1995, LANGMUIR, V11, P3061, DOI 10.1021/la00008a035
   LEE BI, 1992, J MATER SCI, V27, P5692, DOI 10.1007/BF01119724
   LEVIEN L, 1980, AM MINERAL, V65, P920
   Liu XM, 2008, J ADHESION, V84, P322, DOI 10.1080/00218460802004386
   Metwalli E, 2006, J COLLOID INTERF SCI, V298, P825, DOI 10.1016/j.jcis.2006.03.045
   Min H, 2012, ANAL BIOANAL CHEM, V403, P613, DOI 10.1007/s00216-012-5862-5
   Mo YF, 2008, COLLOID SURFACE A, V322, P170, DOI 10.1016/j.colsurfa.2008.03.004
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Mourougou-Candoni N, 2009, J PHYS CHEM B, V113, P13026, DOI 10.1021/jp903021e
   Mueller R, 2003, LANGMUIR, V19, P160, DOI 10.1021/1a025785w
   NAVIROJ S, 1984, J COLLOID INTERF SCI, V97, P308, DOI 10.1016/0021-9797(84)90301-1
   Ogasawara T, 2001, COLLOID SURFACE A, V180, P317, DOI 10.1016/S0927-7757(00)00813-X
   Pasternack RM, 2008, LANGMUIR, V24, P12963, DOI 10.1021/la8024827
   Pena-Alonso R, 2007, J MATER SCI, V42, P595, DOI 10.1007/s10853-006-1138-9
   PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Petri DFS, 1999, LANGMUIR, V15, P4520
   PIERS AS, 1995, J COLLOID INTERF SCI, V174, P97, DOI 10.1006/jcis.1995.1369
   Plueddemann E., 1991, SILANE COUPLING AGEN
   Puretskiy N, 2011, LANGMUIR, V27, P3006, DOI 10.1021/la104614t
   Rahman IA, 2009, CERAM INT, V35, P1883, DOI 10.1016/j.ceramint.2008.10.028
   Riese A. C., 1982, THESIS
   Salon MCB, 2008, COLLOID SURFACE A, V312, P83, DOI 10.1016/j.colsurfa.2007.06.028
   Salon MCB, 2010, COLLOID SURFACE A, V366, P147, DOI 10.1016/j.colsurfa.2010.06.002
   Simon A, 2002, J COLLOID INTERF SCI, V251, P278, DOI 10.1006/jcis.2002.8385
   Suzuki N, 2005, COMPOS INTERFACE, V12, P769, DOI 10.1163/156855405774984084
   Suzuki N, 2003, J APPL POLYM SCI, V87, P589, DOI 10.1002/app.11297
   Tan GX, 2011, THIN SOLID FILMS, V519, P4997, DOI 10.1016/j.tsf.2011.01.068
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   VRANCKEN KC, 1995, J COLLOID INTERF SCI, V170, P71, DOI 10.1006/jcis.1995.1073
   VRANCKEN KC, 1995, COLLOID SURFACE A, V98, P235, DOI 10.1016/0927-7757(95)03119-X
   WANG D, 1992, J MATER SCI, V27, P36, DOI 10.1007/BF02403641
   WANG D, 1993, J MATER SCI, V28, P2481, DOI 10.1007/BF01151683
   Wang L, 2010, EUR PHYS J-APPL PHYS, V52, DOI 10.1051/epjap/2010164
   Wang W, 2008, SCANNING, V30, P65, DOI 10.1002/sca.20097
   Weigel C., 1989, Z ANAL CHEM, V335, P663
   WESSON SP, 1992, J ADHES SCI TECHNOL, V6, P151, DOI 10.1163/156856192X00115
   Yadav AR, 2014, MAT SCI ENG C-MATER, V35, P283, DOI 10.1016/j.msec.2013.11.017
   ZACHARA JM, 1990, ENVIRON SCI TECHNOL, V24, P118, DOI 10.1021/es00071a015
   Zafar A, 2012, SURF INTERFACE ANAL, V44, P811, DOI 10.1002/sia.4825
   Zhang FX, 2004, LANGMUIR, V20, P2309, DOI 10.1021/la0354638
   Zhmud BV, 1996, J NON-CRYST SOLIDS, V195, P16, DOI 10.1016/0022-3093(95)00497-1
   Zhu MJ, 2012, LANGMUIR, V28, P416, DOI 10.1021/la203638g
NR 78
TC 4
Z9 4
U1 8
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 8
PY 2017
VL 9
IS 9
BP 8344
EP 8353
DI 10.1021/acsami.6b14343
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EN7MD
UT WOS:000396186000054
PM 28195455
DA 2018-10-20
ER

PT J
AU Tilocca, A
AF Tilocca, Antonio
TI Dynamical descriptors of bioactivity: a correlation between chemical
   durability and ion migration in biodegradable glasses
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID IN-SITU RADIOTHERAPY; SILICATE-GLASSES; STRUCTURAL ROLE; SIMULATIONS;
   CONDUCTIVITY; DIFFUSION; TRANSPORT; VECTORS; INSIGHT
AB Ion migration in two fluorinated bioactive glasses of significantly different durability was modeled through molecular dynamics simulations. Whereas the very different biodegradation of these glasses cannot be explained on the basis of their structural features alone, the analysis of the diffusive data highlights a strong connection between the glass durability determined experimentally and the activation barriers for ion diffusion extracted by the simulations, clarifying the source of the different solubility and suggesting that `` dynamical'' descriptors of bioactivity could represent a key tool to predict the macroscopic behavior of a biomaterial, in some cases more effectively than with the current structural descriptors.
C1 [Tilocca, Antonio] UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.
RP Tilocca, A (reprint author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.
EM a.tilocca@ucl.ac.uk
RI Tilocca, Antonio/B-6460-2008
OI Tilocca, Antonio/0000-0002-8689-7044
FU UK's Royal Society (University Research Fellowship)
FX Financial support from the UK's Royal Society (University Research
   Fellowship) is gratefully acknowledged.
CR Bonhomme C, 2012, J AM CHEM SOC, V134, P12611, DOI 10.1021/ja303505g
   Brauer DS, 2009, J MATER CHEM, V19, P5629, DOI 10.1039/b900956f
   Christie JK, 2012, J PHYS CHEM B, V116, P12614, DOI 10.1021/jp304200f
   Christie JK, 2011, J PHYS CHEM B, V115, P2038, DOI 10.1021/jp110788h
   Christie JK, 2010, CHEM MATER, V22, P3725, DOI 10.1021/cm100847p
   Cormack AN, 2002, PHYS CHEM CHEM PHYS, V4, P3193, DOI 10.1039/b201721k
   Du JC, 2012, J NON-CRYST SOLIDS, V358, P1059, DOI 10.1016/j.jnoncrysol.2011.12.114
   Goel A, 2013, J MATER CHEM B, V1, P3073, DOI 10.1039/c3tb20163e
   GREAVES GN, 1985, J NON-CRYST SOLIDS, V71, P203, DOI 10.1016/0022-3093(85)90289-3
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h
   Lusvardi G, 2008, J PHYS CHEM B, V112, P12730, DOI 10.1021/jp803031z
   Lusvardi G, 2009, J PHYS CHEM B, V113, P10331, DOI 10.1021/jp809805z
   Murugavel S, 2010, J PHYS CHEM B, V114, P13381, DOI 10.1021/jp105797c
   Natrup FV, 2005, PHYS CHEM CHEM PHYS, V7, P2279, DOI 10.1039/b502501j
   Pedone A, 2008, J PHYS CHEM C, V112, P11034, DOI 10.1021/jp8016776
   Tilocca A, 2007, CHEM MATER, V19, P95, DOI 10.1021/cm061631g
   Tilocca A, 2014, PHYS CHEM CHEM PHYS, V16, P3874, DOI 10.1039/c3cp54913e
   Tilocca A, 2010, J MATER CHEM, V20, P6848, DOI 10.1039/c0jm01081b
   Tilocca A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456712
   Tilocca A, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2972146
NR 22
TC 1
Z9 1
U1 1
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD MAR 7
PY 2017
VL 19
IS 9
BP 6334
EP 6337
DI 10.1039/c6cp07203h
PG 4
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EN5FO
UT WOS:000396031200003
PM 28220167
DA 2018-10-20
ER

PT J
AU Song, HJ
   Yang, G
   Huang, PS
   Kong, DL
   Wang, WW
AF Song, Huijuan
   Yang, Guang
   Huang, Pingsheng
   Kong, Deling
   Wang, Weiwei
TI Self-assembled PEG-poly(L-valine) hydrogels as promising 3D cell culture
   scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID REVERSE THERMAL GELATION; BLOCK-COPOLYMERS; SUPRAMOLECULAR HYDROGELS;
   POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES; RESPONSIVE HYDROGELS;
   TRIBLOCK COPOLYMERS; DIBLOCK COPOLYMER; SOLID-STATE; POLYPEPTIDE
AB Self-assembled polypeptide aggregates have shown great promise in biomedical fields including drug delivery, tissue regeneration and regenerative medicine. In this study, we report self-assembled hydrogels based on mPEG-block-poly(L-valine) (PEV) copolymers. PEV copolymers with varying poly( L-valine) chain lengths were prepared by the ring-opening polymerization of N-carboxy anhydrides of L-valine using mPEG-NH2 as the initiator. H-1 NMR and GPC confirmed their well-defined chemical structures. FT-IR analysis and DSC curves indicated the combined alpha-helix and beta-sheet secondary polypeptide conformation and the PEG crystallization microphase in bulk solid state, respectively. Moreover, the poly(L-valine) block restricted the crystallization of PEG segment. DLS, TEM and circular dichroism spectra were employed to study the self-assembly profiles of PEV copolymers in aqueous solution. The results manifested that in diluted solution, PEV copolymers showed a combination of typical b-sheet and a-helical polypeptide structures and self-assembled into nanostructures with diverse morphologies and sizes. For concentrated PEV solutions, clear hydrogel phases were observed and dynamic rheological analyses demonstrated that the hydrogel modulus was sensitive to the polypeptide length, angular frequency, shear strain and temperature. The hydrogel formation was possibly dominated by the physical aggregation of PEV nanoassemblies as well as driven by the formation of particular polypeptide secondary structures. Human fibroblast NIH/3T3 cells were encapsulated and cultured within the hydrogel scaffolds. The encapsulated cells exhibited high viability, suggesting that PEV hydrogels have excellent cytocompatibility and could be used as three-dimensional (3D) cell culture matrices. Collectively, self-assembled PEGylated poly(L-valine) conjugate hydrogels represented a new kind of biomaterial scaffold in biomedical fields including but not limited to 3D cell culture.
C1 [Song, Huijuan; Huang, Pingsheng; Kong, Deling; Wang, Weiwei] Chinese Acad Med Sci, Tianjin Key Lab Biomat Res, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   [Song, Huijuan; Huang, Pingsheng; Kong, Deling; Wang, Weiwei] Peking Union Med Coll, Tianjin 300192, Peoples R China.
   [Yang, Guang] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Kong, DL; Wang, WW (reprint author), Chinese Acad Med Sci, Tianjin Key Lab Biomat Res, Inst Biomed Engn, Tianjin 300192, Peoples R China.; Kong, DL; Wang, WW (reprint author), Peking Union Med Coll, Tianjin 300192, Peoples R China.
EM kongdeling@nankai.edu.cn; wwwangtj@163.com
FU Natural Science Foundation of China [81301309, 31670977]; Natural
   Science Foundation of Tianjin [16JCQNJC14200]; Tianjin Key Laboratory of
   Radiation Medicine and Molecular Nuclear Medicine, Institute of
   Radiation Medicine, Chinese Academy of Medical Sciences (Tianjin,
   China); Peking Union Medical College (Tianjin, China)
FX The authors are grateful for the financial support from the Natural
   Science Foundation of China (No. 81301309 and 31670977), the Natural
   Science Foundation of Tianjin (16JCQNJC14200) and Tianjin Key Laboratory
   of Radiation Medicine and Molecular Nuclear Medicine, Institute of
   Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union
   Medical College (Tianjin, China).
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Akbulut H, 2015, J POLYM SCI POL CHEM, V53, P1785, DOI 10.1002/pola.27621
   Anraku Y, 2013, J AM CHEM SOC, V135, P1423, DOI 10.1021/ja3096587
   Castelletto V, 2013, EUR POLYM J, V49, P2961, DOI 10.1016/j.eurpolymj.2013.02.016
   Cheng YL, 2013, BIOMACROMOLECULES, V14, P468, DOI 10.1021/bm3017059
   Choi YY, 2010, J MATER CHEM, V20, P3416, DOI 10.1039/b922956f
   Conde J, 2016, NAT MATER, V15, P1128, DOI [10.1038/NMAT4707, 10.1038/nmat4707]
   Ding WW, 2008, J PHYS CHEM B, V112, P776, DOI 10.1021/jp076939p
   Dong H, 2012, ACS NANO, V6, P5320, DOI 10.1021/nn301142r
   Eskandari S., 2016, ADV DRUG DELIVERY RE, DOI [10.1016/j.addr.2016.1006.1013, DOI 10.1016/J.ADDR.2016.1006.1013.]
   Floudas G, 2003, MACROMOLECULES, V36, P3673, DOI 10.1021/ma025918k
   Gkikas M, 2016, BIOMACROMOLECULES, V17, P399, DOI 10.1021/acs.biomac.5b01168
   Habibi N, 2016, NANO TODAY, V11, P41, DOI 10.1016/j.nantod.2016.02.004
   Hamley IW, 2014, BIOMACROMOLECULES, V15, P1543, DOI 10.1021/bm500246w
   Hamley IW, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.062901
   Huang J, 2013, BIOMACROMOLECULES, V14, P200, DOI 10.1021/bm301629f
   Huang PS, 2015, J CONTROL RELEASE, V220, P456, DOI 10.1016/j.jconrel.2015.11.007
   Hwang JY, 2001, BIOMACROMOLECULES, V2, P17, DOI 10.1021/bm005597p
   Joo MK, 2013, SOFT MATTER, V9, P8014, DOI 10.1039/c3sm51272j
   Kim HJ, 2000, BIOMATERIALS, V21, P131, DOI 10.1016/S0142-9612(99)00140-4
   Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107
   Kuo SW, 2009, MACROMOLECULES, V42, P1619, DOI 10.1021/ma802370y
   Lata JP, 2016, ADV MATER, V28, P8632, DOI 10.1002/adma.201602947
   Li JJ, 2013, CHEM COMMUN, V49, P6974, DOI 10.1039/c3cc43576h
   Li L, 2007, J PHYS CHEM B, V111, P6410, DOI 10.1021/jp0712957
   Li L, 2015, ADV MATER, V27, P1294, DOI 10.1002/adma.201405166
   Luo ZC, 2013, J CONTROL RELEASE, V170, P259, DOI 10.1016/j.jconrel.2013.05.027
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Parras P, 2005, SOFT MATTER, V1, P284, DOI 10.1039/b508772b
   Popescu MT, 2016, ACS APPL MATER INTER, V8, P17539, DOI 10.1021/acsami.6b03977
   Popescu MT, 2015, SOFT MATTER, V11, P331, DOI 10.1039/c4sm02092h
   Sarvestani AS, 2007, BIOMACROMOLECULES, V8, P406, DOI 10.1021/bm060648p
   Shen JY, 2013, LANGMUIR, V29, P6271, DOI 10.1021/la401095s
   Thunemann AF, 2000, MACROMOLECULES, V33, P5906
   Tzokova N, 2009, LANGMUIR, V25, P2479, DOI 10.1021/la8035659
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Wang HM, 2016, ADV FUNCT MATER, V26, P1822, DOI 10.1002/adfm.201505188
   Wang WW, 2014, RSC ADV, V4, P30168, DOI 10.1039/c4ra03760j
   Wang WW, 2015, J CONTROL RELEASE, V203, P57, DOI 10.1016/j.jconrel.2015.02.015
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Yan Y, 2008, ANGEW CHEM INT EDIT, V47, P4192, DOI 10.1002/anie.200705242
   Yeon B, 2013, BIOMACROMOLECULES, V14, P3256, DOI 10.1021/bm400868j
   Yesilyurt V, 2016, ADV MATER, V28, P86, DOI 10.1002/adma.201502902
   Zhang GL, 2003, J BIOMAT SCI-POLYM E, V14, P1389, DOI 10.1163/156856203322599725
   Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124
   Zhuang ZL, 2016, ANGEW CHEM INT EDIT, V55, P12522, DOI 10.1002/anie.201607059
NR 48
TC 4
Z9 4
U1 6
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 7
PY 2017
VL 5
IS 9
BP 1724
EP 1733
DI 10.1039/c6tb02969h
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EN3QE
UT WOS:000395922200003
DA 2018-10-20
ER

PT J
AU Levengood, SL
   Erickson, AE
   Chang, FC
   Zhang, MQ
AF Levengood, Sheeny Lan
   Erickson, Ariane E.
   Chang, Fei-chien
   Zhang, Miqin
TI Chitosan-poly(caprolactone) nanofibers for skin repair
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID CELL-PROLIFERATION; CUTANEOUS WOUNDS; GENE-EXPRESSION; CHITOSAN;
   SCAFFOLDS; COLLAGEN; DIFFERENTIATION; REGENERATION; KERATINOCYTES;
   MIGRATION
AB Dermal wounds, both acute and chronic, represent a significant clinical challenge, and therefore the development of novel biomaterial-based skin substitutes to promote skin repair is essential. Nanofibers have gained attention as materials to promote skin regeneration due to the similarities in morphology and dimensionality between nanofibers and native extracellular matrix proteins, which are critical in guiding cutaneous wound healing. Electrospun chitosan-poly(caprolactone) (CPCL) nanofiber scaffolds, which combine the important intrinsic biological properties of chitosan and the mechanical integrity and stability of PCL, were evaluated as skin tissue engineering scaffolds using a mouse cutaneous excisional skin defect model. Gross assessment of the wound size and measurement of defect recovery over time as well as histological evaluation of wound healing showed that CPCL nanofiber scaffolds increased the wound healing rate and promoted more complete wound closure when compared with Tegaderm, a commercially available occlusive dressing. CPCL nanofiber scaffolds represent a biomimetic approach to skin repair by serving as an immediately available provisional matrix to promote wound closure. These nanofiber scaffolds may have significant potential as a skin substitute or as the basis for more complex skin tissue engineering constructs involving integration with biologics.
C1 [Levengood, Sheeny Lan; Erickson, Ariane E.; Chang, Fei-chien; Zhang, Miqin] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
RP Zhang, MQ (reprint author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
EM mzhang@uw.edu
RI Zhang, Miqin/F-5537-2010
OI Zhang, Miqin/0000-0001-8974-1494
FU Kyocera Endowment; Ruth L. Kirschstein NIH Training grant [T32CA138312];
   National Science Foundation Graduate Research Fellowship Program
FX This work is supported in part by Kyocera Endowment to Miqin Zhang.
   Sheeny Lan Levengood acknowledges support from the Ruth L. Kirschstein
   NIH Training grant T32CA138312. Ariane E. Erickson acknowledges support
   from the National Science Foundation Graduate Research Fellowship
   Program. The authors acknowledge the use of resources at the Molecular
   Analysis Facility at the University of Washington.
CR Adolph EJ, 2016, J BIOMED MATER RES B, V104, P1679, DOI 10.1002/jbm.b.33515
   Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Bahou WF, 2004, SEMIN THROMB HEMOST, V30, P473, DOI 10.1055/s-2004-833482
   Bhattarai N, 2009, ADV MATER, V21, P2792, DOI 10.1002/adma.200802513
   Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189
   BYRNE C, 1994, DEVELOPMENT, V120, P2369
   Caetano GF, 2015, J BIOMED MATER RES B, V103, P1013, DOI 10.1002/jbm.b.33277
   Cam C, 2015, J MATER CHEM B, V3, P7986, DOI 10.1039/c5tb00807g
   Chen JL, 2006, J CELL SCI, V119, P5067, DOI 10.1242/jcs.03298
   Chen SH, 2014, ACTA BIOMATER, V10, P4971, DOI 10.1016/j.actbio.2014.08.030
   Choi SK, 2016, J CONTROL RELEASE, V237, P89, DOI 10.1016/j.jconrel.2016.07.006
   Chua AWC, 2008, BURNS, V34, P175, DOI 10.1016/j.burns.2007.07.009
   CLARK RAF, 1985, J INVEST DERMATOL, V84, P378, DOI 10.1111/1523-1747.ep12265466
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   DiTommaso T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004706
   Edmondson D, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095439
   El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Escamez MJ, 2004, J INVEST DERMATOL, V123, P1182, DOI 10.1111/j.0022-202X.23473.x
   Evans ND, 2013, J MECH BEHAV BIOMED, V28, P397, DOI 10.1016/j.jmbbm.2013.04.023
   Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812
   Fukunishi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158555
   GAY S, 1978, ACTA CHIR SCAND, V144, P205
   Girard D, 2017, TISSUE ENG PART B-RE, V23, P59, DOI [10.1089/ten.TEB.2016.0195, 10.1089/ten.teb.2016.0195]
   Gomathysankar S, 2014, ARCH PLAST SURG-APS, V41, P452, DOI 10.5999/aps.2014.41.5.452
   Griffin DR, 2015, NAT MATER, V14, P737, DOI [10.1038/nmat4294, 10.1038/NMAT4294]
   Haines RL, 2012, J CELL SCI, V125, P3923, DOI 10.1242/jcs.099655
   Jana S, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035012
   Jana S, 2012, J MATER CHEM, V22, P6291, DOI [10.1039/C2JM16676C, 10.1039/c2jm16676c]
   Jing X, 2015, ACS APPL MATER INTER, V7, P6955, DOI 10.1021/acsami.5b00900
   KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251
   Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   KOUNADI E, 1995, MICRON, V26, P113, DOI 10.1016/0968-4328(94)00056-V
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Liang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029999
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852
   Lou T, 2014, J BIOMED NANOTECHNOL, V10, P1105, DOI 10.1166/jbn.2014.1793
   Luo S, 2011, INT J LOW EXTR WOUND, V10, P122, DOI 10.1177/1534734611418157
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mayet N, 2014, J PHARM SCI-US, V103, P2211, DOI 10.1002/jps.24068
   Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Prasad Tilak, 2015, J Mater Sci Mater Med, V26, P5352, DOI 10.1007/s10856-014-5352-8
   Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056
   Reddy VJ, 2013, WOUND REPAIR REGEN, V21, P1, DOI 10.1111/j.1524-475X.2012.00861.x
   Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shalumon KT, 2011, INT J BIOL MACROMOL, V48, P571, DOI 10.1016/j.ijbiomac.2011.01.020
   Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187
   Solanas G, 2013, NAT REV MOL CELL BIO, V14, P737, DOI 10.1038/nrm3675
   Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836
   TOFTGARD R, 1985, CANCER RES, V45, P5845
   Tzaphlidou M, 1997, INT J RADIAT BIOL, V71, P109, DOI 10.1080/095530097144481
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039
   Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Viticchie G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.174
   Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399
   Wang Y, 2012, BURNS, V38, P414, DOI 10.1016/j.burns.2011.09.002
   WATANABE S, 1995, HISTOCHEM CELL BIOL, V103, P425, DOI 10.1007/BF01457542
   Wu J, 2016, BIOMACROMOLECULES, V17, P2168, DOI 10.1021/acs.biomac.6b00398
   Yin H, 2016, COLLOID SURFACE B, V145, P226, DOI 10.1016/j.colsurfb.2016.04.056
   Zarkoob H, 2015, CELL MOL BIOENG, V8, P32, DOI 10.1007/s12195-015-0377-8
   Zhou M, 2014, TISSUE ENG PT A, V20, P79, DOI [10.1089/ten.tea.2013.0020, 10.1089/ten.TEA.2013.0020]
NR 73
TC 11
Z9 11
U1 9
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 7
PY 2017
VL 5
IS 9
BP 1822
EP 1833
DI 10.1039/c6tb03223k
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA EN3QE
UT WOS:000395922200013
PM 28529754
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, X
   Tan, J
   Xiao, ZF
   Zhao, YN
   Han, SF
   Liu, DY
   Yin, W
   Li, J
   Li, J
   Wanggou, SY
   Chen, B
   Ren, CP
   Jiang, XJ
   Dai, JW
AF Li, Xing
   Tan, Jun
   Xiao, Zhifeng
   Zhao, Yannan
   Han, Sufang
   Liu, Dingyang
   Yin, Wen
   Li, Jing
   Li, Juan
   Wanggou, Siyi
   Chen, Bing
   Ren, Caiping
   Jiang, Xingjun
   Dai, Jianwu
TI Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar
   formation and promotes functional recovery in canines with chronic
   spinal cord injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; AXONAL REGENERATION;
   REPARATIVE RESPONSE; NERVE REGENERATION; RAT; TRANSECTION; FACILITATE;
   STRATEGIES; IMPROVE
AB Spinal cord injury (SCI) can lead to locomotor deficits, and the repair of chronic SCI is considered one of the most challenging clinical problems. Although extensive studies have evaluated treatments for acute SCI in small animals, comparatively fewer studies have been conducted on large-animal SCI in the chronic phase, which is more clinically relevant. Here, we used a collagen-based biomaterial, named the NeuroRegen scaffold, loaded with human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in a canine chronic SCI model. To generate chronic SCI, the T8 spinal cord segment was removed by complete transection of the spinal cord. Two months later, glial scar tissue was removed and a NeuroRegen scaffold was transplanted into the lesion area. Functionalized NeuroRegen scaffold implantation promoted both locomotor recovery and endogenous neurogenesis in the lesion area. Moreover, some newly generated neurons successfully matured into 5-HT-positive neurons at 1 year post-injury. In addition, many regenerated axon fibers in the lesion area exhibited remyelination and synapse formation at 1 year post-injury in the functionalized NeuroRegen scaffold group. In conclusion, the NeuroRegen scaffold functionalized with hUC-MSCs is a promising potential therapeutic approach to chronic SCI that promotes neuronal regeneration, reduces glial scar formation, and ultimately improves locomotor recovery.
C1 [Li, Xing; Xiao, Zhifeng; Zhao, Yannan; Han, Sufang; Li, Jing; Chen, Bing; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Tan, Jun; Liu, Dingyang; Yin, Wen; Li, Juan; Wanggou, Siyi; Jiang, Xingjun] Cent S Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.
   [Ren, Caiping] Cent S Univ, Sch Basic Med Sci, Collaborat Innovat Ctr Canc Med, Canc Res Inst, Changsha 410008, Hunan, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Jiang, XJ (reprint author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.
EM jiangxingjun@sina.com; jwdai@genetics.ac.cn
FU Strategic Priority Research Program of the Chinese Academy of Sciences
   [XDA01030000]; Program of the Chinese Academy of Sciences
   [ZDRW-ZS-2016-2]
FX This work was supported by the "Strategic Priority Research Program of
   the Chinese Academy of Sciences" (grant no. XDA01030000), the Key
   Research Program of the Chinese Academy of Sciences (grant no.
   ZDRW-ZS-2016-2).
CR Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Cholas R, 2012, TISSUE ENG PT A, V18, P2158, DOI [10.1089/ten.tea.2011.0577, 10.1089/ten.TEA.2011.0577]
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001
   Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841
   English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377
   Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   Han S, 2014, SPINAL CORD, V52, P867, DOI 10.1038/sc.2014.173
   Han SF, 2016, J BIOMED MATER RES A, V104, P1759, DOI 10.1002/jbm.a.35708
   Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031
   Harness ET, 2008, SPINAL CORD, V46, P733, DOI 10.1038/sc.2008.56
   He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340
   Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e
   Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282
   Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027
   Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087
   Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272
   Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   Olby NJ, 2001, AM J VET RES, V62, P1624, DOI 10.2460/ajvr.2001.62.1624
   Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014
   Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437
   Qin Y, 2015, J NEUROSCI RES, V93, P391, DOI 10.1002/jnr.23480
   Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026
   Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64
   Yang ZY, 2015, P NATL ACAD SCI USA, V112, P13354, DOI 10.1073/pnas.1510194112
NR 49
TC 7
Z9 9
U1 3
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 6
PY 2017
VL 7
AR 43559
DI 10.1038/srep43559
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM6OE
UT WOS:000395431200001
PM 28262732
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, YS
   Zhong, NB
   Liao, Q
   Fu, Q
   Huang, Y
   Zhu, X
   Li, QL
AF Li, Yishan
   Zhong, Nianbing
   Liao, Qiang
   Fu, Qian
   Huang, Yun
   Zhu, Xun
   Li, Qiaoliang
TI A biomaterial doped with LaB6 nanoparticles as photothermal media for
   enhancing biofilm growth and hydrogen production in photosynthetic
   bacteria
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article
DE Biofilm growth; Hydrogen production; Photothermal biomaterial;
   Photosynthetic bacteria; LaB6 nanoparticles
ID HOLLOW OPTICAL-FIBER; RHODOPSEUDOMONAS-PALUSTRIS; HEXABORIDE
   NANOPARTICLES; LANTHANUM HEXABORIDE; WASTE-WATER; PERFORMANCE;
   BIOREACTOR; PHOTOBIOREACTOR; IMMOBILIZATION; CANCER
AB A novel photothermal biomaterial, designated GeO2-SiO2-Chitosan-Medium-LaB6 (GSCML), was prepared to improve photosynthetic bacteria (PSB) biofilm development and hydrogen production performance. This biomaterial employed spectral beam splitting technology to increase the overall utilization of the incident light spectrum, which LaB6 nanoparticles (NPs) mainly absorb light at approximately 380-510 and 660-780 nm and convert it into heat energy; the transmit light is around 590 nm for PSB growth. The temperature increased, and the luminous intensity of the light transmitted through the prepared biomaterial are controlled by adjusting the LaB6 NPs' content. The average biofilm growth rate and hydrogen production rate of the biofilm on the created biomaterial were 0.05 mg/cm(2)/day and 2.92 mmol/h/m(2), which were 3.4 and 4.1 times higher than those of the glass slide, respectively. The properties of the GSCML biomaterial provide advantages for applications in immobilized cell technologies and photobioreactors. (C) 2017 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Yishan; Liao, Qiang; Fu, Qian; Huang, Yun; Zhu, Xun] Chongqing Univ, Key Lab Lowgrade Energy Utilizat Technol & Syst, Minist Educ, Chongqing 400044, Peoples R China.
   [Li, Yishan; Liao, Qiang; Fu, Qian; Huang, Yun; Zhu, Xun; Li, Qiaoliang] Chongqing Univ, Inst Engn Thermophys, Chongqing 400044, Peoples R China.
   [Zhong, Nianbing] Chongqing Univ Technol, Chongqing Key Lab Modern Photoelect Detect Techno, Chongqing Key Lab Fiber Opt Sensor & Photodetecto, Chongqing 400054, Peoples R China.
RP Liao, Q (reprint author), Chongqing Univ, Key Lab Lowgrade Energy Utilizat Technol & Syst, Minist Educ, Chongqing 400044, Peoples R China.; Liao, Q (reprint author), Chongqing Univ, Inst Engn Thermophys, Chongqing 400044, Peoples R China.; Zhong, NB (reprint author), Chongqing Univ Technol, Chongqing Key Lab Modern Photoelect Detect Techno, Chongqing Key Lab Fiber Opt Sensor & Photodetecto, Chongqing 400054, Peoples R China.
EM pxlb08@cqut.edu.cn; lqzx@cqu.edu.cn
FU National Natural Science Foundation of China [51406020, 51136007,
   51561145013]; Foundation and Frontier Research Project of Chongqing of
   China [cstc2016jcyjA0311]
FX This work was supported by the National Natural Science Foundation of
   China (grant no. 51406020), the Key Projects of the National Natural
   Science Foundation of China (grant no. 51136007), International
   Cooperation and Exchange of the National Natural Science Foundation of
   China (No. 51561145013) and Foundation and Frontier Research Project of
   Chongqing of China (grant no. cstc2016jcyjA0311).
CR Carlozzi P, 2009, RENEW ENERG, V34, P2577, DOI 10.1016/j.renene.2009.04.016
   Chambon S, 2015, ACS APPL MATER INTER, V7, P25334, DOI 10.1021/acsami.5b06475
   Chen CJ, 2012, CHEM ENG J, V180, P337, DOI 10.1016/j.cej.2011.11.035
   Chen MC, 2015, BIOMACROMOLECULES, V16, P1598, DOI 10.1021/acs.biomac.5b00185
   Chitapornpan S, 2013, BIORESOURCE TECHNOL, V141, P65, DOI 10.1016/j.biortech.2013.02.048
   Erickson D, 2011, NAT PHOTONICS, V5, P583, DOI [10.1038/NPHOTON.2011.209, 10.1038/nphoton.2011.209]
   Fazal S, 2014, ACS APPL MATER INTER, V6, P8080, DOI 10.1021/am500302t
   Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200
   Habouzit F, 2011, BIORESOURCE TECHNOL, V102, P4054, DOI 10.1016/j.biortech.2010.12.023
   Han HL, 2013, INT J HYDROGEN ENERG, V38, P10773, DOI 10.1016/j.ijhydene.2013.02.134
   Jiang F, 2012, ACS APPL MATER INTER, V4, P5833, DOI 10.1021/am301481j
   Kang CS, 2014, BIORESOURCE TECHNOL, V165, P27, DOI 10.1016/j.biortech.2014.03.148
   KIMURA S, 1994, PHYS REV B, V50, P1406, DOI 10.1103/PhysRevB.50.1406
   Li CY, 2013, BIORESOURCE TECHNOL, V131, P390, DOI 10.1016/j.biortech.2012.12.140
   Liao Q, 2015, INT J HYDROGEN ENERG, V40, P4741, DOI 10.1016/j.ijhydene.2015.02.040
   Liao Q, 2014, INT J HYDROGEN ENERG, V39, P10016, DOI 10.1016/j.ijhydene.2014.04.130
   Liao Q, 2013, INT J HYDROGEN ENERG, V38, P15730, DOI 10.1016/j.ijhydene.2013.04.146
   Mattox TM, 2015, CHEM MATER, V27, P6620, DOI 10.1021/acs.chemmater.5b02297
   Mona S, 2011, DESALINATION, V276, P408, DOI 10.1016/j.desal.2011.03.082
   Pakarinen O, 2008, INT J HYDROGEN ENERG, V33, P594, DOI 10.1016/j.ijhydene.2007.10.008
   Park JH, 2015, BIORESOURCE TECHNOL, V188, P109, DOI 10.1016/j.biortech.2015.01.107
   Paule A, 2011, WATER RES, V45, P6107, DOI 10.1016/j.watres.2011.09.007
   Radchenkova N, 2014, PROCESS BIOCHEM, V49, P576, DOI 10.1016/j.procbio.2014.01.010
   Schelm S, 2003, APPL PHYS LETT, V82, P4346, DOI 10.1063/1.1584092
   Song GS, 2014, ACS APPL MATER INTER, V6, P3915, DOI 10.1021/am4050184
   Takeda H, 2008, J AM CERAM SOC, V91, P2897, DOI 10.1111/j.1551-2916.2008.02512.x
   Tian X, 2010, BIORESOURCE TECHNOL, V101, P977, DOI 10.1016/j.biortech.2009.09.007
   Wakayama T, 2000, 21 S BIOT FUELS CHEM, P431
   Zagrodnik R, 2013, INT J HYDROGEN ENERG, V38, P7632, DOI 10.1016/j.ijhydene.2013.01.023
   Zhang CA, 2010, INT J HYDROGEN ENERG, V35, P5284, DOI 10.1016/j.ijhydene.2010.03.085
   Zhong NB, 2013, OPT LETT, V38, P3115, DOI 10.1364/OL.38.003115
NR 31
TC 1
Z9 2
U1 4
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD MAR 2
PY 2017
VL 42
IS 9
BP 5793
EP 5803
DI 10.1016/j.ijhydene.2017.01.082
PG 11
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA ES4LP
UT WOS:000399507100017
DA 2018-10-20
ER

PT J
AU Hayashi, K
   Okamoto, F
   Hoshi, S
   Katashima, T
   Zujur, DC
   Li, X
   Shibayama, M
   Gilbert, EP
   Chung, U
   Ohba, S
   Oshika, T
   Sakai, T
AF Hayashi, Kaori
   Okamoto, Fumiki
   Hoshi, Sujin
   Katashima, Takuya
   Zujur, Denise C.
   Li, Xiang
   Shibayama, Mitsuhiro
   Gilbert, Elliot P.
   Chung, Ung-il
   Ohba, Shinsuke
   Oshika, Tetsuro
   Sakai, Takamasa
TI Fast-forming hydrogel with ultralow polymeric content as an artificial
   vitreous body
SO NATURE BIOMEDICAL ENGINEERING
LA English
DT Article
ID LONG-TERM OBSERVATIONS; IMPLANT; GELS; DEGRADATION; SUBSTITUTE;
   NETWORKS; RABBIT
AB Degradation-induced swelling in implanted hydrogels can cause severe adverse reactions in surrounding tissues. Here, we report a new class of hydrogel with extremely low swelling pressure, and demonstrate its use as an artificial vitreous body. The hydrogel has ultralow polymer content (4.0 g l(-1)), low cytotoxicity, and forms in situ in 10 minutes via the crosslinking of clusters of highly branched polymers of tetra-armed poly(ethylene glycol) prepolymers. After injection and gelation in the eyes of rabbits, the hydrogel functioned as an artificial vitreous body for over a year without adverse effects, and proved effective for the treatment of retinal detachment. The properties of the hydrogel make it a promising candidate as an infill biomaterial for a range of biomedical applications.
C1 [Hayashi, Kaori; Zujur, Denise C.; Chung, Ung-il; Ohba, Shinsuke; Sakai, Takamasa] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
   [Okamoto, Fumiki; Hoshi, Sujin; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.
   [Katashima, Takuya] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.
   [Li, Xiang; Shibayama, Mitsuhiro] Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778583, Japan.
   [Gilbert, Elliot P.] Australian Nucl Sci & Technol Org, Australian Ctr Neutron Scattering, Locked Bag 2001, Kirrawee Dc, NSW 2232, Australia.
   [Chung, Ung-il] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Sakai, Takamasa] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Saitama 3320012, Japan.
RP Okamoto, F (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.
EM fumiki-o@md.tsukuba.ac.jp; sakai@tetrapod.t.u-tokyo.ac.jp
RI Shibayama, Mitsuhiro/E-1646-2015; Li, Xiang/M-8408-2017
OI Shibayama, Mitsuhiro/0000-0002-8683-5070; Li, Xiang/0000-0001-6194-3676;
   Katashima, Takuya/0000-0001-6184-3835
FU Japan Society for the Promotion of Science (JSPS); International Core
   Research Center for Nanobio, Core-to-Core Program A. Advanced Research
   Networks; Japan Science and Technology Agency (JST) through S-innovation
   program; Center of Innovation program; PREST;  [23700555];  [16H06312]; 
   [26462631]
FX This work was supported by the Japan Society for the Promotion of
   Science (JSPS) through Grants-in-Aid for the Graduate Program for
   Leaders in Life Innovation (GPLLI), by the International Core Research
   Center for Nanobio, Core-to-Core Program A. Advanced Research Networks,
   and Grants-in-Aid for Young Scientists (A) grant number 23700555 to
   T.S., Scientific Research (S) grant number 16H06312 to U.C., and
   Scientific Research (C) grant number 26462631 to F.O. This work was also
   supported by the Japan Science and Technology Agency (JST) through the
   S-innovation program and Center of Innovation program (to U.C.) and
   PREST (to T.S.).
CR Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Crafoord S, 2011, GRAEF ARCH CLIN EXP, V249, P1167, DOI 10.1007/s00417-011-1652-6
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Gennes PG, 1979, SCALING CONCEPTS POL
   HO PC, 1984, OPHTHALMIC SURG LAS, V15, P511
   Horkay F, 2000, BIOMACROMOLECULES, V1, P84, DOI 10.1021/bm9905031
   Hoshi S, 2015, INVEST OPHTH VIS SCI, V56, P4705, DOI 10.1167/iovs.14-15349
   Kainthan RK, 2006, MACROMOLECULES, V39, P7708, DOI 10.1021/ma0613483
   Kamata H, 2015, ADV HEALTHC MATER, V4, P2360, DOI 10.1002/adhm.201500076
   Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811
   Kamata H, 2012, SOFT MATTER, V8, P6876, DOI 10.1039/c2sm25168j
   Li X, 2014, CHEM MATER, V26, P5352, DOI 10.1021/cm502480f
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   MARIN JF, 1992, ARCH OPHTHALMOL-CHIC, V110, P86, DOI 10.1001/archopht.1992.01080130088031
   Mours M, 1996, MACROMOLECULES, V29, P7221, DOI 10.1021/ma9517097
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Pritchard CD, 2011, ACTA BIOMATER, V7, P936, DOI 10.1016/j.actbio.2010.11.013
   Ranga A, 2016, BIOMACROMOLECULES, V17, P1553, DOI 10.1021/acs.biomac.5b01587
   Roldan-Pallares M, 2007, ARCH OPHTHALMOL-CHIC, V125, P511, DOI 10.1001/archopht.125.4.511
   Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x
   Sakai T, 2016, POLYM J, V48, P629, DOI 10.1038/pj.2015.124
   Sakai T, 2014, POLYM J, V46, P517, DOI 10.1038/pj.2014.28
   Swindle-Reilly KE, 2009, INVEST OPHTH VIS SCI, V50, P4840, DOI 10.1167/iovs.08-2891
   Tao Y, 2013, ACTA BIOMATER, V9, P5022, DOI 10.1016/j.actbio.2012.09.026
   TOLENTINO FI, 1985, RETINA-J RET VIT DIS, V5, P38, DOI 10.1097/00006982-198500510-00008
   VINK H, 1971, EUR POLYM J, V7, P1411, DOI 10.1016/0014-3057(71)90035-8
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Zheng YC, 2015, CHEM SOC REV, V44, P4091, DOI 10.1039/c4cs00528g
NR 30
TC 18
Z9 18
U1 27
U2 42
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2157-846X
J9 NAT BIOMED ENG
JI Nat. Biomed. Eng
PD MAR
PY 2017
VL 1
IS 3
AR UNSP 0044
DI 10.1038/s41551-017-0044
PG 7
WC Engineering, Biomedical
SC Engineering
GA FR1VD
UT WOS:000418854800006
DA 2018-10-20
ER

PT J
AU Wilkens, CA
   Rivet, CJ
   Akentjew, TL
   Alverio, J
   Khoury, M
   Acevedo, JP
AF Wilkens, Camila A.
   Rivet, Christopher J.
   Akentjew, Tamara L.
   Alverio, Julian
   Khoury, Maroun
   Pablo Acevedo, Juan
TI Layer-by-layer approach for a uniformed fabrication of a cell patterned
   vessel-like construct
SO BIOFABRICATION
LA English
DT Article
DE small diameter blood vessel; tissue engineering; cell patterning; CNC
   device
ID DIAMETER VASCULAR GRAFTS; SMOOTH-MUSCLE-CELLS; ENGINEERED BLOOD-VESSELS;
   VISIBLE-LIGHT; MECHANICAL-PROPERTIES; HYDROGELS; SCAFFOLDS; ALIGNMENT;
   MORPHOLOGY; ARTERIES
AB Successful tissue engineered small diameter blood vessels (SDBV) require manufacturing systems capable of precisely controlling different key elements, such as material composition, geometry and spatial location of specialized biomaterials and cells types. Wereport in this work an automated methodology that enables the manufacture of multilayer cylindrical constructs for SDBV fabrication that uses a layer-by-layer deposition approach while controlling variables such as dipping and spinning speed of a rod and biomaterial viscosity. Different biomaterials including methacrylated gelatin, alginate and chitosan were tested using this procedure to build different parts of the constructs. The system was capable of controlling dimensions of lumen from 0.5 mm up to 6 mm diameter and individual layers from 1 mu m up to 400 mu m thick. A cellular component was successfully added to the biomaterial in the absence of significant cytotoxic effect which was assessed by viability and proliferation assays. Additionally, cells showed a homogenous distribution with well-defined concentric patterns across the multilayer vessel grafts. The challenging generation of inner endothelial cells of approximately 20-30 mu m of thickness was achieved. Preliminary experimental evidences of microstructural alignment of the biomaterial were obtained when the dipping approach was combined with the rod rotation. The study demonstrated the wide versatility and scalability of the automated system to easily and rapidly fabricate complex cellularized multilayer vascular grafts with structural configuration that resembles natural blood vessels.
C1 [Wilkens, Camila A.; Rivet, Christopher J.; Akentjew, Tamara L.; Alverio, Julian; Khoury, Maroun; Pablo Acevedo, Juan] Univ Los Andes, Fac Med, Lab Nanoregenerat Med, Santiago, Chile.
   [Wilkens, Camila A.; Rivet, Christopher J.; Akentjew, Tamara L.; Alverio, Julian; Khoury, Maroun; Pablo Acevedo, Juan] Cells Cells, Santiago, Chile.
   [Khoury, Maroun; Pablo Acevedo, Juan] Consorcio Regenero, Santiago, Chile.
RP Acevedo, JP (reprint author), Univ Los Andes, Ctr Invest Biomed, San Carlos Apoquindo 2500, Santiago, Chile.
EM cwilkens@uandes.cl; chrisjrivet@gmail.com; tlakentj@uc.cl;
   julian.a.alverio@gmail.com; mkhoury@uandes.cl; jpacevedo@uandes.cl
FU Universidad de los Andes PMI - Chilean Ministry of Education [UAN1301];
   Chile's Comision Nacional de Investigacion Cientifica y Tecnologica
   grant FONDEF IDeA [ID15I10545]; Chile's Comision Nacional de
   Investigacion Cientifica y Tecnologica grant FONDECYT [3160680]
FX This work was partially funded by Universidad de los Andes PMI funding
   program, UAN1301, granted by the Chilean Ministry of Education, as well
   as by Chile's Comision Nacional de Investigacion Cientifica y
   Tecnologica grants FONDEF IDeA ID15I10545 and FONDECYT Postdoctoral
   3160680. We acknowledge Prof. Javier Enrione from Universidad de los
   Andes for invaluable support with fundamental knowledge in biomaterials
   and equipments.
CR Bahney CS, 2011, EUR CELLS MATER, V22, P43, DOI 10.22203/eCM.v022a04
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a
   Blackwell DL, 2014, VITAL HLTH STAT, V10, P1
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Choi B, 2015, ACTA BIOMATER, V12, P30, DOI 10.1016/j.actbio.2014.10.013
   Choi JS, 2014, BIOMATERIALS, V35, P63, DOI 10.1016/j.biomaterials.2013.09.106
   Conklin BS, 2004, ARTIF ORGANS, V28, P668, DOI 10.1111/j.1525-1594.2004.00062.x
   Courty S, 2005, P NATL ACAD SCI USA, V102, P13457, DOI 10.1073/pnas.0506864102
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   DODGE JT, 1992, CIRCULATION, V86, P232, DOI 10.1161/01.CIR.86.1.232
   EDWARDS WS, 1966, SURG GYNECOL OBSTETR, V122, P37
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Feng J, 2007, TISSUE ENG, V13, P1003, DOI 10.1089/ten.2006.0223
   Fernandez CE, 2014, CURR OPIN CHEM ENG, V3, P83, DOI 10.1016/j.coche.2013.12.001
   Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028
   Gaudet ID, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0025-y
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hu JJ, 2012, J MECH BEHAV BIOMED, V13, P140, DOI 10.1016/j.jmbbm.2012.04.013
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Huang NF, 2013, BIOMATERIALS, V34, P2928, DOI 10.1016/j.biomaterials.2013.01.017
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jung J, 2014, DIG J NANOMATER BIOS, V9, P503
   Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Klotz BJ, 2016, TRENDS BIOTECHNOL, V34, P394, DOI 10.1016/j.tibtech.2016.01.002
   Kochanek KD, 2011, NATL VITAL STAT REP, V60, P1
   Lai ES, 2012, REGEN MED, V7, P649, DOI [10.2217/RME.12.48, 10.2217/rme.12.48]
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842
   Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402
   Sabnis A, 2009, J BIOMED MATER RES A, V91A, P52, DOI 10.1002/jbm.a.32194
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Steward R, 2015, AM J PHYSIOL-CELL PH, V308, pC657, DOI 10.1152/ajpcell.00363.2014
   Tara S, 2014, CIRC J, V78, P12, DOI 10.1253/circj.CJ-13-1440
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Varma DM, 2014, ACTA BIOMATER, V10, P4996, DOI 10.1016/j.actbio.2014.08.013
   VEITH FJ, 1979, SURGERY, V85, P253
   Wang ZH, 2014, BIOMATERIALS, V35, P5700, DOI 10.1016/j.biomaterials.2014.03.078
   Wong DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139307
   Yang DP, 2009, ANN PLAS SURG, V62, P297, DOI 10.1097/SAP.0b013e318197eb19
   Zhang M, 2012, J MATER SCI-MATER M, V23, P2639, DOI 10.1007/s10856-012-4721-4
   Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331
   Zhang SM, 2014, BIOMATERIALS, V35, P3243, DOI 10.1016/j.biomaterials.2013.12.081
   Zhou M, 2014, TISSUE ENG PT A, V20, P79, DOI [10.1089/ten.tea.2013.0020, 10.1089/ten.TEA.2013.0020]
   Zhou M, 2012, J BIOMED MATER RES B, V100B, P111, DOI 10.1002/jbm.b.31928
NR 55
TC 5
Z9 5
U1 3
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2017
VL 9
IS 1
AR 015001
DI 10.1088/1758-5090/9/1/015001
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FJ3YE
UT WOS:000412668200001
OA Other Gold
DA 2018-10-20
ER

PT J
AU Ong, GKB
   Freeman, RK
AF Ong, Gabie K. B.
   Freeman, Richard K.
TI Endoscopic management of esophageal leaks
SO JOURNAL OF THORACIC DISEASE
LA English
DT Review
DE Esophageal perforation; esophageal fistula; esophageal stent
ID EXPANDING METAL STENTS; ANASTOMOTIC LEAK; GI TRACT; GASTROINTESTINAL
   LEAKS; CLINICAL-EXPERIENCES; PERFORATIONS; PLACEMENT; THERAPY; FISTULA;
   CLOSURE
AB Traditionally, gold standard treatment for an acute esophageal perforation has been operative repair. Over the past two decades, there has been a paradigm shift towards the use of esophageal stents. Recent advances in biomaterial allowed a new generation of stents to be manufactured that combined (I) a non-permeable covering; (II) radial force sufficient to occlude a transmural esophageal injury and (III) improved ease of removability. The amalgamation of these developments set the stage for utilizing esophageal stents as part of the management algorithm of an acute esophageal perforation. This provides a safe and less invasive treatment route in lieu of direct primary repair and its well-documented significant failure rate. Esophageal stent placement for failed operative repair or esophageal leaks also had the potential to minimize the need for esophageal resection and diversion. When included in a multimodality hybrid treatment protocol, esophageal stents can optimize healing success rates and minimize the risks of adverse complications. This review summarizes the modern history of esophageal stent use in the treatment of esophageal perforation as well as the evidenced based recommendations for the use of esophageal stent placement in the treatment of acute esophageal perforation.
C1 [Ong, Gabie K. B.] St Vincent Hosp, Dept Surg, Indianapolis, IN USA.
   [Freeman, Richard K.] St Vincent Hosp, Div Thorac & Cardiovasc Surg, Indianapolis, IN USA.
RP Freeman, RK (reprint author), 8433 Harcourt Rd, Indianapolis, IN 46260 USA.
EM Richard.Freeman@StVincent.org
CR ATKINSON M, 1979, J ROY SOC MED, V72, P894
   Baron TH, 2012, GASTROINTEST ENDOSC, V76, P838, DOI 10.1016/j.gie.2012.04.476
   Ben-David K, 2014, J AM COLL SURGEONS, V218, P768, DOI 10.1016/j.jamcollsurg.2013.12.033
   CELESTIN L R, 1959, Ann R Coll Surg Engl, V25, P165
   Chan ACW, 1999, GASTROINTEST ENDOSC, V49, P462, DOI 10.1016/S0016-5107(99)70043-X
   COYAS A, 1955, LANCET, V2, P647
   D'Cunha J, 2011, J THORAC CARDIOV SUR, V142, P39, DOI 10.1016/j.jtcvs.2011.04.027
   Dasari BVM, 2014, ANN SURG, V259, P852, DOI 10.1097/SLA.0000000000000564
   Decker P, 2001, SURG ENDOSC-ULTRAS, V15, P1444, DOI 10.1007/s004640090099
   ELL C, 1994, AM J GASTROENTEROL, V89, P1496
   Fischer A, 2006, ANN THORAC SURG, V81, P467, DOI 10.1016/j.athoracsur.2005.08.047
   Freeman RK, 2007, ANN THORAC SURG, V83, P2003, DOI 10.1016/j.athoracsur.2007.02.025
   Freeman RK, 2007, J THORAC CARDIOV SUR, V133, P333, DOI 10.1016/j.jtcvs.2006.10.008
   Freeman RK, 2015, ANN THORAC SURG, V100, P422, DOI 10.1016/j.athoracsur.2015.03.085
   Freeman RK, 2015, J THORAC CARDIOV SUR, V149, P1550, DOI 10.1016/j.jtcvs.2015.01.066
   Freeman RK, 2014, ANN THORAC SURG, V97, P1715, DOI 10.1016/j.athoracsur.2014.01.011
   Freeman RK, 2012, ANN THORAC SURG, V94, P959, DOI 10.1016/j.athoracsur.2012.05.047
   Freeman RK, 2011, ANN THORAC SURG, V92, P204, DOI 10.1016/j.athoracsur.2011.02.016
   Freeman RK, 2009, ANN THORAC SURG, V88, P194, DOI 10.1016/j.athoracsur.2009.04.004
   Gelbmann CM, 2004, ENDOSCOPY, V36, P695, DOI 10.1055/s-2004-825656
   Guisez J, 1914, PRESSE MED, V22, P85
   Johnsson E, 2005, DIS ESOPHAGUS, V18, P262, DOI 10.1111/j.1442-2050.2005.00476.x
   Keeling WB, ANN THORAC SURG
   Kirschniak A, 2007, GASTROINTEST ENDOSC, V66, P162, DOI 10.1016/j.gie.2007.01.034
   Leers JM, 2009, SURG ENDOSC, V23, P2258, DOI 10.1007/s00464-008-0302-5
   Licht E, 2016, ANN THORAC SURG, V101, P301, DOI 10.1016/j.athoracsur.2015.06.072
   Mennigen R, 2015, J GASTROINTEST SURG, V19, P1229, DOI 10.1007/s11605-015-2847-7
   MOUSSEAU, 1956, Arch Mal Appar Dig Mal Nutr, V45, P208
   NELSON DB, 1994, GASTROINTEST ENDOSC, V40, P497, DOI 10.1016/S0016-5107(94)70221-7
   Odell JA, 2010, ANN THORAC SURG, V90, P1707, DOI 10.1016/j.athoracsur.2010.02.104
   Persson S, 2016, ENDOSC INT OPEN, V4, pE420, DOI 10.1055/s-0042-102878
   Raju GS, 2009, AM J GASTROENTEROL, V104, P1315, DOI 10.1038/ajg.2009.34
   Ramirez FC, 1997, GASTROINTEST ENDOSC, V45, P360, DOI 10.1016/S0016-5107(97)70144-5
   Roy-Choudhury S H, 2001, AJR Am J Roentgenol, V176, P161
   Saxon RR, 1997, RADIOLOGY, V202, P349, DOI 10.1148/radiology.202.2.9015055
   Schmassmann A, 1997, AM J GASTROENTEROL, V92, P400
   Schorsch T, 2013, SURG ENDOSC, V27, P2040, DOI 10.1007/s00464-012-2707-4
   Segalin A, 1996, SURG ENDOSC-ULTRAS, V10, P928, DOI 10.1007/BF00188486
   Smallwood NR, 2016, SURG ENDOSC, V30, P2473, DOI 10.1007/s00464-015-4501-6
   Souttar HS, 1924, BRIT MED J, V1924, P782, DOI 10.1136/bmj.1.3305.782
   Speer E, 2016, SURG ENDOSC, V30, P3297, DOI 10.1007/s00464-015-4661-4
   Suzuki T, 2016, J CLIN GASTROENTEROL, V50, P373, DOI 10.1097/MCG.0000000000000500
   Symonds C J, 1887, Br Med J, V1, P870
   van Heel NCM, 2010, AM J GASTROENTEROL, V105, P1515, DOI 10.1038/ajg.2010.104
   Verlaan T, 2015, GASTROINTEST ENDOSC, V82, P618, DOI 10.1016/j.gie.2015.03.1977
   Whitelocke D, 2010, J THORAC CARDIOV SUR, V140, pE49, DOI 10.1016/j.jtcvs.2010.03.042
   WRIGHT CD, 1995, ANN THORAC SURG, V60, P245, DOI 10.1016/0003-4975(95)00377-W
   Yilmaz B, 2015, DIGEST ENDOSC, V27, P641, DOI 10.1111/den.12482
NR 48
TC 0
Z9 0
U1 0
U2 0
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2072-1439
EI 2077-6624
J9 J THORAC DIS
JI J. Thorac. Dis.
PD MAR
PY 2017
VL 9
SU 2
BP S135
EP S145
DI 10.21037/jtd.2017.03.100
PG 11
WC Respiratory System
SC Respiratory System
GA EW4OU
UT WOS:000402481600009
PM 28446977
OA Green Published
DA 2018-10-20
ER

PT J
AU Karacali, O
AF Karacali, O.
TI A Study of the Dynamic Anterior Cervical Plate Implant by Computer Aided
   Virtual Engineering Method
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 6th Congress and Exhibition on International Advances in Applied Physics
   and Materials Science (APMAS)
CY JUN 01-03, 2016
CL Istanbul, TURKEY
DE 87.10. Kn; 81.70. Bt; 87.15. La
ID FUSION; FRACTURES; MODELS; SPINE
AB The convenience of dynamic anterior cervical PMMA biomaterial placement of spinal implants is considered by finite element modeling. The maximum fatigue behavior was also studied in surface coated Ti-5A1-2.55n spinal screw-rods. Anterior cervical biomaterial plates reduce the hazard for spinal cord injury and provide outstanding fixation for the anterior column, to stop the relocation and slackening of screws-rods by a cross-split screw crown that may be fastened into the biomaterial plate. This article reports about the hollow Ti-5Al-2.55n screw and cervical biomaterial PMMA plate system. The flexion movement of the spine implant was modeled to control the stresses and strains of the bone and screw interfaces under the external forces, as well as motion of the vertebrae by finite element modeling. This computational engineering analysis is aimed to support patients suffering anterior cervical arthrodesis after degenerative disease or trauma. The data from this research may provide an essential base to estimate the stabilization quality. A model for the biomaterial between C4 and C6 segments of vertebrae of cervical spine was obtained. Study of the cervical biomaterial implant provides instantaneous secure fixation virtual experiment with minimal complications, before the real implant surgery, using computer aided virtual engineering.
C1 [Karacali, O.] Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
FU Istanbul University, Turkey [23472, 24431]
FX This research is funded by Istanbul University, Turkey, projects No:
   23472 and 24431 (The Scientific Research Foundation). Such support is
   greatly acknowledged.
CR Barbera L.L., 2014, P IMECHE H, V228, P1014
   Beltran-Fernandez JA, 2010, APPL MECH MATER, V24-25, P287, DOI 10.4028/www.scientific.net/AMM.24-25.287
   Brandt T, 2005, FRONT NEUROL NEUROSC, V20, P16
   Campos R, 2014, EUR SPINE J, V23, P298, DOI 10.1007/s00586-013-3039-3
   Davies MA, 2006, J BIOMECH ENG-T ASME, V128, P481, DOI 10.1115/1.2205373
   Driscoll M, 2013, BIOMED RES INT, DOI 10.1155/2013/931741
   DuBois CM, 2007, SPINE J, V7, P188, DOI 10.1016/j.spinee.2006.07.004
   Fagan MJ, 2002, P I MECH ENG H, V216, P299, DOI 10.1243/09544110260216577
   Johnston Todd L, 2006, Spine J, V6, P667
   Korres DS, 2007, EUR J ORTHOP SURG TR, V17, P521, DOI 10.1007/s00590-007-0238-9
   Korres Demitrios, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS125, DOI 10.1007/s00590-013-1376-x
   Kurtz SM, 2005, BIOMATERIALS, V26, P3699, DOI 10.1016/j.biomaterials.2004.09.055
   Lazennec Jean-Yves, 2016, Eur J Orthop Surg Traumatol, V26, P9, DOI 10.1007/s00590-015-1695-1
   Park JB, 2005, J BONE JOINT SURG AM, V87A, P558, DOI 10.2106/JBJS.C.01555
   Schleicher P, 2008, EUR SPINE J, V17, P1757, DOI 10.1007/s00586-008-0797-4
   Yen CP, 2005, ACTA NEUROCHIR, V147, P665, DOI 10.1007/s00701-005-0518-2
NR 16
TC 0
Z9 0
U1 0
U2 3
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD MAR
PY 2017
VL 131
IS 3
SI SI
BP 584
EP 587
DI 10.12693/APhysPolA.131.584
PG 4
WC Physics, Multidisciplinary
SC Physics
GA EU3CF
UT WOS:000400905500068
OA Bronze
DA 2018-10-20
ER

PT J
AU Karacali, O
AF Karacali, O.
TI Parametric and Structural Analysis of Dynamic Anterior Cervical
   Biomaterial Plate Implant by Computer Aided Virtual Engineering
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 6th Congress and Exhibition on International Advances in Applied Physics
   and Materials Science (APMAS)
CY JUN 01-03, 2016
CL Istanbul, TURKEY
DE 87.10. Kn; 81.70. Bt; 87.15. La
ID FUSION; FRACTURES; MODELS; SPINE
AB The main objective of this study was to examine the convenience of an accurate model of placement of dynamic anterior cervical plate, made of poly (methl-methacrylate) biomaterial, for testing spinal implants, and to determine the maximum fatigue values of differently surfaced Ti-gAl-2.55n spinal screw-rods, by finite element modeling. Anterior cervical biomaterial plates reduce the hazard for spinal cord injury and provide outstanding fixation for the anterior column to stop the relocation and slackening of screws-rods, using a cross-split screw crown that may be fastened into the biomaterial plate. This article reports about the hollow Ti-5Al-2.55n screw and cervical biomaterial plate system. The flexion movement of the spine implant was modeled, using finite elements method, to control the stresses and strains of the bone and screw interfaces to external forces, as well as motion of the vertebras. This computational engineering analysis was aimed to support patients suffering anterior cervical arthrodesis after a degenerative disease or trauma. The obtained data from this research may provide an essential base to estimate the stabilization quality and mechanical properties of biomaterial selection. Model of the region between C4 and C6 segments of vertebrae of cervical spine was produced to correct the stabilization of implant with non-linear material properties. Study of the cervical biomaterial implant has provided instantaneous virtual experiment of secure fixation with minimal complications before a real implant surgery, using computer aided virtual engineering.
C1 [Karacali, O.] Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
FU Istanbul University, Turkey [24431]
FX This research is funded by Istanbul University, Turkey, project No:
   24431 (The Scientific Research Foundation). Such support is greatly
   acknowledged.
CR Barbera L.L., 2014, P IMECHE H, V228, P1014
   Beltran-Fernandez JA, 2010, APPL MECH MATER, V24-25, P287, DOI 10.4028/www.scientific.net/AMM.24-25.287
   Brandt T, 2005, FRONT NEUROL NEUROSC, V20, P16
   Campos R, 2014, EUR SPINE J, V23, P298, DOI 10.1007/s00586-013-3039-3
   Davies MA, 2006, J BIOMECH ENG-T ASME, V128, P481, DOI 10.1115/1.2205373
   Driscoll M, 2013, BIOMED RES INT, DOI 10.1155/2013/931741
   DuBois CM, 2007, SPINE J, V7, P188, DOI 10.1016/j.spinee.2006.07.004
   Fagan MJ, 2002, P I MECH ENG H, V216, P299, DOI 10.1243/09544110260216577
   Johnston Todd L, 2006, Spine J, V6, P667
   Korres DS, 2007, EUR J ORTHOP SURG TR, V17, P521, DOI 10.1007/s00590-007-0238-9
   Korres Demitrios, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS125, DOI 10.1007/s00590-013-1376-x
   Kurtz SM, 2005, BIOMATERIALS, V26, P3699, DOI 10.1016/j.biomaterials.2004.09.055
   Lazennec Jean-Yves, 2016, Eur J Orthop Surg Traumatol, V26, P9, DOI 10.1007/s00590-015-1695-1
   Park JB, 2005, J BONE JOINT SURG AM, V87A, P558, DOI 10.2106/JBJS.C.01555
   Schleicher P, 2008, EUR SPINE J, V17, P1757, DOI 10.1007/s00586-008-0797-4
   Yen CP, 2005, ACTA NEUROCHIR, V147, P665, DOI 10.1007/s00701-005-0518-2
NR 16
TC 0
Z9 0
U1 1
U2 4
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD MAR
PY 2017
VL 131
IS 3
SI SI
BP 588
EP 591
DI 10.12693/APhysPolA.131.588
PG 4
WC Physics, Multidisciplinary
SC Physics
GA EU3CF
UT WOS:000400905500069
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, L
   Li, S
   Qu, Q
   Zuo, L
   He, Y
   Zhu, B
   Li, C
AF Li, Lei
   Li, Shunling
   Qu, Qing
   Zuo, Limei
   He, Yue
   Zhu, Baolin
   Li, Cong
TI Streptococcus Sanguis Biofilm Architecture and Its Influence on Titanium
   Corrosion in Enriched Artificial Saliva
SO MATERIALS
LA English
DT Article
DE titanium; S. sanguis; pitting corrosion; artificial saliva; corrosion
   mechanism
ID STAINLESS-STEEL; LACTIC-ACID; BEHAVIOR; BIOMATERIAL; FLUORIDE; SEAWATER;
   COMBINATIONS; SENSITIVITY; RESISTANCE; METALS
AB Bacteria biofilm formation on metals is well-known, while biofilm architecture varies under different conditions. To date, few studies have determined the possible contribution to corrosion of titanium made by biofilm architecture. We investigated the interaction between the oral Streptococcus sanguis biofilm architecture and its influence on titanium corrosion in enriched artificial saliva using electrochemical methods and microscopic study. Patchy biofilms were observed on titanium surface after being immersed in solution containing S. sanguis. The thickness and size of the patchy biofilms increased with an increase of immersion time. The extensive pits were clearly observed by scanning electron microscopy, showing that adsorption of S. sanguis on titanium promoted the localized corrosion. The electrochemical results indicated that the corrosion rates were clearly accelerated in the presence of S. sanguis. The low icorr and high R-t in the first 48 h indicated that a typical passive behavior still remained. Our study showed that the pitting corrosion of titanium was mainly attributed to the formation of a self-catalytic corrosion cell by the co-effect of patchy biofilm and organic acid secreted by S. sanguis.
C1 [Li, Lei; Zhu, Baolin] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming 650091, Peoples R China.
   [Li, Shunling; Qu, Qing; Zuo, Limei; He, Yue] Yunnan Univ, Sch Chem Sci & Technol, Kunming 650091, Peoples R China.
   [Li, Cong] Chinese Acad Sci, Kunming Inst Zool, Publ Tech Serv Ctr, Kunming 650223, Peoples R China.
RP Qu, Q (reprint author), Yunnan Univ, Sch Chem Sci & Technol, Kunming 650091, Peoples R China.
EM leelei@ynu.edu.cn; quqing68@gmail.com; quqing@ynu.edu.cn;
   961779457lee@gmail.com; 1201500105@ynu.edu.cn; yajunchenqulee@gmail.com;
   licong78@hotmail.com
FU Chinese Natural Science Foundation [51361028, 51161025, 51661033,
   31660538]
FX This work was financially supported by the Chinese Natural Science
   Foundation under Grant No. 51361028, 51161025, 51661033 and 31660538.
CR Basketter DA, 2000, CONTACT DERMATITIS, V42, P310
   Breur HJA, 2002, ELECTROCHIM ACTA, V47, P2289, DOI 10.1016/S0013-4686(02)00096-8
   Cheng S, 2009, MAT SCI ENG C-BIO S, V29, P751, DOI 10.1016/j.msec.2008.11.013
   Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000
   Darke D. R., 1990, INT J ORAL MAXILLOF, V14, P226
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Elter C, 2008, INT J ORAL MAX IMPL, V23, P327
   Embleton JV, 1998, APPL ENVIRON MICROB, V64, P3503
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P3480, DOI 10.1016/j.electacta.2008.12.060
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Fowler AC, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2015.0798
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Harzer W, 2001, ANGLE ORTHOD, V71, P318
   Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409
   Hu Wen-Qi, 2008, Shanghai Kou Qiang Yi Xue, V17, P88
   IWAMI Y, 1985, INFECT IMMUN, V50, P378
   JACK RF, 1992, CORROS SCI, V33, P1843, DOI 10.1016/0010-938X(92)90188-9
   Koike M, 2001, J ORAL REHABIL, V28, P540, DOI 10.1046/j.1365-2842.2001.00690.x
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Laurent F, 2001, BIOMATERIALS, V22, P2273, DOI 10.1016/S0142-9612(00)00416-6
   Lebrini M, 2007, CORROS SCI, V49, P2254, DOI 10.1016/j.corsci.2006.10.029
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Mansfeld F., 2003, REV MAT CORROS, V49, P489
   Mansfeld F, 2007, ELECTROCHIM ACTA, V52, P7670, DOI 10.1016/j.electacta.2007.05.006
   Misiuk Wieslawa, 2005, Farmaco (Lausanne), V60, P61, DOI 10.1016/j.farmac.2004.09.004
   Moradi M, 2014, CORROS SCI, V84, P103, DOI 10.1016/j.corsci.2014.03.018
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x
   Qu Q, 2015, CORROS SCI, V91, P321, DOI 10.1016/j.corsci.2014.11.032
   Qu Q, 2014, MATERIALS, V7, P5528, DOI 10.3390/ma7085528
   Souza JCM, 2010, BIOFOULING, V26, P471, DOI 10.1080/08927011003767985
   Souza JCM, 2013, J DENT, V41, P528, DOI 10.1016/j.jdent.2013.03.008
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   SVENSATER G, 1985, J DENT RES, V64, P1286, DOI 10.1177/00220345850640110601
   Tagger Green Nirit, 2002, Implant Dent, V11, P137, DOI 10.1097/00008505-200204000-00014
   Takahashi M, 2011, MET MATER INT, V17, P175, DOI 10.1007/s12540-011-0224-y
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   VIDELA HA, 1988, CORROSION, V44, P423, DOI 10.5006/1.3583957
   Wang W, 2004, MATER CORROS, V55, P30, DOI 10.1002/maco.200303690
   Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x
   Wigebder J., 1999, MICROBIAL EXTRACELLU, P1
   WILSON M, 1995, BIOMATERIALS, V16, P721, DOI 10.1016/0142-9612(95)99701-M
   Yamauchi R, 2000, CONTACT DERMATITIS, V42, P52
NR 46
TC 0
Z9 0
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2017
VL 10
IS 3
AR 255
DI 10.3390/ma10030255
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA EU2MM
UT WOS:000400863500038
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bunea, MC
   Vasile, E
   Galateanu, B
   Hudita, A
   Serban, M
   Zaharia, C
AF Bunea, Muiaela Cristina
   Vasile, Eugenia
   Galateanu, Bianca
   Hudita, Ariana
   Serban, Mirela
   Zaharia, Catalin
TI Silk Fibroin Films Decorated with Magnetic Nanoparticles for Wound
   Healling Applications
SO MATERIALE PLASTICE
LA English
DT Article
DE silk fibroin; magnetite; wound dressing; scaffold
ID IN-VITRO; BIOMATERIALS; BEHAVIOR; FE3O4
AB The paper is focused on designing a novel silk fibroin-magnetite biomaterial scaffold for wounds healing in terms of: synthesis, physico-chemical and morphological characterization and in vitro biological behaviour assessment. Magnetic scaffolds were prepared from silk fibroin solutions and magnetic nanoparticles with various concentrations by solvent casting technique. Specimens were investigated by FTIR-ATR spectroscopy and XRD measurements. Morphological investigation including internal structure was employed by AFM and TEM/HRTEM analyses. Biological assay was performed on human adipose derived stem cells isolated from subcutaneous adipose tissue. Results suggested that all the tested magnetic silk-magnetite scaffolds display a good biocompatibility in vitro on hASCs and could be promising candidates for further wound dressing testing.
C1 [Bunea, Muiaela Cristina; Zaharia, Catalin] Univ Politehn Bucuresti, Adv Polymer Mat Grp, 1-7 Gh Polizu Str, Bucharest 011061, Romania.
   [Vasile, Eugenia] Univ Politehn Bucuresti, 313 Splaiul Independentei, Bucharest 060042, Romania.
   [Galateanu, Bianca; Hudita, Ariana; Serban, Mirela] Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Splaiul Independentei, Bucharest 050095, Romania.
RP Zaharia, C (reprint author), Univ Politehn Bucuresti, Adv Polymer Mat Grp, 1-7 Gh Polizu Str, Bucharest 011061, Romania.
EM zaharia.catalin@gmail.com
FU Romanian National Authority for Scientific Research and Innovation, CNCS
   - UEFISCDI [PN-II-RU-TE-2014-4-1272, 3/01.10.2015]
FX This work was supported by a grant of the Romanian National Authority
   for Scientific Research and Innovation, CNCS - UEFISCDI, project number
   PN-II-RU-TE-2014-4-1272, 3/01.10.2015.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Ajeesh M, 2010, J MATER SCI-MATER M, V21, P1427, DOI 10.1007/s10856-010-4005-9
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Galateanu B, 2012, INT J MOL SCI, V13, P15881, DOI 10.3390/ijms131215881
   Ghaemy M, 2012, CARBOHYD POLYM, V90, P1265, DOI 10.1016/j.carbpol.2012.06.069
   Inukai A, 2011, J MAGN MAGN MATER, V323, P965, DOI 10.1016/j.jmmm.2010.11.080
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kuda O, 2009, J MATER PROCESS TECH, V209, P1960, DOI 10.1016/j.jmatprotec.2008.04.061
   Lacoeuille F, 2011, BIOMATERIALS, V32, P7999, DOI 10.1016/j.biomaterials.2011.07.007
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63
   Sah M. K., 2010, International Journal of Environmental Science and Development, V1, P404
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   SRIHANAM P, 2011, BIOTECHNOLOGY, V10, P114
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Zaharia C, 2012, MAT SCI ENG C-MATER, V32, P945, DOI 10.1016/j.msec.2012.02.018
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
NR 24
TC 0
Z9 0
U1 0
U2 2
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD MAR
PY 2017
VL 54
IS 1
BP 83
EP 87
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA ET9LV
UT WOS:000400629900019
DA 2018-10-20
ER

PT J
AU Miclaus, R
   Repanovici, A
   Roman, N
AF Miclaus, Roxana
   Repanovici, Angela
   Roman, Nadinne
TI Biomaterials: Polylactic Acid and 3D Printing Processes for Orthosis and
   Prosthesis
SO MATERIALE PLASTICE
LA English
DT Article
DE biomaterials; 3D printing; medical rehabilitation; polylactic acid
AB Since the development of 3D printing, over the past decades, the domain of application has evolved significantly! Concerning the orthosis and prosthesis manufacturing, the 3D printing offers many possibilities for developing new medical devices for people with disabilities. Our paper wish to synthesize the main 3D printing methods and the biomaterial properties which can be used in orthosis and prosthesis manufacturing, like polylactic acid or acrylonitrile butadiene styrene. Fused Deposition Modeling and Stereo lithography are most used for medical devices manufacturing and usually using polylactic acid, considering the properties of this polymer and de organic componence.
C1 [Miclaus, Roxana; Roman, Nadinne] Transilvania Univ Brasov, Fac Med, 56 Nicolae Balcescu Str, Brasov 500019, Romania.
   [Repanovici, Angela] Transilvania Univ Brasov, Fac Product Design & Environm, 1 Univ Str, Brasov 500068, Romania.
RP Miclaus, R (reprint author), Transilvania Univ Brasov, Fac Med, 56 Nicolae Balcescu Str, Brasov 500019, Romania.
OI Roman, Nadinne/0000-0002-4263-2589
CR BANDYOPADHYAX A., 2015, MRS BULL, P108
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Baronio G, 2016, APPL BIONICS BIOMECH, DOI 10.1155/2016/8347478
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4
   COPPAARD B., 2015, INTRO ORTHOTICS CLIN
   Crivello JV, 2014, CHEM MATER, V26, P533, DOI 10.1021/cm402262g
   DEAN D., 2014, 6 INT C ADV RES VIRT
   Faustini MC, 2008, IEEE T BIO-MED ENG, V55, P784, DOI 10.1109/TBME.2007.912638
   Groth Christian, 2014, J Clin Orthod, V48, P475
   HIEU L.C., 2005, MED RAPID PROTOTYPIN, P284
   HOSPITAL FOR SPECIAL SURGERY, 2016, WHAT IS PHYS
   Kaihara S, 2007, NAT PROTOC, V2, P2767, DOI 10.1038/nprot.2007.391
   Kruth J. P., 2008, P 3 INT C POL MOULDS
   Kruth JP, 2005, RAPID PROTOTYPING J, V11, P26, DOI 10.1108/13552540510573365
   LAM C. X. F., 2008, VIRTUAL PHYS PROTOTY, P193
   LEE T. S., 2013, 5 MECH PROPERTIES PO, P177
   Liggins RT, 2001, INT J PHARM, V222, P19, DOI 10.1016/S0378-5173(01)00690-1
   MANAVITEHRANI I., 2016, POLYMERS
   Mathew AP, 2006, J APPL POLYM SCI, V101, P300, DOI 10.1002/app.23346
   Negi S, 2014, RAPID PROTOTYPING J, V20, P256, DOI 10.1108/RPJ-07-2012-0065
   OKSMAN K., 2003, NATURAL FIBERS REINF, P1317
   OSTHUIZEN G.A., 2013, SAIIE25 P
   Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5
   ROGOZEA L., 2010, 9 WSEAS INT C ED ED
   ROY K.D., 2005, [No title captured], Patent No. [US8048007 B2, 8048007]
   SODERGARD A., 2002, PROGR POLYM SCI, P123
   Stanek M., 2012, INT J MATH COMPUTERS, V6, P550
   TELFER S., 2012, BMC MUSCULOSKELETAL
   Telfer S, 2013, GAIT POSTURE, V38, P443, DOI 10.1016/j.gaitpost.2013.01.012
   YAN C., 2012, COMPOSITE INTERFACES, P257
   ZACHARIASEN J.T., 2014, [No title captured], Patent No. [US20140180185 Al, 20140180185]
NR 32
TC 3
Z9 3
U1 1
U2 10
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD MAR
PY 2017
VL 54
IS 1
BP 98
EP 102
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA ET9LV
UT WOS:000400629900022
DA 2018-10-20
ER

PT J
AU Caliman, LB
   da Silva, SN
   Junkes, JA
   Sagrillo, VP
AF Caliman, Lorena Batista
   da Silva, Sidney Nicodemos
   Junkes, Janaina Accordi
   Della Sagrillo, Viviana Possamai
TI Ostrich Eggshell as an Alternative Source of Calcium Ions for
   Biomaterials Synthesis
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE Hydroxyapatite; beta-TCP; biomaterials; ostrich eggshells; recycling
ID PHOSPHATE APATITES; HYDROXYAPATITE; CATALYSTS; BIODIESEL
AB Ostrich eggshells are a potentially abundant and a high purity and low cost source of calcium to produce beta-Tricalcium Phosphate (beta-TCP) and Hydroxyapatite (HA), important calcium phosphates used as biomaterials. Here, we use a wet precipitation procedure to synthesize these phosphates using ostrich eggshells as a source of calcium ions. The biphasic precipitated powder, calcined at 800 degrees C, is a mixture of both Hydroxyapatite and beta-Tricalcium Phosphate, also known as the biomaterial Biphasic Calcium Phosphate (BCP). Physico-chemical properties of the final powder product show water and CO32- groups absorbed in the particles surface, 0.1 to 100 mu m particles size distribution and 11.70 m(2)/g of specific surface area.
C1 [Caliman, Lorena Batista] Univ Sao Paulo, Dept Met & Mat Engn, Av Prof Mello Moraes 2463, BR-05508030 Sao Paulo, SP, Brazil.
   [da Silva, Sidney Nicodemos] Fed Ctr Technol Educ Minas Gerais CEFET MG, Dept Mat Engn, Av Amazonas 5253, BR-30421169 Belo Horizonte, MG, Brazil.
   [Junkes, Janaina Accordi] Univ Ctr Tiradentes UNIT, Av Comendador Gustavo Paiva 5014, BR-57038000 Maceio, AL, Brazil.
   [Caliman, Lorena Batista; Della Sagrillo, Viviana Possamai] Fed Inst Espirito Santo IFES, Av Vitoria 1729, BR-29040780 Vitoria, ES, Brazil.
RP Junkes, JA (reprint author), Univ Ctr Tiradentes UNIT, Av Comendador Gustavo Paiva 5014, BR-57038000 Maceio, AL, Brazil.
EM janajunkes@gmail.com
RI Junkes, Janaina/K-5749-2018
OI Junkes, Janaina/0000-0002-4442-8856
FU CAPES
FX The authors thanks CAPES, for the financial support; Santa Esmeralda
   Struthio Farm, for the ostrich eggshell supply for this work;
   LABPETRO-UFES, PMT-USP, DEMAT-CEFET-MG, LEEAA-USP for the
   characterization analysis.
CR Ahmed S., 2008, BANGLADESH J SCI IND, V43, P501
   Chen GY, 2014, BIORESOURCE TECHNOL, V171, P428, DOI 10.1016/j.biortech.2014.08.102
   Conz MB, 2010, IMPLANTNEWS, V7, P541
   Dalapicula SS, 2006, IMPLANTNEWS, V3, P487
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dupoirieux L, 1999, BRIT J ORAL MAX SURG, V37, P467, DOI 10.1054/bjom.1999.0041
   Khemthong P, 2012, CATAL TODAY, V190, P112, DOI 10.1016/j.cattod.2011.12.024
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Ribeiro-Junior C., 2008, THESIS
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tan YH, 2015, APPL ENERG, V160, P58, DOI 10.1016/j.apenergy.2015.09.023
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
NR 16
TC 0
Z9 0
U1 2
U2 9
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2017
VL 20
IS 2
BP 413
EP 417
DI 10.1590/1980-5373-MR-2016-0368
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA ET3EN
UT WOS:000400160300014
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Camassa, JA
   Diogo, CC
   Sousa, CP
   Azevedo, JT
   Viegas, CA
   Reis, RL
   Dourado, N
   Dias, IR
AF Camassa, Jose A.
   Diogo, Camila C.
   Sousa, Cristina P.
   Azevedo, Jorge T.
   Viegas, Carlos A.
   Reis, Rui L.
   Dourado, Nuno
   Dias, Isabel R.
TI Bone turnover markers in sheep and goat: A review of the scientific
   literature
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Bone formation markers; bone resorption markers; bone metabolism; small
   ruminants
ID RESISTANT ACID-PHOSPHATASE; INDUCED METABOLIC-ACIDOSIS; C-TERMINAL
   TELOPEPTIDE; BIOCHEMICAL MARKERS; ALKALINE-PHOSPHATASE; I COLLAGEN;
   ANIMAL-MODEL; DAIRY GOATS; GLUCOCORTICOID APPLICATION; BIOMATERIAL
   RESEARCH
AB Bone turnover markers (BTMs) are product of bone cell activity and are generally divided in bone formation and bone resorption markers. The purpose of this review was to structure the available information on the use of BTMs in studies on small ruminants, especially for monitoring their variations related to diet, exercise, gestation and metabolic lactation state, circadian and seasonal variations, and also during skeletal growth. Pre-clinical and translational studies using BTMs with sheep and goats as animal models in orthopaedic research studies to help in the evaluation of the fracture healing process and osteoporosis research are also described in this review. The available information from the reviewed studies was systematically organized in order to highlight the most promising BTMs in small ruminant research, as well as provide a wide view of the use of sheep and goat as animal models in orthopaedic research, type of markers and commercial assay kits with cross-reactivity in sheep and goat, method of sample and storage of serum and urine for bone turnover markers determination and the usefulness and limitations of bone turnover markers in the different studies, therefore an effective tool for researchers that seek answers to different questions while using BTMs in small ruminants.
C1 [Camassa, Jose A.; Diogo, Camila C.; Viegas, Carlos A.; Dias, Isabel R.] Univ Tras Os Montes & Alto Douro UTAD, Agr & Vet Sci Sch ECAV, Dept Vet Sci, P-5000801 Quinta De Prados, Vila Real, Portugal.
   [Sousa, Cristina P.] Ctr Hosp Porto, P-4099001 Oporto, Portugal.
   [Azevedo, Jorge T.] UTAD, Dept Anim Sci ECAV, P-5000801 Quinta De Prados, Vila Real, Portugal.
   [Azevedo, Jorge T.] UTAD, Ctr Anim Sci & Vet Studies CECAV, P-5000801 Quinta De Prados, Vila Real, Portugal.
   [Viegas, Carlos A.; Dias, Isabel R.] UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, P-5000801 Quinta De Prados, Vila Real, Portugal.
   [Reis, Rui L.] Univ Minho, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk Parque Ciencia & Tecnol, P-4805017 Barco Gmr, Portugal.
   [Reis, Rui L.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Campus Gualtar, P-4710057 Braga, Portugal.
   [Dourado, Nuno] Univ Minho, Dept Mech Engn, Azurem Campus, P-4804533 Guimaraes, Portugal.
RP Dias, IR (reprint author), Univ Tras Os Montes & Alto Douro UTAD, Agr & Vet Sci Sch ECAV, Dept Vet Sci, P-5000801 Quinta De Prados, Vila Real, Portugal.; Dias, IR (reprint author), UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, P-5000801 Quinta De Prados, Vila Real, Portugal.
EM idias@utad.pt
RI Dias, Isabel/B-8230-2013; Reis, Rui L./A-8938-2008; Azevedo,
   Jorge/A-5243-2011; Group, 3Bs/E-4374-2012
OI Dias, Isabel/0000-0001-5049-4473; Reis, Rui L./0000-0002-4295-6129;
   Azevedo, Jorge/0000-0003-2383-5206; Group, 3Bs/0000-0002-5195-3456;
   Camassa, Jose Arthur/0000-0002-3734-2798; Viegas,
   Carlos/0000-0002-8796-5037
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil [202248/2015-1]
FX Jose Arthur de A. Camassa acknowledges to the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, for his PhD
   scholarship 202248/2015-1.
CR Allen MJ, 2000, RES VET SCI, V69, P123, DOI 10.1053/rvsc.2000.0397
   Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x
   Altman AR, 2015, BONE, V81, P370, DOI 10.1016/j.bone.2015.07.037
   Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
   Andreasen CM, 2015, BONE, V75, P32, DOI 10.1016/j.bone.2015.02.014
   Arens D, 2007, VET J, V174, P585, DOI 10.1016/j.tvjl.2006.10.001
   Baharuddin NA, 2015, J PERIODONTAL RES, V50, P211, DOI 10.1111/jre.12196
   Cepelak I, 2009, BIOCHEM MEDICA, V19, P17
   Chanetsa F, 2000, J BONE MINER RES, V15, P1361, DOI 10.1359/jbmr.2000.15.7.1361
   CHAVASSIEUX P, 1991, CLIN RHEUMATOL, V10, P269, DOI 10.1007/BF02208688
   Chavassieux P, 2001, J BONE MINER RES, V16, P89, DOI 10.1359/jbmr.2001.16.1.89
   Chavassieux P, 1997, BONE, V20, P451, DOI 10.1016/S8756-3282(97)00016-1
   Chubb SAP, 2012, CLIN BIOCHEM, V45, P928, DOI 10.1016/j.clinbiochem.2012.03.035
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Collignon H, 1996, REPROD FERT DEVELOP, V8, P287, DOI 10.1071/RD9960287
   Coulibaly MO, 2010, CRIT REV EUKAR GENE, V20, P105, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.20
   Cremers S, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1857, DOI 10.1016/B978-0-12-373884-4.00020-3
   Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2
   Dias IR, 2008, LAB ANIM-UK, V42, P465, DOI 10.1258/la.2007.06037e
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   GERRITS MI, 1995, CLIN CHEM, V41, P571
   Goebel S, 2009, J ORTHOP RES, V27, P1141, DOI 10.1002/jor.20857
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Hannon RA, 2004, BONE, V34, P187, DOI 10.1016/j.bone.2003.04.002
   Hintermeister JG, 2008, AM J VET RES, V69, P1481, DOI 10.2460/ajvr.69.11.1481
   Iglesias L, 2011, J BONE MINER METAB, V29, P159, DOI 10.1007/s00774-010-0210-3
   Johnson RB, 2002, J PERIODONTOL, V73, P383, DOI 10.1902/jop.2002.73.4.383
   Kielbowicz Z, 2016, POL J VET SCI, V19, P109, DOI 10.1515/pjvs-2016-0014
   Kielbowicz Z, 2015, POL J VET SCI, V18, P645, DOI 10.1515/pjvs-2015-0083
   Klein P, 2004, CALCIFIED TISSUE INT, V75, P40, DOI 10.1007/s00223-004-0183-0
   Kreipke TC, 2014, J BIOMECH, V47, P1918, DOI 10.1016/j.jbiomech.2014.03.025
   Leeming DJ, 2006, EUR J CLIN PHARMACOL, V62, P781, DOI 10.1007/s00228-006-0174-3
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Liesegang A, 2008, J DAIRY SCI, V91, P2449, DOI 10.3168/jds.2006-838
   Liesegang A, 2007, J ANIM PHYSIOL AN N, V91, P217, DOI 10.1111/j.1439-0396.2007.00695.x
   Liesegang A, 2006, BONE, V38, P794, DOI 10.1016/j.bone.2005.11.006
   Liesegang A, 2005, J ANIM PHYSIOL AN N, V89, P113, DOI 10.1111/j.1439-0396.2005.00548.x
   Liesegang A, 2003, ANIM SCI, V77, P197
   Liesegang A, 2013, J ANIM PHYSIOL AN N, V97, P58, DOI 10.1111/j.1439-0396.2011.01242.x
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P480, DOI 10.1007/s001980200058
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047
   Lomeo A, 2000, CLIN CHEM, V46, P1200
   MacLeay JM, 2004, CALCIFIED TISSUE INT, V75, P431, DOI 10.1007/s00223-004-0217-7
   MacLeay JM, 2004, J BONE MINER METAB, V22, P561, DOI 10.1007/s00774-004-0524-0
   Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6
   Moghaddam A, 2011, INJURY, V42, P758, DOI 10.1016/j.injury.2010.11.017
   Nafei A, 2000, J BONE JOINT SURG BR, V82B, P921, DOI 10.1302/0301-620X.82B6.9837
   Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Newton BI, 2004, J COMP PATHOL, V130, P323, DOI 10.1016/j.jcpa.2003.12.007
   Nicodemo MLF, 1999, EXP PHYSIOL, V84, P579
   O'Loughlin PF, 2008, J BONE JOINT SURG AM, V90A, P79, DOI 10.2106/JBJS.G.01585
   Paskalev M, 2010, TURK J VET ANIM SCI, V34, P227, DOI 10.3906/vet-0711-11
   PASTOUREAU P, 1991, BONE, V12, P143, DOI 10.1016/8756-3282(91)90036-I
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   PRICE JS, 1995, BONE, V17, P221, DOI 10.1016/8756-3282(95)00221-X
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Ravaglioli A, 1996, BIOMATERIALS, V17, P617, DOI 10.1016/0142-9612(96)88712-6
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Reinwald S, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P159, DOI 10.1007/978-0-85729-293-3_13
   Roudsari JM, 2012, CASP J INTERN MED, V3, P478
   Schmidt J, 2008, Z ORTHOP UNFALLCHIR, V146, P490, DOI 10.1055/s-2008-1038766
   Schmit JM, 2012, J VET INTERN MED, V26, P126, DOI 10.1111/j.1939-1676.2011.00834.x
   Scott D, 1997, EXP PHYSIOL, V82, P193, DOI 10.1113/expphysiol.1997.sp004008
   Seebeck P, 2005, BONE, V37, P669, DOI 10.1016/j.bone.2005.06.008
   Seeman E, 2009, CRIT REV EUKAR GENE, V19, P219, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.40
   Seibel Markus J., 2006, Arq Bras Endocrinol Metab, V50, P603, DOI 10.1590/S0004-27302006000400006
   Seibel Markus J, 2005, Clin Biochem Rev, V26, P97
   SEIBEL MJ, 1992, TRENDS ENDOCRIN MET, V3, P263, DOI 10.1016/1043-2760(92)90129-O
   Seibel MJ, 2002, CURR OPIN CLIN NUTR, V5, P525, DOI 10.1097/00075197-200209000-00011
   Seibel MJ, 2001, CLIN CHEM, V47, P1443
   Sigrist IM, 2007, J BONE MINER METAB, V25, P28, DOI 10.1007/s00774-006-0724-x
   Smith SY, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P135, DOI 10.1007/978-0-85729-293-3_12
   Souberbielle Jean-Claude, 1999, Current Opinion in Rheumatology, V11, P312, DOI 10.1097/00002281-199907000-00016
   Sousa C, 2011, ARQ BRAS MED VET ZOO, V63, P1007, DOI 10.1590/S0102-09352011000400029
   Sousa CP, 2015, AN ACAD BRAS CIENC, V87, P1049, DOI 10.1590/0001-3765201520150008
   Sousa CP, 2014, ACTA VET HUNG, V62, P205, DOI 10.1556/AVet.2013.049
   Sousa CP, 2014, LAB ANIMAL, V43, P21, DOI 10.1038/laban.418
   Tatara MR, 2008, EXP PHYSIOL, V93, P763, DOI 10.1113/expphysiol.2007.041145
   Taylor MS, 2009, J DAIRY SCI, V92, P223, DOI 10.3168/jds.2008-1345
   Tralman G, 2013, ANAT HISTOL EMBRYOL, V42, P80, DOI 10.1111/j.1439-0264.2012.01167.x
   Turner AS, 2007, VET J, V174, P460, DOI 10.1016/j.tvjl.2006.10.011
   Turner AS, 2007, J SHOULDER ELB SURG, V16, p158S, DOI 10.1016/j.jse.2007.03.002
   Turner A. Simon, 2001, European Cells & Materials, V1, P66
   TURNER AS, 1995, BONE, V17, pS395, DOI 10.1016/8756-3282(95)00317-7
   van der Donk S, 2001, COMPARATIVE MED, V51, P336
   Vasikaran S, 2011, CLIN CHEM LAB MED, V49, P1271, DOI 10.1515/CCLM.2011.602
   Vernon KL, 2010, J EQUINE VET SCI, V30, P266, DOI 10.1016/j.jevs.2010.03.001
   Watts NB, 1999, CLIN CHEM, V45, P1359
   Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201
   WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439
   Wilkens MR, 2010, DOMEST ANIM ENDOCRIN, V38, P190, DOI 10.1016/j.domaniend.2009.10.003
   Windhagen H, 2002, ARCH ORTHOP TRAUM SU, V122, P279, DOI 10.1007/s00402-001-0380-5
   ZAHARI MW, 1994, EXP PHYSIOL, V79, P175
NR 94
TC 2
Z9 2
U1 1
U2 8
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD MAR
PY 2017
VL 89
IS 1
BP 231
EP 245
DI 10.1590/0001-3765201720160407
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES7VS
UT WOS:000399760100021
PM 28273244
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Delcassian, D
   Sattler, S
   Dunlop, IE
AF Delcassian, Derfogail
   Sattler, Susanne
   Dunlop, Iain E.
TI T cell immunoengineering with advanced biomaterials
SO INTEGRATIVE BIOLOGY
LA English
DT Review
ID ANTIGEN-PRESENTING CELLS; IMMUNOLOGICAL SYNAPSE STRUCTURE; CLASS-II
   MOLECULES; ACTIN CYTOSKELETON; L-SELECTIN; SYNTHETIC NANOPARTICLES;
   ADOPTIVE IMMUNOTHERAPY; RECEPTOR MICROCLUSTERS; LYMPHOCYTE-ACTIVATION;
   SUBSTRATE ELASTICITY
AB Recent advances in biomaterials design offer the potential to actively control immune cell activation and behaviour. Many human diseases, such as infections, cancer, and autoimmune disorders, are partly mediated by inappropriate or insufficient activation of the immune system. T cells play a central role in the host immune response to these diseases, and so constitute a promising cell type for manipulation. In vivo, T cells are stimulated by antigen presenting cells (APC), therefore to design immunoengineering biomaterials that control T cell behaviour, artificial interfaces that mimic the natural APC-T cell interaction are required. This review draws together research in the design and fabrication of such biomaterial interfaces, and highlights efforts to elucidate key parameters in T cell activation, such as substrate mechanical properties and spatial organization of receptors, illustrating how they can be manipulated by bioengineering approaches to alter T cell function.
C1 [Delcassian, Derfogail] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Delcassian, Derfogail] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Sattler, Susanne] Imperial Coll London, Natl Heart & Lung Inst, Du Cane Rd, London W12 0NN, England.
   [Dunlop, Iain E.] Imperial Coll London, Dept Mat, London SW7 2AZ, England.
RP Delcassian, D (reprint author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.; Delcassian, D (reprint author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Dunlop, IE (reprint author), Imperial Coll London, Dept Mat, London SW7 2AZ, England.
EM derfogail.delcassian@nottingham.ac.uk; i.dunlop@imperial.ac.uk
OI Delcassian, Derfogail/0000-0002-8030-7672
FU EPRSC E-TERM Landscape Fellowship scheme [EP/I017801/1]; BHF
   Cardiovascular Regenerative Medicine Centre [RM/13/1/30157]; Engineering
   and Physical Sciences Research Council [EP/I017801/1]
FX DD acknowledges an EPRSC E-TERM Landscape Fellowship scheme
   (EP/I017801/1). SS was supported by the BHF Cardiovascular Regenerative
   Medicine Centre (RM/13/1/30157 to Prof. Sian E. Harding).
CR Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x
   Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849
   Anderson HA, 2000, FASEB J, V14, pA1195
   Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842
   Andorko JI, 2015, AAPS J, V17, P323, DOI 10.1208/s12248-014-9708-2
   Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103
   Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466
   Barsegov VA, 2004, BIOPHYS J, V86, p152A
   Bashour KT, 2014, MOL CELL BIOL, V34, P955, DOI 10.1128/MCB.00842-13
   Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004
   Beemiller P, 2013, IMMUNOL REV, V256, P148, DOI 10.1111/imr.12120
   Bergler T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156900
   Biggs MJP, 2011, J R SOC INTERFACE, V8, P1462, DOI 10.1098/rsif.2011.0025
   BLANDEN RV, 1974, TRANSPLANT REV, V19, P56
   Cai HG, 2015, BIOPHYS J, V108, p631A, DOI 10.1016/j.bpj.2014.11.3433
   Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182
   Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107
   Chen B, 2014, ACS APPL MATER INTER, V6, P18435, DOI 10.1021/am505510m
   Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Comrie WA, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00068
   Crites TJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3892
   Curtsinger J, 1997, J IMMUNOL METHODS, V209, P47, DOI 10.1016/S0022-1759(97)00146-4
   Custodio CA, 2014, LANGMUIR, V30, P10066, DOI 10.1021/la502688h
   Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007
   Deeg J, 2013, NANO LETT, V13, P5619, DOI 10.1021/nl403266t
   Delcassian D, 2013, NANO LETT, V13, P5608, DOI 10.1021/nl403252x
   Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041
   Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547
   Dinic J, 2013, BBA-BIOMEMBRANES, V1828, P1102, DOI 10.1016/j.bbamem.2012.12.004
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066
   Dutta D, 2014, METHOD CELL BIOL, V120, P53, DOI 10.1016/B978-0-12-417136-7.00004-5
   Edozie FC, 2014, TRANSPLANTATION, V98, P370, DOI 10.1097/TP.0000000000000243
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2005, BIOPHYS J, V88, p500A
   Fadel TR, 2014, NAT NANOTECHNOL, V9, P639, DOI [10.1038/NNANO.2014.154, 10.1038/nnano.2014.154]
   Fadel TR, 2013, SMALL, V9, P666, DOI 10.1002/smll.201201684
   Fadel TR, 2010, LANGMUIR, V26, P5645, DOI 10.1021/la902068z
   Fang RH, 2015, SMALL, V11, P5483, DOI [10.1002/smll.201570249, 10.1002/smll.201501284]
   Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598
   Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131
   Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0
   Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209
   Geiger B, 2006, CELL, V127, P879, DOI 10.1016/j.cell.2006.11.020
   Ghassemi S, 2009, J VAC SCI TECHNOL B, V27, P3088, DOI 10.1116/1.3259953
   Ghassemi S, 2008, J VAC SCI TECHNOL B, V26, P2549, DOI 10.1116/1.3013424
   Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102
   Goral S, 2011, DIALYSIS TRANSPLANT, V40, P14, DOI 10.1002/dat.20527
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134
   Hashimoto-Tane A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00255
   Hotaling NA, 2015, ANNU REV BIOMED ENG, V17, P317, DOI 10.1146/annurev-bioeng-071813-104814
   Hotchkiss KM, 2016, ACTA BIOMATER, V31, P425, DOI 10.1016/j.actbio.2015.12.003
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987
   Irvine DJ, 2007, CURR OPIN IMMUNOL, V19, P463, DOI 10.1016/j.coi.2007.05.003
   Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.simm.2007.02.011
   Irvine DJ, 2015, CHEM REV, V115, P11109, DOI 10.1021/acs.chemrev.5b00109
   Jhunjhunwala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137550
   Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011
   June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635
   Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2
   Kaplan A, 2011, J IMMUNOL, V187, P760, DOI 10.4049/jimmunol.1002208
   Klotzsch E, 2015, BBA-MOL CELL RES, V1853, P822, DOI 10.1016/j.bbamcr.2014.10.025
   Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3
   Labowsky M, 2015, NANOMED-NANOTECHNOL, V11, P1019, DOI 10.1016/j.nano.2014.12.019
   Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717
   Lee J, 2012, BIOCONJUGATE CHEM, V23, P1174, DOI 10.1021/bc2006219
   Lee JY, 2013, J UROLOGY, V190, P1192, DOI 10.1016/j.juro.2013.04.077
   Lee JH, 2015, INTEGR BIOL-UK, V7, P1442, DOI 10.1039/c5ib00215j
   Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832
   Lin W, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0108-x
   Liu ZG, 2016, CARBOHYD POLYM, V142, P141, DOI 10.1016/j.carbpol.2016.01.021
   Lohmuller T, 2011, NANO LETT, V11, P4912, DOI 10.1021/nl202847t
   Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043
   Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp
   Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008
   Mandal S, 2015, ACS CHEM BIOL, V10, P485, DOI 10.1021/cb500455g
   Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605
   Matic J, 2013, NANO LETT, V13, P5090, DOI 10.1021/nl4022623
   MESCHER MF, 1992, J IMMUNOL, V149, P2402
   Meyer RA, 2015, SMALL, V11, P1519, DOI 10.1002/smll.201402369
   Milone MC, 2005, CLIN IMMUNOL, V117, P101, DOI 10.1016/j.clim.2005.08.013
   Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019
   Monks CRF, 1998, NATURE, V395, P82
   Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190
   Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238
   Muth CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054778
   O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757
   O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778
   Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]
   Perica K, 2015, ACS NANO, V9, P6861, DOI 10.1021/acsnano.5b02829
   Perica K, 2015, BBA-MOL CELL RES, V1853, P781, DOI 10.1016/j.bbamcr.2014.09.001
   Perica K, 2014, ACS NANO, V8, P2252, DOI 10.1021/nn405520d
   Platzman I, 2013, J AM CHEM SOC, V135, P3339, DOI 10.1021/ja311588c
   Plesa G, 2012, BLOOD, V119, P3420, DOI 10.1182/blood-2011-09-377051
   Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415
   Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488
   Santos LC, 2012, MOL BIOL CELL, V23
   Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044
   Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003
   Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9
   Sheikh Z, 2015, MATERIALS, V8, P5671, DOI 10.3390/ma8095269
   Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105
   Shen KY, 2009, J AM CHEM SOC, V131, P13204, DOI 10.1021/ja904721h
   Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617
   Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P1115, DOI 10.1517/14712590903132513
   Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498
   Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027227
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Sykulev Y., 2012, J IMMUNOL S1, V188
   Thauland TJ, 2008, J IMMUNOL, V181, P393, DOI 10.4049/jimmunol.181.1.393
   Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108
   Tsai J, 2010, BIOPHYS J, V98, p406A, DOI 10.1016/j.bpj.2009.12.2186
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Valensin S, 2002, EUR J IMMUNOL, V32, P435, DOI 10.1002/1521-4141(200202)32:2<435::AID-IMMU435>3.0.CO;2-H
   Valitutti S, 2010, FEBS LETT, V584, P4851, DOI 10.1016/j.febslet.2010.10.010
   van den Berg HA, 2004, J THEOR BIOL, V228, P397, DOI 10.1016/j.jtbi.2004.02.002
   Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779
   Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002
   Wan ZP, 2013, J IMMUNOL, V190, P4661, DOI 10.4049/jimmunol.1202976
   Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Xie JM, 2013, IMMUNOL REV, V251, P65, DOI 10.1111/imr.12017
   Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144
   Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272
   Yoo JW, 2011, ADV DRUG DELIVER REV, V63, P1247, DOI 10.1016/j.addr.2011.05.004
   Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210
   Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030704
   Zhang JL, 2003, LANGMUIR, V19, P7616, DOI 10.1021/la034480u
   Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037
NR 140
TC 5
Z9 5
U1 2
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PD MAR 1
PY 2017
VL 9
IS 3
BP 211
EP 222
DI 10.1039/c6ib00233a
PG 12
WC Cell Biology
SC Cell Biology
GA ER3KB
UT WOS:000398694600003
PM 28252135
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Humar, M
   Kwok, SJJ
   Choi, M
   Yetisen, AK
   Cho, S
   Yun, SH
AF Humar, Matjaz
   Kwok, Sheldon J. J.
   Choi, Myunghwan
   Yetisen, Ali K.
   Cho, Sangyeon
   Yun, Seok-Hyun
TI Toward biomaterial-based implantable photonic devices
SO NANOPHOTONICS
LA English
DT Review
DE biomaterials; biocompatible; biodegradable; optics; photonics
ID OPTICAL WAVE-GUIDES; LIGHT-EMITTING DEVICES; FOREIGN-BODY REACTION;
   CRYSTALLINE COLLOIDAL ARRAYS; SILK FIBROIN FILMS; IN-VIVO; PHOTODYNAMIC
   THERAPY; FLUORESCENT PROTEIN; PLASMONIC NANOSTRUCTURES; BIOMEDICAL
   APPLICATIONS
AB Optical technologies are essential for the rapid and efficient delivery of health care to patients. Efforts have begun to implement these technologies in miniature devices that are implantable in patients for continuous or chronic uses. In this review, we discuss guidelines for biomaterials suitable for use in vivo. Basic optical functions such as focusing, reflection, and diffraction have been realized with biopolymers. Biocompatible optical fibers can deliver sensing or therapeutic-inducing light into tissues and enable optical communications with implanted photonic devices. Wirelessly powered, light-emitting diodes (LEDs) and miniature lasers made of biocompatible materials may offer new approaches in optical sensing and therapy. Advances in biotechnologies, such as optogenetics, enable more sophisticated photonic devices with a high level of integration with neurological or physiological circuits. With further innovations and translational development, implantable photonic devices offer a pathway to improve health monitoring, diagnostics, and light-activated therapies.
C1 [Humar, Matjaz; Kwok, Sheldon J. J.; Choi, Myunghwan; Yetisen, Ali K.; Cho, Sangyeon; Yun, Seok-Hyun] Harvard Med Sch, 65 Landsdowne St,UP-5, Cambridge, MA 02139 USA.
   [Humar, Matjaz; Kwok, Sheldon J. J.; Choi, Myunghwan; Yetisen, Ali K.; Cho, Sangyeon; Yun, Seok-Hyun] Massachusetts Gen Hosp, Wellman Ctr Photomed, 65 Landsdowne St,UP-5, Cambridge, MA 02139 USA.
   [Kwok, Sheldon J. J.; Cho, Sangyeon; Yun, Seok-Hyun] Harvard MIT Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Humar, Matjaz] J Stefan Inst, Condensed Matter Dept, Jamova 39, SI-1000 Ljubljana, Slovenia.
   [Choi, Myunghwan] Sungkyunkwan Univ, Dept Biomed Engn, 2066 Seobu Ro, Suwon, South Korea.
   [Choi, Myunghwan] Inst Basic Sci, Ctr Neurosci & Imaging Res, 2066 Seobu Ro, Suwon, South Korea.
RP Yun, SH (reprint author), Harvard Med Sch, 65 Landsdowne St,UP-5, Cambridge, MA 02139 USA.; Yun, SH (reprint author), Massachusetts Gen Hosp, Wellman Ctr Photomed, 65 Landsdowne St,UP-5, Cambridge, MA 02139 USA.; Yun, SH (reprint author), Harvard MIT Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM seok-hyun_yun@hms.harvard.edu
RI Humar, Matjaz/I-8862-2012
OI Humar, Matjaz/0000-0003-3338-6723; Choi, Myunghwan
   (Mark)/0000-0002-4235-7003
FU Military Photomedicine Program of Department of Defence
   [FA9550-13-1-0068]; U.S. National Institutes of Health [P41-EB015903,
   R01-CA192878]; National Science Foundation [CBET-1264356, ECCS-1505569];
   Marie Curie International Outgoing Fellowship [627274]; Samsung
   Scholarship
FX This research was supported in part by the Military Photomedicine
   Program (FA9550-13-1-0068) of Department of Defence, U.S. National
   Institutes of Health (P41-EB015903, R01-CA192878), National Science
   Foundation (CBET-1264356, ECCS-1505569). M.H. was supported in part by
   the Marie Curie International Outgoing Fellowship No 627274 within the
   7th European Community Framework Programme. S.C. acknowledges a Samsung
   Scholarship.
CR Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386
   Alexeev VL, 2004, CLIN CHEM, V50, P2353, DOI 10.1373/clinchem.2004.039701
   Ameli R, 2013, IEEE ENG MED BIO, P5662, DOI 10.1109/EMBC.2013.6610835
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Amsden JJ, 2009, OPT EXPRESS, V17, P21271, DOI 10.1364/OE.17.021271
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   [Anonymous], 2005, IEEE STANDARD SAFETY
   Anselmo AC, 2015, AAPS J, V17, P1041, DOI 10.1208/s12248-015-9780-2
   Apple DJ, 1996, SURV OPHTHALMOL, V40, P279, DOI 10.1016/S0039-6257(96)82003-0
   Aquilina O, 2006, Images Paediatr Cardiol, V8, P17
   Asbell PA, 2005, LANCET, V365, P599
   Asher SA, 2002, ANAL BIOANAL CHEM, V373, P632, DOI 10.1007/s00216-002-1366-z
   Attili SK, 2009, BRIT J DERMATOL, V161, P170, DOI 10.1111/j.1365-2133.2009.09096.x
   Bagley AF, 2013, ACS NANO, V7, P8089, DOI 10.1021/nn4033757
   Bansal A. K., 2014, ADV MATER, P1
   Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bisland SK, 2004, PHOTOCHEM PHOTOBIOL, V80, P22, DOI 10.1562/2004-03-05-RA-100.1
   Briones-Herrera JC, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4823783
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Camposeo A, 2014, ACS NANO, V8, P10893, DOI 10.1021/nn504720b
   Capelli R., ORG ELECT, V12
   CARLSON RJ, 1984, APPL SPECTROSC, V38, P297, DOI 10.1366/0003702844555548
   Chen JIL, 2010, J AM CHEM SOC, V132, P9600, DOI 10.1021/ja103240g
   Cho MJ, 2010, J POLYM SCI POL CHEM, V48, P1913, DOI 10.1002/pola.23958
   Choi M, 2015, ADV MATER, V27, P4081, DOI 10.1002/adma.201501603
   Choi M, 2013, NAT PHOTONICS, V7, P987, DOI [10.1038/nphoton.2013.278, 10.1038/NPHOTON.2013.278]
   Choi Y, 2015, LAB CHIP, V15, P642, DOI 10.1039/c4lc01171f
   Chuang AT, 2014, BRIT J OPHTHALMOL, V98, P852, DOI 10.1136/bjophthalmol-2013-303708
   Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111
   Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001
   Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f
   Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071
   Domachuk P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3275719
   Domschke A., 2004, SENSORS 2004, P1320
   Donaldson K, 2013, CURR OPIN BIOTECH, V24, P724, DOI 10.1016/j.copbio.2013.05.003
   Drane T. M., 2013, SPIE LASE, V8611
   Dupuis A, 2007, OPT LETT, V32, P109, DOI 10.1364/OL.32.000109
   Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001
   Farandos NM, 2015, ADV HEALTHC MATER, V4, P792, DOI 10.1002/adhm.201400504
   Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Frost M, 2006, ANAL CHEM, V78, P7370, DOI 10.1021/ac069475k
   Gao L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5938
   Gather MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6722
   Gather MC, 2011, OPT LETT, V36, P3299, DOI 10.1364/OL.36.003299
   Gather MC, 2011, NAT PHOTONICS, V5, P406, DOI [10.1038/nphoton.2011.99, 10.1038/NPHOTON.2011.99]
   Gautam V, 2014, ADV MATER, V26, P1751, DOI 10.1002/adma.201304368
   Ghezzi D, 2013, NAT PHOTONICS, V7, P400, DOI [10.1038/nphoton.2013.34, 10.1038/NPHOTON.2013.34]
   Ghezzi D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1164
   Ghosh AP, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1929867
   Gomez E. F., 2015, ADV MATER, V27, P7680
   Gomez EF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07105
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   Guo HW, 2015, PHOTODIAGN PHOTODYN, V12, P504, DOI 10.1016/j.pdpdt.2015.04.007
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hashimoto M, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011002
   Helmus MN, 2008, TOXICOL PATHOL, V36, P70, DOI 10.1177/0192623307310949
   Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111
   Hoffman A. S., ADV DRUG DELIVERY RE, V64, P3
   Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006
   Honari G, 2008, CONTACT DERMATITIS, V59, P7, DOI 10.1111/j.1600-0536.2008.01351.x
   Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a
   Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445
   Huby N, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798552
   Humar M., 2015, CLEO QELS FUNDAMENTA
   Humar M, 2015, NAT PHOTONICS, V9, P572, DOI [10.1038/NPHOTON.2015.129, 10.1038/nphoton.2015.129]
   Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Jain A, 2012, OPT LETT, V37, P1472, DOI 10.1364/OL.37.001472
   Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Jewett SA, 2012, ACTA BIOMATER, V8, P728, DOI 10.1016/j.actbio.2011.09.038
   Jiang GQ, 2010, BIOL MED PHYS BIOMED, P27, DOI 10.1007/978-0-387-98120-8_2
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Jonas A, 2014, LAB CHIP, V14, P3093, DOI 10.1039/c4lc00485j
   Joung YH, 2013, INT NEUROUROL J, V17, P98, DOI 10.5213/inj.2013.17.3.98
   Kabilan S, 2005, BIOSENS BIOELECTRON, V20, P1602, DOI 10.1016/j.bios.2004.07.005
   Kawabe Y, 2000, ADV MATER, V12, P1281, DOI 10.1002/1521-4095(200009)12:17<1281::AID-ADMA1281>3.0.CO;2-0
   Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437
   Kimble KW, 2006, ANAL BIOANAL CHEM, V385, P678, DOI 10.1007/s00216-006-0453-y
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889
   Lace R, 2015, J MATER SCI, V50, P1523, DOI 10.1007/s10853-014-8707-0
   Lahoz F, 2015, LASER PHYS LETT, V12, DOI 10.1088/1612-2011/12/4/045805
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lanzani G, 2014, NAT MATER, V13, P775, DOI 10.1038/nmat4021
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee M, 2015, NANO LETT, V15, P3358, DOI 10.1021/acs.nanolett.5b00680
   Lee SY, 2012, NANO ENERGY, V1, P145, DOI 10.1016/j.nanoen.2011.07.001
   Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011
   Lenhert S, 2010, NAT NANOTECHNOL, V5, P275, DOI [10.1038/nnano.2010.17, 10.1038/NNANO.2010.17]
   Li ZT, 2012, J AM CHEM SOC, V134, P3322, DOI 10.1021/ja209981n
   Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI [10.1038/nphoton.2013.242, 10.1038/NPHOTON.2013.242]
   Lin DM, 2012, ADV MATER, V24, P6088, DOI 10.1002/adma.201201888
   Lorach H, 2015, NAT MED, V21, P476, DOI 10.1038/nm.3851
   Lowe S, 2015, POLYM CHEM-UK, V6, P198, DOI 10.1039/c4py01356e
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   Magjarevic R., 2010, SLOV MED J, V79, P55
   Maier S A, 2007, PLASMONICS FUNDAMENT
   Manocchi AK, 2009, BIOTECHNOL BIOENG, V103, P725, DOI 10.1002/bit.22306
   Marshall AJ, 2003, ANAL CHEM, V75, P4423, DOI 10.1021/ac020730k
   Martino N, 2013, J MATER CHEM B, V1, P3768, DOI 10.1039/c3tb20213e
   Mathieson K, 2012, NAT PHOTONICS, V6, P391, DOI [10.1038/NPHOTON.2012.104, 10.1038/nphoton.2012.104]
   Matthes R, 2000, HEALTH PHYS, V79, P431
   McCall JG, 2013, NAT PROTOC, V8, P2413, DOI 10.1038/nprot.2013.158
   Mei H, 2014, NAT BIOTECHNOL, V32, P1008, DOI 10.1038/nbt.3038
   Meredith P, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/034501
   Merrill DR, 2014, CURR OPIN SOLID ST M, V18, P329, DOI 10.1016/j.cossms.2014.07.002
   Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Naydenova I, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837454
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nizamoglu S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10374
   Nizamoglu S, 2015, ADV OPT MATER, V3, P1197, DOI 10.1002/adom.201500144
   Nizamoglu S, 2013, ADV MATER, V25, P5943, DOI 10.1002/adma201300818
   Oh HJ, 2014, OPT EXPRESS, V22, P31411, DOI 10.1364/OE.22.031411
   Oliva N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1616
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Owens RM, 2010, MRS BULL, V35, P449, DOI 10.1557/mrs2010.583
   Pal RK, 2015, ACS APPL MATER INTER, V7, P8809, DOI 10.1021/acsami.5b01380
   Palanker D, 2005, J NEURAL ENG, V2, pS105, DOI 10.1088/1741-2560/2/1/012
   Park DJ, 2015, P NATL ACAD SCI USA, V112, P977, DOI 10.1073/pnas.1422649112
   Park G, 2014, ADV HEALTHC MATER, V3, P515, DOI 10.1002/adhm.201300220
   Park J, 2015, NANOSCALE, V7, P426, DOI 10.1039/c4nr05172f
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Pietroiusti A, 2012, NANOSCALE, V4, P1231, DOI 10.1039/c2nr11688j
   Pisanello F, 2014, NEURON, V82, P1245, DOI 10.1016/j.neuron.2014.04.041
   Polson RC, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/2/024010
   Polson RC, 2004, APPL PHYS LETT, V85, P1289, DOI 10.1063/1.1782259
   Ratner B. D., SCI TRANSL MED, V7
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RIDLEY H, 1952, BRIT J OPHTHALMOL, V36, P113, DOI 10.1136/bjo.36.3.113
   RUNDQUIST PA, 1989, J CHEM PHYS, V91, P4932, DOI 10.1063/1.456734
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Schubert M, 2015, NANO LETT, V15, P5647, DOI 10.1021/acs.nanolett.5b02491
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Sharma AC, 2004, J AM CHEM SOC, V126, P2971, DOI 10.1021/ja038187s
   Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712
   Smith JT, 2014, J DISP TECHNOL, V10, P514, DOI 10.1109/JDT.2014.2308436
   Sokolov K, 2003, TECHNOL CANCER RES T, V2, P491, DOI 10.1177/153303460300200602
   Someya T, 2010, NAT MATER, V9, P879, DOI 10.1038/nmat2886
   Song QH, 2010, BIOMED OPT EXPRESS, V1, P1401, DOI 10.1364/BOE.1.001401
   Song QH, 2010, OPT LETT, V35, P1425, DOI 10.1364/OL.35.001425
   Stingl K., 1757, P R SOC B, V280
   Sun Q, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841671
   Sun QJ, 2009, ACS NANO, V3, P737, DOI 10.1021/nn8009079
   Sun YL, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.10
   Sun YL, 2012, OPT LETT, V37, P2973, DOI 10.1364/OL.37.002973
   Sun YZ, 2010, P NATL ACAD SCI USA, V107, P16039, DOI 10.1073/pnas.1003581107
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Sykes EA, 2013, NAT PHOTONICS, V7, P940, DOI 10.1038/nphoton.2013.308
   Sznitko L, 2013, CHEM PHYS LETT, V576, P31, DOI 10.1016/j.cplett.2013.05.018
   Sznitko L, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3610566
   Takehara H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06721
   Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939
   Vannahme C, 2013, LAB CHIP, V13, P2675, DOI 10.1039/c3lc50140j
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vezouviou E, 2015, BIOSENS BIOELECTRON, V68, P371, DOI 10.1016/j.bios.2015.01.014
   Wan MT, 2014, CLIN COSMET INVESTI, V7, P145, DOI 10.2147/CCID.S35334
   Wang B, 2013, ACCOUNTS CHEM RES, V46, P761, DOI 10.1021/ar2003336
   Ward W Kenneth, 2004, Diabetes Technol Ther, V6, P137, DOI 10.1089/152091504773731320
   Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042
   Wentz CT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046021
   Wiersma DS, 2008, NAT PHYS, V4, P359, DOI 10.1038/nphys971
   Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/NPHOTON.2013.29, 10.1038/nphoton.2013.29]
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Xin H., 2013, NANO LETT
   Yan XH, 2011, ANGEW CHEM INT EDIT, V50, P11186, DOI 10.1002/anie.201103941
   Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006
   Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535
   Yetisen A.K, 2015, HOLOGRAPHIC SENSORS, P27
   Yetisen AK, 2015, ANAL CHEM, V87, P5101, DOI 10.1021/ac504274q
   Yetisen AK, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4905352
   Yetisen AK, 2014, CHEM REV, V114, P10654, DOI 10.1021/cr500116a
   Yetisen AK, 2014, ADV OPT MATER, V2, P250, DOI 10.1002/adom.201300375
   Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149
   Zeng F, 2002, SENSOR ACTUAT B-CHEM, V81, P273, DOI 10.1016/S0925-4005(01)00965-0
   Zhang CJ, 2013, CHEM MATER, V25, P3239, DOI 10.1021/cm401738p
   Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang XW, 2012, LAB CHIP, V12, P3673, DOI 10.1039/c2lc40183e
   Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098
   Zorzos AN, 2012, OPT LETT, V37, P4841, DOI 10.1364/OL.37.004841
   Zorzos AN, 2010, OPT LETT, V35, P4133, DOI 10.1364/OL.35.004133
   Zrenner E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007399
NR 207
TC 16
Z9 17
U1 11
U2 96
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2192-8606
EI 2192-8614
J9 NANOPHOTONICS-BERLIN
JI Nanophotonics
PD MAR
PY 2017
VL 6
IS 2
BP 414
EP 434
DI 10.1515/nanoph-2016-0003
PG 21
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Optics; Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Optics; Physics
GA ES1JE
UT WOS:000399283100003
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jiang, XJ
   Wang, Y
   Fan, DC
   Zhu, CH
   Liu, L
   Duan, ZG
AF Jiang, Xijuan
   Wang, Ya
   Fan, Daidi
   Zhu, Chenhui
   Liu, Lin
   Duan, Zhiguang
TI A novel human-like collagen hemostatic sponge with uniform morphology,
   good biodegradability and biocompatibility
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Human-like collagen; glutamine transaminase; freeze-drying; uniform;
   biodegradable; biocompatibility; hemostatic sponge
ID RECOMBINANT COLLAGEN; ENDOTOXIN REMOVAL; CHITOSAN; ADHESION; GELATIN;
   CULTURE; INJURY
AB Biodegradable sponges, as a promising hemostatic biomaterial, has been clinically required over the past decades. Current hemostatic sponges are generally prepared by crosslinking and freeze-drying, but the quality control or biocompatibility is often unsatisfactory due to the freezing-caused morphological non-uniformity and the toxicity of raw materials or cross-linkers. The crosslinking often greatly retards the degradation of the sponges and thus affects the healing of the wound. In this work, we prepared a novel hemostatic sponge using human-like collagen and glutamine transaminase (non-toxic cross-linker) and optimized its morphology via "two-step'' freezing instead of conventional "one-step'' freezing. The resulting sponge showed a good biocompatibility in cytotoxicity and implantation tests and had a significant hemostatic effect in ear artery and liver injury models. Moreover, the sponge could be degraded high efficiently by several common enzymes in organisms (e.g. I collagenase, trypsase, and lysozyme), which means that the sponge can be easily digested by metabolism and can facilitate seamless healing. Finally, both the front and back of the sponge prepared via two-step freezing was more uniform in morphology than that prepared via one-step freezing. More importantly, two-step freezing can be used as a universal approach for preparation of diverse uniform biomaterials.
C1 [Jiang, Xijuan; Wang, Ya; Fan, Daidi; Zhu, Chenhui; Liu, Lin; Duan, Zhiguang] Northwest Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Taibai North Rd 229, Xian 710069, Shaanxi, Peoples R China.
   [Jiang, Xijuan; Wang, Ya; Fan, Daidi; Zhu, Chenhui; Liu, Lin; Duan, Zhiguang] Northwest Univ, Sch Chem Engn, Xian, Shaanxi, Peoples R China.
RP Fan, DC (reprint author), Northwest Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Taibai North Rd 229, Xian 710069, Shaanxi, Peoples R China.; Fan, DC (reprint author), Northwest Univ, Sch Chem Engn, Xian, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National High Technology Research and Development Program of China
   [2014AA022108]; National Natural Science Foundation of China [21476182,
   21276210]; Shaanxi Key Laboratory of Degradable Biomedical Materials
   Program [2015SZSj-42, 2014SZS07-P05, 14JS102]; Shaanxi R&D Center of
   Biomaterials and Fermentation Engineering Program [2015HBGC-04]; Shaanxi
   Provincial Scientific Technology Research and Development Program
   [2016JM5027]; NWU Graduate Innovation and Creativity Funds [YZZ14006]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was financially supported by the National High Technology Research and
   Development Program of China (2014AA022108), the National Natural
   Science Foundation of China (21476182, 21276210), Shaanxi Key Laboratory
   of Degradable Biomedical Materials Program (2015SZSj-42, 2014SZS07-P05,
   14JS102), Shaanxi R&D Center of Biomaterials and Fermentation
   Engineering Program (2015HBGC-04), Shaanxi Provincial Scientific
   Technology Research and Development Program (2016JM5027), and the NWU
   Graduate Innovation and Creativity Funds (YZZ14006).
CR Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27
   Chen MM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40998
   Chi HL, 2001, INT J PHARM, V221, P1
   Dai DF, 2005, BIOTECHNOL LETT, V27, P865
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Duan ZG, 2012, AFR J MICROBIOL RES, V6, P2543, DOI 10.5897/AJMR12.102
   [范代娣 Fan Daidi], 2002, [化工学报, Journal of Chemical Industry and Engineering (China)], V53, P752
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fuchs B, 2010, THROMB RES, V125, P239, DOI 10.1016/j.thromres.2009.08.020
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hori H, 2002, J ALLERGY CLIN IMMUN, V110, P652, DOI 10.1067/mai.2002.127862
   Hua XF, 2006, CHINESE J CHEM ENG, V14, P242, DOI 10.1016/S1004-9541(06)60065-7
   Hutchinson RW, 2013, CELLULOSE, V20, P537, DOI 10.1007/s10570-012-9828-8
   Jia LP, 2013, MAT SCI ENG C-MATER, V33, P727, DOI 10.1016/j.msec.2012.10.025
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kralisz U, 1997, THROMB RES, V86, P287, DOI 10.1016/S0049-3848(97)00072-8
   Krishnan LK, 2004, BIOMATERIALS, V25, P5557, DOI 10.1016/j.biomaterials.2004.01.013
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   LI X, 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089856
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Ma R, 2010, SEP SCI TECHNOL, V45, P2400, DOI 10.1080/01496395.2010.484825
   Nie JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07635
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Shilo S, 2013, TISSUE ENG PT A, V19, P1519, DOI [10.1089/ten.tea.2012.0345, 10.1089/ten.TEA.2012.0345]
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Wortham L, 2005, MIL MED, V170, pII
   Zhang HZ, 2014, MAT SCI ENG C-MATER, V42, P124, DOI 10.1016/j.msec.2014.05.015
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 33
TC 4
Z9 4
U1 10
U2 41
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2017
VL 31
IS 8
BP 1099
EP 1107
DI 10.1177/0885328216687663
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ER2PC
UT WOS:000398635300001
PM 28077050
DA 2018-10-20
ER

PT J
AU Hong, SC
   Yoo, SY
   Kim, H
   Lee, J
AF Hong, Seong-Chul
   Yoo, Seung-Yup
   Kim, Hyeongmin
   Lee, Jaehwi
TI Chitosan-Based Multifunctional Platforms for Local Delivery of
   Therapeutics
SO MARINE DRUGS
LA English
DT Review
DE chitosan; local delivery; anti-cancer drugs; medical device
ID OCULAR DRUG-DELIVERY; SOLID LIPID NANOPARTICLES; IRON-OXIDE
   NANOPARTICLES; IN-VITRO; MOLECULAR-WEIGHT; ANTICANCER CHEMOEMBOLIZATION;
   BIOMEDICAL APPLICATIONS; ARTERIAL EMBOLIZATION; OPHTHALMIC DELIVERY;
   CYCLOSPORINE-A
AB Chitosan has been widely used as a key biomaterial for the development of drug delivery systems intended to be administered via oral and parenteral routes. In particular, chitosan-based microparticles are the most frequently employed delivery system, along with specialized systems such as hydrogels, nanoparticles and thin films. Based on the progress made in chitosan-based drug delivery systems, the usefulness of chitosan has further expanded to anti-cancer chemoembolization, tissue engineering, and stem cell research. For instance, chitosan has been used to develop embolic materials designed to efficiently occlude the blood vessels by which the oxygen and nutrients are supplied. Indeed, it has been reported to be a promising embolic material. For better anti-cancer effect, embolic materials that can locally release anti-cancer drugs were proposed. In addition, a complex of radioactive materials and chitosan to be locally injected into the liver has been investigated as an efficient therapeutic tool for hepatocellular carcinoma. In line with this, a number of attempts have been explored to use chitosan-based carriers for the delivery of various agents, especially to the site of interest. Thus, in this work, studies where chitosan-based drug delivery systems have successfully been used for local delivery will be presented along with future perspectives.
C1 [Hong, Seong-Chul; Yoo, Seung-Yup; Kim, Hyeongmin; Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea.
RP Lee, J (reprint author), Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea.
EM shotgun30@naver.com; marin4906@naver.com; hm.kim8905@gmail.com;
   jaehwi@cau.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2015R1A5A1008958]; Chung-Ang University Graduate Research
   Scholarship
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No.
   2015R1A5A1008958). This research was also supported by the Chung-Ang
   University Graduate Research Scholarship in 2017.
CR Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476
   Aranaz I, 2010, CURR ORG CHEM, V14, P308, DOI 10.2174/138527210790231919
   Archana D, 2013, INT J BIOL MACROMOL, V57, P193, DOI 10.1016/j.ijbiomac.2013.03.002
   Avadi MR, 2010, NANOMED-NANOTECHNOL, V6, P58, DOI 10.1016/j.nano.2009.04.007
   Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882
   Baetke SC, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150207
   Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312
   Barnett BP, 2006, MOL PHARMACEUT, V3, P531, DOI [10.1021/mp060056l, 10.1021/mp0600561]
   Behl G, 2016, PHARM RES-DORDR, V33, P1638, DOI 10.1007/s11095-016-1903-7
   Bendszus M, 2000, AM J NEURORADIOL, V21, P255
   Bisht S, 2009, WIRES NANOMED NANOBI, V1, P415, DOI 10.1002/wnan.043
   Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004
   Casettari L, 2014, J CONTROL RELEASE, V190, P189, DOI 10.1016/j.jconrel.2014.05.003
   Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156
   Cho IS, 2016, ACTA BIOMATER, V39, P124, DOI 10.1016/j.actbio.2016.05.011
   Cho IS, 2016, CARBOHYD POLYM, V144, P59, DOI 10.1016/j.carbpol.2016.02.029
   Chung EY, 2012, CARBOHYD POLYM, V90, P1725, DOI 10.1016/j.carbpol.2012.07.058
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8
   Di Colo G, 2004, INT J PHARM, V273, P37, DOI 10.1016/j.ijpharm.2003.12.018
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Fan W, 2012, COLLOID SURFACE B, V90, P21, DOI 10.1016/j.colsurfb.2011.09.042
   Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882
   Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3
   Grandfils C, 1996, J CONTROL RELEASE, V38, P109, DOI 10.1016/0168-3659(95)00102-6
   Hamoudeh M, 2008, ADV DRUG DELIVER REV, V60, P1329, DOI 10.1016/j.addr.2008.04.013
   Hermans K, 2014, INT J PHARMACEUT, V472, P10, DOI 10.1016/j.ijpharm.2014.06.017
   Hong H, 2009, NANO TODAY, V4, P399, DOI 10.1016/j.nantod.2009.07.001
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jaikumar D, 2015, INT J BIOL MACROMOL, V74, P318, DOI 10.1016/j.ijbiomac.2014.12.037
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kang MJ, 2010, CHEM PHARM BULL, V58, P288, DOI 10.1248/cpb.58.288
   Kang MJ, 2009, BIOMOL THER, V17, P98, DOI 10.4062/biomolther.2009.17.1.98
   Kapoor Y, 2008, INT J PHARM, V361, P222, DOI 10.1016/j.ijpharm.2008.05.028
   Kim HM, 2013, J DRUG DELIV SCI TEC, V23, P283
   Kim JK, 2010, INT J PHARMACEUT, V401, P79, DOI 10.1016/j.ijpharm.2010.08.029
   Kim JK, 2006, CLIN CANCER RES, V12, P543, DOI 10.1158/1078-0432.CCR-05-1730
   Kim K, 2010, J CONTROL RELEASE, V146, P219, DOI 10.1016/j.jconrel.2010.04.004
   Ko JA, 2002, INT J PHARM, V249, P165, DOI 10.1016/S0378-5173(02)00487-8
   Kubo M, 2003, AM J NEURORADIOL, V24, P1540
   Lee DH, 1999, J KOREAN RADIOL SOC, V41, P1117, DOI DOI 10.3348/JKRS.1999.41.6.1117
   Lee HS, 2005, J MAGN MAGN MATER, V293, P102, DOI 10.1016/j.jmmm.2005.01.049
   Lee S, 2014, BIOCONJUGATE CHEM, V25, P601, DOI 10.1021/bc500020g
   Lee S, 2014, ARCH PLAST SURG-APS, V41, P466, DOI 10.5999/aps.2014.41.5.466
   LEE YH, 1998, J KOREAN RADIOLOGICA, V38, P83, DOI DOI 10.3348/JKRS.1998.38.1.83
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Li S, 2002, J CONTROL RELEASE, V84, P87, DOI 10.1016/S0168-3659(02)00214-6
   Lim EK, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-467
   Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006
   Liu YJ, 2012, BIOCONJUGATE CHEM, V23, P671, DOI 10.1021/bc200264c
   Luo YC, 2015, CARBOHYD POLYM, V122, P221, DOI 10.1016/j.carbpol.2014.12.084
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Mouez MA, 2014, EUR J PHARM SCI, V51, P59, DOI 10.1016/j.ejps.2013.08.029
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Na JH, 2012, J CONTROL RELEASE, V163, P2, DOI 10.1016/j.jconrel.2012.07.028
   Na JH, 2011, BIOMATERIALS, V32, P5252, DOI 10.1016/j.biomaterials.2011.03.076
   Nishida N, 2006, VASC HEALTH RISK MAN, V2, P213, DOI 10.2147/vhrm.2006.2.3.213
   Ozcan I, 2013, INT J NANOMED, V8, P461, DOI 10.2147/IJN.S40519
   Park H, 2013, ACTA BIOMATER, V9, P4779, DOI 10.1016/j.actbio.2012.08.033
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Park JM, 2012, J MICROENCAPSUL, V29, P695, DOI 10.3109/02652048.2012.686526
   Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004
   Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79
   Pok S, 2013, ACTA BIOMATER, V9, P5630, DOI 10.1016/j.actbio.2012.10.032
   Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024
   Rencber S, 2016, INT J NANOMED, V11, P2641, DOI 10.2147/IJN.S103762
   Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Senyigit T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010032
   Seyfoddin A, 2010, DRUG DELIV, V17, P467, DOI 10.3109/10717544.2010.483257
   Shailendra PG, 2015, HANDBOOK OF POLYMERS FOR PHARMACEUTICAL TECHNOLOGIES: VOL 3, BIODEGRADABLE POLYMERS, P33
   Shu XZ, 2001, J MICROENCAPSUL, V18, P237
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Sonvico F, 2006, INT J PHARM, V324, P67, DOI 10.1016/j.ijpharm.2006.06.036
   Sunkireddy P, 2016, NANOMEDICINE-UK, V11, P495, DOI 10.2217/nnm.15.205
   Suzuki YS, 1998, J NUCL MED, V39, P2161
   Tan Q, 2011, INT J NANOMED, V6, P1621, DOI 10.2147/IJN.S22411
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P2637, DOI 10.1021/sc500634p
   Tsai WB, 2012, CARBOHYD POLYM, V89, P379, DOI 10.1016/j.carbpol.2012.03.017
   Tsai WB, 2011, CARBOHYD POLYM, V85, P129, DOI 10.1016/j.carbpol.2011.02.003
   Tu Y, 2016, INT J NANOMED, V11, P5549, DOI 10.2147/IJN.S109552
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Van Woensel M, 2016, J CONTROL RELEASE, V227, P71, DOI 10.1016/j.jconrel.2016.02.032
   Weiser JR, 2014, J CONTROL RELEASE, V190, P664, DOI 10.1016/j.jconrel.2014.04.048
   Wu X, 2010, SKIN PHARMACOL PHYS, V23, P117, DOI 10.1159/000270381
   Yang Y, 2012, BIOMACROMOLECULES, V13, P2154, DOI 10.1021/bm300545b
   Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056
   Yuan Q, 2010, ACTA BIOMATER, V6, P2732, DOI 10.1016/j.actbio.2010.01.025
NR 92
TC 10
Z9 10
U1 4
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD MAR
PY 2017
VL 15
IS 3
AR UNSP 60
DI 10.3390/md15030060
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ER3TA
UT WOS:000398720300009
PM 28257059
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wo, YQ
   Brisbois, EJ
   Wu, JF
   Li, Z
   Major, TC
   Mohammed, A
   Wang, XL
   Colletta, A
   Bull, JL
   Matzger, AJ
   Xi, CW
   Bartlett, RH
   Meyerhoff, ME
AF Wo, Yaqi
   Brisbois, Elizabeth J.
   Wu, Jianfeng
   Li, Zi
   Major, Terry C.
   Mohammed, Azmath
   Wang, Xianglong
   Colletta, Alessandro
   Bull, Joseph L.
   Matzger, Adam J.
   Xi, Chuanwun
   Bartlett, Robert H.
   Meyerhoff, Mark E.
TI Reduction of Thrombosis and Bacterial Infection via Controlled Nitric
   Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP)
   Impregnated CarboSil Intravascular Catheters
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE nitric oxide; S-nitroso-N-acetylpenicillamine (SNAP); solvent
   impregnation; thromboresistance; bactericidal; antimicrobial catheters
ID RABBIT THROMBOGENICITY MODEL; CENTRAL VENOUS CATHETERS; BLOOD-STREAM
   INFECTIONS; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; BIOMEDICAL
   APPLICATIONS; NOSOCOMIAL INFECTIONS; PREVENTION; DISEASES; DEVICES
AB Nitric oxide (NO) has many important physiological functions, including its ability to inhibit platelet activation and serve as potent antimicrobial agent. The multiple roles of NO in vivo have led to great interest in the development of biomaterials that can deliver NO for specific biomedical applications. Herein, we report a simple solvent impregnation technique to incorporate a nontoxic NO donor, S-nitroso-N-acetylpenicillamine (SNAP), into a more biocompatible biomedical grade polymer, CarboSil 20 80A. The resulting polymer-crystal composite material yields a very stable, long-term NO release biomaterial. The SNAP impregnation process is carefully characterized and optimized, and it is shown that SNAP crystal formation occurs in the bulk of the polymer after solvent evaporation. LC-MS results demonstrate that more than 70% of NO release from this new composite material originates from the SNAP embedded CarboSil phase, and not from the SNAP species leaching out into the soaking solution. Catheters prepared with CarboSil and then impregnated with 15 wt % SNAP provide a controlled NO release over a 14 d period at physiologically relevant fluxes and are shown to significantly reduce long-term (14 day) bacterial biofilm formation against Staphylococcus epidermidis and Pseudonomas aeruginosa in a CDC bioreactor model. After 7 h of catheter implantation in the jugular veins of rabbit, the SNAP CarboSil catheters exhibit a 96% reduction in thrombus area (0.03 +/- 0.01 cm(2)/catheter) compared to the controls (0.84 +/- 0.19 cm(2)/catheter) (n = 3). These results suggest that SNAP impregnated CarboSil can become an attractive new biomaterial for use in preparing intravascular catheters and other implanted medical devices.
C1 [Wo, Yaqi; Li, Zi; Colletta, Alessandro; Matzger, Adam J.; Meyerhoff, Mark E.] Univ Michigan, Med Ctr, Dept Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
   [Brisbois, Elizabeth J.; Major, Terry C.; Mohammed, Azmath; Bartlett, Robert H.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.
   [Wu, Jianfeng; Xi, Chuanwun] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   [Wang, Xianglong; Bull, Joseph L.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Med Ctr, Dept Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
OI Matzger, Adam/0000-0002-4926-2752; Wang, Xianglong/0000-0001-5359-8411
FU National Institutes of Health [HL-128337, DK-100161, GM-106180]
FX This work was supported by grants from the National Institutes of Health
   (HL-128337, DK-100161, and GM-106180). We wish to thank Ms. Judy Poore
   for the help with the use of Leica 3050S cryostat. We also want to thank
   DSM company for the gift of the CarboSil 20 80A polymer.
CR Abad C., 2011, INFECT DIS SPEC ED
   Arora DP, 2015, BIOCHEMISTRY-US, V54, P3717, DOI 10.1021/bi501476n
   Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822
   Baskin JL, 2009, LANCET, V374, P159, DOI 10.1016/S0140-6736(09)60220-8
   Brisbois E. J., 2015, ADV POLYM MED, P481
   Brisbois EJ, 2016, ACTA BIOMATER, V37, P111, DOI 10.1016/j.actbio.2016.04.025
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Cabrera-Contreras Roberto, 2013, ISRN Microbiol, V2013, P918921, DOI 10.1155/2013/918921
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Colletta A, 2015, ACS BIOMATER SCI ENG, V1, P416, DOI 10.1021/acsbiomaterials.5b00032
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003
   Dogra GK, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022890.29656.22
   Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077
   Dunn D. L., 2008, SURG BASIC SCI CLIN, P209
   DUNN DL, 1994, SURG CLIN N AM, V74, P621
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Filippi L, 2007, PEDIATR CRIT CARE ME, V8, P556, DOI 10.1097/01.PCC.0000288711.46009.58
   Fletcher S, 2005, BJA EDUC, V5, P49, DOI 10.1093/bjaceaccp/mki011
   Gahlot Rupam, 2014, Int J Crit Illn Inj Sci, V4, P162, DOI 10.4103/2229-5151.134184
   Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003
   Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0
   Graeme Kimberlie A., 1998, Journal of Emergency Medicine, V16, P45, DOI 10.1016/S0736-4679(97)00241-2
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Handa H, 2014, J MATER CHEM B, V2, P1059, DOI 10.1039/c3tb21771j
   Helms C, 2013, FREE RADICAL BIO MED, V61, P464, DOI 10.1016/j.freeradbiomed.2013.04.028
   Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   JONES MM, 1978, RES COMMUN CHEM PATH, V22, P581
   Kamphuisen PW, 2012, HEMATOL-AM SOC HEMAT, P638, DOI 10.1182/asheducation-2012.1.638
   Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x
   Lavery KS, 2017, ADV DRUG DELIVER REV, V112, P2, DOI 10.1016/j.addr.2016.07.008
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Lee T, 2012, INT J NEPHROL, DOI 10.1155/2012/170857
   Linenberger Michael L, 2006, J Natl Compr Canc Netw, V4, P889
   Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861
   Mack D, 2013, BIOMATERIALS ASS INF
   Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5
   McMullin Bevin B, 2005, Respir Care, V50, P1451
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   Nakajima J, 2013, J INFECT CHEMOTHER, V19, P983, DOI 10.1007/s10156-013-0562-4
   Nurhasni H, 2015, INT J NANOMED, V10, P3065, DOI 10.2147/IJN.S82199
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Parameswaran R, 2011, J INFECT DEV COUNTR, V5, P452
   Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023
   Qiao SX, 2012, APOPTOSIS, V17, P1079, DOI 10.1007/s10495-012-0746-x
   Reighard KP, 2015, ANTIMICROB AGENTS CH, V59, P6506, DOI 10.1128/AAC.01208-15
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   Sligl WI, 2015, INT J INFECT DIS, V37, P129, DOI 10.1016/j.ijid.2015.06.024
   SMITH S, 1991, AM J PEDIAT HEMATOL, V13, P141
   Stephens LC, 1997, TRANSFUS SCI, V18, P187
   Svensson E, 1997, J ANTIMICROB CHEMOTH, V39, P817, DOI 10.1093/jac/39.6.817
   Szacilowski K, 2001, PROG REACT KINET MEC, V26, P1
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   Venturini E., 2012, CASE REP VASC MED, V2012
   Wang HZ, 2012, ANTIMICROB AGENTS CH, V56, P2683, DOI 10.1128/AAC.06486-11
   Wang YY, 2015, J MATER CHEM B, V3, P9212, DOI 10.1039/c5tb02080h
   Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D
   Wo YQ, 2016, BIOMATER SCI-UK, V4, P1161, DOI 10.1039/c6bm00271d
   Wo YQ, 2015, ACS APPL MATER INTER, V7, P22218, DOI 10.1021/acsami.5b07501
   Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667
   Zhang L, 2012, J BACTERIOL, V194, P6639, DOI 10.1128/JB.01693-12
   Zhou X, 2016, CURR MED CHEM, V23, P2579, DOI 10.2174/0929867323666160729104647
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
NR 74
TC 5
Z9 5
U1 7
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2017
VL 3
IS 3
BP 349
EP 359
DI 10.1021/acsbiomaterials.6b00622
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EO0JU
UT WOS:000396384900014
PM 28317023
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Stinson, JA
   Raja, WK
   Lee, S
   Kim, HB
   Diwan, I
   Tutunjian, S
   Panilaitis, B
   Omenetto, FG
   Tzipori, S
   Kaplan, DL
AF Stinson, Jordan A.
   Raja, Waseem K.
   Lee, Sangun
   Kim, Hyeun Bum
   Diwan, Izzuddin
   Tutunjian, Stephen
   Panilaitis, Bruce
   Omenetto, Fiorenzo G.
   Tzipori, Saul
   Kaplan, David L.
TI Silk Fibroin Microneedles for Transdermal Vaccine Delivery
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE influenza; Clostridium difficile; Shigella; device fabrication; soft
   lithography
ID CLOSTRIDIUM-DIFFICILE INFECTION; RELEASE DRUG-DELIVERY; INFLUENZA
   VACCINATION; IN-VITRO; TRANSCUTANEOUS IMMUNIZATION; DISSOLVING
   MICRONEEDLES; POLYMER MICRONEEDLES; IMMUNE-RESPONSES; STABILIZATION;
   FABRICATION
AB Microneedles represent an exciting departure from the existing parenteral injection paradigm for drug delivery, particularly for the administration of vaccines. While the benefit of delivering vaccine antigens to immunocompetent tissue in the skin has been established, there have been varying degrees of success using microneedles to do so. Here, we investigate the use of silk fibroin protein to produce microneedles and evaluate their ability to deliver vaccines against influenza, Clostridium difficile, and Shigella. Fibroin protein from the silkworm Bombyx mori possesses suitable properties for use in a microneedle system, including all-aqueous biocompatibility, and the ability to temperature stabilize biomacromolecules. As such, this biomaterial combines the processing and biocompatibility advantages of a dissolving microneedle system with the product stability and mechanical strength of coated insoluble microneedles. Through successful vaccination of mice against three separate antigens, we establish that silk fibroin is well-suited for use as a solid-coated microneedle delivery system and offers long-term potential similar to that of the leading microneedle biomaterials.
C1 [Stinson, Jordan A.; Raja, Waseem K.; Diwan, Izzuddin; Tutunjian, Stephen; Panilaitis, Bruce; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Raja, Waseem K.] MIT, Dept Brain & Cognit Sci, 43 Vassar St, Cambridge, MA 02139 USA.
   [Lee, Sangun; Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA.
   [Kim, Hyeun Bum] Dankook Univ, Dept Anim Resources Sci, Cheonan 31116, South Korea.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU Defense Technology Research Agency [HDTRA1-14-1-0061]; Air Force Office
   of Scientific Research (AFOSR) [FA9550-14-1-0015]
FX We thank the Defense Technology Research Agency (HDTRA1-14-1-0061) and
   the Air Force Office of Scientific Research (AFOSR, FA9550-14-1-0015)
   for support of these studies.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00137
   Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026
   Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002
   Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002
   Chu LY, 2016, PHARM RES-DORDR, V33, P868, DOI 10.1007/s11095-015-1833-9
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   DeMuth PC, 2013, ADV FUNCT MATER, V23, P161, DOI 10.1002/adfm.201201512
   Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280
   Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017
   Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253
   Gomaa YA, 2010, TOXICOL IN VITRO, V24, P1971, DOI 10.1016/j.tiv.2010.08.012
   Gupta J, 2011, J CONTROL RELEASE, V154, P148, DOI 10.1016/j.jconrel.2011.05.021
   Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426
   Hirobe S, 2015, BIOMATERIALS, V57, P50, DOI 10.1016/j.biomaterials.2015.04.007
   Hong XY, 2014, NANO-MICRO LETT, V6, P191, DOI 10.5101/nml140021r
   Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401
   Horan Rebecca L, 2009, J Knee Surg, V22, P82
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07
   Kim HB, 2014, ANTIMICROB AGENTS CH, V58, P7560, DOI 10.1128/AAC.03447-14
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Kommareddy S, 2013, VACCINE, V31, P3435, DOI 10.1016/j.vaccine.2013.01.050
   Lamberti LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002705
   Lee BY, 2015, VACCINE, V33, P4727, DOI 10.1016/j.vaccine.2015.02.076
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lee J, 2015, EUR J PHARM BIOPHARM, V94, P11, DOI 10.1016/j.ejpb.2015.04.024
   Lee S, 2014, MICROBES INFECT, V16, P796, DOI 10.1016/j.micinf.2014.07.013
   Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI 10.1056/NEJMoa1408913
   Li AB, 2015, J CONTROL RELEASE, V219, P416, DOI 10.1016/j.jconrel.2015.09.037
   Li GH, 2009, INT J PHARM, V368, P109, DOI 10.1016/j.ijpharm.2008.10.008
   Liu S, 2012, J CONTROL RELEASE, V161, P933, DOI 10.1016/j.jconrel.2012.05.030
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Lutton REM, 2015, DRUG DELIV TRANSL RE, V5, P313, DOI 10.1007/s13346-015-0237-z
   Ma YZ, 2014, J PHARM SCI-US, V103, P3621, DOI 10.1002/jps.24159
   Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075
   Martinez-Becerra FJ, 2013, INFECT IMMUN, V81, P4470, DOI 10.1128/IAI.00859-13
   Matsuo K, 2012, J CONTROL RELEASE, V160, P495, DOI 10.1016/j.jconrel.2012.04.001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mishra DK, 2013, EXPERT OPIN DRUG DEL, V10, P183, DOI 10.1517/17425247.2013.746660
   Miyano T, 2005, BIOMED MICRODEVICES, V7, P185, DOI 10.1007/s10544-005-3024-7
   Miyazawa H, 1999, VACCINE, V17, P2176, DOI 10.1016/S0264-410X(98)00368-5
   Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Perez J, 2011, J AOAC INT, V94, P618
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Quan FS, 2010, J CONTROL RELEASE, V147, P326, DOI 10.1016/j.jconrel.2010.07.125
   Raja WK, 2013, SMALL, V9, P3704, DOI 10.1002/smll.201202075
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9
   Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10
   Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182
   Sutherland TD, 2014, ACS APPL MATER INTER, V6, P18189, DOI 10.1021/am5051873
   Thurber AE, 2015, BIOMATERIALS, V71, P145, DOI 10.1016/j.biomaterials.2015.08.039
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12
   Wendorf JR, 2011, PHARM RES-DORDR, V28, P22, DOI 10.1007/s11095-010-0174-y
   You XQ, 2011, MAT SCI ENG C-MATER, V31, P1632, DOI 10.1016/j.msec.2011.06.010
   Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j
NR 64
TC 8
Z9 8
U1 7
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2017
VL 3
IS 3
BP 360
EP 369
DI 10.1021/acsbiomaterials.6b00515
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EO0JU
UT WOS:000396384900015
DA 2018-10-20
ER

PT J
AU Dalmaso, R
   Silva, PA
   Pallotta, RC
   Carvalho, R
   Amaral-Labat, G
   Silva, GFBLE
   Arnold, G
   Rahouadj, R
   Marcuzzo, JS
   Lopes-Martins, RAB
   Marcos, RL
AF Dalmaso, Rachel
   Silva, Patricia Almeida
   Pallotta, Rodney Capp
   Carvalho, Rodrigo
   Amaral-Labat, Gisele
   Lenz e Silva, Guilherme F. B.
   Arnold, Gilles
   Rahouadj, Rachid
   Marcuzzo, Jossano Saldanha
   Lopes-Martins, Rodrigo A. B.
   Marcos, Rodrigo Labat
TI LOW-LEVEL LASER ASSOCIATED WITH CARBON BIOMATERIAL MAY IMPROVE THE BONE
   HEALING PROCESS
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Laser-Medicine-and-Surgery
   (ASLMS)
CY APR 05-09, 2017
CL San Diego, CA
SP Amer Soc Laser Med & Surg
C1 UNINOVE, Sao Paulo, Brazil.
   Univ Sagrado Coracao, Sao Paulo, Brazil.
   POLI USP, Sao Paulo, Brazil.
   Lab Phys & Mecan Text, Mulhouse, France.
   Univ Lorraine INPL, Nancy, Lorraine, France.
   INPE, Sao Jose Dos Campos, Brazil.
   UMC, Sao Paulo, Brazil.
RI Amaral-Labat, Gisele/I-2868-2017
NR 0
TC 0
Z9 0
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0196-8092
EI 1096-9101
J9 LASER SURG MED
JI Lasers Surg. Med.
PD MAR
PY 2017
VL 49
SU 28
MA 167
BP 59
EP 59
PG 1
WC Dermatology; Surgery
SC Dermatology; Surgery
GA ER2DO
UT WOS:000398604500165
DA 2018-10-20
ER

PT J
AU Ronan, K
   Kannan, MB
AF Ronan, Karly
   Kannan, M. Bobby
TI Novel Sustainable Route for Synthesis of Hydroxyapatite Biomaterial from
   Biowastes
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Bioceramic; Eggshell; Urine; Bioimplant; Electrosynthesis
ID HUMAN URINE; NANOCRYSTALLINE HYDROXYAPATITE; CALCIUM PHOSPHATES;
   IN-VITRO; MAGNESIUM; IMPLANTS; COATINGS; STRUVITE; EGGSHELL; RECOVERY
AB In this study, we demonstrated that hydroxyapatite (HAp) biomaterial can be synthesized entirely from biowastes, i.e., eggshells and urine. Eggshells were cleaned, crushed, and calcined at 900 degrees C and then the powder was dissolved in water to form an aqueous calcium hydroxide solution. The aqueous solution was mixed with synthetic urine (SU) in stoichiometric amounts corresponding to HAp (Ca/P ratio similar to 1.67). Calcium phosphate (CaP) was potentiostatically synthesized on magnesium or stainless steel electrode at cathodic potentials (-2 to -4 V). CaP particles formed on the metal surface at -2 V. The growth of the particles increased as the potential was increased from -2 to -3 V. However, at -4 V, the particles formed on the metal surface decreased as a result of excessive hydrogen evolution on the metal surface disrupting particle adhesion. An increase in the electrolyte concentration by 3-fold enhanced the particle growth, but further increase in the concentration by 5-fold did not show any additional improvement. X-ray powder diffraction (XRD), energy dispersive X-ray spectroscopy (EDS), and Fourier transform infrared spectroscopy (FTIR) analysis confirmed that the powder formed on the metal sample was an amorphous CaP. Alkaline treatment at 80 degrees C for 2 h converted the amorphous CaP into crystalline HAp.
C1 [Ronan, Karly; Kannan, M. Bobby] James Cook Univ, Coll Sci & Engn, BEM Lab, 1 James Cook Dr, Townsville, Qld 4811, Australia.
RP Kannan, MB (reprint author), James Cook Univ, Coll Sci & Engn, BEM Lab, 1 James Cook Dr, Townsville, Qld 4811, Australia.
EM bobby.mathan@jcu.edu.au
OI Mathan, Bobby Kannan/0000-0003-0480-8587
CR Al-Sanabani J.S., 2013, INT J BIOMATER, V2013, P1
   Alabbasi A, 2014, MATER LETT, V124, P188, DOI 10.1016/j.matlet.2014.03.094
   Amjad Z., 1998, CALCIUM PHOSPHATES B
   Asri RIM, 2016, J MECH BEHAV BIOMED, V57, P95, DOI 10.1016/j.jmbbm.2015.11.031
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Chutipongtanate S, 2010, ANAL BIOCHEM, V402, P110, DOI 10.1016/j.ab.2010.03.031
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2016, CALCIUM ORTHOPHOSPHA
   Farzadi A, 2014, CERAM INT, V40, P6021, DOI 10.1016/j.ceramint.2013.11.051
   Francis AA, 2016, J CLEAN PROD, V137, P1432, DOI 10.1016/j.jclepro.2016.08.029
   Ganrot Z, 2007, BIORESOURCE TECHNOL, V98, P3112, DOI 10.1016/j.biortech.2006.10.038
   Gergely G, 2010, CERAM INT, V36, P803, DOI 10.1016/j.ceramint.2009.09.020
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Habraken W, 2016, MATER TODAY, V19, P69, DOI 10.1016/j.mattod.2015.10.008
   Kannan B. M., 2015, HYDROXYAPATITE HAP B, P289
   Kannan B. M., 2011, BIOMED MATER, V6, P45003
   Kannan MB, 2016, SURF COAT TECH, V301, P36, DOI 10.1016/j.surfcoat.2015.12.044
   Kannan MB, 2013, J BIOMED MATER RES A, V101, P1248, DOI 10.1002/jbm.a.34423
   Kannan MB, 2013, MAT SCI ENG C-MATER, V33, P675, DOI 10.1016/j.msec.2012.10.017
   Kesteven J, 2015, MAT SCI ENG C-MATER, V46, P226, DOI 10.1016/j.msec.2014.10.038
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Latifian M, 2014, CLEAN-SOIL AIR WATER, V42, P1157, DOI 10.1002/clen.201300070
   Lind BB, 2000, BIORESOURCE TECHNOL, V73, P169, DOI 10.1016/S0960-8524(99)90157-8
   Nayak A. K., 2010, INT J CHEMTECH RES, V2, P903
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   Rivera-Munoz P. E. M., 2011, HYDROXYAPATITE BASED, P75
   Rodriguez-Navarro C, 2009, AM MINERAL, V94, P578, DOI 10.2138/am.2009.3021
   Sasikumar S., 2006, TRENDS BIOMATER ARTI, V19, P70
   Savino K, 2015, CERAM INT, V41, P8568, DOI 10.1016/j.ceramint.2015.03.065
   Stadelman W. J., 2000, ENCY FOOD SCI TECHNO
   Surmeneva MA, 2015, MATER LETT, V152, P280, DOI 10.1016/j.matlet.2015.03.140
   Tilley E, 2008, ENVIRON TECHNOL, V29, P797, DOI 10.1080/09593330801987129
   Walter R, 2015, J BIOMED MATER RES A, V103, P990, DOI 10.1002/jbm.a.35247
   WATT Global Media, 2015, GLOB POULTR TRENDS 2
   Wei T, 2003, GREEN CHEM, V5, P343, DOI 10.1039/b210716n
   Xu B, 2014, PHYS CHEM CHEM PHYS, V16, P17634, DOI 10.1039/c4cp01772b
NR 42
TC 6
Z9 6
U1 6
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAR
PY 2017
VL 5
IS 3
BP 2237
EP 2245
DI 10.1021/acssuschemeng.6b02515
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA EN2NJ
UT WOS:000395846900025
DA 2018-10-20
ER

PT J
AU Singha, P
   Locklin, J
   Handa, H
AF Singha, Priyadarshini
   Locklin, Jason
   Handa, Hitesh
TI A review of the recent advances in antimicrobial coatings for urinary
   catheters
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Catheter-associated urinary tract infections; Antimicrobial coatings;
   Antifouling coatings; Urinary catheters; Urinary catheter coatings;
   Biocides
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN SURFACE INTERACTIONS; BACTERIAL
   BIOFILM FORMATION; RANDOMIZED CONTROLLED-TRIAL; COATED FOLEY CATHETERS;
   NITRIC-OXIDE RELEASE; TRACT-INFECTION; IN-VITRO; SILVER NANOPARTICLES;
   ESCHERICHIA-COLI
AB More than 75% of hospital-acquired or nosocomial urinary tract infections are initiated by urinary catheters, which are used during the treatment of 15-25% of hospitalized patients. Among other purposes, urinary catheters are primarily used for draining urine after surgeries and for urinary incontinence. During catheter-associated urinary tract infections, bacteria travel up to the bladder and cause infection. A major cause of catheter-associated urinary tract infection is attributed to the use of non-ideal materials in the fabrication of urinary catheters. Such materials allow for the colonization of microorganisms, leading to bacteriuria and infection, depending on the severity of symptoms. The ideal urinary catheter is made out of materials that are biocompatible, antimicrobial, and antifouling. Although an abundance of research has been conducted over the last forty-five years on the subject, the ideal biomaterial, especially for long-term catheterization of more than a month, has yet to be developed. The aim of this review is to highlight the recent advances (over the past 10 years) in developing antimicrobial materials for urinary catheters and to outline future requirements and prospects that guide catheter materials selection and design.
   Statement of Significance
   This review article intends to provide an expansive insight into the various antimicrobial agents currently being researched for urinary catheter coatings. According to CDC, approximately 75% of urinary tract infections are caused by urinary catheters and 15-25% of hospitalized patients undergo catheterization. In addition to these alarming statistics, the increasing cost and health related complications associated with catheter associated UTIs make the research for antimicrobial urinary catheter coatings even more pertinent. This review provides a comprehensive summary of the history, the latest progress in development of the coatings and a brief conjecture on what the future entails for each of the antimicrobial agents discussed. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Singha, Priyadarshini; Locklin, Jason; Handa, Hitesh] Univ Georgia, Coll Engn, Sch Mat Chem & Biomed Engn, Athens, GA 30602 USA.
   [Locklin, Jason] Univ Georgia, Dept Chem, Athens, GA USA.
RP Locklin, J (reprint author), Univ Georgia, Coll Engn, Dept Chem, 220 Riverbend Rd, Athens, GA 30602 USA.; Handa, H (reprint author), Univ Georgia, Coll Engn, 220 Riverbend Rd, Athens, GA 30602 USA.
EM jlocklin@uga.edu; hhanda@uga.edu
OI Singha, Priyadarshini/0000-0001-7370-8980
FU National Institutes of Health United States [K25HL111213]
FX The authors acknowledge the support from the National Institutes of
   Health United States, Grant K25HL111213.
CR Aflori M, 2015, HIGH PERFORM POLYM, V27, P655, DOI 10.1177/0954008315584171
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   Akre O, 2013, LANCET, V381, P1535, DOI 10.1016/S0140-6736(13)60972-1
   Armbruster CE, 2014, J INFECT DIS, V209, P1524, DOI 10.1093/infdis/jit663
   Armbruster CE, 2012, NAT REV MICROBIOL, V10, P743, DOI 10.1038/nrmicro2890
   Ashley Bowen W.J.G.H., 2007, URINARY TRACT INFECT
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bernstein R, 2011, ENVIRON SCI TECHNOL, V45, P5973, DOI 10.1021/es1043694
   Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6
   BIRD RL, 1988, THROMB RES, V51, P471
   Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402
   Brisbois E. J., 2015, ADV POLYM MED
   Brisbois EJ, 2015, J MATER CHEM B, V3, P1639, DOI 10.1039/c4tb01839g
   Brisbois EJ, 2014, ACTA BIOMATER, V10, P4136, DOI 10.1016/j.actbio.2014.06.032
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Brisset L, 1996, PATHOL BIOL, V44, P397
   Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Brusch J.L., 2013, INFECTION, V2013
   Bursle EC, 2015, J INFECTION, V70, P585, DOI 10.1016/j.jinf.2015.01.001
   CABRAL JMS, 1986, APPL MICROBIOL BIOT, V23, P157
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Colletta A, 2015, ACS BIOMATER SCI ENG, V1, P416, DOI 10.1021/acsbiomaterials.5b00032
   Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006
   Curtis J, 2008, COMP ASSESSMENT 3 CO
   Dametto FR, 2005, ORAL SURG ORAL MED O, V99, P768, DOI 10.1016/j.tripleo.2004.08.026
   Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8
   Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   Denton G.W., 1991, CHLORHEXIDINE DISINF
   Blanco CD, 2014, ACS APPL MATER INTER, V6, P11385, DOI 10.1021/am501961b
   Diaz C, 2012, INT J ANTIMICROB AG, V40, P221, DOI 10.1016/j.ijantimicag.2012.05.012
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473
   Fang FC, 2012, NITRIC OXIDE-BIOL CH, V27, pS10, DOI 10.1016/j.niox.2012.04.036
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feng W, 2006, BIOINTERPHASES, V1, P50, DOI 10.1116/1.2187495
   Fink R, 2012, AM J INFECT CONTROL, V40, P715, DOI 10.1016/j.ajic.2011.09.017
   Finnegan M, 2010, J ANTIMICROB CHEMOTH, V65, P2108, DOI 10.1093/jac/dkq308
   Fisher LE, 2015, J CONTROL RELEASE, V202, P57, DOI 10.1016/j.jconrel.2015.01.037
   Frank DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007811
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Fuchs A.D., 2006, ANGEW CHEM
   Fuchs AV, 2013, BIOMATER SCI-UK, V1, P470, DOI 10.1039/c2bm00155a
   GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877
   Gaonkar TA, 2003, INFECT CONT HOSP EP, V24, P506, DOI 10.1086/502241
   Gaonkar TA, 2007, INFECT CONT HOSP EP, V28, P596, DOI 10.1086/513449
   Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11
   Goncalves I, 2015, APPL MICROBIOL BIOT, V99, P637, DOI 10.1007/s00253-014-6128-2
   Gonzalez G., 2015, PROTEUS INFECT
   Green J.-B. D., 2009, CHEM REV, V109, P5437
   Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   H.I.C.P.A. Committee, 2009, GUID PREV CATH ASS U
   Halpenny Genevieve M., 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P187
   Hamilton-Brown P, 2009, LANGMUIR, V25, P9149, DOI 10.1021/la900703e
   Hamming L. M., 2008, MAT MATTERS, V3
   Handa H, 2014, J MATER CHEM B, V2, P1059, DOI 10.1039/c3tb21771j
   Handa H, 2013, J MATER CHEM B, V1, P3578, DOI 10.1039/c3tb20277a
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   He W, 2016, SCI REP-UK, V6, DOI 10.1038/srep32140
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Hiraku Y, 2004, CANCER LETT, V215, P141, DOI 10.1016/j.canlet.2004.05.016
   Honda M, 2013, MAT SCI ENG C-MATER, V33, P5008, DOI 10.1016/j.msec.2013.08.026
   Hu R, 2013, LANGMUIR, V29, P3773, DOI 10.1021/la304708b
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   Jacobsen SM, 2011, VIRULENCE, V2, P460, DOI 10.4161/viru.2.5.17783
   Jayaraman R., 2009, CURR SCI, V96
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P4969, DOI 10.1128/AAC.00733-12
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x
   Jones GL, 2006, J ANTIMICROB CHEMOTH, V57, P266, DOI 10.1093/jac/dki447
   Jordan R.P.C., 2015, MICROBIOL DISCOVERY, V3, P1
   Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113
   Kilonzo M, 2014, EUR UROL, V66, P615, DOI 10.1016/j.eururo.2014.05.035
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Knudsen BE, 2005, BJU INT, V95, P726, DOI 10.1111/j.1464-410X.2005.05388.x
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Kowalczuk D, 2012, J BIOMED MATER RES B, V100B, P1874, DOI 10.1002/jbm.b.32755
   Kuang JH, 2012, LANGMUIR, V28, P7258, DOI 10.1021/la300738e
   Kumar CG, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/32/325101
   Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Lansdown A B G, 2002, J Wound Care, V11, P125
   Lasic D.D., 1998, MED APPL LIPOSOMES
   Lawrence E.L., 2005, MED ENG PHYS
   Lederer JW, 2014, J WOUND OSTOMY CONT, V41, P473, DOI 10.1097/WON.0000000000000056
   Lehman SM, 2015, ANTIMICROB AGENTS CH, V59, P1127, DOI 10.1128/AAC.03786-14
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   Leone M, 2012, LANCET, V380, P1891, DOI 10.1016/S0140-6736(12)61515-3
   Leuck AM, 2015, AM J INFECT CONTROL, V43, P260, DOI 10.1016/j.ajic.2014.11.021
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Li X, 2014, ACTA BIOMATER, V10, P258, DOI 10.1016/j.actbio.2013.09.009
   Liao KS, 2012, J APPL MICROBIOL, V113, P1530, DOI 10.1111/j.1365-2672.2012.05432.x
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   Lim KY, 2015, ACTA BIOMATER, V15, P127, DOI 10.1016/j.actbio.2014.12.015
   Lipovsky A, 2015, J MATER CHEM B, V3, P7014, DOI 10.1039/c5tb00671f
   Lo J, 2014, ANTIBIOTICS-BASEL, V3, P87, DOI 10.3390/antibiotics3010087
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Longhi C, 2008, MICROB PATHOGENESIS, V45, P45, DOI 10.1016/j.micpath.2008.01.007
   Loo CY, 2012, ACTA BIOMATER, V8, P1881, DOI 10.1016/j.actbio.2012.01.015
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   MacPhee R, 2014, J UROLOGY, V191, pE81, DOI 10.1016/j.juro.2014.02.361
   McKee C., 2014, EFFECT SILVER ALLOY
   Mi L, 2014, ANGEW CHEM INT EDIT, V53, P1746, DOI 10.1002/anie.201304060
   Miller S., 2014, CATHETER RELATED UTI
   Mishra B, 2014, J MATER CHEM B, V2, P1706, DOI 10.1039/c3tb21300e
   Nablo BJ, 2001, J AM CHEM SOC, V123, P9712, DOI 10.1021/ja0165077
   NACEY J, 1993, AUST NZ J SURG, V63, P815, DOI 10.1111/j.1445-2197.1993.tb00347.x
   NATHAN C, 1992, FASEB J, V6, P3051
   NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G
   NICKEL JC, 1989, UROLOGY, V34, P284
   Nicolle LE, 2014, DRUG AGING, V31, P1, DOI 10.1007/s40266-013-0089-5
   Nouri S, 2015, NURS MIDWIFERY STUD, V4
   Nowatzki PJ, 2012, ACTA BIOMATER, V8, P1869, DOI 10.1016/j.actbio.2012.01.032
   Nyanhongo GS, 2013, EUR J PHARM BIOPHARM, V83, P396, DOI 10.1016/j.ejpb.2012.10.013
   OLSON ME, 1989, J INFECT DIS, V159, P1065, DOI 10.1093/infdis/159.6.1065
   Ona KR, 2009, J BACTERIOL, V191, P4959, DOI 10.1128/JB.00495-09
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Oulahal-Lagsir O, 2003, BIOFOULING, V19, P159, DOI 10.1080/0892701031000064676
   Pearson JP, 1999, J BACTERIOL, V181, P1203
   Phuengkham H, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5418-2
   Pickard R, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI [10.3310/jta16470, 10.3310/hta16470]
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Poverenov E, 2013, COLLOID SURFACE B, V112, P356, DOI 10.1016/j.colsurfb.2013.07.032
   PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473
   Pugach JL, 1999, J UROLOGY, V162, P883, DOI 10.1097/00005392-199909010-00084
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611
   Regev-Shoshani G, 2011, UROLOGY, V78, P334, DOI 10.1016/j.urology.2011.02.063
   REGOS J, 1974, ZBL BAKT-INT J MED M, V226, P390
   Reitzel R, 2014, AM J INFECT CONTROL, V42, P55, DOI 10.1016/j.ajic.2013.07.005
   Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Roig M., 1986, BIOCHEM EDUC, V14, P91
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Russell JC, 2000, J ENDOUROL, V14, P39, DOI 10.1089/end.2000.14.39
   Russo J.L., 2014, BIOMED ENG
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   Salvarci A., 2015, J PAK MED ASS
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Segev G, 2013, J VET INTERN MED, V27, P39, DOI 10.1111/j.1939-1676.2012.01027.x
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Siddiq DM, 2012, NAT REV UROL, V9, P305, DOI 10.1038/nrurol.2012.68
   Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770
   Slater-Radosti C, 2001, J ANTIMICROB CHEMOTH, V48, P1, DOI 10.1093/jac/48.1.1
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Stamm W.E., 1991, AM J MED, V91
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stickler DJ, 2014, J INTERN MED, V276, P120, DOI 10.1111/joim.12220
   Stickler DJ, 2002, INT J ANTIMICROB AG, V19, P499, DOI 10.1016/S0924-8579(02)00091-2
   STICKLER DJ, 1993, CELL MATER, V3, P315
   Sun XB, 2012, ACTA BIOMATER, V8, P1498, DOI 10.1016/j.actbio.2011.12.027
   Tambyah P.A., 2000, ARCH INTERN MED
   Tenke P, 2012, WORLD J UROL, V30, P51, DOI 10.1007/s00345-011-0689-9
   Tenovuo J, 2002, ORAL DIS, V8, P23, DOI 10.1034/j.1601-0825.2002.1o781.x
   Thallinger B, 2016, J BIOMED MATER RES B, V104, P1448, DOI 10.1002/jbm.b.33491
   Thallinger B, 2014, INT J ANTIMICROB AG, V44, P402, DOI 10.1016/j.ijantimicag.2014.06.016
   Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajilc.2003.08.005
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83
   Wagenlehner FME, 2006, EUR UROL, V49, P235, DOI 10.1016/j.eururo.2005.12.017
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wang R, 2015, J BIOMED MATER RES B, V103, P519, DOI 10.1002/jbm.b.33230
   Warren JW, 1997, INFECT DIS CLIN N AM, V11, P609, DOI 10.1016/S0891-5520(05)70376-7
   Wazait HD, 2003, BJU INT, V91, P806, DOI 10.1046/j.1464-410X.2003.04239.x
   WEHRLI W, 1983, REV INFECT DIS, V5, pS407
   Williams GJ, 2008, J MED MICROBIOL, V57, P1135, DOI 10.1099/jmm.0.2008/002295-0
   Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101
   Wood NJ, 2014, INT J NANOMED, V9, P4145, DOI 10.2147/IJN.S65343
   World Health Organization, 2016, ANT RES
   WORLEY SD, 1988, CRIT REV ENV CONTR, V18, P133, DOI 10.1080/10643388809388345
   Xiang L., 2013, PRODUCTION ENG ANTIM
   Yamamoto T, 2000, P SOC EXP BIOL MED, V225, P200, DOI 10.1046/j.1525-1373.2000.22525.x
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27
   ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0
NR 196
TC 14
Z9 14
U1 18
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 20
EP 40
DI 10.1016/j.actbio.2016.11.070
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100002
PM 27916738
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Muller, WEG
   Tolba, E
   Ackermann, M
   Neufurth, M
   Wang, SF
   Feng, QL
   Schroder, HC
   Wang, XH
AF Mueller, Werner E. G.
   Tolba, Emad
   Ackermann, Maximilian
   Neufurth, Meik
   Wang, Shunfeng
   Feng, Qingling
   Schroeder, Heinz C.
   Wang, Xiaohong
TI Fabrication of amorphous strontium polyphosphate microparticles that
   induce mineralization of bone cells in vitro and in vivo
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone; Strontium; Polyphosphate; Microparticles; Sclerostin; Alkaline
   phosphatase; BMP2; Bone repair; Critical size defect; Human mesenchymal
   stem cells; SaOS-2 cells
ID SAOS-2 CELLS; MORPHOGENETIC ACTIVITY; STROMAL CELLS; RANELATE;
   DIFFERENTIATION; OSTEOPOROSIS; OSTEOBLASTS; SCLEROSTIN; RECEPTOR; MODEL
AB Here we describe the fabrication process of amorphous strontium-polyphosphate microparticles ("Sr-a-polyP-MP"). The effects of these particles on growth and gene expression were investigated with SaOS-2 cells as well as with human mesenchymal stem cells (MSC) and compared with those particles prepared of amorphous calcium-polyphosphate ("Ca-a-polyP-MP") and of strontium salt. The results revealed a markedly higher stimulation of growth of MSC by "Sr-a-polyP-MP" compared to "Ca-a-polyP-MP" and a significant increase in mineralization of SaOS-2 cells, as well as an enhanced upregulation of the expression of the genes encoding for alkaline phosphatase and the bone morphogenetic protein 2 (BMP-2), likewise performed with SaOS-2 cells. On the other hand, "Sr-a-polyP-MP" only slightly changes the expression of the osteocyte-specific sclerostin, a negative regulator of the canonical Wnt signaling pathway and an inhibitor of bone cell differentiation as well as of mineralization in SaOS-2 cells. In contrast, "Ca-a-polyP-MP" strongly increased the steady-state expression of the SOST (sclerostin) gene. In animal studies poly(D,L-lactide-co-glycolide (PLGA) microspheres, containing polyP particles, were implanted into critical-size calvarial defects in rats. The results show that the amorphous Sr-polyP-containing microspheres caused an increased healing/mineralization of the bone defect even after short implantation periods of 8-12 weeks, if compared to the B-tri-calcium phosphate control as well as to Ca-polyP. It is proposed that "Sr-a-polyP-MP" might elicit suitable properties to be applied as a regeneratively active implant material for bone repair.
   Statement of Significance
   In this manuscript, we fabricated amorphous strontium-polyphosphate microparticles ("Sr-a-polyP-MP") and studied their effects on bone mineral formation in vitro as well as in vivo. In vitro, those particles substantially increased the expression of the genes encoding for alkaline phosphatase, the bone morphogenetic protein 2 and the mineralization. In vivo, the "Sr-a-polyP-MP" packed into PLGA microspheres and implanted into critical-size calvarial defects in rats resulted in a speeded up of the healing/mineralization of the bone defect. Those properties qualify Sr-a-polyP as a suitable biomaterial for bone regenerative implants. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mueller, Werner E. G.; Tolba, Emad; Neufurth, Meik; Wang, Shunfeng; Schroeder, Heinz C.; Wang, Xiaohong] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
   [Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Johann Joachim Becher Weg 13, D-55099 Mainz, Germany.
   [Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ China, Key Lab Adv Mat, Beijing 100084, Peoples R China.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wmueller@uni-mainz.de; wang013@uni-mainz.de
RI Neufurth, Meik/N-4297-2015
OI Neufurth, Meik/0000-0002-2383-6412; Tolba, Emad/0000-0002-3422-2344
FU ERC Advanced Investigator Grant [268476]; European Commission [268476,
   662486, 604036, 311848]; International Human Frontier Science Program;
   BiomaTiCS research initiative of the University Medical Center, Mainz
FX W.E.G. M. is a holder of an ERC Advanced Investigator Grant (No. 268476
   "BIOSILICA"). This work was supported by grants from the European
   Commission (ERC PoC "MorphoVESPoC", No. 662486; "Bio-Scaffolds, No.
   604036; "MarBioTec*EU-CN*": No. 268476; and "BlueGenics": No. 311848),
   the International Human Frontier Science Program and the BiomaTiCS
   research initiative of the University Medical Center, Mainz.
CR Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0310-8
   Bao X, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/48753525003114
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Brown EM, 2001, PHYSIOL REV, V81, P239
   BROWN MS, 1978, J SUPRAMOL STR CELL, V8, P223, DOI 10.1002/jss.400080302
   Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959
   Chen K, 2013, OPEN J REGEN MED, V2, P8
   Czekanska EM, 2012, EUR CELLS MATER, V24, P1
   Dean W., 2004, WORLDHEALTH
   Devarajan-Ketha H, 2012, BIOCHEM BIOPH RES CO, V417, P830, DOI 10.1016/j.bbrc.2011.12.048
   FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Giacomini A, 2015, ANGIOGENESIS, V18, P499, DOI 10.1007/s10456-015-9481-6
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hodson ME, 2015, GEOCHEM T, V16, DOI 10.1186/s12932-015-0019-z
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608
   Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89
   Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200
   Liebig J., 1843, HDB CHEM RUCKSICHT P
   Mahadevaiah Kumar MSY, 2007, E-J CHEM, V4, P467
   Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b
   MARIE PJ, 1985, MINER ELECTROL METAB, V11, P5
   MCCASLIN FE, 1959, P STAFF M MAYO CLIN, V34, P329
   Meininger S, 2016, ACTA BIOMATER, V31, P401, DOI 10.1016/j.actbio.2015.11.050
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Mori K, 2007, ONCOL REP, V18, P1365
   Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605
   Muller WEG, 2016, FEBS J, V283, P74, DOI 10.1111/febs.13552
   Muller WEG, 2015, CHEMBIOCHEM, V16, P1323, DOI 10.1002/cbic.201500057
   Muller WEG, 2015, MATER LETT, V148, P163, DOI 10.1016/j.matlet.2015.02.070
   Muller WEG, 2015, J MATER CHEM B, V3, P1722, DOI 10.1039/c4tb01586j
   Muller WEG, 2013, BIOMATERIALS, V34, P8671, DOI 10.1016/j.biomaterials.2013.07.096
   Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007
   MULLER WEG, 1977, CANCER, V40, P2787, DOI 10.1002/1097-0142(197712)40:6<2787::AID-CNCR2820400605>3.0.CO;2-G
   Neuprez A, 2008, ADV THER, V25, P1235, DOI 10.1007/s12325-008-0125-8
   Pekkarinen T, 2005, SCAND J SURG, V94, P67, DOI 10.1177/145749690509400116
   Peng SL, 2011, BONE, V49, P1290, DOI 10.1016/j.bone.2011.08.031
   Petrie A, 2013, STAT VET ANIMAL SCI, P85
   Reginster JY, 2015, OSTEOPOROSIS INT, V26, P1667, DOI 10.1007/s00198-015-3109-y
   Romer P, 2011, EUR J PHARMACOL, V654, P195, DOI 10.1016/j.ejphar.2010.12.031
   Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061
   Rybchyn MS, 2011, J BIOL CHEM, V286, P23771, DOI 10.1074/jbc.M111.251116
   Santocildes-Romero ME, 2015, J TISSUE ENG REGEN M, V9, P619, DOI 10.1002/term.2003
   Schroder HC, 2005, J BIOMED MATER RES B, V75B, P387, DOI 10.1002/jbm.b.30322
   Singh SS, 2016, MAT SCI ENG C-MATER, V63, P429, DOI 10.1016/j.msec.2016.02.059
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Tan S., 2014, BIOMED RES INT, V2014
   Tolba E, 2016, J MATER CHEM B, V4, P376, DOI 10.1039/c5tb02228b
   Visualizatoin Sciences Group (VSG) and Konrad-Zuse-Zentrum fur Informationstechnik Berlin, 1995, AVIZO 7 0
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang SF, 2014, BONE, V67, P292, DOI 10.1016/j.bone.2014.07.025
   Wang X.-N., 2014, INT J DIGIT MULTIMED, V2014, P6, DOI [10.1155/2014/305846, DOI 10.1155/2014/305846]
   Wang XH, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/3/035005
   Wang XH, 2016, BIOTECHNOL J, V11, P11, DOI 10.1002/biot.201500168
   Wang XH, 2014, INT REV CEL MOL BIO, V313, P27, DOI 10.1016/B978-0-12-800177-6.00002-5
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Wang XH, 2013, J TISSUE ENG REGEN M, V7, P767, DOI 10.1002/term.1465
   Westhrin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120374
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Wiley J., 2009, STRONTIUM ITS INORGA
   Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
NR 68
TC 3
Z9 3
U1 6
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 89
EP 101
DI 10.1016/j.actbio.2016.12.045
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100007
PM 28017868
DA 2018-10-20
ER

PT J
AU Ciapetti, G
   Di Pompo, G
   Avnet, S
   Martini, D
   Diez-Escudero, A
   Montufar, EB
   Ginebra, MP
   Baldini, N
AF Ciapetti, Gabriela
   Di Pompo, Gemma
   Avnet, Sofia
   Martini, Desiree
   Diez-Escudero, Anna
   Montufar, Edgar B.
   Ginebra, Maria-Pau
   Baldini, Nicola
TI Osteoclast differentiation from human blood precursors on biomimetic
   calcium-phosphate substrates
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osteoclasts; Hydroxyapatite; Differentiation; Topography; Ionic
   exchange; Bone resorption
ID BONE SUBSTITUTE MATERIAL; SURFACE-TOPOGRAPHY; IN-VITRO; RESORPTION;
   HYDROXYAPATITE; CELLS; OSTEOBLASTS; CERAMICS; BIOMATERIALS; METABOLISM
AB The design of synthetic bone grafts to foster bone formation is a challenge in regenerative medicine. Understanding the interaction of bone substitutes with osteoclasts is essential, since osteoclasts not only drive a timely resorption of the biomaterial, but also trigger osteoblast activity.
   In this study, the adhesion and differentiation of human blood-derived osteoclast precursors (OCP) on two different micro-nanostructured biomimetic hydroxyapatite materials consisting in coarse (HA-C) and fine HA (HA-F) crystals, in comparison with sintered stoichiometric HA (sin-HA, reference material), were investigated. Osteoclasts were induced to differentiate by RANKL-containing supernatant using cell/substrate direct and indirect contact systems, and calcium (Ca++) and phosphorus (P5+) in culture medium were measured.
   We observed that OCP adhered to the experimental surfaces, and that osteoclast-like cells formed at a rate influenced by the micro- and nano-structure of HA, which also modulate extracellular Ca++.
   Qualitative differences were found between OCP on biomimetic HA-C and HA-F and their counterparts on plastic and sin-HA. On HA-C and HA-F cells shared typical features of mature osteoclasts, i.e. podosomes, multinuclearity, tartrate acid phosphatase (TRAP)-positive staining, and TRAP5b-enzyme release. However, cells were less in number compared to those on plastic or on sin-HA, and they did not express some specific osteoclast markers. In conclusion, blood-derived OCP are able to attach to biomimetic and sintered HA substrates, but their subsequent fusion and resorptive activity are hampered by surface micro-nano-structure. Indirect cultures suggest that fusion of OCP is sensitive to topography and to extracellular calcium.
   Statement of Significance
   The novelty of the paper is the differentiation of human blood-derived osteoclast precursors, instead of mouse-derived macrophages as used in most studies, directly on biomimetic micro-nano structured HA-based surfaces, as triggered by osteoblast-produced factors (RANKL/OPG), and influenced by chemistry and topography of the substrate(s). Biomimetic HA-surfaces, like those obtained in calcium phosphate cements, are very different from the conventional calcium phosphate ceramics, both in terms of topography and ion exchange. The role of these factors in modulating precursors' differentiation and activity is analysed. The system is closely reproducing the physiological process of attachment of host cells and further maturation to osteoclasts toward resorption of the substrate, which occurs in vivo after filling bone defects with the calcium phosphate grafts. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ciapetti, Gabriela; Di Pompo, Gemma; Avnet, Sofia; Baldini, Nicola] Ist Ortoped Rizzoli, Orthopaed Pathophysiol & Regenerat Med Unit, Bologna, Italy.
   [Di Pompo, Gemma; Martini, Desiree; Baldini, Nicola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Diez-Escudero, Anna; Montufar, Edgar B.; Ginebra, Maria-Pau] Tech Univ Catalonia, BarcelonaTech UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Barcelona, Spain.
   [Ginebra, Maria-Pau] Inst Bioengn Catalonia, Barcelona, Spain.
RP Ciapetti, G (reprint author), Ist Ortoped Rizzoli, SSD Fisiopatol Ortoped & Med Rigenerat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gabriela.ciapetti@ior.it; gemma.dipompo@ior.it; sofia.avnet@ior.it;
   desiree.martini@unibo.it; anna.diez-escudero@upc.edu;
   edgar.montufar@upc.edu; maria.pau.ginebra@upc.edu; nicola.baldini@ior.it
RI Diez-Escudero, Anna/R-4515-2017; Montufar, Edgar/F-8040-2016; Ginebra,
   Maria-Pau/J-8149-2017; Avnet, Sofia/B-3220-2018; Di Pompo,
   Gemma/J-5317-2018
OI Diez-Escudero, Anna/0000-0003-4686-9564; Montufar,
   Edgar/0000-0002-8122-4000; Ginebra, Maria-Pau/0000-0002-4700-5621;
   Avnet, Sofia/0000-0002-7843-0591; Di Pompo, Gemma/0000-0001-5121-4330;
   Ciapetti, Gabriela/0000-0001-6740-0357
FU Italian Ministry of Health, Ricerca Corrente, project 'Strategie di
   rigenerazione ossea: dall'interazione materiale/cellule dell'osso ai
   markers riparativi'; Spanish Government, project MINECO [MAT2015-65601];
   EU through ERDF; Generalitat de Catalunya
FX This research was funded by the Italian Ministry of Health, Ricerca
   Corrente, project 'Strategie di rigenerazione ossea: dall'interazione
   materiale/cellule dell'osso ai markers riparativi' (2013-2016), and the
   Spanish Government, project MINECO MAT2015-65601, co-funded by the EU
   through ERDF. MPG acknowledges the ICREA Academia award by the
   Generalitat de Catalunya.
CR Abdelgawad ME, 2016, HISTOCHEM CELL BIOL, V145, P603, DOI 10.1007/s00418-016-1414-y
   Anderegg F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028583
   Avnet S, 2011, BBA-MOL BASIS DIS, V1812, P711, DOI 10.1016/j.bbadis.2011.03.006
   Bernhardt A, 2015, TISSUE ENG PART C-ME, V21, P160, DOI [10.1089/ten.TEC.2014.0187, 10.1089/ten.tec.2014.0187]
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Choy J, 2014, BONE, V69, P80, DOI 10.1016/j.bone.2014.09.013
   Cianferotti L, 2015, OSTEOPOROSIS INT, V26, P2055, DOI 10.1007/s00198-015-3203-1
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Costa-Rodrigues J, 2016, BBA-GEN SUBJECTS, V1860, P825, DOI 10.1016/j.bbagen.2016.01.014
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   Cuzmar E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131188
   Davison NL, 2015, EUR CELLS MATER, V29, P314, DOI 10.22203/eCM.v029a24
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011
   Detsch R, 2015, J TISSUE ENG REGEN M, V9, P1133, DOI 10.1002/term.1851
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Geblinger D, 2012, J R SOC INTERFACE, V9, P1599, DOI 10.1098/rsif.2011.0659
   Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Granchi D, 2005, BIOMATERIALS, V26, P2371, DOI 10.1016/j.biomaterials.2004.07.0145
   Gross KA, 2012, ACTA BIOMATER, V8, P1948, DOI 10.1016/j.actbio.2012.01.023
   Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7
   Henriksen K, 2012, BONE, V51, P353, DOI 10.1016/j.bone.2012.06.007
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5
   HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204
   Hwang S.Y., 1813, BIOCH BIOPHYS ACTA B, V2011, P979
   Jensen PR, 2014, BIOCHEM BIOPH RES CO, V443, P694, DOI 10.1016/j.bbrc.2013.12.036
   Kajiya H, 2012, ADV EXP MED BIOL, V740, P917, DOI 10.1007/978-94-007-2888-2_41
   Keller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046757
   Konermann A, 2014, INT J ORAL MAX SURG, V43, P514, DOI 10.1016/j.ijom.2013.10.017
   Kovtun A, 2015, ACTA BIOMATER, V12, P242, DOI 10.1016/j.actbio.2014.10.034
   Kruppke B, 2016, ACTA BIOMATER, V32, P275, DOI 10.1016/j.actbio.2015.12.035
   Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Martin T.J., 2014, BONEKEY REPORTS, V3
   Matsunaga T, 1999, J BIOMED MATER RES, V48, P417
   Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x
   Pernelle K, 2017, BONE, V94, P42, DOI 10.1016/j.bone.2016.10.002
   Rahman MM, 2015, BONE, V81, P392, DOI 10.1016/j.bone.2015.08.008
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Shiwaku Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132903
   Sims NA, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00041
   Wang N, 2014, FASEB J, V28, P2249, DOI 10.1096/fj.13-243626
   Wang XH, 2013, J TISSUE ENG REGEN M, V7, P767, DOI 10.1002/term.1465
   Zaidi M, 2004, BIOL REV, V79, P79, DOI 10.1017/S1464793103006262
   Zhang JW, 2014, ACTA BIOMATER, V10, P3254, DOI 10.1016/j.actbio.2014.03.021
   Zhao HY, 2015, CYTOKINE, V71, P199, DOI 10.1016/j.cyto.2014.10.007
   Zimmer G, 2013, J BIOMED MATER RES A, V101, P3365, DOI 10.1002/jbm.a.34639
NR 59
TC 5
Z9 5
U1 11
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 102
EP 113
DI 10.1016/j.actbio.2016.12.013
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100008
PM 27940198
DA 2018-10-20
ER

PT J
AU Vassie, JA
   Whitelock, JM
   Lord, MS
AF Vassie, James A.
   Whitelock, John M.
   Lord, Megan S.
TI Endocytosis of cerium oxide nanoparticles and modulation of reactive
   oxygen species in human ovarian and colon cancer cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cerium oxide; Nanoparticles; Endocytosis; Reactive oxygen species;
   Cancer cells
ID SIZE-DEPENDENT CYTOTOXICITY; OXIDATIVE STRESS; CELLULAR UPTAKE; HUMAN
   FIBROBLASTS; NADPH OXIDASE; ANGIOGENESIS; NANOCERIA; MECHANISM;
   TOXICITY; ANTIOXIDANT
AB Cerium oxide nanoparticles (nanoceria) are widely reported to be cytocompatible and modulate intracellular reactive oxygen species (ROS) in a range of different cell types. In this study, nanoceria (d = 7 and 94 nm) synthesised by flame spray pyrolysis did not affect the proliferation of SKOV3 human ovarian and WiDr human colon cancer cell lines over a 72 h treatment period. The cellular accumulation of nanoceria was uniform and increased up to 24 h post-treatment before decreasing. The uptake of nanoceria in both cell lines was energy-dependent and was found to occur via non-specific pathways as well as clathrin-coated vesicles and caveolae. Nanoceria were localised predominantly in the cytoplasm and, to a lesser extent, with clathrin, caveolin-1 and lysosomes. The intracellular trafficking varied with particle size, treatment time and cell type. The larger nanoceria were found to scavenge intracellular ROS to a greater extent than the smaller nanoceria, and ROS scavenging was found to increase with treatment time. Together these data demonstrated that the diameter of the nanoceria and the cell types determined their mechanisms of uptake and intracellular localisation, as well as their ROS scavenging effects.
   Statement of Significance
   Cerium oxide nanoparticles (nanoceria) are a promising biomaterial that can catalytically scavenge reactive oxygen species (ROS). Modulation of ROS may potentially minimise the inflammatory effects of cancer. However, the antioxidant properties of nanoceria are reported to be pH-dependent and, thus, dependent on their mechanisms of endocytosis. This study is the first to examine the effects of particle size on the uptake and intracellular trafficking of flame spray-synthesised nanoceria in human cancer cells. This study demonstrated that the particle diameter, treatment time and cell type determined the mechanisms of uptake and intracellular localisation of nanoceria, as well as their ROS scavenging effects. This study highlighted the importance of testing new nanoparticle systems rather than making assumptions based on previous uptake studies. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vassie, James A.; Whitelock, John M.; Lord, Megan S.] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Lord, MS (reprint author), Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM m.lord@unsw.edu.au
OI Vassie, James/0000-0002-8062-2795
FU Australian Research Council under the Discovery Project [DP 1097149]
FX This work was supported by funding from the Australian Research Council
   under the Discovery Project (DP 1097149). The authors would also like to
   acknowledge Prof Rose Amal and Dr Wey Yang Teoh from the School of
   Chemical Engineering, UNSW for synthesising the nanoceria, and Prof
   Robert Burford and Dr Victor Wong from the School of Chemical
   Engineering, UNSW for the use of the TGA.
CR Alili L, 2011, BIOMATERIALS, V32, P2918, DOI 10.1016/j.biomaterials.2010.12.056
   Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s
   Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a
   Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91
   Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006
   Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036
   Das S, 2013, NANOMEDICINE-UK, V8, P1483, DOI [10.2217/NNM.13.133, 10.2217/nnm.13.133]
   Deshpande S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061873
   Dowding JM, 2013, ACS NANO, V7, P4855, DOI 10.1021/nn305872d
   Eom HJ, 2009, TOXICOL LETT, V187, P77, DOI 10.1016/j.toxlet.2009.01.028
   Gelderman KA, 2007, ANTIOXID REDOX SIGN, V9, P1541, DOI 10.1089/ars.2007.1569
   Giri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054578
   Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11
   Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014
   HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389
   Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003
   Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042
   Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8
   Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e
   LEDBETTER MLS, 1977, EXP CELL RES, V105, P223, DOI 10.1016/0014-4827(77)90120-3
   Lord MS, 2016, J BIOMED MATER RES A, V104, P1736, DOI 10.1002/jbm.a.35704
   Lord MS, 2013, BIOMATERIALS, V34, P8808, DOI 10.1016/j.biomaterials.2013.07.083
   Lord MS, 2012, BIOMATERIALS, V33, P7915, DOI 10.1016/j.biomaterials.2012.07.024
   MADSHUS IH, 1987, J CELL PHYSIOL, V131, P6, DOI 10.1002/jcp.1041310103
   Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5
   Nagai Y, 2006, J CATAL, V242, P103, DOI 10.1016/j.jcat.2006.06.002
   Nagai Y, 2011, CATAL TODAY, V175, P133, DOI 10.1016/j.cattod.2011.02.046
   Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378
   Park EJ, 2008, TOXICOLOGY, V245, P90, DOI 10.1016/j.tox.2007.12.022
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Pavelka M, 2010, FUNCTIONAL ULTRASTRUCTURE: ATLAS OF TISSUE BIOLOGY AND PATHOLOGY, SECOND EDITION, P2, DOI 10.1007/978-3-211-99390-3
   Perez JM, 2008, SMALL, V4, P552, DOI 10.1002/smll.200700824
   Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k
   Pyrgiotakis G, 2013, LANGMUIR, V29, P11385, DOI 10.1021/la4019585
   Sabella S, 2014, NANOSCALE, V6, P7052, DOI 10.1039/c4nr01234h
   Salvati A, 2011, NANOMED-NANOTECHNOL, V7, P818, DOI 10.1016/j.nano.2011.03.005
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Simko M, 2015, INT J MOL SCI, V16, P26211, DOI 10.3390/ijms161125954
   Singh S, 2010, MOL BIOSYST, V6, P1813, DOI 10.1039/c0mb00014k
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Stover TC, 2008, BIOMATERIALS, V29, P359, DOI 10.1016/j.biomaterials.2007.09.037
   Strobel C, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3007-4
   Tanaka H, 2005, CATAL SURV ASIA, V9, P63, DOI 10.1007/s10563-005-5992-2
   Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f
   Ting SRS, 2013, BIOMATERIALS, V34, P4377, DOI 10.1016/j.biomaterials.2013.02.042
   Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939
   Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044
   Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015
   Vassie JA, 2015, METHODS MOL BIOL, V1229, P557, DOI 10.1007/978-1-4939-1714-3_44
   Vincent A, 2009, ACS NANO, V3, P1203, DOI 10.1021/nn9000148
   Vranic S, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-2
   Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   Zhang F, 2004, SURF SCI, V563, P74, DOI 10.1016/j.susc.2004.05.138
NR 57
TC 7
Z9 7
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 127
EP 141
DI 10.1016/j.actbio.2016.12.010
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100010
PM 27940194
DA 2018-10-20
ER

PT J
AU Minardi, S
   Taraballi, F
   Wang, X
   Cabrera, FJ
   Van Eps, JL
   Robbins, AB
   Sandri, M
   Moreno, MR
   Weiner, BK
   Tasciotti, E
AF Minardi, Silvia
   Taraballi, Francesca
   Wang, Xin
   Cabrera, Fernando J.
   Van Eps, Jeffrey L.
   Robbins, Andrew B.
   Sandri, Monica
   Moreno, Michael R.
   Weiner, Bradley K.
   Tasciotti, Ennio
TI Biomimetic collagen/elastin meshes for ventral hernia repair in a rat
   model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hernia; Collagen; Elastin; Biomimicry; Meshes; Tissue engineering
ID CALCIUM-PHOSPHATE CEMENT; MECHANICAL-PROPERTIES; INCISIONAL HERNIAS;
   BIOLOGICAL MESHES; POROUS SCAFFOLDS; PORCINE MODEL; PORE-SIZE; ELASTIN;
   REGENERATION; BIOMATERIAL
AB Ventral hernia repair remains a major clinical need. Herein, we formulated a type I collagenielastin cross linked blend (CollE) for the fabrication of biomimetic meshes for ventral hernia repair. To evaluate the effect of architecture on the performance of the implants, CollE was formulated both as flat sheets (CollE Sheets) and porous scaffolds (CollE Scaffolds). The morphology, hydrophylicity and in vitro degradation were assessed by SEM, water contact angle and differential scanning calorimetry, respectively. The stiffness of the meshes was determined using a constant stretch rate uniaxial tensile test, and compared to that of native tissue. CollE Sheets and Scaffolds were tested in vitro with human bone marrow-derived mesenchymal stem cells (h-BM-MSC), and finally implanted in a rat ventral hernia model. Neovascularization and tissue regeneration within the implants was evaluated at 6 weeks, by histology, immunofluorescence, and q-PCR. It was found that CollE Sheets and Scaffolds were not only biomechanically sturdy enough to provide immediate repair of the hernia defect, but also promoted tissue restoration in only 6 weeks. In fact, the presence of elastin enhanced the neovascularization in both sheets and scaffolds. Overall, CollE Scaffolds displayed mechanical properties more closely resembling those of native tissue, and induced higher gene expression of the entire marker genes tested, associated with de novo matrix deposition, angiogenesis, adipogenesis and skeletal muscles, compared to CollE Sheets. Altogether, this data suggests that the improved mechanical properties and bioactivity of CollE Sheets and Scaffolds make them valuable candidates for applications of ventral hernia repair.
   Statement of Significance
   Due to the elevated annual number of ventral hernia repair in the US, the lack of successful grafts, the design of innovative biomimetic meshes has become a prime focus in tissue engineering, to promote the repair of the abdominal wall, avoid recurrence. Our meshes (CollE Sheets and Scaffolds) not only showed promising mechanical performance, but also allowed for an efficient neovascularization, resulting in new adipose and muscle tissue formation within the implant, in only 6 weeks. In addition, our meshes allowed for the use of the same surgical procedure utilized in clinical practice, with the commercially available grafts. This study represents a significant step in the design of bioactive acellular off-the shelf biomimetic meshes for ventral hernia repair. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Minardi, Silvia; Taraballi, Francesca; Wang, Xin; Cabrera, Fernando J.; Van Eps, Jeffrey L.; Moreno, Michael R.; Weiner, Bradley K.; Tasciotti, Ennio] HMRI, Ctr Biomimet Med, 6670 Bertner Ave,Suite R10-116, Houston, TX 77030 USA.
   [Minardi, Silvia; Sandri, Monica] Natl Res Council Italy, Inst Sci & Technol Ceram ISTEC CNR, Via Granarolo 64, I-48018 Faenza, RA, Italy.
   [Robbins, Andrew B.; Moreno, Michael R.] Texas A&M Univ, Dept Biomed Engn, 401 Joe Routt Blvd, College Stn, TX 77843 USA.
   [Moreno, Michael R.] Texas A&M Univ, Dept Mech Engn, 3123 TAMU, College Stn, TX 77843 USA.
   [Moreno, Michael R.; Weiner, Bradley K.; Tasciotti, Ennio] Houston Methodist Hosp, Dept Orthoped, 6565 Fannin St, Houston, TX 77030 USA.
RP Tasciotti, E (reprint author), HMRI, Ctr Biomimet Med, 6670 Bertner Ave,Suite R10-116, Houston, TX 77030 USA.
EM etasciotti@houstonmethodist.org
RI Cabrera, Fernando/L-8483-2016
OI Cabrera, Fernando/0000-0002-8651-6790; Van Eps,
   Jeffrey/0000-0003-2086-5119; Sandri, Monica/0000-0001-5782-3137
FU Brown Foundation [18130011]; Cullen Trust for Health Care Foundation
   [18130014]; Hearst foundation [18130017]
FX The authors acknowledge Dr. Jianhua Gu and the HMRI SEM core, and Dr.
   Kemi Cui and the HMRI ACTM core. This study was supported by the Brown
   Foundation (Project ID: 18130011), the Cullen Trust for Health Care
   Foundation (Project ID: 18130014), the Hearst foundation (Project ID:
   18130017). The authors thank Nupur Basu and Jae Hyuk (Evan) Byun for
   their help with the cell cultures.
CR Abdelfatah MM, 2015, HERNIA, V19, P135, DOI 10.1007/s10029-013-1165-9
   Amensag S, 2014, J BIOMED MATER RES A, V102, P1325, DOI 10.1002/jbm.a.34791
   Amoroso NJ, 2012, ACTA BIOMATER, V8, P4268, DOI 10.1016/j.actbio.2012.08.002
   Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Ayala P, 2015, ACTA BIOMATER, V26, P1, DOI 10.1016/j.actbio.2015.08.012
   Badylak S.F., 2016, BIOMATERIALS
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bellon JM, 1997, EUR J CLIN INVEST, V27, P510, DOI 10.1046/j.1365-2362.1997.1400686.x
   Bellows CF, 2013, AM J SURG, V205, P85, DOI 10.1016/j.amjsurg.2012.02.019
   Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228
   Bendavid Robert, 2004, Hernia, V8, P171
   Bilsel Y, 2012, INT J SURG, V10, P317, DOI 10.1016/j.ijsu.2012.05.002
   Bilston LE, 2015, ANN BIOMED ENG, V43, P261, DOI 10.1007/s10439-014-1186-2
   Cavallo JA, 2015, HERNIA, V19, P207, DOI 10.1007/s10029-013-1070-2
   Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712
   Cordero A, 2016, ANN BIOMED ENG, V44, P2181, DOI 10.1007/s10439-015-1503-4
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P880, DOI 10.1016/j.jamcollsurg.2011.01.006
   Feliciano D., 2014, VENTRAL HERNIA REPAI
   Fortelny R.H., 2016, FRONT SURG, V3
   Franz Michael G, 2006, Hernia, V10, P462, DOI 10.1007/s10029-006-0144-9
   Franz MG, 2008, SURG CLIN N AM, V88, P1, DOI 10.1016/j.suc.2007.10.007
   Freed A.D., 2016, ACTA MECH, P1
   Fung Y. C., 2013, BIOMECHANICS MECH PR
   Gefen A., 2009, BIOENGINEERING RES C
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   HALL MJ, 2010, NATL HLTH STAT REPOR, V29, P1, DOI DOI 10.3886/ICPSR28162.V1
   He B, 2013, J ORTHOP RES, V31, P1345, DOI 10.1002/jor.22384
   Hill M.A., 2016, MICROCIRCULATION
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Huerta S, 2016, JAMA SURG, V151, P374, DOI 10.1001/jamasurg.2015.5234
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Krpata D.M., 2016, LAPAROSCOPIC VENTRAL, P223
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Liu ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020520
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Melman L, 2011, HERNIA, V15, P157, DOI 10.1007/s10029-010-0770-0
   Minardi S., 2014, SMALL
   Minardi S., 2016, SMALL
   Minardi S, 2015, BIOMATERIALS, V62, P128, DOI 10.1016/j.biomaterials.2015.05.011
   Mirmehdi I., 2016, SYNTHETIC MESH MAKIN, P53
   Novitsky YW, 2013, SURG CLIN N AM, V93, P1211, DOI 10.1016/j.suc.2013.06.014
   Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203
   Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9
   Quaglino D, 2010, NANO- AND BIOCOMPOSITES, P249
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sadava EE, 2014, J BIOMED MATER RES A, V102, P295, DOI 10.1002/jbm.a.34676
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   Sandvall BK, 2016, ANN PLAS SURG, V76, P674, DOI 10.1097/SAP.0000000000000253
   Smart NJ, 2012, SURG-J R COLL SURG E, V10, P159, DOI 10.1016/j.surge.2012.02.006
   Taraballi F, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731415624667
   UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032
   Zhang JT, 2016, ACTA BIOMATER, V31, P326, DOI 10.1016/j.actbio.2015.11.055
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
   Zhang YN, 2015, ADV FUNCT MATER, V25, P4814, DOI 10.1002/adfm.201501489
NR 65
TC 3
Z9 4
U1 6
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 165
EP 177
DI 10.1016/j.actbio.2016.11.032
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100013
PM 27872012
DA 2018-10-20
ER

PT J
AU Efraim, Y
   Sarig, H
   Anavy, NC
   Sarig, U
   de Berardinis, E
   Chaw, SY
   Krishnamoorthi, M
   Kalifa, J
   Bogireddi, H
   Duc, TV
   Kofidis, T
   Baruch, L
   Boey, FYC
   Venkatraman, SS
   Machluf, M
AF Efraim, Yael
   Sarig, Hadar
   Anavy, Noa Cohen
   Sarig, Udi
   de Berardinis, Elio
   Chaw, Su-Yin
   Krishnamoorthi, Muthukumar
   Kalifa, Jerome
   Bogireddi, Hanumakumar
   Thang Vu Duc
   Kofidis, Theodoros
   Baruch, Limor
   Boey, Freddy Y. C.
   Venkatraman, Subbu S.
   Machluf, Marcelle
TI Biohybrid cardiac ECM-based hydrogels improve long term cardiac function
   post myocardial infarction
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cardiac tissue engineering; Injectable scaffold; Extracellular matrix;
   Biohybrid material
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES;
   CHITOSAN HYDROGEL; IN-VIVO; POSTMYOCARDIAL INFARCTION; INJECTABLE
   BIOMATERIALS; TISSUE; HEART; REPAIR
AB Injectable scaffolds for cardiac tissue regeneration are a promising therapeutic approach for progressive heart failure following myocardial infarction (MI). Their major advantage lies in their delivery modality that is considered minimally invasive due to their direct injection into the myocardium. Biomaterials comprising such scaffolds should mimic the cardiac tissue in terms of composition, structure, mechanical support, and most importantly, bioactivity. Nonetheless, natural biomaterial-based gels may suffer from limited mechanical strength, which often fail to provide the long-term support required by the heart for contraction and relaxation. Here we present newly-developed injectable scaffolds, which are based on solubilized decellularized porcine cardiac extracellular matrix (pcECM) cross-linked with genipin alone or engineered with different amounts of chitosan to better control the gel's mechanical properties while still leveraging the ECM biological activity. We demonstrate that these new biohybrid materials are naturally remodeled by mesenchymal stem cells, while supporting high viabilities and affecting cell morphology and organization. They exhibit neither in vitro nor in vivo immunogenicity. Most importantly, their application in treating acute and long term chronic MI in rat models clearly demonstrates the significant therapeutic potential of these gels in the long-term (12 weeks post MI). The pcECM-based gels enable not only preservation, but also improvement in cardiac function eight weeks post treatment, as measured using echocardiography as well as hemodynamics. Infiltration of progenitor cells into the gels highlights the possible biological remodeling properties of the ECM-based platform.
   Statement of Significance
   This work describes the development of new injectable scaffolds for cardiac tissue regeneration that are based on solubilized porcine cardiac extracellular matrix (ECM), combined with natural biomaterials: genipin, and chitosan. The design of such scaffolds aims at leveraging the natural bioactivity and unique structure of cardiac ECM, while overcoming its limited mechanical strength, which may fail to provide the long-term support required for heart contraction and relaxation. Here, we present a biocompatible gel-platform with custom-tailored mechanical properties that significantly improve cardiac function when injected into rat hearts following acute and chronic myocardial infarction. We clearly demonstrate the substantial therapeutic potential of these scaffolds, which not only preserved heart functions but also alleviated MI damage, even after the formation of a mature scar tissue. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Efraim, Yael; Anavy, Noa Cohen; Baruch, Limor; Machluf, Marcelle] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
   [Sarig, Hadar; Sarig, Udi; de Berardinis, Elio; Chaw, Su-Yin; Krishnamoorthi, Muthukumar; Bogireddi, Hanumakumar; Boey, Freddy Y. C.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Kalifa, Jerome] Univ Michigan, Ctr Arrhythmia Res, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.
   [Thang Vu Duc; Kofidis, Theodoros] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119228, Singapore.
RP Machluf, M (reprint author), Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Lab Canc Drug Delivery & Cell Based Technol, IL-32000 Haifa, Israel.
EM machlufm@tx.technion.ac.il
RI Kofidis, Theodoros/B-9283-2011; Venkatraman, Subramanian/A-2228-2011;
   Boey, Freddy Yin Chiang/G-2618-2017
OI Kofidis, Theodoros/0000-0002-9623-6450; Venkatraman,
   Subramanian/0000-0002-8693-1070; Sarig, Udi/0000-0001-5260-4023
FU Israeli Ministry of Science, Technology and Space [3-11873]; Singapore
   National Research Foundation under the CREATE program: The Regenerative
   Medicine Initiative in Cardiac Restoration Therapy Research; Randy L.
   and Melvin R. Berlin Family Research Center for Regenerative Medicine
FX This research was supported by the Israeli Ministry of Science,
   Technology and Space [grant number 3-11873], the Singapore National
   Research Foundation under the CREATE program: The Regenerative Medicine
   Initiative in Cardiac Restoration Therapy Research, and the Randy L. and
   Melvin R. Berlin Family Research Center for Regenerative Medicine.
CR ATALA A, 2002, METHODS TISSUE ENG
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Camci-Unal G, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.19
   CARRINO DA, 1991, BIOCHEM INT, V24, P485
   Chaimov D, 2016, J CONTROL RELEASE
   Clause KC, 2013, CURR OPIN BIOTECH, V24, P830, DOI 10.1016/j.copbio.2013.04.011
   Dahan N., 2016, TISSUE ENG
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Deng BY, 2015, J BIOMED MATER RES A, V103, P907, DOI 10.1002/jbm.a.35232
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Eitan Y., 2007, NATURAL TISSUE DERIV
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Farnebo S, 2014, TISSUE ENG PT A, V20, P1550, DOI [10.1089/ten.tea.2013.0207, 10.1089/ten.TEA.2013.0207]
   Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukuda K, 2005, CIRC J, V69, P1431, DOI 10.1253/circj.69.1431
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014
   Lee DA, 1998, J MATER SCI-MATER M, V9, P47, DOI 10.1023/A:1008882628142
   Leite S., 2015, AM J PHYSL HEART CIR
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lu SH, 2010, TISSUE ENG PT A, V16, P1303, DOI 10.1089/ten.TEA.2009.0434
   Ma YG, 2014, PFLUG ARCH EUR J PHY, V466, P1113, DOI 10.1007/s00424-014-1463-9
   McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nascimento DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025045
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Oh B, 2013, EXPERT OPIN DRUG DEL, V10, P1565, DOI 10.1517/17425247.2013.830608
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Ruvinov E., 2015, ADV DRUG DELIV REV
   Sarig U., 2016, ACTA BIOMATER
   Sarig U, 2015, TISSUE ENG PT A, V21, P1507, DOI [10.1089/ten.tea.2014.0477, 10.1089/ten.TEA.2014.0477]
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Schmidt A, 2006, EUR J CLIN INVEST, V36, P473, DOI 10.1111/j.1365-2362.2006.01658.x
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Sonofuchi K., 2016, J ORTHOP RES
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Taraballi F, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731415624667
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang Y., 2012, TISSUE ENG A
   WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859
   Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang WG, 2015, MOL MED REP, V11, P133, DOI 10.3892/mmr.2014.2754
   Zhang J., 2016, BIOMATERIALS
NR 70
TC 10
Z9 10
U1 10
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 220
EP 233
DI 10.1016/j.actbio.2016.12.015
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100018
PM 27956366
DA 2018-10-20
ER

PT J
AU Niepa, THR
   Wang, H
   Gilbert, JL
   Ren, D
AF Niepa, Tagbo H. R.
   Wang, Hao
   Gilbert, Jeremy L.
   Ren, Dacheng
TI Eradication of Pseudomonas aeruginosa cells by cathodic electrochemical
   currents delivered with graphite electrodes
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Pseudomonas aeruginosa; Electrochemical current; Carbon; Cathode;
   Electrode; Biofilm; Persister
ID STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PERSISTER CELLS;
   ELECTRICAL-STIMULATION; BIOFILM; METAL; TITANIUM; BACTERIA; FIELDS;
   ANTIBIOTICS
AB Antibiotic resistance is a major challenge to the treatment of bacterial infections associated with medical devices and biomaterials. One important intrinsic mechanism of such resistance is the formation of per sister cells that are phenotypic variants of microorganisms and highly tolerant to antibiotics. Recently, we reported a new approach to eradicating persister cells of Pseudomonas aeruginosa using low-level direct electrochemical current (DC) and synergy with the antibiotic tobramycin. To further understand the underlying mechanism and develop this technology toward possible medical applications, we investigated the electricidal activities of non-metallic biomaterial on persister and biofilm cells of P. aeruginosa using graphite-based TGON (TM) 805 electrodes. We employed both single and dual chamber systems to compare electrochemical factors of TGON and stainless steel 304 electrodes. The results revealed that TGON-based treatments were highly effective against P. aeruginosa persister cells. In the single chamber system, complete eradication of planktonic persister cells (corresponding to a 7-log killing) was achieved with 70 mu A/cm(2) DC using TGON electrodes within 40 min of treatment, while the cell viability in biofilms was reduced by 2 logs within 1 h. The killing effects were dose and time dependent with higher current densities requiring less time. Moreover, reduction reactions were found more effective than oxidation reactions, confirming that metal cations are not indispensable, although they may facilitate cell killing. The findings of this study can help develop electrochemical technologies to eradicate persister and biofilm cells for more effective treatment of medical device and biomaterial associated infections.
   Statement of Significance
   Infections associated with medical devices and biomaterials present a major challenge due to high-level tolerance of microbes to conventional antibiotics. It is well established that such tolerance is due to the formation of dormant persister cells and multicellular structures known as biofilms. Recent studies have demonstrated electrochemical treatment as a promising alternative to eradicate bacterial infections, since the killing mechanism is independent of the growth phase of bacterial cells, but relies on various electrochemical species interplaying during the treatment. The current study investigated major bactericidal properties of the electrochemical currents mediated via TGON, a carbon-based electrode material. Up to total eradication of Pseudomonas aeruginosa persister cells was achieved. The new knowledge of electrochemical properties and the bioactivity of TGON may help develop new methods/devices to eradicate bacterial infections by delivering safe levels of electrochemical currents. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Niepa, Tagbo H. R.; Wang, Hao; Gilbert, Jeremy L.; Ren, Dacheng] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
   [Niepa, Tagbo H. R.; Wang, Hao; Gilbert, Jeremy L.; Ren, Dacheng] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA.
   [Ren, Dacheng] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA.
   [Ren, Dacheng] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.
RP Ren, D (reprint author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
EM dren@syr.edu
CR Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x
   Catelas I, 2011, J BONE JOINT SURG AM, V93A, P76, DOI 10.2106/JBJS.J.01877
   Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Del Pozo JL, 2008, INT J ARTIF ORGANS, V31, P786
   del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P41, DOI 10.1128/AAC.00680-08
   Ehrensberger MT, 2015, BIOMATERIALS, V41, P97, DOI 10.1016/j.biomaterials.2014.11.013
   Ehrensberger MT, 2010, J BIOMED MATER RES A, V93A, P1500, DOI 10.1002/jbm.a.32622
   Ercan B, 2011, ACTA BIOMATER, V7, P3003, DOI 10.1016/j.actbio.2011.04.002
   FALCONE AE, 1986, PLAST RECONSTR SURG, V77, P455, DOI 10.1097/00006534-198603000-00022
   Freebairn D, 2013, EXPERT REV MED DEVIC, V10, P85, DOI [10.1586/ERD.12.70, 10.1586/erd.12.70]
   Geng B, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-9
   Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1111/j.1574-6968.2002.tb11000.x
   Harrison JJ, 2005, MICROBIOL-SGM, V151, P3181, DOI 10.1099/mic.0.27794-0
   Harrison JJ, 2005, ENVIRON MICROBIOL, V7, P981, DOI 10.1111/j.1462-2920.2005.00777.x
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050
   MARINO A A, 1984, Journal of Biological Physics, V12, P93, DOI 10.1007/BF01870559
   McCormick ML, 1998, J BACTERIOL, V180, P622
   Miller RA, 1997, CLIN MICROBIOL REV, V10, P1
   Mohn D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016157
   Niepa THR, 2016, ACTA BIOMATER, V36, P286, DOI 10.1016/j.actbio.2016.03.028
   Niepa THR, 2016, BIOMATERIALS, V74, P267, DOI 10.1016/j.biomaterials.2015.10.007
   Niepa THR, 2012, BIOMATERIALS, V33, P7356, DOI 10.1016/j.biomaterials.2012.06.092
   Nodzo S.R., 2016, CLIN ORTHOP RELAT R, P1
   Pillet F, 2016, SCI REP-UK, V6, DOI 10.1038/srep19778
   Reilly JP, 2012, APPL BIOELECTRICITY
   Ren D., 2014, US Patent, Patent No. [8,663,914, 8663914]
   Ren D., 2013, US Patent, Patent No. [8,569,027, 8569027]
   Sahrmann P, 2014, CLIN IMPLANT DENT R, V16, P552, DOI 10.1111/cid.12018
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876
   Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107
   Sultana ST, 2015, BIOFOULING, V31, P745, DOI 10.1080/08927014.2015.1105222
   Szkotak R, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-39
   Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13
   Zhang JY, 2014, BIOMATERIALS, V35, P7690, DOI 10.1016/j.biomaterials.2014.05.069
   Zituni D, 2014, INT J ORAL SCI, V6, P7, DOI 10.1038/ijos.2013.64
NR 40
TC 5
Z9 5
U1 6
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 344
EP 352
DI 10.1016/j.actbio.2016.12.053
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100029
PM 28049020
DA 2018-10-20
ER

PT J
AU Griffin, MF
   Ibrahim, A
   Seifalian, AM
   Butler, PEM
   Kalaskar, DM
   Ferretti, P
AF Griffin, M. F.
   Ibrahim, A.
   Seifalian, A. M.
   Butler, P. E. M.
   Kalaskar, D. M.
   Ferretti, P.
TI Chemical group-dependent plasma polymerisation preferentially directs
   adipose stem cell differentiation towards osteogenic or chondrogenic
   lineages
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adipose stem cell; Chondrogenesis; Osteogenesis; Surface chemistry;
   Plasma polymerisation; Carboxyl; Amine
ID FOCAL ADHESION KINASE; SURFACE MODIFICATION; IN-VITRO
AB Human adipose derived stem cells (ADSCs) are being explored for the repair of craniofacial defects due to their multi-differentiation potential and ease of isolation and expansion. Crucial to using ADSCs for craniofacial repair is the availability of materials with appropriate biomechanical properties that can support their differentiation into bone and cartilage. We tested the hypothesis that different modifications of chemical groups on the surface of a nanocomposite polymer could increase human ADSC adhesion and selectively enhance their osteogenic and chondrogenic differentiation. We show that the COOH modification significantly promoted initial cell adhesion and proliferation over 14 days compared to NH2 surfaces. Expression of focal adhesion kinase and vinculin was enhanced after plasma surface polymerisation at 24 h. The COOH modification significantly enhanced chondrogenic differentiation as indicated by up-regulation of aggrecan and collagen II transcripts. In contrast, NH2 group functionalised scaffolds promoted osteogenic differentiation with significantly enhanced expression of collagen I, alkaline phosphatase and osteocalcin both at the gene and protein level. Finally, chorioallantoic membrane grafting demonstrated that both NH2 and COOH functionalised scaffolds seeded with ADSCs were biocompatible and supported vessel ingrowth apparently to a greater degree than unmodified scaffolds. In summary, our study shows the ability to direct ADSC chondrogenic and osteogenic differentiation by deposition of different chemical groups through plasma surface polymerisation. Hence this approach could be used to selectively enhance bone or cartilage formation before implantation in vivo to repair skeletal defects.
   Statement of Significance
   Human adipose derived stem cells (hADSCs) are an exciting stem cell source for regenerative medicine due to their plentiful supply and ease of isolation. However, the optimal environmental cues to direct stem cells towards certain lineages change have to has not been identified. We have shown that by modifying the surface of the scaffold with specific chemical groups using plasma surface polymerisation techniques we can control ADSCs differentiation. This study shows that ADSCs can be differentiated towards osteogenic and chondrogenic lineages on amine (NH2) and carboxyl (COOH) modified scaffolds respectively. Plasma polymerisation can be easily applied to other biomaterial surfaces to direct stem cell differentiation for the regeneration of bone and cartilage. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.orgilicensesiby/4.0/).
C1 [Griffin, M. F.; Seifalian, A. M.; Butler, P. E. M.; Kalaskar, D. M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London NW3 2AW, England.
   [Griffin, M. F.; Butler, P. E. M.; Kalaskar, D. M.] Royal Free London NHS Fdn Trust Hosp, London, England.
   [Griffin, M. F.; Ibrahim, A.; Ferretti, P.] UCL, UCL Great Ormond St Inst Child Hlth, Stem Cells & Regenerat Med Sect, 30 Guilford St, London WCIN EH, England.
RP Griffin, MF; Kalaskar, DM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London NW3 2AW, England.; Ferretti, P (reprint author), UCL, UCL Great Ormond St Inst Child Hlth, Stem Cells & Regenerat Med Sect, 30 Guilford St, London WCIN EH, England.
EM 12michellegriffin@gmail.com; d.kalaskar@ucl.ac.uk; p.ferretti@ucl.ac.uk
OI Butler, Peter/0000-0001-7419-1493; Ferretti,
   Patrizia/0000-0002-3590-6772
FU Medical Research Council (MRC); Action Medical Research (AMR) [GN2239];
   Action Medical Research [2239]; Medical Research Council [MC_PC_15014,
   MC_EX_MR/M003485/1]
FX This study was funded by the Medical Research Council (MRC) and Action
   Medical Research (AMR), Grant No. GN2239.
CR Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Chahine NO, 2014, TISSUE ENG PT A, V20, P2305, DOI [10.1089/ten.tea.2013.0328, 10.1089/ten.TEA.2013.0328]
   Chaves C, 2016, ACS APPL MATER INTER, V8, P18701, DOI 10.1021/acsami.6b05788
   Chen M., 2015, COLLOID SURFACE B, V134, P311
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Griffin M, 2014, STEM CELL REV REP, V10, P671, DOI 10.1007/s12015-014-9522-3
   Griffin MF, 2016, BIOMATER SCI-UK, V4, P145, DOI 10.1039/c5bm00265f
   Griffin MF, 2015, WORLD J STEM CELLS, V7, P37, DOI 10.4252/wjsc.v7.i1.37
   Guasti L, 2014, NANOMED-NANOTECHNOL, V10, P279, DOI 10.1016/j.nano.2013.08.006
   Guo LK, 2008, J BIOMED MATER RES A, V87A, P903, DOI 10.1002/jbm.a.31834
   Kalaskar DM, 2013, COLLOID SURFACE B, V111, P134, DOI 10.1016/j.colsurfb.2013.05.035
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Liu XJ, 2014, ACS APPL MATER INTER, V6, P9733, DOI 10.1021/am502170s
   Naderi N, 2014, J PLAST RECONSTR AES, V67, P1726, DOI 10.1016/j.bjps.2014.08.013
   Petersen J, 2012, ACS APPL MATER INTER, V4, P1072, DOI 10.1021/am201699a
   Seo JH, 2013, ACTA BIOMATER, V9, P5493, DOI 10.1016/j.actbio.2012.10.015
   Teven Chad M, 2015, Ann Maxillofac Surg, V5, P4, DOI 10.4103/2231-0746.161044
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
   Wang PY, 2015, ACTA BIOMATER, V11, P58, DOI 10.1016/j.actbio.2014.09.027
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 24
TC 6
Z9 6
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2017
VL 50
BP 450
EP 461
DI 10.1016/j.actbio.2016.12.016
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN4CJ
UT WOS:000395955100039
PM 27956359
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Brooks, BJ
   Arif, KM
   Dirven, S
   Potgieter, J
AF Brooks, Byron James
   Arif, Khalid Mahmood
   Dirven, Steven
   Potgieter, Johan
TI Robot-assisted 3D printing of biopolymer thin shells
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE Biopolymer 3D printing; Thin shell printing; Pellet extrusion;
   Articulated robot; Fused deposition modeling
ID DEPOSITION; SYSTEM
AB The design, development, and testing of a robot-assisted biopolymer thin shell free-form printing system is presented. This fused-deposition style printing system directly extrudes pellets of biomaterial and is capable of printing directly on organically shaped 3D curved surfaces. The screw extrusion method allows direct printing from pellets. The printed structure is supported by a pre-built base (a mandrel), which is manipulated by a six degree-of-freedom industrial robot arm, an ABB IRB120. This robot is used to manipulate the orientation of the support mandrel surface. The print method works by projecting a desired 2D image onto a mathematical model of the pre-built mandrel surface. This produces a 3D point path for the system to follow. These points are then converted into vectors for the robot's pose and orientation of the end effector, which ensures that the extrusion remains normal to the mandrel surface. Inverse kinematics is applied to convert the trajectory into joint positions for the robot to follow. This paper demonstrates the utility of the developed system through simulation and printing of concave surface designs.
C1 [Brooks, Byron James; Arif, Khalid Mahmood; Dirven, Steven; Potgieter, Johan] Massey Univ, Sch Engn & Adv Technol, Ctr Addit Mfg, Auckland 0632, New Zealand.
RP Arif, KM (reprint author), Massey Univ, Sch Engn & Adv Technol, Ctr Addit Mfg, Auckland 0632, New Zealand.
EM k.arif@massey.ac.nz
OI Arif, Khalid/0000-0001-9042-4509
FU Ministry of Business, Innovation, and Employment under High Value
   Manufacturing and Services (HVMS) Enabling Technologies investment
   contract
FX This research was part of the Extrusion Plus program led by Scion and
   Dr. Dawn Smith, and funded by the Ministry of Business, Innovation, and
   Employment funding under High Value Manufacturing and Services (HVMS)
   Enabling Technologies investment contract. The authors thank Dr.
   Marie-Joo Le Guen for providing the materials and related expertise.
   Special thanks are also due to Mr. David Trubridge, a New Zealand based
   artist, for providing the artistic design shown in Fig. 6.
CR Ahn SH, 2002, RAPID PROTOTYPING J, V8, P248, DOI 10.1108/13552540210441166
   Arif KM, 2007, INT C MAN AUT ICMA 2, P616
   Barnett E, 2015, ADDIT MANUF, V7, P27, DOI 10.1016/j.addma.2015.05.001
   Bikas H, 2016, INT J ADV MANUF TECH, V83, P389, DOI 10.1007/s00170-015-7576-2
   Chen YH, 1999, INT J ADV MANUF TECH, V15, P624
   Compton BG, 2014, ADV MATER, V26, P5930, DOI 10.1002/adma.201401804
   Diegel O, 2011, ADV MATER RES-SWITZ, V199-200, P1984, DOI 10.4028/www.scientific.net/AMR.199-200.1984
   Diegel O, 2011, KEY ENG MATER, V467-469, P662, DOI 10.4028/www.scientific.net/KEM.467-469.662
   Harris I. D., 2011, DEV IMPLEMENTATION M
   Hu YN, 1999, INT J ADV MANUF TECH, V15, P630, DOI 10.1007/s001700050112
   Kim C, 2015, J MECH ROBOT, V7
   Li X., 2014, INT J POLYM SCI
   Masood SH, 2004, MATER DESIGN, V25, P587, DOI 10.1016/j.matdes.2004.02.009
   Rauwendaal C., 2014, POLYM EXTRUSION
   Reddy BV, 2007, VIRTUAL PHYS PROTOTY, V2, P51, DOI 10.1080/17452750701336486
   Schweitzer D, 1982, ACM SIGGRAPH COMPUTE, V16, P265
   Tam KMM, 2016, ROBOTIC FABRICATION, P350
   Turner BN, 2015, RAPID PROTOTYPING J, V21, P250, DOI 10.1108/RPJ-02-2013-0017
   Valkenaers H., 2013, P 10 INT C MULT MICR, P235
   Wang GL, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO), P1717, DOI 10.1109/ROBIO.2015.7419019
   Wang ZY, 2016, INT J COMPUT APPL T, V53, P183
   Wilson M., 2014, IMPLEMENTATION ROBOT
   Xu ZQ, 2014, SCI WORLD J, DOI 10.1155/2014/915740
   Zhang YM, 2002, MECHATRONICS, V12, P37, DOI 10.1016/S0957-4158(00)00064-7
NR 24
TC 2
Z9 2
U1 1
U2 9
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-3768
EI 1433-3015
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD MAR
PY 2017
VL 89
IS 1-4
BP 957
EP 968
DI 10.1007/s00170-016-9134-y
PG 12
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA EL3DR
UT WOS:000394500300078
DA 2018-10-20
ER

PT J
AU de la Portilla, F
   Reyes-Diaz, ML
   Maestre, MV
   Jimenez-Rodriguez, R
   Garcia-Cabrera, AM
   Vazquez-Monchul, JM
   Diaz-Pavon, JM
   Padillo-Ruiz, FC
AF de la Portilla, F.
   Reyes-Diaz, M. L.
   Maestre, M. V.
   Jimenez-Rodriguez, R. M.
   Garcia-Cabrera, A. M.
   Vazquez-Monchul, J. M.
   Diaz-Pavon, J. M.
   Padillo-Ruiz, F. C.
TI Ultrasonographic evidence of Gatekeeper (TM) prosthesis migration in
   patients treated for faecal incontinence: a case series
SO INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
LA English
DT Article
DE Faecal incontinence; Prostheses; Migration; Endoanal ultrasound; Results
ID MANAGEMENT; INJECTION
AB Faecal incontinence (FI) is both a medical and social problem, with an underestimated incidence. For patients with internal anal sphincter damage, implantation of biomaterial in the anal canal is a recognised treatment option. One such material, Gatekeeper (TM), has previously shown promising short- and medium-term results without any major complications, including displacement. The main aim of the present study is to assess the degree to which displacement of Gatekeeper prostheses may occur and to determine whether this is associated with patient outcomes.
   Seven patients (six females) with a mean age of 55.6 years [50.5-57.2] and a mean FI duration of 6 +/- 2 years were prospectively enrolled in the study. Each subject was anaesthetised and underwent implantation of six prostheses in the intersphincteric region, guided by endoanal 3D ultrasound (3D-EAU). Follow-up was performed at post-interventional months 1, 3, and 12 (median 12 +/- 4 months), during which data were obtained from a defaecation diary, Wexner scale assessment, anorectal manometry (ARM), 3D-EAU, and a health status and quality of life questionnaire (FIQL).
   At 3-month follow-up, 3D-EAU revealed displacement of 24/42 prostheses in 5/7 patients. Of these, 15 had migrated to the lower portion and 9 to the upper portion of the anal canal and rectum. Despite this migration, treatment was considered successful in 3/7 patients. In one patient, it was necessary to remove a prosthesis due to spontaneous extrusion.
   We have shown that displacement of the Gatekeeper (TM) prosthesis occurs, but is not associated with poorer clinical outcomes.
C1 [de la Portilla, F.; Reyes-Diaz, M. L.; Maestre, M. V.; Jimenez-Rodriguez, R. M.; Garcia-Cabrera, A. M.; Vazquez-Monchul, J. M.; Diaz-Pavon, J. M.; Padillo-Ruiz, F. C.] Univ Seville, Univ Hosp Virgen del Rocio, Seville Biomed Res Inst IBIS,CSIC, Dept Gen & Gastrointestinal Surg,Coloproctol Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.
   [de la Portilla, F.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
RP de la Portilla, F (reprint author), Univ Seville, Univ Hosp Virgen del Rocio, Seville Biomed Res Inst IBIS,CSIC, Dept Gen & Gastrointestinal Surg,Coloproctol Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.; de la Portilla, F (reprint author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
EM fportilla@us.es
CR Al-Ozaibi L, 2014, INT J SURG CASE REP, V5, P936, DOI 10.1016/j.ijscr.2014.08.002
   de la Portilla F, 2016, INT J COLORECTAL DIS, V31, P1251, DOI 10.1007/s00384-015-2451-z
   Ditah I, 2014, CLIN GASTROENTEROL H, V12, P636, DOI 10.1016/j.cgh.2013.07.020
   Duelund-Jakobsen J, 2016, THER ADV GASTROENTER, V9, P86, DOI 10.1177/1756283X15614516
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   Ratto C, 2016, BRIT J SURG, V103, P290, DOI 10.1002/bjs.10050
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   SHAFIK A, 1993, INT SURG, V78, P159
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Van Koughnett JAM, 2013, WORLD J GASTROENTERO, V19, P9216, DOI 10.3748/wjg.v19.i48.9216
NR 11
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-1958
EI 1432-1262
J9 INT J COLORECTAL DIS
JI Int. J. Colorectal Dis.
PD MAR
PY 2017
VL 32
IS 3
BP 437
EP 440
DI 10.1007/s00384-016-2742-z
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA EM0DE
UT WOS:000394988200018
PM 28054134
DA 2018-10-20
ER

PT J
AU Abdel-Naby, W
   Cole, B
   Liu, AH
   Liu, JB
   Wan, PX
   Guaiquil, VH
   Schreiner, R
   Infanger, D
   Lawrence, BD
   Rosenblatt, MI
AF Abdel-Naby, Waleed
   Cole, Brigette
   Liu, Aihong
   Liu, Jingbo
   Wan, Pengxia
   Guaiquil, Victor H.
   Schreiner, Ryan
   Infanger, David
   Lawrence, Brian D.
   Rosenblatt, Mark I.
TI Silk-Derived Protein Enhances Corneal Epithelial Migration, Adhesion,
   and Proliferation
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE corneal epithelium; cell migration; cell adhesion; corneal wound
   healing; silk protein
ID OCULAR SURFACE RECONSTRUCTION; AMNIOTIC MEMBRANE; FIBROIN MEMBRANES;
   CELL-MIGRATION; BIOMATERIAL; INHIBITION; HYDROGEL; VINCULIN; RECEPTOR;
   MATRIX
AB PURPOSE. The corneal surface is vulnerable to a myriad of traumatic insults including mechanical, chemical, and thermal injuries. The resulting trauma may render the naturally occurring regenerative properties of the cornea incapable of restoring a healthy epithelial surface, and may result in the loss of corneal transparency and vision. Healing of the corneal epithelium requires a complex cascade of biological processes that work to restore the tissue after injury. New therapeutic agents that act on the multiple steps of the corneal wound-healing process would offer a potential for improving patient outcomes. Here, a novel silk fibroin-derived protein (SDP) was studied for potential impacts on wound healing through studying an in vitro model.
   METHODS. Solubilized SDP, produced from the Bombyx mori silkworm cocoon, was added to human corneal limbal-epithelial (hCLE) cultures to evaluate the material's effects on epithelial cell migration, proliferation, and adhesion through the use of various scratch wound assays and flow chamber studies.
   RESULTS. Results indicated that the addition of SDP to culture increased hCLE migration rate by over 50%, and produced an approximate 60% increase in cell proliferation. This resulted in a nearly 30% enhancement of in vitro scratch wound closure time. In addition, cultures treated with SDP experienced increased cell-matrix focal adhesion formation by over 95% when compared to controls.
   CONCLUSIONS. The addition of SDP to culture media significantly enhanced hCLE cell sheet migration, proliferation, and attachment when compared to untreated controls, and indicates SDP's potential utility as an ophthalmic therapeutic agent.
C1 [Abdel-Naby, Waleed] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Abdel-Naby, Waleed; Cole, Brigette; Liu, Aihong; Liu, Jingbo; Wan, Pengxia; Schreiner, Ryan] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA.
   [Guaiquil, Victor H.; Rosenblatt, Mark I.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.
   [Infanger, David; Lawrence, Brian D.] Silk Technol Ltd, Plymouth, MN USA.
RP Rosenblatt, MI (reprint author), UIC Dept Ophthalmol, Illinois Eye & Ear Infirm, 1855 W Taylor St,MC 648, Chicago, IL 60612 USA.
EM mrosenbl@uic.edu
FU Research to Prevent Blindness Career Development Award; National Science
   Foundation (NSF) Graduate Research Fellowship Award [DGE-1144153]; NSF
   SBIR [IIP-1013484]; Department of Defense SBIR [A151-061-0107]
FX Supported by Research to Prevent Blindness Career Development Award,
   National Science Foundation (NSF) Graduate Research Fellowship Award
   DGE-1144153, NSF SBIR Phase 2 Award No. IIP-1013484, and Department of
   Defense SBIR Phase 1 Award No. A151-061-0107.
CR Agrawal Vinay B, 2003, Indian J Ophthalmol, V51, P5
   Boulton M, 2004, INT J BIOCHEM CELL B, V36, P643, DOI 10.1016/j.biocel.2003.10.013
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chim SM, 2011, J BIOL CHEM, V286, P22035, DOI 10.1074/jbc.M110.187633
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200
   Cutler TJ, 2004, VET CLIN N AM-EQUINE, V20, P319, DOI 10.1016/j.cveq.2004.04.014
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dieckow Julia, 2011, Ocul Surf, V9, P3
   Doutch J, 2008, BIOPHYS J, V95, P5092, DOI 10.1529/biophysj.108.132316
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Jia L, 2016, J BIOMED MATER RES B, V104, P431, DOI 10.1002/jbm.b.33408
   Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P932, DOI 10.1161/01.ATV.17.5.932
   Ko SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110542
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Maharajan VS, 2007, CLIN EXP OPHTHALMOL, V35, P140, DOI 10.1111/j.1442-9071.2006.01408.x
   Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   PFEIFFER SE, 1967, CANCER RES, V27, P124
   PIERREZ J, 1992, ACTA BIOTHEOR, V40, P131, DOI 10.1007/BF00168142
   Rhee DJ, 1999, WILLS EYE MANUAL OFF
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3
   Taite LJ, 2006, ANN BIOMED ENG, V34, P1705, DOI 10.1007/s10439-006-9173-x
   Taliana L, 2000, INVEST OPHTH VIS SCI, V41, P103
   Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Yiu SC, 2007, CURR OPIN OPHTHALMOL, V18, P509, DOI 10.1097/ICU.0b013e3282f0ab33
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
NR 37
TC 2
Z9 2
U1 0
U2 11
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAR
PY 2017
VL 58
IS 3
BP 1425
EP 1433
DI 10.1167/iovs.16-19957
PG 9
WC Ophthalmology
SC Ophthalmology
GA EQ4ZA
UT WOS:000398089000009
PM 28257533
OA Other Gold
DA 2018-10-20
ER

PT J
AU Chen, P
   Aso, T
   Sasaki, R
   Tsutsumi, Y
   Ashida, M
   Doi, H
   Hanawa, T
AF Chen, Peng
   Aso, Toshihiro
   Sasaki, Ryuichiro
   Tsutsumi, Yusuke
   Ashida, Maki
   Doi, Hisashi
   Hanawa, Takao
TI Micron/Submicron Hybrid Topography of Titanium Surfaces Influences
   Adhesion and Differentiation Behaviors of the Mesenchymal Stem Cells
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Mesenchymal Stem Cell; Adhesion; Differentiation; Titanium; Nano;
   Femtosecond Laser Processing
ID BIODEGRADABLE COLLOIDAL GELS; FEMTOSECOND LASER; MYOGENIC
   DIFFERENTIATION; ENDOTHELIAL-CELLS; DRUG-DELIVERY; ASPECT-RATIO;
   ALIGNMENT; TISSUE; ALLOYS; POLARIZATION
AB To clarify the effects of micron/submicron hybrid topography on cell morphology and functionalization, we investigated the adhesion and differentiation of human mesenchymal stem cells (hMSCs) to titanium (Ti) surfaces with three different topographies: micron, submicron, and hybrid grooves created using a femtosecond laser. hMSCs cultured on Ti specimens showed high alignment on micron and hybrid surfaces after 6 h of incubation, whereas cells attached to submicron and hybrid surfaces were elongated. An examination of vinculin-positive adhesion plaques indicated that micron grooves affected cellular alignment by modifying the initial cell polarization, whereas submicron grooves affected cellular extension. A superposition effect of topography was evidenced by the highly aligned and elongated morphology of hMSCs grown on the hybrid surface, which promoted osteogenic and chondrogenic differentiation. These findings provide a basis for the design of novel biomaterial surfaces that can control specific cellular functions.
C1 [Chen, Peng; Tsutsumi, Yusuke; Ashida, Maki; Doi, Hisashi; Hanawa, Takao] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Tokyo 1010062, Japan.
   [Aso, Toshihiro; Sasaki, Ryuichiro] Aisin Seiki Co Ltd, Kariya, Aichi 4488650, Japan.
   [Tsutsumi, Yusuke] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
FU Japan Society for the Promotion of Science [22240059]
FX This work was partially supported by a Grant-in-Aid for Scientific
   Research (No. 22240059) from the Japan Society for the Promotion of
   Science.
CR Antonini S, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/035010
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K, 1985, 6 EUR S CORR INH FER, P769
   Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Bizi-bandoki P, 2013, APPL SURF SCI, V273, P399, DOI 10.1016/j.apsusc.2013.02.054
   Boinovich LB, 2015, ACS APPL MATER INTER, V7, P19500, DOI 10.1021/acsami.5b06217
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Calzado-Martin A, 2014, J BIOMED MATER RES A, V102, P3154, DOI 10.1002/jbm.a.34987
   Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009
   Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011
   Chen P, 2016, J BIOMED MATER RES A, V104, P639, DOI 10.1002/jbm.a.35598
   Chua JS, 2014, BIOMATERIALS, V35, P7750, DOI 10.1016/j.biomaterials.2014.06.008
   Cozzolino M, 2001, J AM SOC NEPHROL, V12, P2511
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Dreier B, 2013, AM J PHYSIOL-CELL PH, V305, pC290, DOI 10.1152/ajpcell.00264.2012
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038
   Hatano R, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-18
   Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011
   Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087
   Huang Y, 2012, NANOSCALE, V4, P2484, DOI 10.1039/c2nr12072k
   Jacchetti E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03830
   Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103
   Kaivosoja E, 2013, J BIOMATER APPL, V27, P862, DOI 10.1177/0885328211428094
   Kawazoe N, 2009, J NANOSCI NANOTECHNO, V9, P230, DOI 10.1166/jnn.2009.J003
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Nozaki K, 2015, MAT SCI ENG C-MATER, V57, P1, DOI 10.1016/j.msec.2015.07.028
   OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106
   Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176
   Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f
   Petronis S, 2003, J BIOMED MATER RES A, V66A, P707, DOI 10.1002/jbm.a.10056
   Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131
   Rukosuyev MV, 2014, APPL SURF SCI, V313, P411, DOI 10.1016/j.apsusc.2014.05.224
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shen JY, 2006, J BIOMED MATER RES B, V77B, P423, DOI 10.1002/jbm.b.30449
   Shibata T, 2009, MICROELECTRON ENG, V86, P1439, DOI 10.1016/j.mee.2009.01.046
   Shinonaga T, 2015, APPL PHYS B-LASERS O, V119, P493, DOI 10.1007/s00340-015-6082-4
   Song FF, 2015, J BIOMED NANOTECHNOL, V11, P40, DOI 10.1166/jbn.2015.1962
   Song S, 2015, ACTA BIOMATER, V18, P100, DOI 10.1016/j.actbio.2015.02.021
   Song W, 2011, J NANOMATER, DOI 10.1155/2011/265251
   Takahashi H, 2011, BIOMATERIALS, V32, P8830, DOI 10.1016/j.biomaterials.2011.08.006
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Thievessen I, 2015, FASEB J, V29, P4555, DOI 10.1096/fj.14-268235
   Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wang Q, 2015, ADV DRUG DELIVER REV, V91, P125, DOI 10.1016/j.addr.2014.12.003
   Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052
   Wang ZY, 2013, TISSUE ENG PART C-ME, V19, P538, DOI [10.1089/ten.TEC.2012.0472, 10.1089/ten.tec.2012.0472]
   Xin SJ, 2014, J BIOMED NANOTECHNOL, V10, P803, DOI 10.1166/jbn.2014.1748
   Yovich S, 1998, HISTOCHEM J, V30, P267, DOI 10.1023/A:1003263907320
   Yu T, 2013, MACROMOL BIOSCI, V13, P799, DOI 10.1002/mabi.201200481
NR 65
TC 11
Z9 11
U1 4
U2 24
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2017
VL 13
IS 3
BP 324
EP 336
DI 10.1166/jbn.2017.2335
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA EO9SW
UT WOS:000397029400008
PM 29381291
DA 2018-10-20
ER

PT J
AU Park, C
   Vang, MS
   Park, SW
   Lim, HP
AF Park, Chan
   Vang, Mong-Sook
   Park, Sang-Won
   Lim, Hyun-Pil
TI Effect of various polishing systems on the surface roughness and phase
   transformation of zirconia and the durability of the polishing systems
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Article
ID Y-TZP-ZIRCONIA; MONOLITHIC ZIRCONIA; DENTAL CERAMICS; HUMAN ENAMEL;
   IN-VITRO; FLEXURAL STRENGTH; PORCELAIN; WEAR; RELIABILITY; BIOMATERIAL
AB Statement of problem. Although many systems are used to polish zirconia, a comparison of the performance of zirconia and feldspathic porcelain polishing systems is lacking.
   Purpose. The purpose of this in vitro study was to compare the effects of 3 polishing systems on surface roughness, zirconia phase transformation, and durability of the polishing systems when applied to zirconia and feldspathic porcelain.
   Material and methods. Three polishing systems were evaluated: Z1, a zirconia polishing system; Z2, a zirconia polishing system, and F1, a feldspathic porcelain polishing system. Three ceramic systems were evaluated: PR and ZM zirconia specimens (diameter 15 mm, height 2 mm; 23 specimens each) and CB feldspathic porcelain specimens of the same size (15 specimens). A rough surface was created on the 3 types of specimens (15 specimens each) to model an occlusal adjustment under the same conditions. Polishing was carried out with the 3 polishing systems for 2 minutes each. Surface roughness was measured with a 3-dimensional (3D) optical profiler. The surface was also observed with a scanning electron microscopy. X-ray diffraction analysis was performed for 8 PR or ZM zirconia specimens polished by using the Z1 and Z2 systems for 8 minutes to evaluate the phase transformation of zirconia before, during, and after polishing. These specimens were compared and analyzed for phase transformation that might have occurred during the polishing of the specimens. After finishing the surface roughness experiment and the phase transformation experiment, the volumes of the polishers were measured with a 3D volume scanner and compared with those before the experiments to evaluate the durability of the polishing system. A statistical analysis of all data was performed using 2-way ANOVA and the Tukey honest significant difference test (alpha=.05).
   Results. The 2 zirconia polishing systems (Z1, Z2) created a significantly (P <.001) smoother surface, regardless of the type of specimens used for polishing, than the feldspathic porcelain polishing system (F1). When polishing treatment was carried out on zirconia specimens for 8 minutes, the maximum percentages of monoclinic phase increased by 0.03% in the Z1 system and by 0.09% in the Z2 system. The volume change for the durability evaluation of the polishing system was 13.35 and 29.37% in the Z1 system, 2.05 and 5.92% in the Z2 system, and 3.60 and 4.95% in the Fl system, respectively.
   Conclusions. Zirconia polishing systems created a smoother surface on zirconia than the feldspathic porcelain polishing system. No significant changes in the phase transformation of zirconia were found before and after polishing. Each polishing system showed different levels of wear resistance.
C1 [Park, Chan; Vang, Mong-Sook; Park, Sang-Won; Lim, Hyun-Pil] Chonnam Natl Univ, Sch Dent, Dept Prosthodont, 33 Yongbong Ro, Gwangju 500757, South Korea.
RP Lim, HP (reprint author), Chonnam Natl Univ, Sch Dent, Dept Prosthodont, 33 Yongbong Ro, Gwangju 500757, South Korea.
EM mcnihil@jnu.ac.kr
CR Amer R, 2015, J PROSTHET DENT, V114, P260, DOI 10.1016/j.prosdent.2015.02.018
   Bai YY, 2016, J PROSTHET DENT, V116, P584, DOI 10.1016/j.prosdent.2016.02.006
   Blatz MB, 2007, QUINTESSENCE INT, V38, P745
   Bottino Marco Cícero, 2006, Braz. Dent. J., V17, P285, DOI 10.1590/S0103-64402006000400004
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   D'Arcangelo C, 2016, J PROSTHET DENT, V115, P350, DOI 10.1016/j.prosdent.2015.09.010
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hjerppe J, 2016, J PROSTHET DENT, V116, P577, DOI 10.1016/j.prosdent.2016.02.018
   Huh YH, 2016, J PROSTHET DENT, V116, P440, DOI 10.1016/j.prosdent.2016.01.021
   Kim HK, 2016, J PROSTHET DENT, V115, P773, DOI 10.1016/j.prosdent.2015.11.020
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Metzler KT, 1999, J PROSTHET DENT, V81, P356, DOI 10.1016/S0022-3913(99)70280-5
   Miyazaki T, 2009, DENT MATER J, V28, P44, DOI 10.4012/dmj.28.44
   Motro PFK, 2012, J PROSTHET DENT, V108, P231, DOI 10.1016/S0022-3913(12)60168-1
   Park JM, 2016, J PROSTHET DENT, V115, P684, DOI 10.1016/j.prosdent.2015.10.018
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Preis V, 2011, DENT MATER, V27, P796, DOI 10.1016/j.dental.2011.04.001
   Raigrodski AJ, 2012, J PROSTHET DENT, V107, P170, DOI 10.1016/S0022-3913(12)60051-1
   Sarac D, 2006, J PROSTHET DENT, V96, P122, DOI 10.1016/j.prosdent.2006.05.009
   SATO T, 1985, J MATER SCI, V20, P3988, DOI 10.1007/BF00552389
   Steiner R, 2015, J PROSTHET DENT, V113, P616, DOI 10.1016/j.prosdent.2014.12.007
   Sulaiman TA, 2016, J PROSTHET DENT, V116, P436, DOI 10.1016/j.prosdent.2016.01.033
   Tan JP, 2012, J PROSTHET DENT, V107, P163, DOI 10.1016/S0022-3913(12)60050-X
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Wright MD, 2004, J PROSTHET DENT, V92, P486, DOI 10.1016/j.prosdent.2004.07.021
   Zandparsa R, 2016, J PROSTHET DENT, V115, P230, DOI 10.1016/j.prosdent.2015.09.005
NR 33
TC 3
Z9 3
U1 5
U2 20
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD MAR
PY 2017
VL 117
IS 3
BP 430
EP 437
DI 10.1016/j.prosdent.2016.10.005
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EO8VI
UT WOS:000396968200017
PM 28088308
DA 2018-10-20
ER

PT J
AU Aydin, RST
   Akyol, E
   Hazer, B
AF Aydin, R. Seda Tigli
   Akyol, Elvan
   Hazer, Baki
TI Influence of Soybean Oil Blending with Polylactic Acid (PLA) Films: In
   Vitro and In Vivo Evaluation
SO JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
LA English
DT Article
DE Soybean oil; Epoxidized soybean oil; PLA; Biocompatibility
ID VEGETABLE-OIL; POLYMER; BIOCOMPATIBILITY; BIOMATERIALS
AB Due to the great interest in oil-based polymers, which are prepared from renewable resources, different forms and amounts of soybean oil-based PLA films were prepared and evaluated for their potential usage as a medical biomaterial. Soybean oil, epoxidized soybean oil and auto-oxidized soybean oil were blended with PLA and PLA/oil films with appropriate oil amounts [2, 7, 14 and 20% (w/w)] were obtained by solvent casting. Thermal stability and plasticization effect were determined by adjusting oil amounts and type. Epoxidized soybean oil blended films showed the smallest increase in elongation breaks (13-20%) and the highest decrease in thermal decomposition temperatures (364-327 A degrees C) compared to other oil blended films. In vitro quantitative and qualitative cytotoxicity results showed no reactivity (grade 0) for the L929 cells treated with 14% (w/w) oil blended PLA films. In vivo irritation and implantation tests concluded that 14% (w/w) oil blended PLA films were non-irritant. No erythema, no oedema reactions, no traumatic necrosis and foreign debris were observed. Thus, along with superior biocompatibility, PLA/oil films can replace petroleum-based products for several biomedical uses.
C1 [Aydin, R. Seda Tigli] Bulent Ecevit Univ, Dept Biomed Engn, TR-67100 Zonguldak, Turkey.
   [Akyol, Elvan; Hazer, Baki] Bulent Ecevit Univ, Dept Chem, TR-67100 Zonguldak, Turkey.
RP Aydin, RST (reprint author), Bulent Ecevit Univ, Dept Biomed Engn, TR-67100 Zonguldak, Turkey.
EM rseda.tigli@gmail.com
FU Turkish Scientific Research Council [213M375]; Bulent Ecevit University
   Research Fund [2014-39971044-02]
FX This study was financially supported by the Turkish Scientific Research
   Council (Grant Number: 213M375) and Bulent Ecevit University Research
   Fund (Grant Number: 2014-39971044-02). Authors thank TUBITAK-MAM for
   performing animal experiments (Implantation and Irritation tests).
CR Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Aydin RST, 2013, POLYM BULL, V70, P2065, DOI 10.1007/s00289-013-0976-2
   Cakmakli B, 2005, BIOMACROMOLECULES, V6, P1750, DOI 10.1021/bm050063f
   Chieng BW, 2014, MOLECULES, V19, P16024, DOI 10.3390/molecules191016024
   Darie-Nita RN, 2016, J APPL POLYM SCI, V133, DOI [10.1002/APP.43223, 10.1002/app.43223]
   Emad A, 2011, IND CROP PROD, V33, P23
   Fathilah A, 2009, POLYM B, V62, P91
   Gramlich WM, 2010, MACROMOLECULES, V43, P2313, DOI 10.1021/ma902449x
   Guo BC, 2011, BIOMACROMOLECULES, V12, P1312, DOI 10.1021/bm2000378
   Hazer B, 2016, J AM OIL CHEM SOC, V93, P201, DOI 10.1007/s11746-015-2764-7
   Hazer B, 2014, J POLYM ENVIRON, V22, P200, DOI 10.1007/s10924-014-0645-z
   Hazer DB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035011
   HiljanenVainio M, 1996, MACROMOL CHEM PHYSIC, V197, P1503, DOI 10.1002/macp.1996.021970427
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Liu ZX, 2012, SOFT MATTER, V8, P5888, DOI 10.1039/c2sm25115a
   Lligadas G, 2013, MATER TODAY, V16, P337, DOI 10.1016/j.mattod.2013.08.016
   Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c
   Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1165, DOI [10.1002/ejlt.201200050, 10.1002/ejlt.201290028]
   Robertson ML, 2010, MACROMOLECULES, V43, P1807, DOI 10.1021/ma9022795
   Sharma V, 2006, PROG POLYM SCI, V31, P983, DOI 10.1016/j.progpolymsci.2006.09.003
NR 23
TC 5
Z9 5
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0003-021X
EI 1558-9331
J9 J AM OIL CHEM SOC
JI J. Am. Oil Chem. Soc.
PD MAR
PY 2017
VL 94
IS 3
BP 413
EP 424
DI 10.1007/s11746-017-2954-6
PG 12
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA EM7BH
UT WOS:000395466000007
DA 2018-10-20
ER

PT J
AU Hyun, DW
   Kim, YH
   Koh, AY
   Lee, HJ
   Wee, WR
   Jeon, S
   Kim, MK
AF Hyun, Dong Won
   Kim, Yun Hee
   Koh, Ah Young
   Lee, Hyun Ju
   Wee, Won Ryang
   Jeon, Saewha
   Kim, Mee Kum
TI Characterization of biomaterial-free cell sheets cultured from human
   oral mucosal epithelial cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE cornea; ocular surface; oral epithelial cell sheet; limbal stem cell
   deficiency disease (LSCD); colony-forming efficiency (CFE);
   biomaterial-free sheet
ID OCULAR SURFACE RECONSTRUCTION; CULTIVATED CORNEAL EPITHELIUM;
   REGENERATIVE MEDICINE; AMNIOTIC MEMBRANE; HUMAN LIMBAL; TRANSPLANTATION;
   KERATINOCYTE; FIBROBLAST; DISEASE; CARRIER
AB The purpose of this study was to report the characteristics of biomaterial-free sheets cultured from human oral mucosal epithelial cells without fibrin support, in vitro and after transplantation to limbal-deficient models. Human oral mucosal epithelial cells and limbal epithelial cells were cultured for 2 weeks, and the colony-forming efficiency (CFE) rates were compared. Markers of stem cells (p63), cell proliferation (Ki-67) and epithelial differentiation (cytokeratin; K1, K3, K4, K13) were observed in colonies and in biomaterial-free sheets. Biomaterial-free sheets which had been detached with 1% dispase or biomaterial-free sheets generated by fibrin support were transplanted to 12 limbal-deficient rabbit models. In vitro cell viability, in vivo stability and cytokeratin characteristics of biomaterial-free sheets were compared with those of sheets formed by fibrin-coated culture 1 week after transplantation. Mean CFE rate was significantly higher in human oral mucosal epithelial cells (44.8%) than in human limbal epithelial cells(17.7%). K3 and K4 were well expressed in both colonies and sheets. Biomaterial-free sheets had two to six layers of stratified cells and showed an average of 79.8% viable cells in the sheets after detachment. Cytokeratin expressions of biomaterial-free sheets were comparable to those of sheets cultured by fibrin support, in limbal-deficient models. Both p63 and Ki-67 were well expressed in colonies, isolated sheets and sheets transplanted to limbaldeficient models. Our results suggest that biomaterial-free sheets cultured from human oral mucosal epithelial cells without fibrin support can be an alternative option for cell therapy in use for the treatment of limbal-deficient diseases. Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Hyun, Dong Won; Wee, Won Ryang; Kim, Mee Kum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, 103 Daehak Ro, Seoul 110799, South Korea.
   [Hyun, Dong Won; Koh, Ah Young; Lee, Hyun Ju; Wee, Won Ryang; Kim, Mee Kum] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul, South Korea.
   [Kim, Yun Hee; Jeon, Saewha] Tego Sci Inc, Cutigen Res Inst, Seoul, South Korea.
RP Kim, MK (reprint author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, 103 Daehak Ro, Seoul 110799, South Korea.
EM kmk9@snu.ac.kr
FU Korea Healthcare Technology; Ministry for Health,Welfare and Family
   Affairs,Republic of Korea [A111637]; Seoul National University Hospital
   Research Fund [032011-0090]
FX This study was supported by the Korea Healthcare Technology R& D
   Project, Ministry for Health, Welfare and Family Affairs, Republic of
   Korea ( Project No. A111637) and the Seoul National University Hospital
   Research Fund ( Grant No. 032011- 0090).
CR BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302
   Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028
   Brown KD, 2014, TISSUE ENG PT A, V20, P646, DOI 10.1089/ten.TEA.2013.0089
   Eslani M, 2012, SEMIN OPHTHALMOL, V27, P80, DOI 10.3109/08820538.2012.680641
   Ezhkova E, 2010, NATURE, V466, P567, DOI 10.1038/466567a
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664
   Hirayama M, 2012, INVEST OPHTH VIS SCI, V53, P1602, DOI 10.1167/iovs.11-7847
   Igarashi T, 2008, ORAL DIS, V14, P413, DOI 10.1111/j.1601-0825.2007.01390.x
   Ilmarinen T, 2013, ACTA OPHTHALMOL, V91, P744, DOI 10.1111/j.1755-3768.2012.02523.x
   Itabashi Y, 2005, ARTIF ORGANS, V29, P95, DOI 10.1111/j.1525-1594.2005.29020.x
   Jang H, 2013, BIOMED RES INT, V2013
   Kamolz LP, 2005, BURNS, V31, P25, DOI 10.1016/j.burns.2004.06.015
   Kim MK, 2008, J KOREAN MED SCI, V23, P864, DOI 10.3346/jkms.2008.23.5.864
   Krishnan S, 2010, INDIAN J MED RES, V131, P422
   Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017
   Nakamura T, 2007, OPHTHALMOLOGY, V114, P1080, DOI 10.1016/j.ophtha.2006.09.034
   Nakamura T, 2011, CURR OPIN OPHTHALMOL, V22, P274, DOI 10.1097/ICU.0b013e3283477d4d
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Oie Y, 2010, BRIT J OPHTHALMOL, V94, P1244, DOI 10.1136/bjo.2009.175042
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X
   ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2
   Schwartz GS, 2011, SURG TECHNIQUES OCUL, P1727
   Schwartz GS, 2011, CLASSIFICATION STAGI, P1713
   Sharma SM, 2012, STEM CELL REV REP, V8, P696, DOI 10.1007/s12015-011-9319-6
   Sotozono C, 2013, OPHTHALMOLOGY, V120, P193, DOI 10.1016/j.ophtha.2012.07.053
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   Zhang H, 2014, TISSUE ENG PT A, V20, P1593, DOI [10.1089/ten.tea.2013.0320, 10.1089/ten.TEA.2013.0320]
NR 31
TC 2
Z9 2
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2017
VL 11
IS 3
BP 743
EP 750
DI 10.1002/term.1971
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA EQ4KT
UT WOS:000398046600015
PM 25407749
DA 2018-10-20
ER

PT J
AU Schaakxs, D
   Kalbermatten, DF
   Pralong, E
   Raffoul, W
   Wiberg, M
   Kingham, PJ
AF Schaakxs, Dominique
   Kalbermatten, Daniel F.
   Pralong, Etienne
   Raffoul, Wassim
   Wiberg, Mikael
   Kingham, Paul J.
TI Poly-3-hydroxybutyrate strips seeded with regenerative cells are
   effective promoters of peripheral nerve repair
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial; muscle; nerve injury; regeneration; Schwann cells; stem
   cells
ID AUTOLOGOUS SCHWANN-CELLS; RAT SCIATIC-NERVE; STEM-CELLS; GAP REPAIR;
   CONDUIT; RECOVERY; DIFFERENTIATION; TRANSPLANTATION; SCAFFOLD; DELIVERY
AB Peripheral nerve injuries are often associated with loss of nerve tissue and require a graft to bridge the gap. Autologous nerve grafts are still the 'gold standard' in reconstructive surgery but have several disadvantages, such as sacrifice of a functional nerve, neuroma formation and loss of sensation at the donor site. Bioengineered grafts represent a promising approach to address this problem. In this study, poly-3-hydroxybutyrate (PHB) strips were used to bridge a 10 mm rat sciatic nerve gap and their effects on long-term (12 weeks) nerve regeneration were compared. PHB strips were seeded with different cell types, either primary Schwann cells (SCs) or SC-like differentiated adipose-derived stem cells (dASCs) suspended in a fibrin glue matrix. The control group was PHB and fibrin matrix without cells. Functional and morphological properties of the regenerated nerve were assessed using walking track analysis, EMGs, muscle weight ratios and muscle and nerve histology. The animals treated with PHB strips seeded with SCs or dASCs showed significantly better functional ability than the control group. This correlated with less muscle atrophy and greater axon myelination in the cell groups. These findings suggest that the PHB strip seeded with cells provides a beneficial environment for nerve regeneration. Furthermore, dASCs, which are abundant and easily accessible, constitute an attractive cell source for future applications of cell therapy for the clinical repair of traumatic nerve injuries. Copyright (C) 2015 John Wiley & Sons, Ltd.
C1 [Schaakxs, Dominique; Wiberg, Mikael; Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, Umea, Sweden.
   [Schaakxs, Dominique; Raffoul, Wassim] Univ Lausanne Hosp, CHUV, Div Plast Reconstruct & Aesthet Surg, Lausanne, Switzerland.
   [Kalbermatten, Daniel F.] Univ Basel Hosp, Dept Plast Reconstruct & Aesthet Surg, Basel, Switzerland.
   [Pralong, Etienne] Univ Lausanne Hosp, Dept Neurosurg, Lausanne, Switzerland.
   [Wiberg, Mikael] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden.
RP Kingham, PJ (reprint author), Umea Univ, Dept Integrat Med Biol, Sect Anat, SE-90187 Umea, Sweden.
EM paul.kingham@umu.se
OI Kingham, Paul/0000-0003-2596-5936
FU Swedish Research Council; European Union, Umea University; County of
   Vasterbotten, ake Wibergs Stiftelse, Clas Groschinskys Minnesfond, the
   Swiss National Foundation (Fonds National Suisse de la Recherche
   Scientifique); SUVA; University of Lausanne FBM
FX This study was supported by the Swedish Research Council, the European
   Union, Umea University, the County of Vasterbotten, ake Wibergs
   Stiftelse, Clas Groschinskys Minnesfond, the Swiss National Foundation
   (Fonds National Suisse de la Recherche Scientifique), SUVA and the
   University of Lausanne FBM.
CR Aberg M, 2009, J PLAST RECONSTR AES, V62, P1503, DOI 10.1016/j.bjps.2008.06.041
   Albala DM, 2006, J AM COLL SURGEONS, V202, P685, DOI 10.1016/j.jamcollsurg.2005.11.027
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Clavijo-Alvarez JA, 2007, PLAST RECONSTR SURG, V119, P1839, DOI 10.1097/01.prs.0000260232.43019.a0
   Di SF, 2008, MICROSC RES TECHNIQ, V71, P497
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Erba P, 2010, CURR STEM CELL RES T, V5, P153, DOI 10.2174/157488810791268645
   EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Hazari A, 1999, J HAND SURG-BRIT EUR, V24B, P291, DOI 10.1054/jhsb.1998.0001
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4
   Ikeda M, 2012, BRAIN BEHAV, V2, P382, DOI 10.1002/brb3.61
   Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x
   Kalbermatten DF, 2008, J HAND SURG-EUR VOL, V33E, P587, DOI 10.1177/1753193408090755
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5
   Kalbermatten DF, 2009, J RECONSTR MICROSURG, V25, P27, DOI 10.1055/s-0028-1090619
   Kaplan S, 2010, J NEUROSCI METH, V187, P90, DOI 10.1016/j.jneumeth.2010.01.001
   Kim HA, 2013, STEM CELL TRANSL MED, V2, P553, DOI 10.5966/sctm.2013-0011
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2
   Millesi H, 2006, MICROSURG, V26, P295, DOI 10.1002/micr.20242
   Mohammadi R, 2013, J SURG RES, V180, pE91, DOI 10.1016/j.jss.2012.04.011
   Mohanna PN, 2005, SCAND J PLAST RECONS, V39, P129, DOI 10.1080/02844310510006295
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Orbay H, 2012, J PLAST RECONSTR AES, V65, P657, DOI 10.1016/j.bjps.2011.11.035
   Pettersson J, 2011, NEUROSCI LETT, V500, P41, DOI 10.1016/j.neulet.2011.06.002
   Rafuse VF, 1996, J NEUROPHYSIOL, V75, P268
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Schaakxs D, 2013, MUSCLE NERVE, V47, P691, DOI 10.1002/mus.23662
   Shen CC, 2012, J BIOMED MATER RES A, V100A, P48, DOI 10.1002/jbm.a.33227
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370
   Tohill MP, 2004, TISSUE ENG, V10, P1359, DOI 10.1089/ten.2004.10.1359
   Tomita K, 2012, J NEUROSCI RES, V90, P1392, DOI 10.1002/jnr.23002
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Wiberg Mikael, 2003, Surg Technol Int, V11, P303
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
NR 48
TC 6
Z9 6
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2017
VL 11
IS 3
BP 812
EP 821
DI 10.1002/term.1980
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA EQ4KT
UT WOS:000398046600021
PM 25556632
DA 2018-10-20
ER

PT J
AU Leng, XP
   Liu, B
   Su, B
   Liang, M
   Shi, LC
   Li, SQ
   Qu, SH
   Fu, X
   Liu, Y
   Yao, M
   Kaplan, DL
   Wang, YS
   Wang, XQ
AF Leng, Xiaoping
   Liu, Bin
   Su, Bo
   Liang, Min
   Shi, Liangchen
   Li, Shouqiang
   Qu, Shaohui
   Fu, Xin
   Liu, Yue
   Yao, Meng
   Kaplan, David L.
   Wang, Yansong
   Wang, Xiaoqin
TI In situ ultrasound imaging of silk hydrogel degradation and
   neovascularization
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE silk fibroin; hydrogel; ultrasound; biodegradation; neovascularization
ID CONTRAST-ENHANCED ULTRASOUND; VIVO DEGRADATION; FIBROIN; BIOMATERIALS;
   STABILIZATION; ENCAPSULATION; ELASTICITY; SCAFFOLDS; DELIVERY; DEFECTS
AB Ultrasound (US) is a useful technique to monitor morphological and functional changes of biomaterial implants without sacrificing the animal. Contrast-enhanced ultrasound (CEUS) along with two dimensional (2D) US were used to characterize the biodegradation and neovascularization of silk protein (8 wt%) hydrogel implants in rats. Cylinder-shaped silk hydrogel plugs were implanted into the space between the hind limb thigh muscles in Wistar rats (n=6). The increase of echogenicity in 2D US revealed tissue-ingrowth-accompanied gel degradation over 18 weeks. The shape and size of the implanted gels remained qualitatively unchanged until week 15, as confirmed by Bland and Altman analysis and visualization of retrieved samples. Using CEUS, neovascularization was monitored by the presence of microbubbles in the gel area, and the dynamic vascularization process was indicated by the contrast enhancement values, which showed a relatively low level (< 5 dB) during weeks 1-8 and significantly increased levels (around 20 dB at week 15 and > 35 dB at week 18), suggesting that major vascularization had occurred in the gel implants by this time point. Histological and scanning electron microscopic analysis of explants revealed time-dependent increases in the pore size of the gel matrix, the presence of endothelial and red blood cells and the number of blood vessels in the gel implants, indicating that degradation and vascularization did occur in silk gel implants during the time period. The present study demonstrates the use of US imaging formonitoring of in vivo degradation and vascularization of silk implants in a non-destructive way. Copyright (C) 2015 John Wiley & Sons, Ltd.
C1 [Leng, Xiaoping; Li, Shouqiang; Qu, Shaohui; Fu, Xin; Liu, Yue] Harbin Med Univ, Affiliated Hosp 1, Key Lab Myocardial Ischaemia, Dept Ultrasound,Chinese Minist Educ, Harbin, Peoples R China.
   [Liu, Bin] Harbin Med Univ, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China.
   [Su, Bo; Liang, Min; Shi, Liangchen; Yao, Meng; Wang, Yansong] Harbin Med Univ, Affiliated Hosp 2, Dept Spine Surg, Harbin, Peoples R China.
   [Kaplan, David L.; Wang, Xiaoqin] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Wang, Xiaoqin] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China.
RP Wang, YS (reprint author), 194 Xuefu Rd, Nangang Dist, Hei Long Jiang, Peoples R China.
EM wangyansong@ems.hrbmu.edu.cn
FU Natural Science Foundation of China [81271696, 51273138, 81371569]; US
   National Institutes of Health [P41 EB002520]; Natural Science Foundation
   of Hei Long Jiang Province [ZD200916, ZD200902]; WLD Foundation of
   Harbin Medical University [QN1115]; Harbin Technology Innovation Fund
   [2012RFLXS018]; Doctor Foundation of the First Affiliated Hospital of
   Harbin Medical University [2011BS020]; Doctor Foundation of the Second
   Affiliated Hospital of Harbin Medical University [2011BS2011- 03]
FX The study was financially supported by the Natural Science Foundation of
   China (Grant Nos 81271696, 51273138 and 81371569), the US National
   Institutes of Health (NIH; Grant No. P41 EB002520), the Natural Science
   Foundation of Hei Long Jiang Province (Grant Nos ZD200916 and ZD200902),
   the WLD Foundation of Harbin Medical University (Grant No. QN1115), the
   Harbin Technology Innovation Fund (Grant No. 2012RFLXS018), the Doctor
   Foundation of the First Affiliated Hospital of Harbin Medical University
   (Grant No. 2011BS020) and the Doctor Foundation of the Second Affiliated
   Hospital of Harbin Medical University (Grant No. 2011BS2011- 03).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BLAND JM, 1986, LANCET, V1, P307
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gorce JM, 2000, INVEST RADIOL, V35, P661, DOI 10.1097/00004424-200011000-00003
   Guan GP, 2014, BIO-MED MATER ENG, V24, P789, DOI 10.3233/BME-130870
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Heidemann W, 2002, DENTOMAXILLOFAC RAD, V31, P155, DOI 10.1038/sj/dmfr/4600667
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Jary S, 2012, ARCH DIS CHILD, V97, P955, DOI 10.1136/archdischild-2012-301778
   Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P278, DOI 10.1016/j.jmbbm.2009.12.001
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Rice MA, 2008, J TISSUE ENG REGEN M, V2, P418, DOI 10.1002/term.113
   Rognin NG, 2010, IEEE T ULTRASON FERR, V57, P2503, DOI 10.1109/TUFFC.2010.1716
   Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238
   Soder RB, 2009, AM J ROENTGENOL, V192, pW201, DOI 10.2214/AJR.08.2061
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Staub D, 2013, VASA, V42, P17, DOI 10.1024/0301-1526/a000244
   Stride Eleanor, 2009, Cerebrovasc Dis, V27 Suppl 2, P1, DOI 10.1159/000203122
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
NR 36
TC 3
Z9 3
U1 5
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2017
VL 11
IS 3
BP 822
EP 830
DI 10.1002/term.1981
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA EQ4KT
UT WOS:000398046600022
PM 25850825
DA 2018-10-20
ER

PT J
AU Xie, QF
   Xu, ZP
   Hu, BH
   He, XL
   Zhu, LJ
AF Xie, Qifan
   Xu, Zongpu
   Hu, Binhui
   He, Xiuling
   Zhu, Liangjun
TI Preparation of a Novel Silk Microfiber Covered by AgCl Nanoparticles
   with Antimicrobial Activity
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE microfiber; silver chloride; nanoparticle; antimicrobial activity
ID SILVER-CHLORIDE NANOPARTICLES; IN-VITRO; SCAFFOLDS; FABRICATION;
   FIBROIN; FIBERS; NANOCRYSTALS; REPAIR; GROWTH; FILMS
AB We prepared silk fibroin microfibers in which silver chloride (AgCl) nanoparticles were dispersed, by sequential dipping of microfibers obtained using alkaline hydrolysis in alternating solutions of silver nitrate and potassium chloride. Scanning and transmission electron microscopy showed an increase in nanoparticle size and quantity with increase in dipping cycles and solution concentration, but ultrasound irradiation did not affect nanoparticle formation. The presence of cubic AgCl crystals was confirmed by energy dispersive X-ray spectroscopy and X-ray diffractometry. Differential scanning calorimetry and Fourier transform infrared spectroscopy revealed that the nanoparticles do not affect the microfiber properties. The growth of Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria was inhibited by microfiber covered with AgCl nanoparticles. This antimicrobial activity allows to use microfiber as a reinforced or surface additive biomaterial. (C) 2016 Wiley Periodicals, Inc.
C1 [Xie, Qifan; Xu, Zongpu; Hu, Binhui; He, Xiuling; Zhu, Liangjun] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource, Hangzhou 310058, Zhejiang, Peoples R China.
RP He, XL; Zhu, LJ (reprint author), Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource, Hangzhou 310058, Zhejiang, Peoples R China.
EM yiner0611@sina.com; ljzhu@zju.edu.cn
FU China Agriculture Research System [CARS-22-ZJ0402]; National Silk
   Development and Discovery Foundation of China; Science and Technology
   Innovation Team Project for the Sericulture Industry in Zhejiang
   province [2011R50028]
FX Contract grant sponsor: China Agriculture Research System; Contract
   grant number: CARS-22-ZJ0402; Contract grant sponsor: National Silk
   Development and Discovery Foundation of China (2015); Contract grant
   sponsor: Science and Technology Innovation Team Project for the
   Sericulture Industry in Zhejiang province; Contract grant number:
   2011R50028.
CR Abbasi AR, 2010, COLLOID SURFACE A, V371, P113, DOI 10.1016/j.colsurfa.2010.09.014
   Adams AP, 1999, VET SURG, V28, P219, DOI 10.1053/jvet.1999.0219
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bai J, 2008, APPL SURF SCI, V254, P4520, DOI 10.1016/j.apsusc.2008.01.051
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Husein MM, 2005, J COLLOID INTERF SCI, V288, P457, DOI 10.1016/j.jcis.2005.03.023
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Kim F., 2004, ANGEW CHEM, V116, P3759
   Li RJ, 2012, J APPL POLYM SCI, V124, P2080, DOI 10.1002/app.35273
   Liu L, 2014, RSC ADV, V4, P14304, DOI 10.1039/c4ra01284d
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marx David E, 2014, Burns, V40 Suppl 1, pS9, DOI 10.1016/j.burns.2014.09.010
   Mobini S, 2013, J BIOMED MATER RES A, V101, P2392, DOI 10.1002/jbm.a.34537
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Pavoni E, 2016, INT J BIOL MACROMOL, V88, P196, DOI 10.1016/j.ijbiomac.2016.03.057
   Potiyaraj P, 2007, MATER LETT, V61, P2464, DOI 10.1016/j.matlet.2006.09.039
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Taddei P, 2016, J RAMAN SPECTROSC
   Tang YX, 2012, ACS APPL MATER INTER, V4, P438, DOI 10.1021/am2015102
   Tao A, 2006, ANGEW CHEM INT EDIT, V45, P4597, DOI 10.1002/anie.200601277
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2007, J NANOPART RES, V9, P919, DOI 10.1007/s11051-006-9167-5
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Xu ZP, 2015, J MATER CHEM B, V3, P3634, DOI 10.1039/c5tb00226e
   Yinsun M, 2012, ACTA CHIM SINICA, V70, P479
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Zeng J, 2010, J AM CHEM SOC, V132, P8552, DOI 10.1021/ja103655f
   Zhang JA, 2010, J AM CHEM SOC, V132, P14012, DOI 10.1021/ja106394k
NR 38
TC 2
Z9 2
U1 2
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD MAR
PY 2017
VL 80
IS 3
SI SI
BP 272
EP 279
DI 10.1002/jemt.22683
PG 8
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA EM0KP
UT WOS:000395007500001
PM 27207317
DA 2018-10-20
ER

PT J
AU Wang, DY
   Liu, HF
   Fan, YB
AF Wang, Danyan
   Liu, Haifeng
   Fan, Yubo
TI Silk Fibroin for Vascular Regeneration
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Review
DE silk fibroin; scaffold; small-diameter vascular graft; vascular
   regeneration
ID TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; IN-VITRO
   EVALUATION; ENDOTHELIAL-CELLS; BLOOD-VESSEL; COVALENT IMMOBILIZATION;
   MECHANICAL-PROPERTIES; NANOFIBROUS SCAFFOLD; CULTURE-CONDITIONS; GRAFTS
AB Cardiovascular disease is the primary cause of morbidity and mortality in today's world. Due to the lack of healthy autologous vessels, more tissue-engineered blood vessels are needed to repair or replace the damaged arteries. Biomaterials play an indispensable role in creating a living neovessel with biological responses. Silk fibroin produced by silkworms possesses good cytocompatibility, tailorable biodegradability, suitable mechanical properties, and minimal inflammatory reactions. In addition, regenerated silk fibroin solutions can be processed into various forms of scaffolds such as films, fibers, tubes, and porous sponges. These features make silk fibroin a promising biomaterial for small-diameter vascular grafts. The present article focuses on the applications of silk fibroin for vascular regeneration. A brief overview of the properties of silk fibroin is provided, following which the current research status and future directions of the main types of silk fibroin scaffolds for vascular regeneration are reviewed and discussed. (C) 2015 Wiley Periodicals, Inc.
C1 [Wang, Danyan; Liu, Haifeng; Fan, Yubo] Beihang Univ, Minist Educ, Sch Biol Sci & Med Engn, Key Lab Biomechan & Mech, Beijing 100191, Peoples R China.
   [Fan, Yubo] Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
RP Liu, HF; Fan, YB (reprint author), Beihang Univ, Minist Educ, Sch Biol Sci & Med Engn, Key Lab Biomechan & Mech, Beijing 100191, Peoples R China.; Fan, YB (reprint author), Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
EM haifengliu@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Key Technology RD Program [2012BAI18B06]; National Natural
   Science Foundation of China [31470938, 81171473, 61227902, 11120101001];
   International Joint Research Center of Aerospace Biotechnology and
   Medical Engineering from Ministry of Science and Technology of China,
   111 Project [B13003]; Research Fund for the Doctoral Program of Higher
   Education of China [20131102130004]; Fundamental Research Funds for the
   Central Universities; The transformation project for major achievements
   of Central Universities in Beijing [ZDZH20141000601]
FX Contract grant sponsor: National Key Technology R&D Program; Contract
   grant number: 2012BAI18B06; Contract grant sponsor: National Natural
   Science Foundation of China; Contract grant numbers: 31470938, 81171473,
   61227902, and 11120101001; Contract grant sponsor: International Joint
   Research Center of Aerospace Biotechnology and Medical Engineering from
   Ministry of Science and Technology of China, 111 Project; Contract grant
   number: B13003; Contract grant sponsor: Research Fund for the Doctoral
   Program of Higher Education of China; Contract grant number:
   20131102130004; Contract grant sponsor: Fundamental Research Funds for
   the Central Universities; Contract grant sponsor: The transformation
   project for major achievements of Central Universities in Beijing;
   Contract grant number: ZDZH20141000601;.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Aytemiz D, 2013, ADV HEALTHC MATER, V2, P361, DOI 10.1002/adhm.201200227
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Campbell JB, 1985, ASAIO J, V8, P113
   Cao ZB, 2013, MAT SCI ENG C-MATER, V33, P3522, DOI 10.1016/j.msec.2013.04.045
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z
   Du XJ, 2014, COLLOID SURFACE B, V122, P79, DOI 10.1016/j.colsurfb.2014.06.049
   Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005
   Ekemen Z, 2013, BIOMACROMOLECULES, V14, P1412, DOI 10.1021/bm400068k
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Fernandez CE, 2014, CURR OPIN CHEM ENG, V3, P83, DOI 10.1016/j.coche.2013.12.001
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gong FR, 2010, ACTA BIOMATER, V6, P534, DOI 10.1016/j.actbio.2009.07.013
   Gong XH, 2014, BIOMATERIALS, V35, P4782, DOI [10.1016/j.biomaterials2014.02.050, 10.1016/j.biomaterials.2014.02.050]
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hidzir NM, 2012, POLYMER, V53, P6063, DOI 10.1016/j.polymer.2012.10.042
   Higuchi A, 2000, CYTOTECHNOLOGY, V34, P165, DOI 10.1023/A:1008130223190
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   Lanza R, 2000, HEAD PRINCIPLES TIS, P227
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2129
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu HF, 2013, MACROMOL BIOSCI, V13, P755, DOI 10.1002/mabi.201200470
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2009, MAT SCI ENG C-MATER, V29, P2239, DOI 10.1016/j.msec.2009.05.014
   Marelli B, 2010, ACTA BIOMATER, V6, P4019, DOI 10.1016/j.actbio.2010.05.008
   McClure MJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055010
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Mottaghitalab F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074417
   Naito Y, 2011, ADV DRUG DELIVER REV, V63, P312, DOI 10.1016/j.addr.2011.03.001
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Okoshi T, 1996, ASAIO J, V42, pM398, DOI 10.1097/00002480-199609000-00019
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   ROALD HE, 1994, BLOOD COAGUL FIBRIN, V5, P355
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   Saitow C, 2011, MATRIX BIOL, V30, P346, DOI 10.1016/j.matbio.2011.04.005
   Sato M, 2010, MATER LETT, V64, P1786, DOI 10.1016/j.matlet.2010.05.024
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHNEIDER PA, 1988, SURGERY, V103, P456
   Seib FP, 2014, BIOMATERIALS, V35, P83, DOI 10.1016/j.biomaterials.2013.09.053
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Stamati K, 2014, EXP CELL RES, V327, P68, DOI 10.1016/j.yexcr.2014.05.012
   Suganya S, 2014, INT J BIOL MACROMOL, V68, P135, DOI 10.1016/j.ijbiomac.2014.04.031
   Thomas LV, 2013, INT J CARDIOL, V167, P1091, DOI 10.1016/j.ijcard.2012.09.069
   Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vermette P, 1998, J VASC SURG, V28, P527, DOI 10.1016/S0741-5214(98)70140-5
   Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yin AL, 2014, COLLOID SURFACE B, V120, P47, DOI 10.1016/j.colsurfb.2014.04.011
   Zhang WJ, 2015, BIOMATERIALS, V56, P68, DOI 10.1016/j.biomaterials.2015.03.053
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhou J, 2009, INT J BIOL MACROMOL, V45, P504, DOI 10.1016/j.ijbiomac.2009.09.006
   Zhu CH, 2014, MAT SCI ENG C-MATER, V34, P393, DOI 10.1016/j.msec.2013.09.044
   Zhu MF, 2014, ACTA BIOMATER, V10, P2014, DOI 10.1016/j.actbio.2014.01.022
NR 99
TC 4
Z9 4
U1 13
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD MAR
PY 2017
VL 80
IS 3
SI SI
BP 280
EP 290
DI 10.1002/jemt.22532
PG 11
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA EM0KP
UT WOS:000395007500002
PM 26097014
DA 2018-10-20
ER

PT J
AU Jiayao, ZA
   Guanshan, Z
   Jinchi, Z
   Yuyin, C
   Yongqiang, Z
AF Jiayao, Zhuang
   Guanshan, Zhou
   Jinchi, Zhang
   Yuyin, Chen
   Yongqiang, Zhu
TI Antheraea pernyi silk sericin mediating biomimetic nucleation and growth
   of hydroxylapatite crystals promoting bone matrix formation
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE biomineralization; Antheraea pernyi (A. pernyi) sericin; hydroxylapatite
   crystals; human bone marrow-derived mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; HYDROXYAPATITE CRYSTALS; BIOLOGICAL NANOFIBERS;
   FIBROIN; DIFFERENTIATION; MINERALIZATION; DEPOSITION; SCAFFOLDS;
   COLLAGEN; APATITE
AB Bone biomineralization is well-regulated processes mediated by extracellular matrix proteins. The materials that can direct nucleation of hydroxylapatite (HAp) crystals and assembly of well-structure dmaterial-minerals complex are the key to mimicking the natural mineralization. This study used sericin from Antheraea pernyi (A.pernyi), non-mulberry silkworm cocoon as template to mediate nucleation of HAp crystals. Here we find out that AS (Antheraea pernyi sericin) can nucleate the formation HAp crystals in simulated body fluid verified by XRD and FTIR observations. The HAp crystals are organized into nano-rods oriented with c-axis preferentially parallel to the long axis of AS due to hydrogen bonds and electrostatic interaction and finally aggregated into HAp globule. The cell culture of human bone marrow-derived mesenchymal stem cells (BMSCs) showed that the HAp crystals mediated by AS not only stimulate cell adhesion and proliferation but also promote of osteogenic differentiation, suggesting that the resultant mineralized AS biomaterial has potential in promoting bone formation. Thus our work will provide significant implication on biomineralization of A. pernyi silk sericin as a potential scaffold for tissue engineering.
C1 [Jinchi, Zhang; Yongqiang, Zhu] Nanjing Forestry Univ, Co Innovat Ctr Sustainable Forestry South China, Nanjing 210039, Peoples R China.
   [Guanshan, Zhou; Yongqiang, Zhu] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresources, Hangzhou 310058, Peoples R China.
   [Yongqiang, Zhu] Zhejiang Acad Tradit Chinese Med, Hangzhou 310007, Zhejiang, Peoples R China.
RP Yongqiang, Z (reprint author), Zhejiang Acad Tradit Chinese Med, Hangzhou 310007, Zhejiang, Peoples R China.
EM zyq202@sina.com
FU National Natural Science Foundation of China [31170663]; Priority
   Academic Program Development of Chinese Jiangsu Higher Education
   Institutions [164010641]; Project of Science Technology Department of
   ZhejiangProvince [2014F50G5260037]
FX This research was supported by National Natural Science Foundation of
   China (31170663) and Priority Academic Program Development of Chinese
   Jiangsu Higher Education Institutions (164010641). Project of Science
   Technology Department of ZhejiangProvince (2014F50G5260037).
CR Asakura T, 2007, MACROMOLECULES, V40, P8983, DOI 10.1021/ma0713759
   Biswas A, 2010, BIOMACROMOLECULES, V11, P2545, DOI 10.1021/bm1009359
   Cai YR, 2009, J MATER CHEM, V19, P5751, DOI 10.1039/b901620a
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   Hao LJ, 2014, J MATER CHEM B, V2, P4794, DOI 10.1039/c4tb00597j
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   He PF, 2012, BIOMACROMOLECULES, V13, P2692, DOI 10.1021/bm300651q
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   POSNER AS, 1960, NATURE, V188, P486, DOI 10.1038/188486a0
   Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514
   Shchukin DG, 2003, CHEM MATER, V15, P3947, DOI 10.1021/cm0341585
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Wang FK, 2010, CHEM MATER, V22, P3630, DOI 10.1021/cm902727s
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xu H, 2011, BIOMACROMOLECULES, V12, P2193, DOI 10.1021/bm200274r
   Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m
   Yang MY, 2015, J MATER CHEM B, V3, P2455, DOI 10.1039/c4tb01944j
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Yang MY, 2013, J POLYM SCI POL PHYS, V51, P742, DOI 10.1002/polb.23249
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
   Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839
NR 29
TC 1
Z9 1
U1 4
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD MAR
PY 2017
VL 80
IS 3
SI SI
BP 305
EP 311
DI 10.1002/jemt.22793
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA EM0KP
UT WOS:000395007500005
PM 27859871
DA 2018-10-20
ER

PT J
AU Yamano, N
   Kawasaki, N
   Ida, S
   Nakayama, Y
   Nakayama, A
AF Yamano, Naoko
   Kawasaki, Norioki
   Ida, Sayuri
   Nakayama, Yasuhide
   Nakayama, Atsuyoshi
TI Biodegradation of polyamide 4 in vivo
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Biodegradable polymer; Biodegradability; Polyamide 4; Biomaterial
ID ALIPHATIC POLYESTERS; ESCHERICHIA-COLI; DEGRADATION;
   POLY(EPSILON-CAPROLACTONE); DECARBOXYLASE; GLUTAMATE; POLYMERS; ENZYME
AB We determined that polyamide 4 (PA4), which is easily degraded in the environment, is also degraded in vivo. We previously reported that PA4 was degraded by activated sludge. However, the potential biodegradability of PA4 in vivo has not been evaluated. In the present study, we subcutaneously implanted various PA4 samples in the backs of rats, including non-woven fabric as well as film and mold. The weights of implanted and recovered non-woven cloth composed of the PA4 polymer started to decrease at 3 months. At 8.5 months, weights decreased by 90%. For the non-woven PA4 cloth with a fine structure, there was no significant decrease in weight until 8.5 months. These results showed that PA4 was degraded in vivo and that polymer structure was important in determining the degradation rates. Copolymers composed of PA4 and polycaprolactone were also degraded in vivo. Homopolymers of PA4 were not hydrolyzed in phosphate buffer at 37 C after one year. These results suggested the possibility that biochemical reactions were implicated in the degradation of PA4 in vivo. Based on tissue sample observations, implanted PA4 did not modify surrounding tissues. Safety evaluation, mutagenicity testing using bacteria (Ames test), and in vitro cytotoxicity testing using Chinese hamster V79 cells suggested that PA4 had no mutagenicity or cytotoxicity. Our study demonstrates that PA4 has potential as a bioabsorbable polymer material for biomedical applications. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Yamano, Naoko; Kawasaki, Norioki; Ida, Sayuri; Nakayama, Atsuyoshi] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.
   [Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, 5-7-1 Fujishiro dai, Suita, Osaka 5658565, Japan.
RP Yamano, N (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.
EM yamano.naoko@aist.go.jp; n-kawasaki@aist.go.jp; s-ida@aist.go.jp;
   nakayama@ri.ncvc.go.jp; a.nakayama@aist.go.jp
FU JSPS [JP25340097]
FX This work was supported by a JSPS KAKENHI Grant-in-Aid for Scientific
   Research, grant number JP25340097.
CR Deguchi T, 1998, APPL ENVIRON MICROB, V64, P1366
   Deguchi T, 1997, APPL ENVIRON MICROB, V63, P329
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   HASHIMOTO K, 1994, J APPL POLYM SCI, V54, P1579, DOI 10.1002/app.1994.070541023
   HOMOLA AD, 1967, BIOCHEMISTRY-US, V6, P2626, DOI 10.1021/bi00860a046
   Kalcudo S., 1993, APPL ENVIRON MICROB, V59, P3978
   Kawasaki N, 2005, POLYMER, V46, P9987, DOI 10.1016/j.polymer.2005.06.092
   Kawasaki N, 2012, J APPL POLYM SCI, V126, pE425, DOI 10.1002/app.36668
   Luckachan GE, 2011, J POLYM ENVIRON, V19, P637, DOI 10.1007/s10924-011-0317-1
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   NAJJAR VA, 1952, FED PROC, V11, P264
   NAKAYAMA A, 1995, POLYMER, V36, P1295, DOI 10.1016/0032-3861(95)93933-D
   Nakayama A., POLYM DEGRAD STAB, V98
   NEGORO S, 1983, J BACTERIOL, V155, P22
   NEGORO S, 1980, J BACTERIOL, V143, P238
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   SHUKUYA R, 1960, J BIOL CHEM, V235, P1649
   Tachibana K, 2010, POLYM DEGRAD STABIL, V95, P912, DOI 10.1016/j.polymdegradstab.2010.03.031
   Yamano N, 2014, POLYM DEGRAD STABIL, V108, P116, DOI 10.1016/j.polymdegradstab.2014.06.011
   Yamano N, 2013, J POLYM ENVIRON, V21, P528, DOI 10.1007/s10924-012-0466-x
   Yamano N, 2008, J POLYM ENVIRON, V16, P141, DOI 10.1007/s10924-008-0090-y
NR 22
TC 1
Z9 1
U1 2
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD MAR
PY 2017
VL 137
BP 281
EP 288
DI 10.1016/j.polymdegradstab.2017.02.004
PG 8
WC Polymer Science
SC Polymer Science
GA EO8OE
UT WOS:000396948100026
DA 2018-10-20
ER

PT J
AU Julkapli, NM
   Bagheri, S
AF Julkapli, Nurhidayatullaili Muhd
   Bagheri, Samira
TI Progress on nanocrystalline cellulose biocomposites
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Review
DE Natural renewable resources; Nanocomposites; Functionalization;
   Mechanical properties; Degradability
ID CARBON NANOTUBE NANOCOMPOSITE; FORMALDEHYDE RESIN ADHESIVE;
   SULFURIC-ACID HYDROLYSIS; LITHIUM-ION BATTERIES; MICROFIBRILLATED
   CELLULOSE; MECHANICAL-PROPERTIES; NATURAL-RUBBER; BIOMIMETIC
   NANOCOMPOSITES; POLYPROPYLENE COMPOSITE; BACTERIAL NANOCELLULOSE
AB Nanocrystalline cellulose (NCC) a rigid rod-like nanoscale material, can be produced from cellulosic biomass including wood and non-wood based materials in powder, liquid or gel forril by acid and chemical hydrolysis. Owing to its unique and exceptional renewability, biodegradability, mechanical, physicochemical properties and characteristics of abundance, the incorporation of a small amount of NCC to the materials matrix (polymer, ceramic and/or metal) enhances the mechanical strength of the latter by several orders of magnitudes. Besides, NCC as a material derived from natural sources has no serious environmental concerns, providing further impetus for the development and applications of this green and renewable biomaterial to fabricate lightweight and biodegradable composites. Surface functionalization of NCC remains the main focus of NCC research to tailor its properties for dispersion in hydrophilic and hydrophobic media. It is of uttermost importance to develop tools and protocols for imaging of NCC in a complex matrix and quantify its reinforcement, antimicrobial, stability, hydrophilicity and biodegradability effect. This review highlights NCC biocomposites, preparation, modification, and potential applications. (c) 2016 Elsevier B.V. All rights reserved.
C1 [Julkapli, Nurhidayatullaili Muhd; Bagheri, Samira] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur 50603, Malaysia.
RP Bagheri, S (reprint author), Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur 50603, Malaysia.
EM samira_bagheri@um.edu.my
RI muhd julkapli, nurhidayatullaili/J-3519-2016
OI muhd julkapli, nurhidayatullaili/0000-0001-6672-7972; bagheri,
   samira/0000-0003-1130-2656
FU University of Malaya Research Grant [UMRG RP022-2012E]; High Impact
   Research Grant [HIR H21001-F0032]; Fundamental Research Grant Scheme
   [FRGS: FP049-2013B]
FX This work is financially supported by University of Malaya Research
   Grant (UMRG RP022-2012E), High Impact Research Grant (HIR H21001-F0032)
   and Fundamental Research Grant Scheme (FRGS: FP049-2013B).
CR ABBASI Z, 2013, J APPL ENVIRON BIOL, V3, P1
   Abdelmouleh M, 2002, LANGMUIR, V18, P3203, DOI 10.1021/la011657g
   Abdollahi M, 2013, FOOD HYDROCOLLOID, V32, P416, DOI 10.1016/j.foodhyd.2013.02.006
   Agarwal UP, 2012, APPL SPECTROSC, V66, P750, DOI 10.1366/11-06563
   Ago M, 2013, ACS APPL MATER INTER, V5, P11768, DOI 10.1021/am403451w
   Akter N, 2012, RADIAT PHYS CHEM, V81, P995, DOI 10.1016/j.radphyschem.2011.10.029
   Anirudhan TS, 2012, J COLLOID INTERF SCI, V381, P125, DOI 10.1016/j.jcis.2012.05.024
   Anitha S, 2012, CARBOHYD POLYM, V87, P1065, DOI 10.1016/j.carbpol.2011.08.030
   Arora S, 2012, J REINF PLAST COMP, V31, P85, DOI 10.1177/0731684411431765
   Auad M., 2011, POLYM LETT, V61, P321
   Azeredo HMC, 2012, LWT-FOOD SCI TECHNOL, V46, P294, DOI 10.1016/j.lwt.2011.09.016
   BABA Y, 1993, J CHROMATOGR A, V653, P329, DOI 10.1016/0021-9673(93)83191-T
   Bagheri S., 2014, INT J PHOTOENERGY
   Bagheri S., 2014, SCI WORLD J
   Bagheri S., 2013, RES J CHEM SCI, V3, P62
   Barazzouk S, 2012, NANOMATERIALS-BASEL, V2, P187, DOI 10.3390/nano2020187
   Barazzouk S, 2011, CELLULOSE, V18, P643, DOI 10.1007/s10570-011-9503-5
   Bates S, 2006, PHARM RES, V23, P2333, DOI 10.1007/s11095-006-9086-2
   Berndt S, 2013, CELLULOSE, V20, P771, DOI 10.1007/s10570-013-9870-1
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bohner TV, 1999, HELV CHIM ACTA, V82, P198, DOI 10.1002/(SICI)1522-2675(19990210)82:2<198::AID-HLCA198>3.3.CO;2-P
   Bondeson D, 2007, COMPOS PART A-APPL S, V38, P2486, DOI 10.1016/j.compositesa.2007.08.001
   Boumail A, 2013, J AGR FOOD CHEM, V61, P811, DOI 10.1021/jf304439s
   Brown EE, 2013, BIOMACROMOLECULES, V14, P1063, DOI 10.1021/bm3019467
   Brun-Graeppi AKAS, 2010, PROG POLYM SCI, V35, P1311, DOI 10.1016/j.progpolymsci.2010.07.007
   Cao XD, 2013, POLYM TEST, V32, P819, DOI 10.1016/j.polymertesting.2013.04.005
   Cerqueira E. F., 2011, PROCEDIA ENG, V10, P2040
   Chang CP, 2013, CELL CHEM TECHNOL, V47, P111
   Chankvetadze B, 2004, J CHROMATOGR A, V1042, P55, DOI 10.1016/j.chroma.2004.05.011
   Chekin F, 2012, ANAL METHODS-UK, V4, P2977, DOI 10.1039/c2ay25427a
   Chekin F, 2012, J CHIN CHEM SOC-TAIP, V59, P1461, DOI 10.1002/jccs.201200138
   Chekin F, 2012, J SOLID STATE ELECTR, V16, P3245, DOI 10.1007/s10008-012-1767-7
   Chen F, 2013, ADV MATER RES-SWITZ, V785-786, P346, DOI 10.4028/www.scientific.net/AMR.785-786.346
   Cheng Q, 2007, CELLULOSE, V14, P593, DOI 10.1007/s10570-007-9141-0
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   Craston E. D., 2006, BIOMACROMOLECULES, V7, P2522
   Czigany T, 2007, COMPOS INTERFACE, V14, P869, DOI 10.1163/156855407782106447
   Daniele S, 2006, MATER RES BULL, V41, P2210, DOI 10.1016/j.materresbull.2006.04.041
   Dwivedi AD, 2014, CHEM ENG J, V253, P316, DOI 10.1016/j.cej.2014.05.069
   Fernandes SCM, 2009, GREEN CHEM, V11, P2023, DOI 10.1039/b919112g
   Fortunati E, 2012, CARBOHYD POLYM, V90, P948, DOI 10.1016/j.carbpol.2012.06.025
   Fortunati E, 2012, CARBOHYD POLYM, V87, P1596, DOI 10.1016/j.carbpol.2011.09.066
   Fortunati E, 2010, POLYM DEGRAD STABIL, V95, P2200, DOI 10.1016/j.polymdegradstab.2010.02.034
   Frone AN, 2011, BIORESOURCES, V6, P487
   Habibi Y., 2014, CHEM SOC REV
   Habibi Y, 2014, CHEM SOC REV, V43, P1519, DOI 10.1039/c3cs60204d
   Hain J, 2007, MACROMOL SYMP, V254, P128, DOI 10.1002/masy.200750820
   Hatada K., 1987, J LIQ CHROMATOGR, V10, P1614
   Hokkanen S, 2014, CHEM ENG J, V252, P64, DOI 10.1016/j.cej.2014.04.101
   Hua K, 2014, RSC ADV, V4, P2892, DOI 10.1039/c3ra45553j
   Huang XS, 2009, COMPOS SCI TECHNOL, V69, P1009, DOI 10.1016/j.compscitech.2009.01.014
   Huq T, 2012, CARBOHYD POLYM, V90, P1757, DOI 10.1016/j.carbpol.2012.07.065
   Innocenz P., 2013, CHEM MATER, V15, P4790
   Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z
   Jabbour L, 2013, CELLULOSE, V20, P1523, DOI 10.1007/s10570-013-9973-8
   Jiang F, 2013, CARBOHYD POLYM, V95, P32, DOI 10.1016/j.carbpol.2013.02.022
   Jing S., 2013, CURR ORG CHEM, V17, P1647
   Johnsy G., 2012, J MATER CHEM, V22, P22433
   Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005
   Juntaro J, 2007, COMPOS INTERFACE, V14, P753, DOI 10.1163/156855407782106573
   Kaith BS, 2011, CELLULOSE FIBERS: BIO- AND NANO-POLYMER COMPOSITES, P425, DOI 10.1007/978-3-642-17370-7_16
   Kathi J, 2009, COMPOS PART A-APPL S, V40, P800, DOI 10.1016/j.compositesa.2009.04.001
   Kelley J, 2013, J APPL POLYM SCI, V127, P487, DOI 10.1002/app.37790
   Kemell M, 2005, J AM CHEM SOC, V127, P14178, DOI 10.1021/ja0532887
   Khan A., 2012, CARBOHYD POLYM, V90, P1061
   Khan A, 2014, CRIT REV FOOD SCI, V54, P163, DOI 10.1080/10408398.2011.578765
   Kim JU, 2009, SOL ENERG MAT SOL C, V93, P803, DOI 10.1016/j.solmat.2008.09.045
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Koga H, 2013, BIOMACROMOLECULES, V14, P1160, DOI 10.1021/bm400075f
   Laaksonen P, 2011, ANGEW CHEM INT EDIT, V50, P8688, DOI 10.1002/anie.201102973
   Lacroix M, 2014, RADIAT PHYS CHEM, V94, P88, DOI 10.1016/j.radphyschem.2013.04.008
   Laila B. S., 2012, J APPL POLYM SCI, V126, pE442
   Lam E, 2013, ACS SUSTAIN CHEM ENG, V1, P278, DOI 10.1021/sc3001367
   Lam E, 2012, TRENDS BIOTECHNOL, V30, P283, DOI 10.1016/j.tibtech.2012.02.001
   Li HS, 2014, CHEMPLUSCHEM, V79, P128, DOI 10.1002/cplu.201300316
   Li W, 2013, CARBOHYD POLYM, V94, P278, DOI 10.1016/j.carbpol.2013.01.052
   LIAO JL, 1995, J CAPILLARY ELECTROP, V2, P191
   Liu DY, 2014, COMPOS SCI TECHNOL, V99, P31, DOI 10.1016/j.compscitech.2014.05.001
   Liu DY, 2010, EXPRESS POLYM LETT, V4, P26, DOI 10.3144/expresspolymlett.2010.5
   Liu RL, 2010, MATER CHEM PHYS, V121, P432, DOI 10.1016/j.matchemphys.2010.02.002
   Lokanathan AR, 2013, BIOMACROMOLECULES, V14, P2807, DOI 10.1021/bm400633r
   Lonnberg H, 2008, EUR POLYM J, V44, P2991, DOI 10.1016/j.eurpolymj.2008.06.023
   Lonnberg H, 2011, ACS APPL MATER INTER, V3, P1426, DOI 10.1021/am2001828
   Lu J, 2008, POLYMER, V49, P1285, DOI 10.1016/j.polymer.2008.01.028
   Lu Q-L, 2013, GONGNENG CAILIAO, V44, p[2995, 2985]
   Lu T, 2010, ELECTROCHIM ACTA, V55, P4170, DOI 10.1016/j.electacta.2010.02.095
   Luduena L, 2012, CARBOHYD POLYM, V87, P411, DOI 10.1016/j.carbpol.2011.07.064
   Ly B, 2010, MAT SCI ENG C-MATER, V30, P343, DOI 10.1016/j.msec.2009.11.009
   Ma H, 2011, CARBOHYD POLYM, V84, P383, DOI 10.1016/j.carbpol.2010.11.050
   Malmstrom E, 2012, POLYM CHEM-UK, V3, P1702, DOI 10.1039/c1py00445j
   Costa LMM, 2013, IND CROP PROD, V41, P198, DOI 10.1016/j.indcrop.2012.04.025
   Mathew AP, 2005, J APPL POLYM SCI, V97, P2014, DOI 10.1002/app.21779
   Mele P, 2011, BIOMACROMOLECULES, V12, P1487, DOI 10.1021/bm101443a
   Mesquita J. P., 2010, BIOMACROMOLECULES, V11, P473
   Mirna A. M., 2011, ENV FRIENDLY POLYM C
   Mishra SP, 2012, J WOOD CHEM TECHNOL, V32, P137, DOI 10.1080/02773813.2011.624666
   Mofokeng JP, 2012, J THERMOPLAST COMPOS, V25, P927, DOI 10.1177/0892705711423291
   Moritz S, 2014, INT J PHARMACEUT, V471, P45, DOI 10.1016/j.ijpharm.2014.04.062
   Mumalo-Djokic D, 2008, CRYST GROWTH DES, V8, P330, DOI 10.1021/cg0701372
   Nagaoka S, 2002, J MOL CATAL A-CHEM, V177, P255, DOI 10.1016/S1381-1169(01)00271-0
   Luong ND, 2011, J MATER CHEM, V21, P13991, DOI 10.1039/c1jm12134k
   Noorani S, 2007, CELLULOSE, V14, P577, DOI 10.1007/s10570-007-9119-y
   Nyrkova IA, 2000, EUR PHYS J B, V17, P481, DOI 10.1007/s100510070127
   Oksman K, 2006, COMPOS SCI TECHNOL, V66, P2776, DOI 10.1016/j.compscitech.2006.03.002
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Pal D, 2011, AAPS PHARMSCITECH, V12, P1431, DOI 10.1208/s12249-011-9709-8
   Pandey JK, 2014, RSC ADV, V4, P987, DOI 10.1039/c3ra43818j
   Park JH, 2014, CHEMPHYSCHEM, V15, P1477, DOI 10.1002/cphc.201400062
   Park M, 2013, BIOCHIP J, V7, P234, DOI 10.1007/s13206-013-7306-5
   Pirani S, 2013, CARBOHYD POLYM, V93, P357, DOI 10.1016/j.carbpol.2012.06.063
   Ramasubramaniam R, 2003, APPL PHYS LETT, V83, P2928, DOI 10.1063/1.1616976
   Ramimoghadam D, 2015, J MAGN MAGN MATER, V379, P74, DOI 10.1016/j.jmmm.2014.12.005
   Ramimoghadam D, 2014, BIOMED RES INT, DOI 10.1155/2014/205636
   Reddy MM, 2013, PROG POLYM SCI, V38, P1653, DOI 10.1016/j.progpolymsci.2013.05.006
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rescignano N, 2014, CARBOHYD POLYM, V99, P47, DOI 10.1016/j.carbpol.2013.08.061
   Ritchic S. M. C., 1999, LANGMUIR, V15, P6340
   Sakaguchi M, 2012, POLYM DEGRAD STABIL, V97, P257, DOI 10.1016/j.polymdegradstab.2011.12.022
   Samira B., 2013, PHARM CHEM, V5, P265
   Samyn P., 2011, EUR PHYS J-APPL PHYS, P24015
   Sanna R, 2013, CELLULOSE, V20, P2393, DOI 10.1007/s10570-013-9988-1
   Saxena A., 2013, CARBOHYD POLYM, V84, P1371
   Serge R, 2013, J BIOMATERIALS NANOB, V4, DOI DOI 10.4236/JBNB.2013.42022
   Shariki S, 2011, J SOLID STATE ELECTR, V15, P2675, DOI 10.1007/s10008-010-1261-z
   Shi ZJ, 2013, NANOSCALE, V5, P3194, DOI 10.1039/c3nr00408b
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sorvari A, 2014, CARBOHYD POLYM, V106, P283, DOI 10.1016/j.carbpol.2014.02.032
   Sun B, 2014, CARBOHYD POLYM, V111, P419, DOI 10.1016/j.carbpol.2014.03.051
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Suryanegara L, 2009, COMPOS SCI TECHNOL, V69, P1187, DOI 10.1016/j.compscitech.2009.02.022
   Tang XZ, 2011, CARBOHYD POLYM, V85, P7, DOI 10.1016/j.carbpol.2011.01.030
   Tang YJ, 2014, CELLULOSE, V21, P335, DOI 10.1007/s10570-013-0158-2
   Termehyousefi A, 2015, MATER MANUF PROCESS, V30, P59, DOI 10.1080/10426914.2014.961475
   Termehyousefi A., 2014, ADV MAT RES, V832, P778
   Termehyousefi A., 2012, WORLD APPL SCI J, V17, P524
   TermehYousefi A, 2015, SENSOR REV, V35, P190, DOI 10.1108/SR-09-2014-697
   TermehYousefi A, 2014, BIOMED RES INT, DOI 10.1155/2014/691537
   Thomas S, 2009, INT J MATER PROD TEC, V36, P317, DOI 10.1504/IJMPT.2009.027839
   Tingaut P, 2010, BIOMACROMOLECULES, V11, P454, DOI 10.1021/bm901186u
   Tomaz K., 2014, CELLULOSE, V21, P2579
   Tome LC, 2013, CELLULOSE, V20, P1807, DOI 10.1007/s10570-013-9959-6
   Trovatti E, 2013, BIOMACROMOLECULES, V14, P2667, DOI 10.1021/bm400523h
   Urena-Benavides EE, 2011, MACROMOLECULES, V44, P8990, DOI 10.1021/ma201649f
   Uschanov P, 2011, CELLULOSE, V18, P393, DOI 10.1007/s10570-010-9478-7
   Visakh PM, 2012, COMPOS PART A-APPL S, V43, P735, DOI 10.1016/j.compositesa.2011.12.015
   Wang C., 2009, 2 INT C SMART MAT NA
   Wang DX, 2013, COMPOS SCI TECHNOL, V85, P83, DOI 10.1016/j.compscitech.2013.06.004
   Wang M, 2011, BIOMACROMOLECULES, V12, P2074, DOI 10.1021/bm101561m
   Wu CN, 2012, BIOMACROMOLECULES, V13, P1927, DOI 10.1021/bm300465d
   Wu MC, 2011, NANO RES, V4, P360, DOI 10.1007/s12274-010-0090-9
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Xie KL, 2011, CARBOHYD POLYM, V83, P1516, DOI 10.1016/j.carbpol.2010.09.064
   Xie YJ, 2010, COMPOS PART A-APPL S, V41, P806, DOI 10.1016/j.compositesa.2010.03.005
   Xu QH, 2013, INT J BIOL MACROMOL, V60, P241, DOI 10.1016/j.ijbiomac.2013.05.038
   Xu S., 2011, ACTA MATERIAE COMP S
   Xu WN, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1562-0
   YASHIMA E, 1994, J CHROMATOGR A, V677, P11, DOI 10.1016/0021-9673(94)80539-3
   Yoa Y., 2008, ENVIRON SCI TECHNOL, V42, P4952
   Yoshioka M, 2009, J WOOD SCI, V55, P335, DOI 10.1007/s10086-009-1043-3
   Yousefi AT, 2015, MATER RES INNOV, V19, P212, DOI 10.1179/1433075X14Y.0000000246
   Yu HY, 2014, CARBOHYD POLYM, V101, P471, DOI 10.1016/j.carbpol.2013.09.048
   Zadegan S, 2010, CERAM INT, V36, P2375, DOI 10.1016/j.ceramint.2010.07.019
   Zhang H, 2013, KEY ENG MATER, V562-565, P846, DOI 10.4028/www.scientific.net/KEM.562-565.846
   Zhang H, 2013, J ADHES SCI TECHNOL, V27, P1023, DOI 10.1080/01694243.2012.727173
   Zhang J, 2012, J PHYS CHEM C, V116, P8063, DOI 10.1021/jp2109237
   Zheng JW, 2010, J PHYS CHEM C, V114, P7063, DOI 10.1021/jp9115035
   Zhou YT, 2012, PROCEDIA ENVIRON SCI, V16, P145, DOI 10.1016/j.proenv.2012.10.020
   Zoppe JO, 2010, BIOMACROMOLECULES, V11, P2683, DOI 10.1021/bm100719d
   Zou PP, 2012, APPL MECH MATER, V200, P373, DOI 10.4028/www.scientific.net/AMM.200.373
NR 169
TC 9
Z9 9
U1 18
U2 118
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAR
PY 2017
VL 112
BP 9
EP 21
DI 10.1016/j.reactfunctpolym.2016.12.013
PG 13
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA EL3YQ
UT WOS:000394557000002
DA 2018-10-20
ER

PT J
AU Xu, JY
   Solaiman, D
   Ashby, RD
   Garcia, RA
   Gordon, SH
   Harry-O'kuru, RE
AF Xu, Jingyuan
   Solaiman, Daniel
   Ashby, Richard D.
   Garcia, Rafael A.
   Gordon, Sherald H.
   Harry-O'kuru, Rogers E.
TI Properties of starch-polyglutamic acid (PGA) graft copolymer prepared by
   microwave irradiation - Fourier transform infrared spectroscopy (FTIR)
   and rheology studies
SO STARCH-STARKE
LA English
DT Article
DE Attenuated total reflectance; Fourier transform infrared spectroscopy
   (ATR/FTIR); Graft copolymers; Poly-gamma-glutamic acid (PGA); Rheology;
   Starch
ID CARBOPOL GELS
AB The rheological properties of waxy starch--polygutamic acid (PGA) graft copolymers were investigated. Grafting was confirmed by FTIR spectroscopy. The starch-PGA copolymers absorbed water and formed gels, which exhibited concentration-dependent viscoelastic solid properties. Higher starch-PGA concentrations resulted in stronger viscoelastic properties. The analysis for moduli of different concentrations indicated that the starch-PGA graft copolymer gels were physical gels, meaning the cross-links between the molecules were physical junctions. However, stress relaxation measurements showed that the starch-PGA graft copolymer gels had long relaxation times, which result from the presence of the chemical cross-links that were evident in the FTIR spectra. The non-linear steady shearing rheological properties studies indicated that starch-PGA gels exhibited shear thinning behavior, which can be well fitted with the power law constitutive equation. The function and behavior of the starch-PGA graft copolymer gels suggest that this kind of starch-based biomaterial could be a potential candidate for applications in cosmetic gels, skin wound care materials, and agricultural products.
C1 [Xu, Jingyuan; Gordon, Sherald H.; Harry-O'kuru, Rogers E.] ARS, USDA, Natl Ctr Agr Utilizat Res, 1815 North Univ St, Peoria, IL 61604 USA.
   [Solaiman, Daniel; Ashby, Richard D.; Garcia, Rafael A.] ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA USA.
RP Xu, JY (reprint author), ARS, USDA, Natl Ctr Agr Utilizat Res, 1815 North Univ St, Peoria, IL 61604 USA.
EM james.xu@ars.usda.gov
FU US Department of Agriculture, Agricultural Research Service
FX The authors thank Elizabeth Krietemeyer for technical assistance. This
   work was financially supported by US Department of Agriculture,
   Agricultural Research Service.
CR BARRY BW, 1979, INT J PHARM, V2, P27, DOI 10.1016/0378-5173(79)90026-7
   BARRY BW, 1979, INT J PHARMACEUT, V2, P1, DOI 10.1016/0378-5173(79)90025-5
   Bird R. B., 1977, DYNAMICS POLYM LIQUI
   BIRRER GA, 1994, INT J BIOL MACROMOL, V16, P265, DOI 10.1016/0141-8130(94)90032-9
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Clark A. H., 1992, GELS GELLING PHYS CH
   Fanta G. F., 1996, POLYM MAT ENCY, V10
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fletcher Jacqui, 2005, Nurs Times, V101, P53
   Guo WY, 2012, J VINYL ADDIT TECHN, V18, P261, DOI 10.1002/vnl.20313
   Hoogenboom R, 2007, MACROMOL RAPID COMM, V28, P368, DOI 10.1002/marc.200600749
   Kempe K, 2011, MACROMOLECULES, V44, P5825, DOI 10.1021/ma2004794
   Kim JY, 2003, COLLOID POLYM SCI, V281, P614, DOI 10.1007/s00396-002-0808-7
   Liu HS, 2009, PROG POLYM SCI, V34, P1348, DOI 10.1016/j.progpolymsci.2009.07.001
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES
   Matthews KH, 2006, INT J PHARMACEUT, V313, P78, DOI 10.1016/j.ijpharm.2006.01.023
   Nada, 2007, BIORESOURCES, V3, P46
   Seabourn BW, 2008, J AGR FOOD CHEM, V56, P4236, DOI 10.1021/jf703569b
   Singh V, 2007, EXPRESS POLYM LETT, V1, P51, DOI 10.3144/expresspolymlett.2007.10
   Weaver M. O., 1974, APPL POLYM S, V25, P97
   Weaver M. O., 1976, US Patent, Patent No. [3,935,099, 3935099]
   Willett JL, 2006, J POLYM ENVIRON, V14, P125, DOI 10.1007/s10924-006-0002-y
   Xu JY, 2001, CEREAL CHEM, V78, P181, DOI 10.1094/CCHEM.2001.78.2.181
   Zhou J, 2006, CARBOHYD POLYM, V63, P466, DOI 10.1016/j.carbpol.2005.09.019
   Zohuriaan-Mehr MJ, 2008, IRAN POLYM J, V17, P451
NR 25
TC 1
Z9 1
U1 5
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0038-9056
EI 1521-379X
J9 STARCH-STARKE
JI Starch-Starke
PD MAR
PY 2017
VL 69
IS 3-4
SI SI
AR 1600021
DI 10.1002/star.201600021
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA EM9LR
UT WOS:000395633600005
DA 2018-10-20
ER

PT J
AU Hong, KD
   Kim, JS
   Ji, WB
   Um, JW
AF Hong, K. D.
   Kim, J. S.
   Ji, W. B.
   Um, J. W.
TI Midterm outcomes of injectable bulking agents for fecal incontinence: a
   systematic review and meta-analysis
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Review
DE Midterm outcomes; Injectable bulking agents; Fecal incontinence
ID SILICONE BIOMATERIAL PTQ(TM); QUALITY-OF-LIFE; HYALURONIC-ACID;
   SUBMUCOSAL INJECTION; IMPLANTS; EFFICACY; DEXTRANOMER; MANAGEMENT;
   DURASPHERE; THERAPY
AB Background Various bulking agents have been used to treat fecal incontinence. While short-term outcomes are attractive, there is still a lack of long-term data. The aim of this systematic review and meta-analysis was to investigate the midterm outcomes of treatment with injectable bulking agents and to identify predictive factors for improvement in incontinence.
   Methods PubMed, EMBASE, Web of Science, and Cochrane Library databases were searched using the terms injection, bulking agents, and fecal incontinence. Studies with a minimum follow-up of 1 year were included. The improvement rate in incontinence was calculated by percent change in validated fecal incontinence score (FIS) following injection treatment. To explore the impact of predictive factors on improvement in incontinence, univariate meta-regressions were conducted using the randomeffect model.
   Results A total of 889 patients in 23 articles were included. The weighted mean follow-up duration was 23.7 months (95% CI 19.3-28.2). Eleven different bulking agents were used. Four validated FISs were used. The Cleveland Clinic Fecal Incontinence score (CC-FIS) was used in 19 studies. Most studies reported a statistically significant improvement in FIS. The pooled mean preoperative CC-FIS (n = 637) was 12.4 (95% CI 11.4-13.3). The pooled mean CC-FIS at last follow-up (n = 590) was 7.7 (95% CI 6.1-9.3). The weighted mean difference in CC-FIS between preoperative visit and last follow-up was 4.9 (95% CI 4.0-5.8). Hence, the rate of improvement in incontinence was 39.5% based on CC-FIS. Meta-regression revealed that the perianal injection route and implants intact on endoanal ultrasonography were predictive of greater improvement in incontinence. The manometric data revealed that the initial increase in the mean resting pressure following injection was attenuated over time. The pooled rate of adverse events was 18.0% (95% CI 10.0-30.1). In most cases, adverse events were minor and resolved within a couple of weeks.
   Conclusions Administration of injectable bulking agents results in significant midterm improvement in FIS. Perianal injection route and implants intact on EAUS were predictive of higher improvement in incontinence. However, given the paucity of randomized controlled trials in the literature, further research is needed to improve the quality of the evidence.
C1 [Hong, K. D.; Kim, J. S.; Ji, W. B.; Um, J. W.] Korea Univ, Coll Med, Ansan Hosp, Dept Colorectal Surg, Gojan 1 Dong, Ansan, Gyeonggi Do, South Korea.
RP Um, JW (reprint author), Korea Univ, Coll Med, Ansan Hosp, Dept Colorectal Surg, Gojan 1 Dong, Ansan, Gyeonggi Do, South Korea.
EM junwonum@korea.ac.kr
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Al- Abed Y, 2014, INT J SURG, V12, pS33
   Alam NN, 2015, GUT, V64, pA170, DOI 10.1136/gutjnl-2015-309861.361
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Beggs AD, 2010, COLORECTAL DIS, V12, P935, DOI 10.1111/j.1463-1318.2009.01927.x
   Danielson J, 2013, TECH COLOPROCTOL, V17, P389, DOI 10.1007/s10151-012-0949-8
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2009, TECH COLOPROCTOL, V13, P195, DOI 10.1007/s10151-009-0502-6
   Dehli T, 2013, SCAND J GASTROENTERO, V48, P302, DOI 10.3109/00365521.2012.758770
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Grey T, 2013, COLORECTAL DIS, V15, P53
   Guerra F, 2015, TECH COLOPROCTOL, V19, P23, DOI 10.1007/s10151-014-1236-7
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Hussain ZI, 2012, UPDATES SURG-ITALY, V64, P289, DOI 10.1007/s13304-012-0176-x
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Maeda Y, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD007959.PUB3
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Maslekar S, 2013, DIS COLON RECTUM, V56, P354, DOI 10.1097/DCR.0b013e3182805276
   Mellgren A, 2014, NEUROGASTROENT MOTIL, V26, P1087, DOI 10.1111/nmo.12360
   Morris OJ, 2013, TECH COLOPROCTOL, V17, P517, DOI 10.1007/s10151-013-1000-4
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   Rosato G, 2015, DIS COLON RECTUM, V58, P241, DOI 10.1097/DCR.0000000000000300
   Schwandner O, 2011, SURG INNOV, V18, P130, DOI 10.1177/1553350610392243
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stephens JH, 2010, ANZ J SURG, V80, P324, DOI 10.1111/j.1445-2197.2010.05277.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Ullah S, 2011, JCPSP-J COLL PHYSICI, V21, P227, DOI 04.2011/JCPSP.227229
   van der Hagen SJ, 2012, INT J COLORECTAL DIS, V27, P1191, DOI 10.1007/s00384-012-1468-9
   Wald Arnold, 2016, Gastroenterol Hepatol (N Y), V12, P155
   Watson NFS, 2012, COLORECTAL DIS, V14, P29, DOI 10.1111/codi.12047
   Wells G., 2013, NEWCASTLE OTTAWA SCA
NR 37
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
EI 1128-045X
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD MAR
PY 2017
VL 21
IS 3
BP 203
EP 210
DI 10.1007/s10151-017-1593-0
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA EQ3UN
UT WOS:000397998800004
PM 28251356
DA 2018-10-20
ER

PT J
AU Fabiani, B
   Menconi, C
   Martellucci, J
   Giani, I
   Toniolo, G
   Naldini, G
AF Fabiani, B.
   Menconi, C.
   Martellucci, J.
   Giani, I.
   Toniolo, G.
   Naldini, G.
TI Permacol (TM) collagen paste injection for the treatment of complex anal
   fistula: 1-year follow-up
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article
DE Anal fistula; Permacol; Fistula treatment; Seton; Biomaterial; Porcine
   dermal collagen matrix
ID IN-ANO; FIBRIN GLUE; PERIANAL FISTULA; ADVANCEMENT FLAP; CRYPTOGLANDULAR
   ORIGIN; MATRIX INJECTION; CLINICAL-TRIAL; STEM-CELLS; REPAIR; ADHESIVE
AB Background Optimal surgical treatment for anal fistula should result in healing of the fistula track and preserve anal continence. The aim of this study was to evaluate Permacol (TM) collagen paste (Covidien plc, Gosport, Hampshire, UK) injection for the treatment of complex anal fistulas, reporting feasibility, safety, outcome and functional results.
   Methods Between May 2013 and December 2014, 21 consecutive patients underwent Permacol paste injection for complex anal fistula at our institutions. All patients underwent fistulectomy and seton placement 6-8 weeks before Permacol TM paste injection. Follow-up duration was 12 months.
   Results Eighteen patients (85.7%) had a high transsphincteric anal fistula, and three female patients (14.3%) had an anterior transsphincteric fistula. Fistulas were recurrent in three patients (14.3%). Seven patients (33%) had a fistula with multiple tracts. After a follow-up of 12 months, ten patients were considered healed (overall success rate 47.6%). The mean preoperative FISI score was 0.33 +/- 0.57 and 0.61 +/- 1.02 after 12 months.
   Conclusions Permacol TM paste injection was safe and effective in some patients with complex anal fistula without compromising continence.
C1 [Fabiani, B.; Menconi, C.; Giani, I.; Toniolo, G.; Naldini, G.] Cisanello Univ Hosp, Dept Gastroenterol, Proctol & Perineal Surg Unit, Pisa, Italy.
   [Martellucci, J.] Careggi Univ Hosp, Gen Emergency & Minimaly Invas Surg, Largo Brambilla 3, I-50134 Florence, Italy.
RP Martellucci, J (reprint author), Careggi Univ Hosp, Gen Emergency & Minimaly Invas Surg, Largo Brambilla 3, I-50134 Florence, Italy.
EM jamjac64@hotmail.com
CR Chen TA, 2012, COLORECTAL DIS, V14, pe627, DOI 10.1111/j.1463-1318.2012.03050.x
   Cintron JR, 2000, DIS COLON RECTUM, V43, P949
   Cintron JR, 1999, DIS COLON RECTUM, V42, P607, DOI 10.1007/BF02234135
   Cintron JR, 2000, DIS COLON RECTUM, V43, P944, DOI 10.1007/BF02237355
   Dietz DW, 2006, J GASTROINTEST SURG, V10, P631, DOI 10.1016/j.gassur.2006.01.007
   Dubsky PC, 2008, DIS COLON RECTUM, V51, P852, DOI 10.1007/s10350-008-9242-3
   El-Gazzaz G, 2010, COLORECTAL DIS, V12, P442, DOI 10.1111/j.1463-1318.2009.01802.x
   Ellis C Neal, 2007, J Surg Educ, V64, P36, DOI 10.1016/j.cursur.2006.07.005
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P723, DOI 10.1007/BF02054434
   Giordano P, 2016, COLORECTAL DIS, V18, P286, DOI 10.1111/codi.13112
   Gisbertz SS, 2005, DIGEST SURG, V22, P91, DOI 10.1159/000085299
   Gottgens KWA, 2015, INT J COLORECTAL DIS, V30, P583, DOI 10.1007/s00384-014-2091-8
   Herreros MD, 2012, DIS COLON RECTUM, V55, P762, DOI 10.1097/DCR.0b013e318255364a
   Himpson RC, 2009, DIS COLON RECTUM, V52, P602, DOI 10.1007/DCR.0b013e31819ece3e
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Johnson EK, 2006, DIS COLON RECTUM, V49, P371, DOI 10.1007/s10350-005-0288-1
   Koehler A, 2004, DIS COLON RECTUM, V47, P1874, DOI 10.1007/s10350-004-0650-8
   Lehmann JP, 2013, COLORECTAL DIS, V15, P592, DOI 10.1111/codi.12104
   Lindsey I, 2002, DIS COLON RECTUM, V45, P1608, DOI 10.1097/01.DCR.0000034622.59957.55
   Milito G, 2009, J AM COLL SURGEONS, V209, P542, DOI 10.1016/j.jamcollsurg.2009.07.012
   Ritchie RD, 2009, COLORECTAL DIS, V11, P564, DOI 10.1111/j.1463-1318.2008.01713.x
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Safar B, 2009, DIS COLON RECTUM, V52, P248, DOI 10.1007/DCR.0b013e31819c96ac
   Sentovich SM, 2001, J GASTROINTEST SURG, V5, P158, DOI 10.1016/S1091-255X(01)80028-7
   Sileri P, 2012, COLORECTAL DIS, V14, P24, DOI 10.1111/codi.12046
   Singer M, 2005, DIS COLON RECTUM, V48, P799, DOI 10.1007/s10350-004-0898-z
   Soltani A, 2010, DIS COLON RECTUM, V53, P486, DOI 10.1007/DCR.0b013e3181ce8b01
   Tozer P, 2013, J GASTROINTEST SURG, V17, P1960, DOI 10.1007/s11605-013-2198-1
   van Koperen PJ, 2008, DIS COLON RECTUM, V51, P1475, DOI 10.1007/s10350-008-9354-9
   van Koperen PJ, 2011, DIS COLON RECTUM, V54, P387, DOI 10.1007/DCR.0b013e318206043e
   van Onkelen RS, 2012, DIS COLON RECTUM, V55, P163, DOI 10.1097/DCR.0b013e31823c0f74
   Westerterp M, 2003, Colorectal Dis, V5, P549, DOI 10.1046/j.1463-1318.2003.00459.x
   Whitfford MH, 2005, DIS COLON RECTUM, V48, P1337, DOI 10.1007/s10350-005-0055-3
NR 34
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
EI 1128-045X
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD MAR
PY 2017
VL 21
IS 3
BP 211
EP 215
DI 10.1007/s10151-017-1590-3
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA EQ3UN
UT WOS:000397998800005
PM 28210857
DA 2018-10-20
ER

PT J
AU Zong, XM
   Zhang, JS
   Liu, W
   Chen, JA
   Nie, KB
   Xu, CX
AF Zong, Ximei
   Zhang, Jinshan
   Liu, Wei
   Chen, Jingai
   Nie, Kaibo
   Xu, Chunxiang
TI Effects of Li on Microstructures, Mechanical, and Biocorrosion
   Properties of Biodegradable Mg94-xZn2Y4Lix Alloys with Long Period
   Stacking Ordered Phase
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID ZN-Y ALLOYS; HIGH-PURITY MG; CORROSION BEHAVIOR; ZR ALLOYS; STENT
   APPLICATION; HANKS SOLUTION; LITHIUM; CA; PERFORMANCE; AZ91
AB Mg94-xZn2Y4Lix alloys (at%) (x=0, 1, 5, 9, 13) are designed to develop a novel, biodegradable magnesium alloy. Microstructures evolution and mechanical properties are evaluated by using OM, XRD, SEM, and tensile tests. The biocorrosion behaviors of the alloys are investigated by using hydrogen evolution and electrochemical measurements. The precipitation of 18R LPSO phase is facilitated by a little Li (<1at%), while exceeded Li (>1at%) inhibits the formation of 18R LPSO phase and favors the formation of (Mg,Zn)(24)Y-5 eutectic phase. The grain size of -Mg phase is refined with 5at% Li. Besides the optimal combined mechanical properties (UTS=190MPa, elongation=3.1%), the as-cast Mg89Zn2Y4Li5 alloy has the lowest corrosion rate and the highest biocorrosion resistance, which are desirable for use as a biomaterial.
C1 [Zong, Ximei; Zhang, Jinshan; Liu, Wei; Chen, Jingai; Nie, Kaibo; Xu, Chunxiang] Taiyuan Univ Technol, Coll Mat Sci & Engn, Taiyuan 030024, Shanxi, Peoples R China.
   [Zong, Ximei; Zhang, Jinshan; Liu, Wei; Chen, Jingai; Nie, Kaibo; Xu, Chunxiang] Taiyuan Univ Technol, Shanxi Key Lab Adv Magnesium Based Mat, Taiyuan 030024, Shanxi, Peoples R China.
   [Zong, Ximei] Taiyuan Normal Univ, Dept Chem, Taiyuan 030031, Shanxi, Peoples R China.
RP Zhang, JS (reprint author), Taiyuan Univ Technol, Coll Mat Sci & Engn, Taiyuan 030024, Shanxi, Peoples R China.; Zhang, JS (reprint author), Taiyuan Univ Technol, Shanxi Key Lab Adv Magnesium Based Mat, Taiyuan 030024, Shanxi, Peoples R China.
EM jinshansx@tom.com
FU National Natural Science Foundation of China [51474153, 51574175]; Ph.D.
   Programs Foundation of Ministry of Education of China [20111402110004];
   Natural Science Foundation of Shanxi Province [2009011028-3,
   2012011022-1]; Shanxi Key Laboratory of Advanced Magnesium-Based
   Materials, Taiyuan University of Technology [2015-02]
FX This research was supported by the National Natural Science Foundation
   of China (Nos. 51474153 and 51574175), Ph.D. Programs Foundation of
   Ministry of Education of China (20111402110004), Natural Science
   Foundation of Shanxi Province (Nos.2009011028-3 and 2012011022-1), and
   Shanxi Key Laboratory of Advanced Magnesium-Based Materials, Taiyuan
   University of Technology (No. 2015-02)
CR Abidin NIZ, 2011, CORROS SCI, V53, P3542, DOI 10.1016/j.corsci.2011.06.030
   Al-Samman T, 2009, ACTA MATER, V57, P2229, DOI 10.1016/j.actamat.2009.01.031
   Argade GR, 2012, CORROS SCI, V58, P321, DOI 10.1016/j.corsci.2012.01.007
   Atrens A, 2015, ADV ENG MATER, V17, P400, DOI 10.1002/adem.201400434
   Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Cao FY, 2013, CORROS SCI, V76, P60, DOI 10.1016/j.corsci.2013.06.030
   Cao FY, 2013, CORROS SCI, V75, P78, DOI 10.1016/j.corsci.2013.05.018
   Garces G, 2014, J MATER SCI, V49, P2714, DOI 10.1007/s10853-013-7967-4
   Han J, 2011, SCRIPTA MATER, V64, P693, DOI 10.1016/j.scriptamat.2010.11.034
   Hazibullah W., 2013, J MATER SCI, V48, P39
   Izumi S, 2009, CORROS SCI, V51, P395, DOI 10.1016/j.corsci.2008.11.003
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jiang Y, 2015, MAT SCI ENG A-STRUCT, V641, P256, DOI 10.1016/j.msea.2015.06.063
   Jiao YF, 2015, ADV ENG MATER, V17, P876, DOI 10.1002/adem.201400369
   Mao L, 2015, ACS APPL MATER INTER, V7, P5320, DOI 10.1021/am5086885
   Matsuda M, 2005, MATER TRANS, V46, P361, DOI 10.2320/matertrans.46.361
   Nassar A, 2014, ACS CHEM NEUROSCI, V5, P451, DOI 10.1021/cn500038f
   Nayak S, 2016, J MECH BEHAV BIOMED, V59, P57, DOI 10.1016/j.jmbbm.2015.12.010
   Pan FS, 2011, PROG NAT SCI, V21, P485, DOI 10.1016/S1002-0071(12)60087-2
   Peng QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03620
   Qiao ZX, 2012, CORROS SCI, V61, P185, DOI 10.1016/j.corsci.2012.04.030
   Qin FX, 2013, INTERMETALLICS, V42, P9, DOI 10.1016/j.intermet.2013.04.021
   Shi ZM, 2011, CORROS SCI, V53, P226, DOI 10.1016/j.corsci.2010.09.016
   Siebel AM, 2014, ACS CHEM NEUROSCI, V5, P468, DOI 10.1021/cn500046h
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Wang D, 2014, J MAGNES ALLOY, V2, P78, DOI 10.1016/j.jma.2014.01.008
   Wang J, 2015, MAT SCI ENG A-STRUCT, V648, P37, DOI 10.1016/j.msea.2015.09.046
   Xu DK, 2008, J ALLOY COMPD, V461, P248, DOI 10.1016/j.jallcom.2007.07.096
   Yamasaki M, 2011, APPL SURF SCI, V257, P8258, DOI 10.1016/j.apsusc.2011.01.046
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zhang JH, 2013, SCRIPTA MATER, V68, P675, DOI 10.1016/j.scriptamat.2013.01.023
   Zhang JS, 2012, J MATER SCI TECHNOL, V28, P1157, DOI 10.1016/S1005-0302(12)60186-8
   Zhang JS, 2012, MAT SCI ENG A-STRUCT, V552, P81, DOI 10.1016/j.msea.2012.04.119
   Zhang L, 2014, MATER DESIGN, V54, P256, DOI 10.1016/j.matdes.2013.08.048
   Zhang XB, 2014, CORROS SCI, V88, P1, DOI 10.1016/j.corsci.2014.07.004
   Zhang XB, 2012, MATER LETT, V86, P42, DOI 10.1016/j.matlet.2012.07.030
   Zhang ZQ, 2015, J ALLOY COMPD, V624, P116, DOI 10.1016/j.jallcom.2014.10.177
   Zhao MC, 2008, CORROS SCI, V50, P1939, DOI 10.1016/j.corsci.2008.04.01
   Zhao X, 2013, MAT SCI ENG C-MATER, V33, P3627, DOI 10.1016/j.msec.2013.04.051
   Zhao X, 2013, J MECH BEHAV BIOMED, V18, P181, DOI 10.1016/j.jmbbm.2012.11.016
   Zhou WR, 2013, ACTA BIOMATER, V9, P8488, DOI 10.1016/j.actbio.2013.01.032
   Zong XM, 2016, ACTA METALL SIN-ENGL, V29, P32, DOI 10.1007/s40195-015-0359-9
NR 43
TC 2
Z9 2
U1 4
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAR
PY 2017
VL 19
IS 3
AR 1600606
DI 10.1002/adem.201600606
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA EP6MK
UT WOS:000397493400003
DA 2018-10-20
ER

PT J
AU Chien, CS
   Hung, YC
   Hong, TF
   Wu, CC
   Kuo, TY
   Lee, TM
   Liao, TY
   Lin, HC
   Chuang, CH
AF Chien, Chi-Sheng
   Hung, Yu-Chien
   Hong, Ting-Fu
   Wu, Chung-Chun
   Kuo, Tsung-Yuan
   Lee, Tzer-Min
   Liao, Tze-Yuan
   Lin, Huan-Chang
   Chuang, Cheng-Hsin
TI Preparation and characterization of porous bioceramic layers on pure
   titanium surfaces obtained by micro-arc oxidation process
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; PLASMA-SPRAYED COATINGS; ND-YAG LASER;
   HYDROXYAPATITE COATINGS; FLUORAPATITE COATINGS; FLUORIDATED
   HYDROXYAPATITE; ORTHOPEDIC APPLICATIONS; IN-VIVO; TI; MICROSTRUCTURE
AB Fluorapatite (FA) has better chemical and thermal stability than hydroxyapatite (HA), and has thus attracted significant interest for biomaterial applications in recent years. In this study, porous bioceramic layers were prepared on pure titanium surfaces using a micro-arc oxidation (MAO) technique with an applied voltage of 450 V and an oxidation time of 5 min. The MAO process was performed using three different electrolyte solutions containing calcium fluoride (CaF2), calcium acetate monohydrate (Ca(CH3COO)(2)center dot H2O), and sodium phosphate monobasic dihydrate (NaH2PO4 center dot 2H(2)O) mixed in ratios of 0: 2: 1, 1: 1: 1, and 2: 0: 1, respectively. The surface morphology, composition, micro-hardness, porosity, and biological properties of the various MAO coatings were examined and compared. The results showed that as the CaF2/Ca(CH3COO)(2)center dot H2O ratio increased, the elemental composition of the MAO coating transformed from HA, A-TiO2 (Anatase) and R-TiO2 (Rutile); to A-TiO2, R-TiO2, and a small amount of HA; and finally A-TiO2, R-TiO2, CaF2, TiP2O5, and FA. The change in elemental composition was accompanied by a higher micro-hardness and a lower porosity. The coatings exhibited a similar in vitro bioactivity performance during immersion in simulated body fluid for 7-28 days. Furthermore, for in initial in vitro biocompatibility tests performed for 24 h using Dulbecco's Modified Eagle Medium (DMEM) supplement containing 10% Fetal bovine serum, the attachment and spreading of osteoblast-like osteosarcoma MG63 cells were found to increase slightly with an increasing CaF2/Ca(CH3COO)(2)center dot H2O ratio. In general, the results presented in this study show that all three MAO coatings possess a certain degree of in vitro bioactivity and biocompatibility.
C1 [Chien, Chi-Sheng] Chimei Found Hosp, Dept Orthoped, Tainan 710, Tainan, Taiwan.
   [Chien, Chi-Sheng; Hong, Ting-Fu] Southren Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan 710, Tainan, Taiwan.
   [Hung, Yu-Chien; Wu, Chung-Chun; Kuo, Tsung-Yuan; Chuang, Cheng-Hsin] Southren Taiwan Univ Sci & Technol, Dept Engn Mech, Tainan 710, Tainan, Taiwan.
   [Hong, Ting-Fu] Natl Pingtung Univ Sci & Technol, Graduate Inst Mat Engn, Pingtung 912, Pingtung, Taiwan.
   [Lee, Tzer-Min] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan.
   [Liao, Tze-Yuan] Quintain Steel Co, Tainan 721, Tainan, Taiwan.
   [Lin, Huan-Chang] I Shou Univ, Dept Ind Engn & Management, Kaohsiung 84001, Taiwan.
RP Kuo, TY (reprint author), Southren Taiwan Univ Sci & Technol, Dept Engn Mech, Tainan 710, Tainan, Taiwan.
EM tykuo@mail.stust.edu.tw
FU Chi Mei Foundation Hospital, Republic of China (Taiwan) [110990223];
   Ministry of Science and Technology of the Republic of China (Taiwan)
   [MOST 103-2221-E-218-006]
FX The authors gratefully acknowledge the financial support provided to
   this study by the Chi Mei Foundation Hospital, Republic of China
   (Taiwan), under Contract No. 110990223, and the Ministry of Science and
   Technology of the Republic of China (Taiwan) under Contract No. MOST
   103-2221-E-218-006.
CR Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   Al-Noaman A, 2013, J NON-CRYST SOLIDS, V364, P92, DOI 10.1016/j.jnoncrysol.2012.11.051
   Ayed F.B., 2008, CERAM INT, V34, P1885
   Bayati MR, 2010, APPL SURF SCI, V256, P4253, DOI 10.1016/j.apsusc.2010.02.011
   Bhadang KA, 2004, BIOMATERIALS, V25, P4935, DOI 10.1016/j.biomaterials.2004.02.043
   Blind O, 2005, DENT MATER, V21, P1017, DOI 10.1016/j.dental.2004.12.003
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Chen JZ, 2006, MATER LETT, V60, P2538, DOI 10.1016/j.matlet.2006.01.035
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Chien CS, 2011, SURF COAT TECH, V205, P3141, DOI 10.1016/j.surfcoat.2010.11.028
   Chien CS, 2011, APPL SURF SCI, V257, P2387, DOI 10.1016/j.apsusc.2010.09.108
   Chien CS, 2014, J MED BIOL ENG, V34, P109, DOI 10.5405/jmbe.1379
   Chien CS, 2014, P I MECH ENG H, V228, P379, DOI 10.1177/0954411914528307
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   Cui WF, 2013, MAT SCI ENG C-MATER, V33, P3775, DOI 10.1016/j.msec.2013.05.011
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   DHERT WJA, 1993, J BIOMED MATER RES, V27, P127, DOI 10.1002/jbm.820270116
   Duarte LT, 2014, MAT SCI ENG C-MATER, V41, P343, DOI 10.1016/j.msec.2014.04.068
   Dunne C. F., 2015, J MATER SCI-MATER M, V26, P1
   Eslami H, 2009, MAT SCI ENG C-BIO S, V29, P1387, DOI 10.1016/j.msec.2008.10.033
   Hong TF, 2008, J MATER SCI-MATER M, V19, P3489, DOI 10.1007/s10856-008-3527-x
   Huang Y, 2007, BIOMED MATER, V2, P196, DOI 10.1088/1748-6041/2/3/005
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   Kung KC, 2012, J ALLOY COMPD, V515, P68, DOI 10.1016/j.jallcom.2011.11.050
   Kung KC, 2010, SURF COAT TECH, V205, P1714, DOI 10.1016/j.surfcoat.2010.05.018
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mojumdar SC, 2004, J THERM ANAL CALORIM, V78, P73, DOI 10.1023/B:JTAN.0000042155.26913.79
   Mour M, 2010, MATERIALS, V3, P2947, DOI 10.3390/ma3052947
   Nagai A, 2012, J EUR CERAM SOC, V32, P2647, DOI 10.1016/j.jeurceramsoc.2012.03.002
   Ni JH, 2008, MATER RES BULL, V43, P45, DOI 10.1016/j.materresbull.2007.02.019
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   SENNERBY L, 1992, J MATER SCI-MATER M, V3, P262, DOI 10.1007/BF00705291
   Shi X. L., 2009, MINING SCI TECHNOLOG, V19, P220
   Song WH, 2009, J BIOMED MATER RES A, V88A, P246, DOI 10.1002/jbm.a.31877
   STEFLIK DE, 1993, J BIOMED MATER RES, V27, P791, DOI 10.1002/jbm.820270612
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   Weng WJ, 1999, J AM CERAM SOC, V82, P27
   Xiao XF, 2006, MATER LETT, V60, P2627, DOI 10.1016/j.matlet.2006.01.048
   Xie KY, 2013, MAT SCI ENG C-MATER, V33, P3530, DOI 10.1016/j.msec.2013.04.044
   Yang CY, 2010, J MED BIOL ENG, V30, P91
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Zhao Q.-m., 2015, J MATER SCI-MATER M, V26, P1
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 49
TC 2
Z9 2
U1 5
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD MAR
PY 2017
VL 123
IS 3
AR 204
DI 10.1007/s00339-017-0765-0
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EP7SB
UT WOS:000397576400024
DA 2018-10-20
ER

PT J
AU Regier, MC
   Montanez-Sauri, SI
   Schwartz, MP
   Murphy, WL
   Beebe, DJ
   Sung, KE
AF Regier, Mary C.
   Montanez-Sauri, Sara I.
   Schwartz, Michael P.
   Murphy, William L.
   Beebe, David J.
   Sung, Kyung Eun
TI The Influence of Biomaterials on Cytokine Production in 3D Cultures
SO BIOMACROMOLECULES
LA English
DT Article
ID BREAST-CANCER CELLS; GROWTH-FACTORS; MECHANICAL-PROPERTIES; TUMOR
   PROGRESSION; IN-VITRO; MATRIX; EXPRESSION; HYDROGELS; TISSUE; RECEPTORS
AB As a result of improved relevance to in vivo physiology, in vitro studies are increasingly performed in diverse, three-dimensional (3D) biomaterials. However, material cell type pairing effects on cytokine availability remain unclear. We cultured five cell types in agarose, alginate, collagen, Matrigel, or RGD-functionalized polyethylene glycol (PEG) hydrogels. We measured 21 cytokines in the conditioned media, and we identified differences in measured cytokine levels that were cell-type-or material-dependent. We further evaluated our data using principal component analysis. Interestingly, component one identified two classes of biomaterials with characteristic cytokine expression levels. Component two identified cell-type-dependent differences in cytokines related to the wound response. Although elements of soluble cytokine availability are shared despite parameter differences, material and cellular properties variably influenced cytokine levels, underlining the influence of biomaterial cell type pairings on in vitro assay outcomes. Relationships between material properties, cellular responses, and cytokine availability in 3D in vitro models warrant further investigation.
C1 [Regier, Mary C.; Schwartz, Michael P.; Murphy, William L.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Montanez-Sauri, Sara I.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Regier, Mary C.; Montanez-Sauri, Sara I.; Schwartz, Michael P.; Murphy, William L.; Beebe, David J.] Univ Wisconsin, Wisconsin Inst Med Res, Madison, WI 53706 USA.
   [Regier, Mary C.; Montanez-Sauri, Sara I.; Beebe, David J.] Univ Wisconsin, Univ Wisconsin Carbone Canc Ctr, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthopaed & Rehabil, Madison, WI 53706 USA.
   [Sung, Kyung Eun] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Silver Spring, MD 20993 USA.
RP Sung, KE (reprint author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Silver Spring, MD 20993 USA.
EM kyung.sung@fda.hhs.gov
RI Schwartz, Mike/O-7963-2016
OI Schwartz, Mike/0000-0003-3785-6606
FU Division of Cellular and Gene Therapies; National Institutes of Health
   [NIH T32 GM008349, NIH ROI HL093282]; University of Wisconsin Carbone
   Cancer Center Cancer Center [P30 CA014520]; Environmental Protection
   Agency-Human Models for Analysis of Pathways (H-MAPs) Center [83573701]
FX This work was supported by the US Food and Drug Administration
   intramural research fund from the Division of Cellular and Gene
   Therapies. This work was supported by the National Institutes of Health
   NIH T32 GM008349 and NIH grant ROI HL093282, University of Wisconsin
   Carbone Cancer Center Cancer Center Support Grant P30 CA014520,
   Environmental Protection Agency 83573701-Human Models for Analysis of
   Pathways (H-MAPs) Center.
CR Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101
   Asthana A, 2016, DRUG DISCOV TODAY, V21, P950, DOI 10.1016/j.drudis.2016.03.009
   Bachelder RE, 2001, CANCER RES, V61, P5736
   BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648
   Chen J, 2012, BIOPHYS J, V103, P1188, DOI 10.1016/j.bpj.2012.07.054
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   De Jong JS, 1998, J PATHOL, V184, P44
   de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005
   Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790
   Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X
   Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776
   Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eriksson L., 2013, MULTI MEGAVARIATE DA
   Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/i.devcel.2008.03.003
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378
   Furlan A, 2008, J CELL PHYSIOL, V215, P782, DOI 10.1002/jcp.21360
   Garcia-Tunon I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-158
   HAJIKARIM M, 1978, CANCER RES, V38, P1457
   Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x
   Hansen TD, 2014, BIOMATER SCI-UK, V2, P745, DOI [10.1039/C3BM60278H, 10.1039/c3bm60278h]
   Heckel MC, 2011, CELL IMMUNOL, V266, P143, DOI 10.1016/j.cellimm.2010.09.010
   Heinzman JM, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-11
   Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049186
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Krzanowski W. J., 2000, PRINCIPLES MULTIVARI
   Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101
   Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Liu J, 2015, J TISSUE ENG REGEN M, V9, P952, DOI 10.1002/term.1654
   Lopez-Garcia MDC, 2010, BIO-MED MATER ENG, V20, P361, DOI 10.3233/BME-2010-0649
   Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c
   Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9
   MORSTYN G, 1988, CANCER RES, V48, P5624
   Nagai S, 2000, Breast Cancer, V7, P181, DOI 10.1007/BF02967457
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103
   Pantschenko AG, 2003, INT J ONCOL, V23, P269
   Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x
   Rijal G, 2016, BIOMATERIALS, V81, P135, DOI 10.1016/j.biomaterials.2015.12.016
   Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schedin P., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003228
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032
   Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005
   Srabovic N, 2011, BIOCHEM MEDICA, V21, P131
   Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180
   Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373
   Voloshin T, 2011, BLOOD, V118, P3426, DOI 10.1182/blood-2010-11-320812
   VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q
   Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2
   WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263
   WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8
   Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419
   Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095
   Yiangou C, 1997, BRIT J CANCER, V75, P28, DOI 10.1038/bjc.1997.5
   Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205
   Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315
NR 74
TC 3
Z9 3
U1 1
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2017
VL 18
IS 3
BP 709
EP 718
DI 10.1021/acs.biomac.6b01469
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EO0HT
UT WOS:000396379600005
PM 28157290
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Peng, CA
   Russo, J
   Lyda, TA
   Marcotte, WR
AF Peng, Congyue Annie
   Russo, Julia
   Lyda, Todd A.
   Marcotte, William R., Jr.
TI Polyelectrolyte Fiber Assembly of Plant-Derived Spider Silk-like
   Proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID CLAVIPES DRAGLINE SILK; POLYION COMPLEX FIBER; C-TERMINAL DOMAIN;
   MECHANICAL-PROPERTIES; SOLUTION INTERFACES; CHITOSAN; SPIDROIN;
   CONSERVATION; EVOLUTION; SEQUENCES
AB Spider dragline silk is a proteinaceous material that combines superior toughness and biocompatibility, which makes it a promising biomaterial. The distinct protein structure and the fiber formation process contribute to the superior toughness of dragline silk. Previously, we have produced recombinant spider silk-like proteins in transgenic tobacco that are readily purified from plant extracts. The plant derived spidroin-like proteins consisted of native major ampullate spidroin 1 or spidroin 2 N- and C-termini flanking 8, 16, or 32 copies of their respective consensus block repeats (mini-spidroins). Here, we present the generation of fibers from mini-spidroins (rMaSp1R8 and rMaSp2R8) by poly electrolyte complex formation using an anionic polyelectrolyte, gellan gum. Mini-spidroins, when treated with acetic acid and cross-linked by glutaraldehyde, formed a thin film at the interface when overlaid with a gellan gum solution. Immediate pulling of the film resulted in autofluorescent fibrous materials from either mini-spidroin alone or a combination of rMaSp1R8 and rMaSp2R8 (70:30). Addition of chitosan to the mini-spidroin solutions permitted continuous fiber production until the spinning dope supply was exhausted. When air-dried as-spun fibers were rehydrated and stretched in water, the fiber diameter decreased and the overall toughness improved. This study showed that spider silk-like fibers can be produced in large quantities through charge attraction that assembles chitosan, mini-spidroins, and gellan gum into fibrous complexes. We speculate that the spider silk self-assembly process in the duct may involve attraction of variously charged chitinous polymers, spidroins, and glycoproteins.
C1 [Peng, Congyue Annie; Russo, Julia; Lyda, Todd A.; Marcotte, William R., Jr.] Clemson Univ, Robert Poole Agr Ctr, Dept Biochem & Genet, 130 McGinty Court,Room 154, Clemson, SC 29634 USA.
   [Russo, Julia] Sarah Lawrence Coll, Dept Human Genet, One Mead Way, Bronxville, NY 10708 USA.
   [Lyda, Todd A.] High Point Univ, Dept Biol, 1 Univ Pkwy,Congdon 141, High Point, NC 27268 USA.
RP Marcotte, WR (reprint author), Clemson Univ, Robert Poole Agr Ctr, Dept Biochem & Genet, 130 McGinty Court,Room 154, Clemson, SC 29634 USA.
EM marcotw@clemson.edu
OI Peng, Congyue/0000-0002-9992-5737
CR Amaike M, 1998, MACROMOL RAPID COMM, V19, P287, DOI 10.1002/(SICI)1521-3927(19980601)19:6<287::AID-MARC287>3.0.CO;2-X
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Atkins E, 2003, NATURE, V424, P1010, DOI 10.1038/4241010a
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   BECKWITT R, 1994, J BIOL CHEM, V269, P6661
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brown CP, 2011, NANOSCALE, V3, P3805, DOI 10.1039/c1nr10502g
   Carmichael S, 1999, INT J BIOL MACROMOL, V24, P219, DOI 10.1016/S0141-8130(99)00008-2
   Davies GJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073225
   dos Santos-Pinto J. R, 2014, J PROTEOMICS, V105, P174
   Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Guehrs KH, 2008, INSECT MOL BIOL, V17, P553, DOI 10.1111/j.1365-2583.2008.00826.x
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Holland C, 2012, BIOPOLYMERS, V97, P368, DOI 10.1002/bip.22022
   Hopwood D, 1970, Histochem J, V2, P137, DOI 10.1007/BF01003541
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Madurga R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14820
   Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752
   Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2
   Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01
   Ohkawa K, 2001, MACROMOL MATER ENG, V286, P168, DOI 10.1002/1439-2054(20010301)286:3<168::AID-MAME168>3.3.CO;2-Z
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Peng CA, 2016, TRANSGENIC RES, V25, P517, DOI 10.1007/s11248-016-9949-1
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6
   Teule F, 2012, BIOPOLYMERS, V97, P418, DOI 10.1002/bip.21724
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yamamoto H, 2001, J APPL POLYM SCI, V79, P437, DOI 10.1002/1097-4628(20010118)79:3<437::AID-APP60>3.3.CO;2-H
   Zhao J, 2013, INT J BIOL MACROMOL, V56, P106, DOI 10.1016/j.ijbiomac.2013.01.027
   Zubareva A, 2013, MOLECULES, V18, P7848, DOI 10.3390/molecules18077848
NR 44
TC 1
Z9 1
U1 7
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2017
VL 18
IS 3
BP 740
EP 746
DI 10.1021/acs.biomac.6b01552
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EO0HT
UT WOS:000396379600008
PM 28196414
DA 2018-10-20
ER

PT J
AU Nileback, L
   Hedin, J
   Widhe, M
   Floderus, LS
   Krona, A
   Bysell, H
   Hedhammar, M
AF Nileback, Linnea
   Hedin, Jesper
   Widhe, Mona
   Floderus, Lotta S.
   Krona, Annika
   Bysell, Helena
   Hedhammar, My
TI Self-Assembly of Recombinant Silk as a Strategy for Chemical-Free
   Formation of Bioactive Coatings: A Real-Time Study
SO BIOMACROMOLECULES
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; SPIDER SILK; ORTHOPEDIC IMPLANTS; PROTEIN
   COATINGS; DENTAL IMPLANTS; CELL-ADHESION; IN-VIVO; OSSEOINTEGRATION;
   MATRICES; FIBERS
AB Functionalization of biomaterials with biologically active peptides can improve their performance after implantation. By genetic fusion to self-assembling proteins, the functional peptides can easily be presented on different physical formats. Herein, a chemical-free coating method based on self-assembly of the recombinant spider silk protein 4RepCT is described and used to prepare functional coatings on various biomaterial surfaces. The silk assembly was studied in real-time, revealing the occurrence of continuous assembly of silk proteins onto surfaces and the formation of nanofibrillar structures. The adsorbed amounts and viscoelastic properties were evaluated, and the coatings were shown to be stable against wash with hydrogen chloride, sodium hydroxide, and ethanol. Titanium, stainless steel, and hydroxyapatite were coated with silk fused to an antimicrobial peptide or a motif from fibronectin. Human primary cells cultured on the functional silk coatings show good cell viability and proliferation, implying the potential to improve implant performance and acceptance by the body.
C1 [Nileback, Linnea; Widhe, Mona; Floderus, Lotta S.; Hedhammar, My] AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden.
   [Hedin, Jesper; Bysell, Helena] SP Tech Res Inst Technol, SP Chem Mat & Surfaces, Drottning Kristinas Vag 45, SE-11486 Stockholm, Sweden.
   [Krona, Annika] SP Tech Res Inst Technol, SP Food & Biosci, Soft Mat Sci, Box 5401, SE-40229 Gothenburg, Sweden.
RP Hedhammar, M (reprint author), AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden.
EM myh@kth.se
OI /0000-0003-0140-419X
FU Swedish Research Council, Vinnova, and Knut and Alice Wallenberg
   Foundation
FX We thank Matthew Fielden of the Albanova Nanofabrication Facility for
   help with atomic force microscopy and Erik Nygren at SP Food and
   Bioscience, Microbiology and Process Hygiene for consultation regarding
   bacterial assays. We thank Lubica Macakova at SP Chemistry, Materials
   and Surfaces for help with spin coating and for valuable guidance in
   ellipsometry, for which we also thank Lukas Boge, SP Chemistry,
   Materials and Surfaces. Silk proteins were provided by Spiber
   Technologies AB, a research company where M.H. has shares. FORMAS, The
   Swedish Research Council, Vinnova, and Knut and Alice Wallenberg
   Foundation supported this work.
CR Akeson W. H., 1991, BONE, V5, P33
   Berg J. M., 2007, BIOCHEMISTRY-US, P42
   Borkner CB, 2014, ACS APPL MATER INTER, V6, P15611, DOI 10.1021/am5008479
   Clohisy JC, 2004, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000150126.73024.42
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Ding DW, 2015, ADV MATER, V27, P3953, DOI 10.1002/adma.201500280
   Ellingsen JE, 2006, PERIODONTOL 2000, V41, P136, DOI 10.1111/j.1600-0757.2006.00175.x
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Harris TI, 2016, BIOMACROMOLECULES, V17, P3761, DOI 10.1021/acs.biomac.6b01267
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Horbett T. A., 2004, BIOMATERIALS SCI, P240
   Ramos JJI, 2011, MACROMOL RAPID COMM, V32, P1972, DOI 10.1002/marc.201100455
   Jansson R, 2015, ADV FUNCT MATER, V25, P5343, DOI 10.1002/adfm.201501833
   Jansson R, 2014, BIOMACROMOLECULES, V15, P1696, DOI 10.1021/bm500114e
   Johansson U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130169
   Kim MH, 2015, INT J MOL SCI, V16, P10324, DOI 10.3390/ijms160510324
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lyndon JA, 2014, J CONTROL RELEASE, V179, P63, DOI 10.1016/j.jconrel.2014.01.026
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Peyre J, 2012, J PHYS CHEM B, V116, P13839, DOI 10.1021/jp305597y
   Raphel J, 2016, BIOMATERIALS, V84, P301, DOI 10.1016/j.biomaterials.2016.01.016
   Raphel J, 2016, BIOMATERIALS, V83, P269, DOI 10.1016/j.biomaterials.2015.12.030
   Reed R, 1973, Int Rev Connect Tissue Res, V6, P257
   Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X
   Shalaly ND, 2016, BIOMATERIALS, V90, P50, DOI 10.1016/j.biomaterials.2016.03.006
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   ter Boo GJA, 2015, BIOMATERIALS, V52, P113, DOI 10.1016/j.biomaterials.2015.02.020
   Thatikonda N, 2016, BIOTECHNOL J, V11, P437, DOI 10.1002/biot.201500297
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Volkov V, 2015, MACROMOL MATER ENG, V300, P1199, DOI 10.1002/mame.201500179
   Widhe M, 2016, BIOMATERIALS, V74, P256, DOI 10.1016/j.biomaterials.2015.10.013
   Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058
   Widhe M, 2012, BIOPOLYMERS, V97, P468, DOI 10.1002/bip.21715
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
NR 42
TC 12
Z9 12
U1 6
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2017
VL 18
IS 3
BP 846
EP 854
DI 10.1021/acs.biomac.6b01721
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EO0HT
UT WOS:000396379600019
PM 28192654
DA 2018-10-20
ER

PT J
AU Pan, Y
   Ren, XT
   Wang, S
   Li, X
   Luo, XL
   Yin, ZN
AF Pan, Yang
   Ren, Xiaoting
   Wang, Shuang
   Li, Xin
   Luo, Xianglin
   Yin, Zongning
TI Annexin V-Conjugated Mixed Micelles as a Potential Drug Delivery System
   for Targeted Thrombolysis
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE-PLASMINOGEN ACTIVATOR; PHOSPHATIDYLSERINE EXPOSURE;
   POLYETHYLENE-GLYCOL; TRIGGERED RELEASE; GENE DELIVERY; IN-VIVO;
   THROMBOSIS; NANOPARTICLES; CANCER; SITE
AB To alleviate the hemorrhagic side effect of thrombolysis therapy, a thrombus targeted drug delivery system based on the specific affinity of Annexin V to phosphatidylserine exposed on the membrane surface of activated platelet was developed. The amphiphilic and biodegradable biomaterial, polycaprolactone-block-poly(2-(dimethylamino) ethyl methacrylate)-block-poly(2-hydroxyethyl methacrylate) (PCL-b-PDMAEMA-b-PHEMA (PCDH)) triblock polymer, was synthesized via ring opening polymerization (ROP) and atom transfer radical polymerization (ATRP) to use as the nanocarriers of thrombolytic drug. In order to conjugate Annexin V to the polymer, PCDH was modified by succinic anhydride via ring -opening reaction to introduce the carboxyl group (PCDH-COOH). After preparation of PCDH/PCDH-COOH (9/1, mini) mixed micelles, Annexin V was coupled with the micelles using carbodiimide chemistry. The blood clot lysis assay in vitro confirmed that lumbrokinase-loaded targeted micelles (LKTM) had stronger thrombolysis potency than free lumbrokinase (LK) and LK-loaded nontargeted micelles (LKM, P < 0.05). In vivo thrombolytic assay, multispectral, optoacoustic tomography (MSOT) was used to assess the target ability of LKTM. The results of MSOT images indicated the fluorescence intensity of the LKTM group located in the blood clot position were significantly stronger than the LKM group. A 5 mm of carotid artery containing blood clot was cut out 24 h later after administration to assess the degree of thrombolysis. The results of thrombolytic assay in vivo were consistent with the assay in vitro, which the differences between LK, LKM, and LKTM groups were both statistically significant. All the results of thrombolysis assays above proved that the capacity of thrombolysis in the LKTM group was optimal. It suggested that Annexin V -conjugated micelles will be a potential drug delivery system for targeted thrombolysis.
C1 [Pan, Yang; Ren, Xiaoting; Wang, Shuang; Li, Xin; Yin, Zongning] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China.
   [Luo, Xianglin] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Yin, ZN (reprint author), Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China.
EM yzn@scu.edu.cn
FU National Natural Science Foundation of China [81373338]
FX We are thankful to Dr. Qin He for her providing the L929 cell and Dr.
   Yan for her help in MSOT analysis. This work was financially supported
   by National Natural Science Foundation of China (No. 81373338).
CR Absar S, 2013, THROMB RES, V131, pE91, DOI 10.1016/j.thromres.2012.11.030
   Absar S, 2012, J CONTROL RELEASE, V157, P46, DOI 10.1016/j.jconrel.2011.09.060
   Attia A. B., 2016, BIOPHOTONICS, V9, P701
   Berrouschot J, 2016, STROKE, V47, P1936, DOI 10.1161/STROKEAHA.116.013550
   Bian QQ, 2013, J COLLOID INTERF SCI, V392, P141, DOI 10.1016/j.jcis.2012.08.076
   Boeckh-Behrens T, 2016, STROKE, V47, P1864, DOI 10.1161/STROKEAHA.116.013105
   Chan HC, 2013, BLOOD, V122, P3632, DOI 10.1182/blood-2013-05-504639
   Chandel AKS, 2016, ACS APPL MATER INTER, V8, P3182, DOI 10.1021/acsami.5b10675
   Chen W, 2015, J CONTROL RELEASE, V210, P125, DOI 10.1016/j.jconrel.2015.05.273
   Cheng DF, 2015, ACS APPL MATER INTER, V7, P2847, DOI 10.1021/am508118x
   Cheng R, 2014, ACS NANO, V8, P7746, DOI 10.1021/nn5029955
   Chuang CC, 2015, ACS APPL MATER INTER, V7, P7724, DOI 10.1021/acsami.5b00732
   Cui W, 2016, J CONTROL RELEASE, V225, P53, DOI 10.1016/j.jconrel.2016.01.028
   Dostalova S, 2016, ACS APPL MATER INTER, V8, P14430, DOI 10.1021/acsami.6b04286
   Garnier B, 2009, BIOCONJUGATE CHEM, V20, P2114, DOI 10.1021/bc9002579
   Han SC, 2014, ACTA BIOMATER, V10, P670, DOI 10.1016/j.actbio.2013.09.035
   HAWTHORNE TR, 1994, J BIOTECHNOL, V36, P129, DOI 10.1016/0168-1656(94)90049-3
   Hira SK, 2015, ACS APPL MATER INTER, V7, P20021, DOI 10.1021/acsami.5b04905
   Jiang YY, 2014, BIOMACROMOLECULES, V15, P4195, DOI 10.1021/bm501205x
   Kim W, 2015, ANGEW CHEM INT EDIT, V54, P1461, DOI 10.1002/anie.201408529
   Kukla P, 2015, AM J CARDIOL, V115, P825, DOI 10.1016/j.amjcard.2014.12.049
   Kumar A, 2015, ACS APPL MATER INTER, V7, P9211, DOI 10.1021/acsami.5b01731
   Lee H, 2016, BIOMATERIALS, V101, P251, DOI 10.1016/j.biomaterials.2016.06.003
   Maldonado-Pena J, 2016, INT J CARDIOL, V219, P282, DOI 10.1016/j.ijcard.2016.06.020
   Monton H, 2015, NANOSCALE, V7, P4097, DOI 10.1039/c4nr07191c
   Morscher S, 2014, PHOTOACOUSTICS, V2, P103, DOI 10.1016/j.pacs.2014.06.001
   Naik SS, 2005, J CONTROL RELEASE, V101, P35, DOI 10.1016/j.jconrel.2004.07.020
   NAKAJIMA N, 1993, BIOSCI BIOTECH BIOCH, V57, P1726, DOI 10.1271/bbb.57.1726
   Obydennyy SI, 2016, J THROMB HAEMOST, V14, P1867, DOI 10.1111/jth.13395
   Ohya T, 2002, J BIOSCI BIOENG, V94, P467, DOI 10.1263/jbb.94.467
   Pang Y, 2016, ANGEW CHEM INT EDIT, V55, P10296, DOI 10.1002/anie.201604661
   Park YJ, 2003, ADV DRUG DELIVER REV, V55, P251, DOI 10.1016/S0169-409X(02)00181-3
   PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4
   PONCZ M, 1987, J BIOL CHEM, V262, P8476
   Ren J, 2013, BIOMACROMOLECULES, V14, P3434, DOI 10.1021/bm4007387
   Sarda-Mantel L, 2006, ARTERIOSCL THROM VAS, V26, P2153, DOI 10.1161/01.ATV.0000237605.25666.13
   Sharma G, 2013, J CONTROL RELEASE, V167, P1, DOI 10.1016/j.jconrel.2013.01.016
   Shen HH, 2013, BIOMATERIALS, V34, P8361, DOI 10.1016/j.biomaterials.2013.07.042
   Solomon C, 2014, THROMB HAEMOSTASIS, V112, P109, DOI 10.1160/TH13-12-0997
   Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523
   Sun CX, 2016, BIOMATERIALS, V91, P81, DOI 10.1016/j.biomaterials.2016.03.022
   TAIT JF, 1995, J BIOL CHEM, V270, P21594, DOI 10.1074/jbc.270.37.21594
   Teo J, 2016, BIOMACROMOLECULES, V17, P2337, DOI 10.1021/acs.biomac.6b00185
   Tjandrawinata RR, 2014, DRUG DES DEV THER, V8, P1585, DOI 10.2147/DDDT.S66007
   Tutwiler V, 2016, BLOOD, V127, P464, DOI 10.1182/blood-2013-11-539262
   Vaidya B, 2016, DRUG DELIV, V23, P801, DOI 10.3109/10717544.2014.916770
   van Tilborg GAF, 2010, BIOCONJUGATE CHEM, V21, P1794, DOI 10.1021/bc100091q
   Vu T. B. N., 2015, J BIOTECHNOL RES, V6, P96
   Vu TT, 2015, BLOOD, V125, P2712, DOI 10.1182/blood-2014-11-611319
   Wang J, 2015, RSC ADV, V5, P7529, DOI 10.1039/c4ra13228a
   Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x
   Wang XW, 2016, THERANOSTICS, V6, P726, DOI 10.7150/thno.14514
   Wang Y., 2016, ADV DRUG DELIVERY RE
   Wei XL, 2016, ACS APPL MATER INTER, V8, P11765, DOI 10.1021/acsami.6b02006
   Whyte CS, 2015, BLOOD, V125, P2568, DOI 10.1182/blood-2014-09-599480
   Wu JH, 2015, INT J NANOMED, V10, P2925, DOI 10.2147/IJN.S76691
   Wyseure T, 2015, BLOOD, V125, P1325, DOI 10.1182/blood-2014-07-588319
   Xu JJ, 2016, BIOMACROMOLECULES, V17, P345, DOI 10.1021/acs.biomac.5b01454
   Yang WK, 2016, ACS APPL MATER INTER, V8, P15967, DOI 10.1021/acsami.6b05408
   Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610
   Zhang JP, 2014, NEURAL REGEN RES, V9, P1316, DOI 10.4103/1673-5374.137580
   Zhang R, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00032
   Zhao ZL, 2013, ACS APPL MATER INTER, V5, P7808, DOI 10.1021/am401568b
   Zheng XP, 2015, NANOSCALE, V7, P12581, DOI 10.1039/c5nr03068d
   Zheng Y, 2013, TOXICON, V67, P1, DOI 10.1016/j.toxicon.2013.01.021
   Zhou HB, 2016, ANALYST, V141, P4293, DOI 10.1039/c6an00606j
   Zhou J, 2014, ACS APPL MATER INTER, V6, P5566, DOI 10.1021/am406008k
NR 67
TC 4
Z9 4
U1 12
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2017
VL 18
IS 3
BP 865
EP 876
DI 10.1021/acs.biomac.6b01756
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EO0HT
UT WOS:000396379600021
PM 28240872
DA 2018-10-20
ER

PT J
AU Bludau, H
   Czapar, AE
   Pitek, AS
   Shukla, S
   Jordan, R
   Steinmetz, NF
AF Bludau, Herdis
   Czapar, Anna E.
   Pitek, Andrzej S.
   Shukla, Sourabh
   Jordan, Rainer
   Steinmetz, Nicole F.
TI POxylation as an alternative stealth coating for biomedical applications
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Polyoxazoline; Biomaterial; Polymer-conjugates; Nanomedicine; Tobacco
   mosaic virus; Stealth coatings
ID TOBACCO-MOSAIC-VIRUS; IN-VIVO; POLYETHYLENE-GLYCOL; PROTEIN-BINDING;
   VIRAL VECTORS; GENE-THERAPY; PLANT-VIRUS; BIODISTRIBUTION; DELIVERY;
   POLYMER
AB Polyethylene glycol (PEG) polymers are currently used in a variety of medical formulations to reduce toxicity, minimize immune interactions and improve pharmacokinetics. Despite its widespread use however, the presence of anti-PEG antibodies indicates that this polymer has the potential to be immunogenic and antigenic. Here we present an alternative polymer, poly(2-oxazoline) (PDX) for stealth applications, specifically shielding of a proteinaceous nanoparticle from recognition by the immune system. Tobacco mosaic virus (TMV) was used as our testbed due to its potential for use as a nanocarrier for drug delivery and molecular imaging applications. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Bludau, Herdis; Jordan, Rainer] Tech Univ Dresden, Sch Sci, Macromol Chem, D-01069 Dresden, Germany.
   [Czapar, Anna E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Pitek, Andrzej S.; Shukla, Sourabh; Steinmetz, Nicole F.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Steinmetz, Nicole F.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
   [Steinmetz, Nicole F.] Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA.
   [Steinmetz, Nicole F.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
   [Steinmetz, Nicole F.] Case Western Reserve Univ, Case Comprehens Cancer Ctr, Cleveland, OH 44106 USA.
RP Steinmetz, NF (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Jordan, R (reprint author), Tech Univ Dresden, Sch Sci, Macromol Chem, D-01069 Dresden, Germany.
EM rainer.jordan@tu-dresden.de; nicole.steinmetz@case.edu
RI Jordan, Rainer/B-6542-2008
OI Jordan, Rainer/0000-0002-9414-1597
FU Deutscher Akademischer Austauschdienst [IPID4all]; National Science
   Foundation [CHE 1306447]; National Institute of Health [R03 EB020602];
   German initiative of excellence through the Dresden Initiative of
   Bioactive Interfaces & Materials (DIB); NIH [T32 GM007250, TL1 TR000441]
FX This work was supported in part by grants from the Deutscher
   Akademischer Austauschdienst (IPID4all to R.J. and N.F.S.), National
   Science Foundation (CHE 1306447 to N.F.S.), National Institute of Health
   (R03 EB020602 to N.F.S.) and the German initiative of excellence through
   the Dresden Initiative of Bioactive Interfaces & Materials (DIB). A.E.C.
   was supported in part by NIH grants T32 GM007250 and TL1 TR000441. M.Sc.
   Jannick Rub, M.Sc. Jonas Nawroth and Dr. Amy M. Wen are acknowledged for
   their help with MALDI-TOF. We thank Case Western Reserve University Farm
   for support in scaled-up molecular farming.
CR Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739
   Armstrong JK, 2009, MILESTONES DRUG THER, P147, DOI 10.1007/978-3-7643-8679-5_9
   Becker MA, 2013, ANN RHEUM DIS, V72, P1469, DOI 10.1136/annrheumdis-2012-201795
   Bruckman M.A., 2013, CHARACTERIZATION NAN, V1108, P173
   Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m
   Bruckman MA, 2014, VIROLOGY, V449, P163, DOI 10.1016/j.virol.2013.10.035
   Chauhan VP, 2011, ANGEW CHEM INT EDIT, V50, P11417, DOI 10.1002/anie.201104449
   Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001
   Czapar AE, 2016, ACS NANO, V10, P4119, DOI 10.1021/acsnano.5b07360
   Foreman MB, 2003, LANGMUIR, V19, P326, DOI 10.1921/la0261390
   Ganson NJ, 2016, J ALLERGY CLIN IMMUN, V137, P1610, DOI 10.1016/j.jaci.2015.10.034
   Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969
   Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008
   Haller J, 2014, NEUROBIOLOGICAL BASE, P1, DOI [10.1007/978-3-7091-1268-7_1, DOI 10.1007/978-3-7091-1268-7_1]
   He ZJ, 2015, MACROMOL BIOSCI, V15, P1004, DOI 10.1002/mabi.201500021
   Jordan R, 1998, J AM CHEM SOC, V120, P243, DOI 10.1021/ja973392r
   KENWORTHY AK, 1995, BIOPHYS J, V68, P1921, DOI 10.1016/S0006-3495(95)80369-3
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938
   Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562
   Lee KL, 2015, ACTA BIOMATER, V19, P166, DOI 10.1016/j.actbio.2015.03.001
   Liu R., 2013, PLOS ONE, V8
   Lizotte PH, 2016, NAT NANOTECHNOL, V11, P295, DOI [10.1038/NNANO.2015.292, 10.1038/nnano.2015.292]
   Luxenhofer R, 2012, MACROMOL RAPID COMM, V33, P1613, DOI 10.1002/marc.201200354
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Manzenrieder F, 2011, ANGEW CHEM INT EDIT, V50, P2601, DOI 10.1002/anie.201006134
   Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g
   Pidhatika B, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0001-y
   Pitek AS, 2016, SMALL, V12, P1758, DOI 10.1002/smll.201502458
   RICHTER AW, 1984, INT ARCH ALLER A IMM, V74, P36, DOI 10.1159/000233512
   Shukla S, 2016, ACS BIOMATER SCI ENG, V2, P829, DOI 10.1021/acsbiomaterials.6b00060
   Shukla S, 2015, ADV HEALTHC MATER, V4, P874, DOI 10.1002/adhm.201400641
   Shukla S, 2014, NANOMEDICINE-UK, V9, P221, DOI 10.2217/nnm.13.75
   Shukla S, 2013, MOL PHARMACEUT, V10, P33, DOI 10.1021/mp300240m
   Tong J, 2013, MOL PHARMACEUT, V10, P360, DOI 10.1021/mp300496x
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Volet G, 2011, MACROMOL CHEM PHYS, V212, P118, DOI 10.1002/macp.201000556
   Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141
   Wen AM, 2016, BIOCONJUGATE CHEM, V27, P1227, DOI 10.1021/acs.bioconjchem.6b00075
   Wen AM, 2015, ACS BIOMATER SCI ENG, V1, P1050, DOI 10.1021/acsbiomaterials.5b00344
   Wen AM, 2012, BIOMACROMOLECULES, V13, P3990, DOI 10.1021/bm301278f
   Wiesbrock F, 2005, MACROMOLECULES, V38, P5025, DOI 10.1021/ma0474170
   Wiesbrock F, 2004, MACROMOL RAPID COMM, V25, P1895, DOI 10.1002/marc.200400369
   Woller N., 2014, FRONT ONCOL, P1
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   Zalipsky S, 1996, J PHARM SCI, V85, P133, DOI 10.1021/js9504043
   Zhang N, 2012, MACROMOL BIOSCI, V12, P926, DOI 10.1002/mabi.201200026
NR 47
TC 12
Z9 12
U1 3
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAR
PY 2017
VL 88
BP 679
EP 688
DI 10.1016/j.eurpolymj.2016.10.041
PG 10
WC Polymer Science
SC Polymer Science
GA EO8PQ
UT WOS:000396952500056
PM 28713172
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Natori, T
   Fujiyoshi, M
   Uchida, M
   Abe, N
   Kanaki, T
   Fukumoto, Y
   Ishii, I
AF Natori, Tomomi
   Fujiyoshi, Masachika
   Uchida, Masashi
   Abe, Natsuki
   Kanaki, Tatsuro
   Fukumoto, Yasunori
   Ishii, Itsuko
TI Growth arrest of vascular smooth muscle cells in suspension culture
   using low-acyl gellan gum
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE Vascular smooth muscle cells; Low-acyl gellan gum; p27(Kip1);
   Polysaccharide
ID COLLAGEN MATRIX HONEYCOMBS; DEPENDENT KINASE INHIBITORS; RETINOBLASTOMA
   PROTEIN; ATHEROSCLEROTIC LESIONS; UP-REGULATION; DNA-DAMAGE;
   PROLIFERATION; CYCLE; P27(KIP1); PHOSPHORYLATION
AB The proliferation of vascular smooth muscle cells (SMCs) causes restenosis in biomaterial vascular grafts. The purposes of this study were to establish a suspension culture system for SMCs by using a novel substrate, low-acyl gellan gum (GG) and to maintain SMCs in a state of growth inhibition. When SMCs were cultured in suspension with GG, their proliferation was inhibited. Their viability was 70% at day 2, which was maintained at more than 50% until day 5. In contrast, the viability of cells cultured in suspension without GG was 5.6% at day 2. By cell cycle analysis, the ratio of SMCs in the S phase when cultured in suspension with GG was lower than when cultured on plastic plates. In SMCs cultured in suspension with GG, the ratio of phosphorylated retinoblastoma (Rb) protein to Rb protein was decreased and p27(Kip1) expression was unchanged in comparison with SMCs cultured on plastic plates. In addition, SMCs could be induced to proliferate again by changing the culture condition from suspension with GG to plastic plates. These results suggest that our established culturing method for SMCs is useful to maintain SMCs in a state of growth inhibition with high viability.
C1 [Natori, Tomomi; Fujiyoshi, Masachika; Ishii, Itsuko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.
   [Uchida, Masashi; Ishii, Itsuko] Chiba Univ Hosp, Div Pharm, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.
   [Abe, Natsuki; Kanaki, Tatsuro] Nissan Chem Ind Co Ltd, Biol Res Labs, 1470 Shiraoka, Saitama 3690305, Japan.
   [Fukumoto, Yasunori] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.
RP Ishii, I (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.; Ishii, I (reprint author), Chiba Univ Hosp, Div Pharm, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.
EM iishii@faculty.chiba-u.jp
FU Chiba University; Nissan Chemical Industries Ltd
FX This study was performed under a partnership of collaboration between
   Chiba University and Nissan Chemical Industries Ltd. The investigations
   using animals described in this report conformed to the guidelines of
   the Animal Investigation Committee of Chiba University (Chiba, Japan).
CR Allon M, 2013, AM J KIDNEY DIS, V62, P1122, DOI 10.1053/j.ajkd.2013.03.040
   Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devce1.2008.01.013
   BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4
   CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104
   CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1
   CLOWES AW, 1986, CIRC RES, V58, P839, DOI 10.1161/01.RES.58.6.839
   ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287
   DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2
   Egan CG, 2005, CARDIOVASC RES, V67, P308, DOI 10.1016/j.cardiores.2005.03.019
   Fasciano S, 2005, J BIOL CHEM, V280, P15682, DOI 10.1074/jbc.M411458200
   FRITZE LMS, 1985, J CELL BIOL, V100, P1041, DOI 10.1083/jcb.100.4.1041
   Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]
   Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002
   Hedin U, 1997, J CELL PHYSIOL, V172, P109, DOI 10.1002/(SICI)1097-4652(199707)172:1<109::AID-JCP12>3.0.CO;2-7
   Holmstrom TH, 1998, J IMMUNOL, V160, P2626
   Hu YH, 2002, CIRC RES, V91, pE13, DOI 10.1161/01.RES.0000037090.34760.EE
   Hurt-Camejo E, 1999, J BIOL CHEM, V274, P18957, DOI 10.1074/jbc.274.27.18957
   Ishii I, 2001, ATHEROSCLEROSIS, V158, P377, DOI 10.1016/S0021-9150(01)00461-0
   Ishii I, 2012, AMINO ACIDS, V42, P565, DOI 10.1007/s00726-011-1034-8
   Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681
   JAAKKOLA O, 1988, ATHEROSCLEROSIS, V69, P257, DOI 10.1016/0021-9150(88)90022-6
   Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655
   Lee SH, 2010, BIOMETALS, V23, P507, DOI 10.1007/s10534-010-9341-1
   Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753
   Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124
   Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Otsuji TG, 2014, STEM CELL REP, V2, P734, DOI [10.1016/j.stemcr.2014.03.012, 10.1016/j.stemcr.2014.04.013]
   Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.0590062325.x
   Schulein-Volk C, 2014, CELL REP, V9, P1099, DOI 10.1016/j.celrep.2014.09.057
   Stamatiou R, 2012, ISRN Inflamm, V2012, P731472, DOI 10.5402/2012/731472
   Suzuki T, 2009, MICROVASC RES, V77, P143, DOI 10.1016/j.mvr.2008.08.006
   Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022
   Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396
   Uchida M, 2016, MICROVASC RES, V103, P36, DOI 10.1016/j.mvr.2015.10.003
   Uchida M, 2011, CELL PHYSIOL BIOCHEM, V27, P669, DOI 10.1159/000330076
   Walker HA, 2003, MOL BIOL CELL, V14, P1941, DOI 10.1091/mbc.E02-08-0508
   Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326
   Yamashita T, 2013, INT J BIOCHEM CELL B, V45, P1042, DOI 10.1016/j.biocel.2013.02.021
   Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006
NR 45
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD MAR
PY 2017
VL 53
IS 3
BP 191
EP 198
DI 10.1007/s11626-016-0098-x
PG 8
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA EQ1PM
UT WOS:000397842100001
PM 27924445
DA 2018-10-20
ER

PT J
AU Sanchez-Garces, MA
   Alvira-Gonzalez, J
   Sanchez, CM
   Cairo, JRB
   del Pozo, MR
   Gay-Escoda, C
AF Angels Sanchez-Garces, Maria
   Alvira-Gonzalez, Joaquin
   Mueller Sanchez, Claudia
   Barbany Cairo, Joan R.
   Reina del Pozo, Manuel
   Gay-Escoda, Cosme
TI Bone Regeneration Using Adipose-Derived Stem Cells with Fibronectin in
   Dehiscence-Type Defects Associated with Dental Implants: An Experimental
   Study in a Dog Model
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE adipose-derived stem cells; dehiscence-type defects; dental implants;
   stem cells
ID BETA-TRICALCIUM PHOSPHATE; TISSUE-ENGINEERED BONE; PLATELET-RICH PLASMA;
   MARROW STROMAL CELLS; MULTI-LINEAGE CELLS; TITANIUM IMPLANTS;
   CALCIUM-PHOSPHATE; TOOTH EXTRACTION; GROWTH-FACTOR; FIBRIN GLUE
AB Purpose: To determine the bone regeneration potential of a ceramic biomaterial coated with fibronectin and adipose-derived stem cells covered in three-wall critical-size defects associated with dental implants. Materials and Methods: In a total of 18 dogs, four dehiscence-type and critical-size defects were created surgically in the edentulous alveolar ridge with the simultaneous placement of dental implants. Defects were randomly regenerated using biomaterials coated with particulate a-tricalcium phosphate (beta-TCP), beta-TCP with fibronectin (Fn) (beta-TCP-Fn), and beta-TCP with a combination of Fn and autologous adipose-derived stem cells (ADSCs) (beta-TCP-Fn-ADSCs), leaving one defect as the control. The animals were divided into three groups according to the time of euthanasia (1, 2, or 3 months). Results: Statistically significant differences between the three study groups (beta-TCP, beta-TCP-Fn, beta-TCP-Fn-ADSCs) and the control group in the total area of bone regeneration and mineralized and nonmineralized tissue at 1, 2, and 3 months of healing were not observed. At 2 months, defects treated with beta-TCP-Fn-ADSCs showed a significant decrease in the percentage of bone-to-implant contact (BIC) as compared with the beta-TCP-Fn (P =.041) and control (P =.012) groups. At 3 months of healing, however, significant differences in BIC between the three study groups and controls were not found (P =.388). Conclusion: The use of ADSCs in the bone regeneration processes of dehiscence-type defects associated with simultaneous implant insertion does not seem to improve the area of bone regeneration or the percentage of BIC compared with other biomaterials or the control alveolar defect.
C1 [Angels Sanchez-Garces, Maria] Univ Barcelona, Fac Dent, Oral Surg, Barcelona, Spain.
   [Angels Sanchez-Garces, Maria] Univ Barcelona, Fac Dent, Master Degree Program Oral Surg & Implantol, Barcelona, Spain.
   [Angels Sanchez-Garces, Maria; Alvira-Gonzalez, Joaquin] Fundacio Inst Invest Biomed Bellvitge, IDIBELL Inst, Barcelona, Spain.
   [Alvira-Gonzalez, Joaquin] Univ Barcelona, Fac Dent, Oral Surg & Implantol Dept, Barcelona, Spain.
   [Mueller Sanchez, Claudia; Reina del Pozo, Manuel] Univ Barcelona, Fac Biol, Dept Cell Biol, Celltec UB, Barcelona, Spain.
   [Barbany Cairo, Joan R.] Univ Barcelona, Fac Med, Dept Physiol Sci 2, Human Physiol, Campus Bellvitge, Barcelona, Spain.
   [Gay-Escoda, Cosme] Univ Barcelona, Fac Biol, Dept Cell Biol, Cell Biol,Celltec UB, Barcelona, Spain.
   Univ Barcelona, Fac Dent, Oral & Maxillofacial Surg, Barcelona, Spain.
   Fundacio Inst Invest Biomed Bellvitge, IDIBELL Inst, Lhospitalet De Llobregat, Spain.
   Hosp Quiron Teknon, Oral & Maxillofacial Surg Dept, Barcelona, Spain.
RP Gay-Escoda, C (reprint author), Hosp Quiron Teknon, Unit Oral & Maxillofacial Surg, C Viana 12, E-08022 Barcelona, Spain.
EM cgay@ub.edu
FU University of Barcelona; General Health Consortium; Catalan Health
   Service of the Autonomous Government of Catalonia; initiative INGENIO of
   the Spanish Government
FX The authors declare that they do not have any conflicts of interest.
   This study was supported by an educational-clinical agreement in Oral
   Surgery between the University of Barcelona, the General Health
   Consortium, and the Catalan Health Service of the Autonomous Government
   of Catalonia. The study forms part of the Interimplant project
   (Biomateriales Avanzados para una Nueva Generacion de Implantes) under
   the leadership of the Biotechnology Institute and has been one of the 16
   projects approved by the CDTI (Centro para el Desarrollo Tecnologico
   Industrial) in the third announcement of the CENIT program supported by
   the initiative INGENIO 2010 of the Spanish Government.
CR Alava JI, 2005, STRUERS J MATERIALOG, V6, P1
   Alvira-Gonzalez J, 2016, INT J ORAL MAX IMPL, V31, P196, DOI 10.11607/jomi.4190
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Benic GI, 2009, CLIN ORAL IMPLAN RES, V20, P507, DOI 10.1111/j.1600-0501.2008.01583.x
   Bohnenblust ME, 2009, J CRANIOFAC SURG, V20, P340, DOI 10.1097/SCS.0b013e3181992316
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Carpio L, 2000, J PERIODONTOL, V71, P1743, DOI 10.1902/jop.2000.71.11.1743
   Corrente G, 2000, INT J PERIODONT REST, V20, P391
   De Kok IJ, 2005, INT J ORAL MAX IMPL, V20, P511
   De Maeztu MA, 2007, INT J ORAL MAX IMPL, V22, P273
   De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Di Bella C, 2008, TISSUE ENG PT A, V14, P483, DOI 10.1089/tea.2007.0137
   Fu JH, 2011, INT J PERIODONT REST, V31, P429
   Han DS, 2014, J CRANIOFAC SURG, V25, P189, DOI 10.1097/SCS.0000000000000377
   Hanisch O, 2003, J PERIODONTOL, V74, P648, DOI 10.1902/jop.2003.74.5.648
   Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y
   Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2005.01246.X
   Jafarian M, 2008, ORAL SURG ORAL MED O, V105, pE14, DOI 10.1016/j.tripleo.2008.01.010
   Jo YJ, 2011, J PERIODONTAL IMPLAN, V41, P67, DOI 10.5051/jpis.2011.41.2.67
   Kang J, 2014, EUR CELLS MATER, V28, P387
   Kasten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109411
   Khojasteh A, 2012, J ORAL MAXIL SURG, V70, P972, DOI 10.1016/j.joms.2011.02.133
   Khoshzaban A, 2011, CLIN COSMET INVESTIG, V3, P69, DOI 10.2147/CCIDEN.S13115
   Lee JS, 2012, J ORAL MAXIL SURG, V70, P2070, DOI 10.1016/j.joms.2012.04.044
   Lee SH, 2008, INT J ORAL MAX IMPL, V23, P1089
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   Li X., 2014, JOURNAL OF ORAL AND, V72, pe1
   Machado E, 2012, OR SURG OR MED OR PA, V113, P728, DOI 10.1016/j.tripleo.2011.05.039
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Mir-Mari J, 2017, CLIN ORAL IMPLAN RES, V28, P631, DOI 10.1111/clr.12845
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   Park JM, 2006, INT J ORAL MAX IMPL, V21, P859
   Petrovic V, 2012, OR SURG OR MED OR PA, V114, pE1, DOI 10.1016/j.oooo.2012.02.030
   Pourebrahim N, 2013, INT J ORAL MAX SURG, V42, P562, DOI 10.1016/j.ijom.2012.10.012
   Rapuano BE, 2012, INT J ORAL MAX IMPL, V27, P1081
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Ribeiro FV, 2012, INT J ORAL MAX SURG, V41, P121, DOI 10.1016/j.ijom.2011.06.025
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Robey PG, 2006, J AM DENT ASSOC, V137, P961, DOI 10.14219/jada.archive.2006.0317
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schwarz F, 2007, INT J ORAL MAX SURG, V36, P1198, DOI 10.1016/j.ijom.2007.07.014
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P402, DOI 10.1111/j.1600-0501.2007.01486.x
   Schwarz F, 2008, J CLIN PERIODONTOL, V35, P64, DOI 10.1111/j.1600-051X.2007.01159.x
   Sima F, 2015, ACS APPL MATER INTER, V7, P911, DOI 10.1021/am507153n
   Streckbein P, 2013, J CRANIO MAXILL SURG, V41, P496, DOI 10.1016/j.jcms.2013.04.002
   Suba Z, 2004, INT J ORAL MAX IMPL, V19, P832
   Takahashi Y, 2013, INT J ORAL MAX IMPL, V28, P444, DOI 10.11607/jomi.2794
   Vignoletti F, 2012, J CLIN PERIODONTOL, V39, P6, DOI 10.1111/j.1600-051X.2011.01830.x
   von Arx T, 2001, CLIN ORAL IMPLAN RES, V12, P260, DOI 10.1034/j.1600-0501.2001.012003260.x
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
   Zaminy Arash, 2008, Iran Biomed J, V12, P133
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
   Zuk P., 2013, ISRN STEM CELLS, V2013, P1, DOI DOI 10.1155/2013/713959
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 61
TC 1
Z9 1
U1 0
U2 7
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2017
VL 32
IS 2
BP E97
EP E106
DI 10.11607/jomi.5169
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EQ3JW
UT WOS:000397969300006
PM 28291861
OA Bronze
DA 2018-10-20
ER

PT J
AU Scarano, A
   Cholakis, AK
   Piattelli, A
AF Scarano, Antonio
   Cholakis, Anastasia Kelekis
   Piattelli, Adriano
TI Histologic Evaluation of Sinus Grafting Materials After
   Peri-implantitis-Induced Failure: A Case Series
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE implant failure; peri-implantitis; sinus failure; sinus graft infection;
   sinusitis
ID MAXILLARY SINUS; DENTAL IMPLANTS; FLOOR; BONE; COMPLICATION;
   AUGMENTATION; INFECTION
AB Purpose: This human case series presents the clinical and histologic results of five cases of peri-implantitis with subsequent sinus graft infections. Complications may follow maxillary sinus augmentation procedures. It is possible to have an inflammatory reaction, movement of the implant inside the sinus, formation of an insufficient quantity of osseous tissue, and the production of an oroantral fistula. Complications following maxillary subantral augmentation procedures are relatively rare; however, the risks and benefits of any surgery must be carefully evaluated at the onset. Materials and Methods: In this case series, bacterial proliferation from infected implants into the grafted biomaterial in sinus cavities was examined. In five cases, removal of infected implants from augmented sinuses did not result in resolution of the infection, but rather in persistence of the infection in the area of the sinus augmentation procedure. Intraoral examination revealed edema/redness in two cases and edema and sinus tract formation in another case. In all cases, surgical curettage of the affected maxillary sinuses was performed. The inserted biomaterials and the accompanying inflammatory tissue infiltrate were totally removed with curettes. The sample was sent for a histopathologic examination. The maxillary sinuses were filled with an autologous platelet gel. Results: Necrotic bone was found lining the different biomaterial grafts. Macrophages were observed around the grafted particles. No blood vessels were observed. Conclusion: This case series is the first to document the spread of infection from an implant surface to the entirety of the graft in the maxillary antrum. Complete removal of all infected bone graft material is the treatment of choice in such cases.
C1 [Scarano, Antonio] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Oral Surg, Chieti, Italy.
   [Scarano, Antonio] Univ G dAnnunzio, CeSI MeT, Chieti, Italy.
   [Cholakis, Anastasia Kelekis] Univ Manitoba, Fac Hlth Sci, Coll Dent, Grad Periodont Program, Winnipeg, MB, Canada.
   [Piattelli, Adriano] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Oral Pathol, Chieti, Italy.
RP Scarano, A (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM ascarano@unich.it
CR Aghaloo TL, 2007, INT J ORAL MAX SURG, V22, ps49
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Jungner M, 2014, INT J ORAL MAX IMPL, V29, P1380, DOI 10.11607/jomi.3629
   Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x
   Manor Y, 2015, INT J ORAL MAX IMPL, V30, P1156, DOI 10.11607/jomi.4050
   Vazquez JCM, 2014, J ORAL MAXIL SURG, V72, P892, DOI 10.1016/j.joms.2013.11.023
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Scarano A, 2010, J ORAL MAXIL SURG, V68, P1869, DOI 10.1016/j.joms.2009.09.015
   Sohn DS, 2009, ORAL SURG ORAL MED O, V107, P375, DOI 10.1016/j.tripleo.2008.08.002
   Urban IA, 2012, INT J ORAL MAX IMPL, V27, P449
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
NR 14
TC 3
Z9 3
U1 0
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2017
VL 32
IS 2
BP E69
EP E75
DI 10.11607/jomi.5303
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EQ3JW
UT WOS:000397969300003
PM 28291856
OA Bronze
DA 2018-10-20
ER

PT J
AU Moura, MR
   Zucolotto, V
   Aouada, FA
   Mattoso, LHC
AF de Moura, Marcia R.
   Zucolotto, Valtencir
   Aouada, Fauze A.
   Mattoso, Luiz H. C.
TI Efficiency Improvement of Cellulose Derivative Nanocomposite Using
   Titanium Dioxide Nanoparticles
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Polymer-Matrix Composites; Nano-Structures; Mechanical Properties;
   Biomaterial
ID FOOD-PACKAGING FILM; IN-VITRO; COATINGS; TESTS
AB TiO2 nanoparticles were incorporated into hydroxypropyl methylcellulose (HPMC) nanocomposites films. The nanocomposites were investigated in relation to their structural, mechanical, and surface properties using scanning electron microscopy (SEM). The water solubility of the films showed a small decrease with respect to the nanocomposites films content of the TiO2 nanoparticles. Incorporation of TiO2 nanoparticles in the films improved their mechanical and barrier properties significantly. SEM images showed that the lower concentration of nanoparticles were better dispersed in the nanocomposite matrix. The disk diffusion studies revealed a great bactericidal effectiveness for nanocomposite films containing smaller concentration of particles. In general, it was observed that the incorporation of the nanoparticles positively affected the structural properties and enhanced the antibacterial applications of the nanocomposites
C1 [de Moura, Marcia R.; Aouada, Fauze A.] UNESP Univ Estadual Paulista, Fac Engn Ilha Solteira, Dept Fis & Quim, Grp Compositos & Nanocompositos Hibridos GCNH, BR-15385000 Ilha Solteira, SP, Brazil.
   [Zucolotto, Valtencir] Univ Sao Paulo, IFSC, Lab Nanomed & Nanotoxicol, BR-13566970 Sao Carlos, SP, Brazil.
   [Mattoso, Luiz H. C.] EMBRAPA CNPDIA, Lab Nacl Nanotecnol Agronegocio LNNA, Rua XV Novembro, BR-13560970 Sao Carlos, SP, Brazil.
RP Moura, MR (reprint author), UNESP Univ Estadual Paulista, Fac Engn Ilha Solteira, Dept Fis & Quim, Grp Compositos & Nanocompositos Hibridos GCNH, BR-15385000 Ilha Solteira, SP, Brazil.
RI Aouada, Fauze/C-3989-2012; Sao Carlos Institute of Physics,
   IFSC/USP/M-2664-2016; AgroNano, Rede/F-5675-2017; Mattoso, Luiz H
   C/D-2794-2016
OI Aouada, Fauze/0000-0002-6870-6961; Mattoso, Luiz H
   C/0000-0001-7586-1014; Zucolotto, Valtencir/0000-0003-4307-3077; Moura
   Aouada, Marcia Regina de/0000-0002-2534-5553
CR Agrawal H, 2014, POLYM BULL, V71, P1539, DOI 10.1007/s00289-014-1140-3
   Azeredo HMC, 2010, J FOOD SCI, V75, pN1, DOI 10.1111/j.1750-3841.2009.01386.x
   Bodaghi H, 2013, LWT-FOOD SCI TECHNOL, V50, P702, DOI 10.1016/j.lwt.2012.07.027
   Bourtoom T, 2008, LWT-FOOD SCI TECHNOL, V41, P1633, DOI 10.1016/j.lwt.2007.10.014
   Chang PR, 2010, FOOD CHEM, V120, P736, DOI 10.1016/j.foodchem.2009.11.002
   Chawengkijwanich C, 2008, INT J FOOD MICROBIOL, V123, P288, DOI 10.1016/j.ijfoodmicro.2007.12.017
   de Moura MR, 2012, J FOOD ENG, V109, P520, DOI 10.1016/j.jfoodeng.2011.10.030
   de Moura MR, 2009, J FOOD ENG, V92, P448, DOI 10.1016/j.jfoodeng.2008.12.015
   Emregul E, 2013, BIOELECTROCHEMISTRY, V90, P8, DOI 10.1016/j.bioelechem.2012.09.002
   Li YX, 2011, FOOD HYDROCOLLOID, V25, P1098, DOI 10.1016/j.foodhyd.2010.10.006
   MCHUGH TH, 1994, FOOD TECHNOL-CHICAGO, V48, P97
   MOURA M. R, 2011, J FOOD SCI, V76, P25
   Nisperos MO, 1996, FOOD AUST, V48, P27
   Otoni CG, 2014, PACKAG TECHNOL SCI, V27, P549, DOI 10.1002/pts.2063
   Ozcalik O, 2013, J FOOD ENG, V114, P505, DOI 10.1016/j.jfoodeng.2012.09.005
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Salviato M, 2013, COMPOS PART A-APPL S, V48, P144, DOI 10.1016/j.compositesa.2013.01.006
   Sirocic AP, 2014, POLYM BULL, V71, P705, DOI 10.1007/s00289-013-1087-9
   Song NB, 2013, FOOD HYDROCOLLOID, V31, P340, DOI 10.1016/j.foodhyd.2012.11.024
   Tihminlioglu F, 2010, J FOOD ENG, V96, P342, DOI 10.1016/j.jfoodeng.2009.08.018
   Nguyen VG, 2013, COMPOS PART B-ENG, V45, P1192, DOI 10.1016/j.compositesb.2012.09.058
NR 21
TC 0
Z9 0
U1 1
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2017
VL 17
IS 3
BP 2206
EP 2211
DI 10.1166/jnn.2017.13029
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EP1DV
UT WOS:000397126500095
DA 2018-10-20
ER

PT J
AU Mahadik, SA
   Pedraza, F
   Mahadik, SS
   Relekar, BP
   Thorat, SS
AF Mahadik, Satish A.
   Pedraza, F.
   Mahadik, Sarika S.
   Relekar, Brahmanand P.
   Thorat, Sagar S.
TI Biocompatible superhydrophobic coating material for biomedical
   applications
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Superhydrophobicity; Material-cell interaction; Sol-gel;
   Biocompatibility; Dip coating method
ID BLOOD COMPATIBILITY; SURFACES; ADHESION; WETTABILITY; BIOMATERIAL; ACID)
AB Biomaterials and wettability have played a crucial role in the biocompatibility with a host matrix of body fluid and cells. We discuss designing superhydrophobic biomaterials for novel applications such as temporally implant, contact lenses, controlled drug release coatings, coating on medical instruments, etc. Such Superhydrophobic coating surfaces were created with the simple dip coating method by single step base catalyst sol-gel method. Methyltriethoxysilane/trimethoxymethylsilane-based deposition at different dip periods introduces interesting properties in the region, including superhydrophobicity, biocompatibility and transparency. This works reveal the impact of interaction bone marrow mesenchymal stem cells and surface free energy on the biocompatibility of superhydrophobic biomaterial.
C1 [Mahadik, Satish A.; Pedraza, F.] Univ La Rochelle, Lab Sci Ingn Environm LaSIE, FRE, CNRS3474, Ave Michel Crepeau, F-0117042 La Rochelle 01, France.
   [Mahadik, Satish A.] Adarsha Inst Technol & Res Ctr, Dept Phys, Vita 415311, India.
   [Mahadik, Satish A.; Mahadik, Sarika S.; Relekar, Brahmanand P.] Shivaji Univ, Dept Phys, Kolhapur 416004, Maharashtra, India.
   [Thorat, Sagar S.] Natl Chem Lab, CSIR, OCD, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.
RP Mahadik, SA (reprint author), Univ La Rochelle, Lab Sci Ingn Environm LaSIE, FRE, CNRS3474, Ave Michel Crepeau, F-0117042 La Rochelle 01, France.; Mahadik, SA (reprint author), Adarsha Inst Technol & Res Ctr, Dept Phys, Vita 415311, India.; Mahadik, SA (reprint author), Shivaji Univ, Dept Phys, Kolhapur 416004, Maharashtra, India.
EM superhydrophobicmaterial2100@gmail.com
CR Alves NM, 2009, J BIOMED MATER RES A, V91A, P480, DOI 10.1002/jbm.a.32210
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Chen Z, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0037944
   Garrett TR, 2008, PROG NAT SCI, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001
   Ge HL, 2006, THIN SOLID FILMS, V515, P1539, DOI 10.1016/j.tsf.2006.04.022
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gu ZZ, 2003, ANGEW CHEM INT EDIT, V42, P894, DOI 10.1002/anie.200390235
   Hou XM, 2010, COLLOID SURFACE B, V80, P247, DOI 10.1016/j.colsurfb.2010.06.013
   Ishizaki T, 2010, LANGMUIR, V26, P8147, DOI 10.1021/la904447c
   Jagadale PN, 2013, MATER SCI-POLAND, V31, P269, DOI 10.2478/s13536-012-0099-8
   Jeri AH, 2002, NATER MAT, V1, P59
   Khorasani MT, 2004, J APPL POLYM SCI, V91, P2042, DOI 10.1002/app.13355
   Krasteva NA, 2010, J PHYS C SER, V253
   Kubiak KJ, 2011, WEAR, V271, P523, DOI 10.1016/j.wear.2010.03.029
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee YW, 2007, ADV MATER, V19, P2330, DOI 10.1002/adma.200700820
   Li K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3276
   Lourenco B, 2012, BIOINTERPHASES, V7, P1
   Mahadik SA, 2016, J SOL-GEL SCI TECHN, V78, P475, DOI 10.1007/s10971-016-3974-7
   Mahadik SA, 2016, J ALLOY COMPD, V663, P487, DOI 10.1016/j.jallcom.2015.12.016
   Mahadik SA, 2013, APPL SURF SCI, V277, P67, DOI 10.1016/j.apsusc.2013.04.001
   Mahadik SA, 2013, J COLLOID INTERF SCI, V405, P262, DOI 10.1016/j.jcis.2013.04.042
   Mahadik SA, 2012, J SOL-GEL SCI TECHN, V63, P580, DOI 10.1007/s10971-012-2798-3
   Mahadik SA, 2012, J SOL-GEL SCI TECHN, V62, P490, DOI 10.1007/s10971-012-2753-3
   Mahadik SA, 2010, APPL SURF SCI, V257, P333, DOI 10.1016/j.apsusc.2010.06.062
   Nimittrakoolchai OU, 2008, MACROMOL SYMP, V264, P73, DOI 10.1002/masy.200850412
   Oliveira SM, 2011, SOFT MATTER, V7, P8932, DOI 10.1039/c1sm05943b
   Schmidt P, 2012, PHYS CHEM MINER, V39, P455, DOI 10.1007/s00269-012-0499-7
   Shi J, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034003
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 33
TC 1
Z9 1
U1 10
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD MAR
PY 2017
VL 81
IS 3
BP 791
EP 796
DI 10.1007/s10971-016-4244-4
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA EN7BI
UT WOS:000396156700020
DA 2018-10-20
ER

PT J
AU Ommer, A
   Herold, A
   Berg, E
   Furst, A
   Post, S
   Ruppert, R
   Schiedeck, T
   Schwandner, O
   Strittmatter, B
AF Ommer, Andreas
   Herold, Alexander
   Berg, Eugen
   Fuerst, Alois
   Post, Stefan
   Ruppert, Reinhard
   Schiedeck, Thomas
   Schwandner, Oliver
   Strittmatter, Bernhard
TI German S3 guidelines: anal abscess and fistula (second revised version)
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Review
DE Fistula-in-ano; Anal abscess; Anal fistula; Diagnostic; Operative
   treatment; Fecal incontinence
ID MUCOSAL ADVANCEMENT FLAP; CRYPTOGLANDULAR PERIANAL FISTULAS; RANDOMIZED
   CLINICAL-TRIAL; IN-ANO; ANORECTAL ABSCESSES; SETON TREATMENT;
   STEM-CELLS; MANAGEMENT; TRACT; SPHINCTER
AB Background The incidence of anal abscess and fistula is relatively high, and the condition is most common in young men. Methods This is a revised version of the German S3 guidelines first published in 2011. It is based on a systematic review of pertinent literature.
   Results Cryptoglandular abscesses and fistulas usually originate in the proctodeal glands of the intersphincteric space. Classification depends on their relation to the anal sphincter. Patient history and clinical examination are diagnostically sufficient in order to establish the indication for surgery. Further examinations (endosonography, MRI) should be considered in complex abscesses or fistulas. The goal of surgery for an abscess is thorough drainage of the focus of infection while preserving the sphincter muscles. The risk of abscess recurrence or secondary fistula formation is low overall. However, they may result from insufficient drainage. Primary fistulotomy should only be performed in case of superficial fistulas. Moreover, it should be done by experienced surgeons. In case of unclear findings or high fistulas, repair should take place in a second procedure. Anal fistulas can be treated only by surgical intervention with one of the following operations: laying open, seton drainage, plastic surgical reconstruction with suturing of the sphincter (flap, sphincter repair, LIFT), and occlusion with biomaterials. Only superficial fistulas should be laid open. The risk of postoperative incontinence is directly related to the thickness of the sphincter muscle that is divided. All high anal fistulas should be treated with a sphincter-saving procedure. The various plastic surgical reconstructive procedures all yield roughly the same results. Occlusion with biomaterial results in lower cure rate.
   Conclusion In this revision of the German S3 guidelines, instructions for diagnosis and treatment of anal abscess and fistula are described based on a review of current literature.
C1 [Ommer, Andreas] End & Dickdarm Zentrum Essen, Ruttenscheider Str 66, D-45130 Essen, Germany.
   [Herold, Alexander] Deutsch End & Dickdarmzentrum, Mannheim, Germany.
   [Berg, Eugen] Prosper Hosp Recklinghausen, Recklinghausen, Germany.
   [Fuerst, Alois] Caritas Krankenhaus Regensburg, Regensburg, Germany.
   [Post, Stefan] Univ klinikum Mannheim, Mannheim, Germany.
   [Ruppert, Reinhard] Klinikum Neuperlach, Munich, Germany.
   [Schiedeck, Thomas] Klinikum Ludwigsburg, Ludwigsburg, Germany.
   [Schwandner, Oliver] Krankenhaus Barmherzige Bruder, Regensburg, Germany.
   [Strittmatter, Bernhard] Praxisklin, D-2000 Freiburg, Germany.
RP Ommer, A (reprint author), End & Dickdarm Zentrum Essen, Ruttenscheider Str 66, D-45130 Essen, Germany.
EM aommer@online.de
CR Adamo K, 2016, INT J COLORECTAL DIS, V31, P669, DOI 10.1007/s00384-015-2500-7
   Altomare DF, 2010, COLOR DIS, V13, P82
   Amato A, 2015, TECH COLOPROCTOL, V19, P595, DOI 10.1007/s10151-015-1365-7
   Athanasiadis S, 2004, DIS COLON RECTUM, V47, P1174, DOI 10.1007/s10350-004-0551-x
   ATHANASIADIS S, 1995, LANGENBECK ARCH CHIR, V380, P31
   Blumetti J, 2012, WORLD J SURG, V36, P1162, DOI 10.1007/s00268-012-1480-9
   Buchberg B, 2010, AM SURGEON, V76, P1150
   Bussen D, 2004, ZBL CHIR, V129, P404, DOI 10.1055/s-2004-820362
   CHRABOT CM, 1983, DIS COLON RECTUM, V26, P105, DOI 10.1007/BF02562586
   Cioli VM, 2015, INT J COLORECTAL DIS, V30, P1123, DOI 10.1007/s00384-015-2245-3
   Cirocchi R, 2010, ANN ITAL CHIR, V81, P349
   de Groof EJ, 2016, COLORECTAL DIS, V18, pO119, DOI 10.1111/codi.13286
   Devaraj B, 2011, DIS COLON RECTUM, V54, P681, DOI 10.1007/DCR.0b013e31820e7c7a
   Ellis CN, 2010, DIS COLON RECTUM, V53, P1652, DOI 10.1007/DCR.0b013e3181f2e9cd
   Ellis CN, 2010, DIS COLON RECTUM, V53, P1361, DOI 10.1007/DCR.0b013e3181ec4470
   Galanis I, 2016, J GASTROINTEST DIG S, V6, P1
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P723, DOI 10.1007/BF02054434
   Garg P, 2010, COLORECTAL DIS, V12, P965, DOI 10.1111/j.1463-1318.2009.01933.x
   Giamundo P, 2015, TECH COLOPROCTOL, V19, P449, DOI 10.1007/s10151-015-1282-9
   Giordano P, 2016, COLORECTAL DIS
   Gottgens KWA, 2015, INT J COLORECTAL DIS, V30, P583, DOI 10.1007/s00384-014-2091-8
   Gottgens KWA, 2015, INT J COLORECTAL DIS, V30, P213, DOI 10.1007/s00384-014-2072-y
   Hamadani A, 2009, DIS COLON RECTUM, V52, P217, DOI 10.1007/DCR.0b013e31819a5c52
   Hamalainen KPJ, 1998, DIS COLON RECTUM, V41, P1357, DOI 10.1007/BF02237048
   Hamalainen KPJ, 1998, DIS COLON RECTUM, V41, P1362
   Hammond TM, 2011, COLORECTAL DIS, V13, P94, DOI 10.1111/j.1463-1318.2009.02087.x
   Herreros MD, 2012, DIS COLON RECTUM, V55, P762, DOI 10.1097/DCR.0b013e318255364a
   Hoffmann JC, 2004, Z GASTROENTEROL, V42, P979, DOI 10.1055/s-2004-813510
   Khafagy W, 2010, INT J SURG, V8, P321, DOI 10.1016/j.ijsu.2010.03.009
   KLOSTERHALFEN B, 1991, DIS COLON RECTUM, V34, P156, DOI 10.1007/BF02049991
   Kochhar G, 2014, JSLS, V18, P2014, DOI DOI 10.4293/JSLS.2014.00127)
   Kohler A, 1996, CHIRURG, V67, P1244, DOI 10.1007/s001040050133
   Lohsiriwat Varut, 2010, Journal of the Medical Association of Thailand, V93, P61
   Madbouly KM, 2014, DIS COLON RECTUM, V57, P1202, DOI 10.1097/DCR.0000000000000194
   McGee MF, 2010, DIS COLON RECTUM, V53, P1116, DOI 10.1007/DCR.0b013e3181d972a9
   Meinero P, 2012, TECH COLOPROCTOL, V16, P469, DOI 10.1007/s10151-012-0891-9
   Mohite J D, 1997, Indian J Gastroenterol, V16, P96
   Narang SK, 2015, COLOR DIS, V18, P37
   Nomikos IN, 1997, CLIN ANAT, V10, P239, DOI 10.1002/(SICI)1098-2353(1997)10:4<239::AID-CA4>3.0.CO;2-N
   Ommer A, 2008, INT J COLORECTAL DIS, V23, P1023, DOI 10.1007/s00384-008-0524-y
   Ommer A, 2017, COLOPROCTOLOGY, V39, P16, DOI 10.1007/s00053-016-0110-7
   Ommer A, 2016, COLOPROCTOLOGY, V38, P378, DOI 10.1007/s00053-016-0109-0
   Ommer A, 2011, COLOPROCTOLOGY, V33, P378, DOI 10.1007/s00053-011-0225-9
   Ommer A, 2011, COLOPROCTOLOGY, V33, P295, DOI 10.1007/s00053-011-0210-3
   Ommer A, 2012, Ger Med Sci, V10, pDoc13, DOI 10.3205/000164
   Ommer A, 1999, COLOPROCTOLOGY, V21, P161
   Ommer A, 2012, INT J COLORECTAL DIS, V27, P831, DOI 10.1007/s00384-012-1430-x
   Ommer A, 2011, DTSCH ARZTEBL INT, V108, P707, DOI 10.3238/arztebl.2011.0707
   Onaca N, 2001, DIS COLON RECTUM, V44, P1469, DOI 10.1007/BF02234599
   Ortiz H, 2009, BRIT J SURG, V96, P608, DOI 10.1002/bjs.6613
   Perera AP, 2015, LANGENBECK ARCH SURG, V400, P267, DOI 10.1007/s00423-014-1231-5
   Phillips B, 2009, OXFORD CTR EVIDENCE
   Pox C, 2008, Z GASTROENTEROL, V46, pS31, DOI 10.1055/s-2007-963563
   Prosst RL, 2012, COLORECTAL DIS, V14, P1112, DOI 10.1111/j.1463-1318.2011.02902.x
   Ratto C, 2015, TECH COLOPROCTOL, V19, P391, DOI 10.1007/s10151-015-1323-4
   Ritchie RD, 2009, COLORECTAL DIS, V11, P564, DOI 10.1111/j.1463-1318.2008.01713.x
   Rizzo JA, 2010, SURG CLIN N AM, V90, P45, DOI 10.1016/j.suc.2009.10.001
   Rojanasakul Arun, 2007, Journal of the Medical Association of Thailand, V90, P581
   Sahni VA, 2008, ABDOM IMAGING, V33, P26, DOI 10.1007/s00261-007-9309-y
   SAINIO P, 1984, ANN CHIR GYNAECOL FE, V73, P219
   Siddiqui MRS, 2012, DIS COLON RECTUM, V55, P576, DOI 10.1097/DCR.0b013e318249d26c
   Sirany AME, 2015, DIS COLON RECTUM, V58, P604, DOI 10.1097/DCR.0000000000000374
   Sozener U, 2011, DIS COLON RECTUM, V54, P923, DOI 10.1097/DCR.0b013e31821cc1f9
   Steele SR, 2011, DIS COLON RECTUM, V54, P1465, DOI 10.1097/DCR.0b013e31823122b3
   van der Hagen SJ, 2006, INT J COLORECTAL DIS, V21, P784, DOI 10.1007/s00384-005-0072-7
   van der Hagen SJ, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/186350
   van der Hagen SJ, 2011, COLORECTAL DIS, V13, P215, DOI 10.1111/j.1463-1318.2009.01991.x
   van Koperen PJ, 2011, DIS COLON RECTUM, V54, P387, DOI 10.1007/DCR.0b013e318206043e
   Vial M, 2010, COLORECTAL DIS, V12, P172, DOI 10.1111/j.1463-1318.2009.01810.x
   Walega Piotr, 2014, Pol Przegl Chir, V86, P7, DOI 10.2478/pjs-2014-0002
   Wang D, 2014, TECH COLOPROCTOL, V18, P635, DOI 10.1007/s10151-013-1111-y
   Wilhelm A, 2011, TECH COLOPROCTOL, V15, P445, DOI 10.1007/s10151-011-0726-0
   Yano T, 2010, INT J COLORECTAL DIS, V25, P1495, DOI 10.1007/s00384-010-1011-9
   Yilmazlar T, 2010, TECH COLOPROCTOL, V14, P217, DOI 10.1007/s10151-010-0592-1
   Zanotti C, 2007, INT J COLORECTAL DIS, V22, P1459, DOI 10.1007/s00384-007-0334-7
NR 76
TC 3
Z9 3
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1435-2443
EI 1435-2451
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD MAR
PY 2017
VL 402
IS 2
BP 191
EP 201
DI 10.1007/s00423-017-1563-z
PG 11
WC Surgery
SC Surgery
GA EP3QX
UT WOS:000397297900001
PM 28251361
DA 2018-10-20
ER

PT J
AU Sanyasi, S
   Kumar, S
   Ghosh, A
   Majhi, RK
   Kaur, N
   Choudhury, P
   Singh, UP
   Goswami, C
   Goswami, L
AF Sanyasi, Sridhar
   Kumar, Satish
   Ghosh, Arijit
   Majhi, Rakesh Kumar
   Kaur, Navneet
   Choudhury, Priyanka
   Singh, Udai P.
   Goswami, Chandan
   Goswami, Luna
TI A Modified Polysaccharide-Based Hydrogel for Enhanced Osteogenic
   Maturation and Mineralization Independent of Differentiation Factors
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; bone; hydrogel; osteoblasts; polysaccharide; tissue
   engineering
ID TISSUE-ENGINEERING SCAFFOLDS; MESENCHYMAL STEM-CELLS; REGENERATIVE
   MEDICINE; GENE-EXPRESSION; DRUG-DELIVERY; BONE; GROWTH; OSTEOBLAST;
   ADHESION; DESIGN
AB Bone related problems are increasing as a consequence of increased life expectancy, disorders in life style, and other medical conditions enforcing the need for functional bones prepared in vitro at affordable cost. Lack of suitable surface which promotes growth of both osteogenic and nonosteogenic cells is a major limitation. Here a novel biomaterial is reported that is synthesized from natural polysaccharide, namely, tamarind kernel polysaccharide (TKP), which is grafted with hydrophilic acrylic acid (AA) by radical polymerization. Modification in surface functionality removes unwanted proteins and alters hydrophilic/hydrophobic balance. TKP-AA is suitable for the growth of different nonosteogenic and osteogenic cells. This material is suitable for osteoblasts and promotes in vitro mineralization and differentiation without the addition of exogenous growth factors. TKP-AA can be used for the growth of mesenchymal stem cell-derived osteoblasts. It is suggested that TKP-AA can potentially be used as a scaffold for diverse cell types and particularly for bone tissue engineering at low cost.
C1 [Sanyasi, Sridhar; Kumar, Satish; Kaur, Navneet; Choudhury, Priyanka; Goswami, Luna] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India.
   [Ghosh, Arijit; Majhi, Rakesh Kumar; Goswami, Chandan] NISER, Sch Biol Sci, Bhubaneswar 751024, Orissa, India.
   [Singh, Udai P.] KIIT Univ, Sch Elect Engn, Bhubaneswar 751024, Orissa, India.
RP Goswami, L (reprint author), KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India.
EM lunabhattacharyya@yahoo.co.in
OI Ghosh, Arijit/0000-0002-9901-3105
FU Confocal; FE-SEM; ICMR [5/20/1(Bio)/2014/NCD-I]
FX The authors thank Hindustan Gum Pvt. Ltd. (Bhiwandi, India) for
   providing TKP. Support from Confocal and FE-SEM imaging facility, animal
   house facility, NISER is acknowledged. The authors are grateful to Dr.
   Pratap Kumar Sahoo and Mr. Vantari Siva for help in FE-SEM Imaging.
   Funding from ICMR (5/20/1(Bio)/2014/NCD-I) and intramural support from
   NISER is appreciated. MC3T3-E1 was a kind gift from Dr. Naibedya
   Chattopadhyay (CDRI, Lucknow). Inputs from Dr. Abhijit Bandyopadhyay and
   Mr. Ashutosh Kumar are appreciated. Comments from Prof. L. C. Padhy are
   appreciated. We are thankful to Ms. Bhagyashree for generating XRD data.
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Arvind S. R., 2012, SCI WORLD J, V2012
   Avachat AM, 2013, CARBOHYD POLYM, V91, P537, DOI 10.1016/j.carbpol.2012.08.062
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Changez M, 2005, BIOMATERIALS, V26, P2095, DOI 10.1016/j.biomaterials.2004.06.008
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015
   Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049
   Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954
   Goswami C, 2007, J NEUROCHEM, V103, P1319, DOI 10.1111/j.1471-4159.2007.04846.x
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200
   Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004
   Khan F, 2015, J MATER CHEM B, V3, P8224, DOI 10.1039/c5tb01370d
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Malheiro VN, 2011, BIOMATERIALS, V32, P6883, DOI 10.1016/j.biomaterials.2011.06.002
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Nayak AK, 2014, CARBOHYD POLYM, V101, P220, DOI 10.1016/j.carbpol.2013.09.024
   Nejatzadeh-Barandozi Fatemeh, 2012, Org Med Chem Lett, V2, P33, DOI 10.1186/2191-2858-2-33
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Rana V, 2011, CARBOHYD POLYM, V83, P1031, DOI 10.1016/j.carbpol.2010.09.010
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Sanyasi S, 2014, CARBOHYD POLYM, V101, P1033, DOI 10.1016/j.carbpol.2013.10.047
   Singh B, 2014, INT J BIOL MACROMOL, V65, P524, DOI 10.1016/j.ijbiomac.2014.02.004
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stoddart A, 2009, NAT MATER, V8, P444, DOI 10.1038/nmat2447
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 40
TC 2
Z9 2
U1 5
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR
PY 2017
VL 17
IS 3
AR 1600268
DI 10.1002/mabi.201600268
PG 14
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA EP6QE
UT WOS:000397503200008
PM 27767291
DA 2018-10-20
ER

PT J
AU da Costa, RMF
   Pattathil, S
   Avci, U
   Lee, SJ
   Hazen, SP
   Winters, A
   Hahn, MG
   Bosch, M
AF da Costa, Ricardo M. F.
   Pattathil, Sivakumar
   Avci, Utku
   Lee, Scott J.
   Hazen, Samuel P.
   Winters, Ana
   Hahn, Michael G.
   Bosch, Maurice
TI A cell wall reference profile for Miscanthus bioenergy crops highlights
   compositional and structural variations associated with development and
   organ origin
SO NEW PHYTOLOGIST
LA English
DT Article
DE bioenergy; biomass; carbohydrate; cell wall; glycan; lignocellulose;
   miscanthus; recalcitrance
ID BIOMASS RECALCITRANCE; BIOFUEL PRODUCTION; O-ACETYLATION;
   POLYSACCHARIDES; ARABIDOPSIS; CELLULOSE; PATTERN; TISSUES; GRASSES;
   PECTIN
AB Miscanthus spp. are promising lignocellulosic energy crops, but cell wall recalcitrance to deconstruction still hinders their widespread use as bioenergy and biomaterial feedstocks. Identification of cell wall characteristics desirable for biorefining applications is crucial for lignocellulosic biomass improvement. However, the task of scoring biomass quality is often complicated by the lack of a reference for a given feedstock.
   A multidimensional cell wall analysis was performed to generate a reference profile for leaf and stem biomass from several miscanthus genotypes harvested at three developmentally distinct time points. A comprehensive suite of 155 monoclonal antibodies was used to monitor changes in distribution, structure and extractability of noncellulosic cell wall matrix glycans.
   Glycan microarrays complemented with immunohistochemistry elucidated the nature of compositional variation, and in situ distribution of carbohydrate epitopes. Key observations demonstrated that there are crucial differences in miscanthus cell wall glycomes, which may impact biomass amenability to deconstruction.
   For the first time, variations in miscanthus cell wall glycan components were comprehensively characterized across different harvests, organs and genotypes, to generate a representative reference profile for miscanthus cell wall biomass. Ultimately, this portrait of the miscanthus cell wall will help to steer breeding and genetic engineering strategies for the development of superior energy crops.
C1 [da Costa, Ricardo M. F.; Winters, Ana; Bosch, Maurice] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3EE, Dyfed, Wales.
   [Pattathil, Sivakumar; Avci, Utku; Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.
   [Pattathil, Sivakumar; Avci, Utku; Hahn, Michael G.] Oak Ridge Natl Lab, US Dept Energy Bioenergy Sci Ctr, Oak Ridge, TN 37831 USA.
   [Lee, Scott J.; Hazen, Samuel P.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.
RP da Costa, RMF; Bosch, M (reprint author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3EE, Dyfed, Wales.
EM dacosta.rmf@gmail.com; mub@aber.ac.uk
OI Bosch, Maurice/0000-0003-1990-589X
FU European Regional Development Funding through the Welsh Government for
   BEACON [8056]; Biotechnology and Biological Sciences Research Council
   (BBSRC) Institute Strategic Programme Grant on Energy Grasses
   Biorefining [BBS/E/W/10963A01]; Office of Science (BER) Department of
   Energy [DE-SC0006621]; BioEnergy Science Center (BESC); Oak Ridge
   National Laboratory; Office of Biological and Environmental Research,
   Office of Science, U.S. Department of Energy [DE-AC05-00OR22725]; NSF
   Plant Genome Program [DBI-0421683, IOS-0923992]; BBSRC 'Sparking
   Impact'; Society for Experimental Biology Travel Fund; Biotechnology and
   Biological Sciences Research Council [BBS/E/W/10963A01C]
FX This work was supported by European Regional Development Funding through
   the Welsh Government for BEACON, grant number 8056; the Biotechnology
   and Biological Sciences Research Council (BBSRC) Institute Strategic
   Programme Grant on Energy Grasses & Biorefining (BBS/E/W/10963A01); and
   the Office of Science (BER) Department of Energy, grant DE-SC0006621.
   Glycome profiling studies were supported by the BioEnergy Science Center
   (BESC), Oak Ridge National Laboratory, and funded by a grant
   (DE-AC05-00OR22725) from the Office of Biological and Environmental
   Research, Office of Science, U.S. Department of Energy. Generation of
   the CCRC series of monoclonal antibodies used in this work was supported
   by the NSF Plant Genome Program (DBI-0421683 and IOS-0923992). We
   acknowledge BBSRC 'Sparking Impact' funding and a Society for
   Experimental Biology Travel Fund to enable a research visit of
   R.M.F.d.C. to the CCRC, University of Georgia.
CR Allison GG, 2011, BIOMASS BIOENERG, V35, P4740, DOI 10.1016/j.biombioe.2011.10.008
   Anthon GE, 2006, J AGR FOOD CHEM, V54, P204, DOI 10.1021/jf051877q
   Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534
   Avci Utku, 2012, Methods Mol Biol, V908, P73, DOI 10.1007/978-1-61779-956-3_7
   Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010
   Buanafina MMD, 2006, APPL BIOCHEM BIOTECH, V130, P416
   Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067
   Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691
   Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575
   Cao YP, 2014, PLANT CELL REP, V33, P643, DOI 10.1007/s00299-014-1574-y
   Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445
   Carpita NC, 2015, J EXP BOT, V66, P4145, DOI 10.1093/jxb/erv090
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974
   Clifton-Brown J, 2013, BIOENERGY FEEDSTOCKS, P67
   COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111
   Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272
   Costa RMF, 2014, ANN BOT-LONDON, V114, P1265, DOI 10.1093/aob/mcu054
   da Costa RMF, 2015, BIOPROTOCOL, V5, pe1494
   De Souza AP, 2015, J EXP BOT, V66, P4351, DOI 10.1093/jxb/erv183
   de Souza AP, 2013, BIOENERG RES, V6, P564, DOI 10.1007/s12155-012-9268-1
   DEFRA, 2007, PLANT GROW MISC BEST
   DeMartini JD, 2011, ENERG ENVIRON SCI, V4, P4332, DOI 10.1039/c1ee02112e
   Dwiyanti MS, 2013, BIOENERGY FEEDSTOCKS, P49
   Fry SC, 2010, ANN PLANT REV, P1
   Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012
   Harris PJ, 2008, BIOMASS RECALCITRANC, P61, DOI DOI 10.1002/9781444305418
   HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035
   Heaton E. A., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P433, DOI 10.1023/B:MITI.0000038848.94134.be
   Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Huyen TLN, 2010, BIORESOURCE TECHNOL, V101, P8224, DOI 10.1016/j.biortech.2010.05.087
   Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1
   Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16
   Kiemle SN, 2014, BIOMACROMOLECULES
   Lechtenbohmer S, 2011, IPAENVIST201107
   Lee Scott J, 2012, Methods Mol Biol, V918, P341, DOI 10.1007/978-1-61779-995-2_18
   Lee SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-5
   Leroux O, 2012, ANN BOT-LONDON, V110, P1083, DOI 10.1093/aob/mcs186
   Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1111/j.1468-2958.2002.tb00828.x
   Li MY, 2014, RSC ADV, V4, P17282, DOI 10.1039/c4ra00824c
   Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107
   Liu CC, 2013, FOOD ENERGY SECUR, V2, P12, DOI 10.1002/fes3.19
   Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j
   Lucia LA, 2008, BIORESOURCES, V3, P981
   Manabe Y, 2013, PLANT PHYSIOL, V163, P1107, DOI 10.1104/pp.113.225193
   Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989
   Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x
   Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x
   McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001
   McCann MC, 2015, J EXP BOT, V66, P4109, DOI 10.1093/jxb/erv267
   MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x
   Mohnen D., 1999, COMPREHENSIVE NATURA, V3, P497
   Norris JQ, 2016, ANNU REV EARTH PL SC, V44, P321, DOI 10.1146/annurev-earth-060115-012537
   O'Neill M, 2003, PLANT CELL WALL, P1
   OiNeill M., 1990, METHODS PLANT BIOCH, V2, P415
   Park YB, 2015, PLANT CELL PHYSIOL, V56, P180, DOI 10.1093/pcp/pcu204
   Pattathil Sivakumar, 2015, Front Bioeng Biotechnol, V3, P173, DOI 10.3389/fbioe.2015.00173
   Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6
   Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985
   Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x
   Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009
   Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118
   Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266
   Robson P, 2013, J EXP BOT, V64, P4143, DOI 10.1093/jxb/ert225
   Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315
   Schmidt D, 2015, CHEM-EUR J, V21, P5709, DOI 10.1002/chem.201500065
   Shen H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-71
   Sluiter A., 2012, DETERMINATION STRUCT
   Suzuki K, 2000, PLANT CELL PHYSIOL, V41, P948, DOI 10.1093/pcp/pcd019
   Trethewey JAK, 2002, NEW PHYTOL, V154, P347, DOI 10.1046/j.1469-8137.2002.00383.x
   Uraki Y, 2015, J WOOD SCI, V61, P447, DOI 10.1007/s10086-015-1492-9
   Van der Weijde T, 2017, GCB BIOENERGY, V9, P176, DOI 10.1111/gcbb.12355
   van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107
   Vega-Sanchez ME, 2015, PLANT BIOTECHNOL J, V13, P903, DOI 10.1111/pbi.12326
   Vega-Sanchez ME, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23143
   Vega-Sanchez ME, 2012, PLANT PHYSIOL, V159, P56, DOI 10.1104/pp.112.195495
   Wi SG, 2005, ANN BOT-LONDON, V95, P863, DOI 10.1093/aob/mci092
   Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066
   Xu F, 2010, CEREAL STRAW AS A RESOURCE FOR SUSTAINABLE BIOMATERIALS AND BIOFUELS: CHEMISTRY, EXTRACTIVES, LIGNINS, HEMICELLULOSES AND CELLULOSE, P9, DOI 10.1016/B978-0-444-53234-3.00002-X
   Xue J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082114
   Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x
   ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070
NR 83
TC 7
Z9 7
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0028-646X
EI 1469-8137
J9 NEW PHYTOL
JI New Phytol.
PD MAR
PY 2017
VL 213
IS 4
BP 1710
EP 1725
DI 10.1111/nph.14306
PG 16
WC Plant Sciences
SC Plant Sciences
GA EP2UI
UT WOS:000397238600020
PM 27859277
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Xu, HX
   Zhang, LX
   Bao, Y
   Yan, XM
   Yin, YX
   Li, YP
   Wang, XY
   Huang, ZJ
   Xu, PH
AF Xu, Haixing
   Zhang, Lingxi
   Bao, Yun
   Yan, Xiumei
   Yin, Yixia
   Li, Yiping
   Wang, Xinyu
   Huang, Zhijun
   Xu, Peihu
TI Preparation and characterization of injectable chitosan-hyaluronic acid
   hydrogels for nerve growth factor sustained release
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Chitosan; hyaluronic acid; nerve growth factor; injectable hydrogel;
   peripheral nerve regeneration
ID DRUG-DELIVERY; REGENERATION; CONDUITS; SYSTEM; INJURY; REPAIR;
   ENHANCEMENT; BIOMATERIAL; STRATEGIES; SCAFFOLDS
AB The usage of hollow nerve conduits shows inferior recovery effect on the repair of peripheral nerve defects. In this study, a biocompatible and biodegradable pH-induced injectable chitosan-hyaluronic acid hydrogel for nerve growth factor encapsulation and sustained release was developed as the fillers in the lumen of hollow nerve conduit to reform its microenvironment for peripheral nerve regeneration. The physicochemical properties of hydrogel were characterized by gelation time, Fourier transform infrared spectroscopy, scanning electron microscopy, compressive modulus, porosity, swelling ratio, and in vitro degradation. The in vitro nerve growth factor release profiles and cell evaluation were also investigated. The results show that the structure of chitosan-hyaluronic acid hydrogel is composed of interconnected channels with a controllable pore diameter ranging from 20 to 100 mu m. The hydrogel can be degraded more than 70% within 8weeks in vitro and is available for nerve growth factor sustained release. The chitosan-hyaluronic acid/nerve growth factor hydrogel is non-toxic and suitable for adhesion and proliferation of nerve cells and capable of maintaining nerve growth factor activity. Therefore, it could be a promising intraluminal filler of nerve conduits for peripheral nerve regeneration in neural tissue engineering.
C1 [Xu, Haixing; Zhang, Lingxi; Bao, Yun; Yan, Xiumei; Li, Yiping; Huang, Zhijun; Xu, Peihu] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Dept Pharmaceut Engn, Wuhan 430070, Peoples R China.
   [Yin, Yixia; Wang, Xinyu] Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan, Peoples R China.
RP Xu, PH (reprint author), Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Dept Pharmaceut Engn, Wuhan 430070, Peoples R China.
EM whutxph68@126.com
FU National Natural Science Foundation of China [51473130, 51403168,
   51572206]
FX The study is supported by the National Natural Science Foundation of
   China (51473130, 51403168, and 51572206).
CR APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114
   BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Brandl F, 2010, BIOMACROMOLECULES, V11, P496, DOI 10.1021/bm901235g
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Cui L, 2014, CARBOHYD POLYM, V99, P31, DOI 10.1016/j.carbpol.2013.08.048
   Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010
   Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Iwasaki N, 2011, POLYMERS-BASEL, V3, P100, DOI 10.3390/polym3010100
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Li C, 2014, J BIOACT COMPAT POL, V29, P529, DOI 10.1177/0883911514553903
   Li L, 2014, BIOMATERIALS, V35, P3903, DOI 10.1016/j.biomaterials.2014.01.050
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lin YC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024102
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Navarro X, 2005, J PERIPHER NERV SYST, V10, P229, DOI 10.1111/j.1085-9489.2005.10303.x
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001
   Park H, 2013, ACTA BIOMATER, V9, P4779, DOI 10.1016/j.actbio.2012.08.033
   Pescosolido L, 2010, EUR BIOPHYS J BIOPHY, V39, P903, DOI 10.1007/s00249-009-0440-2
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P373, DOI 10.1021/bp020280h
   Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Tan HP, 2010, ORGANOGENESIS, V6, P173, DOI 10.4161/org.6.3.12037
   Wei YT, 2009, J BIOACT COMPAT POL, V24, P205, DOI 10.1177/0883911509102266
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Xu SB, 2016, J BIOACT COMPAT POL, V31, P179, DOI 10.1177/0883911515609941
   Xuejun X, 2004, J BIOACT COMPAT POL, V19, P5, DOI 10.1177/0883911504041608
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Zhang QS, 2010, MAT SCI ENG C-MATER, V30, P160, DOI 10.1016/j.msec.2009.09.013
   Zhao YZ, 2016, ACTA BIOMATER, V29, P71, DOI 10.1016/j.actbio.2015.10.014
NR 47
TC 1
Z9 1
U1 11
U2 51
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2017
VL 32
IS 2
BP 146
EP 162
DI 10.1177/0883911516662068
PG 17
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA EM5AE
UT WOS:000395323500003
DA 2018-10-20
ER

PT J
AU Shavandi, A
   Bekhit, AEA
   Carne, A
   Bekhit, A
AF Shavandi, Amin
   Bekhit, Alaa El-Din A.
   Carne, Alan
   Bekhit, Adnan
TI Evaluation of keratin extraction from wool by chemical methods for
   bio-polymer application
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Wool; keratin; chemical extraction; sulfitolysis; reduction; oxidation
ID STEAM FLASH-EXPLOSION; FEATHER KERATIN; IONIC LIQUIDS; BIOMEDICAL
   APPLICATIONS; HUMAN HAIR; DISSOLUTION; COMPOSITE; REGENERATION;
   PROTEINS; DENATURATION
AB This study investigated some physicochemical properties of keratin extracted from Merino wool using five chemical extraction methods: alkali hydrolysis, sulfitolysis, reduction, oxidation, and extraction using ionic liquid. The ionic liquid method produced the highest protein yield (95%), followed by sulfitolysis method (89%), while the highest extraction yield was obtained with the reduction method (54%). The lowest yield was obtained with the oxidation method (6%). The oxidation extract contained higher molecular weight (>40kDa) protein components, whereas the alkali hydrolysis extract contained protein material of <10kDa. The sulfitolysis, reduction, and ionic liquid extracts contained various protein components between 3.5 and 60kDa. Keratin obtained from various extraction methods had different yield, morphology, and physicochemical properties. None of the samples were toxic to L929 fibroblast cells up to a concentration of 2.5mg/mL. Apart from the alkali hydrolysis extract, all other keratin extracts (reduction, sulfitolysis, ionic liquid, and oxidation) showed Fourier transform infrared adsorption peaks attributed to the sulfitolysis-oxidation stretching vibrations of cysteine-S-sulfonated residues, with the oxidation extract showing the highest content of cysteine-S-sulfonated residues. This study indicates that the properties of the keratin extract obtained vary depending on the extraction method used, which has implications for use in structural biomaterial applications.
C1 [Shavandi, Amin; Bekhit, Alaa El-Din A.] Univ Otago, Dept Food Sci, Dunedin 9054, New Zealand.
   [Carne, Alan] Univ Otago, Dept Biochem, Dunedin, New Zealand.
   [Bekhit, Adnan] Univ Alexandria, Dept Pharmaceut Chem, Fac Pharm, Alexandria, Egypt.
RP Shavandi, A (reprint author), Univ Otago, Dept Food Sci, Dunedin 9054, New Zealand.
EM amin.shavandi@postgrad.otago.ac.nz
OI shavandi, amin/0000-0002-0188-3090; Carne, Alan/0000-0003-3665-1940
FU University of Otago
FX The authors acknowledge the facilities as well as scientific and
   technical assistance from staff at the Otago Centre for Electron
   Microscopy (OCEM) at the University of Otago. We thank Mr Damian Wallas
   for his help and support with the use of XRD. A.S. acknowledges award of
   a PhD scholarship from the University of Otago.
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Aluigi A, 2014, J MATER SCI, V49, P6257, DOI 10.1007/s10853-014-8350-9
   AOAC, 2005, OFFICIAL METHODS ANA
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Attia J, 2011, J BIOACT COMPAT POL, V26, P71, DOI 10.1177/0883911510391445
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   Cardamone Jeanette M, 2009, Research Letters in Materials Science, DOI 10.1155/2009/147175
   Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y
   EARLAND C, 1955, BIOCHIM BIOPHYS ACTA, V17, P457, DOI 10.1016/0006-3002(55)90406-6
   Edwards A, 2015, J BIOMED MATER RES B, V103, P21, DOI 10.1002/jbm.b.33172
   Eslahi N, 2013, PREP BIOCHEM BIOTECH, V43, P624, DOI 10.1080/10826068.2013.763826
   Feng YQ, 2014, CURR EYE RES, V39, P561, DOI 10.3109/02713683.2013.853804
   Fujii T, 2008, J BIOL MACROMOL, V8, P48
   Ghosh A, 2014, POLYM DEGRAD STABIL, V108, P108, DOI 10.1016/j.polymdegradstab.2014.06.007
   Goddard DR, 1935, J BIOL CHEM, V112, P361
   Idris A, 2014, GREEN CHEM, V16, P2857, DOI 10.1039/c4gc00213j
   Idris A, 2013, GREEN CHEM, V15, P525, DOI 10.1039/c2gc36556a
   Kakkar P, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-596
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Khajavi R, 2016, J BIOACT COMPAT POL, V31, P60, DOI 10.1177/0883911515598793
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Li JS, 2012, J BIOMED MATER RES B, V100B, P896, DOI 10.1002/jbm.b.32645
   Li R, 2013, J APPL POLYM SCI, V127, P2648, DOI 10.1002/app.37527
   Morrison T, 2016, SCOOP INDEPENDE 0304
   NAGAI Y, 1970, AGR BIOL CHEM TOKYO, V34, P16, DOI 10.1080/00021369.1970.10859572
   Nakata R, 2014, MAT SCI ENG C-MATER, V41, P59, DOI 10.1016/j.msec.2014.04.016
   Ntumba Y-HT, 2014, INT J CHEM MOL NUCL, V8, P586
   Patterson WI, 1951, J RES NBS, V27, P89
   Pilbrow J, 2016, FOOD CHEM, V203, P165, DOI 10.1016/j.foodchem.2016.02.065
   PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schrooyen PMM, 2001, J COLLOID INTERF SCI, V240, P30, DOI 10.1006/jcis.2001.7673
   Shavandi A, 2015, MAT SCI ENG C-MATER, V55, P373, DOI 10.1016/j.msec.2015.05.029
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75
   Tonin C, 2006, BIOMACROMOLECULES, V7, P3499, DOI 10.1021/bm060597w
   Tsuda Y, 2014, ANIM SCI J, V85, P180, DOI 10.1111/asj.12093
   Wang B, 2016, PROG MATER SCI, V76, P229, DOI 10.1016/j.pmatsci.2015.06.001
   Wang K, 2016, GREEN CHEM, V18, P476, DOI 10.1039/c5gc01254f
   Wortmann FJ, 2007, J COSMET SCI, V58, P311
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Xu HL, 2014, J MATER SCI, V49, P7513, DOI 10.1007/s10853-014-8457-z
   Xu SB, 2016, J BIOACT COMPAT POL, V31, P179, DOI 10.1177/0883911515609941
   Xu WL, 2006, EUR POLYM J, V42, P2168, DOI 10.1016/j.eurpolymj.2006.03.026
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yen MT, 2009, CARBOHYD POLYM, V75, P15, DOI 10.1016/j.carbpol.2008.06.006
   Zhang HL, 2013, J BIOACT COMPAT POL, V28, P141, DOI 10.1177/0883911512472565
   Zhang YQ, 2015, ACS SUSTAIN CHEM ENG, V3, P2036, DOI 10.1021/acssuschemeng.5b00310
   Zhao W, 2012, GREEN CHEM, V14, P3352, DOI 10.1039/c2gc36243k
   Zoccola M, 2012, TEXT RES J, V82, P2006, DOI 10.1177/0040517512452948
NR 51
TC 4
Z9 4
U1 5
U2 33
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2017
VL 32
IS 2
BP 163
EP 177
DI 10.1177/0883911516662069
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA EM5AE
UT WOS:000395323500004
DA 2018-10-20
ER

PT J
AU Kaminska, M
   Kuberski, S
   Maniukiewicz, W
   Owczarz, P
   Komorowski, P
   Modrzejewska, Z
   Walkowiak, B
AF Kaminska, Marta
   Kuberski, Slawomir
   Maniukiewicz, Waldemar
   Owczarz, Piotr
   Komorowski, Piotr
   Modrzejewska, Zofia
   Walkowiak, Bogdan
TI Thermosensitive chitosan gels containing calcium glycerophosphate for
   bone cell culture
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Chitosan; thermosensitive chitosan gels; structural properties; cell
   culture; biomaterial; biocompatibility; scaffolds; tissue engineering;
   calcium glycerophosphate
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE SCAFFOLDS; HYDROGELS;
   PHOSPHATE; PROLIFERATION; ASSAY
AB In this article, properties of thermosensitive chitosan hydrogels prepared with the use of chitosan chloride with -glycerophosphate disodium salt pentahydrate enriched with calcium glycerophosphate are presented and compared with chitosan hydrogels with -glycerophosphate disodium salt pentahydrate. The study is focused on the determination of hydrogel structure and biological testing of hydrogels with human osteoblasts line Saos-2. The structure of gels was visualized by scanning electron microscopy and was investigated by infrared spectroscopy. The crystallinity of gel structure was determined by X-ray diffraction analysis and thermal effects were determined using differential scanning calorimetry thermograms.
C1 [Kaminska, Marta; Komorowski, Piotr; Walkowiak, Bogdan] Lodz Univ Technol, Inst Mat Sci & Engn, Lodz, Poland.
   [Kuberski, Slawomir; Owczarz, Piotr; Modrzejewska, Zofia] Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland.
   [Maniukiewicz, Waldemar] Lodz Univ Technol, Inst Gen & Ecol Chem, Lodz, Poland.
   [Komorowski, Piotr; Walkowiak, Bogdan] BioNanoPk Labs Lodz Reg Pk Sci & Technol, Lodz, Poland.
RP Modrzejewska, Z (reprint author), Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland.
EM zofia.modrzejewska@p.lodz.pl
RI Maniukiewicz, Waldemar/G-6688-2016; Kaminska, Marta/T-1949-2018
OI Maniukiewicz, Waldemar/0000-0001-6094-0748; Kaminska,
   Marta/0000-0002-3427-0944
FU National Science Centre of Poland [NCN UMO-2011/01/B/ST8/06686, NCN
   UMO-2014/15/B/ST8/02512]
FX The research was financed by the National Science Centre of Poland:
   Grant NCN UMO-2011/01/B/ST8/06686 and continued NCN
   UMO-2014/15/B/ST8/02512.
CR Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Budrick AJ, 2011, BIOMATERIALS TISSUE
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Dessi M, 2013, J BIOMED MATER RES A, V101, P2984, DOI 10.1002/jbm.a.34592
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Douglas TEL, 2013, INT J BIOL MACROMOL, V56, P122, DOI 10.1016/j.ijbiomac.2013.02.002
   FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209
   Ji CD, 2011, BIOMATERIALS, V32, P9719, DOI 10.1016/j.biomaterials.2011.09.003
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Kim MS, 2011, TISSUE ENG REGEN MED, V8, P117
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Li BQ, 2009, TISSUE ENG A, V1
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mohamed KR, 2014, J ADV RES, V5, P201, DOI 10.1016/j.jare.2013.02.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niranjan R, 2013, INT J BIOL MACROMOL, V54, P24, DOI 10.1016/j.ijbiomac.2012.11.026
   Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3
   Piai JF, 2012, P 11 M SBPMAT BRAZ S
   Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139
   Sivashanmugam A, 2015, EUR POLYM J, V72, P543, DOI 10.1016/j.eurpolymj.2015.05.014
   Su WT, 2015, MAT SCI ENG C-MATER, V52, P46, DOI 10.1016/j.msec.2015.03.025
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Varlamov VP, 2005, APPL BIOCHEM MICROB, V41, P5, DOI DOI 10.1007/S10438-005-0002-Z
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Yan SQ, 2013, ACTA BIOMATER, V9, P6771, DOI 10.1016/j.actbio.2013.02.016
   Yao K, 2012, CHITOSAN-BASED HYDROGELS: FUNCTIONS AND APPLICATIONS, P1
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Zhou HY, 2015, CARBOHYD POLYM, V117, P524, DOI 10.1016/j.carbpol.2014.09.094
NR 33
TC 3
Z9 3
U1 4
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2017
VL 32
IS 2
BP 209
EP 222
DI 10.1177/0883911516671150
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA EM5AE
UT WOS:000395323500007
DA 2018-10-20
ER

PT J
AU Saini, H
   Vadekeetil, A
   Chhibber, S
   Harjai, K
AF Saini, Hina
   Vadekeetil, Anitha
   Chhibber, Sanjay
   Harjai, Kusum
TI Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial
   Colonization, Biofilm Formation, and Inflammation in a Murine Model of
   Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas
   aeruginosa
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE quorum sensing; urinary tract infection
ID ESCHERICHIA-COLI; NITRIC-OXIDE; PREVENTION; PROTEIN-2
AB Pseudomonas aeruginosa is a multifaceted pathogen causing a variety of biofilm-mediated infections, including catheter-associated urinary tract infections (CAUTIs). The high prevalence of CAUTIs in hospitals, their clinical manifestations, such as urethritis, cystitis, pyelonephritis, meningitis, urosepsis, and death, and the associated economic challenges underscore the need for management of these infections. Biomaterial modification of urinary catheters with two drugs seems an interesting approach to combat CAUTIs by inhibiting biofilm. Previously, we demonstrated the in vitro efficacy of urinary catheters impregnated with azithromycin (AZM) and ciprofloxacin (CIP) against P. aeruginosa. Here, we report how these coated catheters impact the course of CAUTI induced by P. aeruginosa in a murine model. CAUTI was established in female LACA mice with uncoated or AZM-CIPcoated silicone implants in the bladder, followed by transurethral inoculation of 108 CFU/ml of biofilm cells of P. aeruginosa PAO1. AZM-CIP-coated implants (i) prevented biofilm formation on the implant's surface (P <= 0.01), (ii) restricted bacterial colonization in the bladder and kidney (P <= 0.0001), (iii) averted bacteriuria (P <= 0.0001), and (iv) exhibited no major histopathological changes for 28 days in comparison to uncoated implants, which showed persistent CAUTI. Antibiotic implants also overcame implant-mediated inflammation, as characterized by trivial levels of inflammatory markers such as malondialdehyde (P <= 0.001), myeloperoxidase (P <= 0.05), reactive oxygen species (P <= 0.001), and reactive nitrogen intermediates (P <= 0.01) in comparison to those in uncoated implants. Further, AZM-CIP-coated implants showed immunomodulation by manipulating the release of inflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-beta), and IL-10 to the benefit of the host. Overall, the study demonstrates long-term in vivo effectiveness of AZM-CIP-impregnated catheters, which may possibly be a key to success in preventing CAUTIs.
C1 [Saini, Hina; Vadekeetil, Anitha; Chhibber, Sanjay; Harjai, Kusum] Panjab Univ, Dept Microbiol, Chandigarh, India.
RP Harjai, K (reprint author), Panjab Univ, Dept Microbiol, Chandigarh, India.
EM kusumharjai1961@gmail.com
FU University Grants Commission, New Delhi, India, under the scheme of the
   Maulana Azad National Fellowship for Minority Students
   [F1-17.1/2013-2014/MANF-2013-14-SIK-CHA-22060]
FX This work was funded by the University Grants Commission, New Delhi,
   India, under the scheme of the Maulana Azad National Fellowship for
   Minority Students
   [F1-17.1/2013-2014/MANF-2013-14-SIK-CHA-22060/(SA-III/Website)].
CR Allan ND, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/921617
   Anjaneyulu M, 2004, AM J NEPHROL, V24, P488, DOI 10.1159/000080722
   Bala A, 2011, J MED MICROBIOL, V60, P300, DOI 10.1099/jmm.0.025387-0
   Barford J. M. T., 2009, Journal of Infection Prevention, V10, P50, DOI 10.1177/1757177408098265
   CDC, 2015, CATH ASS UR TRACT IN
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Darouiche RO, 2005, CLIN INFECT DIS, V41, P1531, DOI 10.1086/497272
   Dasgupta S, 2015, INDIAN J CRIT CARE M, V19, P14, DOI 10.4103/0972-5229.148633
   Evliyaoglu Y, 2011, UROL RES, V39, P443, DOI 10.1007/s00240-011-0379-5
   Fisher LE, 2015, J CONTROL RELEASE, V202, P57, DOI 10.1016/j.jconrel.2015.01.037
   GARG UC, 1987, MED SCI RES-BIOCHEM, V15, P369
   Guiton PS, 2013, INFECT IMMUN, V81, P329, DOI 10.1128/IAI.00856-12
   Guiton PS, 2010, INFECT IMMUN, V78, P4166, DOI 10.1128/IAI.00711-10
   Ha US, 2006, INT J ANTIMICROB AG, V28, P485, DOI 10.1016/j.ijantimicag.2006.08.020
   Hachem R, 2009, ANTIMICROB AGENTS CH, V53, P5145, DOI 10.1128/AAC.00718-09
   Hang L, 1999, J IMMUNOL, V162, P3037
   Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Hopkins WJ, 1998, INFECT IMMUN, V66, P2798
   IMAMURA M, 1986, ACTA ENDOCRINOL-COP, V112, P210, DOI 10.1530/acta.0.1120210
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Mittal R, 2004, MICROBES INFECT, V6, P1326, DOI 10.1016/j.micinf.2004.08.008
   Mittal R, 2008, MICROB PATHOGENESIS, V45, P323, DOI 10.1016/j.micpath.2008.08.003
   ROCKETT KA, 1994, PARASITE IMMUNOL, V16, P243, DOI 10.1111/j.1365-3024.1994.tb00346.x
   Saini H, 2016, BIOFOULING, V32, P795
   Saini H, 2015, INT J ANTIMICROB AG, V45, P359, DOI 10.1016/j.ijantimicag.2014.11.008
   Song Z, 2010, PHYTOMEDICINE, V17, P1040, DOI 10.1016/j.phymed.2010.03.015
   Stickler DJ, 1998, APPL ENVIRON MICROB, V64, P3486
   Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajilc.2003.08.005
NR 29
TC 2
Z9 3
U1 5
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2017
VL 61
IS 3
AR e01906-16
DI 10.1128/AAC.01906-16
PG 13
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA EL4QM
UT WOS:000394605900049
PM 28031194
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Mihatovic, I
   Golubovic, V
   Becker, J
   Schwarz, F
AF Mihatovic, Ilja
   Golubovic, Vladimir
   Becker, Juergen
   Schwarz, Frank
TI Bone tissue response to experimental zirconia implants
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Osseointegration; Zirconia implants; Animal study; Histomorphometry
ID SURFACE-MODIFIED ZIRCONIA; TITANIUM IMPLANTS; SUBMERGED IMPLANTS;
   ENDOSSEOUS IMPLANT; FORMATION ADJACENT; ORAL IMPLANTS; DOG;
   OSSEOINTEGRATION; RABBITS; REPLACEMENT
AB This study seeks to assess the bone tissue response at experimental zirconia implants in comparison with titanium implants by means of descriptive histology and histomorphometry in a dog model.
   Experimental zirconia implants with three different surface roughnesses (Z1 < Z2 < Z3) and conventional sandblasted large grit and acid-etched titanium implants were inserted bilaterally in the lower jaws of nine beagle dogs. Tissue biopsies were obtained after 3 and 14 days and 10 weeks of transmucosal healing. The tissue response was investigated by assessing new, old, and total bone-to-implant contact (nBIC, oBIC, and tBIC).
   After 3 days, histological specimens of all groups showed an intimate contact between the implant threads and pristine bone (tBIC: Ti 42.3 % > Z2 30.1 % > Z3 28.9 % > Z1 25.1 %, p > 0.05, unpaired t test, respectively). A provisional matrix was evident at all implant surfaces. At 14 days, percentages of BIC increased in all groups (tBIC: Ti 62.1 % > Z3 69.2 % < Z2 44.4 % > Z1 42.3 %; nBIC: Z3 58.9 % > Ti 52.2 % > Z2 35.1 % > Z1 32.5 %). Two implants, one of group Z1 and one of group Z2, were lost. At 10 weeks, 13 of 18 zirconia implants were lost, equally distributed between all three surface modifications. The remaining implants revealed increased BIC values (tBIC: Z3 69.5 % > Ti 58.5 % > Z1 49.7 % > Z2 37.1 %; nBIC: Z3 57.2 % > Ti 46.5 % > Z1 32.3 % > Z2 29.3 %). Histomorphometrical analysis showed comparable mean BIC values in all groups at all healing periods without showing statistical differences (p > 0.05, unpaired t test, respectively).
   The bone tissue response throughout the healing periods was characterized by a constant bone remodeling accompanied by resorption of old bone in favor of new bone formation at both titanium and zirconia implants. Surface roughness had a positive effect on BIC, although not showing statistical significance. Due to the poor survival rate, the experimental zirconia implants investigated may not be suitable for clinical use.
   Zirconia has been introduced as an alternative biomaterial for dental implants. A profound knowledge about the bone tissue response at zirconia implant surfaces is necessary as it plays an important role for proper osseointegration and long-term stability.
C1 [Mihatovic, Ilja; Golubovic, Vladimir; Becker, Juergen; Schwarz, Frank] Heinrich Heine Univ, Dept Oral Surg, Dusseldorf, Germany.
   [Mihatovic, Ilja] Heinrich Heine Univ, Dept Oral Surg, Westdeutsch Kieferklin, D-40225 Dusseldorf, Germany.
RP Mihatovic, I (reprint author), Heinrich Heine Univ, Dept Oral Surg, Dusseldorf, Germany.; Mihatovic, I (reprint author), Heinrich Heine Univ, Dept Oral Surg, Westdeutsch Kieferklin, D-40225 Dusseldorf, Germany.
EM ilja.mihatovic@med.uni-duesseldorf.de
FU 3M ESPE, Seefeld, Germany
FX The study was in part funded by an unrestricted grant of 3M ESPE,
   Seefeld, Germany. The study materials were provided by 3M ESPE.
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   ALBREKTSSON T, 1986, DENT CLIN N AM, V30, P151
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Chung SH, 2013, J CLIN PERIODONTOL, V40, P404, DOI 10.1111/jcpe.12073
   Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Dubruille JH, 1999, INT J ORAL MAX IMPL, V14, P271
   Favero R, 2016, CLIN ORAL IMPLAN RES, V27, P203, DOI 10.1111/clr.12591
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Glauser R, 2004, INT J PROSTHODONT, V17, P285
   Hashim D, 2016, CLIN ORAL
   Hermann JS, 1997, J PERIODONTOL, V68, P1117, DOI 10.1902/jop.1997.68.11.1117
   Hermann JS, 2000, J PERIODONTOL, V71, P1412, DOI 10.1902/jop.2000.71.9.1412
   Heydecke G, 1999, INT J PROSTHODONT, V12, P184
   Hoffmann O, 2012, INT J ORAL MAX IMPL, V27, P352
   Jemt T, 1990, Quintessenz, V41, P1935
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kohal RJ, 2008, PERIODONTOL 2000, V47, P224, DOI 10.1111/j.1600-0757.2007.00243.x
   Kohal RJ, 2004, INT J PERIODONT REST, V24, P147
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Lee J, 2009, J CLIN PERIODONTOL, V36, P610, DOI 10.1111/j.1600-051X.2009.01423.x
   Mainetti T, 2015, CLIN ORAL IMPLAN RES, V26, P435, DOI 10.1111/clr.12389
   Nagasawa M, 2013, INT J ORAL MAX IMPL, V28, P109, DOI 10.11607/jomi.2388
   Park YS, 2013, CLIN ORAL IMPLAN RES, V24, P586, DOI 10.1111/j.1600-0501.2012.02468.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rossi F, 2014, CLIN ORAL IMPLAN RES, V25, P124, DOI 10.1111/clr.12097
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schenk RK, 1984, METHODS CALCIFIED TI, P1
   Schliephake H, 1993, Int J Oral Maxillofac Implants, V8, P502
   Schwarz F, 2007, J PERIODONTOL, V78, P2171, DOI 10.1902/jop.2007.070157
   Schwarz F, 2007, CLIN ORAL INVEST, V11, P245, DOI 10.1007/s00784-007-0110-7
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Valentine-Thon E, 2003, NEUROENDOCRINOL LETT, V24, P57
NR 47
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2017
VL 21
IS 2
BP 523
EP 532
DI 10.1007/s00784-016-1904-2
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EL9ZJ
UT WOS:000394978300004
PM 27501958
DA 2018-10-20
ER

PT J
AU Dutta, RC
   Dey, M
   Dutta, AK
   Basu, B
AF Dutta, Ranjna C.
   Dey, Madhuri
   Dutta, Aroop K.
   Basu, Bikramjit
TI Competent processing techniques for scaffolds in tissue engineering
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Tissue engineering; Scaffolds; Extracellular matrix (ECM); Fabrication
   techniques; Regenerative medicine
ID ASSEMBLING PEPTIDE SCAFFOLDS; FUNCTIONALIZED POLYHIPE SCAFFOLDS;
   AMNIOTIC MEMBRANE TRANSPLANTATION; TEMPLATED POROUS POLYMERS;
   DRUG-DELIVERY DEVICES; MECHANICAL-PROPERTIES; REGENERATIVE MEDICINE;
   EXTRACELLULAR-MATRIX; IN-VITRO; GEOMETRIC CONTROL
AB Engineering a functional tissue ex vivo requires a synchronized effort towards developing technologies for ECM mimicking scaffold and cultivating tissue-specific cells in an integrated and controlled manner. Cell-interactive scaffolds in three dimensions (3D), designed and processed appropriately with an apt biomaterial to yield optimal porosity and mechanical strength is the key in tissue engineering (TE). In order to accomplish these facets in a 3D scaffold, multiple techniques and processes have been explored by researchers all over the world. New techniques offering reasonable flexibility to use blends of different materials for integrated tissue-specific mechanical strength and biocompatibility have an edge over conventional methods. They may allow a combinatorial approach with a mix of materials while incorporating multiple processing techniques for successful creation of tissue-specific ECM mimics. In this review, we analyze the material requirement from different TE perspectives, while discussing pros and cons of advanced fabrication techniques for scale-up manufacturing. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Dutta, Ranjna C.; Dutta, Aroop K.] ExCel Matrix Biol Devices P Ltd, Hyderabad, Andhra Pradesh, India.
   [Dutta, Ranjna C.; Dey, Madhuri; Basu, Bikramjit] Indian Inst Sci, Lab Biomat, Mat Res Ctr, Bangalore, Karnataka, India.
RP Dutta, RC (reprint author), ExCel Matrix Biol Devices P Ltd, Hyderabad, Andhra Pradesh, India.; Dutta, RC; Basu, B (reprint author), Indian Inst Sci, Lab Biomat, Mat Res Ctr, Bangalore, Karnataka, India.
EM ranjna_dutta@rediffmail.com; bikram@mrc.iisc.emet.in
FU Department of Biotechnology (DBT), India [BT/SBIRI/1234/SBIRI-24/14]
FX Department of Biotechnology (DBT) (BT/SBIRI/1234/SBIRI-24/14), India is
   thankfully acknowledged for supporting our ongoing endeavors. We also
   wish to thank Ms. Prerana Shankar for secretarial help.
CR Barbetta A, 2010, SOFT MATTER, V6, P1785, DOI 10.1039/b920049e
   Barbetta A, 2009, BIOMACROMOLECULES, V10, P2328, DOI 10.1021/bm900517q
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Berthiaume F, 1996, FASEB J, V10, P1471
   Bokhari M, 2007, J MATER CHEM, V17, P4088, DOI 10.1039/b707499a
   Cameron NR, 2005, POLYMER, V46, P1439, DOI 10.1016/j.polymer.2004.11.097
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Colosi C, 2013, LANGMUIR, V29, P82, DOI 10.1021/la303788z
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   Dutta Ranjna C, 2012, Front Biosci (Elite Ed), V4, P1043
   Dutta RC, 2011, THER DELIV, V2, P231, DOI 10.4155/TDE.10.100
   Dutta RC, 2010, BIOTECHNOL ADV, V28, P764, DOI 10.1016/j.biotechadv.2010.06.002
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Guo CL, 2012, P NATL ACAD SCI USA, V109, P5576, DOI 10.1073/pnas.1114781109
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Hayward AS, 2013, MACROMOL RAPID COMM, V34, P1844, DOI 10.1002/marc.201300709
   Hayward AS, 2013, BIOMACROMOLECULES, V14, P4271, DOI 10.1021/bm401145x
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jansen J, 2009, BIOMACROMOLECULES, V10, P214, DOI 10.1021/bm801001r
   Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254
   Jiang FZ, 2013, J PHYS CHEM B, V117, P13679, DOI 10.1021/jp4069587
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kokkoli E, 2006, SOFT MATTER, V2, P1015, DOI 10.1039/b608929a
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Leong KF, 2001, P I MECH ENG H, V215, P191, DOI 10.1243/0954411011533751
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63
   Lorber B, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015001
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Matsuno T, 2008, DENT MATER J, V27, P827, DOI 10.4012/dmj.27.827
   Meyer U, 1998, J MATER SCI-MATER M, V9, P301, DOI 10.1023/A:1008894612021
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Nair M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3729
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Persidis A, 1999, NAT BIOTECHNOL, V17, P508, DOI 10.1038/8700
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Pulko I, 2012, MACROMOL RAPID COMM, V33, P1731, DOI 10.1002/marc.201200393
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sanchez-Salcedo S, 2008, KEY ENG MATER, V377, P19, DOI 10.4028/www.scientific.net/KEM.377.19
   Sangwan Virender S., 2007, Indian Journal of Ophthalmology, V55, P251
   Sears NA, 2016, TISSUE ENG PART B-RE, V22, P298, DOI [10.1089/ten.TEB.2015.0464, 10.1089/ten.teb.2015.0464]
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shahini A, 2014, INT J NANOMED, V9, P167, DOI 10.2147/IJN.S54668
   Silverstein MS, 2014, POLYMER, V55, P304, DOI 10.1016/j.polymer.2013.08.068
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Stout DA, 2011, ACTA BIOMATER, V7, P3101, DOI 10.1016/j.actbio.2011.04.028
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Therien-Aubin H, 2013, J AM CHEM SOC, V135, P4834, DOI 10.1021/ja400518c
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Von Bonin W., 1962, MAKROMOL CHEM, V57, P74
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Wu BM, 1996, J CONTROL RELEASE, V40, P77, DOI 10.1016/0168-3659(95)00173-5
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu EC, 2012, ADV FUNCT MATER, V22, P456, DOI 10.1002/adfm.201101905
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao LN, 2015, 3D PRINT ADDIT MANUF, V2, P169, DOI 10.1089/3dp.2015.0033
   Yilgor P, 2008, MACROMOL SYMP, V269, P92, DOI 10.1002/masy.200850911
   Zeng J, 2003, J APPL POLYM SCI, V89, P1085, DOI 10.1002/app.12260
   Zhang H, 2004, CHEM MATER, V16, P4245, DOI 10.1021/cm0492944
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 111
TC 11
Z9 11
U1 4
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD MAR-APR
PY 2017
VL 35
IS 2
BP 240
EP 250
DI 10.1016/j.biotechadv.2017.01.001
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EM9DI
UT WOS:000395611100007
PM 28095322
DA 2018-10-20
ER

PT J
AU Qi, Y
   Wang, H
   Wei, K
   Yang, Y
   Zheng, RY
   Kim, IS
   Zhang, KQ
AF Qi, Yu
   Wang, Hui
   Wei, Kai
   Yang, Ya
   Zheng, Ru-Yue
   Kim, Ick Soo
   Zhang, Ke-Qin
TI A Review of Structure Construction of Silk Fibroin Biomaterials from
   Single Structures to Multi-Level Structures
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE silk fibroin; structure; biomaterials
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; BOMBYX-MORI;
   IN-VITRO; DRUG-DELIVERY; PHYSICAL-PROPERTIES; SURFACE-TOPOGRAPHY;
   AQUEOUS-SOLUTIONS; MOLECULAR-WEIGHT; SCAFFOLDS
AB The biological performance of artificial biomaterials is closely related to their structure characteristics. Cell adhesion, migration, proliferation, and differentiation are all strongly affected by the different scale structures of biomaterials. Silk fibroin (SF), extracted mainly from silkworms, has become a popular biomaterial due to its excellent biocompatibility, exceptional mechanical properties, tunable degradation, ease of processing, and sufficient supply. As a material with excellent processability, SF can be processed into various forms with different structures, including particulate, fiber, film, and three-dimensional (3D) porous scaffolds. This review discusses and summarizes the various constructions of SF-based materials, from single structures to multi-level structures, and their applications. In combination with single structures, new techniques for creating special multi-level structures of SF-based materials, such as micropatterning and 3D-printing, are also briefly addressed.
C1 [Qi, Yu; Wang, Hui; Wei, Kai; Yang, Ya; Zheng, Ru-Yue; Zhang, Ke-Qin] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kim, Ick Soo] Shinshu Univ, Inst Fiber Engn IFES, Div Frontier Fibers, Nano Fus Technol Res Lab,ICCER, Ueda, Nagano 3868567, Japan.
RP Wang, H; Zhang, KQ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM qjy1540945317@163.com; whui@suda.edu.cn; weikai@suda.edu.cn;
   ldxyyang@126.com; ruyuezheng92@126.com; kim@shinshu-u.ac.jp;
   kqzhang@suda.edu.cn
FU National Key Research and Development program [2016YFC1100100]; National
   Science Foundation of China [51373110]; Natural Science Foundation of
   Jiangsu Province of China [BK20161253]; Nanotechnology Foundation of
   Suzhou [ZXG2013037]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD); Qing Lan Project for Excellent
   Scientific and Technological Innovation Team of Jiangsu Province;
   Project for Jiangsu Scientific and Technological Innovation Team
FX We gratefully acknowledge the financial support from the National Key
   Research and Development program (2016YFC1100100), the National Science
   Foundation of China under Grant 51373110, the Natural Science Foundation
   of Jiangsu Province of China under grant BK20161253, and the
   Nanotechnology Foundation of Suzhou under grant ZXG2013037. We also
   acknowledge support from the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD), Qing Lan Project for
   Excellent Scientific and Technological Innovation Team of Jiangsu
   Province (2012), and the Project for Jiangsu Scientific and
   Technological Innovation Team (2013).
CR Alessandrino A, 2008, ENG LIFE SCI, V8, P219, DOI 10.1002/elsc.200700067
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Cai YR, 2017, MAT SCI ENG C-MATER, V70, P148, DOI 10.1016/j.msec.2016.08.070
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen FJ, 2012, MAT SCI ENG C-MATER, V32, P772, DOI 10.1016/j.msec.2012.01.023
   CHEN W, 1993, APPL PHYS LETT, V62, P1499, DOI 10.1063/1.109609
   Cui XD, 2013, J BIOMED MATER RES A, V101, P1511, DOI 10.1002/jbm.a.34444
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   DEMURA M, 1989, BIOTECHNOL BIOENG, V33, P598, DOI 10.1002/bit.260330513
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Du XJ, 2014, COLLOID SURFACE B, V122, P79, DOI 10.1016/j.colsurfb.2014.06.049
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Gupta V, 2009, INT J NANOMED, V4, P115
   Han HY, 2016, ADV FUNCT MATER, V26, P421, DOI 10.1002/adfm.201504160
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   He Y, 2014, J MATER CHEM B, V2, P2220, DOI 10.1039/c4tb00146j
   Huang J, 2011, FIBER POLYM, V12, P1002, DOI 10.1007/s12221-011-1002-7
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jao WC, 2012, POLYM ADVAN TECHNOL, V23, P1066, DOI 10.1002/pat.2014
   Jia L, 2016, J BIOMED MATER RES B, V104, P431, DOI 10.1002/jbm.b.33408
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Keene EC, 2010, CRYST GROWTH DES, V10, P5169, DOI 10.1021/cg1009303
   Khalid A, 2015, ACS BIOMATER SCI ENG, V1, P1104, DOI 10.1021/acsbiomaterials.5b00220
   Kim HH, 2016, POLYMER, V90, P26, DOI 10.1016/j.polymer.2016.02.054
   Kim MK, 2015, INT J BIOL MACROMOL, V79, P988, DOI 10.1016/j.ijbiomac.2015.05.040
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Koh LD, 2015, PROG POLYM SCI, V46, P86, DOI 10.1016/j.progpolymsci.2015.02.001
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lee OJ, 2016, TISSUE ENG REGEN MED, V13, P218, DOI 10.1007/s13770-016-9058-5
   Li XF, 2016, J MATER CHEM B, V4, P2903, DOI 10.1039/c6tb00213g
   Liu B, 2015, COLLOID SURFACE B, V131, P122, DOI 10.1016/j.colsurfb.2015.04.040
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Luo KY, 2016, ADV FUNCT MATER, V26, P872, DOI 10.1002/adfm.201503450
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Melke J, 2016, ACTA BIOMATER, V31, P1, DOI 10.1016/j.actbio.2015.09.005
   Metavarayuth K, 2016, ACS BIOMATER SCI ENG, V2, P142, DOI 10.1021/acsbiomaterials.5b00377
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MORI K, 1995, J MOL BIOL, V251, P217, DOI 10.1006/jmbi.1995.0429
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park J, 2016, RSC ADV, V6, P39330, DOI 10.1039/c6ra04516b
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Phillips DM, 2005, J MATER CHEM, V15, P4206, DOI 10.1039/b510069k
   Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Ribeiro M, 2015, EUR POLYM J, V67, P66, DOI 10.1016/j.eurpolymj.2015.03.056
   Rodriguez MJ, 2017, BIOMATERIALS, V117, P105, DOI 10.1016/j.biomaterials.2016.11.046
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Safdari M, 2016, FIBER POLYM, V17, P744, DOI 10.1007/s12221-016-5822-3
   Sagnella A, 2016, RSC ADV, V6, P9304, DOI 10.1039/c5ra20684g
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Shi PJ, 2012, POWDER TECHNOL, V215-16, P85, DOI 10.1016/j.powtec.2011.09.012
   Sun L, 2012, ADV HEALTHC MATER, V1, P729, DOI 10.1002/adhm.201200057
   Suntivich R, 2014, BIOMACROMOLECULES, V15, P1428, DOI 10.1021/bm500027c
   Swinerd VM, 2007, SOFT MATTER, V3, P1377, DOI 10.1039/b711975e
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Terada D, 2016, MAT SCI ENG C-MATER, V58, P119, DOI 10.1016/j.msec.2015.07.041
   Uttayarat P, 2012, FIBER POLYM, V13, P999, DOI 10.1007/s12221-012-0999-6
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Volkov V, 2015, MACROMOL MATER ENG, V300, P1199, DOI 10.1002/mame.201500179
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang H, 2013, CHEM COMMUN, V49, P1431, DOI 10.1039/c2cc38779d
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wust S, 2011, J FUNCT BIOMATER, V2, P119, DOI 10.3390/jfb2030119
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Yan L., 2016, J TISSUE ENG REGEN M
   Yan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31037
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   You RC, 2014, J BIOMED MATER RES A, V102, P4206, DOI 10.1002/jbm.a.35097
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zeng DM, 2015, MAT SCI ENG C-MATER, V50, P226, DOI 10.1016/j.msec.2015.02.005
   Zhang Q, 2016, J BIOMED MATER RES A, V104, P3045, DOI 10.1002/jbm.a.35851
   Zhao Z, 2015, INT J MOL SCI, V16, P4880, DOI 10.3390/ijms16034880
   Zhong J, 2013, ACS APPL MATER INTER, V5, P737, DOI 10.1021/am302271g
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou J, 2014, ACS APPL MATER INTER, V6, P21813, DOI 10.1021/am502278b
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
   Zhu YR, 2012, MAT SCI ENG C-MATER, V32, P390, DOI 10.1016/j.msec.2011.11.002
NR 116
TC 14
Z9 14
U1 8
U2 47
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2017
VL 18
IS 3
AR 237
DI 10.3390/ijms18030237
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EN8ME
UT WOS:000396253700003
PM 28273799
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Aguilar-Colomer, A
   Doadrio, JC
   Perez-Jorge, C
   Manzano, M
   Vallet-Regi, M
   Esteban, J
AF Aguilar-Colomer, Anna
   Carlos Doadrio, Juan
   Perez-Jorge, Concepcion
   Manzano, Miguel
   Vallet-Regi, Maria
   Esteban, Jaime
TI Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by
   Staphylococcus aureus and Staphylococcus epidermidis
SO JOURNAL OF ANTIBIOTICS
LA English
DT Article
ID PROSTHETIC JOINT INFECTIONS; IN-VITRO SUSCEPTIBILITY; FOREIGN-BODY
   INFECTION; MESOPOROUS MATERIALS; DRUG-DELIVERY; BACTERIAL ADHERENCE;
   FUNCTIONALIZATION; BIOCERAMICS
AB Staphylococcus aureus and Staphylococcus epidermidis are human pathogens involved in implant-related infections. During those diseases, they are able to form biofilms showing resistance to the effect of many different antibiotics. Drug delivery systems allow a local and effective delivery of antibiotics at high concentrations in the infected tissue without causing the cytotoxic effects commonly linked to systemic administration. We report the use of a porous ceramic biomaterial, such as SBA-15 loaded with antibiotics, to deliver them directly to the infected tissue. SBA-15 discs were loaded with Vancomycin, Rifampin and a combination of both, introduced in a suspension of S. aureus 15981 and S. epidermidis ATCC 35984 and incubated during 6 and 24 h. A statistically significant decrease in the biofilm density and the number of viable bacteria was detected for all antibiotics at 6 h in both bacteria. Rifampin showed an increase in the biofilm density and the number of viable bacteria at 24 h. No differences were detected between Vancomycin and the combination of antibiotics. S. epidermidis was more sensitive to the effect of the antibiotics than S. aureus. Here we have demonstrated that SBA-15 is able to act as an effective drug delivery system not only from a pharmaceutical point of view, but also from a biological one.
C1 [Aguilar-Colomer, Anna; Perez-Jorge, Concepcion; Esteban, Jaime] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Av Reyes Catolicos 2, Madrid 28040, Spain.
   [Carlos Doadrio, Juan; Manzano, Miguel; Vallet-Regi, Maria] Univ Complutense Madrid, Dept Inorgan & Bioinorgan Chem, Madrid, Spain.
   [Vallet-Regi, Maria] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
RP Esteban, J (reprint author), IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Av Reyes Catolicos 2, Madrid 28040, Spain.
EM jestebanmoreno@gmail.com
RI Esteban, Jaime/S-6554-2018; Doadrio, Juan Carlos/G-9445-2017; Manzano,
   Miguel/K-3719-2014; Vallet-Regi, Maria/M-3378-2014
OI Esteban, Jaime/0000-0002-8971-3167; Doadrio, Juan
   Carlos/0000-0001-7912-5663; Manzano, Miguel/0000-0001-6238-6111;
   Vallet-Regi, Maria/0000-0002-6104-4889
FU Spanish MINECO [MAT2013-48224-C2-2-R]
FX This work was funded by the following grant from the Spanish MINECO
   (MAT2013-48224-C2-2-R).
CR Argyo C, 2014, CHEM MATER, V26, P435, DOI 10.1021/cm402592t
   Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Benito N, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.004
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   Colilla M, 2014, J MATER CHEM B, V2, P5639, DOI 10.1039/c4tb00690a
   Ferenc M, 2016, MICROPOR MESOPOR MAT, V231, P47, DOI 10.1016/j.micromeso.2016.05.012
   Gomez-Barrena E, 2012, J ORTHOP RES, V30, P1634, DOI 10.1002/jor.22114
   Hamilton M. A., 2010, KSASM06 ENUMERATING
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Holinka J, 2012, INT J ARTIF ORGANS, V35, P735, DOI 10.5301/ijao.5000152
   Hyman W., 1998, ANN BIOMED ENG, V26, P338
   Kinnari TJ, 2009, J BIOMED MATER RES A, V89A, P215, DOI 10.1002/jbm.a.31943
   Lora-Tamayo J, 2013, CLIN INFECT DIS, V56, P182, DOI 10.1093/cid/cis746
   Lozano D, 2010, ACTA BIOMATER, V6, P797, DOI 10.1016/j.actbio.2009.08.033
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   Manzano M, 2010, J MATER CHEM, V20, P5593, DOI 10.1039/b922651f
   Molina-Manso D, 2016, J ANTIBIOT, V69, P686, DOI 10.1038/ja.2016.9
   Molina-Manso D, 2013, INT J ANTIMICROB AG, V41, P521, DOI 10.1016/j.ijantimicag.2013.02.018
   Molina-Manso D, 2012, J ANTIBIOT, V65, P505, DOI 10.1038/ja.2012.62
   Molina-Manso D, 2012, INT J ANTIMICROB AG, V40, P252, DOI 10.1016/j.ijantimicag.2012.05.013
   Moritz M, 2015, MAT SCI ENG C-MATER, V49, P114, DOI 10.1016/j.msec.2014.12.079
   Nieto A, 2008, MICROPOR MESOPOR MAT, V116, P4, DOI 10.1016/j.micromeso.2008.03.025
   Rochford ETJ, 2012, CLIN MICROBIOL INFEC, V18, P1162, DOI 10.1111/j.1469-0691.2012.04002.x
   Senneville E, 2011, CLIN INFECT DIS, V53, P334, DOI 10.1093/cid/cir402
   TAYLOR GJS, 1992, J HOSP INFECT, V22, P241, DOI 10.1016/0195-6701(92)90048-Q
   TAYLOR GJS, 1993, J APPL BACTERIOL, V74, P174
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vallet-Regi M., 2006, INTRO LIBERACION FAR, P7
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 32
TC 1
Z9 1
U1 2
U2 15
PU JAPAN ANTIBIOTICS RESEARCH ASSOC
PI TOKYO
PA 2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN
SN 0021-8820
J9 J ANTIBIOT
JI J. Antibiot.
PD MAR
PY 2017
VL 70
IS 3
BP 259
EP 263
DI 10.1038/ja.2016.154
PG 5
WC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
GA EL9EB
UT WOS:000394921100005
PM 27999440
DA 2018-10-20
ER

PT J
AU Przekora, A
   Klimek, K
   Wojcik, M
   Palka, K
   Ginalska, G
AF Przekora, Agata
   Klimek, Katarzyna
   Wojcik, Michal
   Palka, Krzysztof
   Ginalska, Grazyna
TI New method for HA/glucan bone scaffold preparation reduces cytotoxic
   effect of highly reactive bioceramics
SO MATERIALS LETTERS
LA English
DT Article
DE Ion reactivity; Biomaterials; Composite materials; Cytotoxicity;
   Curdlan; Sintering
ID ION REACTIVITY; CERAMICS; HYDROXYAPATITE; COMPOSITE
AB Highly reactive bioceramics deprive culture medium of Ca2+ ions which is lethal to the cells in vitro. The aim of this work was to demonstrate that new method for HA/glucan scaffold fabrication, involving calcium as a cross-linker for beta-1,3-glucan gel, may support cell survival ih vitro when highly reactive bioceramics are the component of the biomaterial. Two composites made of highly reactive hydroxyapatite (HA) and beta-1,3-glucan were prepared basing on 2 different methods. Then, ion reactivity of the materials and cell behaviour on their surfaces were compared. Obtained results proved that new method for HA/beta-1,3-glucan fabrication protects against Ca2+ uptake by reactive HA supporting osteoblast growth in vitro. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Przekora, Agata; Klimek, Katarzyna; Wojcik, Michal; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1 St, PL-20093 Lublin, Poland.
   [Palka, Krzysztof] Lublin Univ Technol, Dept Mat Engn, Nadbystrzycka 36 St, PL-20618 Lublin, Poland.
RP Przekora, A (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1 St, PL-20093 Lublin, Poland.
EM agata.przekora@umlub.pl
OI Przekora-Kusmierz, Agata/0000-0002-6076-1309; Ginalska,
   Grazyna/0000-0002-9961-4226; Palka, Krzysztof/0000-0003-4920-4613
FU Ministry of Science and Higher Education - Poland
   [POPW.01.03.00-06-010/09-00]
FX The study was supported by Ministry of Science and Higher Education -
   Poland within MNmb1 and DS2 projects and developed using the equipment
   purchased within agreement No. POPW.01.03.00-06-010/09-00 Operational
   Program Development of Eastern Poland 2007-2013, Priority Axis I, Modern
   Economy, Operations 1.3. Innovations Promotion.
CR An SF, 2012, J MATER SCI-MATER M, V23, P789, DOI 10.1007/s10856-011-4531-0
   Belcarz A, 2013, CENT EUR J BIOL, V8, P534, DOI 10.2478/s11535-013-0169-2
   Borkowski L, 2015, MAT SCI ENG C-MATER, V53, P60, DOI 10.1016/j.msec.2015.04.009
   Cao N., 2012, ISRN CHEM ENG
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Klimek K., 2016, J BIOMED MAT RES A
   Klimek K., Polish Patent pending, Patent No. [P.415936, 415936]
   Klimek K, 2016, MAT SCI ENG C-MATER, V65, P70, DOI 10.1016/j.msec.2016.03.105
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Przekora A, 2014, J BIOTECHNOL, V182, P46, DOI 10.1016/j.jbiotec.2014.04.022
   Przekora A, 2014, CENT EUR J BIOL, V9, P277, DOI 10.2478/s11535-013-0261-2
   Vivanco J, 2011, J MECH BEHAV BIOMED, V4, P2150, DOI 10.1016/j.jmbbm.2011.07.015
NR 12
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD MAR 1
PY 2017
VL 190
BP 213
EP 216
DI 10.1016/j.matlet.2017.01.033
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EL1RY
UT WOS:000394399900056
DA 2018-10-20
ER

PT J
AU Kim, HJ
   Yim, EC
   Kim, JH
   Kim, SJ
   Park, JY
   Oh, IK
AF Kim, Hyun-Jun
   Yim, Eun-Chae
   Kim, Jong-Hun
   Kim, Seong-Jun
   Park, Jeong-Young
   Oh, Il-Kwon
TI Bacterial Nano-Cellulose Triboelectric Nanogenerator
SO NANO ENERGY
LA English
DT Article
DE Energy harvesting; Triboelectric nanogenerator; Self-power; Biomaterial;
   Bacterial nanocellulose
ID ACETOBACTER-XYLINUM; ENERGY; ELECTRONICS; GENERATOR; TECHNOLOGY;
   SENSORS; DIPOLE; WASTE; FILM
AB Motivated by a desire to resolve the needs of sustainable energy resources, remote sensing electronics, wireless autonomous devices, mobile internet of things (IoT) and portable self-power generators, triboelectric nanogenerators have recently been suggested. However, more specialized target applications to biomedical and wearable devices will require biocompatible and eco-friendly triboelectric materials in power generators. Herein, we report for the first time a bio-triboelectric nanogenerator based on an eco-friendly and naturally abundant biomaterial, bacterial nanocellulose. Initially, bacterial cellulose pellicles were produced in a gel state by Acetobacter xylinum KJ1 in the Glu-Fruc medium and then a bacterial nanocellulose film having transparent and flexible functionalities was regenerated on a current collector via a solubilization process. The bacterial nanocellulose triboelectric nanogenerator was investigated with various input conditions and structural aspects. The working mechanism was also considered by measuring the contact angle and the surface potential of the friction materials. We believe that this study provides new insights to advancing the biocompatible and ecofriendly triboelectric power generator and optimization strategies to achieve high performance of triboelectric nanogenerators.
C1 [Kim, Hyun-Jun; Oh, Il-Kwon] Korea Adv Inst Sci & Technol, Creat Res Initiat Ctr Functionally Antagonist Nan, Dept Mech Engn, 291 Daehak Ro, Daejeon 34141, South Korea.
   [Yim, Eun-Chae; Kim, Seong-Jun] Chonnam Natl Univ, Dept Environm Engn, 77 Yongbong Ro, Gwangju 61186, South Korea.
   [Kim, Jong-Hun; Park, Jeong-Young] Korea Adv Inst Sci & Technol, Grad Sch EEWS, 291 Daehak Ro, Daejeon 34141, South Korea.
RP Oh, IK (reprint author), Korea Adv Inst Sci & Technol, Creat Res Initiat Ctr Functionally Antagonist Nan, Dept Mech Engn, 291 Daehak Ro, Daejeon 34141, South Korea.
EM ikoh@kaist.ac.kr
RI Park, Jeong Young/A-2999-2008; OH, ILKWON/B-7121-2011
FU National Research Foundation of Korea (NRF) [2015R1A3A2028975]
FX This work was supported by Creative Research Initiative Program
   (2015R1A3A2028975) funded by National Research Foundation of Korea
   (NRF).
CR ALEXANDER WJ, 1949, ANAL CHEM, V21, P1497, DOI 10.1021/ac60036a018
   Bai P, 2014, NANO RES, V7, P990, DOI 10.1007/s12274-014-0461-8
   Brown AJ, 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Byun KE, 2016, ACS APPL MATER INTER, V8, P18519, DOI 10.1021/acsami.6b02802
   Chang WR, 2017, RENEW SUST ENERG REV, V67, P277, DOI 10.1016/j.rser.2016.09.020
   Chun J, 2015, ENERG ENVIRON SCI, V8, P3006, DOI 10.1039/c5ee01705j
   Durmusoglu A, 2016, J CLEAN PROD, V129, P305, DOI 10.1016/j.jclepro.2016.04.068
   Fan FR, 2012, NANO ENERGY, V1, P328, DOI 10.1016/j.nanoen.2012.01.004
   Gao QY, 2011, CARBOHYD POLYM, V83, P1253, DOI 10.1016/j.carbpol.2010.09.029
   Garlapati VK, 2016, RENEW SUST ENERG REV, V54, P874, DOI 10.1016/j.rser.2015.10.106
   Gayathry G, 2014, INDIAN J FIBRE TEXT, V39, P93
   Greason WD, 2004, IEEE T IND APPL, V40, P442, DOI 10.1109/TIA.2004.824439
   Ha M, 2015, ACS NANO, V9, P3421, DOI 10.1021/acsnano.5b01478
   Jeon JH, 2010, SENSOR ACTUAT B-CHEM, V146, P307, DOI 10.1016/j.snb.2010.02.046
   Jie Y, 2015, ACS NANO, V9, P8376, DOI 10.1021/acsnano.5b03052
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Jung YK, 2016, NANO ENERGY, V30, P77, DOI 10.1016/j.nanoen.2016.09.039
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kim D, 2016, ACS NANO, V10, P1017, DOI 10.1021/acsnano.5b06329
   Kim HJ, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502329
   Kim JH, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4923202
   Li SH, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301655
   Lin L, 2013, ACS NANO, V7, P8266, DOI 10.1021/nn4037514
   Niu SM, 2013, ENERG ENVIRON SCI, V6, P3576, DOI 10.1039/c3ee42571a
   Okushita K, 2012, BIOMACROMOLECULES, V13, P1323, DOI 10.1021/bm300537k
   Oliveira RL, 2015, J BRAZIL CHEM SOC, V26, P1861, DOI 10.5935/0103-5053.20150163
   Pang JH, 2013, MATERIALS, V6, P1270, DOI 10.3390/ma6041270
   Rao K.H., 2008, PROCESS J, V1, P6
   Sadewasser S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266103
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   Seol ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep16409
   Sharma S, 2015, RSC ADV, V5, P63111, DOI 10.1039/c5ra09068g
   Son C, 2002, J MICROBIOL BIOTECHN, V12, P722
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Wang F, 2016, COMPOS SCI TECHNOL, V128, P33, DOI 10.1016/j.compscitech.2016.03.012
   Wang F, 2016, SOFT MATTER, V12, P246, DOI 10.1039/c5sm00707k
   Wang JB, 2016, WASTE MANAGE, V53, P218, DOI 10.1016/j.wasman.2016.03.036
   Wang SH, 2012, NANO LETT, V12, P6339, DOI 10.1021/nl303573d
   Wang ZL, 2015, ENERG ENVIRON SCI, V8, P2250, DOI 10.1039/c5ee01532d
   Wang ZL, 2013, ACS NANO, V7, P9533, DOI 10.1021/nn404614z
   Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656
   Yamamoto H, 2006, CELLULOSE, V13, P327, DOI 10.1007/s10570-005-9034-z
   Yang J, 2014, ACS NANO, V8, P2649, DOI 10.1021/nn4063616
   Zhao ZF, 2016, ACS NANO, V10, P1780, DOI 10.1021/acsnano.5b07157
   Zheng L, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501152
   Zheng L, 2014, NANO ENERGY, V9, P291, DOI 10.1016/j.nanoen.2014.07.024
   Zhu G, 2013, NANO LETT, V13, P847, DOI 10.1021/nl4001053
   Zhu G, 2012, NANO LETT, V12, P4960, DOI 10.1021/nl302560k
   Zi YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10987
NR 49
TC 10
Z9 10
U1 18
U2 91
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-2855
EI 2211-3282
J9 NANO ENERGY
JI Nano Energy
PD MAR
PY 2017
VL 33
BP 130
EP 137
DI 10.1016/j.nanoen.2017.01.035
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EP3XE
UT WOS:000397314200014
DA 2018-10-20
ER

PT J
AU Ni, N
   Dumont, MJ
AF Ni, Na
   Dumont, Marie-Josee
TI Protein-Based Hydrogels Derived from Industrial Byproducts Containing
   Collagen, Keratin, Zein and Soy
SO WASTE AND BIOMASS VALORIZATION
LA English
DT Review
DE Hydrogels; Proteins; Industrial byproducts; Extraction; Processing
ID GLUTARALDEHYDE CROSS-LINKING; ACELLULAR DERMAL MATRIX; HUMAN HAIR
   KERATIN; CORN GLUTEN MEAL; RAT TAIL TENDON; BIOMEDICAL APPLICATIONS;
   DRUG-DELIVERY; IN-VITRO; MICROBIAL TRANSGLUTAMINASE;
   ENZYMATIC-HYDROLYSIS
AB Proteins are renewable resources rich in animals and plants and can be extracted from the agricultural and breeding industry byproducts and wastes. Collagen, keratin, zein and soy proteins are found in these byproducts and are extensively studied for protein-based hydrogels, which are especially attractive as a promising biomaterial due to their excellent biocompatibility, biodegradability, nontoxicity and low immune response. In recent years, hydrogels have been playing an increasingly important role in tissue engineering, drug delivery, nutrient encapsulation, controlled release of pesticides and other fields. The diversity of the amino acid composition of proteins leads to significant differences in their processing strategies, and the properties of the resultant hydrogels. This review covers the extraction methods for collagen, keratin, zein and soy proteins from various industrial byproducts, the synthesis of hydrogels from these protein sources, as well as their potential applications.
C1 [Ni, Na; Dumont, Marie-Josee] McGill Univ, Dept Bioresource Engn, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
RP Dumont, MJ (reprint author), McGill Univ, Dept Bioresource Engn, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
EM marie-josee.dumont@mcgill.ca
FU Fonds de Recherche du Quebec-Nature et Technologies (FRQNT)
FX The authors gratefully acknowledge the funding provided by the Fonds de
   Recherche du Quebec-Nature et Technologies (FRQNT).
CR Ahn JI, 2013, ACTA BIOMATER, V9, P7796, DOI 10.1016/j.actbio.2013.04.014
   AjaySharma L., 2015, INT ENDOD J, V49, P471
   Alarcon EI, 2015, NANOSCALE, V7, P18789, DOI 10.1039/c5nr03826j
   Albu MG, 2010, MOL CRYST LIQ CRYST, V523, P97, DOI 10.1080/15421401003724159
   Alting AC, 2002, J AGR FOOD CHEM, V50, P4682, DOI 10.1021/jf011657m
   Anderson TJ, 2011, CEREAL CHEM, V88, P356, DOI 10.1094/CCHEM-08-10-0117
   Anderson TJ, 2011, CEREAL CHEM, V88, P159, DOI 10.1094/CCHEM-06-10-0091
   Antoine EE, 2014, TISSUE ENG PART B-RE, V20, P683, DOI [10.1089/ten.teb.2014.0086, 10.1089/ten.TEB.2014.0086]
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bai XP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045002
   Bai X, 2016, CHEM ENG J, V288, P546, DOI 10.1016/j.cej.2015.12.021
   Barnes AL, 2016, BIOMACROMOLECULES, V17, P723, DOI 10.1021/acs.biomac.5b01251
   Barrows T.H., 2015, U.S. Patent, Patent No. 9023380
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bendtsen ST, 2015, J MATER CHEM B, V3, P3081, DOI 10.1039/c5tb00072f
   Bou-Akl T, 2013, J BIOMED MATER RES A, V101, P2507, DOI 10.1002/jbm.a.34549
   Brauer S, 2007, MACROMOL MATER ENG, V292, P176, DOI 10.1002/mame.200600364
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Cai WB, 2004, J AM CHEM SOC, V126, P15030, DOI 10.1021/ja0442062
   Caillard R, 2008, J FOOD SCI, V73, pC283, DOI 10.1111/j.1750-3841.2008.00780.x
   Caillard R, 2009, FOOD RES INT, V42, P98, DOI 10.1016/j.foodres.2008.10.004
   Campbell DI, 2014, J MAXILLOFAC ORAL SU, V13, P159, DOI 10.1007/s12663-013-0482-y
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Candage R, 2008, SURGERY, V144, P703, DOI 10.1016/j.surg.2008.06.018
   Cansu U, 2015, KOREAN J FOOD SCI AN, V35, P431, DOI 10.5851/kosfa.2015.35.4.431
   Cardamone JM, 2013, TEXT RES J, V83, P661, DOI 10.1177/0040517512468814
   Carter R., 1970, U. S. Patent, Patent No. [3,535,305, 3535305]
   CASSIDY A, 1994, AM J CLIN NUTR, V60, P333
   Chandran PL, 2012, CONNECT TISSUE RES, V53, P285, DOI 10.3109/03008207.2011.640760
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Chen LY, 2009, BIOMACROMOLECULES, V10, P3327, DOI 10.1021/bm900989y
   Chen S., 2016, SCI TECHNOL ADV MAT
   Cheng YM, 2014, CARBOHYD POLYM, V107, P57, DOI 10.1016/j.carbpol.2014.02.034
   Chien KB, 2014, J BIOMATER APPL, V28, P1085, DOI 10.1177/0885328213497413
   DANZER LA, 1975, BIOCHIM BIOPHYS ACTA, V386, P26, DOI 10.1016/0005-2795(75)90242-1
   de Guzman RC, 2013, BIOMATERIALS, V34, P1644, DOI 10.1016/j.biomaterials.2012.11.002
   De Vries A., 2014, EPL, V107
   Deak NA, 2007, J AM OIL CHEM SOC, V84, P259, DOI 10.1007/s11746-007-1035-7
   Delcour J., 2010, PRINCIPLES CEREAL SC, P40
   Demitri C, 2008, J APPL POLYM SCI, V110, P2453, DOI 10.1002/app.28660
   Desobry SA, 1997, J FOOD SCI, V62, P1158, DOI 10.1111/j.1365-2621.1997.tb12235.x
   DeVictor P., 1995, U.S. Patent, Patent No. 5420248
   Doillon CJ, 1997, J BIOMED MATER RES, V37, P212
   Dong FY, 2013, SOFT MATTER, V9, P5933, DOI 10.1039/c3sm50667c
   DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   Dunn M. W., 1980, U. S. Patent, Patent No. 4223984
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   ESEN A, 1990, J PROTEIN CHEM, V9, P453, DOI 10.1007/BF01024621
   Eslahi N, 2013, PREP BIOCHEM BIOTECH, V43, P624, DOI 10.1080/10826068.2013.763826
   Fisher J., 2010, U.S. Patent, Patent No. 7754232
   Foegeding E. A., 1996, FOOD CHEM, V3, P902
   FRANCIS G, 1975, BIOCHEM J, V145, P287, DOI 10.1042/bj1450287
   Fu JX, 2009, MAT SCI ENG C-BIO S, V29, P1161, DOI 10.1016/j.msec.2008.09.031
   Gomez-Estaca J, 2009, J FOOD ENG, V90, P480, DOI 10.1016/j.jfoodeng.2008.07.022
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Gomez-Guillen MC, 2009, TRENDS FOOD SCI TECH, V20, P3, DOI 10.1016/j.tifs.2008.10.002
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Griffey E.S., 2008, U.S Patent, Patent No. 7358284
   Guo J, 2013, FOOD HYDROCOLLOID, V31, P220, DOI 10.1016/j.foodhyd.2012.10.023
   He LR, 2011, INT J BIOL MACROMOL, V48, P354, DOI 10.1016/j.ijbiomac.2010.12.012
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang G., 2005, CHEM BIOENGINEERING, V9, P48
   Hurtado-Lopez P, 2005, J DRUG DELIV SCI TEC, V15, P267, DOI 10.1016/S1773-2247(05)50048-0
   Hwang D., 1998, US Patent No, Patent No. [5,847,089, 5847089]
   Hwang DC, 1997, J APPL POLYM SCI, V64, P891, DOI 10.1002/(SICI)1097-4628(19970502)64:5<891::AID-APP9>3.0.CO;2-K
   Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035
   Kakkar P, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-596
   Kang HG, 2005, POLYM INT, V54, P537, DOI 10.1002/pi.1719
   Kaplan D., 2012, PROTEIN BASED MAT, P133, DOI [10.1007/978-1-4612-4094-5, DOI 10.1007/978-1-4612-4094-5]
   Karthikeyan R, 2007, J SCI IND RES INDIA, V66, P710
   Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3
   Kim J, 2015, J BIOL ENG, V9, DOI 10.1186/1754-1611-9-1
   KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468
   Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kurimoto A, 2003, J BIOSCI BIOENG, V96, P307, DOI 10.1263/jbb.96.307
   Lai YP, 2013, J FOOD ENG, V114, P221, DOI 10.1016/j.jfoodeng.2012.08.012
   Lee H, 2014, TISSUE ENG REGEN MED, V11, P255, DOI 10.1007/s13770-014-0029-4
   Lee JS, 2006, LIFE SCI, V79, P1578, DOI 10.1016/j.lfs.2006.06.030
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li YD, 2008, BIOMACROMOLECULES, V9, P3157, DOI 10.1021/bm800745p
   Liu DS, 2015, FOOD CHEM, V172, P836, DOI 10.1016/j.foodchem.2014.09.147
   Liu LS, 2007, CELLULOSE, V14, P15, DOI 10.1007/s10570-006-9095-7
   Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   Luo YC, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40696
   Ma L, 2015, J MATER CHEM B, V3, P5241, DOI 10.1039/c5tb00523j
   Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]
   Maltais A, 2005, J FOOD SCI, V70, pC67, DOI 10.1111/j.1365-2621.2005.tb09023.x
   MANNHEIM A, 1993, CEREAL CHEM, V70, P115
   Martelli SM, 2012, INT J POLYM MATER, V61, P17, DOI 10.1080/00914037.2011.557809
   Maruyama N, 2002, J AM OIL CHEM SOC, V79, P139, DOI 10.1007/s11746-002-0448-z
   Maruyama N, 2001, EUR J BIOCHEM, V268, P3595, DOI 10.1046/j.1432-1327.2001.02268.x
   Meikle ST, 2012, TISSUE ENG PT A, V18, P1932, DOI [10.1089/ten.tea.2011.0549, 10.1089/ten.TEA.2011.0549]
   Meschia M, 2007, J UROLOGY, V177, P192, DOI 10.1016/j.juro.2006.08.100
   Miyata T., 1981, U.S. Patent, Patent No. 4264155
   Mori H, 2013, MAT SCI ENG C-MATER, V33, P174, DOI 10.1016/j.msec.2012.08.025
   Moros EE, 2002, J AGR FOOD CHEM, V50, P5787, DOI [10.1021/jf020109l, 10.1021/jf0201909l]
   Mukhidinov ZK, 2011, PHARM CHEM J+, V44, P564, DOI 10.1007/s11094-011-0518-x
   Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035
   O'brien R.D., 2010, FATS OILS FORMULATIN
   Ozaki Y, 2014, MAT SCI ENG C-MATER, V42, P146, DOI 10.1016/j.msec.2014.05.018
   Pace LA, 2014, TISSUE ENG PT A, V20, P507, DOI 10.1089/ten.TEA.2013.0084
   Paliwal R, 2014, J CONTROL RELEASE, V189, P108, DOI 10.1016/j.jconrel.2014.06.036
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Perkins E.G., 1995, PRACTICAL HDB SOYBEA
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Przybyla DE, 2008, J AM CHEM SOC, V130, P12610, DOI 10.1021/ja804942w
   Puppo MC, 1998, J AGR FOOD CHEM, V46, P3583, DOI 10.1021/jf980006w
   Quispe-Condori S, 2011, LWT-FOOD SCI TECHNOL, V44, P1880, DOI 10.1016/j.lwt.2011.01.005
   Rad ZP, 2012, J AEROSOL SCI, V51, P49, DOI 10.1016/j.jaerosci.2012.04.007
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Remadnia A, 2009, CONSTR BUILD MATER, V23, P3118, DOI 10.1016/j.conbuildmat.2009.06.027
   Reyes PI, 2013, SENSOR LETT, V11, P539, DOI 10.1166/sl.2013.2822
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sacks FM, 2006, CIRCULATION, V113, P1034, DOI 10.1161/CIRCULATIONAHA.106.171052
   Sahiner M, 2014, POLYM BULL, V71, P3017, DOI 10.1007/s00289-014-1235-x
   Sanami M., 2015, J BIOMED MATER RES B, V104B, P1
   Sanborn TA, 1999, J INVASIVE CARDIOL, V11, p6B
   Santin M, 2008, EXPERT REV MED DEVIC, V5, P349, DOI 10.1586/17434440.5.3.349
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seville PC, 2002, J GENE MED, V4, P428, DOI 10.1002/jgm.282
   Shi W, 2014, EUR POLYM J, V54, P172, DOI 10.1016/j.eurpolymj.2014.03.007
   Shi W, 2014, J MATER SCI, V49, P1915, DOI 10.1007/s10853-013-7933-1
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Singh N, 1998, T ASAE, V41, P1775
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sousa FFO, 2012, INT J PHARMACEUT, V439, P41, DOI 10.1016/j.ijpharm.2012.09.046
   Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516
   Su JF, 2012, MAT SCI ENG C-MATER, V32, P40, DOI 10.1016/j.msec.2011.09.009
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Takami Y, 1996, BURNS, V22, P182, DOI 10.1016/0305-4179(95)00123-9
   Tang CH, 2006, J FOOD BIOCHEM, V30, P35, DOI 10.1111/j.1745-4514.2005.00049.x
   THOMPSON EO, 1965, AUST J BIOL SCI, V18, P1207, DOI 10.1071/BI9651207
   Tihminlioglu F, 2010, J FOOD ENG, V96, P342, DOI 10.1016/j.jfoodeng.2009.08.018
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   UTSUMI S, 1985, J FOOD SCI, V50, P1278, DOI 10.1111/j.1365-2621.1985.tb10461.x
   Vallejos N, 2014, FOOD BIOPHYS, V9, P322, DOI 10.1007/s11483-014-9339-2
   Van Dyke M., 2005, U.S. Patent, Patent No. 6849092
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Walters BD, 2014, ACTA BIOMATER, V10, P1488, DOI 10.1016/j.actbio.2013.08.038
   Wang N., 2006, LEATHER SCI ENG, V16, P42
   Wang Q, 2008, FOOD BIOPHYS, V3, P174, DOI 10.1007/s11483-008-9080-9
   Wang Y., 2015, C.N. Patent, Patent No. 103468771
   Wang Y, 2012, COLLOID POLYM SCI, V290, P1593, DOI 10.1007/s00396-012-2749-0
   Wang Y, 2010, LANGMUIR, V26, P12897, DOI 10.1021/la101688v
   Watson S., 1967, COMP WET MILLING PRO, P488
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wei P.-B., 2006, CHINA LEATHER, V3, P003
   Wolf WJ, 1997, CEREAL CHEM, V74, P530, DOI 10.1094/CCHEM.1997.74.5.530
   Wrzesniewska-Tosik K., 2007, FIBRES TEXT EAST EUR, V15, P60
   Wu SW, 1997, CEREAL CHEM, V74, P258, DOI 10.1094/CCHEM.1997.74.3.258
   Xu GH, 2015, ACTA BIOMATER, V15, P55, DOI 10.1016/j.actbio.2014.12.016
   Xu HL, 2014, LANGMUIR, V30, P8461, DOI 10.1021/la500768b
   Xu SB, 2016, J BIOACT COMPAT POL, V31, P179, DOI 10.1177/0883911515609941
   Xu W, 2007, J AGR FOOD CHEM, V55, P6279, DOI 10.1021/jf0633239
   Yan F., 2012, ABSTR PAP AM CHEM S, P244
   Yaxin S., 2012, J CHIN I FOOD SCI TE, V5, P056
   Yu HS, 2012, J BIOMED MATER RES A, V100A, P2431, DOI 10.1002/jbm.a.34163
   Yu LW, 2008, J APPL POLYM SCI, V108, P1100, DOI 10.1002/app.27689
   Yuan J, 2015, J TISSUE ENG REGEN M, V9, P1027, DOI 10.1002/term.1653
   Zeugolis DI, 2010, MAT SCI ENG C-MATER, V30, P190, DOI 10.1016/j.msec.2009.09.017
   Zhang XM, 2014, J BIOMED MATER RES A, V102, P2669, DOI 10.1002/jbm.a.34938
   Zhang YH, 2013, FOOD CHEM, V141, P2343, DOI 10.1016/j.foodchem.2013.05.058
   Zheng WF, 2010, ADV ENG MATER, V12, pB451, DOI 10.1002/adem.200980087
   Zhong QX, 2009, J FOOD PROCESS PRES, V33, P255, DOI 10.1111/j.1745-4549.2009.00390.x
   Zhong QX, 2009, J AGR FOOD CHEM, V57, P3886, DOI 10.1021/jf803951a
   Zhu h., 2014, C.N. Patent, Patent No. 102888436
   Zohuriaan-Mehr MJ, 2009, POLYM ADVAN TECHNOL, V20, P655, DOI 10.1002/pat.1395
   Zucherman J.F., 2004, U.S. Patent, Patent No. 6783546
NR 180
TC 2
Z9 3
U1 7
U2 46
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1877-2641
EI 1877-265X
J9 WASTE BIOMASS VALORI
JI Waste Biomass Valorization
PD MAR
PY 2017
VL 8
IS 2
BP 285
EP 300
DI 10.1007/s12649-016-9684-0
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EL0ZZ
UT WOS:000394351600003
DA 2018-10-20
ER

PT J
AU Cheraghi, M
   Namdari, M
   Negahdari, B
   Eatemadi, A
AF Cheraghi, Mostafa
   Namdari, Mehrdad
   Negahdari, Babak
   Eatemadi, Ali
TI RETRACTED: Recent advances in cardiac regeneration: Stem cell,
   biomaterial and growth factors (Retracted article. See vol. 96, pg.
   1570, 2017)
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review; Retracted Publication
DE Myocardial infarction; Cell therapy; Protein therapy; Biomaterials;
   Delivery systems
ID ACUTE MYOCARDIAL-INFARCTION; SELF-ASSEMBLING PEPTIDE; BONE-MARROW-CELLS;
   DOUBLE-BLIND; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; PROGENITOR CELLS;
   CLINICAL-TRIAL; HEART-FAILURE; THERAPY
AB Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Cheraghi, Mostafa; Namdari, Mehrdad] Lorestan Univ Med Sci, Dept Cardiol, Khorramabad 6997118544, Iran.
   [Negahdari, Babak; Eatemadi, Ali] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran.
   [Eatemadi, Ali] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Khorramabad, Iran.
   [Eatemadi, Ali] Lorestan Univ Med Sci, Sch Med, Dept Med Biotechnol, Lorestan, Iran.
RP Namdari, M (reprint author), Lorestan Univ Med Sci, Dept Cardiol, Khorramabad 6997118544, Iran.; Eatemadi, A (reprint author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran.
EM hadisdaraee@gmail.com; a-eatemadi@razi.tums.ac.ir
CR Ahmadi B.B., 2014, J TEHRAN U HEART CTR, V9, P70
   Ahmadvand H., 2015, ARYA, V11, P153
   Ahmadvand H, 2016, ARYA ATHEROSCLER, V12, P87
   Aiyelabegan HT, 2016, INT J POLYM MAT POLY
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Baharvand B, 2009, INT J CARDIOL, V135, P187, DOI 10.1016/j.ijcard.2008.03.048
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Beiranvand S, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1520-8
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Cheraghi M, 2010, ARYA ATHEROSCLER, V6, P111
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436
   Da Silva JS, 2013, METHODS MOL BIOL, V1037, P145, DOI 10.1007/978-1-62703-505-7_8
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Daraee H, 2016, ARTIF CELL NANOMED B, V44, P381, DOI 10.3109/21691401.2014.953633
   Daraee H, 2016, ARTIF CELL NANOMED B, V44, P410, DOI 10.3109/21691401.2014.955107
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Diaz-Herraez P, 2013, EUR J PHARM BIOPHARM, V85, P143, DOI 10.1016/j.ejpb.2013.03.022
   Du X. Z. J., 2013, ENVIRON TOXICOL PHAR, V36, P451
   Eatemadi A., 2016, BIOMED PHARMACOTHER
   Eatemadi A, 2016, ARTIF CELL NANOMED B, V44, P1008, DOI 10.3109/21691401.2015.1008510
   Eatemadi A, 2016, ARTIF CELL NANOMED B, V44, P111, DOI 10.3109/21691401.2014.922568
   Eatemadi A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-393
   Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P109, DOI 10.1016/j.carpath.2005.03.004
   Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008
   Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed
   Fukuhara S, 2005, CIRC J, V69, P850, DOI 10.1253/circj.69.850
   Ghafarzadeh M, 2016, CELL MOL BIOL, V62, P102, DOI 10.14715/cmb/2016.62.6.19
   Ghafarzadeh M, 2010, PAK J MED SCI, V26, P987
   Ghafarzadeh M, 2015, ARCH GYNECOL OBSTET, V292, P321, DOI 10.1007/s00404-015-3645-x
   Ghafarzadeh M, 2016, BIOMED PHARMACOTHER, V84, P1163, DOI 10.1016/j.biopha.2016.10.055
   Ghafarzadeh M, 2010, PAK J MED SCI, V26, P407
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703
   Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Jaferian S, 2016, BIOMED PHARMACOTHER, V84, P780, DOI 10.1016/j.biopha.2016.10.004
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kastrup J, 2011, EUROINTERVENTION, V6, P813, DOI 10.4244/EIJV6I7A140
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Khosravi AR, 2011, J RES MED SCI, V16, P640
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Leor J, 2000, CIRCULATION, V102, P56
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Maher KO, 2013, DISCOV MED, V15, P349
   Maleki Ali, 2016, Indian Journal of Physiology and Pharmacology, V60, P30
   Matsudaira K, 2012, CIRC J, V76, P1509, DOI 10.1253/circj.CJ-11-1127
   Mellatyar H, 2014, ASIAN PAC J CANCER P, V15, P8693, DOI 10.7314/APJCP.2014.15.20.8693
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Mi K, 2009, MACROMOL BIOSCI, V9, P437, DOI 10.1002/mabi.200800262
   Mohamadi A, 2015, CARDIOLOGY, V132, P281
   Mohammadian F., 2016, ARTIF CELL NANOMED B, P1
   Mohyeddin-Bonab M, 2007, ARCH IRAN MED, V10, P467
   Moradi K, 2015, IRAN J BASIC MED SCI, V18, P563
   Nadri S., 2016, J MICROENCAPSUL, P1
   Namdari M, 2016, CELL MOL BIOL, V62, P1, DOI 10.14715/cmb/2016.62.11.1
   Namdari M, 2011, CARDIOVASC J AFR, V22, P67, DOI CVJ-21.022
   Namdari M, 2016, BIOMED PHARMACOTHER, V84, P1179, DOI 10.1016/j.biopha.2016.10.058
   Namdari P, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1618-z
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003
   Pourrajab F, 2014, INT J CARDIOL, V173, P12, DOI 10.1016/j.ijcard.2014.02.006
   Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117
   Ruvinov E., 2012, SYNTH LECT TISSUE EN, V4, P1
   Seidi K, 2014, J AIDS CLIN RES, V2014
   Shah Vinod K, 2007, Indian Heart J, V59, P482
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Srivastava D, 2012, ANN NY ACAD SCI, V1270, P66, DOI 10.1111/j.1749-6632.2012.06696.x
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tolabi T., 2012, IJCCN, V5, P53
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vahabi S., 2016, BIOMED PHARMACOTHER
   Vahabi S, 2017, BIOMED PHARMACOTHER, V86, P1, DOI 10.1016/j.biopha.2016.11.137
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058
NR 82
TC 6
Z9 6
U1 3
U2 33
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD MAR
PY 2017
VL 87
BP 37
EP 45
DI 10.1016/j.biopha.2016.12.071
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EM7XM
UT WOS:000395525600005
PM 28040596
DA 2018-10-20
ER

PT J
AU Dubnika, A
   Loca, D
   Rudovica, V
   Parekh, MB
   Berzina-Cimdina, L
AF Dubnika, Arita
   Loca, Dagnija
   Rudovica, Vita
   Parekh, Mansi Bharat
   Berzina-Cimdina, Liga
TI Functionalized silver doped hydroxyapatite scaffolds for controlled
   simultaneous silver ion and drug delivery
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Silver ion release; Lidocaine hydrochloride release; Silver doped
   hydroxyapatite scaffolds; Sodium alginate; Chitosan; Composite polymer
   scaffolds
ID SUBSTITUTED HYDROXYAPATITE; LIDOCAINE HYDROCHLORIDE; COMPOSITE
   SCAFFOLDS; CALCIUM-PHOSPHATE; RELEASE; ANTIBACTERIAL; COATINGS;
   BIOCOMPATIBILITY; NANOPARTICLES; ALGINATE
AB Bacterial infections are a major problem in bone tissue regeneration, thus it is essential to incorporate antibacterial properties within the bone scaffolds. Silver compounds are frequently used as antibacterial agents to prevent bacterial infections and numerous studies have shown that silver ions can be incorporated within the biocompatible and osteoconductive biomaterial hydroxyapatite (HAp) structure, but, so far, no study has thoroughly evaluated silver ion release rates in long term. Therefore, we have established a novel carrier system for local drug delivery based on functionalized silver doped hydroxyapatite with determined long term silver ion release rates. Silver ions from prepared scaffolds were released with a rate of 0.001 0.0005 wt%/h taking into account the incorporated silver amount. Moreover, lidocaine hydrochloride was incorporated in the prepared scaffolds, to provide local anesthetic effect. These scaffolds were functionalized with sodium alginate and chitosan and in vitro drug release rate in simulated body fluid was evaluated. The results suggested that the developed novel composite scaffolds possess the antibacterial activity up to one year as well as controlled anesthetic drug delivery up to two weeks.
C1 [Dubnika, Arita; Loca, Dagnija; Berzina-Cimdina, Liga] Riga Tech Univ, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr, Inst Gen Chem Engn, Pulka Str 3-3, LV-1007 Riga, Latvia.
   [Parekh, Mansi Bharat] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.
   [Rudovica, Vita] Univ Latvia, Dept Analyt Chem, Kr Valdemara Str 48, LV-1013 Riga, Latvia.
RP Dubnika, A (reprint author), Riga Tech Univ, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr, Inst Gen Chem Engn, Pulka Str 3-3, LV-1007 Riga, Latvia.
EM arita.dubnika@rtu.lv; dagnija.loca@rtu.lv; vita.rudovica@lu.lv;
   liga.berzina-cimdina@rtu.lv
OI Dubnika, Arita/0000-0001-8940-5335; Rudovica, Vita/0000-0001-6693-9051
FU Baltic-American Freedom Foundation; European Social Fund within the
   project "Support for the implementation of doctoral studies at Riga
   Technical University" [2009/0144/1DP/1.1.2.1.2/09/IPIA/VIAA/005]; Riga
   Technical University through the Scientific Research Project Competition
   for Young Researchers [ZP-2016/14];  [2014.10-4/VPP-3/21 IMIS2];  [4]
FX This work has been supported by the National Research Programme No.
   2014.10-4/VPP-3/21 IMIS<SUP>2</SUP>, Project No. 4 "Nanomaterials and
   nanotechnologies for medical applications", by Baltic-American Freedom
   Foundation, by the European Social Fund (grant no.
   2009/0144/1DP/1.1.2.1.2/09/IPIA/VIAA/005) within the project "Support
   for the implementation of doctoral studies at Riga Technical University"
   and by Riga Technical University through the Scientific Research Project
   Competition for Young Researchers No. ZP-2016/14.
CR Baradari H, 2012, J EUR CERAM SOC, V32, P2679, DOI 10.1016/j.jeurceramsoc.2012.01.018
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bruschi M. L., 2015, MATH MODELS DRUG REL, P63
   Chen YK, 2010, SURF COAT TECH, V205, P1892, DOI 10.1016/j.surfcoat.2010.08.073
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Ciobanu CS, 2013, MAT SCI ENG C-MATER, V33, P1395, DOI 10.1016/j.msec.2012.12.042
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Colovic B, 2012, CERAM INT, V38, P6181, DOI 10.1016/j.ceramint.2012.04.069
   Dash S, 2010, ACTA POL PHARM, V67, P217
   de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780
   Dubnika A, 2014, CERAM INT, V40, P9923, DOI 10.1016/j.ceramint.2014.02.088
   Dubnika A, 2014, J MATER SCI-MATER M, V25, P435, DOI 10.1007/s10856-013-5079-y
   Dubnika A, 2012, P EST ACAD SCI, V61, P193, DOI 10.3176/proc.2012.3.08
   Hussain Lokhandwala A.D., 2013, INT J PHARM BIO SCI, V4, P728
   Jin HH, 2012, INT J BIOL MACROMOL, V51, P1079, DOI 10.1016/j.ijbiomac.2012.08.027
   Kim HL, 2015, MAT SCI ENG C-MATER, V54, P20, DOI 10.1016/j.msec.2015.04.033
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Kose N, 2016, INJURY, V47, P320, DOI 10.1016/j.injury.2015.10.006
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   Lim PN, 2013, J BIOMED MATER RES A, V101, P2456, DOI 10.1002/jbm.a.34544
   Liu XM, 2013, APPL SURF SCI, V273, P748, DOI 10.1016/j.apsusc.2013.02.130
   Locs J, 2013, J EUR CERAM SOC, V33, P3437, DOI 10.1016/j.jeurceramsoc.2013.06.010
   Melegari C, 2016, EUR J PHARM BIOPHARM, V100, P15, DOI 10.1016/j.ejpb.2015.12.001
   Nath S., 2010, J MAT SCI MAT MED, V21
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Pamela K.J.H., 2005, ANN OCCUP HYG, V49, P575
   Pang X, 2008, SURF COAT TECH, V202, P3815, DOI 10.1016/j.surfcoat.2008.01.022
   Peetsch A, 2013, COLLOID SURFACE B, V102, P724, DOI 10.1016/j.colsurfb.2012.09.040
   Preis M, 2014, EUR J PHARM BIOPHARM, V86, P552, DOI 10.1016/j.ejpb.2013.12.019
   Rambhia KJ, 2015, J CONTROL RELEASE, V219, P119, DOI 10.1016/j.jconrel.2015.08.049
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Ramteke K. H., 2014, SCH ACAD J PHARM, V3, P388
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Sartori C., 1997, THESIS
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Suwanprateeb J, 2012, J MATER SCI-MATER M, V23, P2091, DOI 10.1007/s10856-012-4690-7
   Wei L, 2011, POLYMER, V52, P5139, DOI 10.1016/j.polymer.2011.09.006
   Wu ZJ, 2005, J CONTROL RELEASE, V104, P497, DOI 10.1016/j.jconrel.2005.02.023
   Zairani N.A.S., 2015, CERAM INT
NR 40
TC 7
Z9 7
U1 5
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2017
VL 43
IS 4
BP 3698
EP 3705
DI 10.1016/j.ceramint.2016.11.214
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA EK4ZY
UT WOS:000393937900032
DA 2018-10-20
ER

PT J
AU Conzatti, G
   Cavalie, S
   Combes, C
   Torrisani, J
   Carrere, N
   Tourrette, A
AF Conzatti, G.
   Cavalie, S.
   Combes, C.
   Torrisani, J.
   Carrere, N.
   Tourrette, A.
TI PNIPAM grafted surfaces through ATRP and RAFT polymerization: Chemistry
   and bioadhesion
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Surface functionalization; Reversible addition fragmentation chain
   transfer polymerization; Atom transfer radical polymerization;
   Poly(N-isopropylacrylamide); Bioadhesion
ID TRANSFER RADICAL POLYMERIZATION; SELF-ASSEMBLED MONOLAYERS; N-ISOPROPYL
   ACRYLAMIDE; ION MASS-SPECTROMETRY; INITIATED AGET ATRP; CELL-ADHESION;
   THERMORESPONSIVE POLYMER; METHYL-METHACRYLATE; CATALYST CONCENTRATION;
   BIOMATERIAL SURFACES
AB Biomaterials surface design is critical for the control of materials and biological system interactions. Being regulated by a layer of molecular dimensions, bioadhesion could be effectively tailored by polymer surface grafting. Basically, this surface modification can be controlled by radical polymerization, which is a useful tool for this purpose. The aim of this review is to provide a comprehensive overview of the role of surface characteristics on bioadhesion properties. We place a particular focus on biomaterials functionalized with a brush surface, on presentation of grafting techniques for "grafting to" and "grafting from" strategies and on brush characterization methods. Since atom transfer radical, polymerization (ATRP) and reversible addition-fragmentation chain transfer (RAFT) polymerization are the most frequently used grafting techniques, their main characteristics will be explained. Through the example of poly(N-isopropylacrylamide) (PNIPAM) which is a widely used polymer allowing tuneable cell adhesion, smart surfaces involving PNIPAM will be presented with their main modern applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Conzatti, G.; Cavalie, S.; Tourrette, A.] Univ Toulouse, CNRS, Univ Paul Sabatier,Fac Pharmacie, CIRIMAT,INPT,UPS,, 35 Chemin Maraichers, F-31062 9 Toulouse, France.
   [Combes, C.] Univ Toulouse, CNRS, CIRIMAT, INPT,UPS,ENSIACET, 4 Alee Emile Monso,CS 44362, F-31030 4 Toulouse, France.
   [Torrisani, J.; Carrere, N.] Univ Toulouse III Paul Sabatier, Univ Federate Midi Pyrenees, INSERM, U1037,CRCT Toulouse, 2 Ave Hubert Curien CS 53717, F-31037 1 Toulouse, France.
   [Carrere, N.] Purpan Hosp, CHU Toulouse, Gastrointestinal Surg Dept, Pl Dr Baylac, F-31059 Toulouse, France.
RP Tourrette, A (reprint author), Univ Toulouse, CNRS, Univ Paul Sabatier,Fac Pharmacie, CIRIMAT,INPT,UPS,, 35 Chemin Maraichers, F-31062 9 Toulouse, France.
EM audrey.tourrette@univ-tlse3.fr
RI Tourrette, Audrey/R-2763-2017; TORRISANI, Jerome/M-6203-2014
OI Tourrette, Audrey/0000-0003-1107-2176; Conzatti,
   Guillaume/0000-0002-8002-5894
FU French National Research Agency [ANR-14-CE17-0002-01]
FX Authors would like to thank the French National Research Agency for its
   financial support (ANR-14-CE17-0002-01, FP-BioPrev project).
CR Abbott RD, 2015, TRENDS BIOTECHNOL, V33, P401, DOI 10.1016/j.tibtech.2015.04.003
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Alem H, 2008, J MEMBRANE SCI, V308, P75, DOI 10.1016/j.memsci.2007.09.036
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Audouin F, 2013, EUR POLYM J, V49, P1073, DOI 10.1016/j.eurpolymj.2013.01.013
   Ayres N, 2007, LANGMUIR, V23, P3744, DOI 10.1021/la062417+
   Bacakova L, 2007, J MATER SCI-MATER M, V18, P1317, DOI 10.1007/s10856-006-0074-1
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Barner-Kowollik C, 2003, J POLYM SCI POL CHEM, V41, P365, DOI 10.1002/pola.10567
   Barsbay M, 2009, RADIAT PHYS CHEM, V78, P1054, DOI 10.1016/j.radphyschem.2009.06.022
   Bhut BV, 2012, J MEMBRANE SCI, V390, P43, DOI 10.1016/j.memsci.2011.10.057
   Bigot J, 2010, POLYM CHEM-UK, V1, P1024, DOI 10.1039/c0py00085j
   Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h
   Borges AMG, 2013, MAT SCI ENG C-MATER, V33, P1315, DOI 10.1016/j.msec.2012.12.031
   Brouette N, 2012, EUR PHYS J-SPEC TOP, V213, P343, DOI 10.1140/epjst/e2012-01681-4
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Cao J, 2013, MACROMOL RAPID COMM, V34, P1747, DOI 10.1002/marc.201300513
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen JK, 2009, J COLLOID INTERF SCI, V338, P428, DOI 10.1016/j.jcis.2009.06.040
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Chen JP, 2012, APPL SURF SCI, V262, P95, DOI 10.1016/j.apsusc.2012.02.106
   Chen L, 2009, J AM CHEM SOC, V131, P10467, DOI 10.1021/ja9019935
   Cheng XH, 2006, BIOINTERPHASES, V1, P61, DOI 10.1116/1.2187980
   Cho EC, 2004, POLYMER, V45, P3195, DOI 10.1016/j.polymer.2004.02.052
   Chung PW, 2008, ADV FUNCT MATER, V18, P1390, DOI 10.1002/adfm.200701116
   Cockerill M., 2015, PLOS ONE, P1
   Cooperstein MA, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-19
   Cooperstein MA, 2010, LANGMUIR, V26, P7695, DOI 10.1021/la902587p
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Draper J, 2004, LANGMUIR, V20, P4064, DOI 10.1021/la0361316
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Gao M, 2006, PHYS CHEM CHEM PHYS, V8, P3692, DOI 10.1039/b606019f
   Garner-Kowollik C., 2008, HDB RAFT POLYM
   Gong R, 2008, APPL SURF SCI, V254, P6802, DOI 10.1016/j.apsusc.2008.04.101
   Gunnewiek MK, 2012, ISR J CHEM, V52, P339, DOI 10.1002/ijch.201100118
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Halperin A, 2012, BIOMATERIALS, V33, P4975, DOI 10.1016/j.biomaterials.2012.03.060
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Hou C, 2008, POLYMER, V49, P3424, DOI 10.1016/j.polymer.2008.06.013
   Hsiao CY, 2014, EUR POLYM J, V51, P12, DOI 10.1016/j.eurpolymj.2013.11.013
   Hufendiek A, 2014, BIOMACROMOLECULES, V15, P2563, DOI 10.1021/bm500416m
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005
   Ignacio C, 2011, J MATER SCI-MATER M, V22, P1357, DOI 10.1007/s10856-011-4299-2
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Iyer KS, 2003, MACROMOLECULES, V36, P6519, DOI 10.1021/ma034460z
   Jakubowski W, 2005, MACROMOLECULES, V38, P4139, DOI 10.1021/ma047389l
   Jones DM, 2002, ADV MATER, V14, P1130, DOI 10.1002/1521-4095(20020816)14:16<1130::AID-ADMA1130>3.0.CO;2-7
   Kaneshiro N, 2006, BIOCHEM BIOPH RES CO, V349, P723, DOI 10.1016/j.bbrc.2006.08.096
   Kang CJ, 2014, MACROMOLECULES, V47, P269, DOI 10.1021/ma401951w
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Krol P, 2014, PROG ORG COAT, V77, P913, DOI 10.1016/j.porgcoat.2014.01.027
   Kumar AC, 2009, COLLOID SURFACE B, V70, P60, DOI 10.1016/j.colsurfb.2008.12.004
   Kusolkamabot K, 2013, LANGMUIR, V29, P12317, DOI 10.1021/la402139g
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lee YM, 1997, POLYMER, V38, P1227, DOI 10.1016/S0032-3861(96)00548-4
   Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078
   Lim H, 2003, J POLYM SCI POL PHYS, V41, P1791, DOI 10.1002/polb.10536
   Lindqvist J, 2006, J APPL POLYM SCI, V100, P4155, DOI 10.1002/app.23457
   Liu HW, 2014, INT J BIOCHEM CELL B, V51, P131, DOI 10.1016/j.biocel.2014.04.009
   Liu HL, 2013, ADV MATER, V25, P922, DOI 10.1002/adma.201203826
   Liu JL, 2011, LANGMUIR, V27, P12684, DOI 10.1021/la202749v
   Liu LD, 2014, SOFT MATTER, V10, P2856, DOI 10.1039/c3sm52778f
   Liu P, 2007, E-POLYMERS
   Liu Y, 2005, LANGMUIR, V21, P11806, DOI 10.1021/la051695q
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lodish H., 2014, BIOL MOL CELL, P925
   Lokuge I, 2007, LANGMUIR, V23, P305, DOI 10.1021/la060813m
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Maeda Y, 2001, MACROMOLECULES, V34, P8246, DOI 10.1021/ma010222x
   Malham IB, 2010, LANGMUIR, V26, P4762, DOI 10.1021/la9035387
   Mansfeld U, 2010, POLYM CHEM-UK, V1, P1560, DOI 10.1039/c0py00168f
   Matyjaszewski K, 2006, P NATL ACAD SCI USA, V103, P15309, DOI 10.1073/pnas.0602675103
   Min K, 2007, MACROMOLECULES, V40, P1789, DOI 10.1021/ma0702041
   Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2009.01.004
   Moroni L, 2014, ACTA BIOMATER, V10, P2367, DOI 10.1016/j.actbio.2014.02.048
   Nakanishi S, 2014, CHEM-EUR J, V20, P5802, DOI 10.1002/chem.201304593
   Olivier A, 2012, PROG POLYM SCI, V37, P157, DOI 10.1016/j.progpolymsci.2011.06.002
   Pan K, 2010, J MEMBRANE SCI, V356, P133, DOI 10.1016/j.memsci.2010.03.044
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   Poli R, 2014, PROG POLYM SCI, V39, P1827, DOI 10.1016/j.progpolymsci.2014.06.003
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Qin J, 2011, MACROMOL CHEM PHYS, V212, P999, DOI 10.1002/macp.201000737
   Qiu XY, 2013, CARBOHYD POLYM, V92, P1887, DOI 10.1016/j.carbpol.2012.11.080
   Qu TH, 2009, COLLOID SURFACE B, V72, P94, DOI 10.1016/j.colsurfb.2009.03.020
   Ran J, 2014, PROG POLYM SCI, V39, P124, DOI 10.1016/j.progpolymsci.2013.09.001
   Reed JA, 2012, LANGMUIR, V28, P2281, DOI 10.1021/la102606k
   Ren LL, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0940-3
   Russel F. G. M., 1997, P NATL ACAD SCI USA, V94, P13661
   Sdrobis A, 2012, POLYM INT, V61, P1767, DOI 10.1002/pi.4268
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shivapooja P, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0032-z
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sui XF, 2010, J MATER CHEM, V20, P4981, DOI 10.1039/b924392e
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Takahashi H, 2010, BIOMACROMOLECULES, V11, P1991, DOI 10.1021/bm100342e
   Tamura A, 2012, BIOMACROMOLECULES, V13, P1765, DOI 10.1021/bm300256e
   Tamura A, 2010, J CONTROL RELEASE, V146, P378, DOI 10.1016/j.jconrel.2010.05.031
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Tourrette A, 2009, COLLOID SURFACE A, V352, P126, DOI 10.1016/j.colsurfa.2009.10.014
   Tunc M, 2007, RETINA-J RET VIT DIS, V27, P938, DOI 10.1097/IAE.0b013e318042ae81
   Umapathi R, 2015, COLLOID SURFACE B, V135, P588, DOI 10.1016/j.colsurfb.2015.08.020
   Vasani RB, 2011, LANGMUIR, V27, P7843, DOI 10.1021/la200551g
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang XJ, 2006, LANGMUIR, V22, P817, DOI 10.1021/la052741p
   Wang Y, 2011, MACROMOLECULES, V44, P4022, DOI 10.1021/ma200771r
   Worthley CH, 2011, J MEMBRANE SCI, V385, P30, DOI 10.1016/j.memsci.2011.09.017
   Wu WB, 2016, FIBER POLYM, V17, P495, DOI 10.1007/s12221-016-5877-1
   Xu FJ, 2004, BIOMACROMOLECULES, V5, P2392, DOI 10.1021/bm049675a
   Xu WM, 1998, DEVELOPMENT, V125, P327
   Xue CY, 2012, ADV FUNCT MATER, V22, P2394, DOI 10.1002/adfm.201103056
   Xue CY, 2011, LANGMUIR, V27, P8810, DOI 10.1021/la2001909
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang LL, 2015, CHINESE J POLYM SCI, V33, P1640, DOI 10.1007/s10118-015-1703-2
   Yasaka M., 2010, RIGAKU J, V26, P1, DOI DOI 10.1097/01.SS.0000026967.27546.82
   Yousafzai MS, 2016, OPT LASER ENG, V76, P27, DOI 10.1016/j.optlaseng.2015.02.008
   Yu Q, 2014, ADV FUNCT MATER, V24, P3751, DOI 10.1002/adfm.201304274
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Zdyrko B, 2011, MACROMOL RAPID COMM, V32, P859, DOI 10.1002/marc.201100162
   Zhang CH, 2012, J BIOMED MATER RES B, V100B, P217, DOI 10.1002/jbm.b.31941
   Zhang LF, 2010, POLYM BULL, V64, P233, DOI 10.1007/s00289-009-0139-7
   Zhang YZ, 2012, MACROMOLECULES, V45, P78, DOI 10.1021/ma201963c
   Zhao TL, 2011, COLLOID SURFACE B, V85, P26, DOI 10.1016/j.colsurfb.2010.10.047
   Zhen WJ, 2012, APPL SURF SCI, V258, P6969, DOI 10.1016/j.apsusc.2012.03.145
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
   Zhuang PY, 2016, LANGMUIR, V32, P3433, DOI 10.1021/acs.langmuir.6b00448
NR 139
TC 5
Z9 5
U1 19
U2 114
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2017
VL 151
BP 143
EP 155
DI 10.1016/j.colsurfb.2016.12.007
PG 13
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EL2UJ
UT WOS:000394475400018
PM 27992845
OA Green Published
DA 2018-10-20
ER

PT J
AU Venault, A
   Hsu, KJ
   Yeh, LC
   Chinnathambi, A
   Ho, HT
   Chang, Y
AF Venault, Antoine
   Hsu, Ko-Jen
   Yeh, Lu-Chen
   Chinnathambi, Arunachalam
   Ho, Hsin-Tsung
   Chang, Yung
TI Surface charge-bias impact of amine-contained pseudozwitterionic
   biointerfaces on the human blood compatibility
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Poly(SA-co-amide/amine); Blood compatibility control; Charge bias;
   Pseudozwitterionic biomaterials; Hydrogel interfaces
ID RAY PHOTOELECTRON-SPECTROSCOPY; BIOMEDICAL APPLICATIONS; FIBRINOGEN
   ADSORPTION; PROTEIN ADSORPTION; PLATELET-ADHESION; DRUG-DELIVERY;
   IN-SITU; HYDROGELS; POLYMER; PLASMA
AB This work discusses the impact of the charge bias and the hydrophilicity on the human blood compatibility of pseudozwitterionic biomaterial gels. Four series of hydrogels were prepared, all containing negatively-charged 3-sulfopropyl methacrylate (SA), and either acrylamide, N-isopropylacrylamide, 2-dimethylaminoethyl methacrylate (DMAEMA) or [2-(methacryloyloxy)ethyl] trimethylammonium (TMA), to form S(n)A(m), SnNm, SnDm or SnTm hydrogels, respectively, An XPS analysis proved that the polymerization was well controlled from the initial monomer ratios. All gels present high surface hydrophilicity, but varying bulk hydration, depending on the nature/content of the comonomer, and on the immersion medium. The most negative interfaces (pure SA, S7A3, S5A5) showed significant fibrinogen adsorption, ascribed to the interactions of the alpha C domains of the protein with the gels, then correlated to considerable platelet adhesion; but low leukocyte/erythrocyte attachments were measured. Positive gels (excess of DMAEMA or TMA) are not hemocompatible. They mediate protein adsorption and the adhesion of human blood cells, through electrostatic attractive interactions. The neutral interfaces (zeta potential between -10 mV and +10 mV) are blood-inert only if they present a high surface and bulk hydrophilicity. Overall, this study presents a map of the hemocompatible behavior of hydrogels as a function of their surface charge-bias, essential to the design of blood-contacting devices. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Venault, Antoine; Hsu, Ko-Jen; Yeh, Lu-Chen; Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Venault, Antoine; Hsu, Ko-Jen; Yeh, Lu-Chen; Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
   [Chinnathambi, Arunachalam] King Saud Univ, Coll Sci, Dept Bot & Microbiol, POB 2455, Riyadh 11451, Saudi Arabia.
   [Ho, Hsin-Tsung] Mackay Mem Hosp, Lab Med, Taipei 104, Taiwan.
RP Venault, A; Chang, Y (reprint author), Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.; Venault, A; Chang, Y (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
EM avenault@cycu.edu.tw; ychang@cycu.edu.tw
OI Venault, Antoine/0000-0002-0383-695X
FU project of Outstanding Professor Research Program in the Chung Yuan
   Christian University, Taiwan; Ministry of Science and Technology [MOST
   103-2221-E-033-078-MY3, MOST 105-2622-B-033-001]; International
   Scientific Partnership Program ISPP at King Saud University [0051]
FX The authors would like to acknowledge the project of Outstanding
   Professor Research Program in the Chung Yuan Christian University,
   Taiwan, and the Ministry of Science and Technology (MOST
   103-2221-E-033-078-MY3; MOST 105-2622-B-033-001) for their financial
   support. The authors extend their appreciation to the International
   Scientific Partnership Program ISPP at King Saud University for funding
   this research work through ISPP# 0051.
CR Abraham AA, 2013, ACS APPL MATER INTER, V5, P12832, DOI 10.1021/am4040653
   Akiyama Y, 2007, J NANOSCI NANOTECHNO, V7, P796, DOI 10.1166/jnn.2007.509
   Andrade J. D., 1987, ASAIO J, V33, P75
   Becerra-Bracamontes F, 2007, J APPL POLYM SCI, V106, P3939, DOI 10.1002/app.26992
   Brahim S, 2003, BIOMACROMOLECULES, V4, P1224, DOI 10.1021/bm034048r
   Calo E, 2015, EUR POLYM J, V65, P252, DOI 10.1016/j.eurpolymj.2014.11.024
   Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chang Y, 2011, LANGMUIR, V27, P5445, DOI 10.1021/la1048369
   Chang Y, 2009, BIOMACROMOLECULES, V10, P2092, DOI 10.1021/bm900208u
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Chou YN, 2015, ACS APPL MATER INTER, V7, P10096, DOI 10.1021/acsami.5b01756
   Demirci S, 2013, J POLYM SCI POL CHEM, V51, P2677, DOI 10.1002/pola.26657
   Dobbins SC, 2012, J PHYS CHEM B, V116, P14346, DOI 10.1021/jp307588b
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   Faxalv L, 2010, ACTA BIOMATER, V6, P2599, DOI 10.1016/j.actbio.2009.12.046
   Feng L., 1995, PROTEINS INTERFACES, VII
   Fernandes JC, 2008, BIOMACROMOLECULES, V9, P3346, DOI 10.1021/bm800622f
   Fucinos C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087190
   Geismann C, 2007, LANGMUIR, V23, P76, DOI 10.1021/la0603774
   Han YC, 2012, ACS APPL MATER INTER, V4, P4616, DOI 10.1021/am300992x
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hoffman AS, 2000, J BIOMED MATER RES, V52, P577, DOI 10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.3.CO;2-X
   Jhong JF, 2014, ACS APPL MATER INTER, V6, P9858, DOI 10.1021/am502382n
   Kang ET, 1998, PROG POLYM SCI, V23, P277, DOI 10.1016/S0079-6700(97)00030-0
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lei HY, 2014, LANGMUIR, V30, P501, DOI 10.1021/la403781s
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   Lin S, 2008, BIOMACROMOLECULES, V9, P109, DOI 10.1021/bm7008747
   Liu SQ, 2012, ADV MATER, V24, P6484, DOI 10.1002/adma.201202225
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Ni T, 2010, POLYM J, V42, P357, DOI 10.1038/pj.2010.10
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Ray D, 2008, J BIOMAT SCI-POLYM E, V19, P1487, DOI 10.1163/156856208786140382
   Rezwan K, 2005, BIOMATERIALS, V26, P4351, DOI 10.1016/j.biomaterials.2004.11.017
   Roppolo I, 2015, RSC ADV, V5, P95805, DOI 10.1039/c5ra21521h
   Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369
   Sekine Y, 2014, POLYMER, V55, P6320, DOI 10.1016/j.polymer.2014.10.011
   Shang J, 2008, BIOMACROMOLECULES, V9, P1208, DOI 10.1021/bm701204j
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shih YJ, 2014, LANGMUIR, V30, P6489, DOI 10.1021/la5015779
   Stile RA, 2004, J BIOMAT SCI-POLYM E, V15, P865, DOI 10.1163/1568562041271129
   Terzaki K, 2013, J BIOMED MATER RES A, V101, P2283, DOI 10.1002/jbm.a.34516
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UCHIDA E, 1994, LANGMUIR, V10, P1193, DOI 10.1021/la00016a037
   Uzgun S, 2010, BIOMACROMOLECULES, V11, P39, DOI 10.1021/bm9008759
   Venault A, 2015, LANGMUIR, V31, P2861, DOI 10.1021/la505000m
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Von Hundelshausen P, 2009, MICROCIRCULATION, V16, P84, DOI 10.1080/10739680802564787
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   WELLS RE, 1964, AM J PHYSIOL, V207, P1035
   Xiao LH, 2013, COLLOID POLYM SCI, V291, P2359, DOI 10.1007/s00396-013-2981-2
   Xie LY, 2011, POLYMER, V52, P3738, DOI 10.1016/j.polymer.2011.06.033
   Yang LJ, 2011, J PHYS CHEM B, V115, P12456, DOI 10.1021/jp207652h
   Yang R, 2014, ADV MATER, V26, P1711, DOI 10.1002/adma.201304386
   Yang T.-H., 2008, RECENT PAT MAT SCI, V1, P29, DOI DOI 10.2174/1874465610801010029
   Zeliszewska P, 2014, LANGMUIR, V30, P11165, DOI 10.1021/la5025668
   Zheng R., 2014, J APPL POLYM SCI, V131, P41041
   Zhu Z., 2012, NANOSCALE RES LETT, V7, P519
NR 64
TC 5
Z9 5
U1 6
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2017
VL 151
BP 372
EP 383
DI 10.1016/j.colsurfb.2016.12.040
PG 12
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EL2UJ
UT WOS:000394475400044
PM 28063289
DA 2018-10-20
ER

PT J
AU Zhou, X
   Fang, CQ
   Lei, WQ
   Su, J
   Li, L
   Li, Y
AF Zhou, Xing
   Fang, Changqing
   Lei, Wanqing
   Su, Jian
   Li, Long
   Li, Yan
TI Thermal and Crystalline Properties of Waterborne Polyurethane by in situ
   water reaction process and the potential application as biomaterial
SO PROGRESS IN ORGANIC COATINGS
LA English
DT Article
DE Waterborne polyurethane; Thermal stability; Crystallinity; Nanodots;
   Biomaterial
ID FOAM FORMULATIONS; PHASE; COPOLYMERS; DIISOCYANATE; DEGRADATION;
   MORPHOLOGY; LEVEL
AB Understanding the role of water in waterborne polyurethane synthesis and properties is a central issue. Water may bring some unique and interesting properties and phenomenon for waterborne polyurethane. This paper focus on the impact of the novel water addition procedure on the properties of waterborne polyurethane. The novel poly(neopentyl glycol adipate) (PNA)-based waterborne polyurethane was prepared using the designed in situ water reaction process. As a comparison, waterborne polyurethane was synthesized through the conventional water addition process through prepolymer method. The thermal and crystalline properties of the obtained polyurethanes were detected by XRD, DSC, DMA, POM, TG and SEM. The results indicated that the novel polyurethane dispersion presents unique performance. Furthermore, to explore the application area of the novel polyurethane dispersion, mold resistance experiments were performed. The result suggested that polyurethane dispersion from the novel process is safer and more environmentally friendly than that from conventional water addition process. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhou, Xing; Fang, Changqing; Lei, Wanqing; Li, Long; Li, Yan] Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China.
   [Zhou, Xing; Fang, Changqing; Lei, Wanqing] Xian Univ Technol, Fac Printing Packing Engn & Digital Media Technol, Xian 710048, Peoples R China.
   [Su, Jian] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China.
RP Fang, CQ (reprint author), Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China.
EM fcqxaut@163.com
FU National Natural Science Foundation of China [51372200]; Programs for
   New Century Excellent Talents in University of Ministry of Education of
   China [NCET-12-1045]; Ph.D. Innovation fund projects of Xi'an University
   of Technology [310-252071501]; Special Program for local serving from
   Education Department of Shaanxi Provincial Government [2013JC19];
   Program for Innovation Team in Xi'an University of Technology
   [108-25605T401]
FX The authors acknowledge the financial supports provided by National
   Natural Science Foundation of China (Grant No. 51372200), Programs for
   New Century Excellent Talents in University of Ministry of Education of
   China (Grant No.: NCET-12-1045), Ph.D. Innovation fund projects of Xi'an
   University of Technology (Fund No. 310-252071501), Special Program for
   local serving from Education Department of Shaanxi Provincial Government
   (Grant No. 2013JC19), and Program for Innovation Team in Xi'an
   University of Technology (Grant No. 108-25605T401).
CR Aneja A, 2002, POLYMER, V43, P5551, DOI 10.1016/S0032-3861(02)00355-5
   Athawale VD, 2010, PROG ORG COAT, V67, P44, DOI 10.1016/j.porgcoat.2009.09.015
   Cakic SM, 2009, POLYM DEGRAD STABIL, V94, P2015, DOI 10.1016/j.polymdegradstab.2009.07.015
   Choi T, 2009, POLYMER, V50, P2320, DOI 10.1016/j.polymer.2009.03.024
   Coutinho FMB, 2003, POLYM DEGRAD STABIL, V81, P19, DOI 10.1016/S0141-3910(03)00058-2
   Ding MM, 2009, BIOMACROMOLECULES, V10, P2857, DOI 10.1021/bm9006826
   Engels HW, 2013, ANGEW CHEM INT EDIT, V52, P9422, DOI 10.1002/anie.201302766
   Fang CQ, 2014, PROG ORG COAT, V77, P61, DOI 10.1016/j.porgcoat.2013.08.004
   Garrett JT, 2002, MACROMOLECULES, V35, P161, DOI 10.1021/ma010915d
   GRASSIE N, 1978, J POLYM SCI POL CHEM, V16, P1563, DOI 10.1002/pol.1978.170160710
   Hernandez R, 2007, MACROMOLECULES, V40, P5441, DOI 10.1021/ma070767c
   Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022
   HU CB, 1982, J APPL POLYM SCI, V27, P2167, DOI 10.1002/app.1982.070270627
   Jin C, 2006, J APPL POLYM SCI, V102, P4958, DOI 10.1002/app.24635
   Kaushiva BD, 2000, POLYMER, V41, P285, DOI 10.1016/S0032-3861(99)00135-4
   Lefebvre J, 2005, POLYM DEGRAD STABIL, V88, P28, DOI 10.1016/j.polymdegradstab.2004.01.025
   Li C. Y., 2002, HDB THERMAL ANAL CAL, P256
   Liu Y. J., 2011, POLYURETHANE RESIN A, P461
   Lopez A, 2011, LANGMUIR, V27, P3878, DOI 10.1021/la104830u
   Madbouly SA, 2009, PROG POLYM SCI, V34, P1283, DOI 10.1016/j.progpolymsci.2009.08.002
   Odarchenko YI, 2013, ACTA BIOMATER, V9, P6143, DOI 10.1016/j.actbio.2012.09.038
   Osman AF, 2012, MACROMOLECULES, V45, P198, DOI 10.1021/ma202189e
   Otts DB, 2005, POLYMER, V46, P2699, DOI 10.1016/j.polymer.2005.01.053
   Perez-Liminana MA, 2005, INT J ADHES ADHES, V25, P507, DOI 10.1016/j.ijadhadh.2005.02.002
   Shin S, 2013, CHEM MATER, V25, P3288, DOI 10.1021/cm400988a
   Wagner M., 2016, METTLER TOLEDO COLLE
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Williams SR, 2008, MACROMOLECULES, V41, P9072, DOI 10.1021/ma801942f
   Ye L, 2009, POLYM DEGRAD STABIL, V94, P971, DOI 10.1016/j.polymdegradstab.2009.03.016
   Zhou X, 2015, J MATER SCI TECHNOL, V31, P708, DOI 10.1016/j.jmst.2015.03.002
   Zhou X, 2015, J DISPER SCI TECHNOL, V36, P1178, DOI 10.1080/01932691.2014.961195
   Zia KM, 2014, INT J BIOL MACROMOL, V66, P26, DOI 10.1016/j.ijbiomac.2014.01.073
NR 32
TC 10
Z9 11
U1 15
U2 39
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0300-9440
J9 PROG ORG COAT
JI Prog. Org. Coat.
PD MAR
PY 2017
VL 104
BP 1
EP 10
DI 10.1016/j.porgcoat.2016.12.001
PG 10
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA EK6ZI
UT WOS:000394074400001
DA 2018-10-20
ER

PT J
AU Hauser, S
   Jung, F
   Pietzscht, J
AF Hauser, Sandra
   Jung, Friedrich
   Pietzscht, Jens
TI Human Endothelial Cell Models in Biomaterial Research
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID IN-VITRO; PROGENITOR CELLS; SMOOTH-MUSCLE; RE-ENDOTHELIALIZATION;
   REGENERATIVE MEDICINE; EPSILON-CAPROLACTONE; BONE REGENERATION; VASCULAR
   GRAFTS; GLASS NANOLAYER; BIOACTIVE GLASS
AB Endothelial cell (EC) models have evolved as important tools in biomaterial research due to ubiquitously occurring interactions between implanted materials and the endothelium. However, screening the available literature has revealed a gap between material scientists and physiologists in terms of their understanding of these biomaterial-endothelium interactions and their relative importance. Consequently, EC models are often applied in nonphysiological experimental setups, or too extensive conclusions are drawn from their results. The question arises whether this might be one reason why, among the many potential biomaterials, only a few have found their way into the clinic. In this review, we provide an overview of established EC models and possible selection criteria to enable researchers to determine the most reliable and relevant EC model to use.
C1 [Hauser, Sandra; Pietzscht, Jens] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radiopharmaceut & Chem Biol, Dresden, Germany.
   [Pietzscht, Jens] Tech Univ Dresden, Dept Chem & Food Chem, Dresden, Germany.
   [Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
RP Pietzscht, J (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radiopharmaceut & Chem Biol, Dresden, Germany.; Pietzscht, J (reprint author), Tech Univ Dresden, Dept Chem & Food Chem, Dresden, Germany.
EM j.pietzsch@hzdr.de
RI Jung, Friedrich/L-1301-2013; Pietzsch, Jens/O-5070-2017
OI Jung, Friedrich/0000-0001-8098-7180; Pietzsch, Jens/0000-0002-1610-1493
FU Europaische Sozialfonds (ESF)
FX We wish to apologize to those researchers whose work has not been
   mentioned due to space restrictions. This work is part of the Helmholtz
   Portfolio Topic 'Technologic und Medizin - Multimodale Bildgebung zur
   Aufklarung des In-vivo-Verhaltens von polymeren Biomaterialien' and the
   research initiative 'Radiation-Induced Vascular Dysfunction' (RIVAD).
   S.H. was recipient of a fellowship from the Europaische Sozialfonds
   (ESF). The authors are grateful to their colleagues Christoph Tondera,
   Nadine Herwig, and Christin Neuber, as well as Anne Kruger-Genge, for
   many stimulating and helpful discussions. The authors thank Viktoria
   Bosak for proof-reading the manuscript.
CR ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Aird WC, 2015, HAMOSTASEOLOGIE, V35, P11, DOI 10.5482/HAMO-14-11-0075
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429
   Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32
   BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302
   Behjati M, 2013, INT J CARDIOL, V167, P1560, DOI 10.1016/j.ijcard.2012.04.094
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Braune S, 2016, J BIOMED MATER RES B, V104, P210, DOI 10.1002/jbm.b.33366
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Burrows MC, 2012, MACROMOL BIOSCI, V12, P1660, DOI 10.1002/mabi.201200154
   Carmeliet P, 2001, NAT BIOTECHNOL, V19, P1019, DOI 10.1038/nbt1101-1019
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   Chen WC, 2014, DENT MATER, V30, P535, DOI 10.1016/j.dental.2014.02.007
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Choi DH, 2016, COLLOID SURFACE B, V141, P602, DOI 10.1016/j.colsurfb.2016.01.028
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Fioretta ES, 2014, BIOMACROMOLECULES, V15, P821, DOI 10.1021/bm4016418
   Franke R., 2015, J CELL BLOTECHNOL, V1, P119
   Franke RP, 2011, CLIN HEMORHEOL MICRO, V48, P41, DOI 10.3233/CH-2011-1404
   FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fuchs S, 2010, ADV BIOCHEM ENG BIOT, V123, P201, DOI 10.1007/10_2009_65
   Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007
   Gupta V, 2010, J BIOMED MATER RES A, V94A, P515, DOI 10.1002/jbm.a.32720
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Hoppe A, 2015, MAT SCI ENG C-MATER, V57, P157, DOI 10.1016/j.msec.2015.07.014
   Hytonen J, 2016, ARTERIOSCL THROM VAS, V36, P1534, DOI 10.1161/ATVBAHA.115.306962
   Castellanos MI, 2015, COLLOID SURFACE B, V127, P22, DOI 10.1016/j.colsurfb.2014.12.056
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   Jaganathan SK, 2014, BIOMED RES INT, DOI 10.1155/2014/459465
   Jaganjac M, 2014, J BIOMED MATER RES A, V102, P2305, DOI 10.1002/jbm.a.34911
   JUNG F, 1992, J VASC RES, V29, P71, DOI 10.1159/000158935
   Jung F., 2015, BIOINTERPHASES, V11
   Kang YQ, 2014, ACS APPL MATER INTER, V6, P9622, DOI 10.1021/am502056q
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Lafage-Proust MH, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.29
   Laschke MW, 2016, BIOTECHNOL ADV, V34, P112, DOI 10.1016/j.biotechadv.2015.12.004
   Lewis DM, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045010
   Li H, 2013, ACTA BIOMATER, V9, P6981, DOI 10.1016/j.actbio.2013.02.014
   Malhotra A., 2016, CALCIUM PHOSPHATES A
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Matassi F, 2011, CLIN CASES MINER BON, V8, P21
   Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011
   McDonald SM, 2011, J CELL BIOCHEM, V112, P3762, DOI 10.1002/jcb.23307
   McKee CT, 2012, BIOPHYS J, V102, P1224, DOI 10.1016/j.bpj.2012.01.053
   Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253
   Moore MC, 2015, BIOMATERIALS, V49, P37, DOI 10.1016/j.biomaterials.2015.01.022
   Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006
   Natasha G, 2015, EXPERT OPIN BIOL TH, V15, P231, DOI 10.1517/14712598.2015.980234
   Otto M, 2001, PATHOBIOLOGY, V69, P159, DOI 10.1159/000048771
   Peters EB, 2016, CELL MOL BIOENG, V9, P38, DOI 10.1007/s12195-015-0423-6
   Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   QUINN FD, 1994, PATHOBIOLOGY, V62, P109, DOI 10.1159/000163886
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Richardson MR, 2010, EXPERT REV PROTEOMIC, V7, P823, DOI 10.1586/EPR.10.92
   Rioja AY, 2016, ACTA BIOMATER, V29, P33, DOI 10.1016/j.actbio.2015.10.022
   Roncalli JG, 2008, TRENDS BIOTECHNOL, V26, P276, DOI 10.1016/j.tibtech.2008.01.005
   Rouwkema J, 2016, TRENDS BIOTECHNOL, V34, P733, DOI 10.1016/j.tibtech.2016.03.002
   Rudolph A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142075
   Ruder C, 2013, CLIN HEMORHEOL MICRO, V55, P513, DOI 10.3233/CH-131787
   Rufaihah AJ, 2013, AM J TRANSL RES, V5, P21
   Sagnella S, 2003, J BIOMED MATER RES A, V67A, P689, DOI 10.1002/jbm.a.10035
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   Sasaki M, 2012, COLLOID SURFACE B, V92, P1, DOI 10.1016/j.colsurfb.2011.10.061
   Savoji H, 2014, MACROMOL BIOSCI, V14, P1084, DOI 10.1002/mabi.201300545
   Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4
   Sgarioto M, 2014, J BIOMED MATER RES B, V102, P1711, DOI 10.1002/jbm.b.33137
   Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010
   Soares JS, 2016, ANN BIOMED ENG, V44, P560, DOI 10.1007/s10439-015-1477-2
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Storm T, 2014, J MATER SCI-MATER M, V25, P2003, DOI 10.1007/s10856-014-5226-0
   Sun X., 2015, ADV DRUG DELL REV, V96, P183
   Tan AW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21828
   Thalla PK, 2014, BIOMACROMOLECULES, V15, P2512, DOI 10.1021/bm5003762
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Wallace CS, 2010, AM J PHYSIOL-HEART C, V299, pH338, DOI 10.1152/ajpheart.01029.2009
   Wang K., 2015, BIOMED RES INT, V2015
   Wang XT, 2014, INT J CARDIOL, V174, P688, DOI 10.1016/j.ijcard.2014.04.228
   Wei ZL, 2014, COLLOID SURFACE B, V121, P451, DOI 10.1016/j.colsurfb.2014.06.036
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
   Wu CT, 2014, ACTA BIOMATER, V10, P3295, DOI 10.1016/j.actbio.2014.03.035
   Xu MC, 2014, ACTA BIOMATER, V10, P463, DOI 10.1016/j.actbio.2013.09.011
   Yang ZL, 2015, BIOMATERIALS, V63, P80, DOI 10.1016/j.biomaterials.2015.06.016
   Yang ZL, 2012, ADV HEALTHC MATER, V1, P548, DOI 10.1002/adhm.201200073
   Zhang K, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5693-6
   Zhang YL, 2015, NANOSCALE, V7, P19207, DOI 10.1039/c5nr05421d
   Zhong Q, 2014, COLLOID SURFACE B, V121, P238, DOI 10.1016/j.colsurfb.2014.06.022
   Zhu GC, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5448-9
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 105
TC 10
Z9 11
U1 0
U2 22
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAR
PY 2017
VL 35
IS 3
BP 265
EP 277
DI 10.1016/j.tibtech.2016.09.007
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EN4CH
UT WOS:000395954900010
PM 27789063
DA 2018-10-20
ER

PT J
AU Im, SH
   Kim, CY
   Jung, Y
   Jang, Y
   Kim, SH
AF Im, Seung Hyuk
   Kim, Chang Yong
   Jung, Youngmee
   Jang, Yangsoo
   Kim, Soo Hyun
TI Biodegradable vascular stents with high tensile and compressive
   strength: a novel strategy for applying monofilaments via solid-state
   drawing and shaped-annealing processes
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID FORM POLY(L-LACTIC ACID); MELTING BEHAVIOR; CRYSTALLIZATION BEHAVIOR;
   POLYDIOXANONE PDS; NYLON-6 YARNS; FIBERS; POLY(ETHYLENE-TEREPHTHALATE);
   EXTRUSION; POLYMERS; BIOMATERIALS
AB Monofilaments such as those consisting of polyamide (PA), polydioxanone (PDS), and poly(vinylidene fluoride) (PVDF), have been commonly used in various industries. However, most are non-biodegradable, which is unfavorable for many biomedical applications. Although biodegradable polymers offer significant benefits, they are still limited by their weak mechanical properties, which is an obstacle for use as a biomaterial that requires high strength. To overcome the current limitations of biodegradable monofilaments, a novel solid-state drawing (SSD) process was designed to significantly improve the mechanical properties of both PA and poly(L-lactic acid) (PLLA) monofilaments in this study. Both PA and PLLA monofilaments exhibited more than two-fold increased tensile strength and a highly reduced thickness using SSD. In X-ray diffraction and scanning electron microscopy analyses, it was determined that SSD could not only promote the a-crystal phase, but also smoothen the surface of PLLA monofilaments. To apply SSD-monofilaments with superior properties to cardiovascular stents, a shaped-annealing (SA) process was designed as the follow-up process after SSD. Using this process, three types of vascular stents could be fabricated, composed of SSD-monofilaments: double-helix, single-spring and doublespring shaped stents. The annealing temperature was optimized at 80 degrees C to minimize the loss of mechanical and physical properties of SSD-monofilaments for secondary processing. All three types of vascular stents were tested according to ISO 25539-2. Consequently, it was confirmed that spring-shaped stents had good recovery rate values and a high compressive modulus. In conclusion, this study showed significantly improved mechanical properties of both tensile and compressive strength simultaneously and extended the potential for biomedical applications of monofilaments.
C1 [Im, Seung Hyuk; Kim, Chang Yong; Kim, Soo Hyun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, 145 Anam Ro, Seoul 02841, South Korea.
   [Im, Seung Hyuk; Kim, Chang Yong; Jung, Youngmee; Kim, Soo Hyun] Korea Inst Sci & Technol, Ctr Biomat, Seoul 02792, South Korea.
   [Jung, Youngmee; Kim, Soo Hyun] Korea Univ Sci & Technol, 217 Gajeong Ro, Daejeon 34113, South Korea.
   [Jang, Yangsoo] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Seoul, South Korea.
RP Kim, SH (reprint author), Korea Univ, KU KIST Grad Sch Converging Sci & Technol, 145 Anam Ro, Seoul 02841, South Korea.; Kim, SH (reprint author), Korea Inst Sci & Technol, Ctr Biomat, Seoul 02792, South Korea.; Kim, SH (reprint author), Korea Univ Sci & Technol, 217 Gajeong Ro, Daejeon 34113, South Korea.
EM soohkim@kist.re.kr
OI Im, Seung Hyuk/0000-0002-5255-6903
FU Ministry of Trade, Industry and Energy, Republic Korea [10052732]; Korea
   Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI15C1277]
FX This work was funded by the Ministry of Trade, Industry and Energy,
   Republic Korea through project number "10052732" and a grant of the
   Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI), funded by the Ministry of Health &
   Welfare, Republic of Korea through grant number "HI15C1277".
CR Barbucci R, 2002, INTEGRATED BIOMATERI
   Burger C, 2006, ARCH ORTHOP TRAUM SU, V126, P695, DOI 10.1007/s00402-006-0207-5
   Callahan TL, 2017, J BIOMED MATER RES B, V105, P815, DOI 10.1002/jbm.b.33600
   Cartier L, 2000, POLYMER, V41, P8909, DOI 10.1016/S0032-3861(00)00234-2
   CHENG SZD, 1987, MACROMOLECULES, V20, P2802, DOI 10.1021/ma00177a028
   Chokshi R, 2010, IRAN J PHARM RES, V3, P3
   CHUNG JS, 1992, POLYMER, V33, P2312, DOI 10.1016/0032-3861(92)90522-X
   DENN MM, 1980, ANNU REV FLUID MECH, V12, P365, DOI 10.1146/annurev.fl.12.010180.002053
   Di Lorenzo ML, 2006, J APPL POLYM SCI, V100, P3145, DOI 10.1002/app.23136
   Domb A. J., 1998, HDB BIODEGRADABLE PO
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   Goonoo N, 2015, EUR J PHARM BIOPHARM, V97, P371, DOI 10.1016/j.ejpb.2015.05.024
   Harris AM, 2008, J APPL POLYM SCI, V107, P2246, DOI 10.1002/app.27261
   HOBBS SY, 1975, POLYMER, V16, P462, DOI 10.1016/0032-3861(75)90258-X
   HOLDSWORTH PJ, 1971, POLYMER, V12, P195, DOI 10.1016/0032-3861(71)90045-0
   HOOGSTEEN W, 1990, MACROMOLECULES, V23, P634, DOI 10.1021/ma00204a041
   Hossain KMZ, 2014, EUR POLYM J, V53, P270, DOI 10.1016/j.eurpolymj.2014.02.001
   Hyuk I. Seung, 2016, BIOFABRICATION, V8
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P241, DOI 10.1002/(SICI)1099-0488(19970130)35:2<241::AID-POLB5>3.0.CO;2-V
   Kawai T, 2007, MACROMOLECULES, V40, P9463, DOI 10.1021/ma070082c
   KOBAYASHI J, 1995, J APPL PHYS, V77, P2957, DOI 10.1063/1.358712
   Komatsu F, 2006, J ORTHOP SCI, V11, P70, DOI 10.1007/s00776-005-0973-x
   Lambertz A, 2015, EUR SURG RES, V55, P1, DOI 10.1159/000371797
   LEE YC, 1987, MACROMOLECULES, V20, P1336, DOI 10.1021/ma00172a028
   LEENSLAG JW, 1987, POLYMER, V28, P1695, DOI 10.1016/0032-3861(87)90012-7
   Miyata T, 1997, POLYMER, V38, P4003, DOI 10.1016/S0032-3861(96)00987-1
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   PISKIN E, 1995, J BIOMAT SCI-POLYM E, V6, P775, DOI 10.1163/156856295X00175
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   RAY JA, 1981, SURG GYNECOL OBSTET, V153, P497
   Repka MA, 2012, EXPERT OPIN DRUG DEL, V9, P105, DOI 10.1517/17425247.2012.642365
   Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X
   Sawai D, 2003, MACROMOLECULES, V36, P3601, DOI 10.1021/ma030050z
   Sawai D, 2002, J POLYM SCI POL PHYS, V40, P95, DOI 10.1002/polb.10076
   Sawai D, 2006, MACROMOL SYMP, V242, P93, DOI 10.1002/masy.200651015
   Shalaby S.W., 2003, ABSORBABLE BIODEGRAD
   Singh C, 2016, TEXT RES J, V86, P380, DOI 10.1177/0040517515590413
   Szycher M., 1991, HIGH PERFORMANCE BIO
   Tan SS, 2000, J POLYM SCI POL PHYS, V38, P53, DOI 10.1002/(SICI)1099-0488(20000101)38:1<53::AID-POLB6>3.0.CO;2-G
   TODOKI M, 1977, J POLYM SCI POL PHYS, V15, P1067, DOI 10.1002/pol.1977.180150613
   TODOKI M, 1977, J POLYM SCI POL PHYS, V15, P1507, DOI 10.1002/pol.1977.180150901
   Venkatraman S, 2003, BIOMATERIALS, V24, P2105, DOI 10.1016/S0142-9612(02)00640-3
   Yasuniwa M, 2000, J POLYM SCI POL PHYS, V38, P262, DOI 10.1002/(SICI)1099-0488(20000101)38:1<262::AID-POLB28>3.0.CO;2-5
NR 45
TC 1
Z9 1
U1 6
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAR 1
PY 2017
VL 5
IS 3
BP 422
EP 431
DI 10.1039/c7bm00011a
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EN3CJ
UT WOS:000395886300008
PM 28184401
DA 2018-10-20
ER

PT J
AU Rosenbaum, J
   Versace, DL
   Abbad-Andallousi, S
   Pires, R
   Azevedo, C
   Cenedese, P
   Dubot, P
AF Rosenbaum, Jonathan
   Versace, Davy Louis
   Abbad-Andallousi, Samir
   Pires, Remi
   Azevedo, Christophe
   Cenedese, Pierre
   Dubot, Pierre
TI Antibacterial properties of nanostructured Cu-TiO2 surfaces for dental
   implants
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID GRAM-NEGATIVE BACTERIA; OXIDE NANOTUBE ARRAYS; SILVER NANOPARTICLES;
   BIOFILM FORMATION; ANODIC-OXIDATION; COPPER IONS; TITANIUM; FABRICATION;
   ZINC; ADHESION
AB The influence of copper derived TiO2 surfaces (nCu-nT-TiO2) on the death of nosocomial Staphylococcus aureus (Sa) and Escherichia coli (Ec), was investigated. TiO2 nanotube (nT-TiO2) arrays were fabricated by anodic oxidation of pure titanium sheets in fluorhydric solutions, leading to surface nanostructuration and creation of specific reactive sites. Copper nanocubes with a mean size of 20 nm have been synthesized and deposited on the nT-TiO2 surface by pulsed electrodeposition from a copper sulphate solution. Scanning Electron Microscopy (SEM) reveals that Cu nanocubes are both inserted into the TiO2 nanotubes and on the nanotube edges. X-ray Photoemission Spectroscopy (XPS) and SEM-EDX confirm the metallic nature of copper nanoparticles, covered with a thin mixed CuO-Cu2O thin layer. As the adsorption of proteins is one of the early stages of biomaterial surface interactions with body fluids before bacterial colonization, Infrared Spectroscopy (IR) in reflection-absorption mode, SEM and XPS have been used to follow the evolution of nCu-nT-TiO2 surfaces when exposed to a simulated plasma solution containing Bovine Serum Albumin (BSA). Finally bacterial tests have revealed a high biocide potential of the nCu-nT-TiO2 surface, which leads to the entire death of SA and EC.
C1 [Rosenbaum, Jonathan; Azevedo, Christophe] Univ Paris Diderot Paris 7, UFR Odontol Garanciere, Paris, France.
   [Versace, Davy Louis; Abbad-Andallousi, Samir; Pires, Remi; Cenedese, Pierre; Dubot, Pierre] Univ Paris Est, CNRS, UMR7182, Inst Chim & Mat Paris Est, Thiais, France.
RP Dubot, P (reprint author), Univ Paris Est, CNRS, UMR7182, Inst Chim & Mat Paris Est, Thiais, France.
EM Pdubot@icmpe.cnrs.fr
FU CNRS; UPEC
FX The authors gratefully acknowledge financial support from CNRS and UPEC.
CR Abicht HK, 2013, MICROBIOL-SGM, V159, P1190, DOI 10.1099/mic.0.066928-0
   Aeciola C. R., 2012, BIOMATERIALS, V33, P5967
   Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Bernards MT, 2008, COLLOID SURFACE B, V64, P236, DOI 10.1016/j.colsurfb.2008.01.025
   Cabal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042393
   Cai QY, 2005, J MATER RES, V20, P230, DOI 10.1557/JMR.2005.0020
   Chen SG, 2014, CHEM ENG J, V256, P238, DOI 10.1016/j.cej.2014.07.006
   Chen SG, 2012, MATER LETT, V83, P154, DOI 10.1016/j.matlet.2012.06.007
   Chen SG, 2012, J MATER CHEM, V22, P9092, DOI 10.1039/c2jm00063f
   Chusei C. C., 2002, ENCY PHYS SCI TECHNO, V17, P921
   Chusuei CC, 1999, LANGMUIR, V15, P2806, DOI 10.1021/la9815446
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Esinosa-Cristobal L. F., 2012, MATER SCI ENG, V32, P896
   Esteban-Cubillo A, 2006, J MATER SCI, V41, P5208, DOI 10.1007/s10853-006-0432-x
   GATES BC, 1995, CHEM REV, V95, P511, DOI 10.1021/cr00035a003
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Han AF, 2016, INT J ADHES ADHES, V69, P125, DOI 10.1016/j.ijadhadh.2016.03.018
   Hans M, 2013, LANGMUIR, V29, P16160, DOI 10.1021/la404091z
   Huang L., 2005, COLLOID SURF A, V1-3, P125
   Ibrahim NA, 2006, POLYM-PLAST TECHNOL, V45, P719, DOI 10.1080/03602550600611198
   Khan ST, 2013, MATER LETT, V97, P67, DOI 10.1016/j.matlet.2013.01.085
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028
   Lv LW, 2015, BIOMATERIALS, V39, P193, DOI 10.1016/j.biomaterials.2014.11.002
   Mor GK, 2005, NANO LETT, V5, P191, DOI 10.1021/nl048301k
   Mor GK, 2004, J MATER RES, V19, P628, DOI 10.1557/jmr.2004.19.2.628
   Mor GK, 2003, J MATER RES, V18, P2588, DOI 10.1557/JMR.2003.0362
   Qin YM, 2007, J APPL POLYM SCI, V105, P527, DOI 10.1002/app.26271
   Riyanto, 2015, INT J ELECTROCHEM SC, V10, P4911
   Rodrigues LR, 2011, ADV EXP MED BIOL, V715, P351, DOI 10.1007/978-94-007-0940-9_22
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Singh M, 2008, DIG J NANOMATER BIOS, V3, P115
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sul Young-Taeg, 2004, Clin Implant Dent Relat Res, V6, P101, DOI 10.1111/j.1708-8208.2004.tb00032.x
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Voruganti VS, 2005, BURNS, V31, P711, DOI 10.1016/j.burns.2005.04.026
   Wagner CD, 1990, PRACTICAL SURFACE AN, V1
   Wang XX, 2003, BIOMATERIALS, V24, P4631, DOI 10.1016/S0142-9612(03)00357-0
   Wu HB, 2014, APPL SURF SCI, V308, P43, DOI 10.1016/j.apsusc.2014.04.081
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yin M, 2005, J AM CHEM SOC, V127, P9506, DOI 10.1021/ja050006u
NR 43
TC 5
Z9 5
U1 7
U2 53
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAR 1
PY 2017
VL 5
IS 3
BP 455
EP 462
DI 10.1039/c6bm00868b
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA EN3CJ
UT WOS:000395886300011
PM 28067359
DA 2018-10-20
ER

PT J
AU Holt, BA
   Bellavia, MC
   Potter, D
   White, D
   Stowell, SR
   Sulchek, T
AF Holt, Brandon Alexander
   Bellavia, Michael C.
   Potter, Daniel
   White, David
   Stowell, Sean R.
   Sulchek, Todd
TI Fc microparticles can modulate the physical extent and magnitude of
   complement activity
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; BIOMATERIAL SURFACES; IMMUNE-RESPONSE; MEDIATED
   LYSIS; ACTIVATION; C3; PROTEINS; BINDING; SEPSIS; SYSTEM
AB The complement system is an integral component of the humoral immune system, and describes a cascade of interacting proteins responsible for the opsonization and lysis of foreign pathogens, in addition to the recruitment of immune cells. However, complement activation is also implicated in the progression and complication of immune dysfunctions such as sepsis. Microparticle (MP) biomaterials capable of tuning the local magnitude of serum complement activation could improve complement-mediated cytotoxicity to serum-resistant bacteria or calm an overactive immune response during sepsis. We demonstrate that model Fc-functionalized microparticles can be designed to either enhance or diminish the local cytotoxic effect of complement activation in human serum. The particles were formed with either the antibody Fc domains oriented outward from the particle surface or randomly adsorbed in a nonoriented fashion. In the oriented Fc form, complement products were directly sequestered to the particle surface, including C5a, a potent anaphylatoxin that, when elevated, is associated with poor sepsis prognosis. The oriented particle also lowered the cytotoxicity of serum and thus decreased the antibiotic effect when compared to serum alone. Conversely, the non-oriented microparticles were found to sequester similar levels of C5a, but much lower levels of iC3b and TCC on the microparticle surface, thereby increasing the amount of the soluble terminal complement complex. In addition, the non-oriented microparticles extend the distance over which TCC forms and enhance serum cytotoxicity to bacteria. Together, these two types of complement-modulating particles provide the first biomaterial that can functionally modify the range of complement activation at sites distant from the particle surface. Thus, biomaterials that exploit Fc presentation provide new possibilities to functionally modulate complement activation to achieve a desired clinical result.
C1 [Holt, Brandon Alexander; Bellavia, Michael C.; Sulchek, Todd] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Holt, Brandon Alexander; Bellavia, Michael C.; Sulchek, Todd] Emory Univ, Atlanta, GA 30322 USA.
   [Holt, Brandon Alexander; Bellavia, Michael C.; Potter, Daniel] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Potter, Daniel; Sulchek, Todd] Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [White, David] USDA, Natl Ctr Anim Hlth, Ames, IA USA.
   [Stowell, Sean R.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322 USA.
RP Sulchek, T (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Sulchek, T (reprint author), Emory Univ, Atlanta, GA 30322 USA.; Sulchek, T (reprint author), Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM todd.sulchek@me.gatech.edu
RI Holt, Brandon/R-9023-2017
OI Holt, Brandon/0000-0002-8204-4984
FU NSF DMR [1507238]; Petit Scholars program; National Institutes of Health
   at the Georgia Institute of Technology (MCB) [5T32EB006343T32]
FX The authors thank the Georgia Research Alliance through the
   Immunoengineering Seed Grant for support of this research as well as the
   NSF DMR division (1507238). The authors would also like to thank the
   Petit Scholars program for support of BAH. Research reported in this
   presentation was supported by the National Institutes of Health under
   5T32EB006343T32 (GT BioMAT training grant) at the Georgia Institute of
   Technology (MCB). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health. DH5a bacteria were provided courtesy of
   Caitlin Austin. The authors are grateful to Matt Devlin and Michael
   Harrington for their assistance in preliminary experiments.
CR Abdul Ajees A, 2006, Nature, V444, P221, DOI 10.1038/nature05258
   Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   [Anonymous], 2016, GOAT ANTIRABBIT IGG
   ANTON LC, 1994, EUR J IMMUNOL, V24, P599, DOI 10.1002/eji.1830240316
   BEUTLER B, 1995, J INVEST MED, V43, P227
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Charchaflieh J., 2012, ROLE COMPLEMENT SYST, V2012, P8
   Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761
   Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4
   Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512
   Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943
   DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4
   Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008
   Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004
   GENNARO R, 1986, EUR J BIOCHEM, V155, P77, DOI 10.1111/j.1432-1033.1986.tb09460.x
   Girard-Pierce KR, 2013, BLOOD, V122, P1793, DOI 10.1182/blood-2013-06-508952
   Haider A, 2016, P NATL ACAD SCI USA, V113, P14213, DOI 10.1073/pnas.1608792113
   Heinrich V, 2011, J CELL SCI, V124, P3041, DOI 10.1242/jcs.086413
   HUGHESJONES NC, 1985, EUR J IMMUNOL, V15, P976, DOI 10.1002/eji.1830151003
   Iijima M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00790
   Janeway C. A. J., 2001, IMMUNOBIOLOGY IMMUNE
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014
   Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157
   LACHMANN PJ, 1970, J EXP MED, V131, P643, DOI 10.1084/jem.131.4.643
   LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018
   Law SKA, 1997, PROTEIN SCI, V6, P263
   Liu Y, 2013, BIOMACROMOLECULES, V14, P3321, DOI 10.1021/bm400930k
   LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35
   Maio M, 1998, INT J ONCOL, V13, P305
   MARDINEY MR, 1968, AM J PATHOL, V53, P253
   Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655
   Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Moghimi SM, 2011, ADV DRUG DELIVER REV, V63, P1000, DOI 10.1016/j.addr.2011.06.002
   MONTDARGENT B, 1991, Journal of Biomaterials Science Polymer Edition, V2, P25, DOI 10.1163/156856291X00034
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   MULLEREBERHARD HJ, 1966, J EXP MED, V123, P33, DOI 10.1084/jem.123.1.33
   NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189
   Nakae H, 1996, SURG TODAY, V26, P225, DOI 10.1007/BF00311579
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ouerghi O, 2002, SENSOR ACTUAT B-CHEM, V84, P167, DOI 10.1016/S0925-4005(02)00020-5
   Pacheco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060989
   Pacheco PM, 2013, NANO LIFE, V3, DOI 10.1142/S1793984413410018
   PACKMAN CH, 1979, J CLIN INVEST, V64, P428, DOI 10.1172/JCI109479
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7
   Porter R R, 1979, Adv Protein Chem, V33, P1, DOI 10.1016/S0065-3233(08)60458-1
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Ren YC, 2016, INT J PHARMACEUT, V502, P249, DOI 10.1016/j.ijpharm.2016.02.037
   Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409
   Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004
   Saha B, 2013, RSC ADV, V3, P7867, DOI 10.1039/c3ra23042b
   Savay S, 2002, BBA-BIOMEMBRANES, V1559, P79, DOI 10.1016/S0005-2736(01)00408-4
   SCHUMAKER VN, 1987, ANNU REV IMMUNOL, V5, P21, DOI 10.1146/annurev.iy.05.040187.000321
   SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361
   SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115
   Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017
   TACK BF, 1976, BIOCHEMISTRY-US, V15, P4513, DOI 10.1021/bi00665a028
   Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001
   Tang JL, 2012, LANGMUIR, V28, P10033, DOI 10.1021/la3010079
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269
   Yoon JY, 1996, J COLLOID INTERF SCI, V177, P613, DOI 10.1006/jcis.1996.0075
   Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620
NR 69
TC 2
Z9 2
U1 1
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAR 1
PY 2017
VL 5
IS 3
BP 463
EP 474
DI 10.1039/c6bm00608f
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA EN3CJ
UT WOS:000395886300012
PM 28067347
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Correia, CR
   Gaifem, J
   Oliveira, MB
   Silvestre, R
   Mano, JF
AF Correia, Clara R.
   Gaifem, Joana
   Oliveira, Mariana B.
   Silvestre, Ricardo
   Mano, Joao F.
TI The influence of surface modified poly(L-lactic acid) films on the
   differentiation of human monocytes into macrophages
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID FOREIGN-BODY REACTION; MATRIX METALLOPROTEINASES; POLARIZATION;
   BIOMATERIALS; SCAFFOLDS; INFLAMMATION; CYTOKINES; BONE; REGENERATION;
   ADHESION
AB Macrophages play a crucial role in the biological performance of biomaterials, as key factors in defining the optimal inflammation-healing balance towards tissue regeneration and implant integration. Here, we investigate how different surface modifications performed on poly(L-lactic acid) (PLLA) films would influence the differentiation of human monocytes into macrophages. We tested PLLA films without modification, surface-modified by plasma treatment (pPLLA) or by combining plasma treatment with different coating materials, namely poly(L-lysine) and a series of proteins from the extracellular matrix: collagen I, fibronectin, vitronectin, laminin and albumin. While all the tested films are non-cytotoxic, differences in cell adhesion and morphology are observed. Monocyte-derived macrophages (MDM) present a more rounded shape in non-modified films, while a more elongated phenotype is observed containing filopodia-like and podosome-like structures in all modified films. No major differences are found for the expression of HLA-DR+/CD80(+) and CD206(+)/CD163(+) surface markers, as well as for the ability of MDM to phagocytize. Interestingly, MDM differentiated on pPLLA present the highest expression of MMP9. Upon differentiation, MDM in all surface modified films present lower amounts of IL-6 and IL-10 compared to non-modified films. After stimulating MDM with the potent pro-inflammatory agent LPS, pPLLA and poly(L-lysine) and fibronectin-modified films reveal a significant reduction in IL-6 secretion, while the opposite effect is observed with IL-10. Of note, in comparison to non-modified films, all surface modified films induce a significant reduction of the IL-6/IL-10 ratio, a valuable prognosticator of the pro-versus anti-inflammatory balance. These findings provide important insights into MDM-biomaterial interactions, while strengthening the need for designing immune-informed biomaterials.
C1 [Correia, Clara R.; Oliveira, Mariana B.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, AvePk, P-4805017 Barco, Guimaraes, Portugal.
   [Correia, Clara R.; Gaifem, Joana; Oliveira, Mariana B.; Silvestre, Ricardo; Mano, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Gaifem, Joana; Silvestre, Ricardo] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.
   [Correia, Clara R.; Oliveira, Mariana B.; Mano, Joao F.] Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, AvePk, P-4805017 Barco, Guimaraes, Portugal.; Silvestre, R; Mano, JF (reprint author), ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.; Silvestre, R (reprint author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.; Mano, JF (reprint author), Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
EM ricardosilvestre@med.uminho.pt; jmano@ua.pt
RI Silvestre, Ricardo/C-7243-2011; Group, 3Bs/E-4374-2012; Oliveira,
   Mariana/H-6933-2017; Mano, Joao/A-4418-2009
OI Silvestre, Ricardo/0000-0002-9270-2717; Group, 3Bs/0000-0002-5195-3456;
   Oliveira, Mariana/0000-0002-6104-6075; Mano, Joao/0000-0002-2342-3765;
   R. Correia, Clara/0000-0002-1559-6295; Gaifem, Joana/0000-0001-7306-7378
FU Northern Portugal Regional Operational Programme (NORTE) under Portugal
   Partnership Agreement through European Regional Development Fund (FEDER)
   [NORTE-01-0145-FEDER-000023]; European Research Council for project
   ATLAS [ERC-2014-ADG-669858]; Portuguese Foundation for Science and
   Technology (FCT) [PD/BD/106053/2015]; post-doctoral
   [SFRH/BPD/111354/2015]; FCT Investigator [IF/00021/2014]
FX This work was developed under the scope of the project
   NORTE-01-0145-FEDER-000023, supported by the Northern Portugal Regional
   Operational Programme (NORTE 2020), under the Portugal 2020 Partnership
   Agreement through the European Regional Development Fund (FEDER). C. R.
   Correia and J. F. Mano acknowledge the funding from the European
   Research Council for project ATLAS with the grant agreement number
   ERC-2014-ADG-669858. J. Gaifem, M. B. Oliveira and R. Silvestre
   acknowledge the Portuguese Foundation for Science and Technology (FCT)
   for the doctoral (PD/BD/106053/2015), post-doctoral
   (SFRH/BPD/111354/2015) and FCT Investigator (IF/00021/2014) grants,
   respectively. The authors also acknowledge Hospital de Braga for
   providing the buffy coats.
CR Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Boersema GSA, 2016, BIORESEARCH OPEN ACC, V5, P6, DOI 10.1089/biores.2015.0041
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chen ZT, 2016, MATER TODAY, V19, P304, DOI 10.1016/j.mattod.2015.11.004
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cooper RL, 2015, J THEOR BIOL, V367, P86, DOI 10.1016/j.jtbi.2014.11.008
   Corotti MV, 2009, ARCH ORAL BIOL, V54, P764, DOI 10.1016/j.archoralbio.2009.04.013
   Correia CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21883
   Correia CR, 2013, BIOMACROMOLECULES, V14, P743, DOI 10.1021/bm301833z
   Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016
   Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fuchs AK, 2016, BIOMATERIALS, V85, P78, DOI 10.1016/j.biomaterials.2016.01.064
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514
   Jadhav U, 2004, INT J ONCOL, V25, P1407
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jerin A, 2003, CLIN CHEM LAB MED, V41, P899, DOI 10.1515/CCLM.2003.136
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Lam ATL, 2014, STEM CELLS DEV, V23, P1688, DOI 10.1089/scd.2013.0645
   Landgraeber S., 2014, MEDIATORS INFLAMMATI, V2014
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Lee JT, 2014, ENDOCRINOLOGY, V155, P3409, DOI 10.1210/en.2014-1037
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maciel J, 2012, ACTA BIOMATER, V8, P3669, DOI 10.1016/j.actbio.2012.06.010
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.TEB.2011.0182, 10.1089/ten.teb.2011.0182]
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Pan H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065002
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656
   Rostam HM, 2016, IMMUNOBIOLOGY, V221, P1237, DOI 10.1016/j.imbio.2016.06.010
   Roszer T, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/816460
   Ruiz Stephanie, 2016, Intensive Care Med Exp, V4, P22, DOI 10.1186/s40635-016-0096-z
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Sapan HB, 2016, INT J BURNS TRAUMA, V6, P37
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tate MLK, 2016, BIOMATERIALS, V95, P35, DOI 10.1016/j.biomaterials.2016.03.038
   Thakur S, 2015, REV ADHES ADHES, V3, P53, DOI 10.7569/RAA.2015.097303
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
NR 65
TC 1
Z9 1
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAR 1
PY 2017
VL 5
IS 3
BP 551
EP 560
DI 10.1039/c6bm00920d
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EN3CJ
UT WOS:000395886300020
PM 28128374
DA 2018-10-20
ER

PT J
AU Mallinson, D
   Cheung, DL
   Simionesie, D
   Mullen, AB
   Zhang, ZYJ
   Lamprou, DA
AF Mallinson, David
   Cheung, David L.
   Simionesie, Dorin
   Mullen, Alexander B.
   Zhang, Zhenyu J.
   Lamprou, Dimitrios A.
TI Experimental and computational examination of anastellin
   (FnIII1c)-polymer interactions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE atomic force microscopy; molecular dynamics; polyurethane; poly (methyl
   methacrylate); fibronectin
ID ATOMIC-FORCE MICROSCOPY; INDUCED CONFORMATIONAL-CHANGES;
   PROTEIN-ADSORPTION; MOLECULAR SIMULATION; COPOLYMER SURFACES;
   VISCOELASTIC PROPERTIES; FIBRONECTIN ADSORPTION; CELL-ADHESION; III
   REPEAT; FRAGMENT
AB Using a combination of experimental and computational approaches, the interaction between anastellin, a recombinant fragment of fibronectin, and representative biomaterial surfaces has been examined. Anastellin and superfibronectin have been seen to exhibit antiangiogenic properties and other properties that may make it suitable for consideration for incorporation into biomaterials. The molecular interaction was directly quantified by atomic force microscope (AFM)-based force spectroscopy, complemented by adsorption measurements using quartz crystal microbalance (QCM). Using AFM, it was found that the anastellin molecule facilitates a stronger adhesion on polyurethane films (72.0 pN nm(-1)) than on poly (methyl methacrylate) films (68.6 pN nm(-1)). However, this is not consistent with the QCM adsorption measurements, which show no significant difference. Molecular dynamics simulations of the behavior of anastellin on polyurethane in aqueous solution were performed to rationalize the experimental data, and show that anastellin is capable of rapid adsorption to PU while its secondary structure is stable upon adsorption in water. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 737-745, 2017.
C1 [Mallinson, David; Mullen, Alexander B.; Lamprou, Dimitrios A.] Univ Strathclyde, SIPBS, 161 Cathedral St, Glasgow, Lanark, Scotland.
   [Cheung, David L.] Natl Univ Ireland, Sch Chem, Univ Rd, Galway, Ireland.
   [Simionesie, Dorin; Zhang, Zhenyu J.] Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England.
   [Lamprou, Dimitrios A.] Univ Strathclyde, Ctr Innovat Mfg Continuous Mfg & Crystallisat CMA, Glasgow, Lanark, Scotland.
   [Lamprou, Dimitrios A.] Univ Kent, Medway Sch Pharm, Chatham, Kent, England.
RP Lamprou, DA (reprint author), Univ Strathclyde, SIPBS, 161 Cathedral St, Glasgow, Lanark, Scotland.; Cheung, DL (reprint author), Natl Univ Ireland, Sch Chem, Univ Rd, Galway, Ireland.; Zhang, ZYJ (reprint author), Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England.; Lamprou, DA (reprint author), Univ Strathclyde, Ctr Innovat Mfg Continuous Mfg & Crystallisat CMA, Glasgow, Lanark, Scotland.; Lamprou, DA (reprint author), Univ Kent, Medway Sch Pharm, Chatham, Kent, England.
EM david.cheung@nuigalway.ie; z.j.zhang@bham.ac.uk; d.lamprou@kent.ac.uk
RI Lamprou, Dimitrios/C-4546-2014
OI Lamprou, Dimitrios/0000-0002-8740-1661; Mallinson,
   David/0000-0003-2615-633X
FU EPSRC [EP/K000586/1]; Engineering and Physical Sciences Research Council
   [1489649]
FX Contract grant sponsor: EPSRC; contract grant number: EP/K000586/1
CR Agarwal R, 2015, BIOMATERIALS, V63, P137, DOI 10.1016/j.biomaterials.2015.06.025
   Aissaoui N, 2012, LANGMUIR, V28, P656, DOI 10.1021/la2036778
   Ambesi A, 2005, CANCER RES, V65, P148
   Ambesi A, 2009, MOL CANCER RES, V7, P255, DOI 10.1158/1541-7786.MCR-08-0195
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Cassady AI, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40533
   Collier G, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0024-z
   Couston RG, 2012, INT J PHARMACEUT, V438, P71, DOI 10.1016/j.ijpharm.2012.09.002
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P321, DOI 10.1016/0021-9797(70)90055-X
   Elter P, 2012, COLLOID SURFACE B, V89, P139, DOI 10.1016/j.colsurfb.2011.09.021
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Goodman Roger, 1992, MODERN APPROACHES WE, P1
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Herranz-Diez C, 2016, ACS APPL MATER INTER, V8, P2517, DOI 10.1021/acsami.5b09576
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kelsh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102974
   Kowalczynska HM, 2009, J BIOMED MATER RES A, V91A, P1239, DOI 10.1002/jbm.a.32473
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Kubiak-Ossowska K, 2014, J PHYS CHEM B, V118, P9900, DOI 10.1021/jp5020077
   Lamprou D, 2010, J ADV MICROSC RES, V5, P137
   Lange D, 2009, THER ADV UROL, V1, P143, DOI 10.1177/1756287209341306
   Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Mallinson D, 2017, J BIOMED MATER RES A, V105, P737, DOI 10.1002/jbm.a.35949
   Mallinson D, 2016, RSC ADV, V6, P24939, DOI 10.1039/c6ra01224h
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421
   MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0
   Nigar M, 1996, ACTA POLYM, V47, P48, DOI 10.1002/actp.1996.010470107
   Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P18, DOI 10.1002/jbm.a.33219
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Panos M, 2012, LANGMUIR, V28, P12619, DOI 10.1021/la301546v
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   SCHUMACHER R, 1985, SURF SCI, V163, pL621
   Stine JM, 2015, BIOCHEMISTRY-US, V54, P6724, DOI 10.1021/acs.biochem.5b00818
   SUGAWARA Y, 1993, WEAR, V168, P13, DOI 10.1016/0043-1648(93)90191-N
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Tammelin T, 2004, LANGMUIR, V20, P10900, DOI 10.1021/la0487693
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   To W.S., 2011, FIBROGENESIS TISSUE, V4, P1
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Vanterpool FA, 2014, BIORESEARCH OPEN ACC, V3, P286, DOI 10.1089/biores.2014.0033
   Wagberg L, 2004, J COLLOID INTERF SCI, V274, P480, DOI 10.1016/j.jcis.2003.11.054
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wolff O, 1997, FARADAY DISCUSS, V107, P91, DOI 10.1039/a703017g
   Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620
   You R, 2010, J BIOL CHEM, V285, P36255, DOI 10.1074/jbc.C110.176990
   Zheng MZ, 2011, J CANCER, V2, P478, DOI 10.7150/jca.2.478
NR 60
TC 2
Z9 2
U1 3
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2017
VL 105
IS 3
BP 737
EP 745
DI 10.1002/jbm.a.35949
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK5HO
UT WOS:000393957700006
PM 27774773
DA 2018-10-20
ER

PT J
AU Klopfleisch, R
   Jung, F
AF Klopfleisch, R.
   Jung, F.
TI The pathology of the foreign body reaction against biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE foreign body reaction; biomaterials; biocompatibility; macrophages;
   foreign body giant cells; fibrosis
ID GIANT-CELL FORMATION; MOLECULAR-WEIGHT KININOGEN; HOST TISSUE RESPONSES;
   MACROPHAGE FUSION; CAPSULE FORMATION; IN-VITRO; PROTEIN ADSORPTION;
   PLATELET-ADHESION; POLYMER SURFACES; FACTOR-XII
AB The healing process after implantation of biomaterials involves the interaction of many contributing factors. Besides their in vivo functionality, biomaterials also require characteristics that allow their integration into the designated tissue without eliciting an overshooting foreign body reaction (FBR). The targeted design of biomaterials with these features, thus, needs understanding of the molecular mechanisms of the FBR. Much effort has been put into research on the interaction of engineered materials and the host tissue. This elucidated many aspects of the five FBR phases, that is protein adsorption, acute inflammation, chronic inflammation, foreign body giant cell formation, and fibrous capsule formation. However, in practice, it is still difficult to predict the response against a newly designed biomaterial purely based on the knowledge of its physical-chemical surface features. This insufficient knowledge leads to a high number of factors potentially influencing the FBR, which have to be analyzed in complex animal experiments including appropriate data-based sample sizes. This review is focused on the current knowledge on the general mechanisms of the FBR against biomaterials and the influence of biomaterial surface topography and chemical and physical features on the quality and quantity of the reaction. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 927-940, 2017.
C1 [Klopfleisch, R.] Free Univ Berlin, Inst Vet Pathol, Robert von Ostertag Str 15, D-14163 Berlin, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci & Berlin Brandenburg, Ctr Regenerat Therapies, Teltow, Germany.
RP Klopfleisch, R (reprint author), Free Univ Berlin, Inst Vet Pathol, Robert von Ostertag Str 15, D-14163 Berlin, Germany.
EM robert.klopfleisch@fu-berlin.de
RI Jung, Friedrich/L-1301-2013
OI Jung, Friedrich/0000-0001-8098-7180
CR Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5423-5
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andrade J D, 1973, Med Instrum, V7, P110
   ARAI T, 1990, COLLOID SURFACE, V51, P17, DOI 10.1016/0166-6622(90)80128-Q
   BALE MD, 1989, BLOOD, V74, P2698
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Binnebosel M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-1
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Broughton George 2nd, 2006, Plast Reconstr Surg, V117, p1e, DOI 10.1097/01.prs.0000222562.60260.f9
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6
   Chen HA, 2010, BIOMATERIALS, V31, P8172, DOI 10.1016/j.biomaterials.2010.07.056
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Chinn J, 2000, BIOMEDICAL ENG HDB
   Christo SN, 2015, BIOMED RES INT, DOI 10.1155/2015/342304
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DiEgidio P, 2014, ANN PLAS SURG, V73, P451, DOI 10.1097/SAP.0000000000000287
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Fischer M, 2010, J MATER SCI-MATER M, V21, P931, DOI 10.1007/s10856-009-3912-0
   Friedman HI, 2004, J INVEST SURG, V17, P271, DOI 10.1080/08941930490502844
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB
   Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4
   Haase T, 2017, J TISSUE ENG REGEN M, V11, P1034, DOI 10.1002/term.2002
   Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030
   Hammerstad M, 1996, SCAND J PLAST RECONS, V30, P33, DOI 10.3109/02844319609072402
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HUNTER RL, 1986, SCAND J IMMUNOL, V23, P287, DOI 10.1111/j.1365-3083.1986.tb01970.x
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   KALMAN PG, 1990, J VASC SURG, V11, P591, DOI 10.1067/mva.1990.18048
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Klopfleisch R, 2017, J BIOMED MATER RES A, V105, P927, DOI 10.1002/jbm.a.35958
   Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Kreuger J, 2016, NAT REV DRUG DISCOV, V15, P125, DOI 10.1038/nrd.2015.2
   Kumar V., 2004, PATHOLOGIC BASIS DIS
   Kusaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092634
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Lew DH, 2010, ANN PLAS SURG, V65, P254, DOI 10.1097/SAP.0b013e3181c60f1f
   Lin SH, 2011, BIOMACROMOLECULES, V12, P2573, DOI 10.1021/bm200368p
   Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Love RJ, 2013, J BIOMED MATER RES A, V101, P2740, DOI 10.1002/jbm.a.34577
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Major TC, 2014, J BIOMATER APPL, V29, P479, DOI 10.1177/0885328214538866
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Mooney JE, 2014, IMMUNOL CELL BIOL, V92, P518, DOI 10.1038/icb.2014.19
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Rizik DG, 2015, CATHETER CARDIO INTE, V86, P664, DOI 10.1002/ccd.26172
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rosengren A, 1999, J MATER SCI-MATER M, V10, P75, DOI 10.1023/A:1008964819101
   Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sheng N, 2000, BLOOD, V95, P3788
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sivaraman B, 2012, LANGMUIR, V28, P2745, DOI 10.1021/la204777x
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Volle JM, 2000, INFLAMMATION, V24, P571, DOI 10.1023/A:1007081508211
   VROMAN L, 1980, BLOOD, V55, P156
   WARD CA, 1974, T AM SOC ART INT ORG, VA 20, P77
   WARD CA, 1976, ANN BIOMED ENG, V4, P184, DOI 10.1007/BF02363646
   Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6
   Wermuth PJ, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0047-4
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zandstra J, 2014, EUR CELLS MATER, V28, P335, DOI 10.22203/eCM.v028a23
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 122
TC 25
Z9 26
U1 3
U2 51
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2017
VL 105
IS 3
BP 927
EP 940
DI 10.1002/jbm.a.35958
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK5HO
UT WOS:000393957700023
PM 27813288
DA 2018-10-20
ER

PT J
AU Martins, T
   Oliveira, AAR
   Oliveira, AC
   Boaventura, TP
   Barrioni, BR
   Costa-Junior, ES
   Pereira, MM
AF Martins, Talita
   Oliveira, Agda A. R.
   Oliveira, Ana Celeste
   Boaventura, Tulio P.
   Barrioni, Breno R.
   Costa-Junior, Ezequiel S.
   Pereira, Marivalda M.
TI Novel 3D composites with highly flexible behavior based on chitosan and
   bioactive glass for biomedical applications
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biocomposite; Biomaterial; Scaffolds; Flexible foam; Chitosan; Bioactive
   glass
ID IN-VITRO; SCAFFOLDS; CRYSTALLINITY; DEGRADATION; HYDROGELS; SYSTEMS;
   BLENDS; CHITIN; FOAMS; PH
AB Scaffolds with a 3D cellular solid structure have been studied intensively for tissue engineering. These materials should have adequate porosity, appropriate pore size, interconnectivity, and mechanical behavior compatible with the features of native tissue, allowing cell activities. In this work, novel flexible 3D composite foams of chitosan (CH) combined with bioactive glass (BG) in 1:0 and 1:1 ratios by a foaming method were developed. Physical characterization was performed by FOR, XRD, SEM and micro CT, where as mechanical features were evaluated by static compression and constant deflection compression tests. Resazurin assay was used to assess the cytotoxicity. Both scaffolds obtained presented a highly porous structure with interconnectivity. Our results revealed that CH/BG foams presented increased mechanical properties, probably as a result of greater intermolecular interaction and a more homogeneous pore size and distribution, and permitted a shape recovery greater than 80% of the original shape after 12 h of constant compression. The composites did not produce toxic effects. Therefore, the introduction of the inorganic phase into the chitosan matrix had a crucial effect on the morphologic and mechanical response of the flexible composite foams. These materials may be potential alternative scaffolds for tissue regeneration and stimulation of healing. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Martins, Talita; Oliveira, Agda A. R.; Oliveira, Ana Celeste; Boaventura, Tulio P.; Barrioni, Breno R.; Pereira, Marivalda M.] Univ Fed Minas Gerais, Dept Met & Mat Engn, Escola Engn, Av Antonio Carlos 6627,Bloco 2,Sala 2233, BR-31270901 Belo Horizonte, MG, Brazil.
   [Costa-Junior, Ezequiel S.] Fed Ctr Technol Educ Minas Gerais, Dept Mat Engn, Belo Horizonte, MG, Brazil.
RP Martins, T (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Escola Engn, Av Antonio Carlos 6627,Bloco 2,Sala 2233, BR-31270901 Belo Horizonte, MG, Brazil.
EM martins.talita2009@gmail.com
RI Barrioni, Breno/H-4769-2018
OI Barrioni, Breno/0000-0002-8681-6451
FU CNPq [141273/2013-5]; FAPEMIG [TEC-APQ-00693-14]; CAPES [Proex:
   433/2010]
FX The authors gratefully acknowledge CNPq (141273/2013-5), FAPEMIG
   (TEC-APQ-00693-14), CAPES (Proex: 433/2010) for financial support on
   this project. The authors thank CEFET-MG for the SEM analysis and also
   thank Prof. Ph.D. Rodrigo Orefice for the mechanical analysis, as well
   as Prof. Dr. Maria de Fatima Leite from the Calcium Signaling Laboratory
   for the biological assays.
CR Aline A., 2013, SYNTHESIS CHARACTERI, V8
   [Anonymous], 2008, HERMES WIESB, P133
   Barrioni BR, 2015, MAT SCI ENG C-MATER, V52, P22, DOI 10.1016/j.msec.2015.03.027
   Baskar D, 2011, INT J BIOL MACROMOL, V49, P385, DOI 10.1016/j.ijbiomac.2011.05.021
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bottino M.C.M., 2005, ESTUDO OSTEOINTEGRAC, P150
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Chen RH, 1996, CARBOHYD POLYM, V31, P141, DOI 10.1016/S0144-8617(96)00047-1
   Correia CO, 2015, CARBOHYD POLYM, V123, P39, DOI 10.1016/j.carbpol.2014.12.076
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Jones Julian R, 2015, Acta Biomater, V23 Suppl, pS53, DOI 10.1016/j.actbio.2015.07.019
   KONTOU E, 1990, COLLOID POLYM SCI, V268, P636, DOI 10.1007/BF01410405
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Luz GM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494014
   Maji K., 2016, PREPARATION EVALUATI
   Mansur HS, 2008, CHEM ENG J, V137, P72, DOI 10.1016/j.cej.2007.09.036
   Mansur HS, 2009, MAT SCI ENG C-BIO S, V29, P1574, DOI 10.1016/j.msec.2008.12.012
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Mehdipour M, 2012, CERAM INT, V38, P471, DOI 10.1016/j.ceramint.2011.07.029
   Moreira CDF, 2016, MAT SCI ENG C-MATER, V58, P1207, DOI 10.1016/j.msec.2015.09.075
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nisola GM, 2015, CHEM ENG J, V280, P536, DOI 10.1016/j.cej.2015.05.107
   OGAWA K, 1991, AGR BIOL CHEM TOKYO, V55, P2375, DOI 10.1080/00021369.1991.10870939
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   Pavia D. L., 2009, INTRO SPECTROSCOPY
   Pei AH, 2010, COMPOS SCI TECHNOL, V70, P815, DOI 10.1016/j.compscitech.2010.01.018
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   YUI T, 1992, CARBOHYD RES, V229, P41, DOI 10.1016/S0008-6215(00)90479-8
   Zhang FH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11152
NR 46
TC 3
Z9 3
U1 3
U2 23
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 1
PY 2017
VL 189
BP 1
EP 11
DI 10.1016/j.matchemphys.2016.12.012
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA EK1YN
UT WOS:000393723800001
DA 2018-10-20
ER

PT J
AU Raguvaran, R
   Manuja, BK
   Chopra, M
   Thakur, R
   Anand, T
   Kalia, A
   Manuja, A
AF Raguvaran, R.
   Manuja, Balvinder K.
   Chopra, Meenu
   Thakur, Rajesh
   Anand, Taruna
   Kalia, Anu
   Manuja, Anju
TI Sodium alginate and gum acacia hydrogels of ZnO nanoparticles show wound
   healing effect on fibroblast cells
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Zinc oxide; Nanoparticles; Hydrogels; Fibroblast cells; Sodium alginate;
   Gum acacia
ID ANTIBACTERIAL ACTIVITY; PARTICLE-SIZE; ZINC-OXIDE; POWDERS
AB An ideal biomaterial for wound dressing applications should possess antibacterial and anti-inflammatory properties without any toxicity to the host cells while providing the maximum healing activity. Zinc oxide nanoparticles (ZnONPs) possess antimicrobial activity and enhance wound healing, but the questions regarding their safety arise before application to the biological systems. We synthesized ZnONPs-loaded-sodium alginate-gum acacia hydrogels (SAGA-ZnONPs) by cross linking hydroxyl groups of the polymers sodium alginate and gum acacia with the aldehyde group of gluteradehyde. Here, we report the wound healing properties of sodium alginate/gum acacia/ZnONPs, circumventing the toxicity of ZnONPs simultaneously. We demonstrated the concentration-dependent zones of inhibition in treated cultures of Pseudomonas aerigunosa and Bacillus cereus and biocompatability on peripheral blood mononuclear/fibroblast cells. SAGA-ZnONPs hydrogels showed a healing effect at a low concentration of ZnONPs using sheep fibroblast cells. Our findings suggest that high concentrations of ZnONPs were toxic to cells but SAGA-ZnONPs hydrogels significantly reduced the toxicity and preserved the beneficial antibacterial and healing effect. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Raguvaran, R.; Manuja, Balvinder K.; Chopra, Meenu; Anand, Taruna; Manuja, Anju] ICAR Natl Res Ctr Equines, Sirsa Rd, Hisar 125001, Haryana, India.
   [Raguvaran, R.] ICAR Indian Vet Res Inst, Bareilly, Uttar Pradesh, India.
   [Thakur, Rajesh] Guru Jambheshwar Univ Sci & Technol, Dept Bio & Nano Technol, Hisar 125001, Haryana, India.
   [Kalia, Anu] Punjab Agr Univ, Electron Microscopy & Nanosci Lab, Ludhiana, Punjab, India.
RP Manuja, A (reprint author), ICAR Natl Res Ctr Equines, Sirsa Rd, Hisar 125001, Haryana, India.
EM amanuja@rediffmail.com
FU Indian Council of Agricultural Research, Ministry of Agriculture and
   farmers welfare, New Delhi, India; ICAR
FX The authors thank Indian Council of Agricultural Research, Ministry of
   Agriculture and farmers welfare, New Delhi, India for providing
   financial support. Raguvaran is thankful to ICAR for providing the
   fellowship during his MVSc.
CR Abdelmonem AM, 2015, J INORG BIOCHEM, V153, P334, DOI 10.1016/j.jinorgbio.2015.08.029
   Aneesh P. M., 2007, P SOC PHOTO-OPT INS, V6639
   Argen M. S., 1990, ACTA DERM-VENER    S, V154, P1
   Atmaca S, 1998, TURK J MED SCI, V28, P595
   Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085
   Carrillo-Carrion C, 2014, CURR OPIN CHEM ENG, V4, P88, DOI 10.1016/j.coche.2013.11.006
   Chopra M, 2015, INT J BIOL MACROMOL, V72, P827, DOI 10.1016/j.ijbiomac.2014.09.037
   Dodd AC, 2006, J NANOPART RES, V8, P43, DOI 10.1007/s11051-005-5131-z
   Dolphe M., 1984, INT J COSMETIC SCI, V6, P55
   Heng BC, 2011, ARCH TOXICOL, V85, P695, DOI 10.1007/s00204-010-0608-7
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4
   Kong QS, 2009, MATER SCI FORUM, V610-613, P1188, DOI 10.4028/www.scientific.net/MSF.610-613.1188
   Manuja A., NANOMEDICINE, V9
   Manuja A., 2012, NANOTECHNOL DEV, V2, P4, DOI DOI 10.4081/ND.2012.E4
   Manuja A, 2014, INT IMMUNOPHARMACOL, V22, P366, DOI 10.1016/j.intimp.2014.07.016
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Raguvaran R, 2015, INT J PHARM SCI RES, V6, P1166, DOI 10.13040/IJPSR.0975-8232.6(3).1166-69
   Raguvaran R., 2015, IMMUNOME RES, V11
   Rivera -Gil P., 2012, ACCOUNTS CHEM RES, V11, P743
   Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49
   SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Snyder-Talkington BN, 2012, J TOXICOL ENV HEAL B, V15, P468, DOI 10.1080/10937404.2012.736856
   Voicu G, 2013, DIG J NANOMATER BIOS, V8, P1191
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Yousef JM, 2012, J HEALTH SCI, V2, P38
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 30
TC 19
Z9 20
U1 4
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2017
VL 96
BP 185
EP 191
DI 10.1016/j.ijbiomac.2016.12.009
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EJ5GL
UT WOS:000393245700022
PM 27939272
DA 2018-10-20
ER

PT J
AU Thiruselvi, T
   Raja, STK
   Shanuja, SK
   Iswarya, S
   Gnanamani, A
AF Thiruselvi, T.
   Raja, Thirupathi Kumara S.
   Shanuja, S. K.
   Iswarya, S.
   Gnanamani, A.
TI Induced oxidative stress management in wounds through phenolic acids
   engineered fibrous protein: An in vitro assessment using
   polymorphonuclear (PMN) cells
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Fibrous protein; Phenolic acids; Induced oxidative stress; PMN cells;
   Cell migration
ID ANTIOXIDANT PROPERTIES; DAMAGE; POLYMERS; GELATIN
AB The present study explores the preparation, characterization and the role of phenolic acid tethered fibrous protein in the management of induced oxidative stress studied under in vitro conditions. In brief, the biomaterial is prepared by engineering the fibrous protein with dihydroxy and trihydroxy phenolic acid moieties and subjected to characterization to ensure the tethering. The resultant biomaterial studied for its efficacy as a free radical scavenger using polymorphonuclear (PMN) cells with induced oxidative stress and also as an agent for cell migration using fibroblasts cells. Results revealed that induced oxidative stress in PMN cells after exposure to UVB radiation managed well with the prepared biomaterial by reducing the levels of superoxide anion, oxygen and hydroxyl radicals. Further, the protein and the phenolic acid interaction supports the cell migration as evidenced from the scratch assay. In conclusion, though phenolic acids are well known for their antimicrobial and antioxidant potential, indenting these acids directly to the wounds is not sensible, but tethering to protein explored the scavenging activity as expected. The present study infers that phenolic acid engineered protein has a significant role in managing the imbalance in the redox state prevailing in wounds and supports the healing at appreciable level. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Thiruselvi, T.; Raja, Thirupathi Kumara S.; Shanuja, S. K.; Iswarya, S.; Gnanamani, A.] Cent Leather Res Inst, CSIR, Madras 20, Tamil Nadu, India.
RP Gnanamani, A (reprint author), Cent Leather Res Inst, CSIR, Madras 20, Tamil Nadu, India.
EM gnanamani3@gmail.com
OI Selvaraj, Thirupathi Kumara Raja/0000-0002-0502-1172
FU CSIR, New Delhi
FX The first author acknowledges CSIR, New Delhi for Financial assistance
   in the form of SRF (Senior Research Fellow). The first author also
   acknowledges University of Madras and the present research article is
   part of the Ph.D work.
CR Albu MG, 2009, REV CHIM-BUCHAREST, V60, P666
   Cunningham M., 1985, FREE RADICAL BIO MED, V1, P381
   James TJ, 2003, WOUND REPAIR REGEN, V11, P172, DOI 10.1046/j.1524-475X.2003.11304.x
   Kagan VE, 1998, ANN NY ACAD SCI, V854, P425, DOI 10.1111/j.1749-6632.1998.tb09921.x
   Karamac Magdalena, 2005, Polish Journal of Food and Nutrition Sciences, V14, P165
   Li X, 2011, FFHD, V1, P232
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   MACHLIN LJ, 1987, FASEB J, V1, P441
   Matassi F, 2011, CLIN CASES MINER BON, V8, P21
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Oyaizu M., 1986, EIYOGAKU ZASSHI
   Pandey B. N., 2003, International Journal of Low Radiation, V1, P113, DOI 10.1504/IJLR.2003.003478
   Radhakrishnan N, 2012, INT J RADIAT BIOL, V88, P575, DOI 10.3109/09553002.2012.697644
   Raja STK, 2015, J MATER CHEM B, V3, P1230, DOI 10.1039/c4tb01196a
   RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649
   Sies H, 2004, ANNU REV NUTR, V24, P173, DOI 10.1146/annurev.nutr.24.012003.132320
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Svobodova Alena, 2003, Biomedical Papers (Olomouc), V147, P137
   Thiagarajan P, 2013, INDIAN J FIBRE TEXT, V38, P161
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
NR 22
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2017
VL 96
BP 485
EP 493
DI 10.1016/j.ijbiomac.2016.12.063
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EJ5GL
UT WOS:000393245700055
PM 28034822
DA 2018-10-20
ER

PT J
AU Tozzi, G
   Dall'Ara, E
   Palanca, M
   Curto, M
   Innocente, F
   Cristofolini, L
AF Tozzi, Gianluca
   Dall'Ara, Enrico
   Palanca, Marco
   Curto, Marco
   Innocente, Federica
   Cristofolini, Luca
TI Strain uncertainties from two digital volume correlation approaches in
   prophylactically augmented vertebrae: Local analysis on bone and
   cement-bone microstructures
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Digital volume correlation; Micro-CT; Bone; Strain uncertainties;
   Augmented vertebrae
ID TRABECULAR BONE; FINITE-ELEMENT; MICRODAMAGE; COMPRESSION; BEHAVIOR;
   DISPLACEMENTS; ACCURACY
AB Combination of micro-focus computed tomography (micro-CT) in conjunction with in situ mechanical testing and digital volume correlation (DVC) can be used to access the internal deformation of materials and structures. DVC has been exploited over the past decade to measure complex deformation fields within biological tissues and bone-biomaterial systems. However, before adopting it in a clinically-relevant context (i.e. bone augmentation in vertebroplasty), the research community should focus on understanding the reliability of such method in different orthopaedic applications involving the use of biomaterials. The aim of this study was to evaluate systematic and random errors affecting the strain computed with two different DVC approaches (a global one, "ShIRT-FE", and a local one, "DaVis-DC") in different microstructures within augmented vertebrae, such as trabecular bone, cortical bone and cement-bone interdigitation. The results showed that systematic error was insensitive to the size of the computation sub-volume used for the DVC correlation. Conversely, the random error (which was generally the largest component of error) was lower for a 48-voxel (1872 micrometer) sub-volume (64-221 microstrain for ShIRT-FE, 88-274 microstrain for DaVis-DC), than for a 16-voxel (624 micrometer) sub-volume (359-1203 microstrain for ShIRT-FE, 960-1771 microstrain for DaVis-DC) for the trabecular and cement regions. Overall, the local random error did not appear to be influenced by either bone microarchitecture or presence of biomaterial. For the 48-voxel sub-volume the global approach was less sensitive to the gradients in grey-values at the cortical surface (random error below 200 microstrain), while the local approach showed errors up to 770 microstrain. Mean absolute error (MAER) and standard deviation of error (SDER) were also calculated and substantially improved when compared to recent literature for the cement-bone interface. The multipass approach for DaVis-DC further reduced the random error for the largest volume of interest. The random error did not follow any recognizable pattern with the six strain components and only ShiRT-FE seemed to produce lower random errors in the normal strains. In conclusion this study has provided, for the first time, a preliminary indication of the reliability and limitations for the application of DVC in estimating the micromechanics of bone and cement-bone interface in augmented vertebrae.
C1 [Tozzi, Gianluca; Curto, Marco] Univ Portsmouth, Sch Engn, Portsmouth, Hants, England.
   [Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.
   [Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.
   [Palanca, Marco; Innocente, Federica; Cristofolini, Luca] Univ Bologna, Alma Mater Studiorum, Sch Engn & Architecture, Bologna, Italy.
RP Dall'Ara, E (reprint author), INSIGNEO Inst Silico Med, Dept Oncol & Metab, Sir Frederick Mappin Bldg,Pam Liversidge Bldg, Sheffield S1 3JD, S Yorkshire, England.
EM e.dallara@sheffield.ac.uk
OI Dall'Ara, Enrico/0000-0003-1471-5077; Palanca, Marco/0000-0002-1231-2728
FU Royal Society (University of Portsmouth) [RG130831]; EPSRC (University
   of Sheffield, project MultiSim) [EP/K03877X/1]; Engineering and Physical
   Sciences Research Council [EP/K03877X/1]
FX The authors would like to thank Remo Antelli for donating the porcine
   spines, Renzo Soffiatti and Roberta Tosato (Tecres Spa, Italy) for their
   advice and support in cement injection, Colin Lupton (University of
   Portsmouth) for technical support in micro-CT maintenance, Martino Pani
   (University of Portsmouth) for help with the images, Rod Hose and David
   Barber (University of Sheffield) for sharing the ShIRT software. Funding
   was provided by Royal Society (University of Portsmouth, Grant no.
   RG130831), and EPSRC (University of Sheffield, project MultiSim, Grant
   no. EP/K03877X/1). The bone cement was donated by Tecres Spa (Italy).
CR Christen D, 2012, J MECH BEHAV BIOMED, V8, P184, DOI 10.1016/j.jmbbm.2011.12.009
   Cristofolini L., 2016, J MECH MED IN PRESS
   Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019
   Danesi V, 2016, CLIN BIOMECH, V39, P14, DOI 10.1016/j.clinbiomech.2016.07.010
   Danesi V, 2014, J BIOMECH, V47, P313, DOI 10.1016/j.jbiomech.2013.10.005
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014
   Hussein AI, 2013, J BIOMECH, V46, P1683, DOI 10.1016/j.jbiomech.2013.04.004
   Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013
   Kamano H, 2011, AM J ROENTGENOL, V197, P451, DOI 10.2214/AJR.10.5937
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Liu L, 2007, J BIOMECH, V40, P3516, DOI 10.1016/j.jbiomech.2007.04.019
   Madi K, 2013, MED ENG PHYS, V35, P1298, DOI 10.1016/j.medengphy.2013.02.001
   Nazarian A, 2004, J BIOMECH, V37, P55, DOI 10.1016/S0021-9290(03)00254-9
   Palanca M., 2015, J BIOMECH ENG, V137
   Palanca M., 2016, J BIOMECH IN PRESS
   Palanca M, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415400047
   Roberts BC, 2014, J BIOMECH, V47, P923, DOI 10.1016/j.jbiomech.2014.01.001
   Schreier HW, 2002, EXP MECH, V42, P303, DOI 10.1007/BF02410987
   Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202
   Tozzi G, 2014, J BIOMECH, V47, P3466, DOI 10.1016/j.jbiomech.2014.09.012
   Tozzi G, 2013, J MATER SCI-MATER M, V24, P2509, DOI 10.1007/s10856-013-5000-8
   Tozzi G, 2012, J BIOMECH, V45, P356, DOI 10.1016/j.jbiomech.2011.10.011
   Zhu ML, 2016, J MECH BEHAV BIOMED, V57, P269, DOI 10.1016/j.jmbbm.2015.12.017
NR 24
TC 6
Z9 6
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2017
VL 67
BP 117
EP 126
DI 10.1016/j.jmbbm.2016.12.006
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI7JM
UT WOS:000392673900012
PM 27992842
OA Other Gold
DA 2018-10-20
ER

PT J
AU Abhari, RE
   Mouthuy, PA
   Zargar, N
   Brown, C
   Carr, A
AF Abhari, Roxanna E.
   Mouthuy, Pierre-Alexis
   Zargar, Nasim
   Brown, Cameron
   Carr, Andrew
TI Effect of annealing on the mechanical properties and the degradation of
   electrospun polydioxanone filaments
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Polydioxanone; PDO; Electrospinning; Annealing; In vitro degradation
ID HYDROLYTIC DEGRADATION; POLYMER NANOFIBERS; CRYSTALLIZATION; FIBERS
AB Annealing, or heat treatment, has traditionally been used as a treatment to improve the strength and stiffness of electrospun materials. Understanding the extent to which annealing can improve the mechanical properties and alter the degradation rate of electrospun polydioxanone filaments could influence the range of its potential clinical applications.
   In this study, we investigated the effect of annealing electrospun polydioxanone filaments at varying times and temperatures and subsequently subjecting them to in vitro degradation in phosphate buffer saline for up to 6 weeks. Fibre alignment, tensile strength and thermal properties were assessed.
   It was determined that annealing at 65 degrees C for 3 h only marginally improved the tensile strength (9 +/- 2%) but had a significant effect on reducing strain and rate of degradation, as well as maintaining fibre alignment within the filament. The filament retained significantly more of its force at failure after 4 weeks (82 +/- 15%, compared to 61 +/- 20% for non annealed filaments) and after 6 weeks of degradation (81 +/- 9%, compared to 55 +/- 13% for non annealed filaments). Conversely, annealing filaments at 75 degrees C improved the initial tensile strength of the filament (17 +/- 6%), but over 6 weeks, both samples annealed at 75 degrees C and 85 degrees C otherwise performed similarly or mechanically worse than those not annealed.
   These findings suggest that annealing at low temperatures is more useful as a method to tailor degradation rate than to improve mechanical properties. The ability to modulate the degradation profile with annealing may become useful to tailor the properties of electrospun materials without altering the chemistry of the polymer used. This might better match the degradation of the implant and gradual loss of mechanical properties with the new matrix deposition within the structure, enabling multiple regenerative strategies within a single biomaterial system.
C1 [Abhari, Roxanna E.; Mouthuy, Pierre-Alexis; Zargar, Nasim; Brown, Cameron; Carr, Andrew] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Old Rd, Oxford OX3 7LD, England.
   [Abhari, Roxanna E.; Mouthuy, Pierre-Alexis; Zargar, Nasim; Brown, Cameron; Carr, Andrew] Univ Oxford, Inst Musculoskeletal Sci, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England.
EM roxanna.abhari@gmail.com; mouthuypa@gmail.com;
   nasim.zargarbaboldashti@ndorms.ox.ac.uk; cameron.brown@ndorms.ox.ac.uk;
   andrew.carr@ndorms.ox.ac.uk
OI Mouthuy, Pierre-Alexis/0000-0003-1192-6362; Brown,
   Cameron/0000-0003-2520-9030
FU NIHR Oxford Biomedical Research Unit [HFRWGQ00]; Medical Research
   Council [MC_PC_14103, MC_PC_12020]; National Institute for Health
   Research [NF-SI-0611-10216]; Orthopaedic Research UK [501]
FX This work was supported by the NIHR Oxford Biomedical Research Unit,
   grant number HFRWGQ00.
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   Baji A, 2010, COMPOS SCI TECHNOL, V70, P703, DOI 10.1016/j.compscitech.2010.01.010
   Barber JG, 2013, TISSUE ENG PT A, V19, P1265, DOI 10.1089/ten.tea.2010.0538
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Bonnet M, 1999, COLLOID POLYM SCI, V277, P513, DOI 10.1007/s003960050418
   Cameron RE, 2002, J BIOMED MATER RES, V63, P280
   Cho AR, 2011, J APPL POLYM SCI, V120, P752, DOI 10.1002/app.33262
   Goonoo N, 2015, EUR J PHARM BIOPHARM, V97, P371, DOI 10.1016/j.ejpb.2015.05.024
   HOFFMAN JD, 1969, KOLLOID Z Z POLYM, V231, P564, DOI 10.1007/BF01500015
   Mouthuy PA, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/2/025006
   Nixon AJ, 2012, J SHOULDER ELB SURG, V21, P278, DOI 10.1016/j.jse.2011.11.015
   Ooi CP, 2002, J BIOMED MATER RES, V63, P291, DOI 10.1002/jbm.10181
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Sabino MA, 2000, POLYM DEGRAD STABIL, V69, P209, DOI 10.1016/S0141-3910(00)00062-8
   Srithep Y, 2013, POLYM ENG SCI, V53, P580, DOI 10.1002/pen.23304
   Srithep Y, 2011, POLYM ENG SCI, V51, P1023, DOI 10.1002/pen.21916
   Takayama T, 2011, J MECH BEHAV BIOMED, V4, P255, DOI 10.1016/j.jmbbm.2010.10.003
   Tan E.P.S., 2006, EFFECTS ANNEALING ST
   Tan EPS, 2006, NANOTECHNOLOGY, V17, P2649, DOI 10.1088/0957-4484/17/10/034
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   YEH GSY, 1976, POLYMER, V17, P309, DOI 10.1016/0032-3861(76)90187-7
NR 23
TC 2
Z9 2
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2017
VL 67
BP 127
EP 134
DI 10.1016/j.jmbbm.2016.11.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI7JM
UT WOS:000392673900013
PM 28006712
OA Other Gold
DA 2018-10-20
ER

PT J
AU de Arruda, INQ
   Pereira, VA
   Stefani, R
AF Queiroz de Arruda, Iza Natalia
   Pereira, Valdir Aniceto, Jr.
   Stefani, Ricardo
TI Application of chitosan matrix for delivery of rutin
SO JOURNAL OF THE IRANIAN CHEMICAL SOCIETY
LA English
DT Article
DE Chitosan; Controlled release; Smart polymers; Flavonoids
ID SUBMICRON PARTICLES; CONTROLLED-RELEASE; FILMS; HYDROGELS;
   PRECIPITATION; NANOPARTICLES; ENCAPSULATION; ANTIOXIDANTS; FLAVONOIDS;
   MICELLES
AB Chitosan matrices are an alternative material to the food industry, due to its ability to release bioactive compounds through interconnected cavities. Chitosan is a biomaterial of excellence, because it shows unique features, such as biocompatibility, non-toxicity, bactericidal action and the ability to associate with other compounds. Thus, this study aimed the development of chitosan matrices incorporated with rutin, as well as the evaluation of rutin release. Chitosan matrices with rutin were prepared by the coacervation method in alkaline solution and subsequently characterized through FT-IR, TG-DSC, X-ray diffraction, SEM and further submitted to rutin release assay. Results show the effectiveness in the incorporation of rutin into the polymeric matrix. The polymeric matrix with rutin can quickly release it, which provides a wide range of applications, such as carrier of rutin as a micronutrient food additive.
C1 [Queiroz de Arruda, Iza Natalia; Pereira, Valdir Aniceto, Jr.; Stefani, Ricardo] UFMT, Mat Res Lab LEMat, Campus Univ Araguaia,BR-070,Km 5, BR-78600000 Barra Do Garcas, MT, Brazil.
RP Stefani, R (reprint author), UFMT, Mat Res Lab LEMat, Campus Univ Araguaia,BR-070,Km 5, BR-78600000 Barra Do Garcas, MT, Brazil.
EM rstefani@ufmt.br
RI Stefani, Ricardo/G-2558-2013
OI Stefani, Ricardo/0000-0003-3331-9766
CR Abdelaal MY, 2007, J APPL POLYM SCI, V103, P2864, DOI 10.1002/app.25154
   Reis LCB, 2015, FOOD BIOPROD PROCESS, V94, P382, DOI 10.1016/j.fbp.2014.05.004
   Belscak-Cvitanovic A, 2011, FOOD RES INT, V44, P1094, DOI 10.1016/j.foodres.2011.03.030
   Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m
   Dashtdar H., 2013, KNEE SURG SPORT TR A, V23, P1368
   Demirkol DO, 2011, MICROCHIM ACTA, V173, P537, DOI 10.1007/s00604-011-0596-1
   Ebrahimi MMS, 2014, LANGMUIR, V30, P7842, DOI 10.1021/la501482u
   Hosseini SF, 2013, CARBOHYD POLYM, V95, P50, DOI 10.1016/j.carbpol.2013.02.031
   Islam A, 2012, J APPL POLYM SCI, V124, P4184, DOI 10.1002/app.35392
   Ivanova E.P., 2015, NEW FUNCTIONAL BIOMA, P110
   Kanatt SR, 2012, FOOD HYDROCOLLOID, V29, P290, DOI 10.1016/j.foodhyd.2012.03.005
   Konecsni K, 2012, FOOD CHEM, V134, P1775, DOI 10.1016/j.foodchem.2012.03.070
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Laxmi Banjare, 2012, International Journal of Pharmaceutical and Biological Archives, V3, P326
   Li JH, 2014, FOOD HYDROCOLLOID, V37, P166, DOI 10.1016/j.foodhyd.2013.10.015
   Lof D, 2011, J FOOD SCI, V76, pN35, DOI 10.1111/j.1750-3841.2011.02103.x
   Montes A, 2016, J SUPERCRIT FLUID, V118, P1, DOI 10.1016/j.supflu.2016.07.020
   Nath SD, 2015, CARBOHYD POLYM, V115, P160, DOI 10.1016/j.carbpol.2014.08.077
   Tran NQ, 2011, BIOMACROMOLECULES, V12, P2872, DOI 10.1021/bm200326g
   Prabaharan M, 2008, J BIOMATER APPL, V23, P5, DOI 10.1177/0885328208091562
   Praxedes APP, 2016, APPL SURF SCI, V370, P25, DOI 10.1016/j.apsusc.2016.01.264
   Santos José E. dos, 2003, Polímeros, V13, P242, DOI 10.1590/S0104-14282003000400009
   Silva-Pereira MC, 2015, LWT-FOOD SCI TECHNOL, V61, P258, DOI 10.1016/j.lwt.2014.11.041
   Soni H, 2013, INT J APPL PHARM, V5, P5
   Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006
   Valdes A, 2015, RSC ADV, V5, P40324, DOI 10.1039/c4ra17286h
   Vimala K., 2011, J BIOMATER NANOBIOTE, V2, P55, DOI DOI 10.4236/JBNB.2011.21008
   Wang Q, 2005, J APPL POLYM SCI, V96, P808, DOI 10.1002/app.21518
   Wu SJ, 2013, J APPL POLYM SCI, V127, P4573, DOI 10.1002/app.38073
   Yang B, 2010, CARBOHYD POLYM, V80, P860, DOI 10.1016/j.carbpol.2009.12.044
   Yoshida CMP, 2014, LWT-FOOD SCI TECHNOL, V55, P83, DOI 10.1016/j.lwt.2013.09.015
   Zhou HH, 2012, LANGMUIR, V28, P14553, DOI 10.1021/la303062j
NR 32
TC 2
Z9 2
U1 0
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1735-207X
EI 1735-2428
J9 J IRAN CHEM SOC
JI J. Iran Chem. Soc.
PD MAR
PY 2017
VL 14
IS 3
BP 561
EP 566
DI 10.1007/s13738-016-1004-x
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA EI2LY
UT WOS:000392320000005
DA 2018-10-20
ER

PT J
AU Li, YM
   Li, X
   Zhao, R
   Wang, CY
   Qiu, FP
   Sun, BL
   Ji, H
   Qiu, J
   Wang, C
AF Li, Yumei
   Li, Xiang
   Zhao, Rui
   Wang, Chuying
   Qiu, Fangping
   Sun, Bolun
   Ji, He
   Qiu, Ju
   Wang, Ce
TI Enhanced adhesion and proliferation of human umbilical vein endothelial
   cells on conductive PANI-PCL fiber scaffold by electrical stimulation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Conductive; Electrospinning; PANI-PCL; Electrical stimulation; Vascular
   tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; EMBRYONIC STEM-CELLS; ELECTROSPUN
   NANOFIBERS; IN-VIVO; DIFFERENTIATION; POLYANILINE; SUBSTITUTES;
   PERFORMANCE; FABRICATION; SUBSTRATE
AB Recently, electrically conductive biomaterial scaffolds have shown great potential in tissue regeneration. Herein, we reported an electrically conductive polyaniline (PANI) coated poly(epsilon-caprolactone) (PCL) electrospun micron -fiber scaffold for the enhanced attachment and proliferation of human umbilical vein endothelial cells (HUVECs) under electrical stimulation conditions. After the 02 plasma treatment toward PCL electrospun fiber, PANI could be polymerized onto their surfaces successfully. The obtained PANI-PCL fibers were characterized by SEM observations, FT-IR spectra, XPS analysis, and water contact angle measurement. The mechanical tests indicated that the fibers could satisfy the practical vascular scaffold requirements. The conductivity of the PANI-PCL fibers was 6.71 x 10(-3) S/cm which could provide a conductive in-vitro platform to study the effect of electrical stimulation on HUVECs proliferation. When PANI-coated PCL fibers were compared with PCL fibers, HUVECs exhibited highly enhanced adhesion and viability, especially under electrical stimulation (ES) of 200, 300, and 400 mV/cm. Proliferation of HUVECs on PANI-PCL fibers was strongly dependent on electrical stimulation intensity. The results showed new insights into conductive scaffolds for vascular tissue engineering. (C) 2016 Published by Elsevier B.V.
C1 [Li, Yumei; Li, Xiang; Zhao, Rui; Sun, Bolun; Ji, He; Qiu, Ju; Wang, Ce] Jilin Univ, Alan G MacDiarmid Inst, Changchun 130012, Peoples R China.
   [Li, Yumei; Wang, Chuying] Changchun Univ Chinese Med, Sch Pharmaceut Sci, Dept Clin Pharm & Tradit Chinese Med Pharmacol, Changchun 130117, Peoples R China.
   [Qiu, Fangping] Changchun Univ Technol, Chem & Biol Sci Coll, Changchun 130012, Peoples R China.
RP Wang, C (reprint author), Jilin Univ, Alan G MacDiarmid Inst, Changchun 130012, Peoples R China.; Qiu, FP (reprint author), Changchun Univ Technol, Chem & Biol Sci Coll, Changchun 130012, Peoples R China.
EM qfp2004@126.com; cwang@jlu.edu.cn
RI Zhao, Rui/P-2684-2018
OI Zhao, Rui/0000-0002-2909-8561; Sun, Bolun/0000-0002-5333-1589
FU National Natural Science Foundation of China [21274052, 51303060,
   21474043]; Jilin Provincial Science and Technology Department Project
   [20130206064GX]
FX This work is supported by the research grants from the National Natural
   Science Foundation of China (Nos. 21274052, 51303060 and 21474043), and
   the Jilin Provincial Science and Technology Department Project (No.
   20130206064GX).
CR Adabi M., 2016, ARTIF CELL NANOMED B, P1
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   BASSETT CA, 1964, NATURE, V204, P652, DOI 10.1038/204652a0
   Bera S, 2016, APPL SURF SCI, V383, P165, DOI 10.1016/j.apsusc.2016.05.009
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Dehdilani N, 2016, CELL J, V17, P629
   Diaz-Gomez L, 2014, MAT SCI ENG C-MATER, V40, P180, DOI 10.1016/j.msec.2014.03.065
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   He W, 2013, CELL BIOCHEM BIOPHYS, V66, P855, DOI 10.1007/s12013-013-9528-5
   Hitscherich P, 2016, BIOTECHNOL BIOENG, V113, P1577, DOI 10.1002/bit.25918
   Hosseinzadeh S, 2016, BIOPROC BIOSYST ENG, V39, P1163, DOI 10.1007/s00449-016-1592-y
   Ketabchi N, 2016, NEURAL COMPUT APPL, P1
   Kim JH, 2013, J BIOMED MATER RES A, V101, P1447, DOI 10.1002/jbm.a.34446
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lei JY, 2015, ELECTROCHIM ACTA, V176, P149, DOI 10.1016/j.electacta.2015.07.028
   Li MY, 2007, CHINESE J POLYM SCI, V25, P331, DOI 10.1142/S0256767907002199
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Massoumi B, 2015, RSC ADV, V5, P21197, DOI 10.1039/c5ra02121a
   McCullen SD, 2009, WIRES NANOMED NANOBI, V1, P369, DOI 10.1002/wnan.039
   Mercado-Pagan AE, 2016, MAT SCI ENG C-MATER, V64, P61, DOI 10.1016/j.msec.2016.03.068
   Mercado-Pagan AE, 2015, MAT SCI ENG C-MATER, V49, P541, DOI 10.1016/j.msec.2015.01.051
   Montero RB, 2012, ACTA BIOMATER, V8, P1778, DOI 10.1016/j.actbio.2011.12.008
   Pan CJ, 2016, MAT SCI ENG C-MATER, V67, P132, DOI 10.1016/j.msec.2016.05.038
   Puckert C, 2016, RSC ADV, V6, P62270, DOI 10.1039/c6ra11682e
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Su WT, 2015, MAT SCI ENG C-MATER, V46, P427, DOI 10.1016/j.msec.2014.10.076
   Tang JY, 2015, J MATER CHEM B, V3, P8537, DOI 10.1039/c5tb01144b
   Thrivikraman G, 2014, BIOMATERIALS, V35, P6219, DOI 10.1016/j.biomaterials.2014.04.018
   Wan H, 1997, J MATER SCI-MATER M, V8, P45, DOI 10.1023/A:1018542313236
   Wang JQ, 2013, RSC ADV, V3, P8978, DOI 10.1039/c3ra40616d
   Wilhelmi M, 2014, BIOMED ENG-BIOMED TE, V59, P185, DOI 10.1515/bmt-2013-0112
   Wu YB, 2016, ACTA BIOMATER, V33, P122, DOI 10.1016/j.actbio.2016.01.036
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yu L, 2015, REACT FUNCT POLYM, V91-92, P19, DOI 10.1016/j.reactfunctpolym.2015.04.003
   Zhang JG, 2014, J MATER CHEM B, V2, P7945, DOI 10.1039/c4tb01185f
   Zhang JM, 2016, COLLOID SURFACE B, V146, P280, DOI 10.1016/j.colsurfb.2016.06.023
   Zou YW, 2016, ACS APPL MATER INTER, V8, P12576, DOI 10.1021/acsami.6b00957
NR 42
TC 7
Z9 7
U1 6
U2 113
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2017
VL 72
BP 106
EP 112
DI 10.1016/j.msec.2016.11.052
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EI0LI
UT WOS:000392165600013
PM 28024565
DA 2018-10-20
ER

PT J
AU Anzai, R
   Takami, T
   Uchida, Y
   Murakami, Y
AF Anzai, Ryosuke
   Takami, Taku
   Uchida, Yusuke
   Murakami, Yoshihiko
TI Poly(epsilon-caprolactone) (PCL) hybrid sheets containing polymeric
   micelles: Effects of inner structures on the material properties of the
   sheets
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Sheet; Polymeric micelle; Poly(epsilon-caprolactone); Poly(ethylene
   glycol)
ID INCORPORATE HYDROPHILIC COMPOUNDS; AMPHIPHILIC BLOCK-COPOLYMERS;
   TISSUE-ADHESIVE HYDROGEL; MECHANICAL-PROPERTIES; IN-VITRO; ANHYDROUS
   ISOOCTANE; DIBLOCK COPOLYMER; BANDED SPHERULITE; GROWTH-FACTOR;
   DRUG-RELEASE
AB In the present paper, we clarify the effects that the composition of three types of sheets-the PCLsheet, the PCL-BC (PCL-block copolymer composite) sheet, and the PCL-PM (PCL-polymeric micelle composite) sheet can have on (1) the sheets' inner structure, (2) the dispersity of hydrophilic compounds in the sheets, (3) the sheets' mechanical properties, and (4) the sheets' degradability. Our results show that (1) the PCL-PM sheet can disperse hydrophilic compounds uniformly, (2) the molecular state (free or micellar) of a co-existing compound (PEG-b-PCL block copolymers) affects the strength and the inner structures of the sheets, whereas the presence of a co-existing compound affects the flexibility of the sheets, and (3) according to our degradation experiment, hard-to-handle PCL having extremely low hydrolysis could serve as materials with a controllable surface morphology by the effective use of co-existing compounds. The results obtained in this paper show that the PCL-CM sheet, with its uniformly dispersed polymeric micelles providing hydrophilic spaces, could be an effective biomaterial platform for incorporating hydrophilic polymers. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Anzai, Ryosuke; Takami, Taku; Uchida, Yusuke; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, Fuchu, Tokyo 183, Japan.
RP Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, Fuchu, Tokyo 183, Japan.
EM muray@cc.tuat.ac.jp
RI Murakami, Yoshihiko/C-9485-2013
CR Anzai R, 2015, COLLOID SURFACE B, V127, P292, DOI 10.1016/j.colsurfb.2015.01.028
   Bisoi AK, 2001, PATTERN RECOGN LETT, V22, P631, DOI 10.1016/S0167-8655(00)00132-X
   Chen M, 2002, J MACROMOL SCI PHYS, VB41, P1063, DOI 10.1081/MB-120013083
   Crist B, 2016, PROG POLYM SCI, V56, P1, DOI 10.1016/j.progpolymsci.2015.11.006
   Fajardo AR, 2013, MAT SCI ENG C-MATER, V33, P588, DOI 10.1016/j.msec.2012.09.025
   Gao Y, 2006, EUR POLYM J, V42, P764, DOI 10.1016/j.eurpolymj.2005.09.028
   He CL, 2004, BIOMACROMOLECULES, V5, P2042, DOI 10.1021/bm049720e
   He CL, 2006, BIOMACROMOLECULES, V7, P252, DOI 10.1021/bm050627f
   Ito T, 2013, MAT SCI ENG C-MATER, V33, P3697, DOI 10.1016/j.msec.2013.04.056
   Jiang SC, 2004, MACROMOL CHEM PHYSIC, V205, P2229, DOI 10.1002/macp.200400204
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017
   Kolate A, 2014, J CONTROL RELEASE, V192, P67, DOI 10.1016/j.jconrel.2014.06.046
   Kramer G, 2014, EUR POLYM J, V55, P123, DOI 10.1016/j.eurpolymj.2014.03.026
   Lao LL, 2008, J BIOMED MATER RES A, V87A, P1, DOI 10.1002/jbm.a.31706
   Lei L, 2010, J CONTROL RELEASE, V146, P45, DOI 10.1016/j.jconrel.2010.05.017
   Liakos I, 2014, INT J PHARMACEUT, V463, P137, DOI 10.1016/j.ijpharm.2013.10.046
   Lin M, 2009, J BIOMED MATER RES B, V90B, P939, DOI 10.1002/jbm.b.31366
   Liu YL, 2014, POLYM DEGRAD STABIL, V101, P10, DOI 10.1016/j.polymdegradstab.2014.01.023
   Lu CH, 2002, J BIOMED MATER RES, V63, P220, DOI 10.1002/jbm.10120
   Moroishi H, 2013, COLLOID SURFACE B, V102, P597, DOI 10.1016/j.colsurfb.2012.08.050
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Murakami Y, 2003, J MOL CATAL B-ENZYM, V22, P79, DOI 10.1016/S1381-1177(03)00009-2
   Murakami Y, 1998, SEIBUTSU-KOGAKU KAIS, V76, P238
   Murakami Y, 1999, BIOTECHNOL TECH, V13, P545, DOI 10.1023/A:1008987431361
   Murakami Y, 2001, BIOTECHNOL LETT, V23, P125, DOI 10.1023/A:1010345318275
   Murakami Y, 1999, J BIOSCI BIOENG, V88, P441, DOI 10.1016/S1389-1723(99)80224-2
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Murakami Y, 2009, J BIOMED MATER RES B, V91B, P102, DOI 10.1002/jbm.b.31378
   NOJIMA S, 1992, POLYM J, V24, P1271, DOI 10.1295/polymj.24.1271
   Orava E, 2007, POLYM DEGRAD STABIL, V92, P14, DOI 10.1016/j.polymdegradstab.2006.10.004
   Pang X, 2013, DRUG DISCOV TODAY, V18, P1316, DOI 10.1016/j.drudis.2013.09.007
   Park SB, 2014, POLYM DEGRAD STABIL, V99, P99, DOI 10.1016/j.polymdegradstab.2013.11.019
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Ro AJ, 2011, J BIOMED MATER RES B, V97B, P30, DOI 10.1002/jbm.b.31777
   Saha SK, 2006, REACT FUNCT POLYM, V66, P1362, DOI 10.1016/j.reactfunctpolym.2006.03.020
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Song JQ, 2015, CARBON, V95, P1039, DOI 10.1016/j.carbon.2015.09.011
   Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Sun QJ, 2013, CARBOHYD POLYM, V98, P630, DOI 10.1016/j.carbpol.2013.06.040
   Takami T, 2014, LANGMUIR, V30, P3329, DOI 10.1021/la500324j
   Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004
   Tan LP, 2004, INT J PHARM, V283, P89, DOI 10.1016/j.ijpharm.2004.06.022
   Tang MF, 2010, INT J PHARMACEUT, V400, P66, DOI 10.1016/j.ijpharm.2010.08.031
   Uchida Y, 2013, J POLYM SCI POL PHYS, V51, P124, DOI 10.1002/polb.23187
   Uchida Y, 2011, COLLOID SURFACE B, V84, P346, DOI 10.1016/j.colsurfb.2011.01.025
   Uchida Y, 2010, COLLOID SURFACE B, V79, P198, DOI 10.1016/j.colsurfb.2010.03.047
   Umeki N., 2011, INT J PHARMACEUT, V404, P10
   Umemoto S, 2005, POLYMER, V46, P8790, DOI 10.1016/j.polymer.2005.05.132
   Wang BL, 2016, COLLOID SURFACE B, V145, P757, DOI 10.1016/j.colsurfb.2016.05.092
   Wang X., 2006, CHINESE MED EQUIPMEN, V27, P27
   Woo EM, 2015, EUR POLYM J, V71, P27, DOI 10.1016/j.eurpolymj.2015.07.045
   Xu CH, 2014, POLYM TEST, V37, P94, DOI 10.1016/j.polymertesting.2014.05.005
   Yang G, 2016, ACTA BIOMATER, V35, P68, DOI 10.1016/j.actbio.2016.03.004
   Yoneki N, 2015, COLLOID SURFACE A, V469, P66, DOI 10.1016/j.colsurfa.2015.01.011
   Zhang Q, 2015, INT J BIOL MACROMOL, V76, P94, DOI 10.1016/j.ijbiomac.2015.01.063
NR 58
TC 3
Z9 3
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2017
VL 72
BP 325
EP 331
DI 10.1016/j.msec.2016.11.090
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EI0LI
UT WOS:000392165600039
PM 28024593
DA 2018-10-20
ER

PT J
AU Yahia, IS
   Shkir, M
   AlFaify, S
   Ganesh, V
   Zahran, HY
   Kilany, M
AF Yahia, I. S.
   Shkir, Mohd
   AlFaify, S.
   Ganesh, V.
   Zahran, H. Y.
   Kilany, Mona
TI Facile microwave-assisted synthesis of Te-doped hydroxyapatite nanorods
   and nanosheets and their characterizations for bone cement applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Nano-rods; XRD/FE-SEM; Linear absorption coefficient;
   FT1R/Raman spectroscopy; Dielectric properties; Biomaterial
ID CALCIUM-PHOSPHATE CERAMICS; SUBSTITUTED HYDROXYAPATITES; ANTIBACTERIAL
   PROPERTIES; IRRADIATION TECHNIQUE; DIELECTRIC-PROPERTIES;
   ALKALINE-PHOSPHATASE; IN-VITRO; NANOSTRUCTURES; NANOPARTICLES; FLUORIDE
AB In this work, the authors have fabricated the nanorods and nanosheets of pure and Te-doped HAp with different Te concentrations (0.04, 0.08, 0.16, 024 wt%) by microwave-assisted technique at low temperature. The crystallite size, degree of crystallinity and lattice parameters are calculated. FE-SEM study confirms that the fabricated nanostructures are nanorods of diameter about 10 nm in undoped and at low concentration of Te doping. However, at and higher concentration, it becomes nanosheets of about 5 nm thickness. X-ray diffraction, FT-IR and FT-Raman studies shows that the prepared products are of HAp and Te has been successfully incorporated. From EDX the Ca/P molar ratio of the pure HAp is about 1.740, while this ratio for 0.04, 0.08, 0.16, 0.24 wt% Te doped is about 1.53, 1.678, 1.724, 1.792, respectively. Crystallite size was found to be increased with Te doping from 15 nm to 62 nm. The value of dielectric constant is found to be enhanced at higher concentrations of Te. The values of linear absorption coefficient were also determined and show that the prepared material with Te doping is more absorbable than pure and will be highly applicable in radiation detection applications. Furthermore, the antimicrobial potential of pure and Te doped HAp was examined against some Gram-negative and positive bacteria and fungi by agar disk diffusion method. The results demonstrated that the antimicrobial activity of Te doped HAp is stronger than that of pure HAp where it exhibited the highest activity against Bacillus subtilis > Candida albicans > Shigella dysenteriae. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yahia, I. S.; Shkir, Mohd; AlFaify, S.; Ganesh, V.; Zahran, H. Y.] King Khalid Univ, Fac Sci, Dept Phys, AFMOL, POB 9004, Abha 61413, Saudi Arabia.
   [Yahia, I. S.; Zahran, H. Y.] Ain Shams Univ, Fac Educ, Dept Phys, Nanosci & Semicond Labs,Met Lab, Cairo 11757, Egypt.
   [Kilany, Mona] King Khalid Univ, Fac Sci, Dept Biol, POB 9004, Abha 61413, Saudi Arabia.
   [Kilany, Mona] NODCAR, Dept Microbiol, Cairo, Egypt.
RP Shkir, M (reprint author), King Khalid Univ, Fac Sci, Dept Phys, AFMOL, POB 9004, Abha 61413, Saudi Arabia.
EM shkirphysics@gmail.com
CR Adzila S, 2013, INDIAN J CHEM A, V52, P739
   Aina V, 2012, J MATER SCI-MATER M, V23, P2867, DOI 10.1007/s10856-012-4767-3
   ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   Badea M, 2016, CERAM INT, V42, P1801, DOI 10.1016/j.ceramint.2015.09.143
   Basar B, 2010, CERAM INT, V36, P1633, DOI 10.1016/j.ceramint.2010.02.033
   Bin T., 2006, DEVITRIFLCATION TEO2
   Bowen SP, 2008, ANN BIOMED ENG, V36, P195, DOI 10.1007/s10439-007-9408-5
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Chanda A, 2009, MAT SCI ENG C-BIO S, V29, P1144, DOI 10.1016/j.msec.2008.09.008
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Ciobanu C., 2015, BIOMED RES INT, V2015
   Coelho JM, 2010, J MATER SCI-MATER M, V21, P2543, DOI 10.1007/s10856-010-4122-5
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   de Melo Costa A.C.F., 2009, REV ELETRONICA MAT P, V4
   Dorozhkin SV, 2013, J MATER SCI-MATER M, V24, P1335, DOI 10.1007/s10856-013-4898-1
   Dubey AK, 2013, J EUR CERAM SOC, V33, P3445, DOI 10.1016/j.jeurceramsoc.2013.07.012
   Escudero A, 2013, LANGMUIR, V29, P1985, DOI 10.1021/la304534f
   Eshtiagh-Hosseini H, 2007, MATER CHEM PHYS, V106, P310, DOI 10.1016/j.matchemphys.2007.06.002
   Eslami H, 2008, J CERAM PROCESS RES, V9, P224
   Faeda RS, 2012, MICROSC RES TECHNIQ, V75, P940, DOI 10.1002/jemt.22018
   Georgieva B, 2014, SENSORS-BASEL, V14, P8950, DOI 10.3390/s140508950
   Goller G, 2002, MATER LETT, V56, P142
   Hall SL, 1999, CALCIFIED TISSUE INT, V64, P163, DOI 10.1007/s002239900597
   Hassan MN, 2016, CERAM INT, V42, P3725, DOI 10.1016/j.ceramint.2015.11.044
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hill RG, 2015, MATER LETT, V156, P69, DOI 10.1016/j.matlet.2015.04.140
   Horiuchi N, 2013, J CERAM SOC JPN, V121, P770, DOI 10.2109/jcersj2.121.770
   Iribarrena A., 42 RCF DOI
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kanchana P, 2010, J CRYST GROWTH, V312, P808, DOI 10.1016/j.jcrysgro.2009.12.032
   Kaygili O, 2013, J SOL-GEL SCI TECHN, V65, P105, DOI 10.1007/s10971-012-2913-5
   Kaygili O, 2015, MAT SCI ENG C-MATER, V55, P538, DOI 10.1016/j.msec.2015.05.081
   Kaygili O, 2015, MAT SCI ENG C-MATER, V47, P333, DOI 10.1016/j.msec.2014.11.039
   Kaygili O, 2014, CERAM INT, V40, P9395, DOI 10.1016/j.ceramint.2014.02.009
   Kaygili O, 2013, POWDER TECHNOL, V245, P1, DOI 10.1016/j.powtec.2013.04.012
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Koumoulidis GC, 2001, J AM CERAM SOC, V84, P1203
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LEE WK, 1991, PHYS REV LETT, V67, P1559, DOI 10.1103/PhysRevLett.67.1559
   Liu JB, 2004, CHEM PHYS LETT, V396, P429, DOI 10.1016/j.cplett.2004.08.094
   Magalhaes M. C. F., 2007, THERMODYNAMICS SOLUB, P327
   Martin J. E., 2006, PHYS RAD PROTECTION
   Meaney P.M., 2012, J BIOMEDICAL IMAGING, V2012, P7
   Okada M., 2016, SCI TECHNOLOGY ADV M
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   Peretz A, 2001, J TRACE ELEM MED BIO, V15, P175, DOI 10.1016/S0946-672X(01)80063-8
   Pickering S A W, 2002, Int J Low Extrem Wounds, V1, P152
   Popa C., 2015, J NANOMATER, V2015, P2
   Pu YF, 2015, MAT SCI ENG C-MATER, V55, P126, DOI 10.1016/j.msec.2015.05.053
   Rodriguez V, 2013, J RAMAN SPECTROSC, V44, P739, DOI 10.1002/jrs.4251
   Shakir M, 2009, SOLID STATE COMMUN, V149, P2047, DOI 10.1016/j.ssc.2009.08.021
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Shi D, 2006, INTRODUCTION TO BIOMATERIALS, P1
   Shkir M, 2016, MATER LETT, V176, P135, DOI 10.1016/j.matlet.2016.04.062
   Shkir M, 2016, J MOL STRUCT, V1110, P83, DOI 10.1016/j.molstruc.2016.01.014
   Shkir M, 2012, NANOSCI NANOTECH LET, V4, P405, DOI 10.1166/nnl.2012.1328
   Silva CC, 2005, J NON-CRYST SOLIDS, V351, P2945, DOI 10.1016/j.jnoncrysol.2005.04.082
   Simon V, 2009, MATER SCI ENG B-ADV, V165, P247, DOI 10.1016/j.mseb.2009.06.010
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sutton W.H, 1989, CERAM B, V68, P376
   Tank K.P., 2014, SOLID STATE PHENOM, P151
   Testino A, 2004, J AM CERAM SOC, V87, P79, DOI 10.1111/j.1551-2916.2004.00079.x
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Torrent-Burgues J, 2001, CRYST RES TECHNOL, V36, P1075, DOI 10.1002/1521-4079(200110)36:8/10<1075::AID-CRAT1075>3.0.CO;2-E
   Turkoz M, 2013, CERAM INT, V39, P8925, DOI 10.1016/j.ceramint.2013.04.088
   Veljovic D, 2009, CERAM INT, V35, P1407, DOI 10.1016/j.ceramint.2008.07.007
   Wiglusz RJ, 2012, J BIOMED NANOTECHNOL, V8, P605, DOI 10.1166/jbn.2012.1424
   Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008
   Xue D, 2002, SOLID STATE COMMUN, V122, P537, DOI 10.1016/S0038-1098(02)00180-1
   Zare B, 2012, MATER RES BULL, V47, P3719, DOI 10.1016/j.materresbull.2012.06.034
   Zhang LY, 2005, J ALLOY COMPD, V391, P156, DOI 10.1016/j.jallcom.2004.07.072
   Zhong C.L, 2013, T TECH PUBL J NANORE, P8
   Zou S., J MAT SCI MAT MED, V16, P1143
NR 75
TC 7
Z9 7
U1 3
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2017
VL 72
BP 472
EP 480
DI 10.1016/j.msec.2016.11.074
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EI0LI
UT WOS:000392165600055
PM 28024611
DA 2018-10-20
ER

PT J
AU Bolanos, MAC
   Buttigieg, J
   Triana, JCB
AF Castilla Bolanos, Maria Alejandra
   Buttigieg, Josef
   Briceno Triana, Juan Carlos
TI Development and characterization of a novel porous small intestine
   submucosa-hydroxyapatite scaffold for bone regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Small intestine submucosa; Hydroxyapatite; Scaffold; Artificial
   trabecular bone; Bone tissue regeneration
AB The fabricated small intestine submucosa (SIS) - hydroxyapatite (HAp) sponges can act as biomimetic scaffolds to be utilized in tissue engineering and regeneration. Here we developed SIS-HAp sponges and investigated their mechanical, physical and chemical characteristics using scanning electron microscopy, Fourier transformed infrared spectroscopy, uniaxial compression, porosity, and swelling testing techniques. The results demonstrated mechanical properties superior to comparable bone substitutes fabricated with similar methods. SIS-HAp scaffolds possess an interconnected macroporosity, similar to that of trabecular bone, hence presenting a novel biomaterial that may serve as a superior bone substitute and tissue scaffold. (C) 2016 Published by Elsevier B.V.
C1 [Castilla Bolanos, Maria Alejandra; Buttigieg, Josef; Briceno Triana, Juan Carlos] Univ Los Andes, Dept Biomed Engn, Carrera 1A 18A-12, Bogota, Colombia.
RP Bolanos, MAC (reprint author), Univ Los Andes, Dept Biomed Engn, Carrera 1A 18A-12, Bogota, Colombia.
EM ma.castilla964@uniandes.edu.co
FU Biomedical Engineering Department of Universidad de los Andes, Bogota.
   DC, Colombia
FX This study was financially supported by the Biomedical Engineering
   Department of Universidad de los Andes, Bogota. DC, Colombia. The
   authors are furthermore thankful to Dr. Marianne Jacobsen (Department of
   Biology, University of Regina, Canada) for supporting this research.
CR Cunniffe GM, 2010, J MATER SCI-MATER M, V21, P2293, DOI 10.1007/s10856-009-3964-1
   Friess W., 2002, HDB POROUS SOLID, P2933
   Han KS, 2014, MACROMOL RES, V22, P1253, DOI 10.1007/s13233-014-2175-x
   He D, 2008, APPL SURF SCI, V255, P361, DOI 10.1016/j.apsusc.2008.06.151
   J. T. M. C. Changa, 2002, BIOMATERIALS, V23, P4811
   Kane RJ, 2012, J MECH BEHAV BIOMED, V7, P41, DOI 10.1016/j.jmbbm.2011.09.010
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Liu C. G. Y., 2012, MAT SCI ENG C, V32, P2361
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma X, 2016, COLLOID SURFACE B, V143, P81, DOI 10.1016/j.colsurfb.2016.03.025
   Mohan J., 2003, ORGANIC ANAL CHEM TH
   Netti Paulo, 2014, BIOMEDICAL FOAMS TIS
   Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821
   Rabbani A, 2014, J PETROL SCI ENG, V123, P164, DOI 10.1016/j.petrol.2014.08.020
   Sanchez-Palencia DM, 2014, J BIOMECH, V47, P2766, DOI 10.1016/j.jbiomech.2014.04.048
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Tarride, 2012, BURDEN ILLNESS OSTEO
NR 19
TC 6
Z9 6
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2017
VL 72
BP 519
EP 525
DI 10.1016/j.msec.2016.11.113
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EI0LI
UT WOS:000392165600060
PM 28024616
DA 2018-10-20
ER

PT J
AU da Silva, GT
   Voss, GT
   Kaplum, V
   Nakamura, CV
   Wilhelm, EA
   Luchese, C
   Fajardo, AR
AF da Silva, Gabriela T.
   Voss, Guilherme T.
   Kaplum, Vanessa
   Nakamura, Celso V.
   Wilhelm, Ethel A.
   Luchese, Cristiane
   Fajardo, Andre R.
TI Development, characterization and biocompatibility of chondroitin
   sulfate/poly(vinyl alcohol)/bovine bone powder porous biocomposite
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous materials; Biocomposites; Composites; Chondroitin sulfate;
   Biomaterial; Tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; MECHANICAL-PROPERTIES;
   EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLDS; HUMAN SKIN; IN-VIVO;
   HYDROGELS; SULFATE; ACID; BIOMATERIALS
AB Chondroitin sulfate (ChS), a sulfated glycosaminoglycan, poly(vinyl alcohol) (PVA) and bovine bone powder (BBP) were blended to form a novel eco-friendly biocomposite through cyclic freeze-thawing under mild conditions. The systematic investigation reveals that the content of BBP has a remarkable effect on the pore size, porosity, mechanical and liquid uptake properties and biodegradability. At 10 wt.% BBP the biocomposite exhibited enhanced mechanical properties and biodegradability rate as compared to the pristine sample. Further, different properties of the biocomposite can be tailored according to the content of BBP. In vitro assays showed that ChS/PVA-BBP does not exert cytotoxicity against healthy cells. In vivo and ex vivo expetiments revealed that ChS/PVA-BBP biocomposites are biocompatibility materials without exert pro-inflammatory responses. The biocomposite was completely biodegraded and bioresorbed after 15 days of treatment. Taken together, BBP is a low-cost source of hydroxyapatite and collagen, which are insurance. All these results suggest that the biocomposite designed in this study is a promising biomaterial for potential skin tissue engineering. (C) 2016 Elsevier B.V. All rights reserved.
C1 [da Silva, Gabriela T.; Fajardo, Andre R.] Univ Fed Pelotas UFPel, Lab Tecnol & Desenvolvimento Mat Polimer & Compos, Ctr Ciencias Quim Farmaceut & Alimentos, BR-96010900 Pelotas, RS, Brazil.
   [Voss, Guilherme T.; Wilhelm, Ethel A.; Luchese, Cristiane] Univ Fed Pelotas UFPel, GPN, Ctr Ciencias Quim Farmaceut & Alimentos, BR-96010900 Pelotas, RS, Brazil.
   [Kaplum, Vanessa; Nakamura, Celso V.] Univ Estadual Maringa, Lab Microbiol Aplicada Prod Nat & Sintet, BR-87020900 Maringa, Parana, Brazil.
   [Kaplum, Vanessa; Nakamura, Celso V.] Univ Estadual Maringa, Lab Inovacao Tecnol Desenvolvimento Farm & Cosmet, BR-87020900 Maringa, Parana, Brazil.
RP Fajardo, AR (reprint author), Univ Fed Pelotas UFPel, Lab Tecnol & Desenvolvimento Mat Polimer & Compos, Ctr Ciencias Quim Farmaceut & Alimentos, BR-96010900 Pelotas, RS, Brazil.
EM andre.fajardo@pq.cnpq.br
RI Fajardo, Andre/H-1783-2012
OI Fajardo, Andre/0000-0001-5362-6478
FU CAPES; CNPq [Process 441888/2014-3]
FX The authors thank to CAPES for a master fellowship to G.T.S and to CNPq
   for their financial support (Universal grant. - Process 441888/2014-3).
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Alves NO, 2016, CARBOHYD POLYM, V148, P115, DOI 10.1016/j.carbpol.2016.04.049
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bradford M. M., 1976, ANAL BIOCHEM, V72, P6
   Cao H, 2015, COLLOID SURFACE B, V136, P1098, DOI 10.1016/j.colsurfb.2015.10.022
   Chang C, 2013, CARBOHYD POLYM, V91, P7, DOI 10.1016/j.carbpol.2012.07.070
   Chang PR, 2011, J HAZARD MATER, V186, P2144, DOI 10.1016/j.jhazmat.2010.12.119
   Crispim EG, 2012, EXPRESS POLYM LETT, V6, P383, DOI 10.3144/expresspolymlett.2012.41
   Curley C, 2014, J MECH BEHAV BIOMED, V40, P13, DOI 10.1016/j.jmbbm.2014.08.003
   El-Zaher NA, 2005, J APPL POLYM SCI, V96, P1914, DOI 10.1002/app.21628
   Fajardo AR, 2014, BIOMACROMOLECULES, V15, P2691, DOI 10.1021/bm5005355
   Fajardo AR, 2013, MAT SCI ENG C-MATER, V33, P588, DOI 10.1016/j.msec.2012.09.025
   Fajardo AR, 2012, CARBOHYD POLYM, V87, P1950, DOI 10.1016/j.carbpol.2011.09.096
   Fan MR, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015012
   Figueiredo MM, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P315
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Guha A., 2016, TREND NANOTECH MAT S, V1, P1
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hou RX, 2013, COLLOID SURFACE B, V103, P318, DOI 10.1016/j.colsurfb.2012.10.067
   Huang M, 2012, FIBER POLYM, V13, P955, DOI 10.1007/s12221-012-0955-5
   Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344
   Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774
   Liu MM, 2013, POLYM BULL, V70, P2815, DOI 10.1007/s00289-013-0990-4
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mathews S, 2014, J TISSUE ENG REGEN M, V8, P143, DOI 10.1002/term.1507
   Matsiko A, 2013, MATERIALS, V6, P637, DOI 10.3390/ma6020637
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Pailler-Mattei C, 2004, J ADHES SCI TECHNOL, V18, P1739, DOI 10.1163/1568561042708368
   Pietrucha K, 2015, INT J BIOL MACROMOL, V80, P732, DOI 10.1016/j.ijbiomac.2015.07.005
   Podichetty JT, 2014, J BIOMED MATER RES B, V102, P737, DOI 10.1002/jbm.b.33054
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   Ramya JR, 2016, CERAM INT, V42, P11045, DOI 10.1016/j.ceramint.2016.04.001
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Salerno A, 2014, RSC ADV, V4, P61491, DOI 10.1039/c4ra07732f
   Sergeeva A, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500386
   Shelke NB, 2014, POLYM ADVAN TECHNOL, V25, P448, DOI 10.1002/pat.3266
   TAKIGAWA T, 1990, POLYM BULL, V24, P613, DOI 10.1007/BF00300157
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Thitiset T, 2013, INT J MOL SCI, V14, P2056, DOI 10.3390/ijms14012056
   Tocchio A, 2015, BIOMATERIALS, V45, P124, DOI 10.1016/j.biomaterials.2014.12.031
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Vittekova M, 2014, CELL TISSUE BANK, V15, P345, DOI 10.1007/s10561-013-9390-0
   Wade RJ, 2014, NANO TODAY, V9, P722, DOI 10.1016/j.nantod.2014.10.002
   Wang WH, 2010, TISSUE ENG PART C-ME, V16, P269, DOI [10.1089/ten.tec.2009.0161, 10.1089/ten.TEC.2009.0161]
   Yan SQ, 2013, ACTA BIOMATER, V9, P6771, DOI 10.1016/j.actbio.2013.02.016
NR 54
TC 1
Z9 1
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2017
VL 72
BP 526
EP 535
DI 10.1016/j.msec.2016.11.069
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EI0LI
UT WOS:000392165600061
PM 28024617
DA 2018-10-20
ER

PT J
AU Andhare, P
   Delattre, C
   Pierre, G
   Michaud, P
   Pathak, H
AF Andhare, Prasad
   Delattre, Cedric
   Pierre, Guillaume
   Michaud, Philippe
   Pathak, Hilor
TI Characterization and rheological behaviour analysis of the succinoglycan
   produced by Rhizobium radiobacter strain CAS from curd sample
SO FOOD HYDROCOLLOIDS
LA English
DT Article
DE Rhizobium radiobacter; Exopolysaccharide; Characterization; Rheology;
   Succinoglycan
ID LEUCONOSTOC-CITREUM SK24.002; AGROBACTERIUM-RADIOBACTER; PHYSICOCHEMICAL
   CHARACTERISTICS; EXOPOLYSACCHARIDE PRODUCTION; OPTIMIZATION;
   TUMEFACIENS; GUM; POLYSACCHARIDE; BIOPOLYMER; CULTURE
AB An exopolysaccharide (EPS) producing strain CAS grown in a Bushnell Haas medium was isolated from curd sample and identified as Rhizobium radiobacter CAS. The biopolymer was duly characterized by FTIR and NMR spectroscopy and was found to be composed of glucose and galactose in a molar ratio of 6.99:1 as confirmed by HPAEC; thus depicting it to be succinoglycan type exopolysaccharide. In addition, conceivable presence of one succinate and two acetate groups of succinoglycan was estimated using H-1 NMR analysis by specific signal integration. Furthermore, as a documented fact, the insights into the rheological behaviors portray phenomenal influences in food, cosmetics and pharmaceutical industries as thickening, gelling, stabilizing and emulsifying agent. However, this piece of information has remained unnoticed from the existing literature. Thus, in the present study the rheological properties of succinoglycan type biopolymer in aqueous solution were systematically investigated. The flow behaviour testing in an aqueous solution verified its pseudoplastic character and higher apparent viscosity. Furthermore, study on its potential strength and tolerance in various thermal conditions, cation salts, and pH has been studied in depth. Such a study can provide a thorough guidance on the rheological behaviour of the biomaterial and thus impart significant insights into postulating its application spectrum into food, cosmetics and pharmaceutical industrial sectors. The present study is thus, one of its kinds which decipher the complete rheological behavioural portrait. (C) 2016 Published by Elsevier Ltd.
C1 [Andhare, Prasad; Pathak, Hilor] Charotar Univ Sci & Technol CHARUSAT, PD Patel Inst Appl Sci, Changa 388421, Gujarat, India.
   [Delattre, Cedric; Pierre, Guillaume; Michaud, Philippe] Univ Blaise Pascal, Univ Clermont Auvergne, Inst Pascal, BP 10448, F-63000 Clermont Ferrand, France.
   [Delattre, Cedric; Pierre, Guillaume; Michaud, Philippe] CNRS, UMR 6602, IP, F-63171 Aubiere, France.
RP Pathak, H (reprint author), Charotar Univ Sci & Technol CHARUSAT, PD Patel Inst Appl Sci, Changa 388421, Gujarat, India.
EM hilor1111@gmail.com
OI Michaud, Philippe/0000-0002-6677-4549; PIERRE,
   Guillaume/0000-0001-9919-7058
FU Charotar University of Science and Technology
FX The authors are thankful to Charotar University of Science and
   Technology for providing grant and extending the infra structure for the
   present study.
CR Andhare P., 2014, BIOTECHNOLOGY, V3
   Bakhtiyari M, 2015, FOOD HYDROCOLLOID, V45, P18, DOI 10.1016/j.foodhyd.2014.11.002
   Bhatia SK, 2015, 3 BIOTECH, V5, P735, DOI 10.1007/s13205-014-0273-2
   Boeriu CG, 2013, INT J CARBOHYDR CHEM, V2013, P14, DOI [DOI 10.1155/2013/624967, 10.1155/9160]
   Calliari CM, 2011, SEMIN-CIENC AGRAR, V32, P1915, DOI 10.5433/1679-0359.2011v32Suplp1915
   Chouly C, 1995, INT J BIOL MACROMOL, V17, P357, DOI 10.1016/0141-8130(96)81846-0
   Cruz M, 2011, INT J BIOL MACROMOL, V48, P695, DOI 10.1016/j.ijbiomac.2011.02.012
   Delattre C, 2015, CARBOHYD POLYM, V116, P34, DOI 10.1016/j.carbpol.2014.04.054
   Diaz-Barrera A, 2014, BIOPROC BIOSYST ENG, V37, P1133, DOI 10.1007/s00449-013-1084-2
   DUSSAP CG, 1991, BIOTECHNOL BIOENG, V38, P65, DOI 10.1002/bit.260380109
   Fusconi R, 2010, CARBOHYD POLYM, V79, P403, DOI 10.1016/j.carbpol.2009.08.023
   Godale C. H., 2016, INDIAN J APPL RES, V6
   GRAVANIS G, 1990, INT J BIOL MACROMOL, V12, P201, DOI 10.1016/0141-8130(90)90033-7
   HALDEMAN DL, 1993, APPL ENVIRON MICROB, V59, P933
   Han J, 2014, CARBOHYD POLYM, V112, P556, DOI 10.1016/j.carbpol.2014.06.035
   Jahanbin K, 2012, FOOD HYDROCOLLOID, V27, P14, DOI 10.1016/j.foodhyd.2011.09.007
   Kaneda I, 2009, NIHON REOROJI GAKK, V37, P167, DOI 10.1678/rheology.37.167
   Kayacier A, 2006, J FOOD ENG, V72, P261, DOI 10.1016/j.jfoodeng.2004.12.005
   Kumar A., 2014, INT J PHARM SCI REV, V25, P110
   Lang MM, 2001, LETT APPL MICROBIOL, V33, P65, DOI 10.1046/j.1472-765X.2001.00949.x
   Castellane TCL, 2015, REV BRAS CIENC SOLO, V39, P1566, DOI 10.1590/01000683rbcs20150084
   Castellane TCL, 2014, CARBOHYD POLYM, V111, P191, DOI 10.1016/j.carbpol.2014.04.066
   Maalej H, 2016, FOOD HYDROCOLLOID, V52, P634, DOI 10.1016/j.foodhyd.2015.07.010
   Marcotte M, 2001, FOOD RES INT, V34, P695, DOI 10.1016/S0963-9969(01)00091-6
   Maurya AK, 2011, TUBERK TORAK, V59, P213, DOI 10.5578/tt.2680
   McKellar RC, 2003, FOOD HYDROCOLLOID, V17, P429, DOI 10.1016/S0268-005X(03)00030-4
   Meade MJ, 1995, CAN J MICROBIOL, V41, P1147, DOI 10.1139/m95-160
   Mende S, 2013, FOOD HYDROCOLLOID, V32, P178, DOI 10.1016/j.foodhyd.2012.12.011
   Miao M, 2015, FOOD HYDROCOLLOID, V50, P37, DOI 10.1016/j.foodhyd.2015.04.009
   Miao M, 2014, FOOD HYDROCOLLOID, V36, P265, DOI 10.1016/j.foodhyd.2013.10.014
   Moosavi-Nasab M, 2012, FOOD BIOPROCESS TECH, V5, P638, DOI 10.1007/s11947-010-0407-4
   Navarini L, 1997, BIOTECHNOL LETT, V19, P1231, DOI 10.1023/A:1018498106893
   Nwokocha LM, 2009, CARBOHYD POLYM, V78, P462, DOI 10.1016/j.carbpol.2009.05.003
   Petera B, 2015, CARBOHYD POLYM, V127, P372, DOI 10.1016/j.carbpol.2015.04.001
   Priyanka P, 2015, CARBOHYD POLYM, V126, P215, DOI 10.1016/j.carbpol.2015.03.017
   Ruiz SP, 2015, J MOL CATAL B-ENZYM, V122, P15, DOI 10.1016/j.molcatb.2015.08.016
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   Sarker Abdul Qayum, 2011, Agriculturae Conspectus Scientificus, V76, P147
   Shao P, 2014, CARBOHYD POLYM, V113, P365, DOI 10.1016/j.carbpol.2014.07.008
   Stredansky M, 1999, BIOTECHNOL TECH, V13, P7, DOI 10.1023/A:1008849113682
   Stredansky M, 1998, J FERMENT BIOENG, V85, P398, DOI 10.1016/S0922-338X(98)80083-4
   Sun FY, 2014, CARBOHYD POLYM, V114, P506, DOI 10.1016/j.carbpol.2014.08.055
   Sworn G, 2012, ROY SOC CH, P89
   Xiu AH, 2011, FOOD HYDROCOLLOID, V25, P1719, DOI 10.1016/j.foodhyd.2011.03.013
   Yang M, 2016, INT J BIOL MACROMOL, V89, P25, DOI 10.1016/j.ijbiomac.2016.04.027
   Zevenhuizen LPTM, 1997, CARBOHYD POLYM, V33, P139, DOI 10.1016/S0144-8617(97)00054-4
   Zhang J, 2015, CARBOHYD POLYM, V115, P694, DOI 10.1016/j.carbpol.2014.09.029
   Zhou FF, 2014, FOOD HYDROCOLLOID, V36, P362, DOI 10.1016/j.foodhyd.2013.08.016
NR 48
TC 3
Z9 3
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-005X
EI 1873-7137
J9 FOOD HYDROCOLLOID
JI Food Hydrocolloids
PD MAR
PY 2017
VL 64
BP 1
EP 8
DI 10.1016/j.foodhyd.2016.10.008
PG 8
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA EG0KK
UT WOS:000390721500001
DA 2018-10-20
ER

PT J
AU Todai, M
   Nagase, T
   Hori, T
   Matsugaki, A
   Sekita, A
   Nakano, T
AF Todai, Mitsuharu
   Nagase, Takeshi
   Hori, Takao
   Matsugaki, Aira
   Sekita, Aiko
   Nakano, Takayoshi
TI Novel TiNbTaZrMo high-entropy alloys for metallic biomaterials
SO SCRIPTA MATERIALIA
LA English
DT Article
DE Biomaterials; High-entropy alloys (HEAs); Microstructure;
   Solidification; Crystal structure
ID LOW YOUNGS MODULUS; MULTICOMPONENT ALLOYS; TITANIUM-ALLOYS;
   SOLID-SOLUTION; IMPLANTS; TI-29NB-13TA-4.6ZR; MICROSTRUCTURE; CRYSTALS;
   BEHAVIOR; ELEMENTS
AB A novel equiatomicTiNbTaZrMo high-entropy alloy (HEA) was developed as a new metallic biomaterial. The constituent elements of the HEA were biocomparable, and the HEA was designed based on parameters such as the mixing enthalpy (Delta H-mix), the omega parameter (Omega), the delta parameter (delta), and the valence electron concentration (VEC) theory. The bcc solid solution phases with the different lattice constants were obtained in as-cast and annealed states. The HEA showed considerable strength with deformability and superior biocompatibility comparable to pure Ti. This study demonstrated the possibility of using HEAs as a new class of metallic biomaterials. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Todai, Mitsuharu; Nagase, Takeshi; Hori, Takao; Matsugaki, Aira; Sekita, Aiko; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Nagase, Takeshi] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, 7-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
RP Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM nakano@mat.eng.osaka-u.ac.jp
RI Nagase, Takeshi/M-1189-2015
OI Nagase, Takeshi/0000-0003-4868-0773
FU JSPS KAKENHI [25220912]; Council for Science, Technology and Innovation
   (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP);
   Innovative design/manufacturing technologies (Establishment and
   Validation of the base for 3D Design & Additive Manufacturing Standing
   on the Concepts of "Anisotropy" & "Customization") of the NEDO; Japan
   Foundry Engineering Society (JFS)
FX This work was partially supported by JSPS KAKENHI (grant number
   25220912), the Council for Science, Technology and Innovation (CSTI),
   Cross-Ministerial Strategic Innovation Promotion Program (SIP),
   Innovative design/manufacturing technologies (Establishment and
   Validation of the base for 3D Design & Additive Manufacturing Standing
   on the Concepts of "Anisotropy" & "Customization") of the New Energy and
   Industrial Technology Development Organization (NEDO), and by scientific
   grants from the Japan Foundry Engineering Society (JFS).
CR Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257
   Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005
   Fang SS, 2003, J NON-CRYST SOLIDS, V321, P120, DOI 10.1016/S0022-3093(03)00155-8
   Gao M.C., 2015, HIGH ENTROPY ALLOYS
   Guo S, 2013, INTERMETALLICS, V41, P96, DOI 10.1016/j.intermet.2013.05.002
   Guo S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3587228
   Hagihara K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29779
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   Lee SH, 2012, J MECH BEHAV BIOMED, V14, P48, DOI 10.1016/j.jmbbm.2012.05.005
   Lee SH, 2012, METALL MATER TRANS A, V43A, P1588, DOI 10.1007/s11661-011-0986-3
   Murty BS, 2014, HIGH-ENTROPY ALLOYS, P1
   Narushima T, 2005, J JPN I LIGHT METALS, V55, P561
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Poletti MG, 2016, J ALLOY COMPD, V655, P138, DOI 10.1016/j.jallcom.2015.09.118
   Ranganathan S, 2003, CURR SCI INDIA, V85, P1404
   Senkov ON, 2012, J MATER SCI, V47, P4062, DOI 10.1007/s10853-012-6260-2
   Senkov ON, 2011, J ALLOY COMPD, V509, P6043, DOI 10.1016/j.jallcom.2011.02.171
   Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817
   Vegard L, 1921, Z PHYS, V5, P17, DOI 10.1007/BF01349680
   Yang X, 2012, MATER CHEM PHYS, V132, P233, DOI 10.1016/j.matchemphys.2011.11.021
   Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567
   Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
NR 27
TC 15
Z9 15
U1 5
U2 72
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD MAR 1
PY 2017
VL 129
BP 65
EP 68
DI 10.1016/j.scriptamat.2016.10.028
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA EF7MO
UT WOS:000390513900015
OA Other Gold
DA 2018-10-20
ER

PT J
AU Fernandes, J
   Nicodemo, D
   Oliveira, JE
   Silva, FA
   Fidelis, MEA
   Silva, LE
   Tonoli, GHD
AF Fernandes, J.
   Nicodemo, D.
   Oliveira, J. E.
   Silva, F. A.
   Fidelis, M. E. A.
   Silva, L. E.
   Tonoli, G. H. D.
TI Enhanced silk performance by enriching the silkworm diet with bordeaux
   mixture
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID SISAL FIBERS; BOMBYX-MORI; BEHAVIOR; BIOMATERIAL
AB This work evaluated the effect of different concentrations (5, 10, and 20%) of Bordeaux mixture (Bm) in the diet of the silkworm caterpillars in order to improve the cocoon production and structural and mechanical properties of the ensuing silk. The cocoon yield, tensile properties, and microstructure (X-ray diffraction, surface fracture, and qualitative composition) of the obtained silk fiber threads were determined. The mortality levels of caterpillars fed on mulberry leaves with Bm were up to 80% higher than the rates observed on caterpillars fed on non-treated leaves. The consumption of leaves decreased as the amount of Bm introduced to the caterpillars' diets was increased. However, the lower demand of leaves by caterpillars fed on leaves treated with 5 and 10% of Bm did not imply in obtaining lower cocoon productivity, as the raw silk rates were not different in comparison to the control group. The tensile strength and maximum strain of the fiber were greatly improved, whereas the toughness was not statistically improved by the presence of Bm in the diet. There was an increase in the concentration of Ca and Cu in the silk fiber threads treated with Bm, leading to higher crystallinity. If the cocoon producers were rewarded with an increase in cocoon quality, the application of Bm could be interesting, despite the increase in caterpillars' mortality.
C1 [Fernandes, J.; Nicodemo, D.] Univ Estadual Paulista, Fac Ciencias Agr & Tecnol, Campus Dracena, BR-17900000 Dracena, SP, Brazil.
   [Oliveira, J. E.] Univ Fed Lavras, Dept Engn, Campus Univ, BR-37200000 Lavras, MG, Brazil.
   [Silva, F. A.] Pontificia Univ Catolica Rio de Janeiro PUC Rio, Dept Civil Engn, Rua Marques Sao Vicente 225, BR-22453900 Rio De Janeiro, RJ, Brazil.
   [Fidelis, M. E. A.] COPPE Univ Fed Rio de Janeiro, Dept Engn Civil, Ctr Technol, Bloco 1 Sala 216,Caixa Postal 68506, BR-21941972 Rio De Janeiro, RJ, Brazil.
   [Silva, L. E.; Tonoli, G. H. D.] Univ Fed Lavras, Dept Ciencias Florestais, Campus Univ,Caixa Postal 3037, BR-37200000 Lavras, MG, Brazil.
RP Nicodemo, D (reprint author), Univ Estadual Paulista, Fac Ciencias Agr & Tecnol, Campus Dracena, BR-17900000 Dracena, SP, Brazil.
EM nicodemo@dracena.unesp.br
RI tonoli, gustavo/I-4821-2013
OI tonoli, gustavo/0000-0002-6502-8974; de Andrade Silva,
   Flavio/0000-0002-0160-7619; Nicodemo, Daniel/0000-0001-6594-5791
FU Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientificoe Tecnologico (CNPq) Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP-process [12/24430-1]; Fundacao de Amparo a Pesquisa
   do Estado de Minas Gerais (FAPEMIG)
FX The authors would like to thank Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientificoe Tecnologico (CNPq) Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP-process no 12/24430-1) and Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG).
CR Perea GB, 2013, J EXP BIOL, V216, P4722, DOI 10.1242/jeb.094011
   Cai LY, 2015, ACS SUSTAIN CHEM ENG, V3, P2551, DOI 10.1021/acssuschemeng.5b00749
   Chen X, 2002, BIOCHEMISTRY-US, V41, P14944, DOI 10.1021/bi026550m
   International A., 2014, STAND TEST METH TENS
   Kameda T, 2011, J MATER SCI, V46, P7923, DOI 10.1007/s10853-011-5925-6
   Ki CS, 2013, FIBER POLYM, V14, P1460, DOI 10.1007/s12221-013-1460-1
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Peruch LA, 2008, CIENC RURAL, V38, P2413, DOI 10.1590/S0103-84782008000900001
   Milanese AC, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.335
   Okamoto F, 2006, PESQUI AGROPECU BRAS, V41, P195, DOI 10.1590/S0100-204X2006000200003
   Polycarpo GD, 2012, CIENC RURAL, V42, P1669, DOI 10.1590/S0103-84782012000900024
   Purohit KM, 1996, SERICOLOGIA, V36, P27
   Sabbag Omar Jorge, 2013, Pesqui. Agropecu. Trop., V43, P187, DOI 10.1590/S1983-40632013000200004
   Sappington TW, 2002, REPROD BIOL INVERTEB
   Silva FD, 2009, MAT SCI ENG A-STRUCT, V516, P90, DOI 10.1016/j.msea.2009.03.026
   Silva FD, 2008, COMPOS SCI TECHNOL, V68, P3438, DOI 10.1016/j.compscitech.2008.10.001
   Singh A, 2015, SERICULTURE HELPLINE
   Takahashi R, 2009, SERICICULTURA PROMIS
   Takano K., 1978, J SERIC SCI JPN, V47, P134
   Taniai K, 2014, J COMP PHYSIOL B, V184, P827, DOI 10.1007/s00360-014-0846-8
   Tonoli GHD, 2011, J MATER CIVIL ENG, V23, P177, DOI 10.1061/(ASCE)MT.1943-5533.0000152
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Zhang YC, 2012, J MATER SCI, V47, P3713, DOI 10.1007/s10853-011-6220-2
   Zhou L, 2003, FEBS LETT, V554, P337, DOI 10.1016/S0014-5793(03)01184-0
NR 25
TC 1
Z9 1
U1 2
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2017
VL 52
IS 5
BP 2684
EP 2693
DI 10.1007/s10853-016-0559-3
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA EE4YF
UT WOS:000389611000025
DA 2018-10-20
ER

PT J
AU Bera, S
   Kolay, J
   Banerjee, S
   Mukhopadhyay, R
AF Bera, Sudipta
   Kolay, Jayeeta
   Banerjee, Siddhartha
   Mukhopadhyay, Rupa
TI Nanoscale On-Silico Electron Transport via Ferritins
SO LANGMUIR
LA English
DT Article
ID HORSE SPLEEN FERRITIN; METALLIC NANOPARTICLES; APOFERRITIN CAVITY;
   PROTEIN CAGE; IRON; STATE; OXIDE; CONDUCTIVITY; FABRICATION; BEHAVIOR
AB Silicon is a solid-state semiconducting material that has long been recognized as a technologically useful one, especially in electronics industry. However, its application in the next generation metalloprotein-based electronics approaches has been limited. In this work, the applicability of silicon as a solid support for anchoring the iron-storage protein ferritin, which has a semiconducting iron nanocore, and probing electron transport via the ferritin molecules trapped between silicon substrate and a conductive scanning probe has been investigated. Ferritin protein is an attractive bioelectronic material because its size (X-ray crystallographic diameter similar to 12 nm) should allow it to fit well in the larger tunnel gaps (>5 nm), fabrication of which is relatively more established, than the smaller ones. The electron transport events occurring through the ferritin molecules that are covalently anchored onto the MPTMS-modified silicon surface could be detected at the molecular level by current-sensing atomic force spectroscopy (CSAFS). Importantly, the distinct electronic signatures of the metal types (i.e., Fe, Mn, Ni, and Au) within the ferritin nanocore could be distinguished from each other using the transport band gap analyses. The CSAFS measurements on holoferritin, apoferritin, and the metal core reconstituted ferritins reveal that some of these ferritins behave like n-type semiconductors, while the others behave as p-type semiconductors. The band gaps for the different ferritins are found to be within 0.8 to 2.6 eV, a range that is valid for the standard semiconductor technology (e.g., diodes based on p-n junction). The present work indicates effective on-silico integration of the ferritin protein, as it remains functionally viable after silicon binding and its electron transport activities can be detected. Potential use of the ferritin-silicon nanohybrids may therefore be envisaged in applications other than bioelectronics, too, as ferritin is a versatile nanocore-containing biomaterial (for storage/transport of metals and drugs) and silicon can be a versatile nanoscale solid support (for its biocompatible nature).
C1 [Bera, Sudipta; Kolay, Jayeeta; Banerjee, Siddhartha; Mukhopadhyay, Rupa] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 700032, India.
RP Mukhopadhyay, R (reprint author), Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 700032, India.
EM bcrm@iacs.res.in
OI Banerjee, Siddhartha/0000-0001-8462-6286; Mukhopadhyay,
   Rupa/0000-0002-6753-079X
FU IACS, Kolkata; DST, Govt. of India [SB/SO/BB-33/2014]; CSIR, Govt. of
   India [01(2775)/14/EMR-II]; DST-INSPIRE, Govt. of India
FX R.M. acknowledges financial support from IACS, Kolkata; DST, Govt. of
   India (grant no. SB/SO/BB-33/2014) and CSIR, Govt. of India (grant no.
   01(2775)/14/EMR-II). The research fellowships of S. Bera, J. Kolay, and
   S. Banerjee from DST-INSPIRE, Govt. of India; CSIR, Govt. of India; and
   IACS, Kolkata, respectively, are acknowledged.
CR Amdursky N, 2014, ADV MATER, V26, P7142, DOI 10.1002/adma.201402304
   Axford D, 2007, J PHYS CHEM B, V111, P9062, DOI 10.1021/jp070262o
   Axford DN, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145502
   DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061
   Davis JJ, 2005, J MATER CHEM, V15, P2160, DOI 10.1039/b417712f
   Dennis N., 2000, U. S. Patent, Patent No. [US6121642A, 6121642]
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   Fan RL, 2010, SMALL, V6, P1483, DOI 10.1002/smll.201000457
   Formanowicz Dorota, 2011, Biotechnologia (Poznan), V92, P193
   Galvez N, 2006, J MATER CHEM, V16, P2757, DOI 10.1039/b604860a
   Galvez N, 2005, DALTON T, P2492, DOI 10.1039/b506290j
   Galvez N, 2008, CR CHIM, V11, P1207, DOI 10.1016/j.crci.2008.09.003
   Granick S, 1942, J BIOL CHEM, V146, P0451
   Gutierrez L, 2006, J INORG BIOCHEM, V100, P1790, DOI 10.1016/j.jinorgbio.2006.06.010
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Hosein HA, 2004, LANGMUIR, V20, P10283, DOI 10.1021/la0491100
   Kasyutich O, 2010, J AM CHEM SOC, V132, P3621, DOI 10.1021/ja910918b
   Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k
   MACKLE P, 1993, J AM CHEM SOC, V115, P8471, DOI 10.1021/ja00071a076
   MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0
   MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   Okuda M, 2003, BIOTECHNOL BIOENG, V84, P187, DOI 10.1002/bit.10748
   Rakshit T, 2010, LANGMUIR, V26, P16005, DOI 10.1021/la101776m
   Rakshit T, 2013, LANGMUIR, V29, P12511, DOI 10.1021/la402522m
   Rakshit T, 2012, J COLLOID INTERF SCI, V388, P282, DOI 10.1016/j.jcis.2012.08.028
   Rakshit T, 2011, LANGMUIR, V27, P9681, DOI 10.1021/la202045a
   Ron I, 2010, ACCOUNTS CHEM RES, V43, P945, DOI 10.1021/ar900161u
   Ron I, 2010, J AM CHEM SOC, V132, P4131, DOI 10.1021/ja907328r
   Schon P, 2007, LANGMUIR, V23, P9921, DOI 10.1021/la700236z
   Snow CL, 2011, J INORG BIOCHEM, V105, P972, DOI 10.1016/j.jinorgbio.2011.04.003
   Son J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3651612
   Suzumoto Y, 2012, CRYST GROWTH DES, V12, P4130, DOI 10.1021/cg3006376
   TAUC J, 1968, MATER RES BULL, V3, P37, DOI 10.1016/0025-5408(68)90023-8
   Tchaplyguine M, 2015, J PHYS CHEM C, V119, P8937, DOI 10.1021/acs.jpcc.5b00811
   Ueno T, 2004, ANGEW CHEM INT EDIT, V43, P2527, DOI 10.1002/anie.200353436
   Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656
   Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1
   Xu DG, 2005, NANO LETT, V5, P571, DOI 10.1021/nl048218x
   Yi JY, 1999, J ELECTROCERAM, V3, P361, DOI 10.1023/A:1009913913732
   Zhang B, 2005, INORG CHEM, V44, P3738, DOI 10.1021/ic0490851
   Zhou Y, 2013, CRIT REV SOLID STATE, V38, P286, DOI 10.1080/10408436.2012.719131
NR 42
TC 2
Z9 2
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 28
PY 2017
VL 33
IS 8
BP 1951
EP 1958
DI 10.1021/acs.langmuir.6b04120
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA EM5OI
UT WOS:000395360800023
PM 28145712
DA 2018-10-20
ER

PT J
AU Sivashanmugan, K
   Liu, PC
   Tsai, KW
   Chou, YN
   Lin, CH
   Chang, Y
   Wen, TC
AF Sivashanmugan, Kundan
   Liu, Po-Chun
   Tsai, Kai-Wei
   Chou, Ying-Nien
   Lin, Chen-Hsueh
   Chang, Yung
   Wen, Ten-Chin
TI An anti-fouling nanoplasmonic SERS substrate for trapping and releasing
   a cationic fluorescent tag from human blood solution
SO NANOSCALE
LA English
DT Article
ID ENHANCED RAMAN-SCATTERING; OPTICAL-PROPERTIES; BIOMATERIAL INTERFACES;
   ACTIVE SUBSTRATE; SILVER NANOCUBES; POLYMER BRUSHES; SINGLE-MOLECULE;
   COMPLEX MEDIA; AG-NANOCUBES; SURFACE
AB In bioenvironmental detection, surface-enhanced Raman scattering (SERS) signals are greatly affected by anti-specific biomolecule adsorption, which generates strong background noise, reducing detection sensitivity and selectivity. It is thus necessary to modify the SERS substrate surface to make it anti-fouling to maintain excellent SERS signals. Herein, we propose a zwitterionic copolymer, namely poly(glycidyl methacrylate-co-sulfobetaine methacrylate) (poly(GMA-co-SBMA)), for the surface modification of SERS substrates, which were fabricated and characterized spectroscopically. The copolymer was grafted onto Ag nanocubes (NCs) on an Ag surface with massive nanogaps via 1,2-ethanedithiol, which acted as a metal-insulator-metal (MIM) substrate. The high density of poly(GMA-co-SBMA) grafted near NCs favored the formation of connections between adjacent NCs, causing strong surface plasmon resonance at these junctions. With the zwitterionic-copolymer-modified surface, the adhesion of large biomolecules in platelet-rich plasma (PRP) solution can be effectively resisted, as determined from immunoassay and fibrinogen adsorption results. The SERS signals for malachite green (MG) in PRP solution (10(-6) M) were effectively distinguished using the copolymer-grafted MIM substrate. MG was deposited on adjacent copolymer-grafted NCs, which amplified the SERS signals. Moreover, the copolymer connected adjacent NCs, inducing the electromagnetic effect at copolymer-grafted surfaces, which improved the SERS mechanism. The hydration process restructured the MG-trapped copolymer-grafted surface, decreasing the number of MG characteristic peak regions and increasing that of the copolymer regions. These results reveal that grafting a copolymer onto an MIM substrate allows MG to be easily trapped and released in complex biomatrices and increases surface reproducibility due to anti-fouling, leading to high SERS enhancement.
C1 [Sivashanmugan, Kundan; Liu, Po-Chun; Tsai, Kai-Wei; Chou, Ying-Nien; Lin, Chen-Hsueh; Wen, Ten-Chin] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
RP Wen, TC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
EM tcwen@mail.ncku.edu.tw
RI Kundan, Sivashanmugan/N-9965-2018
OI Kundan, Sivashanmugan/0000-0002-6785-8904
FU Ministry of Science and Technology of Taiwan [MOST. 104-2221-E-006-160-
   MY3, MOST. 104-2811-E-066-077]
FX This work was financially supported by the Ministry of Science and
   Technology of Taiwan under grant MOST. 104-2221-E-006-160- MY3 and MOST.
   104-2811-E-066-077.
CR Akcora P, 2009, NAT MATER, V8, P354, DOI [10.1038/nmat2404, 10.1038/NMAT2404]
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Cheng IF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02365
   Cheng N, 2008, MACROMOLECULES, V41, P6317, DOI 10.1021/ma800625y
   Cheng SC, 2014, RSC ADV, V4, P44457, DOI 10.1039/c4ra06977c
   Cheng SC, 2014, MATER CHEM PHYS, V143, P1331, DOI 10.1016/j.matchemphys.2013.11.043
   Chou YN, 2016, ACTA BIOMATER, V40, P78, DOI 10.1016/j.actbio.2016.03.046
   Chou YN, 2015, ACS APPL MATER INTER, V7, P10096, DOI 10.1021/acsami.5b01756
   Fleischmann C, 2015, POLYMERS-BASEL, V7, P717, DOI 10.3390/polym7040717
   Gao B, 2012, NAT NANOTECHNOL, V7, P433, DOI [10.1038/nnano.2012.83, 10.1038/NNANO.2012.83]
   Guerrini L, 2013, J AM CHEM SOC, V135, P10314, DOI 10.1021/ja405120x
   Guo PZ, 2015, NANOSCALE, V7, P2862, DOI 10.1039/c4nr06429a
   Gupta S, 2010, ADV FUNCT MATER, V20, P1756, DOI 10.1002/adfm.201000025
   Gurunatha KL, 2015, NANO LETT, V15, P7377, DOI 10.1021/acs.nanolett.5b02748
   Guven B, 2011, ANALYST, V136, P740, DOI 10.1039/c0an00473a
   Huang ZL, 2014, NANO RES, V7, P1177, DOI 10.1007/s12274-014-0480-5
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Klinkova A, 2014, NANO LETT, V14, P6314, DOI 10.1021/nl502746h
   Koczkur KM, 2015, DALTON T, V44, P17883, DOI 10.1039/c5dt02964c
   Kubackova J, 2014, PHYS CHEM CHEM PHYS, V16, P11461, DOI 10.1039/c4cp00424h
   LASSER R, 1981, PHYS REV B, V24, P1895, DOI 10.1103/PhysRevB.24.1895
   Lassiter JB, 2013, NANO LETT, V13, P5866, DOI 10.1021/nl402660s
   Liu TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1546
   Liu WJ, 2014, RSC ADV, V4, P11003, DOI 10.1039/c3ra47829g
   Liu Y, 2013, NANOSCALE, V5, P7458, DOI 10.1039/c3nr01952g
   Luo SC, 2014, BIOSENS BIOELECTRON, V61, P232, DOI 10.1016/j.bios.2014.05.013
   Mahmoud MA, 2009, J PHYS CHEM C, V113, P5493, DOI 10.1021/jp900648r
   Moran CH, 2011, J PHYS CHEM C, V115, P21852, DOI 10.1021/jp207868a
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Muehlethaler C, 2016, ANAL CHEM, V88, P152, DOI 10.1021/acs.analchem.5b04131
   Pourjavadi A, 2016, RSC ADV, V6, P38042, DOI 10.1039/c6ra02517j
   Radziuk D, 2015, PHYS CHEM CHEM PHYS, V17, P21072, DOI 10.1039/c4cp04946b
   Roiter Y, 2012, NANOSCALE, V4, P284, DOI 10.1039/c1nr10932d
   Rozin M. J., 2015, NAT COMMUN, P6
   Sainudeen Z, 2005, J PHYS CHEM A, V109, P9095, DOI 10.1021/jp052820+
   Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j
   Schlucker S, 2014, ANGEW CHEM INT EDIT, V53, P4756, DOI 10.1002/anie.201205748
   Shao Q, 2010, J PHYS CHEM B, V114, P16625, DOI 10.1021/jp107272n
   Sivashanmugan K, 2015, BIOSENS BIOELECTRON, V72, P61, DOI 10.1016/j.bios.2015.04.091
   Sivashanmugan K, 2015, SENSOR ACTUAT B-CHEM, V207, P430, DOI 10.1016/j.snb.2014.10.088
   Sivashanmugan K, 2013, SENSOR ACTUAT B-CHEM, V181, P361, DOI 10.1016/j.snb.2013.01.035
   Sun F, 2015, BIOSENS BIOELECTRON, V73, P202, DOI 10.1016/j.bios.2015.05.060
   Sun F, 2015, ACS NANO, V9, P2668, DOI 10.1021/nn506447k
   Sun F, 2014, ANAL CHEM, V86, P2387, DOI 10.1021/ac4040983
   Tsai KW, 2016, J TAIWAN INST CHEM E, V69, P146, DOI 10.1016/j.jtice.2016.10.005
   Wang Y, 2014, ANAL CHEM, V86, P9930, DOI 10.1021/ac5027012
   Xia XH, 2012, J AM CHEM SOC, V134, P1793, DOI 10.1021/ja210047e
   Xu LJ, 2015, J AM CHEM SOC, V137, P5149, DOI 10.1021/jacs.5b01426
   Yan ZQ, 2013, RSC ADV, V3, P8021, DOI 10.1039/c3ra40690c
   Yang JT, 2015, LANGMUIR, V31, P9125, DOI 10.1021/acs.langmuir.5b02119
   Zhang QA, 2010, CHEM-EUR J, V16, P10234, DOI 10.1002/chem.201000341
   Zhang X, 2007, J PHYS CHEM C, V111, P4132, DOI 10.1021/jp065953j
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 56
TC 6
Z9 6
U1 13
U2 68
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PD FEB 28
PY 2017
VL 9
IS 8
BP 2865
EP 2874
DI 10.1039/c6nr08077d
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EN2YM
UT WOS:000395876200023
PM 28169391
DA 2018-10-20
ER

PT J
AU Ferraris, S
   Miola, M
   Cochis, A
   Azzimonti, B
   Rimondini, L
   Prenesti, E
   Verne, E
AF Ferraris, S.
   Miola, M.
   Cochis, A.
   Azzimonti, B.
   Rimondini, L.
   Prenesti, E.
   Verne, E.
TI In situ reduction of antibacterial silver ions to metallic silver
   nanoparticles on bioactive glasses functionalized with polyphenols
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Bioactive glasses; Polyphenols; Silver nanoparticles; In situ reduction;
   Antibacterial activity
ID SURFACE FUNCTIONALIZATION; GREEN SYNTHESIS; ANTIMICROBIAL APPLICATIONS;
   BIOLOGICAL SIGNIFICANCE; ALKALINE-PHOSPHATASE; NATURAL MOLECULES;
   TITANIUM SURFACES; BIOFILM FORMATION; GALLIC ACID; EXTRACT
AB The realization of surfaces with antibacterial properties due to silver nanoparticles loaded through a green approach is a promising research challenge of the biomaterial field.
   In this research work, two bioactive glasses have been doubly surface functionalized with polyphenols (gallic acid or natural polyphenols extracted from red grape skins and green tea leaves) and silver nanoparticles deposited by in situ reduction from a silver nitrate aqueous solution. The presence of biomolecules -showing reducing ability to directly obtain in situ metallic silver -and silver nanoparticles was investigated by means of UV-vis spectroscopy, X-Ray Photoelectron Spectroscopy (XPS) and Field Emission Scanning Electron Microscopy (FESEM). The antibacterial activity of the modified surfaces was tested against a multidrug resistant Staphylococcus aureus bacterial strain. (C) 2016 Elsevier B. V. All rights reserved.
C1 [Ferraris, S.; Miola, M.; Verne, E.] Politecn Torino, Dept Appl Sci & Technol, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
   [Miola, M.; Cochis, A.; Azzimonti, B.; Rimondini, L.] UPO, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.
   [Prenesti, E.] Univ Turin, Dept Chem, Via Pietro Giuria 7, I-10125 Turin, Italy.
RP Ferraris, S (reprint author), Politecn Torino, Dept Appl Sci & Technol, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM sara.ferraris@polito.it
OI Cochis, Andrea/0000-0003-2455-8239; Verne, Enrica/0000-0002-8649-4739
CR Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007
   Aladpoosh R, 2014, CELLULOSE, V21, P3755, DOI 10.1007/s10570-014-0369-1
   [Anonymous], 2013, XRAY PHOTOELECTRON S
   Azzimonti B, 2015, MOLECULES, V20, P9344, DOI 10.3390/molecules20059344
   Barnaby SN, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/22/225605
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Cazzola M, 2016, APPL SURF SCI, V367, P237, DOI 10.1016/j.apsusc.2016.01.138
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Cochis A, 2016, BIOMATERIALS, V80, P80, DOI 10.1016/j.biomaterials.2015.11.042
   Cochis A, 2015, J BIOMED MATER RES A, V103, P1176, DOI 10.1002/jbm.a.35270
   Cochis A, 2012, OR SURG OR MED OR PA, V113, P755, DOI 10.1016/j.oooo.2011.11.004
   Dauthal P, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1366-7
   El-Kheshen A.A., 2012, DER PHARM CHEM, V4, P53
   Ferraris M, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1287-5
   Ferraris S, 2016, MAT SCI ENG C-MATER, V61, P965, DOI 10.1016/j.msec.2015.12.062
   Ferraris S, 2014, APPL SURF SCI, V311, P279, DOI 10.1016/j.apsusc.2014.05.056
   Ferraris S, 2016, J NON-CRYST SOLIDS, V432, P167, DOI 10.1016/j.jnoncrysol.2015.05.023
   Ferraz MP, 1999, J BIOMED MATER RES, V45, P376, DOI 10.1002/(SICI)1097-4636(19990615)45:4<376::AID-JBM13>3.0.CO;2-S
   Graves JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00042
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Jacob JA, 2008, LANGMUIR, V24, P528, DOI 10.1021/la702073r
   Kheybari S, 2010, DARU, V18, P168
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   Kumar KM, 2012, SPECTROCHIM ACTA A, V91, P228, DOI 10.1016/j.saa.2012.02.001
   Liu ZY, 2015, COMPOS PART B-ENG, V79, P217, DOI 10.1016/j.compositesb.2015.04.037
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Morra M, 2003, INT J ORAL MAX IMPL, V18, P40
   Mowlder J.F., 1995, REFERENCE BOOK STAND
   Naumkin A.V., 2013, NIST STANDARD REFERE
   Ocwieja M, 2015, ADV COLLOID INTERFAC, V222, P530, DOI 10.1016/j.cis.2014.07.001
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Panigrahi S, 2004, J NANOPART RES, V6, P411, DOI 10.1007/s11051-004-6575-2
   Qiao GY, 2012, DENT MATER J, V31, P564, DOI 10.4012/dmj.2011-159
   Rabiee SM, 2015, CERAM INT, V41, P7241, DOI 10.1016/j.ceramint.2015.02.140
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ramya M, 2012, INT J PHARM MED BIO, V1, P54
   Rauwel P., 2015, ADV MATER SCI ENG, V2015, DOI DOI 10.1155/2015/682749
   Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295
   Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s
   Stephens P., 2014, ANTIBIOTIC RESISTANC
   Sun Q, 2014, COLLOID SURFACE A, V444, P226, DOI 10.1016/j.colsurfa.2013.12.065
   Textor M., 2001, TITANIUM MED, P171
   Verne E, 2015, SURF COAT TECH, V264, P132, DOI 10.1016/j.surfcoat.2015.01.001
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025
   Wang ZM, 2015, COLLOID SURFACE A, V485, P102, DOI 10.1016/j.colsurfa.2015.09.015
   Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914
   Zhang X, 2013, APPL SURF SCI, V287, P329, DOI 10.1016/j.apsusc.2013.09.151
   Zhang X, 2013, APPL SURF SCI, V287, P341, DOI 10.1016/j.apsusc.2013.09.152
NR 52
TC 9
Z9 9
U1 4
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2017
VL 396
BP 461
EP 470
DI 10.1016/j.apsusc.2016.10.177
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EN8AO
UT WOS:000396223500055
DA 2018-10-20
ER

PT J
AU Chen, EY
   Chu, SH
   Gov, L
   Kim, YK
   Lodoen, MB
   Tenner, AJ
   Liu, WF
AF Chen, Esther Y.
   Chu, Shu-Hui
   Gov, Lanny
   Kim, Yoon Kyung
   Lodoen, Melissa B.
   Tenner, Andrea J.
   Liu, Wendy F.
TI CD200 modulates macrophage cytokine secretion and phagocytosis in
   response to poly(lactic-co-glycolic acid)microparticles and films
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PLGA MICROPARTICLES; IN-VITRO; CONTROLLED-RELEASE; SUSTAINED-RELEASE;
   DRUG-DELIVERY; PARTICLE-SIZE; DEXAMETHASONE; NANOPARTICLES; CELLS;
   SYSTEM
AB Biocompatibility is a major concern for developing biomaterials used in medical devices, tissue engineering and drug delivery. Poly(lactic-co-glycolic acid) (PLGA) is one of the most widely used biodegradable materials, yet still triggers a significant foreign body response that impairs healing. Immune cells including macrophages respond to the implanted biomaterial and mediate the host response, which can eventually lead to device failure. Previously in our laboratory, we found that CD200, an immunomodulatory protein, suppressed macrophage inflammatory activation in vitro and reduced local immune cell infiltration around a biomaterial implant. While in our initial study we used polystyrene as a model material, here we investigate the effect of CD200 on PLGA, a commonly used biomaterial with many potential clinical applications. We fabricated PLGA with varied geometries, modified their surfaces with CD200, and examined macrophage cytokine secretion and phagocytosis. We found that CD200 suppressed secretion of the pro-inflammatory cytokine TNF-alpha and enhanced secretion of the anti-inflammatory cytokine IL-10, suggesting a role for CD200 in promoting wound healing and tissue remodeling. In addition, we found that CD200 increased phagocytosis in both murine macrophages and human monocytes. Together, these data suggest that modification with CD200 leads to a response that simultaneously prevents inflammation and enhances phagocytosis. This immunomodulatory feature may be used as a strategy to mitigate inflammation or deliver drugs or anti-inflammatory agents targeting macrophages.
C1 [Chen, Esther Y.; Kim, Yoon Kyung; Liu, Wendy F.] Dept Chem Engn & Mat Sci, 916 Engn Tower, Irvine, CA 92697 USA.
   [Chen, Esther Y.; Kim, Yoon Kyung; Liu, Wendy F.] Edwards Lifesci Ctr Adv Cardiovasc Technol, 2400 Engn Hall, Irvine, CA 92697 USA.
   [Chu, Shu-Hui; Gov, Lanny; Lodoen, Melissa B.; Tenner, Andrea J.] Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.
   [Kim, Yoon Kyung; Liu, Wendy F.] Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci II, Irvine, CA 92697 USA.
RP Liu, WF (reprint author), Dept Chem Engn & Mat Sci, 916 Engn Tower, Irvine, CA 92697 USA.; Liu, WF (reprint author), Edwards Lifesci Ctr Adv Cardiovasc Technol, 2400 Engn Hall, Irvine, CA 92697 USA.; Liu, WF (reprint author), Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci II, Irvine, CA 92697 USA.
EM wendy.liu@uci.edu
OI Tenner, Andrea/0000-0003-3000-024X
FU National Institutes of Health (NIH) National institute of Dental and
   Craniofacial Research (NIDCR) and Office of the Director's Grant
   [DP2DE023319]; National Institute on Aging (NIA) Grant [AG00538];
   National Institute of Allergy and Infectious Diseases (NIAID) Grant
   [AI120846]; National Center for Research Resources, NIH [UL1 TR001414];
   National Center for Advancing Translational Sciences, NIH [UL1 TR001414]
FX This work was supported by the National Institutes of Health (NIH)
   National institute of Dental and Craniofacial Research (NIDCR) and
   Office of the Director's Grant DP2DE023319 (to W. F. L), National
   Institute on Aging (NIA) Grant AG00538 (to A. J. T.), National Institute
   of Allergy and Infectious Diseases (NIAID) Grant AI120846 (to M. B. L.).
   The project described was also supported by the National Center for
   Research Resources and the National Center for Advancing Translational
   Sciences, NIH, through Grant UL1 TR001414. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH. We gratefully acknowledge the Laboratory for
   Electron and X-ray Instrumentation (LEXI), the Stem Cell Research
   Center, and the Institute for Immunology Flow Cytometry Facilities at
   the University of California, Irvine. We thank the staff of the
   University of California, Irvine, Institute for Clinical and
   Translational Science for obtaining blood and healthy volunteers for
   donating blood. We thank Xiuhui Gao and Ci Ren for technical assistance
   in the laboratory.
CR Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Bhardwaj Upkar, 2007, J Diabetes Sci Technol, V1, P8
   Bivas-Benita M, 2004, EUR J PHARM BIOPHARM, V58, P1, DOI 10.1016/j.ejpb.2004.03.008
   BOBAK DA, 1987, J IMMUNOL, V138, P1150
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen WL, 2006, OCUL IMMUNOL INFLAMM, V14, P215, DOI 10.1080/09273940600732380
   Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013
   Dang TT, 2011, BIOMATERIALS, V32, P4464, DOI 10.1016/j.biomaterials.2011.02.048
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232
   Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Kim I, 2012, BIOMATERIALS, V33, P5574, DOI 10.1016/j.biomaterials.2012.04.018
   Kim YK, 2016, J MATER CHEM B, V4, P1600, DOI 10.1039/c5tb01605c
   Kim YK, 2014, ADV HEALTHC MATER, V3, P989, DOI 10.1002/adhm.201300532
   Kingston RE, 2001, CURRENT PROTOCOLS MO
   Kohane DS, 2010, CHEM SCI, V1, P441, DOI 10.1039/c0sc00203h
   Morgado P, 2011, INFECT IMMUN, V79, P4401, DOI 10.1128/IAI.05562-11
   Naahidi S, 2013, J CONTROL RELEASE, V166, P182, DOI 10.1016/j.jconrel.2012.12.013
   Nepomuceno RR, 1999, J IMMUNOL, V162, P3583
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Patil Siddhesh D, 2004, Diabetes Technol Ther, V6, P887, DOI 10.1089/dia.2004.6.887
   Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568
   Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184
   Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632
   Saroja CH, 2011, INT J PHARM INVESTIG, V1, P64, DOI 10.4103/2230-973X.82384
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970
   Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603
   Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   Tamura K, 2004, KEY ENG MAT, V254-2, P919, DOI 10.4028/www.scientific.net/KEM.254-256.919
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Venkatraman SS, 2006, BIOMATERIALS, V27, P1573, DOI 10.1016/j.biomaterials.2005.09.002
   Vishwakarma A, 2016, TRENDS BIOTECHNOL, V34, P470, DOI 10.1016/j.tibtech.2016.03.009
   Wang XT, 2006, BIOMATERIALS, V27, P5588, DOI 10.1016/j.biomaterials.2006.07.016
   Webster SD, 2001, J IMMUNOL, V166, P7496, DOI 10.4049/jimmunol.166.12.7496
   Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012
   WOLFF JEA, 1993, BRAIN RES, V604, P79, DOI 10.1016/0006-8993(93)90354-P
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
NR 43
TC 4
Z9 4
U1 5
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 28
PY 2017
VL 5
IS 8
BP 1574
EP 1584
DI 10.1039/c6tb02269c
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EN3PT
UT WOS:000395921100005
PM 28736613
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, Q
   Hao, XF
   Lv, J
   Ren, XK
   Zhang, KY
   Ullah, I
   Feng, YK
   Shi, CC
   Zhang, WC
AF Li, Qian
   Hao, Xuefang
   Lv, Juan
   Ren, Xiangkui
   Zhang, Kunyu
   Ullah, Ihsan
   Feng, Yakai
   Shi, Changcan
   Zhang, Wencheng
TI Mixed micelles obtained by co-assembling comb-like and grafting
   copolymers as gene carriers for efficient gene delivery and expression
   in endothelial cells
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID LINKED POLYMERIC MICELLES; IN-VITRO; TRIBLOCK COPOLYMERS; VASCULAR
   TISSUE; TRANSFER VECTOR; REDV PEPTIDE; SIGNALING PATHWAYS; COMPLEX
   MICELLES; PAMAM DENDRIMER; SIRNA DELIVERY
AB Gene delivery can enhance the endothelialization of biomaterial surfaces. However, the lack of efficient target function is still the major concern that hinders the clinical application of gene therapy. With the aim to develop a specific targeting gene carrier for endothelial cells (ECs), the Cys-Arg-Glu-Asp-Val-Trp (CREDVW) peptide was linked to the comb-like copolymer of poly(lactide-co-3(S)-methyl-morpholine2,5- dione)-poly(poly(ethylene glycol) monomethacrylate) (PLMD-PPEGMA) to form the CREDVW modified copolymer PLMD-PPEGMA-CREDVW, which could enhance the special recognition of ECs. Mixed micelles were then prepared by co-assembling this comb-like copolymer and the amphiphilic grafting copolymer poly(lactide-co-3(S)-methyl-morpholine-2,5-dione)-g-polyethylenimine (PLMD-g-PEI). These mixed micelles with the CREDVW-functional peptide exhibited good pEGFP-ZNF580 (pDNA) binding ability and could condense it into complexes with proper size and positive zeta potential. The MTT results demonstrated the low cytotoxicity of the CREDVW-modified mixed micelle/pDNA complexes. The internalization efficiency of the CREDVW-modified complexes with targeting function was about two times higher than the dysfunctional CREVDW-modified complexes. Besides, the transfection efficiency of these complexes was more pronounced, compared to the control group, PEI(10 kDa)/pDNA, as detected by means of in vitro transfection studies. Western blot analysis demonstrated relatively high protein levels in the transfected cells by CREDVW-modified mixed micelle/pDNA complexes, up to 75%, in comparison to the control group (26%). In addition, the cell migration ability was significantly improved as demonstrated by the wound healing assay. These results indicated that the mixed micelles could act as an active targeting gene carrier, having both tunable gene transfection efficiency and low cytotoxicity, which are beneficial for the endothelialization of biomaterial surface.
C1 [Li, Qian; Hao, Xuefang; Lv, Juan; Ren, Xiangkui; Zhang, Kunyu; Ullah, Ihsan; Feng, Yakai] Tianjin Univ, Sch Chem Engn & Technol, Yaguan Rd 135, Tianjin 300350, Peoples R China.
   [Li, Qian; Hao, Xuefang; Lv, Juan; Feng, Yakai] Collaborat Innovat Ctr Chem Sci & Chem Engn Tianj, Weijin Rd 92, Tianjin 300072, Peoples R China.
   [Ren, Xiangkui; Feng, Yakai] Tianjin Univ Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Yaguan Rd 135, Tianjin 300350, Peoples R China.
   [Feng, Yakai] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Weijin Rd 92, Tianjin 300072, Peoples R China.
   [Shi, Changcan] Wenzhou Med Univ, Inst Biomat & Engn, Wenzhou 325011, Zhejiang, Peoples R China.
   [Shi, Changcan] Chinese Acad Sci, CNITECH, Wenzhou Inst Biomat & Engn, Wenzhou 325011, Zhejiang, Peoples R China.
   [Zhang, Wencheng] Logist Univ Chinese Peoples Armed Police Force, Dept Physiol & Pathophysiol, Tianjin 300162, Peoples R China.
RP Ren, XK; Feng, YK (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Yaguan Rd 135, Tianjin 300350, Peoples R China.; Feng, YK (reprint author), Collaborat Innovat Ctr Chem Sci & Chem Engn Tianj, Weijin Rd 92, Tianjin 300072, Peoples R China.; Ren, XK; Feng, YK (reprint author), Tianjin Univ Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Yaguan Rd 135, Tianjin 300350, Peoples R China.; Feng, YK (reprint author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Weijin Rd 92, Tianjin 300072, Peoples R China.; Shi, CC (reprint author), Wenzhou Med Univ, Inst Biomat & Engn, Wenzhou 325011, Zhejiang, Peoples R China.; Shi, CC (reprint author), Chinese Acad Sci, CNITECH, Wenzhou Inst Biomat & Engn, Wenzhou 325011, Zhejiang, Peoples R China.
EM yakaifeng@tju.edu.cn
OI feng, yakai/0000-0002-4511-0874
FU State Key Project of Research and Development [2016YFC1100300]; National
   Natural Science Foundation of China [31370969, 51673145]; International
   Science & Technology Cooperation Program of China [2013DFG52040];
   Wenzhou government's startup fund [WIBEZD2014005-03, WIBEZD2015009-03];
   Wenzhou Science and Technology Bureau [Y20150088]
FX This project was supported by State Key Project of Research and
   Development (Grant No. 2016YFC1100300), the National Natural Science
   Foundation of China (Grant No. 31370969 and 51673145), International
   Science & Technology Cooperation Program of China ( Grant No.
   2013DFG52040), Wenzhou government's startup fund (Grant No.
   WIBEZD2014005-03 and WIBEZD2015009-03), and Wenzhou Science and
   Technology Bureau (Grant No. Y20150088).
CR Endres T, 2014, MOL PHARMACEUT, V11, P1273, DOI 10.1021/mp400744a
   Endres TK, 2011, BIOMATERIALS, V32, P7721, DOI 10.1016/j.biomaterials.2011.06.064
   Feng YK, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8030058
   Feng YK, 2013, J MATER SCI-MATER M, V24, P61, DOI 10.1007/s10856-012-4685-4
   Feng YK, 2009, INT J MOL SCI, V10, P589, DOI 10.3390/ijms10020589
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Forbes DC, 2014, ACS NANO, V8, P2908, DOI 10.1021/nn500101c
   Gao B, 2013, MAT SCI ENG C-MATER, V33, P2871, DOI 10.1016/j.msec.2013.03.007
   Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040
   Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445
   Goh D, 2013, MOL PHARMACEUT, V10, P1279, DOI 10.1021/mp3006616
   Hao XF, 2015, ACS APPL MATER INTER, V7, P12128, DOI 10.1021/acsami.5b02399
   Hasan SS, 2015, CURR OPIN CELL BIOL, V36, P86, DOI 10.1016/j.ceb.2015.07.009
   He H, 2015, BIOMACROMOLECULES, V16, P1390, DOI 10.1021/acs.biomac.5b00180
   He YY, 2013, BIOMATERIALS, V34, P1235, DOI 10.1016/j.biomaterials.2012.09.049
   Huang HL, 2010, BIOMATERIALS, V31, P1830, DOI 10.1016/j.biomaterials.2009.11.012
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Ji Y, 2012, J BIOMED MATER RES A, V100A, P1387, DOI 10.1002/jbm.a.34077
   Kodama Y, 2014, EUR J PHARM BIOPHARM, V87, P472, DOI 10.1016/j.ejpb.2014.04.013
   Kumar A, 2015, ACS APPL MATER INTER, V7, P9211, DOI 10.1021/acsami.5b01731
   Li HM, 2012, MOL PHARMACEUT, V9, P2974, DOI 10.1021/mp300321n
   Li Q, 2015, ADV HEALTHC MATER, V4, P1225, DOI 10.1002/adhm.201400817
   Liu L, 2012, BIOCONJUGATE CHEM, V23, P1211, DOI 10.1021/bc300025d
   Luo YY, 2014, MOL CELL BIOCHEM, V393, P199, DOI 10.1007/s11010-014-2061-z
   Luo YY, 2011, CELL BIOL INT, V35, P1153, DOI 10.1042/CBI20110050
   Lv J, 2016, J MATER CHEM B, V4, P997, DOI 10.1039/c5tb02310f
   Lv J, 2014, MACROMOL CHEM PHYS, V215, P2463, DOI 10.1002/macp.201400345
   Malhotra M, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S43683
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Miura Y, 2013, ACS NANO, V7, P8583, DOI 10.1021/nn402662d
   Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773
   Ng JF, 2011, J BIOMED MATER RES B, V99B, P282, DOI 10.1002/jbm.b.31897
   Pan R, 2015, ACTA BIOMATER, V21, P74, DOI 10.1016/j.actbio.2015.04.002
   Park CH, 2010, MACROMOL RES, V18, P526, DOI 10.1007/s13233-010-0517-9
   Peng Q, 2008, BIOCONJUGATE CHEM, V19, P499, DOI 10.1021/bc7003236
   Ping YA, 2010, ADV FUNCT MATER, V20, P3106, DOI 10.1002/adfm.201000177
   Qu W, 2013, BIOCONJUGATE CHEM, V24, P960, DOI 10.1021/bc300677n
   Ren DL, 2012, MOL CELL BIOCHEM, V359, P183, DOI 10.1007/s11010-011-1013-0
   Ren XK, 2015, CHEM SOC REV, V44, P5680, DOI 10.1039/c4cs00483c
   Saurer EM, 2013, BIOMACROMOLECULES, V14, P1696, DOI 10.1021/bm4005222
   Shi CC, 2015, ACS APPL MATER INTER, V7, P20389, DOI 10.1021/acsami.5b06286
   Shi CC, 2014, BIOMATERIALS, V35, P7133, DOI 10.1016/j.biomaterials.2014.04.110
   Shi CC, 2014, J MATER CHEM B, V2, P1825, DOI 10.1039/c3tb21601b
   Shuai XT, 2003, MACROMOLECULES, V36, P5751, DOI 10.1021/ma034390w
   Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221
   Sun HY, 2010, BIOCHEM BIOPH RES CO, V395, P361, DOI 10.1016/j.bbrc.2010.04.019
   Sun J, 2013, BIOMACROMOLECULES, V14, P728, DOI 10.1021/bm301826m
   Tan MQ, 2013, MACROMOL RES, V21, P541, DOI 10.1007/s13233-013-1028-3
   Tian HY, 2011, J CONTROL RELEASE, V155, P47, DOI 10.1016/j.jconrel.2011.01.025
   Tsai YJ, 2011, BIOMACROMOLECULES, V12, P4283, DOI 10.1021/bm201196p
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Wang HX, 2015, J MATER CHEM B, V3, P3379, DOI 10.1039/c4tb02019g
   Wang HY, 2013, MACROMOL RES, V21, P860, DOI 10.1007/s13233-013-1105-7
   Wang W, 2015, J BIOMED MATER RES A, V103, P1703, DOI 10.1002/jbm.a.35306
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yang J, 2013, MACROMOL BIOSCI, V13, P1681, DOI 10.1002/mabi.201300264
   Yue ZG, 2011, BIOMACROMOLECULES, V12, P2440, DOI 10.1021/bm101482r
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhang Z, 2012, J BIOMED MATER RES B, V100B, P1599, DOI 10.1002/jbm.b.32728
   Zheng M, 2012, BIOMACROMOLECULES, V13, P881, DOI 10.1021/bm2017965
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
NR 63
TC 11
Z9 11
U1 11
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 28
PY 2017
VL 5
IS 8
BP 1673
EP 1687
DI 10.1039/c6tb02212j
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA EN3PT
UT WOS:000395921100016
DA 2018-10-20
ER

PT J
AU Montano-Machado, V
   Noel, C
   Chevallier, P
   Turgeon, S
   Houssiau, L
   Pauthe, E
   Pireaux, JJ
   Mantovani, D
AF Montano-Machado, Vanessa
   Noel, Celine
   Chevallier, Pascale
   Turgeon, Stephane
   Houssiau, Laurent
   Pauthe, Emmanuel
   Pireaux, Jean-Jacques
   Mantovani, Diego
TI Interaction of phosphorylcholine with fibronectin coatings: Surface
   characterization and biological performances
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Fibronectin; Phosphorylcholine; Grafting; Endothelialization;
   Hemocompatibility; Biomaterials
ID ION MASS-SPECTROMETRY; STENT APPLICATIONS; ENDOTHELIAL-CELLS; TITANIUM;
   ADHESION; POLYMER; FILMS; HEMOCOMPATIBILITY; BIOCOMPATIBILITY; PROTEINS
AB Coating medical devices with several bioactive molecules is an interesting approach to achieve specific biological targets upon the interaction of the biomaterial with the living environment. In this work, a fluorocarbon polymer (CFx) was first deposited by plasma treatment on stainless steel (SS) substrate and thereafter, coatings containing fibronectin (FN) and phosphorylcholine (PRC) were created for cardiovascular applications. These two biomolecules were chosen to promote endothelialization and to avoid thrombus formation, respectively. Adsorption and grafting techniques were applied - and combined - to accomplish 4 different coatings containing both molecules. However, big challenge was found to characterize a small molecule (PRC: 184 g/mol) interacting with a protein (FN: 450 kD). For the first time XPS, dynamic water contact angle, immunostaining and ToF-SIMS (imaging and depth profiling) analyses were combined to accomplish the characterization of such a coating. The most encouraging biological performances were obtained for samples where FN was grafted to the CFx film followed by the adsorption of PRC: proliferation of endothelial cells and hemocompatibility properties were observed. Promising coatings for cardiovascular applications were developed. The relevance of characterizing the coatings with high sensitive techniques and the further correlation with their biological performances were evidenced. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Montano-Machado, Vanessa; Chevallier, Pascale; Turgeon, Stephane; Mantovani, Diego] Univ Laval, Lab Biomat & Bioengn, Dept Min Met Mat Engn, Univ Campus,PLT 1745G, Quebec City, PQ G1V 0A6, Canada.
   [Montano-Machado, Vanessa; Chevallier, Pascale; Turgeon, Stephane; Mantovani, Diego] Univ Laval, Univ Hosp Res Ctr, Univ Campus,PLT 1745G, Quebec City, PQ G1V 0A6, Canada.
   [Montano-Machado, Vanessa; Pauthe, Emmanuel] Univ Cergy Pontoise, ERRMECe, Site St Martin,2 Ave Adolphe Chauvin, F-95302 Cergy Pontoise, France.
   [Noel, Celine; Houssiau, Laurent; Pireaux, Jean-Jacques] Univ Namur, Res Ctr Phys Matter & Radiat PMR, 61 Rue Bruxelles, B-5000 Namur, Belgium.
RP Mantovani, D (reprint author), Univ Laval, Pavillon Adrien Pouliot 1065,Ave Med,Local 1745-G, Quebec City, PQ G1V 0A6, Canada.
EM vanessa.montano-machado.1@ulaval.ca; celine.noel@unamur.be;
   pascale.chevallier@crchudequebec.ulaval.ca;
   stephane.turgeon@crchudequebec.ulaval.ca; laurent.houssiau@unamur.be;
   emmanuel.pauthe@u-cergy.fr; jean-jacques.pireaux@unamur.be;
   diego.mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU Natural Science and Engineering Research Council (NSERC) of Canada;
   Samuel de Champlain Program, Centre de Recherche sur les Materiaux
   Avances (CERMA-ULaval); Research Center of the CHU de Quebec;
   Wallonie-Bruxelles International; CONACYT Mexico
FX This work was supported by the Natural Science and Engineering Research
   Council (NSERC) of Canada, Samuel de Champlain Program, Centre de
   Recherche sur les Materiaux Avances (CERMA-ULaval) and Research Center
   of the CHU de Quebec and Wallonie-Bruxelles International. Vanessa
   Montano-Machado is recipient of a PhD scholarship from CONACYT Mexico.
   The authors would like to express their gratitude for their
   collaboration on the performance of experiments and/or their technical
   assistance to Remy Agniel, Laurent Nittler, Ludivine Hugoni, Ranna
   Tolouei and Andree-Anne Guay-Begin, as well as the blood donor
   volunteers.
CR Alves CM, 2010, SOFT MATTER, V6, P4135, DOI 10.1039/c002972f
   Chen JL, 2012, J COLLOID INTERF SCI, V368, P636, DOI 10.1016/j.jcis.2011.11.039
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   Chevallier P, 2005, MACROMOL BIOSCI, V5, P829, DOI 10.1002/mabi.200500088
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Gong M, 2013, SOFT MATTER, V9, P4501, DOI 10.1039/c3sm00086a
   Haidopoulos M, 2006, J MATER SCI-MATER M, V17, P647, DOI 10.1007/s10856-006-9228-4
   Hale P, 2008, LANGMUIR, V24, P7897, DOI 10.1021/la8002788
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Holvoet S, 2010, ELECTROCHIM ACTA, V55, P1042, DOI 10.1016/j.electacta.2009.09.079
   Houssiau L, 2011, SURF INTERFACE ANAL, V43, P146, DOI 10.1002/sia.3528
   Jawanda M, 2013, POLYM CHEM-UK, V4, P3140, DOI 10.1039/c3py00248a
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lewis F, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/4/045310
   Lewis F, 2010, PLASMA PROCESS POLYM, V7, P309, DOI 10.1002/ppap.200900107
   Lewis F, 2009, MACROMOL MATER ENG, V294, P11, DOI 10.1002/mame.200800229
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Montano-Machado V., 2015, BIOMATTER, V5
   Montano-Machado V, 2016, PHYS CHEM CHEM PHYS, V18, P24704, DOI 10.1039/c6cp04527h
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   Tardif K, 2011, BIOMATERIALS, V32, P5046, DOI 10.1016/j.biomaterials.2011.04.002
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   Vallieres K, 2007, MACROMOL BIOSCI, V7, P738, DOI 10.1002/mabi.200600267
   Vanterpool FA, 2014, BIORESEARCH OPEN ACC, V3, P286, DOI 10.1089/biores.2014.0033
   Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100
   Wehbe N, 2014, J PHYS CHEM C, V118, P26613, DOI 10.1021/jp501851f
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Xia N, 2003, J BIOMED MATER RES A, V67A, P179, DOI 10.1002/jbm.a.10063
NR 33
TC 0
Z9 0
U1 1
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2017
VL 396
BP 1613
EP 1622
DI 10.1016/j.apsusc.2016.11.224
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EG9YQ
UT WOS:000391418200051
DA 2018-10-20
ER

PT J
AU Zhang, ML
   Cheng, J
   Xiao, YC
   Yin, RF
   Feng, X
AF Zhang, Ming-Lei
   Cheng, Ji
   Xiao, Ye-Chen
   Yin, Ruo-Feng
   Feng, Xu
TI Raloxifene microsphere-embedded collagen/chitosan/beta-tricalcium
   phosphate scaffold for effective bone tissue engineering
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Bone tissue engineering; Raloxifene; Scaffold; Chitosan; Collagen
ID DELIVERY-SYSTEMS; REGENERATION; HYDROCHLORIDE; COMPOSITE; CHITOSAN;
   CEMENT
AB Engineering novel scaffolds that can mimic the functional extracellular matrix (ECM) would be a great achievement in bone tissue engineering. This paper reports the fabrication of novel collagen/chitosan/ beta-tricalcium phosphate (CCTP) based tissue engineering scaffold. In order to improve the regeneration ability of scaffold, we have embedded raloxifene (RLX)-loaded PLGA microsphere in the CCTP scaffold. The average pore of scaffold was in the range of 150-200 mu m with ideal mechanical strength and swelling/degradation characteristics. The release rate of RLX from the microsphere (MS) embedded scaffold was gradual and controlled. Also a significantly enhanced cell proliferation was observed in RLX-MS exposed cell group suggesting that microsphere/scaffold could be an ideal biomaterial for bone tissue engineering. Specifically, RLX-MS showed a significantly higher Alizarin red staining indicating the higher mineralization capacity of this group. Furthermore, a high alkaline phosphatase (ALP) activity for RLX-MS exposed group after 15 days incubation indicates the bone regeneration capacity of MC3T3-E1 cells. Overall, present study showed that RLX-loaded microsphere embedded scaffold has the promising potential for bone tissue engineering applications. (C) 2016 Published by Elsevier B.V.
C1 [Zhang, Ming-Lei; Yin, Ruo-Feng] Jilin Univ, China Japan Union Hosp, Dept Orthopaed, 126 Xian Tai St, Changchun, Jilin Province, Peoples R China.
   [Cheng, Ji] Jilin Univ, China Japan Union Hosp, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China.
   [Xiao, Ye-Chen] Jilin Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Changchun, Jilin, Peoples R China.
   [Feng, Xu] Jilin Univ, Hosp 1, Dept Spine Surg, 71 Xinmin St, Changchun, Peoples R China.
RP Yin, RF (reprint author), Jilin Univ, China Japan Union Hosp, Dept Orthopaed, 126 Xian Tai St, Changchun, Jilin Province, Peoples R China.; Feng, X (reprint author), Jilin Univ, Hosp 1, Dept Spine Surg, 71 Xinmin St, Changchun, Peoples R China.
EM yinruofeng009@hotmail.com; xufengxf0@126.com
FU research grant of Jilin University, China
FX The research work was supported from the research grant of Jilin
   University, China.
CR Bauer AJP, 2014, SOFT MATER, V12, P359, DOI 10.1080/1539445X.2014.925474
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Elsheikh MA, 2012, INT J NANOMED, V7, P3787, DOI 10.2147/IJN.S33186
   Link DP, 2009, J BIOMED MATER RES A, V90A, P372, DOI 10.1002/jbm.a.32091
   Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006
   Nagai N, 2010, J MATER SCI-MATER M, V21, P1891, DOI 10.1007/s10856-010-4054-0
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Ramirez L, 1999, J MICROENCAPSUL, V16, P105, DOI 10.1080/026520499289356
   RAMTOOLA Z, 1992, J MICROENCAPSUL, V9, P415, DOI 10.3109/02652049209040480
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Singh J, 2006, METHODS, V38, P96, DOI 10.1016/j.ymeth.2005.11.003
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Tan HP, 2011, MACROMOL RAPID COMM, V32, P905, DOI 10.1002/marc.201100125
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Yu XH, 2013, J TISSUE ENG REGEN M, V7, P974, DOI 10.1002/term.1490
   Zugravu MV, 2013, J BIOMATER APPL, V28, P566, DOI 10.1177/0885328212465662
NR 20
TC 2
Z9 2
U1 3
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD FEB 25
PY 2017
VL 518
IS 1-2
BP 80
EP 85
DI 10.1016/j.ijpharm.2016.12.031
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EL1SU
UT WOS:000394402100009
PM 27988379
DA 2018-10-20
ER

PT J
AU You, I
   Jeon, H
   Lee, K
   Do, M
   Seo, YC
   Lee, HA
   Lee, H
AF You, Inseong
   Jeon, Hyejin
   Lee, Kyueui
   Do, Minjae
   Seo, Young Chang
   Lee, Haesung A.
   Lee, Haeshin
TI Polydopamine coating in organic solvent for material-independent
   immobilization of water-insoluble molecules and avoidance of substrate
   hydrolysis
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Polydopamine; Surface functionalization; One-step coating; Organic
   Solvents; Drug immobilization
ID SELF-ASSEMBLED MONOLAYERS; CARBON NANOTUBES; SURFACES; CELLS;
   CATECHOLAMINE; PACLITAXEL; CANCER
AB Polydopamine (pDA) coating is the first material-independent surface chemistry utilized in energy storage systems, environmental technology, and biomaterial science. However, the conventional coating method requires use of aqueous solutions, which restrict immobilization of water-insoluble molecules onto surfaces, and the coating cannot be applied to degradable polyester substrates. Herein, methods to form pDA in organic protic solvents (o-pDA) with fast coating kinetics resulting in similar to 50 nm in thickness just for 4h. One-step immersion of surfaces in a one-pot mixture of a water-insoluble molecule, dopamine, and piperidine results in o-pDA coating with robust surface immobilization of molecules of interest. (C) 2016 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [You, Inseong] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, 291 Univ Rd, Daejeon 305701, South Korea.
   [Jeon, Hyejin; Lee, Kyueui; Do, Minjae; Seo, Young Chang; Lee, Haesung A.; Lee, Haeshin] Korea Adv Inst Sci & Technol, Dept Chem, 291 Univ Rd, Daejeon 305701, South Korea.
   [Lee, Haeshin] Korea Adv Inst Sci & Technol, KAIST Sch Mol Sci, 291 Univ Rd, Daejeon 305701, South Korea.
RP Lee, H (reprint author), Korea Adv Inst Sci & Technol, Dept Chem, 291 Univ Rd, Daejeon 305701, South Korea.
EM haeshin@kaist.ac.kr
RI Lee, Haeshin/C-1720-2011; Lee, Kyueui/P-8152-2018
OI Lee, Haeshin/0000-0003-3961-9727; Lee, Kyueui/0000-0002-1622-8806
FU National Research Foundation of South Korea: Mid-career Scientist Grant
   [2015021564]
FX This work is supported from National Research Foundation of South Korea:
   Mid-career Scientist Grant (2015021564).
CR BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BRICENO G, 1995, SCIENCE, V270, P273, DOI 10.1126/science.270.5234.273
   BRYZEK J, 1994, IEEE SPECTRUM, V31, P20, DOI 10.1109/6.278394
   Bryzek J., 1996, SENSORS          JUL, P4
   Chien HW, 2012, LANGMUIR, V28, P5775, DOI 10.1021/la300147p
   Clark RA, 1997, ANAL CHEM, V69, P259, DOI 10.1021/ac960559a
   Feng JJ, 2011, J SEP SCI, V34, P2482, DOI 10.1002/jssc.201100375
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Ko JW, 2013, J MATER CHEM A, V1, P241, DOI 10.1039/c2ta00782g
   Kovacs GTA, 1996, ANAL CHEM, V68, pA407, DOI 10.1021/ac961977i
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lee M, 2012, CHEMPLUSCHEM, V77, P987, DOI 10.1002/cplu.201200209
   Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Majewska A, 2000, ACTA SOC BOT POL, V69, P185
   Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Nijhuis AWG, 2013, TISSUE ENG PART C-ME, V19, P610, DOI [10.1089/ten.tec.2012.0313, 10.1089/ten.TEC.2012.0313]
   Niles AL, 2007, ANAL BIOCHEM, V366, P197, DOI 10.1016/j.ab.2007.04.007
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Vecchia D. N., 2012, ADV FUNCT MATER, V23, P1331
   Wang YL, 2011, BIOSENS BIOELECTRON, V30, P107, DOI 10.1016/j.bios.2011.08.038
   Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956
   Wink T, 1997, ANALYST, V122, pR43, DOI 10.1039/a606964i
   Wu MC, 1996, LASER FOCUS WORLD, V32, P64
   Yang SH, 2011, J AM CHEM SOC, V133, P2795, DOI 10.1021/ja1100189
   Yue Q, 2013, J MATER CHEM B, V1, P6085, DOI 10.1039/c3tb21028f
   Zheng TT, 2012, ANALYST, V137, P1316, DOI 10.1039/c2an16023d
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 33
TC 7
Z9 8
U1 9
U2 37
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD FEB 25
PY 2017
VL 46
BP 379
EP 385
DI 10.1016/j.jiec.2016.11.007
PG 7
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA EJ5FQ
UT WOS:000393243500045
DA 2018-10-20
ER

PT J
AU Aktug, SL
   Kutbay, I
   Usta, M
AF Aktug, Salim Levent
   Kutbay, Isil
   Usta, Metin
TI Characterization and formation of bioactive hydroxyapatite coating on
   commercially pure zirconium by micro arc oxidation
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Micro arc oxidation; Bioactive hydroxyapatite coatings; X-ray
   diffraction; Fourier transform infrared spectroscopy; X-ray
   photoelectron spectroscopy
ID PLASMA ELECTROLYTIC OXIDATION; CALCIUM-PHOSPHATE COATINGS; OXIDIZED
   ZIRCONIUM; IN-VITRO; SURFACE MODIFICATION; STABILIZED ZIRCONIA; APATITE
   FORMATION; UV-IRRADIATION; FILMS; ZRO2
AB Hydroxyapatite (HA, Ca-10(PO4)(6)(OH)(2)) based coatings are used in biomaterial applications and biomedical industrial applications due to its bioactive and biocompatible properties. In this study, commercially pure zirconium was coated in the solution consisting of calcium acetate (CA, (CH3COO)(2)Ca)) and beta-calcium glycerophosphate (beta-Ca-GP, (beta-C3H5(OH2)PO4Ca)) by micro arc oxidation (MAO) in a single-step process for 1, 10 and 30 min duration times to produce HA-based coatings.
   The phase structures, surface morphologies, functional groups of molecules, chemical composition of surface and the binding energies of atoms on the coatings were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), attenuated total reflectance-fourier transform infrared spectroscopy (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS), respectively. Zirconium (Zr), monoclinic and cubic zirconium oxide (ZrO2), cubic calcium zirconium oxide (Ca0.15Zr0.85O1.85), orthorhombic calcium zirconium oxide (CaZrO3) and HA phases on the coatings were detected by XRD analysis. The strongest intensity of crystal HA was also observed in XRD for the coating produced at 30 min. The surface morphologies of coatings produced by MAO method at 1 min have very porous structures because of the existence of micro discharge channels during the process. The surface coatings morphologically have HA microstructure owing to the crystallization of HA particles at 10 min and the existence of growing HA particles in MAO process at 30 min. The HA phase is confirmed by nu(3) (PO4-3) and nu(s) (OH-) FTIR band assignments in ATR-FTIR and by the binding energies of Ca2p, P2p and O1s in XPS for coating produced at 30 min. (C) 2016 Elsevier B. V. All rights reserved.
C1 [Aktug, Salim Levent; Kutbay, Isil; Usta, Metin] Gebze Tech Univ, Dept Mat Sci & Engn, TR-41400 Gebze, Kocaeli, Turkey.
   [Kutbay, Isil] Univ Hlth Sci, Dept Elect & Automat, TR-34668 Istanbul, Turkey.
   [Usta, Metin] TUBITAK, Marmara Res Ctr, Mat Inst, TR-41470 Gebze, Kocaeli, Turkey.
RP Kutbay, I (reprint author), Gebze Tech Univ, Dept Mat Sci & Engn, TR-41400 Gebze, Kocaeli, Turkey.
EM kutbay@gtu.edu.tr
RI Aydin, Ebru/D-1403-2010
OI Aktug, Salim Levent/0000-0001-7755-0279
FU TUBITAK-MAG project [113M162]
FX This work was supported by the number of 113M162 TUBITAK-MAG project.
   The authors would like to thank Mr. A. Sen for X-ray diffractometer
   (XRD), Mr. A. Nazim for scanning electron microscope (SEM) on Department
   of Materials Science and Engineering, Mr. B. Sakar for X-ray
   photoelectron spectrometer (XPS) Nanotechnology Research Center and to
   Dean of the Department of Chemistry for ATR-FTIR measurements at Gebze
   Technical University.
CR Aktug S.L., 2015, INT POR POWD MAT S E, P95
   Aktug SL, 2016, CERAM INT, V42, P1246, DOI 10.1016/j.ceramint.2015.09.056
   Baciu DE, 2012, DIG J NANOMATER BIOS, V7, P1779
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Dorozhkin SV, 2015, MAT SCI ENG C-MATER, V55, P272, DOI 10.1016/j.msec.2015.05.033
   Durdu S, 2013, J ALLOY COMPD, V551, P422, DOI 10.1016/j.jallcom.2012.11.024
   Epple M., 2007, BIOMATERIALS BIOMINE
   Arce JE, 2016, CERAM INT, V42, P10322, DOI 10.1016/j.ceramint.2016.02.177
   Sanchez AG, 2013, J MATER SCI-MATER M, V24, P161, DOI 10.1007/s10856-012-4770-8
   Sanchez AG, 2011, APPL SURF SCI, V257, P6397, DOI 10.1016/j.apsusc.2011.02.005
   Good V, 2005, MATER DESIGN, V26, P618, DOI 10.1016/j.matdes.2004.08.014
   Ha JY, 2011, SURF COAT TECH, V205, P4948, DOI 10.1016/j.surfcoat.2011.04.079
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Hao L, 2004, THIN SOLID FILMS, V468, P12, DOI 10.1016/j.tsf.2004.03.032
   Heimann RB, 2013, SURF COAT TECH, V233, P27, DOI 10.1016/j.surfcoat.2012.11.013
   Hobbs LW, 2005, INT J APPL CERAM TEC, V2, P221, DOI 10.1111/j.1744-7402.2005.02025.x
   Ksapabutr B, 2004, MATER CHEM PHYS, V83, P34, DOI 10.1016/j.matchemphys.2003.08.016
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Meskinfam M., 2012, INT J CHEM BIOL ENG, V6, P192
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Nomura Y. T. Naoyuki, 2009, MAT T, V50, P2466
   Pan YK, 2013, MATER CHEM PHYS, V141, P842, DOI 10.1016/j.matchemphys.2013.06.013
   Pauporte T, 2005, SURF COAT TECH, V199, P213, DOI 10.1016/j.surfcoat.2005.03.003
   Pecheva EV, 2004, APPL SURF SCI, V235, P176, DOI 10.1016/j.apsusc.2004.05.174
   Rapacz-Kmita A, 2005, J MOL STRUCT, V744, P653, DOI 10.1016/j.molstruc.2004.11.070
   Ride D. R., 2006, MAGNETIC SUSCEPTIBIL, P142
   Sandhyarani M, 2014, SURF COAT TECH, V238, P58, DOI 10.1016/j.surfcoat.2013.10.039
   Sandhyarani M, 2013, J ALLOY COMPD, V553, P324, DOI 10.1016/j.jallcom.2012.11.147
   Santos V, 2008, REV ADV MATER SCI, V17, P62
   Shaltout AA, 2011, SPECTROCHIM ACTA A, V83, P56, DOI 10.1016/j.saa.2011.07.036
   Sharkeev YP, 2014, RUSS PHYS J+, V56, P1170, DOI 10.1007/s11182-014-0158-1
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Slosarczyk A., 2005, J MOL STRUCT, V744-747, P657
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Suyalatu NN, 2010, ACTA BIOMATER, V6, P1033
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Wang LN, 2011, J BIOMED MATER RES B, V99B, P291, DOI 10.1002/jbm.b.31898
   Yamamoto R.H.A., 1998, J BIOMED MATER RES A, P331
   Yan YY, 2008, APPL SURF SCI, V254, P4833, DOI 10.1016/j.apsusc.2008.01.117
   Yan YY, 2007, SURF COAT TECH, V201, P5692, DOI 10.1016/j.surfcoat.2006.07.058
   Zain NM, 2014, APPL SURF SCI, V322, P169, DOI 10.1016/j.apsusc.2014.09.179
   Zhang L, 2014, MAT SCI ENG C-MATER, V43, P86, DOI 10.1016/j.msec.2014.06.029
   Zhang L, 2011, MAT SCI ENG C-MATER, V31, P1104, DOI 10.1016/j.msec.2011.04.004
   Zhang ZQ, 2012, COLLOID SURFACE B, V89, P40, DOI 10.1016/j.colsurfb.2011.08.020
NR 48
TC 10
Z9 10
U1 10
U2 60
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD FEB 25
PY 2017
VL 695
BP 998
EP 1004
DI 10.1016/j.jallcom.2016.10.217
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA EH5MQ
UT WOS:000391817600122
DA 2018-10-20
ER

PT J
AU Yesilyurt, V
   Veiseh, O
   Doloff, JC
   Li, J
   Bose, S
   Xie, X
   Bader, AR
   Chen, M
   Webber, MJ
   Vegas, AJ
   Langer, R
   Anderson, DG
AF Yesilyurt, Volkan
   Veiseh, Omid
   Doloff, Joshua C.
   Li, Jie
   Bose, Suman
   Xie, Xi
   Bader, Andrew R.
   Chen, Michael
   Webber, Matthew J.
   Vegas, Arturo J.
   Langer, Robert
   Anderson, Daniel G.
TI A Facile and Versatile Method to Endow Biomaterial Devices with
   Zwitterionic Surface Coatings
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID FOREIGN-BODY REACTION; POLYMER-COATINGS; COPOLYMERS; CHEMISTRY;
   CAPSULES; PRIMATES; MICE
C1 [Yesilyurt, Volkan; Veiseh, Omid; Doloff, Joshua C.; Li, Jie; Bose, Suman; Xie, Xi; Bader, Andrew R.; Chen, Michael; Webber, Matthew J.; Vegas, Arturo J.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Yesilyurt, Volkan; Doloff, Joshua C.; Li, Jie; Bose, Suman; Bader, Andrew R.; Chen, Michael; Webber, Matthew J.; Vegas, Arturo J.; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.
   [Veiseh, Omid; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Massachusetts Inst Technol Div Hlth Sci &, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Veiseh, Omid] Sigilon Inc, 161 First St, Cambridge, MA 02142 USA.
   [Veiseh, Omid] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   [Vegas, Arturo J.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.
RP Anderson, DG (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.; Anderson, DG (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Harvard Massachusetts Inst Technol Div Hlth Sci &, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
EM dgander@mit.edu
OI Webber, Matthew/0000-0003-3111-6228; Chen, Michael/0000-0002-1590-768X;
   Doloff, Joshua/0000-0002-4323-3264
FU Juvenile Diabetes Research Foundation (JDRF) [3-SRA-2014-285-M-R]; Leona
   M. and Harry B. Helmsley Charitable Trust Foundation [2014PG-T1D002];
   Koch Institute Support (core) Grant from the National Cancer Institute
   [P30-CA 14051]; National Science Foundation [DMR-1419807]; JDRF
   [3-2013-178]; DOD/CDMRP [W81XWH-13-1-0215]; JDRF postdoctoral fellowship
   [3-PDF-2015-91-A-N, 3-PDF-2015-90-A-N]; National Institutes of Health
   through Ruth L. Kirschstein National Research Service [F32DK101335]
FX This work was supported by the Juvenile Diabetes Research Foundation
   (JDRF) (Grant No. 3-SRA-2014-285-M-R), the Leona M. and Harry B.
   Helmsley Charitable Trust Foundation (Grant No. 2014PG-T1D002), the Koch
   Institute Support (core) Grant No. P30-CA 14051 from the National Cancer
   Institute, and also by a generous gift from the Tayebati Family
   Foundation. Additionally, this work made use of the MRSEC shared
   experimental facilities at MIT, supported by the National Science
   Foundation under Award No. DMR-1419807. O.V. was supported by JDRF and
   DOD/CDMRP postdoctoral fellowships (Grant Nos. 3-2013-178 and
   W81XWH-13-1-0215, respectively). J.C.D. and S.B. were supported by the
   JDRF postdoctoral fellowship (Grant Nos. 3-PDF-2015-91-A-N and
   3-PDF-2015-90-A-N, respectively). M.J.W. is extremely grateful for the
   financial support from the National Institutes of Health through Ruth L.
   Kirschstein National Research Service (Award No. F32DK101335). The
   authors also thank the Koch Institute Swanson Biotechnology Center for
   technical support, specifically Microscopy and Flow Cytometry. The
   authors would like to acknowledge the use of resources at the W. M. Keck
   Biological Imaging Facility (Whitehead Institute). The authors would
   also like to thank W. Salmon for assistance with confocal microscopy and
   E. L. Shaw for assistance with XPS.
CR Akilbekova D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130386
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Blaszykowski C, 2015, BIOMATER SCI-UK, V3, P1335, DOI 10.1039/c5bm00085h
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Chen XJ, 2013, MACROMOLECULES, V46, P119, DOI 10.1021/ma301288m
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kim BJ, 2014, ANGEW CHEM INT EDIT, V53, P14443, DOI 10.1002/anie.201408454
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Laschewsky A, 2014, POLYMERS-BASEL, V6, P1544, DOI 10.3390/polym6051544
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lowe AB, 2002, CHEM REV, V102, P4177, DOI 10.1021/cr020371t
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   Ma XD, 2010, INT J CLIN EXP MED, V3, P192
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Seetho K, 2015, ACS MACRO LETT, V4, P505, DOI 10.1021/mz500818c
   Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120
   Spasojevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109837
   Spasojevic M, 2014, J BIOMED MATER RES A, V102, P1887, DOI 10.1002/jbm.a.34863
   Sundaram HS, 2014, ACS APPL MATER INTER, V6, P6664, DOI 10.1021/am500362k
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546
   Yang C, 2014, ADV MATER, V26, P7346, DOI 10.1002/adma.201402059
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
   Yu K, 2014, COLLOID SURFACE B, V124, P69, DOI 10.1016/j.colsurfb.2014.08.009
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 37
TC 5
Z9 5
U1 9
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB 22
PY 2017
VL 6
IS 4
AR 1601091
DI 10.1002/adhm.201601091
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA EO9NK
UT WOS:000397015200005
PM 27976536
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bachhuka, A
   Hayball, JD
   Smith, LE
   Vasilev, K
AF Bachhuka, Akash
   Hayball, John Dominic
   Smith, Louise E.
   Vasilev, Krasimir
TI The Interplay between Surface Nanotopography and Chemistry Modulates
   Collagen I and III Deposition by Human Dermal Fibroblasts
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterials; plasma polymerization; surface nanotopography; collagens I
   and III; foreign body response
ID OXYGEN RADICAL PRODUCTION; FOREIGN-BODY RESPONSE; EXTRACELLULAR-MATRIX;
   CHEMICAL FUNCTIONALITIES; CONTAINING MONOMERS; PLASMA-PROTEINS;
   CELL-ADHESION; GIANT-CELLS; STEM-CELLS; VITRO
AB The events within the foreign body response are similar to, but ultimately different than, the wound healing cascade. Collagen production by fibroblasts is known to play a vital role in wound healing and device fibrous encapsulation. However, the influence of surface nanotopography on collagen deposition by these cells has not been reported so far. To address this gap, we have developed model substrata having surface nanotopography of controlled height of 16, 38, and 68 nm and tailored outermost surface chemistry of amines, carboxyl acid, and pure hydrocarbon. Fibroblast adhesion was reduced on nano topographically modified surfaces compared to the smooth control. Furthermore, amine and acid functionalized surfaces showed increased cell proliferation over hydrophobic hydrocarbon surfaces. Collagen III production increased from day 3 to day 8 and then decreased from day 8 to day 16 on all surfaces, while collagen I deposition increased throughout the duration of 16 days. Our data show that the initial collagen I and III deposition can be modulated by selecting desired combinations of surface nanotopography and chemistry. This study provides useful knowledge that could help in tuning fibrous capsule formation and in turn govern the fate of implantable biomaterial devices.
C1 [Bachhuka, Akash; Smith, Louise E.; Vasilev, Krasimir] Univ South Australia, Future Ind Inst, Adelaide, SA 5095, Australia.
   [Smith, Louise E.; Vasilev, Krasimir] Univ South Australia, Sch Engn, Adelaide, SA 5095, Australia.
   [Bachhuka, Akash] Univ Adelaide, Inst Photon & Adv Sensing, Sch Phys Sci, ARC Ctr Excellence Nanoscale Biophoton, Adelaide, SA 5005, Australia.
   [Hayball, John Dominic] Univ South Australia, Sansom Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Hayball, John Dominic] Univ South Australia, Sch Pharm & Med Sci, Hanson Inst, Adelaide, SA 5000, Australia.
RP Smith, LE; Vasilev, K (reprint author), Univ South Australia, Future Ind Inst, Adelaide, SA 5095, Australia.; Smith, LE; Vasilev, K (reprint author), Univ South Australia, Sch Engn, Adelaide, SA 5095, Australia.
EM louise.smith@unisa.edu.au; krasimir.vasilev@unisa.edu.au
OI Smith, Louise/0000-0003-0659-0884
FU ARC [ARC DP15104212]; NHMRC [APP1122825]; Humboldt Foundation
FX The authors thank Professor Michael Roberts at the School of Pharmacy,
   University of South Australia, for help with the sourcing and collection
   of the skin. K.V. and J.H. are thankful for ARC Grant ARC DP15104212.
   K.V. also thanks NHMRC for Fellowship APP1122825 and the Humboldt
   Foundation for the Humboldt Fellowship for Experienced Researchers.
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Avula M, 2016, BIOSENS BIOELECTRON, V77, P149, DOI 10.1016/j.bios.2015.08.059
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Bachhuka A, 2015, ACS APPL MATER INTER, V7, P23767, DOI 10.1021/acsami.5b08249
   Bachhuka A, 2015, J COLLOID INTERF SCI, V457, P9, DOI 10.1016/j.jcis.2015.06.040
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Cao H., 2009, J BIOMED MATER RES A, V93A, P1151
   Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x
   Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003
   Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7
   Christo S. N., 2015, BIOMED RES INT, V10
   Cousins BG, 2004, J MATER SCI-MATER M, V15, P355, DOI 10.1023/B:JMSM.0000021101.64938.b3
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Damanik FFR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06325
   Goreham RV, 2013, RSC ADV, V3, P10309, DOI 10.1039/c3ra23193c
   Goreham RV, 2013, THIN SOLID FILMS, V528, P106, DOI 10.1016/j.tsf.2012.04.087
   Goreham RV, 2011, J PHYS CHEM C, V115, P3429, DOI 10.1021/jp111221g
   Goreish HH, 2004, J BIOMED MATER RES A, V68A, P1, DOI 10.1002/jbm.a.10141
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hirsh SL, 2013, COLLOID SURFACE B, V103, P395, DOI 10.1016/j.colsurfb.2012.10.039
   Holt DJ, 2011, BIOMATERIALS, V32, P3977, DOI 10.1016/j.biomaterials.2011.02.021
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kastellorizios M, 2015, J CONTROL RELEASE, V214, P103, DOI 10.1016/j.jconrel.2015.07.021
   Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038
   Kumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08729
   Liu XJ, 2013, APPL SURF SCI, V270, P473, DOI 10.1016/j.apsusc.2013.01.063
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9
   Menzies DJ, 2010, LANGMUIR, V26, P13987, DOI 10.1021/la102033d
   Michelmore A, 2011, PLASMA PROCESS POLYM, V8, P367, DOI 10.1002/ppap.201000140
   Mierczynska A, 2012, SOFT MATTER, V8, P8399, DOI 10.1039/c2sm25221j
   Moreira M, 2010, WOUND REPAIR REGEN, V18, P417, DOI 10.1111/j.1524-475X.2010.00601.x
   Neyts EC, 2015, CHEM REV, V115, P13408, DOI 10.1021/acs.chemrev.5b00362
   Nimeri G, 2003, J BIOMED MATER RES A, V67A, P439, DOI 10.1002/jbm.a.10081
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Ostrikov K, 2007, J PHYS D APPL PHYS, V40, P2223, DOI 10.1088/0022-3727/40/8/S01
   Ostrikov K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174003
   Pujari S, 2014, J BIOMED MATER RES A, V102, P3773, DOI 10.1002/jbm.a.35048
   Ruiz JC, 2014, PLASMA PROCESS POLYM, V11, P888, DOI 10.1002/ppap.201400016
   Shin YN, 2008, APPL SURF SCI, V255, P293, DOI 10.1016/j.apsusc.2008.06.173
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
   Vasilev K, 2010, PLASMA PROCESS POLYM, V7, P824, DOI 10.1002/ppap.201000030
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhu T, 2003, LANGMUIR, V19, P9518, DOI 10.1021/la035157u
NR 52
TC 2
Z9 2
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 22
PY 2017
VL 9
IS 7
BP 5874
EP 5884
DI 10.1021/acsami.6b15932
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EL7VQ
UT WOS:000394829800024
PM 28156094
DA 2018-10-20
ER

PT J
AU Kim, K
   Lang, ZX
   Liu, ML
   Fan, DL
AF Kim, Kwanoh
   Lang, Zexi
   Liu, Minliang
   Fan, Donglei Emma
TI Biobased High-Performance Rotary Micromotors for Individually
   Reconfigurable Micromachine Arrays and Microfluidic Applications
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterials; diatoms; micromotors; nanomotors; biocompatibility;
   electric tweezers; microfluidics; nanomanipulation; reconfigurability;
   micromixers
ID DRIVEN ROTATION; NANOROD MOTORS; FABRICATION; NANOTECHNOLOGY;
   ULTRASOUND; PROPULSION; NANOMOTORS; DELIVERY; CARGO; NANOSTRUCTURES
AB In this work, we report an innovative type of rotary biomicromachines by using diatom frustules as integrated active components, including the assembling, operation, and performance characterization. We further investigate and demonstrate unique applications of the biomicromachines in achieving individually reconfigurable micro machine arrays and microfluidic mixing. Diatom frustules are porous cell walls of diatoms made of silica. We assembled rotary micromachines consisting of diatom frustules serving as rotors and patterned magnets serving as bearings in electric fields. Ordered arrays of micromotors can be integrated and rotated with controlled orientation and a speed up to similar to 3000 rpm, one of the highest rotational speeds in biomaterial-based rotary micromachines. Moreover, by exploiting the distinct electromechanical properties of diatom frustules and metallic nanowires, we realized the first reconfigurable rotary micro/nanomachine arrays with controllability in individual motors. Finally, the diatom micromachines are successfully integrated in microfluidic channels and operated as mixers. This work demonstrated the high-performance rotary micromachines by using bioinspired diatom frustules and their applications, which are essential for low-cost bio-microelectromechanical system/nanoelectromechanical system (bio-MEMS/NEMS) devices and relevant to microfluidics.
C1 [Kim, Kwanoh; Liu, Minliang; Fan, Donglei Emma] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
   [Lang, Zexi; Fan, Donglei Emma] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA.
   [Liu, Minliang] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
RP Fan, DL (reprint author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.; Fan, DL (reprint author), Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA.
EM dfan@austin.utexas.edu
OI Liang, Zexi/0000-0001-9309-4496
FU Welch Foundation [F-1734]; National Science Foundation [CMMI 1150767,
   ECCS-1446489]; National Institutes of Health [9R42ES024023-02]
FX This work is supported by Welch Foundation (Grant No. F-1734), the
   National Science Foundation (CAREER Award Grant No. CMMI 1150767 and
   ECCS-1446489), and, in part, by the National Institutes of Health (No.
   9R42ES024023-02).
CR Ahmed S, 2014, ACS NANO, V8, P11053, DOI 10.1021/nn5039614
   Al-Fandi M, 2010, IET NANOBIOTECHNOL, V4, P61, DOI 10.1049/iet-nbt.2010.0003
   AREF H, 1984, J FLUID MECH, V143, P1, DOI 10.1017/S0022112084001233
   Autumn K, 2000, NATURE, V405, P681
   Balk AL, 2014, ACS NANO, V8, P8300, DOI 10.1021/nn502753x
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Campuzano S, 2011, ANALYST, V136, P4621, DOI 10.1039/c1an15599g
   Chien C.-L., 2015, [No title captured], Patent No. [US 9044808 B2, 9044808]
   Duan WT, 2015, ANNU REV ANAL CHEM, V8, P311, DOI 10.1146/annurev-anchem-071114-040125
   Fan DL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891091
   Fan DL, 2012, P NATL ACAD SCI USA, V109, P9309, DOI 10.1073/pnas.1200342109
   Fan DL, 2011, NANO TODAY, V6, P339, DOI 10.1016/j.nantod.2011.05.003
   Fan DL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.247208
   Fan DL, 2010, NAT NANOTECHNOL, V5, P545, DOI [10.1038/NNANO.2010.104, 10.1038/nnano.2010.104]
   Gao W, 2014, ACS NANO, V8, P3170, DOI 10.1021/nn500077a
   Gao W, 2014, NANO LETT, V14, P305, DOI 10.1021/nl404044d
   Gao W, 2012, SMALL, V8, P460, DOI 10.1002/smll.201101909
   Garcia-Gradilla V, 2013, ACS NANO, V7, P9232, DOI 10.1021/nn403851v
   Gebeshuber IC, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70141-X
   Ghosh A, 2009, NANO LETT, V9, P2243, DOI 10.1021/nl900186w
   Gibbs JG, 2015, CHEM COMMUN, V51, P4192, DOI 10.1039/c5cc00565e
   Gibbs JG, 2014, NANOSCALE, V6, P9457, DOI 10.1039/c4nr00403e
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974
   Guix M, 2014, CHEM REV, V114, P6285, DOI 10.1021/cr400273r
   Guo J, 2015, NANOSCALE, V7, P11363, DOI 10.1039/c5nr02347e
   Hall SR, 2003, CHEM COMMUN, P2784, DOI 10.1039/b309877j
   Hawkeye MM, 2007, J VAC SCI TECHNOL A, V25, P1317, DOI 10.1116/1.2764082
   Huang JY, 2006, NANO LETT, V6, P2325, DOI 10.1021/nl061851t
   Jones T., 1995, ELECTROMECHANICS PAR
   Kang TG, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066303
   Keshoju K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789184
   Kim K, 2016, NANOSCALE, V8, P10471, DOI 10.1039/c5nr08768f
   Kim K, 2015, SMALL, V11, P4037, DOI 10.1002/smll.201500407
   Kim K, 2015, ACS NANO, V9, P548, DOI 10.1021/nn505798w
   Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4632
   Lee SH, 2009, LAB CHIP, V9, P479, DOI 10.1039/b814371d
   Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778
   Lu LH, 2002, J MICROELECTROMECH S, V11, P462, DOI 10.1109/JMEMS.2002.802899
   Malachowski K, 2014, NANO LETT, V14, P4164, DOI 10.1021/nl500136a
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903
   Ren F., 2014, IEEE J SEL TOP QUANT, V20, P127
   Ren FH, 2013, OPT EXPRESS, V21, P15308, DOI 10.1364/OE.21.015308
   Rida A, 2004, ANAL CHEM, V76, P6239, DOI 10.1021/ac049415j
   Round F. E., 1990, DIATOMS BIOL MORPHOL
   Soler L, 2013, ACS NANO, V7, P9611, DOI 10.1021/nn405075d
   Solovev AA, 2012, ACS NANO, V6, P1751, DOI 10.1021/nn204762w
   Srivastava SK, 2016, ADV MATER, V28, P832, DOI 10.1002/adma.201504327
   Sundararajan S, 2008, NANO LETT, V8, P1271, DOI 10.1021/nl072275j
   Tottori S, 2012, ADV MATER, V24, P811, DOI 10.1002/adma.201103818
   Townley HE, 2008, ADV FUNCT MATER, V18, P369, DOI 10.1002/adfm.200700609
   Ukita H, 2002, IEEE J SEL TOP QUANT, V8, P111, DOI 10.1109/2944.991406
   Wang H, 2015, CHEM REV, V115, P8704, DOI [10.1021/acs.chemrev.5b00047, 10.1021/acs.chemrev.5600047]
   Wang W, 2015, ACCOUNTS CHEM RES, V48, P1938, DOI 10.1021/acs.accounts.5b00025
   Wang W, 2014, ANGEW CHEM INT EDIT, V53, P3201, DOI 10.1002/anie.201309629
   Xi W, 2013, NANOSCALE, V5, P1294, DOI 10.1039/c2nr32798h
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Xu XB, 2015, ANGEW CHEM INT EDIT, V54, P2525, DOI 10.1002/anie.201410754
   Xu XB, 2014, ADV FUNCT MATER, V24, P4843, DOI 10.1002/adfm.201303505
   Xu XB, 2013, ADV FUNCT MATER, V23, P4332, DOI 10.1002/adfm.201203822
   Xu XB, 2012, ADV MATER, V24, P5457, DOI 10.1002/adma.201201820
   Yang J, 2015, J BIOPHOTONICS, V8, P659, DOI 10.1002/jbio.201400070
   Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e
   Zhao YF, 2009, ACS NANO, V3, P4009, DOI 10.1021/nn901055d
NR 65
TC 2
Z9 2
U1 8
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 22
PY 2017
VL 9
IS 7
BP 6144
EP 6152
DI 10.1021/acsami.6b13997
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EL7VQ
UT WOS:000394829800054
PM 28032745
DA 2018-10-20
ER

PT J
AU Fleischer, S
   Shapira, A
   Feiner, R
   Dvir, T
AF Fleischer, Sharon
   Shapira, Assaf
   Feiner, Ron
   Dvir, Tal
TI Modular assembly of thick multifunctional cardiac patches
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cardiac tissue engineering; electrospinning; laser patterning;
   vascularization; controlled release
ID ON-A-CHIP; TISSUE ARCHITECTURE; ALGINATE SCAFFOLDS; HEART; MUSCLE;
   VASCULARIZATION; REGENERATION; ORGANIZATION; COLLAGEN; CELLS
AB In cardiac tissue engineering cells are seeded within porous biomaterial scaffolds to create functional cardiac patches. Here, we report on a bottom-up approach to assemble a modular tissue consisting of multiple layers with distinct structures and functions. Albumin electrospun fiber scaffolds were laser-patterned to create microgrooves for engineering aligned cardiac tissues exhibiting anisotropic electrical signal propagation. Microchannels were patterned within the scaffolds and seeded with endothelial cells to form closed lumens. Moreover, cage-like structures were patterned within the scaffolds and accommodated poly(lactic-co-glycolic acid) (PLGA) microparticulate systems that controlled the release of VEGF, which promotes vascularization, or dexamethasone, an anti-inflammatory agent. The structure, morphology, and function of each layer were characterized, and the tissue layerswere grown separately in their optimal conditions. Before transplantation the tissue and microparticulate layers were integrated by an ECM-based biological glue to form thick 3D cardiac patches. Finally, the patches were transplanted in rats, and their vascularization was assessed. Because of the simple modularity of this approach, we believe that it could be used in the future to assemble other multicellular, thick, 3D, functional tissues.
C1 [Fleischer, Sharon; Shapira, Assaf; Feiner, Ron; Dvir, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.
   [Feiner, Ron; Dvir, Tal] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel.
   [Dvir, Tal] Tel Aviv Univ, Dept Mat Sci & Engn, IL-69978 Tel Aviv, Israel.
RP Dvir, T (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.; Dvir, T (reprint author), Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel.; Dvir, T (reprint author), Tel Aviv Univ, Dept Mat Sci & Engn, IL-69978 Tel Aviv, Israel.
EM tdvir@post.tau.ac.il
FU Adams Fellowship Program of the Israel Academy of Sciences and
   Humanities; Marian Gertner Institute for Medical Nanosystems Fellowship;
   European Research Council [637943]; Slezak Foundation; Israeli Science
   Foundation [700/13]
FX S.F. is supported by the Adams Fellowship Program of the Israel Academy
   of Sciences and Humanities. R.F. is the recipient of a Marian Gertner
   Institute for Medical Nanosystems Fellowship. T.D. received support from
   European Research Council Starting Grant 637943, the Slezak Foundation,
   and the Israeli Science Foundation (700/13). This work is part of S.F.'s
   doctoral thesis at Tel Aviv University.
CR Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Corno AF, 2006, EUR J CARDIO-THORAC, V29, pS61, DOI 10.1016/j.ejcts.2006.02.049
   Dvir T, 2006, TISSUE ENG, V12, P2843, DOI 10.1089/ten.2006.12.2843
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885
   Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043
   Feiner R, 2016, NAT MATER, V15, P679, DOI [10.1038/nmat4590, 10.1038/NMAT4590]
   Fleischer S, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/29/291002
   Fleischer S, 2014, NANOSCALE, V6, P9410, DOI 10.1039/c4nr00300d
   Fleischer S, 2014, BIOTECHNOL BIOENG, V111, P1246, DOI 10.1002/bit.25185
   Fleischer S, 2013, BIOMATERIALS, V34, P8599, DOI 10.1016/j.biomaterials.2013.07.054
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Marsano A, 2013, BIOMATERIALS, V34, P393, DOI 10.1016/j.biomaterials.2012.09.038
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Ogle BM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2304
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Parsa H, 2016, ADV DRUG DELIVER REV, V96, P195, DOI 10.1016/j.addr.2015.06.012
   Pope AJ, 2008, AM J PHYSIOL-HEART C, V295, pH1243, DOI 10.1152/ajpheart.00484.2008
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Ruvinov E, 2016, ADV DRUG DELIVER REV, V96, P54, DOI 10.1016/j.addr.2015.04.021
   Sapir Y, 2012, BIOMATERIALS, V33, P4100, DOI 10.1016/j.biomaterials.2012.02.037
   Shevach M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034106
   Shevach M, 2014, NANO LETT, V14, P5792, DOI 10.1021/nl502673m
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Vishwakarma A, 2016, TRENDS BIOTECHNOL, V34, P470, DOI 10.1016/j.tibtech.2016.03.009
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Ye XF, 2014, ADV MATER, V26, P7202, DOI 10.1002/adma.201403074
   Zhang BY, 2016, NAT MATER, V15, P669, DOI [10.1038/NMAT4570, 10.1038/nmat4570]
   Zhang YS, 2016, BIOMATERIALS, V110, P45, DOI 10.1016/j.biomaterials.2016.09.003
NR 39
TC 9
Z9 10
U1 9
U2 33
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 21
PY 2017
VL 114
IS 8
BP 1898
EP 1903
DI 10.1073/pnas.1615728114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM1TI
UT WOS:000395099500064
PM 28167795
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Knoller, A
   Runcevski, T
   Dinnebier, RE
   Bill, J
   Burghard, Z
AF Knoeller, Andrea
   Runcevski, Tomce
   Dinnebier, Robert E.
   Bill, Joachim
   Burghard, Zaklina
TI Cuttlebone-like V2O5 Nanofibre Scaffolds - Advances in Structuring
   Cellular Solids
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MECHANICAL-PROPERTIES; POROUS CERAMICS; FREEZE; BONE
AB The synthesis of ceramic materials combining high porosity and permeability with good mechanical stability is challenging, as optimising the latter requires compromises regarding the first two properties. Nonetheless, significant progress can be made in this direction by taking advantage of the structural design principles evolved by nature. Natural cellular solids achieve good mechanical stability via a defined hierarchical organisation of the building blocks they are composed of. Here, we report the first synthetic, ceramic-based scaffold whose architecture closely mimics that of cuttlebone - a structural biomaterial whose porosity exceeds that of most other natural cellular solids, whilst preserving an excellent mechanical strength. The nanostructured, single-component scaffold, obtained by ice-templated assembly of V2O5 nanofibres, features a highly sophisticated and elaborate architecture of equally spaced lamellas, which are regularly connected by pillars as lamella support. It displays an unprecedented porosity of 99.8 %, complemented by an enhanced mechanical stability. This novel bioinspired, functional material not only displays mechanical characteristics similar to natural cuttlebone, but the multifunctionality of the V2O5 nanofibres also renders possible applications, including catalysts, sensors and electrodes for energy storage.
C1 [Knoeller, Andrea; Bill, Joachim; Burghard, Zaklina] Univ Stuttgart, Inst Mat Sci, Heisenbergstr 3, D-70569 Stuttgart, Germany.
   [Runcevski, Tomce] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   [Runcevski, Tomce] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.
   [Dinnebier, Robert E.] Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.
RP Burghard, Z (reprint author), Univ Stuttgart, Inst Mat Sci, Heisenbergstr 3, D-70569 Stuttgart, Germany.
EM zaklina.burghard@imw.uni-stuttgart.de
FU Max-Planck-Institutes in Stuttgart, Germany; DFG [BI 469/17-2];
   International Max-Planck Research School for Condensed Matter Science
FX The authors thank F. Adams for conducting XRD measurements, S. Schildt
   for taking the photos, R. Segar for proofreading as well as the
   department of J. Spatz and the scientific facility Nanostrukturlabor of
   J. Weis from the Max-Planck-Institutes in Stuttgart, Germany, for their
   support and equipment access. Financial support by the DFG (BI
   469/17-2), International Max-Planck Research School for Condensed Matter
   Science and Landesgraduiertenfoderung is highly appreciated.
CR ASHBY MF, 1983, METALL TRANS A, V14, P1755, DOI 10.1007/BF02645546
   Bai H., 2015, SCI ADV, V1
   BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Burghard Z, 2013, ADV MATER, V25, P2468, DOI 10.1002/adma.201300135
   Cadman J, 2010, ACTA MECH SINICA-PRC, V26, P27, DOI 10.1007/s10409-009-0310-2
   Checa AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11513
   Chen J, 2013, ADV APPL CERAM, V112, P436, DOI 10.1179/1743676113Y.0000000099
   Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006
   Deville S, 2013, ACTA MATER, V61, P2077, DOI 10.1016/j.actamat.2012.12.027
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Deville S, 2013, J MATER RES, V28, P2202, DOI 10.1557/jmr.2013.105
   Deville S, 2009, NAT MATER, V8, P966, DOI [10.1038/NMAT2571, 10.1038/nmat2571]
   Gu G, 2003, NAT MATER, V2, P316, DOI 10.1038/nmat880
   Hunger PM, 2013, ACTA BIOMATER, V9, P6338, DOI 10.1016/j.actbio.2013.01.012
   Liu RP, 2016, CERAM INT, V42, P2907, DOI 10.1016/j.ceramint.2015.10.148
   LIVAGE J, 1991, CHEM MATER, V3, P578, DOI 10.1021/cm00016a006
   Parlett CMA, 2013, CHEM SOC REV, V42, P3876, DOI 10.1039/c2cs35378d
   Petkov V, 2002, J AM CHEM SOC, V124, P10157, DOI 10.1021/ja026143y
   Plotze M, 2011, EUR J WOOD WOOD PROD, V69, P649, DOI 10.1007/s00107-010-0504-0
   Porter MM, 2013, JOM-US, V65, P720, DOI 10.1007/s11837-013-0606-3
   Wang XD, 2003, J ORTHOPAED RES, V21, P312, DOI 10.1016/S0736-0266(02)00157-2
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
   Zhang RB, 2015, CERAM INT, V41, P11517, DOI 10.1016/j.ceramint.2015.05.099
   Zuo KH, 2008, INT J APPL CERAM TEC, V5, P198, DOI 10.1111/j.1744-7402.2008.02190.x
NR 26
TC 5
Z9 5
U1 7
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 20
PY 2017
VL 7
AR 42951
DI 10.1038/srep42951
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL0SU
UT WOS:000394332900001
PM 28218301
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Aliperta, R
   Welzel, PB
   Bergmann, R
   Freudenberg, U
   Berndt, N
   Feldmann, A
   Arndt, C
   Koristka, S
   Stanzione, M
   Cartellieri, M
   Ehninger, A
   Ehninger, G
   Werner, C
   Pietzsch, J
   Steinbach, J
   Bornhauser, M
   Bachmann, MP
AF Aliperta, Roberta
   Welzel, Petra B.
   Bergmann, Ralf
   Freudenberg, Uwe
   Berndt, Nicole
   Feldmann, Anja
   Arndt, Claudia
   Koristka, Stefanie
   Stanzione, Marcello
   Cartellieri, Marc
   Ehninger, Armin
   Ehninger, Gerhard
   Werner, Carsten
   Pietzsch, Jens
   Steinbach, Joerg
   Bornhaeuser, Martin
   Bachmann, Michael P.
TI Cryogel-supported stem cell factory for customized sustained release of
   bispecific antibodies for cancer immunotherapy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BONE-MARROW; T-CELLS; SCAFFOLDS; HYDROGELS; LYMPHOMA; ANTIGEN; MEMBERS;
   FAMILY; TRIAL
AB Combining stem cells with biomaterial scaffolds provides a promising strategy for the development of drug delivery systems. Here we propose an innovative immunotherapeutic organoid by housing human mesenchymal stromal cells (MSCs), gene-modified for the secretion of an anti-CD33-anti-CD3 bispecific antibody (bsAb), in a small biocompatible star-shaped poly(ethylene glycol)-heparin cryogel scaffold as a transplantable and low invasive therapeutic machinery for the treatment of acute myeloid leukemia (AML). The macroporous biohybrid cryogel platform displays effectiveness in supporting proliferation and survival of bsAb-releasing-MSCs overtime in vitro and in vivo, avoiding cell loss and ensuring a constant release of sustained and detectable levels of bsAb capable of triggering T-cell-mediated anti-tumor responses and a rapid regression of CD33(+) AML blasts. This therapeutic device results as a promising and safe alternative to the continuous administration of short-lived immunoagents and paves the way for effective bsAb-based therapeutic strategies for future tumor treatments.
C1 [Aliperta, Roberta; Bergmann, Ralf; Berndt, Nicole; Feldmann, Anja; Arndt, Claudia; Koristka, Stefanie; Pietzsch, Jens; Steinbach, Joerg; Bachmann, Michael P.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Bautzner Landstr 400, D-01328 Dresden, Germany.
   [Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten] Leibniz Inst Polymer Res Dresden IPF, Hohe Str 6, D-01069 Dresden, Germany.
   [Stanzione, Marcello] Tech Univ Dresden, Inst Physiol Chem, Fetscherstr 74, D-01307 Dresden, Germany.
   [Cartellieri, Marc] Cellex Patient Treatment GmbH, Tatzberg 47, D-01307 Dresden, Germany.
   [Cartellieri, Marc] Tech Univ Dresden, UCC, Tumorimmunol, Fetscherstr 74, D-01307 Dresden, Germany.
   [Ehninger, Armin] GEMoaB Monoclonals GmbH, Tatzberg 47, D-01307 Dresden, Germany.
   [Ehninger, Gerhard; Bornhaeuser, Martin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Policlin 1, Fetscherstr 4, D-01307 Dresden, Germany.
   [Ehninger, Gerhard; Bornhaeuser, Martin; Bachmann, Michael P.] DKTK, German Consortium Translat Canc Res, Dresden, Germany.
   [Ehninger, Gerhard; Bornhaeuser, Martin; Bachmann, Michael P.] Carl Gustav Carus TU Dresden, Nat Ctr Tumor Dis NCT, Dresden, Germany.
   [Werner, Carsten; Bornhaeuser, Martin; Bachmann, Michael P.] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Fetscherstr 105, D-01307 Dresden, Germany.
   [Pietzsch, Jens; Steinbach, Joerg] Tech Univ Dresden, Sch Sci, Dept Chem & Food Chem, D-01069 Dresden, Germany.
RP Bachmann, MP (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Bautzner Landstr 400, D-01328 Dresden, Germany.; Bachmann, MP (reprint author), DKTK, German Consortium Translat Canc Res, Dresden, Germany.; Bachmann, MP (reprint author), Carl Gustav Carus TU Dresden, Nat Ctr Tumor Dis NCT, Dresden, Germany.; Bachmann, MP (reprint author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Fetscherstr 105, D-01307 Dresden, Germany.
EM m.bachmann@hzdr.de
RI Steinbach, Joerg/B-5940-2015; Bachmann, Michael/E-8850-2010; Pietzsch,
   Jens/O-5070-2017; Werner, Carsten/F-8127-2010; Umlauf,
   Ursula/D-3356-2014
OI Steinbach, Joerg/0000-0002-1708-6440; Bachmann,
   Michael/0000-0002-8029-5755; Pietzsch, Jens/0000-0002-1610-1493; Werner,
   Carsten/0000-0003-0189-3448; 
FU Deutsche Jose Carreras Leukamie-Stiftung e.V; Deutsche
   Forschungsgemeinschaft through CRC [TR 67, FR 2267/2-1, WE 2539-7,
   FOR/EXC999, BE 2607/1-2, ZI 1362/2-2, SFB655]; Leibniz Association
   [SAW-2011-IPF-2 68]; European Union through the Integrated Project
   ANGIOSCAFF
FX We thank Milauscha Grimmer, Anne-Sophie Gimpel (both IPF), Andrea Suhr,
   Regina Herrlich and Sebastian Meister (all HZDR) for excellent technical
   assistance, Dr. Mikhail Tsurkan (IPF) for fluorescence labeling of
   heparin and peptide synthesis, Dr. Jens Friedrichs (IPF) for performing
   the AFM nanoindentation experiments and Matthias Schieker (Munich) for
   providing the SCP-1 cell line. This study was supported by the Deutsche
   Jose Carreras Leukamie-Stiftung e.V (M.P.B), the Deutsche
   Forschungsgemeinschaft through CRC TR 67 (U.F., C.W.), FR 2267/2-1
   (U.F.), WE 2539-7 (C.W.), FOR/EXC999 (C.W.), BE 2607/1-2 (R.B.,J.P.), ZI
   1362/2-2 (R.B., J.P.) and SFB655 (M.B., C.W. and M.P.B.), by the Leibniz
   Association (SAW-2011-IPF-2 68, C.W.), and by the European Union through
   the Integrated Project ANGIOSCAFF (C.W.).
CR Aliperta R., 2015, BLOOD CANC J, pe348
   Aliperta RA, 2014, BLOOD, V124, P4810
   Arndt C, 2013, LEUKEMIA, V27, P964, DOI 10.1038/leu.2013.18
   Arndt C, 2013, LEUKEMIA, V1, P56
   Arndt C, 2013, BLOOD, V122
   Banerjee SS, 2012, J DRUG DELIV, DOI 10.1155/2012/103973
   Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]
   Bruechner K, 2009, INT J RADIAT BIOL, V85, P772, DOI 10.1080/09553000903043067
   Byrne H, 2013, TRENDS BIOTECHNOL, V31, P621, DOI 10.1016/j.tibtech.2013.08.007
   Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949
   Cheung AS, 2015, NANO TODAY, V10, P511, DOI 10.1016/j.nantod.2015.06.007
   Chollet C, 2012, BIOCONJUGATE CHEM, V23, P771, DOI 10.1021/bc2005889
   Compte Marta, 2013, Biomatter, V3, DOI 10.4161/biom.23897
   Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831
   Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148
   Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148
   Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919
   Eliopoulos N, 2008, CANCER RES, V68, P4810, DOI 10.1158/0008-5472.CAN-08-0160
   Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341
   Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315
   Goren A, 2012, CANCER SCI, V103, P116, DOI 10.1111/j.1349-7006.2011.02124.x
   Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3
   Herrington-Symes A. P., 2013, ADV BIOSCI BIOTECHNO, V4, P689, DOI DOI 10.4236/ABB.2013.45090
   Ho SS, 2016, STEM CELL TRANSL MED, V5, P773, DOI 10.5966/sctm.2015-0211
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Koi L, 2014, RADIOTHER ONCOL, V110, P362, DOI 10.1016/j.radonc.2013.12.001
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Li ZH, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-33
   Mau-Sorensen M, 2015, CANCER CHEMOTH PHARM, V75, P1065, DOI 10.1007/s00280-015-2728-5
   Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673
   Newland B, 2015, SMALL, V11, P5047, DOI 10.1002/smll.201500898
   PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1
   Rothe A, 2015, BLOOD, V125, P4024, DOI 10.1182/blood-2014-12-614636
   Rustad K. C., 2012, ADV WOUND CARE, V4, P147
   del Burgo LS, 2015, J DRUG TARGET, V23, P170, DOI 10.3109/1061186X.2014.971327
   Schutze C, 2014, RADIOTHER ONCOL, V111, P81, DOI 10.1016/j.radonc.2014.02.005
   Schuster Manfred, 2006, Biotechnology Journal, V1, P138, DOI 10.1002/biot.200500044
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247
   van den Berk L. C. J., 2009, JLB, V87, P283
   Wang N, 2009, MOL THER, V17, P1241, DOI 10.1038/mt.2009.82
   Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839
   Welzel PB, 2014, ADV HEALTHC MATER, V3, P1849, DOI 10.1002/adhm.201400102
   Welzel PB, 2012, BIOMACROMOLECULES, V13, P2349, DOI 10.1021/bm300605s
   Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526
   Xie F, 2015, J MED CHEM, V58, P5395, DOI 10.1021/acs.jmedchem.5b00593
NR 49
TC 4
Z9 4
U1 4
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 16
PY 2017
VL 7
AR 42855
DI 10.1038/srep42855
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK9FK
UT WOS:000394229200001
PM 28205621
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Abdullah, AM
   Rahim, TNAT
   Mohamad, D
   Aid, HM
   Rajion, ZA
AF Abdullah, Abdul Manaf
   Rahim, Tuan Noraihan Azila Tuan
   Mohamad, Dasmawati
   Aid, Hazizan Md
   Rajion, Zainul Ahmad
TI Mechanical and physical properties of highly ZrO2/beta-TCP filled
   polyamide 12 prepared via fused deposition modelling (FDM) 3D printer
   for potential craniofacial reconstruction application
SO MATERIALS LETTERS
LA English
DT Article
DE FDM; 3D Printing; PA 12; ZrO2; beta-TCP; Filament feedstock
AB This research aims to evaluate the mechanical and physical properties of highly ceramic filled polyamide 12 fabricated via FDM 3D printer for potential craniofacial reconstruction application. Unfilled, as well as 30, 35 and 40 wt% of ceramics filled PA 12 filament feedstock were prepared to fabricate tensile and flexural specimens via FDM 3D printer, prior to characterization. The mechanical and physical properties of the composites were insignificantly affected by the increment of filler loading. The mechanical properties of the composites were lower than expected; however, they did exhibit high surface roughness - which is desirable for biomaterial applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Abdullah, Abdul Manaf; Mohamad, Dasmawati; Rajion, Zainul Ahmad] Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.
   [Rahim, Tuan Noraihan Azila Tuan; Aid, Hazizan Md] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia.
RP Mohamad, D (reprint author), Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.
EM dasmawati@usm.my
RI abdullah, abdul manaf/I-3212-2017
OI Abdullah, Abdul Manaf/0000-0001-6080-7605
FU USM Research University Team [1001/PPSG/852004]
FX This study is supported by USM Research University Team grant number
   (1001/PPSG/852004).
CR Abdullah AM, 2015, J TEKNOL, V76, P75
   Berberi A, 2014, BIOMED RES INT, DOI 10.1155/2014/320790
   Christ S, 2015, MATER LETT, V139, P165, DOI 10.1016/j.matlet.2014.10.065
   Daniels A. U., 2005, WELL CEMENTED TOTAL
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Goodridge RD, 2012, PROG MATER SCI, V57, P229, DOI 10.1016/j.pmatsci.2011.04.001
   Ortona A, 2012, MATER LETT, V80, P95, DOI 10.1016/j.matlet.2012.04.050
   Rahim TNAT, 2015, J REINF PLAST COMP, V34, P1628, DOI 10.1177/0731684415594692
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yao DX, 2015, MATER LETT, V147, P116, DOI 10.1016/j.matlet.2015.02.037
NR 11
TC 4
Z9 4
U1 11
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2017
VL 189
BP 307
EP 309
DI 10.1016/j.matlet.2016.11.052
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EJ5HI
UT WOS:000393248000079
DA 2018-10-20
ER

PT J
AU Kumar, GS
   Girija, EK
   Venkatesh, M
   Karunakaran, G
   Kolesnikov, E
   Kuznetsov, D
AF Kumar, Govindan Suresh
   Girija, Easwaradas Kreedapathy
   Venkatesh, Manickam
   Karunakaran, Gopalu
   Kolesnikov, Evgeny
   Kuznetsov, Denis
TI One step method to synthesize flower-like hydroxyapatite architecture
   using mussel shell bio-waste as a calcium source
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Microwave processing; X-ray methods; Apatite; Biomedical applications.
ID MICROWAVE IRRADIATION; RAPID FORMATION; NANOSIZED HYDROXYAPATITE;
   NANO-HYDROXYAPATITE; SNAIL SHELLS; NANOSTRUCTURES; NANOPARTICLES;
   SUBSTITUTION; CARBONATE; SIZE
AB Mussel shell, a calcium-rich resource, is found plenty in nature. We have developed a novel and facile method to convert mussel shell bio-waste into hydroxyapatite (HAp) biomaterial using microwave irradiation with the aid of ethylenediaminetetraacetic acid (EDTA) as chelating agent. The obtained HAp had flower-like morphology which can be a potential candidate for developing biomaterial for orthopedic applications. Moreover, the developed method has the potential to recover the bio-waste and reduce environment pollution.
C1 [Kumar, Govindan Suresh; Venkatesh, Manickam] KS Rangasamy Coll Arts & Sci Autonomous, Dept Phys, Tiruchengode 637215, Tamil Nadu, India.
   [Girija, Easwaradas Kreedapathy] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
   [Karunakaran, Gopalu; Kolesnikov, Evgeny; Kuznetsov, Denis] Natl Univ Sci & Technol MISiS, Dept Funct Nanosyst & High Temp Mat, Leninskiy Pr 4, Moscow 119049, Russia.
   [Karunakaran, Gopalu] KS Rangasamy Coll Arts & Sci Autonomous, Dept Biotechnol, Tiruchengode 637215, Tamil Nadu, India.
RP Kumar, GS (reprint author), KS Rangasamy Coll Arts & Sci Autonomous, Dept Phys, Tiruchengode 637215, Tamil Nadu, India.
EM gsureshkumar1986@gmail.com
RI KARUNAKARAN, GOPALU/H-9378-2014; Kolesnikov, Evgeny/H-8515-2015
OI KARUNAKARAN, GOPALU/0000-0003-0863-9442; Kolesnikov,
   Evgeny/0000-0001-7241-6214
FU University Grant Commission, India [4-4/2015-16]; Ministry of Education
   and Science of the Russian Federation [K4-2015-017, N 211]
FX Dr. Govindan Suresh Kumar would like to express his sincere thanks to
   University Grant Commission, India for financial support through minor
   research project scheme (File No: 4-4/2015-16 (MRP/UGC SERO)). The work
   was carried out with financial support from the Ministry of Education
   and Science of the Russian Federation in the framework of Increase
   Competitiveness Program of NUST "MISiS" (No K4-2015-017), implemented by
   a governmental decree dated 16th of March 2013, N 211.
CR Arami H, 2009, J ALLOY COMPD, V469, P391, DOI 10.1016/j.jallcom.2008.01.116
   Bilecka I, 2010, NANOSCALE, V2, P1358, DOI 10.1039/b9nr00377k
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Chandra VS, 2015, CERAM INT, V41, P13153, DOI 10.1016/j.ceramint.2015.07.088
   Ergun C, 2008, J EUR CERAM SOC, V28, P2137, DOI 10.1016/j.jeurceramsoc.2008.03.007
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Girija EK, 2012, POWDER TECHNOL, V225, P190, DOI 10.1016/j.powtec.2012.04.007
   Heinemann F, 2011, BIOPHYS CHEM, V153, P126, DOI 10.1016/j.bpc.2010.11.003
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Jones M.I., 2011, IOP C SER MAT SCI EN, V18, P4
   Kalita SJ, 2010, MAT SCI ENG C-MATER, V30, P295, DOI 10.1016/j.msec.2009.11.007
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2015, RSC ADV, V5, P39544, DOI 10.1039/c5ra04402b
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Lak A, 2008, J AM CERAM SOC, V91, P3580, DOI 10.1111/j.1551-2916.2008.02690.x
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Liu JB, 2004, CHEM PHYS LETT, V396, P429, DOI 10.1016/j.cplett.2004.08.094
   Lopez-Macipe A, 1998, ADV MATER, V10, P49, DOI 10.1002/(SICI)1521-4095(199801)10:1<49::AID-ADMA49>3.0.CO;2-R
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Macha IJ, 2013, J AUST CERAM SOC, V49, P122
   Mishra VK, 2014, CERAM INT, V40, P11319, DOI 10.1016/j.ceramint.2014.03.128
   Mishra VK, 2016, NEW J CHEM, V40, P5432, DOI 10.1039/c5nj03322e
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Murugan R, 2006, ACTA BIOMATER, V2, P201, DOI 10.1016/j.actbio.2005.09.005
   Okada M, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064103
   Ramesh S, 2016, CERAM INT, V42, P7824, DOI 10.1016/j.ceramint.2016.02.015
   Rubankumar A., 2010, CRYST RES TECHNOL, V45, P776
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Shavandi A, 2015, MATER CHEM PHYS, V149, P607, DOI 10.1016/j.matchemphys.2014.11.016
   Sun Q, 2014, POWDER TECHNOL, V261, P49, DOI 10.1016/j.powtec.2014.04.014
   Vallet-Regi M., 2008, BIOMIMETIC NANOCERAM
   Wang YS, 2009, J COLLOID INTERF SCI, V339, P69, DOI 10.1016/j.jcis.2009.07.023
   Zhou H, 2016, CERAM INT, V42, P16671, DOI 10.1016/j.ceramint.2016.07.101
   Zhu YJ, 2014, CHEM REV, V114, P6462, DOI 10.1021/cr400366s
NR 36
TC 2
Z9 2
U1 6
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD FEB 15
PY 2017
VL 43
IS 3
BP 3457
EP 3461
DI 10.1016/j.ceramint.2016.11.163
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA EI8PK
UT WOS:000392769600079
DA 2018-10-20
ER

PT J
AU Bosio, VE
   Brown, J
   Rodriguez, MJ
   Kaplan, DL
AF Bosio, V. E.
   Brown, J.
   Rodriguez, M. J.
   Kaplan, D. L.
TI Biodegradable porous silk microtubes for tissue vascularization
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VITRO; MECHANICAL-PROPERTIES; BIOMATERIAL COATINGS; FIBROIN
   SCAFFOLDS; BLOOD-VESSEL; STEM-CELLS; GRAFTS; REGENERATION;
   BIOCOMPATIBILITY; IMPLANTATION
AB Cardiovascular diseases are the leading cause of mortality around the globe, and microvasculature replacements to help stem these diseases are not available. Additionally, some vascular surgeries needing small-diameter vascular grafts present different performance requirements. In this work, silk fibroin scaffolds based on silk/polyethylene oxide blends were developed as microtubes for vasculature needs and for different tissue regeneration times, mechanical properties and structural designs. Systems with 13, 14 and 15% silk alone or blended with 1 or 2% of polyethylene oxide (PEO) were used to generate porous microtubes by gel spinning. Microtubes with inner diameters (IDs) of 150-300 mm and 100 mm wall thicknesses were fabricated. The systems were assessed for porosity, mechanical properties, enzymatic degradability, and in vitro vascular endothelial cell attachment and metabolic activity. After 14 days, all the tubes supported the proliferation of cells and the cell attachment increased with porosity. The silk tubes with PEO had similar crystallinity but a higher elastic modulus compared with the systems without PEO. The silk (13%)/PEO (1%) system showed the highest porosity (20 mm pore diameter on average), the highest cell attachment and the fastest degradation profile. There was a good correlation between these parameters with silk concentration and the presence of PEO. The results demonstrate the ability to generate versatile and tunable tubular biomaterials based on silk-PEO blends with potential for microvascular grafts.
C1 [Bosio, V. E.] Univ Nacl La Plata, Inst Appl Biotechnol, CINDEFI, CCT La Plata,CONICET,Fac Ciencias Exactas, Calle 47 & 115, RA-1900 La Plata, Buenos Aires, Argentina.
   [Bosio, V. E.; Brown, J.; Rodriguez, M. J.; Kaplan, D. L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Bosio, VE (reprint author), Univ Nacl La Plata, Inst Appl Biotechnol, CINDEFI, CCT La Plata,CONICET,Fac Ciencias Exactas, Calle 47 & 115, RA-1900 La Plata, Buenos Aires, Argentina.; Bosio, VE (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM vbosio@gmail.com
FU Tissue Engineering Resource Center (TERC) from the National Institute of
   Biomedical Imaging and Bioengineering [NIH EB002520]; American Society
   of Biochemistry and Molecular Biology (ASBMB) (PROLAB Program); National
   Council of Research and Technology from Argentina (CONICET)
FX The authors thank Jeannine Coburn for her assistance with cell culture
   as well as Veronica Ranner for her assistance with Bombyx mori
   photo-imaging. We would like to acknowledge funding from the Tissue
   Engineering Resource Center (TERC) (NIH EB002520) from the National
   Institute of Biomedical Imaging and Bioengineering, from the American
   Society of Biochemistry and Molecular Biology (ASBMB) (PROLAB Program),
   as well as from the National Council of Research and Technology from
   Argentina (CONICET).
CR Ahn H, 2015, ACTA BIOMATER, V16, P14, DOI 10.1016/j.actbio.2015.01.030
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anwarul H., 2014, ACTA BIOMATER, V1, P11
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Catto V, 2014, ISRN VASC MED, V2014, P1, DOI [10.1155/2014/923030, DOI 10.1155/2014/923030]
   Catto V, 2015, MAT SCI ENG C-MATER, V54, P101, DOI 10.1016/j.msec.2015.05.003
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Engler A. J., 2016, CELL, V4, P677
   Gui LQ, 2014, CURR OPIN CHEM ENG, V3, P68, DOI 10.1016/j.coche.2013.11.004
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang S, 2010, J CONTROL RELEASE, V142, P149, DOI 10.1016/j.jconrel.2009.10.018
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Karimi A, 2013, MAT SCI ENG C-MATER, V33, P2550, DOI 10.1016/j.msec.2013.02.016
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   L'Heureux N, 1998, FASEB J, V12, P47
   Lanza J., 2007, PRINCIPLE TISSUE ENG, V3, P1936
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lv Q, 2005, POLYM INT, V54, P1076, DOI [10.1002/pi.1814, 10.1002/pi.l814]
   Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011
   Mercado-Pagan AE, 2015, MAT SCI ENG C-MATER, V49, P541, DOI 10.1016/j.msec.2015.01.051
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Patra S, 2016, CELL BIOCHEM BIOPHYS, V74, P93, DOI 10.1007/s12013-016-0730-0
   Rasband WS, 1997, IMAGEJ
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Shafiee A, 2016, TRENDS MOL MED, V22, P254, DOI 10.1016/j.molmed.2016.01.003
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Stekelenburg M, 2009, TISSUE ENG PT A, V15, P1081, DOI 10.1089/ten.tea.2008.0183
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Watanabe T, 2007, J ARTIF ORGANS, V10, P10, DOI 10.1007/s10047-006-0361-0
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Yucel T, 2014, J CONTROL RELEASE, V190, P381, DOI 10.1016/j.jconrel.2014.05.059
   Zhang CC, 2012, BIOMACROMOLECULES, V13, P2148, DOI 10.1021/bm300541g
   Zhang WJ, 2015, BIOMATERIALS, V56, P68, DOI 10.1016/j.biomaterials.2015.03.053
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
NR 54
TC 2
Z9 2
U1 7
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 14
PY 2017
VL 5
IS 6
BP 1227
EP 1235
DI 10.1039/c6tb02712a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EN3NA
UT WOS:000395914000012
PM 28944059
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Xue, CB
   Ren, HC
   Zhu, H
   Gu, XK
   Guo, Q
   Zhou, Y
   Huang, J
   Wang, SR
   Zha, GB
   Gu, JH
   Yang, YM
   Gu, Y
   Gu, XS
AF Xue, Chengbin
   Ren, Hechun
   Zhu, Hui
   Gu, Xiaokun
   Guo, Qi
   Zhou, Yi
   Huang, Jing
   Wang, Shengran
   Zha, Guangbin
   Gu, Jianhui
   Yang, Yumin
   Gu, Yun
   Gu, Xiaosong
TI Bone marrow mesenchymal stem cell-derived acellular matrix-coated
   chitosan/silk scaffolds for neural tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; DOG SCIATIC-NERVE; FIBROIN-BASED
   SCAFFOLD; EXTRACELLULAR-MATRIX; SILK FIBROIN; IN-VITRO; BIOCOMPATIBILITY
   EVALUATION; SCHWANN-CELLS; STROMAL CELLS; REPAIR
AB Extracellular/acellular matrix-containing neural scaffolds represent a promising design of a tissue engineered nerve graft (TENG) for peripheral nerve repair. In this study, we engineered a composite neural scaffold by culturing dog bone marrow mesenchymal stem cells (BMSCs) onto the surface of a chitosan/silk fibroin-based scaffold and then exposing the cell culture to decellularization to deposit acellular matrix (ACM) coatings on the scaffold. This natural biomaterial-based, cell-derived ACM-coated neural scaffold, as a novel nerve graft, was used to bridge a 60 mm long nerve gap in a dog sciatic nerve. At 12 months after grafting, behavioral, functional, and histological evaluation indicated that our developed neural scaffold achieved satisfactory regenerative outcomes, which were very close to those achieved by autologous nerve grafts, the accepted golden standard for peripheral nerve repair. Moreover, additional therapeutic benefits produced by the modification of a neural scaffold with BMSC-derived ACM may be associated with the unique neural activity of the ACM, as evidenced by in vitro experimental findings that the ACM significantly enhanced axonal regrowth and Schwann cell proliferation. Our results will provide a further experimental basis for the translation of ACM-containing neural scaffolds into the clinic.
C1 [Xue, Chengbin; Zhu, Hui; Gu, Xiaosong] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China.
   [Xue, Chengbin; Zhu, Hui; Gu, Xiaosong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China.
   [Xue, Chengbin; Ren, Hechun; Zhu, Hui; Zhou, Yi; Huang, Jing; Wang, Shengran; Zha, Guangbin; Yang, Yumin; Gu, Yun; Gu, Xiaosong] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, 19 Qixiu Rd, Nantong 226001, JS, Peoples R China.
   [Xue, Chengbin; Ren, Hechun; Zhu, Hui; Zhou, Yi; Huang, Jing; Wang, Shengran; Zha, Guangbin; Yang, Yumin; Gu, Yun; Gu, Xiaosong] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, JS, Peoples R China.
   [Zhu, Hui] Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, JS, Peoples R China.
   [Gu, Xiaokun; Gu, Jianhui] Nantong Univ, Dept Hand Surg, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, JS, Peoples R China.
   [Guo, Qi] Jilin Univ, China Japan Union Hosp, Dept Hand Surg, Changchun 130033, Jilin Province, Peoples R China.
RP Gu, XS (reprint author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China.; Gu, XS (reprint author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China.; Gu, Y; Gu, XS (reprint author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, 19 Qixiu Rd, Nantong 226001, JS, Peoples R China.; Gu, Y; Gu, XS (reprint author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, JS, Peoples R China.
EM guyun@ntu.edu.cn; nervegu@ntu.edu.cn
OI Xue, Chengbin/0000-0003-1378-672X
FU Hi-Tech Research and Development Program of China (863 Program)
   [2012AA020502]; National Key Basic Research Program of China (973
   programs) [2014CB542202]; National Natural Science Foundation of China
   [81130080, 81402447, 81471255, 31300942]; Basic Research Program of
   Jiangsu Education Department [14KJA310004]; Priority Academic Program
   Development (PAPD) of Jiangsu Higher Education Institutions
FX The authors thank Professor Jie Liu for helping with the preparation of
   this manuscript. This work was graciously supported by the Hi-Tech
   Research and Development Program of China (863 Program, Grant No.
   2012AA020502), the National Key Basic Research Program of China (973
   programs, Grant No. 2014CB542202), the National Natural Science
   Foundation of China (Grant No. 81130080, 81402447, 81471255 and
   31300942), the Basic Research Program of Jiangsu Education Department
   (Grant No. 14KJA310004) and the Priority Academic Program Development
   (PAPD) of Jiangsu Higher Education Institutions.
CR Aamodt JM, 2016, BIOMATERIALS, V86, P68, DOI 10.1016/j.biomaterials.2016.02.003
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Bubela T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-133
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004
   Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Gu XS, 2015, FRONT MED-PRC, V9, P401, DOI 10.1007/s11684-015-0415-x
   Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Gu Y, 2017, J TISSUE ENG REGEN M, V11, P2250, DOI 10.1002/term.2123
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   Hu N, 2013, BIOMATERIALS, V34, P100, DOI 10.1016/j.biomaterials.2012.09.020
   Ji SZ, 2011, BIOMATERIALS, V32, P7801, DOI 10.1016/j.biomaterials.2011.06.076
   Jiang MR, 2014, NEUROSCI LETT, V581, P32, DOI 10.1016/j.neulet.2014.08.014
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Kano WT, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0631-2
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091
   Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106
   Luo HL, 2015, TISSUE ENG PT A, V21, P267, DOI [10.1089/ten.tea.2013.0565, 10.1089/ten.TEA.2013.0565]
   McAllister TN, 2008, REGEN MED, V3, P925, DOI 10.2217/17460751.3.6.925
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14
   Stoppel WL, 2015, ANN BIOMED ENG, V43, P657, DOI 10.1007/s10439-014-1206-2
   Tang S, 2013, BIOMATERIALS, V34, P7086, DOI 10.1016/j.biomaterials.2013.05.080
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Vassalo FG, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0158-3
   von Tigerstrom BJ, 2008, TRENDS BIOTECHNOL, V26, P653, DOI 10.1016/j.tibtech.2008.08.004
   Walsh S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E2
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wang X, 2013, MATH MECH COMPLEX SY, V1, P1, DOI 10.1186/2052-8426-1-1
   Wang YJ, 2016, MOL NEUROBIOL, V53, P28, DOI 10.1007/s12035-014-8968-2
   Xue CB, 2012, NEUROREHAB NEURAL RE, V26, P96, DOI 10.1177/1545968311420444
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Yao M, 2016, CELL TRANSPLANT, V25, P983, DOI 10.3727/096368916X690494
   Yin HY, 2016, ACTA BIOMATER, V33, P96, DOI 10.1016/j.actbio.2016.01.024
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang YQ, 2016, CELL TRANSPLANT, V25, P365, DOI 10.3727/096368915X687930
   Zhao YH, 2013, BIO-MED MATER ENG, V23, P545, DOI 10.3233/BME-130775
NR 49
TC 3
Z9 3
U1 2
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 14
PY 2017
VL 5
IS 6
BP 1246
EP 1257
DI 10.1039/c6tb02959k
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA EN3NA
UT WOS:000395914000014
DA 2018-10-20
ER

PT J
AU Jo, YY
   Kweon, H
   Kim, DW
   Kim, MK
   Kim, SG
   Kim, JY
   Chae, WS
   Hong, SP
   Park, YH
   Lee, S
   Choi, JY
AF Jo, You-Young
   Kweon, HaeYong
   Kim, Dae-Won
   Kim, Min-Keun
   Kim, Seong-Gon
   Kim, Jwa-Young
   Chae, Weon-Sik
   Hong, Sam-Pyo
   Park, Young-Hwan
   Lee, SiYoung
   Choi, Je-Yong
TI Accelerated biodegradation of silk sutures through matrix
   metalloproteinase activation by incorporating 4-hexylresorcinol
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENE-EXPRESSION; DRUG-DELIVERY; WOUND REPAIR; KB CELLS; FIBROIN;
   SURGERY; SPECTROSCOPY; BIOMATERIAL; MACROPHAGES; SUPPRESSION
AB Silk suture material is primarily composed of silk fibroin and regarded as a non-resorbable material. It is slowly degraded by proteolysis when it is implanted into the body. 4-Hexylresorcinol (4HR) is a well-known antiseptic. In this study, the biodegradability of 4HR-incorporated silk sutures were compared to that of untreated silk sutures and polyglactin 910 sutures, a commercially available resorbable suture. 4HR-incorporated silk sutures exhibited anti-microbial properties. Matrix metalloproteinase (MMP) can digest a wide spectrum of proteins. 4HR increased MMP-2, -3, and -9 expression in RAW264.7 cells. MMP-2, -3, and -9 were able to digest not only silk fibroin but also silk sutures. Consequently, 59.5% of the 4HR-incorporated silk suture material remained at 11 weeks after grafting, which was similar to that of polyglactin 910 degradation (56.4% remained). The residual amount of bare silk suture material at 11 weeks after grafting was 91.5%. The expression levels of MMP-2, -3 and -9 were high in the 4HR-incorporated silk suture-implanted site 12 weeks after implantation. In conclusion, 4HR-treated silk sutures exhibited anti-microbial properties and a similar level of bio-degradation to polyglactin 910 sutures and induced higher expression of MMP-2, -3, and -9 in macrophages.
C1 [Jo, You-Young; Kweon, HaeYong] Rural Dev Adm, Jeonju Si 55365, Jeollabuk Do, South Korea.
   [Kim, Dae-Won] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Biochem, Kangnung 25457, South Korea.
   [Kim, Min-Keun; Kim, Seong-Gon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung 25457, South Korea.
   [Kim, Jwa-Young] Hallym Univ, Coll Med, Dept Oral & Maxillofacial Surg, Anyang 14068, South Korea.
   [Chae, Weon-Sik] Korea Basic Sci Inst, Daegu Ctr, Anal Res Div, Yusung Gu, Daejeon, South Korea.
   [Hong, Sam-Pyo] Seoul Natl Univ, Coll Dent, Dept Oral Pathol, Seoul 03080, South Korea.
   [Park, Young-Hwan] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul, South Korea.
   [Lee, SiYoung] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Microbiol, Kangnung 25457, South Korea.
   [Choi, Je-Yong] Kyungpook Natl Univ, Skeletal Dis Genome Res Ctr, Sch Biochem & Cell Biol, Daegu 700842, South Korea.
RP Kim, SG (reprint author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung 25457, South Korea.
EM kimsg@gwnu.ac.kr
FU Cooperative Research Program for Agriculture Science and Technology
   Development, Rural Development Administration, Republic of Korea
   [PJ01121404]
FX This work was carried out with the support of "Cooperative Research
   Program for Agriculture Science and Technology Development (Project No.
   PJ01121404)", Rural Development Administration, Republic of Korea.
CR Ahn J, 2016, BURNS, V42, P1534, DOI 10.1016/j.burns.2016.04.016
   Al-Qattan MM, 2005, J HAND SURG-BRIT EUR, V30B, P90, DOI 10.1016/j.jhsb.2004.08.005
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   Banche G, 2007, J ORAL MAXIL SURG, V65, P1503, DOI 10.1016/j.joms.2006.10.066
   Bide M, 2007, AATCC REV, V7, P44
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chen XJ, 2015, J MECH BEHAV BIOMED, V50, P160, DOI 10.1016/j.jmbbm.2015.06.013
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   Dennis C, 2016, J BIOMED MATER RES A, V104, P1544, DOI 10.1002/jbm.a.35683
   Durairaj R. B., 2005, RESORCINOL CHEM TECH, P60
   EVANS RT, 1977, J PERIODONTOL, V48, P156, DOI 10.1902/jop.1977.48.3.156
   Gogoi D, 2014, BIOPOLYMERS, V101, P355, DOI 10.1002/bip.22369
   Iqbal M, 2013, CHEM PAP, V67, P444, DOI 10.2478/s11696-012-0282-8
   Kang Yei-Jin, 2016, Maxillofac Plast Reconstr Surg, V38, P29
   Kim SG, 2011, ONCOL REP, V26, P1527, DOI 10.3892/or.2011.1436
   Kim SG, 2011, ONCOL REP, V25, P1597, DOI 10.3892/or.2011.1218
   Krupyanskii YF, 2012, RUSS J PHYS CHEM B+, V6, P301, DOI 10.1134/S1990793112020078
   Krupyanskii Yu. F., 2011, Biofizika, V56, P13
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon H, 2014, BIOMATERIALS, V35, P8576, DOI 10.1016/j.biomaterials.2014.06.050
   Lee Sang-Woon, 2015, Maxillofac Plast Reconstr Surg, V37, P32, DOI 10.1186/s40902-015-0034-0
   Lu Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.75
   Luo XY, 2012, ANAL LETT, V45, P1286, DOI 10.1080/00032719.2012.673098
   MAGOSHI J, 1985, APPL POLYM SYMP, P187
   Marco Fernando, 2007, Surg Infect (Larchmt), V8, P359, DOI 10.1089/sur.2006.013
   Martinez-Alvarez O, 2008, FOOD CHEM, V108, P624, DOI 10.1016/j.foodchem.2007.11.029
   MOY RL, 1992, J DERMATOL SURG ONC, V18, P785, DOI 10.1111/j.1524-4725.1992.tb03036.x
   Naleway SE, 2015, J BIOMED MATER RES B, V103, P735, DOI 10.1002/jbm.b.33171
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Nissinen LM, 2015, J INVEST DERMATOL, V135, P2350, DOI 10.1038/jid.2015.246
   OKADA T, 1992, BIOMATERIALS, V13, P448, DOI 10.1016/0142-9612(92)90165-K
   Park Yong-Tae, 2014, Maxillofac Plast Reconstr Surg, V36, P192, DOI 10.14402/jkamprs.2014.36.5.192
   Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890
   Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002
   Rozzelle CJ, 2008, J NEUROSURG-PEDIATR, V2, P111, DOI 10.3171/PED/2008/2/8/111
   Siasos G, 2012, CURR TOP MED CHEM, V12, P1132, DOI 10.2174/1568026611208011132
   Storch Mark L, 2004, Surg Infect (Larchmt), V5, P281
   Stuart B., 1996, MODERN INFRARED SPEC
   Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208
   Wang X., 2016, BBA-GEN SUBJECTS, DOI [10.1016/j.bbagen,2016.11.025, DOI 10.1016/J.BBAGEN,2016.11.025]
   Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb0306152
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Yang WG., 2016, J ANAL SCI TECHNOL, V7, P9
   Yu L, 2010, BIOMACROMOLECULES, V11, P2766, DOI 10.1021/bm1008316
NR 51
TC 3
Z9 3
U1 3
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 13
PY 2017
VL 7
AR 42441
DI 10.1038/srep42441
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK8EB
UT WOS:000394155600001
PM 28205580
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Qin, HM
   Miyakawa, T
   Inoue, A
   Nishiyama, R
   Nakamura, A
   Asano, A
   Sawano, Y
   Ojima, T
   Tanokura, M
AF Qin, Hui-Min
   Miyakawa, Takuya
   Inoue, Akira
   Nishiyama, Ryuji
   Nakamura, Akira
   Asano, Atsuko
   Sawano, Yoriko
   Ojima, Takao
   Tanokura, Masaru
TI Structure and Polymannuronate Specificity of a Eukaryotic Member of
   Polysaccharide Lyase Family 14
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HALIOTIS-DISCUS-HANNAI; ALGINATE LYASE; CRYSTAL-STRUCTURE; CDNA CLONING;
   LITTORINA-BREVICULA; APLYSIA-KURODAI; HEAT-STABILITY; ABALONE; PROTEIN;
   SUBSTRATE
AB Alginate is an abundant algal polysaccharide, composed of beta-D-mannuronate and its C5 epimer alpha-L-guluronate, that is a useful biomaterial in cell biology and tissue engineering, with applications in cancer and aging research. The alginate lyase (EC 4.2.2.3) from Aplysia kurodai, AkAly30, is a eukaryotic member of the polysaccharide lyase 14 (PL-14) family and degrades alginate by cleaving the glycosidic bond through a beta-elimination reaction. Here, we present the structural basis for the substrate specificity, with a preference for polymannuronate, of AkAly30. The crystal structure of AkAly30 at a 1.77 angstrom resolution and the putative substrate-binding model show that the enzyme adopts a beta-jelly roll fold at the core of the structure and that Lys-99, Tyr-140, and Tyr-142 form catalytic residues in the active site. Their arrangements allow the carboxyl group of mannuronate residues at subsite +1 to form ionic bonds with Lys-99. The coupled tyrosine forms a hydrogen bond network with the glycosidic bond, and the hydroxy group of Tyr-140 is located near the C5 atom of the mannuronate residue. These interactions could promote the beta-elimination of the mannuronate residue at subsite +1. More interestingly, Gly-118 and the disulfide bond formed by Cys-115 and Cys-124 control the conformation of an active-site loop, which makes the space suitable for substrate entry into subsite -1. The cleavage efficiency of AkAly30 is enhanced relative to that of mutants lacking either Gly-118 or the Cys-115-Cys-124 disulfide bond. The putative binding model and mutagenesis studies provide a novel substrate recognition mode explaining the polymannuronate specificity of PL-14 alginate lyases.
C1 [Qin, Hui-Min; Miyakawa, Takuya; Nakamura, Akira; Asano, Atsuko; Sawano, Yoriko; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
   [Qin, Hui-Min] Tianjin Univ Sci & Technol, Coll Biotechnol, 29,13th Ave, Tianjin 300457, Peoples R China.
   [Inoue, Akira; Nishiyama, Ryuji; Ojima, Takao] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.
   [Sawano, Yoriko] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Chem Lab, 2-8-30 Kounodai, Ichikawa, Chiba 2720827, Japan.
RP Tanokura, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM amtanok@mail.ecc.u-tokyo.ac.jp
FU Tohoku Marine Science Project of the Ministry of Education, Culture,
   Sports, Science, and Technology (MEXT), Japan; overseas High-level
   Talents Program of Tianjin University of Science and Technology, China
FX This work was supported by the Tohoku Marine Science Project of the
   Ministry of Education, Culture, Sports, Science, and Technology (MEXT),
   Japan, and the overseas High-level Talents Program of Tianjin University
   of Science and Technology, China. The authors declare that they have no
   conflicts of interest with the contents of this article.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Chaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1819, DOI 10.1271/bbb.60620
   Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1
   ELYAKOVA LA, 1974, BIOCHIM BIOPHYS ACTA, V358, P341, DOI 10.1016/0005-2744(74)90464-1
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265
   Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200
   Hata M, 2009, FISHERIES SCI, V75, P755, DOI 10.1007/s12562-009-0079-z
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7
   Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566
   Inoue A, 2016, J BIOL CHEM, V291, P15551, DOI 10.1074/jbc.M115.713230
   Inoue A, 2011, MAR BIOTECHNOL, V13, P256, DOI 10.1007/s10126-010-9290-2
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kumagai Y, 2009, COMP BIOCHEM PHYS B, V154, P113, DOI 10.1016/j.cbpb.2009.05.005
   Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933
   Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k
   Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071
   Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X
   Mochizuki S, 2015, J BIOL CHEM, V290, P30962, DOI 10.1074/jbc.M115.686725
   Muramatsu T, 1996, J PROTEIN CHEM, V15, P709, DOI 10.1007/BF01887144
   Nishida Y, 2007, BIOCHIMIE, V89, P1002, DOI 10.1016/j.biochi.2007.03.015
   Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450
   Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008
   Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056
   Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Papworth C., 1996, STRATEGIES, V9, P3
   Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111
   Rahman MM, 2012, CARBOHYD RES, V360, P69, DOI 10.1016/j.carres.2012.05.019
   Rahman MM, 2011, BIOCHIMIE, V93, P1720, DOI 10.1016/j.biochi.2011.06.004
   Rahman MM, 2010, COMP BIOCHEM PHYS B, V157, P317, DOI 10.1016/j.cbpb.2010.07.006
   Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X
   Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009
   Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0
   Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032
   Suzuki K., 2004, MAR BIOTECHNOL, V6, pS502
   Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217
   Wang L, 2012, FISHERIES SCI, V78, P889, DOI 10.1007/s12562-012-0517-1
   WEISSBACH A, 1959, J BIOL CHEM, V234, P705
   Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509
NR 46
TC 7
Z9 7
U1 8
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 10
PY 2017
VL 292
IS 6
BP 2182
EP 2190
DI 10.1074/jbc.M116.749929
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EM7ZG
UT WOS:000395530300012
PM 28011642
OA Green Published
DA 2018-10-20
ER

PT J
AU Ribeiro, AC
   Rocha, A
   Soares, RMD
   Fonseca, LP
   da Silveira, NP
AF Ribeiro, Andresa C.
   Rocha, Angelo
   Soares, Rosane M. D.
   Fonseca, Luis P.
   da Silveira, Nadya P.
TI Synthesis and characterization of acetylated amylose and development of
   inclusion complexes with rifampicin
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Amylose; Acetylation; Rifampicin; Inclusion complexes; Drug delivery
   system
ID MOLECULAR ENCAPSULATION; ENZYMATIC MODIFICATIONS; DELIVERY APPLICATIONS;
   CORN STARCH; IN-VITRO; NANOPARTICLES; COMPOSITES; STABILITY; LIPOSOMES;
   IBUPROFEN
AB Amylose (AM) tends to form single helical inclusion complexes with suitable agents. These complexes are considered promising biomaterial carrier since the guest molecules can be released later, leading to many applications, especially in the pharmaceutical industry. Rifampicin (RIF) has long been recognized as an active drug against Mycobacterium tuberculosis, however, the administration of RIF in high dosages can originate unwanted side-effects. Due to the fact that the use of native amylose (AM) in the formation of complexes is limited by their low water solubility, it was acetylated with a medium degree of substitution (DS), allowing solubilizing (0.5 gL(-1)) acetylated amylose (AMA) in water at neutral pH, in opposition to that observed with native amylose (trace solubility). The resulting acetylated amylose was characterized by means of Fourier Transform Infrared (FT-IR) spectroscopy and Scanning Electron Microscopy (SEM). FT-IR results indicated that the acetylation of anhydroglucose units of amylose corresponds to a low DS, whereas SEM results suggested that the smooth surfaces of amylose granules were changed into rougher surfaces after acetylation. Ultraviolet absorption spectroscopy (UV-vis) analysis confirmed the formation and allowed the quantification of both native (AM-RIF) and acetylated (AMA-RIF) amylose inclusion complexes. Their characterization in solution was performed by dynamic light scattering (DLS) and zeta potential (ZP) measurements. The average size of inclusion complexes as determined by DLS, ranged between 70 and 100 nm. Besides, ZP analysis showed that both complexes are more stable in the presence of RIF. This study may lead to the development of an effective method for the preparation of amylose inclusion complexes, which is beneficial to their further application in drug delivery systems. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ribeiro, Andresa C.; da Silveira, Nadya P.] Univ Fed Rio Grande do Sul, Inst Chem, Lab Instrumentat & Mol Dynam LINDIM, Grp Studies, BR-91501970 Porto Alegre, RS, Brazil.
   [Rocha, Angelo; Fonseca, Luis P.] Univ Lisbon, Inst Super Tecn, Inst Bioengn & Biosci, Dept Bioengn, Av Rovisco Pais 1, P-1049001 Lisbon, Portugal.
   [Soares, Rosane M. D.] Univ Fed Rio Grande do Sul, Inst Chem, Grp Studies Polymer Biomat POLI BIO, BR-91501970 Porto Alegre, RS, Brazil.
RP da Silveira, NP (reprint author), Univ Fed Rio Grande do Sul, Inst Chem, Campus Vale, Porto Alegre, RS, Brazil.
EM nadya@iq.ufrgs.br
RI silveira, nadya/G-9970-2016; Soares, Rosane/H-2156-2018; P. Fonseca,
   Luis/A-4228-2013
OI silveira, nadya/0000-0002-1556-7304; Soares, Rosane/0000-0002-5225-7559;
   P. Fonseca, Luis/0000-0001-8429-6977; Rocha, Angelo/0000-0003-3054-6269
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior);
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico);
   Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/93049/2013]
FX The authors thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for their financial support. Angelo Rocha is
   grateful for financial support from Fundacao para a Ciencia e Tecnologia
   (FCT) through a Ph.D. grant (SFRH/BD/93049/2013).
CR Anshakova AV, 2015, RUSS J PHYS CHEM A+, V89, P797, DOI 10.1134/S0036024415050052
   Arijaje EO, 2015, J AGR FOOD CHEM, V63, P4202, DOI 10.1021/acs.jafc.5b00125
   Arijaje EO, 2014, J AGR FOOD CHEM, V62, P2963, DOI 10.1021/jf5004682
   Booysen LLIJ, 2013, INT J PHARMACEUT, V444, P10, DOI 10.1016/j.ijpharm.2013.01.038
   Cai X, 2010, CARBOHYD RES, V345, P922, DOI 10.1016/j.carres.2010.02.008
   Carbinatto FM, 2016, J PHARM SCI-US, V105, P231, DOI 10.1002/jps.24702
   Chadha R, 2010, J INCL PHENOM MACRO, V67, P109, DOI 10.1007/s10847-009-9682-y
   Cohen R, 2008, J AGR FOOD CHEM, V56, P4212, DOI 10.1021/jf800255c
   Colussi R, 2015, LWT-FOOD SCI TECHNOL, V62, P1076, DOI 10.1016/j.lwt.2015.01.053
   Do DP, 2010, INT J PHARMACEUT, V386, P114, DOI 10.1016/j.ijpharm.2009.11.009
   Doostmohammadi A, 2011, CERAM INT, V37, P2311, DOI 10.1016/j.ceramint.2011.03.026
   Elsabahy M, 2012, CHEM SOC REV, V41, P2545, DOI 10.1039/c2cs15327k
   Ferreira Denise Alves, 2004, Rev. Bras. Cienc. Farm., V40, P43, DOI 10.1590/S1516-93322004000100008
   Ferreira QS, 2015, J RAMAN SPECTROSC, V46, P765, DOI 10.1002/jrs.4718
   Golachowski A, 2015, FOOD CHEM, V176, P350, DOI 10.1016/j.foodchem.2014.12.060
   Goncalves C, 2008, EUR POLYM J, V44, P3529, DOI 10.1016/j.eurpolymj.2008.08.034
   Halal S.L.M.E., 2015, FOOD CHEM, V168, P247
   Han F, 2013, INT J BIOL MACROMOL, V59, P372, DOI 10.1016/j.ijbiomac.2013.04.080
   He D, 2013, COLLOID SURFACE B, V103, P580, DOI 10.1016/j.colsurfb.2012.10.062
   Hu CH, 2012, COLLOID SURFACE B, V95, P162, DOI 10.1016/j.colsurfb.2012.02.030
   Kaur G, 2015, J PHARM SCI-US, V104, P2203, DOI 10.1002/jps.24469
   Kaur K, 2015, NEW J CHEM, V39, P8855, DOI 10.1039/c5nj00924c
   Kida T., 2007, CHEM COMMUN, V15, P1559
   Kim JY, 2016, CARBOHYD POLYM, V136, P394, DOI 10.1016/j.carbpol.2015.08.069
   Kong LY, 2014, CARBOHYD POLYM, V111, P256, DOI 10.1016/j.carbpol.2014.04.033
   Kulkarni SD, 2015, INT J BIOL MACROMOL, V72, P1005, DOI 10.1016/j.ijbiomac.2014.10.007
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lii CY, 2003, CARBOHYD POLYM, V51, P93, DOI 10.1016/S0144-8617(02)00122-4
   Luo ZG, 2016, CARBOHYD POLYM, V137, P314, DOI 10.1016/j.carbpol.2015.10.100
   Manca ML, 2012, J PHARM SCI-US, V101, P566, DOI 10.1002/jps.22775
   Marinopoulou A, 2016, CARBOHYD POLYM, V141, P106, DOI 10.1016/j.carbpol.2015.12.062
   MARK AM, 1972, STARKE, V24, P73, DOI 10.1002/star.19720240302
   Minimol PF, 2013, CARBOHYD POLYM, V95, P1, DOI 10.1016/j.carbpol.2013.02.021
   Niamnont N, 2015, RSC ADV, V5, P64763, DOI 10.1039/c5ra10273a
   Seo TR, 2015, LWT-FOOD SCI TECHNOL, V64, P889, DOI 10.1016/j.lwt.2015.06.021
   Silveira N, 2016, MAT SCI ENG C-MATER, V58, P458, DOI 10.1016/j.msec.2015.08.062
   Singh C., 2016, AAPS PHARMSCITECH, P1
   Singh C, 2015, INT J PHARMACEUT, V495, P627, DOI 10.1016/j.ijpharm.2015.09.036
   Sun YJ, 2016, CARBOHYD POLYM, V139, P28, DOI 10.1016/j.carbpol.2015.12.002
   Teodoro AP, 2015, CARBOHYD POLYM, V126, P9, DOI 10.1016/j.carbpol.2015.03.021
   Tewes F, 2008, J CONTROL RELEASE, V129, P93, DOI 10.1016/j.jconrel.2008.04.007
   Uchino T, 2002, J INCL PHENOM MACRO, V43, P31, DOI 10.1023/A:1020418005040
   Wulff G, 1998, CARBOHYD RES, V307, P19, DOI 10.1016/S0008-6215(97)10097-0
   Wurzburg O., 1964, METHODS CARBOHYDRATE, V4, P286
   Yang LQ, 2013, STARCH-STARKE, V65, P593, DOI 10.1002/star.201200161
   Zaru M, 2009, J LIPOSOME RES, V19, P68, DOI 10.1080/08982100802610835
   Zhang LM, 2016, J DRUG DELIV SCI TEC, V31, P101, DOI 10.1016/j.jddst.2015.12.006
   Zhou Y, 2016, CARBOHYD POLYM, V138, P41, DOI 10.1016/j.carbpol.2015.11.040
NR 48
TC 6
Z9 6
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2017
VL 157
BP 267
EP 274
DI 10.1016/j.carbpol.2016.09.064
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA EH6PT
UT WOS:000391896800031
PM 27987927
DA 2018-10-20
ER

PT J
AU Wang, X
   Liang, K
   Tian, YL
   Ji, YL
AF Wang, Xin
   Liang, Kai
   Tian, Yaling
   Ji, Yali
TI A facile and green emulsion casting method to prepare chitin nanocrystal
   reinforced citrate-based bioelastomer
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Bioelastomer; Chitin nanocrystal; Nanocomposite; Emulsion; Pluronic F127
ID ALPHA-CHITIN; MECHANICAL-PROPERTIES; BLOCK-COPOLYMERS; BIODEGRADABLE
   ELASTOMERS; NANOCOMPOSITE FIBERS; WHISKER; ACID; NANOFIBERS; FILMS;
   HYDROXYAPATITE
AB Chitin nanocrystal (ChiNC) is a promising reinforcing nanofiller for biomedical polymers. However, its self-aggregation characteristics caused processing difficulty in developing ChiNC-based nanocomposites. Herein, a new degradable crosslinked bioelastomer, designated as poly(1,8-octanediol-co-Pluronic F127 citrate) (POFC) was synthesized by melt polycondensation of citric acid, 1,8-octanediol, and Pluronic F127. In comparison to poly(1,8-octanediol citrate) (POC), POFC pre-polymer exhibited self-emulsifying property. Once ChiNC was introduced into the emulsion, a ChiNC stabilized Pickering emulsion was formed. Coupled with a facile green emulsion casting/evaporation method, the ChiNC ultimately reinforced ChiNC/POFC nanocomposite elastomer was fabricated. The presence of F127 segments endowed POFC with better hydrophilicity and shorter degradation time relative to POC. The incorporation of ChiNC into POFC network led to highly increased tensile modulus and strength. In vitro cytotoxicity tests indicated that the ChiNC/POFC elastomer nanocomposite had a good cytocompatibility and it appeared as a potential biomaterial for tissue engineering application. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Wang, Xin; Tian, Yaling; Ji, Yali] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
   [Liang, Kai] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
RP Ji, YL (reprint author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
EM jiyali@dhu.edu.cn
FU National Natural Science Foundation of China [51303024]; Fundamental
   Research Funds for the Central Universities
FX This work was supported by the program from the National Natural Science
   Foundation of China (Grant No. 51303024), and the Fundamental Research
   Funds for the Central Universities.
CR Chung EJ, 2011, ACTA BIOMATER, V7, P4057, DOI 10.1016/j.actbio.2011.07.001
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Dufresne A, 2008, CAN J CHEM, V86, P484, DOI 10.1139/V07-152
   Elluru M, 2013, POLYMER, V54, P2088, DOI 10.1016/j.polymer.2013.02.017
   Fan Y, 2008, BIOMACROMOLECULES, V9, P192, DOI 10.1021/bm700966g
   Feng LD, 2009, J APPL POLYM SCI, V112, P2830, DOI 10.1002/app.29731
   Hariraksapitak P, 2010, J APPL POLYM SCI, V117, P3406, DOI 10.1002/app.32095
   Hatanaka D, 2014, INT J BIOL MACROMOL, V69, P35, DOI 10.1016/j.ijbiomac.2014.05.022
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ifuku S, 2010, CARBOHYD POLYM, V81, P134, DOI 10.1016/j.carbpol.2010.02.006
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d
   Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876
   Ji YL, 2014, RSC ADV, V4, P41357, DOI 10.1039/c4ra08033e
   Kadokawa J, 2011, CARBOHYD POLYM, V84, P1408, DOI 10.1016/j.carbpol.2011.01.049
   Lee JH, 2013, J BIOMED MATER RES A, V101, P942, DOI 10.1002/jbm.a.34393
   Li J, 1996, J COLLOID INTERF SCI, V183, P365, DOI 10.1006/jcis.1996.0558
   Li XX, 2011, CARBOHYD POLYM, V85, P747, DOI 10.1016/j.carbpol.2011.03.040
   Liu MX, 2015, EUR POLYM J, V68, P190, DOI 10.1016/j.eurpolymj.2015.04.035
   Liu MX, 2015, INT J BIOL MACROMOL, V78, P23, DOI 10.1016/j.ijbiomac.2015.03.059
   Lu YS, 2004, BIOMACROMOLECULES, V5, P1046, DOI 10.1021/bm0314516x
   Lu Y, 2013, CARBOHYD POLYM, V98, P1497, DOI 10.1016/j.carbpol.2013.07.038
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Muzzarelli RAA, 2007, CARBOHYD POLYM, V70, P274, DOI 10.1016/j.carbpol.2007.04.008
   Nair K. G., 2003, CRAB SHELL CHITIN WH
   Nair KG, 2003, BIOMACROMOLECULES, V4, P1835, DOI 10.1021/bm030058g
   Patel A, 2013, BIOMATERIALS, V34, P3970, DOI 10.1016/j.biomaterials.2013.01.045
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   Perrin E, 2014, BIOMACROMOLECULES, V15, P3766, DOI 10.1021/bm5010417
   Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042
   Rubentheren V, 2015, CARBOHYD POLYM, V115, P379, DOI 10.1016/j.carbpol.2014.09.007
   Salaberria AM, 2015, EUR POLYM J, V68, P503, DOI 10.1016/j.eurpolymj.2015.03.005
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223
   Tran Richard T., 2009, Recent Patents on Biomedical Engineering, V2, P216, DOI 10.2174/1874764710902030216
   Tran RT, 2010, SOFT MATTER, V6, P2449, DOI 10.1039/c001605e
   Uddin AJ, 2012, POLYM INT, V61, P1010, DOI 10.1002/pi.4174
   Uddin AJ, 2012, CARBOHYD POLYM, V87, P799, DOI 10.1016/j.carbpol.2011.08.071
   Vapor J. P., 2015, J MATER CHEM B, V3, P9233
   Watthanaphanit A, 2008, J APPL POLYM SCI, V110, P890, DOI 10.1002/app.28634
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Zeng JB, 2012, BIOMACROMOLECULES, V13, P1, DOI 10.1021/bm201564a
   Zhang QX, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39809
   Zhang Y, 2013, BIOMATERIALS, V34, P4048, DOI 10.1016/j.biomaterials.2013.02.040
   Zhao HC, 2009, J APPL POLYM SCI, V114, P1464, DOI 10.1002/app.30735
   Zhou YM, 2014, CARBOHYD POLYM, V112, P277, DOI 10.1016/j.carbpol.2014.05.062
NR 46
TC 4
Z9 4
U1 8
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2017
VL 157
BP 620
EP 628
DI 10.1016/j.carbpol.2016.10.034
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA EH6PT
UT WOS:000391896800070
PM 27987970
DA 2018-10-20
ER

PT J
AU Xiao, QR
   Zhang, N
   Wang, X
   Man, XY
   Yang, K
   Lu, LX
   Huang, NP
AF Xiao, Qian-Ru
   Zhang, Ning
   Wang, Xi
   Man, Xin-Yao
   Yang, Ke
   Lu, Lan-Xin
   Huang, Ning-Ping
TI Oriented Surface Nanotopography Promotes the Osteogenesis of Mesenchymal
   Stem Cells
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID INVERSE OPALS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; ADHESION; FATE;
   BIOMATERIALS; STIMULATION; INDUCTION; GUIDANCE
AB Stem cells could regulate their fate by responding to physical signals from their microenvironment. Recently, a few studies have shown that the spontaneous osteogenic differentiation of mesenchymal stem cells (MSCs) could occur on surfaces with nanoscaled structures (e.g., nanotubes and nanopits), which is essentially useful when designing biomaterial scaffolds for bone tissue engineering applications. However, the osteogenic nanotopography has not been widely investigated and the osteogenic mechanism of surfaces is still not well understood. In this study, oriented nanograting-like surfaces are fabricated by stretching the nanoholed inverse opal films, which are made through a convenient bottom-up approach of the self-assembly of colloidal nanoparticles. The effect of different surface nanotopography on the osteogenic differentiation of rat bone marrow-derived MSCs (rBMSCs) is examined in the absence of osteogenic inducing media and the underlying mechanisms are investigated using immunofluorescence staining and quantitative realtime polymerase chain reaction (PCR) analysis. It is found that rBMSCs on the oriented nanograting-like surfaces show significantly higher expression levels of osteogenic genes and more phosphorylation of Smad1/5, extracellular signal-regulated kinases (ERKs), and p38, confirming the activation of Smad and mitogen-activated protein kinase signaling pathways in the nanotopography-induced osteogenesis. Thus, the oriented nanograting-like surface nanotopography may provide a new strategy for the surface design of biomaterial scaffolds in bone tissue engineering.
C1 [Xiao, Qian-Ru; Zhang, Ning; Wang, Xi; Man, Xin-Yao; Yang, Ke; Lu, Lan-Xin; Huang, Ning-Ping] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
RP Huang, NP (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM nphuang@seu.edu.cn
FU National Science Foundation of China [31340049, 31671008]; National High
   Technology Research & Development Program of China [2015AA020502]
FX This work was financially supported by the National Science Foundation
   of China (Grant Nos. 31340049 and 31671008) and the National High
   Technology Research & Development Program of China (Grant No.
   2015AA020502).
CR Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296
   Kang H, 2015, ADV MATER, V27, P1282, DOI 10.1002/adma.201404706
   Kantawong F, 2009, BIOMATERIALS, V30, P4723, DOI 10.1016/j.biomaterials.2009.05.040
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Lee SY, 2014, ADV MATER, V26, P2391, DOI 10.1002/adma.201304654
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Lu J, 2014, NANOSCALE, V6, P10650, DOI 10.1039/c4nr02626h
   Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Nikukar H, 2013, ACS NANO, V7, P2758, DOI 10.1021/nn400202j
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Seo CH, 2014, BIOMATERIALS, V35, P2245, DOI 10.1016/j.biomaterials.2013.11.089
   Shao Y, 2014, ADV MATER, V26, P1494, DOI 10.1002/adma.201304431
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Wang W, 2014, ACTA BIOMATER, V10, P3705, DOI 10.1016/j.actbio.2014.04.019
   Wang YC, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035011
   Yang JL, 2014, ACS NANO, V8, P9941, DOI 10.1021/nn504767g
   Zhou ZC, 2005, LANGMUIR, V21, P4717, DOI 10.1021/la046775t
NR 32
TC 0
Z9 0
U1 7
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD FEB 8
PY 2017
VL 4
IS 3
AR 1600652
DI 10.1002/admi.201600652
PG 9
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA ER7WW
UT WOS:000399027100001
DA 2018-10-20
ER

PT J
AU Thampi, S
   Nandkumar, AM
   Muthuvijayan, V
   Parameswaran, R
AF Thampi, Sudhin
   Nandkumar, A. Maya
   Muthuvijayan, Vignesh
   Parameswaran, Ramesh
TI Differential Adhesive and Bioactive Properties of the Polymeric Surface
   Coated with Graphene Oxide Thin Film
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE surface modification; implant; biomaterial; polyurethane; graphene;
   electrospraying; electrospinning; adhesion
ID BACTERIAL ADHESION; CELL-ADHESION; POLYURETHANE; ROUGHNESS; ENERGY; MATS
AB Surface engineering of implantable devices involving polymeric biomaterials has become an essential aspect for medical implants. A surface enhancement technique can provide an array of unique surface properties that improve its biocompatibility and functionality as an implant. Polyurethane-based implants that have found extensively acclaimed usage as an implant in biomedical applications, especially in the area of cardiovascular devices, still lack any mechanism to ward off bacterial or platelet adhesion. To bring out such a defense mechanism we are proposing a surface modification technique. Graphene oxide (GO) in very thin film form was wrapped onto the electrospun fibroporous polycarbonate urethane (PCU) membrane (GOPCU) by a simple method of electrospraying. In the present study, we have developed a simple single-step method for coating a polymeric substrate with a thin GO film and evaluated the novel antiadhesive activity of these films. SEM micrographs after coating showed the presence of very thin GO films over the PCU membrane. On the GOPCU surface, the contact angle was shifted by similar to 30 degrees, making the hydrophobic PCU surface slightly hydrophilic, while Raman spectral characterization and mapping showed the presence and distribution of GO over 75% of the membrane. A reduced platelet adhesion on the GOPCU surface was observed; meanwhile, bacterial adhesion also got reduced by 85% for Staphylococcus aureus (Gram positive, cocci) and 64% for Pseudomonas aeruginosa (Gram negative, bacilli). A cell adhesion study conducted using mammalian fibroblast cells projected its proliferation percentage in a MTT assay, with 82% cell survival on PCU and 86% on GOPCU after 24 h culture, while a study for an extended period of 72 h showed 87% of survival on PCU and 88% on GOPCU. This plethora of functionalities by a simple modification technique makes thin GO films a self-sufficient surface engineering material for future biomedical applications.
C1 [Thampi, Sudhin; Muthuvijayan, Vignesh] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
   [Thampi, Sudhin; Parameswaran, Ramesh] Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Med Devices, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
   [Nandkumar, A. Maya] Sree Chitra Tirunal Inst Med Sci & Technol, Div Microbial Technol, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
RP Parameswaran, R (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Med Devices, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
EM rameshsctimst@hotmail.com
RI Thampi, Sudhin/V-6525-2017; Muthuvijayan, Vignesh/M-8266-2016
OI Thampi, Sudhin/0000-0003-3516-0787; Muthuvijayan,
   Vignesh/0000-0003-4921-9073
FU IITM
FX This study was performed at the Sree Chitra Tirunal Institute for
   Medical Sciences and Technology (SCTIMST) in collaboration with the
   Indian Institute of Technology Madras (IITM). One of the authors (S.T.)
   acknowledges the IITM for fellowship and the SCTIMST for facility
   provided to perform this study. Authors also extend thanks to Mr.
   Pradeep Kumar at Division of Microbial Technology, SCTIMST, for
   providing technical assistance in carrying out bacterial studies and Mr.
   Sarath at Amrita Center for Nanosciences & Molecular Medicine, Amrita
   Institute of Medical Sciences, for XPS analysis.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Barbolina I, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/2/025025
   Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Childres I, 2013, NEW DEV PHOTON MAT R, V1
   de Faria AF, 2015, ACS APPL MATER INTER, V7, P12751, DOI 10.1021/acsami.5b01639
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ganguly A, 2011, J PHYS CHEM C, V115, P17009, DOI 10.1021/jp203741y
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gupta A, 2006, NANO LETT, V6, P2667, DOI 10.1021/nl061420a
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442
   Ji HW, 2016, ADV DRUG DELIVER REV, V105, P176, DOI 10.1016/j.addr.2016.04.009
   Jia ZJ, 2016, ACS APPL MATER INTER, V8, P17151, DOI 10.1021/acsami.6b05198
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Mayuri PV, 2016, MAT SCI ENG C-MATER, V60, P19, DOI 10.1016/j.msec.2015.11.004
   Nagaoka S, 1990, J BIOACT COMPAT POLY, V5, P212
   Perreault F, 2015, ACS NANO, V9, P7226, DOI 10.1021/acsnano.5b02067
   Redondo-Foj B, 2015, POLYM INT, V64, P284, DOI 10.1002/pi.4788
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Thampi S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41809
   Treter J., 2011, HDB SCI MICROBIAL PA, P835
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vadgama P, 2005, ANN RP CH C, V101, P14, DOI 10.1039/b408906p
   Wang SR, 2009, LANGMUIR, V25, P11078, DOI 10.1021/la901402f
   Yang J, 2014, FRONT CHEM SCI ENG, V8, P188, DOI 10.1007/s11705-014-1414-1
   Yao C, 2014, J BIOMED MATER RES A, V102, P1823, DOI 10.1002/jbm.a.34856
   Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154
   Yuan WJ, 2013, MAT SCI ENG C-MATER, V33, P3644, DOI 10.1016/j.msec.2013.04.048
   ZINGG W, 1982, CAN J SURG, V25, P16
NR 35
TC 9
Z9 9
U1 9
U2 76
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 8
PY 2017
VL 9
IS 5
BP 4498
EP 4508
DI 10.1021/acsami.6b14863
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EK3SX
UT WOS:000393848900027
PM 28090771
DA 2018-10-20
ER

PT J
AU Dhawan, U
   Pan, HA
   Shie, MJ
   Chu, YH
   Huang, GS
   Chen, PC
   Chen, WL
AF Dhawan, Udesh
   Pan, Hsu-An
   Shie, Meng-Je
   Chu, Ying Hao
   Huang, Guewha S.
   Chen, Po-Chun
   Chen, Wen Liang
TI The Spatiotemporal Control of Osteoblast Cell Growth, Behavior, and
   Function Dictated by Nanostructured Stainless Steel Artificial
   Microenvironments
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article
DE Nanotopography; Osteoblast; Nanoporous; Stainless steel; Extracellular
   matrix; Artificial microenvironment
ID FOCAL ADHESION KINASE; IN-VITRO; CONTACT GUIDANCE; TEMPORAL CONTROL;
   NANOTOPOGRAPHY; DIFFERENTIATION; BIOCOMPATIBILITY; CORROSION; SURFACES;
   TITANIUM
AB The successful application of a nanostructured biomaterial as an implant is strongly determined by the nanotopography size triggering the ideal cell response. Here, nanoporous topography on 304L stainless steel substrates was engineered to identify the nanotopography size causing a transition in the cellular characteristics, and accordingly, the design of nanostructured stainless steel surface as orthopedic implants is proposed. A variety of nanopore diameters ranging from 100 to 220 nm were fabricated by one-step electrolysis process and collectively referred to as artificial microenvironments. Control over the nanopore diameter was achieved by varying bias voltage. MG63 osteoblasts were cultured on the nanoporous surfaces for different days. Immunofluorescence (IF) and scanning electron microscopy (SEM) were performed to compare the modulation in cell morphologies and characteristics. Osteoblasts displayed differential growth parameters and distinct transition in cell behavior after nanopore reached a certain diameter. Nanopores with 100-nm diameter promoted cell growth, focal adhesions, cell area, viability, vinculin-stained area, calcium mineralization, and alkaline phosphatase activity. The ability of these nanoporous substrates to differentially modulate the cell behavior and assist in identifying the transition step will be beneficial to biomedical engineers to develop superior implant geometries, triggering an ideal cell response at the cell-nanotopography interface.
C1 [Dhawan, Udesh; Pan, Hsu-An; Shie, Meng-Je; Chu, Ying Hao; Huang, Guewha S.] Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Univ Rd, Hsinchu, Taiwan.
   [Chen, Po-Chun] Natl Taipei Univ Technol, Inst Mat Sci & Engn, Sect 3,Zhongxiao E Rd, Taipei 106, Taiwan.
   [Chen, Wen Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, 1001 Univ Rd, Hsinchu 300, Taiwan.
RP Chen, PC (reprint author), Natl Taipei Univ Technol, Inst Mat Sci & Engn, Sect 3,Zhongxiao E Rd, Taipei 106, Taiwan.; Chen, WL (reprint author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, 1001 Univ Rd, Hsinchu 300, Taiwan.
EM cpc@mail.ntut.edu.tw; wenurea@yahoo.com.tw
OI Chen, Wen Liang/0000-0003-4308-3128
FU Taiwan Ministry of Science and Technology [MOST 105-2633-B-009-003, MOST
   105-2622-E-009-008-CC2]
FX This study was funded by the Taiwan Ministry of Science and Technology
   under grant numbers (MOST 105-2633-B-009-003 and MOST
   105-2622-E-009-008-CC2).
CR Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Cadosch D, 2009, J ORTHOP RES, V27, P841, DOI 10.1002/jor.20831
   Carson D, 2016, ACS APPL MATER INTER, V8, P21923, DOI 10.1021/acsami.5b11671
   Castro-Raucci LMS, 2016, J CELL BIOCHEM, V117, P1718, DOI 10.1002/jcb.25469
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dhawan U, SCI REP, V6, P31998
   Dhawan U, 2016, IEEE T NANOBIOSCI, V15, P704, DOI 10.1109/TNB.2016.2605686
   Dhawan U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158425
   Dhawan U, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0144-y
   Driscoll MK, 2014, ACS NANO, V8, P3546, DOI 10.1021/nn406637c
   Hung YC, 2010, LAB CHIP, V10, P1189, DOI 10.1039/b921354f
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Lee CH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-250
   Li JY, 2012, SURF COAT TECH, V206, P2161, DOI 10.1016/j.surfcoat.2011.09.052
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Lu YL, 2008, ELECTROPHORESIS, V29, P3123, DOI 10.1002/elps.200700824
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Martinesi M, 2007, J BIOMED MATER RES A, V80A, P131, DOI 10.1002/jbm.a.30846
   Mikulewicz M, 2011, BIOL TRACE ELEM RES, V142, P865, DOI 10.1007/s12011-010-8798-7
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Olivares-Navarrete R, 2012, J BONE MINER RES, V27, P1773, DOI 10.1002/jbmr.1628
   Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078
   Pan HA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/33/335703
   Pan HA, 2012, BIOMATERIALS, V33, P20, DOI 10.1016/j.biomaterials.2011.09.054
   Pan HA, 2009, NANOSCALE RES LETT, V4, P903, DOI 10.1007/s11671-009-9333-7
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Roguska A, 2011, APPL SURF SCI, V257, P5037, DOI 10.1016/j.apsusc.2011.01.018
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Wang J, 2015, LANGMUIR, V31, P307, DOI 10.1021/la503254x
   Ward BC, 2006, BIOMATERIALS, V27, P3064, DOI 10.1016/j.biomaterials.2005.12.027
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 40
TC 2
Z9 2
U1 0
U2 63
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD FEB 6
PY 2017
VL 12
AR 86
DI 10.1186/s11671-016-1810-1
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA FM9JD
UT WOS:000415582500001
PM 28168610
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Calabrese, G
   Forte, S
   Gulino, R
   Cefali, F
   Figallo, E
   Salvatorelli, L
   Maniscalchi, ET
   Angelico, G
   Parenti, R
   Gulisano, M
   Memeo, L
   Giuffrida, R
AF Calabrese, Giovanna
   Forte, Stefano
   Gulino, Rosario
   Cefali, Francesco
   Figallo, Elisa
   Salvatorelli, Lucia
   Maniscalchi, Eugenia T.
   Angelico, Giuseppe
   Parenti, Rosalba
   Gulisano, Massimo
   Memeo, Lorenzo
   Giuffrida, Raffaella
TI Combination of Collagen-Based Scaffold and Bioactive Factors Induces
   Adipose-Derived Mesenchymal Stem Cells Chondrogenic Differentiation In
   vitro
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE mesenchymal stem cells; 3D scaffolds; cartilage repair; chondrogenic
   differentiation; regenerative medicine
ID TISSUE ENGINEERING APPLICATIONS; ARTICULAR-CARTILAGE; BONE-MARROW;
   CHONDROCYTES; REPAIR; POLYURETHANE; REGENERATION; IMPLANTATION;
   HYDROGEL; DEFECTS
AB Recently, multipotent mesenchymal stem cells (MSCs) have attracted much attention in the field of regenerative medicine due to their ability to give rise to different cell types, including chondrocytes. Damaged articular cartilage repair is one of the most challenging issues for regenerative medicine, due to the intrinsic limited capability of cartilage to heal because of its avascular nature. While surgical approaches like chondral autografts and allografts provide symptoms and function improvement only for a short period, MSC based stimulation therapies, like microfracture surgery or autologous matrix-induced chondrogenesis demonstrate to be more effective. The use of adult chondrocytes, which are the main cellular constituent of cartilage, in medical practice, is indeed limited due to their instability in monolayer culture and difficulty to collect donor tissue (articular and nasal cartilage). The most recent cartilage engineering approaches combine cells, biomaterial scaffold and bioactive factors to promote functional tissue replacements. Many recent evidences demonstrate that scaffolds providing specific microenvironmental conditions can promote MSCs differentiation toward a functional phenotype. In the present work, the chondrogenic potential of a new Collagen I based 3D scaffold has been assessed in vitro, in combination with human adipose-derived MSCs which possess a higher chondrogenic potential compared to MSCs isolated from other tissues. Our data indicate that the scaffold was able to promote the early stages of chondrogenic commitment and that supplementation of specific soluble factors was able to induce the complete differentiation of MSCs in chondrocytes as demonstrated by the appearance of cartilage distinctive markers (Sox 9, Aggrecan, Matrilin-1, and Collagen II), as well as by the cartilage-specific Alcian Blue staining and by the acquisition of typical cellular morphology. Such evidences suggest that the investigated scaffold formulation could be suitable for the production of medical devices that can be beneficial in the field of articular cartilage engineering, thus improving the efficacy and durability of the current therapeutic options.
C1 [Calabrese, Giovanna; Forte, Stefano; Gulino, Rosario; Giuffrida, Raffaella] Ist Oncol Mediterraneo Ricerca Viagrande, Catania, Italy.
   [Calabrese, Giovanna; Gulino, Rosario; Maniscalchi, Eugenia T.; Parenti, Rosalba; Gulisano, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, Physiol Sect, Catania, Italy.
   [Cefali, Francesco; Figallo, Elisa] Finceram Faenza, Faenza, Italy.
   [Salvatorelli, Lucia; Angelico, Giuseppe] Univ Catania, GF Ingrassia Policlin Vittorio Emanuele, Dept Med & Surg Sci & Adv Technol, Anat Pathol Sect, Catania, Italy.
   [Memeo, Lorenzo] Mediterranean Inst Oncol, Dept Expt Oncol, Viagrande, Italy.
RP Forte, S; Giuffrida, R (reprint author), Ist Oncol Mediterraneo Ricerca Viagrande, Catania, Italy.
EM stefano.forte@grupposamed.com; giuffrida.raffaella69@gmail.com
FU Italian "PON Ricerca e Competitivita" [ASSE I 829]
FX The present research was partially funded by the Italian "PON Ricerca e
   Competitivita 2007-2013, ASSE I 829" grant program entitled "Piattaforme
   tecnologiche innovative per Fingegneria tissutale."
CR Arufe MC, 2010, J CELL BIOCHEM, V111, P834, DOI 10.1002/jcb.22768
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bi WM, 1999, NAT GENET, V22, P85
   Calabrese G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36399
   Calabrese G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151181
   Calabrese G, 2015, INT J MOL SCI, V16, P15609, DOI 10.3390/ijms160715609
   Chow JCY, 2004, ARTHROSCOPY, V20, P681, DOI 10.1016/j.arthro.2004.06.005
   Coons DA, 2005, ORTHOP CLIN N AM, V36, P447, DOI 10.1016/j.ocl.2005.05.007
   Dahlin RL, 2014, BIOMATERIALS, V35, P7460, DOI 10.1016/j.biomaterials.2014.05.055
   Deponti D, 2014, TISSUE ENG PT A, V20, P1113, DOI [10.1089/ten.tea.2013.0171, 10.1089/ten.TEA.2013.0171]
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Eglin D, 2010, J BIOMED MATER RES A, V92A, P393, DOI 10.1002/jbm.a.32385
   Fan WS, 2016, BIOCHEM BIOPH RES CO, V474, P338, DOI 10.1016/j.bbrc.2016.04.101
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   He PF, 2016, ACTA BIOMATER, V35, P87, DOI 10.1016/j.actbio.2016.02.026
   Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196
   HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879
   Hung KC, 2016, BIOMATERIALS, V83, P156, DOI 10.1016/j.biomaterials.2016.01.019
   Jackson D W, 2001, Clin Orthop Relat Res, pS14, DOI 10.1097/00003086-200110001-00003
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Lafont JE, 2010, INT J EXP PATHOL, V91, P99, DOI 10.1111/j.1365-2613.2010.00707.x
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853
   Minguell JJ, 2013, STEM CELLS DEV, V22, P193, DOI 10.1089/scd.2012.0417
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0
   Raftery RM, 2016, ACTA BIOMATER, V43, P160, DOI 10.1016/j.actbio.2016.07.009
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Solorio LD, 2013, TISSUE ENG PART B-RE, V19, P209, DOI [10.1089/ten.teb.2012.0252, 10.1089/ten.TEB.2012.0252]
   Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Stott NS, 1999, J CELL PHYSIOL, V180, P314, DOI 10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.3.CO;2-P
   Tsai MC, 2015, COLLOID SURFACE B, V125, P34, DOI 10.1016/j.colsurfb.2014.11.003
   Vicari L, 2016, STEM CELLS INT, DOI 10.1155/2016/5282185
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
NR 46
TC 6
Z9 7
U1 3
U2 25
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD FEB 2
PY 2017
VL 8
AR 50
DI 10.3389/fphys.2017.00050
PG 13
WC Physiology
SC Physiology
GA EJ5CR
UT WOS:000393234600001
PM 28210226
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Aguiari, P
   Iop, L
   Favaretto, F
   Fidalgo, CML
   Naso, F
   Milan, G
   Vindigni, V
   Spina, M
   Bassetto, F
   Bagno, A
   Vettor, R
   Gerosa, G
AF Aguiari, Paola
   Iop, Laura
   Favaretto, Francesca
   Fidalgo, Catia Marisa Lourenco
   Naso, Filippo
   Milan, Gabriella
   Vindigni, Vincenzo
   Spina, Michel
   Bassetto, Franco
   Bagno, Andrea
   Vettor, Roberto
   Gerosa, Gino
TI In vitro comparative assessment of decellularized bovine pericardial
   patches and commercial bioprosthetic heart valves
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE bovine pericardium; alphaGal; decellularization; heart valves;
   tissue-guided regeneration; in situ tissue engineering
ID PORCINE AORTIC VALVES; MACROPHAGE-LIKE CELLS; TISSUE; MATRIX;
   CALCIFICATION; BIOMATERIAL; ACTIVATION; EXTRACTION; MODEL
AB Notwithstanding their wide exploitation, biological prosthetic heart valves are characterized by limited durability (10-15 years). The treatment of biological tissues with chemical crosslinking agents such as glutaraldehyde accounts for the enhanced risk of structural deterioration associated with the early failure of bioprosthetic valves. To overcome the shortcomings of the currently available solutions, adoption of decellularized biological tissues of animal origin has emerged as a promising approach. The present study aims to assess. in vitro cardiovascular scaffolds composed of bovine pericardium decellularized with the novel TRITDOC (TRIton-X100 and TauroDeOxyCholic acid) procedure. The effects of the treatment have been assessed by means of histological, biomolecular, cellular, biochemical and biomechanical analyses. The TRITDOC procedure grants the complete decellularization of bovine pericardial scaffolds while preserving the extracellular matrix architecture and the biomechanical properties. With a dedicated ELISA test, the TRITDOC procedure has been proven to ensure the complete removal of the alphaGal antigen, responsible for hyperacute rejection and for long-term deterioration of xenogenic biomaterials. Static seeding of the acellular pericardial patches with human adipose-derived stem cells resulted in an evenly repopulated scaffold without signs of calcification. The in vitro cyto-/immuno-compatibility response of the TRITDOC-bovine pericardium was compared with glutaraldehyde-treated xenogenic pericardium collected from two bioprosthetic devices currently used in clinical practice: PERIMOUNTMAGNAand TRIFECTA (TM). TRITDOC-bovine pericardium exhibited lower complement activation, lower cytotoxicity and a lower tendency to secrete pro-inflammatory cytokines compared to the tested commercial bioprostheses. Therefore, TRITDOC-decellularized pericardium could be considered as possible candidate material for the production of prosthetic heart valves.
C1 [Aguiari, Paola; Iop, Laura; Fidalgo, Catia Marisa Lourenco; Naso, Filippo; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.
   [Aguiari, Paola; Iop, Laura; Fidalgo, Catia Marisa Lourenco; Gerosa, Gino] Venetian Inst Mol Med, Padua, Italy.
   [Favaretto, Francesca; Milan, Gabriella; Vettor, Roberto] Univ Padua, Dept Med, Internal Med, Clin Med 3, Via Giustiniani 2, I-35128 Padua, Italy.
   [Vindigni, Vincenzo; Bassetto, Franco] Univ Padua, Dept Neurosci, Via Giustiniani 2, Padua, Italy.
   [Spina, Michel] Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, Padua, Italy.
   [Bagno, Andrea] Univ Padua, Dept Ind Engn, Via Marzolo 9, I-35128 Padua, Italy.
RP Gerosa, G (reprint author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.; Gerosa, G (reprint author), Venetian Inst Mol Med, Padua, Italy.
EM paola.aguiari@unipd.it; laura.iop@unipd.it;
   francesca.favaretto@unipd.it; catiamarisa.lourencofidalgo@unipd.it;
   biotechster@gmail.com; gabriella.milan@unipd.it;
   vincenzo.vindigni@unipd.it; michele.spina@unipd.it;
   franco.bassetto@unipd.it; andrea.bagno@unipd.it;
   roberto.vettor@unipd.it; gino.gerosa@unipd.it
OI Fidalgo, Catia/0000-0002-2846-9279; Vindigni,
   Vincenzo/0000-0001-6638-9010; Naso, Filippo/0000-0002-8198-8799; Bagno,
   Andrea/0000-0002-4296-3601
FU 'Fondazione Cassa di Risparmio di Padua e Rovigo' (Padua Heart Project);
   Ricerca Finalizzata of Veneto Region [RF-2009-1526404]
FX The authors would like to thank Dr Giorgio De Rossi for the assistance
   in bovine pericardium supply. This research has been supported by the
   'Fondazione Cassa di Risparmio di Padua e Rovigo' (Padua Heart Project)
   and by the Ricerca Finalizzata of Veneto Region (RF-2009-1526404).
CR Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   Buratto E., 2011, HEART LUNG CIRCULATI, V20, pS229
   Buratto E J, 2012, QSCIENCE PROC, V2012, P36
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573
   GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I
   Galili U, 2012, TRANSPLANTATION, V93, P11, DOI 10.1097/TP.0b013e31823be870
   Gao GQ, 2004, J AM COLL CARDIOL, V44, P384, DOI 10.1016/j.jacc.2004.01.053
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Grotenhuis N, 2013, BIOCHEM BIOPH RES CO, V433, P115, DOI 10.1016/j.bbrc.2013.02.054
   Iop L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099593
   Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Manji RA, 2014, XENOTRANSPLANTATION, V21, P1, DOI 10.1111/xen.12080
   Mathapati S, 2013, MAT SCI ENG C-MATER, V33, P1561, DOI 10.1016/j.msec.2012.12.062
   Matheson LA, 2006, BIOCHEM CELL BIOL, V84, P763, DOI 10.1139/O06-093
   Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019
   McBane JE, 2009, J BIOMAT SCI-POLYM E, V20, P437, DOI 10.1163/156856209X416467
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Moczar M, 1996, J HEART VALVE DIS, V5, pS276
   Mozaffarian D, 2016, CIRCULATION
   Nam J, 2012, KOREAN J THORAC CARD, V45, P380
   Naso F, 2011, ACTA BIOMATER, V7, P1728, DOI 10.1016/j.actbio.2010.11.030
   Naso F, 2013, XENOTRANSPLANTATION, V20, P252, DOI 10.1111/xen.12044
   Neethling WML, 2008, J HEART VALVE DIS, V17, P456
   Park CS, 2010, J HEART VALVE DIS, V19, P124
   Peterson MD, 2005, J IMMUNOL, V174, P8072, DOI 10.4049/jimmunol.174.12.8072
   Pettenazzo E, 2001, J THORAC CARDIOV SUR, V121, P500, DOI 10.1067/mtc.2001.112464
   Ramm R, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0560-7
   Sanna M, 2009, CLIN LIPIDOL, V4, P245, DOI 10.2217/CLP.09.8
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Sharma V, 2015, EUR J CARDIO-THORAC, V47, P4, DOI 10.1093/ejcts/ezu272
   Siddiqui RF, 2009, HISTOPATHOLOGY, V55, P135, DOI 10.1111/j.1365-2559.2008.03190.x
   THIENE G, 1994, EUR J CARDIO-THORAC, V8, P476, DOI 10.1016/1010-7940(94)90017-5
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yang M, 2009, J BIOMED MATER RES B, V91B, P354, DOI 10.1002/jbm.b.31409
NR 40
TC 3
Z9 3
U1 6
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2017
VL 12
AR 015021
DI 10.1088/1748-605X/aa5644
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FJ4PI
UT WOS:000412722400001
PM 28157718
OA Bronze
DA 2018-10-20
ER

PT J
AU Sandhya, S
   Mohanan, PV
   Sabareeswaran, A
   Varma, HK
   Komath, M
AF Sandhya, Sony
   Mohanan, Parayanthala Valappil
   Sabareeswaran, Arumugan
   Varma, Hari Krishna
   Komath, Manoj
TI Preclinical safety and efficacy evaluation of 'BioCaS' bioactive calcium
   sulfate bone cement
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE biomaterial; calcium sulfate; self-setting bone cement; bone filler;
   biocompatibility; osteotransductivity; bone implantation
ID SUBSTITUTE; STRONTIUM; SBF
AB A new bioactive calcium sulfate-based formulation (named 'BioCaS') has been developed for bone filler applications. This is a self-setting injectable cement where the preset form comprises bassanite obtained from the uniform submicron-sized precursor crystals of gypsum, modified with hydrogen orthophosphate ions. The results of the safety and efficacy evaluation of BioCaS cement, done as per the International Standards and guidelines, are presented in this paper. The study plan consisted of in vitro screening tests of cytotoxicity and haemolysis and in vivo biocompatibility evaluation, including an acute systemic toxicity test (in mice), an intracutaneous reactivity test (in rabbits), a pyrogen test (in rabbits) and a maximization sensitization test (in guinea pigs). The efficacy of the material in healing bone defects was investigated by implanting it in artificially created defects in rabbit femora, with clinically established hydroxyapatite porous ceramic as the control, followed by histological analysis at 12, 26 and 52 weeks. Set BioCaS cement consisted of hydrogen orthophosphate incorporating low-dimensional gypsum crystal lattices, the bioactivity of which has been identified by immersion in simulated body fluid. BioCaS was proved to be non-cytotoxic and non-haemolytic in the screening tests. In the live/dead assay, human osteoblast-like human osteosarcoma cells adhered well and spread on the surface of the material, attaining typical morphology and affirming the bone cell compatibility of the material. In the biocompatibility evaluation there were no acute systemic effects and the material proved non-pyrogenic. There was no intracutaneous erythemic or oedematous reactivity and no hypersensitivity observed in the Magnusson-Kligman method. The material satisfied the biocompatibility requirements. Bone implantation study revealed BioCaS to be osteoconductive and its efficacy of healing the experimental bone defects in rabbit femora is on a par with that of hydroxyapatite ceramic. The material resorbed at a pace matching that of new bone formation. This property of osteotransductivity will help the defect to heal and gain strength faster.
C1 [Sandhya, Sony; Mohanan, Parayanthala Valappil; Sabareeswaran, Arumugan; Varma, Hari Krishna; Komath, Manoj] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
RP Komath, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
EM manoj@sctimst.ac.in
CR [Anonymous], 2009, 109935 ISO
   [Anonymous], 2009, 109931 ISO
   [Anonymous], 2010, 1099310 ISO
   [Anonymous], 2009, F2014222409 ASTM
   [Anonymous], 2006, ISO10993112006
   Beuerlein MJS, 2010, J ORTHOP TRAUMA, V24, pS46, DOI 10.1097/BOT.0b013e3181cec48e
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Clayer M, 2008, ANZ J SURG, V78, P366, DOI 10.1111/j.1445-2197.2008.04479.x
   Ding TT, 2012, IEEE T NANOBIOSCI, V11, P336, DOI 10.1109/TNB.2012.2190418
   Fernandez AC, 2006, CURR SCI INDIA, V91, P1678
   Howlin RP, 2015, ANTIMICROB AGENTS CH, V59, P111, DOI 10.1128/AAC.03676-14
   International Organization for Standardization, 2006, 1099311 ISO
   International Organization for Standardization(ISO), 2007, 109936 ISO
   ISO, 2002, 109934 ISO
   Jalota S, 2008, MAT SCI ENG C-BIO S, V28, P129, DOI 10.1016/j.msec.2007.10.058
   Kapusetti G, 2013, J MATER CHEM B, V1, P2275, DOI 10.1039/c3tb00004d
   Kelly CM, 2004, ORTHOPEDICS, V27, pS131
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumari B, 2014, COMPEN CONTIN ED DEN, V35, P36
   Larsson S, 2011, INJURY, V42, pS30, DOI 10.1016/j.injury.2011.06.013
   Lee WK, 2009, J IND ENG CHEM, V15, P677, DOI 10.1016/j.jiec.2009.09.044
   Lin M, 2014, J MATER CHEM B, V2, P2030, DOI 10.1039/c3tb21786h
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   Magnusson B, 1975, ANIMAL MODELS DERMAT, P76
   Menon K V, 2005, EUR J ORTHOP SURG TR, V15, P205, DOI DOI 10.1007/S00590-005-0238-6
   Mirzayan R, 2001, J BONE JOINT SURG AM, V83A, P355, DOI 10.2106/00004623-200103000-00006
   Mohan BG, 2013, J MATER SCI-MATER M, V24, P2831, DOI 10.1007/s10856-013-5018-y
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   Parker AC, 2011, CLIN ORTHOP RELAT R, V469, P3008, DOI 10.1007/s11999-011-1911-1
   Peters CL, 2006, J BIOMED MATER RES A, V76A, P456, DOI 10.1002/jbm.a.30569
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Reardon PJT, 2015, J BIOMED MATER RES A, V103, P3781, DOI 10.1002/jbm.a.35508
   Sabareeswaran A, 2013, BIOMATERIALS, V34, P9278, DOI 10.1016/j.biomaterials.2013.08.070
   Sandhya S, 2012, CRYST RES TECHNOL, V47, P780, DOI 10.1002/crat.201200098
   Sasidharan S, 2016, ACS APPL MATER INTER, V8, P15889, DOI 10.1021/acsami.6b03428
   Sony S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5355-5
   Thai VV, 2010, J MATER SCI-MATER M, V21, P1867, DOI 10.1007/s10856-010-4058-9
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P599
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Upman P, 1999, HDB BIOMATERIALS EVA, P275
   Urban RM, 2004, ORTHOPEDICS, V27, pS113
   Ustariz I H, 2011, MAKE IT SIMPLE NEWS, V27, P1
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zaiss S, 2016, MATERIALS, V9, DOI 10.3390/ma9040232
NR 45
TC 0
Z9 0
U1 3
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2017
VL 12
AR 015022
DI 10.1088/1748-605X/aa5522
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FJ4PI
UT WOS:000412722400002
PM 28157719
DA 2018-10-20
ER

PT J
AU Sadtler, K
   Sommerfeld, SD
   Wolf, MT
   Wang, XK
   Majumdar, S
   Chung, L
   Kelkar, DS
   Pandey, A
   Elisseeff, JH
AF Sadtler, Kaitlyn
   Sommerfeld, Sven D.
   Wolf, Matthew T.
   Wang, Xiaokun
   Majumdar, Shoumyo
   Chung, Liam
   Kelkar, Dhanashree S.
   Pandey, Akhilesh
   Elisseeff, Jennifer H.
TI Proteomic composition and immunomodulatory properties of urinary bladder
   matrix scaffolds in homeostasis and injury
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Biomaterials; Immunology; T cells; Macrophages
ID EXTRACELLULAR-MATRIX; MACROPHAGE PHENOTYPE; REGENERATIVE MEDICINE;
   VACCINES; CANCER; IDENTIFICATION; IMMUNOTHERAPY; TISSUES; CELLS; GRAFT
AB Urinary bladder matrix (UBM) is used clinically for management of wounds and reinforcement of surgical soft tissue repair, among other applications. UBM consists of the lamina propria and basal lamina of the porcine urinary bladder, and is decellularized as part of the process to manufacture the medical device. UBM is composed mainly of Collagen I, but also contains a wide variety of fibrillar and basement membrane collagens, glycoproteins, proteoglycans and ECM-associated factors. Upon application of the biomaterial in a traumatic or non traumatic setting in a mouse model, there is a cascade of immune cells that respond to the damaged tissue and biomaterial. Here, through the use of multicolor flow cytometry, we describe the various cells that infiltrate the UBM scaffold in a subcutaneous and volumetric muscle injury model. A wide variety of immune cells are found in the UBM scaffold immune microenvironment (SIM) including F4/80(+) macrophages, CD11c(+) dendritic cells, CD3(+) T cells and CD19(+) B cells. A systemic IL-4 upregulation and a local M2-macrophage response were observed in the proximity of the implanted UBM. The recruitment and activation of these cells is dependent upon signals from the scaffold and communication between the different cell types present.
C1 [Sadtler, Kaitlyn] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Sadtler, Kaitlyn] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA.
   [Sadtler, Kaitlyn; Sommerfeld, Sven D.; Wolf, Matthew T.; Wang, Xiaokun; Majumdar, Shoumyo; Chung, Liam; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr,Wilmer Eye Inst, Baltimore, MD 21205 USA.
   [Sadtler, Kaitlyn; Wolf, Matthew T.; Chung, Liam; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA.
   [Majumdar, Shoumyo; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   [Kelkar, Dhanashree S.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.
   [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Baltimore, MD USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr,Wilmer Eye Inst, Baltimore, MD 21205 USA.
EM jhe@jhu.edu
RI Wang, Xiaokun/D-7461-2018
OI Wang, Xiaokun/0000-0003-1992-4951
FU ACell Inc.; Hartwell Foundation Postdoctoral Fellowship; Center for
   Proteomics Discovery at the Johns Hopkins University;  [S10OD021844]
FX The authors would like to acknowledge ACell Inc. for providing UBM
   material and funding for this study. The Sidney Kimmel Comprehensive
   Cancer Center Flow Cytometry Core, Ada Tam, and Lee Blosser for guidance
   in flow cytometric studies. The Michael Delannoy and Barbara Smith at
   the Institute for Basic Biomedical Sciences microscope facility for
   assistance in electron microscopy. Jeeyoen Sohn for assistance with
   qRT-PCR studies. We acknowledge support of the Center for Proteomics
   Discovery at the Johns Hopkins University and shared instrumentation
   grant S10OD021844. M.T.W. would like to acknowledge support from the
   Hartwell Foundation Postdoctoral Fellowship.
CR Afaneh C, 2015, ANN SURG ONCOL, V22, P1252, DOI 10.1245/s10434-014-4125-4
   Agrawal V, 2015, J PEDIAT SURG CASE R, V3, P230, DOI 10.1016/j.epsc.2015.03.016
   Ali OA, 2014, CANCER RES, V74, P1670, DOI 10.1158/0008-5472.CAN-13-0777
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619
   Brown B., TISSUE ENG, V12
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Dziki J, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.8
   Faulk DM, 2014, BIOMATERIALS, V35, P8585, DOI 10.1016/j.biomaterials.2014.06.057
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Frykberg RG, 2016, J WOUND CARE, V25, pS18, DOI [10.12968/jowc.2016.25.Sup7.S18, 10.12968/jowc.2016.25.7.S18]
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Irvine DJ, 2015, CHEM REV, V115, P11109, DOI 10.1021/acs.chemrev.5b00109
   Kim J. S., ADV WOUND CARE, V5
   Kim J, 2011, NANO TODAY, V6, P466, DOI 10.1016/j.nantod.2011.08.005
   Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Leleux J., ADV HEALTHC MAT, V2
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Naba A., 2011, MOL CELL PROTEOMICS, V11
   Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647
   Parcells AL, 2014, WOUNDS, V26, P189
   Rose PT, 2015, CLIN COSMET INVESTI, V8, P361, DOI 10.2147/CCID.S53980
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Sadder K., 2016, TISSUE ENG A
   Sadtler K, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.40
   Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272
   Salzberg CA, 2006, ANN PLAS SURG, V57, P1, DOI 10.1097/01.sap.0000214873.13102.9f
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   WETZELS RHW, 1991, AM J PATHOL, V139, P451
   Wilson CB, 1996, WORLD J UROL, V14, pS30
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009
   Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]
NR 53
TC 4
Z9 4
U1 1
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD FEB
PY 2017
VL 29
SI SI
BP 14
EP 23
DI 10.1016/j.smim.2017.05.002
PG 10
WC Immunology
SC Immunology
GA FJ0EM
UT WOS:000412381300003
PM 28583764
DA 2018-10-20
ER

PT J
AU Brown, BN
   Haschak, MJ
   Lopresti, ST
   Stahl, EC
AF Brown, Bryan N.
   Haschak, Martin J.
   Lopresti, Samuel T.
   Stahl, Elizabeth C.
TI Effects of age-related shifts in cellular function and local
   microenvironment upon the innate immune response to implants
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Macrophage; Polarization; Host response; Aging; Implant
ID GLYCATION END-PRODUCTS; FOREIGN-BODY REACTION; BIOMATERIAL
   SURFACE-CHEMISTRY; EXTRACELLULAR-MATRIX SCAFFOLD; TISSUE-RESIDENT
   MACROPHAGES; T-LYMPHOCYTE SUBPOPULATIONS; CALCIUM-ION BINDING; SOURCE
   ANIMAL AGE; HOST RESPONSE; INFLAMMATORY RESPONSE
AB The host macrophage response is now well recognized as a predictor of the success or failure of biomaterial implants following placement. More specifically, shifts from an "M1" pro-inflammatory towards a more "M2- like" anti-inflammatory macrophage polarization profile have been shown to result in enhanced material integration and/or tissue regeneration downstream. As a result, a number of biomaterials-based approaches to controlling macrophage polarization have been developed. However, the ability to promote such activity is predicated upon an in-depth, context-dependent understanding of the host response to biomaterials. Recent work has shown the impacts of both tissue location and tissue status (i.e. underlying pathology) upon the host innate immune response to implants, representing a departure from a focus upon implant material composition and form. Thus, the ideas of "biocompatibility," the host macrophage reaction, and ideal material requirements and modification strategies may need to be revisited on a patient, tissue, and disease basis. Immunosenescence, dysregulation of macrophage function, and delayed resolution of immune responses in aged individuals have all been demonstrated, suggesting that the host response to biomaterials in aged individuals should differ from that in younger individuals. However, despite the increasing usage of implantable medical devices in aged patients, few studies examining the effects of aging upon the host response to biomaterials and the implications of this response for long-term integration and function have been performed. The objective of the present manuscript is to review the putative effects of aging upon the host response to implanted materials and to advance the hypothesis that age-related changes in the local microenvrionement, with emphasis on the extracellular matrix, play a previously unrecognized role in determining the host response to implants.
C1 [Brown, Bryan N.; Haschak, Martin J.; Lopresti, Samuel T.; Stahl, Elizabeth C.] Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
   [Brown, Bryan N.; Haschak, Martin J.; Lopresti, Samuel T.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15260 USA.
   [Brown, Bryan N.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15213 USA.
   [Stahl, Elizabeth C.] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.
RP Brown, BN (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM brownb@upmc.edu
FU National Institutes of Health [K12HD043441, R03AG043606, R01GM121558,
   T32EB001026]
FX This work was supported by National Institutes of Health
   awardsK12HD043441 (BNB), R03AG043606 (BNB), R01GM121558 (BNB) and
   T32EB001026 (STL, MJH, and ECS). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Alvarez E, 1996, CELL IMMUNOL, V169, P152, DOI 10.1006/cimm.1996.0103
   Alvarez M. M., 2016, J CONTROL RELEASE
   Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ashcroft GS, 1998, LAB INVEST, V78, P47
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2
   Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005
   Blaszykowski C, 2012, CHEM SOC REV, V41, P5599, DOI 10.1039/c2cs35170f
   Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009
   Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308
   Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800
   Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272
   Cicin-Sain L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002849
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI [10.1146/annurev-pathol-121808-102144, 10.1140/annurev-pathol-121808-102144]
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Dearth CL, 2016, ACTA BIOMATER, V31, P50, DOI 10.1016/j.actbio.2015.11.043
   DELAFUENTE M, 1985, COMP BIOCHEM PHYS A, V81, P935, DOI 10.1016/0300-9629(85)90933-8
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949
   Finley MJ, 2013, BIOMATERIALS, V34, P8640, DOI 10.1016/j.biomaterials.2013.07.088
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Fleckman P, 2012, J BIOMED MATER RES A, V100A, P1256, DOI 10.1002/jbm.a.34012
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283
   Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x
   Gaillard V, 2005, HYPERTENSION, V46, P372, DOI 10.1161/01.HYP.0000171472.24422.33
   Garash R, 2016, EXP BIOL MED, V241, P1054, DOI 10.1177/1535370216649444
   Gattazzo F., 2014, BIOCH BIOPHYS ACTA, V1840
   Gong L, 2016, ONCOTARGET, V7, P18458, DOI 10.18632/oncotarget.7607
   Guo R, 2015, BIOMATERIALS, V73, P85, DOI 10.1016/j.biomaterials.2015.09.005
   Hachim D., 2015, FEMALE PELVIC MED RE, V21, pS10
   Hachim D, 2017, J BIOMED MATER RES A, V105, P1281, DOI 10.1002/jbm.a.36013
   Hachim D, 2017, BIOMATERIALS, V112, P95, DOI 10.1016/j.biomaterials.2016.10.019
   Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013
   Haynes L, 2011, AGING DIS, V2, P374
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Herrero C, 2002, EXP GERONTOL, V37, P389, DOI 10.1016/S0531-5565(01)00205-4
   Holt DJ, 2012, BIOMATERIALS, V33, P7497, DOI 10.1016/j.biomaterials.2012.06.099
   Hotchkiss KM, 2016, ACTA BIOMATER, V31, P425, DOI 10.1016/j.actbio.2015.12.003
   Jin X., 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/732450, DOI 10.1155/2015/732450]
   JOHN WG, 1993, EYE, V7, P230, DOI 10.1038/eye.1993.55
   Johnson KM, 2002, INT IMMUNOL, V14, P1313, DOI 10.1093/intimm/dxf092
   Juranek JK, 2013, DIABETES, V62, P931, DOI [10.2337/db12-0632/-/DC1, 10.2337/db12-0632]
   KARP RD, 1973, J NATL CANCER I, V51, P1275, DOI 10.1093/jnci/51.4.1275
   Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0
   Keane TJ, 2015, J TISSUE ENG REGEN M, V9, P504, DOI 10.1002/term.1874
   Keeney M, 2013, BIOMATERIALS, V34, P10287, DOI 10.1016/j.biomaterials.2013.09.028
   Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Klopfleisch R., 2016, J BIOMED MAT RES A
   Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489
   Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112
   Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x
   Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845
   Lindsey ML, 2012, CARDIOVASC THER, V30, P31, DOI 10.1111/j.1755-5922.2010.00207.x
   Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   Liu YY, 2010, ATHEROSCLEROSIS, V208, P34, DOI 10.1016/j.atherosclerosis.2009.06.007
   LoPresti S, 2015, TISSUE ENG PT A, V21, pS344
   Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   McWhorter FY, 2015, CELL MOL LIFE SCI, V72, P1303, DOI 10.1007/s00018-014-1796-8
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810
   Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10
   Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245
   Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   (NCOA) N. C. o. A, 2015, CHRON DIS MAN
   NEEPER M, 1992, J BIOL CHEM, V267, P14998
   Nguyen DH, 2004, MECH AGEING DEV, V125, P641, DOI 10.1016/j.mad.2004.08.002
   Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320
   Olsson J, 2000, MECH AGEING DEV, V121, P187
   Ortman JM, 2014, AGING NATION OLDER P
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Paul N. E., 2008, BIOMATERIALS, V29
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Pierce L. M., 2009, AM J OBSTET GYNECOL, V200
   Pierce L. M., 2009, AM J OBSTET GYNECOL, V200
   Pollreisz A, 2010, ATHEROSCLEROSIS, V212, P451, DOI 10.1016/j.atherosclerosis.2010.07.011
   Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544
   Rhee I, 2014, MOL CELL BIOL, V34, P888, DOI 10.1128/MCB.01369-13
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272
   Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179
   Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321
   Sebastian C, 2009, HDB IMMUNOSENESCENCE, P919, DOI DOI 10.1007/S11481-011-9312-5
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30
   Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Springer NL, 2016, CURR OPIN BIOTECH, V40, P16, DOI 10.1016/j.copbio.2016.02.003
   Stahl EC, 2015, ORGANOGENESIS, V11, P159, DOI 10.1080/15476278.2015.1120046
   STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x
   Stephan RP, 1998, BLOOD, V91, P75
   Sun DW, 2015, CANCER EPIDEMIOL, V39, P135, DOI 10.1016/j.canep.2015.01.009
   Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tengood JE, 2016, EXP BIOL MED, V241, P1033, DOI 10.1177/1535370216647130
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125
   URRY DW, 1974, BIOINORG CHEM, V3, P305, DOI 10.1016/S0006-3061(00)82010-4
   URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810
   Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415
   Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013
   van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970
   Vishwakarma A, 2016, TRENDS BIOTECHNOL, V34, P470, DOI 10.1016/j.tibtech.2016.03.009
   Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1
   Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350
   Webster L, 1997, BIOCHEM SOC T, V25, pS250, DOI 10.1042/bst025250s
   Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013
   Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu DY, 2004, BRAIN BEHAV IMMUN, V18, P487, DOI 10.1016/j.bbi.2004.05.003
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023
   Zhang F, 2009, ANN SURG, V250, P416, DOI [10.1097/SLA.0b013e3181b41a18, 10.1097/SLA.0b013e3e181b41a18]
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zissel G, 1999, J INVEST MED, V47, P51
NR 147
TC 1
Z9 1
U1 1
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD FEB
PY 2017
VL 29
SI SI
BP 24
EP 32
DI 10.1016/j.smim.2017.05.001
PG 9
WC Immunology
SC Immunology
GA FJ0EM
UT WOS:000412381300004
PM 28539184
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Al-Maawi, S
   Orlowska, A
   Sader, R
   Kirkpatrick, CJ
   Ghanaati, S
AF Al-Maawi, Sarah
   Orlowska, Anna
   Sader, Robert
   Kirkpatrick, C. James
   Ghanaati, Shahram
TI In vivo cellular reactions to different biomaterials-Physiological and
   pathological aspects and their consequences
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Cellular inflammatory response; Multinucleated giant cells; Integration;
   Disintegration; Tissue engineering; Vascularization
ID MULTINUCLEATED GIANT-CELLS; FOREIGN-BODY RESPONSE; OSTEOCLAST-LIKE
   CELLS; MACROPHAGE FUSION; BONE SUBSTITUTES; IMPLANTATION BED;
   INFLAMMATORY CELLS; SURFACE-CHEMISTRY; IMMUNE-RESPONSE; TISSUE REACTION
AB Biomaterials are widely used in guided bone regeneration (GBR) and guided tissue regeneration (GTR). After application, there is an interaction between the host immune system and the implanted biomaterial, leading to a biomaterial-specific cellular reaction. The present review focuses on cellular reactions to numerous biomaterials in vivo with consideration of different implantation models and microenvironments in different species, such as subcutaneous implantation in mice and rats, a muscle model in goats and a femur model in rabbits. Additionally, cellular reactions to different biomaterials in various clinical indications within the oro-maxillofacial surgical field were considered. Two types of cellular reactions were observed. There was a physiological reaction with the induction of only mononuclear cells and a pathological reaction with the induction of multinucleated giant cells (MNGCs). Attention was directed to the frequently observed MNGCs and consequences of their appearance within the implantation region. MNGCs have different subtypes. Therefore, the present review addresses the different morphological phenotypes observed within the biomaterial implantation bed and discusses the critical role of MNGCs, their subtypes and their precursors as well as comparing the characteristics and differences between biomaterial-related MNGCs and osteoclasts. Polymeric biomaterials that only induced mononuclear cells underwent integration and maintained their integrity, while polymeric biomaterials that induced MNGCs underwent disintegration with material breakdown and loss of integrity. Hence, there is a question regarding whether our attention should be directed to alternative biological concepts, in combination with biomaterials that induce a physiological mononuclear cellular reaction to optimize biomaterial-based tissue regeneration.
C1 [Al-Maawi, Sarah; Orlowska, Anna; Sader, Robert; Kirkpatrick, C. James; Ghanaati, Shahram] Univ Hosp Frankfurt Goethe Univ, Dept Oral Craniomaxillofacial & Facial Plast Surg, FORM Frankfurt Orofacial Regenerat Med Lab, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
RP Ghanaati, S (reprint author), Univ Hosp Frankfurt Goethe Univ, Dept Oral Craniomaxillofacial & Facial Plast Surg, FORM Frankfurt Orofacial Regenerat Med Lab, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
FU Marie Curie Actions under EU FP7 Initial Training Network SNAL [608184]
FX This work was partially funded by Marie Curie Actions under EU FP7
   Initial Training Network SNAL 608184.
CR Ahmed GJ, 2016, ACTA HISTOCHEM CYTOC, V49, P97, DOI 10.1267/ahc.16007
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Ballanti P, 1997, OSTEOPOROSIS INT, V7, P39, DOI 10.1007/BF01623458
   Barbeck M, 2016, J BIOMED MATER RES A, V104, P2928, DOI 10.1002/jbm.a.35834
   Barbeck M., 2015, BIOMATTER, V5
   Barbeck M, 2017, J BIOMED MATER RES A, V105, P1105, DOI 10.1002/jbm.a.36006
   Barbeck M, 2016, J ORAL IMPLANTOL, V42, P127, DOI 10.1563/aaid-joi-D-14-00203
   Barbeck M, 2016, J BIOMED MATER RES A, V104, P413, DOI 10.1002/jbm.a.35579
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE267, DOI 10.1563/aaid-joi-D-14-00155
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE238, DOI 10.1563/aaid-joi-D-14-00274
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE212, DOI 10.1563/aaid-joi-D-14-00168
   Barbeck M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/5/055007
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Caballe-Serrano J, 2015, J DENT RES, V94, P192, DOI 10.1177/0022034514553977
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   CHEN NX, 1995, TRANSPLANTATION, V59, P933, DOI 10.1097/00007890-199504150-00002
   Choukroun J, 2017, EUR J TRAUMA EMERG S
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   FRIEDLAENDER GE, 1992, ORTHOPEDICS, V15, P1171
   Garcia-Jimenez WL, 2013, VET IMMUNOL IMMUNOP, V156, P54, DOI 10.1016/j.vetimm.2013.09.008
   Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003
   Ghanaati S., 2014, ANN MAXILLOFAC SURG, V4, P150, DOI DOI 10.4103/2231-0746.147106
   Ghanaati S, 2016, J CELL COMMUN SIGNAL, V10, P3, DOI 10.1007/s12079-015-0313-7
   Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010
   Ghanaati S, 2014, J ORAL IMPLANTOL, V40, P679, DOI 10.1563/aaid-joi-D-14-00138
   Ghanaati Shahram, 2013, Ann Maxillofac Surg, V3, P126, DOI 10.4103/2231-0746.119221
   Ghanaati S, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-1
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Ghanaati SM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025004
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gupta G, 2014, INDIAN J DERMATOL, V59, P481, DOI [10.4103/0019-5154.139887, 10.4103/0019-5154.119967]
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Jackson MF, 2017, FEBS LETT, V591, P728, DOI 10.1002/1873-3468.12588
   Jensen SS, 2015, CLIN ORAL IMPLAN RES, V26, P859, DOI 10.1111/clr.12376
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Klar AS, 2014, PEDIATR SURG INT, V30, P1257, DOI 10.1007/s00383-014-3616-5
   Kumar Anoop, 2015, Indian J Dent Res, V26, P295, DOI 10.4103/0970-9290.162872
   Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092
   LEE SK, 1995, ENDOCRINOLOGY, V136, P4572, DOI 10.1210/en.136.10.4572
   Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566
   Lisi L, 2017, NEUROSCI LETT, V645, P106, DOI 10.1016/j.neulet.2017.02.076
   Londono R, 2017, J BIOMED MATER RES A, V105, P2109, DOI 10.1002/jbm.a.36055
   Lorenz J., 2017, JOMI IN PRESS
   Lorenz J, 2016, CLIN ORAL INVESTIG
   Lorenz J, 2016, J ORAL IMPLANTOL, V42, P273, DOI 10.1563/aaid-joi-D-15-00133
   Lorenz J, 2015, J ORAL IMPLANTOL, V41, pE257, DOI [10.1563/aaid-joi-D-14-00273, 10.1563/AAID-JOI-D-14-00273]
   LUNDGREN D, 1994, CLIN ORAL IMPLAN RES, V5, P177, DOI 10.1034/j.1600-0501.1994.050309.x
   Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   MATSUMIYA G, 1994, TRANSPLANT P, V26, P1214
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012
   Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mills CD, 2014, J INNATE IMMUN, V6, P716, DOI 10.1159/000364945
   Mohan H., 2011, ESSENTIAL PATHOLOGY, P103
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9
   Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293
   Pereira-Suarez AL, 2006, VET PATHOL, V43, P709, DOI 10.1354/vp.43-5-709
   Piccotti JR, 1997, TRANSPLANTATION, V63, P619, DOI 10.1097/00007890-199703150-00001
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065
   Puissant E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165004
   Ravarian R, 2013, ACS NANO, V7, P8469, DOI 10.1021/nn402157n
   RUCO LP, 1993, HISTOPATHOLOGY, V23, P29, DOI 10.1111/j.1365-2559.1993.tb01180.x
   Sakai H, 2012, INT IMMUNOL, V24, P5, DOI 10.1093/intimm/dxr088
   SHEVACH EM, 1973, J EXP MED, V138, P1213, DOI 10.1084/jem.138.5.1213
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Stubinger S, 2009, EUR SURG RES, V42, P143, DOI 10.1159/000197215
   Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a
   Teitelbaum SL, 2005, J CLIN ENDOCR METAB, V90, P2466, DOI 10.1210/jc.2005-0338
   UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.immunol.2.1.395
   van Maarsseveen TCMT, 2009, CLIN EXP IMMUNOL, V155, P476, DOI 10.1111/j.1365-2249.2008.03841.x
   VANDERRHEE HJ, 1978, ARCH DERMATOL RES, V263, P13, DOI 10.1007/BF00446849
   Vervelle A., 2001, UNEOPPORTUNITE PARO, P55
NR 97
TC 5
Z9 5
U1 4
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD FEB
PY 2017
VL 29
SI SI
BP 49
EP 61
DI 10.1016/j.smim.2017.06.001
PG 13
WC Immunology
SC Immunology
GA FJ0EM
UT WOS:000412381300007
PM 28647227
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Huynh, K
AF Huynh, Karina
TI Shear-thinning biomaterial for endovascular embolization
SO NATURE REVIEWS CARDIOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5002
EI 1759-5010
J9 NAT REV CARDIOL
JI Nat. Rev. Cardiol.
PD FEB
PY 2017
VL 14
IS 2
BP 67
EP 67
DI 10.1038/nrcardio.2016.202
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FD2GF
UT WOS:000407352700008
PM 27929027
DA 2018-10-20
ER

PT J
AU Triplett, RG
   Budinskaya, O
AF Triplett, R. Gilbert
   Budinskaya, Oksana
TI New Frontiers in Biomaterials
SO ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Tissue engineering; Regenerative medicine; Biomaterials; Angiogenesis;
   Nanophase biomaterial; Atmospheric cold plasma
ID DIABETIC FOOT ULCERS; PERIPHERAL-NERVE REGENERATION; ACELLULAR DERMAL
   MATRIX; BONE REGENERATION; TENDON REPAIR; TISSUE MATRIX; SCHWANN-CELLS;
   STEM-CELLS; SCAFFOLDS; MANAGEMENT
AB Scientific and technological advances have combined to lead the way into a new era of the ever-developing science of biomaterials and tissue regeneration. This field has rapidly grown and new frontiers have quickly been established. Despite obtaining satisfactory results with current methods, improved techniques that lead to diminished patient discomfort, more favorable long-term prognosis, and decreased health care costs continue to be the goals of researchers, patients, and surgeons. Biomaterials have undergone a rapid evolution from materials that simply replaced tissues to factors that stimulate a biological response in the body.
C1 [Triplett, R. Gilbert] Texas A&M Coll Dent, Dept Oral & Maxillofacial Surg, 3302 Gaston Ave, Dallas, TX 75246 USA.
   [Triplett, R. Gilbert] Baylor Univ, Med Ctr, Dept Surg, Div Dent, Dallas, TX 75246 USA.
   [Budinskaya, Oksana] Texas A&M Coll Dent, Oral Diag Texas, 3302 Gaston Ave, Dallas, TX 75246 USA.
RP Triplett, RG (reprint author), Texas A&M Coll Dent, Dept Oral & Maxillofacial Surg, 3302 Gaston Ave, Dallas, TX 75246 USA.; Triplett, RG (reprint author), Baylor Univ, Med Ctr, Dept Surg, Div Dent, Dallas, TX 75246 USA.
EM Gtriplett@bcd.tamhsc.edu
CR Abou Neel EA, 2014, J DENT, V42, P915, DOI 10.1016/j.jdent.2014.05.008
   Akman AC, 2010, ARTIF ORGANS, V34, P65, DOI 10.1111/j.1525-1594.2009.00798.x
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Anderson JM, 2006, J MATER SCI-MATER M, V17, P1025, DOI 10.1007/s10856-006-0439-5
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   Ba-bai-ke-re MMTJA, 2010, WORLD J GASTROENTERO, V16, P3279, DOI 10.3748/wjg.v16.i26.3279
   Bhat S, 2013, BOMATTER, V3
   Bletch NKimeman, 2011, MOL THER, V19, P53
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Brown S, 2001, KEY ENG MAT, V218-220
   Budinskaya OV, 2012, WOUNDS, V24, P99
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Egli RJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13647
   Egusa H, 2012, J PROSTHODONT RES, V56, P229, DOI 10.1016/j.jpor.2012.10.001
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   Fassina L, 2012, INT J IMMUNOPATH PH, V25, P165, DOI 10.1177/039463201202500119
   Fieshman JW, 2014, DIS COLON RECTUM, V57, P623
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610
   Hants Y, 2014, J MATERN-FETAL NEO M, V27, P1637, DOI 10.3109/14767058.2013.879114
   Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091
   Hottot A, 2005, PDA J PHARM SCI TECH, V59, P138
   Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106
   Ikeda T., 2014, BIOMED RES INT, V2014, P8
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kavros SJ, 2014, ADV SKIN WOUND CARE, V27, P356, DOI 10.1097/01.ASW.0000451891.87020.69
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kim S, 2014, ACTA BIOMATER, V10, P5021, DOI 10.1016/j.actbio.2014.08.028
   Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11
   Lazic T, 2011, PLAST RECONSTR SURG, V127, p75S, DOI 10.1097/PRS.0b013e3182009d9f
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Mclek LN., 2015, TARTS DENT J, V12, P211
   Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Pati F, 2015, BIOMATERIALS, V62, P164, DOI 10.1016/j.biomaterials.2015.05.043
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rodriguez-Vazquez M, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/821279.
   Shearn JT, 2007, J BIOMECH ENG-T ASME, V129, P848, DOI 10.1115/1.2800769
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Whnworth IH, 1995, J END SURG BR, V20, P429
   Wu GH, 2015, J MED BIOL ENG, V35, P285, DOI 10.1007/s40846-015-0038-3
   Wu HD, 2012, MAT SCI ENG C-MATER, V32, P207, DOI 10.1016/j.msec.2011.10.020
   Yan W, 2007, TISSUE ENG, V13, P2781, DOI 10.1089/ten.2006.0408
   Yost MJ, 2000, AM J PHYSIOL-HEART C, V279, pH3124
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Zelen CM, 2013, INT WOUND J, V10, P502, DOI 10.1111/iwj.12097
   Zhang YS, 2016, ANN BIOMED ENG
   Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087
   Ziuzina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138209
NR 61
TC 3
Z9 3
U1 4
U2 12
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1042-3699
EI 1558-1365
J9 ORAL MAXIL SURG CLIN
JI Oral Maxillofac. Surg. Clin. N. Am.
PD FEB
PY 2017
VL 29
IS 1
BP 105
EP +
DI 10.1016/j.coms.2016.08.011
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FB6KY
UT WOS:000406253100010
PM 27890224
DA 2018-10-20
ER

PT J
AU Worthington, P
   Langhans, S
   Pochan, D
AF Worthington, Peter
   Langhans, Sigrid
   Pochan, Darrin
TI beta-hairpin peptide hydrogels for package delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Peptide; Hydrogel; Biomaterial; Self assembly; Drug encapsulation; Cell
   scaffolding
ID MESENCHYMAL STEM-CELLS; DRUG-DELIVERY; GROWTH-FACTOR; OSTEOGENIC
   DIFFERENTIATION; DESIGNED PEPTIDE; NETWORKS; PROTEIN; ENCAPSULATION;
   THERAPIES; KINETICS
AB The underlying challenge of drug delivery is the safe, controlled transport of a supply of therapeutic agent to its intended location at its effective dose. New and expanding solutions to payload delivery are being discovered in the field of hydrogels. Hydrogels are highly hydrated polymer networks that vary greatly depending on the underlying molecular structure. The subgroup of hydrogels that will be the focus of this chapter is the beta-hairpin peptide hydrogel. These peptide-based materials are formed through a molecular self-assembly mechanism that only occurs after desired triggering of intramolecular peptide folding. Once folded, the beta-hairpins assemble inter-molecularly into a nanofibrillar network. The physical properties of the hydrogel network and its peptide foundation result in advantageous material properties which can be used for multiple biomedical applications including drug delivery. As a shear thinning solid that is easily injectable, cytocompatible, customizable, and well characterized, beta-hairpin hydrogels are an exciting candidate as a drug delivery vehicle. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Worthington, Peter] Univ Delaware, Delaware Biotechnol Inst, Dept Biomed Engn, Newark, DE USA.
   [Worthington, Peter; Langhans, Sigrid] Nemours Ctr Childhood Canc Res, Alfred I duPont Hosp Children, Wilmington, DE USA.
   [Pochan, Darrin] Univ Delaware, Delaware Biotechnol Inst, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RP Pochan, D (reprint author), Univ Delaware, Delaware Biotechnol Inst, Dept Mat Sci & Engn, Newark, DE 19716 USA.
EM pochan@udel.edu
FU NIST [UD CNS 70NANB12H239]; NIH [P30114736]; DO Believe Foundation;
   Nemours Foundation
FX This work is supported by NIST UD CNS 70NANB12H239, NIH grant P30114736,
   and funds from the DO Believe and Nemours Foundations.
CR Aenlle KK, 2014, MOL ENDOCRINOL, V28, P722, DOI 10.1210/me.2013-1286
   Altunbas A, 2011, BIOMATERIALS, V32, P5906, DOI 10.1016/j.biomaterials.2011.04.069
   Bakota EL, 2013, BIOMACROMOLECULES, V14, P1370, DOI 10.1021/bm4000019
   Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Branco MC, 2009, BIOMACROMOLECULES, V10, P1374, DOI 10.1021/bm801396e
   Canazza A, 2014, FRONTIER NEUROLOGY, V5, P1, DOI DOI 10.3389/FNEUR.2014.00019
   Cardoso AZ, 2016, SOFT MATTER, V12, P3612, DOI 10.1039/c5sm03072b
   Choe S, 2017, NANOMED-NANOTECHNOL, V13, P95, DOI 10.1016/j.nano.2016.08.032
   Foster AA, 2017, CURR OPIN CHEM ENG, V15, P15, DOI 10.1016/j.coche.2016.11.003
   Giano MC, 2011, BIOMATERIALS, V32, P6471, DOI 10.1016/j.biomaterials.2011.05.052
   Glassman MJ, 2016, BIOMACROMOLECULES, V17, P415, DOI 10.1021/acs.biomac.5b01210
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hule RA, 2008, FARADAY DISCUSS, V139, P251, DOI 10.1039/b717616c
   Hule RA, 2009, MACROMOLECULES, V42, P7137, DOI 10.1021/ma9003242
   Iwamoto T, 2013, BIOL PHARM BULL, V36, P715, DOI 10.1248/bpb.b12-01102
   Ji E., 2014, BIOMATERIALS FIBRIN, V35, DOI [10.1016/j.biomaterials.2013.10.064, DOI 10.1016/J.BIOMATERIALS.2013.10.064]
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kabu S, 2015, J CONTROL RELEASE, V219, P141, DOI 10.1016/j.jconrel.2015.08.060
   Kang MK, 2014, BIOMACROMOLECULES, V15, P2004, DOI 10.1021/bm500075r
   King PJS, 2016, SOFT MATTER, V12, P1915, DOI 10.1039/c5sm02039e
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Lamm MS, 2005, J AM CHEM SOC, V127, P16692, DOI 10.1021/ja05472ff
   Li I., 2016, MISSING TOOTH MULTID
   Lindsey S, 2015, BIOMACROMOLECULES, V16, P2672, DOI 10.1021/acs.biomac.5b00541
   Maslovskis A, 2014, LANGMUIR, V30, P10471, DOI 10.1021/la502358b
   Medina SH, 2015, BIOMATERIALS, V53, P545, DOI 10.1016/j.biomaterials.2015.02.125
   Micklitsch CM, 2015, MACROMOLECULES, V48, P1281, DOI 10.1021/ma5024796
   Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nagy-smith K., 2015, MOL STRUCTURE MONOMO
   Ozbas B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268106
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Patenaude M, 2014, MACROMOL RAPID COMM, V35, P598, DOI 10.1002/marc.201300818
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024
   Nguyen QV, 2015, EUR POLYM J, V72, P602, DOI 10.1016/j.eurpolymj.2015.03.016
   Rajagopal K, 2006, EUR BIOPHYS J BIOPHY, V35, P162, DOI 10.1007/s00249-005-0017-7
   Rajagopal K, 2009, BIOMACROMOLECULES, V10, P2619, DOI 10.1021/bm900544e
   Rughani RV, 2010, MACROMOLECULES, V43, P7924, DOI 10.1021/ma1014808
   Salem M, 2014, RSC ADV, V4, P10815, DOI 10.1039/c3ra46396f
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   Sathaye S, 2015, WIRES NANOMED NANOBI, V7, P34, DOI 10.1002/wnan.1299
   Sathaye S, 2014, BIOMACROMOLECULES, V15, P3891, DOI 10.1021/bm500874t
   Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014
   Sinthuvanich C, 2012, BIOMATERIALS, V33, P7478, DOI 10.1016/j.biomaterials.2012.06.097
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Sonmez C, 2015, BIOMATERIALS, V37, P62, DOI 10.1016/j.biomaterials.2014.10.011
   Steichen SD, 2013, EUR J PHARM SCI, V48, P416, DOI 10.1016/j.ejps.2012.12.006
   Stuckey DW, 2014, NAT REV CANCER, V14, P683, DOI 10.1038/nrc3798
   Sun JEP, 2016, BIOMATER SCI-UK, V4, P839, DOI 10.1039/c5bm00538h
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
   Yucel T, 2008, MACROMOLECULES, V41, P5763, DOI 10.1021/ma702840q
   Zhou M, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414531593
NR 62
TC 9
Z9 9
U1 10
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB
PY 2017
VL 110
BP 127
EP 136
DI 10.1016/j.addr.2017.02.002
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EX2KG
UT WOS:000403054600010
PM 28257999
DA 2018-10-20
ER

PT J
AU Eskandari, S
   Guerin, T
   Toth, I
   Stephenson, RJ
AF Eskandari, Sharareh
   Guerin, Thalia
   Toth, Istvan
   Stephenson, Rachel J.
TI Recent advances in self-assembled peptides: Implications for targeted
   drug delivery and vaccine engineering
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Biomaterial; Peptide design; Drug delivery; Peptide hydrogel;
   Self-adjuvant; Self-assembled peptide; Supramolecular nanostructure;
   Vaccine delivery
ID GROUP-A STREPTOCOCCUS; COILED-COIL PEPTIDE; IN-VITRO DELIVERY;
   CONTROLLED-RELEASE; GENE DELIVERY; MOLECULAR TRANSPORTERS; HYDROPHOBIC
   COMPOUNDS; AMPHIPHILE MICELLES; POTENTIAL CARRIER; IMMUNE-RESPONSES
AB Self-assembled peptides have shown outstanding characteristics for vaccine delivery and drug targeting. Peptide molecules can be rationally designed to self-assemble into specific nanoarchitectures in response to changes in their assembly environment including: pH, temperature, ionic strength, and interactions between host (drug) and guest molecules. The resulting supramolecular nanostructures include nanovesicles, nanofibers, nanotubes, nanoribbons, and hydrogels and have a diverse range of mechanical and physicochemical properties. These molecules can be designed for cell-specific targeting by including adhesion ligands, receptor recognition ligands, or peptide-based antigens in their design, often in a multivalent display. Depending on their design, self-assembled peptide nanostructures have advantages in biocompatibility, stability against enzymatic degradation, encapsulation of hydrophobic drugs, sustained drug release, shear-thinning viscoelastic properties, and/or adjuvanting properties. These molecules can also act as intracellular transporters and respond to changes in the physiological environment. Furthermore, this class of materials has shown sequence-and structure-dependent impacts on the immune system that can be tailored to non-immunogenic for drug targeting, and immunogenic for vaccine delivery. This review explores self-assembled peptide nanostructures (beta sheets, alpha helices, peptide amphiphiles, amino acid pairing, elastin like polypeptides, cyclic peptides, short peptides, Fmoc peptides, and peptide hydrogels) and their application in vaccine delivery and drug targeting. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Eskandari, Sharareh; Guerin, Thalia; Toth, Istvan; Stephenson, Rachel J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
   [Toth, Istvan] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia.
   [Toth, Istvan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.
RP Toth, I; Stephenson, RJ (reprint author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
EM i.toth@uq.edu.au; r.stephenson@uq.edu.au
RI Stephenson, Rachel/C-4500-2016; Toth, Istvan/C-1965-2013
OI Stephenson, Rachel/0000-0001-6424-7502; Toth, Istvan/0000-0002-4572-397X
CR Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111
   Alam S, 2012, INT J NANOMED, V7, P4207, DOI 10.2147/IJN.S33015
   Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   Altunbas A, 2011, BIOMATERIALS, V32, P5906, DOI 10.1016/j.biomaterials.2011.04.069
   Amiram M, 2013, P NATL ACAD SCI USA, V110, P2792, DOI 10.1073/pnas.1214518110
   Ashkenasy N, 2006, SMALL, V2, P99, DOI 10.1002/smll.200500252
   Azmi F, 2014, BIOORGAN MED CHEM, V22, P6401, DOI 10.1016/j.bmc.2014.09.042
   Baral A, 2014, LANGMUIR, V30, P929, DOI 10.1021/la4043638
   Barnard A, 2012, ANGEW CHEM INT EDIT, V51, P6572, DOI 10.1002/anie.201200076
   Berezhnoy NV, 2014, ADV COLLOID INTERFAC, V205, P221, DOI 10.1016/j.cis.2013.08.008
   Black M, 2012, ADV MATER, V24, P3845, DOI 10.1002/adma.201200209
   Boato F, 2007, ANGEW CHEM, V119, P9173
   Boekhoven J, 2015, RSC ADV, V5, P8753, DOI 10.1039/c4ra16593d
   Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   Brea RJ, 2010, CHEM SOC REV, V39, P1448, DOI 10.1039/b805753m
   Briuglia ML, 2014, INT J PHARMACEUT, V474, P103, DOI 10.1016/j.ijpharm.2014.08.025
   Burkhard P., 2012, US Patent, Patent No. [20140242104A1, 20140242104]
   CALVETE JJ, 1992, EUR J BIOCHEM, V206, P759, DOI 10.1111/j.1432-1033.1992.tb16982.x
   Castelletto V, 2012, LANGMUIR, V28, P11599, DOI 10.1021/la302210b
   Castelletto V, 2012, LANGMUIR, V28, P12575, DOI 10.1021/la302071e
   Castelletto V, 2010, CHEM COMMUN, V46, P9185, DOI 10.1039/c0cc03793a
   Castillo J, 2012, SELF ASSEMBLED PEPTI
   Chang J, 2011, J AM CHEM SOC, V133, P1745, DOI 10.1021/ja110191f
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chen JX, 2013, MACROMOL BIOSCI, V13, P84, DOI 10.1002/mabi.201200283
   Chen YR, 2015, MACROMOLECULES, V48, P2647, DOI 10.1021/ma502572w
   Chesson CB, 2014, VACCINE, V32, P1174, DOI 10.1016/j.vaccine.2013.11.047
   Chua BY, 2008, VACCINE, V26, P4866, DOI 10.1016/j.vaccine.2008.03.032
   Chung EJ, 2014, BIOMATERIALS, V35, P1249, DOI 10.1016/j.biomaterials.2013.10.064
   Chung EK, 2010, CHEM-EUR J, V16, P5305, DOI 10.1002/chem.200903145
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Conda-Sheridan M, 2014, CHEM COMMUN, V50, P13757, DOI 10.1039/c4cc06340f
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Deming T., 2012, PEPTIDE BASED MAT
   Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   El Bissati K, 2014, VACCINE, V32, P3243, DOI 10.1016/j.vaccine.2014.03.092
   Fatouros DG, 2014, ACS APPL MATER INTER, V6, P8184, DOI 10.1021/am501673x
   Fletcher NL, 2011, SOFT MATTER, V7, P10210, DOI 10.1039/c1sm06261a
   Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68
   Fung SY, 2007, COLLOID SURFACE B, V55, P200, DOI 10.1016/j.colsurfb.2006.12.002
   Fung SY, 2009, ADV FUNCT MATER, V19, P74, DOI 10.1002/adfm.200800860
   Fung SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001956
   Fung SY, 2011, ADV FUNCT MATER, V21, P2456, DOI 10.1002/adfm.201002497
   Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Goncalves C, 2010, MATERIALS, V3, P1420, DOI 10.3390/ma3021420
   Gu FX, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70083-X
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Gupta M, 2007, ADV MATER, V19, P858, DOI 10.1002/adma.200601774
   Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hajizade A, 2015, J APPL BIOTECHNOL RE, V1, P125
   Hamley IW, 2013, LANGMUIR, V29, P5050, DOI 10.1021/la400163q
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hayashi T., 2010, NIHON RINSHO MENEKI, V34, P329
   Henricus MM, 2008, BIOCONJUGATE CHEM, V19, P2394, DOI 10.1021/bc800254n
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t
   Horne WS, 2003, J AM CHEM SOC, V125, P9372, DOI 10.1021/ja034358h
   Hua D, 2014, DRUG DES DEV THER, V8, P1839, DOI 10.2147/DDDT.S67305
   Huang RL, 2011, SOFT MATTER, V7, P6222, DOI 10.1039/c1sm05375b
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   HUNTER DD, 1991, J NEUROSCI, V11, P3960
   Huntimer L, 2013, ADV HEALTHC MATER, V2, P369, DOI 10.1002/adhm.201200181
   HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369
   Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jeong JH, 2011, PHARM RES-DORDR, V28, P2072, DOI 10.1007/s11095-011-0412-y
   Jiang HZ, 2007, SOFT MATTER, V3, P454, DOI 10.1039/b614426h
   Jiang T, 2014, INT J PHARMACEUT, V475, P547, DOI 10.1016/j.ijpharm.2014.08.067
   Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957
   Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297
   Kim JK, 2009, MOL PHARMACEUT, V6, P978, DOI 10.1021/mp900009n
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Krogstad D. V., 2013, INVESTIGATING STRUCT
   Kumar Pradeep, 2011, Recent Pat Drug Deliv Formul, V5, P24, DOI 10.2174/187221111794109510
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   Lee CH, 2009, J CONTROL RELEASE, V136, P88, DOI 10.1016/j.jconrel.2009.02.013
   Lee JH, 2010, EXPERT OPIN DRUG DEL, V7, P341, DOI 10.1517/17425240903559841
   Li JY, 2013, J AM CHEM SOC, V135, P542, DOI 10.1021/ja310019x
   Liang L., 2011, J BIOMATER NANOBIOTE, V2, P622, DOI DOI 10.4236/JBNB.2011.225074
   Liang L, 2010, J BIOMED MATER RES B, V93B, P324, DOI 10.1002/jbm.b.31562
   Lim YB, 2009, CHEM SOC REV, V38, P925, DOI 10.1039/b809741k
   Lin YA, 2014, BIOMACROMOLECULES, V15, P1419, DOI 10.1021/bm500020j
   Lindsey S, 2015, BIOMACROMOLECULES, V16, P2672, DOI 10.1021/acs.biomac.5b00541
   Liu HF, 2010, MOL PHARMACEUT, V7, P1985, DOI 10.1021/mp100274f
   Liu JF, 2014, INT J NANOMED, V9, P197, DOI 10.2147/IJN.S55875
   Liu L, 2014, INT J NANOMED, V9, P3509, DOI 10.2147/IJN.S63717
   Liu MJ, 1999, PHARM SCI TECHNOL TO, V2, P393, DOI 10.1016/S1461-5347(99)00203-5
   Lomander A, 2005, NANO LETT, V5, P1255, DOI 10.1021/nl050203r
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   Mandal D, 2014, ORG BIOMOL CHEM, V12, P3544, DOI 10.1039/c4ob00447g
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   Matson JB, 2012, SOFT MATTER, V8, P6689, DOI 10.1039/c2sm25785h
   Matson JB, 2012, SOFT MATTER, V8, P3586, DOI 10.1039/c2sm07420f
   Matson JB, 2011, CHEM COMMUN, V47, P7962, DOI 10.1039/c1cc12570b
   Maude S, 2012, TOP CURR CHEM, V310, P27, DOI 10.1007/128_2011_234
   Mazza M, 2013, FARADAY DISCUSS, V166, P181, DOI 10.1039/c3fd00100h
   Mazza M, 2013, ACS NANO, V7, P1016, DOI 10.1021/nn305193d
   McDaniel JR, 2012, J CONTROL RELEASE, V159, P362, DOI 10.1016/j.jconrel.2012.02.030
   McDaniel JR, 2010, ADV DRUG DELIVER REV, V62, P1456, DOI 10.1016/j.addr.2010.05.004
   Missirlis D, 2009, BIOCHEMISTRY-US, V48, P3304, DOI 10.1021/bi802356k
   Moktan S, 2012, MOL CANCER THER, V11, P1547, DOI 10.1158/1535-7163.MCT-11-0998
   Moyer T., 2013, SELF ASSEMBLING PEPT
   Moyle PM, 2006, J PEPT SCI, V12, P800, DOI 10.1002/psc.815
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nangia A., 2007, ENCY SUPRAMOLECULAR
   Naskar J, 2011, ORG BIOMOL CHEM, V9, P6610, DOI 10.1039/c1ob05757j
   Ouboter D. d. Bruyn, 2011, RATIONAL DESIGN PURE
   Ouyang L, 2009, LETT ORG CHEM, V6, P272, DOI 10.2174/157017809788489981
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Panda JJ, 2008, BIOMACROMOLECULES, V9, P2244, DOI 10.1021/bm800404z
   Panda JJ, 2013, J CONTROL RELEASE, V172, P1151, DOI 10.1016/j.jconrel.2013.09.016
   Panda JJ, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-18
   Panda JJ, 2011, THER DELIV, V2, P193, DOI 10.4155/TDE.10.93
   Panda JJ, 2014, POLYM CHEM-UK, V5, P4418, DOI 10.1039/c4py00173g
   Patel Ashaben, 2013, World J Pharmacol, V2, P47
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Puig-Sanvicens VAC, 2013, DRUG DELIV TRANSL RE, V3, P330, DOI 10.1007/s13346-012-0125-8
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rapaport H., 2014, US Patent, Patent No. [US8658763 B2, 8658763]
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Ryadnov M. G., 2008, LEUCINE ZIPPER BUILD, P35
   Sadatmousavi P., 2009, PEPTIDE MEDIATED ANT
   Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886
   Shiose Y, 2009, BIOCONJUGATE CHEM, V20, P60, DOI 10.1021/bc800238f
   Shirazi AN, 2013, MOL PHARMACEUT, V10, P4717, DOI 10.1021/mp400539r
   Shirazi AN, 2013, MOL PHARMACEUT, V10, P3137, DOI 10.1021/mp400199e
   Shirazi AN, 2013, MOL PHARMACEUT, V10, P2008, DOI 10.1021/mp400046u
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Sikandar MK, 2011, INT J PHARM SCI RES, V2, P1168, DOI 10.13040/IJPSR.0975-8232.2(5).1168-75
   Singh V, 2015, SOFT MATTER, V11, P5353, DOI 10.1039/c5sm00843c
   Skwarczynski M., 2013, BIOCH COMPD, V1, P2
   Skwarczynski M, 2011, DRUG DELIVERY LETT, V1, P2
   Skwarczynski M, 2013, CURR DRUG DELIV, V10, P39, DOI 10.2174/1567201811310010007
   Skwarczynskim M., 2013, HDB BIOL ACTIVE PEPT, P571
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Son SJ, 2013, AUST J CHEM, V66, P23, DOI 10.1071/CH12347
   Sone ED, 2004, J AM CHEM SOC, V126, P12756, DOI 10.1021/ja0499344
   Soukasene S, 2011, ACS NANO, V5, P9113, DOI 10.1021/nn203343z
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   Stephenson R., 2014, NANOMEDICINE
   Sun X. S., 2012, US Patent, Patent No. [US20140086952 A1, 20140086952]
   Sur S, 2013, BIOMATERIALS, V34, P4749, DOI 10.1016/j.biomaterials.2013.03.025
   Sutton S, 2009, LANGMUIR, V25, P10285, DOI 10.1021/la9011058
   Tan A, 2012, J CONTROL RELEASE, V163, P342, DOI 10.1016/j.jconrel.2012.08.009
   Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q
   Temming K, 2005, DRUG RESIST UPDATE, V8, P381, DOI 10.1016/j.drup.2005.10.002
   Trent A., 2014, AAPS J, P1
   Tsutsumi H, 2013, MOL BIOSYST, V9, P609, DOI 10.1039/c3mb25442a
   Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI DOI 10.1016/J.EUPR0T.2014.05.003
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   Verma G, 2013, PHYS CHEM CHEM PHYS, V15, P17016, DOI 10.1039/c3cp51207j
   Wang QR, 2014, RSC ADV, V4, P25461, DOI 10.1039/c4ra03304c
   Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Webber MJ, 2011, SOFT MATTER, V7, P9665, DOI 10.1039/c1sm05610g
   Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001
   Wilkinson BL, 2012, CHEM-EUR J, V18, P16540, DOI 10.1002/chem.201202629
   Wiradharma N, 2009, BIOMATERIALS, V30, P3100, DOI 10.1016/j.biomaterials.2009.03.006
   Woessner Jr J. F., 2001, MATRIX METALLOPROTEI, P1
   Wu EC, 2012, ADV FUNCT MATER, V22, P456, DOI 10.1002/adfm.201101905
   Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Xu XH, 2014, ACS NANO, V8, P9255, DOI 10.1021/nn503118f
   Xu XH, 2014, SMALL, V10, P1133, DOI 10.1002/smll.201301885
   Xu XD, 2010, ACS APPL MATER INTER, V2, P2663, DOI 10.1021/am100484c
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3
   Zaman M, 2014, NANOMEDICINE-UK, V9, P2613, DOI [10.2217/NNM.14.190, 10.2217/nnm.14.190]
   Zha RH, 2013, ADV HEALTHC MATER, V2, P126, DOI 10.1002/adhm.201200118
   Zhang JM, 2011, CHEM COMMUN, V47, P10296, DOI 10.1039/c1cc12633d
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu J, 2013, WOODH PUBL SER BIOM, V57, P238, DOI 10.1533/9780857098887.2.238
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 197
TC 37
Z9 37
U1 92
U2 259
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB
PY 2017
VL 110
BP 169
EP 187
DI 10.1016/j.addr.2016.06.013
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EX2KG
UT WOS:000403054600013
PM 27356149
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Walden, G
   Liao, X
   Donell, S
   Raxworthy, MJ
   Riley, GP
   Saeed, A
AF Walden, Grace
   Liao, Xin
   Donell, Simon
   Raxworthy, Mike J.
   Riley, Graham P.
   Saeed, Aram
TI A Clinical, Biological, and Biomaterials Perspective into Tendon
   Injuries and Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
DE tendon injury; tissue engineering; tendinopathy; tendon rupture;
   injectable scaffold; implant
ID MESENCHYMAL STEM-CELLS; MEDIATED GENE-TRANSFER; PLATELET-RICH PLASMA;
   TISSUE ENGINEERING TECHNIQUES; DIGITAL FLEXOR TENDONS; FACTOR-BETA
   ISOFORMS; TENOCYTE-LIKE CELLS; ACHILLES-TENDON; IN-VIVO; TENOGENIC
   DIFFERENTIATION
AB Tendon injury is common and debilitating, and it is associated with long-term pain and ineffective healing. It is estimated to afflict 25% of the adult population and is often a career-ending disease in athletes and racehorses. Tendon injury is associated with high morbidity, pain, and long-term suffering for the patient. Due to the low cellularity and vascularity of tendon tissue, once damage has occurred, the repair process is slow and inefficient, resulting in mechanically, structurally, and functionally inferior tissue. Current treatment options focus on pain management, often being palliative and temporary and ending in reduced function. Most treatments available do not address the underlying cause of the disease and, as such, are often ineffective with variable results. The need for an advanced therapeutic that addresses the underlying pathology is evident. Tissue engineering and regenerative medicine is an emerging field that is aimed at stimulating the body's own repair system to produce de novo tissue through the use of factors such as cells, proteins, and genes that are delivered by a biomaterial scaffold. Successful tissue engineering strategies for tendon regeneration should be built on a foundation of understanding of the molecular and cellular composition of healthy compared with damaged tendon, and the inherent differences seen in the tissue after disease. This article presents a comprehensive clinical, biological, and biomaterials insight into tendon tissue engineering and regeneration toward more advanced therapeutics.
C1 [Walden, Grace; Liao, Xin; Saeed, Aram] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England.
   [Donell, Simon] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England.
   [Donell, Simon] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.
   [Raxworthy, Mike J.] Neotherix Ltd, York, N Yorkshire, England.
   [Raxworthy, Mike J.] Univ Leeds, Leeds, W Yorkshire, England.
   [Riley, Graham P.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.
RP Saeed, A (reprint author), Univ East Anglia, Sch Pharm, Norwich, Norfolk, England.
EM aram.saeed@uea.ac.uk
RI Riley, Graham/D-3809-2009
OI Riley, Graham/0000-0001-5528-5611; Saeed, Aram/0000-0003-2903-5875
FU EPSRC ICASE award [EP/L505729/1]; Rosetrees trust; Norwich Research Park
   Translational fund [REF3.7]; Engineering and Physical Sciences Research
   Council [1500761]; Rosetrees Trust [M446]
FX The authors are grateful for the funding provided by the EPSRC ICASE
   award (Grant EP/L505729/1). A.S. acknowledges funding from Rosetrees
   trust and from Norwich Research Park Translational fund (REF3.7).
CR Abbah SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20922
   Abbah SA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt426
   Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117
   Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750
   Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020
   Bolt P, 2007, J BONE JOINT SURG AM, V89A, P1315, DOI 10.2106/JBJS.F.00257
   Bosch G, 2010, J ORTHOP RES, V28, P211, DOI 10.1002/jor.20980
   Cai XY, 2015, MOL MED REP, V11, P3047, DOI 10.3892/mmr.2014.3081
   Chan BP, 2000, ACTA ORTHOP SCAND, V71, P513, DOI 10.1080/000164700317381234
   Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x
   Chen B, 2012, BIOMATERIALS, V33, P6086, DOI 10.1016/j.biomaterials.2012.05.022
   Chen CH, 2011, KNEE SURG SPORT TR A, V19, P1597, DOI 10.1007/s00167-010-1373-0
   Chen JM, 2011, TISSUE ENG PT A, V17, P2037, DOI [10.1089/ten.tea.2010.0492, 10.1089/ten.TEA.2010.0492]
   Clarke AW, 2011, AM J SPORT MED, V39, P614, DOI 10.1177/0363546510387095
   Connell D, 2009, BRIT J SPORT MED, V43, P293, DOI 10.1136/bjsm.2008.056457
   Correia SI, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0784
   Dai Q, 2003, J ORTHOPAED RES, V21, P604, DOI 10.1016/S0736-0266(02)00239-5
   de Vos RJ, 2010, BRIT MED BULL, V95, P63, DOI 10.1093/bmb/ldq006
   Delalande A, 2015, NANOMED-NANOTECHNOL, V11, P1735, DOI 10.1016/j.nano.2015.05.004
   Deng D, 2014, BIOMATERIALS, V35, P8801, DOI 10.1016/j.biomaterials.2014.06.058
   Dex S, 2016, GENE, V587, P1, DOI 10.1016/j.gene.2016.04.051
   Divani K, 2010, MANUAL THER, V15, P463, DOI 10.1016/j.math.2010.03.011
   Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   El Khoury L, 2015, INT J SPORTS MED, V36, P333, DOI 10.1055/s-0034-1390492
   Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023
   Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x
   Gomes MJ, 2015, AGEING RES REV, V21, P43, DOI 10.1016/j.arr.2015.03.001
   Guercio A, 2015, J EQUINE VET SCI, V35, P19, DOI 10.1016/j.jevs.2014.10.006
   Guevara-Alvarez Alberto, 2014, Muscles Ligaments Tendons J, V4, P378
   Hee CK, 2011, AM J SPORT MED, V39, P1630, DOI 10.1177/0363546511404942
   Heisterbach PE, 2012, KNEE SURG SPORT TR A, V20, P1903, DOI 10.1007/s00167-011-1772-x
   Hochberg C., 2010, RHEUMATOLOGY TENDONS
   Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689
   Hoffmann A, 2007, INT ORTHOP, V31, P791, DOI 10.1007/s00264-007-0395-9
   Hou Y, 2009, BIOCHEM BIOPH RES CO, V383, P235, DOI 10.1016/j.bbrc.2009.03.159
   Jo CH, 2012, AM J SPORT MED, V40, P1035, DOI 10.1177/0363546512437525
   Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x
   KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009
   Kaux J.F., 2014, MUSCLES LIGAMENTS TE, V111, P24
   Kaux Jean-Francois, 2014, Muscles Ligaments Tendons J, V4, P24
   Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324
   Keller TC, 2011, CONNECT TISSUE RES, V52, P353, DOI 10.3109/03008207.2010.534208
   Kesikburun S, 2013, AM J SPORT MED, V41, P2609, DOI 10.1177/0363546513496542
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kim HM, 2011, CONNECT TISSUE RES, V52, P87, DOI 10.3109/03008207.2010.483026
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x
   Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d
   Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuo Catherine K, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P20, DOI 10.1186/1758-2555-2-20
   Kuo SM, 2014, CARBOHYD POLYM, V114, P230, DOI 10.1016/j.carbpol.2014.07.049
   Kwan KHL, 2014, NANOMED-NANOTECHNOL, V10, P1375, DOI 10.1016/j.nano.2013.11.015
   Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI81589, 10.1172/JCI84508]
   Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016806
   Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI [10.1089/ten.TEB.2010.0662, 10.1089/ten.teb.2010.0662]
   Lo KWH, 2014, TRENDS BIOTECHNOL, V32, P74, DOI 10.1016/j.tibtech.2013.12.002
   Lomas AJ, 2015, ADV DRUG DELIVER REV, V84, P257, DOI 10.1016/j.addr.2014.11.022
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Lu P, 2013, CELL TRANSPLANT, V22, P1507, DOI 10.3727/096368912X661292
   Lu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021154
   Lui PPY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0097-y
   Lui PPY, 2013, RHEUMATOLOGY, V52, P2116, DOI 10.1093/rheumatology/ket165
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lyras DN, 2010, ACTA ORTHOP BELG, V76, P380
   Magra M, 2008, J SCI MED SPORT, V11, P243, DOI 10.1016/j.jsams.2007.04.007
   Manning CN, 2011, J ORTHOP RES, V29, P1099, DOI 10.1002/jor.21301
   Mehta V, 2005, J HAND SURG-AM, V30A, P136, DOI 10.1016/j.jhsa.2004.08.010
   Meimandi-Parizi A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-28
   Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x
   Moshiri A, 2013, J SPORTS MED DOPING, V3, P126, DOI DOI 10.4172/2161-0673.1000126
   Moshiri A, 2015, J CELL MOL MED, V19, P1308, DOI 10.1111/jcmm.12511
   Naghashzargar E, 2015, J APPL BIOMATER FUNC, V13, pE156, DOI 10.5301/jabfm.5000216
   Ning LJ, 2015, BIOMATERIALS, V52, P539, DOI 10.1016/j.biomaterials.2015.02.061
   Nixon AJ, 2012, J SHOULDER ELB SURG, V21, P278, DOI 10.1016/j.jse.2011.11.015
   Notarnicola Angela, 2012, Muscles Ligaments Tendons J, V2, P33
   Omae H, 2012, J TISSUE ENG REGEN M, V6, P238, DOI 10.1002/term.423
   Ozkan I, 1999, EUR J CLIN INVEST, V29, P63
   Pierre-Alexis M., 2015, BIOFABRICATION, V7
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Rawson Shelley, 2013, Muscles Ligaments Tendons J, V3, P220
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rickert M, 2005, CONNECT TISSUE RES, V46, P175, DOI 10.1080/03008200500237120
   Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448
   Riley GP, 2005, SCAND J MED SCI SPOR, V15, P241, DOI 10.1111/j.1600-0838.2005.00456.x
   Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700
   Rolf CG, 2001, RHEUMATOLOGY, V40, P256, DOI 10.1093/rheumatology/40.3.256
   Rudge W.B.J., 2014, ISRN PLAST SURG, V1, P2014
   Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887
   Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Siu YS, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0016-4
   Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697
   Subramanian A, 2015, DEVELOPMENT, V142, P4191, DOI 10.1242/dev.114777
   Suwalski A, 2010, BIOMATERIALS, V31, P5237, DOI 10.1016/j.biomaterials.2010.02.077
   Tang JB, 2008, J BONE JOINT SURG AM, V90A, P1078, DOI 10.2106/JBJS.F.01188
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Thomopoulos S, 2010, ANN BIOMED ENG, V38, P225, DOI 10.1007/s10439-009-9844-5
   Thorpe CT, 2015, EQUINE VET J, V47, P137, DOI 10.1111/evj.12346
   Thorpe CT, 2015, J MECH BEHAV BIOMED, V52, P85, DOI 10.1016/j.jmbbm.2015.04.009
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011
   Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29
   Wang A, 2013, AM J SPORT MED, V41, P2925, DOI 10.1177/0363546513504285
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342
   White LJ, 2013, MAT SCI ENG C-MATER, V33, P2578, DOI 10.1016/j.msec.2013.02.020
   Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   Zhang C, 2015, BIOMATERIALS, V53, P716, DOI 10.1016/j.biomaterials.2015.02.051
   Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088
   Zhao S, 2014, INT J NANOMED, V9, P2373, DOI 10.2147/IJN.S59536
   Zhou YL, 2015, CYTOTHERAPY, V17, P320, DOI 10.1016/j.jcyt.2014.09.004
   Zhou YL, 2013, BIOMATERIALS, V34, P8269, DOI 10.1016/j.biomaterials.2013.07.072
   Zumstein MA, 2014, J SHOULDER ELB SURG, V23, P3, DOI 10.1016/j.jse.2013.08.017
NR 121
TC 10
Z9 10
U1 5
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB
PY 2017
VL 23
IS 1
BP 44
EP 58
DI 10.1089/ten.teb.2016.0181
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA EL3CN
UT WOS:000394497300004
PM 27596929
OA Green Published
DA 2018-10-20
ER

PT J
AU Foster, AA
   Marquardt, LM
   Heilshorn, SC
AF Foster, Abbygail A.
   Marquardt, Laura M.
   Heilshorn, Sarah C.
TI The diverse roles of hydrogel mechanics in injectable stem cell
   transplantation
SO CURRENT OPINION IN CHEMICAL ENGINEERING
LA English
DT Article
ID EXTRACELLULAR-MATRIX HYDROGEL; SPINAL-CORD-INJURY;
   MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; TISSUE-REPAIR; CROSS-LINKING;
   SUBSTRATE STIFFNESS; GELATIN HYDROGEL; RAPID GENERATION; SHEAR-STRESS
AB Stem cell delivery by local injection has tremendous potential as a regenerative therapy but has seen limited clinical success. Several mechanical challenges hinder therapeutic efficacy throughout all stages of cell transplantation, including mechanical forces during injection and loss of mechanical support post-injection. Recent studies have begun exploring the use of biomaterials, in particular hydrogels, to enhance stem cell transplantation by addressing the often-conflicting mechanical requirements associated with each stage of the transplantation process. This review explores recent biomaterial approaches to improve the therapeutic efficacy of stem cells delivered through local injection, with a focus on strategies that specifically address the mechanical challenges that result in cell death and/or limit therapeutic function throughout the stages of transplantation.
C1 [Foster, Abbygail A.; Marquardt, Laura M.; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU National Institutes of Health [R21-EB020235, T32-HL098049-06]; Stanford
   Bio-X [IIP-7-75]; CIRM [RT3-07948]; Coulter Foundation [CP-2014-4];
   Stanford Geballe Laboratory for Advanced Materials Postdoctoral
   Fellowship
FX This work was supported by the National Institutes of Health
   (R21-EB020235 to S.C.H. and T32-HL098049-06 to A.F.), Stanford Bio-X
   (IIP-7-75), CIRM (RT3-07948), Coulter Foundation (CP-2014-4), and
   Stanford Geballe Laboratory for Advanced Materials Postdoctoral
   Fellowship (to L.M.).
CR Abdeen AA, 2014, TISSUE ENG PT A, V20, P2737, DOI [10.1089/ten.TEA.2013.0661, 10.1089/ten.tea.2013.0661]
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Amin S, 2014, CELL BIOL INT, V38, P219, DOI 10.1002/cbin.10194
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Cai L, 2016, ADV HEALTHC MATER, V5, P2758, DOI 10.1002/adhm.201600497
   Cai L, 2015, ADV FUNCT MATER, V25, P1344, DOI 10.1002/adfm.201403631
   Camci-Unal G, 2013, POLYM INT, V62, P843, DOI 10.1002/pi.4502
   Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365
   Choi B, 2014, ACS APPL MATER INTER, V6, P20110, DOI 10.1021/am505723k
   Choi CH, 2016, LAB CHIP, V16, P1549, DOI 10.1039/c6lc00261g
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Dan P, 2015, J CELL SCI, V128, P2415, DOI 10.1242/jcs.167783
   Delaine-Smith Robin M, 2012, Muscles Ligaments Tendons J, V2, P169
   Dhote V, 2013, J MECH BEHAV BIOMED, V19, P61, DOI 10.1016/j.jmbbm.2012.10.016
   Donnelly EM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt115
   Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720
   Du HM, 2012, CELLS TISSUES ORGANS, V196, P313, DOI 10.1159/000335905
   Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fenn SL, 2016, J BIOMED MATER RES B, V104, P1229, DOI 10.1002/jbm.b.33476
   Franco CL, 2011, ACTA BIOMATER, V7, P3267, DOI 10.1016/j.actbio.2011.06.011
   Fuhrmann T, 2016, BIOMATERIALS, V83, P23, DOI 10.1016/j.biomaterials.2015.12.032
   Gaffey AC, 2015, J THORAC CARDIOV SUR, V150, P1268, DOI 10.1016/j.jtcvs.2015.07.035
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Glassman MJ, 2013, ADV FUNCT MATER, V23, P1182, DOI 10.1002/adfm.201202034
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Griffin DR, 2015, NAT MATER, V14, P737, DOI [10.1038/nmat4294, 10.1038/NMAT4294]
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Hotaling NA, 2015, ANNU REV BIOMED ENG, V17, P317, DOI 10.1146/annurev-bioeng-071813-104814
   Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796
   Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Iwasaki M, 2014, BIOMATERIALS, V35, P2617, DOI 10.1016/j.biomaterials.2013.12.019
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kwon JS, 2013, INT J PHARMACEUT, V454, P183, DOI 10.1016/j.ijpharm.2013.06.023
   Lam J, 2015, ADV HEALTHC MATER, V4, P534, DOI 10.1002/adhm.201400410
   Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483
   Lawyer T, 2012, INT J CELL BIOL, V2012, P9
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leslie SK, 2013, BIOMATERIALS, V34, P8172, DOI 10.1016/j.biomaterials.2013.07.017
   Leslie SK, 2016, J MAT CHEM B
   Li L, 2016, STEM CELLS INT, V2016
   Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709
   Lin H, 2014, TISSUE ENG PT A, V20, P2402, DOI [10.1089/ten.tea.2013.0642, 10.1089/ten.TEA.2013.0642]
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Liu ZJ, 2015, CARBOHYD POLYM, V132, P490, DOI 10.1016/j.carbpol.2015.06.013
   Lu P., 2011, COLD SPRING HARB PER, V3
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   Markusen JF, 2006, TISSUE ENG, V12, P821, DOI 10.1089/ten.2006.12.821
   Marquardt Laura M, 2016, Curr Stem Cell Rep, V2, P207, DOI 10.1007/s40778-016-0058-0
   Mulyasasmita W, 2014, J CONTROL RELEASE, V191, P71, DOI 10.1016/j.jconrel.2014.05.015
   Nguyen PK, 2014, CELL STEM CELL, V14, P431, DOI 10.1016/j.stem.2014.03.009
   Olabisi RM, 2010, TISSUE ENG PT A, V16, P3727, DOI 10.1089/ten.TEA.2010.0234
   Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293
   Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pouliot RA, 2016, J BIOMED MATER RES A, V104, P1922, DOI 10.1002/jbm.a.35726
   Quarta M, 2016, NAT BIOTECHNOL, V34, P752, DOI 10.1038/nbt.3576
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Rodell CB, 2015, ADV FUNCT MATER, V25, P636, DOI 10.1002/adfm.201403550
   Rubach M, 2014, STEM CELLS DEV, V23, P643, DOI 10.1089/scd.2013.0272
   Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Shav D, 2010, ANN NY ACAD SCI, V1188, P25, DOI 10.1111/j.1749-6632.2009.05079.x
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Sukarto A, 2012, BIOMACROMOLECULES, V13, P2490, DOI 10.1021/bm300733n
   Sun JEP, 2016, BIOMATER SCI-UK, V4, P839, DOI 10.1039/c5bm00538h
   Sun W, 2014, CELL MOL BIOENG, V7, P205, DOI 10.1007/s12195-014-0324-0
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Thorpe AA, 2016, ACTA BIOMATER, V36, P99, DOI 10.1016/j.actbio.2016.03.029
   Tian S, 2015, J STEM CELL TRANSPLA, P1
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Trensz F, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0030-1
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang LM, 2013, CELLS TISSUES ORGANS, V197, P333, DOI 10.1159/000348359
   Wang Y, 2011, J AM SOC NEPHROL, V22, P704, DOI 10.1681/ASN.2010040403
   Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007
   Wilson JL, 2014, BIOTECHNOL BIOENG, V111, P618, DOI 10.1002/bit.25121
   Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782
   Wong Po Foo C. T., 2009, P NATL ACAD SCI USA, V106, P22067, DOI DOI 10.1073/PNAS.0904851106
   Wright B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070860
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Ye YP, 2012, INT J MOL MED, V30, P1327, DOI 10.3892/ijmm.2012.1123
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Zhao X, 2016, ADV FUNCT MATER, V26, P2809, DOI 10.1002/adfm.201504943
   Zhu RJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt507
NR 109
TC 8
Z9 8
U1 3
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-3398
J9 CURR OPIN CHEM ENG
JI Curr. Opin. Chem. Eng.
PD FEB
PY 2017
VL 15
BP 15
EP 23
DI 10.1016/j.coche.2016.11.003
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA EU6FP
UT WOS:000401129700005
PM 29085771
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ngatu, NR
   Ikeda, M
   Watanabe, H
   Tanaka, M
   Inoue, M
   Kanbara, S
   Nojima, S
AF Ngatu, Nlandu Roger
   Ikeda, Mitsunori
   Watanabe, Hiroyuki
   Tanaka, Mamoru
   Inoue, Masataka
   Kanbara, Sakiko
   Nojima, Sayumi
TI Uncovering Adiponectin Replenishing Property of Sujiaonori Algal
   Biomaterial in Humans
SO MARINE DRUGS
LA English
DT Article
DE adiponectin; BMI; blood pressure; dietary supplementation; Sujiaonori
ID INDUCED INSULIN-RESISTANCE; METABOLIC SYNDROME; ENTEROMORPHA-PROLIFERA;
   CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; THERAPEUTIC TARGET;
   OBESITY; MICE; IMMUNITY; AGONIST
AB The replenishment of adiponectin-an adipocyte-derived hormone with salutary health effects-has recently been proposed as a new approach to treat hypertension, also ameliorate cardiovascular and metabolic risks. We conducted a prospective placebo-controlled, non-randomized and investigator-blinded dietary intervention study to evaluate the health effects of dietary intake of Sujiaonori (Ulva/Enteromorpha prolifera Muller) algal biomaterial (SBM), especially on adiponectin production, blood pressure (BP), and body mass index (BMI) in human subjects. Participants (N = 32) were divided into two equally sized groups (n = 16 for each group): SBM group (subjects supplemented with 3 g SBM powder twice a day during meal) and the control group (subjects who took 3 g of a supplement made of 70% corn starch powder and 30% spinach twice a day) for four weeks. Two health survey questionnaires (dietary and current health questionnaires) were completed anonymously, saliva sampling was done for adiponectin measurement by ELISA, and blood pressure (BP) and anthropometric parameters were measured at baseline and four weeks later. Student paired t-test was performed to compare baseline and post-intervention data on outcome variables between the two study groups. Results showed a 2.24-fold increase in adiponectin level in SBM group (2.81 and 6.26 ng/mL at baseline and at the end of study, respectively) (p < 0.01); whereas no significant change was observed in controls (3.58 and 3.51 ng/mL, respectively) (p > 0.05). In SBM subjects, an improvement of BP profile was noted with a significant decrease in systolic BP (p < 0.01). A positive correlation was found between SBM supplementation and adiponectin level, whereas an inverse correlation was noted between SBM supplementation and blood pressure, and also BMI. These findings suggest that SBM-increased adiponectin level and improved BP in a sample of Japanese young adults, and has the potential to improve blood pressure in humans.
C1 [Ngatu, Nlandu Roger; Ikeda, Mitsunori; Inoue, Masataka; Kanbara, Sakiko; Nojima, Sayumi] Univ Kochi, Grad Sch Hlth & Nursing Sci, Kochi 7818515, Japan.
   [Watanabe, Hiroyuki; Tanaka, Mamoru] Univ Kochi, Fac Nutr, Kochi 7818515, Japan.
RP Ngatu, NR (reprint author), Univ Kochi, Grad Sch Hlth & Nursing Sci, Kochi 7818515, Japan.
EM doc.rogerngatu@gmail.com; mikeda@cc.u-kochi.ac.jp;
   watana@cc.u-kochi.ac.jp; m-tanaka@cc.u-kochi.ac.jp;
   inoue@cc.u-kochi.ac.jp; kanbara@cc.u-kochi.ac.jp;
   nojimas@cc.u-kochi.ac.jp
OI Ngatu, Nlandu Roger/0000-0002-8847-3667
CR Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103
   Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061
   Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002
   Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x
   Huimin Q., 2015, MAR DRUGS, V13, P3407
   Ishikawa Y, 2014, J ORAL BIOSCI, V56, P110, DOI 10.1016/j.job.2014.06.001
   Ishizaka N, 2005, HYPERTENS RES, V28, P27, DOI 10.1291/hypres.28.27
   Jones PJH, 2014, AM J CLIN NUTR, V100, P88, DOI 10.3945/ajcn.113.081133
   Katira A, 2015, EXPERT OPIN THER TAR, V19, P1105, DOI 10.1517/14728222.2015.1035710
   Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051
   Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787, DOI 10.5551/jat.11833
   Kotani Kazuhiko, 2008, Diabetes Care, V31, pe47, DOI 10.2337/dc08-0186
   Lancaster GI, 2011, NAT MED, V17, P37, DOI 10.1038/nm0111-37
   Lee CH, 2015, J DIABETES INVEST, V6, P264, DOI 10.1111/jdi.12263
   Lefils-Lacourtablaise J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063997
   Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724
   Ngatu N. R., 2015, INT J GEN MED, V4, P1
   Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1
   Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656
   Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19
   Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00093
   Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90
   Patel S, 2012, BIO-TECHNOL, V2, P171, DOI DOI 10.1007/S13205-012-0061-9
   Qi HM, 2015, INT J BIOL MACROMOL, V76, P326, DOI 10.1016/j.ijbiomac.2015.03.006
   Sakata S, 2015, HYPERTENS RES, V38, P560, DOI 10.1038/hr.2015.35
   Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONHA.106.618918
   Smith L, 2005, AM FAM PHYSICIAN, V72, P1391
   Tang ZH, 2013, INT J BIOL MACROMOL, V58, P186, DOI 10.1016/j.ijbiomac.2013.03.048
   Teramoto T, 2008, HYPERTENS RES, V31, P2011, DOI 10.1291/hypres.31.2011
   Toda M, 2007, ACTA DIABETOL, V44, P20, DOI 10.1007/s00592-007-0236-8
   Tsai JS, 2011, ATHEROSCLEROSIS, V218, P168, DOI 10.1016/j.atherosclerosis.2011.04.025
   Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24923
   Wei JT, 2014, INT J BIOL MACROMOL, V64, P1, DOI 10.1016/j.ijbiomac.2013.11.013
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999
   Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014
   Zhao C., 2016, MOJ FOOD PROCESS TEC, V2
NR 38
TC 1
Z9 1
U1 0
U2 4
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD FEB
PY 2017
VL 15
IS 2
AR 32
DI 10.3390/md15020032
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EU2LI
UT WOS:000400860200004
PM 28208744
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ilnicka, A
   Kamedulski, P
   Lukaszewicz, JP
AF Ilnicka, Anna
   Kamedulski, Piotr
   Lukaszewicz, Jerzy P.
TI Pyrolysis of Chlorella vulgaris as a green chemistry method for
   manufacturing of nitrogen doped porous carbon materials of high
   application potential
SO MATERIALS EXPRESS
LA English
DT Article
DE Chitosan; Chlorella vulgaris; N-Rich Activated Carbon; Nitrogen Content;
   XPS
ID MICROBIAL FUEL-CELLS; OXYGEN REDUCTION REACTION; ACTIVATED CARBON;
   MICROPOROUS CARBONS; CO2 CAPTURE; CHITOSAN; PERFORMANCE;
   SUPERCAPACITORS; DETOXIFICATION; CATALYSTS
AB In this paper we present results on the synthesis of N-rich porous carbon matrixes from an inexpensive, and renewal raw materials i.e., Chlorella vulgaris being an undesired component of aquatic ecosystems. Moreover, manufacturing procedure involves a nontoxic reagent of CaCO3. The method includes carbonization of mixtures of chitosan or Chlorella vulgaris with CaCO3 at temperature in the range of 600-900 degrees C. The resulting carbon matrixes are nanostructured and poses high surface area up to 754 m(2)/g and high nitrogen content up to 9.83 wt.%. The created micro-, mesoporous structure is required by several emerging electrochemical applications. XPS studies revealed the formation of pyridinic and pyrrolic N-based surface species. The presence of such N-based surface functionalities is background for further investigation if the synthetized materials as non-platinum electrode material in some electrochemical power devices. Comparative studies were performed by pyrolysis of a well-known alternative biomaterial i.e., chitosan.
C1 [Ilnicka, Anna; Kamedulski, Piotr; Lukaszewicz, Jerzy P.] Nicholas Copernicus Univ, Fac Chem, Ul Gagarina 7, PL-87100 Torun, Poland.
RP Lukaszewicz, JP (reprint author), Nicholas Copernicus Univ, Fac Chem, Ul Gagarina 7, PL-87100 Torun, Poland.
EM jerzy_lukaszewicz@o2.pl
FU National Science Centre (Poland) [UMO-2014/15/N/ST8/03399]
FX This work was supported in part by the National Science Centre (Poland)
   under UMO-2014/15/N/ST8/03399.
CR Ahn Y, 2014, J POWER SOURCES, V269, P212, DOI 10.1016/j.jpowsour.2014.06.115
   Alabadi A, 2014, J MATER CHEM A, V2, P11697, DOI 10.1039/c4ta01215a
   Anastas P. T., 1998, PRONCIPLES GREEN CHE, P30
   Bai RZ, 2015, CARBON, V81, P465, DOI 10.1016/j.carbon.2014.09.079
   Chang YM, 2015, BIORESOURCE TECHNOL, V184, P344, DOI 10.1016/j.biortech.2014.09.131
   Cho EA, 2014, CARBON LETT, V15, P210, DOI 10.5714/CL.2014.15.3.210
   Eom SW, 2006, ELECTROCHIM ACTA, V52, P1592, DOI 10.1016/j.electacta.2006.02.067
   Fan XQ, 2013, CARBON, V61, P423, DOI 10.1016/j.carbon.2013.05.026
   Gao F, 2016, ELECTROCHIM ACTA, V190, P1134, DOI 10.1016/j.electacta.2016.01.005
   Ilnicka A., 2015, FRONTIERS MAT, V2, P1
   Jia SP, 2016, ELECTROCHIM ACTA, V196, P527, DOI 10.1016/j.electacta.2016.02.196
   Kim YJ, 2009, NUTR RES PRACT, V3, P89, DOI 10.4162/nrp.2009.3.2.89
   Konwar LJ, 2016, MATER LETT, V173, P145, DOI 10.1016/j.matlet.2016.03.032
   Kucinska A, 2014, SCI ADV MATER, V6, P290, DOI 10.1166/sam.2014.1714
   Kucinska A, 2012, CARBON, V50, P3098, DOI 10.1016/j.carbon.2012.02.042
   Kuciska A., 2013, INZYNIERIA OCHRONA S, V16, P191
   Lee I, 2015, ENVIRON TOXICOL PHAR, V39, P441, DOI 10.1016/j.etap.2014.11.015
   Li B, 2016, ENERG ENVIRON SCI, V9, P102, DOI 10.1039/c5ee03149d
   Lota K, 2016, MATER LETT, V173, P72, DOI 10.1016/j.matlet.2016.03.031
   Morita K, 1999, J NUTR, V129, P1731
   Song YF, 2014, ELECTROCHIM ACTA, V146, P485, DOI 10.1016/j.electacta.2014.09.078
   Wang H, 2015, RSC ADV, V5, P48965, DOI 10.1039/c5ra09144f
   Watson VJ, 2013, J POWER SOURCES, V242, P756, DOI 10.1016/j.jpowsour.2013.05.135
   Wei QL, 2015, CATALYSTS, V5, P1574, DOI 10.3390/catal5031574
   Wrobel-Iwaniec I, 2015, INT J HYDROGEN ENERG, V40, P5788, DOI 10.1016/j.ijhydene.2015.03.034
   Yang XL, 2014, J POWER SOURCES, V266, P36, DOI 10.1016/j.jpowsour.2014.04.126
   Zhang B, 2014, ACS APPL MATER INTER, V6, P7464, DOI 10.1021/am5008547
   Zhao ZJ, 2015, RSC ADV, V5, P34803, DOI 10.1039/c5ra01569c
NR 28
TC 2
Z9 2
U1 2
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2158-5849
EI 2158-5857
J9 MATER EXPRESS
JI Mater. Express
PD FEB
PY 2017
VL 7
IS 1
BP 25
EP 34
DI 10.1166/mex.2017.1350
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA ET8VG
UT WOS:000400580700004
DA 2018-10-20
ER

PT J
AU Jang, JW
   Lee, JS
   Jung, UW
   Kim, CS
   Cho, KS
AF Jang, Ji-Woong
   Lee, Jung-Seok
   Jung, Ui-Won
   Kim, Chang-Sung
   Cho, Kyoo-Sung
TI In Vivo Evaluation of Commercially Available Gel-Type Polyethylene
   Glycol Membrane for Carrier of Recombinant Human Bone Morphogenetic
   Protein-2
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID RAT CALVARIAL DEFECTS; BIODEGRADABLE MEMBRANE; DENTAL IMPLANTS;
   REGENERATION; HYDROGELS; DELIVERY; SYSTEM; MATRIX
AB Purpose: This study evaluated a commercially available, 3-dimensional gel-type polyethylene glycol (PEG) membrane as a carrier for recombinant human bone morphogenetic protein-2 (rhBMP-2) using a rat calvarial defect model. Another gel-type carrier, fibrin-fibronectin system (FFS), was used as a positive control.
   Materials and Methods: Critical-size defects were made in the rat calvarium, which were allocated to 1 of 10 groups comprising 2 healing periods and biomaterial conditions: 1) sham control, 2) FFS only, 3) FFS plus BMP-2, 4) PEG only, and 5) PEG plus BMP-2. Radiographic and histologic analyses were performed at 2 and 8 weeks after surgery.
   Results: After 2 weeks, some parts of the FFS were biodegraded and extensive cellular infiltration was observed at sites that received FFS or FFS plus BMP-2. The PEG membrane retained its augmented volume without cellular infiltration at sites that received PEG or PEG plus BMP-2. After 8 weeks, the FFS was completely degraded and replaced by new bone and connective tissues. In contrast, the volume of residual PEG was similar to that at 2 weeks, with slight cellular infiltration. In particular, there was progressive bone regeneration around micro-cracks and resorbed outer surface in the PEG + BMP-2 group. Although the PEG + BMP-2 group showed increased area and percentage of new bone, there was no statistical relevance after 2 and 8 weeks in histomorphometric analyses. However, the appearance of the healing differed (with new bone formation along micro-cracks in the PEG + BMP-2 group), and further studies with longer healing periods are needed to draw conclusions about clinical applications.
   Conclusion: Evidence of mechanical stability and new bone formation along micro-cracks when using PEG plus BMP-2 might support the PEG membrane as a candidate carrier material for rhBMP-2. Copyright (C) 2016 American Association of Oral and Maxillofacial Surgeons.
C1 [Jang, Ji-Woong; Lee, Jung-Seok; Jung, Ui-Won; Kim, Chang-Sung; Cho, Kyoo-Sung] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
RP Cho, KS (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM KSCHO@yuhs.ac
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [NRF-2013R1A1A2060464]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea funded by the Ministry
   of Education (NRF-2013R1A1A2060464).
CR Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   Coulthard P, 2003, COCHRANE DB SYST REV, V3
   Esposito M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003607.pub2
   Esposito M, 2009, COCHRANE DB SYST REV, V4
   Hanseler P, 2012, ACTA BIOMATER, V8, P116, DOI 10.1016/j.actbio.2011.08.002
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Herten M, 2009, CLIN ORAL IMPLAN RES, V20, P116, DOI 10.1111/j.1600-0501.2008.01622.x
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P188, DOI 10.1111/j.1600-0501.2007.01431.x
   Jung RE, 2006, CLIN ORAL IMPLAN RES, V17, P426, DOI 10.1111/j.1600-0501.2005.01228.x
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P151, DOI 10.1111/j.1600-0501.2008.01633.x
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P162, DOI 10.1111/j.1600-0501.2008.01634.x
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ramel CF, 2012, INT J ORAL MAX IMPL, V27, P435
   Thoma DS, 2011, CLIN ORAL IMPLAN RES, V22, P1247, DOI 10.1111/j.1600-0501.2010.02075.x
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P7, DOI 10.1111/j.1600-0501.2008.01604.x
   Wechsler S, 2008, J BIOMED MATER RES A, V85A, P285, DOI 10.1002/jbm.a.31477
   Wehrhan F, 2012, CLIN ORAL IMPLAN RES, V23, P805, DOI 10.1111/j.1600-0501.2011.02223.x
   Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817
NR 21
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD FEB
PY 2017
VL 75
IS 2
DI 10.1016/j.joms.2016.05.004
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ES0MV
UT WOS:000399221600020
PM 27288839
DA 2018-10-20
ER

PT J
AU Rhee, YH
   Oh, SH
   Lim, HJ
   Shin, JI
   Kim, C
   Oh, CH
AF Rhee, Yun-Hee
   Oh, Seong-Hwa
   Lim, Hyun-Ju
   Shin, Jang-In
   Kim, Chan
   Oh, Chung-Hun
TI Bone regeneration potential of sub-microfibrous membranes with
   osteogenic induction of rBMSC for tissue engineering
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Biocompatibility; Hard tissue; Biomaterial availability; Bone
   remodeling; Polylactic acid; Poly-epsilon-caprolactone; Osteoinductive
   potential; Sub-microfibrous membranes
ID IN-VIVO; STEM-CELLS; NANOFIBER; SCAFFOLDS; POLY(EPSILON-CAPROLACTONE);
   MATRIX; VITRO
AB Purpose: To examine the biocompatibility and osteoinductive potential of sub-microfibrous membranes with cells in vitro and in vivo.
   Methods: Polylactic acid (PLA) and poly-e-caprolactone (PCL) were blended at various volume ratios (PLA: PCL = 100: 0, 70: 30, 50: 50, 30: 70 and 0: 100) and each membrane form was prepared by electrospinning. Cell viability, biocompatibility, and bone regeneration were measured.
   Results: The membranes from the PLA/PCL blends prepared by an electrospinning process showed a range of diameter distribution ranging from 1,580 to 550 nm. The cells of 100 % PCL membrane (smallest diameter) exhibited significantly higher adhesion and proliferation than those of the other membranes. Among the membranes from PLA/PCL blends, PCL membrane showed weak inflammatory changes in the early stages of implantation without acute or chronic inflammation. PCL membranes with osteogenically-induced cells successfully stimulated new bone formation in a rate calvarial defect model.
   Conclusion: The results indicate that biodegradable PCL sub-microfibrous membrane produced by electrospinning process seems to have excellent biocompatibility, and may be used as a scaffold for bone tissue engineering.
C1 [Rhee, Yun-Hee; Shin, Jang-In; Oh, Chung-Hun] Dankook Univ, Coll Dent, Dept Oral Physiol, Cheonan 330714, South Korea.
   [Oh, Seong-Hwa; Oh, Chung-Hun] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Oh, Seong-Hwa; Oh, Chung-Hun] Dankook Univ, WCU Res Ctr, Cheonan 330714, South Korea.
   [Lim, Hyun-Ju; Oh, Chung-Hun] Dankook Univ, Grad Sch, Dept Med Laser, Cheonan 330714, South Korea.
   [Kim, Chan] AMOMEDI Co Ltd, New Mat Res Ctr, 597-2 Wonsanri, Kimpo 415887, Kyungkido, South Korea.
RP Oh, CH (reprint author), Dankook Univ, Coll Dent, Dept Oral Physiol, Cheonan 330714, South Korea.; Oh, CH (reprint author), Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.; Oh, CH (reprint author), Dankook Univ, WCU Res Ctr, Cheonan 330714, South Korea.; Oh, CH (reprint author), Dankook Univ, Grad Sch, Dept Med Laser, Cheonan 330714, South Korea.
EM choh@dankook.ac.kr
FU Korea Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET) through High Value-added Food
   Technology Development Program - Ministry of Agriculture, Food and Rural
   Affairs (MAFRA) [31606203]
FX This work was supported by Korea Institute of Planning and Evaluation
   for Technology in Food, Agriculture, Forestry and Fisheries (IPET)
   through High Value-added Food Technology Development Program, funded by
   Ministry of Agriculture, Food and Rural Affairs (MAFRA, no. 31606203).
CR Baiguera S, J MAT SCI MAT MED, V21, P1353
   Cao H, J BIOMED MAT RES A, V93, P1151
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Chen ZCC, 2008, J BIOMAT SCI-POLYM E, V19, P693, DOI 10.1163/156856208784089580
   Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd
   Gurevitch O, 2003, STEM CELLS, V21, P588, DOI 10.1634/stemcells.21-5-588
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kwan MD, 2011, J BIOL CHEM, V286, P11307, DOI 10.1074/jbc.M110.180042
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Ndreu A, 2008, NANOMEDICINE-UK, V3, P45, DOI 10.2217/17435889.3.1.45
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Saadai P, 2011, J PEDIATR SURG, V46, P2279, DOI 10.1016/j.jpedsurg.2011.09.014
   Shen YQ, 2000, J BIOMED MATER RES, V50, P528, DOI 10.1002/(SICI)1097-4636(20000615)50:4<528::AID-JBM8>3.0.CO;2-S
   Taub PJ, 2009, PLAST RECONSTR SURG, V123, P1178, DOI 10.1097/PRS.0b013e31819f2949
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zellin G, 1998, Swed Dent J Suppl, V129, P7
NR 23
TC 0
Z9 0
U1 0
U2 2
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD FEB
PY 2017
VL 16
IS 2
BP 271
EP 278
DI 10.4314/tjpr.v16i2.3
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EQ1EJ
UT WOS:000397812100003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Awad, MA
   Hendi, AA
   Virk, P
   Ortashi, KM
   Elobeid, MA
   Merghani, NM
   Siddiqui, MI
   Ibrahim, EM
AF Awad, Manal A.
   Hendi, Awatif A.
   Virk, P.
   Ortashi, Khalid Mo
   Elobeid, Mai A.
   Merghani, Nada M.
   Siddiqui, Muzzammil I.
   Ibrahim, E. M.
TI Preparation, characterization and antibacterial effects of eco-friendly
   gold nanorods
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Olea europaea; Acacia nilotica; Gold nanorods; Eco-friendly synthesis;
   Gram-positive and Gram-negative microorganisms
ID NANOPARTICLES; BACTERIA; SIZE
AB Purpose: To synthesize and characterize eco-friendly gold nanorods (Au-NRs) and to assess their effects against two bacterial strains.
   Methods: Synthesis of eco-friendly gold nanorods was done from an aqueous solution of chloroauric acid and cetyltrimethylammonium bromide by mixing Olea europaea fruit and Acacia nilotica husk extracts with the latter as a reducing agent. The synthesis was monitored by ultraviolet-visible (UV) spectrophotmetry and a zetasizer, while the morphology of the resulting nanorods was assessed by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) coupled with an energy-dispersive spectrophotometer (EDS). The effect of the prepared eco-nanorods on growth of Escherichia coli and Staphylococcus aureus bacteria were investigated by agar diffusion method.
   Results: The synthesized Au-NRs were mostly rod-shaped, with mean size of 96 nm. They exhibited a potent antibacterial activity against Gram-positive and Gram-negative microorganisms (Escherichia coli and Staphylococcus aureus).
   Conclusion: The findings suggest that the nanoformulation of the biomaterial mix of Olea europaea fruit and Acacia nilotica husk extracts is a cost-effective, eco-friendly, and non-toxic synthesis of Au-NRs which has therpeautic potential.
C1 [Awad, Manal A.] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia.
   [Hendi, Awatif A.] King Saud Univ, Fac Sci, Dept Phys, Riyadh, Saudi Arabia.
   [Virk, P.; Elobeid, Mai A.; Siddiqui, Muzzammil I.] King Saud Univ, Dept Zool, Riyadh, Saudi Arabia.
   [Ortashi, Khalid Mo] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia.
   [Merghani, Nada M.; Ibrahim, E. M.] King Saud Univ, Cent Lab, Riyadh, Saudi Arabia.
   [Merghani, Nada M.; Ibrahim, E. M.] King Saud Univ, Prince Naif Ctr Heath Sci Res, Riyadh, Saudi Arabia.
RP Awad, MA (reprint author), King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia.
EM a.manalawad@gmail.com
FU Deanship of Scientific Research at King Saud University [RGP- 278]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through Research
   Group no. RGP- 278.
CR Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013
   Daglia M, 2007, J AGR FOOD CHEM, V55, P5038, DOI 10.1021/jf070352q
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   DUSHENKOV V, 1995, ENVIRON SCI TECHNOL, V29, P1239, DOI 10.1021/es00005a015
   Gilaki M., 2010, Journal of Biological Sciences, V10, P465
   Gutierrez FM, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI DOI 10.1016/J.NAN0.2010.02.001
   Han G., 2007, NANOBIOTECHNOLOGY, V3, P40, DOI DOI 10.1007/S12030-007-0005-3
   Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964
   JARVINEN H, 1993, ANTIMICROB AGENTS CH, V37, P1158, DOI 10.1128/AAC.37.5.1158
   Kato H, 2011, NAT NANOTECHNOL, V6, P139, DOI 10.1038/nnano.2011.25
   Kumar SA, 2010, J PHYS CHEM SOLIDS, V71, P1484, DOI 10.1016/j.jpcs.2010.07.015
   Liu J, 2011, SMALL, V7, P425, DOI 10.1002/smll.201001402
   Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x
   NIRMALA GA, 2007, COLLOID SURF A, V297, P63
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Ryan BM, 2001, EXPERT OPIN INV DRUG, V10, P1409, DOI 10.1517/13543784.10.8.1409
   Savithramma N., 2011, International Journal of ChemTech Research, V3, P1394
   Singh M, 2011, J NANOSCI NANOTECHNO, V2011, P1, DOI [10.4172/2155-6148.S1-001, DOI 10.4172/2155-6148.S1-001]
   Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872
   Zharov VP, 2006, BIOPHYS J, V90, P619, DOI 10.1529/biophysj.105.061895
NR 21
TC 0
Z9 0
U1 6
U2 18
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD FEB
PY 2017
VL 16
IS 2
BP 313
EP 318
DI 10.4314/tjpr.v16i2.8
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EQ1EJ
UT WOS:000397812100008
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ivirico, JLE
   Bhattacharjee, M
   Kuyinu, E
   Nair, LS
   Laurencin, CT
AF Ivirico, Jorge L. Escobar
   Bhattacharjee, Maumita
   Kuyinu, Emmanuel
   Nair, Lakshmi S.
   Laurencin, Cato T.
TI Regenerative Engineering for Knee Osteoarthritis Treatment: Biomaterials
   and Cell-Based Technologies
SO ENGINEERING
LA English
DT Review
DE Knee osteoarthritis; Osteoarthritic pain; Mesenchymal stem cells;
   Biomaterials; Regenerative engineering
ID MESENCHYMAL STEM-CELLS; RANDOMIZED CONTROLLED-TRIALS; LAND-BASED
   EXERCISE; INTRAARTICULAR INJECTION; ARTICULAR-CARTILAGE;
   HYALURONIC-ACID; IN-VITRO; DOUBLE-BLIND; MECHANICAL-PROPERTIES; AQUATIC
   EXERCISE
AB Knee osteoarthritis (OA) is the most common form of arthritis worldwide. The incidence of this disease is rising and its treatment poses an economic burden. Two early targets of knee OA treatment include the predominant symptom of pain, and cartilage damage in the knee joint. Current treatments have been beneficial in treating the disease but none is as effective as total knee arthroplasty (TKA). However, while TKA is an end-stage solution of the disease, it is an invasive and expensive procedure. Therefore, innovative regenerative engineering strategies should be established as these could defer or annul the need for a TKA. Several biomaterial and cell-based therapies are currently in development and have shown early promise in both preclinical and clinical studies. The use of advanced biomaterials and stem cells independently or in conjunction to treat knee OA could potentially reduce pain and regenerate focal articular cartilage damage. In this review, we discuss the pathogenesis of pain and cartilage damage in knee OA and explore novel treatment options currently being studied, along with some of their limitations. (C) 2017 THE AUTHORS. Published by Elsevier LTD on behalf of the Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Ivirico, Jorge L. Escobar; Bhattacharjee, Maumita; Kuyinu, Emmanuel; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.
   [Ivirico, Jorge L. Escobar; Bhattacharjee, Maumita; Kuyinu, Emmanuel; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Farmington, CT 06030 USA.
   [Ivirico, Jorge L. Escobar; Bhattacharjee, Maumita; Kuyinu, Emmanuel; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Sch Engn, Dept Biomed Engn, Storrs, CT 06269 USA.
   [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Sch Engn, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
   [Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06030 USA.
   [Laurencin, Cato T.] Univ Connecticut, Sch Engn, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.
RP Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.; Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Farmington, CT 06030 USA.; Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Laurencin, CT (reprint author), Univ Connecticut, Sch Engn, Dept Biomed Engn, Storrs, CT 06269 USA.; Laurencin, CT (reprint author), Univ Connecticut, Sch Engn, Dept Mat Sci & Engn, Storrs, CT 06269 USA.; Laurencin, CT (reprint author), Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.; Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06030 USA.; Laurencin, CT (reprint author), Univ Connecticut, Sch Engn, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.
EM laurencin@uchc.edu
RI Escobar ivirico, Jorge/J-1203-2016
OI Escobar ivirico, Jorge/0000-0002-1077-2333; Kuyinu,
   Emmanuel/0000-0003-2543-1053
FU Raymond and Beverly Sackler Center for Biomedical, Biological, Physical
   and Engineering Sciences, NIH [DP1 AR068147]; Biomedical Trust Fund from
   the State of Connecticut
FX Support from the Raymond and Beverly Sackler Center for Biomedical,
   Biological, Physical and Engineering Sciences, NIH DP1 AR068147, and
   from the Biomedical Trust Fund from the State of Connecticut is
   gratefully acknowledged.
CR Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8
   Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018
   Altman RD, 2004, OSTEOARTHR CARTILAGE, V12, P642, DOI 10.1016/j.joca.2004.04.010
   Altman R, 2015, CURR MED RES OPIN, V31, P2331, DOI 10.1185/03007995.2015.1112772
   Amini AA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024105
   [Anonymous], 2014, SYNV ON PACK INS
   [Anonymous], 2014, EUFL PACK INS
   [Anonymous], 2006, ORTH PACK INS
   [Anonymous], 2014, SYNV PACK INS
   [Anonymous], 2014, MON PACK INS
   [Anonymous], 2012, GEL ON PACK INS
   [Anonymous], 2015, SUP FX PACK INS
   [Anonymous], 2014, HYALG PACK INS
   Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003
   Baker K, 2010, ANN RHEUM DIS, V69, P1779, DOI 10.1136/ard.2009.121426
   BALAZS EA, 1993, J RHEUMATOL, V20, P3
   Barker AL, 2014, ARCH PHYS MED REHAB, V95, P1776, DOI 10.1016/j.apmr.2014.04.005
   Batterham SI, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-123
   Benke M, 2009, CURR PAIN HEADACHE R, V13, P440, DOI 10.1007/s11916-009-0072-3
   Bhattacharjee M, 2015, ADV DRUG DELIVER REV, V84, P107, DOI 10.1016/j.addr.2014.08.010
   Biondi David M, 2015, J Opioid Manag, V11, P393, DOI 10.5055/jom.2015.0289
   Browne J E, 2000, J Am Acad Orthop Surg, V8, P180
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Camarero-Espinosa S, 2016, BIOMATER SCI-UK, V4, P734, DOI 10.1039/c6bm00068a
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796
   Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
   Centeno CJ, 2008, MED HYPOTHESES, V71, P900, DOI 10.1016/j.mehy.2008.06.042
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Cohen SB, 2016, J KNEE SURG, V29, P555, DOI 10.1055/s-0035-1568988
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Connelly AE, 2015, PAIN RES MANAG, V20, P241, DOI 10.1155/2015/389084
   Davatchi F, 2011, INT J RHEUM DIS, V14, P211, DOI 10.1111/j.1756-185X.2011.01599.x
   Dean CS, 2016, ARTHROSC TEC, V5, pE157, DOI 10.1016/j.eats.2015.10.015
   Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007400.pub2
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Dinescu S, 2015, STEM CELLS INT, DOI 10.1155/2015/252909
   Domingues RMA, 2015, BIOCONJUGATE CHEM, V26, P1571, DOI 10.1021/acs.bioconjchem.5b00209
   Emadedin M, 2012, ARCH IRAN MED, V15, P422, DOI 012157/AIM.0010
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Fan JB, 2009, TISSUE ENG PART B-RE, V15, P75, DOI 10.1089/ten.teb.2008.0586
   Foss C, 2013, BIOMACROMOLECULES, V14, P38, DOI 10.1021/bm301174x
   Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3
   Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058
   FRASER JRE, 1979, ANN RHEUM DIS, V38, P287, DOI 10.1136/ard.38.3.287
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3
   Grenier S, 2014, J BIOMECH, V47, P645, DOI 10.1016/j.jbiomech.2013.11.050
   Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116
   He F, 2009, TISSUE ENG PT A, V15, P3809, DOI [10.1089/ten.tea.2009.0188, 10.1089/ten.TEA.2009.0188]
   Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596
   Hoff P, 2013, INT ORTHOP, V37, P145, DOI 10.1007/s00264-012-1724-1
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   Inacio MCS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0970-6
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Khanna IK, 2015, J PAIN RES, V8, DOI 10.2147/JPR.S85951
   Kirchner M, 2006, OSTEOARTHR CARTILAGE, V14, P154, DOI 10.1016/j.joca.2005.09.003
   Ko CL, 2012, J MECH BEHAV BIOMED, V14, P227, DOI 10.1016/j.jmbbm.2012.06.019
   Koh YG, 2015, KNEE SURG SPORT TR A, V23, P1308, DOI 10.1007/s00167-013-2807-2
   Kolasinski SL, 2005, J ALTERN COMPLEM MED, V11, P689, DOI 10.1089/acm.2005.11.689
   Kon E, 2016, AM J SPORT MED, V44, P602, DOI 10.1177/0363546515620194
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kuyinu EL, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0346-5
   Lahm A, 2010, ARCH ORTHOP TRAUM SU, V130, P557, DOI 10.1007/s00402-009-0981-y
   Lam J, 2016, BIOMATERIALS, V83, P332, DOI 10.1016/j.biomaterials.2016.01.020
   Lapane KL, 2015, ARTHRITIS RHEUMATOL, V67, P724, DOI 10.1002/art.38933
   Laurencin CT, 2016, REGEN BIOMATER, V3, P123, DOI 10.1093/rb/rbw002
   Laurencin CT, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004467
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Le TK, 2012, PAIN PRACT, V12, P633, DOI 10.1111/j.1533-2500.2012.00535.x
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee JC, 2012, TISSUE ENG PT A, V18, P2173, DOI [10.1089/ten.tea.2011.0643, 10.1089/ten.TEA.2011.0643]
   Leijten JCH, 2013, TISSUE ENG PART B-RE, V19, P31, DOI [10.1089/ten.teb.2012.0273, 10.1089/ten.TEB.2012.0273]
   Leopold SS, 2003, J BONE JOINT SURG AM, V85A, P1197, DOI 10.2106/00004623-200307000-00003
   Levorson EJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014103
   Li JT, 2012, TISSUE ENG PART B-RE, V18, P270, DOI [10.1089/ten.teb.2011.0583, 10.1089/ten.TEB.2011.0583]
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Mak J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23076
   Maldonado M, 2013, BIOMED RES INT, DOI 10.1155/2013/284873
   McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003
   McCarberg Bill, 2007, Ther Clin Risk Manag, V3, P401
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759
   Migliaresi C, 2007, TOP BONE BIOL, V3, P95
   Miller RE, 2014, CYTOKINE, V70, P185, DOI 10.1016/j.cyto.2014.06.019
   Minas T, 2010, CLIN ORTHOP RELAT R, V468, P147, DOI 10.1007/s11999-009-0998-0
   Mort JS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0944-8
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021
   Nanda HS, 2014, BIOMED RES INT, DOI 10.1155/2014/623805
   Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018
   Neogi T, 2013, RHEUM DIS CLIN N AM, V39, P1, DOI 10.1016/j.rdc.2012.10.004
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Oommen OP, 2013, ADV FUNCT MATER, V23, P1273, DOI 10.1002/adfm.201201698
   Orozco L, 2013, TRANSPLANTATION, V95, P1535, DOI 10.1097/TP.0b013e318291a2da
   Ossendorf Christian, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P11, DOI 10.1186/1758-2555-3-11
   Oussedik S, 2015, ARTHROSCOPY, V31, P732, DOI 10.1016/j.arthro.2014.11.023
   Ozeki N, 2016, OSTEOARTHR CARTILAGE, V24, P1061, DOI 10.1016/j.joca.2015.12.018
   Pei M, 2013, TISSUE ENG PT A, V19, P1144, DOI [10.1089/ten.tea.2012.0351, 10.1089/ten.TEA.2012.0351]
   Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x
   Petrella RJ, 2006, J RHEUMATOL, V33, P951
   Ramiro S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008886.pub2
   Rannou F, 2016, SEMIN ARTHRITIS RHEU, V45, pS18, DOI 10.1016/j.semarthrit.2015.11.007
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Roberts JJ, 2011, J BIOMED MATER RES A, V97A, P281, DOI 10.1002/jbm.a.33057
   Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7
   Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003
   Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42
   Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786
   Silva JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055451
   Silva LE, 2008, PHYS THER, V88, P12, DOI 10.2522/ptj.20060040
   Soler R, 2016, KNEE, V23, P647, DOI 10.1016/j.knee.2015.08.013
   Song JE, 2015, J BIOMAT SCI-POLYM E, V26, P181, DOI 10.1080/09205063.2014.987570
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Steinwachs M, 2007, ARTHROSCOPY, V23, P381, DOI 10.1016/j.arthro.2006.12.003
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626
   Toghraie F, 2012, ARCH IRAN MED, V15, P495, DOI 012158/AIM.0011
   Torricelli P, 2014, MAT SCI ENG C-MATER, V36, P130, DOI 10.1016/j.msec.2013.11.050
   Trigkilidas D, 2013, ANN ROY COLL SURG, V95, P545, DOI 10.1308/003588413X13629960049432
   Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020
   Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015
   van Laar Mart, 2012, Open Rheumatol J, V6, P320, DOI 10.2174/1874312901206010320
   Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298
   Vilar JM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-143
   Wade WE, 2009, CLIN THER, V31, P2804, DOI 10.1016/j.clinthera.2009.12.003
   Wadsworth LT, 2016, CURR MED RES OPIN, V32, P241, DOI 10.1185/03007995.2015.1113400
   Wang CC, 2012, BIOMATERIALS, V33, P120, DOI 10.1016/j.biomaterials.2011.09.042
   Wang SJ, 2013, BIOMACROMOLECULES, V14, P2427, DOI 10.1021/bm400612h
   Wang ZY, 2015, PAIN MED, V16, P1373, DOI 10.1111/pme.12800
   Wilkie R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120042
   Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141
   Xu CC, 2012, SCI WORLD J, P1, DOI 10.1100/2012/695137
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Ye JJ, 2014, J PHYS THER SCI, V26, P1133, DOI 10.1589/jpts.26.1133
   Yoo JY, 2016, J ARTHROPLASTY, V31, P2188, DOI 10.1016/j.arth.2015.12.051
   Younesi M, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/035001
   Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
   Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013
   Zhao W, 2013, J CHEM TECHNOL BIOT, V88, P327, DOI 10.1002/jctb.3970
   Zhu YJ, 2014, COLLOID SURFACE B, V113, P352, DOI 10.1016/j.colsurfb.2013.09.028
NR 151
TC 3
Z9 3
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2095-8099
EI 2096-0026
J9 ENGINEERING-PRC
JI Engineering
PD FEB
PY 2017
VL 3
IS 1
BP 16
EP 27
DI 10.1016/J.ENG.2017.01.003
PG 12
WC Engineering, Multidisciplinary
SC Engineering
GA EQ4IS
UT WOS:000398040300004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Li, WY
   Lan, R
   Wang, JY
AF Zhang, Yue
   Li, Wei-Ying
   Lan, Run
   Wang, Jin-Ye
TI Quality Monitoring of Porous Zein Scaffolds: A Novel Biomaterial
SO ENGINEERING
LA English
DT Article
DE Zein; Amino acid analysis; SDS-PAGE; Gamma-ray sterilization; MTT assay;
   CCK-8 assay
ID MECHANICAL-PROPERTIES; STERILIZATION; BIOCOMPATIBILITY; ASSAY;
   PROLIFERATION; INTERFERENCE; PROTEIN; CELLS; CORN
AB Our previous studies have shown that zein has good biocompatibility and good mechanical properties. The first product from a porous scaffold of zein, a resorbable bone substitute, has passed the biological evaluation of medical devices (ISO 10993) by the China Food and Drug Administration. However, Class III medical devices need quality monitoring before being placed on the market, and such monitoring includes quality control of raw materials, choice of sterilization method, and evaluation of biocompatibility. In this paper, we investigated four sources of zein through amino acid analysis (AAA) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in order to monitor the composition and purity, and control the quality of raw materials. We studied the effect of three kinds of sterilization method on a porous zein scaffold by SDS-PAGE. We also compared the changes in SDS-PAGE patterns when irradiated with different doses of gamma radiation. We found that polymerization or breakage did not occur on peptide chains of zein during gamma-ray (.-ray) sterilization in the range of 20-30 kGy, which suggested that.-ray sterilization is suitable for porous zein scaffolds. Regarding cell compatibility, we found a difference between using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and a cell-counting kit-8 (CCK-8) assay to assess cell proliferation on zein film, and concluded that the CCK-8 assay is more suitable, due to its low background optical density. (C) 2017 THE AUTHORS. Published by Elsevier LTD on behalf of the Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
C1 [Zhang, Yue; Li, Wei-Ying; Lan, Run; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China.
RP Wang, JY (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China.
EM jinyewang@sjtu.edu.cn
RI Wang, Jin-Ye/H-1450-2011
FU International S&T Cooperation Program of China [2014DFG02330,
   2015DFG32730]; Medical Engineering Cooperation Program of Shanghai Jiao
   Tong University [YG2013MS77, YG2014ZD03]
FX The authors are grateful to the financial support provided by the
   International S&T Cooperation Program of China (2014DFG02330 and
   2015DFG32730). We also thank the Shanghai Municipal Science and
   Technology Commission (13JC1403400 and 15540723900) and the Medical
   Engineering Cooperation Program of Shanghai Jiao Tong University
   (YG2013MS77 and YG2014ZD03).
CR [Anonymous], 2006, 1113712006 ISO
   Bruggisser R, 2002, PLANTA MED, V68, P445, DOI 10.1055/s-2002-32073
   Cetin Y, 2005, J AGR FOOD CHEM, V53, P6558, DOI 10.1021/jf051120z
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Faraj KA, 2011, TISSUE ENG REGEN MED, V8, P460
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   GIANAZZA E, 1977, PHYTOCHEMISTRY, V16, P315, DOI 10.1016/0031-9422(77)80054-X
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Han YL, 2014, COLLOID SURFACE B, V120, P55, DOI 10.1016/j.colsurfb.2014.04.019
   Jia J, 2003, 50091242003 GBT
   Lee MH, 2008, SURF COAT TECH, V202, P5762, DOI 10.1016/j.surfcoat.2008.06.114
   Peng F, 2010, SOPO, P1, DOI [10.1109/SOPO.2010.5504091, DOI 10.1109/SOPO.2010.5504091]
   Phillip E, 2013, J BIOMED MATER RES B, V101B, P532, DOI 10.1002/jbm.b.32853
   Rnjak-Kovacina J, 2015, MACROMOL BIOSCI, V15, P861, DOI 10.1002/mabi.201500013
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang J, 2008, PLOS GENET, P4
   Wang LP, 2015, LANGMUIR, V31, P12315, DOI 10.1021/acs.langmuir.5b00992
   Yan T, 2010, J MATER SCI-MATER M, V21, P2425, DOI 10.1007/s10856-010-4094-5
   Zhang ZL, 2002, CHINESE MED J-PEKING, V115, P518
NR 21
TC 1
Z9 1
U1 3
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2095-8099
EI 2096-0026
J9 ENGINEERING-PRC
JI Engineering
PD FEB
PY 2017
VL 3
IS 1
BP 130
EP 135
DI 10.1016/J.ENG.2017.01.001
PG 6
WC Engineering, Multidisciplinary
SC Engineering
GA EQ4IS
UT WOS:000398040300017
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zarei, M
   Jafarian, AH
   Harandi, A
   Javidi, M
   Gharechahi, M
AF Zarei, Mina
   Jafarian, Amir Hossein
   Harandi, Azadeh
   Javidi, Maryam
   Gharechahi, Maryam
TI Evaluation of the expression of VIII factor and VEGF in the regeneration
   of non-vital teeth in dogs using propolis
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article
DE Regeneration; Propolis; VIII Factor; VEGF
ID MINERAL TRIOXIDE AGGREGATE; ENDOTHELIAL GROWTH-FACTOR; HUMAN
   DENTAL-PULP; STEM-CELLS; IN-VITRO; IMMATURE TEETH; REVASCULARIZATION;
   PERIODONTITIS; PROTOCOLS; CONTACT
AB Objective(s): The purpose of the present study was the immunohistochemical evaluation of VEGF and VII factors in dog's teeth pulp revascularized with MTA and propolis.
   Materials and Methods: 144 mature and immature two rooted dog's premolar canals were selected. Pulp necrosis and infection were established after 2 weeks and the disinfection of the canals was done with copious NaOCl irrigation and triantibiotic mixture (ciprofloxacin, metronidazole, and minocycline) for 3 weeks. Subsequently, the blood clot was evoked in the canal by periapical tissue irritation with a k-file. The samples were randomly divided into 6 experimental groups: propolis (groups 1, 2), MTA (groups 3, 4), and parafilm (groups 5, 6) in immature and mature teeth. The animals were sacrificed and samples were prepared for immunohistochemical evaluation of VEGF and the VIII factor.
   Results: Tissue regeneration was seen in 64.5% of MTA, 38% of propolis, and 0% of parafilm group samples. Expression of VEGF and VIII factor in the propolis group was more than the MTA group and it showed a reduction after 3 months in comparison to 1 month. VEGF and VIII factor were seen in stromal cells in addition to endothelial vessel cells. Overall, expression of angiogenic factors was more in the open apex teeth compared to close apex ones.
   Conclusion: According to the results of this study, propolis can induce the expression of VEGF and VIII factor in infected mature and immature dog's teeth and is a suitable biomaterial for the revascularization technique.
C1 [Zarei, Mina; Javidi, Maryam] Mashhad Univ Med Sci, Mashhad Dent Sch, Dept Endodont, Dent Res Ctr, Mashhad, Iran.
   [Jafarian, Amir Hossein] Mashhad Univ Med Sci, Pathol Res Ctr, Mashhad, Iran.
   [Harandi, Azadeh] Mazandaran Univ, Sch Dent, Dept Endodont, Babol Sar, Iran.
   [Gharechahi, Maryam] Mashhad Univ Med Sci, Mashhad Dent Sch, Dept Endodont, Dent Mat Res Ctr, Mashhad, Iran.
RP Gharechahi, M (reprint author), Mashhad Univ Med Sci, Mashhad Dent Sch, Dept Endodont, Dent Mat Res Ctr, Mashhad, Iran.
EM gharechahim@mums.ac.ir
RI Harandi, Azadeh/N-3686-2017
OI Harandi, Azadeh/0000-0002-8202-4887
FU Mashhad University of Medical Sciences
FX The authors would like to thank the Vice Chancellor for Research of
   Mashhad University of Medical Sciences for financial support. The
   results presented in this study have been taken from a postgraduate
   thesis (no: 534) at Mashhad University of Medical Sciences, Mashhad,
   Iran.
CR Artese L, 2002, J ENDODONT, V28, P20, DOI 10.1097/00004770-200201000-00005
   Becerra P, 2014, J ENDODONT, V40, P133, DOI 10.1016/j.joen.2013.07.017
   Botero TM, 2010, J DENT RES, V89, P264, DOI 10.1177/0022034509357556
   Chueh LH, 2006, J ENDODONT, V32, P1205, DOI 10.1016/j.joen.2006.07.010
   de Groot AC, 2013, DERMATITIS, V24, P263, DOI 10.1097/DER.0000000000000011
   Dissanayaka WL, 2012, J ENDODONT, V38, P454, DOI 10.1016/j.joen.2011.12.024
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Guven G, 2007, J ENDODONT, V33, P447, DOI 10.1016/j.joen.2006.12.020
   Hoshino E, 1996, INT ENDOD J, V29, P125, DOI 10.1111/j.1365-2591.1996.tb01173.x
   Jastrzebska-Stojko Z, 2013, MOLECULES, V18, P14397, DOI 10.3390/molecules181114397
   Kenneth M., 2011, PATHWAY OF THE PULP
   Li William W, 2005, Adv Skin Wound Care, V18, P491, DOI 10.1097/00129334-200511000-00013
   Li WW, 2005, ADV SKIN WOUND CARE, V18, P1
   Li Yu-Ling, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1568
   Mente J, 2013, J ENDODONT, V39, P20, DOI 10.1016/j.joen.2012.10.007
   Nagata JY, 2014, J ENDODONT, V40, P606, DOI 10.1016/j.joen.2014.01.032
   Nagy MM, 2014, J ENDODONT, V40, P192, DOI 10.1016/j.joen.2013.10.027
   Nakanishi Y, 2007, INT J ORAL MAX SURG, V36, P928, DOI 10.1016/j.ijom.2007.06.013
   NYGAARD-OSTBY B, 1971, Scandinavian Journal of Dental Research, V79, P333
   Paranjpe A, 2011, J ENDODONT, V37, P1691, DOI 10.1016/j.joen.2011.09.012
   Parolia A, 2010, AUST DENT J, V55, P59, DOI 10.1111/j.1834-7819.2009.01179.x
   Petrino JA, 2010, J ENDODONT, V36, P536, DOI 10.1016/j.joen.2009.10.006
   Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3
   Sabir A, 2005, J ORAL SCI, V47, P35
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Thibodeau B, 2007, J ENDODONT, V33, P680, DOI 10.1016/j.joen.2007.03.001
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Virtej A, 2013, EUR J ORAL SCI, V121, P92, DOI 10.1111/eos.12019
   Yamauchi N, 2011, J ENDODONT, V37, P390, DOI 10.1016/j.joen.2010.11.010
NR 30
TC 1
Z9 1
U1 3
U2 10
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
EI 2008-3874
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD FEB
PY 2017
VL 20
IS 2
BP 172
EP 177
DI 10.22038/ijbms.2017.8243
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EQ4KX
UT WOS:000398047000010
PM 28293394
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Glew, D
   Stringer, LC
   Acquaye, A
   McQueen-Mason, S
AF Glew, David
   Stringer, Lindsay C.
   Acquaye, Adolf
   McQueen-Mason, Simon
TI Evaluating the Potential for Harmonized Prediction and Comparison of
   Disposal-Stage Greenhouse Gas Emissions for Biomaterial Products
SO JOURNAL OF INDUSTRIAL ECOLOGY
LA English
DT Article
DE disposal; greenhouse gas ( GHG); hemp; industrial ecology; life cycle
   assessment ( LCA); waste
ID LIFE-CYCLE ASSESSMENT; ENVIRONMENTAL IMPACTS; ASSESSMENT LCA; WASTE;
   METHODOLOGIES; BIOFUELS; CHAIN; SUSTAINABILITY; BIOETHANOL; MANAGEMENT
AB The carbon footprint (CF) of biofuels and biomaterials is a barrier to their acceptance, yet the greenhouse gas emissions associated with disposing of biomaterials are frequently omitted from analyses. This article investigates whether harmonization is appropriate for calculating the importance of biomaterials' disposal. This research shows that disposal stages could double a biomaterial's CF, or reduce it to the point that it could claim to be zero carbon. Incineration with combined heat and power coupled with on-site energy production in the biorefinery are identified as prerequisites to being zero carbon. The article assesses the current UK waste infrastructure's ability to support a low-carbonbio-based future economy, and finds that presently it only achieves marginal net reductions when compared to landfill and so cannot be said to support low-carbon biomaterials, though the article challenges the polluter pays principle where low- carbon disposal infrastructure are not available. Reuse and recycling are shown to have the potential to offset all the emissions caused by landfill of biomaterials. However, the savings are not so great as to offset the biomaterial's upstream emissions. The study explores the ability to overcome the barriers to incorporating disposal into life cycle assessment while identifying limitations of using harmonization as an assessment method. Specifically, data availability and industry consensus are flagged as major barriers. The study also uses sensitivity analysis to investigate the influence of methodological choices, such as allowing additional reuse and recycling stages, classifying biomaterials into different types, and choosing between opposing allocation methods.
C1 [Glew, David] Leeds Beckett Univ Leeds, Leeds Sustainabil Inst, Broadcasting Pl,Woodhouse Lane, Leeds, W Yorkshire, England.
   [Stringer, Lindsay C.] Univ Leeds, Sustainabil Res Inst, Kent, Leeds, Kent, England.
   [Acquaye, Adolf] Kent Business Sch, Quaye is Iecturer, Kent, OH USA.
   [McQueen-Mason, Simon] York Univ, Ctr Novel Agricul tural Prod, York, N Yorkshire, England.
RP Glew, D (reprint author), Leeds Beckett Univ Leeds, Leeds Sustainabil Inst, Broadcasting Pl,Woodhouse Lane, Leeds, W Yorkshire, England.
EM d.w.glew@leedsmet.ac.uk
OI Stringer, Lindsay/0000-0003-0017-1654
FU Yorkshire White Rose Consortium of Universities
FX The research is funded by the Yorkshire White Rose Consortium of
   Universities. None of the authors are aware of any conflicts related to
   the preparation of this research.
CR Acquaye Adolf A., 2012, International Journal of Engineering Management and Economics, V3, P175
   Acquaye AA, 2012, RENEW SUST ENERG REV, V16, P5414, DOI 10.1016/j.rser.2012.04.046
   Amaducci S, 2000, IND CROP PROD, V11, P179, DOI 10.1016/S0926-6690(99)00063-1
   Ambec S, 2016, ECON J, V126, P884, DOI 10.1111/ecoj.12184
   BRE, 2012, SAP 2012 GOV STAND A
   Carbon Trust, 2011, CONVERSION FACTORS E
   Carus M., 2012, MULTIPURPOSE HEMP IN
   Cherubini F, 2010, ENERG CONVERS MANAGE, V51, P1412, DOI 10.1016/j.enconman.2010.01.015
   Cherubini F, 2010, RENEW ENERG, V35, P1565, DOI 10.1016/j.renene.2009.11.035
   Cherubini F, 2010, INT J LIFE CYCLE ASS, V15, P53, DOI 10.1007/s11367-009-0124-2
   Cherubini F, 2010, APPL ENERG, V87, P47, DOI 10.1016/j.apenergy.2009.08.024
   Committee on Climate Change, 2015, CLIM CHANG LEG EU
   Cooper JS, 2003, INT J LIFE CYCLE ASS, V8, P337, DOI 10.1065/lca2003.09.134
   De Boer J., 2003, BUSINESS STRATEGY EN, V12, P254, DOI DOI 10.1002/BSE.362
   DEFRA, 2015, DIG WAST RES STAT 20
   DEFRA (Department for Environment Food & Rural Affairs), 2014, EN WAST GUID DEB FEB
   DEFRA (Department for Environment Food & Rural Affairs), 2011, ENV STAT KEY FACTS
   [EC (European Commission) European Commission Directorate General for Energy and Transport], 2010, EV IMPR ENDC EFF BIO
   [EC (European Commission) AEA Technology], 2001, WAST MAN OPT CLIM CH
   Ekvall T, 1997, INT J LIFE CYCLE ASS, V2, P155, DOI 10.1007/BF02978810
   [Environment Agency Water Resource Action Plan (WRAP)], 2008, QU PROT AN DIG
   [Environment Agency Water Resource Action Plan (WRAP)], 2008, QUAL PROT AN DIG
   [Environment Agency Water Resource Action Plan (WRAP).], 2008, QUAL PROT COMP
   Essel R, 2012, 5 INT C BIOB PLAST C
   Fahd S, 2012, ENERGY, V37, P79, DOI 10.1016/j.energy.2011.08.023
   Falloon P, 2010, SCI TOTAL ENVIRON, V408, P5667, DOI 10.1016/j.scitotenv.2009.05.002
   Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018
   Frischknecht R, 2005, J CLEAN PROD, V13, P1337, DOI 10.1016/j.jclepro.2005.05.002
   Gallagher E., 2008, GALLAGHER REV INDIRE
   Georgilakis P.S., 2006, INT J DISTRIB ENERGY, V2, P129
   Glew D, 2013, WASTE MANAGE, V33, P1499, DOI 10.1016/j.wasman.2013.03.005
   Glew D, 2012, J CLEAN PROD, V29-30, P122, DOI 10.1016/j.jclepro.2012.02.005
   Golden JS, 2010, ECOL SOC, V15
   Gonzalez-Garcia S, 2010, RESOUR CONSERV RECY, V54, P923, DOI 10.1016/j.resconrec.2010.01.011
   Guinee J. B., 2001, LIFE CYCLE ASSESSMEN
   Hakkinen T, 2010, J CLEAN PROD, V18, P1458, DOI 10.1016/j.jclepro.2010.05.005
   Harding KG, 2007, J BIOTECHNOL, V130, P57, DOI 10.1016/j.jbiotec.2007.02.012
   Hermann BG, 2011, POLYM DEGRAD STABIL, V96, P1159, DOI 10.1016/j.polymdegradstab.2010.12.026
   Huber C., 1998, J ENVIRON ECON MANAG, V35, P68
   ISO (International Organization for Standardization), 2006, 14040 ISO
   Lynes JK, 2008, J INT MANAG, V14, P377, DOI 10.1016/j.intman.2007.09.004
   Madival S, 2009, J CLEAN PROD, V17, P1183, DOI 10.1016/j.jclepro.2009.03.015
   Nawrocka D, 2009, J CLEAN PROD, V17, P1435, DOI 10.1016/j.jclepro.2009.05.004
   Nemoto J, 2004, INT J IND ORGAN, V22, P67, DOI 10.1016/S0167-7187(03)00091-2
   Nicholson AL, 2009, ISSST 09, P1
   NNFCC (National Non-Food Crop Center), 2012, MARK REV BIOB PROD A
   OECD (Organization for Economic Cooperation and Development), 2014, BIOB CHEM BIOPL FIND, V17
   Overmars KP, 2011, ENVIRON SCI POLICY, V14, P248, DOI 10.1016/j.envsci.2010.12.012
   Pawelzik P, 2013, RESOUR CONSERV RECY, V73, P211, DOI 10.1016/j.resconrec.2013.02.006
   Prade T., 2011, THESIS
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Ross S, 2003, J CLEAN PROD, V11, P561, DOI 10.1016/S0959-6526(02)00089-6
   Rowley HV, 2009, INT J LIFE CYCLE ASS, V14, P508, DOI 10.1007/s11367-009-0093-5
   Roy P, 2009, J FOOD ENG, V90, P1, DOI 10.1016/j.jfoodeng.2008.06.016
   Schlegel S., 2007, J AGR FOOD IND ORG, V5
   Schmitt E, 2012, BIORESOURCE TECHNOL, V104, P400, DOI 10.1016/j.biortech.2011.10.094
   Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007
   Seguin B, 2007, AGR FOREST METEOROL, V142, P278, DOI 10.1016/j.agrformet.2006.07.012
   Seuring S, 2008, J CLEAN PROD, V16, P1545, DOI 10.1016/j.jclepro.2008.02.002
   Sevenster, 2014, SEL BIOP LCA WORLD R
   Shen L, 2010, RESOUR CONSERV RECY, V55, P34, DOI 10.1016/j.resconrec.2010.06.014
   Stichnothe H, 2009, RESOUR CONSERV RECY, V53, P624, DOI 10.1016/j.resconrec.2009.04.012
   Tabone MD, 2010, ENVIRON SCI TECHNOL, V44, P8264, DOI 10.1021/es101640n
   UNEP, 2010, WAST CLIM CHANG GLOB
   [US EPA (U.S. Environmental Protection Agency) Partnership C.H.A.P.], 2002, CAT CHP TECHN
   van der Werf HMG, 2008, IND CROP PROD, V27, P1, DOI 10.1016/j.indcrop.2007.05.003
   Vandermeulen V, 2012, BIOFUEL BIOPROD BIOR, V6, P453, DOI 10.1002/bbb.1333
   Wang L, 2012, BIORESOURCE TECHNOL, V120, P89, DOI 10.1016/j.biortech.2012.05.130
   Weiss M, 2012, J IND ECOL, V16, pS169, DOI 10.1111/j.1530-9290.2012.00468.x
   Whittaker C, 2011, ENERG POLICY, V39, P5950, DOI 10.1016/j.enpol.2011.06.054
   Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003
   WRAP (Water Resource Action Plan), 2010, ENV BEN RECYCL 2010
NR 72
TC 1
Z9 1
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1088-1980
EI 1530-9290
J9 J IND ECOL
JI J. Ind. Ecol.
PD FEB
PY 2017
VL 21
IS 1
BP 101
EP 115
DI 10.1111/jiec.12421
PG 15
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA EP5HW
UT WOS:000397410600008
OA Green Published
DA 2018-10-20
ER

PT J
AU Saldin, LT
   Cramer, MC
   Velankar, SS
   White, LJ
   Badylak, SF
AF Saldin, Lindsey T.
   Cramer, Madeline C.
   Velankar, Sachin S.
   White, Lisa J.
   Badylak, Stephen F.
TI Extracellular matrix hydrogels from decellularized tissues: Structure
   and function
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Extracellular matrix; Hydrogel; Decellularization; Naturally derived;
   Injectable; Regenerative medicine; Biomaterial; Tissue engineering
ID SMALL-INTESTINAL SUBMUCOSA; DERMIS-DERIVED HYDROGELS; URINARY-BLADDER
   MATRIX; PHENOTYPE IN-VITRO; COLLAGEN FIBRILLOGENESIS; BIOLOGIC
   SCAFFOLDS; STEM-CELLS; POSTMYOCARDIAL INFARCTION; POLYPROPYLENE MESH;
   NUCLEUS-PULPOSUS
AB Extracellular matrix (ECM) bioscaffolds prepared from decellularized tissues have been used to facilitate constructive and functional tissue remodeling in a variety of clinical applications. The discovery that these ECM materials could be solubilized and subsequently manipulated to form hydrogels expanded their potential in vitro and in vivo utility; i.e. as culture substrates comparable to collagen or Matrigel, and as injectable materials that fill irregularly-shaped defects. The mechanisms by which ECM hydrogels direct cell behavior and influence remodeling outcomes are only partially understood, but likely include structural and biological signals retained from the native source tissue. The present review describes the utility, formation, and physical and biological characterization of ECM hydrogels. Two examples of clinical application are presented to demonstrate in vivo utility of ECM hydrogels in different organ systems. Finally, new research directions and clinical translation of ECM hydrogels are discussed.
   Statement of Significance
   More than 70 papers have been published on extracellular matrix (ECM) hydrogels created from source tissue in almost every organ system. The present manuscript represents a review of ECM hydrogels and attempts to identify structure-function relationships that influence the tissue remodeling outcomes and gaps in the understanding thereof. There is a Phase 1 clinical trial now in progress for an ECM hydrogel. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Saldin, Lindsey T.; Cramer, Madeline C.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, 360B CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.
   [Saldin, Lindsey T.; Cramer, Madeline C.; White, Lisa J.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Suite 300,450 Technol Dr, Pittsburgh, PA 15219 USA.
   [Velankar, Sachin S.] Univ Pittsburgh, Dept Chem Engn, 940 Benedum Hall, Pittsburgh, PA 15261 USA.
   [White, Lisa J.] Univ Nottingham, Sch Pharm, Univ Pk, Nottingham NG7 2RD, England.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.
RP Badylak, SF (reprint author), Suite 300,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM saldinlt@upmc.edu; cramerm2@upmc.edu; velankar@pitt.edu;
   lisa.white@nottingham.ac.uk; badylaks@upmc.edu
OI White, Lisa/0000-0003-0571-999X
FU National Institute of Biomedical Imaging and Bioengineering of the
   National Institutes of Health - United States [2T32 EB001026-11]; Marie
   Curie International Outgoing Fellowship under REA [624841]
FX Funding sources: LTS was supported by the National Institute of
   Biomedical Imaging and Bioengineering of the National Institutes of
   Health - United States (2T32 EB001026-11). LJW was funded by a Marie
   Curie International Outgoing Fellowship under REA grant agreement no.
   624841.
CR Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]
   Agrawal V, 2011, TISSUE ENG PT A, V17, P3033, DOI [10.1089/ten.TEA.2011.0257, 10.1089/ten.tea.2011.0257]
   Ahearne M, 2015, TISSUE ENG PART C-ME, V21, P1059, DOI [10.1089/ten.tec.2015.0008, 10.1089/ten.TEC.2015.0008]
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5
   Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Chaimov D, 2016, J CONTROL RELEASE
   Cheng MH, 2010, J BIOMED MATER RES A, V92A, P852, DOI 10.1002/jbm.a.32410
   Choi JS, 2012, TISSUE ENG PT A, V18, P80, DOI 10.1089/ten.tea.2011.0103
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   D'Amore A, 2016, BIOMATERIALS, V107, P1, DOI 10.1016/j.biomaterials.2016.07.039
   D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   DRAKE MP, 1966, BIOCHEMISTRY-US, V5, P301, DOI 10.1021/bi00865a039
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   ELLIOTT RA, 1973, PLAST RECONSTR SURG, V52, P401, DOI 10.1097/00006534-197352040-00013
   Engel H, 2015, BIOMED J, V38, P58, DOI 10.4103/2319-4170.132899
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Farnebo S, 2014, TISSUE ENG PT A, V20, P1550, DOI [10.1089/ten.tea.2013.0207, 10.1089/ten.TEA.2013.0207]
   Faulk DM, 2014, BIOMATERIALS, V35, P8585, DOI 10.1016/j.biomaterials.2014.06.057
   Fisher MB, 2012, KNEE SURG SPORT TR A, V20, P1357, DOI 10.1007/s00167-011-1800-x
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Freytes Donald O, 2014, Methods Mol Biol, V1181, P69, DOI 10.1007/978-1-4939-1047-2_7
   Fu YH, 2016, J CELL MOL MED, V20, P740, DOI 10.1111/jcmm.12776
   Fujita K., 2015, CHARACTERIZING MODUL, P1
   Gaetani R., 2015, CELL TRANSPLANT
   Ghuman H, 2016, BIOMATERIALS, V91, P166, DOI 10.1016/j.biomaterials.2016.03.014
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Gothard D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145080
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Huleihel L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600502
   Hulmes D.J.S., 2008, COLLAGEN DIVERSITY S
   Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041
   Jang J, 2016, ACTA BIOMATER, V33, P88, DOI 10.1016/j.actbio.2016.01.013
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Johnson Todd D, 2014, Methods Mol Biol, V1181, P109, DOI 10.1007/978-1-4939-1047-2_10
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kappler B, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5730-5
   Keane T.J., 2016, J CHRONS COLITIS
   Keane T. J., 2015, J BIOMED MAT RES B
   Keane TJ, 2015, TISSUE ENG PT A, V21, P2293, DOI [10.1089/ten.tea.2015.0322, 10.1089/ten.TEA.2015.0322]
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kim EJ, 2016, BIOMACROMOLECULES, V17, P4, DOI 10.1021/acs.biomac.5b01566
   Kim MY, 2014, PLAST RECONSTR SURG, V133, p645E, DOI 10.1097/PRS.0000000000000106
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039
   Liang R, 2015, J ORTHOP TRANSL, V3, P114, DOI 10.1016/j.jot.2015.05.001
   LIN CY, 2016, BIOMED MATER, V11
   Londono R, 2015, ANN BIOMED ENG, V43, P577, DOI 10.1007/s10439-014-1103-8
   Loneker AE, 2016, J BIOMED MATER RES A, V104, P957, DOI 10.1002/jbm.a.35636
   Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Meng FW, 2015, BIOMATERIALS, V46, P131, DOI 10.1016/j.biomaterials.2014.12.044
   Mercuri JJ, 2013, TISSUE ENG PT A, V19, P952, DOI [10.1089/ten.TEA.2012.0088, 10.1089/ten.tea.2012.0088]
   Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001
   MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005
   Nagao R.J., 2016, TISSUE ENG A
   Paduano F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148225
   Park KM, 2016, TISSUE ENG PT A, V22, P449, DOI [10.1089/ten.tea.2015.0313, 10.1089/ten.TEA.2015.0313]
   PARKINSON J, 1995, J MOL BIOL, V247, P823, DOI 10.1016/S0022-2836(05)80157-3
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Pilipchuk SP, 2013, J BIOMED MATER RES A, V101, P2883, DOI 10.1002/jbm.a.34602
   Poon CJ, 2013, ACTA BIOMATER, V9, P5609, DOI 10.1016/j.actbio.2012.11.003
   Pouliot RA, 2016, J BIOMED MATER RES A, V104, P1922, DOI 10.1002/jbm.a.35726
   Ravi S, 2012, BIOMATERIALS, V33, P7736, DOI 10.1016/j.biomaterials.2012.07.010
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Seif-Naraghi S., 2010, J VIS EXP
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Sood D, 2016, ACS BIOMATER SCI ENG, V2, P131, DOI 10.1021/acsbiomaterials.5b00446
   Stoppel W.L., 2016, J BIOMED MAT RES A
   Stoppel WL, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034105
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tukmachev D, 2016, TISSUE ENG PT A, V22, P306, DOI [10.1089/ten.TEA.2015.0422, 10.1089/ten.tea.2015.0422]
   Ungerleider JL, 2015, METHODS, V84, P53, DOI 10.1016/j.ymeth.2015.03.024
   Ungerleider Jessica L, 2016, JACC Basic Transl Sci, V1, P32
   Uriel S., 2009, TISSUE ENG PART C-ME, P15
   Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028
   Ventrix I., STUDY VENTRIGEL EARL
   Viswanath A., 2016, J BIOMED MAT RES A
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   Wang RM, 2016, ADV DRUG DELIVER REV, V96, P77, DOI 10.1016/j.addr.2015.06.002
   Wassenaar JW, 2016, J MATER CHEM B, V4, P2794, DOI 10.1039/c5tb02564h
   Wassenaar JW, 2016, J AM COLL CARDIOL, V67, P1074, DOI 10.1016/j.jacc.2015.12.035
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wu JL, 2015, ACTA BIOMATER, V16, P49, DOI 10.1016/j.actbio.2015.01.027
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
   Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]
NR 116
TC 35
Z9 36
U1 29
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 1
EP 15
DI 10.1016/j.actbio.2016.11.068
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100001
PM 27915024
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU McMasters, J
   Panitch, A
AF McMasters, James
   Panitch, Alyssa
TI Collagen-binding nanoparticles for extracellular anti-inflammatory
   peptide delivery decrease platelet activation, promote endothelial
   migration, and suppress inflammation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE N-isopropylacrylamide; Thermosensitive polymer; Collagen; Platelet;
   Anti-inflammatory peptides
ID PERIPHERAL ARTERIAL-DISEASE; SMOOTH-MUSCLE-CELLS; GRAFT COPOLYMER
   HYDROGELS; ANKLE-BRACHIAL INDEX; DRUG-ELUTING STENTS; THERMOSENSITIVE
   NANOPARTICLES; PENETRATING PEPTIDES; BALLOON ANGIOPLASTY; CYTOKINE
   PRODUCTION; RELEASE
AB Peripheral artery disease is an atherosclerotic stenosis in the peripheral vasculature that is typically treated via percutaneous transluminal angioplasty. Deployment of the angioplasty balloon damages the endothelial layer, exposing the underlying collagen and allowing for the binding and activation of circulating platelets which initiate an inflammatory cascade leading to eventual restenosis. Here, we report on collagen-binding sulfated poly(N-isopropylacrylamide) nanoparticles that are able to target to the denuded endothelium. Once bound, these nanoparticles present a barrier that reduces cellular and platelet adhesion to the collagenous surface by 67% in whole blood and 59% in platelet-rich plasma under biologically relevant shear rates. In vitro studies indicate that the collagen-binding nanoparticles are able to load and release therapeutic quantities of anti-inflammatory peptides, with the particles reducing inflammation in endothelial and smooth muscle cells by 30% and 40% respectively. Once bound to collagen, the nanoparticles increased endothelial migration while avoiding uptake by smooth muscle cells, indicating that they may promote regeneration of the damaged endothelium while remaining anchored to the collagenous matrix and locally releasing anti-inflammatory peptides into the injured area. Combined, these collagen-binding nanoparticles have the potential to reduce inflammation, and the subsequent restenosis, while simultaneously promoting endothelial regeneration following balloon angioplasty.
   Statement of Significance
   In this manuscript, we present our work on the development and characterization of a novel temperature sensitive collagen-binding nanoparticle system. We demonstrate that when bound to a collagenous matrix, the nanoparticles are able to promote endothelial migration while avoiding cellular uptake. We also show that the nanoparticles are able to reduce inflammation via the release of anti-inflammatory peptides which, when combined with its ability to inhibit platelet binding, could lead to reduced intimal hyperplasia following balloon angioplasty. The drug delivery platform presented represents a unique dual therapy biomaterial wherein the nanoparticle itself plays a crucial role in the system's overall therapeutic potential while simultaneously releasing anti-inflammatory peptides. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [McMasters, James; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, 206 South Martin Jischke Dr, W Lafayette, IN 47906 USA.
   [McMasters, James; Panitch, Alyssa] Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.
RP Panitch, A (reprint author), Purdue Univ, Weldon Sch Biomed Engn, 206 South Martin Jischke Dr, W Lafayette, IN 47906 USA.; Panitch, A (reprint author), Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.
EM apanitch@ucdavis.edu
FU National Institutes of Health [HL106792]
FX This work was supported by the National Institutes of Health [HL106792].
   Funding sources had no involvement in study design, collection and
   analysis of data, or decision to publish.
CR AARTS PAMM, 1983, BLOOD, V62, P214
   AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223
   Anderson R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3089
   Aronow WS, 2009, AM J CARDIOL, V103, P130, DOI 10.1016/j.amjcard.2008.08.037
   AZRIN MA, 1994, CIRCULATION, V90, P433, DOI 10.1161/01.CIR.90.1.433
   Bartlett RL, 2013, NANOMED-NANOTECHNOL, V9, P419, DOI 10.1016/j.nano.2012.09.003
   Bartlett RL, 2012, BIOMACROMOLECULES, V13, P2578, DOI 10.1021/bm300826v
   Bartlett RL, 2012, BIOMACROMOLECULES, V13, P1204, DOI 10.1021/bm300173x
   Brugnano J, 2013, J PEPT SCI, V19, P629, DOI 10.1002/psc.2541
   Brugnano JL, 2011, J CONTROL RELEASE, V155, P128, DOI 10.1016/j.jconrel.2011.05.007
   BUNDGAARD H, 1992, ADV DRUG DELIVER REV, V8, P1, DOI 10.1016/0169-409X(92)90014-H
   Cacoub P, 2009, INT J CLIN PRACT, V63, P63, DOI 10.1111/j.1742-1241.2008.01953.x
   Cimminiello C, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-35
   CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510
   Culbert AA, 2006, J BIOL CHEM, V281, P23658, DOI 10.1074/jbc.M51364200
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Dalmia S., 2005, 5 YEAR DUPLEX FOLLOW
   Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092
   Elaissari A, 2006, PROG COLL POL SCI S, V133, P9, DOI 10.1007/2882_063
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Garcia-Touchard A, 2006, EUR HEART J, V27, P988, DOI 10.1093/eurheartj/ehi752
   Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621
   Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441
   HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651
   Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913
   Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317
   HOEKS APG, 1995, HYPERTENSION, V26, P26, DOI 10.1161/01.HYP.26.1.26
   Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075
   Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030
   Jones CD, 2003, LANGMUIR, V19, P4544, DOI 10.1021/la034392+
   KAPLAN KL, 1979, BLOOD, V53, P604
   KARAS SP, 1992, J AM COLL CARDIOL, V20, P467, DOI 10.1016/0735-1097(92)90119-8
   Knobloch J, 2014, BASIC CLIN PHARMACOL, V114, P202, DOI 10.1111/bcpt.12129
   KOMPELLA UB, 1992, ADV DRUG DELIVER REV, V8, P115
   Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281
   Krajcer Z, 2000, TEX HEART I J, V27, P369
   Latif F, 2008, CATHETER CARDIO INTE, V72, P294, DOI 10.1002/ccd.21598
   LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209
   Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058
   MACLEOD DC, 1994, J AM COLL CARDIOL, V23, P59, DOI 10.1016/0735-1097(94)90502-9
   Matter CM, 2006, J CARDIOVASC PHARM, V48, P286, DOI 10.1097/01.fjc.0000248233.22570.8b
   McMasters J, 2015, AAPS J, V17, P1117, DOI 10.1208/s12248-015-9794-9
   Mongiardo Annalisa, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P275
   Muto A, 2012, VASC PHARMACOL, V56, P47, DOI 10.1016/j.vph.2011.07.008
   Overstreet DJ, 2013, SOFT MATER, V11, P294, DOI 10.1080/1539445X.2011.640731
   Overstreet DJ, 2013, J BIOMED MATER RES A, V101, P1437, DOI 10.1002/jbm.a.34443
   Paderi JE, 2011, BIOMATERIALS, V32, P2516, DOI 10.1016/j.biomaterials.2010.12.025
   Perez J, 2011, AM J PHYSIOL-CELL PH, V301, pC242, DOI 10.1152/ajpcell.00315.2010
   Poh S, 2015, BIOMACROMOLECULES, V16, P1191, DOI 10.1021/bm501849p
   Saikia AK, 2013, INT J POLYM MATER PO, V62, P39, DOI 10.1080/00914037.2012.664208
   Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schuliga M, 2013, AM J RESP CELL MOL, V49, P751, DOI 10.1165/rcmb.2012-0404OC
   Scott RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082456
   Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0
   STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Ward BC, 2011, J SURG RES, V169, pE27, DOI 10.1016/j.jss.2011.01.043
   Yeh JL, 2013, ATHEROSCLEROSIS, V226, P364, DOI 10.1016/j.atherosclerosis.2012.12.005
   Zhu QS, 2013, COLLOID SURFACE B, V104, P61, DOI 10.1016/j.colsurfb.2012.12.004
NR 63
TC 1
Z9 1
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 78
EP 88
DI 10.1016/j.actbio.2016.11.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100006
PM 27840254
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dinjaski, N
   Plowright, R
   Zhou, S
   Belton, DJ
   Perry, CC
   Kaplan, DL
AF Dinjaski, Nina
   Plowright, Robyn
   Zhou, Shun
   Belton, David J.
   Perry, Carole C.
   Kaplan, David L.
TI Osteoinductive recombinant silk fusion proteins for bone regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Spider silk; Hydroxyapatite; Fusion proteins; Biomaterials;
   Calcification
ID IN-VITRO; INFRARED-SPECTROSCOPY; BINDING PEPTIDES; STEM-CELLS; SPIDER;
   BIOMATERIALS; SCAFFOLDS; MATRIX; CARTILAGE; COLLAGEN
AB Protein polymers provide a unique opportunity for tunable designs of material systems due to the genetic basis of sequence control. To address the challenge of biomineralization interfaces with protein based materials, we genetically engineered spider silks to design organic-inorganic hybrid systems. The spider silk inspired domain (SGRGGLGGQG AGAAAAAGGA GQGGYGGLGSQGT)(15) served as an organic scaffold to control material stability and to allow multiple modes of processing, whereas the hydroxyapatite binding domain VTKHLNQISQSY (VTK), provided control over osteogenesis. The VTK domain was fused either to the N-, C- or both terminals of the spider silk domain to understand the effect of position on material properties and mineralization. The addition of the VTK domain to silk did not affect the physical properties of the silk recombinant constructs, but it had a critical role in the induction of biomineralization. When the VTK domain was placed on both the C- and N-termini the formation of crystalline hydroxyapatite was significantly increased. In addition, all of the recombinant proteins in film format supported the growth and proliferation of human mesenchymal stem cells (hMSC5). Importantly, the presence of the VTK domain enhanced osteoinductive properties up to 3-fold compared to the control (silk alone without VTK). Therefore, silk-VTK fusion proteins have been shown suitable for mineralization and functionalization for specific biomedical applications.
   Statement of Significance
   Organic-inorganic interfaces are integral to biomaterial functions in many areas of repair and regeneration. Several protein polymers have been investigated for this purpose. Despite their success the limited options to fine-tune their material properties, degradation patterns and functionalize them for each specific biomedical application limits their application. Various studies have shown that the biological performance of such proteins can be improved by genetic engineering. The present study provides data relating protein design parameters and functional outcome quantified by biomineralization and human mesenchymal stem cell differentiation. As such, it helps the design of osteoinductive recombinant biomaterials for bone regeneration. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dinjaski, Nina; Zhou, Shun; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Plowright, Robyn; Belton, David J.; Perry, Carole C.] Nottingham Trent Univ, Sch Sci & Technol, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Clifton Lane, Nottingham NG11 8NS, England.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.; Perry, CC (reprint author), Nottingham Trent Univ, Sch Sci & Technol, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Clifton Lane, Nottingham NG11 8NS, England.
EM Carole.Perry@ntu.ac.uk; David.Kaplan@Tufts.edu
OI Perry, Professor Carole/0000-0003-1517-468X
FU NIH [R01 DE017207]
FX We thank the NIH (R01 DE017207) for support of this work.
CR Addison WN, 2010, BIOMATERIALS, V31, P9422, DOI 10.1016/j.biomaterials.2010.08.064
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   Belton DJ, 2012, LANGMUIR, V28, P4373, DOI 10.1021/la205084z
   BOCCIARELLI DS, 1970, CALC TISS RES, V5, P261, DOI 10.1007/BF02017554
   CARLSTROM D, 1954, BIOCHIM BIOPHYS ACTA, V13, P183, DOI 10.1016/0006-3002(54)90302-9
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Plowright R, 2016, RSC ADV, V6, P21776, DOI 10.1039/c6ra03706b
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Roseberry HH, 1931, J BIOL CHEM, V90, P395
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Tsuji T, 2011, J CRYST GROWTH, V314, P190, DOI 10.1016/j.jcrysgro.2010.10.167
   U. S. Depart H. Services, 2010, 2020 NEW VIS FUT REG, P1
   Walsh G., 2002, PROTEINS BIOCH BIOTE
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhou S, 2015, ACTA BIOMATER, V15, P173, DOI 10.1016/j.actbio.2014.10.040
NR 40
TC 6
Z9 6
U1 3
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 127
EP 139
DI 10.1016/j.actbio.2016.12.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100010
PM 27940162
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Barr, S
   Hill, EW
   Bayat, A
AF Barr, S.
   Hill, E. W.
   Bayat, A.
TI Development, fabrication and evaluation of a novel biomimetic human
   breast tissue derived breast implant surface
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Breast implant; Capsular contracture; Biomaterial; Novel surface
   development; Biocompatibility; Biomimetics
ID CAPSULAR CONTRACTURE; MACROPHAGE ACTIVATION; CYTOKINE EXPRESSION;
   IMAGE-ANALYSIS; IN-VITRO; AUGMENTATION; FIBROBLASTS; COMPLICATIONS;
   BIOMATERIALS; POLARIZATION
AB Breast implant use has tripled in the last decade with over 320,000 breast implant based reconstructions and augmentations performed in the US per annum. Unfortunately a considerable number of women will experience capsular contracture, the irrepressible and disfiguring, tightening and hardening of the fibrous capsule that envelops the implant. Functionalising implant surfaces with biocompatible tissue-specific textures may improve in vivo performance. A novel biomimetic breast implant is presented here with anti-inflammatory in vitro abilities.
   Topographical assessment of native breast tissue facilitated the development of a statistical model of adipose tissue. 3D grayscale photolithography and ion etching were combined to successfully replicate a surface modelled upon the statistics of breast tissue.
   Pro-inflammatory genes IL beta 1, TNF alpha, and IL6 were downregulated (p < 0.001) and anti-inflammatory gene IL-10 were upregulated on the novel surface. Pro-inflammatory cytokines Gro-Alpha, TNF alpha. and neutrophil chemoattractant 18 were produced in lower quantities and anti-inflammatory IL-10 in higher quantities in culture with the novel surface (p < 0.01). Immunocytochemistry and SEM demonstrated favourable fibroblast and macrophage responses to these novel surfaces.
   This study describes the first biomimetic breast tissue derived breast implant surface. Our findings attest to its potential translational ability to reduce the inflammatory phase of the implant driven foreign body reaction.
   Statement of Significance
   Breast implants are still manufactured using outdated techniques and have changed little since their inception in the 1960's. Breast implants can cause a medical condition, capsular contracture which often results in disfigurement, pain, implant removal and further surgery. This condition is due to the body's reaction to these breast implants. This article describes the successful development and testing of a novel breast implant surface inspired by the native shapes present in breast tissue. Results show that this novel implant surface is capable of reducing the negative reaction of human cells to these surfaces which may help reduce capsular contracture formation. This work represents the first steps in producing a biocompatible breast implant. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Barr, S.; Bayat, A.] Univ Manchester, Plast & Reconstruct Surg Res, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
   [Barr, S.; Hill, E. W.] Univ Manchester, Dept Comp Sci, Manchester M13 9PL, Lancs, England.
   [Bayat, A.] Univ Manchester, Fac Engn & Phys Sci, Sch Mat, Bioengn Res Grp, Manchester, Lancs, England.
RP Bayat, A (reprint author), Univ Manchester, Plast & Reconstruct Surg Res, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM ardeshir.bayat@manchester.ac.uk
FU Establishment Labs, Costa Rica
FX This work was funded by Establishment Labs, Costa Rica. Establishment
   Labs did not take part in the study design, collection or analysis of
   the data; in writing the journal article or the decision to submit for
   publication.
CR Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26
   ASHLEY FL, 1970, PLAST RECONSTR SURG, V45, P421, DOI 10.1097/00006534-197005000-00001
   Bainbridge P, 2013, J WOUND CARE, V22, P407
   Barnsley GP, 2006, PLAST RECONSTR SURG, V117, P2182, DOI 10.1097/01.prs.0000218184.47372.d5
   Barr S. H., 2009, EPLASTY
   Barr SP, 2016, EJSO-EUR J SURG ONC, V42, P591, DOI 10.1016/j.ejso.2016.02.240
   Barr S, 2011, AESTHET SURG J, V31, P56, DOI 10.1177/1090820X10390921
   BATICH C, 1989, J BIOMED MATER RES-A, V23, P311, DOI 10.1002/jbm.820231406
   Berry MG, 2010, J PLAST RECONSTR AES, V63, P2098, DOI 10.1016/j.bjps.2010.04.011
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   BRANDT B, 1984, SCAND J PLAST RECONS, V18, P311, DOI 10.3109/02844318409052856
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Buddy D.R., 1993, J BIOMED MATER RES, V27, P837
   Cash TF, 2002, PLAST RECONSTR SURG, V109, P2112, DOI 10.1097/00006534-200205000-00049
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Collis N, 2000, PLAST RECONSTR SURG, V106, P792, DOI 10.1097/00006534-200009040-00006
   Danino AM, 2001, PLAST RECONSTR SURG, V108, P2047, DOI 10.1097/00006534-200112000-00032
   DENICOLA RR, 1950, J UROLOGY, V63, P168, DOI 10.1016/S0022-5347(17)68748-2
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001
   GASPERONI C, 1992, ANN PLAS SURG, V29, P303, DOI 10.1097/00000637-199210000-00005
   Gerullis H., 2014, BIOMED RES INT, V2014, P6
   Handel N, 2006, PLAST RECONSTR SURG, V117, P757, DOI 10.1097/01.prs.0000201457.00772.1d
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KOSSOVSKY N, 1993, IMMUNOMETHODS, V3, P43
   Kyle DJT, 2015, BIOMATERIALS, V52, P88, DOI 10.1016/j.biomaterials.2015.02.003
   Kyle DJT, 2013, WOUND REPAIR REGEN, V21, P762, DOI 10.1111/wrr.12077
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44
   Puskas JE, 2012, WIRES NANOMED NANOBI, V4, P153, DOI 10.1002/wnan.164
   Rasband WS, IMAGEJ1997 2012
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Spear SL, 2012, PLAST RECONSTR SURG, V130, P423, DOI 10.1097/PRS.0b013e3182589ea9
   Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Ward KW., 2008, J DIABETES SCI TECHN, V2, P768
   Wong CH, 2006, PLAST RECONSTR SURG, V118, P1224, DOI 10.1097/01.prs.0000237013.50283.d2
NR 45
TC 2
Z9 2
U1 3
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 260
EP 271
DI 10.1016/j.actbio.2016.11.052
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100020
PM 27919840
DA 2018-10-20
ER

PT J
AU Oliveira, MI
   Pinto, ML
   Goncalves, RM
   Martins, MCL
   Santos, SG
   Barbosa, MA
AF Oliveira, Marta I.
   Pinto, Marta L.
   Goncalves, Raquel M.
   Martins, M. Cristina L.
   Santos, Susana G.
   Barbosa, Mario A.
TI Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2
   expression
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adsorbed Fibrinogen; Monocytes; BMP-2; Signalling pathways; Bone
   regeneration
ID BONE MORPHOGENETIC PROTEIN-2; VALVE INTERSTITIAL-CELLS; MESENCHYMAL
   STEM-CELLS; IN-VITRO; CHITOSAN; ACTIVATION; TOLL-LIKE-RECEPTOR-4;
   DIFFERENTIATION; BIOMATERIALS; REGENERATION
AB Modulation of inflammatory responses to implanted biomaterials towards tissue regeneration has gained prominence as an innovative tissue engineering strategy. Recent in vitro and in vivo studies showed that Fibrinogen (Fg) adsorbed to Chitosan (Ch) substrates modulates immune cell responses, enhances the production of osteogenic factors by monocytes/macrophages and promotes bone regeneration, but the mechanisms involved remain poorly understood. Thus, the present work was conducted to clarify the molecular mechanisms of interaction between primary human monocytes and the above substrates.
   Cell surface expression of TLR-4 was significantly downregulated in the presence of pre-adsorbed Fg, when compared to Ch control, indicating an interaction via this receptor. The same substrate triggered MAPK activation, specifically the ERK 1/2 and JNK pathways. Importantly, both ERK 1/2 and JNK phosphorylation were reduced when TLR-4 signalling was blocked using a specific pharmacological inhibitor. Functionally, adsorbed Fg induced production of the potent osteogenic mediator BMP-2 by monocytes, while TLR-4 inhibition resulted in a significant decrease of BMP-2 mRNA and protein levels, in response to Fg stimulation. Overall, our data reveals that adsorbed Fg exerts a pro-osteogenic effect on human monocytes through its interaction with TLR-4 and subsequent production of BMP-2, elucidating two key aspects of the immunomodulatory action of adsorbed Fg in bone regeneration.
   Statement of Significance
   Recent studies showed that when Fibrinogen (Fg) is used to modify Chitosan (Ch) substrates, it modulates the immune response, enhances production of osteogenic factors by monocytes/macrophages, and promotes bone regeneration. However, the mechanisms involved in monocyte-Fg interaction, were only partially known. Current work addresses the interaction between primary human monocytes and Ch surfaces modified by Fg adsorption (Ch-Fg) at the molecular level. Results show that monocytes interact specifically with Ch-Fg via TLR-4, triggering particular intracellular signalling pathways (ERK and JNK, but not p38), downstream of TLR-4. Functionally, Ch-Fg induced monocytes to produce the osteogenic mediator BMP-2. Thus, we clarify herein two essential aspects of the interaction between adsorbed Fg and monocytes, with impact on immunomodulation and regeneration, upon biomaterial implantation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oliveira, Marta I.; Pinto, Marta L.; Goncalves, Raquel M.; Martins, M. Cristina L.; Santos, Susana G.; Barbosa, Mario A.] Univ Porto, i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Oliveira, Marta I.; Pinto, Marta L.; Goncalves, Raquel M.; Martins, M. Cristina L.; Santos, Susana G.; Barbosa, Mario A.] Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
   [Oliveira, Marta I.] INL Int Iberian Nanotechnol Lab, Ave Mestre Jose Veiga S-N, P-4715330 Braga, Portugal.
   [Pinto, Marta L.; Goncalves, Raquel M.; Martins, M. Cristina L.; Barbosa, Mario A.] Univ Porto, ICBAS, Largo Prof Abel Salazar 2, P-4099003 Oporto, Portugal.
RP Oliveira, MI (reprint author), INL Int Iberian Nanotechnol Lab, Ave Mestre Jose Veiga S-N, P-4715330 Braga, Portugal.
EM marta.oliveira@inl.int
RI Santos, Susana/L-9351-2013; Oliveira, Marta/M-9386-2013; Goncalves,
   Raquel/C-5940-2012; Barbosa, Mario/F-5964-2011
OI Santos, Susana/0000-0002-8604-2978; Oliveira, Marta/0000-0002-0578-9202;
   Goncalves, Raquel/0000-0003-2841-0485; Barbosa,
   Mario/0000-0003-3568-7482; Pinto, Marta/0000-0002-5783-3965; Martins, M.
   Cristina/0000-0002-6574-4794
FU Norte Portugal Regional Operational Programme (NORTE), under the
   PORTUGAL Partnership Agreement, through the European Regional
   Development Fund (ERDF) [NORTE-01-0145-FEDER-000012]; FCT
   [SFRH/BPD/37090/2007, SFRH/BD/81103/2011, IF/00638/2014]
FX The authors would like to thank the Immunohemotherapy Service of Centro
   Hospitalar de Sao Joao, Porto, Portugal, for kindly donating buffy
   coats; the Biointerfaces and Nanotechnology Unit of i3S, and Ricardo
   Vidal for help with the FTIR. This work was funded by the project
   NORTE-01-0145-FEDER-000012, supported by Norte Portugal Regional
   Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership
   Agreement, through the European Regional Development Fund (ERDF). MIO
   and MLP and RMG were supported by FCT, through post-doc, PhD and IF
   fellowships, references SFRH/BPD/37090/2007, SFRH/BD/81103/2011,
   IF/00638/2014, respectively.
CR Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076
   Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8
   Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   FAN ST, 1993, J IMMUNOL, V150, P2972
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Gugutkov D, 2013, BIOMATER SCI-UK, V1, P1065, DOI 10.1039/c3bm60124b
   Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991
   Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146
   Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569
   Kaneider NC, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-2
   Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95
   Kim S, 2014, J BIOMED MATER RES B, V102, P1393, DOI 10.1002/jbm.b.33118
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   KREUTZ M, 1993, BLOOD, V82, P1300
   Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869
   Kuhns DB, 2007, INFLAMMATION, V30, P178, DOI 10.1007/s10753-007-9035-1
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Kurt-Jones EA, 2002, BLOOD, V100, P1860
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]
   Maciel J, 2014, TISSUE ENG PT A, V20, P250, DOI [10.1089/ten.tea.2012.0439, 10.1089/ten.TEA.2012.0439]
   Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007
   Ode A, 2010, J BIOMED MATER RES A, V95A, P1114, DOI 10.1002/jbm.a.32909
   OdrIjin T. M., 2001, AM J RESP CELL MOL B, V24, P12
   Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Rajangam T, 2013, INT J NANOMED, V8, P3641, DOI 10.2147/IJN.S43945
   Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3
   Rubel C, 2002, J IMMUNOL, V168, P3527, DOI 10.4049/jimmunol.168.7.3527
   Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164
   Santos SG, 2013, ACTA BIOMATER, V9, P7209, DOI 10.1016/j.actbio.2013.04.008
   SIMON DI, 1993, BLOOD, V82, P2414
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Su X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214619
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Torres AL, 2013, ACTA BIOMATER, V9, P6553, DOI 10.1016/j.actbio.2013.01.015
   Vasconcelos DM, 2016, BIOMATERIALS, V111, P163, DOI 10.1016/j.biomaterials.2016.10.004
   Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107
   Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052
   Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022
   Zhan Qiong, 2015, Int J Biol Sci, V11, P482, DOI 10.7150/ijbs.10905
NR 58
TC 3
Z9 3
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 296
EP 305
DI 10.1016/j.actbio.2016.11.034
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100023
PM 27856281
DA 2018-10-20
ER

PT J
AU Hunt, NC
   Hallam, D
   Karimi, A
   Mellough, CB
   Chen, JJ
   Steel, DHW
   Lako, M
AF Hunt, Nicola C.
   Hallam, Dean
   Karimi, Ayesha
   Mellough, Carla B.
   Chen, Jinju
   Steel, David H. W.
   Lako, Majlinda
TI 3D culture of human pluripotent stem cells in RGD-alginate hydrogel
   improves retinal tissue development
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Retina; Tissue engineering; Embryonic stem cells; Induced pluripotent
   stem cells; Biomaterials
ID PIGMENT EPITHELIAL-CELLS; ADULT HUMAN RETINA; INTERPHOTORECEPTOR MATRIX;
   EXTRACELLULAR-MATRIX; MACULAR DEGENERATION; DIFFERENTIAL DISTRIBUTION;
   OPHTHALMIC APPLICATIONS; 3-DIMENSIONAL CULTURE; VISUAL IMPAIRMENT;
   ENDOTHELIAL-CELLS
AB No treatments exist to effectively treat many retinal diseases. Retinal pigmented epithelium (RPE) and neural retina can be generated from human embryonic stem cells/induced pluripotent stem cells (hESCs/hiPSCs). The efficacy of current protocols is, however, limited. It was hypothesised that generation of laminated neural retina and/or RPE from hiPSCs/hESCs could be enhanced by three dimensional (3D) culture in hydrogels. hiPSC- and hESC-derived embryoid bodies (EBs) were encapsulated in 0.5% RGD-alginate; 1% RGD-alginate; hyaluronic acid (HA) or HA/gelatin hydrogels and maintained until day 45. Compared with controls (no gel), 0.5% RGD-alginate increased: the percentage of EBs with pigmented RPE foci; the percentage EBs with optic vesicles (OVs) and pigmented RPE simultaneously; the area covered by RPE; frequency of RPE cells (CRALBP-F); expression of RPE markers (TYR and RPE65) and the retinal ganglion cell marker, MATHS. Furthermore, 0.5% RGD-alginate hydrogel encapsulation did not adversely affect the expression of other neural retina markers (PROX1, CRX, RCVRN, AP2 alpha or VSX2) as determined by qRT-PCR, or the percentage of VSX2 positive cells as determined by flow cytometry. 1% RGD-alginate increased the percentage of EBs with OVs and/or RPE, but did not significantly influence any other measures of retinal differentiation. HA-based hydrogels had no significant effect on retinal tissue development. The results indicated that derivation of retinal tissue from hESCs/hiPSCs can be enhanced by culture in 0.5% RGD-alginate hydrogel. This RGD-alginate scaffold may be useful for derivation, transport and transplantation of neural retina and RPE, and may also enhance formation of other pigmented, neural or epithelial tissue.
   Statement of Significance
   The burden of retinal disease is ever growing with the increasing age of the world-wide population. Transplantation of retinal tissue derived from human pluripotent stem cells (PSCs) is considered a promising treatment. However, derivation of retinal tissue from PSCs using defined media is a lengthy process and often variable between different cell lines.
   This study indicated that alginate hydrogels enhanced retinal tissue development from PSCs, whereas hyaluronic acid-based hydrogels did not. This is the first study to show that 3D culture with a biomaterial scaffold can improve retinal tissue derivation from PSCs.
   These findings indicate potential for the clinical application of alginate hydrogels for the derivation and subsequent transplantation retinal tissue. This work may also have implications for the derivation of other pigmented, neural or epithelial tissue. Crown Copyright (C) 2016 Published by Elsevier Ltd on behalf of Acta Materialia Inc.
C1 [Hunt, Nicola C.; Hallam, Dean; Mellough, Carla B.; Steel, David H. W.; Lako, Majlinda] Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle NE1 3BZ, England.
   [Chen, Jinju] Newcastle Univ, Sch Mech & Syst Engn, Stephenson Bldg, Newcastle Upon Tyne, Tyne & Wear, England.
   [Karimi, Ayesha] North Cumbria Univ Hosp NHS Trust, Cumberland Infirm, Carlisle CA2 7HY, England.
   [Steel, David H. W.] Sunderland Eye Infirm, Queen Alexandra Rd, Sunderland SR2 9HP, England.
RP Lako, M (reprint author), Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle NE1 3BZ, England.
EM nicola.hunt@ncl.ac.uk; dean.hallam@ncl.ac.uk; carla.mellough@ncl.ac.uk;
   jinju.chen@ncl.ac.uk; david.steel@ncl.ac.uk; majlindadako@ncl.ac.uk
OI Steel, David/0000-0001-8734-3089; Mellough, Carla/0000-0003-3685-6516
FU ERC Consolidator award [614620]; RPFB Innovation award [GR584]; Fight
   for Sight [1870, 1456/57]; Biotechnology and Biological Sciences
   Research Council [BB/E012841/1, BB/I02333X/1]; National Centre for the
   Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
   [NC/C016106/1]; Medical Research Council [MC_PC_15030]
FX We are grateful to Matthew Satterfield, Martin Kiening, Dr. Katarina
   Novakovik, Dr. Fernando Abegao, Katherine White and other members of the
   EM facility for SEM sample preparation and imaging assistance, and Dr.
   Andrew Filby and Gillian Hulme for assistance with FACS. We would like
   to thank members of our group for useful discussions and technical
   assistance, Pedram Panahi and Jonathan Kossoff for assistance with RPE
   quantification, and Jiajun Wang and Pengfei Duan for assistance with
   rheology. This work was funded by the ERC Consolidator award (#614620)
   and the RPFB Innovation award (#GR584) to ML. Author contributions were
   as follows: NH designed and performed research, data acquisition and
   analysis, and wrote the manuscript; DH performed research, data
   acquisition and analysis; AK performed data analysis; JC acquired and
   analysed data; CBM performed research and contributed to fundraising;
   DHWS performed research and contributed to fundraising; ML designed and
   performed research, manuscript writing and fundraising. All authors
   contributed to the final approval of manuscript.
CR Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021
   Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945
   Aizawa Y, 2012, BIOMATERIALS, V33, P5198, DOI 10.1016/j.biomaterials.2012.03.062
   Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536
   Anderson RH, 2012, CARDIOVASC RES, V95, P108, DOI 10.1093/cvr/cvs147
   Aramant RB, 2002, EXP EYE RES, V75, P115, DOI 10.1006/exer.2002.2001
   Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004
   Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002
   Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013
   Bellas E, 2014, CURR OPIN CELL BIOL, V31, P92, DOI 10.1016/j.ceb.2014.09.006
   CAIAZZO M, 2016, NAT MAT, V15
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chen FM, 2015, PROG POLYM SCI
   Chen J, 2012, BIOPHYS J, V103, P1188, DOI 10.1016/j.bpj.2012.07.054
   Chen KN, 2014, J BIOMED MATER RES A, V102, P2001, DOI 10.1002/jbm.a.34858
   Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909
   Daruich A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-77
   des Senanayake P, 2001, J CELL SCI, V114, P199
   Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eurell TE, 2003, VET OPHTHALMOL, V6, P237, DOI 10.1046/j.1463-5224.2003.00300.x
   Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z
   Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k
   Frischknecht R, 2008, NEURON GLIA BIOL, V4, P249, DOI 10.1017/S1740925X09990226
   Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198
   German OL, 2008, J NEUROSCI RES, V86, P3503, DOI 10.1002/jnr.21813
   Gobaa S, 2015, INTEGR BIOL-UK, V7, P1135, DOI 10.1039/c4ib00176a
   Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189
   Gross JM, 2005, GENETICS, V170, P245, DOI 10.1534/genetics.104.039727
   Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416
   Hausman RE, 2007, PROG RETIN EYE RES, V26, P162, DOI 10.1016/j.preteyeres.2006.11.001
   Heidari R, 2015, APPL BIOCHEM BIOTECH, V175, P2399, DOI 10.1007/s12010-014-1431-z
   Henrich Paul B, 2012, Invest Ophthalmol Vis Sci, V53, P2561, DOI 10.1167/iovs.11-8502
   Hiler D, 2015, CELL STEM CELL, V17, P101, DOI 10.1016/j.stem.2015.05.015
   Hohenester E, 2014, CURR OPIN STRUC BIOL, V29, P10, DOI 10.1016/j.sbi.2014.08.009
   Holley RJ, 2014, BIOCHEM SOC T, V42, P689, DOI 10.1042/BST20140064
   Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767
   Hoon M, 2014, PROG RETIN EYE RES, V42, P44, DOI 10.1016/j.preteyeres.2014.06.003
   Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531
   Huang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10310
   Humphries J.D., 2006, HUMPHRIES HUMPHRIES
   Hunt Nicola C, 2013, Methods Mol Biol, V1014, P201, DOI 10.1007/978-1-62703-432-6_14
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Inoue Y, 2009, BRAIN RES, V1256, P55, DOI 10.1016/j.brainres.2008.12.023
   Ishikawa M, 2015, EXP EYE RES, V133, P3, DOI 10.1016/j.exer.2015.02.017
   Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797
   Keung AJ, 2012, INTEGR BIOL-UK, V4, P1049, DOI 10.1039/c2ib20083j
   Kirchhof S., 2015, EUR J PHARM BIOPHARM
   Kloeckener-Gruissem B., 2012, EUR J HUM GENET, V352-356
   Kunitomi A, 2016, STEM CELL REP, V6, P825, DOI 10.1016/j.stemcr.2016.04.015
   Kuznetsova AV, 2014, J OPHTHALMOL, DOI 10.1155/2014/801787
   Leach L., 2016, J OCUL PHARMACOL TH, V32, P1
   Leach LL, 2015, STEM CELLS, V33, P2363, DOI 10.1002/stem.2010
   Lee JM, 2015, BIOMATERIALS, V69, P174, DOI 10.1016/j.biomaterials.2015.08.005
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Li LL, 2011, BIOMATERIALS, V32, P4489, DOI 10.1016/j.biomaterials.2011.03.019
   Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001
   Liu Y, 2013, TISSUE ENG PT A, V19, P135, DOI [10.1089/ten.tea.2012.0209, 10.1089/ten.TEA.2012.0209]
   Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939
   Lukovic D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12910
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622
   Manes G, 2013, AM J HUM GENET, V93, P571, DOI 10.1016/j.ajhg.2013.07.018
   May C.A., 2012, ISRN OPHTHALMOL, V2012
   Mazumder MAJ, 2012, J BIOMED MATER RES A, V100A, P1877, DOI 10.1002/jbm.a.34021
   Mellough C.B., 2014, VISUAL NEUROSCI, P1
   Mellough CB, 2015, STEM CELLS, V33, P2416, DOI 10.1002/stem.2023
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   NAKAZATO H, 1993, KIDNEY INT, V44, P1091, DOI 10.1038/ki.1993.353
   Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024
   Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51
   Parvini M, 2015, IN VITRO CELL DEV-AN, V51, P310, DOI 10.1007/s11626-014-9835-1
   Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539
   Patricia S., 2006, EXP EYE RES, V82, P739
   Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997
   Pearson RA, 2014, BIOTECHNOL ADV, V32, P485, DOI 10.1016/j.biotechadv.2014.01.001
   Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645
   Radtke ND, 2008, AM J OPHTHALMOL, V146, P172, DOI 10.1016/j.ajo.2008.04.009
   Rah MJ, 2011, OPTOMETRY, V82, P38, DOI 10.1016/j.optm.2010.08.003
   Ratnapriya R, 2014, HUM MOL GENET, V23, P5827, DOI 10.1093/hmg/ddu276
   Reinhard J, 2015, EXP EYE RES, V133, P132, DOI 10.1016/j.exer.2014.07.001
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Savige J, 2010, INVEST OPHTH VIS SCI, V51, P1621, DOI 10.1167/iovs.08-3323
   Schramm C, 2012, INVEST OPHTH VIS SCI, V53, P613, DOI 10.1167/iovs.11-7322
   Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051
   Shao Y, 2015, BIOMATERIALS, V52, P26, DOI 10.1016/j.biomaterials.2015.01.078
   Shin JW, 2016, CELL STEM CELL, V18, P16, DOI 10.1016/j.stem.2015.12.007
   Shirai H., 2016, INFLAMM REGENER, V36, P10
   Smith AM, 2012, BIOMACROMOLECULES, V13, P4032, DOI 10.1021/bm301321d
   Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025
   Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Thomas BB, 2016, INVEST OPHTH VIS SCI, V57, P2877, DOI 10.1167/iovs.16-19238
   Tian J, 2005, BRIT J OPHTHALMOL, V89, P1510, DOI 10.1136/bjo.2005.072108
   Tucker B.A., 2013, ELIFE, V2013, P1
   Uren PJ, 2014, MOL VIS, V20, P1612
   Vigneswara V, 2015, MOL CELL NEUROSCI, V68, P212, DOI 10.1016/j.mcn.2015.08.001
   Viswanathan P, 2015, BIOMATERIALS, V52, P140, DOI 10.1016/j.biomaterials.2015.01.034
   Wang QJ, 2016, ADV EXP MED BIOL, V854, P543, DOI 10.1007/978-3-319-17121-0_72
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267
   Wikstrom J, 2008, BIOMATERIALS, V29, P869, DOI 10.1016/j.biomaterials.2007.10.056
   Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1
   Worthington KS, 2014, EXP EYE RES, V121, P194, DOI 10.1016/j.exer.2014.02.020
   YAMAMOTO M, 1995, EXP CELL RES, V219, P249, DOI 10.1006/excr.1995.1225
   Zarembinski TI, 2014, ACTA BIOMATER, V10, P94, DOI 10.1016/j.actbio.2013.09.029
   Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047
NR 115
TC 18
Z9 19
U1 10
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2017
VL 49
BP 329
EP 343
DI 10.1016/j.actbio.2016.11.016
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK6UU
UT WOS:000394062100026
PM 27826002
OA Other Gold
DA 2018-10-20
ER

PT J
AU Okada, Y
   Abe, N
   Hisamori, N
   Kaneeda, T
   Moriyama, S
   Ohmori, H
   Mizutani, M
   Yanai, H
   Nakashima, Y
   Yokoyama, Y
   Ozaki, T
AF Okada, Yoshiki
   Abe, Nobuhiro
   Hisamori, Noriyuki
   Kaneeda, Toshiaki
   Moriyama, Shigeaki
   Ohmori, Hitoshi
   Mizutani, Masayoshi
   Yanai, Hiroyuki
   Nakashima, Yoshio
   Yokoyama, Yusuke
   Ozaki, Toshifumi
TI Verification of Implant Surface Modification by a Novel Processing
   Method
SO ACTA MEDICA OKAYAMA
LA English
DT Article
DE biomaterial; surface modification; metal implant; wear; metal ion
ID METAL HIP-ARTHROPLASTY; JOINT REPLACEMENT; TITANIUM-ALLOY; WEAR DEBRIS;
   IN-VIVO; OSSEOINTEGRATION; CHROMIUM; COBALT; CARCINOGENICITY;
   PSEUDOTUMOR
AB Metals have been used clinically as biomaterials, especially in the orthopaedic and dental fields. Metals used as implants wear at contact surfaces, producing metal particles and metal ions that may be harmful. Newly developed metal implants and methods of implant surface modification are currently under scrutiny. We evaluated the use of electrolytic in-process dressing (ELID) as a surface finishing method for metal implants. Metal implants processed using the ELID method (ELID group) or not processed (Non-ELID group) were inserted surgically into rabbit femurs. The rabbits were sacrificed postoperatively over a 24-week period. We assessed the concentrations of the cytokines, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-a, the resistance to implant pull-out, and histopathology at the implant site. There was no significant difference between the groups regarding the cytokine concentrations or implant pull-out resistance. Many particles indicating wear around the implant were noted in the Non-ELID group (n=10) but not the ELID group (n=13), while a fibrous membrane adhering to the every implant was noted in the ELID group. The formation of a fibrous membrane rather than metal particles in the ELID group may indicate improved biocompatibility, and it suggests that ELID may prevent corrosion in the areas of contact.
C1 [Okada, Yoshiki; Yokoyama, Yusuke; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama 7008558, Japan.
   [Yanai, Hiroyuki] Okayama Univ Hosp, Dept Pathol, Okayama 7008558, Japan.
   [Abe, Nobuhiro] Kawasaki Med Univ, Gen Med Ctr, Dept Orthopaed Surg & Sport Med, Okayama 7008505, Japan.
   [Hisamori, Noriyuki] Sophia Univ, Dept Sci & Engn, Chiyoda Ku, Tokyo 1028554, Japan.
   [Kaneeda, Toshiaki] Okayama Univ Sci, Dept Mech Syst Engn, Okayama 7000005, Japan.
   [Moriyama, Shigeaki] Fukuoka Univ, Dept Mech Engn, Fukuoka 8140180, Japan.
   [Ohmori, Hitoshi] Riken Ohmori Mat Fabricat Lab, Wako, Saitama 3510198, Japan.
   [Mizutani, Masayoshi] Tohoku Univ, Grad Sch Engn, Dept Mech Syst & Design, Sendai, Miyagi 9808576, Japan.
   [Nakashima, Yoshio] Nakashima Med Co Ltd, Okayama 7090625, Japan.
RP Abe, N (reprint author), Kawasaki Med Univ, Gen Med Ctr, Dept Orthopaed Surg & Sport Med, Okayama 7008505, Japan.
EM nobuabe@med.kawasaki-m.ac.jp
CR AKATSU T, 1991, J BONE MINER RES, V6, P183
   Bouchard PR, 1996, J BIOMED MATER RES, V32, P37, DOI 10.1002/(SICI)1097-4636(199609)32:1<37::AID-JBM5>3.0.CO;2-Q
   Brama M, 2007, BIOMATERIALS, V28, P595, DOI 10.1016/j.biomaterials.2006.08.018
   Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   Delaunay C, 2010, ORTHOP TRAUMATOL-SUR, V96, P894, DOI 10.1016/j.otsr.2010.05.008
   Facca S, 2011, ACS NANO, V5, P4790, DOI 10.1021/nn200768c
   FERGUSON AB, 1962, J BONE JOINT SURG AM, V44, P317, DOI 10.2106/00004623-196244020-00008
   Fritzsche J, 2012, CLIN ORTHOP RELAT R, V470, P2325, DOI 10.1007/s11999-012-2398-0
   Granchi D, 2012, J BONE JOINT SURG BR, V94B, P1126, DOI 10.1302/0301-620X.94B8.28135
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903
   Kim T, 2003, J BIOMED MATER RES B, V64B, P19, DOI 10.1002/jbm.b.10469
   Krecisz B, 2012, INT J OCCUP MED ENV, V25, P463, DOI 10.2478/S13382-012-0029-3
   Kubo T, 1999, J BIOMED MATER RES, V45, P363, DOI 10.1002/(SICI)1097-4636(19990615)45:4<363::AID-JBM11>3.0.CO;2-3
   Kusy RR, 2002, ANGLE ORTHOD, V72, P501
   Lardanchet JF, 2012, ORTHOP TRAUMATOL-SUR, V98, P265, DOI 10.1016/j.otsr.2011.11.009
   Lewis CG, 1996, CLIN ORTHOP RELAT R, pS264
   Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005
   Machida T, 2004, NIHON U J ORAL SCI, V30, P245
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Mizutani M, 2011, ADV MATER RES-SWITZ, V325, P201, DOI 10.4028/www.scientific.net/AMR.325.201
   Nakajima H, 1996, Dent Mater J, V15, P77
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Pieske O, 2008, J TRAUMA, V64, P1275, DOI 10.1097/TA.0b013e31815e40e0
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUNDERMAN FW, 1989, FUND APPL TOXICOL, V13, P205, DOI 10.1016/0272-0590(89)90257-1
   TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924
   Vendittoli PA, 2010, J BONE JOINT SURG BR, V92B, P12, DOI 10.1302/0301-620X.92B1.22226
   WAGNER CNJ, 1976, J BIOMED MATER RES, V10, P653, DOI 10.1002/jbm.820100503
   Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884
   Ziaee H, 2007, J BONE JOINT SURG BR, V89B, P301, DOI 10.1302/0301-620X.89B3.18520
NR 36
TC 0
Z9 0
U1 0
U2 8
PU OKAYAMA UNIV MED SCHOOL
PI OKAYAMA
PA EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL
   2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN
SN 0386-300X
J9 ACTA MED OKAYAMA
JI Acta Med. Okayama
PD FEB
PY 2017
VL 71
IS 1
BP 49
EP 57
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EO1NC
UT WOS:000396464200007
PM 28238010
DA 2018-10-20
ER

PT J
AU Topuz, F
   Bartneck, M
   Pan, Y
   Tacke, F
AF Topuz, Fuat
   Bartneck, Matthias
   Pan, Yu
   Tacke, Frank
TI One-Step Fabrication of Biocompatible Multifaceted Nanocomposite Gels
   and Nanolayers
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; OSTEOGENIC DIFFERENTIATION;
   MECHANICAL-PROPERTIES; HYDROGELS; CELLS; CLAY; TOUGHNESS; DELIVERY;
   STAR; BICYCLONONYNES
AB Nanocomposite gels are a fascinating class of polymeric materials with an integrative assembly of organic molecules and organic/inorganic nanoparticles, offering a unique hybrid network with synergistic properties. The mechanical properties of such networks are similar to those of natural tissues, which make them ideal biomaterial candidates for tissue engineering applications. Existing nano composite gel systems, however, lack many desirable gel properties, and their suitability for surface coatings is often limited. To address this issue, this article aims at generating multifunctional nanocomposite gels that are injectable with an appropriate time window, functional with bicyclononynes (BCN), biocompatible and slowly degradable, and possess high mechanical strength. Further, the in situ network-forming property of the proposed system allows the fabrication of ultrathin nanocomposite coatings in the submicrometer range with tunable wettability and roughness. Multifunctional nanocomposite gels were fabricated under cytocompatible conditions (pH 7.4 and T = 37 degrees C) using laponite clays, isocyanate (NCO)-terminated sP(EO-stat-PO) macromers, and clickable BCN. Several characterization techniques were employed to elucidate the structure property relationships of the gels. Even though the NCO-sP(EO-stat-PO) macromers could form a hydrogel network in situ on contact with water, the incorporation of laponite led to significant improvement of the mechanical properties. BCN motifs with carbamate links were used for a metal-free click ligation with azide-functional molecules, and the subsequent gradual release of the tethered molecules through the hydrolysis of carbamate bonds was shown. The biocompatibility of the hydrogels was examined through murine macrophages, showing that the material composition strongly affects cell behavior.
C1 [Topuz, Fuat] Rhein Westfal TH Aachen, DWI Leibniz Inst Interact Mat eV, Forkenbeckstr 50, D-52074 Aachen, Germany.
   [Topuz, Fuat] Bilkent Univ, UNAM, Nat Nanotechnol Res Ctr, TR-06800 Ankara, Turkey.
   [Bartneck, Matthias; Tacke, Frank] Rhein Westfal TH Aachen, Fac Med, Dept Med 3, Pauwelsstr 30, D-52074 Aachen, Germany.
   [Pan, Yu] Rhein Westfal TH Aachen, Biomed Engn, Biointerface Lab, D-52074 Aachen, Germany.
RP Topuz, F (reprint author), Rhein Westfal TH Aachen, DWI Leibniz Inst Interact Mat eV, Forkenbeckstr 50, D-52074 Aachen, Germany.; Topuz, F (reprint author), Bilkent Univ, UNAM, Nat Nanotechnol Res Ctr, TR-06800 Ankara, Turkey.
EM fuat.topuz@rwth-aachen.de
CR Annaka M, 2012, SOFT MATTER, V8, P7185, DOI 10.1039/c2sm25534k
   Appel EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7295
   Banik SJ, 2012, MACROMOLECULES, V45, P5712, DOI 10.1021/ma300859b
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Buenger D, 2012, PROG POLYM SCI, V37, P1678, DOI 10.1016/j.progpolymsci.2012.09.001
   Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669
   Dalton PD, 2008, MACROMOL BIOSCI, V8, P923, DOI 10.1002/mabi.200800080
   Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197
   Dommerholt J, 2010, ANGEW CHEM INT EDIT, V49, P9422, DOI 10.1002/anie.201003761
   Gaharwar AK, 2014, ACS NANO, V8, P9833, DOI 10.1021/nn503719n
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2012, MACROMOL BIOSCI, V12, P779, DOI 10.1002/mabi.201100508
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Garcia-Astrain C., 2015, BIOMACROMOLECULES, V16, P1301
   Gotz H, 2002, MACROMOL MATER ENG, V287, P223, DOI 10.1002/1439-2054(20020401)287:4<223::AID-MAME223>3.0.CO;2-Z
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Hao JK, 2011, MACROMOLECULES, V44, P9390, DOI 10.1021/ma202130u
   Haraguchi K, 2012, MACROMOLECULES, V45, P385, DOI 10.1021/ma202114z
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Jurkic LM, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-2
   Karpovich AL, 2016, METHODSX, V3, P19, DOI 10.1016/j.mex.2015.12.002
   Kim YS, 2015, NAT MATER, V14, P1002, DOI [10.1038/nmat4363, 10.1038/NMAT4363]
   Kochumalayil JJ, 2013, BIOMACROMOLECULES, V14, P3842, DOI 10.1021/bm400883e
   LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160
   Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g
   Lee S, 2013, SOFT MATTER, V9, P472, DOI 10.1039/c2sm26979a
   Li JY, 2014, ACS MACRO LETT, V3, P520, DOI 10.1021/mz5002355
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liu JQ, 2012, ACS NANO, V6, P8194, DOI 10.1021/nn302874v
   Liu MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3029
   Merino S, 2015, ACS NANO, V9, P4686, DOI 10.1021/acsnano.5b01433
   Na YH, 2013, KOREA-AUST RHEOL J, V25, P185, DOI 10.1007/s13367-013-0020-y
   Neffe AT, 2015, ADV MATER, V27, P1738, DOI 10.1002/adma.201404787
   Negrete-Herrera N, 2006, PROG SOLID STATE CH, V34, P121, DOI 10.1016/j.progsolidstchem.2005.11.040
   Nie JJ, 2005, MACROMOLECULES, V38, P5729, DOI 10.1021/ma050589s
   Okay O, 2007, MACROMOLECULES, V40, P3378, DOI 10.1021/ma062929v
   Raghuram GV, 2010, REPROD TOXICOL, V30, P377, DOI 10.1016/j.reprotox.2010.05.087
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Sharifi S, 2012, ACTA BIOMATER, V8, P4233, DOI 10.1016/j.actbio.2012.09.014
   Sureshbabu V. V., 2011, AMINO ACIDS PEPTIDES, P1
   Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g
   Topuz F., 2011, COMPREHENSIVE BIOMAT, P491
   Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Wang M, 2013, LANGMUIR, V29, P7087, DOI 10.1021/la401269p
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Yang JL, 2016, J MATER CHEM B, V4, P1733, DOI 10.1039/c6tb00135a
   Zachman AL, 2013, TISSUE ENG PT A, V19, P437, DOI [10.1089/ten.tea.2012.0158, 10.1089/ten.TEA.2012.0158]
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 52
TC 4
Z9 4
U1 8
U2 53
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2017
VL 18
IS 2
BP 386
EP 397
DI 10.1021/acs.biomac.6b01483
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EK8TV
UT WOS:000394198400009
PM 27977144
OA Green Published
DA 2018-10-20
ER

PT J
AU Lee, JS
   Shin, HK
   Yun, JH
   Cho, KS
AF Lee, Jung-Seok
   Shin, Hyun-Ki
   Yun, Jeong-Ho
   Cho, Kyoo-Sung
TI Randomized Clinical Trial of Maxillary Sinus Grafting using
   Deproteinized Porcine and Bovine Bone Mineral
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE alveolar bone grafting; Bio-Oss; randomized controlled trial; sinus
   floor augmentation
ID BETA-TRICALCIUM PHOSPHATE; AUTOGENOUS BONE; FLOOR AUGMENTATION;
   SUBSTITUTE; MULTICENTER; DEFECTS
AB s
   BackgroundDeproteinized porcine bone mineral (DPBM) was recently developed and commercially available in maxillary sinus grafting, in which demineralized bovine bone mineral (DBBM) was widely used.
   ObjectivesThe present randomized controlled clinical trial aimed to compare histological bone quality and radiographic volume stability in maxillary sinuses grafted with DPBM and DBBM.
   Materials and MethodsTwenty sinuses in 16 participants were enrolled and randomly allocated to control and test groups using sequentially numbered, sealed envelopes; laterally approached sinus grafting with DBBM and DPBM, respectively. All participants were blinded to the group assignment during the entire experiment. After standardized osteotomy at the lateral wall of the maxillary sinus, the sinus membrane was elevated, and the control or test biomaterial was grafted. Computed tomography (CT) images were taken immediately after surgery, and another CT and trephine biopsy was taken for radiographic and histological analyses after 6 months. The histological bone quality was measured as a primary outcome, and changes in the height and volume of the graft were evaluated in the reconstructed CT images as secondary outcomes.
   ResultsFifteen sites (7 and 8 sites for control and test group) in 11 participants were finally included in the per protocol (PP) analysis, and 16 sites (7 and 9 sites, respectively) in 12 participants were included in the intention-to-treat (ITT) analysis; there were four drop-outs and one minor protocol violation. In both statistical analyses, the test groups showed comparable new bone formation and residual biomaterials in histology, and both groups exhibited minimal volume/height changes in radiographies. However, smaller sizes of residual biomaterials were observed in the histological samples from the test compared to control sites, despite the use of the same sizes of both biomaterials.
   ConclusionsThe results suggested that DPBM might produce comparable bone formation and volumetric stability with DBBM in maxillary sinus grafting, however, further clinical study with longer-term periods and larger sample sizes should be needed for confirming this suggestion.
C1 [Lee, Jung-Seok; Shin, Hyun-Ki; Cho, Kyoo-Sung] Yonsei Univ, Coll Dent, Res Inst periodontal regenerat, Dept Periodontol, 50 Yonsei ro, Seoul 03722, South Korea.
   [Yun, Jeong-Ho] Chonbuk Natl Univ, Sch Dent, Dept Periodontol, Jeonju, South Korea.
   [Yun, Jeong-Ho] Chonbuk Natl Univ, Inst Oral Biosci, Jeonju, South Korea.
RP Cho, KS (reprint author), Yonsei Univ, Coll Dent, Res Inst periodontal regenerat, Dept Periodontol, 50 Yonsei ro, Seoul 03722, South Korea.
EM kscho@yuhs.ac
FU Medical Device Comparative Clinical Trial and Performance Evaluation
   Program - Small and Medium Business Administration (SMBA, Korea)
FX This work was supported by the Medical Device Comparative Clinical Trial
   and Performance Evaluation Program funded by the Small and Medium
   Business Administration (SMBA, Korea).
CR Al-Nawas B, 2014, EUR J ORAL IMPLANTOL, V7, pS219
   Araujo MG, 2015, CLIN ORAL IMPLAN RES, V26, P407, DOI 10.1111/clr.12366
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Barone A, 2016, CLIN ORAL IMPLAN RES, V27, pe105, DOI 10.1111/clr.12572
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Benic GI, 2016, CLIN ORAL IMPLAN RES, V27, P567, DOI 10.1111/clr.12625
   Cosso MG, 2014, CLIN ORAL IMPLAN RES, V25, P1251, DOI 10.1111/clr.12261
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Esposito M, 2014, COCHRANE DB SYST REV, V5
   Gorla LFD, 2015, INT J ORAL MAX SURG, V44, P1486, DOI 10.1016/j.ijom.2015.07.003
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Iezzi G, 2012, CLIN ORAL IMPLAN RES, V23, P1369, DOI 10.1111/j.1600-0501.2011.02308.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P902, DOI 10.1111/j.1600-0501.2011.02245.x
   Kim MS, 2015, CLIN ORAL IMPLAN RES, V26, P1361, DOI 10.1111/clr.12471
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Kim Y, 2013, CLIN IMPLANT DENT R, V15, P645, DOI 10.1111/j.1708-8208.2011.00407.x
   Kolerman Roni, 2012, Int J Periodontics Restorative Dent, V32, pe21
   Lee DZ, 2012, CLIN ORAL IMPLAN RES, V23, P918, DOI 10.1111/j.1600-0501.2011.02239.x
   Lee JH, 2013, BIOMATER RES, V17, P160
   Lindgren C, 2012, CLIN IMPLANT DENT R, V14, P41, DOI 10.1111/j.1708-8208.2010.00224.x
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Pagliani L, 2012, CLIN IMPLANT DENT R, V14, P746, DOI 10.1111/j.1708-8208.2010.00314.x
   Park JW, 2012, J BIOMED MATER RES A, V100A, P834, DOI 10.1002/jbm.a.34017
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Testori T, 2013, INT J PERIODONT REST, V33, P467, DOI 10.11607/prd.1423
   Tete S, 2014, J CRANIOFAC SURG, V25, P835, DOI 10.1097/SCS.0000000000000679
NR 29
TC 5
Z9 5
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD FEB
PY 2017
VL 19
IS 1
BP 140
EP 150
DI 10.1111/cid.12430
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EL5QF
UT WOS:000394675100014
PM 27324175
DA 2018-10-20
ER

PT J
AU Bai, MY
   Wang, CW
   Wang, JY
   Lin, MF
   Chan, WP
AF Bai, Meng-Yi
   Wang, Ching-Wei
   Wang, Jyun-Yi
   Lin, Ming-Fang
   Chan, Wing P.
TI Three-dimensional structure and cytokine distribution of platelet-rich
   fibrin
SO CLINICS
LA English
DT Article
DE Biomaterial; Cytokine; Platelet-Rich Fibrin (PRF)
ID PLASMA PRP; PERSPECTIVES; REPAIR; GEL
AB OBJECTIVES: Previous reports have revealed that several cytokines (including platelet-derived growth factor-BB, transforming growth factors-beta 1 and insulin- like growth factor-1) can enhance the rate of bone formation and synthesis of extracellular matrix in orthopaedics or periodontology. This study aimed to determine the concentration of cytokines within platelet-rich fibrin microstructures and investigate whether there are differences in the different portions of platelet-rich fibrin, which has implications for proper clinical use of platelet-rich fibrin gel.
   METHODS: Whole blood was obtained from six New Zealand rabbits (male, 7 to 39 weeks old, weight 2.7-4 kg); it was then centrifuged for preparation of platelet-rich fibrin gels and harvest of plasma. The resultant plateletrich fibrin gels were used for cytokine determination, histological analyses and scanning electron microscopy. All plasmas obtained were subject to the same cytokine determination assays for the purpose of comparison.
   RESULTS: Cytokines platelet-derived growth factor-BB and transforming growth factor-beta 1 formed concentration gradients from high at the red blood cell end of the platelet-rich fibrin gel (p=1.88 x 10(-5)) to low at the plasma end (p = 0.19). Insulin-like growth factor-1 concentrations were similar at the red blood cell and plasma ends. The porosities of the platelet-rich fibrin samples taken in sequence from the red blood cell end to the plasma end were 6.5% +/- 4.9%, 24.8% +/- 7.5%, 30.3% +/- 8.5%, 41.4% +/- 12.3%, and 40.3% +/- 11.7%, respectively, showing a gradual decrease in the compactness of the platelet-rich fibrin network.
   CONCLUSION: Cytokine concentrations are positively associated with platelet-rich fibrin microstructure and portion in a rabbit model. As platelet-rich fibrin is the main entity currently used in regenerative medicine, assessing cytokine concentration and the most valuable portion of PRF gels is essential and recommended to all physicians.
C1 [Bai, Meng-Yi; Wang, Ching-Wei; Wang, Jyun-Yi] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan.
   [Lin, Ming-Fang; Chan, Wing P.] Taipei Med Univ, Wan Fang Hosp, Dept Radiol, Taipei 116, Taiwan.
   [Chan, Wing P.] Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, Taipei 110, Taiwan.
   [Bai, Meng-Yi] Natl Def Med Ctr, Dept Biomed Engn, Taipei 116, Taiwan.
RP Chan, WP (reprint author), Taipei Med Univ, Wan Fang Hosp, Dept Radiol, Taipei 116, Taiwan.; Chan, WP (reprint author), Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, Taipei 110, Taiwan.
EM wingchan@tmu.edu.tw
FU Taipei Medical University-National Taiwan University of Science and
   Technology Joint Research Program in Taiwan [TMU-NTUST-102-10]
FX This work was supported by grants from the Taipei Medical
   University-National Taiwan University of Science and Technology Joint
   Research Program (TMU-NTUST-102-10) in Taiwan.
CR Baek HS, 2011, TISSUE ENG REGEN MED, V8, P530
   Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1153, DOI 10.2174/138920112800624373
   Borie E, 2015, INT J CLIN EXP MED, V8, P7922
   Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011
   Chang YC, 2011, J DENT SCI, V6, P181, DOI 10.1016/j.jds.2011.05.010
   Civinini R, 2011, CLIN CASES MINER BON, V8, P25
   Desai Chirag B, 2013, J Cutan Aesthet Surg, V6, P35, DOI 10.4103/0974-2077.110096
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan DM, 2006, ORAL SURG ORAL MED O, V101, P45, DOI DOI 10.1016/J.TRIPLE0.2005.07.009
   Dohan E, 2012, CURRENT PHARM BIOTEC, V13, P1131, DOI DOI 10.2174/138920112800624328
   Dohan ED, 2009, GROWTH FACTORS, V27, P63, DOI DOI 10.1080/08977190802636713
   Dohan EDM, 2012, CURR PHARM BIOTECHNO, V13, P1145, DOI DOI 10.2174/138920112800624382
   Dohan Ehrenfest DM, 2014, POSEIDO, V2, P129
   Dohan Ehrenfest DM, 2010, J PERIODONTOL, V81, P546
   Dohan Ehrenfest DM, 2014, MUSCLES LIGAMENTS TE, V4, P3
   Dohan Ehrenfest DM, 2010, ORAL SURG ORAL MED O, V110, P275
   Ehrenfest DMD, 2010, ORAL SURG ORAL MED O, V110, P413, DOI 10.1016/j.tripleo.2010.05.057
   Giannobile WV, 1996, BONE, V19, pS23, DOI 10.1016/S8756-3282(96)00127-5
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007
   Hotwani Kavita, 2014, Restor Dent Endod, V39, P1, DOI 10.5395/rde.2014.39.1.1
   Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137
   Kuo TF, 2011, CLINICS, V66, P1835, DOI 10.1590/S1807-59322011001000026
   Landesberg R, 2005, J ORAL MAXIL SURG, V63, P529, DOI 10.1016/j.joms.2004.12.007
   Landesberg R, 2000, J ORAL MAXIL SURG, V58, P297, DOI 10.1016/S0278-2391(00)90058-2
   Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Naik Balaram, 2013, J Conserv Dent, V16, P284, DOI 10.4103/0972-0707.114344
   OSTMAN A, 1992, J CELL BIOL, V118, P509, DOI 10.1083/jcb.118.3.509
   Panicker G, 2007, CYTOKINE, V37, P176, DOI 10.1016/j.cyto.2007.03.006
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.0.CO;2-9
   Pretorius E, 2009, INT J MORPHOL, V27, P69, DOI 10.4067/S0717-95022009000100013
   Pretorius E, 2007, ANAT REC, V290, P188, DOI 10.1002/ar.a.20413
   RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769
   Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4
   Saluja Harish, 2011, Ann Maxillofac Surg, V1, P53, DOI 10.4103/2231-0746.83158
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Simonpieri A, 2012, CURR PHARM BIOTECHNO, V13, P1231, DOI 10.2174/138920112800624472
   Wang R. R., 2012, THESIS
   WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1
   Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962
NR 41
TC 5
Z9 5
U1 2
U2 7
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD FEB
PY 2017
VL 72
IS 2
BP 116
EP 124
DI 10.6061/clinics/2017(02)09
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA EN1ZJ
UT WOS:000395808800009
PM 28273236
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nerantzaki, M
   Koliakou, I
   Kaloyianni, MG
   Koumentakou, I
   Siska, E
   Diamanti, E
   Karakassides, MA
   Boccaccini, AR
   Bikiaris, DN
AF Nerantzaki, Maria
   Koliakou, Iro
   Kaloyianni, Martha G.
   Koumentakou, Ioanna
   Siska, Evangelia
   Diamanti, Eleftheria
   Karakassides, Michael A.
   Boccaccini, Aldo R.
   Bikiaris, Dimitrios N.
TI A biomimetic approach for enhancing adhesion and osteogenic
   differentiation of adipose-derived stem cells on poly(butylene
   succinate) composites with bioactive ceramics and glasses
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Polymeric composites; Bioceramics; Nanoparticles; Biomimetic
ID TISSUE ENGINEERING APPLICATIONS; STRONTIUM HYDROXYAPATITE NANORODS;
   IN-VITRO EVALUATION; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   STROMAL CELLS; ENZYMATIC-HYDROLYSIS; BONE REGENERATION; NANOCOMPOSITES;
   SCAFFOLDS
AB The great potential application of poly(butylene succinate) (PBSu) as a novel biomaterial has not yet been realized, mainly owing to its insufficient bioactivity and low mechanical properties, which compromise the in vivo efficacy. Our strategy is based on the hypothesis that the incorporation of bioactive ceramics with similar microstructure to native bone structure into PBSu improves its bioactivity and affects new bone growth enhancing bone formation. Bioactive CaO-MgO-SiO2-Na2O-P2O5-CaF2 glass microparticles and fibrous hydroxyapatite nanoparticles were successfully synthesized and the resulting powders were characterized using different techniques. Afterwards, PBSu nanocomposites containing 2.5 wt% of micro-Bioglass (mBG), nano-hydroxyapatite (nHA) or mBG-nHA were prepared via in situ polymerization and were studied thoroughly in terms of their physicochemical and biological properties. We show here that our strategy was effective in accelerating the in vitro biodegradability of PBSu, in enhancing apatite formation in contact with simulated body fluid (SBF), while inducing cytocompatibility and osteogenic differentiation of rat Adipose Stem Cells (rASCs). (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Nerantzaki, Maria; Koumentakou, Ioanna; Bikiaris, Dimitrios N.] Aristotle Univ Thessaloniki, Lab Organ Chem Technol, Dept Chem, Thessaloniki 54124, Greece.
   [Koliakou, Iro; Kaloyianni, Martha G.] Aristotle Univ Thessaloniki, Dept Biol, Physiol Anim Lab, Thessaloniki, Macedonia.
   [Siska, Evangelia] Aristotle Univ Thessaloniki, Biochem Lab, Fac Med, Thessaloniki, Macedonia.
   [Diamanti, Eleftheria] Soft Matter Nanotechnol Grp, CIC biomaGUNE, Paseo Miraman 182 C, San Sebastian 20009, Spain.
   [Karakassides, Michael A.] Univ Ioannina, Dept Mat Sci & Engn, Lab Ceram & Composite Mat, Ioannina 45110, Greece.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomaterials, Dept Mat Sci & Engn, Cauerstrasse 6, D-91058 Erlangen, Germany.
RP Bikiaris, DN (reprint author), Aristotle Univ Thessaloniki, Lab Organ Chem Technol, Dept Chem, Thessaloniki 54124, Greece.
EM dbic@chem.auth.gr
RI biomaGUNE, CIC/J-9136-2014; Boccaccini, Aldo/C-7905-2013
OI biomaGUNE, CIC/0000-0001-7690-0660; Diamanti,
   Eleftheria/0000-0001-6927-3785
FU IKY (Greece); DAAD (Germany) [IKYDA 20122013]
FX The authors wish to acknowledge co-funding of this research by IKY
   (Greece) and DAAD (Germany), Action "IKYDA 20122013".
CR Agathopoulos S, 2006, BIOMATERIALS, V27, P1832, DOI 10.1016/j.biomaterials.2005.10.033
   Andrades JA, 2013, REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P615, DOI 10.5772/56389
   Arphavasin S, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055008
   Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123
   Bikiaris DN, 2013, POLYM DEGRAD STABIL, V98, P1908, DOI 10.1016/j.polymdegradstab.2013.05.016
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chavan PN, 2010, MATER SCI ENG B-ADV, V168, P224, DOI 10.1016/j.mseb.2009.11.012
   Chen HL, 2016, BIOMATERIALS, V76, P261, DOI 10.1016/j.biomaterials.2015.10.071
   Chen Q., 2008, TOPICS TISSUE ENG, V4, P1, DOI DOI 10.1586/17434440.2.3.303.
   Cholas R, 2016, MAT SCI ENG C-MATER, V63, P499, DOI 10.1016/j.msec.2016.03.022
   Erol-Taygun M, 2013, INT J APPL GLASS SCI, V4, P136, DOI 10.1111/ijag.12029
   Fan RR, 2014, J MACROMOL SCI B, V53, P296, DOI 10.1080/00222348.2013.810104
   Fan RR, 2013, INT J BIOL MACROMOL, V59, P227, DOI 10.1016/j.ijbiomac.2013.04.051
   Gadaleta SJ, 1996, CALCIFIED TISSUE INT, V58, P9, DOI 10.1007/BF02509540
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gigli M, 2016, EUR POLYM J, V75, P431, DOI 10.1016/j.eurpolymj.2016.01.016
   Gigli M, 2012, GREEN CHEM, V14, P2885, DOI 10.1039/c2gc35876j
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Grigoriadou I, 2014, COMPOS PART B-ENG, V60, P49, DOI 10.1016/j.compositesb.2013.12.015
   Guo CG, 2013, POLYM POLYM COMPOS, V21, P449, DOI 10.1177/096739111302100706
   Guo WM, 2013, J BIOMED MATER RES A, V101, P2500, DOI 10.1002/jbm.a.34552
   Hester TR, 2013, AESTHET SURG J, V33, P487, DOI 10.1177/1090820X13479969
   Karakassides MA, 1997, CLAY CLAY MINER, V45, P649, DOI 10.1346/CCMN.1997.0450504
   Karathanasis V, 2013, EUR J PLAST SURG, V36, P281, DOI 10.1007/s00238-013-0810-y
   Kim EK, 2001, J APPL POLYM SCI, V80, P1388, DOI 10.1002/app.1228
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Michel J, 2015, STEM CELLS INT, DOI 10.1155/2015/305217
   Nerantzaki M, 2015, EXPRESS POLYM LETT, V9, P773, DOI 10.3144/expresspolymlett.2015.73
   Nerantzaki M, 2014, POLYM DEGRAD STABIL, V108, P257, DOI 10.1016/j.polymdegradstab.2014.03.018
   Nerantzaki MC, 2017, INT J POLYM MATER PO, V66, P71, DOI 10.1080/00914037.2016.1182913
   Ngamviriyavong P, 2014, COMPOS INTERFACE, V21, P431, DOI 10.1080/15685543.2014.872959
   Papageorgiou GZ, 2005, POLYMER, V46, P12081, DOI 10.1016/j.polymer.2005.10.073
   Petrakis S, 2012, BIOTECHNOL J, V7, P891, DOI 10.1002/biot.201100471
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ravarian R, 2015, J BIOMED MATER RES A, V103, P2898, DOI 10.1002/jbm.a.35423
   Ren J., 2010, EURASIP J WIREL COMM, V2010, P1, DOI DOI 10.1155/2010/287082
   Someya Y, 2004, J APPL POLYM SCI, V91, P1463, DOI 10.1002/app.13366
   Tavakol S, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1373-8
   Vasileiou AA, 2013, POLYMER, V54, P1018, DOI 10.1016/j.polymer.2012.12.036
   Vassiliou AA, 2011, J APPL POLYM SCI, V119, P2010, DOI 10.1002/app.32887
   Wu HC, 2016, MATERIALS, V9, DOI 10.3390/ma9030198
   Xue CB, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1018-9
NR 47
TC 2
Z9 3
U1 5
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD FEB
PY 2017
VL 87
BP 159
EP 173
DI 10.1016/j.eurpolymj.2016.12.014
PG 15
WC Polymer Science
SC Polymer Science
GA EM3JL
UT WOS:000395210900014
DA 2018-10-20
ER

PT J
AU Tang, H
   Wu, T
   Xu, FJ
   Tao, W
   Jian, X
AF Tang, Hui
   Wu, Tao
   Xu, Fangjun
   Tao, Wei
   Jian, Xian
TI Fabrication and Characterization of Mg(OH)(2) Films on AZ31 Magnesium
   Alloy by Alkali Treatment
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Magnesium alloy; Alkali treatment; Magnesium hydroxide; Bonding
   strength; Corrosion; Biomaterial
ID ENHANCED CORROSION-RESISTANCE; IN-VITRO CORROSION; COATINGS;
   BIODEGRADATION; DEPOSITION; PHOSPHATE; LAYER
AB Mg and its alloys have shown potential application as a bio-absorbable biomaterial, such as for bone screws and plates, however, their fast corrosion rate may result in the sudden failure of the implants. In this paper, compact and dense films are formed on AZ31 magnesium alloy by alkali treatment. The microstructure and composition of the films are examined by SEM, EDS and XRD, respectively. The bonding strength and corrosion behaviour of the films are characterized by tensile strength test, potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) studies. The results show that the main composition of the films is Mg(OH)(2), the bonding strength between the film and the substrate is stronger than 60 MPa. And the corrosion resistance is improved by the alkali treatment compared with that of the bare AZ31 magnesium alloy in the simulated body fluid (SBF) solution. It is increased with increasing the treatment time.
C1 [Tang, Hui; Wu, Tao; Tao, Wei; Jian, Xian] Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610000, Peoples R China.
   [Tang, Hui] Univ Elect Sci & Technol China, Ctr Informat BioMed, Chengdu 610054, Peoples R China.
   [Tang, Hui; Xu, Fangjun] Taiyuan Univ Technol, Shanxi Key Lab Adv Magnesium Based Mat, Taiyuan 030024, Peoples R China.
   [Tang, Hui] Harbin Inst Technol, Sch Chem Engn & Technol, Harbin 150001, Peoples R China.
RP Tang, H; Jian, X (reprint author), Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610000, Peoples R China.; Tang, H (reprint author), Univ Elect Sci & Technol China, Ctr Informat BioMed, Chengdu 610054, Peoples R China.; Tang, H (reprint author), Taiyuan Univ Technol, Shanxi Key Lab Adv Magnesium Based Mat, Taiyuan 030024, Peoples R China.; Tang, H (reprint author), Harbin Inst Technol, Sch Chem Engn & Technol, Harbin 150001, Peoples R China.
EM tanghui@uestc.edu.cn; jianxian@uestc.edu.cn
FU National Natural Science Foundation of China [51402045]; Fundamental
   Research Funds for the Central Universities [ZYGX2014J089]
FX This research was supported by the National Natural Science Foundation
   of China (Grant No.51402045) and the Fundamental Research Funds for the
   Central Universities (No.ZYGX2014J089).
CR Butev E, 2015, APPL SURF SCI, V327, P437, DOI 10.1016/j.apsusc.2014.12.005
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Dorozhkin SV, 2014, ACTA BIOMATER, V10, P2919, DOI 10.1016/j.actbio.2014.02.026
   Feng J, 2013, MATER CHEM PHYS, V143, P322, DOI 10.1016/j.matchemphys.2013.09.005
   Gong FB, 2016, APPL SURF SCI, V365, P268, DOI 10.1016/j.apsusc.2016.01.028
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Gupta RK, 2014, J MATER SCI TECHNOL, V30, P47, DOI 10.1016/j.jmst.2013.07.012
   Hofstetter J, 2015, CORROS SCI, V91, P29, DOI 10.1016/j.corsci.2014.09.008
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Huang K, 2014, SURF COAT TECH, V240, P137, DOI 10.1016/j.surfcoat.2013.12.026
   Ishizaki T, 2015, J ELECTROCHEM SOC, V162, pC741, DOI 10.1149/2.0351514jes
   Jokanovic V, 2014, CORROS SCI, V82, P180, DOI 10.1016/j.corsci.2014.01.014
   Kamiyama N, 2016, SURF COAT TECH, V286, P172, DOI 10.1016/j.surfcoat.2015.11.051
   Kannan MB, 2013, MAT SCI ENG C-MATER, V33, P675, DOI 10.1016/j.msec.2012.10.017
   Lee J. W., 2016, PNAS, V113, P717
   Li B, 2016, CERAM INT, V42, P13074, DOI 10.1016/j.ceramint.2016.05.090
   Niu JL, 2013, MAT SCI ENG C-MATER, V33, P4833, DOI 10.1016/j.msec.2013.08.008
   Rojaee R, 2014, CERAM INT, V40, P15149, DOI 10.1016/j.ceramint.2014.06.129
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Zeng RC, 2015, T NONFERR METAL SOC, V25, P4028, DOI 10.1016/S1003-6326(15)64052-3
   Zhang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09940
   Zhang X, 2014, ACS APPL MATER INTER, V6, P513, DOI 10.1021/am404574t
   Zhao Q, 2016, APPL SURF SCI, V367, P249, DOI 10.1016/j.apsusc.2016.01.055
   Zhu YY, 2012, SURF COAT TECH, V206, P2961, DOI 10.1016/j.surfcoat.2011.12.029
   Zhu YY, 2011, APPL SURF SCI, V257, P6129, DOI 10.1016/j.apsusc.2011.02.017
   Zong QF, 2014, CORROS SCI, V89, P127, DOI 10.1016/j.corsci.2014.08.024
NR 28
TC 5
Z9 5
U1 5
U2 22
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2017
VL 12
IS 2
BP 1377
EP 1388
DI 10.20964/2017.02.35
PG 12
WC Electrochemistry
SC Electrochemistry
GA EP3BB
UT WOS:000397256400043
OA Bronze
DA 2018-10-20
ER

PT J
AU Nourbakhsh, H
   Emam-Djomeh, Z
   Madadlou, A
   Mousavi, ME
   Moosavi-Movahedi, AA
   Gunasekaran, S
AF Nourbakhsh, Himan
   Emam-Djomeh, Zahra
   Madadlou, Ashkan
   Mousavi, Mohammad E.
   Moosavi-Movahedi, Ali A.
   Gunasekaran, Sundaram
TI Antioxidant Peptidic Particles for Delivery of Gallic Acid
SO JOURNAL OF FOOD PROCESSING AND PRESERVATION
LA English
DT Article
ID WHEY-PROTEIN ISOLATE; WET CROSS-LINKING; CITRIC-ACID; NANOPARTICLES;
   ENCAPSULATION; MICROENCAPSULATION; DESOLVATION; SUBMICRON; FIBERS
AB A whey protein isolate (WPI) solution was hydrolyzed to a highly antioxidant hydrolysate (WPH) and particulated by ethanol addition to encapsulate gallic acid (GA). Particle-forming peptides were cross-linked with citric acid by several procedures including GA charging-cross-linking-desolvation (where the hydrolysate was charged with GA, then cross-linked with citric acid, and finally desolvated), cross-linking-GA charging-desolvation (where the hydrolysate was cross-linked, then charged with GA and finally desolvated), and GA charging-desolvation-cross-linking (where the hydrolysate was charged with GA, then desolvated to particles and finally particles were cross-linked with citric acid). The cross-linking-GA charging-desolvation method formed smaller particles and provided a higher encapsulation efficiency. -Potential measurements showed that isoelectric point of all three kinds of peptidic particles was almost 4.3. Scanning electron microscopy indicated spherical and almost uniformly shaped particles. GA release kinetics and particle size monitoring informed that core is released mostly by a diffusion-based mechanism, not particle bursting.
   Practical ApplicationsResults suggest that potentially bioactive peptides can be used as the matrix-forming biomaterial for the nanoencapsulation of gallic acid. The generated capsule has dual functional benefits by which a nutraceutical has been enclosed within another bioactive component. It can be employed at the formulation of value-added products.
C1 [Nourbakhsh, Himan; Emam-Djomeh, Zahra; Madadlou, Ashkan; Mousavi, Mohammad E.] Univ Tehran, Univ Coll Agr & Nat Resources, Dept Food Sci & Engn, Karaj, Iran.
   [Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem Biophys IBB, Tehran, Iran.
   [Gunasekaran, Sundaram] Univ Wisconsin Madison, Coll Agr & Life Sci, Dept Biol Syst Engn, Madison, WI USA.
RP Madadlou, A (reprint author), Univ Tehran, Univ Coll Agr & Nat Resources, Dept Food Sci & Engn, Karaj, Iran.
EM a.madadlou@ut.ac.ir
RI mousavi, mohammad/A-4841-2018; Emam-Djomeh, zahra/D-2277-2016
OI mousavi, mohammad/0000-0001-5194-0260; Emam-Djomeh,
   zahra/0000-0002-1690-1968; Madadlou, Ashkan/0000-0003-4572-868X
CR Adjonu R, 2013, FOOD CHEM, V136, P1435, DOI 10.1016/j.foodchem.2012.09.053
   Arroyo-Maya IJ, 2014, BIOPHYS CHEM, V193, P27, DOI 10.1016/j.bpc.2014.07.003
   Augustin MA, 2003, AUST J DAIRY TECHNOL, V58, P156
   Bagheri L, 2014, J MICROENCAPSUL, V31, P636, DOI 10.3109/02652048.2014.911377
   Bagheri L, 2014, J FUNCT FOODS, V6, P462, DOI 10.1016/j.jff.2013.11.012
   Bagheri L, 2013, FOOD RES INT, V51, P866, DOI 10.1016/j.foodres.2013.01.058
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Betz M, 2011, PROC FOOD SCI, V1, P2047, DOI 10.1016/j.profoo.2011.10.006
   Giroux HJ, 2010, FOOD HYDROCOLLOID, V24, P341, DOI 10.1016/j.foodhyd.2009.10.013
   Gulseren I, 2012, FOOD HYDROCOLLOID, V29, P258, DOI 10.1016/j.foodhyd.2012.03.015
   Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Ju ZY, 1998, J AGR FOOD CHEM, V46, P1830, DOI 10.1021/jf9710185
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0
   Li CY, 2013, INT J PHARMACEUT, V448, P79, DOI 10.1016/j.ijpharm.2013.03.019
   Liu G, 2013, BIOMACROMOLECULES, V14, P2146, DOI 10.1021/bm400521b
   Marianecci C., 2013, FUNDAMENTALS PHARM N, P67
   Munin Aude, 2011, Pharmaceutics, V3, P793, DOI 10.3390/pharmaceutics3040793
   Mutilangi WAM, 1996, J FOOD SCI, V61, P270, DOI 10.1111/j.1365-2621.1996.tb14174.x
   Poletto FS, 2011, NANOCOSMETICS AND NANOMEDICINES: NEW APPROACHES FOR SKIN CARE, P49
   Rahimnejad M, 2012, COLLOID SURFACE A, V412, P96, DOI 10.1016/j.colsurfa.2012.07.022
   Reddy N, 2009, BIOTECHNOL PROGR, V25, P139, DOI [10.1021/bp.86, 10.1002/btpr.86]
   Reddy N, 2012, IND CROP PROD, V39, P26, DOI 10.1016/j.indcrop.2012.02.004
   Reddy N, 2009, J AGR FOOD CHEM, V57, P90, DOI 10.1021/jf802341u
   Sadeghi R, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2565-1
   Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0
   Stuart B., 2004, INFRARED SPECTROSCOP, P113
   Teng Z, 2013, BIOMACROMOLECULES, V14, P2848, DOI 10.1021/bm4006886
   Teng Z, 2012, J AGR FOOD CHEM, V60, P2712, DOI 10.1021/jf205238x
   Yildirim A, 2001, J AGR FOOD CHEM, V49, P4083, DOI 10.1021/jf0103572
   Zhang Y, 2012, J AGR FOOD CHEM, V60, P7526, DOI 10.1021/jf3021656
NR 32
TC 2
Z9 2
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8892
EI 1745-4549
J9 J FOOD PROCESS PRES
JI J. Food Process Preserv.
PD FEB
PY 2017
VL 41
IS 1
AR e12767
DI 10.1111/jfpp.12767
PG 10
WC Food Science & Technology
SC Food Science & Technology
GA EL7QW
UT WOS:000394816700033
DA 2018-10-20
ER

PT J
AU McCloskey, AP
   Draper, ER
   Gilmore, BF
   Laverty, G
AF McCloskey, Alice P.
   Draper, Emily R.
   Gilmore, Brendan F.
   Laverty, Garry
TI Ultrashort self-assembling Fmoc-peptide gelators for anti-infective
   biomaterial applications
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE nanomaterial; biofilm; infection; bacteria; nosocomial; antimicrobial
   resistance
ID ANTIMICROBIAL PEPTIDES; MATRIX FORMATION; HYDROGELS; AMPHIPHILES;
   INFECTIONS; DESIGN; DIPEPTIDES; ADHESION
AB Biomaterial-related infections have a significant impact on society and are amajor contributor to the growing threat of antimicrobial resistance. Current licensed antibiotic classes struggle to breakdown or penetrate the exopolysaccharide biofilm barrier, resulting in sub-therapeutic concentrations of antibiotic at the surface of the biomaterial, treatment failure and increased spread of resistant isolates. This paper focuses for the first time on the ability of ultrashort Fmoc-peptide gelators to eradicate established bacterial biofilms implicated in a variety of medical device infections (Gram-positive: Staphylococcus aureus, Staphylococcus epidermidis and Gram-negative Escherichia coli, Pseudomonas aeruginosa). The effect of increasing the cationicity of FmocFF via addition of di-lysine and di-orntithine was also studied with regard to antibacterial activity. Our studies demonstrated that Fmoc-peptides (FmocFF, FmocFFKK, FmocFFFKK, FmocFFOO) formed surfactant-like soft gels at concentrations of 1% w/v and above using a method of glucono-delta-Lactone pH induction. The majority of Fmoc-peptides (0.5-2% w/v) demonstrated selective action against established (grown for 24h) biofilms of Gram-positive and Gram-negative pathogens. These results are likely to increase the clinical translation of short-peptide gelator platforms within the area of anti-infective biomaterials including as wound dressings and coatings for prostheses, catheters, heart valves and surgical tubes. In the long term, thiswill lead towider treatment choices for clinicians and patients involved in the management of medical device infections and reduce the burden of antimicrobial resistance. Copyright (C) 2017 European Peptide Society and John Wiley & Sons, Ltd.
C1 [McCloskey, Alice P.; Gilmore, Brendan F.; Laverty, Garry] Queens Univ Belfast, Biofunct Nanomat Grp, Sch Pharm, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
   [Draper, Emily R.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.
RP Laverty, G (reprint author), Queens Univ Belfast, Biofunct Nanomat Grp, Sch Pharm, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM garry.laverty@qub.ac.uk
OI McCloskey, Alice/0000-0003-3014-1624; Laverty, Garry/0000-0002-1435-2942
FU Queen's University Research Support Package for New Academic Staff;
   Royal Society Research Grant [RG150171]; N. Ireland Department of
   Employment and Learning PhD studentship grant
FX This work was supported by a Queen's University Research Support Package
   for New Academic Staff and a Royal Society Research Grant (RG150171) for
   GL. APM acknowledges funding provided by a N. Ireland Department of
   Employment and Learning PhD studentship grant. The manuscript was
   written through contributions of all authors, and they have provided
   approval to the final version of the manuscript. APM, ERD and BFG
   contributed equally. We acknowledge help from Prof. Dave Adams
   (University of Liverpool) for allowing us access to his Anton Paar
   Physica MCR301 rheometer for rheological studies.
CR Adams DJ, 2010, SOFT MATTER, V6, P1971, DOI 10.1039/b921863g
   Adams DJ, 2009, SOFT MATTER, V5, P1856, DOI 10.1039/b901556f
   [Anonymous], 2009, 109935 ISO
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Bucki R, 2006, ANTIMICROB AGENTS CH, V50, P2932, DOI 10.1128/AAC.00134-06
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Debnath S, 2010, J PHYS CHEM B, V114, P4407, DOI 10.1021/jp909520w
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Du XW, 2015, CHEM REV, V115, P13165, DOI 10.1021/acs.chemrev.5b00299
   Edwards IA, 2016, ACS INFECT DIS, V2, P442, DOI 10.1021/acsinfecdis.6b00045
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fleming S, 2013, CHEM COMMUN, V49, P10587, DOI 10.1039/c3cc45822a
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Helen W, 2011, SOFT MATTER, V7, P1732, DOI 10.1039/c0sm00649a
   Hsu BB, 2015, ACS NANO, V9, P9394, DOI 10.1021/acsnano.5b02374
   Huang RL, 2011, SOFT MATTER, V7, P6222, DOI 10.1039/c1sm05375b
   Hughes M, 2012, SOFT MATTER, V8, P11565, DOI 10.1039/c2sm26092a
   Irwansyah I, 2015, ADV MATER, V27, P648, DOI 10.1002/adma.201403339
   Ischakov R, 2013, BIOORGAN MED CHEM, V21, P3517, DOI 10.1016/j.bmc.2013.03.012
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020
   Kamimori H, 2005, BIOL PHARM BULL, V28, P148, DOI 10.1248/bpb.28.148
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Koutsopoulos S, 2016, J BIOMED MATER RES A, V104, P1002, DOI 10.1002/jbm.a.35638
   Laverty G., 2015, BIOMATERIALS MED DEV, P19
   Laverty G, 2015, J PEPT SCI, V21, P770, DOI 10.1002/psc.2805
   Laverty G, 2014, BIOMACROMOLECULES, V15, P3429, DOI 10.1021/bm500981y
   Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566
   Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x
   Li JY, 2013, ADV HEALTHC MATER, V2, P1586, DOI 10.1002/adhm.201300041
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Lian M, 2016, ACS APPL MAT INTERFA
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   McCloskey AP, 2014, PATHOGENS, V3, P791, DOI 10.3390/pathogens3040791
   Mogen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133886
   Ng VWL, 2014, ADV DRUG DELIVER REV, V78, P46, DOI 10.1016/j.addr.2014.10.028
   Paladini F, 2013, J MATER SCI-MATER M, V24, P2461, DOI 10.1007/s10856-013-4986-2
   Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k
   Rafferty J, 2016, CURR MED CHEM, V23, P4231, DOI 10.2174/0929867323666160909155222
   Saini A, 2016, ACTA BIOMATER, V31, P71, DOI 10.1016/j.actbio.2015.11.059
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Strempel N, 2015, CURR PHARM DESIGN, V21, P67, DOI 10.2174/1381612820666140905124312
   Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q
   Thota CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31167
   Xu DW, 2015, CHEM COMMUN, V51, P1289, DOI 10.1039/c4cc08808e
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Zhang Y, 2011, LANGMUIR, V27, P529, DOI 10.1021/la1020324
   Zhou J, 2016, J AM CHEM SOC, V138, P3813, DOI 10.1021/jacs.5b13541
   Zhou J, 2015, BIOCONJUGATE CHEM, V26, P987, DOI 10.1021/acs.bioconjchem.5b00196
   Zhou M, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414531593
NR 54
TC 2
Z9 2
U1 8
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD FEB
PY 2017
VL 23
IS 2
BP 131
EP 140
DI 10.1002/psc.2951
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA EO7TT
UT WOS:000396893700007
PM 28066954
OA Green Published
DA 2018-10-20
ER

PT J
AU Duval, JL
   Dinis, T
   Vidal, G
   Vigneron, P
   Kaplan, DL
   Egles, C
AF Duval, Jean-Luc
   Dinis, Tony
   Vidal, Guillaume
   Vigneron, Pascale
   Kaplan, David L.
   Egles, Christophe
TI Organotypic culture to assess cell adhesion, growth and alignment of
   different organs on silk fibroin
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE silk fibroin; electrospinning; organotypic culture; biocompatibility;
   cell adhesion; cell morphology
ID IN-VITRO; SCAFFOLDS; SUPPORT; KIDNEY; LIVER; CYTOCOMPATIBILITY;
   MICROCHANNELS; NANOFIBERS
AB Glass sheets covered with aligned electrospun silk fibroin (Bombyx mori) were compared to tissue culture-treated Thermanox(R) coverslips, using an organotypic culture method. Different chick embryo organ behaviours were analysed in terms of circularity, cell growth and cell adhesion after being cultivated in contact with these two materials. The circularity (cell layer shape corresponding to the trend of the biomaterials to induce a specific directionality) depends on the organ used when in contact with silk fibroin. This biomaterial induced higher cell adhesion (kidney) or lower cell adhesion (spine) compared to Thermanox. Cell growth, represented by the cell layer area (mm(2)), was also drastically reduced (gonad) or increased (blood vessel) on the silk fibroin. Organotypic culture is a rapid, cost effective and relatively simple method to evaluate different parameters, allowing prescreening of morphology and cytocompatibility to select the appropriate applications for new biomaterials. In the present study we compared the morphology of different organotypic cultures on orientated silk and Thermanox as growth supports to rapidly evaluate the benefit of a silk-based biomaterial for tissue engineering. Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Duval, Jean-Luc; Dinis, Tony; Vidal, Guillaume; Vigneron, Pascale; Egles, Christophe] Univ Technol Compiegne, UMR CNRS 7338, Laboratoire BioMecan & BioIngenierie BMBI, Rue Roger Couttolenc, F-60319 Compiegne, France.
   [Dinis, Tony; Kaplan, David L.] Tufts Univ, Ctr Sci & Technol, Biodmed Engn, Medford, MA USA.
   [Egles, Christophe] Tufts Univ Sch Dent Med, Dept Oral & Maxillofacial Pathol, Boston, MA USA.
RP Egles, C (reprint author), Univ Technol Compiegne, UMR CNRS 7338, Laboratoire BioMecan & BioIngenierie BMBI, Rue Roger Couttolenc, F-60319 Compiegne, France.
EM Christophe.Egles@utc.fr
OI EGLES, Christophe/0000-0003-0982-7752
FU Region Picardie through their SilkNerve grant; NIH [EB002520]
FX The authors are very grateful to Region Picardie for financial support
   through their SilkNerve grant. We also wish to thank Frederic Nadaud for
   his technical help with the SEM pictures. We also thank the NIH
   (EB002520) for support of this work.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Almelkar SI, 2013, TISSUE ENG, V1, P1
   Bhattacharjee M, 2012, ACTA BIOMATER, V8, P3313, DOI 10.1016/j.actbio.2012.05.023
   Brunot-Gohin C, 2013, DENT MATER, V29, pE205, DOI 10.1016/j.dental.2013.05.004
   Cirillo B, 2004, INT J ARTIF ORGANS, V27, P60
   Demangel C, 2012, MAT SCI ENG C-MATER, V32, P1919, DOI 10.1016/j.msec.2012.05.037
   Duval JL, 2006, J CONTROL RELEASE, V116, pE50, DOI 10.1016/j.jconrel.2006.09.045
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   DUVAL JL, 1992, CELL MATER, V2, P179
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Kasoju N, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/049501
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kim KH, 2009, TISSUE ENG REGEN MED, V6, P1420
   Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14
   Leclerc E, 2007, BIOMATERIALS, V28, P1820, DOI 10.1016/j.biomaterials.2006.11.044
   Leclerc E, 2009, MAT SCI ENG C-BIO S, V29, P861, DOI 10.1016/j.msec.2008.07.019
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Sgarioto M, 2012, CR BIOL, V335, P520, DOI 10.1016/j.crvi.2012.07.003
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   SIGOTLUIZARD MF, 1977, CR ACAD SCI D NAT, V284, P1839
   Siri S, 2010, INT J BIOL MACROMOL, V46, P529, DOI [10.1016/j.fibiomac.2010.03.002, 10.1016/j.ijbiomac.2010.03.002]
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vernon RB, 2005, BIOMATERIALS, V26, P3131, DOI 10.1016/j.biomateriasl.2004.08.011
   Vidal G, 2013, TECHN INGENIEUR, VRE218, P1
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Wittmer CR, 2011, ACTA BIOMATER, V7, P3789, DOI 10.1016/j.actbio.2011.06.001
   Wittmer CR, 2012, ADV FUNCT MATER, V21, P4202
   WOLFF E, 1952, TEX REP BIOL MED, V10, P463
NR 37
TC 6
Z9 6
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD FEB
PY 2017
VL 11
IS 2
BP 354
EP 361
DI 10.1002/term.1916
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA EO9GC
UT WOS:000396996200005
PM 24889557
DA 2018-10-20
ER

PT J
AU El Hadad, AA
   Peon, E
   Garcia-Galvan, FR
   Barranco, V
   Parra, J
   Jimenez-Morales, A
   Galvan, JC
AF El Hadad, Amir A.
   Peon, Eduardo
   Garcia-Galvan, Federico R.
   Barranco, Violeta
   Parra, Juan
   Jimenez-Morales, Antonia
   Galvan, Juan Carlos
TI Biocompatibility and Corrosion Protection Behaviour of Hydroxyapatite
   Sol-Gel-Derived Coatings on Ti6Al4V Alloy
SO MATERIALS
LA English
DT Article
DE biomaterial; hydroxyapatite; calcium phosphate; sol-gel; Ti6Al4V alloy;
   corrosion protection; bioactivity; biocompatibility
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; IN-VITRO BIOCOMPATIBILITY;
   BOVINE BONE; STEEL; COMPOSITE; VIABILITY; MECHANISM; SYSTEMS; APATITE;
   GROWTH
AB The aim of this work was to prepare hydroxyapatite coatings (HAp) by a sol-gel method on Ti6Al4V alloy and to study the bioactivity, biocompatibility and corrosion protection behaviour of these coatings in presence of simulated body fluids (SBFs). Thermogravimetric/Differential Thermal Analyses (TG/DTA) and X-ray Diffraction (XRD) have been applied to obtain information about the phase transformations, mass loss, identification of the phases developed, crystallite size and degree of crystallinity of the obtained HAp powders. Fourier Transformer Infrared Spectroscopy (FTIR) has been utilized for studying the functional groups of the prepared structures. The surface morphology of the resulting HAp coatings was studied by Scanning Electron Microscopy (SEM). The bioactivity was evaluated by soaking the HAp-coatings/Ti6Al4V system in Kokubo's Simulated Body Fluid (SBF) applying Inductively Coupled Plasma (ICP) spectrometry. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and Alamar blue cell viability assays were used to study the biocompatibility. Finally, the corrosion behaviour of HAp-coatings/Ti6Al4V system was researched by means of Electrochemical Impedance Spectroscopy (EIS). The obtained results showed that the prepared powders were nanocrystalline HAp with little deviations from that present in the human bone. All the prepared HAp coatings deposited on Ti6Al4V showed well-behaved biocompatibility, good bioactivity and corrosion protection properties.
C1 [El Hadad, Amir A.; Garcia-Galvan, Federico R.; Galvan, Juan Carlos] CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   [El Hadad, Amir A.] Al Azhar Univ, Biophys Branch, Dept Phys, Cairo 11884, Egypt.
   [Peon, Eduardo] Univ La Habana, Ctr Biomat, Havana 10600, Cuba.
   [Barranco, Violeta] CSIC, Inst Ciencia Mat Madrid, E-28049 Madrid, Spain.
   [Parra, Juan] Hosp Prov Avila, CSIC, Unidad Asociada, Unidad Invest Clin & Biopatol Expt, Avila 05003, Spain.
   [Parra, Juan] CIBER BBN, Madrid 28029, Spain.
   [Jimenez-Morales, Antonia] Univ Carlos III Madrid, Dept Ciencia & Ingn Mat & Ingn Quim, Leganes 28911, Madrid, Spain.
RP Galvan, JC (reprint author), CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
EM amirelhadad@yahoo.com; epeon@biomat.uh.cu; f.garciag@cenim.csic.es;
   violeta.barranco@gmail.com; jparra@ictp.csic.es; toni@ing.uc3m.es;
   jcgalvan@cenim.csic.es
RI Jimenez-Morales, Antonia/C-3913-2013; Garcia-Galvan,
   Federico/Q-2207-2018; Galvan, Juan Carlos/B-9751-2011
OI Jimenez-Morales, Antonia/0000-0002-9861-2309; Garcia-Galvan,
   Federico/0000-0001-6349-8166; Galvan, Juan Carlos/0000-0002-8841-9716
FU Ministry of Economy and Competitiveness of Spain [MAT2012-30854,
   MAT2015-65445-C2-1-R]
FX The authors would like to acknowledge financial support from the
   Ministry of Economy and Competitiveness of Spain (MAT2012-30854 and
   MAT2015-65445-C2-1-R Projects).
CR Barranco V, 2010, PROG ORG COAT, V68, P347, DOI 10.1016/j.porgcoat.2010.02.009
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII
   Cheng K, 2006, J SOL-GEL SCI TECHN, V38, P13, DOI 10.1007/s10971-005-5630-5
   Chico B, 2007, PROG ORG COAT, V60, P45, DOI 10.1016/j.porgcoat.2007.06.007
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   Wang DG, 2008, J MATER SCI-MATER M, V19, P2281, DOI 10.1007/s10856-007-3338-5
   Doorn P. F., 1998, J BIOMED MATER RES, V42, P103, DOI [10.1002/(SICI)1097-4636(199810)42:1<less than>103::AID-JBM13<greater than>3. 0. CO;2-M, DOI 10.1002/(SICI)1097-4636(199810)42:1<LESS]
   El hadad AA, 2014, J MATER CHEM B, V2, P7955, DOI 10.1039/c4tb01175a
   El Hadad AA, 2014, J MATER CHEM B, V2, P3886, DOI 10.1039/c4tb00173g
   El hadad A. A., 2012, THESIS
   El Hadad A. A., 2010, J PHYS C SER, V252
   FELIU S, 1989, PROG ORG COAT, V17, P143, DOI 10.1016/0033-0655(89)80020-2
   Galvan JC, 2016, J ALLOY COMPD, V676, P414, DOI 10.1016/j.jallcom.2016.03.162
   Gloeckner H, 2001, J IMMUNOL METHODS, V252, P131, DOI 10.1016/S0022-1759(01)00347-7
   Govers Roland, 2008, V440, P129, DOI 10.1007/978-1-59745-178-9_10
   Guo YP, 2015, J MATER CHEM B, V3, P4679, DOI 10.1039/c5tb00175g
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hsieh MF, 2001, BIOMATERIALS, V22, P2601, DOI 10.1016/S0142-9612(00)00448-8
   Hsu CH, 2001, CORROSION, V57, P747, DOI 10.5006/1.3280607
   Kim HM, 2004, J ROY SOC INTERFACE, V1, P17, DOI 10.1098/rsif.2004.0003
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Klung H. P., 1974, XRAY DIFFRACTION PRO
   Kokubo C. O. T., 1992, J NONCRYST SOLIDS, V143, P84
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEIDHEISER H, 1991, J COATING TECHNOL, V63, P21
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x
   MACDONALD JR, 1992, ANN BIOMED ENG, V20, P289, DOI 10.1007/BF02368532
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Aves EP, 2009, J MATER SCI-MATER M, V20, P543, DOI 10.1007/s10856-008-3609-9
   Peon E., 2017, MODERN TECH IN PRESS
   Rajabi-Zamani AH, 2008, MAT SCI ENG C-BIO S, V28, P1326, DOI 10.1016/j.msec.2008.02.001
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Shavandi A, 2015, J BIOMIM BIOMATER BI, V25, P98, DOI 10.4028/www.scientific.net/JBBBE.25.98
   Shirazi HA, 2016, MATER TECHNOL, V31, P448, DOI 10.1080/10667857.2015.1105577
   SILVERMAN DC, 1991, CORROSION, V47, P87, DOI 10.5006/1.3585234
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   WALTER GW, 1986, CORROS SCI, V26, P681, DOI 10.1016/0010-938X(86)90033-8
   WAN H, 1994, J MATER SCI-MATER M, V5, P154, DOI 10.1007/BF00053336
   Wang DG, 2008, COLLOID SURFACE B, V66, P155, DOI 10.1016/j.colsurfb.2008.06.003
   Wu HC, 2016, MATERIALS, V9, DOI 10.3390/ma9030198
NR 47
TC 2
Z9 2
U1 8
U2 26
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2017
VL 10
IS 2
AR 94
DI 10.3390/ma10020094
PG 25
WC Materials Science, Multidisciplinary
SC Materials Science
GA EM6TT
UT WOS:000395445800001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xiao, Y
   Ahadian, S
   Radisic, M
AF Xiao, Yun
   Ahadian, Samad
   Radisic, Milica
TI Biochemical and Biophysical Cues in Matrix Design for Chronic and
   Diabetic Wound Treatment
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
DE wound healing; dressing; diabetic; matrix; biomaterial
ID NITRIC-OXIDE-SYNTHASE; VACUUM-ASSISTED CLOSURE; EPIDERMAL-GROWTH-FACTOR;
   NORMAL HUMAN KERATINOCYTES; CRITICAL LIMB ISCHEMIA; GENE-THERAPY;
   IN-VITRO; ELECTRICAL-STIMULATION; EXTRACELLULAR-MATRIX; SKIN
   REGENERATION
AB Progress in biomaterial science and engineering and increasing knowledge in cell biology have enabled us to develop functional biomaterials providing appropriate biochemical and biophysical cues for tissue regeneration applications. Tissue regeneration is particularly important to treat chronic wounds of people with diabetes. Understanding and controlling the cellular microenvironment of the wound tissue are important to improve the wound healing process. In this study, we review different biochemical (e.g., growth factors, peptides, DNA, and RNA) and biophysical (e.g., topographical guidance, pressure, electrical stimulation, and pulsed electromagnetic field) cues providing a functional and instructive acellular matrix to heal diabetic chronic wounds. The biochemical and biophysical signals generally regulate cell-matrix interactions and cell behavior and function inducing the tissue regeneration for chronic wounds. Some technologies and devices have already been developed and used in the clinic employing biochemical and biophysical cues for wound healing applications. These technologies can be integrated with smart biomaterials to deliver therapeutic agents to the wound tissue in a precise and controllable manner. This review provides useful guidance in understanding molecular mechanisms and signals in the healing of diabetic chronic wounds and in designing instructive biomaterials to treat them.
C1 [Xiao, Yun; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Xiao, Yun; Ahadian, Samad; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
RP Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, 164 Coll St,Room 407, Toronto, ON M5S 3G9, Canada.
EM m.radisic@utoronto.ca
FU National Sciences and Engineering Research Council of Canada (NSERC)
   Steacie Fellowship; Canadian Institutes of Health Research (CIHR)
   Operating Grant [MOP-126027]; Heart and Stroke Foundation GIA;
   NSERC-CIHR Collaborative Health Research Grant; NSERC Discovery Grant
FX Our work is supported by the National Sciences and Engineering Research
   Council of Canada (NSERC) Steacie Fellowship to M.R., the Canadian
   Institutes of Health Research (CIHR) Operating Grant (MOP-126027), the
   Heart and Stroke Foundation GIA, NSERC-CIHR Collaborative Health
   Research Grant, and NSERC Discovery Grant.
CR Abbah SA, 2015, ADV HEALTHC MATER, V4, P2488, DOI 10.1002/adhm.201500004
   Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Agren MS, 1999, J INVEST DERMATOL, V112, P463, DOI 10.1046/j.1523-1747.1999.00549.x
   Ahadian S, 2013, ORGANOGENESIS, V9, P87, DOI 10.4161/org.25121
   Albrecht-Schgoer K, 2014, ANGIOGENESIS, V17, P27, DOI 10.1007/s10456-013-9375-4
   ALVAREZ OM, 1983, J INVEST DERMATOL, V81, P144, DOI 10.1111/1523-1747.ep12543498
   ANDREW PJ, 1995, BIOCHEM BIOPH RES CO, V214, P949, DOI 10.1006/bbrc.1995.2378
   Aoyagi S, 2007, INT J PHARM, V330, P138, DOI 10.1016/j.ijpharm.2006.09.016
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Baker LL, 1997, DIABETES CARE, V20, P405, DOI 10.2337/diacare.20.3.405
   Banerjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089239
   Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010
   Barhate RS, 2007, J MEMBRANE SCI, V296, P1, DOI 10.1016/j.memsci.2007.03.038
   BASSETT CAL, 1974, SCIENCE, V184, P575
   Baudouin JE, 1996, J INVEST DERMATOL, V106, P428, DOI 10.1111/1523-1747.ep12343523
   BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498
   Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107
   Blecher K, 2012, NANOMED-NANOTECHNOL, V8, P1364, DOI 10.1016/j.nano.2012.02.014
   Boateng J, 2015, J PHARM SCI-US, V104, P3653, DOI 10.1002/jps.24610
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105
   Bouchie A, 2002, NAT BIOTECHNOL, V20, P1178, DOI 10.1038/nbt1202-1178
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Brimson CH, 2013, J EUR ACAD DERMATOL, V27, P411, DOI 10.1111/j.1468-3083.2012.04650.x
   Brismar K, 1997, Wound Repair Regen, V5, P147
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   BruchGerharz D, 1996, J EXP MED, V184, P2007, DOI 10.1084/jem.184.5.2007
   Caskey RC, 2014, WOUND REPAIR REGEN, V22, P515, DOI 10.1111/wrr.12199
   Cavaliere S, 2011, ENERG ENVIRON SCI, V4, P4761, DOI 10.1039/c1ee02201f
   Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294
   Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583
   Charafeddine RA, 2015, J INVEST DERMATOL, V135, P2309, DOI 10.1038/jid.2015.94
   Cheing GLY, 2014, BIOELECTROMAGNETICS, V35, P161, DOI 10.1002/bem.21832
   Chen L, 2010, CIRCULATION, V122, P910, DOI 10.1161/CIRCULATIONAHA.109.931931
   Chen Shao-Zong, 2005, Asian J Surg, V28, P211, DOI 10.1016/S1015-9584(09)60346-8
   Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d
   Chester AL, 2004, J BURN CARE REHABIL, V25, P266, DOI 10.1097/01.BCR.0000124749.85552.CD
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103
   Cho H, 2013, MACROMOL MATER ENG, V298, P475, DOI 10.1002/mame.201200364
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Deveci M, 2005, BRIT J DERMATOL, V152, P217, DOI 10.1111/J.1365-2133.2004.06329.X
   Dongargaonkar AA, 2013, BIOMACROMOLECULES, V14, P4038, DOI 10.1021/bm401143p
   Dou CQ, 2014, MOL THER, V22, P752, DOI 10.1038/mt.2014.2
   Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/NCHEM.1753, 10.1038/nchem.1753]
   Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337
   Ezhilvalavan S., 2014, PROCEDIA ENG, V75, P159
   Fabian TS, 2000, AM SURGEON, V66, P1136
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Fan K, 2011, PLAST RECONSTR SURG, V127, p44S, DOI 10.1097/PRS.0b013e3181fbe275
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   FISCHER BH, 1969, LANCET, V2, P405
   Friedman A, 2009, EXPERT OPIN DRUG DEL, V6, P1113, DOI 10.1517/17425240903196743
   Frykberg RG, 2015, ADV WOUND CARE, V4, P560, DOI 10.1089/wound.2015.0635
   Frykberg RG, 2011, OSTOMY WOUND MANAG, V57, P22
   Fu XL, 2014, BIOMATERIALS, V35, P1496, DOI 10.1016/j.biomaterials.2013.11.013
   Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710
   Gardner SE, 1999, WOUND REPAIR REGEN, V7, P495, DOI 10.1046/j.1524-475X.1999.00495.x
   Goldman R, 1996, BIOELECTROMAGNETICS, V17, P450, DOI 10.1002/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2
   Gould LJ, 2016, ADV WOUND CARE, V5, P19, DOI 10.1089/wound.2014.0595
   Gu YQ, 2011, J GENE MED, V13, P602, DOI 10.1002/jgm.1614
   Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   HARTMANN M, 1992, EUR J SURG, V158, P521
   Hasan A, 1997, J DERMATOL SCI, V16, P59, DOI 10.1016/S0923-1811(97)00622-1
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   HEVEL JM, 1991, J BIOL CHEM, V266, P22789
   HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0
   Hinsenkamp M, 1997, BIOELECTROMAGNETICS, V18, P250, DOI 10.1002/(SICI)1521-186X(1997)18:3<250::AID-BEM8>3.0.CO;2-1
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holmes C, 2013, DIABET METAB SYND OB, V6, P17, DOI 10.2147/DMSO.S36024
   Honda W, 2014, ADV FUNCT MATER, V24, P3299, DOI 10.1002/adfm.201303874
   Jaklenec A, 2012, TISSUE ENG PART B-RE, V18, P155, DOI [10.1089/ten.teb.2011.0553, 10.1089/ten.TEB.2011.0553]
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434
   Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karoly J, 2010, BIOFABRICATION, V2
   Katsuhiko A, 2008, SCI TECHNOL ADV MAT, V9
   Kim HS, 2013, GENE THER, V20, P378, DOI 10.1038/gt.2012.49
   Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038
   Kim HS, 2013, ACTA BIOMATER, V9, P7371, DOI 10.1016/j.actbio.2013.03.018
   Kinstlinger IS, 2016, LAB CHIP, V16, P2025, DOI 10.1039/c6lc00193a
   Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23
   Kloth LC, 2014, ADV WOUND CARE, V3, P81, DOI 10.1089/wound.2013.0459
   Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P629, DOI 10.1163/092050611X555687
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kuhn A, 1998, J INVEST DERMATOL, V111, P149, DOI 10.1046/j.1523-1747.1998.00253.x
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Kwon MJ, 2012, J GENE MED, V14, P272, DOI 10.1002/jgm.2618
   Labovitiadi O, 2009, J PHARM PHARMACOL, V61, pA19
   Lan CCE, 2009, BRIT J DERMATOL, V160, P1206, DOI 10.1111/j.1365-2133.2009.09089.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JW, 2010, ARCH OTOLARYNGOL, V136, P714, DOI 10.1001/archoto.2010.107
   Leng L, 2012, ADV MATER, V24, P3650, DOI 10.1002/adma.201201442
   Li DQ, 2015, J CLIN INVEST, V125, P3008, DOI 10.1172/JCI79052
   Li DQ, 2015, J INVEST DERMATOL, V135, P1676, DOI 10.1038/jid.2015.48
   Li P, 2011, J PATHOL, V223, P659, DOI 10.1002/path.2831
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256
   Liu X, 2013, BIOMATERIALS, V34, P2038, DOI 10.1016/j.biomaterials.2012.11.062
   Livstone Michael S., 2006, Natural Computing, V5, P1, DOI 10.1007/s11047-005-3803-3
   Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195
   Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x
   Loots MAM, 2002, EUR J CELL BIOL, V81, P153, DOI 10.1078/0171-9335-00228
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lowe A, 2015, ACTA BIOMATER, V13, P121, DOI 10.1016/j.actbio.2014.11.032
   Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lysaght M J, 1995, Tissue Eng, V1, P221, DOI 10.1089/ten.1995.1.221
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   Ma B, 2014, BIOMATERIALS, V35, P630, DOI 10.1016/j.biomaterials.2013.09.111
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120
   Marmaras A, 2012, SOFT MATTER, V8, P6922, DOI 10.1039/c2sm00030j
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Masters KSB, 2002, WOUND REPAIR REGEN, V10, P286, DOI 10.1046/j.1524-475X.2002.10503.x
   Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443
   MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3
   McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moffett J, 2010, J DIABET FOOT COMPLI, V2, P57
   Morgado PI, 2015, J MEMBRANE SCI, V490, P139, DOI 10.1016/j.memsci.2015.04.064
   Morishita R, 2011, ARTERIOSCL THROM VAS, V31, P713, DOI 10.1161/ATVBAHA.110.219550
   Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001
   Moues CM, 2011, AM J SURG, V201, P544, DOI 10.1016/j.amjsurg.2010.04.029
   Nelson RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003431.pub3
   Nguyen PD, 2010, WOUND REPAIR REGEN, V18, P553, DOI 10.1111/j.1524-475X.2010.00638.x
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a
   Nuschke A, 2014, ORGANOGENESIS, V10, P29, DOI 10.4161/org.27405
   Obregon R, 2014, J NANOSCI NANOTECHNO, V14, P487, DOI 10.1166/jnn.2014.9051
   Ojeh N, 2016, INT WOUND J, V13, P1180, DOI 10.1111/iwj.12438
   Ozbolat IT, 2016, BIOMATERIALS, V76, P321, DOI 10.1016/j.biomaterials.2015.10.076
   Ozbolat IT, 2015, TRENDS BIOTECHNOL, V33, P395, DOI 10.1016/j.tibtech.2015.04.005
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   Park HJ, 2012, BIOMATERIALS, V33, P9148, DOI 10.1016/j.biomaterials.2012.09.005
   Parkinson LG, 2012, TISSUE ENG PT A, V18, P703, DOI [10.1089/ten.tea.2011.0307, 10.1089/ten.TEA.2011.0307]
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135
   Pawar HV, 2013, COLLOID SURFACE B, V102, P102, DOI 10.1016/j.colsurfb.2012.08.014
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   PUOLAKKAINEN PA, 1995, J SURG RES, V58, P321, DOI 10.1006/jsre.1995.1050
   Rabkin J., 1988, INFECT OXYGEN, P1
   Randeria PS, 2015, P NATL ACAD SCI USA, V112, P5573, DOI 10.1073/pnas.1505951112
   Reddy VJ, 2013, WOUND REPAIR REGEN, V21, P1, DOI 10.1111/j.1524-475X.2012.00861.x
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052
   Rouabhia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071660
   Sahay R, 2012, J MATER CHEM, V22, P12953, DOI 10.1039/c2jm30966a
   Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41
   Saxena V, 2004, PLAST RECONSTR SURG, V114, P1086, DOI 10.1097/01.prs.0000135330.51408.97
   Sayag J, 1996, J Wound Care, V5, P357
   Schaffer MR, 1997, J IMMUNOL, V158, P2375
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014
   Seabra AB, 2004, BRIT J DERMATOL, V151, P977, DOI 10.1111/j.1365-2133.2004.06213.x
   Seetharaman S, 2011, ACTA BIOMATER, V7, P2787, DOI 10.1016/j.actbio.2011.04.003
   Seo SJ, 2002, BRIT J DERMATOL, V147, P655, DOI 10.1046/j.1365-2133.2002.04849.x
   Sheffield P., 1988, PROBLEM WOUNDS ROLE, P17
   Shigematsu H, 2011, INT ANGIOL, V30, P140
   Shimizu Yoshinori, 1997, Journal of Dermatology (Tokyo), V24, P80
   Siafaka PI, 2016, CARBOHYD POLYM, V143, P90, DOI 10.1016/j.carbpol.2016.02.009
   Signorelli SS, 2005, VASC MED, V10, P1, DOI 10.1191/1358863x05vm582oa
   Sinha M, 2013, J POROUS MAT, V20, P799, DOI 10.1007/s10934-012-9655-1
   Sirsjo A, 1996, BRIT J DERMATOL, V134, P643, DOI 10.1111/j.1365-2133.1996.tb06963.x
   Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Soneja A, 2005, PHARMACOL REP, V57, P108
   Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627
   Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x
   Stanley AC, 2005, J SURG RES, V124, P112, DOI 10.1016/j.jss.2004.09.013
   STEED DL, 1995, DIABETES CARE, V18, P39, DOI 10.2337/diacare.18.1.39
   Steinstraesser L, 2014, MOL THER, V22, P734, DOI 10.1038/mt.2013.258
   Stinner DJ, 2010, J ORTHOP TRAUMA, V24, P592, DOI 10.1097/BOT.0b013e3181ed296c
   STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773
   Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17
   Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836
   Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890
   Tack CJ, 2002, DIABETES, V51, P3545, DOI 10.2337/diabetes.51.12.3545
   Takei T, 1997, J CELL BIOCHEM, V67, P327, DOI 10.1002/(SICI)1097-4644(19971201)67:3<327::AID-JCB5>3.0.CO;2-Y
   Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2
   Taskan I, 1997, PLAST RECONSTR SURG, V100, P966
   Thakral G, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.22081
   Thavandiran N, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt162
   Thornton FJ, 1998, BIOCHEM BIOPH RES CO, V246, P654, DOI 10.1006/bbrc.1998.8681
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   UNDERWOOD PA, 1995, BIOCHEM J, V309, P765, DOI 10.1042/bj3090765
   Unnithan AR, 2012, CARBOHYD POLYM, V90, P1786, DOI 10.1016/j.carbpol.2012.07.071
   Vacanti JP, 1999, LANCET, V354, pSI32
   Van Slyke P, 2009, TISSUE ENG PT A, V15, P1269, DOI 10.1089/ten.tea.2007.0400
   Vaz ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136116
   Velve-Casquillas G, 2010, NANO TODAY, V5, P28, DOI 10.1016/j.nantod.2009.12.001
   Viticchie G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.174
   Vodovotz Y, 1999, CANCER RES, V59, P2142
   Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x
   Wackenfors A, 2005, ANN THORAC SURG, V79, P1724, DOI 10.1016/j.athoracsur.2004.10.053
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang RJ, 1996, J INVEST DERMATOL, V106, P419, DOI 10.1111/1523-1747.ep12343428
   Wang T, 2012, AM J PATHOL, V181, P1911, DOI 10.1016/j.ajpath.2012.08.022
   Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012
   Wang YW, 2014, J INVEST DERMATOL, V134, P2016, DOI 10.1038/jid.2014.84
   Wetterau M, 2011, WOUND REPAIR REGEN, V19, P481, DOI 10.1111/j.1524-475X.2011.00697.x
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Wirsing PG, 2015, INT WOUND J, V12, P693, DOI 10.1111/iwj.12204
   Xiao Y, 2015, METHODS, V84, P44, DOI 10.1016/j.ymeth.2015.04.025
   Xie JW, 2011, SMALL, V7, P293, DOI 10.1002/smll.201001446
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Xu JS, 2001, J CELL BIOL, V155, P859
   Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997
   Yang LL, 2014, BIOCHEM BIOPH RES CO, V453, P153, DOI 10.1016/j.bbrc.2014.09.077
   Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685
   Yang Y, 2012, MOL PHARMACEUT, V9, P48, DOI 10.1021/mp200246b
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Yang ZM, 2007, CHEM COMMUN, P843, DOI 10.1039/b616563
   Yu B, 2016, NAT MATER, V15, P911, DOI [10.1038/NMAT4635, 10.1038/nmat4635]
   Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhao R, 2013, MATRIX BIOL, V32, P265, DOI 10.1016/j.matbio.2013.02.004
   Zheng Y, 2011, BIOMATERIALS, V32, P5391, DOI 10.1016/j.biomaterials.2011.04.001
   Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451
   ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557
   Zykova SN, 2000, DIABETES, V49, P1451, DOI 10.2337/diabetes.49.9.1451
NR 243
TC 5
Z9 6
U1 7
U2 39
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB
PY 2017
VL 23
IS 1
BP 9
EP 26
DI 10.1089/ten.teb.2016.0200
PG 18
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA EL3CN
UT WOS:000394497300002
PM 27405960
OA Green Published
DA 2018-10-20
ER

PT J
AU Werner, M
   Blanquer, SBG
   Haimi, SP
   Korus, G
   Dunlop, JWC
   Duda, GN
   Grijpma, DW
   Petersen, A
AF Werner, Maike
   Blanquer, Sebastien B. G.
   Haimi, Suvi P.
   Korus, Gabriela
   Dunlop, John W. C.
   Duda, Georg N.
   Grijpma, Dirk. W.
   Petersen, Ansgar
TI Surface Curvature Differentially Regulates Stem Cell Migration and
   Differentiation via Altered Attachment Morphology and Nuclear
   Deformation
SO ADVANCED SCIENCE
LA English
DT Article
ID CYTOSKELETAL TENSION; MATRIX ELASTICITY; TISSUE-GROWTH; SHAPE; GEOMETRY;
   CONTRACTILITY; MECHANICS; MOVEMENT; CONVEX
AB Signals from the microenvironment around a cell are known to influence cell behavior. Material properties, such as biochemical composition and substrate stiffness, are today accepted as significant regulators of stem cell fate. The knowledge of how cell behavior is influenced by 3D geometric cues is, however, strongly limited despite its potential relevance for the understanding of tissue regenerative processes and the design of biomaterials. Here, the role of surface curvature on the migratory and differentiation behavior of human mesenchymal stem cells (hMSCs) has been investigated on 3D surfaces with well-defined geometric features produced by stereolithography. Time lapse microscopy reveals a significant increase of cell migration speed on concave spherical compared to convex spherical structures and flat surfaces resulting from an upward-lift of the cell body due to cytoskeletal forces. On convex surfaces, cytoskeletal forces lead to substantial nuclear deformation, increase lamin-A levels and promote osteogenic differentiation. The findings of this study demonstrate a so far missing link between 3D surface curvature and hMSC behavior. This will not only help to better understand the role of extracellular matrix architecture in health and disease but also give new insights in how 3D geometries can be used as a cell-instructive material parameter in the field of biomaterial-guided tissue regeneration.
C1 [Werner, Maike; Korus, Gabriela; Duda, Georg N.; Petersen, Ansgar] Charite Univ Med Berlin, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Werner, Maike; Blanquer, Sebastien B. G.; Haimi, Suvi P.; Grijpma, Dirk. W.] Univ Twente, Dept Biomed Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.
   [Werner, Maike] Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Haimi, Suvi P.] Univ Helsinki, Dept Oral & Maxillofacial Dis, Haartmaninkatu 8, FI-00014 Helsinki, Finland.
   [Dunlop, John W. C.] Max Planck Inst Colloids & Interfaces, Muhlenberg 1, D-14476 Potsdam, Germany.
   [Duda, Georg N.; Petersen, Ansgar] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Grijpma, Dirk. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RP Petersen, A (reprint author), Charite Univ Med Berlin, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany.; Petersen, A (reprint author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM ansgar.petersen@charite.de
RI Petersen, Ansgar/O-1945-2015; Duda, Georg/H-2085-2016
OI Duda, Georg/0000-0001-7605-3908
FU Berlin-Brandenburg Center for Regenerative Therapies
FX The authors acknowledge the technical support for scanning electron
   microscopy by Paul Zaslansky, Julius Wolff Institute, Charite
   Universitatsmedizin Berlin. This work was financially supported by the
   Berlin-Brandenburg Center for Regenerative Therapies.
CR Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Hersen P, 2011, NATURE, V470, P340, DOI 10.1038/470340a
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110
   Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021
   Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2015, BIOMATERIALS, V48, P161, DOI 10.1016/j.biomaterials.2015.01.023
   Kim MH, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-13
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Li QS, 2014, BIOMATERIALS, V35, P961, DOI 10.1016/j.biomaterials.2013.10.037
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lo YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep21253
   Malheiro V, 2016, BIOMATER SCI-UK, V4, P1562, DOI 10.1039/c6bm00425c
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Neffe AT, 2015, ADV MATER, V27, P1738, DOI 10.1002/adma.201404787
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park JY, 2009, LAB CHIP, V9, P2043, DOI 10.1039/b820955c
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Sachs F, 2015, J GEN PHYSIOL, V145, P373, DOI 10.1085/jgp.201411297
   Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
NR 40
TC 17
Z9 17
U1 5
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD FEB
PY 2017
VL 4
IS 2
AR 1600347
DI 10.1002/advs.201600347
PG 11
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EO9PO
UT WOS:000397020800012
PM 28251054
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chellappa, M
   Thejaswini, B
   Vijayalakshmi, U
AF Chellappa, Maniickam
   Thejaswini, Bezawada
   Vijayalakshmi, Uthirapathy
TI Biocompatibility assessment of SiO2-TiO2 composite powder on MG63
   osteoblast cell lines for orthopaedic applications
SO IET NANOBIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Nanomaterials and Nanotechnology (NANO)
CY 2015
CL Tiruchengode, INDIA
SP K S Rangasamy Coll Technol, Ctr Nanoscience & Technol, GIST, World Class Univ
ID TIO2-SIO2 IMPLANT COATINGS; DIRECT TISSUE ATTACHMENT; SOL-GEL METHOD;
   TITANIA
AB The objective of this study is to evaluate the biocompatibility of composite powder consisting of silica and titania (SiO2-TiO2)for biomedical applications. The advancement of nanoscience and nanotechnology encourages researchers to actively participate in reinvention of existing materials with improved physical, chemical and biological properties. Hence, a composite/hybrid material has given birth of new materials with intriguing properties. In the present investigation, SiO2-TiO2 composite powder was synthesised by sol-gel method and the prepared nanocomposite was characterised for its phase purity, functional groups, surface topography by powder X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and scanning electron microscopy. Furthermore, to understand the adverse effects of composite, biocompatibility test was analysed by cell culture method using MG63 osteoblast cell lines as a basic screening method. From the results, it was observed that typical Si-O-Ti peaks in FT-IR confirms the formation of composite and the crystallinity of the composite powder was analysed by XRD analysis. Further in vitro biocompatibility and acridine orange results have indicated better biocompatibility at different concentrations on osteoblast cell lines. On the basis of these observations, we envision that the prepared silica-titania nanocomposite is an intriguing biomaterial for better biomedical applications.
C1 [Chellappa, Maniickam; Thejaswini, Bezawada; Vijayalakshmi, Uthirapathy] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
RP Vijayalakshmi, U (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM lakesminat@yahoo.com
FU DST, New Delhi, India [SB/FT/CS- 091/2012]
FX The authors thank VIT University, Vellore for providing all required
   facilities and also one of the author Dr U. Vijayalakshmi highly
   acknowledge DST, New Delhi, India (SB/FT/CS- 091/2012) for financial
   support.
CR Aaritalo V, 2007, J MATER SCI-MATER M, V18, P1863, DOI 10.1007/s10856-007-3062-1
   Areva S, 2007, J MATER SCI-MATER M, V18, P1633, DOI 10.1007/s10856-007-3064-z
   Balachandaran K, 2010, INT J ENG SCI TECHNO, V2, P3695
   Chellappa M., 2014, INT J CHEMTECH RES, V7, P1259
   Guo N, 2014, APPL SURF SCI, V305, P562, DOI 10.1016/j.apsusc.2014.03.136
   Jung KY, 2004, MATER LETT, V58, P2897, DOI 10.1016/j.matlet.2004.05.015
   Lindstrom Sara, 2010, Journal of Biomechanical Science and Engineering, V5, P272, DOI 10.1299/jbse.5.272
   Meretoja V, 2010, MAT SCI APPL, V1, P118
   Nogueira DR, 2014, NANOMATERIALS-BASEL, V4, P454, DOI 10.3390/nano4020454
   Pabon E, 2007, J POROUS MAT, V14, P151, DOI 10.1007/s10934-006-9019-9
   Rilda Y., 2014, RES J PHARM BIOL CHE, V5, P1417
   Rubia F. S., 2002, MAT RES, V5, P497
   Sava B. A., 2005, UPB SCI B B, V69, P11
   Shao GN, 2012, POWDER TECHNOL, V217, P489, DOI 10.1016/j.powtec.2011.11.008
   Venckatesh R, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-15
   Vijayalakshmi U, 2012, METALL MATER TRANS A, V43A, P4907, DOI 10.1007/s11661-012-1283-5
   Vijayalakshmi U.U., 2005, TRENDS BIOMATER ARTI, V18, P101
NR 17
TC 1
Z9 1
U1 1
U2 4
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD FEB
PY 2017
VL 11
IS 1
SI SI
BP 77
EP 82
DI 10.1049/iet-nbt.2016.0063
PG 6
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA EP0RJ
UT WOS:000397094100014
PM 28476966
DA 2018-10-20
ER

PT J
AU Mazzoni, S
   Mohammadi, S
   Tromba, G
   Diomede, F
   Piattelli, A
   Trubiani, O
   Giuliani, A
AF Mazzoni, Serena
   Mohammadi, Sara
   Tromba, Giuliana
   Diomede, Francesca
   Piattelli, Adriano
   Trubiani, Oriana
   Giuliani, Alessandra
TI Role of Cortico-Cancellous Heterologous Bone in Human Periodontal
   Ligament Stem Cell Xeno-Free Culture Studied by Synchrotron Radiation
   Phase-Contrast Microtomography
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE periodontal ligament stem cells; phase-contrast microtomography;
   biomaterial; osteogenesis; xeno-free medium
ID TISSUE; SCAFFOLDS
AB This study was designed to quantitatively demonstrate via three-dimensional (3D) images, through the Synchrotron Radiation Phase-Contrast Microtomography (SR-PhC-MicroCT), the osteoinductive properties of a cortico-cancellous scaffold (Osteobiol Dual BlockDB) cultured with human Periodontal Ligament Stem Cells (hPDLSCs) in xeno-free media. In vitro cultures of hPDLSCs, obtained from alveolar crest and horizontal fibers of the periodontal ligament, were seeded onto DB scaffolds and cultured in xeno-free media for three weeks. 3D images were obtained by SR-PhC-microCT after one and three weeks from culture beginning. MicroCT data were successively processed with a phase-retrieval algorithm based on the Transport of Intensity Equation (TIE). The chosen experimental method, previously demonstratively applied for the 3D characterization of the same constructs in not xeno-free media, quantitatively monitored also in this case the early stages of bone formation in basal and differentiating conditions. Interestingly, it quantitatively showed in the xeno-free environment a significant acceleration of the mineralization process, regardless of the culture (basal/differentiating) medium. This work showed in 3D that the DB guides the osteogenic differentiation of hPDLSCs in xeno-free cultures, in agreement with 2D observations and functional studies previously performed by some of the authors. Indeed, here we fully proved in 3D that expanded hPDLSCs, using xeno-free media formulation, not only provide the basis for Good Manufacturing Practice (preserving the stem cells' morphological features and their ability to differentiate into mesenchymal lineage) but have to be considered, combined to DB scaffolds, as interesting candidates for potential clinical use in new custom made tissue-engineered constructs.
C1 [Mazzoni, Serena; Giuliani, Alessandra] Polytech Univ Marche, Unit Biochem Biol & Phys, Dept Clin Sci, Via Brecce Bianche 1, I-60131 Ancona, Italy.
   [Mohammadi, Sara; Tromba, Giuliana] Sincrotrone Trieste SCpA, Str Statale 14 Km 163-5 AREA Sci Pk, I-34149 Trieste, Italy.
   [Diomede, Francesca; Piattelli, Adriano; Trubiani, Oriana] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy.
RP Giuliani, A (reprint author), Polytech Univ Marche, Unit Biochem Biol & Phys, Dept Clin Sci, Via Brecce Bianche 1, I-60131 Ancona, Italy.
EM s.mazzoni@alisf1.univpm.it; patezian@gmail.com;
   giuliana.tromba@elettra.trieste.it; francesca.diomede@unich.it;
   apiattelli@unich.it; trubiani@unich.it; a.giuliani@univpm.it
RI Giuliani, Alessandra/O-9097-2018
OI Giuliani, Alessandra/0000-0003-4177-7441
FU OT; Program PRIN funds of Ministero dell'Istruzione; Universita e
   Ricerca [20102ZLNJ5]
FX The authors acknowledge the Elettra-Sincrotrone Trieste SCpA User Office
   for kindly providing beamtime and Timur Gureyev, Principal Research
   Scientist at CSIRO Materials Science and Engineering (Australia), for
   his fundamental suggestions during X-TRACT data analysis. This work
   arises from a collaboration between the MPNS Action COST MP1005 ("From
   nano to macro biomaterials (design, processing, characterization,
   modeling) and applications to stem cells regenerative orthopedic and
   dental medicine-NAMABIO") partners (Alessandra Giuliani, Serena Mazzoni,
   and Adriano Piattelli) and was partially financed from 60% OT and from
   the Program PRIN funds of Ministero dell'Istruzione, Universita e
   Ricerca (Prot. 20102ZLNJ5, "Stem cells and 3D scaffolds: a novel
   construct in bone regeneration").
CR Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Canciani B, 2015, J MECH BEHAV BIOMED, V51, P1, DOI 10.1016/j.jmbbm.2015.06.014
   Costa D, 2013, J CELL PHYSIOL, V228, P2210, DOI 10.1002/jcp.24391
   Diomede F, 2016, EUR CELLS MATER, V32, P181, DOI 10.22203/eCM.v032a12
   Fennis JPM, 2004, INT J ORAL MAX SURG, V33, P48, DOI 10.1054/ijom.2003.0452
   Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794
   Gureyev TE, 2004, OPT COMMUN, V231, P53, DOI 10.1016/j.optcom.2003.12.020
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Manescu A, 2016, J PERIODONTAL RES, V51, P112, DOI 10.1111/jre.12289
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Shah N, 2014, WORLD J RADIOL, V6, P794, DOI 10.4329/wjr.v6.i10.794
   Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179
   Trubiani O, 2007, Int J Immunopathol Pharmacol, V20, P87
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Trubiani O, 2015, TISSUE ENG PART C-ME, V21, P52, DOI [10.1089/ten.TEC.2014.0024, 10.1089/ten.tec.2014.0024]
   Trubiani O, 2010, J CELL PHYSIOL, V225, P123, DOI 10.1002/jcp.22203
   Yang H, 2013, BIOMATERIALS, V34, P7033, DOI 10.1016/j.biomaterials.2013.05.025
   Zhu WJ, 2015, STEM CELLS INT, DOI 10.1155/2015/972313
   Zwingenberger S, 2014, TISSUE ENG PT A, V20, P810, DOI 10.1089/ten.TEA.2013.0222
NR 20
TC 3
Z9 3
U1 0
U2 0
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2017
VL 18
IS 2
AR 364
DI 10.3390/ijms18020364
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EM6YD
UT WOS:000395457700132
PM 28208578
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, XF
   Zhang, Q
   Ye, DZ
   Zhang, J
   Guo, YH
   You, RC
   Yan, SQ
   Li, MZ
   Qu, J
AF Li, Xiufang
   Zhang, Qiang
   Ye, Dezhan
   Zhang, Jie
   Guo, Yuhang
   You, Renchuan
   Yan, Shuqin
   Li, Mingzhong
   Qu, Jing
TI Fabrication and Characterization of Electrospun PCL/Antheraea Pernyi
   Silk Fibroin Nanofibrous Scaffolds
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; CELL-ADHESION; BIOCOMPATIBILITY;
   BIOMATERIALS; PCL; RGD; POLY(EPSILON-CAPROLACTONE); REGENERATION;
   ATTACHMENT; MEMBRANE
AB To engineer tissue restoration, it is necessary to provide a bioactive, mechanically robust scaffold. Electrospun poly( epsilon-caprolactone) (PCL) nanofiber is a promising biomaterial candidate with excellent mechanical properties, but PCL scaffolds are inert and lack natural cell recognition sites. To overcome this problem we investigated the incorporation of Antheraea pernyi silk fibroin (ASF) containing inherent RGD tripeptides with PCL in electrospinning process. The mixing ratios showed remarkable impact on the properties of hybrid nanofibers. Increasing PCL content significantly enhanced the mechanical properties of nanofibers. In particular, the mechanical properties were remarkably enhanced when PCL content increased from 50 wt% to 70 wt%. Moreover, the biological assays based on endothelial cells showed promoted cell viability when ASF content reached to 30 wt%. The data demonstrated that the nanofiber containing 70% of PCL and 30% of ASF achieved the most balanced performances for integrating the mechanical properties of PCL and the bioactivity of ASF. Furthermore, biomimetic alignment of 70PCL/30ASF nanofibers was achieved, which could support PC12 neuron-like cell growth and guide neurite outgrowth, providing a potentially useful option for the engineering of oriented tissues. The results show that the PCL/ASF hybrid nanofibers can be considered as a promising candidate for tissue engineering scaffolds. POLYM. ENG. SCI., 57: 206-213, 2017. (C) 2016 Society of Plastics Engineers
C1 [Li, Xiufang; Zhang, Qiang; Ye, Dezhan; Zhang, Jie; Guo, Yuhang; You, Renchuan; Yan, Shuqin] Wuhan Text Univ, Coll Text Sci & Engn, Natl Engn Lab Adv Yarn & Fabr Format & Clean Prod, Wuhan 430200, Peoples R China.
   [Li, Mingzhong; Qu, Jing] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
RP You, RC (reprint author), Wuhan Text Univ, Coll Text Sci & Engn, Natl Engn Lab Adv Yarn & Fabr Format & Clean Prod, Wuhan 430200, Peoples R China.
EM yourenchuan1182@126.com
FU Nature Science Foundation of Wuhan Textile University [155017]; National
   Natural Science Foundation of China [51303141, 51403163]
FX Nature Science Foundation of Wuhan Textile University; contract grant
   number: 155017; contract grant sponsor: National Natural Science
   Foundation of China; contract grant number: 51303141, 51403163.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Battista E, 2015, BIOMATERIALS, V45, P72, DOI 10.1016/j.biomaterials.2014.12.012
   Bean AC, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015018
   Bhattacharjee P, 2016, CELL TISSUE RES, V363, P525, DOI 10.1007/s00441-015-2232-6
   Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Cho SJ, 2015, POLYMER, V69, P95, DOI 10.1016/j.polymer.2015.05.037
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Feng B, 2015, J BIOMED MATER RES A, V103, P431, DOI 10.1002/jbm.a.35184
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gupta P, 2015, POLYM ENG SCI, V55, P485, DOI 10.1002/pen.23928
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jiang T, 2015, PROG POLYM SCI, V46, P1, DOI 10.1016/j.progpolymsci.2014.12.001
   Kundu B, 2014, INT J BIOL MACROMOL, V70, P70, DOI 10.1016/j.ijbiomac.2014.06.022
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Leal-Egana A, 2013, ADV MATER, V25, P4049, DOI 10.1002/adma.201301227
   Lei CH, 2015, POLYM ENG SCI, V55, P907, DOI 10.1002/pen.23958
   Li LH, 2011, INT J BIOL MACROMOL, V49, P223, DOI 10.1016/j.ijbiomac.2011.04.018
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Li XF, 2016, J MATER CHEM B, V4, P2903, DOI 10.1039/c6tb00213g
   Lim JS, 2012, BIOPOLYMERS, V97, P265, DOI 10.1002/bip.22016
   Liu G., 2014, POLYM ADV TECHNOL, V25
   Liu Y, 2014, INT J MOL SCI, V15, P7049, DOI 10.3390/ijms15057049
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Shao WL, 2016, MAT SCI ENG C-MATER, V62, P823, DOI 10.1016/j.msec.2016.01.078
   Sheikh FA, 2014, J BIOACT COMPAT POL, V29, P500, DOI 10.1177/0883911514549717
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010
   Xiang P, 2014, BIOMATERIALS, V35, P9777, DOI 10.1016/j.biomaterials.2014.08.040
   Xie JW, 2014, ACS NANO, V8, P1878, DOI 10.1021/nn406363j
   Yao Y, 2014, ACTA BIOMATER, V10, P2739, DOI 10.1016/j.actbio.2014.02.042
   Yao Y, 2015, J BIOACT COMPAT POL, V30, P633, DOI 10.1177/0883911515585185
   You RC, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015003
   You RC, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4914028
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   [张衍国 Zhang Yanguo], 2005, [环境污染治理技术与设备, Techniques and equipment for environmental pollution control], V6, P6
NR 39
TC 3
Z9 3
U1 9
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0032-3888
EI 1548-2634
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD FEB
PY 2017
VL 57
IS 2
BP 206
EP 213
DI 10.1002/pen.24402
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA EO9UA
UT WOS:000397032400010
DA 2018-10-20
ER

PT J
AU Chang, TZ
   Stadmiller, SS
   Staskevicius, E
   Champion, JA
AF Chang, Timothy Z.
   Stadmiller, Samantha S.
   Staskevicius, Erika
   Champion, Julie A.
TI Effects of ovalbumin protein nanoparticle vaccine size and coating on
   dendritic cell processing
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME;
   IMMUNE-RESPONSES; PARTICLE UPTAKE; PHAGOSOMAL PH; IN-VITRO; ADJUVANT;
   DELIVERY; CORONA
AB Nanoparticle vaccine delivery platforms are a promising technology for enhancing vaccine immunogenicity. Protein nanoparticles (PNPs), made entirely from antigen, have been shown to induce protective immune responses against influenza. However, the fundamental mechanisms by which PNPs enhance component protein immunogenicity are not understood. Here, we investigate the role of size and coating of model ovalbumin (OVA) PNPs on particle uptake and trafficking, as well as on inflammation and maturation factor expression in dendritic cells (DCs) in vitro. OVA PNPs enhance antigen uptake in a size-independent manner, and experience attenuated endosomal acidification as compared to soluble OVA. OVA PNPs also trigger Fc receptor upregulation. Expression of cytokines IL-1 beta and TNF-alpha were PNP size-and coating-dependent, with small 270 nm) nanoparticles triggering greater inflammatory cytokine production than large (similar to 560 nm) particles. IL-1 beta expression by DCs in response to PNP stimulation implies activation of the inflammasome, a pathway known to be activated by certain types of nanoparticulate adjuvants. The attenuated acidification and pro-inflammatory profile generated by PNPs in DCs demonstrate that physical biomaterial properties can modulate dendritic cell-mediated antigen processing and adjuvancy. In addition to nanoparticles' enhancement of DC antigen uptake, our work suggests that vaccine nanoparticle size and coating are uptake-independent modulators of immunogenicity.
C1 [Chang, Timothy Z.; Stadmiller, Samantha S.; Staskevicius, Erika; Champion, Julie A.] Georgia Inst Technol, Sch Chem & Biomol Engn, 950 Atlantic Dr NW, Atlanta, GA 30332 USA.
RP Champion, JA (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, 950 Atlantic Dr NW, Atlanta, GA 30332 USA.
EM julie.champion@chbe.gatech.edu
FU National Institutes of Health [1R01AI101047-01]; National Science
   Foundation [DGE-1148903]; Georgia Institute of Technology's President's
   Undergraduate Research Award
FX This work was supported by the National Institutes of Health (Grant #
   1R01AI101047-01), by the National Science Foundation's Graduate Research
   Fellowship Program (Grant # DGE-1148903 for T. Z. C.) and by the Georgia
   Institute of Technology's President's Undergraduate Research Award for
   S. S. S. The funders had no role in study design, data collection,
   analysis, decision to publish, or preparation of this manuscript. No
   conflict of interest was found for any of the authors.
CR Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106
   Autenrieth SE, 2009, IMMUNOLOGY, V127, P523, DOI 10.1111/j.1365-2567.2008.02960.x
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Brewer JM, 2004, J IMMUNOL, V173, P6143, DOI 10.4049/jimmunol.173.10.6143
   BROWN EJ, 1996, BIOMEMBR, V4, P33
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Chu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040873
   Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048
   Cruz LJ, 2011, MOL PHARMACEUT, V8, P104, DOI 10.1021/mp100178k
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   Estrada LPH, 2015, BIOMATER SCI-UK, V3, P787, DOI 10.1039/c5bm00052a
   Estrada LH, 2014, J PHARM SCI-US, V103, P1863, DOI 10.1002/jps.23974
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Fleischer CC, 2014, ACCOUNTS CHEM RES, V47, P2651, DOI 10.1021/ar500190q
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Getts DR, 2015, TRENDS IMMUNOL, V36, P419, DOI 10.1016/j.it.2015.05.007
   Gregory A. E., 2013, FRONT CELL INFECT MI, P3
   Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
   Gunawan C, 2014, J MATER CHEM B, V2, P2060, DOI 10.1039/c3tb21526a
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202
   Karlson TD, 2013, METHODS, V60, P275, DOI 10.1016/j.ymeth.2013.02.009
   Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0
   Koppolu B, 2013, BIOMATERIALS, V34, P2359, DOI 10.1016/j.biomaterials.2012.11.066
   Kumar S, 2015, J CONTROL RELEASE, V220, P141, DOI 10.1016/j.jconrel.2015.09.069
   Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0
   Leleux J, 2015, J CONTROL RELEASE, V219, P610, DOI 10.1016/j.jconrel.2015.09.063
   Leleux J, 2013, ADV HEALTHC MATER, V2, P72, DOI 10.1002/adhm.201200268
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Liu LX, 2016, J CONTROL RELEASE, V225, P230, DOI 10.1016/j.jconrel.2016.01.050
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Mamo T, 2012, VACCINE, V30, P6609, DOI 10.1016/j.vaccine.2012.08.023
   Manmohan S., 2007, VACCINE ADJUVANTS DE
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p
   Murphy K., 2012, JANEWAYS IMMUNOBIOLO
   Neumann S, 2014, IMMUNOL CELL BIOL, V92, P535, DOI 10.1038/icb.2014.21
   Plummer EM, 2013, MOL PHARMACEUT, V10, P26, DOI 10.1021/mp300238w
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   Pradhan P, 2014, BIOMATERIALS, V35, P5491, DOI 10.1016/j.biomaterials.2014.03.039
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Ritter M, 2014, CLIN EXP IMMUNOL, V178, P212, DOI 10.1111/cei.12400
   Salerno-Goncalves R, 2006, TRENDS MICROBIOL, V14, P536, DOI 10.1016/j.tim.2006.10.004
   Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011
   Stano A, 2012, VACCINE, V30, P7541, DOI 10.1016/j.vaccine.2012.10.050
   Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Thomann-Harwood LJ, 2013, J CONTROL RELEASE, V166, P95, DOI 10.1016/j.jconrel.2012.11.015
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Wang L., 2016, NANOMEDICINE, V13, P253, DOI DOI 10.1016/J.NAN0.2016.09.001
   Wang L, 2014, NANOMED-NANOTECHNOL, V10, P473, DOI 10.1016/j.nano.2013.08.005
   Willett TA, 2004, P NATL ACAD SCI USA, V101, P1303, DOI 10.1073/pnas.0305680101
   Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 61
TC 10
Z9 11
U1 11
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD FEB 1
PY 2017
VL 5
IS 2
BP 223
EP 233
DI 10.1039/c6bm00500d
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EM6QW
UT WOS:000395438200005
PM 27918020
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chesson, CB
   Ekpo-Otu, S
   Endsley, JJ
   Rudra, JS
AF Chesson, Charles B.
   Ekpo-Otu, Shaunte
   Endsley, Janice J.
   Rudra, Jai S.
TI Biomaterials-Based Vaccination Strategies for the Induction of CD8(+)T
   Cell Responses
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Review
DE biomaterial; CD8(+)T cell; cellular immunity; polymer; vaccine
ID T-LYMPHOCYTE RESPONSES; MUCOSAL IMMUNE-RESPONSES; ANTIGEN-PRESENTING
   CELLS; CHITOSAN-BASED HYDROGELS; SELF-ASSEMBLING PEPTIDE; IN-VIVO;
   NANOPARTICLE VACCINES; DENDRITIC CELLS; BIOMEDICAL APPLICATIONS;
   CATIONIC LIPOSOMES
AB Natural and synthetic biomaterials are increasingly being used for the development of vaccines and immunotherapies as alternatives to traditional live attenuated formulations due to their improved safety profiles and no risk of reversion to virulence. Polymeric materials in particular enjoy attention due to the ease of fabrication, control over physicochemical properties, and their wide range of immunogenicity. While the majority of studies focus on inducing protective antibody responses, in recent years, materials-based strategies for the delivery of antigens and immunomodulators to improve CD8(+)T cell immunity against infectious and noninfectious diseases have gained momentum. Notably, platforms based on polymeric nanoparticles, liposomes, micelles, virus-like particles, self-assembling peptides and peptidomimetics, and multilayer thin films show considerable promise in preclinical studies. In this Review, we first introduce the concepts of CD8(+)T cell activation, effector and memory functions, and cytotoxic activity, followed by vaccine design for eliciting robust and protective long-lived CD8(+)T cell immunity. We then discuss different materials-based vaccines developed in the past decade to elicit CD8(+)T cell responses based on molecular composition or fabrication methods and conclude with a summary and glimpse at the future trends in this area.
C1 [Chesson, Charles B.; Ekpo-Otu, Shaunte; Rudra, Jai S.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Endsley, Janice J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Chesson, Charles B.; Ekpo-Otu, Shaunte; Endsley, Janice J.; Rudra, Jai S.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
RP Rudra, JS (reprint author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Rudra, JS (reprint author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
EM jarudra@utmb.edu
CR Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546
   Ahmadi F, 2015, RES PHARM SCI, V10, P1
   Ai WQ, 2013, MICROBIOL IMMUNOL, V57, P224, DOI 10.1111/1348-0421.12027
   Appavu R, 2015, ACS BIOMATER SCI ENG, V1, P601, DOI 10.1021/acsbiomaterials.5b00139
   Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774
   Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114
   Azmi F, 2014, HUM VACC IMMUNOTHER, V10, P778, DOI 10.4161/hv.27332
   Bencherif SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8556
   Bergmann-Leitner ES, 2014, VACCINES, V2, P252, DOI 10.3390/vaccines2020252
   Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001
   Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Black M, 2012, ADV MATER, V24, P3845, DOI 10.1002/adma.201200209
   Boesteanu AC, 2010, VACCINE, V29, P314, DOI 10.1016/j.vaccine.2010.10.036
   Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v
   Boudier A, 2009, BIOMATERIALS, V30, P233, DOI 10.1016/j.biomaterials.2008.09.033
   Bowerman CJ, 2012, BIOPOLYMERS, V98, P169, DOI 10.1002/bip.22058
   Brubaker CE, 2016, ACS BIOMATER SCI ENG, V2, P231, DOI 10.1021/acsbiomaterials.5b00456
   Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b
   Carbone FR, 2015, J IMMUNOL, V195, P17, DOI 10.4049/jimmunol.1500515
   Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96
   Chauhan A, 2011, VACCINE, V29, P5424, DOI 10.1016/j.vaccine.2011.05.066
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chen WS, 2008, CANCER IMMUNOL IMMUN, V57, P517, DOI 10.1007/s00262-007-0390-4
   Chesson CB, 2014, VACCINE, V32, P1174, DOI 10.1016/j.vaccine.2013.11.047
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Chong SF, 2009, BIOMATERIALS, V30, P5178, DOI 10.1016/j.biomaterials.2009.05.078
   Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]
   Davis HL, 2008, HUM VACCINES, V4, P246, DOI 10.4161/hv.4.3.5318
   De Geest BG, 2012, ACS NANO, V6, P2136, DOI 10.1021/nn205099c
   de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   Ding Y, 2016, J CONTROL RELEASE, V236, P22, DOI 10.1016/j.jconrel.2016.06.019
   Eby JK, 2012, ACTA BIOMATER, V8, P3210, DOI 10.1016/j.actbio.2012.06.007
   Endsley Janice J, 2009, Open Microbiol J, V3, P92, DOI 10.2174/1874285800903010092
   Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607
   Fan YC, 2015, J CONTROL RELEASE, V208, P121, DOI 10.1016/j.jconrel.2015.04.010
   Flanary S, 2009, BIOCONJUGATE CHEM, V20, P241, DOI 10.1021/bc800317a
   Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x
   Goesmann H, 2010, ANGEW CHEM INT EDIT, V49, P1362, DOI 10.1002/anie.200903053
   Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950
   Gray SM, 2014, IMMUNOL REV, V261, P157, DOI 10.1111/imr.12205
   Grenfell RFQ, 2015, CLIN VACCINE IMMUNOL, V22, P336, DOI 10.1128/CVI.00714-14
   Gupta B, 2012, J IMMUNOTHER, V35, P488, DOI 10.1097/CJI.0b013e31826183a7
   Hamdy S, 2011, PHARM RES-DORDR, V28, P2288, DOI 10.1007/s11095-011-0459-9
   Hao J, 2006, INT J NANOMED, V1, P97, DOI 10.2147/nano.2006.1.1.97
   He J, 2016, THERANOSTICS, V6, P752, DOI 10.7150/thno.14527
   Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758
   Herzog C, 2009, VACCINE, V27, P4381, DOI 10.1016/j.vaccine.2009.05.029
   Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008
   Highton AJ, 2015, IMMUNOL CELL BIOL, V93, P634, DOI 10.1038/icb.2015.14
   Hotaling NA, 2015, ANNU REV BIOMED ENG, V17, P317, DOI 10.1146/annurev-bioeng-071813-104814
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Hudalla GA, 2013, ADV HEALTHC MATER, V2, P1114, DOI 10.1002/adhm.201200435
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jagannath C, 2010, NAT MED, V16, P828, DOI 10.1038/nm0710-828b
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jimenez-Sanchez G, 2015, PHARM RES-DORDR, V32, P311, DOI 10.1007/s11095-014-1465-5
   Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238
   Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010
   Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307
   Karami Z, 2016, DRUG DISCOV TODAY, V21, P789, DOI 10.1016/j.drudis.2016.01.004
   Keller S, 2014, J CONTROL RELEASE, V191, P24, DOI 10.1016/j.jconrel.2014.03.041
   Khan TA, 2014, ACTA BIOMATER, V10, P1720, DOI 10.1016/j.actbio.2013.12.011
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Knuschke T, 2013, J IMMUNOL, V190, P6221, DOI 10.4049/jimmunol.1202654
   Kong Xiaoyuan, 2008, Allergy Asthma Clin Immunol, V4, P95, DOI 10.1186/1710-1492-4-3-95
   Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x
   Korsholm KS, 2014, VACCINE, V32, P3927, DOI 10.1016/j.vaccine.2014.05.050
   Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252
   Kwok R, 2011, NATURE, V473, P436, DOI 10.1038/473436a
   Lai SK, 2007, BIOMATERIALS, V28, P2876, DOI 10.1016/j.biomaterials.2007.02.021
   Laskar P, 2015, RSC ADV, V5, P16265, DOI 10.1039/c4ra11479e
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee PP, 1999, NAT MED, V5, P677
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Li P, 2013, J CONTROL RELEASE, V168, P271, DOI 10.1016/j.jconrel.2013.03.025
   Lieberman J, 2010, IMMUNOL REV, V235, P5, DOI 10.1111/j.0105-2896.2010.00914.x
   Lu Y, 2016, MOL THER, V24, P364, DOI 10.1038/mt.2015.165
   Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143
   Luo ZC, 2013, J CONTROL RELEASE, V170, P259, DOI 10.1016/j.jconrel.2013.05.027
   Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012
   Marradi M, 2013, CHEM SOC REV, V42, P4728, DOI 10.1039/c2cs35420a
   Milicic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034255
   Minigo G, 2007, VACCINE, V25, P1316, DOI 10.1016/j.vaccine.2006.09.086
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Moon JH, 2011, KOREAN J PARASITOL, V49, P303, DOI 10.3347/kjp.2011.49.3.303
   Moser C, 2011, EXPERT REV VACCINES, V10, P437, DOI [10.1586/erv.11.15, 10.1586/ERV.11.15]
   Motta V, 2015, PHYSIOL REV, V95, P149, DOI 10.1152/physrev.00009.2014
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005
   Niu YT, 2012, THER DELIV, V3, P1217, DOI 10.4155/TDE.12.98
   Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053
   Ochoa MT, 2001, NAT MED, V7, P174, DOI 10.1038/84620
   Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001
   Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620
   Pavot V, 2014, AIDS, V28, P1701, DOI 10.1097/QAD.0000000000000308
   Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011
   Pompano RR, 2014, ADV HEALTHC MATER, V3, P1898, DOI 10.1002/adhm.201400137
   Powell BS, 2015, CLIN EXP VACCINE RES, V4, P23, DOI 10.7774/cevr.2015.4.1.23
   Powell TJ, 2011, VACCINE, V29, P558, DOI 10.1016/j.vaccine.2010.10.001
   Rahimian S, 2015, BIOMATERIALS, V37, P469, DOI 10.1016/j.biomaterials.2014.10.043
   Rappuoli R, 2012, NAT REV IMMUNOL, V12, P225, DOI 10.1038/nri3168
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Richardson JJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2491
   Rizwan SB, 2013, J CONTROL RELEASE, V165, P16, DOI 10.1016/j.jconrel.2012.10.020
   Rizwan SB, 2011, EUR J PHARM BIOPHARM, V79, P15, DOI 10.1016/j.ejpb.2010.12.034
   Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b
   Rudra JS, 2016, ACS CHEM NEUROSCI, V7, P546, DOI 10.1021/acschemneuro.5b00345
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x
   Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030
   Schmidt ST, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8010007
   Scott EA, 2012, BIOMATERIALS, V33, P6211, DOI 10.1016/j.biomaterials.2012.04.060
   Seo SH, 2009, CLIN EXP METASTAS, V26, P179, DOI 10.1007/s10585-008-9228-5
   Sexton A, 2009, ACS NANO, V3, P3391, DOI 10.1021/nn900715g
   Sharma SK, 2006, VACCINE, V24, P1800, DOI 10.1016/j.vaccine.2005.10.025
   Siefert AL, 2016, BIOMATERIALS, V97, P85, DOI 10.1016/j.biomaterials.2016.03.039
   Sokolova V, 2015, J MATER CHEM B, V3, P4767, DOI 10.1039/c5tb00618j
   Sokolova V, 2013, ACTA BIOMATER, V9, P7527, DOI 10.1016/j.actbio.2013.02.034
   Sokolova VV, 2006, BIOMATERIALS, V27, P3147, DOI 10.1016/j.biomaterials.2005.12.030
   Stano A, 2013, BIOMATERIALS, V34, P4339, DOI 10.1016/j.biomaterials.2013.02.024
   Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11
   Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121
   Stone GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007334
   Stone J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/29/295102
   Sun T, 2016, ACTA BIOMATER, V30, P62, DOI 10.1016/j.actbio.2015.11.019
   Syed FM, 2003, VACCINE, V21, P2383, DOI 10.1016/S0264-410X(03)00106-3
   Tao WQ, 2014, NANOMEDICINE-UK, V9, P237, DOI 10.2217/nnm.13.58
   Tel J, 2013, J IMMUNOL, V191, P5005, DOI 10.4049/jimmunol.1300787
   Tong WJ, 2012, CHEM SOC REV, V41, P6103, DOI 10.1039/c2cs35088b
   Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939
   Trimaille T, 2015, VACCINES, V3, P803, DOI 10.3390/vaccines3040803
   Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979
   van Dissel JT, 2014, VACCINE, V32, P7098, DOI 10.1016/j.vaccine.2014.10.036
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Varypataki EM, 2015, AAPS J, V17, P216, DOI 10.1208/s12248-014-9686-4
   Voelter V, 2008, INT IMMUNOL, V20, P1087, DOI 10.1093/intimm/dxn066
   Wang AZ, 2008, EXPERT OPIN BIOL TH, V8, P1063, DOI [10.1517/14712590802181330, 10.1517/14712598.8.8.1063 ]
   Wang C, 2016, BIOMATERIALS, V79, P88, DOI 10.1016/j.biomaterials.2015.11.040
   Watson DS, 2012, VACCINE, V30, P5799, DOI 10.1016/j.vaccine.2012.06.061
   Wen Y, 2015, CURR OPIN IMMUNOL, V35, P73, DOI 10.1016/j.coi.2015.06.007
   Wilschut J, 2009, IMMUNOL LETT, V122, P118, DOI 10.1016/j.imlet.2008.11.006
   Wilson JT, 2013, ACS NANO, V7, P3912, DOI 10.1021/nn305466z
   Xiao FX, 2016, CHEM SOC REV, V45, P3088, DOI 10.1039/c5cs00781j
   Xu LG, 2012, NANO LETT, V12, P2003, DOI 10.1021/nl300027p
   Xu W, 2013, J DRUG DELIV, DOI 10.1155/2013/340315
   Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025
   Yan WL, 2008, J CONTROL RELEASE, V130, P22, DOI 10.1016/j.jconrel.2008.05.005
   Yan WL, 2007, MOL IMMUNOL, V44, P3672, DOI 10.1016/j.molimm.2007.04.009
   Yang L, 2016, BIOMATER SCI-UK, V4, P785, DOI 10.1039/c5bm00507h
   Yao H, 2011, MOL CANCER THER, V10, P1082, DOI 10.1158/1535-7163.MCT-10-0717
   Youngblood Ben, 2015, F1000Prime Rep, V7, P38, DOI 10.12703/P7-38
   Yu X, 2013, ASIAN PAC J TROP MED, V6, P467, DOI 10.1016/S1995-7645(13)60076-0
   Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335
   Zeng Q, 2015, J CONTROL RELEASE, V200, P1, DOI 10.1016/j.jconrel.2014.12.024
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zheng CF, 2007, BLOOD, V109, P2049, DOI 10.1182/blood-2006-03-009720
   Zhou QQ, 2016, ACS NANO, V10, P2678, DOI 10.1021/acsnano.5b07716
   Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x
NR 168
TC 5
Z9 6
U1 7
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD FEB
PY 2017
VL 3
IS 2
BP 126
EP 143
DI 10.1021/acsbiomaterials.6b00412
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA EK8UZ
UT WOS:000394201400003
DA 2018-10-20
ER

PT J
AU Rohner, NA
   Thomas, SN
AF Rohner, Nathan Andrew
   Thomas, Susan Napier
TI Flexible Macromolecule versus Rigid Particle Retention in the Injected
   Skin and Accumulation in Draining Lymph Nodes Are Differentially
   Influenced by Hydrodynamic Size
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biodistribution; intradermal; drug delivery; lymphatic
ID DRUG-DELIVERY; DENDRITIC CELLS; IN-VIVO; CANCER-IMMUNOTHERAPY;
   TUMOR-IMMUNOTHERAPY; ANTITUMOR IMMUNITY; NANOPARTICLES; RESPONSES;
   VACCINES; TRANSPORT
AB Therapeutic immunomodulation in the skin, its draining lymph nodes, or both tissues simultaneously using an intradermal administration scheme is desirable for a variety of therapeutic scenarios. To inform how drug carriers comprising engineered biomaterials can be leveraged to improve treatment efficacy by enhancing the selective accumulation or retention of payload within these target tissues, we analyzed the influence of particle versus macromolecule hydrodynamic size on profiles of retention in the site of dermal injection as well as the corresponding extent of accumulation in draining lymph nodes and systemic off-target tissues. Using a panel of fluorescently labeled tracers comprising inert polymers that are resistant to hydrolysis and proteolytic degradation that span a size range of widely used drug carrier systems, we find that macromolecule but not rigid particle retention within the skin is size-dependent, whereas the relative dermal enrichment compared to systemic tissues increases with size for both tracer types. Additionally, macromolecules 10 nm in hydrodynamic size and greater accumulate in draining lymph nodes more extensively and selectively than particles, suggesting that intra- versus extracellular availability of delivered payload within draining lymph nodes may be influenced by both the size and form of engineered drug carriers. Our results inform how biomaterial-based drug carriers can be designed to enhance the selective exposure of formulated drug in target tissues to improve the therapeutic efficacy as well as minimize off-target effects of locoregional immunotherapy.
C1 [Rohner, Nathan Andrew; Thomas, Susan Napier] Georgia Inst Technol, George W Woodruff Sch Mech Engn, 801 Ferst Dr, Atlanta, GA 30332 USA.
   [Rohner, Nathan Andrew; Thomas, Susan Napier] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.
   [Thomas, Susan Napier] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Thomas, Susan Napier] Emory Univ, Atlanta, GA 30332 USA.
   [Thomas, Susan Napier] Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd Northeast, Atlanta, GA 30322 USA.
RP Thomas, SN (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 801 Ferst Dr, Atlanta, GA 30332 USA.; Thomas, SN (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.; Thomas, SN (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Thomas, SN (reprint author), Emory Univ, Atlanta, GA 30332 USA.; Thomas, SN (reprint author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd Northeast, Atlanta, GA 30322 USA.
EM susan.thomas@gatech.edu
RI Thomas, Susan/B-4592-2016
FU National Institutes of Health (NIH) Grant [R01CA207619]; NIH Cell and
   Tissue Engineering Training Grant [T32 GM008433]; Clinical and
   Translational Science Award Program, NIH, National Center for Advancing
   Translational Sciences [UL1TR000454]; National Science Foundation Award
   [1342194]; Department of Defense Grant [CA150523]
FX This work was supported by National Institutes of Health (NIH) Grant
   R01CA207619, the NIH Cell and Tissue Engineering Training Grant T32
   GM008433, PHS Grant UL1TR000454 from the Clinical and Translational
   Science Award Program, NIH, National Center for Advancing Translational
   Sciences, National Science Foundation Award 1342194, and Department of
   Defense Grant CA150523.
CR Arnida, 2011, EUR J PHARM BIOPHARM, V77, P417, DOI 10.1016/j.ejpb.2010.11.010
   Babu S, 2009, J BIOMED MATER RES A, V91A, P140, DOI 10.1002/jbm.a.32197
   Bippes CA, 2006, EUR BIOPHYS J BIOPHY, V35, P287, DOI 10.1007/s00249-005-0023-9
   Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209
   CORNELL RC, 1990, J AM ACAD DERMATOL, V23, P694, DOI 10.1016/0190-9622(90)70276-N
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   EDWARDS L, 1990, J AM ACAD DERMATOL, V22, P496, DOI 10.1016/0190-9622(90)70070-X
   Egilmez NK, 1998, CANCER IMMUNOL IMMUN, V46, P21, DOI 10.1007/s002620050455
   Fan YC, 2015, VACCINES, V3, P662, DOI 10.3390/vaccines3030662
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Fransen MF, 2013, INT J CANCER, V132, P1971, DOI 10.1002/ijc.27755
   Fromen CA, 2015, P NATL ACAD SCI USA, V112, P488, DOI 10.1073/pnas.1422923112
   Gillies SD, 2011, CLIN CANCER RES, V17, P3673, DOI 10.1158/1078-0432.CCR-10-2921
   Guo D, 2014, LANGMUIR, V30, P7206, DOI 10.1021/la501485e
   Hatzifoti C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002368
   Hotaling NA, 2015, ANNU REV BIOMED ENG, V17, P317, DOI 10.1146/annurev-bioeng-071813-104814
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jeanbart L, 2014, CANCER IMMUNOL RES, V2, P436, DOI 10.1158/2326-6066.CIR-14-0019-T
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   Kamath AT, 2002, BLOOD, V100, P1734
   Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   Lawler S. E., 2016, JAMA ONCOLOGY
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Longmire MR, 2011, BIOCONJUGATE CHEM, V22, P993, DOI 10.1021/bc200111p
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   MEHVAR R, 1995, J PHARM SCI, V84, P815, DOI 10.1002/jps.2600840706
   Melder RJ, 2005, CANCER IMMUNOL IMMUN, V54, P535, DOI 10.1007/s00262-004-0624-7
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Muraoka D, 2014, ACS NANO, V8, P9209, DOI 10.1021/nn502975r
   Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127
   Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]
   Peiris PM, 2015, CANCER RES, V75, P1356, DOI 10.1158/0008-5472.CAN-14-1540
   Platt AM, 2013, J IMMUNOL, V190, P4608, DOI 10.4049/jimmunol.1202600
   Radiom M, 2013, J APPL PHYS, V113, DOI 10.1063/1.4772646
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Rao DA, 2010, J PHARM SCI-US, V99, P2018, DOI 10.1002/jps.21970
   Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006
   Rohner NA, 2016, J CONTROL RELEASE, V223, P99, DOI 10.1016/j.jconrel.2015.12.027
   Ruiz P, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210506
   Sabel MS, 2004, ANN SURG ONCOL, V11, P147, DOI 10.1245/ASO.2004.03.022
   Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105
   Shah PP, 2012, BIOMATERIALS, V33, P1607, DOI 10.1016/j.biomaterials.2011.11.011
   Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112
   Sun BB, 2013, ACS NANO, V7, P10834, DOI 10.1021/nn404211j
   Thomas SN, 2016, ANNU REV BIOMED ENG, V18, P207, DOI 10.1146/annurev-bioeng-101515-014413
   Thomas SN, 2015, CURR OPIN CHEM ENG, V7, P65, DOI 10.1016/j.coche.2014.11.003
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545
   Uto Tomofumi, 2013, Results Immunol, V3, P1, DOI 10.1016/j.rinim.2012.11.002
   Wang C, 2016, NANO LETT, V16, P2334, DOI 10.1021/acs.nanolett.5b05030
   Weber JS, 2015, NAT BIOTECHNOL, V33, P44, DOI 10.1038/nbt.3119
   Wu F, 2012, PHARM RES-DORDR, V29, P1843, DOI 10.1007/s11095-012-0708-6
   Xu ZH, 2013, J CONTROL RELEASE, V172, P259, DOI 10.1016/j.jconrel.2013.08.021
   Zaharoff DA, 2010, J IMMUNOTHER, V33, P697, DOI 10.1097/CJI.0b013e3181eb826d
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j
   Zhuang Y, 2012, J CONTROL RELEASE, V159, P135, DOI 10.1016/j.jconrel.2011.12.017
NR 61
TC 5
Z9 5
U1 1
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD FEB
PY 2017
VL 3
IS 2
BP 153
EP 159
DI 10.1021/acsbiomaterials.6b00438
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EK8UZ
UT WOS:000394201400005
PM 29888321
DA 2018-10-20
ER

PT J
AU Dawson, E
   Leleux, JA
   Pradhan, P
   Roy, K
AF Dawson, Eileen
   Leleux, Jardin A.
   Pradhan, Pallab
   Roy, Krishnendu
TI Surface-Presentation of CpG and Protein-Antigen on Pathogen-Like Polymer
   Particles Generate Strong Prophylactic and Therapeutic Antitumor
   Protection
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE microparticles; PLGA; polyethylenimine; vaccines; immunotherapy; TLR9;
   cancer
ID B-CELL LYMPHOMA; DENDRITIC CELLS; DELIVERY-SYSTEMS; BIODEGRADABLE
   MICROPARTICLES; IMMUNE-RESPONSES; P40 HOMODIMER; DNA VACCINES;
   CO-DELIVERY; RECEPTOR; SIRNA
AB Despite significant efforts, development of clinically relevant prophylactic and therapeutic cancer vaccines has proven challenging. Cancer-associated antigens, which are often self antigens, do not activate innate immune cells sufficiently, underscoring the need for codelivery of appropriate immune stimulatory adjuvants. Recent research has underscored the need for biomaterial-based carriers for vaccine delivery, not only to target antigens and adjuvants to antigen-presenting cells or to create "depot" like systems but also to avoid acute systemic toxicity of molecular adjuvants that occurs when adjuvants are delivered in their "naked" form. The work presented here focuses on surface presentation of both antigens and adjuvants on a pathogen-like particle (PLP) platform and understanding how PLP-induced antitumor responses differ when protein antigens and adjuvants, specifically the TLR9 agonist CpG, are delivered on the surface of the same particle (dual-loaded) versus being codelivered on separate particles. Surface-presentation allows easier access of antigens and adjuvants to intracellular targets (e.g., to TLR9 in the phagosomal compartments) and also allows controlled multivalent presentation. Our results show that, surface presentation, as opposed to soluble molecules, was more efficient in activating dendritic cells (DCs) and polarizing them toward generating a stronger cytotoxic T cell response. Signaling and DC polarization between separate and dual-loaded particles were similar, although NF-kappa B signaling at higher doses was stronger in dual-loaded PLPs. In vivo, dual loaded PLPs performed better than separately loaded PLPs in a prophylactic tumor model of melanoma and were comparable to immunization using incomplete Freud's adjuvant (IFA). In contrast both PLP-based delivery modalities performed similarly in a therapeutic melanoma-vaccine model and significantly outperformed IFA-based vaccination. These results indicate that surface-presentation of antigens and adjuvants on polymer-particles is a promising modality for efficient anticancer vaccines.
C1 [Dawson, Eileen] Univ Texas Austin, Austin, TX 78712 USA.
   [Leleux, Jardin A.; Pradhan, Pallab; Roy, Krishnendu] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Leleux, Jardin A.; Pradhan, Pallab; Roy, Krishnendu] Emory Univ, Parker H Petit Inst Bioengn & Biosci, Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Roy, K (reprint author), Georgia Inst Technol, Georgia Tech & Emory, Parker H Petit Inst Bioengn & Biosci,Georgia Tech, Ctr Immunoengn,Wallace H Coulter Dept Biomed Engn, IBB 2314, Atlanta, GA 30332 USA.
EM krish.roy@gatech.edu
OI Pradhan, Pallab/0000-0002-6573-3024
FU Cancer Prevention and Research Institute of Texas (CPRIT); CPRIT;
   National Defense Science and Education Graduate (NDSEG); National
   Science Foundation Graduate Research Fellowship Program (NSF GRFP)
FX This work was partially supported by an individual investigator grant
   from the Cancer Prevention and Research Institute of Texas (CPRIT) as
   well as by fellowships (1) to E.D. from CPRIT and the National Defense
   Science and Education Graduate (NDSEG) fellowship programs; and (2) to
   JA.L. from the National Science Foundation Graduate Research Fellowship
   Program (NSF GRFP).
CR Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498
   Borges O, 2008, EUR J PHARM BIOPHARM, V69, P405, DOI 10.1016/j.ejpb.2008.01.019
   Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037
   Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013
   Davis HL, 1998, J IMMUNOL, V160, P870
   Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4
   Friede M, 2005, ADV DRUG DELIVER REV, V57, P325, DOI 10.1016/j.addr.2004.10.001
   GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133
   Halperin SA, 2003, VACCINE, V21, P2461, DOI 10.1016/S0264-410X(03)00045-8
   Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Kasturi SP, 2005, BIOMATERIALS, V26, P6375, DOI 10.1016/j.biomaterials.2005.03.043
   Kasturi SP, 2006, J CONTROL RELEASE, V113, P261, DOI 10.1016/j.jcornel.2006.04.006
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545
   Kim SY, 2015, ANGEW CHEM INT EDIT, V54, P8139, DOI 10.1002/anie.201501380
   Leleux J, 2013, ADV HEALTHC MATER, V2, P72, DOI 10.1002/adhm.201200268
   Li XR, 2011, EUR J PHARM BIOPHARM, V78, P107, DOI 10.1016/j.ejpb.2010.12.017
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Malyala P, 2008, J PHARM SCI-US, V97, P1155, DOI 10.1002/jps.21065
   Milacic V, 2012, ADV DEL SCI TECHNOL, P429, DOI 10.1007/978-1-4614-0554-2_21
   Pradhan P, 2014, BIOMATERIALS, V35, P5491, DOI 10.1016/j.biomaterials.2014.03.039
   Roman BS, 2009, INT ARCH ALLERGY IMM, V149, P111, DOI 10.1159/000189193
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Schmidt C, 2007, NAT BIOTECHNOL, V25, P825, DOI 10.1038/nbt0807-825
   Singh A, 2011, J CLIN TOXICOL S, V1, P1, DOI DOI 10.4172/2161-0495.S4-001
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Singh M, 2004, J PHARM SCI-US, V93, P273, DOI 10.1002/jps.10538
   Sousa CRE, 1999, IMMUNITY, V11, P637
   Vajdy M, 2004, IMMUNOL CELL BIOL, V82, P617, DOI 10.1111/j.1440-1711.2004.01288.x
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4
   Wang X, 1999, EUR J IMMUNOL, V29, P2007, DOI 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0
   Xie H, 2005, INFECT IMMUN, V73, P828, DOI 10.1028/IAI.73.2.828-833.2005
   Zhang XQ, 2007, J PHARM SCI-US, V96, P3283, DOI 10.1002/jps.20978
   Zwiorek K, 2008, PHARM RES-DORDR, V25, P551, DOI 10.1007/s11095-007-9410-5
NR 38
TC 4
Z9 4
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD FEB
PY 2017
VL 3
IS 2
BP 169
EP 178
DI 10.1021/acsbiomaterials.6b00384
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EK8UZ
UT WOS:000394201400007
DA 2018-10-20
ER

PT J
AU Thames, SF
   White, JB
   Ong, KL
AF Thames, Shelby F.
   White, Joshua B.
   Ong, Kevin L.
TI The myth: in vivo degradation of polypropylene-based meshes
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Polypropylene; Mesh; Explant analysis; Stability; Formalin fixation
ID PELVIC-ORGAN PROLAPSE; TRANSVAGINAL MESH; EXPLANTED POLYPROPYLENE;
   HERNIA MESHES; FOLLOW-UP; TISSUE; BIODEGRADATION; POLYMERS; EFFICACY;
   REPAIR
AB Polypropylene is a base polymer used in biomaterial applications, including sutures and mesh products, for the treatment of pelvic organ prolapse, stress urinary incontinence, and hernia repairs. Previous studies have dismissed the value of formulation additives employed in polypropylene, and the importance and necessity of an effective mesh explant cleaning protocol when characterizing explanted devices. However, both are critical to understanding the alleged degradation of polypropylene-based meshes.
   An effective, nondestructive, hydrolytic cleaning process, supplemented with light microscopy (LM), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) data, was used to evaluate 78 explanted Prolene meshes (with duration of implantation ranging from 0.4 to 11.7 years).
   The cleaning process exposed clean, unoxidized, nondegraded Prolene fibers with smooth surfaces and with no visible evidence of gradient-type or ductile damage. LM showed identical translucent and sometimes clear, cracked/flaking material on both blue and clear fibers, instead of clear cracked/flaking material on the clear fibers and blue cracked/flaking material on the blue fibers. FTIR confirmed progressive protein removal and loss of protein absorption intensity after each cleaning step.
   Our effective cleaning of explanted Prolene meshes and subsequent analyses showed that they did not degrade in vivo, confirming the in vivo stability of properly formulated polypropylene. Instead, the cracked layer that some researchers have identified as degraded Prolene is an adsorbed protein-formaldehyde coating, resulting from the well-established formalin-protein fixation process, which occurs immediately upon placing an explant in formalin.
C1 [Thames, Shelby F.] Univ Southern Mississippi, Hattiesburg, MS USA.
   [White, Joshua B.; Ong, Kevin L.] Exponent Inc, 3440 Market St,Suite 600, Philadelphia, PA 19104 USA.
RP Ong, KL (reprint author), Exponent Inc, 3440 Market St,Suite 600, Philadelphia, PA 19104 USA.
EM kong@exponent.com
FU Ethicon, Inc.
FX Although no company directly funded this manuscript, the manuscript was
   based on findings from earlier work that was paid for by Ethicon, Inc.
CR Al-Malaika S, 1999, POLYPROPYLENE A Z RE
   Altman D, 2011, NEW ENGL J MED, V364, P1826, DOI 10.1056/NEJMoa1009521
   American Society for Testing and Materials, 2005, F56105A ASTM
   American Urogynecologic Society, 2013, POS STAT RESTR SURG
   Baxter RM, 2009, J BIOMED MATER RES B, V91B, P409, DOI 10.1002/jbm.b.31416
   Bhargava R, 2003, ADV POLYM SCI, V163, P137, DOI 10.1007/b11052
   Clave A, 2010, INT UROGYNECOL J, V21, P261, DOI 10.1007/s00192-009-1021-8
   Costello CR, 2007, J BIOMED MATER RES B, V83B, P44, DOI 10.1002/jbm.b.30764
   Cozad MJ, 2010, J BIOMED MATER RES B, V94B, P455, DOI 10.1002/jbm.b.31675
   Dobrin PB, 1996, J SURG RES, V61, P413, DOI 10.1006/jsre.1996.0138
   Feiner B, 2009, BJOG-INT J OBSTET GY, V116, P15, DOI 10.1111/j.1471-0528.2008.02023.x
   Gahleitner M, 1999, POLYPROPYLENE A Z RE
   Guelcher SA, 2015, INT UROGYNECOL J S1, V26, pS23
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Halaska M, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.016
   Iakovlev VV, 2017, J BIOMED MATER RES B, V105, P237, DOI 10.1002/jbm.b.33502
   Imel A, 2015, BIOMATERIALS, V73, P131, DOI 10.1016/j.biomaterials.2015.09.015
   Jacquetin B, 2010, INT UROGYNECOL J, V21, P1455, DOI 10.1007/s00192-010-1223-0
   Julian TM, 1996, AM J OBSTET GYNECOL, V175, P1472, DOI 10.1016/S0002-9378(96)70092-3
   Kerns MJJ, 2008, J CUTAN PATHOL, V35, P1093, DOI 10.1111/j.1600-0560.2007.00943.x
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Kyriakides TR, 2015, HOST RESPONSE BIOMAT
   Lester SC, 2010, MANUAL SURG PATHOLOG
   LIEBERT TC, 1976, J BIOMED MATER RES, V10, P939, DOI 10.1002/jbm.820100611
   Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015
   Miller D, 2011, FEMALE PELVIC MED RE, V17, P139, DOI 10.1097/SPV.0b013e3182175da6
   O Faolain E, 2005, VIB SPECTROSC, V38, P121, DOI 10.1016/j.vibspec.2005.02.013
   PUCHTLER H, 1985, HISTOCHEMISTRY, V82, P201, DOI 10.1007/BF00501395
   SANDERSON C, 1988, J HISTOTECHNOL, V11, P61
   Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction and American Urogynecologic Society, 2014, POS STAT MESH MID SL
   US Food and Drug Administration, 1998, SUMM SAF EFF TENS FR
   USHER FC, 1963, SURG GYNECOL OBSTET, V117, P239
   Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   Wood AJ, 2013, J MATER SCI-MATER M, V24, P1113, DOI 10.1007/s10856-013-4872-y
   Zhang Z, 1996, BIOMATERIALS, V17, P1843, DOI 10.1016/0142-9612(95)00246-4
NR 38
TC 2
Z9 2
U1 0
U2 10
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD FEB
PY 2017
VL 28
IS 2
BP 285
EP 297
DI 10.1007/s00192-016-3131-4
PG 13
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA EK9RI
UT WOS:000394261200013
PM 27600700
DA 2018-10-20
ER

PT J
AU Ansari, HM
   Niu, ZY
   Ge, C
   Dregia, SA
   Akbar, SA
AF Ansari, Haris M.
   Niu, Zhiyuan
   Ge, Chen
   Dregia, Suliman A.
   Akbar, Sheikh A.
TI Spontaneous Rippling and Subsequent Polymer Molding on Yttria-Stabilized
   Zirconia (110) Surfaces
SO ACS NANO
LA English
DT Article
DE self-assembly; nanobars; rare-earth oxides; surface patterning;
   nanoimprinting
ID GADOLINIA-DOPED CERIA; CHEMICAL SOLUTIONS; SELF-ORGANIZATION; OXIDE
   NANOSTRUCTURES; NANOWIRES; GROWTH; DIFFUSION; SHAPE; HETEROSTRUCTURES;
   NANOISLANDS
AB Spontaneous nanoripple formation on (110) surfaces of yttria-stabilized zirconia, YSZ-(110), is achieved by diffusional surface doping with rare-earth oxides. Periodic arrays of parallel nanobars separated by channels (period''similar to 100 nm) grow out of the dopant sources, covering relatively wide areas of the surface (-10 mu m). The nanobars mound up on the surface by diffusion, exhibiting morphological uniformity and alignment, with their long axis lying parallel to the [110] direction in the YSZ-(110) surface. The process for forming these nanobar arrays can be as simple as sprinkling of rare-earth oxide powder (dopant source) on YSZ-(110) surface and annealing in a high temperature air furnace. However, higher control on dopant dispersion on the surface is demonstrated with other techniques, including photolithography and inkjet printing. The ripple arrays extend anisotropically on the (110) surface, obeying the parabolic growth law, and showing principal values of the rate constant along [110] (maximum) and [001] (minimum), as expected from the symmetry of the (110) surface. The self-patterned ceramic substrates are well-suited for pattern transfer by replica molding, as illustrated by single-step molding with polydimethylsiloxane (PDMS), which is a widely used biomaterial in cell-culture studies.
C1 [Ansari, Haris M.; Niu, Zhiyuan; Ge, Chen; Dregia, Suliman A.; Akbar, Sheikh A.] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
   [Ansari, Haris M.] NUST, Sch Chem & Mat Engn, H-12, Islamabad, Pakistan.
RP Akbar, SA (reprint author), Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
EM akbar.1@osu.edu
OI Ansari, Haris/0000-0002-7321-5358; Akbar, Sheikh/0000-0003-3567-274X
FU OSU Institute for Materials Research (IMR); Fulbright - HEC Pakistan
   Scholarship Program
FX This work was supported in part by the OSU Institute for Materials
   Research (IMR) and the Fulbright - HEC Pakistan Scholarship Program.
CR Aminuddin NI, 2016, MATER DESIGN, V94, P274, DOI 10.1016/j.matdes.2015.12.173
   Ansari HM, 2013, CERAM INT, V39, P9749, DOI 10.1016/j.ceramint.2013.05.014
   Ansari HM, 2013, NANO LETT, V13, P2116, DOI 10.1021/nl4005282
   Aqua JN, 2013, PHYS REP, V522, P59, DOI 10.1016/j.physrep.2012.09.006
   ASARO RJ, 1972, METALL TRANS, V3, P1789, DOI 10.1007/BF02642562
   Azad S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1894615
   Ballabio G, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075417
   Bekale VM, 2006, DEFECT DIFFUS FORUM, V258-260, P46, DOI 10.4028/www.scientific.net/DDF.258-260.46
   Bergamaschini R, 2016, ADV PHYS-X, V1, P331, DOI 10.1080/23746149.2016.1181986
   Carretero-Genevrier A, 2014, CHEM SOC REV, V43, P2042, DOI 10.1039/c3cs60288e
   Carretero-Genevrier A, 2012, CHEM COMMUN, V48, P6223, DOI 10.1039/c2cc31367g
   Chai J, 2007, NAT NANOTECHNOL, V2, P500, DOI 10.1038/nnano.2007.227
   Chen WH, 2005, J AM CHEM SOC, V127, P5014, DOI 10.1021/ja042617c
   Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Drucker J, 2002, IEEE J QUANTUM ELECT, V38, P975, DOI 10.1109/JQE.2002.800962
   EAGLESHAM DJ, 1990, PHYS REV LETT, V64, P1943, DOI 10.1103/PhysRevLett.64.1943
   Esch F, 2005, SCIENCE, V309, P752, DOI 10.1126/science.1111568
   Fabrichnaya O, 2005, J PHASE EQUILIB DIFF, V26, P591, DOI 10.1361/154770305X74395
   Garcia-Barriocanal J, 2008, SCIENCE, V321, P676, DOI 10.1126/science.1156393
   Garzon FH, 2000, SOLID STATE IONICS, V136, P633, DOI 10.1016/S0167-2738(00)00348-9
   Gibert M, 2007, ADV MATER, V19, P3937, DOI 10.1002/adma.200700361
   Gibert M, 2011, CRYSTENGCOMM, V13, P6719, DOI 10.1039/c1ce05533j
   Gibert M, 2010, SMALL, V6, P2716, DOI 10.1002/smll.201001237
   Grinfeld M. A., 1986, PHYS DOKL, V31, P831
   INGEL RP, 1988, J AM CERAM SOC, V71, P265, DOI 10.1111/j.1151-2916.1988.tb05858.x
   INGEL RP, 1986, J AM CERAM SOC, V69, P325, DOI 10.1111/j.1151-2916.1986.tb04741.x
   Jung YS, 2010, NANO LETT, V10, P3722, DOI 10.1021/nl1023518
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Li A, 2000, PHYS REV LETT, V85, P1922, DOI 10.1103/PhysRevLett.85.1922
   Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Madey TE, 2008, CHEM SOC REV, V37, P2310, DOI 10.1039/b719551f
   MO YW, 1990, PHYS REV LETT, V65, P1020, DOI 10.1103/PhysRevLett.65.1020
   Norton DP, 1996, SCIENCE, V274, P755, DOI 10.1126/science.274.5288.755
   Obeid E, 2014, SOLID STATE IONICS, V262, P253, DOI 10.1016/j.ssi.2013.12.015
   Obradors X, 2014, CHEM SOC REV, V43, P2200, DOI 10.1039/c3cs60365b
   Parikh KS, 2012, MAT SCI ENG C-MATER, V32, P2469, DOI 10.1016/j.msec.2012.07.028
   Persichetti L, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075315
   Queralto A, 2016, RSC ADV, V6, P97226, DOI 10.1039/c6ra23717g
   Queralto A, 2017, CRYST GROWTH DES, V17, P504, DOI 10.1021/acs.cgd.6b01358
   Rauscher MD, 2008, ADV MATER, V20, P1699, DOI 10.1002/adma.200701383
   Sata N, 2000, NATURE, V408, P946, DOI 10.1038/35050047
   Shriram R., 2009, J VAC SCI TECHNOL A, V27, P1126
   Taylor MA, 2004, SOLID STATE IONICS, V173, P51, DOI 10.1016/j.ssi.2004.07.051
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   TERSOFF J, 1993, PHYS REV LETT, V70, P2782, DOI 10.1103/PhysRevLett.70.2782
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zabaleta J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025302
   Zhang JJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.085502
   Zhang KHL, 2010, NANO LETT, V10, P3740, DOI 10.1021/nl102403t
   Zheng H, 2004, SCIENCE, V303, P661, DOI 10.1126/science.1094207
   Zhou T, 2015, NANOSCALE, V7, P5835, DOI 10.1039/c4nr07433e
   Zimmerman LB, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/4/045304
   Zorlutuna P, 2009, ACTA BIOMATER, V5, P2451, DOI 10.1016/j.actbio.2009.03.027
NR 55
TC 0
Z9 0
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD FEB
PY 2017
VL 11
IS 2
BP 2257
EP 2265
DI 10.1021/acsnano.7b00081
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EM5NC
UT WOS:000395357300122
PM 28165701
DA 2018-10-20
ER

PT J
AU Chiang, YC
   Lin, HP
   Chang, HH
   Cheng, YW
   Tang, HY
   Yen, WC
   Lin, PY
   Chang, KW
   Lin, CP
AF Chiang, Yu-Chih
   Lin, Hong -Ping
   Chang, Hao-Hueng
   Cheng, Ya-Wen
   Tang, Hsin-Yen
   Yen, Wei -Ching
   Lin, Po -Yen
   Chang, Kei-Wen
   Lin, Chun-Pin
TI A Mesoporous Silica Biomaterial for Dental Biomimetic Crystallization
   (vol 8, pg 12502, 2014)
SO ACS NANO
LA English
DT Correction
CR Chiang YC, 2014, ACS NANO, V8, P12502, DOI 10.1021/nn5053487
NR 1
TC 1
Z9 1
U1 3
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD FEB
PY 2017
VL 11
IS 2
BP 2305
EP 2305
DI 10.1021/acsnano.7b00761
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EM5NC
UT WOS:000395357300127
PM 28199081
DA 2018-10-20
ER

PT J
AU Singh, N
   Sharma, M
   Mondal, D
   Pereira, MM
   Prasad, K
AF Singh, Nripat
   Sharma, Mukesh
   Mondal, Dibyendu
   Pereira, Matheus M.
   Prasad, Kamalesh
TI Very High Concentration Solubility and Long-Term Stability of DNA in an
   Ammonium-Based Ionic Liquid: A Suitable Medium for Nucleic Acid
   Packaging and Preservation
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE DNA; Solubility; Ionic liquid; Docking; Long-term stability
ID CHEMICAL-STABILITY; DISSOLUTION; SOLVENTS; EXTRACTION; CHITIN; GROOVE
AB Packaging as well as preservation of DNA in nonaqueous media at ambient conditions for long durations is an important research endeavor considering the biomacromolecule as nanoscale substrate for functional biomaterial design and for biotechnological applications. From this perspective, the present work reports both very high concentration dissolution and packaging of DNA in an ionic liquid (IL) without affecting the structural integrity of the biopolymer upon long-term storage. 2-Hydroxyethylammonium formate (2-HEAF), which is an ammonium based IL was able to solubilize 25% w/w of DNA (salmon testes) within 12 h at 25 C. The solubilized DNA in the IL showed long-term chemical and structural stability upon storage under ambient conditions for more than 1 year, which makes the IL a suitable medium for nucleic acid preservation. From isothermal calorimetric (ITC) studies it was evident that the hydrogen bond formed between the IL and DNA was responsible for the high concentration solubility and extended stability, unlike earlier observations for choline based ILs, where both the electrostatic interactions and hydrogen bond were collectively found to be responsible for the phenomenon. Upon auto DNA docking analyses, higher preference for minor-groove over major-groove binding on DNA structure was observed for the IL, and it showed strong ability to promote hydrogen bonding with nucleic acids.
C1 [Singh, Nripat; Sharma, Mukesh; Mondal, Dibyendu; Prasad, Kamalesh] Cent Salt & Marine Chem Res Inst, CSIR, Nat Prod & Green Chem Div, Gijubhai Badheka Marg, Bhavnagar 364002, Gujarat, India.
   [Singh, Nripat; Sharma, Mukesh; Mondal, Dibyendu; Prasad, Kamalesh] Cent Salt & Marine Chem Res Inst, AcSIR, Gijubhai Badheka Marg, Bhavnagar 364002, Gujarat, India.
   [Sharma, Mukesh; Mondal, Dibyendu; Pereira, Matheus M.] Univ Aveiro, Dept Chem, CICECO, Aveiro Inst Mat, P-3810193 Aveiro, Portugal.
RP Prasad, K (reprint author), Cent Salt & Marine Chem Res Inst, CSIR, Nat Prod & Green Chem Div, Gijubhai Badheka Marg, Bhavnagar 364002, Gujarat, India.; Prasad, K (reprint author), Cent Salt & Marine Chem Res Inst, AcSIR, Gijubhai Badheka Marg, Bhavnagar 364002, Gujarat, India.
EM kamlesh@csmcri.org
RI Pereira, Matheus/L-8064-2016
OI Pereira, Matheus/0000-0003-3524-6900; Mondal,
   Dibyendu/0000-0002-1715-5514; Sharma, Mukesh/0000-0002-3438-3367
FU CSIR, New Delhi; UGC; CSIR; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior-Capes [2740-13-3]
FX K.P. thanks CSIR, New Delhi, for the grant of CSIR-Young Scientist
   Awardees Project and overall financial support. N.S., MS., and D.M.
   thank UGC and CSIR for NET-JRF and SRF fellowships and AcSIR for PhD
   registration. Analytical and centralized instrument facility division of
   the institute is acknowledged for overall analytical support. M.M.P.
   acknowledges the PhD grant (2740-13-3) and financial support from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Capes. Dr.
   Vishal Gupta is acknowledged for his help extended during agarose-gel
   electrophoresis and PCR amplification work. Gopal Bhojani is
   acknowledged for his help extended during determination of melting point
   of DNA. This is CSIR-CSMCRI communication No. 167/2016.
CR Bicak N, 2005, J MOL LIQ, V116, P15, DOI 10.1016/j.molliq.2004.03.006
   Cardoso L, 2011, CHEMPHYSCHEM, V12, P275, DOI 10.1002/cphc.201000645
   Chandran A, 2012, J AM CHEM SOC, V134, P20330, DOI 10.1021/ja304519d
   Clark KD, 2016, RSC ADV, V6, P39846, DOI 10.1039/c6ra05932e
   Clark KD, 2015, ANAL CHEM, V87, P1552, DOI 10.1021/ac504260t
   Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200
   Gupta V, 2011, AQUACULTURE, V318, P389, DOI 10.1016/j.aquaculture.2011.06.009
   Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321
   Hud NV, 1999, J MOL BIOL, V286, P651, DOI 10.1006/jmbi.1998.2513
   Jaumot J, 2012, CURR PHARM DESIGN, V18, P1900, DOI 10.2174/138161212799958486
   LaBean TH, 2007, NANO TODAY, V2, P26, DOI 10.1016/S1748-0132(07)70056-7
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Mamajanov I, 2010, ANGEW CHEM INT EDIT, V49, P6310, DOI 10.1002/anie.201001561
   Mantz RA, 2007, Z NATURFORSCH A, V62, P275
   Markarian SA, 2006, BIOPOLYMERS, V82, P1, DOI 10.1002/bip.20454
   Mondal D, 2013, CHEM COMMUN, V49, P9606, DOI 10.1039/c3cc45849k
   MORRIS ER, 1980, CARBOHYD RES, V81, P305, DOI 10.1016/S0008-6215(00)85661-X
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mukesh C, 2013, CHEM COMMUN, V49, P6849, DOI 10.1039/c3cc42829j
   Papadopoulou AA, 2016, GREEN CHEM, V18, P1147, DOI 10.1039/c5gc02381e
   Prasad K, 2010, POLYM COMPOSITE, V31, P799, DOI 10.1002/pc.20862
   Prasad K, 2009, INT J BIOL MACROMOL, V45, P221, DOI 10.1016/j.ijbiomac.2009.05.004
   Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   SADHU C, 1984, J BIOSCIENCE, V6, P817, DOI 10.1007/BF02716841
   Saenger W., 1984, PRINCIPLES NUCL STRU
   Schiffels D, 2013, ACS NANO, V7, P6700, DOI 10.1021/nn401362p
   Sharma M, 2015, RSC ADV, V5, P40546, DOI 10.1039/c5ra03512k
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Teng ZG, 2009, J MATER CHEM, V19, P1811, DOI 10.1039/b812367e
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vijayaraghavan R, 2010, ANGEW CHEM INT EDIT, V49, P1631, DOI 10.1002/anie.200906610
   Wang H, 2012, CHEM SOC REV, V41, P1519, DOI 10.1039/c2cs15311d
   Wang JH, 2007, ANAL CHEM, V79, P620, DOI 10.1021/ac061145c
   Wang WT, 2010, J MACROMOL SCI B, V49, P528, DOI 10.1080/00222341003595634
   Yang DY, 2010, WIRES NANOMED NANOBI, V2, P648, DOI 10.1002/wnan.111
   Yuan XL, 2007, J CHEM ENG DATA, V52, P596, DOI 10.1021/je060479w
   Zhao H, 2015, J CHEM TECHNOL BIOT, V90, P19, DOI 10.1002/jctb.4511
NR 38
TC 3
Z9 3
U1 4
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD FEB
PY 2017
VL 5
IS 2
BP 1998
EP 2005
DI 10.1021/acssuschemeng.6602842
PG 8
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA EK0RK
UT WOS:000393634600087
DA 2018-10-20
ER

PT J
AU Altmann, B
   Rabel, K
   Kohal, RJ
   Proksch, S
   Tomakidi, P
   Adolfsson, E
   Bernsmann, F
   Palmero, P
   Furderer, T
   Steinberg, T
AF Altmann, Brigitte
   Rabel, Kerstin
   Kohal, Ralf J.
   Proksch, Susanne
   Tomakidi, Pascal
   Adolfsson, Erik
   Bernsmann, Falk
   Palmero, Paola
   Fuerderer, Tobias
   Steinberg, Thorsten
TI Cellular transcriptional response to zirconia-basedimplant materials
SO DENTAL MATERIALS
LA English
DT Article
DE Alveolar bone osteoblasts; Gingiva fibroblasts; Gene profiling; Zirconia
   composite; Dental implants
ID COLONY-STIMULATING FACTOR; SOFT-TISSUE INTEGRATION; SURFACE-TOPOGRAPHY;
   GENE-EXPRESSION; HUMAN OSTEOBLASTS; ALVEOLAR BONE; IN-VITRO; GM-CSF;
   TITANIUM; PATHWAY
AB Objective. To adequately address clinically important issues such as osseointegration and soft tissue integration, we screened for the direct biological cell response by culturing human osteoblasts and gingival fibroblasts on novel zirconia-based dental implant biomaterials and subjecting them to transcriptional analysis.
   Methods. Biomaterials used for osteoblasts involved micro-roughened surfaces made of a new type of ceria-stabilized zirconia composite with two different topographies, zirco-nium dioxide, and yttria-stabilized zirconia (control). For fibroblasts smooth ceria-and yttria-stabilized zirconia surface were used. The expression of 90 issue-relevant genes was determined on mRNA transcription level by real-time PCR Array technology after growth periods of 1 and 7 days.
   Results. Generally, modulation of gene transcription exhibited a dual dependence, first by time and second by the biomaterial, whereas biomaterial-triggered changes were pre dominantly caused by the biomaterials' chemistry rather than surface topography. Per se, modulated genes assigned to regenerative tissue processes such as fracture healing and wound healing and in detail included colony stimulating factors (CSF2 and CSF3), growth factors, which regulate bone matrix properties (e.g. BMP3 and TGFB1), osteogenic BMPs (BMP2/4/6/7) and transcription factors (RUNX2 and SP7), matrix collagens and osteocalcin, laminins as well as integrin 1 and MMP-
   Significance. With respect to the biomaterials under study, the screening showed that a new zirconia-based composite stabilized with ceria may be promising to provide clinically desired periodontal tissue integration. Moreover, by detecting biomarkers modulated in a time-and/or biomaterial-dependent manner, we identified candidate genes for the targeted analysis of cell-implant bioresponse during biomaterial research and development. (C) 2016 The Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Altmann, Brigitte; Rabel, Kerstin; Kohal, Ralf J.] Univ Med Ctr Freiburg, Dept Prosthet Dent, Hugstetter Str 55, D-79106 Freiburg, Germany.
   [Altmann, Brigitte] Univ Med Ctr Freiburg, Dept Oral & Maxillofacial Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.
   [Rabel, Kerstin; Tomakidi, Pascal; Steinberg, Thorsten] Univ Med Ctr Freiburg, Dept Oral Biotechnol, Hugstetter Str 55, D-79106 Freiburg, Germany.
   [Proksch, Susanne] Univ Med Ctr Freiburg, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.
   [Adolfsson, Erik] Swerea IVF AB, Argongatan 30, S-43153 Molndal, Sweden.
   [Bernsmann, Falk] NTTF Coatings GmbH, Maarweg 30, D-53619 Rheinbreitbach, Germany.
   [Palmero, Paola] Politecn Torino, LINCE Lab, INSTM RU PoliTO, Dept Appl Sci & Technol, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
   [Fuerderer, Tobias] MOESCHTER Grp Holding GmbH & Co KG, Hesslingsweg 65-67, D-44309 Dortmund, Germany.
RP Altmann, B (reprint author), Univ Med Ctr Freiburg, Dept Oral & Maxillofacial Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM Brigitte.altmann@uniklinik-freiburg.de
OI Kohal, Ralf/0000-0001-7095-4190
FU European Community [280741]
FX This study has been performed within the LONGLIFE project and received
   funding from the European Community's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. 280741.
CR Altmann B, 2013, TISSUE ENG PART C-ME, V19, P850, DOI [10.1089/ten.tec.2012.0695, 10.1089/ten.TEC.2012.0695]
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026
   Bartold PM, 2000, PERIODONTOL 2000, V24, P28, DOI 10.1034/j.1600-0757.2000.2240103.x
   Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008
   Daluiski A, 2001, NAT GENET, V27, P84
   Davies John E, 2003, J Dent Educ, V67, P932
   Denry I, 2010, MATERIALS, V3, P351, DOI 10.3390/ma3010351
   Fujii Y, 2003, FEBS LETT, V539, P45, DOI 10.1016/S0014-5793(03)00182-0
   Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037
   Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686
   Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z
   Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314
   Lieu S, 2011, DIS MODEL MECH, V4, P203, DOI 10.1242/dmm.006304
   Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577
   Lisignoli G, 2004, J CELL PHYSIOL, V198, P388, DOI 10.1002/jcp.10427
   Lu ZF, 2010, BIOCHEM BIOPH RES CO, V394, P323, DOI 10.1016/j.bbrc.2010.02.178
   Mandelin J, 2006, BONE, V38, P769, DOI 10.1016/j.bone.2005.10.017
   Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Noel D, 2003, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74
   Palmero P, 2015, BIOMATERIALS, V50, P38, DOI 10.1016/j.biomaterials.2015.01.018
   Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519
   Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451
   Poniatowski LA, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/137823
   Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Salvi GE, 2015, PERIODONTOL 2000, V68, P135, DOI 10.1111/prd.12054
   Schulz S, 2012, TISSUE ENG PART C-ME, V18, P785, DOI 10.1089/ten.tec.2012.0027
   Schulz SD, 2015, DENT MATER, V31, P1321, DOI 10.1016/j.dental.2015.08.157
   Sfeir C, BONE AND REPAIR
   Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x
   Takamatsu Y, 1998, BLOOD, V92, P3465
   TANAKA Y, 1995, J BONE MINER RES, V10, P1462
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tomakidi P, 1998, CELL TISSUE RES, V292, P355, DOI 10.1007/s004410051066
   Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4
   Valles G, 2008, J BIOMED MATER RES A, V84A, P324, DOI 10.1002/jbm.a.31315
   Wang W, 2013, BIOMATERIALS, V34, P631, DOI 10.1016/j.biomaterials.2012.10.021
   Wataha JC, 2004, J BIOMED MATER RES B, V69B, P11, DOI 10.1002/jbm.b.20029
   Wataha JC, 2012, DENT MATER, V28, P23, DOI 10.1016/j.dental.2011.08.595
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yang HY, 2013, MOL CELL PROTEOMICS, V12, P2674, DOI 10.1074/mcp.M112.026740
   Yoshimura Y, 2001, J BONE MINER RES, V16, P876, DOI 10.1359/jbmr.2001.16.5.876
NR 46
TC 3
Z9 3
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD FEB
PY 2017
VL 33
IS 2
BP 241
EP 255
DI 10.1016/j.dental.2016.12.005
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA EO0TB
UT WOS:000396409800016
PM 28087075
DA 2018-10-20
ER

PT J
AU Lalhmunsiama
   Gupta, PL
   Jung, H
   Tiwari, D
   Kong, SH
   Lee, SM
AF Lalhmunsiama
   Gupta, Prabuddha L.
   Jung, Hyunhoon
   Tiwari, Diwakar
   Kong, Sung-Ho
   Lee, Seung-Mok
TI Insight into the mechanism of Cd(II) and Pb(II) removal by sustainable
   magnetic biosorbent precursor to Chlorella vulgaris
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Chlorella vulgaris; Fe3O4; XPS; Magnetic biomaterial; Toxic metal ions
ID HEAVY-METAL IONS; ENHANCED ADSORPTION; AQUEOUS-SOLUTION; BIOSORPTION;
   CADMIUM; WASTE; OXIDE; BIOCHAR; SULFATE; BIOMASS
AB Iron oxide nanoparticles were impregnated with the Chlorella vulgaris (CV) microalgae in order to obtain the magnetic biomaterial (magnetic-CV). The materials were characterized by SEM-EDX, HR-TEM, FT-IR and XPS analyses. Further, the magnetic-CV was successfully employed in the removal of Cd(II) and Pb(II) from aqueous solutions. High percentage uptakes of these two toxic ions were observed in a wide range of pH and initial sorbate concentrations. The material was found to be efficient in the rapid uptake of Cd(II)/Pb(II) from aqueous solutions. The increases in background electrolyte concentrations (i.e., 0.001-0.1 mol/L NaNO3) affected the uptake of Cd(II) to a greater extent whereas Pb(II) removal was almost unaffected. This implied that Cd(II) was sorbed with weaker forces whereas the Pb(II) ions were aggregated specifically onto the solid surface forming an inner sphere complexes. Moreover, a simultaneous sorption study inferred that Cd(II) and Pb(II) were sorbed at the different binding sites available at the hybrid biomaterial. Furthermore, the sorption mechanism discussed with FT-IR and XPS analyses has shown that Cd(II) bound with weak electrostatic forces to the dissociated carboxyl or hydroxyl groups available onto the solid surface whereas Pb(II) ions were chemically bound with the amino group of magnetic-CV. (C) 2016 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Lalhmunsiama; Lee, Seung-Mok] Catholic Kwandong Univ, Dept Environm Engn, Kangnung 210701, Gangwon Do, South Korea.
   [Gupta, Prabuddha L.; Jung, Hyunhoon] Catholic Kwandong Univ, Dept Energy & Environm Convergence Technol, Kangnung 210701, Gangwon Do, South Korea.
   [Tiwari, Diwakar] Mizoram Univ, Sch Phys Sci, Dept Chem, Aizawl 796004, Mizoram, India.
   [Kong, Sung-Ho] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
RP Lee, SM (reprint author), Catholic Kwandong Univ, Dept Environm Engn, Kangnung 210701, Gangwon Do, South Korea.; Kong, SH (reprint author), Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
EM shkong@hanyang.ac.kr; leesm@cku.ac.kr
FU Catholic Kwandong University, Gangneung, Korea [CKU-201601190001]; Korea
   Ministry of Environment (MOE) as "The advancement of scientific research
   and technological development in environmental science Program"
FX This work was supported by the research fund of Catholic Kwandong
   University, Gangneung, Korea (CKU-201601190001) and Korea Ministry of
   Environment (MOE) as "The advancement of scientific research and
   technological development in environmental science Program".
CR Akar T, 2006, BIORESOURCE TECHNOL, V97, P1780, DOI 10.1016/j.biortech.2005.09.009
   Chen T, 2015, CHEMOSPHERE, V134, P286, DOI 10.1016/j.chemosphere.2015.04.052
   Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001
   Da'na E, 2012, DESALINATION, V285, P62, DOI 10.1016/j.desal.2011.09.034
   Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Guo H, 2015, CARBOHYD POLYM, V115, P177, DOI 10.1016/j.carbpol.2014.08.041
   Guo ZZ, 2016, J TAIWAN INST CHEM E, V58, P290, DOI 10.1016/j.jtice.2015.05.041
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011
   Kumar KS, 2015, ECOTOX ENVIRON SAFE, V113, P329, DOI 10.1016/j.ecoenv.2014.12.019
   Lalhmunsiama, 2016, CHEM ENG J, V283, P1414, DOI 10.1016/j.cej.2015.08.072
   Lalhmunsiama, 2014, APPL SURF SCI, V321, P275, DOI 10.1016/j.apsusc.2014.09.200
   Lalhmunsiama, 2013, CHEM ENG J, V225, P128, DOI 10.1016/j.cej.2013.03.083
   Lee SM, 2014, ENVIRON SCI POLLUT R, V21, P3686, DOI 10.1007/s11356-013-2310-9
   Lee SM, 2012, CHEM ENG J, V195, P103, DOI 10.1016/j.cej.2012.04.075
   Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]
   Pagnanelli F, 2013, CHEM ENG J, V231, P94, DOI 10.1016/j.cej.2013.07.013
   Pradhan S, 2007, BIORESOURCE TECHNOL, V98, P595, DOI 10.1016/j.biortech.2006.02.041
   Qin H, 2015, J MAGN MAGN MATER, V381, P120, DOI 10.1016/j.jmmm.2014.12.076
   Rady MM, 2015, ECOTOX ENVIRON SAFE, V119, P178, DOI 10.1016/j.ecoenv.2015.05.008
   Rodrigues MS, 2012, J HAZARD MATER, V217, P246, DOI 10.1016/j.jhazmat.2012.03.022
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Shan RR, 2015, J HAZARD MATER, V299, P42, DOI 10.1016/j.jhazmat.2015.06.003
   Shen QH, 2013, CHEM ENG J, V228, P993, DOI 10.1016/j.cej.2013.05.074
   Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6
   Wang J, 2014, BIORESOURCE TECHNOL, V163, P374, DOI 10.1016/j.biortech.2014.04.073
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Wu SB, 2015, CHEM ENG J, V262, P1292, DOI 10.1016/j.cej.2014.10.092
   Yang GX, 2014, WATER RES, V48, P396, DOI 10.1016/j.watres.2013.09.050
   Yargic AS, 2015, J CLEAN PROD, V88, P152, DOI 10.1016/j.jclepro.2014.05.087
   Zhang Y, 2016, J TAIWAN INST CHEM E, V65, P304, DOI 10.1016/j.jtice.2016.05.023
   Zhang ZQ, 2016, J TAIWAN INST CHEM E, V60, P361, DOI 10.1016/j.jtice.2015.10.034
NR 33
TC 11
Z9 12
U1 17
U2 87
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD FEB
PY 2017
VL 71
BP 206
EP 213
DI 10.1016/j.jtice.2016.12.007
PG 8
WC Engineering, Chemical
SC Engineering
GA EL9CZ
UT WOS:000394918300023
DA 2018-10-20
ER

PT J
AU Ju, XJ
   Wang, XX
   Liu, Z
   Xie, R
   Wang, W
   Chu, LY
AF Ju, Xiaojie
   Wang, Xiaoxue
   Liu, Zhuang
   Xie, Rui
   Wang, Wei
   Chu, Liangyin
TI Red-blood-cell-shaped chitosan microparticles prepared by
   electrospraying
SO PARTICUOLOGY
LA English
DT Article
DE Chitosan microparticle; Red blood cell; Electrospraying; Solvent
   evaporation; Solvent diffusion
ID SYNTHETIC BIOMATERIAL PARTICLES; POLYMER MICROSPHERES; DELIVERY;
   NANOPARTICLES; FABRICATION; DESIGN
AB Red-blood-cell-shaped chitosan microparticles with acid-triggered dissolution and auto-fluorescence were successfully fabricated by a simple strategy combining electrospraying with a solvent diffusion process controlled by solvent evaporation. The sizes of the prepared chitosan microparticles were relatively uniform. Control of the solvent diffusion process was crucial for the formation of microparticles with concave morphology. A chitosan aqueous solution containing 20 vol% ethanol as the evaporable solvent and 30 vol% dimethyl sulfoxide as the diffusible solvent was optimal for preparation of chitosan microparticles with the desired red-blood-cell-like size and shape. These chitosan microparticles will be highly attractive for many biological and biomedical applications. (C) 2016 Chinese Society of Particuology and Institute of Process Engineering, Chinese Academy of Sciences. Published by Elsevier B.V. All rights reserved.
C1 [Ju, Xiaojie; Wang, Xiaoxue; Liu, Zhuang; Xie, Rui; Wang, Wei; Chu, Liangyin] Sichuan Univ, Sch Chem Engn, Chengdu 610065, Peoples R China.
   [Ju, Xiaojie; Xie, Rui; Wang, Wei; Chu, Liangyin] Sichuan Univ, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.
   [Ju, Xiaojie; Xie, Rui; Wang, Wei; Chu, Liangyin] Sichuan Univ, Collaborat Innovat Ctr Biomat Sci & Technol, Chengdu 610065, Peoples R China.
RP Ju, XJ (reprint author), Sichuan Univ, Sch Chem Engn, Chengdu 610065, Peoples R China.; Ju, XJ (reprint author), Sichuan Univ, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.; Ju, XJ (reprint author), Sichuan Univ, Collaborat Innovat Ctr Biomat Sci & Technol, Chengdu 610065, Peoples R China.
EM juxiaojie@scu.edu.cn
FU National Natural Science Foundation of China [21322605, 21276002,
   81321002]; Training Program of Sichuan Province Distinguished Youth
   Academic and Technology Leaders [2013JQ0035]; State Key Laboratory of
   Polymer Materials Engineering, China [sklpme2014-3-02]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 21322605, 21276002, 81321002); the Training Program of
   Sichuan Province Distinguished Youth Academic and Technology Leaders
   (Grant No. 2013JQ0035); and the State Key Laboratory of Polymer
   Materials Engineering, China (Grant No. sklpme2014-3-02).
CR Balmert SC, 2012, ADV MATER, V24, P3757, DOI 10.1002/adma.201200224
   Chaturvedi K, 2013, J CONTROL RELEASE, V165, P129, DOI 10.1016/j.jconrel.2012.11.005
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Gao JF, 2014, POLYMER, V55, P2913, DOI 10.1016/j.polymer.2014.04.033
   Gao JF, 2014, NANOSCALE, V6, P1056, DOI [10.1039/C3NR05281H, 10.1039/c3nr05281h]
   Harvestine JN, 2014, PART PART SYST CHAR, V31, P955, DOI 10.1002/ppsc.201400002
   Hayashi K, 2010, SMALL, V6, P2384, DOI 10.1002/smll.201000399
   Kozlovskaya V, 2014, ACS NANO, V8, P5725, DOI 10.1021/nn500512x
   Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101
   Lippi G, 2010, INT J SPORTS MED, V31, P75, DOI 10.1055/s-0030-1247540
   Liu L, 2011, SOFT MATTER, V7, P4821, DOI 10.1039/c0sm01393e
   Merkel TJ, 2012, J CONTROL RELEASE, V162, P37, DOI 10.1016/j.jconrel.2012.06.009
   Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Park CH, 2011, J COLLOID INTERF SCI, V361, P423, DOI 10.1016/j.jcis.2011.06.003
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   She SP, 2013, ADV MATER, V25, P5814, DOI 10.1002/adma.201302875
   Wang LH, 2011, J APPL POLYM SCI, V122, P2552, DOI 10.1002/app.34374
   Wang XX, 2015, RSC ADV, V5, P34243, DOI 10.1039/c5ra04726a
   Yao J, 2008, J AEROSOL SCI, V39, P987, DOI 10.1016/j.jaerosci.2008.07.003
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Zhang QC, 2010, COLLOID POLYM SCI, V288, P1385, DOI 10.1007/s00396-010-2273-z
NR 22
TC 5
Z9 5
U1 6
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1674-2001
EI 2210-4291
J9 PARTICUOLOGY
JI Particuology
PD FEB
PY 2017
VL 30
BP 151
EP 157
DI 10.1016/j.partic.2016.05.011
PG 7
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA EK6ZG
UT WOS:000394074200015
DA 2018-10-20
ER

PT J
AU Higuchi, A
   Kumar, SS
   Ling, QD
   Alarfaj, AA
   Munusamy, MA
   Murugan, K
   Hsu, ST
   Benelli, G
   Umezawa, A
AF Higuchi, Akon
   Kumar, S. Suresh
   Ling, Qing-Dong
   Alarfaj, Abdullah A.
   Munusamy, Murugan A.
   Murugan, Kadarkarai
   Hsu, Shih-Tien
   Benelli, Giovanni
   Umezawa, Akihiro
TI Polymeric design of cell culture materials that guide the
   differentiation of human pluripotent stem cells
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Biomaterial; Embryonic stem cell; Induced pluripotent stem cell;
   Differentiation; Hydrogel; Nanofiber
ID SUSPENDED MICROCARRIER CULTURES; ESC-DERIVED CARDIOMYOCYTES; NEURAL
   PROGENITOR CELLS; HEPATOCYTE-LIKE CELLS; TERM SELF-RENEWAL; IN-VITRO;
   DOPAMINERGIC-NEURONS; BETA-CELLS; SONIC HEDGEHOG; XENO-FREE
AB Human pluripotent stem cells (hPSCs), including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), have the potential to differentiate into many cell types that originate from the three germ layers, such as dopamine-secreting cells and insulin-secreting cells for the treatment of Alzheimer's disease and diabetes, respectively. However, it is challenging to guide hPSC differentiation into desired cell lineages due to their varying differentiation ability. A reasonable strategy is to mimic the stem cell microenvironment for the differentiation of hPSCs into specific cell lineages using optimal polymeric biomaterials for hPSC culture. This review summarizes various methods for differentiating hPSCs cultured on polymeric biomaterials and discusses the optimal methods and cell culture polymeric biomaterials for hPSC differentiation into specific cell lineages. The recent trend in protocols avoids embryoid body (EB, aggregated,cells) formation because EBs contain different types of cells. The combination of appropriate differentiation protocols and cell culture polymeric biomaterials for the differentiation of hPSCs into specific cell lineages will produce a large quantity of highly pure GMP-grade differentiated cells for use in translational medicine. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
   [Higuchi, Akon] RIKEN, Nano Med Engn Lab, 2-1 Hirosawa, Wako, Saitama 351098, Japan.
   [Higuchi, Akon; Alarfaj, Abdullah A.; Munusamy, Murugan A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Higuchi, Akon; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.
   [Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang 43400, Slangor, Malaysia.
   [Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, 32 Ln 160,Jian Cheng Rd, Taipei 221, Taiwan.
   [Ling, Qing-Dong] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, 300 Jhongda RD, Taoyuan 32001, Taiwan.
   [Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India.
   [Hsu, Shih-Tien] Taiwan Landseed Hosp, Dept Internal Med, 77 Kuangtai Rd, Taoyuan 32405, Taiwan.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
EM higuchi@ncu.edu.tw
RI Benelli, Giovanni/A-9100-2013
FU Ministry of Science and Technology, Taiwan [104-2221-E-008-107-MY3];
   LandSeed Hospital project [NCU-LSH-104-A-001, NCU-LSH-105-A-001]; Cathay
   General Hospital Project [104CGH-NCU-A3, 105CGH-NCU-A3]; Ministry of
   Education, Culture, Sports, Science, and Technology of Japan [15K06591]
FX The content of Section 2. "hPSC differentiation methods" was adapted
   from Ref. [18] from The Royal Society of Chemistry. This research was
   partially supported by the Ministry of Science and Technology, Taiwan,
   under grant number 104-2221-E-008-107-MY3. This work was also supported
   by the LandSeed Hospital project (NCU-LSH-104-A-001, NCU-LSH-105-A-001)
   and the Cathay General Hospital Project (104CGH-NCU-A3, 105CGH-NCU-A3).
   A Grant-in-Aid for Scientific Research (15K06591) from the Ministry of
   Education, Culture, Sports, Science, and Technology of Japan is also
   acknowledged. The Deanship of Scientific Research, College of Science
   Research Center, King Saud University, Kingdom of Saudi Arabia, is also
   acknowledged.
CR Abu-Absi SF, 2004, CYTOTECHNOLOGY, V45, P125, DOI 10.1007/s10616-004-7996-6
   Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849
   Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274
   Ankam S, 2015, BIOMATERIALS, V47, P20, DOI 10.1016/j.biomaterials.2015.01.003
   Arshi A, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/025003
   Bardy J, 2013, TISSUE ENG PART C-ME, V19, P166, DOI [10.1089/ten.tec.2012.0146, 10.1089/ten.TEC.2012.0146]
   Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295
   Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]
   Carlberg B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045004
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chan LY, 2013, TISSUE ENG PART C-ME, V19, P156, DOI [10.1089/ten.tec.2012.0150, 10.1089/ten.TEC.2012.0150]
   Chan LY, 2013, BIOMATERIALS, V34, P382, DOI 10.1016/j.biomaterials.2012.09.033
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen SW, 2015, BIOMATERIALS, V73, P23, DOI 10.1016/j.biomaterials.2015.09.010
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]
   Chun YW, 2015, BIOMATERIALS, V67, P52, DOI 10.1016/j.biomaterials.2015.07.004
   Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d
   D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Du C, 2014, BIOMATERIALS, V35, P6006, DOI 10.1016/j.biomaterials.2014.04.011
   Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005
   Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Farzaneh Z, 2010, STEM CELL REV REP, V6, P601, DOI 10.1007/s12015-010-9179-5
   Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007
   FERNANDEZTERAN MA, 1982, ANAT REC, V204, P137, DOI 10.1002/ar.1092040207
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gonzalez R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01463
   Gu JY, 2009, HEPATOL RES, V39, P398, DOI 10.1111/j.1872-034X.2008.00472.x
   Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181
   Hamidi S, 2014, TISSUE ENG PT A, V20, P1285, DOI [10.1089/ten.tea.2013.0149, 10.1089/ten.TEA.2013.0149]
   Hazeltine LB, 2014, ACTA BIOMATER, V10, P604, DOI 10.1016/j.actbio.2013.10.033
   Higuchi A, 2015, J MATER CHEM B, V3, P8032, DOI 10.1039/c5tb01276g
   Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Higuchi A, 2014, PROG POLYM SCI, V39, P1348, DOI 10.1016/j.progpolymsci.2014.01.002
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Hirsinger E, 1997, DEVELOPMENT, V124, P4605
   Hoganson DM, 2014, J BIOMED MATER RES A, V102, P2875, DOI 10.1002/jbm.a.34941
   Horton RE, 2012, BIOMATERIALS, V33, P6313, DOI 10.1016/j.biomaterials.2012.05.063
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111
   Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]
   Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392
   Ikonen L, 2013, BIOMED RES INT, V2013
   Jha R, 2015, BIOMATERIALS, V50, P176, DOI 10.1016/j.biomaterials.2015.01.043
   Jiang B, 2015, BIOMATERIALS, V65, P103, DOI 10.1016/j.biomaterials.2015.06.024
   Jing DH, 2010, CELL TRANSPLANT, V19, P1397, DOI 10.3727/096368910X513955
   Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005
   Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084
   Kimbrel EA, 2015, NAT REV DRUG DISCOV, V14, P681, DOI 10.1038/nrd4738
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI [10.1089/ten.tea.2009.0414, 10.1089/ten.TEA.2009.0414]
   Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103
   Lecina M, 2010, TISSUE ENG PART C-ME, V16, P1609, DOI [10.1089/ten.tec.2010.0104, 10.1089/ten.TEC.2010.0104]
   Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee TJ, 2015, TISSUE ENG PT A, V21, P374, DOI [10.1089/ten.tea.2014.0015, 10.1089/ten.TEA.2014.0015]
   Leong MF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3353
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094
   Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543
   Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622
   Lu D, 2015, TISSUE ENG PART C-ME, V21, P242, DOI [10.1089/ten.tec.2013.0725, 10.1089/ten.TEC.2013.0725]
   Lu HF, 2014, BIOMATERIALS, V35, P2816, DOI 10.1016/j.biomaterials.2013.12.050
   Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   Mak SK, 2012, STEM CELLS INT, V2012
   Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Mihic A, 2014, BIOMATERIALS, V35, P2798, DOI 10.1016/j.biomaterials.2013.12.052
   Miki T, 2011, TISSUE ENG PART C-ME, V17, P557, DOI [10.1089/ten.tec.2010.0437, 10.1089/ten.TEC.2010.0437]
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a
   Mohtaram NK, 2015, J BIOMED MATER RES A, V103, P2591, DOI 10.1002/jbm.a.35392
   Moyes KW, 2013, STEM CELLS DEV, V22, P2315, DOI 10.1089/scd.2012.0586
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Narayanan K, 2014, TISSUE ENG PT A, V20, P424, DOI [10.1089/ten.TEA.2013.0257, 10.1089/ten.tea.2013.0257]
   Nasonkin I, 2009, STEM CELLS, V27, P2414, DOI 10.1002/stem.177
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236
   Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040
   Pan F, 2013, BIOMATERIALS, V34, P8131, DOI 10.1016/j.biomaterials.2013.07.025
   Park Y, 2014, J BIOTECHNOL, V174, P39, DOI 10.1016/j.jbiotec.2014.01.025
   Patel AK, 2015, BIOMATERIALS, V61, P257, DOI 10.1016/j.biomaterials.2015.05.019
   Peng IC, 2016, BIOMATERIALS, V76, P76, DOI 10.1016/j.biomaterials.2015.10.039
   Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101
   Ramasamy TS, 2013, TISSUE ENG PT A, V19, P360, DOI 10.1089/ten.tea.2012.0190
   Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034
   Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033
   Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711
   Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112
   Ribeiro MC, 2015, BIOMATERIALS, V51, P138, DOI 10.1016/j.biomaterials.2015.01.067
   Robertson C, 2013, STEM CELLS, V31, P829, DOI 10.1002/stem.1331
   Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Saadai P, 2013, J PEDIATR SURG, V48, P158, DOI 10.1016/j.jpedsurg.2012.10.034
   Salick MR, 2014, BIOMATERIALS, V35, P4454, DOI 10.1016/j.biomaterials.2014.02.001
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369
   Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380
   Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616
   Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233
   Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029
   Tan KKB, 2015, BIOMATERIALS, V43, P32, DOI 10.1016/j.biomaterials.2014.11.036
   Tasnim F, 2015, BIOMATERIALS, V70, P115, DOI 10.1016/j.biomaterials.2015.08.002
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thowfeequ S, 2007, DIABETOLOGIA, V50, P1688, DOI 10.1007/s00125-007-0724-y
   Ting S, 2014, STEM CELL RES, V13, P202, DOI 10.1016/j.scr.2014.06.002
   Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039
   Vazin T, 2014, BIOMATERIALS, V35, P941, DOI 10.1016/j.biomaterials.2013.10.025
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039
   Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026
   Wu SM, 2012, STEM CELLS DEV, V21, P729, DOI 10.1089/scd.2011.0134
   Wu SQ, 2014, BIOMATERIALS, V35, P8496, DOI 10.1016/j.biomaterials.2014.06.039
   Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023
   Yamazoe T, 2013, J CELL SCI, V126, P5391, DOI 10.1242/jcs.129767
   Yanai A, 2013, TISSUE ENG PART C-ME, V19, P755, DOI [10.1089/ten.tec.2012.0524, 10.1089/ten.TEC.2012.0524]
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yang MY, 2015, J BIOMED NANOTECHNOL, V11, P447, DOI 10.1166/jbn.2015.2038
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zanden C, 2014, NANOMED-NANOTECHNOL, V10, P949, DOI 10.1016/j.nano.2014.01.010
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005
   Zoldan J, 2011, BIOMATERIALS, V32, P7793, DOI 10.1016/j.biomaterials.2011.06.057
NR 156
TC 15
Z9 15
U1 8
U2 68
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD FEB
PY 2017
VL 65
BP 83
EP 126
DI 10.1016/j.progpolymsci.2016.09.002
PG 44
WC Polymer Science
SC Polymer Science
GA EK8UI
UT WOS:000394199700004
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steinar
TI SEM, EDS AND XPS ANALYSIS OF NANOSTRUCTURED COATING FORMED ON NiTi
   BIOMATERIAL ALLOY BY PLASMA ELECTROLYTIC OXIDATION (PEO)
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE biomaterials; coatings; electrochemical techniques; energy dispersive
   X-ray spectroscopy (EDS); NiTi alloy; X-ray photoelectron spectroscopy
   (XPS)
ID MICRO-ARC OXIDATION; TITANIUM; ANTIBACTERIAL; SURFACE; FILMS; BEHAVIOR;
   LAYERS
AB Plasma Electrolytic Oxidation (PEO) of NiTi alloy was studied in the electrolyte consisting generally of concentrated orthophosphoric acid with an addition of copper II nitrate. The PEO process was used to obtain a nanostructured coating on the Nitinol surface. The surface layer analyses methods, such as scanning electron microscopy (SEM) with the energy-dispersive X-ray spectroscopy (EDS), and X-ray photoelectron spectroscopy (XPS), allowed determining the structure and composition of the most expected coatings and revealing the conditions for obtaining them. It was found that the porous PEO coating obtained in the electrolyte containing copper nitrate in an amount higher than 1,6 mol/L consists mainly of copper-titanium-nickel phosphates. Moreover, in comparison with matrix, the emergence of carcinogenic nickel appearing in the coating fortunately appears in very small quantities, i.e. below 1 at%.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Fac Mech Engn, Div BioEngn & Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] Norwegian Univ Sci & Technol NTNU, Dept Phys, Realfagbygget E3-124 Hgsk Ringen 5, NO-7491 Trondheim, Norway.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div BioEngn & Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   steinar.raaen@ntnu.no
CR Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2008, MATER LETT, V62, P3073, DOI 10.1016/j.matlet.2008.01.130
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Jin FY, 2006, MATER CHEM PHYS, V100, P31, DOI 10.1016/j.matchemphys.2005.12.001
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokicki R, 2015, J MATER ENG PERFORM, V24, P1634, DOI 10.1007/s11665-015-1429-x
   Rokosz K., 2016, SURFACE INTERFACE AN
   Rokosz K., 2016, WORLD SCI NEWS, V57, P289
   Rokosz K., 2016, WORLD SCI NEWS, V35, P44
   Rokosz K, 2017, INT J ADV MANUF TECH, V89, P2953, DOI 10.1007/s00170-016-9206-z
   Rokosz K, 2016, J SPECTROSC, DOI 10.1155/2016/7093071
   Rokosz K, 2016, INT J ADV MANUF TECH, V87, P3497, DOI 10.1007/s00170-016-8692-3
   Rokosz K, 2016, J NANOSCI NANOTECHNO, V16, P7814, DOI 10.1166/jnn.2016.12558
   Rokosz K, 2016, MATERIALS, V9, DOI 10.3390/ma9050318
   Rokosz K, 2016, INT J ADV MANUF TECH, V85, P2425, DOI 10.1007/s00170-015-8086-y
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
NR 29
TC 7
Z9 7
U1 2
U2 15
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD FEB
PY 2017
VL 24
IS 1
BP 193
EP 198
DI 10.17559/TV-20151021112657
PG 6
WC Engineering, Multidisciplinary
SC Engineering
GA EL3LB
UT WOS:000394519500024
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kocer, G
   Jonkheijm, P
AF Kocer, Gulistan
   Jonkheijm, Pascal
TI Guiding hMSC Adhesion and Differentiation on Supported Lipid Bilayers
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID STEM-CELL DIFFERENTIATION; PROGENITOR CELLS; MEMBRANES; BIOMATERIALS;
   MOBILITY; SURFACE; DENSITY; MATRIX; MICROENVIRONMENTS; ARCHITECTURE
AB Mesenchymal stem cells (MSCs) are intensively investigated for regenerative medicine applications due to their ease of isolation and multilineage differentiation capacity. Hence, designing instructive microenvironments to guide MSC behavior is important for the generation of smart interfaces to enhance biomaterial performance in guiding desired tissue formation. Supported lipid bilayers (SLBs) as cell membrane mimetics can be employed as biological interfaces with easily tunable characteristics such as biospecificity, mobility, and density of predesigned ligand molecules. Arg-Gly-Asp (RGD) ligand functionalized SLBs are explored for guiding human MSC (hMSC) adhesion and differentiation by studying the effect of changes in ligand density and mobility. Cellular and molecular analyses show that adhesion occurs through specific interactions with RGD ligands where the extent is positively correlated to changes in ligand density. Furthermore, cell area is significantly regulated by ligand density on ligand-mobile SLBs when compared to ligand-immobile SLBs. Finally, the osteogenic differentiation capacity of hMSCs is positively correlated to ligand density on ligand-mobile SLBs indicating that regulation of cell spreading is linked to cell differentiation capacity. These results demonstrate that hMSC behavior can be directed on SLBs by molecular design and presents SLBs as versatile platforms for future engineering of smart biomaterial coatings.
C1 [Kocer, Gulistan; Jonkheijm, Pascal] Univ Twente, MIRA Inst Biomed Technol Tech Med, Bioinspired Mol Engn Lab, NL-7500 AE Enschede, Netherlands.
   [Kocer, Gulistan; Jonkheijm, Pascal] Univ Twente, MESA Inst Nanotechnol, Mol Nanofabricat Grp, NL-7500 AE Enschede, Netherlands.
RP Jonkheijm, P (reprint author), Univ Twente, MIRA Inst Biomed Technol Tech Med, Bioinspired Mol Engn Lab, NL-7500 AE Enschede, Netherlands.; Jonkheijm, P (reprint author), Univ Twente, MESA Inst Nanotechnol, Mol Nanofabricat Grp, NL-7500 AE Enschede, Netherlands.
EM p.jonkheijm@utwente.nl
OI Jonkheijm, Pascal/0000-0001-6271-0049; Kocer,
   Gulistan/0000-0003-3449-7388
FU Netherlands Organisation for Scientific Research (NWO) [NWO-VIDI
   723.012.106]
FX The authors acknowledge the Netherlands Organisation for Scientific
   Research (NWO) (NWO-VIDI 723.012.106) for financial support. The authors
   are also thankful to Dr. Natalie Fekete for helpful discussions in
   setting up the cell experiments, and Dr. Jenny Brinkmann for her help in
   setting up the immunofluorescence analyses.
CR Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   Andreasson-Ochsner M, 2011, LAB CHIP, V11, P2876, DOI 10.1039/c1lc20067d
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Biswas KH, 2015, P NATL ACAD SCI USA, V112, P10932, DOI 10.1073/pnas.1513775112
   Brinkmann J, 2014, CHEM SOC REV, V43, P4449, DOI 10.1039/c4cs00034j
   Burk AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09370
   Campbell Iain D, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004994
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245
   Charnley M, 2012, INTEGR BIOL-UK, V4, P1059, DOI 10.1039/c2ib20111a
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010
   Evans SF, 2013, BIOMATERIALS, V34, P1878, DOI 10.1016/j.biomaterials.2012.09.024
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033
   Gonzalez-Garcia C, 2012, INTEGR BIOL-UK, V4, P531, DOI 10.1039/c2ib00139j
   Gooding JJ, 2014, LANGMUIR, V30, P3290, DOI 10.1021/la4037919
   Groves JT, 2001, LANGMUIR, V17, P5129, DOI 10.1021/la010481f
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Korner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054749
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Lee IC, 2014, ACS APPL MATER INTER, V6, P14439, DOI 10.1021/am503750w
   Lin Wan-Chen, 2010, Curr Protoc Chem Biol, V2, P235, DOI 10.1002/9780470559277.ch100131
   Lohmuller T, 2011, NANO LETT, V11, P4912, DOI 10.1021/nl202847t
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Mao AS, 2016, BIOMATERIALS, V98, P184, DOI 10.1016/j.biomaterials.2016.05.004
   Mas-Moruno C, 2016, ANGEW CHEM INT EDIT, V55, P7048, DOI 10.1002/anie.201509782
   MasMoruno C., 2016, ANGEW CHEM, V128, P7162
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   Nam JM, 2006, CHEMBIOCHEM, V7, P436, DOI 10.1002/cbic.200500479
   Oliver AE, 2009, LANGMUIR, V25, P6992, DOI 10.1021/la900166u
   Picas L, 2012, BIOPHYS J, V102, pL1, DOI 10.1016/j.bpj.2011.11.4001
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c
   Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729
   Sandrin L, 2010, ORG BIOMOL CHEM, V8, P1531, DOI 10.1039/b924523e
   Sankaran S, 2015, SMALL, V11, P6187, DOI 10.1002/smll.201502471
   Satav T, 2015, SMALL, V11, P5184, DOI 10.1002/smll.201500747
   Seo JH, 2013, J AM CHEM SOC, V135, P5513, DOI 10.1021/ja400817q
   Stabley D, 2013, INTEGR BIOL-UK, V5, P659, DOI 10.1039/c3ib20239a
   Thid D, 2007, LANGMUIR, V23, P11693, DOI 10.1021/la701159u
   van Weerd J, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600055
   van Weerd J, 2015, ADV HEALTHC MATER, V4, P2743, DOI 10.1002/adhm.201500398
   van Weerd J, 2014, J AM CHEM SOC, V136, P100, DOI 10.1021/ja411287u
   Xue RY, 2013, J ORTHOP RES, V31, P1360, DOI 10.1002/jor.22374
   Yu CH, 2012, CELL ADHES MIGR, V6, P280, DOI 10.4161/cam.20753
   Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108
NR 54
TC 3
Z9 3
U1 2
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB
PY 2017
VL 6
IS 3
AR 1600862
DI 10.1002/adhm.201600862
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA EK0CB
UT WOS:000393593000008
PM 27893196
DA 2018-10-20
ER

PT J
AU Santos, D
   Wieringa, P
   Moroni, L
   Navarro, X
   Del Valle, J
AF Santos, Daniel
   Wieringa, Paul
   Moroni, Lorenzo
   Navarro, Xavier
   Del Valle, Jaume
TI PEOT/PBT Guides Enhance Nerve Regeneration in Long Gap Defects
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID PERIPHERAL-NERVES; ELECTROSPINNING FABRICATION; MECHANICAL-PROPERTIES;
   SILICONE CHAMBERS; TISSUE FORMATION; IN-VIVO; REPAIR; CONDUITS;
   SCAFFOLDS; INJURY
AB Development of new nerve guides is required for replacing autologous nerve grafts for the repair of long gap defects after nerve injury. A nerve guide comprised only of electrospun fibers able to bridge a critical (15 mm) nerve gap in a rat animal model is reported for the first time. The nerve conduits are made of poly(ethylene oxide terephthalate) and poly(butylene terephthalate) (PEOT/PBT), a biocompatible copolymer composed of alternating amorphous, hydrophilic poly(ethylene oxide terephthalate), and crystalline, hydrophobic poly(butylene terephthalate) segments. These guides show suitable mechanical properties, high porosity, and fibers aligned in the longitudinal axis of the guide. In vitro studies show that both neurites and Schwann cells exhibit growth alignment with PA fibers. In vivo studies reveal that, after rat sciatic nerve transection and repair with PEOT/PBT guides, axons grow occupying a larger area compared to silicone tubes. Moreover, after repair of limiting (10 mm) and critical (15 mm) nerve gaps, PEOT/PBT guides significantly increase the percentage of regenerated nerves, the number of regenerated myelinated axons, and improve motor, sensory, and autonomic reinnervation in both gaps. This nerve conduit design combines the properties of PEOT/PBT with electrospun structure, demonstrating that nerve regeneration through long gaps can be achieved through the design of instructive biomaterial constructs.
C1 [Santos, Daniel; Navarro, Xavier; Del Valle, Jaume] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Bellaterra 08193, Spain.
   [Santos, Daniel; Navarro, Xavier; Del Valle, Jaume] CIBERNED, Bellaterra 08193, Spain.
   [Wieringa, Paul; Moroni, Lorenzo] Maastricht Univ, MERLN Inst, Dept Complex Tissue Regenerat, NL-6229 ER Maastricht, Netherlands.
   [Del Valle, Jaume] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, E-08193 Bellaterra, Spain.
RP Del Valle, J (reprint author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Bellaterra 08193, Spain.; Del Valle, J (reprint author), CIBERNED, Bellaterra 08193, Spain.; Del Valle, J (reprint author), Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, E-08193 Bellaterra, Spain.
EM jaume.delvalle@uab.cat
OI Navarro, Xavier/0000-0001-9849-902X; del valle,
   Jaume/0000-0002-6703-8244; Moroni, Lorenzo/0000-0003-1298-6025
FU European Union [280778, 611687]; Instituto de Salud Carlos III of Spain;
   Natural Science and Engineering Research Council of Canada (NSERC);
   Dutch Province of Limburg
FX D.S. and P.W. contributed equally to this work. This research was
   supported by the European Union FP7-NMP project MERIDIAN under contract
   number 280778 and FPT-ICT project NEBIAS under contract number 611687,
   TERCEL and CIBERNED funds from the Instituto de Salud Carlos III of
   Spain, FEDER funds, and the Natural Science and Engineering Research
   Council of Canada (NSERC). This research was also made possible with the
   support of the Dutch Province of Limburg. The authors acknowledge the
   support of Prof. Silvestro Micera, from Scuola Superiore Sant'Anna,
   Pisa, throughout this study and thank the technical help of Monica
   Espejo, Jessica Jaramillo, and Marta Morell.
CR Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Boeckstyns MEH, 2013, J HAND SURG-AM, V38A, P2405, DOI 10.1016/j.jhsa.2013.09.038
   Buitinga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064772
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Buti M, 1996, EXP NEUROL, V137, P26, DOI 10.1006/exnr.1996.0003
   Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Cobianchi S, 2014, EXP NEUROL, V255, P1, DOI 10.1016/j.expneurol.2014.02.008
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Daly WT, 2013, BIOMATERIALS, V34, P8630, DOI 10.1016/j.biomaterials.2013.07.086
   Danti S, 2015, HEARING BALANC COMMU, V13, P133, DOI 10.3109/21695717.2015.1092372
   Das S, 2015, BIOMATERIALS, V62, P66, DOI 10.1016/j.biomaterials.2015.04.047
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dinis TM, 2015, J MECH BEHAV BIOMED, V41, P43, DOI 10.1016/j.jmbbm.2014.09.029
   FERNANDEZ E, 1991, J NEUROSCI METH, V39, P271, DOI 10.1016/0165-0270(91)90106-A
   Georgeu GA, 2005, CELL TISSUE RES, V320, P229, DOI 10.1007/s00441-004-1031-2
   Gomez N, 1996, RESTOR NEUROL NEUROS, V10, P187, DOI 10.3233/RNN-1996-10401
   Gonzalez-Perez F, 2015, MICROSURG, V35, P300, DOI 10.1002/micr.22362
   Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1
   Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700
   Henley D., 2002, FOOD DRUG ADM DRUG E
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Ijpma FFA, 2008, J HAND SURG-EUR VOL, V33E, P581, DOI 10.1177/1753193408091349
   Jansen EJP, 2009, J BIOMED MATER RES A, V89A, P444, DOI 10.1002/jbm.a.31986
   Jayasinghe SN, 2013, ANALYST, V138, P2215, DOI 10.1039/c3an36599a
   Jha BS, 2011, ACTA BIOMATER, V7, P203, DOI 10.1016/j.actbio.2010.08.004
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Koh HS, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046003
   Li Y, 2014, J MECH BEHAV BIOMED, V40, P210, DOI 10.1016/j.jmbbm.2014.08.027
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036
   Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   MEIJER GJ, 1995, J ORAL REHABIL, V22, P167, DOI 10.1111/j.1365-2842.1995.tb01560.x
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Milleret V, 2011, EUR CELLS MATER, V21, P286, DOI 10.22203/eCM.v021a22
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   NAVARRO X, 1995, J NEUROSCI RES, V41, P111, DOI 10.1002/jnr.490410113
   Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570
   Ni HC, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035010
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Panahi-Joo Y, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/025017
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pinho AC, 2016, ADV HEALTHC MATER, V5, P2732, DOI 10.1002/adhm.201600236
   Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184
   Ramburrun P, 2014, BIOMED RES INT, DOI 10.1155/2014/132350
   Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   Rodriguez FJ, 1999, RESTOR NEUROL NEUROS, V14, P65
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Santos D, 2016, BRAIN RES, V1636, P93, DOI 10.1016/j.brainres.2016.01.051
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Serban MA, 2016, CURR OPIN BIOTECH, V40, P31, DOI 10.1016/j.copbio.2016.02.009
   SINGH R, 1992, SURG NEUROL, V37, P425, DOI 10.1016/0090-3019(92)90130-F
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Whitehead T. J., 2014, JOVE-J VIS EXP, V1
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Yannas IV, 2004, BIOMATERIALS, V25, P1593, DOI 10.1016/S0142-9612(03)00505-2
   Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68
   Zhu YQ, 2011, TISSUE ENG PART C-ME, V17, P705, DOI 10.1089/ten.tec.2010.0565
NR 77
TC 6
Z9 6
U1 7
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB
PY 2017
VL 6
IS 3
AR 1600298
DI 10.1002/adhm.201600298
PG 13
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA EK0CB
UT WOS:000393593000006
PM 27973708
DA 2018-10-20
ER

PT J
AU Noia, CF
   Ortega-Lopes, R
   Kluppel, LE
   de Sa, BCM
AF Noia, Claudio Ferreira
   Ortega-Lopes, Rafael
   Kluppel, Leandro Eduardo
   Martins de Sa, Bruno Costa
TI Sandwich Osteotomies to Treat Vertical Defects of the Alveolar Ridge
SO IMPLANT DENTISTRY
LA English
DT Article
DE alveolar bone loss; interpositional bone graft; dental implants
ID DENTAL IMPLANTS; AUGMENTATION
AB Purpose: To evaluate the vertical bone gain after osteotomy sandwich.
   Materials and Methods: Fourteen patients (mean age, 41 years) underwent 17 procedures of osteotomy sandwich. Of these 17 procedures, 15 involved reconstructive surgery and 2 involved the repositioning of implants. The patients were submitted to computed tomography before the surgical procedure and 4 months after the completion of the graft, with measurements taken to assess the vertical gain that had been achieved.
   Results: The results confirmed a satisfactory vertical gain in all cases (mean, 5.12 mm). The use of autogenous graft or biomaterial particles (in isolation) between the osteotomized segments proved to be viable. Three patients reported postoperative paresthesia, which healed spontaneously after 3 months. One patient exhibited dehiscence due to not following the postoperative recommendations. Forty implants were installed in the grafted regions, and 2 implants were repositioned.
   Conclusion: The technique of sandwich osteotomy was found to be effective for height gain, and different materials can be used between the osteotomized segments.
C1 [Noia, Claudio Ferreira] Univ Araras, Dept Dent, Sch Dent, Araras, Brazil.
   [Ortega-Lopes, Rafael] APCD Piracicaba Dent Sch, Dept Dent, Piracicaba, Brazil.
   [Kluppel, Leandro Eduardo] Univ Fed Parana, Dept Dent, Sch Dent, Curitiba, Parana, Brazil.
   [Martins de Sa, Bruno Costa] Coll Ciodonto, Dept Dent, Sch Dent, Porto Velho, Brazil.
RP Noia, CF (reprint author), Univ Araras UNIARARAS, Dept Dent, Ave Doutor Maximiliano Baruto 500, BR-13607339 Araras, Brazil.
EM claudioferreira2004@yahoo.com.br
CR Bell RE, 2013, J ORAL MAXIL SURG, V71, P1005, DOI 10.1016/j.joms.2013.01.026
   Bormann KH, 2010, INT J ORAL MAX SURG, V39, P554, DOI 10.1016/j.ijom.2010.03.002
   Bormann KH, 2011, J ORAL MAXIL SURG, V69, P1562, DOI 10.1016/j.joms.2010.10.054
   Choi BH, 2004, J CRANIO MAXILL SURG, V32, P51, DOI 10.1016/j.jcms.2003.08.006
   Felice P, 2014, IMPLANT DENT, V23, P738, DOI 10.1097/ID.0000000000000168
   Hashemi HM, 2010, J ORAL MAXIL SURG, V68, P1853, DOI [10.1016/j.joms.2009.09.073, 10.1016/j.jams.2009.09.073]
   Jensen OT, 2006, J ORAL MAXIL SURG, V64, P471, DOI 10.1016/j.joms.2005.11.030
   Jensen OT, 2006, J ORAL MAXIL SURG, V64, P290, DOI 10.1016/j.joms.2005.10.021
   Kluppel LE, 2008, RECONSTRUCOES IMPLAN, P250
   Laviv A, 2014, J ORAL MAXIL SURG, V72, P292, DOI 10.1016/j.joms.2013.09.036
   Lopez-Cedrun JL, 2011, INT J ORAL MAX IMPL, V26, P195
   Noia CF, 2012, INT J ORAL MAX SURG, V41, P1563, DOI 10.1016/j.ijom.2012.05.006
   Politi M, 1999, J ORAL MAXIL SURG, V57, P1380, DOI 10.1016/S0278-2391(99)90883-2
   SCHETTLER D, 1977, J MAXILLOFAC SURG, V5, P199, DOI 10.1016/S0301-0503(77)80106-9
   Triaca A, 2014, BRIT J ORAL MAX SURG, V52, P664, DOI 10.1016/j.bjoms.2014.04.013
   Xuan F, 2014, J ORAL MAXIL SURG, V72, P1660, DOI 10.1016/j.joms.2014.04.003
NR 16
TC 0
Z9 0
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD FEB
PY 2017
VL 26
IS 1
BP 101
EP 105
DI 10.1097/ID.0000000000000522
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EK1EJ
UT WOS:000393668300014
PM 27930404
DA 2018-10-20
ER

PT J
AU You, JS
   Cho, IA
   Kang, KR
   Oh, JS
   Yu, SJ
   Lee, GJ
   Seo, YS
   Kim, SG
   Kim, CS
   Kim, DK
   Im, HJ
   Kim, JS
AF You, Jae-Seek
   Cho, In-A
   Kang, Kyeong-Rok
   Oh, Ji-Su
   Yu, Sang-Joun
   Lee, Gyeong-Je
   Seo, Yo-Seob
   Kim, Su-Gwan
   Kim, Chun Sung
   Kim, Do Kyung
   Im, Hee-Jeong
   Kim, Jae-Sung
TI Coumestrol Counteracts Interleukin-1 beta-Induced Catabolic Effects by
   Suppressing Inflammation in Primary Rat Chondrocytes
SO INFLAMMATION
LA English
DT Article
DE osteoarthritis; inflammation; chondrocyte; coumestrol; anti-catabolic
   effects
ID INTERVERTEBRAL DISC; KNEE OSTEOARTHRITIS; CARTILAGE MATRIX; DEGRADATION;
   EXPRESSION; CHEMOKINE; CELLS; PAIN; IL-1
AB In the present study, we investigated the anti-catabolic effects of coumestrol, a phytoestrogen derived from herbal plants, against interleukin-1 beta-induced cartilage degeneration in primary rat chondrocytes and articular cartilage. Coumestrol did not affect the viability of human normal oral keratinocytes and primary rat chondrocytes treated for 24 h and 21 days, respectively. Although coumestrol did not significantly increase the proteoglycan contents in long-term culture, it abolished the interleukin-1 beta-induced loss of proteoglycans in primary rat chondrocytes and knee articular cartilage. Furthermore, coumestrol suppressed the expression of matrix-degrading enzymes such as matrix metalloproteinase-13, -3, and -1 in primary rat chondrocytes stimulated with interleukin-1 beta. Moreover, the expression of catabolic factors such as nitric oxide synthase, cyclooxygenase-2, prostaglandin E-2, and inflammatory cytokines in interleukin-1 beta-stimulated primary rat chondrocytes was suppressed by coumestrol. In summary, these results indicate that coumestrol counteracts the catabolic effects induced by interleukin-1 beta through the suppression of inflammation. Therefore, based on its biological activity and safety profile, coumestrol could be used as a potential anti-catabolic biomaterial for osteoarthritis.
C1 [You, Jae-Seek; Cho, In-A; Kang, Kyeong-Rok; Oh, Ji-Su; Kim, Su-Gwan] Chosun Univ, Dept Oral & Maxillofacial Surg, Gwangju 61452, South Korea.
   [Yu, Sang-Joun] Chosun Univ, Dept Periodontol, Gwangju 61452, South Korea.
   [Lee, Gyeong-Je] Chosun Univ, Dept Prosthodont, Gwangju 61452, South Korea.
   [Seo, Yo-Seob] Chosun Univ, Dept Oral & Maxillofacial Radiol, Gwangju 61452, South Korea.
   [Kim, Chun Sung; Kim, Do Kyung; Kim, Jae-Sung] Chosun Univ, Sch Dent, Predent, 309 Philmun Daero, Gwangju 61452, South Korea.
   [Im, Hee-Jeong] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA.
RP Kim, JS (reprint author), Chosun Univ, Sch Dent, Predent, 309 Philmun Daero, Gwangju 61452, South Korea.
EM js_kim@chosun.ac.kr
FU Chosun University Dental Hospital
FX This study was supported by research fund from Chosun University Dental
   Hospital, 2015.
CR Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368
   Akkiraju H, 2015, J DEV BIOL, V3, P177, DOI 10.3390/jdb3040177
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012
   BICKOFF EM, 1957, SCIENCE, V126, P969, DOI 10.1126/science.126.3280.969-a
   BICKOFF EM, 1960, ARCH BIOCHEM BIOPHYS, V88, P262, DOI 10.1016/0003-9861(60)90232-0
   Crepaldi G, 2003, AGING CLIN EXP RES, V15, P355, DOI 10.1007/BF03327355
   Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P1966, DOI 10.1016/j.joca.2015.01.008
   Hedbom E, 2002, CELL MOL LIFE SCI, V59, P45, DOI 10.1007/s00018-002-8404-z
   Heidari B, 2011, CASP J INTERN MED, V2, P205
   Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X
   Huang BJ, 2016, BIOMATERIALS, V98, P1, DOI 10.1016/j.biomaterials.2016.04.018
   Huo LW, 2015, J INVEST MED, V63, P626, DOI 10.1097/JIM.0000000000000158
   Jantaratnotai N, 2013, INT IMMUNOPHARMACOL, V17, P483, DOI 10.1016/j.intimp.2013.07.013
   Jin SE, 2012, ARCH PHARM RES, V35, P823, DOI 10.1007/s12272-012-0508-x
   Kean W. F., 2004, Inflammopharmacology, V12, P3, DOI 10.1163/156856004773121347
   Kim JS, 2013, J CELL PHYSIOL, V228, P1884, DOI 10.1002/jcp.24350
   Kim JS, 2012, J CELL PHYSIOL, V227, P1512, DOI 10.1002/jcp.22867
   Kim JS, 2010, ARTHRITIS RHEUM-US, V62, P3706, DOI 10.1002/art.27733
   KNUCKLES BE, 1976, J AGR FOOD CHEM, V24, P1177, DOI 10.1021/jf60208a034
   Konttinen YT, 2012, ARTHRITIS RHEUM-US, V64, P613, DOI 10.1002/art.33451
   Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652
   Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069
   Lee GJ, 2015, BIOL PHARM BULL, V38, P1199, DOI 10.1248/bpb.b15-00198
   Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002
   Martin-Millan M, 2013, JOINT BONE SPINE, V80, P368, DOI 10.1016/j.jbspin.2012.11.008
   Miller RE, 2014, CYTOKINE, V70, P185, DOI 10.1016/j.cyto.2014.06.019
   Oh JS, 2016, BIOCHEM BIOPH RES CO, V477, P723, DOI 10.1016/j.bbrc.2016.06.126
   Oshima A., 2016, BIOSCIENCE BIOTECHNO, V13, P1
   Park MR, 2015, FOOD CHEM TOXICOL, V77, P34, DOI 10.1016/j.fct.2014.12.013
   Reed KN, 2014, MOL CELL BIOCHEM, V397, P195, DOI 10.1007/s11010-014-2187-z
   Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200
   Ruth JH, 2003, LAB INVEST, V83, P579, DOI 10.1097/01.LAB.0000062854.30195.52
   Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027
   Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868
   Yoshida K, 2014, ARTHRITIS RHEUMATOL, V66, P2716, DOI 10.1002/art.38750
   Yuan PW, 2010, J TRADIT CHIN MED, V30, P254, DOI 10.1016/S0254-6272(10)60052-0
NR 37
TC 4
Z9 5
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0360-3997
EI 1573-2576
J9 INFLAMMATION
JI Inflammation
PD FEB
PY 2017
VL 40
IS 1
BP 79
EP 91
DI 10.1007/s10753-016-0455-7
PG 13
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA EK0ZL
UT WOS:000393655500008
PM 27709316
DA 2018-10-20
ER

PT J
AU Ghaneian, MT
   Bhatnagar, A
   Ehrampoush, MH
   Amrollahi, M
   Jamshidi, B
   Dehvari, M
   Taghavi, M
AF Ghaneian, M. T.
   Bhatnagar, A.
   Ehrampoush, M. H.
   Amrollahi, M.
   Jamshidi, B.
   Dehvari, M.
   Taghavi, M.
TI Biosorption of hexavalent chromium from aqueous solution onto
   pomegranate seeds: kinetic modeling studies
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Adsorption; Chromium; Water treatment; Pomegranate seeds
ID ACTIVATED CARBON; ADSORPTION; REMOVAL; EQUILIBRIUM; WASTE; ADSORBENTS;
   MECHANISM; LEAD(II); BIOMASS; POWDER
AB Hexavalent chromium has been proved to be the reason of several health hazards. This study aimed at evaluating the application of pomegranate seeds powder for chromium adsorption (VI) from aqueous solution. Chromium adsorption percentage (VI) increased with increasing the adsorbent dosage. Chromium adsorption capacity (VI), at pH = 2 and 10 mg/L initial metal concentration, decreased from 3.313 to 1.6 mg/g through increasing dosage of adsorbent from 0.2 to 0.6 g/100 ml. The adsorption rate increased through increase in chromium initial concentration (VI). However, there was a removal percentage reduction of chromium (VI). Chromium adsorption kinetics by different models (pseudo-first-order, modified pseudo-first-order, pseudo-second-order, Elovich, intraparticle diffusion, Boyd kinetic) was investigated as well. Studies on adsorption kinetic indicated that the experimental data were matched by pseudo-second-order model (R (2) = 0.999) better. Obtained results demonstrated the pomegranate seeds can be used as an effective biomaterial and biosorbent for hexavalent chromium adsorption from aqueous solutions.
C1 [Ghaneian, M. T.; Ehrampoush, M. H.; Amrollahi, M.; Jamshidi, B.; Dehvari, M.] Shahid Sadoughi Univ Med Sci, Dept Environm Hlth Engn, Yazd, Iran.
   [Bhatnagar, A.] Univ Eastern Finland, Dept Environm & Biol Sci, POB 1627, Kuopio 70211, Finland.
   [Taghavi, M.] Gonabad Univ Med Sci, Dept Environm Hlth Engn, Gonabad, Iran.
RP Taghavi, M (reprint author), Gonabad Univ Med Sci, Dept Environm Hlth Engn, Gonabad, Iran.
EM taghavi66@yahoo.com
RI Ehrampoush, mohammad hassan/Q-5028-2017
OI Ehrampoush, mohammad hassan/0000-0002-0388-3211; ehrampoush, Mohammad
   Hassan/0000-0001-7019-569X
FU Shahid Sadoughi University of Medical Sciences [2773]
FX The authors wish to thank Shahid Sadoughi University of Medical Sciences
   for supporting this research (Grant Number: 2773).
CR Acharya J, 2009, CHEM ENG J, V149, P249, DOI 10.1016/j.cej.2008.10.029
   Aliabadi M, 2012, INT J ENVIRON SCI TE, V9, P319, DOI 10.1007/s13762-012-0045-7
   Aravind J, 2016, GLOB J ENVIRON SCI M, V2, P61, DOI 10.7508/gjesm.2016.01.007
   Aravindhan R, 2012, CLEAN TECHNOL ENVIR, V14, P727, DOI 10.1007/s10098-011-0440-7
   AWWA A, 2005, STANDARD METHODS EXA
   Barkakati P, 2010, CHEM ENG J, V161, P34, DOI 10.1016/j.cej.2010.04.018
   Boparai HK, 2011, J HAZARD MATER, V186, P458, DOI 10.1016/j.jhazmat.2010.11.029
   Brungesh K, 2015, J ENV ANAL TOXICOL, V5, P1
   Dehvari M., 2013, J COMMUNITY HLTH RES, V1, P153
   Di Natale F, 2007, J HAZARD MATER, V145, P381, DOI 10.1016/j.jhazmat.2006.11.028
   Dubey SP, 2007, J HAZARD MATER, V145, P465, DOI 10.1016/j.jhazmat.2006.11.041
   El Nemr A, 2015, ARAB J CHEM, V8, P105, DOI 10.1016/j.arabjc.2011.01.016
   El-Batouti M., 2015, Asian Journal of Chemistry, V27, P3721
   EPA EPA, 2015, 2187 EPA OFF WAT, V138, P142
   Ghaneian MT, 2015, RES CHEM INTERMEDIAT, V41, P3223, DOI 10.1007/s11164-013-1427-2
   Ghaneian MT, 2013, POL J CHEM TECHNOL, V15, P40, DOI 10.2478/pjct-2013-0022
   Heimberg JA, 2001, APPL PHYS LETT, V78, P2449, DOI 10.1063/1.1366649
   Jain M, 2016, INT J ENVIRON SCI TE, V13, P493, DOI 10.1007/s13762-015-0855-5
   Jamshidi B., 2013, ENV TREAT TECH, V1, P150
   Kaya K, 2014, FOOD CHEM, V158, P112, DOI 10.1016/j.foodchem.2014.02.107
   Kumar E, 2010, CHEM ENG J, V159, P84, DOI 10.1016/j.cej.2010.02.043
   Kumar PS, 2011, CHEM ENG J, V167, P122, DOI 10.1016/j.cej.2010.12.010
   Levankumar L, 2009, J HAZARD MATER, V161, P709, DOI 10.1016/j.jhazmat.2008.04.031
   Najim TS, 2009, E-J CHEM, V6, pS129, DOI 10.1155/2009/936541
   Nharingo T, 2016, J ENV RES, V10, P85
   Ofomaja AE, 2010, J ENVIRON MANAGE, V91, P1674, DOI 10.1016/j.jenvman.2010.03.005
   Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026
   Owlad M, 2010, BIORESOURCE TECHNOL, V101, P5098, DOI 10.1016/j.biortech.2010.01.135
   Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Pehlivan E, 2008, J HAZARD MATER, V155, P378, DOI 10.1016/j.jhazmat.2007.11.071
   Rahimi HR, 2012, IRAN J PHARM RES, V11, P385
   Rudzinski W, 2000, J PHYS CHEM B, V104, P9149, DOI 10.1021/jp000045m
   Sahranavard M., 2011, EUROPEAN J SCI RES, V58, P392
   Samarghandy MR, 2011, BIORESOURCES, V6, P4840
   Shadborestan A., 2013, J MAZANDARAN U MED S, V22, P122
   Taghavi M., 2015, ENVIRON MONIT ASSESS, V187, P1
   Yousef RI, 2011, CHEM ENG J, V171, P1143, DOI 10.1016/j.cej.2011.05.012
   Zarrabi M., 2015, KOOMESH, V16, P213
   Zazouli M. A., 2013, J MAZANDARAN U MED S, V23, P37
NR 40
TC 3
Z9 3
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1735-1472
EI 1735-2630
J9 INT J ENVIRON SCI TE
JI Int. J. Environ. Sci. Technol.
PD FEB
PY 2017
VL 14
IS 2
BP 331
EP 340
DI 10.1007/s13762-016-1216-8
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EK1NY
UT WOS:000393693700012
DA 2018-10-20
ER

PT J
AU Terukina, T
   Saito, H
   Tomita, Y
   Hattori, Y
   Otsuka, M
AF Terukina, Takayuki
   Saito, Hanae
   Tomita, Yuya
   Hattori, Yusuke
   Otsuka, Makoto
TI Development and effect of a sustainable and controllable
   simvastatin-releasing device based on PLGA microspheres/carbonate
   apatite cement composite: In vitro evaluation for use as a drug delivery
   system from bone-like biomaterial
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bone regeneration; Simvastatin; Poly(lactic-co-glycolic acid)
   microspheres; Carbonated hydroxyapatite; Drug delivery system;
   Controlled release
ID CALCIUM-PHOSPHATE CEMENT; CARBONATE APATITE; CELL-CULTURES;
   HYDROXYAPATITE; MECHANISMS; MICROPARTICLES; MINERALIZATION; OSTEOBLASTS;
   PARTICLES; MATRICES
AB Carbonated apatite cement can be a potential biomaterial to be used as a drug carrier. We reported previously that sustainable release of simvastatin (SIM) from poly(lactic-co-glycolic acid) (PLGA) formulations could induce bone formation. The aim of this study was to develop a SIM-loaded PLGA microspheres (SPLGAMs)/carbonated hydroxyapatite (CHAP) composite, and investigate the effect of SIM released from that composite in comparison with a SIM/CHAP composite used as a control. X-ray diffraction analysis (XRD) and Fourier-transformed infrared spectroscopy (FT-IR) results showed most parts of the cement bulk powder transformed into carbonated hydroxyapatite. The SPLGAMs and SPLGAMs/CHAP composites were able to produce sustained release of SIM for 1 month, whereas the SIM/CHAP composite released SIM for 2 weeks. The mechanisms of the drug release patterns from these composites were confirmed by several mathematical models. The proliferation of MC3T3-E1 cells on the SPLGAMs/CHAP composite showed no significant difference in comparison with the SIM/CHAP composite. However, the SPLGAMs/CHAP composite significantly increased alkaline phosphate activity, a differentiation marker of MC3T3-E1 cells, compared with the SIM/CHAP composite. These results suggested that the SPLGAMs/CHAP composite could release SIM sustainably and induce proliferation and differentiation of MOT3-E1 more effectively than the SIM/CHAP composite. (C) 2016 Published by Elsevier B.V.
C1 [Terukina, Takayuki; Hattori, Yusuke; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, 1-1-20 Shinmachi, Tokyo 2028585, Japan.
   [Saito, Hanae; Tomita, Yuya] Musashino Univ, Fac Pharm, 1-1-20 Shinmachi, Tokyo 2028585, Japan.
RP Otsuka, M (reprint author), Musashino Univ, Pharmaceut Sci Res Inst, 1-1-20 Shinmachi, Tokyo 2028585, Japan.
EM motsuka@mushashino-u.ac.jp
CR Boskey AL, 2007, ELEMENTS, V3, P385, DOI 10.2113/GSELEMENTS.3.6.385
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Chou J, 2013, ADV HEALTHC MATER, V2, P678, DOI 10.1002/adhm.201200342
   Della Porta G, 2016, J PHARM SCI-US, V105, P2164, DOI 10.1016/j.xphs.2016.05.002
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8
   Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4
   Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   Hasegawa M, 2003, J BONE JOINT SURG BR, V85B, P142, DOI 10.1302/0301-620X.85B1.13414
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Jiang LM, 2013, J BIOMED NANOTECHNOL, V9, P1921, DOI 10.1166/jbn.2013.1692
   Kanayama K, 2011, J BIOMATER APPL, V26, P435, DOI 10.1177/0885328210374672
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Korsmeyer R W, 1983, J Pharm Sci, V72, P1189
   Lanao RPF, 2011, BIOMATERIALS, V32, P8839, DOI 10.1016/j.biomaterials.2011.08.005
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Meng ZX, 2013, MAT SCI ENG C-MATER, V33, P699, DOI 10.1016/j.msec.2012.10.021
   Meyer F, 2012, J ORTHOP RES, V30, P864, DOI 10.1002/jor.22019
   Montazerolghaem M, 2014, J BIOMED MATER RES A, V102, P340, DOI 10.1002/jbm.a.34702
   MOONGA BS, 1990, J PHYSIOL-LONDON, V429, P29, DOI 10.1113/jphysiol.1990.sp018242
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Naito Y, 2014, INT J PHARMACEUT, V461, P157, DOI 10.1016/j.ijpharm.2013.11.046
   NORDSTROM EG, 1990, J MATER SCI-MATER M, V1, P182, DOI 10.1007/BF00700880
   Otsuka M, 1997, PHARMACEUT RES, V14, P444, DOI 10.1023/A:1012039214184
   Qi XP, 2008, ACTA BIOMATER, V4, P1837, DOI 10.1016/j.actbio.2008.05.009
   Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Tai IC, 2013, INT J NANOMED, V8, P3895, DOI 10.2147/IJN.S48694
   Terukina T, 2016, J DRUG DELIV SCI TEC, V33, P136, DOI 10.1016/j.jddst.2016.03.005
   Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015
   Wang JW, 2007, OSTEOPOROSIS INT, V18, P1641, DOI 10.1007/s00198-007-0412-2
   Yin H, 2012, J BIOMED MATER RES A, V100A, P2991, DOI 10.1002/jbm.a.34228
   YOHAY DA, 1994, J CELL PHYSIOL, V158, P467, DOI 10.1002/jcp.1041580311
NR 36
TC 8
Z9 8
U1 4
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD FEB
PY 2017
VL 37
BP 74
EP 80
DI 10.1016/j.jddst.2016.10.007
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EK0OS
UT WOS:000393626900010
DA 2018-10-20
ER

PT J
AU Orlando, G
AF Orlando, Giuseppe
TI ImmunoCloak as a Paradigm of the Biomaterial Approach to
   Immunomodulation: Where Regenerative Medicine Meets Organ
   Transplantation
SO TRANSPLANTATION
LA English
DT Editorial Material
C1 [Orlando, Giuseppe] Wake Forest Univ, Sch Med, Dept Surg, Salem, NC USA.
RP Orlando, G (reprint author), Wake Forest Univ Hlth Sci, Sect Transplantat, Dept Surg, Winston Salem, NC 27157 USA.
EM gorlando@wakehealth.edu
CR Brasile L, 2017, TRANSPLANTATION, V101, pE49, DOI 10.1097/TP.0000000000001537
   GATES RJ, 1977, LANCET, V2, P1257
   Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251
   Orlando G, 2013, ANN SURG, V258, P221, DOI 10.1097/SLA.0b013e31829c79cf
   Orlando G, 2010, ANN SURG, V252, P915, DOI 10.1097/SLA.0b013e3181f3efb0
   Orlando G, 2009, J HEPATOL, V50, P1247, DOI 10.1016/j.jhep.2009.03.006
   Peloso A, 2016, ANN SURG, V264, P169, DOI 10.1097/SLA.0000000000001364
   Petrosyan A, MATRIX BIOL IN PRESS
   Salvatori M, 2015, XENOTRANSPLANTATION, V22, P1, DOI 10.1111/xen.12122
   Starzl TE, 1996, TRANSPLANTATION LIVE
   Stubenitsky BM, 2009, J PLAST RECONSTR AES, V62, P520, DOI 10.1016/j.bjps.2007.12.001
NR 11
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD FEB
PY 2017
VL 101
IS 2
BP 234
EP 235
DI 10.1097/TP.0000000000001551
PG 2
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA EK0WI
UT WOS:000393647400015
PM 27798511
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, LM
   Han, M
   Jiang, XC
   Yin, XZ
   Chen, F
   Zhang, TY
   Ren, H
   Zhang, JW
   Hou, TJ
   Chen, Z
   Ou-Yang, HW
   Tabata, Y
   Shen, YQ
   Gao, JQ
AF Li, Li-Ming
   Han, Min
   Jiang, Xin-Chi
   Yin, Xian-Zhen
   Chen, Fu
   Zhang, Tian-Yuan
   Ren, Hao
   Zhang, Ji-Wen
   Hou, Ting-Jun
   Chen, Zhong
   Ou-Yang, Hong-Wei
   Tabata, Yasuhiko
   Shen, You-Qing
   Gao, Jian-Qing
TI Peptide-Tethered Hydrogel Scaffold Promotes Recovery from Spinal Cord
   Transection via Synergism with Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hyaluronic acid; hydrogel scaffold; mesenchymal stem cells; adhesive
   peptide; spinal cord injury; tissue engineering
ID HYALURONIC-ACID HYDROGELS; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY;
   AXON REGENERATION; GENE DELIVERY; IN-VIVO; INJURY; REPAIR; BRAIN;
   TRANSPLANTATION
AB Spinal cord injury (SCI) is one of the most devastating injuries. Treatment strategies for SCI are required to overcome comprehensive issues. Implantation of biomaterial scaffolds and stem cells has been demonstrated to be a promising strategy. However, a comprehensive recovery effect is difficult to achieve. In the comprehensive treatment process, the specific roles of the implanted scaffolds and of stem cells in combined strategy are usually neglected. In this study, a peptide modified scaffold is developed based on hyaluronic acid and an adhesive peptide PPFLMLLKGSTR. Synchrotron radiation micro computed tomography measurement provides insights to the three-dimensional inner topographical property and perspective porous structure of the scaffold. The modified scaffold significantly improves cellular survival and adhesive growth of mesenchymal stem cells during 3D culture in vitro. After implantation in transected spinal cord, the modified scaffold and mesenchymal stems are found to function in synergy to restore injured spinal cord tissue, with respective strengths. Hindlimb motor function scores exhibit the most significant impact of the composite implant at 2 weeks post injury, which is the time secondary injury factors begin to take hold. Investigation on the secondary injury factors including inflammatory response and astrocyte overactivity at 10 days post injury reveals the possible underlying reason. Implants of the scaffold, cells, and especially the combination of both elicit inhibitory effects on these adverse factors. The study develops a promising implant for spinal cord tissue engineering and reveals the roles of the scaffold and stem cells. More importantly, the results provide the first understanding of the bioactive peptide PPFLMLLKGSTR concerning its functions on mesenchymal stem cells and spinal cord tissue restoration.
C1 [Li, Li-Ming; Han, Min; Jiang, Xin-Chi; Zhang, Tian-Yuan; Gao, Jian-Qing] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.
   [Chen, Fu; Hou, Ting-Jun] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China.
   [Ren, Hao; Ou-Yang, Hong-Wei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Chen, Zhong] Zhejiang Univ, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol, Dept Pharmacol,Minist Hlth China,Coll Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.
   [Ou-Yang, Hong-Wei; Gao, Jian-Qing] Zhejiang Univ, Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Hangzhou 310058, Zhejiang, Peoples R China.
   [Yin, Xian-Zhen; Zhang, Ji-Wen] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 201210, Peoples R China.
   [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn, Kyoto 6068507, Japan.
   [Shen, You-Qing] Zhejiang Univ, Coll Chem & Biol Engn, Minist Educ, Ctr Bionanoengn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Shen, You-Qing] Zhejiang Univ, Coll Chem & Biol Engn, Minist Educ, Key Lab Biomass Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China.
RP Gao, JQ (reprint author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.; Gao, JQ (reprint author), Zhejiang Univ, Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Hangzhou 310058, Zhejiang, Peoples R China.
EM gaojianqing@zju.edu.cn
RI Hou, Tingjun/C-7492-2011; Shen, Youqing/E-6144-2011; Hou,
   Tingjun/D-7216-2012
OI Hou, Tingjun/0000-0001-7227-2580; Shen, Youqing/0000-0003-1837-7976; 
FU National Natural Science Foundation of China [81102392, 81620108028,
   81473143, 81430087]; Natural Science Foundation of Zhejiang Province
   [LZ14H300001]; Zhejiang Provincial Program for the Cultivation of High
   -Level Innovative Health Talents; National Science and Technology Major
   Project [2013ZX09402103]
FX We acknowledge the support of the National Natural Science Foundation of
   China (No. 81102392, 81620108028, 81473143), the Natural Science
   Foundation of Zhejiang Province (LZ14H300001), and Zhejiang Provincial
   Program for the Cultivation of High -Level Innovative Health Talents.
   The National Natural Science Foundation of China (No. 81430087) and
   National Science and Technology Major Project (2013ZX09402103) are also
   acknowledged. We thank Jianyang Pan (Pharmaceutical Informatics
   Insistute, Zhejiang University) for performing NMR spectrometry for
   structure elucidation.
CR Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
   Caron I, 2016, BIOMATERIALS, V75, P135, DOI 10.1016/j.biomaterials.2015.10.024
   Chang KH, 2013, ACTA BIOMATER, V9, P9012, DOI 10.1016/j.actbio.2013.06.046
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Damodaran G, 2009, ACTA BIOMATER, V5, P2441, DOI 10.1016/j.actbio.2009.03.018
   Damodaran G, 2009, J BIOMED MATER RES A, V89A, P1001, DOI 10.1002/jbm.a.32045
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296
   Fuhrmann T, 2015, METHODS, V84, P60, DOI 10.1016/j.ymeth.2015.03.023
   HEARN MTW, 1987, METHOD ENZYMOL, V135, P102
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415
   Kabu S, 2015, J CONTROL RELEASE, V219, P141, DOI 10.1016/j.jconrel.2015.08.060
   Karimi-Abdolrezaee S, 2012, ADV EXP MED BIOL, V760, P53
   Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009
   Lei YG, 2011, BIOMATERIALS, V32, P39, DOI 10.1016/j.biomaterials.2010.08.103
   Li LM, 2015, INT J PHARMACEUT, V488, P1, DOI 10.1016/j.ijpharm.2015.04.050
   Liu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12777
   Liu X, 2016, ADV MATER, V28, P1743, DOI 10.1002/adma.201504288
   Madigan NN, 2014, TISSUE ENG PT A, V20, P2985, DOI [10.1089/ten.tea.2013.0551, 10.1089/ten.TEA.2013.0551]
   Min SK, 2010, BIOMATERIALS, V31, P4725, DOI 10.1016/j.biomaterials.2010.02.045
   Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055
   Oh JE, 2009, EXP CELL RES, V315, P3187, DOI 10.1016/j.yexcr.2009.08.002
   Owens J, 2009, NATURE, V458, P1101, DOI 10.1038/4581101a
   Papa S, 2016, BIOMATERIALS, V75, P13, DOI 10.1016/j.biomaterials.2015.10.015
   Qiu XC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0100-7
   Radulovic M, 2015, NEUROBIOL DIS, V83, P75, DOI 10.1016/j.nbd.2015.08.021
   Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023
   Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Somamoto S, 2013, ACTA BIOMATER, V9, P5194, DOI 10.1016/j.actbio.2012.07.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Uchida S, 2016, BIOMATERIALS, V109, P1, DOI 10.1016/j.biomaterials.2016.09.007
   Wang J, 2012, NEUROSCIENCE, V210, P467, DOI 10.1016/j.neuroscience.2012.03.016
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Yao L., 2009, J BIOMED MATER RES A, V9999A, P484
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Zeng X, 2015, BIOMATERIALS, V53, P184, DOI 10.1016/j.biomaterials.2015.02.073
   Zhang LX, 2015, NEUROSCIENTIST, V21, P277, DOI 10.1177/1073858414532171
   Zhao H, 2016, MOL NEUROBIOL, V53, P187, DOI 10.1007/s12035-014-9000-6
   Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004
NR 49
TC 4
Z9 4
U1 10
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 1
PY 2017
VL 9
IS 4
BP 3330
EP 3342
DI 10.1021/acsami.6b12829
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EJ6UW
UT WOS:000393355900014
PM 28058831
DA 2018-10-20
ER

PT J
AU Kosmides, AK
   Meyer, RA
   Hickey, JW
   Aje, K
   Cheung, KN
   Green, JJ
   Schneck, JP
AF Kosmides, A. K.
   Meyer, R. A.
   Hickey, J. W.
   Aje, K.
   Cheung, K. N.
   Green, J. J.
   Schneck, J. P.
TI Biomimetic biodegradable artificial antigen presenting with PD-1
   blockade to treat melanoma cells synergize
SO BIOMATERIALS
LA English
DT Article
DE Artificial antigen presenting cell; Immunotherapy; CD8+T-cell; PD-1;
   Combination therapy
ID CD8(+) T-CELLS; EX-VIVO; IN-VIVO; EXPANSION; LYMPHOCYTES; IMMUNOTHERAPY;
   ACTIVATION; EFFICACY; CANCER
AB Biomimetic materials that target the immune system and generate an anti-tumor responses hold promise in augmenting cancer immunotherapy. These synthetic materials can be engineered and optimized for their biodegradability, physical parameters such as shape and size, and controlled release of immune-modulators. As these new platforms enter the playing field, it is imperative to understand their interaction with existing immunotherapies since single-targeted approaches have limited efficacy. Here, we investigate the synergy between a PLGA-based artificial antigen presenting cell (aAPC) and a checkpoint blockade molecule, anti-PD1 monoclonal antibody (mAb). The combination of antigen specific aAPC-based activation and anti-PD-1 mAb checkpoint blockade induced the greatest IFN-y secretion by CD8+ T cells in vitro. Combination treatment also acted synergistically in an in vivo murine melanoma model to result in delayed tumor growth and extended survival, while either treatment alone had no effect. This was shown mechanistically to be due to decreased PD-1 expression and increased antigen-specific proliferation of CD8+ T cells within the tumor microenvironment and spleen. Thus, biomaterial-based therapy can synergize with other immunotherapies and motivates the translation of biomimetic combinatorial treatments. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Kosmides, A. K.; Meyer, R. A.; Hickey, J. W.; Cheung, K. N.; Green, J. J.] Johns Hopkins Univ, Dept Biomed Engn, Sch Med, Baltimore, MD 21231 USA.
   [Kosmides, A. K.; Hickey, J. W.; Aje, K.; Schneck, J. P.] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21231 USA.
   [Kosmides, A. K.; Hickey, J. W.; Aje, K.; Schneck, J. P.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21231 USA.
   [Meyer, R. A.; Cheung, K. N.; Green, J. J.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Sch Med, Baltimore, MD 21231 USA.
   [Kosmides, A. K.; Meyer, R. A.; Hickey, J. W.; Green, J. J.; Schneck, J. P.] Johns Hopkins Univ, Inst Nanobiotechnol, Sch Med, Baltimore, MD 21231 USA.
   [Green, J. J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Sch Med, Baltimore, MD 21231 USA.
   [Green, J. J.] Johns Hopkins Univ, Dept Ophthalmol, Sch Med, Baltimore, MD 21231 USA.
   [Green, J. J.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21231 USA.
   [Schneck, J. P.] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Sch Med, Baltimore, MD 21231 USA.; Schneck, JP (reprint author), Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21231 USA.
EM green@jhu.edu; jschnecl@jhmi.edu
OI Hickey, John/0000-0001-9961-7673
FU JHU-Coulter Translational Partnership; TEDCO Maryland Innovation
   Initiative; Troper Wojcicki Foundation; NIH [R01-EB016721, P30-EY001865,
   AI44129, CA108835]; NIH Cancer Nanotechnology Training Center at the JHU
   Institute for Nano biotechnology [R25CA153952]; Achievement Rewards for
   College Scientists (ARCS); National Science Foundation [DGE-1232825];
   NIH Cancer Nanotechnology Training Center at the JHU Institute for
   Nanobiotechnology [2T32CA153952-06]; National Cancer Institute of the
   NIH [F31CA206344]
FX The authors thank the JHU-Coulter Translational Partnership, the TEDCO
   Maryland Innovation Initiative, The Troper Wojcicki Foundation, the NIH
   (R01-EB016721, P30-EY001865, AI44129, and CA108835), and sponsored
   research agreements with Miltenyi Biotec and NexImmune for support of
   this research. Antibody and lymphocyte images reproduced under a
   Creative Commons License from Servier Medical Art
   (http://www.servier.com/Powerpoint-image-bank). RAM thanks the NIH
   Cancer Nanotechnology Training Center (R25CA153952) at the JHU Institute
   for Nano biotechnology and the Achievement Rewards for College
   Scientists (ARCS) for fellowship support. AKK thanks the National
   Science Foundation (DGE-1232825), the NIH Cancer Nanotechnology Training
   Center at the JHU Institute for Nanobiotechnology (2T32CA153952-06), and
   the National Cancer Institute of the NIH (F31CA206344) for fellowship
   support. JWH is supported by a National Science Foundation Graduate
   Research Fellowship (DGE-1232825).
CR Ascierto PA, 2015, EBIOMEDICINE, V2, P92, DOI 10.1016/j.ebiom.2015.01.011
   Buchan SL, 2015, J IMMUNOL, V194, P125, DOI 10.4049/jimmunol.1401644
   Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905
   Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631
   Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012
   Chen SH, 2015, CANCER IMMUNOL RES, V3, P149, DOI 10.1158/2326-6066.CIR-14-0118
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Durai M, 2009, CANCER IMMUNOL IMMUN, V58, P209, DOI 10.1007/s00262-008-0542-1
   Gong WJ, 2008, CELL MOL IMMUNOL, V5, P47, DOI 10.1038/cmi.2008.6
   Jhunjhunwala S, 2012, ADV MATER, V24, P4735, DOI 10.1002/adma.201202513
   Latouche JB, 2000, NAT BIOTECHNOL, V18, P405
   Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825
   lwai Y., 2002, P NATL ACAD SCI USA, V99, P12293
   Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143
   Meyer R a, 2014, SMALL, P1
   Oelke M, 2010, IMMUNOL RES, V47, P248, DOI 10.1007/s12026-009-8156-z
   Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762
   Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082
   Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2
   Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967
   Sasawatari S, 2006, IMMUNOL CELL BIOL, V84, P512, DOI 10.1111/j.1440-1711.2006.01462.x
   Shen CL, 2013, IMMUNOL LETT, V150, P1, DOI 10.1016/j.imlet.2013.01.003
   Shindo Y, 2015, ANTICANCER RES, V35, P129
   Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11
   Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Ugel S, 2009, CANCER RES, V69, P9376, DOI 10.1158/0008-5472.CAN-09-0400
   Vilgelm A.E., 2016, J LEUKOCYTE BIOL, V100, P149
   Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc
   Ye QR, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-131
NR 33
TC 16
Z9 18
U1 5
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2017
VL 118
BP 16
EP 26
DI 10.1016/j.biomaterials.2016.11.038
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5JQ
UT WOS:000393254700002
PM 27940380
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Selvakumar, M
   Kumar, PS
   Das, B
   Dhara, S
   Chattopadhyay, S
AF Selvakumar, M.
   Kumar, P. Senthil
   Das, Bodhisatwa
   Dhara, Santanu
   Chattopadhyay, Santanu
TI Structurally Tuned Antimicrobial Mesoporous Hydroxyapatite Nanorods by
   Cyclic Oligosaccharides Regulation To Release a Drug for Osteomyelitis
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID GUIDED BONE REGENERATION; HYDROTHERMAL SYNTHESIS; CALCIUM-PHOSPHATE;
   NANOCRYSTALLINE HYDROXYAPATITE; SONOCHEMICAL SYNTHESIS; MICROBIAL
   PROTECTION; DOPED HYDROXYAPATITE; HEMOSTATIC ACTIVITY; NANOPARTICLES;
   FIBERS
AB This work unveils a straightforward and controlled biomimetic synthesis (combined modified coprecipitation and sonochemistry method) of rod-like two-dimensional (2D) hydroxyapatite (HA) nanopartides with an aspect ratio of similar to 13.2 and their mesoporous nanorods (small and large pore) by fine regulation of the morphology using a beta-cyclodextrin (beta-CD) oligomer. Various methodical characterization results such as from wide-angle X-ray diffraction, high-resolution transmission electron microscopy (HRTEM), Brunauer-Emmett-Teller analysis, and Fourier transform infrared spectroscopy comprehensively established that beta-CD acts as an effective nucleating agent by virtue of strong adsorption of alpha-D-glucopyranoside moieties of beta-CD on the surface of calcium phosphate as well as owing to electrostatic interactions due to the toroid and cyclic structure of beta-CD. Besides, improved crystallinity of HA nanorods, as well as induced crystal growth of nanorods along the [110] crystallographic direction, was observed from the HRTEM micrographs. Consequently, a plausible mechanism also is proposed for the nucleation and growth of the nanorods followed by their crystallization. Subsequently, the prepared tuned mesoporous nanorods were employed as a drug carrier and delivery system using ciprofloxacin (CFX) drug for the treatment of osteomyelitis. Eventually, CFX-encapsulated beta CD wrapped mesoporous hydroxyapatite (MPHA) nanocrystals showed a greater drug loading capability (similar to 79%). They also showed sustained release characteristics (in vitro). Furthermore, antimicrobial activity showed a significant zone of inhibition of similar to 33 mm of the CFX-loaded mesoporous frames, especially for the beta CD-MPHA nanocrystals. A hemolysis assay with human erythrocytes displayed good blood compatibility (less than similar to 1% of hemolysis) of the prepared various HA nanorods. Besides, robust cell proliferation at day 7 as well as zero toxicity level of the prepared different HA nanocrystals was confirmed by MTT assays and monitoring of cell adhesion as well as cell morphology (cytoskeleton) by fluorescence microscopy using osteoblast cells. Thus, these structurally tuned nanocrystals along with combinatorial properties indicate a broad range of potential biomedical applications particularly as a biomaterial for osteomyelitis therapy. Likewise, they can also be used as nanofillers in fabricating a bio-nanocomposite with a suitable matrix for bone tissue engineering, where infection is a major problem of osteoblast proliferation.
C1 [Selvakumar, M.; Chattopadhyay, Santanu] Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
   [Selvakumar, M.] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Ctr Rapid Prototyping Based Tissue Organ Printing, 77 Cheongam Ro, Pohang 790784, Kyungbuk, South Korea.
   [Kumar, P. Senthil] VHNSN Coll, Dept Chem, Virudunagar 626001, Tamil Nadu, India.
   [Das, Bodhisatwa; Dhara, Santanu] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
RP Chattopadhyay, S (reprint author), Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
EM santanuchat71@yahoo.com
CR Asharani PV, 2010, ADV FUNCT MATER, V20, P1233, DOI 10.1002/adfm.200901846
   Choi HW, 2006, J COLLOID INTERF SCI, V304, P277, DOI 10.1016/j.jcis.2006.05.069
   Cui WG, 2010, BIOMATERIALS, V31, P4620, DOI 10.1016/j.biomaterials.2010.02.050
   Cui WG, 2008, CRYST GROWTH DES, V8, P4576, DOI 10.1021/cg800641s
   Dalhoff A, 2015, EUR J CLIN MICROBIOL, V34, P661, DOI 10.1007/s10096-014-2296-3
   Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615
   He QJ, 2015, CRYST GROWTH DES, V15, P723, DOI 10.1021/cg501515c
   Hooper DC, 1999, DRUGS, V58, P6, DOI 10.2165/00003495-199958002-00002
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Huang FZ, 2007, J MATER SCI, V42, P8599, DOI 10.1007/s10853-007-1861-x
   Jamwal D, 2015, J PHYS CHEM C, V119, P5062, DOI 10.1021/jp510428z
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Khan AS, 2008, ACTA BIOMATER, V4, P1275, DOI 10.1016/j.actbio.2008.04.016
   Klinkamnarong J, 2009, SOLID STATE SCI, V11, P1023, DOI 10.1016/j.solidstatesciences.2009.02.003
   Kumar GS, 2014, J MATER CHEM B, V2, P5052, DOI 10.1039/c4tb00339j
   Li JH, 2012, MICROCHIM ACTA, V176, P73, DOI 10.1007/s00604-011-0693-1
   Liang T, 2013, J MATER SCI, V48, P5334, DOI 10.1007/s10853-013-7328-3
   Lin KL, 2014, ACTA BIOMATER, V10, P4071, DOI 10.1016/j.actbio.2014.06.017
   Liu J, 2009, J MATER CHEM, V19, P6073, DOI 10.1039/b900116f
   Liu YK, 2004, MATER CHEM PHYS, V86, P69, DOI 10.1016/j.matchemphys.2004.02.009
   Ma J, 2015, CRYST GROWTH DES, V15, P1273, DOI 10.1021/cg501659x
   Martins MA, 2008, J COLLOID INTERF SCI, V318, P210, DOI 10.1016/j.jcis.2007.10.008
   Matsunaga K, 2010, ACTA BIOMATER, V6, P2289, DOI 10.1016/j.actbio.2009.11.029
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Ostomel TA, 2006, J AM CHEM SOC, V128, P8384, DOI 10.1021/ja061717a
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   Peng Q, 2003, ANGEW CHEM INT EDIT, V42, P3027, DOI 10.1002/anie.200250695
   Pramanik N, 2012, LANGMUIR, V28, P14018, DOI 10.1021/la302066e
   Prouzet E, 2002, J MATER CHEM, V12, P1553, DOI 10.1039/b111236h
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rejinold NS, 2011, J COLLOID INTERF SCI, V360, P39, DOI 10.1016/j.jcis.2011.04.006
   Roy N, 2012, J PHYS CHEM C, V116, P26551, DOI 10.1021/jp305373w
   Roy N, 2012, J PHYS CHEM C, V116, P8763, DOI 10.1021/jp210835a
   Schaechter M, 1999, MICROBIOL MOL BIOL R, V63, P265
   Selvakumar M, 2016, ACS APPL MATER INTER, V8, P5941, DOI 10.1021/acsami.6b01014
   Selvakumar M, 2016, ACS APPL MATER INTER, V8, P4086, DOI 10.1021/acsami.5b11723
   Selvakumar M, 2015, J BIOMED NANOTECHNOL, V11, P291, DOI 10.1166/jbn.2015.1975
   Selvakumar M., 2015, ADV POLYM TECHNOL, V34
   Teng SH, 2006, J CRYST GROWTH, V290, P683, DOI 10.1016/j.jcrysgro.2006.02.014
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Venkatasubbu GD, 2011, 3 BIOTECH, V1, P173, DOI 10.1007/s13205-011-0021-9
   Wang SF, 2006, LANGMUIR, V22, P398, DOI 10.1021/la0518647
   Wang YM, 2015, CRYST GROWTH DES, V15, P1949, DOI 10.1021/acs.cgd.5b00113
   Wu F, 2015, CRYST GROWTH DES, V15, P2452, DOI 10.1021/acs.cgd.5b00231
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yang YS, 2014, CRYST GROWTH DES, V14, P4864, DOI 10.1021/cg501063j
   YOLLES S, 1976, ACTA PHARM SUEC, V13, P32
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhou YY, 2015, INT J NANOMED, V10, P3203, DOI 10.2147/IJN.S79241
   Zhu JJ, 2003, ADV MATER, V15, P156, DOI 10.1002/adma.200390033
NR 53
TC 4
Z9 4
U1 6
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
EI 1528-7505
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD FEB
PY 2017
VL 17
IS 2
BP 433
EP 445
DI 10.1021/acs.cgd.6b01190
PG 13
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA EJ6UG
UT WOS:000393354100006
DA 2018-10-20
ER

PT J
AU Lee, S
   Nakano, T
   Kasuga, T
AF Lee, Sungho
   Nakano, Takayoshi
   Kasuga, Toshihiro
TI Formation and structural analysis of 15MgO-15CaO-8P(2)O(5)-4SiO(2) glass
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Biomaterial; Phosphate invert glass; Magnesium; Silicate; Structure;
   Dissolution
ID PHOSPHATE INVERT GLASSES; DISSOLUTION BEHAVIORS; BIOACTIVE GLASSES;
   NMR-SPECTROSCOPY; SIO2-P2O5; SI-29; RATIO; RAMAN
AB MgO-CaO-P2O5-SiO2 invert glass in the orthophosphate region was successfully prepared using a melt quenching method, and its structure and dissolution behavior were evaluated. The P-31 and Si-29 solid-state nuclear magnetic resonance and Raman spectroscopies showed that the glass structure consisted of orthophosphate (Q(p)(0)) and orthosilicate (Q(Si)(0)) tetrahedra cross-linked by cations such as Mg2+ and Ca2+ ions; there were no chain phosphate groups and silicate network structures. MgO present in the glass acts as an intermediate oxide that cross-links Q(p)(0), and O-Si(0) thereby imparting excellent glass-forming ability. Mg2+ and Ca2+ ions present in the glass were preferentially bonded with silicate and phosphate groups to form S-O-Mg and P-O-Ca bonds, respectively. The ions-releasing amount from the glass was higher than that from previously reported phosphate invert glasses. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lee, Sungho; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Div Adv Ceram, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
   [Lee, Sungho; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Lee, Sungho] Osaka Univ, Div Mat & Mfg Sci, Suita, Osaka 565, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Div Adv Ceram, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.; Lee, S (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM leesungho@mat.eng.osaka-u.ac.jp; kasuga.toshihiro@nitech.ac.jp
RI Lee, Sungho/T-1734-2017
OI Lee, Sungho/0000-0002-4367-9573
FU JSPS KAKENHI [26289238]
FX This work was supported in part by JSPS KAKENHI Grant Number 26289238.
CR Abou Neel EA, 2009, J MATER CHEM, V19, P690, DOI 10.1039/b810675d
   Ahsan R, 2005, J NON-CRYST SOLIDS, V351, P2333, DOI 10.1016/j.jnoncryol.2005.05.030
   Brauer DS, 2015, ANGEW CHEM INT EDIT, V54, P4160, DOI 10.1002/anie.201405310
   Brauer DS, 2009, J MATER CHEM, V19, P5629, DOI 10.1039/b900956f
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   CHAKRABORTY IN, 1985, PHYS CHEM GLASSES, V26, P68
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   DUPREE R, 1987, NATURE, V328, P416, DOI 10.1038/328416a0
   Fayon F, 2013, J PHYS CHEM C, V117, P2283, DOI 10.1021/jp312263j
   Hansen MR, 2003, INORG CHEM, V42, P2368, DOI 10.1021/ic020647f
   HARTMANN P, 1994, J NON-CRYST SOLIDS, V176, P157, DOI 10.1016/0022-3093(94)90073-6
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006
   Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111
   Kasuga Toshihiro, 2012, Phosphorus Research Bulletin, V26, P8
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   Kim YI, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195205
   Lee S, 2016, MATER LETT, V175, P135, DOI 10.1016/j.matlet.2016.04.027
   Lee S, 2016, J NON-CRYST SOLIDS, V438, P18, DOI 10.1016/j.jnoncrysol.2016.02.006
   Lee S, 2015, J CERAM SOC JPN, V123, P942, DOI 10.2109/jcersj2.123.942
   Lee S, 2015, J NON-CRYST SOLIDS, V426, P35, DOI 10.1016/j.jnoncrysol.2015.06.024
   LI D, 1995, J NON-CRYST SOLIDS, V188, P181, DOI 10.1016/0022-3093(95)00100-X
   Mysen B., 2005, SILICATE GLASSES MEL, P387
   MYSEN BO, 1980, AM MINERAL, V65, P690
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Oliveira JM, 2000, J NON-CRYST SOLIDS, V265, P221, DOI 10.1016/S0022-3093(99)00957-6
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Pedone A, 2010, CHEM MATER, V22, P5644, DOI 10.1021/cm102089c
   Sales BC, 2000, J NON-CRYST SOLIDS, V263, P155, DOI 10.1016/S0022-3093(99)00644-4
   Sun YQ, 2015, J NON-CRYST SOLIDS, V420, P26, DOI 10.1016/j.jnoncrysol.2015.04.017
   Waclawska I, 2006, J THERM ANAL CALORIM, V84, P185, DOI 10.1007/s10973-005-7183-9
   Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
NR 35
TC 1
Z9 1
U1 3
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD FEB 1
PY 2017
VL 457
BP 73
EP 76
DI 10.1016/j.jnoncrysol.2016.11.020
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA EJ1ZL
UT WOS:000393009200011
DA 2018-10-20
ER

PT J
AU Myers, DR
   Qiu, YZ
   Fay, ME
   Tennenbaum, M
   Chester, D
   Cuadrado, J
   Sakurai, Y
   Baek, J
   Tran, R
   Ciciliano, JC
   Ahn, B
   Mannino, RG
   Bunting, ST
   Bennett, C
   Briones, M
   Fernandez-Nieves, A
   Smith, ML
   Brown, AC
   Sulchek, T
   Lam, WA
AF Myers, David R.
   Qiu, Yongzhi
   Fay, Meredith E.
   Tennenbaum, Michael
   Chester, Daniel
   Cuadrado, Jonas
   Sakurai, Yumiko
   Baek, Jong
   Tran, Reginald
   Ciciliano, Jordan C.
   Ahn, Byungwook
   Mannino, Robert G.
   Bunting, Silvia T.
   Bennett, Carolyn
   Briones, Michael
   Fernandez-Nieves, Alberto
   Smith, Michael L.
   Brown, Ashley C.
   Sulchek, Todd
   Lam, Wilbur A.
TI Single-platelet nanomechanics measured by high-throughput cytometry
SO NATURE MATERIALS
LA English
DT Article
ID KNOB-HOLE INTERACTIONS; CONTRACTILE-FORCE; CLOT; FIBRIN; POLYMERIZATION;
   ELASTICITY; ACTIVATION; STRESS
AB Haemostasis occurs at sites of vascular injury, where flowing blood forms a clot, a dynamic and heterogeneous fibrin based biomaterial. Paramount in the clot's capability to stem haemorrhage are its changing mechanical properties, the major drivers of which are the contractile forces exerted by platelets against the fibrin scaffold(1). However, how platelets transduce microenvironmental cues to mediate contraction and alter clot mechanics is unknown. This is clinically relevant, as overly softened and stiffened clots are associated with bleeding(2) and thrombotic disorders(3). Here, we report a high throughput hydrogel-based platelet-contraction cytometer that quantifies single-platelet contraction forces in different clot microenvironments. We also show that platelets, via the Rho/ROCK pathway, synergistically couple mechanical and biochemical inputs to mediate contraction. Moreover, highly contractile platelet subpopulations present in healthy controls are conspicuously absent in a subset of patients with undiagnosed bleeding disorders, and therefore may function as a clinical diagnostic biophysical biomarker.
C1 [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ciciliano, Jordan C.; Ahn, Byungwook; Mannino, Robert G.; Bennett, Carolyn; Briones, Michael; Lam, Wilbur A.] Emory Univ, Sch Med, Aflac Canc Ctr, Dept Pediat,Div Pediat Hematol Oncol, Atlanta, GA 30322 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ciciliano, Jordan C.; Ahn, Byungwook; Mannino, Robert G.; Bennett, Carolyn; Briones, Michael; Lam, Wilbur A.] Emory Univ, Sch Med, Blood Disorders Serv, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ahn, Byungwook; Mannino, Robert G.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ahn, Byungwook; Mannino, Robert G.; Lam, Wilbur A.] Emory Univ, Atlanta, GA 30332 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ciciliano, Jordan C.; Ahn, Byungwook; Mannino, Robert G.; Lam, Wilbur A.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ciciliano, Jordan C.; Ahn, Byungwook; Mannino, Robert G.; Fernandez-Nieves, Alberto; Lam, Wilbur A.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Myers, David R.; Qiu, Yongzhi; Fay, Meredith E.; Sakurai, Yumiko; Baek, Jong; Tran, Reginald; Ciciliano, Jordan C.; Ahn, Byungwook; Mannino, Robert G.; Lam, Wilbur A.] Georgia Inst Technol, Inst Elect & Nanotechnol, Atlanta, GA 30332 USA.
   [Tennenbaum, Michael; Cuadrado, Jonas; Fernandez-Nieves, Alberto] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.
   [Chester, Daniel; Brown, Ashley C.] North Carolina State Univ & Univ North Carolina C, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
   [Chester, Daniel; Brown, Ashley C.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.
   [Ciciliano, Jordan C.; Sulchek, Todd] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Bunting, Silvia T.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Dept Pathol, Atlanta, GA 30322 USA.
   [Smith, Michael L.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Lam, WA (reprint author), Emory Univ, Sch Med, Aflac Canc Ctr, Dept Pediat,Div Pediat Hematol Oncol, Atlanta, GA 30322 USA.; Lam, WA (reprint author), Emory Univ, Sch Med, Blood Disorders Serv, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.; Lam, WA (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Lam, WA (reprint author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Lam, WA (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Lam, WA (reprint author), Georgia Inst Technol, Inst Elect & Nanotechnol, Atlanta, GA 30332 USA.
EM wilbur.lam@emory.edu
RI Fernandez-Nieves, Alberto/S-1955-2018; Myers, David/G-7542-2017
OI Fernandez-Nieves, Alberto/0000-0002-1286-9809; Myers,
   David/0000-0001-9659-3274
FU NIH R01 [HL121264]; NSF CAREER [1150235]; AHA Postdoctoral Fellowship;
   NIH U54 [HL112309]
FX The authors wish to thank A. Shaw of the Parker H. Petit Institute for
   Bioengineering and Bioscience at the Georgia Institute of Technology
   (GT); N. Anthony and the Emory University Integrated Cellular Imaging
   Microscopy Core of the Children's Pediatric Research Center; and the GT
   Institute for Electronics and Nanotechnology (IEN) cleanroom. Financial
   support provided by NIH R01 (HL121264), NIH U54 (HL112309), and NSF
   CAREER (1150235) to W.A.L., as well as an AHA Postdoctoral Fellowship to
   D.R.M. are acknowledged. D.R.M. thanks Christy R. Dillon and Gabriel A.
   Kwong for comments and discussion.
CR Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090
   Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55
   COHEN I, 1973, NATURE, V246, P36, DOI 10.1038/246036a0
   Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c
   De Gennes P.-G., SCALING CONCEPTS POL
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   GODWIN HA, 1974, BRIT J HAEMATOL, V26, P117, DOI 10.1111/j.1365-2141.1974.tb00455.x
   Henriques SS, 2012, J CELL SCI, V125, P3914, DOI 10.1242/jcs.108126
   Hvas AM, 2007, J THROMB HAEMOST, V5, P2408, DOI 10.1111/j.1538-7836.2007.02755.x
   JEN CJ, 1982, CELL MOTIL CYTOSKEL, V2, P445, DOI 10.1002/cm.970020504
   Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026437
   Kroll MH, 1996, BLOOD, V88, P1525
   Lam WA, 2011, NAT MATER, V10, P61, DOI [10.1038/nmat2903, 10.1038/NMAT2903]
   Liang XM, 2010, LAB CHIP, V10, P991, DOI 10.1039/b918719g
   Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039
   Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910
   Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Qiu YZ, 2014, P NATL ACAD SCI USA, V111, P14430, DOI 10.1073/pnas.1322917111
   Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667
   Shcherbina A, 2010, BRIT J HAEMATOL, V148, P416, DOI 10.1111/j.1365-2141.2009.07959.x
   Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739
   Suzuki-Inoue K, 2007, THROMB RES, V120, P251, DOI 10.1016/j.thromres.2006.09.003
   Weisel JW, 2008, SCIENCE, V320, P456, DOI 10.1126/science.1154210
   Young G, 2013, BLOOD, V121, P1944, DOI 10.1182/blood-2012-08-378935
NR 26
TC 19
Z9 19
U1 2
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD FEB
PY 2017
VL 16
IS 2
BP 230
EP 235
DI 10.1038/NMAT4772
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EJ6ST
UT WOS:000393349800017
PM 27723740
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Musa, A
   Ahmad, MB
   Hussein, MZ
   Saiman, MI
   Sani, HA
AF Musa, Aminu
   Ahmad, Mansor B.
   Hussein, Mohd Zobir
   Saiman, Mohd Izham
   Sani, Hannatu Abubakar
TI Preparation, characterization and catalytic activity of
   biomaterial-supported copper nanoparticles
SO RESEARCH ON CHEMICAL INTERMEDIATES
LA English
DT Article
DE Nanocrystalline cellulose; Copper nanoparticles; Hydrazine hydrate;
   Methylene blue; Catalyst
ID IN-SITU SYNTHESIS; HYDROLYTIC DEHYDROGENATION; CELLULOSE NANOCRYSTALS;
   COUPLING REACTION; AG NANOPARTICLES; AMMONIA BORANE; STEP SYNTHESIS;
   REDUCTION; 4-NITROPHENOL; SILVER
AB Synthesis of copper nanoparticles was carried out with nanocrystalline cellulose (NCC) as a support by reducing CuSO(4.)5H(2)O ions using hydrazine. Ascorbic acid and aqueous NaOH were also used as an antioxidant and pH controller, respectively. The synthesized copper nanoparticles supported on NCC (CuNPs@NCC) were characterized by UV-vis, XRD, TEM, XRF, TGA, DSC, N-2 adsorption-desorption method at 77 K and FTIR. The UV-vis confirmed the formation and stability of the CuNPs, which indicated that the maximum absorbance of CuNPs@NCC was at 590 nm due to the surface plasmon absorption of CuNPs. Morphological characterization clearly showed the formation of a spherical structure of the CuNPs with the mean diameter and standard deviation of 2.71 +/- 1.12 nm. Similarly, XRD showed that the synthesized CuNPs@NCC was of high purity. The thermal analysis showed that the CuNPs@NCC exhibited better thermal behaviors than NCC. BET surface area revealed that the N-2 adsorption-desorption isotherms of CuNPs@NCC featured a type IV isotherm with an H3 hysterisis loop. This chemical method is simple, cost effective, and environmentally friendly. Compared to NCC-supported CuNPs and unsupported CuNPs, the as-prepared CuNPs@NCC exhibit a superior catalytic activity and high sustainability for the reduction of methylene blue with NaBH4 in aqueous solution at room temperature. The CuNPs@NCC achieved complete reduction of MB with completion time, rate constant and correlation coefficient (R-2) of 12 min, 0.7421 min(-1) and 0.9922, respectively.
C1 [Musa, Aminu; Ahmad, Mansor B.; Saiman, Mohd Izham; Sani, Hannatu Abubakar] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.
   [Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Adv Mat & Nanotechnol Lab, Serdang 43400, Selangor, Malaysia.
   [Musa, Aminu] Umaru Musa Yaradua Univ, Fac Nat & Appl Sci, Dept Pure & Ind Chem, Dutsin Ma Rd,PMB 2218, Katsina 820001, Nigeria.
RP Musa, A; Ahmad, MB (reprint author), Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.; Musa, A (reprint author), Umaru Musa Yaradua Univ, Fac Nat & Appl Sci, Dept Pure & Ind Chem, Dutsin Ma Rd,PMB 2218, Katsina 820001, Nigeria.
EM aminuy2008@yahoo.com; mansorahmad@upm.edu.my
CR Ali Soomro R, 2014, ADV MAT LETT, V5, P191
   Bindhu MR, 2014, SPECTROCHIM ACTA A, V128, P37, DOI 10.1016/j.saa.2014.02.119
   Bogdanovic U, 2014, MATER LETT, V128, P75, DOI 10.1016/j.matlet.2014.04.106
   Charinpanitkul T, 2009, MATER CHEM PHYS, V116, P125, DOI 10.1016/j.matchemphys.2009.02.060
   Dang T. M. D., 2011, NANOSCIENCE NANOTECH, V2, P15009, DOI DOI 10.1088/2043-6262/2/1/015009
   Dong CF, 2014, PHYSICA E, V57, P12, DOI 10.1016/j.physe.2013.10.025
   Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043
   Ghosh BK, 2015, POWDER TECHNOL, V269, P371, DOI 10.1016/j.powtec.2014.09.027
   Huang CC, 2013, CHEM ENG J, V219, P311, DOI 10.1016/j.cej.2013.01.016
   Huang JZ, 2014, RICE, V7, DOI 10.1186/s12284-014-0013-6
   Kawasaki H, 2011, CHEM COMMUN, V47, P7740, DOI 10.1039/c1cc12346g
   Liang M, 2014, J MATER SCI, V49, P1639, DOI 10.1007/s10853-013-7847-y
   Lu P, 2012, CARBOHYD POLYM, V87, P564, DOI 10.1016/j.carbpol.2011.08.022
   Lu P, 2010, CARBOHYD POLYM, V82, P329, DOI 10.1016/j.carbpol.2010.04.073
   Maity P, 2013, ACS CATAL, V3, P182, DOI 10.1021/cs3007318
   Mao AQ, 2015, J MOL STRUCT, V1079, P396, DOI 10.1016/j.molstruc.2014.09.003
   Muniz-Miranda M, 2011, J PHYS CHEM C, V115, P5021, DOI 10.1021/jp1086027
   Musa A, 2016, J NANOMATER, DOI 10.1155/2016/2490906
   Naik B, 2012, POWDER TECHNOL, V232, P1, DOI 10.1016/j.powtec.2012.07.052
   Naik B, 2011, CATAL COMMUN, V12, P1104, DOI 10.1016/j.catcom.2011.03.028
   Nasrollahzadeh M, 2014, RSC ADV, V4, P47313, DOI 10.1039/c4ra08863h
   Padalkar S, 2010, LANGMUIR, V26, P8497, DOI 10.1021/la904439p
   Rezayat M, 2014, ACS SUSTAIN CHEM ENG, V2, P1241, DOI 10.1021/sc500079q
   Salavati-Niasari M, 2010, APPL SURF SCI, V256, P4003, DOI 10.1016/j.apsusc.2010.01.067
   Seah K., 2013, J NANOPARTICLES RESO, V15, P1537
   Shameli K, 2011, INT J NANOMED, V6, P271, DOI 10.2147/IJN.S16043
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Solanki JN, 2010, SOLID STATE SCI, V12, P1560, DOI 10.1016/j.solidstatesciences.2010.06.021
   Usman MS, 2013, INT J NANOMED, V8, P4467, DOI 10.2147/IJN.S50837
   Usman MS, 2012, MOLECULES, V17, P14928, DOI 10.3390/molecules171214928
   Venkatakrishnan S, 2014, RSC ADV, V4, P15003, DOI 10.1039/c4ra01126k
   Yang YW, 2014, RSC ADV, V4, P13749, DOI 10.1039/c3ra47023g
   Yao QL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07597
   Zhou RM, 2008, NUCL INSTRUM METH B, V266, P599, DOI 10.1016/j.nimb.2007.11.040
   Zhu MY, 2013, J MATER CHEM A, V1, P2118, DOI 10.1039/c2ta00669c
NR 35
TC 3
Z9 3
U1 8
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0922-6168
EI 1568-5675
J9 RES CHEM INTERMEDIAT
JI Res. Chem. Intermed.
PD FEB
PY 2017
VL 43
IS 2
BP 801
EP 815
DI 10.1007/s11164-016-2665-x
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA EL1IQ
UT WOS:000394374300014
DA 2018-10-20
ER

PT J
AU Khan, I
   Dutta, JR
   Ganesan, R
AF Khan, Imran
   Dutta, Jayati Ray
   Ganesan, Ramakrishnan
TI Lactobacillus sps. lipase mediated poly (epsilon-caprolactone)
   degradation
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Lactobacilllus sps.; Poly (epsilon-caprolactone); Lipase
ID ENZYMATIC DEGRADATION; POLY(EPSILON-CAPROLACTONE); FILMS;
   POLY(L-LACTIDE); BIODEGRADABILITY; BIOMATERIAL; PLASTICS; BLEND
AB Polymer degradation through lipase appears to be an enthralling alternative to bulk chemical routes. Poly (epsilon-caprolactone) (PCL) is an artificial polyester that can be degraded by microbes and enzymes like lipases and esterases. The environmental degradation of PCL is dependent on the activity of bacteria that characterization techniques such as thermogravimetric analysis, differential thermal are widely present in the ecosystem. In this study, three different lipases derived from Lactobacillus brevis, Lactobacillus plantarum and their co-culture have been utilized to explore their efficiency towards PCL enzymatic degradation. The effect of parameters such as enzyme loading and degradation time has been explored to understand the efficiency of the enzymes used in this study. Various analysis, scanning electron microscopy and Fourier transform infrared spectroscopy have been employed to study the enzymatic degradation and its possible mechanistic insight. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Khan, Imran; Dutta, Jayati Ray] BITS Pilani, Dept Biol Sci, Hyderabad Campus, Hyderabad 500078, Telangana, India.
   [Ganesan, Ramakrishnan] BITS Pilani, Dept Chem, Hyderabad Campus, Hyderabad 500078, Telangana, India.
RP Dutta, JR (reprint author), BITS Pilani, Dept Biol Sci, Hyderabad Campus, Hyderabad 500078, Telangana, India.; Ganesan, R (reprint author), BITS Pilani, Dept Chem, Hyderabad Campus, Hyderabad 500078, Telangana, India.
EM jayati@hyderabad.bits-pilani.ac.in;
   ram.ganesan@hyderabad.bits-pilani.ac.in
FU Birla Institute of Technology & Science (BITS), Pilani Hyderabad campus
FX The authors would like to thank Birla Institute of Technology & Science
   (BITS), Pilani Hyderabad campus for their financial support. All
   technical staff in the Biological Sciences department and Central
   Analytical Laboratory of BITS, Pilani, Hyderabad Campus, are greatly
   acknowledged for their kind assistance.
CR Banerjee A, 2014, MATER SCI TECH-LOND, V30, P567, DOI 10.1179/1743284713Y.0000000503
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P327, DOI 10.1002/app.1983.070280128
   Bosworth LA, 2010, POLYM DEGRAD STABIL, V95, P2269, DOI 10.1016/j.polymdegradstab.2010.09.007
   Cho K, 2002, J APPL POLYM SCI, V83, P868, DOI 10.1002/app.10084
   Eldsater C, 2000, POLYMER, V41, P1297, DOI 10.1016/S0032-3861(99)00278-5
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   Ganesh M, 2012, POLYMER, V53, P3454, DOI 10.1016/j.polymer.2012.06.017
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8
   Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016
   Hoshino A, 2002, BIODEGRADATION, V13, P141, DOI 10.1023/A:1020450326301
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Kyrikou I, 2007, J POLYM ENVIRON, V15, P227, DOI 10.1007/s10924-007-0063-6
   Lebendiker T.D. Mario, 2010, METHOD MOL BIOL, V681, P281
   Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k
   Maia MDD, 1999, REV MICROBIOL, V30, P304
   Martins AM, 2009, TISSUE ENG PT A, V15, P295, DOI 10.1089/ten.tea.2008.0025
   MCKAY LL, 1990, FEMS MICROBIOL LETT, V87, P3, DOI 10.1016/0378-1097(90)90694-L
   Miao ZM, 2007, J BIOMED MATER RES B, V81B, P40, DOI 10.1002/jbm.b.30634
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Murphy CA, 1996, APPL ENVIRON MICROB, V62, P456
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pastorino L, 2004, ENZYME MICROB TECH, V35, P321, DOI 10.1016/j.enzmictec.2004.05.005
   Pera LM, 2006, FOOD TECHNOL BIOTECH, V44, P247
   Plackett DV, 2006, PACKAG TECHNOL SCI, V19, P1, DOI 10.1002/pts.704
   Ramyasree S., 2013, BIOCATAL AGR BIOTECH, V4, P393
   Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003
   Schneider T, 2011, MACROMOL SYMP, V309-310, P28, DOI 10.1002/masy.201100057
   Shah AA, 2015, INT BIODETER BIODEGR, V98, P35, DOI 10.1016/j.ibiod.2014.11.017
   Song JH, 2009, PHILOS T R SOC B, V364, P2127, DOI 10.1098/rstb.2008.0289
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722
   Wischke C, 2011, MACROMOL SYMP, V309-310, P59, DOI 10.1002/masy.201100050
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092
NR 36
TC 4
Z9 4
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2017
VL 95
BP 126
EP 131
DI 10.1016/j.ijbiomac.2016.11.040
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EJ0MK
UT WOS:000392903000017
PM 27865950
DA 2018-10-20
ER

PT J
AU Gharibzahedi, SMT
   Mohammadnabi, S
AF Gharibzahedi, Seyed Mohammad Taghi
   Mohammadnabi, Sara
TI Effect of novel bioactive edible coatings based on jujube gum and nettle
   oil-loaded nanoemulsions on the shelf-life of Beluga sturgeon fillets
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Jujube mucilage; Ziziphus jujuba Mill.; Edible coating; Nanoemulsion;
   Quality maintenance; Fish fillet
ID CHILLED STORAGE; CANTHAXANTHIN EMULSIONS; ANTIMICROBIAL ACTIVITY;
   HIGH-PRESSURE; QUALITY; CHITOSAN; STABILITY; FILMS; PRESERVATION; FISH
AB Effect of jujube gum (JG; 4,8 and 12% wt)-based nanoemulsions (NEs) containing nettle essential oil (NEO; 2,3.5 and 5% wt) as new edible coatings was investigated to preserve Beluga sturgeon fillets (BSFs) during 15 day-refrigerated storage at 4 degrees C. Physical (weight loss, cooking loss, color and texture), chemical (pH, FFA, PV, TBARS and TVB-N), microbiological (total and psychrotrophic bacterial counts), and sensorial characteristics of BSFs were kinetically analyzed. Preliminary studies showed that the NEs formulated with NEO lower than 5% at all JG concentrations were able to form stable coating solutions owing to the highest short-term stability (>90%) and entrapment efficiency (94.4-98.3%). Edible NE coating formulated with 12% JG and 3.5% NEO as a novel antimicrobial and antioxidant biomaterial exhibited the lowest weight and cooking losses, pH changes, textural and color deterioration, lipid oxidation and microbial growth in BSFs refrigerated over a period of 15 days (P<0.05). (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gharibzahedi, Seyed Mohammad Taghi] Islamic Azad Univ, Sci & Res Branch, Young Researchers & Elites Club, Tehran 1477893855, Iran.
   [Mohammadnabi, Sara] Univ Tehran Med Sci, Osteoporosis Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.
RP Gharibzahedi, SMT (reprint author), Islamic Azad Univ, Sci & Res Branch, Young Researchers & Elites Club, Tehran 1477893855, Iran.
EM smt.gharibzahedi@gmail.com
OI Gharibzahedi, Seyed Mohammad Taghi/0000-0001-6280-8361
CR AOCS, 1990, OFFICIAL METHODS REC
   Atares L, 2016, TRENDS FOOD SCI TECH, V48, P51, DOI 10.1016/j.tifs.2015.12.001
   Aubourg SP, 2001, J AM OIL CHEM SOC, V78, P857, DOI 10.1007/s11746-001-0355-3
   Cheret R, 2005, J FOOD SCI, V70, pE477, DOI 10.1111/j.1365-2621.2005.tb11518.x
   Dehnad D, 2014, CARBOHYD POLYM, V109, P148, DOI 10.1016/j.carbpol.2014.03.063
   Delbarre-Ladrat C, 2006, CRIT REV FOOD SCI, V46, P409, DOI 10.1080/10408390591000929
   Fan WJ, 2008, FOOD CHEM, V108, P148, DOI 10.1016/j.foodchem.2007.10.057
   Feng X, 2016, FOOD CHEM, V200, P283, DOI 10.1016/j.foodchem.2016.01.030
   Frank B., 1998, HAGERS HDB DROGEN AR, P710
   Galus S, 2015, TRENDS FOOD SCI TECH, V45, P273, DOI 10.1016/j.tifs.2015.07.011
   Genc IY, 2013, J FOOD ENG, V115, P486, DOI 10.1016/j.jfoodeng.2012.09.007
   Gharibzahedi SMT, 2016, J MOL LIQ, V224, P1332, DOI 10.1016/j.molliq.2016.10.120
   Gharibzahedi SMT, 2015, J FOOD PROCESS PRES, V39, P2947, DOI 10.1111/jfpp.12546
   Gharibzahedi SMT, 2013, CARBOHYD POLYM, V96, P21, DOI 10.1016/j.carbpol.2013.03.085
   Gharibzahedi SMT, 2013, CARBOHYD POLYM, V92, P2002, DOI 10.1016/j.carbpol.2012.11.083
   Gharibzahedi SMT, 2012, INT J BIOL MACROMOL, V50, P376, DOI 10.1016/j.ijbiomac.2011.12.008
   Hashemi FS, 2015, RSC ADV, V5, P42346, DOI 10.1039/c5ra03190g
   Hung CF, 2012, NUTRITION, V28, P98, DOI 10.1016/j.nut.2011.05.009
   Schelegueda LI, 2015, LWT-FOOD SCI TECHNOL, V64, P794, DOI 10.1016/j.lwt.2015.06.017
   Jeon YJ, 2002, J AGR FOOD CHEM, V50, P5167, DOI 10.1021/jf011693l
   Jung S, 2003, LEBENSM-WISS TECHNOL, V36, P625, DOI 10.1016/S0023-6438(03)00082-3
   Kanatt SR, 2013, LWT-FOOD SCI TECHNOL, V53, P321, DOI 10.1016/j.lwt.2013.01.019
   Kirk R. S., 1991, PEARSONS COMPOSITION
   Lalitharani S, 2010, J HERB MED TOXICOL, V4, P191
   Li TT, 2013, FOOD CHEM, V138, P821, DOI 10.1016/j.foodchem.2012.11.092
   Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x
   Mahmoud BSM, 2004, FOOD MICROBIOL, V21, P657, DOI 10.1016/j.fm.2004.03.001
   McClements DJ, 2011, SOFT MATTER, V7, P2297, DOI 10.1039/c0sm00549e
   Mehrnia MA, 2016, INT J BIOL MACROMOL, V84, P261, DOI 10.1016/j.ijbiomac.2015.12.029
   Natseba A, 2005, FOOD RES INT, V38, P469, DOI 10.1016/j.foodres.2004.10.014
   Ojagh SM, 2010, FOOD CHEM, V120, P193, DOI 10.1016/j.foodchem.2009.10.006
   PARK HJ, 1995, J FOOD ENG, V25, P497, DOI 10.1016/0260-8774(94)00029-9
   Pinelli P, 2008, J AGR FOOD CHEM, V56, P9127, DOI 10.1021/jf801552d
   Raso J, 2003, CRIT REV FOOD SCI, V43, P265, DOI 10.1080/10408690390826527
   Rostami H, 2016, CARBOHYD POLYM, V143, P100, DOI 10.1016/j.carbpol.2016.01.075
   Sallam KI, 2007, FOOD CONTROL, V18, P566, DOI 10.1016/j.foodcont.2006.02.002
   Salvia-Trujillo L, 2015, FOOD HYDROCOLLOID, V43, P547, DOI 10.1016/j.foodhyd.2014.07.012
   Serdaroglu M, 2005, J FOOD QUALITY, V28, P109, DOI 10.1111/j.1745-4557.2005.00016.x
   Skipnes D, 2007, J FOOD ENG, V80, P1078, DOI 10.1016/j.jfoodeng.2006.08.015
   Song YL, 2011, FOOD CONTROL, V22, P608, DOI 10.1016/j.foodcont.2010.10.012
   Tyburcy A., 2006, Roczniki Instytutu Przemyslu Miesnego i Tluszczowego, V44, P149
   Volpe MG, 2015, LWT-FOOD SCI TECHNOL, V60, P615, DOI 10.1016/j.lwt.2014.08.048
   Yue PF, 2009, AAPS PHARMSCITECH, V10, P376, DOI 10.1208/s12249-009-9216-3
NR 43
TC 6
Z9 6
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2017
VL 95
BP 769
EP 777
DI 10.1016/j.ijbiomac.2016.11.119
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EJ0MK
UT WOS:000392903000095
PM 27919809
DA 2018-10-20
ER

PT J
AU Shankar, KG
   Gostynska, N
   Montesi, M
   Panseri, S
   Sprio, S
   Kon, E
   Marcacci, M
   Tampieri, A
   Sandri, M
AF Shankar, K. Gopal
   Gostynska, Natalia
   Montesi, Monica
   Panseri, Silvia
   Sprio, Simone
   Kon, Elizaveta
   Marcacci, Maurilio
   Tampieri, Anna
   Sandri, Monica
TI Investigation of different cross-linking approaches on 3D gelatin
   scaffolds for tissue engineering application: A comparative analysis
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Gelatin; Dehydrothermal; BDDGE; Genipin; Tissue engineering; Cartilage
ID COMPOSITE SCAFFOLDS; BONE TISSUE; IN-VITRO; GENIPIN; COLLAGEN; CHITOSAN;
   REGENERATION; ACID; STABILIZATION; BIOMATERIAL
AB The present study aims to investigate the physical-chemical and biological features exhibited by porous scaffolds for regeneration of cartilaginous tissues obtained through stabilization of 3D gelatin hydrogels by physical (DHT), chemical (BDDGE) and natural (Genipin) cross-linking approaches. The study aimed at comparatively assessing the porous microstructure and the long-term resistance of the scaffolds upon degradation in wet physiological conditions (37 degrees C, pH = 7.4). The degree of cross-linking increases as function of incorporation of cross-linkers which was maximum up to 73% for BDDGE. The infrared spectroscopy and thermal analysis confirmed the gelatin structure was preserved during the cross-linking treatments. Mechanical properties of the scaffolds were analysed by static and dynamic compression test, which showed different viscoelastic behaviour upon various cross-linking strategies. The biological performance of the scaffolds investigated using human chondrocytes showed good cell adhesion, viability and proliferation, as well as extensive 3D scaffold colonization. Besides, the analysis of gene expression related to the formation of new chondral tissue reported increasing ability with time in the formation of new extra-cellular matrix. In conclusion, out of three different cross-linking methods, the gelatin scaffolds subjected to dehydrothermal treatment (DHT) represented to be the most favourable 3D scaffold for cartilage regeneration. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Shankar, K. Gopal; Gostynska, Natalia; Kon, Elizaveta; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Clin Biomech Lab 2, I-40136 Bologna, Italy.
   [Montesi, Monica; Panseri, Silvia; Sprio, Simone; Tampieri, Anna; Sandri, Monica] CNR, Inst Sci & Technol Ceram, Faenza, RA, Italy.
RP Shankar, KG; Gostynska, N (reprint author), Rizzoli Orthopaed Inst, Clin Biomech Lab 2, I-40136 Bologna, Italy.
EM gopal.krishnakumar2@unibo.it; nataliaewa.gostynska@ior.it
OI Sandri, Monica/0000-0001-5782-3137; Sprio, Simone/0000-0003-1526-7915;
   Gostynska, Natalia/0000-0003-3648-2577
FU European Project BIOINSPIRE-Training program on new bio-inspired bone
   regeneration" [FP7-PEOPLE-2013 ITN-607051]
FX This work is supported by "European Project BIOINSPIRE-Training program
   on new bio-inspired bone regeneration (FP7-PEOPLE-2013 ITN-607051)".
CR Agarwal T., 2016, INT J BIOL MACROMOL
   Amadori S, 2015, MACROMOL BIOSCI, V15, P941, DOI 10.1002/mabi.201500014
   Arora A, 2015, J MECH BEHAV BIOMED, V51, P169, DOI 10.1016/j.jmbbm.2015.06.033
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Comes S. R., 2013, MAT SCI ENG C, V33, P1219
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Fwu M. I., 2000, J POLYM SCI A, V38, P2804
   Gentile P, 2012, J BIOMED MATER RES A, V100A, P2654, DOI 10.1002/jbm.a.34205
   Gorczyca G, 2014, CARBOHYD POLYM, V102, P901, DOI 10.1016/j.carbpol.2013.10.060
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Islam MM, 2015, MAT SCI ENG C-MATER, V49, P648, DOI 10.1016/j.msec.2015.01.066
   Ko JH, 2010, MACROMOL RES, V18, P137, DOI 10.1007/s13233-009-0103-2
   Koh LB, 2013, J FUNCT BIOMATER, V4, P162, DOI 10.3390/jfb4030162
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Nicoletti A, 2013, J MATER SCI-MATER M, V24, P17, DOI 10.1007/s10856-012-4782-4
   Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021
   Poursamar SA, 2015, MAT SCI ENG C-MATER, V48, P63, DOI 10.1016/j.msec.2014.10.074
   Prasertsung I, 2010, SURF COAT TECH, V205, pS133, DOI 10.1016/j.surfcoat.2010.06.063
   Rathore HS, 2016, MATER LETT, V177, P108, DOI 10.1016/j.matlet.2016.04.185
   Rose P. J., 1982, ENCY CHEM TECHNOLOGY, V7
   Sprio S, 2012, J NANOMATER, DOI 10.1155/2012/418281
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200
   Tonda-Turo C, 2011, INT J BIOL MACROMOL, V49, P700, DOI 10.1016/j.ijbiomac.2011.07.002
   Tungtasana H, 2010, J MATER SCI-MATER M, V21, P3151, DOI 10.1007/s10856-010-4159-5
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Whu SW, 2013, MAT SCI ENG C-MATER, V33, P2855, DOI 10.1016/j.msec.2013.03.003
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
NR 41
TC 9
Z9 9
U1 2
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2017
VL 95
BP 1199
EP 1209
DI 10.1016/j.ijbiomac.2016.11.010
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA EJ0MK
UT WOS:000392903000143
PM 27836656
DA 2018-10-20
ER

PT J
AU Iyer, NR
   Wilems, TS
   Sakiyama-Elbert, SE
AF Iyer, Nisha R.
   Wilems, Thomas S.
   Sakiyama-Elbert, Shelly E.
TI Stem cells for spinal cord injury: Strategies to inform differentiation
   and transplantation
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE induced pluripotent stem cells; embryonic stem cells; neuronal
   differentiation; biomaterial scaffolds; transcriptional reprogramming;
   combination therapy
ID CENTRAL-NERVOUS-SYSTEM; NEURAL PROGENITOR CELLS; ADULT HUMAN
   FIBROBLASTS; ANTI-INHIBITORY MOLECULES; IN-VITRO DIFFERENTIATION;
   FUNCTIONAL RECOVERY; DIRECT CONVERSION; MOTOR-NEURONS; AXONAL
   REGENERATION; MOUSE FIBROBLASTS
AB The complex pathology of spinal cord injury (SCI), involving a cascade of secondary events and the formation of inhibitory barriers, hampers regeneration across the lesion site and often results in irreversible loss of motor function. The limited regenerative capacity of endogenous cells after SCI has led to a focus on the development of cell therapies that can confer both neuroprotective and neuroregenerative benefits. Stem cells have emerged as a candidate cell source because of their ability to self-renew and differentiate into a multitude of specialized cell types. While ethical and safety concerns impeded the use of stem cells in the past, advances in isolation and differentiation methods have largely mitigated these issues. A confluence of work in stem cell biology, genetics, and developmental neurobiology has informed the directed differentiation of specific spinal cell types. After transplantation, these stem cell-derived populations can replace lost cells, provide trophic support, remyelinate surviving axons, and form relay circuits that contribute to functional recovery. Further refinement of stem cell differentiation and transplantation methods, including combinatorial strategies that involve biomaterial scaffolds and drug delivery, is critical as stem cell-based treatments enter clinical trials. Biotechnol. Bioeng. 2017;114: 245-259. (c) 2016 Wiley Periodicals, Inc.
C1 [Iyer, Nisha R.; Wilems, Thomas S.; Sakiyama-Elbert, Shelly E.] Univ Texas Austin, Dept Biomed Engn, 107 W Dean Keeton St,Stop C0800 BME 3-314, Austin, TX 78712 USA.
EM sakiyama@utexas.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NINDS NIH HHS [R01 NS090617, F31 NS090760, R01 NS051454]
CR Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002
   Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Asterias B, 2016, ASTERIAS BIOTHERAPEU
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014
   Benveniste RJ, 2005, J NEUROSURG, V103, P115, DOI 10.3171/jns.2005.103.1.0115
   Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887
   Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2
   Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207
   Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0
   Brown CR, 2014, STEM CELLS DEV, V23, P1765, DOI 10.1089/scd.2013.0628
   Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754
   Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007
   Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002
   Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   Corti S, 2012, EXP CELL RES, V318, P1528, DOI 10.1016/j.yexcr.2012.02.040
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682
   Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401
   Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024
   David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9
   Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85
   Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410
   Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868
   Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382
   DeVivo MJ, 2011, TOPICS SPINAL CORD I, V16, P1
   Diez del Corral R., 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8
   Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075
   Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X
   Dyck J, 2012, J NEUROPHYSIOL, V107, P3256, DOI 10.1152/jn.01132.2011
   Emdad L, 2012, STEM CELLS DEV, V21, P404, DOI 10.1089/scd.2010.0560
   Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Falnikar A, 2015, BRAIN RES, V1619, P91, DOI 10.1016/j.brainres.2014.09.037
   Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007
   Filli L, 2015, NEURAL REGEN RES, V10, P509, DOI 10.4103/1673-5374.155425
   Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016
   Fuhrmann T, 2015, METHODS, V84, P60, DOI 10.1016/j.ymeth.2015.03.023
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1
   Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409
   Gunther MI, 2015, ACTA BIOMATER, V27, P140, DOI 10.1016/j.actbio.2015.09.001
   Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203
   Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2
   Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135
   Hitoshi S, 2002, DEVELOPMENT, V129, P233
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Hollis ER, 2016, NEUROTHERAPEUTICS, V13, P360, DOI 10.1007/s13311-015-0416-0
   Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Husch A, 2012, J NEUROSCI, V32, P13145, DOI 10.1523/JNEUROSCI.2995-12.2012
   Isa T, 2014, NEUROSCI RES, V78, P3, DOI 10.1016/j.neures.2013.10.008
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iyer NR, 2016, EXP NEUROL, V277, P305, DOI 10.1016/j.expneurol.2016.01.011
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   Kabu S, 2015, J CONTROL RELEASE, V219, P141, DOI 10.1016/j.jconrel.2015.08.060
   Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010
   KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Khazaei M, 2015, J CLIN MED, V4, P37, DOI 10.3390/jcm4010037
   Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108
   Kim M, 2009, DEV BIOL, V328, P456, DOI 10.1016/j.ydbio.2009.02.001
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kim M, 2014, HISTOL HISTOPATHOL, V29, P1395, DOI 10.14670/HH-29.1395
   Knight GT, 2015, CHEM COMMUN, V51, P5238, DOI 10.1039/c4cc08665a
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kubinova S, 2015, J TISSUE ENG REGEN M, V9, P1298, DOI 10.1002/term.1694
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030461
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261
   Lee KJ, 2000, NATURE, V403, P734
   Li HY, 2013, J MATER SCI-MATER M, V24, P2001, DOI 10.1007/s10856-013-4956-8
   Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]
   Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109
   Luna-Zurita L, 2013, CURR OPIN GENET DEV, V23, P556, DOI 10.1016/j.gde.2013.07.002
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212
   Marro S, 2014, METHODS MOL BIOL, V1150, P237, DOI 10.1007/978-1-4939-0512-6_16
   Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   McCreedy DA, 2014, BIOTECHNOL BIOENG, V111, P2041, DOI 10.1002/bit.25260
   McCreedy DA, 2012, STEM CELL RES, V8, P368, DOI 10.1016/j.scr.2011.12.003
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Meinhardt A, 2014, STEM CELL REP, V3, P987, DOI 10.1016/j.stemcr.2014.09.020
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   Mitchell RR, 2014, STEM CELLS DEV, V23, P1937, DOI 10.1089/scd.2014.0023
   Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24
   Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3
   Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X
   Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786
   Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561
   National Spinal Cord Injury Statistical Center, 2014, SPIN CORD INJ FACTS
   Nicaise C, 2015, WORLD J STEM CELLS, V7, P380, DOI 10.4252/wjsc.v7.i2.380
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006
   Nutt SE, 2013, EXP NEUROL, V248, P491, DOI 10.1016/j.expneurol.2013.07.010
   OH TH, 1995, GLIA, V13, P319, DOI 10.1002/glia.440130408
   Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2
   Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757
   Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216
   Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013
   Philippidou P, 2013, NEURON, V80, P12, DOI 10.1016/j.neuron.2013.09.020
   Pomeshchik Y, 2015, CELL TRANSPLANT, V24, P1799, DOI 10.3727/096368914X684079
   Raspa A, 2016, BIOTECHNOL BIOENG, V113, P253, DOI 10.1002/bit.25689
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Romanyuk N, 2015, CELL TRANSPLANT, V24, P1781, DOI 10.3727/096368914X684042
   Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852
   Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021
   Rungarunlert Sasitorn, 2009, World J Stem Cells, V1, P11, DOI 10.4252/wjsc.v1.i1.11
   Saric T, 2008, CELLS TISSUES ORGANS, V188, P78, DOI 10.1159/000118784
   Satake K, 2000, NEUROREPORT, V11, P3877, DOI 10.1097/00001756-200011270-00054
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245
   Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003
   Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8
   Tang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107517
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomas AM, 2015, J CONTROL RELEASE, V204, P1, DOI 10.1016/j.jconrel.2015.02.032
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Timmer JR, 2002, DEVELOPMENT, V129, P2459
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tso D, 2015, NEURAL REGEN RES, V10, P1356, DOI 10.4103/1673-5374.165209
   Tuinstra HM, 2014, TISSUE ENG PT A, V20, P1027, DOI [10.1089/ten.tea.2013.0111, 10.1089/ten.TEA.2013.0111]
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Tyler JY, 2013, NANOSCALE, V5, P8821, DOI 10.1039/c3nr00957b
   Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720
   Urdzikova LM, 2014, INT J MOL SCI, V15, P11275, DOI 10.3390/ijms150711275
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Walthers CM, 2015, BIOMARK INSIGHTS, V10, P11, DOI [10.4137/BMIMI.S20063, 10.4137/BMI.S20063]
   Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Weitzer G, 2006, HANDB EXP PHARM, V174, P21
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001
   Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018
   Wilems TS, 2015, J CONTROL RELEASE, V213, P103, DOI 10.1016/j.jconrel.2015.06.031
   Willerth SM, 2008, COMBINING STEM CELLS
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0
   Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027
   Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xu H, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0213-z
   Xu H, 2015, STEM CELLS DEV, V24, P2723, DOI 10.1089/scd.2015.0122
   Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005
   Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Zeis T, 2016, BRAIN RES, V1641, P139, DOI 10.1016/j.brainres.2015.09.021
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 224
TC 7
Z9 8
U1 2
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD FEB
PY 2017
VL 114
IS 2
BP 245
EP 259
DI 10.1002/bit.26074
PG 15
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EI5MU
UT WOS:000392539800001
PM 27531038
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, PP
   Andorko, JI
   Jewell, CM
AF Zhang, Peipei
   Andorko, James I.
   Jewell, Christopher M.
TI Impact of dose, route, and composition on the immunogenicity of immune
   polyelectrolyte multilayers delivered on gold templates
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE vaccine; adjuvant; polyelectrolyte multilayer; immunology;
   nanotechnology; cancer
ID DENDRITIC CELLS; TLR AGONISTS; ADJUVANTS; RESPONSES; EFFICACY; SYSTEM;
   CANCER; BIODISTRIBUTION; NANOPARTICLES; BIOMATERIALS
AB Biomaterial vaccines offer new capabilities that can be exploited for both infectious disease and cancer. We recently developed a novel vaccine platform based on self-assembly of immune signals into immune polyelectrolyte multilayers (iPEMs). These iPEM vaccines are electrostatically assembled from peptide antigens and nucleic acid-based toll-like receptor agonists (TLRas) that serve as molecular adjuvants. Gold nanoparticles (AuNPs) coated with iPEMs stimulate effector cytokine secretion in vitro and expand antigen-specific T cells in mice. Here we investigated how the dose, injection route, and choice of molecular adjuvant impacts the ability of iPEMs to generate T cell immunity and anti-tumor response in mice. Three injection routesintradermal, subcutaneous, and intramuscularand three iPEM dosing levels were employed. Intradermal injection induced the most potent antigen-specific T cell responses and, for all routes, the level of response was dose-dependent. We further discovered that these vaccines generate durable memory, indicated by potent, antigen-specific CD8(+) T cell recall responses in mice challenged with vaccine 49 days after a prime-boost immunization regimen. In a common exogenous antigen melanoma model, iPEM vaccines slowed or stopped tumor growth more effectively than equivalent ad-mixed formulations. Further, iPEMs containing CpGa TLR9awere more potent compared with iPEMs containing polyIC, a TLR3a. These findings demonstrate the ability of iPEMs to enhance response to several different classes of vaccine cargos, supporting iPEMs as a simple vaccine platform that mimics attractive features of other nanoparticles using immune signals that can be self-assembled or coated on substrates. Biotechnol. Bioeng. 2017;114: 423-431. (c) 2016 Wiley Periodicals, Inc.
C1 [Zhang, Peipei; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg,8228 Paint Branch Dr, College Pk, MD 20742 USA.
   [Andorko, James I.; Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] US Dept Vet Affairs, Baltimore, MD 21201 USA.
EM cmjewell@umd.edu
FU NSF CAREER Award [1351688]; Alliance for Cancer Gene Therapy Young
   Investigator Award [15051543]; University of Maryland Division of
   Research (Tier 1); Damon Runyon Foundation [DRR3415]; Melanoma Research
   Alliance [348963]; NIH Grant [T32 AI089621]; American Association of
   Pharmaceutical Scientists Foundation
FX Contract grant sponsor: NSF CAREER Award; Contract grant number:
   #1351688; Contract grant sponsor: Alliance for Cancer Gene Therapy Young
   Investigator Award; Contract grant number: #15051543; Contract grant
   sponsor: University of Maryland Division of Research (Tier 1); Contract
   grant sponsor: Damon Runyon Foundation; Contract grant number: #DRR3415;
   Contract grant sponsor: Melanoma Research Alliance; Contract grant
   number: #348963; Contract grant sponsor: NIH Grant; Contract grant
   number: #T32 AI089621; Contract grant sponsor: American Association of
   Pharmaceutical Scientists Foundation
CR Andorko JI, 2015, AAPS J, V17, P323, DOI 10.1208/s12248-014-9708-2
   Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164
   Bremer PT, 2014, MOL PHARMACEUT, V11, P1075, DOI 10.1021/mp400631w
   Chiu YC, 2016, ACS APPL MATER INTER, V8, P18722, DOI 10.1021/acsami.6b06275
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4
   Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x
   Eggert AAO, 1999, CANCER RES, V59, P3340
   Gammon JM, 2016, ONCOTARGET, V7, P15421, DOI 10.18632/oncotarget.7304
   Goetsch L, 2000, VACCINE, V18, P2735, DOI 10.1016/S0264-410X(00)00057-8
   Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680
   Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008
   Jelley-Gibbs D, 2012, J IMMUNOL, V188
   Josefsberg JO, 2012, BIOTECHNOL BIOENG, V109, P1443, DOI 10.1002/bit.24493
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Lu FJ, 2013, VACCINE, V31, P3979, DOI 10.1016/j.vaccine.2013.05.107
   Luhrs P, 2001, J INVEST DERMATOL, V117, P451
   Melchels FP, 2015, BIOTECHNOL BIOENG, V112, P1927, DOI 10.1002/bit.25593
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005
   Pavoor PV, 2004, MACROMOLECULES, V37, P4865, DOI 10.1021/ma049777t
   Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184
   Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003
   Pittman PR, 2002, VACCINE, V20, pS48, DOI 10.1016/S0264-410X(02)00172-X
   Shirota H, 2015, VACCINES, V3, P390, DOI 10.3390/vaccines3020390
   Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715
   Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x
   Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
   Tom JK, 2013, CHEM COMMUN, V49, P9618, DOI 10.1039/c3cc45468a
   Wilson KD, 2007, INT IMMUNOPHARMACOL, V7, P1064, DOI 10.1016/j.intimp.2007.04.002
   Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980
   Zhang L, 2015, EXPERT REV VACCINES, V14, P1509, DOI 10.1586/14760584.2015.1081067
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
   Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293
   Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x
NR 37
TC 7
Z9 8
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD FEB
PY 2017
VL 114
IS 2
BP 423
EP 431
DI 10.1002/bit.26083
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EI5MU
UT WOS:000392539800017
PM 27567213
OA Bronze
DA 2018-10-20
ER

PT J
AU Bhaskar, P
   Bosworth, LA
   Wong, R
   O'brien, MA
   Kriel, H
   Smit, E
   McGrouther, DA
   Wong, JK
   Cartmell, SH
AF Bhaskar, Prajwal
   Bosworth, Lucy A.
   Wong, Richard
   O'brien, Marie A.
   Kriel, Haydn
   Smit, Eugene
   McGrouther, Duncan A.
   Wong, Jason K.
   Cartmell, Sarah H.
TI Cell response to sterilized electrospun poly(-caprolactone) scaffolds to
   aid tendon regeneration in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tendon repair; electrospinning polycaprolactone; sterilization; gamma
   irradiation; ethanol
ID GAMMA-IRRADIATION; REPAIR; INJURY
AB The functional replacement of tendon represents an unmet clinical need in situations of tendon rupture, tendon grafting, and complex tendon reconstruction, as usually there is a finite source of healthy tendon to use as donors. The microfibrous architecture of tendon is critical to the function of tendon. This study investigates the use of electrospun poly(-caprolactone) scaffolds as potential biomaterial substitutes for tendon grafts. We assessed the performance of two electrospinning manufacturers (small- and large-scale) and the effect of two sterilization techniquesgamma irradiation and ethanol submersionon cell response to these electrospun scaffolds after their implantation into a murine tendon model. Cell infiltration and proliferation analyses were undertaken to determine the effect on cell response within the implant over a 6-week period. Immunohistochemical analysis was performed to characterize inflammatory response and healing characteristics (proliferation, collagen deposition, myofibroblast activity, and apoptosis). Neither the sterilization techniques nor the manufacturer was observed to significantly affect the cell response to the scaffold. At each time point, cell response was similar to the autograft control. This suggests that ethanol submersion can be used for research purposes and that the scaffold can be easily reproduced by a large-scale manufacturer. These results further imply that this electrospun scaffold may provide an alternative to autograft, thus eliminating the need for sourcing healthy tendon tissue from a secondary site. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 389-397, 2017.
C1 [Bhaskar, Prajwal; Bosworth, Lucy A.; O'brien, Marie A.; Cartmell, Sarah H.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
   [Wong, Richard; McGrouther, Duncan A.; Wong, Jason K.] Univ Manchester, Inst Inflammat & Repair, Oxford Rd, Manchester M13 9PL, Lancs, England.
   [Kriel, Haydn; Smit, Eugene] Stellenbosch Nanofiber Co Ltd, Cape Town, South Africa.
   [Smit, Eugene] Univ Stellenbosch, Dept Chem & Polymer Sci, Stellenbosch, South Africa.
EM sarah.cartmell@manchester.ac.uk
FU MRC-DPFS [G1000788-98812]; Medical Research Council [G1000788]
FX Contract grant sponsor: MRC-DPFS; contract grant number: G1000788-98812
CR Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Augustine R, 2015, INT J POLYM MATER PO, V64, P526, DOI 10.1080/00914037.2014.977900
   Bhaskar P, 2017, J BIOMED MATER RES A, V105, P389, DOI 10.1002/jbm.a.35911
   Bosworth L, 2009, WOODHEAD PUBL MATER, P3, DOI 10.1533/9781845695477.1.3
   Bosworth LA, 2014, J MECH BEHAV BIOMED, V39, P175, DOI 10.1016/j.jmbbm.2014.07.009
   Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8
   Bosworth LA, 2011, WOODHEAD PUBL MATER, P148
   Bosworth LA, 2012, J POLYM SCI POL PHYS, V50, P870, DOI 10.1002/polb.23072
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   DAGLEY S, 1950, J BACTERIOL, V60, P369
   FALINI B, 1990, HUM PATHOL, V21, P624, DOI 10.1016/S0046-8177(96)90009-X
   Gorna K, 2003, POLYM DEGRAD STABIL, V79, P465, DOI 10.1016/S0141-3910(02)00362-2
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hinsenkamp M, 2012, INT ORTHOP, V36, P633, DOI 10.1007/s00264-011-1391-7
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Lovati AB, 2016, STEM CELLS INT, DOI 10.1155/2016/7276150
   Maffulli Renstrom NP, 2005, TENDON INJURIES BASI, P345
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Rogers W, 2005, STERILISATION POLYM
   Schmitt T, 2013, PLAST RECONSTR SURG, V132, p567E, DOI 10.1097/PRS.0b013e3182a033cf
   Schoffl V, 2012, J ORTHOP, V3, P62
   Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Vang P, 2006, ADVANTAGES DISADVANT, P82
   Wong R, 2014, J TISSUE ENG REGEN M, V8, P463
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041
NR 30
TC 2
Z9 2
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 389
EP 397
DI 10.1002/jbm.a.35911
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300004
PM 27649836
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Jayash, SN
   Hashim, NM
   Misran, M
   Baharuddin, NA
AF Jayash, Soher Nagi
   Hashim, Najihah Mohd
   Misran, Misni
   Baharuddin, N. A.
TI Formulation and in vitro and in vivo evaluation of a new
   osteoprotegerin-chitosan gel for bone tissue regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoprotegerin; chitosan; normal human periodontal ligament cells;
   normal human osteoblast cells; rabbit
ID KAPPA-B LIGAND; MOLECULAR-WEIGHT; MORPHOGENETIC PROTEIN-2; RECEPTOR
   ACTIVATOR; COMMERCIAL ENZYME; ALAMAR BLUE; SCAFFOLDS; DEGRADATION;
   APOPTOSIS; HEPARIN
AB The osteoprotegerin (OPG) system plays a critical role in bone remodelling by regulating osteoclast formation and activity. The study aimed to determine the physicochemical properties and biocompatibility of a newly formulated OPG-chitosan gel. The OPG-chitosan gel was formulated using human OPG protein and water-soluble chitosan. The physicochemical properties were determined using Fourier transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Gel morphology was determined using scanning electron microscopy (SEM) and then it was subjected to a protein release assay and biodegradability test. An in vitro cytotoxicity test on normal human periodontal ligament (NHPL) fibroblasts and normal human (NH) osteoblasts was carried out using the AlamarBlue assay. In vivo evaluation in a rabbit model involved creating critical-sized defects in calvarial bone, filling with the OPG-chitosan gel and sacrificing at 12 weeks. In vitro results demonstrated that the 25 kDa OPG-chitosan gel had the highest rate of protein release and achieved 90% degradation in 28 days. At 12 weeks, the defects filled with 25 kDa OPG-chitosan gel showed significant (p<0.05) new bone formation and the highest expression of osteocalcin and osteopontin compared to controls. Thus, the 25 kDa OPG-chitosan gel could be a promising new biomaterial for tissue engineering. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 398-407, 2017.
C1 [Jayash, Soher Nagi; Baharuddin, N. A.] Univ Malaya, Fac Dent, Dept Restorat Dent, Kuala Lumpur 50603, Malaysia.
   [Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Hashim, Najihah Mohd] Univ Malaya, Fac Sci, Dept Chem, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia.
   [Misran, Misni] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia.
EM soheernaji20@yahoo.com; najihahmh@gmail.com
RI Management Center, Dental Research/C-2478-2013; BAHARUDDIN, NOR
   ADINAR/B-9296-2010; MISRAN, MISNI/B-9010-2010
OI BAHARUDDIN, NOR ADINAR/0000-0001-6824-3744; MISRAN,
   MISNI/0000-0002-9849-9190
CR Al-Hijazi AY, SCI J PUBL COLL DENT, V31, P32
   Banerjee I, 2009, INT J BIOMATER, DOI 10.1155/2009/143659
   Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001
   Body JJ, 2003, CANCER-AM CANCER SOC, V97, P887, DOI 10.1002/cncr.11138
   Bondarenko A, 2014, J BIOMED MATER RES A, V102, P1449, DOI 10.1002/jbm.a.34828
   Bonnier F, 2015, TOXICOL IN VITRO, V29, P124, DOI 10.1016/j.tiv.2014.09.014
   Bourbon AI, 2011, J FOOD ENG, V106, P111, DOI 10.1016/j.jfoodeng.2011.03.024
   Coimbra P, 2011, INT J BIOL MACROMOL, V49, P573, DOI 10.1016/j.ijbiomac.2011.06.011
   EL-Haflan E, 2010, TURK J CHEM, V34, P47
   Ezoddini-Ardakani F, 2011, HEALTH, V3, P200, DOI DOI 10.4236/HEALTH.2011.34036
   Florczyk SJ, 2013, J BIOMED MATER RES A, V101, P2974, DOI 10.1002/jbm.a.34593
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Gentile P, 2015, INT J MOL SCI, V16, P20492, DOI 10.3390/ijms160920492
   Gruber H.E., 2003, HDB HISTOLOGY METHOD, P281
   Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193
   Hofbauer LC, 2001, CANCER, V92, P460, DOI 10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Ishibe T, 2009, ORAL SURG ORAL MED O, V108, P867, DOI 10.1016/j.tripleo.2009.06.039
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Jung HD, 2014, J BIOMED MATER RES B, V102, P913, DOI 10.1002/jbm.b.33072
   Karadag E, 2002, POLYM BULL, V48, P299, DOI 10.1007/s00289-002-0029-8
   Katime Issa, 2010, Material Sciences and Applications, V1, P162, DOI 10.4236/msa.2010.13026
   Kim MO, 2015, INT J MOL MED, V35, P153, DOI 10.3892/ijmm.2014.1978
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130
   Li J, 2007, POLYM DEGRAD STABIL, V92, P515, DOI 10.1016/j.polymdegradstab.2006.04.028
   Lutz RJ, 2000, BIOCHEM SOC T, V28, P51, DOI 10.1042/bst0280051
   Mourino V, 2013, EXPERT OPIN DRUG DEL, V10, P1353, DOI 10.1517/17425247.2013.808183
   PORSTMANN B, 1989, CLIN BIOCHEM, V22, P349, DOI 10.1016/S0009-9120(89)80031-1
   Pranoto Y, 2005, LWT-FOOD SCI TECHNOL, V38, P859, DOI [10.1016/j.lwt.2004.09.014, 10.1016/j.lwt.2004.lwt.2004.09.014]
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   Rastogi RP, 2009, EXCLI J, V8, P155
   Rodrigues J, 2012, THERM BEHAV CONVENT, V24, P48
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120
   Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yao YS, 2011, J ORAL MAXIL SURG, V69, pE446, DOI 10.1016/j.joms.2011.07.002
   Yun YP, 2013, TISSUE ENG REGEN MED, V10, P183, DOI 10.1007/s13770-013-0389-1
   Zare Jahromi Maryam, 2014, J Dent Res Dent Clin Dent Prospects, V8, P130, DOI 10.5681/joddd.2014.024
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
NR 43
TC 6
Z9 6
U1 2
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 398
EP 407
DI 10.1002/jbm.a.35919
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300005
PM 27684563
DA 2018-10-20
ER

PT J
AU Konovalova, MV
   Markov, PA
   Durnev, EA
   Kurek, DV
   Popov, SV
   Varlamov, VP
AF Konovalova, Mariya V.
   Markov, Pavel A.
   Durnev, Eugene A.
   Kurek, Denis V.
   Popov, Sergey V.
   Varlamov, Valery P.
TI Preparation and biocompatibility evaluation of pectin and chitosan
   cryogels for biomedical application
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE pectin; chitosan; cryogel; biomaterial; biocompatibility
ID TISSUE ENGINEERING APPLICATIONS; IN-VIVO BIOCOMPATIBILITY;
   DRUG-DELIVERY; MECHANICAL-PROPERTIES; HYDROGELS; SCAFFOLDS;
   BIOMATERIALS; GELATIN; POLYURETHANE; COMPLEMENT
AB Today, there is a need for the development of biomaterials with novel properties for biomedical purposes. The biocompatibility of materials is a key factor in determining its possible use in biomedicine. In this study, composite cryogels were obtained based on pectin and chitosan using ionic cryotropic gelation. For cryogel preparation, apple pectin (AP), Heracleum L. pectin (HP), and chitosan samples with different physical and chemical characteristics were used. The properties of pectin-chitosan cryogels were found to depend on the structural features and physicochemical characteristics of the pectin and chitosan within them. The addition of chitosan to cryogels can increase their mechanical strength, cause change in surface morphology, increase the degradation time, and enhance adhesion to biological tissues. Cryogels based on AP were less immunogenic when compared with cryogels from HP. Cryogels based on AP and HP were hemocompatible and the percentage of red blood cells hemolysis was less than 5%. Unlike cryogels based on HP, which exhibited moderate cytotoxicity, cryogels based on AP exhibited light cytotoxicity. Based on the results of low immunogenicity, light cytotoxicity data as well as a low level of hemolysis of composite cryogels based on AP and chitosan are biocompatible and can potentially be used in biomedicine. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 547-556, 2017.
C1 [Konovalova, Mariya V.; Kurek, Denis V.; Varlamov, Valery P.] Russian Acad Sci, Biotechnol Res Ctr, Inst Bioengn, Moscow, Russia.
   [Markov, Pavel A.; Popov, Sergey V.] Russian Acad Sci, Urals Branch, Komi Sci Ctr, Inst Physiol, Syktyvkar, Russia.
   [Durnev, Eugene A.] Vyatka State Univ, Kirov, Russia.
RP Konovalova, MV (reprint author), Russian Acad Sci, Biotechnol Res Ctr, Inst Bioengn, Moscow, Russia.
EM mariya.v.konovalova@gmail.com
RI Konovalova, Mariya/F-2886-2017; Popov, Sergey/F-7627-2016
OI Konovalova, Mariya/0000-0003-3923-6304; Popov,
   Sergey/0000-0003-1763-8898
FU Program of UD RAS [15-3-4-38]; FASIE, the program "UMNIK" [7077GU/2015];
   RSF [16-14-00046]
FX Contract grant sponsor: Program of UD RAS; contract grant number:
   15-3-4-38; Contract grant sponsor: FASIE, the program "UMNIK"; contract
   grant number: 7077GU/2015; Contract grant sponsor: RSF; contract grant
   number: 16-14-00046
CR Abueva CDG, 2015, J BIOMATER APPL, V30, P182, DOI 10.1177/0885328215577892
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   [Anonymous], 1099342002 ISO
   Barrioni BR, 2015, MAT SCI ENG C-MATER, V52, P22, DOI 10.1016/j.msec.2015.03.027
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Berillo D, 2012, MACROMOL BIOSCI, V12, P1090, DOI 10.1002/mabi.201200023
   Bhat S, 2012, J BIOSCI BIOENG, V114, P663, DOI 10.1016/j.jbiosc.2012.07.005
   Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g
   Carlini AS, 2016, MACROMOLECULES, V49, P4379, DOI 10.1021/acs.macromol.6b00439
   Coimbra P, 2011, INT J BIOL MACROMOL, V48, P112, DOI 10.1016/j.ijbiomac.2010.10.006
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Das S, 2011, INT J PHARMACEUT, V406, P11, DOI 10.1016/j.ijpharm.2010.12.015
   De Clercq K, 2016, BIOMATERIALS, V96, P33, DOI 10.1016/j.biomaterials.2016.04.012
   Debele TA, 2016, MAT SCI ENG C-MATER, V68, P964, DOI 10.1016/j.msec.2016.05.121
   Fan L, 2011, J BIOMAT SCI-POLYM E, V5063, P2119
   Gunter EA, 2016, CARBOHYD POLYM, V147, P490, DOI 10.1016/j.carbpol.2016.04.026
   Hastuti B., 2013, International Journal of Chemical Engineering and Applications, V4, P349
   Hoagland PD, 1996, J AGR FOOD CHEM, V44, P1915, DOI 10.1021/jf950162s
   Iviglia G, 2016, MAT SCI ENG C-MATER, V68, P701, DOI 10.1016/j.msec.2016.06.050
   Jain E, 2015, COLLOID SURFACE B, V136, P761, DOI 10.1016/j.colsurfb.2015.10.012
   Kane RJ, 2015, ACTA BIOMATER, V17, P16, DOI 10.1016/j.actbio.2015.01.031
   Kastner H, 2012, FOOD HYDROCOLLOID, V27, P42, DOI 10.1016/j.foodhyd.2011.09.001
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Konovalova MV, 2017, J BIOMED MATER RES A, V105, P547, DOI 10.1002/jbm.a.35936
   Kuo CY, 2015, CARBOHYD POLYM, V117, P722, DOI 10.1016/j.carbpol.2014.10.056
   Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001
   Lin HY, 2015, J BIOMAT SCI-POLYM E, V26, P855, DOI 10.1080/09205063.2015.1061350
   Lonnroth Emma Christin, 2005, Int J Occup Saf Ergon, V11, P131
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   Lozinsky VI, 1998, RUSS CHEM REV, V67, P573, DOI DOI 10.1070/RC1998V067N07ABEH000399
   Martinez YN, 2013, BIORESOURCE TECHNOL, V145, P280, DOI 10.1016/j.biortech.2013.02.063
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   Morris GA, 2010, BIOTECHNOL GENET ENG, V27, P257, DOI 10.1080/02648725.2010.10648153
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ovodov YS, 2009, RUSS J BIOORG CHEM+, V35, P269, DOI 10.1134/S1068162009030017
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Podaralla S, 2014, AAPS PHARMSCITECH, V15, P928, DOI 10.1208/s12249-014-0124-9
   Rampino A, 2016, EUR J PHARM SCI, V84, P37, DOI 10.1016/j.ejps.2016.01.004
   Sanak M, 2010, B POL ACAD SCI-TECH, V58, P317, DOI 10.2478/v10175-010-0029-z
   Seo KH, 2009, TISSUE ENG REGEN MED, V6, P414
   Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001
   Sokolov A, 2011, J BIOMED MATER RES B, V98B, P323, DOI 10.1002/jbm.b.31855
   Sowasod N, 2012, MAT SCI ENG C-MATER, V32, P790, DOI 10.1016/j.msec.2012.01.027
   Stoyneva V, 2014, CARBOHYD POLYM, V99, P825, DOI 10.1016/j.carbpol.2013.08.095
   Takei T, 2012, ACTA BIOMATER, V8, P686, DOI 10.1016/j.actbio.2011.10.005
   Thankam FG, 2014, J MECH BEHAV BIOMED, V35, P111, DOI 10.1016/j.jmbbm.2014.03.010
   Upadhyaya L, 2013, CARBOHYD POLYM, V91, P452, DOI 10.1016/j.carbpol.2012.07.076
   Wattanakorn N, 2010, AAPS PHARMSCITECH, V11, P743, DOI 10.1208/s12249-010-9424-x
   Yang C, 2010, CARBOHYD POLYM, V82, P1297, DOI 10.1016/j.carbpol.2010.07.013
   Younes I, 2015, MAR DRUGS, V13, P1133, DOI 10.3390/md13031133
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 52
TC 7
Z9 8
U1 7
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 547
EP 556
DI 10.1002/jbm.a.35936
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300020
PM 27750379
DA 2018-10-20
ER

PT J
AU Hogrebe, NJ
   Reinhardt, JW
   Gooch, KJ
AF Hogrebe, Nathaniel J.
   Reinhardt, James W.
   Gooch, Keith J.
TI Biomaterial microarchitecture: a potent regulator of individual cell
   behavior and multicellular organization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE microarchitecture; fibrous matrix; stromal extracellular matrix;
   collagen fiber; 3D cell culture
ID 3-DIMENSIONAL COLLAGEN MATRICES; MESENCHYMAL STEM-CELLS; FIBRONECTIN
   EXTRACELLULAR-MATRIX; TISSUE-ENGINEERING SCAFFOLDS; FIBRILLIN-RICH
   MICROFIBRILS; HYPERTENSIVE HEART-DISEASE; POROUS CHITOSAN SCAFFOLDS;
   IN-VITRO CHONDROGENESIS; HUMAN-SKIN FIBROBLASTS; BREAST-TUMOR CELLS
AB Insoluble cues from a cell's surrounding microenvironment have increasingly been shown to be important regulators of cell behavior. The microarchitecture of biomaterials used for 3D cell encapsulation, however, is often underappreciated as an important insoluble factor guiding cell activity. In this review, we illustrate that the subcellular physical features of a scaffold influence a range of cell behaviors, including morphology, cytoskeletal organization, migration, matrix remodeling, and long-range force transmission. We emphasize that the microarchitecture of stromal extracellular matrix (ECM)specifically the fact that it consists of a network of long interconnecting fibers with micron and nanometer-sized diametersis an important determinant of how cells naturally interact with their surrounding matrix and each other. Synthetic biomaterials with a microarchitecture similar to stromal ECM can support analogous cellular responses, suggesting that this fibrous microarchitecture is a key regulator of these cell behaviors. Drawing upon examples from in vitro, in silico, and in vivo studies, we compare these behaviors in fibrous matrices to those of cells cultured within nanoporous matrices (e.g., alginate and PEG gels) as well as macroporous scaffolds to highlight key differences in the cellular response to each type of microarchitecture. Understanding how microarchitecture affects cell behavior can lead to more efficient biomaterial selection when designing tissue engineered scaffolds for therapeutic applications. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 640-661, 2017.
C1 [Hogrebe, Nathaniel J.; Reinhardt, James W.; Gooch, Keith J.] Ohio State Univ, Dept Biomed Engn, 270 Bevis Hall 1080 Carmack Rd, Columbus, OH 43210 USA.
   [Gooch, Keith J.] Ohio State Univ, Davis Heart Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.
EM gooch.20@osu.edu
FU NSF [CBET-1067481, CMMI-1334757]; American Heart Association
   [15GRNT2579003]
FX This work was supported by NSF (CBET-1067481,CMMI-1334757) and the
   American Heart Association (15GRNT2579003). We would also like to thank
   Drs. Gunjan Agarwal and Jennifer Leight for their helpful comments on
   this manuscript.
CR Abhilash AS, 2014, BIOPHYS J, V107, P1829, DOI 10.1016/j.bpj.2014.08.029
   Aghvami M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024460
   Akbarzadeh R., 2015, J MATER SCI-MATER M, V26, P1
   Anderson CR, 2004, J HISTOCHEM CYTOCHEM, V52, P1063, DOI 10.1369/jhc.4a6250.2004j
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]
   Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045
   BARD JBL, 1975, J CELL BIOL, V67, P400, DOI 10.1083/jcb.67.2.400
   Barnes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093325
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044
   Berry DP, 1998, PLAST RECONSTR SURG, V102, P124, DOI 10.1097/00006534-199807000-00019
   Bertassoni LE, 2012, ACTA BIOMATER, V8, P2419, DOI 10.1016/j.actbio.2012.02.022
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bradshaw M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06903
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brilla CG, 1996, HYPERTENSION, V28, P269, DOI 10.1161/01.HYP.28.2.269
   Brownfield DG, 2013, CURR BIOL, V23, P703, DOI 10.1016/j.cub.2013.03.032
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029
   Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x
   Caulfield J B, 1997, Technol Health Care, V5, P95
   Chandran PL, 2012, ACTA BIOMATER, V8, P3, DOI 10.1016/j.actbio.2011.08.011
   Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]
   Coburn J, 2011, SMART STRUCT SYST, V7, P213, DOI 10.12989/sss.2011.7.3.213
   Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   da Cunha CB, 2014, BIOMATERIALS, V35, P8927, DOI 10.1016/j.biomaterials.2014.06.047
   Davidson LA, 2004, DEV DYNAM, V231, P888, DOI 10.1002/dvdy.20217
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Ehrlich HP, 2012, ADV WOUND CARE, V1, P3, DOI 10.1089/wound.2011.0311
   Ehrlich HP, 2013, METHODS MOL BIOL, V1037, P45, DOI 10.1007/978-1-62703-505-7_3
   Fernandes LL, 2011, POLIMEROS, V21, P1, DOI 10.1590/S0104-14282011005000008
   Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   Green EM, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0058
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI [10.1146/annurev.cellbio.042308.113318, 10.1146/annurev.cellbio.012308.113318]
   GUIDRY C, 1985, J CELL SCI, V79, P67
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI [10.1089/ten.tea.2010.0273, 10.1089/ten.TEA.2010.0273]
   HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747
   Hayen W, 1999, J CELL SCI, V112, P2241
   HEATH JP, 1989, CELL MOTIL CYTOSKEL, V14, P382, DOI 10.1002/cm.970140308
   Hellmann W, 1975, J BIOL CHEM, V250, P1877
   Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7
   Hogrebe NJ, 2017, J BIOMED MATER RES A, V105, P640, DOI 10.1002/jbm.a.35914
   Hogrebe NJ, 2016, J BIOMED MATER RES A, V104, P2356, DOI 10.1002/jbm.a.35755
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Janicki JS, 2002, J CARD FAIL, V8, pS319, DOI 10.1054/jcaf.2002.129260
   Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001
   Jansen KA, 2013, BIOPHYS J, V105, P2240, DOI 10.1016/j.bpj.2013.10.008
   Jensen SA, 2012, STRUCTURE, V20, P215, DOI 10.1016/j.str.2011.12.008
   Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x
   Keller R, 2012, SCIENCE, V338, P201, DOI 10.1126/science.1230718
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kielty CM, 2002, J MUSCLE RES CELL M, V23, P581, DOI 10.1023/A:1023479010889
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kniazeva E, 2012, INTEGR BIOL-UK, V4, P431, DOI 10.1039/c2ib00120a
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Koroleva A, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025005
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003
   Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lee YH, 2013, INTEGR BIOL-UK, V5, P1447, DOI 10.1039/c3ib40161h
   Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Li B, 2013, P NATL ACAD SCI USA, V109, P5576
   Li W, 2016, BIOPHYS J, V110, P1400, DOI 10.1016/j.bpj.2016.02.021
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Liu L, 2012, J BIOMED MATER RES B, V100B, P956, DOI 10.1002/jbm.b.32658
   Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709
   LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7
   Lowe SB, 2014, BIOCONJUGATE CHEM, V25, P1581, DOI 10.1021/bc500310v
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma XY, 2013, BIOPHYS J, V104, P1410, DOI 10.1016/j.bpj.2013.02.017
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   McLeod C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023984
   McMurtrey RJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/066009
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064
   Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902
   Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   OHTSUKA A, 1992, CELL TISSUE RES, V269, P403, DOI 10.1007/BF00353895
   Orsi S, 2010, J MATER SCI-MATER M, V21, P1013, DOI 10.1007/s10856-009-3972-1
   Ozdemir T, 2013, INTEGR BIOL-UK, V5, P1407, DOI 10.1039/c3ib40068a
   Pamula E, 2009, J BIOMED MATER RES A, V89A, P432, DOI 10.1002/jbm.a.31977
   PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X
   Pazzaglia UE, 2014, J ANAT, V224, P132, DOI 10.1111/joa.12138
   Petroll WM, 2008, J CELL PHYSIOL, V217, P162, DOI 10.1002/jcp.21487
   Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126
   Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004
   Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108
   Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561
   Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116
   Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38
   Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005
   Qin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119094
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reinhardt JW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026179
   Reinhardt JW, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024463
   Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331
   Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200
   Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025
   Rudnicki MS, 2013, BIOPHYS J, V105, P11, DOI 10.1016/j.bpj.2013.05.032
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106
   Sander LM, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024199
   Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011
   Seifert AW, 2014, INT REV CEL MOL BIO, V310, P129, DOI 10.1016/B978-0-12-800180-6.00004-9
   Sen S, 2009, CELL MOL BIOENG, V2, P39
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Sephel GC, 1996, MATRIX BIOL, V15, P263, DOI 10.1016/S0945-053X(96)90117-1
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sidani M, 2006, J MAMMARY GLAND BIOL, V11, P151, DOI 10.1007/s10911-006-9021-5
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020
   Singh RK, 2013, BIOMATERIALS, V34, P9331, DOI 10.1016/j.biomaterials.2013.08.016
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stevenson MD, 2013, ACTA BIOMATER, V9, P7651, DOI 10.1016/j.actbio.2013.04.002
   Stevenson MD, 2010, BIOPHYS J, V99, P19, DOI 10.1016/j.bpj.2010.03.041
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001
   TOMASEK JJ, 1982, DEV BIOL, V92, P107, DOI 10.1016/0012-1606(82)90155-5
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   TUAN TL, 1989, J CELL PHYSIOL, V140, P577, DOI 10.1002/jcp.1041400324
   Ulrich TA, 2011, BIOMATERIALS, V32, P5633, DOI 10.1016/j.biomaterials.2011.04.045
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223
   VERNON RB, 1995, AM J PATHOL, V147, P873
   Walters BD, 2014, ACTA BIOMATER, V10, P1488, DOI 10.1016/j.actbio.2013.08.038
   Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang WG, 2002, CANCER RES, V62, P6278
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005
   Wyckoff JB, 2000, CANCER RES, V60, P2504
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Zhang JC, 2006, J MATER SCI, V41, P1725, DOI 10.1007/s10853-06-2873-7
   Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308
NR 188
TC 9
Z9 10
U1 9
U2 57
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 640
EP 661
DI 10.1002/jbm.a.35914
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300028
PM 27682265
DA 2018-10-20
ER

PT J
AU Zhang, GG
   Brion, A
   Willemin, AS
   Piet, MH
   Moby, V
   Bianchi, A
   Mainard, D
   Galois, L
   Gillet, P
   Rousseau, M
AF Zhang, Ganggang
   Brion, Alice
   Willemin, Anne-Sophie
   Piet, Marie-Helene
   Moby, Vanessa
   Bianchi, Arnaud
   Mainard, Didier
   Galois, Laurent
   Gillet, Pierre
   Rousseau, Marthe
TI Nacre, a natural, multi-use, and timely biomaterial for bone graft
   substitution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE nacre; bone graft substitute; biomineralization; biomaterial; clinical
   applications
ID OSTEOBLASTS MAINTAINED INVITRO; ALKALINE-PHOSPHATASE ACTIVITY;
   WATER-SOLUBLE MATRIX; MECHANICAL-PROPERTIES; PINCTADA-MAXIMA; ORGANIC
   MATRIX; IN-VITRO; SHEEP; MINERALIZATION; INTERFACE
AB During the past two decades, with a huge and rapidly increasing clinical need for bone regeneration and repair, bone substitutes are more and more seen as a potential solution. Major innovation efforts are being made to develop such substitutes, some having advanced even to clinical practice. It is now time to turn to natural biomaterials. Nacre, or mother-of-pearl, is an organic matrix-calcium carbonate coupled shell structure produced by molluscs. In vivo and in vitro studies have revealed that nacre is osteoinductive, osteoconductive, biocompatible, and biodegradable. With many other outstanding qualities, nacre represents a natural and multi-use biomaterial as a bone graft substitute. This review aims at summarising the current needs in orthopaedic clinics and the challenges for the development of bone substitutes; most of all, we systematically review the physiological characteristics and biological evidence of nacre's effects centred on osteogenesis, and finally we put forward the potential use of nacre as a bone graft substitute. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 662-671, 2017.
C1 [Zhang, Ganggang; Brion, Alice; Willemin, Anne-Sophie; Piet, Marie-Helene; Moby, Vanessa; Bianchi, Arnaud; Mainard, Didier; Galois, Laurent; Gillet, Pierre; Rousseau, Marthe] Univ Lorraine, Fac Med, CNRS, IMoPA,UMR 7365, Vandoeuvre Les Nancy, France.
RP Rousseau, M (reprint author), Univ Lorraine, Fac Med, CNRS, IMoPA,UMR 7365, Vandoeuvre Les Nancy, France.
EM marthe.rousseau@univ-lorraine.fr
FU China Scholarship Council
FX Contract grant sponsor: China Scholarship Council
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Asvanund P, 2012, IMPLANT DENT, V21, P248, DOI 10.1097/ID.0b013e3182563ae0
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bellaaj-Zouari A, 2012, J MAR BIOL ASSOC UK, V92, P553, DOI 10.1017/S0025315411001925
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Bobbio A, 1972, Bull Hist Dent, V20, P1
   Brion A, 2015, J STRUCT BIOL, V192, P500, DOI 10.1016/j.jsb.2015.10.012
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   CAMPRASSE G, 1988, CR ACAD SCI III-VIE, V307, P485
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   Chaturvedi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084584
   Curran D, 2010, JOINT BONE SPINE, V77, P546, DOI 10.1016/j.jbspin.2010.02.006
   Currey JD, 2001, P ROY SOC B-BIOL SCI, V268, P107, DOI 10.1098/rspb.2000.1337
   Duplat D, 2007, BIOMATERIALS, V28, P2155, DOI 10.1016/j.biomaterials.2007.01.015
   Graham SM, 2010, EXPERT OPIN BIOL TH, V10, P885, DOI 10.1517/14712598.2010.481669
   Green DW, 2015, MOL CELLS, V38, P267, DOI 10.14348/molcells.2015.2315
   Green DW, 2014, MAR DRUGS, V12, P2877, DOI 10.3390/md12052877
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098
   Kim YW, 2002, BIOMATERIALS, V23, P2089, DOI 10.1016/S0142-9612(01)00340-4
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Lafage-Proust MH, 2010, JOINT BONE SPINE, V77, P521, DOI 10.1016/j.jbspin.2010.09.009
   Lamghari M, 1999, BIOMATERIALS, V20, P2107, DOI 10.1016/S0142-9612(99)00113-1
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 2003, KEY ENG MATER, V254-256, P733
   Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099
   Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Moutahir-Belqasmi F, 2001, J MATER SCI-MATER M, V12, P1, DOI 10.1023/A:1026759431595
   Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   Pascaretti-Grizon F, 2014, J RAMAN SPECTROSC, V45, P558, DOI 10.1002/jrs.4506
   Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
   Rousseau M, 2012, BIO-MED MATER ENG, V22, P227, DOI 10.3233/BME-2012-0712
   Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1
   Wang Jian-jun, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1838
   WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1
   Zhang G, 2016, J STRUCT BIOL
   Zhang GG, 2017, J BIOMED MATER RES A, V105, P662, DOI 10.1002/jbm.a.35939
   Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.0.CO;2-A
NR 57
TC 6
Z9 6
U1 5
U2 45
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 662
EP 671
DI 10.1002/jbm.a.35939
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300029
PM 27750380
DA 2018-10-20
ER

PT J
AU Galarraga-Vinueza, ME
   Mesquita-Guimaraes, J
   Magini, RS
   Souza, JCM
   Fredel, MC
   Boccaccini, AR
AF Galarraga-Vinueza, M. E.
   Mesquita-Guimaraes, J.
   Magini, R. S.
   Souza, J. C. M.
   Fredel, M. C.
   Boccaccini, A. R.
TI Anti-biofilm properties of bioactive glasses embedding organic active
   compounds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE bioactive glass; mesoporous materials; antibacterial compounds;
   anti-biofilm activity; drug delivery system
ID DRUG-DELIVERY SYSTEM; IN-VITRO BIOACTIVITY; COMMON ORAL BACTERIA;
   COMPOSITE SCAFFOLDS; BONE REGENERATION; ANTIBACTERIAL; S53P4;
   OSTEOMYELITIS; TRICLOSAN; PH
AB Bioactive glasses (BGs) are promising materials for bone repair due to their desirable properties such as osteoconductivity, biodegradability, angiogenic potential, and antibacterial activity. Ionic dissolution products from bioactive glasses increase the medium pH inhibiting surrounding bacteria proliferation. The activity of BGs against biofilm formation has been enhanced by incorporating organic antibacterial compounds. The aim of this review was to summarize evidence in literature which assesses the efficacy of antibacterial and anti-biofilm compounds embedded in bioactive glasses to prevent peri-implant infection during bone healing. A PubMed bibliographical research was carried out including articles published in the last 20 years. Most previous studies evaluated antibacterial efficiency in planktonic cultures but did not investigate biofilm inhibition, underestimating biofilm clinical relevance. Multifactorial features such as biocompatibility of embedded compounds, receptor site characteristics, and drug delivery efficiency have been found to influence the bioactive glass capability of acting both as an anti-biofilm agent and as a bone repairing biomaterial. Accordingly, further in vitro and in vivo studies are required to select the most promising anti-biofilm agents which should be incorporated into bioactive glasses to counteract biofilm proliferation, without inducing toxic effects on human cells, and with the added functionality of promoting bone regeneration. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 672-679, 2017.
C1 [Galarraga-Vinueza, M. E.; Magini, R. S.; Souza, J. C. M.] Fed Univ Santa Catarina UFSC, Dept Dent ODT, Postgrad Program Dent PPGO, Ctr Educ & Res Dent Implants CEPID, BR-88040900 Florianopolis, SC, Brazil.
   [Mesquita-Guimaraes, J.; Souza, J. C. M.; Fredel, M. C.] Univ Fed Santa Catarina, Dept Mech Engn EMC, Ceram & Composite Mat Res Grp CERMAT, BR-88040900 Florianopolis, SC, Brazil.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
OI Mesquita-Guimaraes, Joana/0000-0002-6342-7824; Matias de Souza, Julio
   Cesar/0000-0001-7999-4009
CR Allan I, 2002, CLIN ORAL IMPLAN RES, V13, P53, DOI 10.1034/j.1600-0501.2002.130106.x
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bedoux G, 2012, ENVIRON SCI POLLUT R, V19, P1044, DOI 10.1007/s11356-011-0632-z
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bortolin M, 2016, J ANTIMICROB CHEMOTH, V71, P123, DOI 10.1093/jac/dkv327
   Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x
   Coleman NJ, 2009, J MATER SCI-MATER M, V20, P1347, DOI 10.1007/s10856-009-3698-0
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Cui X, 2013, J MATER SCI-MATER M, V24, P2391, DOI 10.1007/s10856-013-4996-0
   Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201
   Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20
   FBonfim RA, 2009, PLANTA MED, V75, P1078
   Galarraga-Vinueza ME, 2017, J BIOMED MATER RES A, V105, P672, DOI 10.1002/jbm.a.35934
   Goh YF, 2014, INT J APPL GLASS SCI, V5, P255, DOI 10.1111/ijag.12061
   Grenho L, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/2/025004
   Gubler M, 2008, INT ENDOD J, V41, P670, DOI 10.1111/j.1365-2591.2008.01413.x
   Hench L., 2015, BIOMEDICAL GLASSES, V1, DOI [10.1515/bglass-2015-0001, DOI 10.1515/BGLASS-2015-0001]
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Jafarzadeh Kashi T, 2011, IRAN J PHARM RES, V10, P363
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   Li Y, 2013, J MATER SCI-MATER M, V24, P1951, DOI 10.1007/s10856-013-4960-z
   Liberio SA, 2009, J ETHNOPHARMACOL, V125, P1, DOI 10.1016/j.jep.2009.04.047
   Lindfors NC, 2011, WOODHEAD PUBL MATER, P209
   Liu YZ, 2014, MAT SCI ENG C-MATER, V41, P196, DOI 10.1016/j.msec.2014.04.037
   Mabrouk M, 2014, CERAM INT, V40, P4833, DOI 10.1016/j.ceramint.2013.09.033
   Mehrvarzfar Payman, 2011, Iran Endod J, V6, P29
   Miola M, 2013, J BIOMATER APPL, V28, P308, DOI 10.1177/0885328212447665
   Mori Graziela Garrido, 2014, Braz. Dent. J., V25, P104, DOI 10.1590/0103-6440201302206
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nandi SK, 2009, CERAM INT, V35, P3207, DOI 10.1016/j.ceramint.2009.05.005
   Olson ME, 2002, CAN J VET RES, V66, P86
   Prabhu M, 2014, BIOMED RES INT, V2014, DOI 1155/2014/950691
   Quarto Rodolfo, 2016, Methods Mol Biol, V1416, P21, DOI 10.1007/978-1-4939-3584-0_2
   Rahaman MN, 2014, MAT SCI ENG C-MATER, V41, P224, DOI 10.1016/j.msec.2014.04.055
   Rastegar Lari A, 1998, BURNS, V24, P637, DOI 10.1016/S0305-4179(98)00090-4
   Rathke A, 2010, J MATER SCI-MATER M, V21, P2971, DOI 10.1007/s10856-010-4126-1
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rivadeneira J, 2014, J APPL MICROBIOL, V116, P1438, DOI 10.1111/jam.12476
   Rivadeneira J, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015011
   Salehi S, 2015, AM J DENT, V28, P111
   Salles Branco-de-Almeida L, 2011, PLANTA MED, V77, P40, DOI [10.1055/s-0030-1250121, DOI 10.1055/S-0030-1250121]
   Sanchez-Salcedo S, 2014, J MATER CHEM B, V2, P4836, DOI 10.1039/c4tb00403e
   Sforcin JM, 2016, PHYTOTHER RES, V30, P894, DOI 10.1002/ptr.5605
   Stoor P, 1999, J BIOMED MATER RES, V48, P869, DOI 10.1002/(SICI)1097-4636(1999)48:6<869::AID-JBM16>3.3.CO;2-Y
   Subapriya R., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P149, DOI 10.2174/1568011053174828
   Vallet-Regi M, 2012, PHILOS T R SOC A, V370, P1400, DOI 10.1098/rsta.2011.0258
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Xavier JG, 2016, MAT SCI ENG C-MATER, V68, P837, DOI 10.1016/j.msec.2016.07.013
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2008, EUR J PHARM BIOPHARM, V69, P546, DOI 10.1016/j.ejpb.2007.11.018
   Xie ZP, 2008, J ANTIMICROB CHEMOTH, V62, P1162, DOI 10.1093/jac/dkn336
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Xu YT, 2015, ARCH ORAL BIOL, V60, P1059, DOI 10.1016/j.archoralbio.2015.03.007
   Yao QQ, 2013, CERAM INT, V39, P7517, DOI 10.1016/j.ceramint.2013.03.002
   Zhang D, 2006, KEY ENG MAT, V309-311, P345, DOI 10.4028/www.scientific.net/KEM.309-311.345
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
NR 66
TC 8
Z9 8
U1 4
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2017
VL 105
IS 2
BP 672
EP 679
DI 10.1002/jbm.a.35934
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5AR
UT WOS:000392506300030
PM 27750384
DA 2018-10-20
ER

PT J
AU Mozdzen, LC
   Vucetic, A
   Harley, BAC
AF Mozdzen, Laura C.
   Vucetic, Alan
   Harley, Brendan A. C.
TI Modifying the strength and strain concentration profile within collagen
   scaffolds using customizable arrays of poly-lactic acid fibers
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Collagen; Scaffold; Fiber-reinforced; Composite; Spatially-graded; 3D
   printing
ID BONE INSERTION SITE; GLYCOSAMINOGLYCAN SCAFFOLDS; MECHANICAL-PROPERTIES;
   NANOFIBER SCAFFOLDS; GAG SCAFFOLD; TENDON; TISSUE; REGENERATION; MATRIX;
   REPAIR
AB The tendon-to-bone junction is a highly specialized tissue which dissipates stress concentrations between mechanically dissimilar tendon and bone. Upon injury, the local heterogeneities across this insertion are not regenerated, leading to poor functional outcomes such as formation of scar tissue at the insertion and re-failure rates exceeding 90%. Although current tissue engineering methods are moving towards the development of spatially-graded biomaterials to begin to address these injuries, significant opportunities remain to engineer the often complex local mechanical behavior of such biomaterials to enhance their bioactivity. Here, we describe the use of three-dimensional printing techniques to create customizable arrays of poly-lactic acid (PLA) fibers that can be incorporated into a collagen scaffold under development for tendon bone junction repair. Notably, we use additive manufacturing concepts to generate arrays of spatially-graded fibers from biodegradable PLA that are incorporated into collagen scaffolds to create a collagen-PLA composite. We demonstrate the ability to tune the mechanical performance of the fiber-scaffold composite at the bulk scale. We also demonstrate the incorporation of spatially-heterogeneous fiber designs to establish non-uniform local mechanical performance of the composite biomaterial under tensile load, a critical element in the design of multi-compartment biomaterials for tendon-to-bone regeneration applications. Together, this work highlights the capacity to use multi-scale composite biomaterials to control local and bulk mechanical properties, and provides key insights into design elements under consideration for mechanically competent, multi-tissue regeneration platforms.
C1 [Mozdzen, Laura C.; Vucetic, Alan; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
EM bharley@illinois.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21 AR063331]; National Science
   Foundation [0965918]; Support for Under-Represented Groups in
   Engineering (SURGE) Fellowship; DuPont Science and Engineering
   Fellowship; U.S. Department of Energy [DE-FG02-07ER46453,
   DE-FG02-07ER46471]
FX The authors would like to acknowledge assistance from Ryan Rodgers the
   creation of AutoDesk fiber design files. Research reported in this
   publication was supported by the National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the National Institutes of Health
   under Award Numbers R21 AR063331. LCM was partially funded via National
   Science Foundation Grant 0965918 IGERT: Training the Next Generation of
   Researchers in Cellular & Molecular Mechanics and BioNanotechnology, as
   well as the Support for Under-Represented Groups in Engineering (SURGE)
   Fellowship and the DuPont Science and Engineering Fellowship. This
   research was carried out in part in the Frederick Seitz Materials
   Research Laboratory Central Facilities, University of Illinois, which
   are partially supported by the U.S. Department of Energy under grants
   DE-FG02-07ER46453 and DE-FG02-07ER46471.
CR Abd Elhady AA, 2010, AIN SHAMS ENG J, V1, P139, DOI 10.1016/j.asej.2011.03.001
   Almodovar J, 2013, LAB CHIP, V13, P1562, DOI 10.1039/c3lc41407h
   Atesok K., 2014, KNEE SURG SPORT TR A, P1
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Chandrashekar N, 2012, KNEE, V19, P65, DOI 10.1016/j.knee.2010.11.014
   Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]
   Chen SW, 2015, BIOMATERIALS, V73, P23, DOI 10.1016/j.biomaterials.2015.09.010
   Farnebo S, 2014, J HAND SURG-AM, V39, P65, DOI 10.1016/j.jhsa.2013.09.033
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Foolen J, 2014, ACTA BIOMATER, V10, P1876, DOI 10.1016/j.actbio.2013.12.001
   Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067
   Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Jones E.M.C, 2013, IMPROVED DIGITAL IMA
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   Killian ML, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3846
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Lionello G, 2014, J MECH BEHAV BIOMED, V39, P1, DOI 10.1016/j.jmbbm.2014.07.007
   Lipner J, 2014, J MECH BEHAV BIOMED, V40, P59, DOI 10.1016/j.jmbbm.2014.08.002
   Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x
   Marino M, 2014, COMPUT METHOD BIOMEC, V17, P11, DOI 10.1080/10255842.2012.658043
   Mathew A.P., 2016, MACROMOL BIOSCI
   Mozdzen LC, 2016, ACTA BIOMATER, V33, P25, DOI 10.1016/j.actbio.2016.02.004
   Myers KM, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.3197847
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pu J, 2014, ACTA BIOMATER, V10, P2718, DOI 10.1016/j.actbio.2013.12.060
   Qu J., 2013, J ORTHOP RES
   Sano H, 2013, AM J SPORT MED, V41, P2262, DOI 10.1177/0363546513497565
   Serra T, 2013, ACTA BIOMATER, V9, P5521, DOI 10.1016/j.actbio.2012.10.041
   Smith LJ, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0070
   Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425
   Stops AJF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979873
   Szabo B., 1991, FINITE ELEMENT ANAL
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Weisgerber DW, 2016, J MECH BEHAV BIOMED, V61, P318, DOI 10.1016/j.jmbbm.2016.03.032
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   ZIENKIEWICZ OC, 1977, FINITE ELEMENT METHO
NR 45
TC 4
Z9 4
U1 3
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2017
VL 66
BP 28
EP 36
DI 10.1016/j.jmbbm.2016.10.017
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EI5XW
UT WOS:000392570600004
PM 27829193
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gao, AQ
   Xie, KL
   Song, XY
   Zhang, K
   Hou, AQ
AF Gao, Aiqin
   Xie, Kongliang
   Song, Xiyu
   Zhang, Kai
   Hou, Aiqin
TI Removal of the heavy metal ions from aqueous solution using modified
   natural biomaterial membrane based on silk fibroin
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Silk fibroin membrane; Modification; Selective adsorption; Metal ion
ID ADSORPTION BEHAVIOR; ETHANOL-TREATMENT; COPPER IONS; ULTRAFILTRATION;
   COMPLEXES; ADSORBENT; WATER
AB Water-insoluble silk fibroin (WSF) membrane was prepared by co-blending and interaction of fibroin and silane coupling agent. A novel Schiff base with a chelating group, 3,5-bis-{2-hydroxyphenyl-5-[(2-sulphate-4-sulphatoethylsulphonyl-azobenzol) methylene amino]} benzoic acid (BHSABA), was applied to modify WSF membrane. The morphological structure and surface element analysis of WSF and its modified membrane (MWSF) were investigated by scanning electron microscopy (SEM) and energy dispersive spectrometer (SEM-EDS). The sorption behavior of MWSF membrane for six metal ions, Cu(II), Co(II), Ni(II), Cr(III), Pb(II) and Cd(II), were measured. MWSF membrane had the significantly selective sorption for Pb(II) and Cd(II) metal ions and the removal percentage being 82% and 56%, respectively. The adsorption kinetics of MWSF membrane for Cd(II) was analyzed by the pseudo-first-order and pseudo-second-order equations. The adsorption removal process for Cd(II) metal ion was in line with the pseudo-second-order model. MWSF membrane as bioabsorbent has potential application for removal heavy metal ions from the aqueous solution. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gao, Aiqin; Xie, Kongliang; Song, Xiyu; Zhang, Kai] Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Gao, Aiqin; Xie, Kongliang; Song, Xiyu; Zhang, Kai] Donghua Univ, Shanghai 201620, Peoples R China.
   [Hou, Aiqin] Donghua Univ, Natl Engn Res Ctr Dyeing & Finishing Text, Shanghai 201620, Peoples R China.
RP Hou, AQ (reprint author), Donghua Univ, Natl Engn Res Ctr Dyeing & Finishing Text, Shanghai 201620, Peoples R China.
EM aiqinhou@dhu.edu.cn
FU Chinese Universities Scientific Fund [CUSF-DH-D- 2014033]; Shanghai
   Natural Science Foundation [13ZR1400300]
FX This work was financially supported by Chinese Universities Scientific
   Fund (Grant No. CUSF-DH-D- 2014033) and Shanghai Natural Science
   Foundation (Grant No. 13ZR1400300).
CR Baek DH, 2007, FIBER POLYM, V8, P271, DOI 10.1007/BF02877269
   Baycin D, 2007, J AGR FOOD CHEM, V55, P1227, DOI 10.1021/jf062829o
   Burkinshaw SM, 2011, DYES PIGMENTS, V88, P396, DOI 10.1016/j.dyepig.2010.08.018
   Canet L, 2002, SEPAR SCI TECHNOL, V37, P1851, DOI 10.1081/SS-120003047
   Chen JH, 2007, J MEMBRANE SCI, V292, P125, DOI 10.1016/j.memsci.2007.01.026
   Chen ZJ, 2012, APPL SURF SCI, V258, P5291, DOI 10.1016/j.apsusc.2012.02.021
   Elsayed-Ali OH, 2011, J HAZARD MATER, V185, P1550, DOI 10.1016/j.jhazmat.2010.10.086
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Hou AQ, 2010, MATER SCI ENG B-ADV, V167, P124, DOI 10.1016/j.mseb.2010.01.065
   Ji F, 2012, CHEM ENG J, V209, P325, DOI 10.1016/j.cej.2012.08.014
   Khosa M.A., 2013, J FOOD PROCESSING BE, V1, P1
   Khosa MA, 2014, CHEM ENG J, V244, P446, DOI 10.1016/j.cej.2014.01.091
   Landaburu-Aguirre J, 2010, J HAZARD MATER, V180, P524, DOI 10.1016/j.jhazmat.2010.04.066
   Lee K., 2011, INT J BIOL MACROMOL
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Mohsen-Nia M, 2007, DESALINATION, V217, P276, DOI 10.1016/j.desal.2006.01.043
   Moreno D, 2010, J INORG BIOCHEM, V104, P496, DOI 10.1016/j.jinorgbio.2009.12.016
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Ren Y, 2013, CHEM ENG J, V226, P300, DOI 10.1016/j.cej.2013.04.059
   Ren YM, 2008, J HAZARD MATER, V158, P14, DOI 10.1016/j.jhazmat.2008.01.044
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Terada D, 2016, MAT SCI ENG C-MATER, V58, P119, DOI 10.1016/j.msec.2015.07.041
   Thurber AE, 2015, BIOMATERIALS, V71, P145, DOI 10.1016/j.biomaterials.2015.08.039
   Tumer M, 2008, J COORD CHEM, V61, P2935, DOI 10.1080/00958970801989902
   Um I. C., 2001, INT J BIOL
   VOLCHEK K, 1993, J MEMBRANE SCI, V79, P253, DOI 10.1016/0376-7388(93)85120-L
   Wang MH, 2013, CHEM ENG J, V221, P264, DOI 10.1016/j.cej.2013.02.036
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Yavuz O, 2003, WATER RES, V37, P948, DOI 10.1016/S0043-1354(02)00409-8
   Zhang K, 2015, TEXT RES J, V85, P1704, DOI 10.1177/0040517515573411
   Zhou W., 2011, CHEM ENG J, V221, P264
   Zhou WT, 2015, APPL SURF SCI, V345, P169, DOI 10.1016/j.apsusc.2015.03.036
NR 32
TC 6
Z9 6
U1 5
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
EI 1872-6992
J9 ECOL ENG
JI Ecol. Eng.
PD FEB
PY 2017
VL 99
BP 343
EP 348
DI 10.1016/j.ecoleng.2016.11.008
PG 6
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA EH5UO
UT WOS:000391838600038
DA 2018-10-20
ER

PT J
AU Lim, TC
   Spector, M
AF Lim, Teck Chuan
   Spector, Myron
TI Biomaterials for Enhancing CNS Repair
SO TRANSLATIONAL STROKE RESEARCH
LA English
DT Article
DE Scaffolds; Hydrogels; Cell transplantation; Drug and protein delivery;
   Immunomodulation; Glycomimetics; Matrix architecture; Bioimaging;
   Temporal control; Endogenous cells and molecules
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; HYALURONIC-ACID HYDROGEL; FOCAL
   CEREBRAL-ISCHEMIA; GROWTH-FACTOR DELIVERY; BLOOD-BRAIN-BARRIER;
   DRUG-DELIVERY; IN-VIVO; ELECTROSPUN SCAFFOLDS; PRECURSOR CELLS
AB The health of the central nervous system (CNS) does not only rely on the state of the neural cells but also on how various extracellular components organize cellular behaviors into proper tissue functions. Biomaterials have been valuable in restoring or augmenting the roles of extracellular components in the CNS in the event of injury and disease. In this review, we highlight how biomaterials have been enabling tools in important therapeutic strategies involving cell transplantation and drug/protein delivery. We further discuss advances in biomaterial design and applications that can potentially be translated into the CNS to provide unprecedented benefits.
C1 [Lim, Teck Chuan] Inst Bioengn & Nanotechnol, Singapore, Singapore.
   [Spector, Myron] VA Boston Healthcare Syst, Tissue Engn, Boston, MA USA.
   [Spector, Myron] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped, Boston, MA USA.
RP Lim, TC (reprint author), Inst Bioengn & Nanotechnol, Singapore, Singapore.
EM tclim@ibn.a-star.edu.sg
OI Spector, Myron/0000-0003-3328-4858
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Bencherif SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8556
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Chan KWY, 2013, NAT MATER, V12, P268, DOI [10.1038/NMAT3525, 10.1038/nmat3525]
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/NNANO.2013.205, 10.1038/nnano.2013.205]
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013
   Cui YN, 2013, BIOMATERIALS, V34, P8511, DOI 10.1016/j.biomaterials.2013.07.075
   Dorsey SM, 2015, ACS BIOMATER SCI ENG, V1, P227, DOI 10.1021/ab500097d
   Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   He LM, 2013, MACROMOL BIOSCI, V13, P1601, DOI 10.1002/mabi.201300177
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656
   Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040
   Huang ML, 2014, J AM CHEM SOC, V136, P10565, DOI 10.1021/ja505012a
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009
   Karumbaiah L, 2015, BIOCONJUGATE CHEM, V26, P2336, DOI 10.1021/acs.bioconjchem.5b00397
   Ke WL, 2009, BIOMATERIALS, V30, P6976, DOI 10.1016/j.biomaterials.2009.08.049
   Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kim JI, 2012, BIOMATERIALS, V33, P4836, DOI 10.1016/j.biomaterials.2012.03.048
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268
   Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013
   Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Li LH, 2008, BIOMATERIALS, V29, P1509, DOI 10.1016/j.biomaterials.2007.11.014
   Liang YJ, 2015, BIOMATERIALS, V42, P144, DOI 10.1016/j.biomaterials.2014.11.050
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515
   Lin CC, 2008, BIOMACROMOLECULES, V9, P789, DOI 10.1021/bm700940w
   Liu P, 2015, CHEM SCI, V6, P450, DOI 10.1039/c4sc02553a
   Luu TU, 2015, ACS APPL MATER INTER, V7, P28665, DOI 10.1021/acsami.5b10589
   Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   Mishra V, 2006, J DRUG TARGET, V14, P45, DOI 10.1080/10611860600612953
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Nakaguchi K, 2012, STEM CELLS INT, DOI 10.1155/2012/915160
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Purushothaman A, 2012, J BIOL CHEM, V287, P2935, DOI 10.1074/jbc.R111.298430
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Skop Nolan B, 2014, Mol Cell Ther, V2, P19, DOI 10.1186/2052-8426-2-19
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244
   TAMARGO RJ, 1993, CANCER RES, V53, P329
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang X, 2014, CARBOHYD POLYM, V110, P95, DOI 10.1016/j.carbpol.2014.03.070
   Zhang JJ, 2011, ADV MATER, V23, P5098, DOI 10.1002/adma.201103349
   Zhang Y, 2014, MACROMOL BIOSCI, V14, P1249, DOI 10.1002/mabi.201400117
NR 79
TC 2
Z9 2
U1 6
U2 26
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1868-4483
EI 1868-601X
J9 TRANSL STROKE RES
JI Transl. Stroke Res.
PD FEB
PY 2017
VL 8
IS 1
BP 57
EP 64
DI 10.1007/s12975-016-0470-x
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EI4TQ
UT WOS:000392486700007
PM 27251413
DA 2018-10-20
ER

PT J
AU Vahabzadeh, S
   Hack, VK
   Bose, S
AF Vahabzadeh, Sahar
   Hack, Vaughn Kohsei
   Bose, Susmita
TI Lithium-doped beta-tricalcium phosphate: Effects on physical, mechanical
   and in vitro osteoblast cell-material interactions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE beta-tricalcium phosphate; lithium; phase composition; compressive
   strength; osteoblast cell biomaterial interaction
ID WNT SIGNALING PATHWAY; MONOVALENT METAL-IONS; OSTEOGENIC
   DIFFERENTIATION; ILIAC CREST; BONE; SCAFFOLDS; CERAMICS; SIO2; ZNO;
   ANGIOGENESIS
AB In this work, we have investigated the effects of lithium (Li) dopant at different concentrations and sintering temperatures on the physical and mechanical properties of p-tricalcium phosphate (beta-TCP). Our results showed that Li addition at concentrations of 0.65 and 1.0 wt % inhibits the p-TCP to c-TCP phase transformation. 0.15 wt % Li addition resulted in grain growth and extensive liquid phase was formed at higher concentrations. At 1150 degrees C, compressive strength of beta-TCP increased from 138.7 +/- 19.9 MPa to 170.9 +/- 29.8 MPa with the addition of 0.15 wt % Li. Addition of higher amounts of Li decreased the compressive strength and the lowest compressive strength of 99.8 +/- 13.7 MPa was found in samples containing 1.0 wt % Li. After 3 days of culture, osteoblast cells grew to confluence on samples containing 0.65 and 1.0 wt % Li. Cells grew to confluence on all doped samples after 11 days of culture and optical cell density was 4-5 folds higher on 0.15 and 1.0 wt % Li -doped TCP samples. Our results show that both Li content and sintering temperature have significant influence toward physicochemical and mechanical properties of p-TCP which affects the osteoblast cell materials interaction in Li -doped TCP scaffolds. (C) 2015 Wiley Periodicals, Inc.
C1 [Vahabzadeh, Sahar; Hack, Vaughn Kohsei; Bose, Susmita] Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
RP Bose, S (reprint author), Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
EM sbose@wsu.edu
FU NIH National Institute of Biomedical Imaging and Bioengineering
   [N1H-R01-EB-007351]; NIH National Institute of Arthritis and
   Musculoskeletal and Skin Diseases [1R01AR066361]
FX Contract grant sponsor: NIH National Institute of Biomedical Imaging and
   Bioengineering; contract grant number: N1H-R01-EB-007351; Contract grant
   sponsor: NIH National Institute of Arthritis and Musculoskeletal and
   Skin Diseases; contract grant number: 1R01AR066361
CR Bandyopadhyay A, 2013, CHARACTERIZATION OF BIOMATERIALS, P1
   Bandyopadhyay A, 2006, J AM CERAM SOC, V89, P2675, DOI 10.1111/j.1551-2916.2006.01207.x
   Bandyopadhyay A, 2012, J BIOMED MATER RES B, V100B, P2203, DOI 10.1002/jbm.b.32789
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Becker ST, 2011, J ORAL MAXIL SURG, V69, P48, DOI 10.1016/j.joms.2010.05.061
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   Fielding G, 2013, ACTA BIOMATER, V9, P9137, DOI 10.1016/j.actbio.2013.07.009
   Han PP, 2014, BIOMATER SCI-UK, V2, P1230, DOI 10.1039/c4bm00111g
   Han PP, 2012, BIOMATERIALS, V33, P6370, DOI 10.1016/j.biomaterials.2012.05.061
   Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552
   Itatani K, 2002, J MATER SCI-MATER M, V13, P707, DOI 10.1023/A:1015754229181
   Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551
   Lee JH, 2014, ARTIF ORGANS, V38, P149, DOI 10.1111/aor.12275
   Matsumoto N, 2010, J CERAM SOC JPN, V118, P451, DOI 10.2109/jcersj2.118.451
   Matsumoto N, 2009, MATER RES BULL, V44, P1889, DOI 10.1016/j.materresbull.2009.05.012
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   Ravaglioli A, 1992, BIOCERAMICS, P16
   Roy M, 2013, BIOMATER SCI-UK, V1, P74, DOI [10.1039/c2bm00012a, 10.1039/C2BM00012A]
   Roy M, 2012, J BIOMED MATER RES A, V100A, P2450, DOI 10.1002/jbm.a.34181
   Roy M, 2011, J BIOMED MATER RES B, V99B, P258, DOI 10.1002/jbm.b.31893
   Schaaf H, 2010, ORAL SURG ORAL MED O, V109, P52, DOI 10.1016/j.tripleo.2009.08.023
   Tarafder S, 2013, BIOMATER SCI-UK, V1, P1250, DOI 10.1039/c3bm60132c
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Thorfve A, 2014, ACTA BIOMATER, V10, P1451, DOI 10.1016/j.actbio.2013.12.012
   Timmer RT, 1999, J AM SOC NEPHROL, V10, P666
   Wang JW, 2009, DENT MATER, V25, P353, DOI 10.1016/j.dental.2008.07.013
   Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044
   Yin XL, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205205
   Yoshida K, 2006, J AM CERAM SOC, V89, P688, DOI 10.1111/j.1551-2916.2005.00727.x
   Yoshida K, 2005, J AM CERAM SOC, V88, P2315, DOI 10.1111/j.1551-2916.2005.00399.x
   Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 36
TC 5
Z9 5
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2017
VL 105
IS 2
BP 391
EP 399
DI 10.1002/jbm.b.33485
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EH5IK
UT WOS:000391806300015
PM 26525914
DA 2018-10-20
ER

PT J
AU Yadav, YS
   Prasad, K
AF Yadav, Y. S.
   Prasad, K.
TI Development and characterization of shelf stable quick cooking carrot
SO INTERNATIONAL FOOD RESEARCH JOURNAL
LA English
DT Article
DE Carrot; Dehydration Reliydratiou; Processing; Characterization
ID REHYDRATION; PRODUCTS
AB Carrot (Daucus carota L.) being a rich source of bioactive and functional components helps significantly as an important health-promoting biomaterial. Presevance of functional components with extended shelf life and ease in use are the common challenges associated with the vegetables of perishable catagories. To meet the objectives of developing shelf stable quick cooking carrot, effect of blanching, freezing and salt treatments were assessed for the dehydrated and relwdrated products characteristics over the control. Pretreated carrot cubes were subjected to hot air drying at 70 degrees C in order to get shelf stable carrot. Depending on the rehvdrated product characteristics, treatment conditions were screened out and were characterized on various aspects such as dehydration, rehydration, gravimetric and optical characteristics, proximate composition, beta-carotene, total antioxidant capacity, total phenol content. Results were statistically evaluated using two-way ANOVA to elucidate the effects of treatment provided to carrot cubes. Significant effects of treatments were observed for physicochemical, dehydration, rehydration and optical characteristics. All Rights Reserved
C1 [Yadav, Y. S.] Lala Lajpat Rai Univ Vet & Anim Sci, Coll Dairy Sci Technol, Hisar 125004, Haryana, India.
   [Yadav, Y. S.; Prasad, K.] St Longowal Inst Engn & Technol, Dept Food Engn & Technol, Longowal 148106, Punjab, India.
RP Yadav, YS (reprint author), Lala Lajpat Rai Univ Vet & Anim Sci, Coll Dairy Sci Technol, Hisar 125004, Haryana, India.; Yadav, YS (reprint author), St Longowal Inst Engn & Technol, Dept Food Engn & Technol, Longowal 148106, Punjab, India.
EM yogender784@yahoo.co.in
OI Prasad, Kamlesh/0000-0001-7086-9391
CR AOAC, 2000, APPR METH AN
   Bala Manju, 2011, Indian Journal of Agricultural Biochemistry, V24, P55
   BAO B, 1994, J FOOD SCI, V59, P1155, DOI 10.1111/j.1365-2621.1994.tb14665.x
   Haq Raees-ul, 2013, INT J AGR FOOD SCI T, V4, P331
   Krokida MK, 2001, INT J FOOD SCI TECH, V36, P529, DOI 10.1046/j.1365-2621.2001.00483.x
   KULKARNI KD, 1994, J SCI FOOD AGR, V64, P205, DOI 10.1002/jsfa.2740640209
   Naczk Marian, 2003, Preventive Nutrition and Food Science, V8, P200
   Prasad K., 2012, Journal of Tropical Agriculture and Food Science, V40, P193
   Prasad K, 2010, FOOD RES INT, V43, P483, DOI 10.1016/j.foodres.2009.09.038
   Prasad K., 2013, ORYZA, V50, P174
   Prasad K., 2010, RICE BASED FUNCTIONA
   Prasad K., 2014, 19 INT DRYING S IDS
   Rais M., 2015, Journal of Food Processing and Technology, V6, P427
   Ranganna S, 1997, HDB ANAL QUALITY CON
   Shivhare US, 2009, J FOOD PROCESS ENG, V32, P587, DOI 10.1111/j.1745-4530.2007.00234.x
   Singh Y., 2013, EMERGING SCI TECHNOL, P423
   Singh Y., 2013, INT J AGR FOOD SCI T, V4, P317
   Suman M, 2002, J FOOD SCI TECH MYS, V39, P677
NR 18
TC 0
Z9 0
U1 0
U2 1
PU UNIV PUTRA MALAYSIA PRESS
PI SELANGOR
PA SERDANG, SELANGOR, 00000, MALAYSIA
SN 1985-4668
EI 2231-7546
J9 INT FOOD RES J
JI Int. Food Res. J.
PD FEB
PY 2017
VL 24
IS 1
BP 465
EP 470
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA FY8EY
UT WOS:000427097600062
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Mao, LN
   Liu, J
   Liu, TJ
AF Zhang, Yan
   Mao, Lina
   Liu, Juan
   Liu, Tianjun
TI Self-fluorescent drug delivery vector based on genipin-crosslinked
   polyethylenimine conjugated globin nanoparticle
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Self-fluorescence; Globin; Drug delivery; Fluorescence imaging;
   Genipin-crosslink
ID BLOOD SUBSTITUTES; LINKING REACTION; HEMOGLOBIN; COLLAGEN; DESIGN;
   SYSTEMS; PROTEIN; CARRIER; OXYGEN; LIGHT
AB A kind of self-fluorescent, biocompatible, and low-toxic Genipin crosslinked Globin-PEI nanoparticle (Gb-G-PEI NP) with high enzymolysis-stability and photo-stability was synthesized successfully. The properties of the Gb-G-PEI NP were characterized, including its particle size, surface zeta potential, morphology, paclitaxel (PTX) loading capacity and release. The Gb-G-PEI NPs as imaging probe were investigated by Confocal Laser Scanning Microscope (CLSM) in vitro and by fluorescence imaging system in vivo. Cell imaging results showed that the tumor cell line (HepG-2) had the faster cell uptake rate and metabolism rate than the normal cell line (L-O2), this difference showed its tumor selectivity. MIT assay revealed that the PTX-loaded Gb-G-PEI NPs showed almost the equal potence to tumor cell HepG-2 as the free PTX at the same PTX concentration, while a lower cytotoxicity to normal cell L-O2, suggesting its promising utilization as a drug delivery system. The imaging on mice demonstrated the possibility of the self-fluorescent Gb-G-PEI NPs as probe in vivo. So Gb-G-PEI NPs can be potentially utilized as both tracking marker and tumor cell selective drug delivery system in the biomaterial field. (C) 2016 Published by Elsevier B.V.
C1 [Liu, Tianjun] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   Peking Union Med Coll, Tianjin Key Lab Biomat Res, Tianjin 300192, Peoples R China.
RP Liu, TJ (reprint author), Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.
EM liutianjun@hotmail.com
FU Key Technologies R & D Program of Tianjin [12ZCDZSY11900]; Peking Union
   Medical College Postdoctoral Fund
FX This work was supported by the Key Technologies R & D Program of Tianjin
   (12ZCDZSY11900) and Peking Union Medical College Postdoctoral Fund.
CR Abassi Z, 1997, J LAB CLIN MED, V129, P603, DOI 10.1016/S0022-2143(97)90194-3
   Abbasi S, 2011, CELL BIOCHEM BIOPHYS, V61, P277, DOI 10.1007/s12013-011-9201-9
   Alayash AI, 2000, FREE RADICAL RES, V33, P341, DOI 10.1080/10715760000300881
   Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Cabrales P, 2013, ASAIO J, V59, P337, DOI 10.1097/MAT.0b013e318291fbaa
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Chen KY, 2011, BIOMEDICINE-TAIWAN, V1, P29, DOI 10.1016/j.biomed.2011.10.005
   Cho J, 2005, CHEM MATER, V17, P4547, DOI 10.1021/cm050972b
   Ego C, 2003, J AM CHEM SOC, V125, P437, DOI 10.1021/ja0205784
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031
   Estrin DA, 2011, BIOPHYS J, V100, P379
   Hu Yuan-Dong, 2001, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V9, P263
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Ivanov VT, 1997, BIOPOLYMERS, V43, P171
   Kichler A, 2004, J GENE MED, V6, pS3, DOI 10.1002/jgm.507
   Kunitsyn V., 2015, J ASIAN SCI RES, V5, P92
   Li JH, 2013, INT J NANOMED, V8, P3415, DOI 10.2147/IJN.S51203
   Lin YH, 2013, BIOMATERIALS, V34, P4466, DOI 10.1016/j.biomaterials.2013.02.028
   Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024
   Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733
   MORRISON M, 1965, ANAL BIOCHEM, V12, P77, DOI 10.1016/0003-2697(65)90144-2
   Mulder WJM, 2006, NANO LETT, V6, P1, DOI 10.1021/nl051935m
   Murata M, 2015, MOL PHARMACEUT, V12, P1422, DOI 10.1021/mp5007129
   Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007
   NHO K, 1992, BIOMAT ARTIF CELL IM, V20, P511, DOI 10.3109/10731199209119677
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Paik YS, 2001, J AGR FOOD CHEM, V49, P430, DOI 10.1021/jf000978f
   Qiu JC, 2013, ACS APPL MATER INTER, V5, P344, DOI 10.1021/am302272k
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sivan S, 2003, BIOMOL ENG, V20, P83, DOI 10.1016/S1389-0344(02)00115-6
   Song F, 2009, INT J PHARMACEUT, V373, P41, DOI 10.1016/j.ijpharm.2009.02.005
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   WALDER JA, 1979, BIOCHEMISTRY-US, V18, P4265, DOI 10.1021/bi00587a001
   Yin X., 2016, MACROMOLECULES
   Zhao LH, 2015, BIOORG MED CHEM LETT, V25, P2540, DOI 10.1016/j.bmcl.2015.04.051
NR 39
TC 9
Z9 10
U1 4
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 17
EP 24
DI 10.1016/j.msec.2016.09.059
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200003
PM 27987695
DA 2018-10-20
ER

PT J
AU Wang, HN
   Zheng, Y
   Liu, JH
   Jiang, CB
   Li, Y
AF Wang, Henan
   Zheng, Yang
   Liu, Jinghua
   Jiang, Chengbao
   Li, Yan
TI In vitro corrosion properties and cytocompatibility of Fe-Ga alloys as
   potential biodegradable metallic materials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biodegradable metals; Fe-Ga alloys; Corrosion; Cytocompatibility
ID IMPLANTED NITI ALLOY; IRON-GALLIUM ALLOYS; CELL VIABILITY; PURE IRON;
   BIOCOMPATIBILITY; BIOMATERIAL; DEGRADATION
AB The in vitro biodegradable properties and cytocompatibility of Fe-Ga alloys including Fe81Ga19, (Fe81Ga19)(98)B-2 and (Fe81Ga19)(99.5)(TaC)(0.5), and pure Fe were investigated for biomedical applications. The microstructure of the alloys was characterized using X-ray diffraction spectroscopy and optical microscopy. The results showed that A2 and D0(3) phases were detected for the three types of Fe-Ga alloys, and additional Fe2B and TaC phases were found in the (Fe81Ga19)(98)B-2 and (Fe81Ga19)(99.5) (TaC)(0.5) alloys, respectively. The corrosion rates of the Fe-Ga alloys were higher than that of pure Fe, as demonstrated by both potentiodynamic polarization measurements and immersion tests in simulated body fluid. The alloying element Ga lowered the corrosion potential of the Fe matrix and made it more susceptible to corrosion. Severe pitting corrosion developed on the surface of the Fe81Ga19 alloy after the addition of ternary B or TaC due to the multi-phase microstructures. The MC3T3-E1 cells exhibited good adhesion and proliferation behavior on the surfaces pf the Fe-Ga alloys after culture for 4 h and 24 h. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Henan; Zheng, Yang; Liu, Jinghua; Jiang, Chengbao; Li, Yan] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
RP Li, Y (reprint author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
EM liyan@buaa.edu.cn
RI Li, Yan/E-1417-2018
OI Li, Yan/0000-0002-5610-5341; Zheng, Yang/0000-0003-3575-7321
FU National Natural Science Foundation of China (NSFC) [51674011, 51331001]
FX This work is supported by the National Natural Science Foundation of
   China (NSFC, Nos. 51674011 and 51331001).
CR [Anonymous], 2004, G3172 ASTM
   Bormio-Nunes C, 2013, J ALLOY COMPD, V574, P467, DOI 10.1016/j.jallcom.2013.05.122
   Bormio-Nunes C, 2011, J APPL PHYS, V109, DOI 10.1063/1.3561782
   Chen XB, 2014, ACTA BIOMATER, V10, P1463, DOI 10.1016/j.actbio.2013.11.016
   Clark AE, 2007, J APPL PHYS, V101, DOI 10.1063/1.2670376
   Cullen JR, 2001, J MAGN MAGN MATER, V226, P948, DOI 10.1016/S0304-8853(00)00612-0
   Emdadi A, 2015, RARE METALS, V34, P251, DOI 10.1007/s12598-015-0450-4
   Esmaeili M., 2015, J NEW MAT, V5, P45
   Hazer DB, 2016, SPINE, V41, pE323, DOI 10.1097/BRS.0000000000001223
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Kellogg RA, 2004, ACTA MATER, V52, P5043, DOI 10.1016/j.actamat.2004.07.007
   Kellogg RA, 2003, P SOC PHOTO-OPT INS, V5053, P534, DOI 10.1117/12.484347
   Li JH, 2015, RARE METALS, V34, P472, DOI 10.1007/s12598-013-0127-9
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1227, DOI 10.1016/j.msec.2010.07.001
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Lograsso TA, 2003, J ALLOY COMPD, V350, P95, DOI 10.1016/S0925-8388(02)00933-7
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Na SM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838772
   Nie F. L., 2010, BIOMED MATER, V5, P9595
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pouponneau P, 2011, J MATER SCI-MATER M, V22, P237, DOI 10.1007/s10856-010-4206-2
   Roberge P.R., 2012, HDB CORROSION ENG
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Stepan LL, 2007, J BIOMED MATER RES A, V82A, P768, DOI 10.1002/jbm.a.31192
   Sun AL, 2015, MAT SCI ENG A-STRUCT, V639, P370, DOI 10.1016/j.msea.2015.05.021
   Takahashi T, 2009, SCRIPTA MATER, V60, P847, DOI 10.1016/j.scriptamat.2009.01.020
   Wang YB, 2012, MAT SCI ENG C-MATER, V32, P599, DOI 10.1016/j.msec.2011.12.018
   Xue PF, 2015, MAT SCI ENG C-MATER, V50, P179, DOI 10.1016/j.msec.2015.02.004
   Yong H. U., 2012, T NONFERR METAL SOC, V22, P2146
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhang SY, 2016, MAT SCI ENG C-MATER, V68, P414, DOI 10.1016/j.msec.2016.06.017
   Zhao TT, 2012, J BIOMED MATER RES B, V100B, P646, DOI 10.1002/jbm.b.31989
   Zhao TT, 2011, SURF COAT TECH, V205, P4404, DOI 10.1016/j.surfcoat.2011.03.061
NR 34
TC 6
Z9 6
U1 3
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 60
EP 66
DI 10.1016/j.msec.2016.09.086
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200008
PM 27987750
DA 2018-10-20
ER

PT J
AU Wang, SP
   Guan, S
   Zhu, ZB
   Li, WF
   Liu, TQ
   Ma, XH
AF Wang, Shuping
   Guan, Shui
   Zhu, Zhibo
   Li, Wenfang
   Liu, Tianqing
   Ma, Xuehu
TI Hyaluronic acid doped-poly(3,4-ethylenedioxythiophene)/chitosan/gelatin
   (PEDOT-HA/Cs/Gel) porous conductive scaffold for nerve regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Conducting polymer; Chitosan and gelatin; Porous scaffold; PC12 cells;
   Nerve regeneration
ID NEURAL STEM-CELLS; ELECTRICAL-STIMULATION; EDIBLE FILMS; TISSUE;
   DIFFERENTIATION; POLYPYRROLE; POLYMERS; GROWTH; ADHESION; POLYMERIZATION
AB Conducting polymer, as a "smart" biomaterial, has been increasingly used to construct tissue engineered scaffold for nerve tissue regeneration. In this study, a novel porous conductive scaffold was prepared by incorporating conductive hyaluronic acid (HA) doped-poly(3,4-ethylenedioxythiophene) (PEDOT-HA) nanoparticles into a chitosan/gelatin (Cs/Gel) matrix. The physicochemical characteristics of Cs/Gel scaffold with 0-10 wt PEDOT-HA were analyzed and the results indicated that the incorporation of PEDOT-HA into scaffold increased the electrical and mechanical properties while decreasing the porosity and water absorption. Moreover, in vitro biodegradation of scaffold displayed a declining trend with the PEDOT-HA content increased. About the biocompatibility of conductive scaffold, neuron-like rat phaeochromocytoma (PC12) cells were cultured in scaffold to evaluate cell adhesion and growth. 8% PEDOT-HA/Cs/Gel scaffold had a higher cell adhesive efficiency and cell viability than the other conductive scaffolds. Furthermore, cells in the scaffold with 8 wt PEDOT-HA expressed higher synapse growth gene of GAP43 and SYP compared with Cs/Gel control group. These results suggest that 8%PEDOT-HA/Cs/Gel scaffold is an attractive cell culture conductive substrate which could support cell adhesion, survival, proliferation, and synapse growth for the application in nerve tissue regeneration. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Shuping; Guan, Shui; Zhu, Zhibo; Li, Wenfang; Liu, Tianqing; Ma, Xuehu] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian 116024, Peoples R China.
RP Guan, S (reprint author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian 116024, Peoples R China.
EM guanshui@dlut.edu.cn
RI Guan, Shui/D-7759-2017
OI Guan, Shui/0000-0001-7617-8081
FU National Natural Science Foundation of China [30800288]; Fundamental
   Research Funds for the Central Universities [DUT16QY08]
FX The financial support for this work was provided by the National Natural
   Science Foundation of China (30800288) and the Fundamental Research
   Funds for the Central Universities (DUT16QY08).
CR Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Deng H, 2014, PROG POLYM SCI, V39, P627, DOI 10.1016/j.progpolymsci.2013.07.007
   Durgam H, 2010, J BIOMAT SCI-POLYM E, V21, P1265, DOI 10.1163/092050609X12481751806330
   Elsabee MZ, 2013, MAT SCI ENG C-MATER, V33, P1819, DOI 10.1016/j.msec.2013.01.010
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Guan S, 2013, J BIOMAT SCI-POLYM E, V24, P999, DOI 10.1080/09205063.2012.731374
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Guo WB, 2016, NANOSCALE, V8, P1897, DOI 10.1039/c5nr06602f
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   Hsiao YS, 2016, ACS APPL MATER INTER, V8, P9275, DOI 10.1021/acsami.6b00916
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Hughes-Davis EJ, 2005, NEUROSCIENCE, V135, P1231, DOI 10.1016/j.neuroscience.2005.07.017
   Jin G., 2014, MAT SCI ENG C, V45, P671
   Jridi M, 2014, INT J BIOL MACROMOL, V67, P373, DOI 10.1016/j.ijbiomac.2014.03.054
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Lakard B, 2009, BIOELECTROCHEMISTRY, V75, P148, DOI 10.1016/j.bioelechem.2009.03.010
   Lavik Erin, 2002, Methods Mol Biol, V198, P89
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Li LY, 2015, BIOMATERIALS, V41, P132, DOI 10.1016/j.biomaterials.2014.10.075
   Lu CH, 2013, BBA-GEN SUBJECTS, V1830, P4321, DOI 10.1016/j.bbagen.2012.08.028
   Lu Y, 2012, BIOMATERIALS, V33, P378, DOI 10.1016/j.biomaterials.2011.09.083
   Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510
   McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]
   Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696
   Niple JC, 2004, BIOELECTROMAGNETICS, V25, P369, DOI 10.1002/bem.20000
   Peramo A, 2008, TISSUE ENG PT A, V14, P423, DOI 10.1089/tea.2007.0123
   Pires F, 2015, BBA-GEN SUBJECTS, V1850, P1158, DOI 10.1016/j.bbagen.2015.01.020
   Richardson-Burns SM, 2007, J NEURAL ENG, V4, pL6, DOI 10.1088/1741-2560/4/2/L02
   Sarem M, 2013, MAT SCI ENG C-MATER, V33, P4777, DOI 10.1016/j.msec.2013.07.036
   Shahini A, 2014, INT J NANOMED, V9, P167, DOI 10.2147/IJN.S54668
   Shi GX, 2008, J BIOMED MATER RES A, V84A, P1026, DOI 10.1002/jbm.a.31337
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   SIMPSON DL, 1991, J NEUROSCI RES, V28, P486, DOI 10.1002/jnr.490280405
   Song KD, 2015, MAT SCI ENG C-MATER, V55, P384, DOI 10.1016/j.msec.2015.05.062
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999
   Wang S., 2016, J BIOSCI BI IN PRESS
   Wickham A, 2016, NANOSCALE, V8, P14146, DOI 10.1039/c6nr02027e
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang LP, 2008, MACROMOLECULES, V41, P7671, DOI 10.1021/ma8013228
NR 47
TC 7
Z9 7
U1 18
U2 87
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 308
EP 316
DI 10.1016/j.msec.2016.10.029
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200037
PM 27987712
DA 2018-10-20
ER

PT J
AU Berg, NG
   Pearce, BL
   Rohrbaugh, N
   Jiang, L
   Nolan, MW
   Ivanisevic, A
AF Berg, Nora G.
   Pearce, Brady L.
   Rohrbaugh, Nathaniel
   Jiang, Lin
   Nolan, Michael W.
   Ivanisevic, Albena
TI Gallium containing composites as a tunable material to understand
   neuronal behavior under variable stiffness and radiation conditions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Multifunctional; Gallium; Stiffness; Radiation; Radiosensitizing
ID LOW-DOSE RADIATION; IN-VIVO; CELLS; NANOPARTICLES; SUBSTRATE; CANCER;
   DIFFERENTIATION; OUTGROWTH; DELIVERY; NITRIDE
AB We report a composite biomaterial containing nanostructured GaOOH and Matrigel (TM) that can be modulated with respect to its stiffness and radiosensitization properties. A variety of concentrations of GaOOH were added to the composite to alter the mechanical properties of the material as well as to tune the radiosensitizing properties to the composite. PC-12 cells were used to study the combined effects of different stimuli on cell behavior. NGF was given to the cells to record their morphology as well as viability. An increase in the substrate stiffness caused an increase in neurite outgrowth but a decrease in cell viability. In addition, increasing the radiation dose decreased neurite outgrowth but increased cell viability when radiosensitizing particles were present A subtractive effect between radiosensitizing and mechanical stimuli was observed when PC-12 cells were grown on the GaOOH containing composite. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Berg, Nora G.; Pearce, Brady L.; Rohrbaugh, Nathaniel; Ivanisevic, Albena] North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   [Jiang, Lin] Univ New South Wales, Mat Sci & Engn, Sydney, NSW, Australia.
   [Nolan, Michael W.] North Carolina State Univ, Comparat Med Inst, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27606 USA.
RP Ivanisevic, A (reprint author), North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
EM ivanisevic@ncsu.edu
FU State of North Carolina; National Science Foundation; NSF [IIA-1357113];
   Australian Governments Study Overseas Short-term Mobility Program
FX We acknowledge the use of the Analytical Instrumentation Facility (AIF)
   at North Carolina State University, which is supported by the State of
   North Carolina and the National Science Foundation. We thank NSF
   (IIA-1357113) and Australian Governments Study Overseas Short-term
   Mobility Program for support of this work.
CR ABEYAMA K, 1995, FEBS LETT, V364, P298, DOI 10.1016/0014-5793(95)00412-3
   Albert JM, 2013, AM J ROENTGENOL, V201, pW81, DOI 10.2214/AJR.12.9226
   Bain LE, 2016, MAT SCI ENG C-MATER, V58, P1194, DOI 10.1016/j.msec.2015.09.084
   Berg N. G., 2016, ACS APPL MAT INTERFA
   Chua JS, 2014, BIOMATERIALS, V35, P7750, DOI 10.1016/j.biomaterials.2014.06.008
   Elliott SP, 2011, WORLD J UROL, V29, P35, DOI 10.1007/s00345-010-0603-x
   Eom HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147538
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gordon J, 2013, METHODS MOL BIOL, V1078, P1, DOI 10.1007/978-1-62703-640-5_1
   Greene LA, 1982, ADV CELL NEUROBIOL, V3, P373, DOI DOI 10.1016/B978-0-12-008303-9.50016-5
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008
   Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a
   Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966
   Jennie BL, 2007, J NEURAL ENG, V4, P26
   Jewett SA, 2012, ACTA BIOMATER, V8, P728, DOI 10.1016/j.actbio.2011.09.038
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Katsura M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20027
   Klein S, 2014, J PHYS CHEM B, V118, P6159, DOI 10.1021/jp5026224
   Klein S, 2013, BIOCHEM BIOPH RES CO, V434, P217, DOI 10.1016/j.bbrc.2013.03.042
   Klymov A, 2015, HEARING RES, V320, P11, DOI 10.1016/j.heares.2014.12.009
   Kundu A, 2013, LAB CHIP, V13, P3070, DOI 10.1039/c3lc50174d
   Liu H., 2011, ANGEW CHEM, V123, P921
   Liu PD, 2013, NANOSCALE, V5, P11829, DOI 10.1039/c3nr01351k
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   Meng S., 2010, NANOTECHNOLOGY, V21
   Miladi I, 2014, SMALL, V10, P1116, DOI [10.1002/smll.201470036, 10.1002/smll.201302303]
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Pearce B. L, 2016, SCANNING
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   RUSSELL J, 1995, CANCER RES, V55, P4915
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sergi PN, 2015, INTEGR BIOL-UK, V7, P1242, DOI 10.1039/c5ib00045a
   Sergi PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070304
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Spedden E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106709
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Wang XS, 2015, ACTA BIOMATER, V22, P164, DOI 10.1016/j.actbio.2015.04.010
   Wang XS, 2015, RSC ADV, V5, P12886, DOI 10.1039/c4ra14348e
NR 42
TC 1
Z9 1
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 317
EP 321
DI 10.1016/j.msec.2016.10.022
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200038
PM 27987713
DA 2018-10-20
ER

PT J
AU Alhalawani, AMF
   Mehrvar, C
   Stone, W
   Waldman, SD
   Towler, MR
AF Alhalawani, Adel M. F.
   Mehrvar, Cina
   Stone, Wendy
   Waldman, Stephen D.
   Towler, Mark R.
TI A novel tantalum-containing bioglass. Part II. Development of a
   bioadhesive for sternal fixation and repair
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Glass polyalkenoate cements; Sternal fixation; Bone cements; Bioactive
   glass; Tantalum pentoxide; Biocompatibility; Cytotoxicity
ID GLASS POLYALKENOATE CEMENTS; BONELIKE APATITE FORMATION; SIMULATED
   BODY-FLUID; DENTAL MATERIALS; PHYSICAL-PROPERTIES; IONOMER CEMENTS;
   ANTIBACTERIAL PROPERTIES; MECHANICAL-PROPERTIES; CLOSURE TECHNIQUES;
   WOUND-INFECTION
AB With over a million median sternotomy surgeries performed worldwide every year, sternal wound complications have posed a serious risk to the affected patients. A rigid therapeutic stemal fixation device has therefore become a necessity. In this work, the incorporation of up to 0.5 rnol% of tantalum pentoxide (Ta2O5), in exchange for zinc oxide (ZnO), into the SiO2-ZnO-CaO-SrO-P2O5 glass system is presented. The effect of Ta incorporation on the physical, chemical and biological properties of the glass polyalkenoate cements (GPCs) prepared from them have been presented in this manuscript The data obtained have confirmed that Ta2O5 incorporation into the reference glass system results in increased working times, radiopacity, ion solubility, and long-term mechanical stability. The formulated glass systems have also shown clear antibacterial and antifungal activity against both Gram-negative (Escherichia coil) and Gram-positive prokaryotes (Staphylococcus aureus and Streptococcus epidermidis), as well as eukaryotes (Fusarium solani). Cytotoxicity testing showed that Ta incorporation results in no toxicity effect and may simulate osseo-integration when tested in animal models. These new metallic-containing biomaterial adhesives have been developed for sternal fixation and repair. As a permanent implant, the formulated adhesives can be used in conjunction with sternal cable ties to offer optimal fixation for patients and reduce post-operative complications such as bacterial infection and pain from micro-motion. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Alhalawani, Adel M. F.; Mehrvar, Cina; Towler, Mark R.] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON, Canada.
   [Alhalawani, Adel M. F.; Waldman, Stephen D.; Towler, Mark R.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Stone, Wendy] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.
   [Waldman, Stephen D.] Ryerson Univ, Dept Chem Engn, Toronto, ON, Canada.
RP Towler, MR (reprint author), Fac Engn & Architectural Sci, Dept Mech & Ind Engn, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM mtowler@ryerson.ca
OI Alhalawani, Adel/0000-0002-3374-3172
FU Collaborative Health Research Project, CIHR/NSERC [315694-DAN]
FX The authors gratefully acknowledge the financial assistance of the
   Collaborative Health Research Project, CIHR/NSERC (315694-DAN). The
   authors are also thankful to Dr. Declan Curran (Medtronic, Ireland) for
   his advice, Dr. Daniel Boyd (Dalhousie University, Canada) for his
   assistance with radiopacity testing, Dr. Ahmad Varvani for the bone
   sample design and Mr. Chao Ma for machining the samples (both Ryerson
   University).
CR AKINMADE AO, 1993, J MATER SCI-MATER M, V4, P95, DOI 10.1007/BF00120376
   Alhalawani AMF, 2016, MATER CHARACT, V114, P218, DOI 10.1016/j.matchar.2016.03.004
   Alhalawani AMF, 2016, J POLYM ENG, V36, P221, DOI 10.1515/polyeng-2015-0079
   Alhalawani AMF, 2014, MATER CHEM PHYS, V147, P360, DOI 10.1016/j.matchemphys.2014.06.020
   Alhalawani AMF, 2013, J FUNCT BIOMATER, V4, P329, DOI 10.3390/jfb4040329
   Alhalawani AMF, 2013, J BIOMATER APPL, V28, P483, DOI 10.1177/0885328213495426
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   [Anonymous], 2007, 991712007 ISO
   Balla VK, 2010, JOM-US, V62, P61, DOI 10.1007/s11837-010-0110-y
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Boyd D, 2008, J MATER SCI, V43, P1170, DOI 10.1007/s10853-007-2362-7
   Boyd D, 2008, ACTA BIOMATER, V4, P425, DOI 10.1016/j.actbio.2007.07.010
   Bruins MR, 2000, ECOTOX ENVIRON SAFE, V45, P198, DOI 10.1006/eesa.1999.1860
   Chang YY, 2014, SURF COAT TECH, V259, P193, DOI 10.1016/j.surfcoat.2014.03.061
   Clarkin OM, 2009, J MATER SCI-MATER M, V20, P1563, DOI 10.1007/s10856-009-3701-9
   Cohen DJ, 2002, ANN THORAC SURG, V73, P563
   Cordeiro L, 2014, J NON-CRYST SOLIDS, V402, P44, DOI 10.1016/j.jnoncrysol.2014.05.015
   Coughlan A, 2010, BIO-MED MATER ENG, V20, P99, DOI 10.3233/BME-2010-0620
   DARLING M, 1994, BIOMATERIALS, V15, P299, DOI 10.1016/0142-9612(94)90055-8
   de Pietro GM, 2015, J AM CERAM SOC, V98, P2086, DOI 10.1111/jace.13555
   Driessen MD, 1998, J MOL CATAL A-CHEM, V131, P149, DOI 10.1016/S1381-1169(97)00262-8
   Eidem TM, 2014, J BIOMATER APPL, V28, P1235, DOI 10.1177/0885328213503388
   ElBatal FH, 2011, SILICON-NETH, V3, P185, DOI 10.1007/s12633-011-9095-6
   Fedak PWM, 2011, SURG INNOV, V18, pNP8, DOI 10.1177/1553350611412057
   Fedak PWM, 2010, ANN THORAC SURG, V90, P979, DOI 10.1016/j.athoracsur.2010.05.009
   Ford M., 2011, BIOENG C NEBEC IEEE, P1
   Friberg O, 2006, THORAC CARDIOV SURG, V54, P468, DOI 10.1055/s-2006-924437
   Grech L, 2013, DENT MATER, V29, pE20, DOI 10.1016/j.dental.2012.11.007
   Guida A, 2003, J MATER SCI LETT, V22, P1401, DOI 10.1023/A:1025794927195
   Harrison JJ, 2006, FEMS MICROBIOL ECOL, V55, P479, DOI 10.1111/j.1574-6941.2005.00045.x
   Holland M, 2010, CAN J CARDIOL, V26, p155D
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jolly S, 2012, ANN THORAC SURG, V94, P1359, DOI 10.1016/j.athoracsur.2012.05.067
   KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743
   Lewis G, 2010, J MATER SCI-MATER M, V21, P59, DOI 10.1007/s10856-009-3845-7
   Almodovar LFL, 2008, ANN THORAC SURG, V86, P1016, DOI 10.1016/j.athoracsur.2008.02.046
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Matsuya S, 1996, J DENT RES, V75, P1920, DOI 10.1177/00220345960750120201
   Matsuya S, 1999, Dent Mater J, V18, P155
   Mavros MN, 2012, J THORAC CARDIOV SUR, V144, P1235, DOI 10.1016/j.jtcvs.2012.06.040
   MCCABE JF, 1990, J DENT, V18, P90, DOI 10.1016/0300-5712(90)90091-R
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   Moritz N, 2004, J MATER SCI-MATER M, V15, P787, DOI 10.1023/B:JMSM.0000032819.64994.42
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nicholson J.W., 1991, CLIN MATER, V7, P289, DOI 10.1016/0267-6605(91)90072-N
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Nicholson JW, 1998, INT J ADHES ADHES, V18, P229, DOI 10.1016/S0143-7496(98)00027-X
   Persson C, 2006, P I MECH ENG H, V220, P787, DOI 10.1243/09544119JEIM88
   Rajamathi JT, 2005, J CHEM SCI, V117, P629, DOI 10.1007/BF02708291
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Saper RB, 2009, AM FAM PHYSICIAN, V79, P768
   Schimmer C, 2008, ANN THORAC SURG, V86, P1897, DOI 10.1016/j.athoracsur.2008.08.071
   Schimmer C, 2012, J THORAC CARDIOV SUR, V143, P194, DOI 10.1016/j.jtcvs.2011.05.035
   Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9
   Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583
   Tomlinson SK, 2007, VIB SPECTROSC, V45, P10, DOI 10.1016/j.vibspec.2007.03.009
   Towler MR, 2004, BIO-MED MATER ENG, V14, P565
   Wetherall K. M., 2009, J PHYS CONDENS MATT, V21, P37
   Williams JA, 2002, DENT MATER, V18, P376, DOI 10.1016/S0109-5641(01)00053-7
   Wren AW, 2013, J MATER SCI-MATER M, V24, P2255, DOI 10.1007/s10856-013-4974-6
   Wren AW, 2013, J MATER SCI-MATER M, V24, P271, DOI 10.1007/s10856-012-4813-1
   Wren AW, 2012, J MATER SCI-MATER M, V23, P1823, DOI 10.1007/s10856-012-4624-4
   Wren AW, 2010, J MATER SCI-MATER M, V21, P2355, DOI 10.1007/s10856-010-4089-2
   Zhang Y, 2008, NANOSCALE RES LETT, V3, P201, DOI 10.1007/s11671-008-9136-2
NR 67
TC 4
Z9 4
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 401
EP 411
DI 10.1016/j.msec.2016.10.024
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200048
PM 27987724
DA 2018-10-20
ER

PT J
AU Gurlek, AC
   Sevinc, B
   Bayrak, E
   Erisken, C
AF Gurlek, Ayse Cansu
   Sevinc, Burcu
   Bayrak, Ece
   Erisken, Cevat
TI Synthesis and characterization of polycaprolactone for anterior cruciate
   ligament regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polycaprolactone; Synthesis; Anterior cruciate ligament; Biomechanics;
   Tissue engineering
ID ROTATOR CUFF REPAIR; TENDON AUTOGRAFT; RECONSTRUCTION; SCAFFOLDS
AB Anterior cruciate ligament (ACL) is the most frequently torn ligament in the knee, and complete healing is unlikely due to lack of vascularization. Current approaches for the treatment of ACL injuries include surgical interventions and grafting, however recent reports show that surgeries have 94% recurrency, and that repaired tissues are biomechanically inferior to the native tissue. These necessitate the need for new strategies for scar-free repair/regeneration of ACL injuries.
   Polycaprolactone (PCL) is a biodegradable and biocompatible synthetic polymer, which has been widely used in the connective tissue repair/regeneration attempts. Here, we report on the synthesis of PCL via ring opening polymerization using epsilon-caprolactone as the monomer, and ammonium heptamolybdate as a catalyst. The synthesized PCL was characterized using Fourier Transform Infrared Spectroscopy (FTIR) and Nuclear Magnetic Resonance (NMR) spectroscopy. It was then processed using electrospinning to form nanofiber-based scaffolds. These scaffolds were characterized in terms of surface as well as mechanical properties, and compared to the properties of commercially available PCL, and of native ACL tissue harvested from sheep. In addition, scaffolds fabricated with synthesized PCL were evaluated regarding their cell attachment capacity using human bone marrow mesenchymal stem cells (hBMSCs).
   Our findings demonstrated that the synthesized PCL is similar to its commercially available counterpart in terms of surface morphology and mechanical properties. In addition, fibrous scaffolds generated with electrospinning showed weaker mechanical properties visa vis native ACL tissue in terms of ultimate stress, and elastic modulus. Also, the synthesized PCL can accommodate cell attachment when tested with hBMSCs. Putting together, these observations reveal that the PCL synthesized in this study could be a good candidate as a biomaterial for ligament repair or regeneration. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Gurlek, Ayse Cansu; Sevinc, Burcu; Bayrak, Ece; Erisken, Cevat] TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
RP Erisken, C (reprint author), TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
EM cerisken@etu.edu.tr
OI Erisken, Cevat/0000-0002-6337-8022
CR Bayrak E., 2016, J POLYM ENG
   Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Dalton PD, 2009, BIOMATERIALS, V30, P2420, DOI 10.1016/j.biomaterials.2009.01.049
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Erisken C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165302
   Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]
   Griffin LY, 2000, J AM ACAD ORTHOP SUR, V8, P141, DOI DOI 10.5435/00124635-200005000-00001
   Gulotta LV, 2009, CLIN SPORT MED, V28, P13, DOI 10.1016/j.csm.2008.09.002
   Herfat ST, 2012, ANN BIOMED ENG, V40, P1545, DOI 10.1007/s10439-011-0500-5
   Hernandez A. R., 2013, AM J POLYM SCI, V3, P70
   Jose E. B., 2003, POLYMER, V44, P6767
   Klibanov AM, 1997, TRENDS BIOTECHNOL, V15, P97, DOI 10.1016/S0167-7799(97)01013-5
   Kondo E, 2012, AM J SPORT MED, V40, P315, DOI 10.1177/0363546511426417
   Kumar A, 2000, BIOMACROMOLECULES, V1, P133, DOI 10.1021/bm990510p
   Lui PPY, 2015, STEM CELLS CLONING, V8, P163, DOI 10.2147/SCCAA.S60832
   LYON RM, 1991, CLIN ORTHOP RELAT R, P279
   NG GY, 1995, J ORTHOP RES, V13, P602, DOI 10.1002/jor.1100130416
   Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175
   Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Seitz H, 2013, INT ORTHOP, V37, P2305, DOI 10.1007/s00264-013-2098-8
   Sykes A. G., 2000, ADV INORGANIC CHEM
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   Yefang Z, 2007, INT J ORAL MAX SURG, V36, P137, DOI 10.1016/j.ijom.2006.08.012
NR 25
TC 6
Z9 6
U1 10
U2 71
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 820
EP 826
DI 10.1016/j.msec.2016.10.071
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200096
PM 27987777
DA 2018-10-20
ER

PT J
AU Stankevich, KS
   Danilenko, NV
   Gadirov, RM
   Goreninskii, SI
   Tverdokhlebov, SI
   Filimonov, VD
AF Stankevich, Ksenia S.
   Danilenko, Nadezhda V.
   Gadirov, Ruslan M.
   Goreninskii, Semen I.
   Tverdokhlebov, Sergei I.
   Filimonov, Victor D.
TI A new approach for the immobilization of poly(acrylic) acid as a
   chemically reactive cross-linker on the surface of poly(lactic)
   acid-based biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(lactic) acid; Poly(acrylic) acid; Surface modification; Entrapment;
   Composite materials; Fluorescent compounds; Bovine serum albumin
ID POLYLACTIC ACID; POLY(D,L-LACTIC ACID); BIODEGRADABLE POLYMERS;
   IN-VITRO; ENTRAPMENT; BIOMACROMOLECULES; BIOCOMPATIBILITY; WETTABILITY;
   DEGRADATION; BEHAVIORS
AB A new approach for the immobilization of poly(acrylic) acid (PAA) as a chemically reactive cross-linker on the surface of poly(lactic) acid-based (PLA) biomaterials is described. The proposed technique includes non covalent attachment of a PAA layer to the surface of PLA-based biomaterial via biomaterial surface treatment with solvent/non-solvent mixture followed by the entrapment of PAA from its solution. Surface morphology and wettability of the obtained PLA-PAA composite materials were investigated by AFM and the sitting drop method respectively. The amount of the carboxyl groups on the composites surface was determined by using the fluorescent compounds (2-(5-aminobenzo[d]oxazol-2-yl)phenol (ABO) and its acyl derivative N-(2-(2-hydroxyphenyl)benzo[d]oxazol-5-yl)acetamide (AcABO)). It was shown that it is possible to obtain PLA-PAA composites with various surface relief and tunable wettability (57 degrees, 62 degrees and 66 degrees). The capacity of the created PM layer could be varied from 1.5 nmol/cm2 to 0.1 mu mol/cm(2) depending on the modification conditions. Additionally, using bovine serum albumin (BSA) it was demonstrated that such composites could be modified with proteins with high binding density (around 0.18 nmol/cm(2)). Obtained fluoro-labeled PLA-PAA materials, as well as PLA-PM composites themselves, are valuable since they can be used for biodegradable polymer implants tracking in living systems and as drug delivery systems. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Stankevich, Ksenia S.; Danilenko, Nadezhda V.; Goreninskii, Semen I.; Filimonov, Victor D.] Natl Res Tomsk Polytech Univ, Dept Biotechnol & Organ Chem, Tomsk, Russia.
   [Stankevich, Ksenia S.; Danilenko, Nadezhda V.; Tverdokhlebov, Sergei I.] Natl Res Tomsk Polytech Univ, Dept Expt Phys, Tomsk, Russia.
   [Gadirov, Ruslan M.] Siberian Phys Tech Inst Tomsk State Univ, Tomsk, Tomskaya Oblast, Russia.
RP Tverdokhlebov, SI (reprint author), Natl Res Tomsk Polytech Univ, Dept Expt Phys, Tomsk, Russia.
EM tverd@tpu.ru
RI Gadirov, Ruslan/A-7960-2014; Stankevich, Ksenia/R-8357-2016
OI Gadirov, Ruslan/0000-0003-3953-3384; Stankevich,
   Ksenia/0000-0002-6701-7582; Tverdokhlebov, Sergei/0000-0002-2242-6358;
   Filimonov, Victor/0000-0003-4729-8871
FU Russian Science Foundation [16-13-10239]; PLA-PAA [4.1991.2014/K]; RFBR
   [16-33-00528]
FX The production of PLA-PAA composites and AFM measurements of
   biomaterials surface were carried out with the financial support of
   Russian Science Foundation (project no, 16-13-10239). Synthesis of the
   fluorescent compounds and covalent modification of the surface of
   PLA-PAA biomaterials were performed within the frame of the Scientific
   Programm "Nauka", project No. 4.1991.2014/K. The development of the
   described method, the surface wettability measurements and protein
   attachment were carried out with the funding from RFBR according to the
   research project No. 16-33-00528.
CR Alarcos N, 2015, PHOTOCH PHOTOBIO SCI, V14, P1306, DOI 10.1039/c5pp00079c
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Cai KY, 2002, J BIOMED MATER RES, V62, P283, DOI 10.1002/jbm.10067
   Chancellor DR, 2011, J MED CHEM, V54, P3241, DOI 10.1021/jm200135z
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Davachi SM, 2015, POLYM-PLAST TECHNOL, V54, P944, DOI 10.1080/03602559.2014.979507
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoglund A, 2010, LANGMUIR, V26, P378, DOI 10.1021/la902166j
   Huang Y., 2006, Patent No. [US 7037983 B2, 7037983]
   Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z
   Janorkar AV, 2006, J POLYM SCI POL CHEM, V44, P6534, DOI 10.1002/pola.21700
   Janorkar AV, 2004, MACROMOLECULES, V37, P9151, DOI 10.1021/ma049056u
   Johnson RM, 2004, BIOMACROMOLECULES, V5, P580, DOI 10.1021/bm034421v
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Mahjoubi H, 2014, ACS APPL MATER INTER, V6, P9975, DOI 10.1021/am502752j
   Mao C.-T., 2015, MAT SCI ENG C, V56, P165
   Matsui T, 2015, ACTA BIOMATER, V13, P32, DOI 10.1016/j.actbio.2014.11.011
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Muller C., 2012, J NANOPART RES, V15, P1
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Peng CR, 2013, J APPL POLYM SCI, V130, P704, DOI 10.1002/app.39243
   Quirk RA, 2001, LANGMUIR, V17, P2817, DOI 10.1021/la001509a
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Rhim JW, 2006, J APPL POLYM SCI, V101, P3736, DOI 10.1002/app.23403
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Stankevich KS, 2015, MAT SCI ENG C-MATER, V51, P117, DOI 10.1016/j.msec.2015.02.047
   Steffens GCM, 2002, BIOMATERIALS, V23, P3523, DOI 10.1016/S0142-9612(02)00091-1
   Sudwilai T, 2014, J BIOMAT SCI-POLYM E, V25, P1240, DOI 10.1080/09205063.2014.926578
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tverdokhlebov SI, 2015, APPL SURF SCI, V329, P32, DOI 10.1016/j.apsusc.2014.12.127
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Zhang JX, 2003, MACROMOLECULES, V36, P1215, DOI 10.1021/ma0213551
   Zhu HG, 2002, MACROMOL RAPID COMM, V23, P819, DOI 10.1002/1521-3927(20021001)23:14<819::AID-MARC819>3.0.CO;2-9
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 37
TC 2
Z9 2
U1 5
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 862
EP 869
DI 10.1016/j.msec.2016.10.078
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200101
PM 27987783
DA 2018-10-20
ER

PT J
AU Vazquez-Hernandez, F
   Mendoza-Acevedo, S
   Mendoza-Barrera, CO
   Mendoza-Alvarez, J
   Luna-Arias, JP
AF Vazquez-Hernandez, Fabiola
   Mendoza-Acevedo, Salvador
   Oliva Mendoza-Barrera, Claudia
   Mendoza-Alvarez, Julio
   Pedro Luna-Arias, Juan
TI Antibody-coupled hydroxyapatite nanoparticles as efficient tools for
   labeling intracellular proteins
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bioconjugation; Cell viability; Functionalization; Hydroxyapatite;
   Immunofluorescence; Nanoparticle
AB Smart biomaterials for active targeting area novel way for biosensing, gene and drug delivery, and bioimaging. The functional additives are chosen according to the material carrier characteristics, i.e. the functional mercapto acids of different lengths. In order to identify the target tissue, cell, organ or molecule, the biomaterial must be equipped with a recognizing molecule on its surface. In most cases, semiconductor o metal materials are employed in bioimaging and biosensing applications; in gene and drug delivery area, it is useful to employ porous nanoparticles as carriers, Hydroxyapatite nanoparticles have been proved efficiently in drug delivery. In this work we established a new protocol to obtain smart hydroxyapatite nanoparticles with 3-mercaptopropionic acid and anti-Actin molecules in order to localize actin molecules in cells. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Vazquez-Hernandez, Fabiola; Pedro Luna-Arias, Juan] Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Programa Doctorado Nanociencias & Nanotecnol, Av IPN 2508, Mexico City 07360, DF, Mexico.
   [Mendoza-Acevedo, Salvador] Inst Politecn Nacl CIC IPN, Ctr Invest Comp, Av Juan de Dios Batiz, Mexico City 07738, DF, Mexico.
   [Oliva Mendoza-Barrera, Claudia] Univ Veracruzana, Ctr Invest Micro & Nanotecnol MICRONA, Lab Nanobiotecnol, Boca Del Rio 94294, Veracruz, Mexico.
   [Mendoza-Alvarez, Julio] Cinvestav IPN, Dept Fis, Av IPN 2508, Mexico City 07360, DF, Mexico.
   [Pedro Luna-Arias, Juan] Cinvestav IPN, Dept Biol Celular, Av IPN 2508, Mexico City 07360, DF, Mexico.
   [Vazquez-Hernandez, Fabiola] Univ Autonoma Ciudad Mexico, Plantel Cuautepec, Av La Corona 320, Mexico City 07160, DF, Mexico.
   [Mendoza-Acevedo, Salvador] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75083 USA.
RP Luna-Arias, JP (reprint author), Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Programa Doctorado Nanociencias & Nanotecnol, Av IPN 2508, Mexico City 07360, DF, Mexico.
EM fvazquez_84@yahoo.com.mx; smendozaa10@gmail.com;
   cmendoza_barrera@hotmail.com; juliogma1@gmail.com; jpluna2003@gmail.com
RI Mendoza-Acevedo, Salvador/Q-8129-2018
OI Mendoza-Acevedo, Salvador/0000-0002-6989-0406
FU Conacyt Mexico [231022]; Secretaria de Ciencia, Tecnologia e Innovation
   de la Ciudad de Mexico, SECITI [PINV11-48]; Departmento de Biologia
   Celular del Cinvestav-IPN; Conacyt
FX Authors thank Marcela Guerrero for XRD and FT-IR analysis (Departamento
   de Fisica, Cinvestav-IPN), Maria de Lourdes Rojas for TEM analysis, M.
   I. Alvaro Angeles Pascual for HRTEM analysis (LaNSE, Cinvestav-IPN), Dr.
   Luis Lartundo Rojas for XPS analysis (CNMN-IPN). Fabiola
   Vazquez-Hernandez acknowledges Conacyt Mexico for the fellowship 231022.
   This work has been supported by the Institute de Ciencia y Tecnologia
   del Distrito Federal (PINV11-48) (ICyTDF, now renamed Secretaria de
   Ciencia, Tecnologia e Innovation de la Ciudad de Mexico, SECITI) and
   Conacyt to Dr. Juan Pedro Luna Arias, as well as funding from the
   Departmento de Biologia Celular del Cinvestav-IPN.
CR Balamurugan A, 2008, DENT MATER, V24, P1374, DOI 10.1016/j.dental.2008.02.017
   Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Chu SH, 2012, INT J NANOMED, V7, P3659, DOI 10.2147/IJN.S33584
   Cui XH, 2016, MAT SCI ENG C-MATER, V67, P453, DOI 10.1016/j.msec.2016.05.034
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Ebara M, 2014, SMART BIOMATERIALS, P67, DOI 10.1007/978-4-431-54400-5_3
   Frixione E, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 1: SCIENTIFIC FUNDAMENTALS OF BIOTECHNOLOGY, 2ND EDITION, P367
   Jiang W., 2006, DESIGN CHARACTERIZAT
   Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G
   Maia ALC, 2016, NUCL MED COMMUN, V37, P775, DOI 10.1097/MNM.0000000000000510
   Meena R., EFFECTS HYDROXYAPATI, DOI [10.1007/s11051-011-0712-5, DOI 10.1007/S11051-011-0712-5]
   Meizhen Y., 2014, J WUHAN U TECHNOL SC
   Qing K, SELECTIVE EFFECTS HY, DOI [10.1007/s10856-012-4703-6, DOI 10.1007/S10856-012-4703-6]
   Salimi MN, 2012, POWDER TECHNOL, V218, P109, DOI 10.1016/j.powtec.2011.11.049
   Silverstein R., 2005, SPECTROMETRIC IDENTI
   Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036
   Vazquez-Hernandez F, 2010, MATER SCI ENG B-ADV, V174, P290, DOI 10.1016/j.mseb.2010.03.011
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
   Yuca E, 2011, BIOTECHNOL BIOENG, V108, P1021, DOI 10.1002/bit.23041
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang L., 2010, EURASIP J ADV SIG PR, V2010, P1, DOI DOI 10.1109/EC0C.2010.5622099
   ZHANG Y, 2008, J MAT SCI TECHNOL, V24
NR 25
TC 3
Z9 3
U1 3
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 909
EP 918
DI 10.1016/j.msec.2016.10.082
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200106
PM 27987788
DA 2018-10-20
ER

PT J
AU Gupta, SK
   Kumar, R
   Mishra, NC
AF Gupta, Sweta K.
   Kumar, Ritesh
   Mishra, Narayan C.
TI Influence of quercetin and nanohydroxyapatite modifications of
   decellularized goat-lung scaffold for bone regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tissue engineering; Goat-lung; Scaffold; Decellularization; Quercetin;
   Stem cells; Nanohydroxyapatite; Bone
ID CREUTZFELDT-JAKOB-DISEASE; TISSUE ENGINEERING APPLICATIONS;
   HYDROXYAPATITE NANOCOMPOSITES; CROSS-LINKING; COLLAGEN; DIFFERENTIATION;
   MINERALIZATION; PROLIFERATION; RESORPTION; CHITOSAN
AB In the present study, goat-lung scaffold was fabricated by decellularization of lung tissue and verified for complete cell removal by DNA quantification, DAPI and H&E staining. The scaffold was then modified by crosslinking with quercetin and nanohydroxyapatite (nHAp), and characterized to evaluate the suitability of quercetin-crosslinked nHAp-modified scaffold for regeneration of bone tissue. The crosslinking chemistry between quercetin and decellularized scaffold was established theoretically by AutoDock Vina program (in silico docking study), which predicted multiple intermolecular hydrogen bonding interactions between quercetin and decellularized scaffold, and FTIR spectroscopy analysis also proved the same. From MTT assay and SEM studies, it was found that the quercetin-crosslinked nHAp-modified decellularized scaffold encouraged better growth and proliferation of bone-marrow derived mesenchymal stem cells (BMMSCs) in comparison to unmodified decellularized scaffold, quercetin-crosslinked decellularized scaffold and nHAp-modified decellularized scaffold. Alkaline Phosphatase (ALP) assay results showed highest expression of ALP over quercetin-crosslinked nHAp-modified scaffold among all the tested scaffolds (unmodified decellularized scaffold, quercetin-crosslinked decellularized scaffold and nHAp-modified decellularized scaffold) indicating that quercetin and nHAp is very much efficient in stimulating the differentiation of BMMSCs into osteoblast cells. Alizarin red test quantified in vitro mineralization (calcium deposits), and increased expression of alizarin red over quercetin-crosslinked nHAp-modified scaffold indicating better stimulation of osteogenesis in BMMSCs. The above findings suggest that quercetin-crosslinked nHAp-modified decellularized goat-lung scaffold provides biomimetic bone-like microenvironment for BMMSCs to differentiate into osteoblast and could be applied as a potential promising biomaterial for bone regeneration. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gupta, Sweta K.; Mishra, Narayan C.] Indian Inst Technol Roorkee, Dept Polymer & Proc Engn, Roorkee 247667, Uttar Pradesh, India.
   [Kumar, Ritesh] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA.
   [Gupta, Sweta K.] Univ Rhode Isl, Dept Chem Engn, Kingston, RI 02881 USA.
   [Kumar, Ritesh] 1 Chestnut St, Providence, RI 02903 USA.
RP Mishra, NC (reprint author), Indian Inst Technol Roorkee, Dept Polymer & Proc Engn, Roorkee 247667, Uttar Pradesh, India.
EM mishrawise@gmail.com
FU Council of Scientific and Industrial Research [27(0222)/10/EM R-II];
   Ministry of Human Resource and Development
FX The authors are thankful to Prof. Partha Roy and Dr. Swati Srivastava
   for the support in carrying out cell culture experiment The authors also
   acknowledge the Council of Scientific and Industrial Research (Grant No.
   27(0222)/10/EM R-II dated 31.05.10) for the financial assistance and
   Sweta K. Gupta received fellowship from Ministry of Human Resource and
   Development to complete this work.
CR Anh DJ, 1998, CALCIFIED TISSUE INT, V62, P332, DOI 10.1007/s002239900441
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943
   Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191
   Boskey Adele L, 2013, Bonekey Rep, V2, P447, DOI 10.1038/bonekey.2013.181
   BROWN P, 1987, NEUROLOGY, V37, P895, DOI 10.1212/WNL.37.6.895
   Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411
   Carvalho J. L., 2012, J TISSUE SCI ENG S, V11, P1
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Charlton AJ, 1996, FEBS LETT, V382, P289, DOI 10.1016/0014-5793(96)00186-X
   Collignon B, 2011, J COMPUT CHEM, V32, P1202, DOI 10.1002/jcc.21696
   Valles CC, 2012, ADV EXP MED BIOL, V741, P73, DOI 10.1007/978-1-4614-2098-9_6
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1053/ybeem.2003.246
   Eslaminejad Mohamadreza Baghaban, 2010, Iranian Journal of Biotechnology, V8, P234
   Fernandez-Moure JS, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731415626018
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gupta Sweta, 2011, Journal of Biomimetics, Biomaterials, and Tissue Engineering, V12, P59, DOI 10.4028/www.scientific.net/JBBTE.12.59
   Gupta SK, 2013, J BIOMATER TISS ENG, V3, P643, DOI 10.1166/jbt.2013.1122
   Gupta SK, 2013, MAT SCI ENG C-MATER, V33, P4032, DOI 10.1016/j.msec.2013.05.045
   Gupta SK, 2013, BIOMED RES INT, DOI 10.1155/2013/651945
   HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113
   Hwang J.J., 2002, METHODS TISSUE ENG, P741
   Hwang MP, 2016, BIOMATERIALS, V103, P22, DOI 10.1016/j.biomaterials.2016.06.052
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   KONDO K, 1982, ANN NEUROL, V11, P377, DOI 10.1002/ana.410110410
   Kroeze RJ, 2009, MATERIALS, V2, P833, DOI 10.3390/ma2030833
   Leite TB, 2007, NUCLEIC ACIDS RES, V35, pW568, DOI 10.1093/nar/gkm289
   LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mendoza-Novelo B, 2011, BIOMATERIALS - PHYSICS AND CHEMISTRY, P159
   Mitra T, 2013, MATER RES-IBERO-AM J, V16, P755, DOI [10.1590/S1516-14392013000400009, 10.1590/S1516-14392013005000059]
   Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054036
   Nichols Joan E, 2008, Proc Am Thorac Soc, V5, P723, DOI 10.1513/pats.200802-022AW
   Oh S., 2006, AM J BIOCH BIOTECHNO, V2, P49, DOI DOI 10.3844/AJBBSP.2006.49.56
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Shahri NM, 2013, CELL J, V15, P83
   SHI B, 1994, J AM LEATHER CHEM AS, V89, P98
   Siddiqui JA, 2011, OSTEOPOROSIS INT, V22, P3013, DOI 10.1007/s00198-010-1519-4
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   Tiete AR, 2004, ANN THORAC SURG, V77, P2151, DOI 10.1016/j.athoracsur.2003.12.068
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van der Woude H, 2005, MOL NUTR FOOD RES, V49, P763, DOI 10.1002/mnfr.200500036
   Verma D, 2010, PHILOS T R SOC A, V368, P2083, DOI 10.1098/rsta.2010.0013
   Wang LN, 2013, ACTA BIOMATER, V9, P8921, DOI 10.1016/j.actbio.2013.06.035
   Wattel A, 2004, J CELL BIOCHEM, V92, P285, DOI 10.1002/jcb.20071
   Wattel A, 2003, BIOCHEM PHARMACOL, V65, P35, DOI 10.1016/S0006-2952(02)01445-4
   Wong R W K, 2008, Open Orthop J, V2, P27, DOI 10.2174/1874325000802010027
   Woo JT, 2004, BIOL PHARM BULL, V27, P504, DOI 10.1248/bpb.27.504
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang XZ, 2009, J AGR FOOD CHEM, V57, P3431, DOI 10.1021/jf803671s
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Yoshida A, 2004, MATER TRANS, V45, P994, DOI 10.2320/matertrans.45.994
   Yuan K, 2007, J PERIODONTAL RES, V42, P420, DOI 10.1111/j.1600-0765.2006.00963.x
   Zhai WY, 2010, ACTA BIOMATER, V6, P389, DOI 10.1016/j.actbio.2009.07.035
NR 56
TC 3
Z9 4
U1 7
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 919
EP 928
DI 10.1016/j.msec.2016.10.085
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200107
PM 27987789
DA 2018-10-20
ER

PT J
AU Carvalho, CR
   Lopez-Cebral, R
   Silva-Correia, J
   Silva, JM
   Mano, JF
   Silva, TH
   Freier, T
   Reis, RL
   Oliveira, JM
AF Carvalho, Cristiana R.
   Lopez-Cebral, Rita
   Silva-Correia, Joana
   Silva, Joana M.
   Mano, Joao F.
   Silva, Tiago H.
   Freier, Thomas
   Reis, Rui L.
   Oliveira, Joaquim M.
TI Investigation of cell adhesion in chitosan membranes for peripheral
   nerve regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Peripheral nerve injuries; Biomaterials; Chitosan; Degree of
   acetylation; Schwann cells; L929 mouse fibroblast cells
ID IN-VITRO; MECHANICAL-PROPERTIES; N-ACETYLATION; REPAIR; FILMS;
   SCAFFOLDS; INJURY; DEGRADATION; WATER; RAT
AB Peripheral nerve injuries have produced major concerns in regenerative medicine for several years, as the recovery of normal nerve function continues to be a significant clinical challenge. Chitosan (CHT), because of its good biocompatibility, biodegradability and physicochemical properties, has been widely used as a biomaterial in tissue engineering scaffolding. In this study, CHT membranes were produced with three different Degrees of Acetylation (DA), envisioning its application in peripheral nerve regeneration. The three CHT membranes (DA I: 1%, DA II: 2%, DA III: 5%) were extensively characterized and were found to have a smooth and flat surface, with DA III membrane having slightly higher roughness and surface energy. All the membranes presented suitable mechanical properties and did not show any signs of calcification after SBF test. Biodegradability was similar for all samples, and adequate to physically support neurite outgrowth. The in vitro cell culture results indicate selective cell adhesion. The CHT membranes favoured Schwann cells invasion and proliferation, with a display of appropriate cytoskeletal morphology. At the same time they presented low fibroblast infiltration. This fact may be greatly beneficial for the prevention of fibrotic tissue formation, a common phenomenon impairing peripheral nerve regeneration. The great deal of results obtained during this work permitted to select the formulation with the greatest potential for further biological tests. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Carvalho, Cristiana R.; Lopez-Cebral, Rita; Silva-Correia, Joana; Silva, Joana M.; Mano, Joao F.; Silva, Tiago H.; Reis, Rui L.; Oliveira, Joaquim M.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk,Parque Ciencia & Tecnol, P-4805017 Barco, Guimaraes, Portugal.
   [Carvalho, Cristiana R.; Lopez-Cebral, Rita; Silva-Correia, Joana; Silva, Joana M.; Mano, Joao F.; Silva, Tiago H.; Reis, Rui L.; Oliveira, Joaquim M.] ICVS 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal.
   [Freier, Thomas] MEDOVENT GmbH, Friedrich Koenig Str 3, D-55129 Mainz, Germany.
RP Oliveira, JM (reprint author), ICVS 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Silva-Correia, Joana/D-4980-2012; Group,
   3Bs/E-4374-2012; Oliveira, Joaquim Miguel/H-8636-2012; Reis, Rui
   L./A-8938-2008
OI Mano, Joao/0000-0002-2342-3765; Silva-Correia,
   Joana/0000-0003-1312-3109; Group, 3Bs/0000-0002-5195-3456; Oliveira,
   Joaquim Miguel/0000-0001-7052-8837; Reis, Rui L./0000-0002-4295-6129;
   Lopez Cebral, Rita/0000-0003-1387-4391; Silva, Joana
   M./0000-0001-9487-4259; Silva, Tiago Henriques da/0000-0001-8520-603X
FU European Community's Seventh Framework Programme (FP7-HEALTH) [278612];
   European Union's FP7 Programme [REGPOT-CT2012-316331-POLARIS]
FX This work has received funding from the European Community's Seventh
   Framework Programme (FP7-HEALTH-2011) under grant agreement no 278612
   (BIOHYBRID), This study was also funded by European Union's FP7
   Programme under grant agreement no REGPOT-CT2012-316331-POLARIS. The
   authors thank the chitosan raw material provided by Altakitin S.A.,
   (Lisboa, Portugal).
CR Agrawal AM, 2004, J PHARM SCI-US, V93, P1766, DOI 10.1002/jps.20085
   Amaral I. F., 2007, J BIOMATER SCI POLYM, V18
   Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   Atkins S, 2006, NEUROREPORT, V17, P1245, DOI 10.1097/01.wnr.0000230519.39456.ea
   Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Chang H- I, 2011, CELL RESPONSES SURFA
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chatterjee S, 2014, LETT APPL MICROBIOL, V59, P155, DOI 10.1111/lam.12259
   Cho MH, 2008, TISSUE ENG PT A, V14, P1099, DOI [10.1089/ten.tea.2007.0305, 10.1089/tea.2007.0305]
   Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   de Luca AC, 2014, J TISSUE ENG REGEN M, V8, P153, DOI 10.1002/term.1509
   Dhawade PP, 2012, ADV APPL SCI RES, V3, P1372
   Dhiman HK, 2004, BIOMATERIALS, V25, P5147, DOI 10.1016/j.biomaterials.2003.12.025
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gamiz-Gonzalez MA, 2015, CARBOHYD POLYM, V133, P110, DOI 10.1016/j.carbpol.2015.07.020
   Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001
   Gnavi S, 2013, INT REV NEUROBIOL, V109, P1, DOI 10.1016/B978-0-12-420045-6.00001-8
   Gonzalez-Perez F, 2015, MICROSURG, V35, P300, DOI 10.1002/micr.22362
   Guinesi LS, 2006, THERMOCHIM ACTA, V444, P128, DOI 10.1016/j.tca.2006.03.003
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Ignatova M, 2014, J BIOMAT SCI-POLYM E, V25, P287, DOI 10.1080/09205063.2013.857543
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kubiak KJ, 2011, SCANNING, V33, P370, DOI 10.1002/sca.20289
   Kulshrestha A. S., 2010, ACS S SERIES
   Lai HC, 2010, J BIOMED MATER RES A, V93A, P289, DOI 10.1002/jbm.a.32542
   Ceci ML, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-22
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Li J, 1997, J COLLOID INTERF SCI, V192, P447, DOI 10.1006/jcis.1997.5003
   Lieder R, 2012, J BIOMED MATER RES A, V100A, P3392, DOI 10.1002/jbm.a.34283
   Lim SM, 2007, IFMBE PROC, V15, P94
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   MILLESI H, 1995, CLIN ORTHOP RELAT R, P76
   Mobasseri SA, 2013, J MATER SCI-MATER M, V24, P1639, DOI 10.1007/s10856-013-4922-5
   Mogilevskaya E.L., 2005, POLYM SCI SER A, V48, P216
   Namgung U, 2014, CELLS TISSUES ORGANS, V200, P6, DOI 10.1159/000370324
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Ngeow WC, 2010, ORAL SURG ORAL MED O, V109, P357, DOI 10.1016/j.tripleo.2009.06.030
   Ning LQ, 2016, J BIOMAT SCI-POLYM E, V27, P898, DOI 10.1080/09205063.2016.1170415
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park JS, 2011, CLIN ORTHOP SURG, V3, P315, DOI 10.4055/cios.2011.3.4.315
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Que J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.56
   Ray WZ, 2011, J HAND SURG-AM, V36A, P201, DOI 10.1016/j.jhsa.2010.09.034
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0
   Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Steed Martin B, 2011, Atlas Oral Maxillofac Surg Clin North Am, V19, P119, DOI 10.1016/j.cxom.2010.11.007
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Wang Y., 2014, NEUROBIOL
   Wong JPF, 2014, ACTA BIOMATER, V10, P5005, DOI 10.1016/j.actbio.2014.08.038
   Wrobel S, 2014, TISSUE ENG PT A, V20, P2339, DOI [10.1089/ten.tea.2013.0621, 10.1089/ten.TEA.2013.0621]
   Xu XF, 2013, INT J BIOL MACROMOL, V62, P418, DOI 10.1016/j.ijbiomac.2013.09.053
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Younes I, 2015, MAR DRUGS, V13, P1133, DOI 10.3390/md13031133
   Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009
   Zilic L, 2016, BIOTECHNOL BIOENG, V113, P2041, DOI 10.1002/bit.25964
   Zilic L, 2015, J ANAT, V227, P302, DOI 10.1111/joa.12341
NR 81
TC 4
Z9 4
U1 2
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 1122
EP 1134
DI 10.1016/j.msec.2016.11.100
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200131
PM 27987669
DA 2018-10-20
ER

PT J
AU Chou, SF
   Luo, LJ
   Lai, JY
   Ma, DHK
AF Chou, Shih-Feng
   Luo, Li-Jyuan
   Lai, Jui-Yang
   Ma, David Hui-Kang
TI Role of solvent-mediated carbodiimide cross-linking in fabrication of
   electrospun gelatin nanofibrous membranes as ophthalmic biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Gelatin; Electrospun nanofibrous membrane; Carbodiimide cross-linking;
   Solvent composition; Ophthalmic biomaterial
ID OCULAR EPITHELIAL REGENERATION; HYDROGEN PHOSPHATE/GELATIN COMPOSITES;
   LINKED AMNIOTIC MEMBRANES; SITU GELLING COPOLYMERS; CELL SHEET DELIVERY;
   LIMBAL STEM-CELLS; HYALURONIC-ACID; DRUG-DELIVERY; BIOMEDICAL
   APPLICATIONS; BIOMIMETIC COMPOSITE
AB Due to their ability to mimic the structure of extracellular matrix, electrospun gelatin nanofibers are promising cell scaffolding materials for tissue engineering applications. However, the hydrophilic gelatin molecules usually need stabilization before use in aqueous physiological environment. Considering that biomaterials cross-linked via film immersion technique may have a more homogeneous cross-linked structure than vapor phase cross linking, this work aims to investigate the chemical modification of electrospun gelatin nanofibrous membranes by liquid phase carbodiimide in the presence of ethanol/water co-solvents with varying ethanol concentrations ranging from 80 to 99.5 vol%. The results of characterization showed that increasing water content in the binary reaction solvent system increases the extent of cross-linking of gelatin nanofibers, but simultaneously promotes the effect of biopolymer swelling and distortion in fiber mat structure. As compared to non-cross-linked counterparts, carbodiimide treated gelatin nanofibrous mats exhibited better thermal and biological stability where the shrinkage temperature and resistance to enzymatic degradation varied in response to ethanol/water solvent composition-mediated generation of cross-links. Irrespective of their cross-linking density, all studied membrane samples did not induce any responses in ocular epithelial cell cultures derived from cornea, lens, and retina. Unlike many other cross-linking agents and/or methods (e.g., excessive vapor phase cross-linking) that may pose a risk of toxicity, our study demonstrated that these nanofibrous materials are well tolerated by anterior segment tissues. These findings also indicate the safety of using ethanol/water co-solvents for chemical cross-linking of gelatin to engineer nanofibrous materials with negligible biological effects. In summary, the present results suggest the importance of solvent-mediated carbodiimide cross-linking in modulating structure-property relationship without compromising in vitro and in vivo biocompatibility of electrospun gelatin nanofibers for future ophthalmic applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Chou, Shih-Feng] Univ Texas Tyler, Dept Mech Engn, Tyler, TX 75799 USA.
   [Luo, Li-Jyuan] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang; Ma, David Hui-Kang] Chang Gung Mem Hosp, Ctr Tissue Engn, Taoyuan 33305, Taiwan.
   [Lai, Jui-Yang; Ma, David Hui-Kang] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan 33305, Taiwan.
   [Lai, Jui-Yang] Ming Chi Univ Technol, Dept Mat Engn, New Taipei 24301, Taiwan.
   [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Taoyuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU Chang Gung Memorial Hospital [BMRPA53, CMRPD3D0101]
FX This work was supported by grants from Chang Gung Memorial Hospital
   (BMRPA53 and CMRPD3D0101)
CR Ambekar R, 2011, J MECH BEHAV BIOMED, V4, P223, DOI 10.1016/j.jmbbm.2010.09.014
   Araujo JV, 2010, TISSUE ENG PT A, V16, P557, DOI [10.1089/ten.tea.2009.0223, 10.1089/ten.TEA.2009.0223]
   Baradaran-Rafii A, 2016, CURR EYE RES, V41, P326, DOI 10.3109/02713683.2015.1019004
   Baradaran-Rafii A, 2015, INT J POLYM MATER PO, V64, P879, DOI 10.1080/00914037.2015.1030658
   Biazar E, 2015, J BIOMAT SCI-POLYM E, V26, P1139, DOI 10.1080/09205063.2015.1078930
   Bulgarelli E, 1999, INT J PHARM, V190, P175, DOI 10.1016/S0378-5173(99)00262-8
   Chen J, 2015, INT J NANOMED, V10, P3337, DOI 10.2147/IJN.S77706
   Chou SF, 2016, INT J PHARMACEUT, V511, P30, DOI 10.1016/j.ijpharm.2016.06.129
   Chou SF, 2016, ACTA BIOMATER, V38, P116, DOI 10.1016/j.actbio.2016.04.035
   Colak HN, 2016, CONTACT LENS ANTERIO, V39, P380, DOI 10.1016/j.clae.2016.06.005
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gashti MP, 2016, NEW J CHEM, V40, P5495, DOI 10.1039/c5nj03575a
   Gashti MP, 2014, J COLLOID INTERF SCI, V431, P149, DOI 10.1016/j.jcis.2014.06.010
   Gashti MP, 2013, COLLOID SURFACE B, V110, P426, DOI 10.1016/j.colsurfb.2013.04.051
   Gashti MP, 2013, CRYST GROWTH DES, V13, P2166, DOI 10.1021/cg4002434
   Gashti MP, 2013, J MATER CHEM B, V1, P1501, DOI 10.1039/c3tb00088e
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gnavi S, 2015, INT J MOL SCI, V16, P12925, DOI 10.3390/ijms160612925
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496
   Huang CH, 2012, MAT SCI ENG C-MATER, V32, P2476, DOI 10.1016/j.msec.2012.07.029
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2016, MAT SCI ENG C-MATER, V59, P411, DOI 10.1016/j.msec.2015.10.050
   Lai JY, 2015, BIOMACROMOLECULES, V16, P2950, DOI 10.1021/acs.biomac.5b00854
   Lai JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136067
   Lai JY, 2015, MAT SCI ENG C-MATER, V51, P28, DOI 10.1016/j.msec.2015.02.021
   Lai JY, 2014, INT J NANOMED, V9, P5117, DOI 10.2147/IJN.S69689
   Lai JY, 2014, RSC ADV, V4, P18871, DOI 10.1039/c4ra01930j
   Lai JY, 2014, CARBOHYD POLYM, V101, P203, DOI 10.1016/j.carbpol.2013.09.060
   Lai JY, 2014, MAT SCI ENG C-MATER, V34, P334, DOI 10.1016/j.msec.2013.09.026
   Lai JY, 2013, INT J NANOMED, V8, P4157, DOI 10.2147/IJN.S52731
   Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734
   Lai JY, 2013, J MATER SCI-MATER M, V24, P2201, DOI 10.1007/s10856-013-4961-y
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2013, INT J MOL SCI, V14, P2036, DOI 10.3390/ijms14012036
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   LEACH AA, 1957, BIOCHEM J, V67, P83, DOI 10.1042/bj0670083
   Li YC, 2014, BIOMACROMOLECULES, V15, P319, DOI 10.1021/bm401558c
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liu R, 2012, FIBER POLYM, V13, P613, DOI 10.1007/s12221-012-0613-y
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu WP, 2015, MATER LETT, V140, P1, DOI 10.1016/j.matlet.2014.10.146
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Manna PJ, 2015, INT J BIOL MACROMOL, V75, P437, DOI 10.1016/j.ijbiomac.2015.01.047
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nam K, 2007, BIOMATERIALS, V28, P1, DOI 10.1016/j.biomaterials.2006.08.002
   Natu MV, 2007, BIOMED MATER, V2, P241, DOI 10.1088/1748-6041/2/4/006
   Linh NTB, 2013, J BIOMED MATER RES A, V101, P2412, DOI 10.1002/jbm.a.34533
   Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932
   Okutan N, 2014, FOOD HYDROCOLLOID, V39, P19, DOI 10.1016/j.foodhyd.2013.12.022
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ozeki M, 2005, J BIOMAT SCI-POLYM E, V16, P549, DOI 10.1163/1568562053783731
   Sajkiewicz P, 2014, J BIOMAT SCI-POLYM E, V25, P2009, DOI 10.1080/09205063.2014.975392
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Sharifi E, 2016, MAT SCI ENG C-MATER, V59, P533, DOI 10.1016/j.msec.2015.09.037
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Skotak M, 2010, J BIOMED MATER RES A, V95A, P828, DOI 10.1002/jbm.a.32850
   Sun CC, 2016, MAT SCI ENG C-MATER, V63, P222, DOI 10.1016/j.msec.2016.02.069
   Takigawa T, 2006, J OCCUP HEALTH, V48, P75, DOI 10.1539/joh.48.75
   TRIPATHI RC, 1982, EXP EYE RES, V35, P611, DOI 10.1016/S0014-4835(82)80074-2
   Uzunalli G, 2014, ACTA BIOMATER, V10, P1156, DOI 10.1016/j.actbio.2013.12.002
   Vimal SK, 2016, MAT SCI ENG C-MATER, V63, P616, DOI 10.1016/j.msec.2016.03.008
   Wang WY, 2016, CARBOHYD POLYM, V140, P356, DOI 10.1016/j.carbpol.2015.12.061
   Yan J, 2012, J BIOMED MATER RES A, V100A, P527, DOI 10.1002/jbm.a.33301
NR 74
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 1145
EP 1155
DI 10.1016/j.msec.2016.11.105
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200133
PM 27987671
DA 2018-10-20
ER

PT J
AU Gultekinoglu, M
   Kurum, B
   Karahan, S
   Kart, D
   Sagiroglu, M
   Ertas, N
   Ozen, AH
   Ulubayram, K
AF Gultekinoglu, Merve
   Kurum, Baris
   Karahan, Siyami
   Kart, Didem
   Sagiroglu, Meral
   Ertas, Nusret
   Ozen, A. Haluk
   Ulubayram, Kezban
TI Polyethyleneimine brushes effectively inhibit encrustation on
   polyurethane ureteral stents both in dynamic bioreactor and in vivo
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Antibacterial brushes; Polyethyleneimine; Ureteral; stent; Biofilm
   Encrustation
ID URINARY CATHETERS; ANTIBACTERIAL SURFACES; INFECTION; POLYMERS;
   COATINGS; MODEL; NANOPARTICLES; BIOMATERIAL; PREVENTION; HYDROGEL
AB Polyurethane (PU) ureteral stents have been widely used as biomedical devices to aid the flow of the urine. Due to the biofilm formation and encrustation complications it has been hindered their long term clinical usage. To overcome these complications, in this study, cationic polyethyleneimine (PEI) brushes grafted on PU stents and their performances were tested both in a dynamic biofilm reactor system (in vitro) and in a rat model (in vivo). Thus, we hypothesized that PEI brushes inhibit bacterial adhesion owing to the dynamic motion of brushes in liquid environment. In addition, cationic structure of PEI disrupts the membrane and so kills the bacteria on time of contact. Cationic PEI brushes decreased the biofilm formation up to 2 orders of magnitude and approximately 50% of encrustation amount in respect to unmodified PU, in vitro. In addition, according to Atomic Absorption Spectroscopy (AAS) results, approximately 90% of encrustation was inhibited on in vivo animal models. Decrease in encrustation was clearly observed on the stents obtained from rat model, by Scanning Electron Microscopy (SEM). Also, histological evaluations showed that; PEI brush grafting decreased host tissue inflammation in close relation to decrease in biofilm formation and encrustation. As a results; dual effect of anti adhesive and contact-killing antibacterial strategy showed high efficiency on PEI brushes grafted PU stents both in vitro and in vivo. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gultekinoglu, Merve; Ulubayram, Kezban] Hacettepe Univ, Dept Basic Pharmaceut Sci, Fac Pharm, TR-06100 Ankara, Turkey.
   [Gultekinoglu, Merve; Ulubayram, Kezban] Hacettepe Univ, Inst Grad Studies Sci & Engn, Bioengn Div, TR-06532 Ankara, Turkey.
   [Kurum, Baris] Kirikkale Univ, Dept Surg, Fac Vet Med, TR-71450 Kirikkale, Turkey.
   [Karahan, Siyami] Kirikkale Univ, Dept Histol & Embryol, Fac Vet Med, TR-71450 Kirikkale, Turkey.
   [Kart, Didem; Sagiroglu, Meral] Hacettepe Univ, Dept Pharmaceut Microbiol, Fac Pharm, TR-06100 Ankara, Turkey.
   [Ertas, Nusret] Gazi Univ, Dept Analyt Chem, Fac Pharm, TR-06330 Ankara, Turkey.
   [Ozen, A. Haluk] Hacettepe Univ, Dept Urol, Fac Med, TR-06100 Ankara, Turkey.
RP Ulubayram, K (reprint author), Hacettepe Univ, Dept Basic Pharmaceut Sci, Fac Pharm, TR-06100 Ankara, Turkey.
EM ukezban@hacettepe.edu.tr
RI Ertas, Nusret/B-8083-2016
FU Scientific and Technological Research Council Turkey of (TUBITAK)
   [112M293]
FX This study is financially supported by The Scientific and Technological
   Research Council Turkey of (TUBITAK) (Grant no: 112M293).
CR ATMANI F, 1995, UROL RES, V23, P95, DOI 10.1007/BF00307939
   Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0
   Cauda F, 2008, J ENDOUROL, V22, P465, DOI 10.1089/end.2007.0218
   Chen RX, 2016, BIOMATERIALS, V85, P142, DOI 10.1016/j.biomaterials.2016.01.063
   EDINLILJEGREN A, 1994, UROLITHIASIS 2, P365
   Francesko A, 2016, ACTA BIOMATER, V33, P203, DOI 10.1016/j.actbio.2016.01.020
   Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697
   Gibney KA, 2012, MACROMOL BIOSCI, V12, P1279, DOI 10.1002/mabi.201200052
   Gilmore BF, 2010, J BIOMED MATER RES B, V93B, P128, DOI 10.1002/jbm.b.31567
   Gultekinoglu M, 2016, RSC ADV, V6, P17092, DOI 10.1039/c5ra22434a
   Gultekinoglu M, 2015, ACTA BIOMATER, V21, P44, DOI 10.1016/j.actbio.2015.03.037
   Hadaschik BA, 2008, J UROLOGY, V180, P1161, DOI 10.1016/j.juro.2008.05.003
   Jana P, 2016, RSC ADV, V6, P13730, DOI 10.1039/c5ra23447f
   Lange D, 2015, ROLE BACTERIA UROLOG
   Lee I, 2016, POLYMER, V83, P223, DOI 10.1016/j.polymer.2015.12.032
   Lin J, 2002, BIOTECHNOL PROGR, V18, P1082, DOI 10.1021/bp025597w
   Liu Y, 2010, MOL NUTR FOOD RES, V54, P1744, DOI 10.1002/mnfr.200900535
   Lo J, 2014, ANTIBIOTICS-BASEL, V3, P87, DOI 10.3390/antibiotics3010087
   Marconi W, 2001, J BIOACT COMPAT POL, V16, P393, DOI 10.1106/G5EB-LL73-K59A-7YBF
   Miyake O, 1998, BRIT J UROL, V81, P14
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Prywer J, 2010, CRYST RES TECHNOL, V45, P1283, DOI 10.1002/crat.201000344
   Rajaram A, 2015, J BIOMAT SCI-POLYM E, V26, P433, DOI 10.1080/09205063.2015.1016383
   Reid G, 1998, URINARY TRACT INFECT, P111
   Saini S, 2016, CARBOHYD POLYM, V135, P239, DOI 10.1016/j.carbpol.2015.09.002
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Schierholz JM, 2002, INT J ANTIMICROB AG, V19, P511, DOI 10.1016/S0924-8579(02)00096-1
   Shi C, 2016, BIOMATER SCI-UK, V4, P699, DOI 10.1039/c6bm00009f
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   Venkatesan N, 2011, UROL RES, V39, P29, DOI 10.1007/s00240-010-0280-7
   Venkateswaran S, 2014, J MATER CHEM B, V2, P6723, DOI 10.1039/c4tb01129e
   Wang L, 2016, J MATER CHEM B, V4, P273, DOI 10.1039/c5tb01238d
   Wang R, 2015, J BIOMED MATER RES B, V103, P519, DOI 10.1002/jbm.b.33230
   Yan SJ, 2016, BIOMACROMOLECULES, V17, P1696, DOI 10.1021/acs.biomac.6b00115
   Yang SH, 2007, J BIOMED MATER RES B, V83B, P304, DOI 10.1002/jbm.b.30796
   Yao C, 2008, J MEMBRANE SCI, V320, P259, DOI 10.1016/j.memsci.2008.04.012
   Zeng GH, 2015, ACTA BIOMATER, V24, P64, DOI 10.1016/j.actbio.2015.05.037
NR 40
TC 5
Z9 5
U1 2
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 1166
EP 1174
DI 10.1016/j.msec.2016.11.125
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200135
PM 27987673
DA 2018-10-20
ER

PT J
AU Ebrahimi, M
   Botelho, MG
   Dorozhkin, SV
AF Ebrahimi, Mehdi
   Botelho, Michael G.
   Dorozhkin, Sergey V.
TI Biphasic calcium phosphates bioceramics (HA/TCP): Concept,
   physicochemical properties and the impact of standardization of study
   protocols in biomaterials research
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Biphasic calcium phosphates; Bioceramics; Bone tissue engineering; Bone
   substitutes; Pre-clinical study; Study protocol
ID BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN; CRITICAL-SIZE
   DEFECT; THERMAL-STABILITY; ANIMAL RESEARCH; HA/BETA-TCP; IN-VITRO;
   DISSOLUTION BEHAVIOR; INDUCED OSTEOGENESIS; DEFICIENT APATITE
AB Biphasic calcium phosphates (BCP) bioceramics have become the materials of choice in various orthopedic and maxillofacial bone repair procedures. One of their main advantages is their biodegradation rate that can be modified by changing the proportional ratio of the composition phases, For enhanced bone tissue regeneration, the bioactivity of BCP should be increased by optimizing their physicochemical properties. To date, the ideal physicochemical properties of BCP for bone applications have not been defined, This is mostly related to lack of standard study protocols in biomaterial science especially with regards to their characterizations and clinical applications. In this paper we provided a review on BCP and their physicochemical properties relevant to clinical applications, In addition, we summarized the available literature on their use in animal models and evaluated the influences of different composition ratios on bone healing. Controversies in literature with regards to ideal corn position ratio of BCP have also been discussed in detail. We illustrated the discrepancies in study protocols among researchers in animal studies and emphasized the need to develop and follow a set of generally accepted standardized guidelines. Finally; we provided general recommendations for future pre-clinical studies that allow better standardization of study protocols. This will allow better comparison and contrast of newly developed bone substitute biomaterials that help further progress in the field of biomaterial science. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ebrahimi, Mehdi; Botelho, Michael G.] Univ Hong Kong, Fac Dent, Oral Rehabil, Hong Kong, Hong Kong, Peoples R China.
   [Dorozhkin, Sergey V.] Kudrinskaja Sq 1-155, Moscow 123242, Russia.
RP Ebrahimi, M (reprint author), Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Dept Oral Rehabil, 34 Hosp Rd, Hong Kong, Hong Kong, Peoples R China.
EM ebrahimi@hku.hk
RI Dorozhkin, Sergey/H-1808-2011
OI Dorozhkin, Sergey/0000-0002-8439-9527
CR Ahn MK, 2013, CERAM INT, V39, P5879, DOI 10.1016/j.ceramint.2013.01.006
   [Anonymous], 2014, F2721092014 ASTM, DOI [10.1520/F2721-09R14, DOI 10.1520/F2721-09R14]
   Anuta DA R.D., 1985, T ANN M SOC BIOMATER, V62, P8
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Babu NR, 2004, T INDIAN I METALS, V57, P85
   Balcik C, 2007, ACTA BIOMATER, V3, P985, DOI 10.1016/j.actbio.2007.04.004
   Berzina-Cimdina L., 2012, INFRARED SPECTROSC M, V2012
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/bjm.a.30990
   Boden SD, 1999, CLIN ORTHOP RELAT R, pS84
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Brown O, 2010, J MATER SCI-MATER M, V21, P2271, DOI 10.1007/s10856-010-4032-6
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Chissov VI, 2008, B EXP BIOL MED+, V146, P139, DOI 10.1007/s10517-008-0222-3
   Cho JS, 2010, BIOCERAM DEV APPL, V1, P1
   Cho JS, 2010, J MATER SCI-MATER M, V21, P1143, DOI 10.1007/s10856-009-3980-1
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G., 2009, ADV BIOCERAM POROUS, V30, P45
   Daculsi G, 2006, ENCY BIOMATERIALS BI, P1
   Daculsi G, 2010, CERAM ENG SCI PROC, V30, P45
   Descamps M, 2013, J EUR CERAM SOC, V33, P1263, DOI 10.1016/j.jeurceramsoc.2012.12.020
   Dorozhkin S. V., 2012, INT J MAT CHEM, V1, P1
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Dorozhkin SV, 2003, RUSS CHEM B+, V52, P2369, DOI 10.1023/B:RUCB.0000012357.20616.15
   Dorozhkina EI, 2002, CHEM MATER, V14, P4267, DOI 10.1021/cm0203060
   Ebrahimi M, 2012, J BIOMED MATER RES A, V100A, P2260, DOI 10.1002/jbm.a.34160
   Ellinger R F, 1986, Int J Periodontics Restorative Dent, V6, P22
   Erb HN., 1990, ILAR NEWS, V32, P11, DOI 10.1093/ilar.32.1.11
   [Europian Commission Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) SCENIHR], 2007, OPIN SCI ASP EX PROP, P2007
   EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300
   Faggion CM, 2015, EUR J ORAL SCI, V123, P61, DOI 10.1111/eos.12175
   Faggion CM, 2009, J DENT, V37, P737, DOI 10.1016/j.jdent.2009.06.010
   Farina NM, 2008, J MATER SCI-MATER M, V19, P1565, DOI 10.1007/s10856-008-3400-y
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Festing Michael F W, 2002, ILAR J, V43, P244
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Garrido Carlos A, 2011, Int J Biomater, V2011, P129727, DOI 10.1155/2011/129727
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gibson IR, 2000, J MATER SCI-MATER M, V11, P799, DOI 10.1023/A:1008905613182
   Gomes S, 2010, ACTA BIOMATER, V6, P3264, DOI 10.1016/j.actbio.2010.02.034
   Gomes S, 2009, ACS APPL MATER INTER, V1, P505, DOI 10.1021/am800162a
   Guha AK, 2009, COLLOID SURFACE B, V73, P146, DOI 10.1016/j.colsurfb.2009.05.009
   Guo DG, 2010, J MATER SCI-MATER M, V21, P1927, DOI 10.1007/s10856-010-4044-2
   Hahn BD, 2009, J AM CERAM SOC, V92, P793, DOI 10.1111/j.1551-2916.2009.02949.x
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Hong JY, 2014, CLIN ORAL IMPLAN RES, V25, pE30, DOI 10.1111/clr.12041
   Hsu CK, 2003, MATER CHEM PHYS, V80, P409, DOI 10.1016/S0254-0584(02)00166-9
   Hubbard C. R., 1988, POWDER DIFFR, V3, P74, DOI [DOI 10.1017/S0885715600013257, 10.1017/S0885715600013257]
   Hung CL, 2011, DENT MATER J, V30, P21, DOI 10.4012/dmj.2010-060
   Jaw KS, 2006, J THERM ANAL CALORIM, V83, P145, DOI 10.1007/s10973-006-7047-y
   Jaykaran, 2010, INT J PHARMACOL, V6, P354
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Jin HB, 2010, J CERAM SOC JPN, V118, P52, DOI 10.2109/jcersj2.118.52
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453
   Jun YK, 2006, J AM CERAM SOC, V89, P2295, DOI [10.1111/j.1551-2916.2006.00977.x, 10.1111/j.1551-2916.2006.0097.x]
   Kannan S, 2008, CERAM INT, V34, P7, DOI 10.1016/j.ceramint.2006.07.007
   Kannan S, 2008, J AM CERAM SOC, V91, P1, DOI 10.1111/j.1551-2916.2007.02117.x
   Kannan S, 2007, CERAM INT, V33, P1489, DOI 10.1016/j.ceramint.2006.05.016
   Kannan S, 2007, J EUR CERAM SOC, V27, P2287, DOI 10.1016/j.jeurceramsoc.2006.07.004
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   Kannan S, 2005, CHEM MATER, V17, P3065, DOI [10.1021/cm050342+, 10.1021/cm.050342+]
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   KILKENNY C, 2014, ANIMALS, V4, P35, DOI DOI 10.3390/ani4010035
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Kong YM, 2008, J BIOMED MATER RES B, V84B, P334, DOI 10.1002/jbm.b.30876
   Kreethawate L, 2014, KEY ENG MATER, V608, P259, DOI 10.4028/www.scientific.net/KEM.608.259
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kunert-Keil C, 2015, ANN ANAT, V199, P79, DOI 10.1016/j.aanat.2013.12.001
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149
   Li B, 2009, ACTA BIOMATER, V5, P134, DOI 10.1016/j.actbio.2008.07.035
   Lim HC, 2015, INT J ORAL MAX IMPL, V30, P65, DOI 10.11607/jomi.3709
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Lin SJ, 2003, KEY ENG MAT, V240-2, P473, DOI 10.4028/www.scientific.net/KEM.240-242.473
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   LOEB JM, 1989, JAMA-J AM MED ASSOC, V262, P2716, DOI 10.1001/jama.262.19.2716
   Lukic M, 2011, J EUR CERAM SOC, V31, P19, DOI 10.1016/j.jeurceramsoc.2010.09.006
   Manjubala I, 2001, J MATER SCI LETT, V20, P1225, DOI 10.1023/A:1010926923815
   Manjubala I, 2001, MATER CHEM PHYS, V71, P272, DOI 10.1016/S0254-0584(01)00293-0
   Marchi J, 2009, INT J APPL CERAM TEC, V6, P60, DOI 10.1111/j.1744-7402.2008.02254.x
   Mayer I, 2006, EUR J INORG CHEM, P1460, DOI 10.1002/ejic.200501009
   McCusker LB, 1999, J APPL CRYSTALLOGR, V32, P36, DOI 10.1107/S0021889898009856
   Miramond T., 2015, Key Engineering Materials, V631, P73, DOI 10.4028/www.scientific.net/KEM.631.73
   Moore DC, 1985, T ANN M SOC BIOM CON, V8, P160
   Morejón-Alonso Loreley, 2007, Mat. Res., V10, P15, DOI 10.1590/S1516-14392007000100005
   Mostafa NY, 2013, CENT EUR J CHEM, V11, P140, DOI 10.2478/s11532-012-0142-y
   Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]
   Naduvilath T J, 2000, Indian J Ophthalmol, V48, P245
   Nawawi N. A., 2014, ADV MAT RES, V970, P20
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nilen RWN, 2008, J MATER SCI-MATER M, V19, P1693, DOI 10.1007/s10856-007-3252-x
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P268, DOI 10.1111/j.1600-0501.2009.01846.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   Perez RA, 2016, MAT SCI ENG C-MATER, V61, P922, DOI 10.1016/j.msec.2015.12.087
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   RADIN SR, 1994, J BIOMED MATER RES, V28, P1303, DOI 10.1002/jbm.820281108
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521
   ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739
   Rouvillain JL, 2009, KNEE, V16, P392, DOI 10.1016/j.knee.2008.12.015
   Rutala W. A., 2008, HICPAC HICPAC CDC 20
   Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182
   Ryu HS, 2006, J MATER RES, V21, P428, DOI 10.1557/JMR.2006.0049
   Ryu HS, 2004, BIOMATERIALS, V25, P393, DOI 10.1016/S0142-9612(03)00538-6
   Sarin P, 2011, J AM CERAM SOC, V94, P2362, DOI 10.1111/j.1551-2916.2011.04404.x
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Sogo Y, 2002, J BIOMED MATER RES, V62, P457, DOI 10.1002/jbm.10200
   Sopyan I, 2011, CERAM INT, V37, P3703, DOI 10.1016/j.ceramint.2011.06.033
   Sopyan I, 2010, ADV MATER RES-SWITZ, V93-94, P393, DOI 10.4028/www.scientific.net/AMR.93-94.393
   Sopyan I, 2009, IONICS, V15, P735, DOI 10.1007/s11581-009-0330-8
   Spassova E, 2007, MATERIALWISS WERKST, V38, P1027, DOI 10.1002/mawe.200700232
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Tadjiev TR, 2007, KEY ENG MATER, V330-332, P7, DOI 10.4028/www.scientific.net/KEM.330-332.7
   Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y
   Tanimoto Y, 2009, J HARD TISSUE BIOL, V18, P71, DOI 10.2485/jhtb.18.71
   Tavangarian F, 2010, INT J MOD PHYS B, V24, P3365, DOI 10.1142/S0217979210055329
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Veljovic D, 2010, J MATER SCI, V45, P3175, DOI 10.1007/s10853-010-4324-8
   Veljovic D, 2010, CERAM INT, V36, P595, DOI 10.1016/j.ceramint.2009.09.038
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   von Aulock S, 2014, ALTEX-ALTERN ANIM EX, V31, P1
   Wang H, 2010, J MATER SCI, V45, P1237, DOI 10.1007/s10853-009-4072-9
   Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107044
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Wongwitwichot P, 2010, Open Biomed Eng J, V4, P279, DOI 10.2174/1874120701004010279
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yang DJ, 2006, KEY ENG MAT, V309-311, P227, DOI 10.4028/www.scientific.net/KEM.309-311.227
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuehuei H., 1999, ANIMAL MODELS ORTHOP
   Yun PY, 2014, J CRANIO MAXILL SURG, V42, P1909, DOI 10.1016/j.jcms.2014.07.011
   Zhang Y, 2007, KEY ENG MATER, V330-332, P91, DOI 10.4028/www.scientific.net/KEM.330-332.91
   Zhang Y, 2007, KEY ENG MAT, V336-338, P1688, DOI 10.4028/www.scientific.net/KEM.336-338.1688
   Zhu XD, 2007, J BIOMED MATER RES B, V82B, P65, DOI 10.1002/jbm.b.30706
   Zyman ZZ, 2008, J MATER SCI-MATER M, V19, P2819, DOI 10.1007/s10856-008-3402-9
NR 167
TC 20
Z9 20
U1 8
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 1293
EP 1312
DI 10.1016/j.msec.2016.11.039
PG 20
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200145
PM 27987685
DA 2018-10-20
ER

PT J
AU Gupta, N
   Santhiya, D
AF Gupta, Nidhi
   Santhiya, Deenan
TI In situ mineralization of bioactive glass in gelatin matrix
SO MATERIALS LETTERS
LA English
DT Article
DE In situ mineralization; Bioglass; Gelatin; Viscoelasticity; Biomaterial
ID GLUTARALDEHYDE
AB Bioactive glass has been focused recently in soft tissue engineering, which requires biomaterials suitable for complex designing along with mechanical strength. Considering this, first time an attempt has been made to investigate in situ mineralization of bioactive glass nodules in gelatin matrix with noticeable creep property in comparison to in situ mineralized bioactive glass needles in glutaraldehyde crosslinked gelatin film along with substantially improved toughness and textural properties.
C1 [Gupta, Nidhi; Santhiya, Deenan] Delhi Technol Univ, Dept Appl Chem & Polymer Technol, Bawana Rd, Delhi 110042, India.
RP Santhiya, D (reprint author), Delhi Technol Univ, Dept Appl Chem & Polymer Technol, Bawana Rd, Delhi 110042, India.
EM deenan.santhiya@dce.ac.in
CR Farris S, 2010, J AGR FOOD CHEM, V58, P998, DOI 10.1021/jf9031603
   Gupta N, 2015, RSC ADV, V5, P56794, DOI 10.1039/c5ra04441c
   Koudehi M.F., 2013, J MATER SCI-MATER M, V25, P363
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Saravanan D., 2011, ARCH APPL SCI RES, V3, P342
   Shirazi AN, 2016, ACS APPL MATER INTER, V8, P1676, DOI 10.1021/acsami.5b09006
   Wu Y, 2014, INT J MOL SCI, V15, P21980, DOI 10.3390/ijms151221980
   Xing Q., SCI REPORTS, V4, P4706
   Young R.J., INTRO POLYM
NR 13
TC 0
Z9 0
U1 2
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 1
PY 2017
VL 188
BP 127
EP 129
DI 10.1016/j.matlet.2016.11.045
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EG0RS
UT WOS:000390740500034
DA 2018-10-20
ER

PT J
AU Tronci, G
   Buiga, P
   Alhilou, A
   Do, T
   Russell, SJ
   Wood, DJ
AF Tronci, Giuseppe
   Buiga, Petronela
   Alhilou, Ahmed
   Do, Thuy
   Russell, Stephen J.
   Wood, David J.
TI Hydrolytic and lysozymic degradability of chitosan systems with
   heparin-mimicking pendant groups
SO MATERIALS LETTERS
LA English
DT Article
DE Chitosan; Biomaterial; Functional; Structure-function relationship
ID ANTIBACTERIAL ACTIVITY; HYDROGELS
AB Chitosan (CT) is an antibacterial polysaccharide that has been investigated for drug carriers, haemostats and wound dressings. For these applications, customised CT devices can often be obtained with specific experimental conditions, which can irreversibly alter native biopolymer properties and functions and lead to unreliable material behaviour. In order to investigate the structure-function relationships in CT covalent networks, monosodium 5-sulfoisophthalate (PhS) was selected as heparin-mimicking, growth factor-binding crosslinking segment, whilst 1,4-phenylenediacetic acid (4Ph) and poly(ethylene glycol) bis(carboxymethyl) ether (PEG) were employed as sulfonic acid-free diacids of low and high crosslinker length, respectively. Hydrogels based on short crosslinkers (PhS and 4Ph) displayed increased crosslink density, decreased swelling ratio as well as minimal hydrolytic and lysozymic degradation, whilst addition of lysozymes to PEG-based networks resulted in 70 wt% mass loss. PhS-crosslinked CT hydrogels displayed the highest loss (40 +/- 6 CFU%) of antibacterial activity upon incubation with Porphyromottas gingivalis, whilst respective extracts were tolerated by L929 mouse fibroblasts. (C) 2016 Published by Elsevier B.V.
C1 [Tronci, Giuseppe; Russell, Stephen J.] Univ Leeds, Sch Design, Nonwovens Res Grp, Leeds LS2 9JT, W Yorkshire, England.
   [Tronci, Giuseppe; Buiga, Petronela; Alhilou, Ahmed; Do, Thuy; Wood, David J.] Univ Leeds, St Jamess Univ Hosp, Sch Dent, Leeds LS2 9JT, W Yorkshire, England.
RP Tronci, G (reprint author), Univ Leeds, Sch Design, Nonwovens Res Grp, Leeds LS2 9JT, W Yorkshire, England.; Tronci, G (reprint author), Univ Leeds, St Jamess Univ Hosp, Sch Dent, Leeds LS2 9JT, W Yorkshire, England.
EM g.tronci@leeds.ac.uk
OI Tronci, Giuseppe/0000-0002-9426-4220
FU Clothworkers' Centre for Textile Materials Innovation for Healthcare;
   Engineering and Physical Sciences Research Council [EP/K029592/1]
FX The authors wish to thank Assoc. Prof. Hiroharu Ajiro (NAIST, JP) and
   Prof. Mitsuru Akashi (Osaka University, JP) for the initial scientific
   discussions. The financial support from the Clothworkers' Centre for
   Textile Materials Innovation for Healthcare is gratefully acknowledged.
CR Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Birch NP, 2014, LANGMUIR, V30, P3441, DOI 10.1021/la500491c
   Ciulik CB, 2014, POLYMER, V55, P2645, DOI 10.1016/j.polymer.2014.04.018
   Dowling MB, 2011, BIOMATERIALS, V32, P3351, DOI 10.1016/j.biomaterials.2010.12.033
   Jou CH, 2013, POLYM INT, V62, P507, DOI 10.1002/pi.4368
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Lu Y, 2014, BIOMATERIALS, V35, P1716, DOI 10.1016/j.biomaterials.2013.11.015
   Malhotra M, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S43683
   Matsumoto M., 2016, MACROMOL RAPID COMMU
   Perelshtein I, 2013, J MATER CHEM B, V1, P1968, DOI 10.1039/c3tb00555k
   Salihu G, 2012, CELLULOSE, V19, P739, DOI 10.1007/s10570-012-9666-8
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x
   Tachaboonyakiat W, 2001, POLYM J, V33, P177, DOI 10.1295/polymj.33.177
   Tronci G., 2013, MRS P, V1498, P145
   Tronci G, 2014, ACTA BIOMATER, V10, P821, DOI 10.1016/j.actbio.2013.10.014
NR 16
TC 0
Z9 0
U1 3
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 1
PY 2017
VL 188
BP 359
EP 363
DI 10.1016/j.matlet.2016.11.109
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EG0RS
UT WOS:000390740500094
OA Green Published
DA 2018-10-20
ER

PT J
AU Caralapatti, VK
   Narayanswamy, S
AF Caralapatti, Vinodh Krishna
   Narayanswamy, Sivakumar
TI Effect of high repetition laser shock peening on biocompatibility and
   corrosion resistance of magnesium
SO OPTICS AND LASER TECHNOLOGY
LA English
DT Article
DE High repetition laser shock peening; Magnesium; Corrosion;
   Biocompatibility; Micro-hardness
ID HIGH-PURITY MG; HANKS SOLUTION; PURE MAGNESIUM; ALLOYS; BEHAVIOR;
   SURFACE; BONE; AZ91; PH; AL
AB Magnesium, as a biomaterial has the potential to replace conventional implant materials owing to its numerous advantages. However, high corrosion rate is a major obstacle that has to be addressed for its implementation as implants. This study aims to evaluate the feasibility and effects of High Repetition Laser Shock Peening (HRLSP) on biocompatibility and corrosion resistance of Mg samples and as well as to analyze the effect of operational parameters such as peening with overlap on corrosion rate. From the results obtained using hydrogen evolution and mass loss methods, it was found that corrosion rates of both 0% overlap and 66% overlap peened samples reduced by more than 50% compared to that of unpeened sample and sample peened with 66% overlap exhibited least corrosion. The biocompatibility of peened Mg samples was also enhanced as there was neither rapid pH variation nor large hydrogen bubble formation around samples.
C1 [Caralapatti, Vinodh Krishna; Narayanswamy, Sivakumar] Concordia Univ, Dept Mech Engn, Montreal, PQ H3G 1M8, Canada.
RP Caralapatti, VK (reprint author), Concordia Univ, Dept Mech Engn, Montreal, PQ H3G 1M8, Canada.
FU NSERC [N01332]
FX This research was supported by NSERC (Grant no. N01332). The authors
   also acknowledge Thermodynamics of Materials Group at Concordia
   University for permitting to access their Laboratory facilities.
CR Abidin NIZ, 2011, CORROS SCI, V53, P862, DOI 10.1016/j.corsci.2010.10.008
   Atrens A, 2013, J MAGNES ALLOY, V1, P177, DOI 10.1016/j.jma.2013.09.003
   Braisted W, 1999, INT J FATIGUE, V21, P719, DOI 10.1016/S0142-1123(99)00035-3
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   DUHM J, 1971, PFLUG ARCH EUR J PHY, V326, P341, DOI 10.1007/BF00586998
   Gujba AK, 2014, MATERIALS, V7, P7925, DOI 10.3390/ma7127925
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Han G, 2012, CORROS SCI, V63, P316, DOI 10.1016/j.corsci.2012.06.011
   Irizalp SG, 2014, OPT LASER TECHNOL, V56, P273, DOI 10.1016/j.optlastec.2013.08.011
   Johnston S, 2015, CORROS SCI, V101, P182, DOI 10.1016/j.corsci.2015.09.018
   Kamkarrad H, 2015, J LASER MICRO NANOEN, V10, P291, DOI 10.2961/jlmn.2015.03.0010
   Kamkarrad H, 2014, INT J ADV MANUF TECH, V74, P1237, DOI 10.1007/s00170-014-6051-9
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Lee JY, 2009, MET MATER INT, V15, P955, DOI 10.1007/s12540-009-0955-1
   Li HF, 2014, PROG NAT SCI-MATER, V24, P414, DOI 10.1016/j.pnsc.2014.08.014
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lu JZ, 2014, CORROS SCI, V80, P53, DOI 10.1016/j.corsci.2013.11.003
   Lu JZ, 2012, CORROS SCI, V60, P145, DOI 10.1016/j.corsci.2012.03.044
   Ma WH, 2015, CORROS SCI, V98, P201, DOI 10.1016/j.corsci.2015.05.012
   Mareci D, 2016, MAT SCI ENG C-MATER, V60, P402, DOI 10.1016/j.msec.2015.11.069
   Montross CS, 2002, INT J FATIGUE, V24, P1021, DOI 10.1016/S0142-1123(02)00022-1
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Saklakoglu N, 2014, OPT LASER TECHNOL, V64, P235, DOI 10.1016/j.optlastec.2014.05.028
   Salahshoor M, 2011, J MECH BEHAV BIOMED, V4, P1888, DOI 10.1016/j.jmbbm.2011.06.006
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Sathyajith S, 2013, OPT LASER TECHNOL, V45, P389, DOI 10.1016/j.optlastec.2012.06.019
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Trdan U, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/705306
   Trdan U, 2014, MATER CHARACT, V97, P57, DOI 10.1016/j.matchar.2014.08.020
   Trdan U, 2014, CORROS SCI, V82, P328, DOI 10.1016/j.corsci.2014.01.032
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wan TT, 2013, CORROS SCI, V66, P33, DOI 10.1016/j.corsci.2012.08.051
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Zhang L, 2013, CORROS SCI, V66, P5, DOI 10.1016/j.corsci.2012.08.034
   Zhao MC, 2008, CORROS SCI, V50, P1939, DOI 10.1016/j.corsci.2008.04.01
   Zhao MC, 2009, CORROS SCI, V51, P1277, DOI 10.1016/j.corsci.2009.03.014
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zomorodian A, 2015, ELECTROCHIM ACTA, V179, P431, DOI 10.1016/j.electacta.2015.04.013
NR 43
TC 9
Z9 9
U1 6
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0030-3992
EI 1879-2545
J9 OPT LASER TECHNOL
JI Opt. Laser Technol.
PD FEB
PY 2017
VL 88
BP 75
EP 84
DI 10.1016/j.optlastec.2016.09.003
PG 10
WC Optics; Physics, Applied
SC Optics; Physics
GA EG1XE
UT WOS:000390826900009
DA 2018-10-20
ER

PT J
AU Hou, P
   Zhao, CL
   Cheng, PF
   Wu, HL
   Ni, JH
   Zhang, SX
   Lou, TF
   Wang, CY
   Han, P
   Zhang, XN
   Chai, YM
AF Hou, Peng
   Zhao, Changli
   Cheng, Pengfei
   Wu, Hongliu
   Ni, Jiahua
   Zhang, Shaoxiang
   Lou, Tengfei
   Wang, Chunyang
   Han, Pei
   Zhang, Xiaonong
   Chai, Yimin
TI Reduced antibacterial property of metallic magnesium in vivo
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE magnesium; antibacterial property; in vivo
ID STAPHYLOCOCCUS-AUREUS; MG ALLOYS; VITRO; CORROSION; IMPLANTS; TITANIUM;
   BEHAVIOR
AB Magnesium and its alloys have drawn interest as antibacterial biomaterials, owing to their ability to alkalize the surrounding medium during degradation. The antibacterial effect of pure Mg and Mg alloys in vitro has previously been reported. However, the antibacterial property of Mg in vivo might be different because of the apparently dissimilar corrosion characteristics. In this study, pure Mg rods were implanted and bacterial suspension were injected into rat femurs to investigate the antibacterial property of Mg in vivo. The results showed that contrary to the high antibacterial rate in vitro, Mg exhibited a dramatic drop in antibacterial effect in vivo. Bacteria proliferated on the surface of the Mg rods as well as in the femur. Inflammatory cells filled cavities in the cortical bone of the femur, which was demonstrated by histological and micro-CT examination after 2 and 4 weeks of implantation. It is suggested that a reduced corrosion rate in vivo would result in insufficient pH value. In addition, the deposition layer would prevent further corrosion of Mg and provide a favorite site for bacteria adhesion. Hence, the dramatically reduced antibacterial property of Mg needs to be noticed when it is used as a biomaterial.
C1 [Hou, Peng; Cheng, Pengfei; Lou, Tengfei; Wang, Chunyang; Han, Pei; Chai, Yimin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Zhao, Changli; Wu, Hongliu; Ni, Jiahua; Zhang, Xiaonong] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
   [Zhang, Shaoxiang; Zhang, Xiaonong] Suzhou Origin Med Technol Co Ltd, Suzhou 215513, Peoples R China.
RP Chai, YM (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
EM hanpei_cn@163.com; xnzhang@sjtu.edu.cn; ymchai@sjtu.edu.cn
FU Natural Science Foundation of China [51571142, 51271117, 81371935,
   81572122]; Science and Technology innovation project of Shanghai
   [14441901801, 14441901802]
FX The authors are grateful to the financial support of the Natural Science
   Foundation of China (No. 51571142, 51271117, 81371935, 81572122) and the
   Science and Technology innovation project of Shanghai (No. 14441901801,
   14441901802).
CR Badar M, 2013, ACTA BIOMATER, V9, P7580, DOI 10.1016/j.actbio.2013.03.012
   Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x
   Charyeva O, 2015, OPEN J MED MICROBIOL, V5, P1, DOI DOI 10.4236/OJMM.2015.51001
   Dorkhan M, 2012, MICROBIOL-SGM, V158, P390, DOI 10.1099/mic.0.054536-0
   Haude M, 2016, LANCET, V387, P31, DOI 10.1016/S0140-6736(15)00447-X
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   Lock JY, 2012, IEEE ENG MED BIO, P1378, DOI 10.1109/EMBC.2012.6346195
   Qin H, 2015, RSC ADV, V5, P21434, DOI 10.1039/c5ra00027k
   Rahim MI, 2016, J BIOMED MATER RES A, V104, P1489, DOI 10.1002/jbm.a.35680
   Rahim MI, 2015, J BIOMED MATER RES A, V103, P3526, DOI 10.1002/jbm.a.35503
   Ren L, 2011, MATER LETT, V65, P3509, DOI 10.1016/j.matlet.2011.07.109
   Robinson DA, 2010, ACTA BIOMATER, V6, P1869, DOI 10.1016/j.actbio.2009.10.007
   Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048
   Seitz JM, 2016, JOM-US, V68, P1177, DOI 10.1007/s11837-015-1773-1
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207
   Walker J, 2012, J BIOMED MATER RES B, V100B, P1134, DOI 10.1002/jbm.b.32680
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte Frank, 2015, Acta Biomater, V23 Suppl, pS28, DOI 10.1016/j.actbio.2015.07.017
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Zeng JH, 2013, J MATER SCI-MATER M, V24, P2405, DOI 10.1007/s10856-013-4982-6
NR 21
TC 3
Z9 3
U1 6
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2017
VL 12
IS 1
AR 015010
DI 10.1088/1748-605X/12/1/015010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EG1SL
UT WOS:000390812400004
DA 2018-10-20
ER

PT J
AU Park, KH
   Kim, SJ
   Lee, WY
   Song, HJ
   Park, YJ
AF Park, Kyung Hee
   Kim, Seok-Jae
   Lee, Woon-Young
   Song, Ho-Jun
   Park, Yeong-Joon
TI Hydrothermal fabrication and characterization of calcium phosphate
   anhydrous/chitosan composites
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Monetite; Chitosan; Hydrothermal; Morphology; Electrochemical properties
ID MONETITE; HYDROXYAPATITE; NANOCOMPOSITE; TEMPERATURE; RESORPTION; CEMENT
AB Calcium phosphate-based biomaterials are of special interest in bone regeneration due to their biocompatibility and biodegradability; on the other hand, chitosan has novel properties such as antibacterial properties, biocompatibility, and biodegradability. In the present study, a new calcium phosphate (CaP)/chitosan (Chi) nanocomposite biomaterial has been introduced, which was prepared using in situ precipitation by the hydrothermal method. The fabricated nanocomposites were characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and electrochemical method. The results showed that crystalline calcium phosphate nanoparticles were mineralized in chitosan and the interaction was formed between the phosphate ion in CaP and positively charged functional groups in chitosan molecular chains. The X-ray diffraction pattern of the synthesized powder showed monetite as the major phase. The effect of chitosan on the crystallization of calcium phosphate particles was studied, and it was confirmed that the polymer has a controlling role over the growth of calcium phosphate crystals and morphologies.
C1 [Park, Yeong-Joon] Chonnam Natl Univ, Sch Dent, Dept Dent Mat, Gwangju 61186, South Korea.
   Chonnam Natl Univ, Med Res Ctr Biomineralizat Disorders, Sch Dent, Gwangju 61186, South Korea.
RP Park, YJ (reprint author), Chonnam Natl Univ, Sch Dent, Dept Dent Mat, Gwangju 61186, South Korea.
EM yjpark@jnu.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2011-0030121]
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030121).
CR Anik M, 2007, CORROS SCI, V49, P1878, DOI 10.1016/j.corsci.2006.10.016
   BABAEI Z, 2013, MIDDLE EAST J SCI RE, V13, P963, DOI DOI 10.5829/idosi.mejsr.2013.13.7.3219
   Boroujeni NM, 2014, J BIOMED MATER RES B, V102, P260, DOI 10.1002/jbm.b.33003
   Di Martino A., 2005, BIOMATERIALS, V26, P5983
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Higuita LP, 2016, MATER LETT, V175, P169, DOI 10.1016/j.matlet.2016.04.011
   Li QL, 2006, MATER LETT, V60, P3533, DOI 10.1016/j.matlet.2006.03.046
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   Montazerolghaem M, 2015, MAT SCI ENG C-MATER, V52, P212, DOI 10.1016/j.msec.2015.03.038
   Salimi E., 2012, J NANOMATER, V2012
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tas AC, 2009, J AM CERAM SOC, V92, P2907, DOI 10.1111/j.1551-2916.2009.03351.x
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Yang C, 2015, CERAM INT, V41, P11153, DOI 10.1016/j.ceramint.2015.05.064
NR 15
TC 1
Z9 1
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD FEB 1
PY 2017
VL 43
IS 2
BP 2786
EP 2790
DI 10.1016/j.ceramint.2016.11.112
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA EG0OM
UT WOS:000390732100160
DA 2018-10-20
ER

PT J
AU Pezzotti, G
   Bal, BS
   Casagrande, E
   Sugano, N
   McEntire, BJ
   Zhu, WL
   Puppulin, L
AF Pezzotti, Giuseppe
   Bal, B. Sonny
   Casagrande, Elisa
   Sugano, Nobuhiko
   McEntire, Bryan J.
   Zhu, Wenliang
   Puppulin, Leonardo
TI On the molecular interaction between femoral heads and polyethylene
   liners in artificial hip joints: phenomenology and molecular scale
   phenomena
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE zirconia-toughened alumina; silicon nitride; femoral head; polyethylene
   liner; oxidative degradation
ID WEIGHT POLYETHYLENE; GAMMA-IRRADIATION; SILICON-NITRIDE; OXIDATION;
   ALUMINA; RADIATION; HYDROGEN; UHMWPE; TRANSFORMATION; CRYSTALLINITY
AB The chemical interaction of femoral heads with polyethylene liners is an important new area of research in total hip arthroplasty (THA) as a consequence of an unabating quest for elongated artificial joint lifetimes. It is a topic that goes beyond simple mechanical behavior or wear. It seeks to describe the prosthetic device as a whole by adding chemical considerations to mechanics and abrasion. One of the poorly understood chemical interactions is oxygen affinity of the femoral heads. While oxygen unavoidably diffuses into the non-crystalline enclaves of the polyethylene liner as a result of its contact with the tribolayer, a ceramic femoral head can either attract or release oxygen due to its tribochemical interactions. In this study, changes in liner crystallinity and oxidation were observed during simple static contact with different femoral heads within a hydrothermal environment. Examinations were made using Raman microprobe spectroscopy coupled with nanometer-scale spectroscopic analyses (x-ray photoelectron spectroscopy (XPS) and cathodoluminescence (CL) spectroscopy) on different sets of ceramic and polyethylene couples exposed for increasing periods to a hydrothermal environment. Even in the absence of frictional loading, structural modifications were clearly detected, statistically validated, and correlated with the oxygen affinity of various femoral head materials. It was found that oxide (Al2O3, Al2O3/ZrO2, and m-ZrO2) and non-oxide (Si3N4) ceramic heads release or attract nascent oxygen species, respectively. This research unequivocally identified a new gap in our knowledge of THA biomaterial interactions, with future studies and material improvements undoubtedly leading to an increase in longevity for prosthetic joints.
C1 [Pezzotti, Giuseppe; Casagrande, Elisa] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
   [Bal, B. Sonny] Univ Missouri, Dept Orthopaed Surg, Columbia, MO 65212 USA.
   [Bal, B. Sonny; McEntire, Bryan J.] Amedica Corp, 1885 West 2100 South, Salt Lake City, UT 84119 USA.
   [Sugano, Nobuhiko; Zhu, Wenliang] Osaka Univ, Dept Med Engn Treatment Bone & Joint Disorders, 2-2 Yamadaoka, Suita, Osaka 5650854, Japan.
   [Puppulin, Leonardo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kamigyo Ku, Kyoto 6028566, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
EM pezzotti@kit.ac.jp; pampu78@gmail.com
CR BHATEJA SK, 1989, POLYM J, V21, P739, DOI 10.1295/polymj.21.739
   Billingham N. C., 1980, DEV POLYM STABIL, P139
   Bracco P, 2006, POLYM DEGRAD STABIL, V91, P3057, DOI 10.1016/j.polymdegradstab.2006.08.002
   Brach Del Prever EM, 2009, J ORTHOP TRAUMATOL, V10, P1, DOI DOI 10.1007/S10195-008-0038-Y
   Buchanan FJ, 2001, J MATER SCI-MATER M, V12, P29, DOI 10.1023/A:1026796817483
   Castanho SM, 1997, J MATER SCI, V32, P157, DOI 10.1023/A:1018543703475
   CORNELIUS EB, 1955, J PHYS CHEM-US, V59, P809, DOI 10.1021/j150531a003
   Costa L, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P309, DOI 10.1016/B978-0-12-374721-1.00021-3
   Foster AS, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.224108
   Fukatsu K, 2012, ACTA BIOMATER, V8, P1639, DOI 10.1016/j.actbio.2011.12.019
   Ghamnia M, 2003, J ELECTRON SPECTROSC, V133, P55, DOI 10.1016/j.elspec.2003.08.003
   GLOTIN M, 1982, COLLOID POLYM SCI, V260, P182, DOI 10.1007/BF01465438
   Goldman M, 1998, J MATER SCI-MATER M, V9, P207, DOI 10.1023/A:1008836107186
   Goldman M, 1998, POLYM DEGRAD STABIL, V62, P97, DOI 10.1016/S0141-3910(97)00265-6
   Hansch W, 1999, APPL PHYS LETT, V75, P1535, DOI 10.1063/1.124747
   Kasprzyk-Hordern B, 2004, ADV COLLOID INTERFAC, V110, P19, DOI 10.1016/j.cis.2004.02.002
   LAVALLEY JC, 1984, J CHEM SOC CHEM COMM, P908, DOI 10.1039/c39840000908
   Lu YH, 2015, PHYS CHEM CHEM PHYS, V17, P6834, DOI 10.1039/c4cp05789a
   Medel FJ, 2005, POLYM DEGRAD STABIL, V88, P435, DOI 10.1016/j.polymdegradstab.2004.11.015
   NAYLOR CC, 1995, MACROMOLECULES, V28, P2969, DOI 10.1021/ma00112a050
   Norby T, 2004, DALTON T, P3012, DOI 10.1039/b403011g
   OLIVERO JJ, 1977, J QUANT SPECTROSC RA, V17, P233, DOI 10.1016/0022-4073(77)90161-3
   Oral E, 2011, J BIOMED MATER RES B, V97B, P167, DOI 10.1002/jbm.b.31799
   Pezzotti G, 2014, MATERIALS, V7, P4367, DOI 10.3390/ma7064367
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Pezzotti G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710247
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Poon MC, 2004, THIN SOLID FILMS, V462, P42, DOI 10.1016/j.tsf.2004.05.043
   Puppulin L, 2016, J MECH BEHAV BIOMED, V53, P414, DOI 10.1016/j.jmbbm.2015.08.035
   SKUJA L, 1994, J NON-CRYST SOLIDS, V179, P51, DOI 10.1016/0022-3093(94)90684-X
   Stephen CP, 2005, NUCL INSTRUM METH B, V236, P540, DOI 10.1016/j.nimb.2005.04.037
   STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704
   Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014
   ZHAO Y, 1993, J APPL POLYM SCI, V50, P1797, DOI 10.1002/app.1993.070501015
NR 34
TC 1
Z9 1
U1 1
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2017
VL 12
IS 1
AR 015005
DI 10.1088/1748-605X/12/1/015005
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EF5IL
UT WOS:000390363800005
DA 2018-10-20
ER

PT J
AU Ganjalinia, A
   Akbari, S
   Solouk, A
AF Ganjalinia, Atiyeah.
   Akbari, Somaye.
   Solouk, Atefeh.
TI PLLA scaffolds surface-engineered via poly (propylene imine) dendrimers
   for improvement on its biocompatibility/controlled pH biodegradability
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Poly (L) lactic acid; Poly (propylene imine) dendrimer; Aminolysis;
   Biodegradability; Biocompatibility; pH Control
ID IN-VITRO; BIOMEDICAL APPLICATIONS; GELATIN IMMOBILIZATION;
   POLY(L-LACTIDE) FILM; FIBROUS SCAFFOLDS; PLASMA TREATMENT;
   DRUG-DELIVERY; GENE DELIVERY; ACID); POLYESTERS
AB Novel aminolyzed Poly (L) Lactic Acid (PLLA) films and electrospun nanofibrous scaffolds were fabricated and characterized as potential substrates for tissue engineering. The second generation polypropylene imine dendrimer (PPI-G2) was used as the aminolysis agent to functionalize the inert surface of PLLA substrates directly without any pre-modification process. The effect of the solvent type, G2 concentration, reaction temperature and time were studied by following weight reduction percentage, FTIR and contact angle measurements due to determined optimum conditions. In addition, the modified scaffolds abbreviated by PLLA/G2 were analyzed using mechanical properties, SEM images and dye assays as host-guest modeling. The results indicate that under the 0.5 (wt.%) G2 concentration, ethanol as the solvent, room temperature and 4 h of treatment, the optimum conditions were obtained. It was shown that the hydrophilic properties of PLLA/G2 were greatly enhanced. Also, pH value analysis revealed that after 4 weeks, the biodegradation of PLLA caused massive immune cells infusion and inflammation in the medium through increasing the acidic rate by secretion the lactic acid, whereas the PLLA/ G2 scaffolds greatly reduced and stabilize the acidic rate through aminolysis reaction. Finally, promoted cell adhesion and viability underlined the favorable properties of PLLA/G2 scaffolds as a biodegradable biomaterial for biomedical implants. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ganjalinia, Atiyeah.; Akbari, Somaye.] Amirkabir Univ Technol, Tehran Polytech, Text Engn Dept, Tehran, Iran.
   [Solouk, Atefeh.] Amirkabir Univ Technol, Tehran Polytech, Dept Biomed Engn, Tehran, Iran.
RP Akbari, S (reprint author), Amirkabir Univ Technol, Tehran Polytech, Text Engn Dept, Tehran, Iran.
EM akbari_s@aut.ac.ir
CR Ardeshirylajimi A, 2015, CELL PROLIFERAT, V48, P47, DOI 10.1111/cpr.12156
   Bertram JP, 2009, ACTA BIOMATER, V5, P2860, DOI 10.1016/j.actbio.2009.04.012
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Cheng YY, 2008, J PHYS CHEM B, V112, P8884, DOI 10.1021/jp801742t
   Chuysinuan P, 2012, ACS APPL MATER INTER, V4, P3031, DOI 10.1021/am300404v
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Cui WG, 2012, POLYMER, V53, P2298, DOI 10.1016/j.polymer.2012.03.039
   Dai Z, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416648810
   Danmark S, 2011, ACTA BIOMATER, V7, P2035, DOI 10.1016/j.actbio.2011.02.011
   Dogan A, 2014, MAT SCI ENG C-MATER, V44, P246, DOI 10.1016/j.msec.2014.08.035
   Dongargaonkar AA, 2013, BIOMACROMOLECULES, V14, P4038, DOI 10.1021/bm401143p
   Farhadi M, 2012, J BIOMED MATER RES A, V100A, P549, DOI 10.1002/jbm.a.33293
   Gartner H, 2015, APPL SURF SCI, V332, P488, DOI 10.1016/j.apsusc.2015.01.157
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hegemann D, 2003, NUCL INSTRUM METH B, V208, P281, DOI 10.1016/S0168-583X(03)00644-X
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Irena G, 2009, APPL SURF SCI, V255, P8293, DOI 10.1016/j.apsusc.2009.05.126
   Janorkar AV, 2007, J BIOMED MATER RES B, V81B, P142, DOI 10.1002/jbm.b.30647
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Khaliliazar S, 2016, APPL SURF SCI, V363, P593, DOI 10.1016/j.apsusc.2015.12.070
   Khorshidi S, 2016, J TISSUE ENG REGEN M, V10, P715, DOI 10.1002/term.1978
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Li H, 2012, ACS APPL MATER INTER, V4, P687, DOI 10.1021/am201795g
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Lin YM, 2010, ADV ENG MATER, V12, pB101, DOI 10.1002/adem.200980031
   Liu XH, 2014, ACS APPL MATER INTER, V6, P8173, DOI 10.1021/am500812h
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Lou T, 2013, INT J BIOL MACROMOL, V61, P353, DOI 10.1016/j.ijbiomac.2013.07.025
   Mahjoubi H, 2014, ACS APPL MATER INTER, V6, P9975, DOI 10.1021/am502752j
   Maingi V, 2012, J PHYS CHEM B, V116, P4370, DOI 10.1021/jp211515g
   Manavitehrani I, 2015, ACS APPL MATER INTER, V7, P22421, DOI 10.1021/acsami.5b06407
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j
   Moraczewski K, 2015, APPL SURF SCI, V346, P11, DOI 10.1016/j.apsusc.2015.03.202
   Nyanhongo GS, 2013, REACT FUNCT POLYM, V73, P1399, DOI 10.1016/j.reactfunctpolym.2012.12.007
   Patel H. N., 2013, INT J PHARM BIO SCI, V4, P454
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Scott RWJ, 2005, J PHYS CHEM B, V109, P692, DOI 10.1021/jp0469665
   Seo HS, 2010, APPL SURF SCI, V257, P596, DOI 10.1016/j.apsusc.2010.07.040
   Sevenson S, 2012, ADV DRUG DELIVER REV, V64, P102, DOI 10.1016/j.addr.2012.09.030
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Sowinska M, 2014, NEW J CHEM, V38, P2168, DOI 10.1039/c3nj01239e
   Sridhar R, 2015, CHEM SOC REV, V44, P790, DOI 10.1039/c4cs00226a
   Tan HP, 2010, MACROMOL BIOSCI, V10, P156, DOI 10.1002/mabi.200900160
   Ye T, 2008, APPL SURF SCI, V255, P446, DOI 10.1016/j.apsusc.2008.06.073
   Tsuji H, 2006, POLYM DEGRAD STABIL, V91, P1128, DOI 10.1016/j.polymdegradstab.2005.07.007
   Tsuji H, 2003, POLYM INT, V52, P843, DOI 10.1002/pi.1199
   Tsuji H, 2001, MACROMOL MATER ENG, V286, P398, DOI 10.1002/1439-2054(20010701)286:7<398::AID-MAME398>3.0.CO;2-G
   Tsuji H, 2007, MACROMOL RAPID COMM, V28, P1651, DOI 10.1002/marc.200700249
   Tverdokhlebov SI, 2015, APPL SURF SCI, V329, P32, DOI 10.1016/j.apsusc.2014.12.127
   Vogtle F, 2000, PROG POLYM SCI, V25, P987, DOI 10.1016/S0079-6700(00)00017-4
   Wang F, 2012, ACTA BIOMATER, V8, P4304, DOI 10.1016/j.actbio.2012.07.031
   Wang SG, 2014, ACS APPL MATER INTER, V6, P2153, DOI 10.1021/am405273v
   Wu XZ, 2016, APPL SURF SCI, V364, P86, DOI 10.1016/j.apsusc.2015.12.084
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang YJ, 2016, ACS APPL MATER INTER, V8, P3719, DOI 10.1021/acsami.5b08119
   Zhao YL, 2014, J MATER CHEM B, V2, P7384, DOI 10.1039/c4tb01278j
   Zhu N, 2013, FRONT MATER SCI, V7, P76, DOI 10.1007/s11706-013-0188-6
   Zhu Y, 2013, RSC ADV, V3, P2509, DOI 10.1039/c2ra22358a
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zulkifli FH, 2014, POLYM DEGRAD STABIL, V110, P473, DOI 10.1016/j.polymdegradstab.2014.10.017
NR 62
TC 3
Z9 3
U1 9
U2 81
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 1
PY 2017
VL 394
BP 446
EP 456
DI 10.1016/j.apsusc.2016.10.110
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA ED8WZ
UT WOS:000389152900052
DA 2018-10-20
ER

PT J
AU Tran, TN
   Athanassiou, A
   Basit, A
   Bayer, IS
AF Thi Nga Tran
   Athanassiou, Athanassia
   Basit, Abdul
   Bayer, Ilker S.
TI Starch-based bio-elastomers functionalized with red beetroot natural
   antioxidant
SO FOOD CHEMISTRY
LA English
DT Article
DE Red beetroot waste; Bio-elastomers; Starch; PDMS; Antioxidant; Food
   packaging
ID POLYDIMETHYLSILOXANE PDMS; ACTIVE FILMS; BLENDS; SPECTROSCOPY;
   INTERFACE; PRODUCTS; EXTRACTS; ROBUST; ASSAY
AB Red beetroot (RB) powder was incorporated into starch-based bio-elastomers to obtain flexible biocomposites with tunable antioxidant properties. Starch granules within the bio-elastomers affected the release of the antioxidant molecule betanin in the RB powder. The bio-elastomers were hydrophobic and resisted dissolution in water, hence the release of betanin was due to diffusion rather than polymer matrix disintegration. Hydrophobicity was maintained even after water immersion. Released betanin demonstrated highly efficient antioxidant scavenging activity against 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH center dot) and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS(center dot+)). RB powder was also found to increase the Young's modulus of the bio-elastomers without compromising their elongation ability. Infrared spectral analysis indicated weak interactions through hydrogen bonding among starch granules, RB powder and PDMS polymer within the bio-elastomers. Hence, as a simple but intelligent biomaterial consisting of mainly edible starch and RB powder the present bioelastomers can be used in active packaging for a variety of pharmaceutical, medical, and food applications. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Thi Nga Tran; Athanassiou, Athanassia; Bayer, Ilker S.] Ist Italiano Tecnol, Smart Mat, Via Morego 30, I-16163 Genoa, Italy.
   [Basit, Abdul] Ist Italian Tecnol, Drug Discovery & Dev, Via Morego 30, I-16163 Genoa, Italy.
RP Tran, TN; Athanassiou, A; Bayer, IS (reprint author), Ist Italiano Tecnol, Smart Mat, Via Morego 30, I-16163 Genoa, Italy.
EM thi-nga.tran@iit.it; athanassia.athanassiou@iit.it; ilker.bayer@iit.it
RI ATHANASSIOU, ATHANASSIA/B-4197-2018
OI ATHANASSIOU, ATHANASSIA/0000-0002-6533-3231; Basit,
   Abdul/0000-0002-1164-5520
CR Akhtar MJ, 2012, CARBOHYD POLYM, V89, P1150, DOI 10.1016/j.carbpol.2012.03.088
   Bijlsma S, 2000, ANAL CHIM ACTA, V419, P197, DOI 10.1016/S0003-2670(00)00994-6
   Brook MA, 1997, LANGMUIR, V13, P6279, DOI 10.1021/la970419b
   Cai YZ, 2005, TRENDS FOOD SCI TECH, V16, P370, DOI 10.1016/j.tifs.2005.03.020
   Ceseracciu L, 2015, ACS APPL MATER INTER, V7, P3742, DOI 10.1021/am508515z
   Coimbra MA, 1999, CARBOHYD RES, V317, P145, DOI 10.1016/S0008-6215(99)00071-3
   Latorre ME, 2010, J FOOD ENG, V98, P178, DOI 10.1016/j.jfoodeng.2009.12.024
   Esatbeyoglu T, 2015, MOL NUTR FOOD RES, V59, P36, DOI 10.1002/mnfr.201400484
   Fan J, 2015, ACS SUSTAIN CHEM ENG, V3, P1866, DOI 10.1021/acssuschemeng.5b00469
   Fogliano V, 1999, J AGR FOOD CHEM, V47, P1035, DOI 10.1021/jf980496s
   Iniguez-Franco F, 2012, J AGR FOOD CHEM, V60, P6515, DOI 10.1021/jf300668u
   Karacelik AA, 2015, FOOD CHEM, V175, P106, DOI 10.1016/j.foodchem.2014.11.085
   Kim S, 2012, POLYM COMPOSITE, V33, P904, DOI 10.1002/pc.22218
   Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q
   Loginova KV, 2011, J FOOD ENG, V106, P127, DOI 10.1016/j.jfoodeng.2011.04.019
   MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940
   Park EJ, 2014, LANGMUIR, V30, P10256, DOI 10.1021/la502915r
   Pokorny J., 2001, ANTIOXIDANTS FOOD PR
   Privas E, 2013, CARBOHYD POLYM, V96, P91, DOI 10.1016/j.carbpol.2013.03.042
   Ravichandran K, 2013, FOOD RES INT, V50, P670, DOI 10.1016/j.foodres.2011.07.002
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Schieber A, 2001, TRENDS FOOD SCI TECH, V12, P401, DOI 10.1016/S0924-2244(02)00012-2
   Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008
   Sin LT, 2010, POLYMER, V51, P1206, DOI 10.1016/j.polymer.2010.01.021
   Siracusa V, 2008, TRENDS FOOD SCI TECH, V19, P634, DOI 10.1016/j.tifs.2008.07.003
   Sonkaew P, 2012, J AGR FOOD CHEM, V60, P5388, DOI 10.1021/jf301311g
   Stintzing FC, 2007, TRENDS FOOD SCI TECH, V18, P514, DOI 10.1016/j.tifs.2007.04.012
   Tang XZ, 2011, CARBOHYD POLYM, V85, P7, DOI 10.1016/j.carbpol.2011.01.030
   Tran TN, 2016, CHEM ENG J, V287, P196, DOI 10.1016/j.cej.2015.10.114
   Tongnuanchan P, 2012, FOOD CHEM, V134, P1571, DOI 10.1016/j.foodchem.2012.03.094
   Walker AM, 2007, POLYMER, V48, P1066, DOI 10.1016/j.polymer.2006.12.038
   Wang LY, 2013, FOOD HYDROCOLLOID, V32, P35, DOI 10.1016/j.foodhyd.2012.11.034
   Wells M, 2005, ENVIRON SCI TECHNOL, V39, P1055, DOI 10.1021/es035067b
   Wettasinghe M, 2002, J AGR FOOD CHEM, V50, P6704, DOI 10.1021/jf020575a
   Wootton-Beard PC, 2011, J FUNCT FOODS, V3, P329, DOI 10.1016/j.jff.2011.05.007
   Wu D, 2014, ACS SUSTAIN CHEM ENG, V2, P2172, DOI 10.1021/sc500355w
   Wu JL, 2013, FOOD HYDROCOLLOID, V32, P42, DOI 10.1016/j.foodhyd.2012.11.029
   Xu HL, 2015, ACS SUSTAIN CHEM ENG, V3, P2631, DOI 10.1021/acssuschemeng.5b00353
   Zhang NZ, 2013, CARBOHYD POLYM, V95, P649, DOI 10.1016/j.carbpol.2013.03.045
NR 39
TC 10
Z9 10
U1 3
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 1
PY 2017
VL 216
BP 324
EP 333
DI 10.1016/j.foodchem.2016.08.055
PG 10
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA DY0JO
UT WOS:000384783300043
PM 27596427
DA 2018-10-20
ER

PT J
AU Kumari, J
   Kumar, A
AF Kumari, Jyoti
   Kumar, Ashok
TI Development of polymer based cryogel matrix for transportation and
   storage of mammalian cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GELATIN CRYOGELS; IN-VITRO; TISSUE; PROLIFERATION; CRYOPRESERVATION;
   CRYOPROTECTANT; ENCAPSULATION; STIMULATION; BIOMATERIAL; SCAFFOLDS
AB We studied the potential of polymeric cryogel matrices such as 2-hydroxyethyl methacrylate (HEMA)agarose (HA) and gelatin matrix as a transporting and storage material for mammalian cells. Both the HA and gelatin matrices were found to possess a homogenous distribution of pores as shown by scanning electron microscopic (SEM) images and flow rate of 8 and 5 mL/min, respectively. In the case of HA cryogel, after 5 days of simulated transportation, C2C12 cells kept in cryogel matrix showed higher percentage viability (89%) as compared to 64.5% viability of cells kept in suspension culture. The cells recovered from the HA cryogel were able to proliferate as revealed by the microscopic analysis. In the case of gelatin cryogel, it was shown that C2C12 cells seeded on the cryogel under simulated transportation condition were found to proliferate over the period of 5 days. It was also observed that the cells after simulation can be cryopreserved and the duration of cryopreservation does not affect their viability. Furthermore, gelatin cryogel was used for cryopreservation of HepG2 and HUVEC cells to extend the system for other cell types. These results show the potential of cryogels as efficient, low-cost transporting matrix at room temperature and in cryo-conditions.
C1 [Kumari, Jyoti; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
FU department of biotechnology (DBT), ministry of science and technology,
   Govt. of India [BT/PR7376/MED/29/669/2012, BT/PR11841/MED/32/105/2009];
   Department of Science and Technology-UK India Education and Research
   Initiative (DST-UKIERI) [DST/INT/UK/P-58/2014]; DST-Japan Society for
   Promotion of Science [DST/INT/JSPS/P-184/2014]; DBT-TATA Innovation
   Fellowship
FX We would like to acknowledge department of biotechnology (DBT), ministry
   of science and technology, Govt. of India (project nos
   BT/PR7376/MED/29/669/2012 and BT/PR11841/MED/32/105/2009), the
   Department of Science and Technology-UK India Education and Research
   Initiative (DST-UKIERI) (project no. DST/INT/UK/P-58/2014) and the
   DST-Japan Society for Promotion of Science (project no.
   DST/INT/JSPS/P-184/2014) for partially funding the project. AK
   acknowledges DBT-TATA Innovation Fellowship. We also duly acknowledge
   Dr. Ankur Gupta for his contribution in discussion and helping in
   writing of the manuscript.
CR Acker JP, 1999, CRYOBIOLOGY, V38, P363, DOI 10.1006/cryo.1999.2179
   Baicu SC, 2002, CRYOBIOLOGY, V45, P33, DOI 10.1016/S0011-2240(02)00104-9
   Baust J. M., 2007, PROPERTIES CELLS TIS
   Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000
   BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   Ebertz SL, 2004, CRYOBIOLOGY, V49, P37, DOI 10.1016/j.cryobiol.2004.04.003
   EDWARDS JG, 1971, J CELL SCI, V8, P53
   Farris S, 2010, J AGR FOOD CHEM, V58, P998, DOI 10.1021/jf9031603
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Gupta A, 2014, TISSUE ENG PT A, V20, P3101, DOI [10.1089/ten.TEA.2013.0702, 10.1089/ten.tea.2013.0702]
   Han YA, 2009, CHINESE J POLYM SCI, V27, P359, DOI 10.1142/S025676790900400X
   Hennink WE, 1997, J CONTROL RELEASE, V48, P107, DOI 10.1016/S0168-3659(97)00047-3
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Katsen-Globa A, 2014, J MATER SCI-MATER M, V25, P857, DOI 10.1007/s10856-013-5108-x
   Konno T, 2007, BIOMATERIALS, V28, P1770, DOI 10.1016/j.biomaterials.2006.12.017
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Kumari J, 2016, ACS APPL MATER INTER, V8, P264, DOI 10.1021/acsami.5b08607
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410
   Mishra R, 2015, INT J BIOL SCI, V11, P1325, DOI 10.7150/ijbs.13139
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ohyabu Y, 2014, J BIOSCI BIOENG, V118, P112, DOI 10.1016/j.jbiosc.2013.12.005
   Rainov NG, 2000, BIOTECHNOL LETT, V22, P383, DOI 10.1023/A:1005624718463
   Sarkar J, 2016, ANALYST, V141, P2553, DOI 10.1039/c6an00356g
   Singh D, 2010, INT J BIOL SCI, V6, P371
   Smith BH, 2011, CANCER RES, V71, P725, DOI 10.1158/0008-5472.CAN-10-2258
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Tako M, 1988, CARBOHYD RES, V180, P277, DOI 10.1016/0008-6215(88)80084-3
   Umemura E, 2011, TISSUE ENG PART C-ME, V17, P799, DOI 10.1089/ten.tec.2011.0003
   Vishnoi T, 2013, J MATER SCI-MATER M, V24, P447, DOI 10.1007/s10856-012-4795-z
   Vrana NE, 2012, J TISSUE ENG REGEN M, V6, P280, DOI 10.1002/term.431
   Xue W, 2004, EUR POLYM J, V40, P467, DOI 10.1016/j.eurpolymj.2003.11.004
   Yang Lingzhi, 2009, Curr Chem Genomics, V3, P50, DOI 10.2174/1875397300903010050
NR 33
TC 5
Z9 5
U1 4
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 31
PY 2017
VL 7
AR 41551
DI 10.1038/srep41551
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EJ1FN
UT WOS:000392956000001
PM 28139669
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Burnum-Johnson, KE
   Kyle, JE
   Eisfeld, AJ
   Casey, CP
   Stratton, KG
   Gonzalez, JF
   Habyarimana, F
   Negretti, NM
   Sims, AC
   Chauhan, S
   Thackray, LB
   Halfmann, PJ
   Walters, KB
   Kim, YM
   Zink, EM
   Nicora, CD
   Weitz, KK
   Webb-Robertson, BJM
   Nakayasu, ES
   Ahmer, B
   Konkel, ME
   Motin, V
   Baric, RS
   Diamond, MS
   Kawaoka, Y
   Waters, KM
   Smith, RD
   Metz, TO
AF Burnum-Johnson, Kristin E.
   Kyle, Jennifer E.
   Eisfeld, Amie J.
   Casey, Cameron P.
   Stratton, Kelly G.
   Gonzalez, Juan F.
   Habyarimana, Fabien
   Negretti, Nicholas M.
   Sims, Amy C.
   Chauhan, Sadhana
   Thackray, Larissa B.
   Halfmann, Peter J.
   Walters, Kevin B.
   Kim, Young-Mo
   Zink, Erika M.
   Nicora, Carrie D.
   Weitz, Karl K.
   Webb-Robertson, Bobbie-Jo M.
   Nakayasu, Ernesto S.
   Ahmer, Brian
   Konkel, Michael E.
   Motin, Vladimir
   Baric, Ralph S.
   Diamond, Michael S.
   Kawaoka, Yoshihiro
   Waters, Katrina M.
   Smith, Richard D.
   Metz, Thomas O.
TI MPLEx: a method for simultaneous pathogen inactivation and extraction of
   samples for multi-omics profiling
SO ANALYST
LA English
DT Article
ID EMERGING INFECTIOUS-DISEASES; INFLUENZA-VIRUS; HEALTH; CHLOROFORM;
   VACCINE; PROTEIN; BACTERIOPHAGE; PURIFICATION; BIODIVERSITY; SPORULATION
AB The continued emergence and spread of infectious agents is of great concern, and systems biology approaches to infectious disease research can advance our understanding of host-pathogen relationships and facilitate the development of new therapies and vaccines. Molecular characterization of infectious samples outside of appropriate biosafety containment can take place only subsequent to pathogen inactivation. Herein, we describe a modified Folch extraction using chloroform/methanol that facilitates the molecular characterization of infectious samples by enabling simultaneous pathogen inactivation and extraction of proteins, metabolites, and lipids for subsequent mass spectrometry-based multi-omics measurements. This single-sample metabolite, protein and lipid extraction (MPLEx) method resulted in complete inactivation of clinically important bacterial and viral pathogens with exposed lipid membranes, including Yersinia pestis, Salmonella Typhimurium, and Campylobacter jejuni in pure culture, and Yersinia pestis, Campylobacter jejuni, and West Nile, MERS-CoV, Ebola, and influenza H7N9 viruses in infection studies. In addition, >99% inactivation, which increased with solvent exposure time, was also observed for pathogens without exposed lipid membranes including community-associated methicillin-resistant Staphylococcus aureus, Clostridium difficile spores and vegetative cells, and adenovirus type 5. The overall pipeline of inactivation and subsequent proteomic, metabolomic, and lipidomic analyses was evaluated using a human epithelial lung cell line infected with wild-type and mutant influenza H7N9 viruses, thereby demonstrating that MPLEx yields biomaterial of sufficient quality for subsequent multi-omics analyses. Based on these experimental results, we believe that MPLEx will facilitate systems biology studies of infectious samples by enabling simultaneous pathogen inactivation and multi-omics measurements from a single specimen with high success for pathogens with exposed lipid membranes.
C1 [Burnum-Johnson, Kristin E.; Kyle, Jennifer E.; Casey, Cameron P.; Stratton, Kelly G.; Kim, Young-Mo; Zink, Erika M.; Nicora, Carrie D.; Weitz, Karl K.; Nakayasu, Ernesto S.; Waters, Katrina M.; Smith, Richard D.; Metz, Thomas O.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.
   [Eisfeld, Amie J.; Halfmann, Peter J.; Walters, Kevin B.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA.
   [Gonzalez, Juan F.; Habyarimana, Fabien; Ahmer, Brian] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.
   [Negretti, Nicholas M.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Sims, Amy C.; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA.
   [Chauhan, Sadhana; Motin, Vladimir] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.
   [Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.
   [Webb-Robertson, Bobbie-Jo M.] Pacific Northwest Natl Lab, Computat & Stat Analyt Div, Richland, WA USA.
RP Metz, TO (reprint author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.
EM thomas.metz@pnnl.gov
RI Burnum, Kristin/B-1308-2011; Smith, Richard/J-3664-2012; Kim,
   Young-Mo/D-3282-2009; Motin, Vladimir/O-1535-2013
OI Burnum, Kristin/0000-0002-2722-4149; Smith, Richard/0000-0002-2381-2349;
   Kim, Young-Mo/0000-0002-8972-7593; Nakayasu,
   Ernesto/0000-0002-4056-2695; Casey, Cameron/0000-0001-6790-2170; Waters,
   Katrina/0000-0003-4696-5396
FU Systems Biology Program of the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health [U19AI106772];
   National Institute of General Medical Sciences [GM103493]; DOE
   [DE-AC05-76RLO01830]
FX This project was funded by the Systems Biology Program of the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health, via grant U19AI106772. Portions of the work utilized
   capabilities developed under National Institute of General Medical
   Sciences grant GM103493. Multi-omics measurements were performed in the
   Environmental Molecular Science Laboratory, a U.S. DOE national
   scientific user facility at Pacific Northwest National Laboratory (PNNL)
   in Richland, WA. Battelle operates PNNL for the DOE under contract
   DE-AC05-76RLO01830. We would like to thank PNNL Graphic Designer Michael
   Perkins for assistance in preparing the figures.
CR Ackermann H. W., 2006, CLASSIFICATION BACTE
   Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10
   Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15
   Barra-Carrasco J, 2013, J BACTERIOL, V195, P3863, DOI 10.1128/JB.00369-13
   Belle J. E. L., 2002, NMR BIOMED, V15, P37
   Bergey D. H., 1984, BERGEYS MANUAL SYSTE
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044
   Cham BE, 2006, J VIROL METHODS, V137, P160, DOI 10.1016/j.jviromet.2006.05.027
   Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051
   Cowan AE, 2004, P NATL ACAD SCI USA, V101, P7733, DOI 10.1073/pnas.0306859101
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031
   de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652
   Dichtelmuller Herbert O, 2012, Results Immunol, V2, P19, DOI 10.1016/j.rinim.2012.01.002
   Du WX, 2010, J FOOD SCI, V75, pM7, DOI 10.1111/j.1750-3841.2009.01393.x
   Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157
   Favero MS, 2001, DISINFECTION STERILI
   FAY D, 1978, J VIROL, V27, P432
   FEINSTONE SM, 1983, INFECT IMMUN, V41, P816
   FELDMAN HA, 1961, P SOC EXP BIOL MED, V106, P736
   Ferraz TPL, 2004, J BIOCHEM BIOPH METH, V58, P187, DOI 10.1016/j.jbbm.2003.10.008
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fontana JM, 2012, TRANSL RES, V159, P430, DOI 10.1016/j.trsl.2011.12.009
   Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9
   FRIES LF, 1993, INFECT IMMUN, V61, P1251
   Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552
   Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224
   HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Josset L, 2013, VIRUS RES, V178, P151, DOI 10.1016/j.virusres.2013.02.011
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08
   Maillard JY, 2011, J HOSP INFECT, V77, P204, DOI 10.1016/j.jhin.2010.06.028
   McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921
   McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970
   Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Morrison J, 2014, J VIROL, V88, P10556, DOI 10.1128/JVI.00570-14
   Nakayasu E. S., 2016, MSYSTEMS, V1
   OLSEN RH, 1974, J VIROL, V14, P689
   Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477
   Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003
   PARISIUS W, 1969, APPL MICROBIOL, V17, P379
   Pelletier JPR, 2006, BEST PRACT RES CL HA, V19, P205, DOI 10.1016/j.beha.2005.04.001
   Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936
   Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182
   Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899
   Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.22356210100
   Turner RB, 2010, ANTIMICROB AGENTS CH, V54, P1363, DOI 10.1128/AAC.01498-09
   VIDAVER AK, 1973, J VIROL, V11, P799
   Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247
   Wenk MR, 2006, FEBS LETT, V580, P5541, DOI 10.1016/j.febslet.2006.07.007
   Zak DE, 2014, ANNU REV IMMUNOL, V32, P547, DOI 10.1146/annurev-immunol-032713-120254
NR 62
TC 1
Z9 1
U1 3
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD JAN 30
PY 2017
VL 142
IS 3
BP 442
EP 448
DI 10.1039/c6an02486f
PG 7
WC Chemistry, Analytical
SC Chemistry
GA EM6KI
UT WOS:000395421000003
PM 28091625
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dhanyalayam, D
   Scriyano, L
   Parisi, OI
   Sinicropi, MS
   Fazio, A
   Saturnino, C
   Plutino, MR
   Di Cristo, F
   Puoci, F
   Cappello, AR
   Longo, P
AF Dhanyalayam, Dhanya
   Scriyano, Luca
   Parisi, Ortensia Ilaria
   Sinicropi, Maria Stefania
   Fazio, Antonietta
   Saturnino, Carmela
   Plutino, Maria Rosaria
   Di Cristo, Francesca
   Puoci, Francesco
   Cappello, Anna Rita
   Longo, Pasquale
TI Biopolymeric self-assembled nanoparticles for enhanced antibacterial
   activity of Ag-based compounds
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Dextran; Hydrophilic-hydrophobic polymer; Oleic acid; Antibacterial
   drug; Polymer nanovesicles; Silver; N-heterocyclic carbene
ID HETEROCYCLIC CARBENE COMPLEXES; BREAST-CANCER CELLS; ANTIMICROBIAL
   ACTIVITY; BIODEGRADABLE POLYMERSOMES; TITANOCENE DERIVATIVES;
   ANTIBIOTIC-RESISTANCE; BACTERIAL-RESISTANCE; SILVER SULFADIAZINE;
   CRYSTAL-STRUCTURE; DRUG
AB Microbial infections still remain one of the main issues for human health. The rapid development of resistance towards the most common antimicrobial drugs in bacteria represents today a challenge in the infections management. In the present work we have investigated the antibacterial activity of a group of compounds, namely silver N-heterocyclic carbene complexes, against a broad spectrum of bacteria. For the most promising compound, a biopolymeric nanocarrier has been developed, in order to potentiate the metal complex activity against both Gram +ve and Gram -ve. The polymeric nanovehicle is based on dextran, modified with oleic acid residues, that confer amphiphilic properties to the polysaccharide. We have characterized the obtained biomaterial and studied its ability to self-assemble into nanoparticles in aqueous environment. Next, the transdermal diffusion analyses have been carried out to evaluate the ability of the polymeric particles to penetrate tissues. Thanks to the strategy adopted, we have fabricated an antibacterial system to which K. pneumoniae and E. coil are the most sensitive. (C) 2016 Published by Elsevier B.V.
C1 [Dhanyalayam, Dhanya; Scriyano, Luca; Parisi, Ortensia Ilaria; Sinicropi, Maria Stefania; Fazio, Antonietta; Puoci, Francesco; Cappello, Anna Rita] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.
   [Saturnino, Carmela] Univ Basilicata, Dept Sci, Potenza, Italy.
   [Plutino, Maria Rosaria] Univ Messina, Inst Study Nanostruct Mat, ISMN CNR, OU Palermo,Deptartment ChiBioFarAm, Viale F Stagno dAlcontres 31, I-98166 Messina, Italy.
   [Di Cristo, Francesca] Univ Salerno, Dept Pharmaceut & Biomed Sci, Fisciano, SA, Italy.
   [Longo, Pasquale] Univ Salerno, Dept Biol & Chem, Fisciano, SA, Italy.
RP Puoci, F (reprint author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.; Saturnino, C (reprint author), Univ Basilicata, Dept Sci, Potenza, Italy.
EM saturnino@unisa.it; francesco.puoci@unical.it
RI Scrivano, Luca/E-3293-2018
OI Scrivano, Luca/0000-0003-3773-5492; Longo, Pasquale/0000-0002-7685-1093;
   Parisi, Ortensia Ilaria/0000-0002-2556-9864; PLUTINO,
   MARIAROSARIA/0000-0002-5980-2003
FU Italian Minister of University and Research; University of Calabria
FX This research is funded by Italian Minister of University and Research
   and University of Calabria.
CR Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0
   Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Ahmed F, 2006, MOL PHARMACEUT, V3, P340, DOI 10.1021/mp050103u
   Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Becker K, 2006, INT J MED MICROBIOL, V296, P179, DOI 10.1016/j.ijmm.2005.12.015
   Benson H. J., 2002, MICROBIOLOGICAL APPL, P432
   Benson H. J., 1998, MICROBIOLOGICAL APPL, P139
   BRUNO G, 1995, J CHEM SOC DALTON, P17, DOI 10.1039/dt9950000017
   Chimento A, 2015, BIOORGAN MED CHEM, V23, P7302, DOI 10.1016/j.bmc.2015.10.030
   Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467
   Clinical and Laboratory Standards Institute, 2012, M02A11 CLSI, V32
   Clinical and Laboratory Standards Institute, 2012, M07A9 CLSI
   Clinical Laboratory Standards Institute, 2013, M100S23 CLSI
   Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009
   de Gracia CG, 2001, BURNS, V27, P67, DOI 10.1016/S0305-4179(00)00061-9
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619
   Geilich BM, 2015, NANOSCALE, V7, P3511, DOI 10.1039/c4nr05823b
   Hindi KM, 2008, J MED CHEM, V51, P1577, DOI 10.1021/jm0708679
   Iqbal MA, 2013, MED CHEM RES, V22, P2455, DOI 10.1007/s00044-012-0240-6
   Kalinowska-Lis U, 2016, MOLECULES, V21, DOI 10.3390/molecules21020087
   Kalinowska-Lis U, 2014, CHEMMEDCHEM, V9, P169, DOI 10.1002/cmdc.201300333
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Kyros L, 2014, J BIOL INORG CHEM, V19, P449, DOI 10.1007/s00775-014-1089-6
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Maestrelli F, 2005, INT J PHARMACEUT, V298, P55, DOI 10.1016/j.ijpharm.2005.03.033
   Mariconda A, 2014, NEW J CHEM, V38, P762, DOI 10.1039/c3nj01281f
   Melaiye A, 2004, J MED CHEM, V47, P973, DOI 10.1021/jm030262m
   Meng FH, 2005, J CONTROL RELEASE, V101, P187, DOI 10.1016/j.jconrel.2004.09.026
   MODAK SM, 1973, BIOCHEM PHARMACOL, V22, P2391, DOI 10.1016/0006-2952(73)90341-9
   Napoli M, 2013, J ORGANOMET CHEM, V725, P46, DOI 10.1016/j.jorganchem.2012.10.040
   Napoli M, 2011, EUR J MED CHEM, V46, P122, DOI 10.1016/j.ejmech.2010.10.021
   Nomiya K, 1997, J INORG BIOCHEM, V68, P39, DOI 10.1016/S0162-0134(97)00006-8
   Oehninger L, 2013, DALTON T, V42, P3269, DOI 10.1039/c2dt32617e
   Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248
   Ozdemir I, 2010, MOLECULES, V15, P2499, DOI 10.3390/molecules15042499
   Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994
   Parisi OI, 2014, INT J PHARMACEUT, V461, P163, DOI 10.1016/j.ijpharm.2013.11.048
   Patil SA, 2015, FUTURE MED CHEM, V7, P1305, DOI [10.4155/FMC.15.61, 10.4155/fmc.15.61]
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4
   Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276
   Saturnino C, 2016, FUTURE MED CHEM, V8, P2213, DOI 10.4155/fmc-2016-0160
   Saturnino C, 2014, BIOORG MED CHEM LETT, V24, P136, DOI 10.1016/j.bmcl.2013.11.058
   Saturnino C, 2010, EUR J MED CHEM, V45, P4169, DOI 10.1016/j.ejmech.2010.06.008
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Sinicropi M.S., 2010, PHARMACOLOGYONLINE, V2, P329
   Sinicropi MS, 2010, ARCH TOXICOL, V84, P501, DOI 10.1007/s00204-010-0544-6
   Sirignano E, 2013, BIOORG MED CHEM LETT, V23, P3458, DOI 10.1016/j.bmcl.2013.03.059
   Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589
   Tan SJ, 2010, FUTURE MED CHEM, V2, P1591, DOI 10.4155/FMC.10.234
   Vittorio O, 2012, PHARM RES-DORDR, V29, P2601, DOI 10.1007/s11095-012-0790-9
   Wayakanon K, 2013, FASEB J, V27, P4455, DOI 10.1096/fj.12-225219
NR 54
TC 2
Z9 3
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JAN 30
PY 2017
VL 517
IS 1-2
BP 395
EP 402
DI 10.1016/j.ijpharm.2016.12.039
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EI8RL
UT WOS:000392775100043
PM 28007546
DA 2018-10-20
ER

PT J
AU Garcia-Caballero, M
   Van de Velde, MV
   Blacher, S
   Lambert, V
   Balsat, C
   Erpicum, C
   Durre, T
   Kridelka, F
   Noel, A
AF Garcia-Caballero, Melissa
   Van de Velde, Maureen
   Blacher, Silvia
   Lambert, Vincent
   Balsat, Cedric
   Erpicum, Charlotte
   Durre, Tania
   Kridelka, Frederic
   Noel, Agnes
TI Modeling pre-metastatic lymphvascular niche in the mouse ear sponge
   assay
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LYMPHATIC ENDOTHELIAL-CELLS; IN-VIVO; TUMOR LYMPHANGIOGENESIS; CORNEAL
   LYMPHANGIOGENESIS; MELANOMA METASTASIS; CANCER METASTASIS; VEGF-C;
   ANGIOGENESIS; NODE; MICROPARTICLES
AB Lymphangiogenesis, the formation of new lymphatic vessels, occurs in primary tumors and in draining lymph nodes leading to pre-metastatic niche formation. Reliable in vivo models are becoming instrumental for investigating alterations occurring in lymph nodes before tumor cell arrival. In this study, we demonstrate that B16F10 melanoma cell encapsulation in a biomaterial, and implantation in the mouse ear, prevents their rapid lymphatic spread observed when cells are directly injected in the ear. Vascular remodeling in lymph nodes was detected two weeks after sponge implantation, while their colonization by tumor cells occurred two weeks later. In this model, a huge lymphangiogenic response was induced in primary tumors and in pre-metastatic and metastatic lymph nodes. In control lymph nodes, lymphatic vessels were confined to the cortex. In contrast, an enlargement and expansion of lymphatic vessels towards paracortical and medullar areas occurred in pre-metastatic lymph nodes. We designed an original computerized-assisted quantification method to examine the lymphatic vessel structure and the spatial distribution. This new reliable and accurate model is suitable for in vivo studies of lymphangiogenesis, holds promise for unraveling the mechanisms underlying lymphatic metastases and pre-metastatic niche formation in lymph nodes, and will provide new tools for drug testing.
C1 [Garcia-Caballero, Melissa; Van de Velde, Maureen; Blacher, Silvia; Lambert, Vincent; Balsat, Cedric; Erpicum, Charlotte; Durre, Tania; Kridelka, Frederic; Noel, Agnes] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, B-4000 Liege, Belgium.
   [Kridelka, Frederic] CHU Liege, Dept Obstet & Gynecol, B-4000 Liege, Belgium.
RP Garcia-Caballero, M (reprint author), Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, B-4000 Liege, Belgium.
EM melissa.garciacaballero@ulg.ac.be
RI Garcia-Caballero, Melissa/A-6978-2018
OI Garcia-Caballero, Melissa/0000-0002-4263-5536
FU FP7-PEOPLE-IEF Marie Curie Postdoctoral Fellowship; Televie; Action de
   Recherche Concertee (ARC) (Universite de Liege) (Belgium); Fonds de la
   Recherche Scientifique-FNRS (F.R.S.-FNRS) (Belgium); Foundation against
   Cancer (foundation of public interest) (Belgium); Centre Anticancereux
   pres l'Universite de Liege (Belgium); Fonds Leon Fredericq (University
   of Liege) (Belgium); Interuniversity Attraction Poles Programme-Belgian
   Science Policy (Belgium); Plan National Cancer ("Service Public Federal"
   from Belgium)
FX This work has been supported by personal funding by FP7-PEOPLE-2013-IEF
   Marie Curie Postdoctoral Fellowship (MGC) and Televie (MVDV). Supporting
   grants from the Action de Recherche Concertee (ARC) (Universite de
   Liege), the Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS), the
   Foundation against Cancer (foundation of public interest), the Centre
   Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq
   (University of Liege), the Interuniversity Attraction Poles
   Programme-Belgian Science Policy (all from Belgium) and the Plan
   National Cancer ("Service Public Federal" from Belgium). We acknowledge
   animal platform of the GIGA (University of Liege). The authors are
   indebted to Emilie Feyereisen, Isabelle Dasoul, Nathalie Lefin and Marie
   Dehuy for their excellent technical assistance.
CR Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545
   ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755
   Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003
   Balsat C, 2014, MODERN PATHOL, V27, P887, DOI 10.1038/modpathol.2013.195
   Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005
   Bobek V, 2010, ANTICANCER RES, V30, P4799
   Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359
   Card CM, 2014, J CLIN INVEST, V124, P943, DOI [10.1172/JC173316, 10.1172/JCI73316]
   Chen L, 2011, J SURG ONCOL, V103, P475, DOI 10.1002/jso.21794
   Coso S, 2014, BLOOD, V123, P2614, DOI 10.1182/blood-2013-12-297317
   Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3
   De Vlieghere E, 2015, BIOMATERIALS, V54, P148, DOI 10.1016/j.biomaterials.2015.03.012
   Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856
   Dieterich LC, 2016, ADV DRUG DELIVER REV, V99, P148, DOI 10.1016/j.addr.2015.12.011
   Eklund L, 2013, MOL ONCOL, V7, P259, DOI 10.1016/j.molonc.2013.02.007
   Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238
   Goren A, 2010, FASEB J, V24, P22, DOI 10.1096/fj.09-131888
   Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761
   Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758
   Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y
   KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2
   Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606
   Karpanen T, 2011, METHOD CELL BIOL, V105, P223, DOI 10.1016/B978-0-12-381320-6.00009-6
   Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776
   KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633
   Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96
   Lee E, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.2
   Lenoir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092715
   Liersch R, 2012, INT J ONCOL, V41, P2073, DOI 10.3892/ijo.2012.1665
   Ma MZ, 2012, WORLD J GASTROENTERO, V18, P257, DOI [10.3748/wjg.v18.i3.257, 10.3748/wjg.v17.i3.257]
   Maertens L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106976
   Marsden CG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-10
   Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x
   Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.2755/jcmm010.003.01
   Ny A, 2013, BIOL OPEN, V2, P882, DOI 10.1242/bio.20134739
   Olszewski WL, 2012, LYMPHAT RES BIOL, V10, P112, DOI 10.1089/lrb.2012.0008
   Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420
   PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472
   Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002
   Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008
   Roma AA, 2006, MODERN PATHOL, V19, P392, DOI 10.1038/modpathol.3800546
   Sleeman JP, 2015, J MOL MED, V93, P1173, DOI 10.1007/s00109-015-1351-6
   Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55
   Soille P., 1999, MORPHOGICAL IMAGE AN
   Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677
   Ursini-Siegel J, 2016, CANCER LETT, V380, P281, DOI 10.1016/j.canlet.2015.11.009
   Wang WC, 2015, MOL NUTR FOOD RES, V59, P2345, DOI 10.1002/mnfr.201500399
   Wu PZ, 2016, EXP THER MED, V12, P2201, DOI 10.3892/etm.2016.3573
   Zhang YW, 2014, TUMOR BIOL, V35, P10905, DOI 10.1007/s13277-014-2408-9
NR 49
TC 1
Z9 1
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 27
PY 2017
VL 7
AR 41494
DI 10.1038/srep41494
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EJ4DA
UT WOS:000393165100001
PM 28128294
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shah, BS
   Chen, M
   Suzuki, T
   Embree, M
   Kong, K
   Lee, CH
   He, L
   Xiang, LS
   Ahn, JA
   Ding, S
   Mao, JJ
AF Shah, Bhranti S.
   Chen, Mo
   Suzuki, Takahiro
   Embree, Mildred
   Kong, Kimi
   Lee, Chang H.
   He, Ling
   Xiang, Lusai
   Ahn, Jeffrey A.
   Ding, Sheng
   Mao, Jeremy J.
TI Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous
   Cells
SO Scientific Reports
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ACTIVATED-RECEPTOR-GAMMA; HUMAN BONE-MARROW;
   ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION;
   STROMAL CELLS; PPAR-GAMMA; IN-VITRO; MEDIATED PHOSPHORYLATION
AB Focal adipose deficiency, such as lipoatrophy, lumpectomy or facial trauma, is a formidable challenge in reconstructive medicine, and yet scarcely investigated in experimental studies. Here, we report that Pyrintegrin (Ptn), a 2,4-disubstituted pyrimidine known to promote embryonic stem cells survival, is robustly adipogenic and induces postnatal adipose tissue formation in vivo of transplanted adipose stem/progenitor cells (ASCs) and recruited endogenous cells. In vitro, Ptn stimulated human adipose tissue derived ASCs to differentiate into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPAR gamma) and CCAAT/enhancer-binding protein-alpha (C/EBP alpha), with differentiated cells increasingly secreting adiponectin, leptin, glycerol and total triglycerides. Ptn-primed human ASCs seeded in 3D-bioprinted biomaterial scaffolds yielded newly formed adipose tissue that expressed human PPAR gamma, when transplanted into the dorsum of athymic mice. Remarkably, Ptn-adsorbed 3D scaffolds implanted in the inguinal fat pad had enhanced adipose tissue formation, suggesting Ptn's ability to induce in situ adipogenesis of endogenous cells. Ptn promoted adipogenesis by upregulating PPAR gamma and C/EBP alpha not only in adipogenesis induction medium, but also in chemically defined medium specifically for osteogenesis, and concurrently attenuated Runx2 and Osx via BMP-mediated SMAD1/5 phosphorylation. These findings suggest Ptn's novel role as an adipogenesis inducer with a therapeutic potential in soft tissue reconstruction and augmentation.
C1 [Shah, Bhranti S.; Chen, Mo; Suzuki, Takahiro; Embree, Mildred; Kong, Kimi; Lee, Chang H.; He, Ling; Xiang, Lusai; Ahn, Jeffrey A.; Mao, Jeremy J.] Columbia Univ Med Ctr, Med Ctr, Ctr Craniofacial Regenerat, 630 W 168 St PH7E, New York, NY 10032 USA.
   [Shah, Bhranti S.; Mao, Jeremy J.] Columbia Univ, Dept Biomed Engn, 500W 120th St,Mudd 510, New York, NY 10027 USA.
   [He, Ling; Xiang, Lusai; Mao, Jeremy J.] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, 56 Lingyuanxi Rd, Guangzhou 510055, Guangdong, Peoples R China.
   [Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, 505 Parnassus Ave, San Francisco, CA 94122 USA.
RP Mao, JJ (reprint author), Columbia Univ Med Ctr, Med Ctr, Ctr Craniofacial Regenerat, 630 W 168 St PH7E, New York, NY 10032 USA.; Mao, JJ (reprint author), Columbia Univ, Dept Biomed Engn, 500W 120th St,Mudd 510, New York, NY 10027 USA.; Mao, JJ (reprint author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, 56 Lingyuanxi Rd, Guangzhou 510055, Guangdong, Peoples R China.
EM jmao@columbia.edu
FU NIH [R01DE023112, R01DE025643, R01AR065023]; Guangdong Pioneer Grant
   [52000-3210002]; Guangdong Science and Technology Program
   [2016B030229003]
FX We thank P. Ralph-Birkett, Q. Guo and A. Tse for administrative and
   technical assistance. This study was supported by NIH grants
   R01DE023112, R01DE025643 and R01AR065023 and Guangdong Pioneer Grant
   (52000-3210002) and Guangdong Science and Technology Program
   (2016B030229003).
CR Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Bunnell Bruce A., 2008, V456, P155, DOI 10.1007/978-1-59745-245-8_12
   CALVO JC, 1991, J BIOL CHEM, V266, P11237
   CHAPMAN AB, 1985, J CELL BIOL, V101, P1227, DOI 10.1083/jcb.101.4.1227
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]
   Contador D, 2015, EXP BIOL MED, V240, P1235, DOI 10.1177/1535370214566565
   Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015
   Gregoire FM, 1998, PHYSIOL REV, V78, P783
   Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4
   Hammer-Hansen N, 2015, PLAST SURG INT, V2015
   Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7
   Hong L, 2006, CELLS TISSUES ORGANS, V183, P133, DOI 10.1159/000095987
   HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856
   Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100
   Hu L, 2015, STEM CELLS, V33, P2483, DOI 10.1002/stem.2052
   Huang SH, 2015, INT J MED SCI, V12, P154, DOI 10.7150/ijms.9964
   Hung SH, 2008, LIFE SCI, V82, P561, DOI 10.1016/j.lfs.2007.11.033
   Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   KAWAI K, 1985, J BONE JOINT SURG AM, V67A, P755, DOI 10.2106/00004623-198567050-00010
   Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800
   Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376
   Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7
   Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI81589, 10.1172/JCI84508]
   Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696
   Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee SY, 2014, CELL PHYSIOL BIOCHEM, V34, P1339, DOI 10.1159/000366341
   Li J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.348
   LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757
   Lu WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149543
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Moioli EK, 2010, TISSUE ENG PT A, V16, P3299, DOI [10.1089/ten.tea.2010.0157, 10.1089/ten.TEA.2010.0157]
   Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002
   Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490
   Patel JJ, 2014, CELL BIOCHEM FUNCT, V32, P368, DOI 10.1002/cbf.3025
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611
   Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Savopoulos C, 2011, HIPPOKRATIA, V15, P18
   Song B, 2009, CYTOKINE GROWTH F R, V20, P379, DOI 10.1016/j.cytogfr.2009.10.010
   Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723
   Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7
   Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com
   Takabe K, 2003, HEPATOLOGY, V38, P1107, DOI 10.1053/jhep.2003.50483
   TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5
   TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224
   Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019
   van de Vyver M, 2014, J ENDOCRINOL, V223, P119, DOI 10.1530/JOE-14-0425
   Vashi AV, 2008, BIOMATERIALS, V29, P573, DOI 10.1016/j.biomaterials.2007.10.017
   Wagner ER, 2015, TISSUE ENG PT A, V21, P2703, DOI [10.1089/ten.tea.2015.0183, 10.1089/ten.TEA.2015.0183]
   Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010
   Wang Dongqing, 2011, Biomed Sci Instrum, V47, P213
   Wang LN, 2013, ACTA BIOMATER, V9, P8921, DOI 10.1016/j.actbio.2013.06.035
   WEBER PSD, 1992, P SOC EXP BIOL MED, V201, P47
   Xiao YL, 2010, J TISSUE ENG REGEN M, V4, P374, DOI 10.1002/term.250
   Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107
   Yang Q, 2015, MOL CELL, V57, P721, DOI 10.1016/j.molcel.2015.01.004
   Yazawa M, 2015, J BIOMED MATER RES B, V103, P92, DOI 10.1002/jbm.b.33180
   Yuasa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116462
   Zhang H, 2011, CURR MOL MED, V11, P489, DOI 10.2174/156652411796268704
NR 67
TC 3
Z9 3
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 27
PY 2017
VL 7
AR 36402
DI 10.1038/srep36402
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI8ZO
UT WOS:000392797000001
PM 28128224
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU You, XF
   Yang, SW
   Li, JP
   Deng, Y
   Dai, LQ
   Peng, X
   Huang, HG
   Sun, J
   Wang, G
   He, P
   Ding, GQ
   Xie, XM
AF You, Xiaofei
   Yang, Siwei
   Li, Jipeng
   Deng, Yuan
   Dai, Lianqi
   Peng, Xiong
   Huang, Haoguang
   Sun, Jing
   Wang, Gang
   He, Peng
   Ding, Guqiao
   Xie, Xiaoming
TI Green and Mild Oxidation: An Efficient Strategy toward Water-Dispersible
   Graphene
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE graphene; dispersibility; reduced graphene oxide; hydroxyl radical;
   biomaterial
ID PROCESSABLE AQUEOUS DISPERSIONS; SOLUBLE GRAPHENE; FUNCTIONALIZED
   GRAPHENE; HYDROGEN-PEROXIDE; QUANTUM DOTS; GRAPHITE FLUORIDE;
   HIGH-QUALITY; OXIDE; EXFOLIATION; SHEETS
AB Scalable fabrication of water-dispersible graphene (W-Gr) is highly desirable yet technically challenging for most practical applications of graphene. Herein, a green and mild oxidation strategy to prepare bulk W-Gr (dispersion, slurry, and powder) with high yield was proposed by fully exploiting structure defects of thermally reduced graphene oxide (TRGO) and oxidizing: radicals generated from hydrogen peroxide (H2O2). Owing to the increased carboxyl group from the mild oxidation process, the obtained W-Gr can be redispersed in low-boiling solvents with a reasonable concentration. Benefiting from the modified surface chemistry, macroscopic samples processed from the W-Gr show good hydrophilicity (water contact angle of 55.7 degrees) and excellent biocompatibility, which is expected to be an alternative biomaterial for bone, vessel, and skin regeneration. In addition, the green and mild oxidation strategy is also proven to be effective for dispersing other carbon nanomaterials in a water system.
C1 [You, Xiaofei; Yang, Siwei; Huang, Haoguang; Sun, Jing; Wang, Gang; He, Peng; Ding, Guqiao; Xie, Xiaoming] Chinese Acad Sci, SIMIT, State Key Lab Funct Mat Informat, 865 Changning Rd, Shanghai 200050, Peoples R China.
   [You, Xiaofei; Yang, Siwei; Huang, Haoguang; He, Peng; Ding, Guqiao; Xie, Xiaoming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Li, Jipeng; Deng, Yuan] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai 200011, Peoples R China.
   [Dai, Lianqi; Peng, Xiong] Zhejiang CHINT Cable Co Ltd, Jiaxing 314006, Zhejiang, Peoples R China.
RP He, P; Ding, GQ (reprint author), Chinese Acad Sci, SIMIT, State Key Lab Funct Mat Informat, 865 Changning Rd, Shanghai 200050, Peoples R China.; He, P; Ding, GQ (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
EM hepeng@mail.sim.ac.cn; gqding@mail.sim.ac.cn
RI You, Xiaofei/R-8531-2017
OI You, Xiaofei/0000-0003-4564-5534; He, Peng/0000-0003-0606-8762
FU Chinese Academy of Sciences [KGZD-EW-303, XDA02040000]; Natural Science
   Foundation of China [81501605]; Science and Technology Commission of
   Shanghai Municipality [15YF1406800]
FX This work was supported by projects from the Chinese Academy of Sciences
   (grant nos. KGZD-EW-303 and XDA02040000), the Natural Science Foundation
   of China (grant no. 81501605), and Science and Technology Commission of
   Shanghai Municipality (grant no. 15YF1406800).
CR Cheng C, 2013, ADV MATER, V25, P13, DOI 10.1002/adma.201203567
   Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Dinesh MM, 2015, J POWER SOURCES, V276, P32, DOI 10.1016/j.jpowsour.2014.11.079
   Nguyen DD, 2012, ENERG ENVIRON SCI, V5, P7908, DOI 10.1039/c2ee21848h
   Everett D. H., 1988, BASIC PRINCIPLES COL
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gomez-Navarro C, 2010, NANO LETT, V10, P1144, DOI 10.1021/nl9031617
   He P, 2015, CHEM COMMUN, V51, P4651, DOI 10.1039/c5cc00059a
   He P, 2015, CHEM MATER, V27, P218, DOI 10.1021/cm503782p
   Huang H, 2012, J MATER CHEM, V22, P10452, DOI 10.1039/c2jm00092j
   Ishibashi K, 2000, ELECTROCHEM COMMUN, V2, P207, DOI 10.1016/S1388-2481(00)00006-0
   KITAJIMA N, 1978, J PHYS CHEM-US, V82, P1505, DOI 10.1021/j100502a009
   Korkut S, 2011, ACS NANO, V5, P5214, DOI 10.1021/nn2013723
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Li JH, 2015, J MATER CHEM B, V3, P1544, DOI 10.1039/c4tb01510j
   Li XB, 2014, CARBON, V78, P38, DOI 10.1016/j.carbon.2014.06.034
   Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y
   Liang XQ, 2014, MATER LETT, V135, P92, DOI 10.1016/j.matlet.2014.07.119
   Liao F, 2015, J MATER CHEM A, V3, P7568, DOI 10.1039/c5ta00675a
   Liu CY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03965
   Liu F, 2012, ADV MATER, V24, P1089, DOI 10.1002/adma.201104691
   Long J, 2011, J MATER CHEM, V21, P10421, DOI 10.1039/c0jm04564k
   Lotya M, 2010, ACS NANO, V4, P3155, DOI 10.1021/nn1005304
   McEvoy N, 2013, CARBON, V54, P283, DOI 10.1016/j.carbon.2012.11.040
   Mhamane D, 2011, GREEN CHEM, V13, P1990, DOI 10.1039/c1gc15393e
   Park S, 2008, CHEM MATER, V20, P6592, DOI 10.1021/cm801932u
   Park YJ, 2011, J IND ENG CHEM, V17, P298, DOI 10.1016/j.jiec.2011.02.027
   Parviz D, 2012, ACS NANO, V6, P8857, DOI 10.1021/nn302784m
   Pei SF, 2012, CARBON, V50, P3210, DOI 10.1016/j.carbon.2011.11.010
   Piera J, 2008, ANGEW CHEM INT EDIT, V47, P3506, DOI 10.1002/anie.200700604
   Qian W, 2009, NANO RES, V2, P706, DOI 10.1007/s12274-009-9074-z
   Ramadoss A, 2015, NANO ENERGY, V15, P587, DOI 10.1016/j.nanoen.2015.05.009
   Rubio N, 2015, ACS APPL MATER INTER, V7, P18920, DOI 10.1021/acsami.5b06250
   Shen JF, 2009, CHEM MATER, V21, P3514, DOI 10.1021/cm901247t
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Storm MM, 2015, CARBON, V85, P233, DOI 10.1016/j.carbon.2014.12.104
   Su CL, 2013, ACCOUNTS CHEM RES, V46, P2275, DOI 10.1021/ar300118v
   Sun J, 2016, ACS APPL MATER INTER, V8, P10226, DOI 10.1021/acsami.6b02032
   Sun J, 2015, PART PART SYST CHAR, V32, P434, DOI 10.1002/ppsc.201400189
   Taherian F, 2013, LANGMUIR, V29, P1457, DOI 10.1021/la304645w
   Tian S., 2016, SCI REP, V6, P31127
   Tian SY, 2017, CARBON, V111, P617, DOI 10.1016/j.carbon.2016.10.044
   Wang SR, 2009, LANGMUIR, V25, P11078, DOI 10.1021/la901402f
   Wei N, 2014, ACS APPL MATER INTER, V6, P5877, DOI 10.1021/am500777b
   Withers F, 2014, NANO LETT, V14, P3987, DOI 10.1021/nl501355j
   Xu XJ, 2012, J MATER CHEM, V22, P22624, DOI 10.1039/c2jm34002j
   Xu ZM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06450
   Yang SW, 2015, CHEM MATER, V27, P2004, DOI 10.1021/acs.chemmater.5b00112
   Yang SW, 2014, J MATER CHEM A, V2, P8660, DOI 10.1039/c4ta00860j
   YIM MB, 1990, P NATL ACAD SCI USA, V87, P394, DOI 10.1073/pnas.87.1.394
   Zhang GX, 2016, CARBON, V96, P1022, DOI 10.1016/j.carbon.2015.10.020
   Zhang L, 2014, ACS NANO, V8, P6663, DOI 10.1021/nn502289w
   Zhang YW, 2012, J MATER CHEM, V22, P13064, DOI 10.1039/c2jm32231e
   Zhao GX, 2011, ADV MATER, V23, P3959, DOI 10.1002/adma.201101007
   Zhou XF, 2010, CHEM COMMUN, V46, P2611, DOI 10.1039/b914412a
   Zhu C, 2015, J MATER CHEM B, V3, P6871, DOI 10.1039/c5tb01093d
   Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770
   Zu SZ, 2009, J PHYS CHEM C, V113, P13651, DOI 10.1021/jp9035887
NR 60
TC 4
Z9 4
U1 8
U2 81
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JAN 25
PY 2017
VL 9
IS 3
BP 2856
EP 2866
DI 10.1021/acsami.6b13703
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EJ0OP
UT WOS:000392909500097
PM 28029764
DA 2018-10-20
ER

PT J
AU Hui, N
   Sun, XT
   Niu, SY
   Luo, XL
AF Hui, Ni
   Sun, Xiaotian
   Niu, Shuyan
   Luo, Xiliang
TI PEGylated Polyaniline Nanofibers: Antifouling and Conducting Biomaterial
   for Electrochemical DNA Sensing
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE polyaniline; polyethylene glycol; antifouling; nonspecific adsorption;
   biosensor
ID CANCER SUSCEPTIBILITY GENE; LABEL-FREE; POLY(ETHYLENE GLYCOL); POLYMER
   BRUSHES; POLYETHYLENE-GLYCOL; GOLD NANOPARTICLES; PROTEIN ADSORPTION;
   GLUCOSE-OXIDASE; METHYLENE-BLUE; DRUG-DELIVERY
AB Biofouling arising from nonspecific adsorption is a substantial outstanding challenge in diagnostics and disease monitoring, and antifouling sensing interfaces capable of reducing the nonspecific adsorption of proteins from biological complex samples are highly desirable. We present herein the preparation of novel composite nanofibers through the grafting of polyethylene glycol (PEG) polymer onto polyaniline (PANT) nanofibers and their application in the development of antifouling electrochemical biosensors. The PEGylated PANI (PANI/PEG) nanofibers possessed large surface area and remained conductive and at the same time demonstrated excellent antifouling performances in single protein solutions as well as complex human serum samples. Sensitive and low fouling electrochemical biosensors for the breast cancer susceptibility gene (BRCA1) can be easily fabricated through the attachment of DNA probes to the PANI/PEG nanofibers. The biosensor showed a very high sensitivity to target BRCA1 with a linear range from 0.01 pM to 1 nM and was also efficient enough to detect DNA mismatches with satisfactory selectivity. Moreover, the DNA biosensor based on the PEGylated PANI nanofibers supported the quantification of BRCA1 in complex human serum, indicating great potential of this novel biomaterial for application in biosensors and bioelectronics.
C1 [Hui, Ni; Sun, Xiaotian; Niu, Shuyan; Luo, Xiliang] Qingdao Univ Sci & Technol, Key Lab Sensor Anal Tumor Marker, Minist Educ, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
RP Luo, XL (reprint author), Qingdao Univ Sci & Technol, Key Lab Sensor Anal Tumor Marker, Minist Educ, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
EM xiliangluo@qust.edu.cn
RI Luo, Xiliang/B-4764-2008
OI Luo, Xiliang/0000-0001-6075-7089
FU National Natural Science Foundation of China [21422504, 21675093];
   Taishan Scholar Program of Shandong Province of China [ts20110829];
   Natural Science Foundation of Shandong Province of China [JQ201406,
   ZR2016BM05]
FX The authors greatly acknowledge support from the National Natural
   Science Foundation of China (Grants 21422504 and 21675093), the Taishan
   Scholar Program of Shandong Province of China (Grant ts20110829), and
   the Natural Science Foundation of Shandong Province of China (Grants
   JQ201406 and ZR2016BM05).
CR Bai SL, 2015, SMALL, V11, P306, DOI 10.1002/smll.201401865
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Brahim S, 2002, BIOSENS BIOELECTRON, V17, P973, DOI 10.1016/S0956-5663(02)00089-1
   Briand E, 2006, BIOSENS BIOELECTRON, V22, P440, DOI 10.1016/j.bios.2006.05.018
   Bryan T, 2012, CHEM SCI, V3, P3468, DOI 10.1039/c2sc21221h
   Chen LG, 2016, CHEM RES TOXICOL, V29, P1020, DOI 10.1021/acs.chemrestox.6b00074
   Chen M, 2016, BIOSENS BIOELECTRON, V85, P684, DOI 10.1016/j.bios.2016.05.051
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Danelian E, 2000, J MED CHEM, V43, P2083, DOI 10.1021/jm991156g
   del Pino P, 2016, ANGEW CHEM INT EDIT, V55, P5483, DOI 10.1002/anie.201511733
   Devi R, 2011, BIOCHEM ENG J, V58-59, P148, DOI 10.1016/j.bej.2011.09.008
   Dey A, 2012, J MATER CHEM, V22, P14763, DOI 10.1039/c2jm31663c
   Elshafey R, 2015, BIOSENS BIOELECTRON, V68, P295, DOI 10.1016/j.bios.2015.01.002
   Emilsson G, 2015, ACS APPL MATER INTER, V7, P7505, DOI 10.1021/acsami.5b01590
   Erdem A, 2001, ANAL CHIM ACTA, V437, P107, DOI 10.1016/S0003-2670(01)00942-4
   Fan HX, 2013, ANAL CHIM ACTA, V770, P62, DOI 10.1016/j.aca.2013.01.066
   Fan XC, 2016, J MEMBRANE SCI, V499, P56, DOI 10.1016/j.memsci.2015.10.026
   Favel BS, 2013, LANGMUIR, V29, P8355, DOI 10.1021/la400721c
   Gangopadhyay R, 2012, SENSOR ACTUAT B-CHEM, V171, P777, DOI 10.1016/j.snb.2012.05.071
   Guo QX, 2005, POLYMER, V46, P3185, DOI 10.1016/j.polymer.2005.01.092
   Hao YQ, 2014, BIOSENS BIOELECTRON, V52, P422, DOI 10.1016/j.bios.2013.09.023
   Perez JPH, 2016, TALANTA, V149, P310, DOI 10.1016/j.talanta.2015.11.053
   Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Ishikawa FN, 2009, ACS NANO, V3, P1219, DOI 10.1021/nn900086c
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Kang S, 2016, ACTA BIOMATER, V40, P70, DOI 10.1016/j.actbio.2016.03.006
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Lai GS, 2014, ANAL CHEM, V86, P1789, DOI 10.1021/ac4037119
   Lau KHA, 2012, LANGMUIR, V28, P2288, DOI 10.1021/la203905g
   Lee I, 2011, BIOSENS BIOELECTRON, V26, P3297, DOI 10.1016/j.bios.2011.01.001
   Li FY, 2015, ANAL CHEM, V87, P4806, DOI 10.1021/acs.analchem.5b00093
   Lin SH, 2011, BIOMACROMOLECULES, V12, P2573, DOI 10.1021/bm200368p
   Loo AH, 2016, ACS APPL MATER INTER, V8, P1951, DOI 10.1021/acsami.5b10160
   Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010
   Luo XL, 2007, CHEM-EUR J, V13, P2138, DOI 10.1002/chem.200601248
   Luo XL, 2014, ANAL CHEM, V86, P5553, DOI 10.1021/ac5010037
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Masson JF, 2007, ANAL CHEM, V79, P612, DOI 10.1021/ac061089f
   Matharu Z, 2007, LANGMUIR, V23, P13188, DOI 10.1021/la702123a
   Mazzotta F, 2015, ACS PHOTONICS, V2, P256, DOI 10.1021/ph500360d
   Meyerbroker N, 2013, ACS APPL MATER INTER, V5, P2641, DOI 10.1021/am400065f
   Pan D, 2007, SENSORS-BASEL, V7, P2671, DOI 10.3390/s7112671
   Reddy KR, 2009, SYNTHETIC MET, V159, P595, DOI 10.1016/j.synthmet.2008.11.030
   Ren X, 2014, ANALYST, V139, P3061, DOI 10.1039/c4an00099d
   Salomon S, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495501
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Stadler V, 2008, LANGMUIR, V24, P8151, DOI 10.1021/la800772m
   Sun QQ, 2016, ANAL CHEM, V88, P8364, DOI 10.1021/acs.analchem.6b02091
   Tian JQ, 2015, BIOSENS BIOELECTRON, V71, P1, DOI 10.1016/j.bios.2015.04.009
   Tran HD, 2009, ADV MATER, V21, P1487, DOI 10.1002/adma.200802289
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Wang L, 2014, BIOSENS BIOELECTRON, V51, P201, DOI 10.1016/j.bios.2013.07.049
   Wang N, 2013, BIOMATERIALS, V34, P888, DOI 10.1016/j.biomaterials.2012.10.049
   Wang WT, 2015, BIOSENS BIOELECTRON, V71, P51, DOI 10.1016/j.bios.2015.04.018
   Weathers A, 2015, ADV MATER, V27, P2101, DOI 10.1002/adma.201404738
   Wu ZS, 2015, ADV MATER, V27, P4054, DOI 10.1002/adma.201501643
   Xu MY, 2013, BIOSENS BIOELECTRON, V39, P21, DOI 10.1016/j.bios.2012.06.014
   Yang WR, 2002, ELECTROANAL, V14, P1299, DOI 10.1002/1521-4109(200210)14:18<1299::AID-ELAN1299>3.0.CO;2-Y
   Ye HJ, 2015, ACS APPL MATER INTER, V7, P22448, DOI 10.1021/acsami.5b06500
   Yun W, 2016, BIOSENS BIOELECTRON, V77, P421, DOI 10.1016/j.bios.2015.09.065
   Zamfir LG, 2011, SENSOR ACTUAT B-CHEM, V159, P178, DOI 10.1016/j.snb.2011.06.069
   Zhao M, 2009, J PHYS CHEM C, V113, P4987, DOI 10.1021/jp807621y
NR 65
TC 20
Z9 20
U1 24
U2 107
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JAN 25
PY 2017
VL 9
IS 3
BP 2914
EP 2923
DI 10.1021/acsami.6b11682
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EJ0OP
UT WOS:000392909500104
PM 28026927
DA 2018-10-20
ER

PT J
AU Ehtemam-Haghighi, S
   Cao, GH
   Zhang, LC
AF Ehtemam-Haghighi, Shima
   Cao, Guanghui
   Zhang, Lai-Chang
TI Nanoindentation study of mechanical properties of Ti based alloys with
   Fe and Ta additions
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Titanium alloy; Microstructure; Nanoindentation; Mechanical property
ID BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS; PHASE-STABILITY; YOUNGS
   MODULUS; ELASTIC-MODULUS; BETA; MICROSTRUCTURE; NB; HARDNESS; BEHAVIOR
AB In this work, the effect of Fe and Ta content on the microstructure and b phase stability of as-cast designed Ti-xFe-yTa (x = 8, 9, 10 wt% and y = 0, 5, 8, 9, 10 wt%) alloys was investigated. Additionally, its influence on the resulting mechanical properties including hardness (H), reduced elastic modulus (E-r), elastic recovery and wear resistance of the alloys was evaluated using nanoindentation. Microstructural studies and phase analysis showed that all alloys are comprised of body-centered cubic b and orthorhombic alpha '' phases, the proportion of which depends on their Fe and Ta contents. Nanoindentation measurements indicated that the reduced elastic modulus of the alloys decreases with increase in the Fe and Ta contents owing to increase in their beta phase proportion and its stability. It was also observed that the hardness and elastic recovery of the alloys are in the range of 3.38-5.73 GPa and 0.241-0.298, respectively, which are higher than the corresponding ones for the commonly used CP-Ti biomaterial. Additionally, their H/E-r and H-3/E-r(2) ratios are higher than those of CP-Ti suggesting a better wear resistance of the designed Ti-Fe-Ta alloys. It is concluded that among the studied alloys, Ti-10Fe-10Ta with dominant beta phase microstructure exhibits a good combination of mechanical properties which make it more desirable than CP-Ti for orthopedic application. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ehtemam-Haghighi, Shima; Zhang, Lai-Chang] Edith Cowan Univ, Sch Engn, 270 Joondalup Dr, Perth, WA 6027, Australia.
   [Cao, Guanghui] Shanghai Univ, Shanghai Key Lab Modern Met & Mat Proc, Dept Mat Engn, 149 Yanchang Rd, Shanghai 200072, Peoples R China.
RP Ehtemam-Haghighi, S; Zhang, LC (reprint author), Edith Cowan Univ, Sch Engn, 270 Joondalup Dr, Perth, WA 6027, Australia.
EM sehtemam@our.ecu.edu.au; l.zhang@ecu.edu.au
RI Zhang, Lai-Chang/B-9769-2011
OI Zhang, Lai-Chang/0000-0003-0661-2051; Ehtemam-Haghighi,
   Shima/0000-0002-1667-6625
CR Ahmed M, 2015, ACTA MATER, V84, P124, DOI 10.1016/j.actamat.2014.10.043
   Bao YW, 2004, ACTA MATER, V52, P5397, DOI 10.1016/j.actamat.2004.08.002
   Carter CB, 2007, CERAMIC MAT SCI ENG
   Dimic I, 2016, MATER DESIGN, V91, P340, DOI 10.1016/j.matdes.2015.11.088
   Ehtemam-Haghighi S, 2016, MATER DESIGN, V111, P592, DOI 10.1016/j.matdes.2016.09.029
   Ehtemam-Haghighi S, 2016, MATER DESIGN, V97, P279, DOI 10.1016/j.matdes.2016.02.094
   Ehtemam-Haghighi S, 2016, MAT SCI ENG C-MATER, V60, P503, DOI 10.1016/j.msec.2015.11.072
   Fornell J, 2011, J MECH BEHAV BIOMED, V4, P1709, DOI 10.1016/j.jmbbm.2011.05.028
   Gabriel SB, 2012, J ALLOY COMPD, V536, pS208, DOI 10.1016/j.jallcom.2011.11.035
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Haghighi SE, 2015, MATER DESIGN, V76, P47, DOI 10.1016/j.matdes.2015.03.028
   Haghighi SE, 2010, J ALLOY COMPD, V503, P375, DOI 10.1016/j.jallcom.2010.03.150
   Haghighi SE, 2010, J ALLOY COMPD, V495, P260, DOI 10.1016/j.jallcom.2010.01.145
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   Hsu HC, 2013, MAT SCI ENG A-STRUCT, V568, P1, DOI 10.1016/j.msea.2013.01.002
   Hynowska A, 2013, MATERIALS, V6, P4930, DOI 10.3390/ma6114930
   Hynowska A, 2012, MAT SCI ENG C-MATER, V32, P2418, DOI 10.1016/j.msec.2012.07.016
   Kent D, 2013, J MECH BEHAV BIOMED, V28, P15, DOI 10.1016/j.jmbbm.2013.07.007
   Faria ACL, 2011, J MECH BEHAV BIOMED, V4, P1873, DOI 10.1016/j.jmbbm.2011.06.004
   Li CL, 2013, J ALLOY COMPD, V549, P152, DOI 10.1016/j.jallcom.2012.08.065
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Li YH, 2015, MATER DESIGN, V85, P7, DOI 10.1016/j.matdes.2015.06.176
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Liu YJ, 2016, ACTA MATER, V113, P56, DOI 10.1016/j.actamat.2016.04.029
   Majumdar P, 2011, J MECH BEHAV BIOMED, V4, P1132, DOI 10.1016/j.jmbbm.2011.03.023
   Mareci D, 2013, EUR J SCI THEOL, V9, P189
   Masanta M, 2011, MAT SCI ENG A-STRUCT, V528, P5327, DOI 10.1016/j.msea.2011.03.057
   Medeiros BB, 2015, J NON-CRYST SOLIDS, V425, P103, DOI 10.1016/j.jnoncrysol.2015.05.035
   Min XH, 2010, MAT SCI ENG A-STRUCT, V527, P2693, DOI 10.1016/j.msea.2009.12.050
   Morinaga M., 1988, 6 WORLD C TIT, VIII, P1601
   Musil J, 2002, SURF COAT TECH, V154, P304, DOI 10.1016/S0257-8972(01)01714-5
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Ozmetin AE, 2015, J ALLOY COMPD, V619, P262, DOI 10.1016/j.jallcom.2014.09.015
   Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003
   Pellicer E, 2011, MATER CHEM PHYS, V130, P1380, DOI 10.1016/j.matchemphys.2011.09.032
   Sattler K. D., 2010, HDB NANOPHYSICFUNC
   Wang P, 2015, MAT SCI ENG C-MATER, V51, P148, DOI 10.1016/j.msec.2015.02.028
   Xu J, 2014, CERAM INT, V40, P8621, DOI 10.1016/j.ceramint.2014.01.079
   Xu W, 2006, SCRIPTA MATER, V54, P1943, DOI 10.1016/j.scriptamat.2006.02.002
   Yang HW, 2009, J NON-CRYST SOLIDS, V355, P235, DOI 10.1016/j.jnoncrysol.2008.12.001
   Zhang LC, 2016, ADV ENG MATER, V18, P463, DOI 10.1002/adem.201500419
   Zhang P, 2011, MAT SCI ENG A-STRUCT, V529, P62, DOI 10.1016/j.msea.2011.08.061
   Zhang S., 2010, NANOSTRUCTURED THIN
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 48
TC 27
Z9 27
U1 3
U2 50
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD JAN 25
PY 2017
VL 692
BP 892
EP 897
DI 10.1016/j.jallcom.2016.09.123
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA DZ9WH
UT WOS:000386231200116
DA 2018-10-20
ER

PT J
AU Liang, YK
   Li, LQ
   Scott, RA
   Kiick, KL
AF Liang, Yingkai
   Li, Linqing
   Scott, Rebecca A.
   Kiick, Kristi L.
TI 50th Anniversary Perspective: Polymeric Biomaterials: Diverse Functions
   Enabled by Advances in Macromolecular Chemistry
SO MACROMOLECULES
LA English
DT Article
ID ELASTIN-LIKE POLYPEPTIDES; THIOL-MICHAEL ADDITION; STEM-CELL FATE;
   TISSUE ENGINEERING APPLICATIONS; PHOTOCLICK REACTION STRATEGY;
   SPYTAG-SPYCATCHER CHEMISTRY; HYALURONIC-ACID HYDROGELS; RESILIN-LIKE
   POLYPEPTIDE; CIRCULATING TUMOR-CELLS; BIOMEDICAL APPLICATIONS
AB Biomaterials have been extensively used to leverage beneficial outcomes in various therapeutic applications, such as providing spatial and temporal control over the release of therapeutic agents in drug delivery as well as engineering functional tissues and promoting the healing process in tissue engineering and regenerative medicine. This Perspective presents important milestones in the development of polymeric biomaterials with defined structures and properties. Contemporary studies of biomaterial design have been reviewed with focus on constructing materials with controlled structure, dynamic functionality, and biological complexity. Examples of these polymeric biomaterials enabled by advanced synthetic methodologies, dynamic chemistry/assembly strategies, and modulated cell material interactions have been highlighted. As the field of polymeric biomaterials continues to evolve with increased sophistication, current challenges and future directions for the design and translation of these materials are also summarized.
C1 [Liang, Yingkai; Li, Linqing; Scott, Rebecca A.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Kiick, Kristi L.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.
   [Scott, Rebecca A.] Nemours Alfred I duPont Hosp Children, Dept Biomed Res, 1600 Rockland Rd, Wilmington, DE 19803 USA.
   [Kiick, Kristi L.] Delaware Biotechnol Inst, 15 Innovat Way, Newark, DE 19711 USA.
   [Liang, Yingkai] Merck & Co Inc, Discovery Pharmaceut Sci, Merck Res Labs, Kenilworth, NJ 07033 USA.
   [Li, Linqing] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Li, Linqing] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Kiick, KL (reprint author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.; Kiick, KL (reprint author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.; Kiick, KL (reprint author), Delaware Biotechnol Inst, 15 Innovat Way, Newark, DE 19711 USA.
EM kiick@udel.edu
OI Li, Linqing/0000-0003-3003-9902
FU University of Delaware Research Foundation; Nemours Foundation; National
   Science Foundation [DGE-0221651, DMR-0907478, CBET-1159466]; National
   Institutes of Health [R01-EB003172-01, R01-DC011377A, R01-HL108110,
   F32-HL127983]; Delaware COBRE program; Delaware INBRE program; National
   Institute of General Medical Sciences-NIGMS from the National Institutes
   of Health [1 P30 GM110758-01, 1 P20 GM103541, 5 P20 RR016472-10]
FX Related work in the authors' laboratories was supported by University of
   Delaware Research Foundation, the Nemours Foundation, the National
   Science Foundation (DGE-0221651, DMR-0907478, CBET-1159466), the
   National Institutes of Health (R01-EB003172-01, R01-DC011377A,
   R01-HL108110, F32-HL127983), and the Delaware COBRE and INBRE programs,
   with grants from the National Institute of General Medical
   Sciences-NIGMS (1 P30 GM110758-01; 1 P20 GM103541; 5 P20 RR016472-10)
   from the National Institutes of Health. The contents of this manuscript
   are solely the responsibility of the authors and do not necessarily
   represent the official views of the funding agencies.
CR Adzima BJ, 2011, NAT CHEM, V3, P256, DOI 10.1038/NCHEM.980
   Aghaei-Ghareh-Bolagh B, 2016, CURR OPIN BIOTECH, V39, P56, DOI 10.1016/j.copbio.2015.12.020
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Al-Ahmady ZS, 2012, ACS NANO, V6, P9335, DOI 10.1021/nn302148p
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Alzahrani AA, 2014, POLYM CHEM-UK, V5, P1874, DOI 10.1039/c3py01064c
   Amiram M, 2011, NAT MATER, V10, P141, DOI [10.1038/nmat2942, 10.1038/NMAT2942]
   Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Baldwin AD, 2013, POLYM CHEM-UK, V4, P133, DOI 10.1039/c2py20576a
   Baldwin AD, 2011, BIOCONJUGATE CHEM, V22, P1946, DOI 10.1021/bc200148v
   Balog ERM, 2016, ACS BIOMATER SCI ENG, V2, P1135, DOI 10.1021/acsbiomaterials.6b00137
   Balu R, 2014, ACTA BIOMATER, V10, P4768, DOI 10.1016/j.actbio.2014.07.030
   Bao CY, 2015, ADV MATER, V27, P1647, DOI 10.1002/adma.201403783
   Bole AL, 2016, ADV MATER, V28, P5349, DOI 10.1002/adma.201503962
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Broyer RM, 2011, CHEM COMMUN, V47, P2212, DOI 10.1039/c0cc04062b
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Cai L, 2015, ADV FUNCT MATER, V25, P1344, DOI 10.1002/adfm.201403631
   Cai L, 2014, ACTA BIOMATER, V10, P1751, DOI 10.1016/j.actbio.2013.12.028
   Callahan DJ, 2012, NANO LETT, V12, P2165, DOI 10.1021/nl300630c
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]
   Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Cobo I, 2015, NAT MATER, V14, P143, DOI [10.1038/NMAT4106, 10.1038/nmat4106]
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Delplace V, 2015, NAT CHEM, V7, P771, DOI [10.1038/NCHEM.2343, 10.1038/nchem.2343]
   Deming TJ, 2016, CHEM REV, V116, P786, DOI 10.1021/acs.chemrev.5b00292
   deRonde BM, 2015, BIOPOLYMERS, V104, P265, DOI 10.1002/bip.22658
   Despanie J, 2016, J CONTROL RELEASE, V240, P93, DOI 10.1016/j.jconrel.2015.11.010
   Dinjaski N, 2016, CURR OPIN BIOTECH, V39, P1, DOI 10.1016/j.copbio.2015.11.002
   Dooling LJ, 2016, ADV MATER, V28, P4651, DOI 10.1002/adma.201506216
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Dutta NK, 2011, ANGEW CHEM INT EDIT, V50, P4428, DOI 10.1002/anie.201007920
   Dutta NK, 2009, BIOMATERIALS, V30, P4868, DOI 10.1016/j.biomaterials.2009.06.019
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engelis NG, 2017, NAT CHEM, V9, P171, DOI [10.1038/nchem.2634, 10.1038/NCHEM.2634]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2015, ADV DRUG DELIVER REV, V91, P141, DOI 10.1016/j.addr.2015.05.016
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fomina N, 2011, MACROMOLECULES, V44, P8590, DOI 10.1021/ma201850q
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Foster AA, 2015, ADV HEALTHC MATER, V4, P760, DOI 10.1002/adhm.201400671
   Freudenberg U, 2016, ADV MATER, V28, P8861, DOI 10.1002/adma.201601908
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Gao WW, 2010, MOL PHARMACEUT, V7, P1913, DOI 10.1021/mp100253e
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   Girotti A, 2015, ADV HEALTHC MATER, V4, P2423, DOI 10.1002/adhm.201500152
   Glassman MJ, 2013, ADV FUNCT MATER, V23, P1182, DOI 10.1002/adfm.201202034
   Gody G, 2016, J AM CHEM SOC, V138, P4061, DOI 10.1021/jacs.5b11831
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gong T, 2013, ADV MATER, V25, P2024, DOI 10.1002/adma.201203815
   Green MD, 2014, POLYM CHEM-UK, V5, P5535, DOI [10.1039/C4PY00638K, 10.1039/c4py00638k]
   Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s
   Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w
   Gustafson JA, 2013, BIOMACROMOLECULES, V14, P618, DOI 10.1021/bm3013692
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hassouneh W, 2013, BIOMACROMOLECULES, V14, P2347, DOI 10.1021/bm400464s
   Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a
   Haugh MG, 2016, CURR OPIN SOLID ST M, V20, P171, DOI 10.1016/j.cossms.2016.04.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t
   Hotaling NA, 2015, ANNU REV BIOMED ENG, V17, P317, DOI 10.1146/annurev-bioeng-071813-104814
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Jee JA, 2015, CHEM COMMUN, V51, P5456, DOI 10.1039/c4cc10091c
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kharkar PM, 2015, POLYM CHEM-UK, V6, P5565, DOI 10.1039/c5py00750j
   Kharkar PM, 2014, J MATER CHEM B, V2, P5511, DOI 10.1039/c4tb00496e
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kiick KL, 2007, POLYM REV, V47, P1, DOI 10.1080/15583720601109545
   Kim SH, 2010, MACROMOL RAPID COMM, V31, P1231, DOI 10.1002/marc.201000130
   Kim Y, 2014, BIOMATER SCI-UK, V2, P1110, DOI 10.1039/c3bm60333d
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kramer JR, 2015, ACS MACRO LETT, V4, P1283, DOI 10.1021/acsmacrolett.5b00651
   Kramer JR, 2014, POLYM CHEM-UK, V5, P671, DOI 10.1039/c3py01081c
   Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u
   Kuo-Haller P, 2010, MOL PHARMACEUT, V7, P1585, DOI 10.1021/mp100009e
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lau HK, 2017, ACS BIOMATER SCI ENG, V3, P757, DOI 10.1021/acsbiomaterials.6b00076
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Li LQ, 2016, BIOMATERIALS, V108, P91, DOI 10.1016/j.biomaterials.2016.08.054
   Li LQ, 2016, ADV HEALTHC MATER, V5, P266, DOI 10.1002/adhm.201500411
   Li LQ, 2015, MACROMOL RAPID COMM, V36, P90, DOI 10.1002/marc.201400521
   Li LQ, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00021
   Li L, 2013, ACS MACRO LETT, V2, P635, DOI 10.1021/mz4002194
   Li LQ, 2013, SOFT MATTER, V9, P665, DOI 10.1039/c2sm26812d
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Li LQ, 2010, POLYM CHEM-UK, V1, P1160, DOI 10.1039/b9py00346k
   Li Y, 2013, CURR OPIN CHEM BIOL, V17, P968, DOI 10.1016/j.cbpa.2013.10.018
   Liang YK, 2016, BIOMACROMOLECULES, V17, P601, DOI 10.1021/acs.biomac.5b01541
   Liang YK, 2016, J BIOMED MATER RES A, V104, P113, DOI 10.1002/jbm.a.35545
   Liang YK, 2014, ACTA BIOMATER, V10, P1588, DOI 10.1016/j.actbio.2013.07.031
   Liang YK, 2014, POLYM CHEM-UK, V5, P1728, DOI 10.1039/c3py01269g
   Lilly JL, 2016, LANGMUIR, V32, P5681, DOI 10.1021/acs.langmuir.6b01146
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Liu B, 2010, J AM CHEM SOC, V132, P13630, DOI 10.1021/ja1054669
   Liu S, 2015, ADV MATER, V27, P2783, DOI 10.1002/adma.201500360
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Lorenzo MM, 2016, MACROMOLECULES, V49, P30, DOI 10.1021/acs.macromol.5b02323
   Luo TZ, 2015, J AM CHEM SOC, V137, P15362, DOI 10.1021/jacs.5b09941
   Luo TZ, 2013, EUR POLYM J, V49, P2998, DOI 10.1016/j.eurpolymj.2013.05.013
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lux CD, 2012, ACS MACRO LETT, V1, P922, DOI 10.1021/mz3002403
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2012, BIOTECHNOL BIOENG, V109, P2947, DOI 10.1002/bit.24565
   Ma YR, 2016, BIOMACROMOLECULES, V17, P1486, DOI 10.1021/acs.biomac.6b00088
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   MacEwan SR, 2012, NANO LETT, V12, P3322, DOI 10.1021/nl301529p
   Madkour AE, 2010, MACROMOLECULES, V43, P4557, DOI 10.1021/ma100330u
   Madl CM, 2016, ADV FUNCT MATER, V26, P3612, DOI 10.1002/adfm.201505329
   Mahadevaiah S, 2015, BIOMATERIALS, V62, P24, DOI 10.1016/j.biomaterials.2015.05.021
   Maitz M. F., 2015, BIOSURF BIOTRIBOL, V1, P161, DOI DOI 10.1016/J.BSBT.2015.08.002
   Maitz MF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3168
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   Marine JE, 2015, CHEM COMMUN, V51, P14314, DOI 10.1039/c5cc05468k
   Marquardt Laura M, 2016, Curr Stem Cell Rep, V2, P207, DOI 10.1007/s40778-016-0058-0
   Matyjaszewski K, 2005, PROG POLYM SCI, V30, P858, DOI 10.1016/j.progpolymsci.2005.06.004
   McDaniel JR, 2014, NANO LETT, V14, P2890, DOI 10.1021/nl5009376
   McDaniel JR, 2013, BIOMACROMOLECULES, V14, P2866, DOI 10.1021/bm4007166
   McGann CL, 2016, BIOMACROMOLECULES, V17, P128, DOI 10.1021/acs.biomac.5b01255
   McGann CL, 2013, MACROMOL CHEM PHYS, V214, P203, DOI 10.1002/macp.201200412
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956
   Miranda-Nieves D, 2017, ACS BIOMATER SCI ENG, V3, P694, DOI 10.1021/acsbiomaterials.6b00250
   Miyata T, 2006, P NATL ACAD SCI USA, V103, P1190, DOI 10.1073/pnas.0506786103
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Mohammed JS, 2009, ADV MATER, V21, P2361, DOI 10.1002/adma.200803785
   Mora-Solano C, 2014, J MATER CHEM B, V2, P2409, DOI 10.1039/c3tb21549k
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Myung JH, 2012, POLYM CHEM-UK, V3, P2336, DOI 10.1039/c2py20420g
   Navon Y, 2016, BIOMACROMOLECULES, V17, P262, DOI 10.1021/acs.biomac.5b01371
   Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Norris SCP, 2016, ACS BIOMATER SCI ENG, V2, P1309, DOI 10.1021/acsbiomaterials.6b00237
   Olsen BD, 2010, MACROMOLECULES, V43, P9094, DOI 10.1021/ma101434a
   Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293
   Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a
   Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075
   Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a
   Perez CMR, 2014, CHEM COMMUN, V50, P8174, DOI 10.1039/c4cc03171g
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Qu ZY, 2015, ACS APPL MATER INTER, V7, P14537, DOI 10.1021/acsami.5b02912
   Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/NMAT4418, 10.1038/nmat4418]
   Ravikrishnan A, 2016, ACS APPL MATER INTER, V8, P17915, DOI 10.1021/acsami.6b05646
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Renner JN, 2012, BIOMACROMOLECULES, V13, P3678, DOI 10.1021/bm301129b
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rikkou MD, 2011, PROG POLYM SCI, V36, P1079, DOI 10.1016/j.progpolymsci.2011.01.004
   Robinson KG, 2012, J BIOMED MATER RES A, V100A, P1356, DOI 10.1002/jbm.a.34075
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   Romero G, 2015, ACS APPL MATER INTER, V7, P17598, DOI 10.1021/acsami.5b06298
   Rosales AM, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.12
   Rosales AM, 2015, BIOMACROMOLECULES, V16, P798, DOI 10.1021/bm501710e
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Schultz KM, 2015, P NATL ACAD SCI USA, V112, pE3757, DOI 10.1073/pnas.1511304112
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shah AM, 2012, ANAL CHEM, V84, P3682, DOI 10.1021/ac300190j
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shih H, 2016, BIOMACROMOLECULES, V17, P3872, DOI 10.1021/acs.biomac.6b00931
   Siegwart DJ, 2012, PROG POLYM SCI, V37, P18, DOI 10.1016/j.progpolymsci.2011.08.001
   Siegwart DJ, 2011, P NATL ACAD SCI USA, V108, P12996, DOI 10.1073/pnas.1106379108
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Srokowski EM, 2013, J MATER SCI-MATER M, V24, P71, DOI 10.1007/s10856-012-4772-6
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Steg H., 2015, J MATER SCI-MATER M, V26, P1
   Steinhilber D, 2013, ANGEW CHEM INT EDIT, V52, P13538, DOI 10.1002/anie.201308005
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092
   Sun F, 2014, P NATL ACAD SCI USA, V111, P11269, DOI 10.1073/pnas.1401291111
   Sun T, 2014, ANAL CHEM, V86, P977, DOI 10.1021/ac403777g
   Tang NC, 2016, NAT MATER, V15, P419, DOI [10.1038/NMAT4521, 10.1038/nmat4521]
   Tang W, 2014, CHEM SOC REV, V43, P7013, DOI 10.1039/c4cs00139g
   Teeuwen RLM, 2009, CHEM COMMUN, P4022, DOI 10.1039/b903903a
   Tong ZX, 2013, TISSUE ENG PT A, V19, P1862, DOI [10.1089/ten.tea.2012.0694, 10.1089/ten.TEA.2012.0694]
   Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j
   Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI DOI 10.1155/2013/972913
   Trimble SP, 1997, BIOCONJUGATE CHEM, V8, P416, DOI 10.1021/bc970037h
   Trudeau KM, 2016, J CELL BIOL, V214, P25, DOI 10.1083/jcb.201511042
   van Dijk M, 2010, BIOMACROMOLECULES, V11, P1608, DOI 10.1021/bm1002637
   van Eldijk MB, 2016, SMALL, V12, P2476, DOI 10.1002/smll.201503889
   van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j
   Viger ML, 2013, ADV MATER, V25, P3733, DOI 10.1002/adma.201300902
   Vishwakarma A, 2016, TRENDS BIOTECHNOL, V34, P470, DOI 10.1016/j.tibtech.2016.03.009
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wang HY, 2015, ADV MATER, V27, P3717, DOI 10.1002/adma.201501558
   Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077
   Wang W, 2014, J CONTROL RELEASE, V191, P4, DOI 10.1016/j.jconrel.2014.04.028
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Xi WX, 2014, MACROMOLECULES, V47, P6159, DOI 10.1021/ma501366f
   Xi WX, 2013, CHEM COMMUN, V49, P4504, DOI 10.1039/c3cc41123k
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yan B, 2011, J AM CHEM SOC, V133, P19714, DOI 10.1021/ja209793b
   Yang C, 2016, P NATL ACAD SCI USA, V113, pE4439, DOI 10.1073/pnas.1609731113
   Yu Q, 2016, NANOSCALE, V8, P680, DOI 10.1039/c5nr07107k
   Zhang H, 2014, ACS MACRO LETT, V3, P727, DOI 10.1021/mz5002993
   Zhang SS, 2015, ACS BIOMATER SCI ENG, V1, P705, DOI 10.1021/acsbiomaterials.5b00153
   Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124
   Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452
   Zhang XP, 2016, ACS MACRO LETT, V5, P229, DOI 10.1021/acsmacrolett.5b00923
   Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037
   Zhou HX, 2013, ANGEW CHEM INT EDIT, V52, P2235, DOI 10.1002/anie.201207966
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zhu YJ, 2015, CHEM-ASIAN J, V10, P284, DOI 10.1002/asia.201402715
   Zisch A. H., 2003, FASEB J
NR 238
TC 9
Z9 9
U1 10
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD JAN 24
PY 2017
VL 50
IS 2
BP 483
EP 502
DI 10.1021/acs.macromol.6b02389
PG 20
WC Polymer Science
SC Polymer Science
GA EJ0GS
UT WOS:000392887200001
PM 29151616
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gong, ZN
   Cheng, HY
   Zhang, M
   Liu, X
   Zeng, Y
   Xiang, KW
   Xu, Y
   Wang, YW
   Zhu, ZH
AF Gong, Zheni
   Cheng, Haoyan
   Zhang, Meng
   Liu, Xi
   Zeng, Yan
   Xiang, Kaiwen
   Xu, Yuan
   Wang, Yinwei
   Zhu, Zhihong
TI Osteogenic activity and angiogenesis of a SrTiO3 nano- gridding
   structure on titanium surface
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID BIOACTIVE GLASS SCAFFOLDS; BETA-TRICALCIUM PHOSPHATE; MESENCHYMAL
   STEM-CELLS; IN-VITRO; BIOMEDICAL APPLICATIONS; TOPOGRAPHICAL TITANIUM;
   STRONTIUM RANELATE; BONE-FORMATION; HYDROXYAPATITE COATINGS;
   HYDROTHERMAL SYNTHESIS
AB Osteogenesis and angiogenesis have been considered to be the most direct and necessary requirements for Ti-based implants used in bone regeneration. In this study, an alveolate double-layered SrTiO3 nanogridding (NG-Sr) was obtained using two steps of anodization followed by a hydrothermal process. Different Sr gradient contents (NG-Sr0.02, NG-Sr0.04, NG-Sr0.08, NG-Sr0.12 and NG-Sr0.16) were generated by altering the precursor solution concentrations. The in vitro studies indicated that NG-Sr samples with nanoscale topography and long-lasting Sr release could enhance the biofunction of both osteoblast-like cells (MC3T3-E1 cells) and human umbilical vein endothelial cells (HUVECs) to varying degrees. The NG-Sr0.08 was the optimal substrate for MC3T3-E1 cell growth, while the NG-Sr0.04 was the best choice for HUVEC growth. In vivo X-ray analysis and histological observations demonstrated that the NG-Sr0.08 samples had notable osteogenesis and angiogenesis, as significant new bone formation and fresh blood vessels were observed. Hence, the nanoscale topography with sufficient Sr supplementation offers a new independent regulator of two types of cell growth, which should be considered in biomaterial design for regenerative medicine.
C1 [Gong, Zheni; Cheng, Haoyan; Zhang, Meng; Liu, Xi; Xu, Yuan; Wang, Yinwei; Zhu, Zhihong] Cent China Normal Univ, Coll Phys Sci & Technol, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
   [Zeng, Yan] Cent China Normal Univ, Coll Chem, Wuhan 430079, Peoples R China.
   [Xiang, Kaiwen] Cent China Normal Univ, Hosp Cent China Normal Univ, Wuhan 430079, Peoples R China.
RP Zhu, ZH (reprint author), Cent China Normal Univ, Coll Phys Sci & Technol, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
EM zhzhu@phy.ccnu.edu.cn
FU National Natural Science Foundation of China [50802032]; Key Project of
   Natural Science Foundation of Hubei Province [2011CDA092]; Key
   Scientific Project of Wuhan City [2013011801010598]; Scientific Project
   of AQSIQ [2013IK093]; self-determined research funds of CCNU from the
   colleges' basic research and operation of MOE [CCNU15A02035]; plan of
   preeminent doctoral dissertation [2015YBYB013]
FX This work was supported by the National Natural Science Foundation of
   China (No. 50802032), the Key Project of Natural Science Foundation of
   Hubei Province (No. 2011CDA092), the Key Scientific Project of Wuhan
   City (No. 2013011801010598), the Scientific Project of AQSIQ (No.
   2013IK093), self-determined research funds of CCNU from the colleges'
   basic research and operation of MOE (No. CCNU15A02035) and plan of
   preeminent doctoral dissertation (2015YBYB013).
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bakker AD, 2013, BONE, V53, P112, DOI 10.1016/j.bone.2012.11.044
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Bornapour M, 2016, MAT SCI ENG C-MATER, V67, P72, DOI 10.1016/j.msec.2016.04.108
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Chen Y, 2015, ACTA BIOMATER, V11, P435, DOI 10.1016/j.actbio.2014.09.028
   Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249
   Cheng H, 2016, ACTA BIOMATER, V31, P388, DOI 10.1016/j.actbio.2015.11.046
   Cheng HY, 2015, BIOMATER SCI-UK, V3, P665, DOI 10.1039/c4bm00263f
   Cheng HY, 2015, RSC ADV, V5, P14470, DOI 10.1039/c4ra17058j
   Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   Eckert JO, 1996, J AM CERAM SOC, V79, P2929, DOI 10.1111/j.1151-2916.1996.tb08728.x
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gruenewald TA, 2016, ACTA BIOMATER, V31, P448, DOI 10.1016/j.actbio.2015.11.049
   Jang HL, 2016, ADV HEALTHC MATER, V5, P128, DOI 10.1002/adhm.201400824
   Jin Z, 2016, ACS APPL MATER INTER, V8, P5273, DOI 10.1021/acsami.5b11259
   Kaur G, 2010, BIOMATERIALS, V31, P5813, DOI 10.1016/j.biomaterials.2010.04.017
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Li JY, 2016, ACTA BIOMATER, V36, P254, DOI 10.1016/j.actbio.2016.03.011
   Li Y, 2016, BBA-GEN SUBJECTS, V1860, P2137, DOI 10.1016/j.bbagen.2016.05.031
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Lin KL, 2013, CHEM ENG J, V222, P49, DOI 10.1016/j.cej.2013.02.037
   Liu WJ, 2015, ACTA BIOMATER, V21, P217, DOI 10.1016/j.actbio.2015.04.012
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu YT, 2014, J MATER CHEM B, V2, P7927, DOI 10.1039/c4tb00822g
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lu J., 2006, MATER RES SOC S P, V591
   Lu YC, 2015, ACTA BIOMATER, V20, P147, DOI 10.1016/j.actbio.2015.03.034
   Lu ZS, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/21/215102
   Luo XM, 2015, ACTA BIOMATER, V26, P331, DOI 10.1016/j.actbio.2015.07.044
   Mehrali M, 2014, ACS APPL MATER INTER, V6, P3947, DOI 10.1021/am500845x
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Neve A, 2013, REGUL PEPTIDES, V184, P81, DOI 10.1016/j.regpep.2013.03.014
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peng SL, 2010, J ORTHOP RES, V28, P1208, DOI 10.1002/jor.21127
   Qiao YQ, 2014, BIOMATERIALS, V35, P6882, DOI 10.1016/j.biomaterials.2014.04.101
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Rzhepishevska O, 2013, BIOMATER SCI-UK, V1, P589, DOI 10.1039/c3bm00197k
   Schunck A, 2016, ACTA BIOMATER, V31, P412, DOI 10.1016/j.actbio.2015.11.044
   Shi MC, 2016, ACTA BIOMATER, V30, P334, DOI 10.1016/j.actbio.2015.11.033
   Shruti S, 2016, APPL SURF SCI, V378, P216, DOI 10.1016/j.apsusc.2016.03.209
   Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25
   Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wang Y, 2015, ACS APPL MATER INTER, V7, P16018, DOI 10.1021/acsami.5b04304
   Wen J, 2015, J MATER CHEM B, V3, P4790, DOI 10.1039/c5tb00128e
   Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675
   Xu K, 2016, J MATER CHEM B, V4, P4549, DOI 10.1039/c6tb00724d
   Xu K, 2016, J MATER CHEM B, V4, P1797, DOI 10.1039/c5tb02391b
   Xu X., 2014, PLOS ONE, V9
   Yamaguchi S, 2014, ACTA BIOMATER, V10, P2282, DOI 10.1016/j.actbio.2014.01.026
   Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646
   Zhang JH, 2014, ACTA BIOMATER, V10, P2269, DOI 10.1016/j.actbio.2014.01.001
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhang WJ, 2016, NANOSCALE, V8, P5291, DOI 10.1039/c5nr08580b
   Zhang WJ, 2016, ACTA BIOMATER, V33, P290, DOI 10.1016/j.actbio.2016.01.042
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
   Zhao SC, 2015, BIOMATERIALS, V53, P379, DOI 10.1016/j.biomaterials.2015.02.112
   Zhao SC, 2015, ACTA BIOMATER, V12, P270, DOI 10.1016/j.actbio.2014.10.015
NR 66
TC 6
Z9 6
U1 11
U2 53
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD JAN 21
PY 2017
VL 5
IS 3
BP 537
EP 552
DI 10.1039/c6tb02329k
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA EL2DZ
UT WOS:000394431600018
DA 2018-10-20
ER

PT J
AU Wang, GF
   Roohani-Esfahani, SI
   Zhang, WJ
   Lv, KG
   Yang, GZ
   Ding, X
   Zou, DR
   Cui, DX
   Zreiqat, H
   Jiang, XQ
AF Wang, Guifang
   Roohani-Esfahani, Seyed-Iman
   Zhang, Wenjie
   Lv, Kaige
   Yang, Guangzheng
   Ding, Xun
   Zou, Derong
   Cui, Daxiang
   Zreiqat, Hala
   Jiang, Xinquan
TI Effects of Sr-HT-Gahnite on osteogenesis and angiogenesis by adipose
   derived stem cells for critical-sized calvarial defect repair
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SILICATE BIOACTIVE CERAMICS; VEIN ENDOTHELIAL-CELLS; TISSUE-ENGINEERED
   BONE; MAXILLARY SINUS FLOOR; MARROW STROMAL CELLS; CALCIUM SILICATE;
   BIOLOGICAL-PROPERTIES; PHOSPHATE SCAFFOLD; GROWTH-FACTORS; IN-VITRO
AB Tissue engineering strategies to construct vascularized bone grafts are now attracting much attention. Strontium-hardystonite-Gahnite (Sr-HT-Gahnite) is a strong, highly porous, and biocompatible calcium silicate based bio-ceramic that contains strontium and zinc ions. Adipose derived stem cells (ASCs) have been demonstrated to have the ability in promoting osteogenesis and angiogenesis. In this study, the effects of Sr-HT-Gahnite on cell morphology, cell proliferation, and osteogenic differentiation of ASCs were systematically investigated. The cell proliferation, migration and angiogenic differentiation of human umbilical vein endothelial cell (HUVECs) were studied. Beta-tricalcium phosphate/hydroxyapatite (TCP/HA) bioceramic scaffolds were set as the control biomaterial. Both bio-ceramics exhibited no adverse influence on cell viability. The Sr-HT-Gahnite scaffolds promoted cell attachment and alkaline phosphatase (ALP) activity of ASCs. The Sr-HT-Gahnite dissolution products enhanced ALP activity, matrix mineralization, and angiogenic differentiation of ASCs. They could also improve cell proliferation, migration, and angiogenic differentiation of HUVECs. Levels of in vivo bone formation with Sr-HT Gahnite were significantly higher than that for TCP/HA. The combination of Sr-HT-Gahnite and ASCs promoted both osteogenesis and angiogenesis in vivo study, compared to Sr-HT-Gahnite and TCP/HA bio-ceramics when administered alone, suggesting Sr-HT-Gahnite can act as a carrier for ASCs for construction of vascularized tissue-engineered bone.
C1 [Wang, Guifang; Zhang, Wenjie; Lv, Kaige; Ding, Xun; Jiang, Xinquan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Wang, Guifang; Zhang, Wenjie; Lv, Kaige; Yang, Guangzheng; Ding, Xun; Jiang, Xinquan] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Res Inst Stomatol, Oral Bioengn Lab,Peoples Hosp 9,Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Roohani-Esfahani, Seyed-Iman; Zreiqat, Hala] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Zou, Derong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Stomatol, 600 Yishan Rd, Shanghai 200233, Peoples R China.
   [Cui, Daxiang] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn,Collaborat Innovat Ctr Sy, Key Lab Thin Film & Microfabricat Technol,Natl Ct, Minist Educ,Dept Instrument Sci & Engn,Sch Elect, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
RP Jiang, XQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Jiang, XQ (reprint author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Res Inst Stomatol, Oral Bioengn Lab,Peoples Hosp 9,Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Zreiqat, H (reprint author), Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
EM hala.zreiqat@sydney.edu.au; xinquanj@aliyun.com
OI Roohani, Iman/0000-0001-6618-8577
FU National Key Research and Development Program of China [2016YFC1102900];
   Outstanding academic leaders of Shanghai, China [15XD1502500]; National
   Natural Science Foundation of China [81430012]; Shanghai Summit &
   Plateau Disciplines
FX This work was jointly supported by the National Key Research and
   Development Program of China (2016YFC1102900), Outstanding academic
   leaders of Shanghai, China (15XD1502500), Key Program of National
   Natural Science Foundation of China (81430012) and the Shanghai Summit &
   Plateau Disciplines. We acknowledge the assistance in manuscript
   preparation provided by A/Prof Colin R Dunstan. The authors acknowledge
   the Australia National Health and Medical Research Council, Australian
   Research Council, and the Rebecca Cooper Foundation.
CR Buschmann J, 2012, INJURY, V43, P1689, DOI 10.1016/j.injury.2012.06.004
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Fielding G, 2013, ACTA BIOMATER, V9, P9137, DOI 10.1016/j.actbio.2013.07.009
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Jin YQ, 2014, TISSUE ENG PT A, V20, P3303, DOI [10.1089/ten.tea.2013.0556, 10.1089/ten.TEA.2013.0556]
   Kang YQ, 2013, ACTA BIOMATER, V9, P4906, DOI 10.1016/j.actbio.2012.08.008
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Kim Beom-Su, 2015, Biomater Res, V19, P18, DOI 10.1186/s40824-015-0040-4
   Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]
   Murohara T, 2009, CURR PHARM DESIGN, V15, P2784, DOI 10.2174/138161209788923796
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Nardone V., 2015, STEM CELLS INT, V2015, DOI DOI 10.1155/2015/871863
   Nardone V, 2012, INT J BIOMATER, V2012
   Overman JR, 2013, BIOCHIMIE, V95, P2304, DOI 10.1016/j.biochi.2013.08.034
   Park YJ, 2008, VASC PHARMACOL, V49, P32, DOI 10.1016/j.vph.2008.05.001
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rohringer S, 2014, ANGIOGENESIS, V17, P921, DOI 10.1007/s10456-014-9439-0
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Roohani-Esfahani SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19468
   Roohani-Esfahani SI, 2011, MATER LETT, V65, P2578, DOI 10.1016/j.matlet.2011.06.019
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006
   Shi MC, 2015, ACTA BIOMATER, V21, P178, DOI 10.1016/j.actbio.2015.04.019
   Wang C, 2013, BIOMATERIALS, V34, P64, DOI 10.1016/j.biomaterials.2012.09.021
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu L, 2007, MOL CELL BIOCHEM, V301, P83, DOI 10.1007/s11010-006-9399-9
   Wu QJ, 2014, J MATER CHEM B, V2, P6738, DOI 10.1039/c4tb00923a
   Xia LG, 2014, BIOMATERIALS, V35, P8514, DOI 10.1016/j.biomaterials.2014.06.028
   Xia LG, 2013, J MATER CHEM B, V1, P5403, DOI 10.1039/c3tb20945h
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Zeng DL, 2012, TISSUE ENG PT A, V18, P871, DOI [10.1089/ten.TEA.2011.0379, 10.1089/ten.tea.2011.0379]
   Zhang HX, 2016, MAT SCI ENG C-MATER, V60, P298, DOI 10.1016/j.msec.2015.11.055
   Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581
   Zhang WJ, 2016, NANOSCALE, V8, P5291, DOI 10.1039/c5nr08580b
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhi W, 2014, J BIOMED MATER RES A, V102, P2491, DOI 10.1002/jbm.a.34919
   Zhou YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129605
   Zhu YF, 2013, ACTA BIOMATER, V9, P6723, DOI 10.1016/j.actbio.2013.01.021
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 44
TC 7
Z9 8
U1 4
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 20
PY 2017
VL 7
AR 41135
DI 10.1038/srep41135
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI2VJ
UT WOS:000392346200001
PM 28106165
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sarma, SJ
   Ayadi, M
   Brar, SK
   Berry, R
AF Sarma, Saurabh Jyoti
   Ayadi, Mariem
   Brar, Satinder Kaur
   Berry, Richard
TI Sustainable commercial nanocrystalline cellulose manufacturing process
   with acid recycling
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Acid hydrolysis; Nanocrystalline cellulose; Activated carbon; Sugar
   removal
ID GRANULAR ACTIVATED CARBON; SURFACE FUNCTIONAL-GROUPS; SOLID-STATE NMR;
   MOLECULAR-STRUCTURE; AQUEOUS-SOLUTIONS; ADSORPTION; REMOVAL; BAGASSE;
   HUMINS; WASTE
AB Nanocrystalline cellulose (NCC) is a biomaterial having potential applications in a wide range of industries. It is industrially produced by concentrated acid hydrolysis of cellulosic materials. In this process, the sulfuric acid rich liquor can be concentrated and reused. However, removal of sugar monomers and oligomers is necessary for such recycling. Membrane and ion exchange technology can be employed to remove sugars; however, such technologies are not efficient in meeting the quality required to recycle the acid solution. As a part of the present study, activated carbon (AC) has been evaluated as an adsorbent for sugar removal from the acidic solution generated during commercial nanocrystalline cellulose manufacturing process. Almost complete removal of sugar can be achieved by this approach. The maximum sugar removal observed during this study was 3.4 g/g of AC. Based on this finding, a sustainable method has been proposed for commercial nanocrystalline cellulose manufacturing. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Sarma, Saurabh Jyoti; Brar, Satinder Kaur] INRS, Ctr Eau Terre & Environm, 490 Couronne, Quebec City, PQ G1K 9A9, Canada.
   [Ayadi, Mariem] Natl Engn Sch Tunis, Lab Mat Optimizat & Energy Sustainabil, BP 37 Le Belvedere, Tunis 1002, Tunisia.
   [Berry, Richard] CelluForce, 625 President Kennedy Ave,Off 1501, Montreal, PQ H3A 1K2, Canada.
RP Brar, SK (reprint author), INRS, Ctr Eau Terre & Environm, 490 Couronne, Quebec City, PQ G1K 9A9, Canada.
EM satinder.brar@ete.inrs.ca
FU NSERC CRD; Prima-Quebec
FX NSERC CRD and Prima-Quebec have been acknowledged for financial support.
   Contributions of technical staff of INRS involved in sample analysis
   have been acknowledged. CelluForce is acknowledged for providing the
   waste acid stream samples.
CR Attia AA, 2010, BRAZ J CHEM ENG, V27, P183, DOI 10.1590/S0104-66322010000100016
   Brinchi L, 2013, CARBOHYD POLYM, V94, P154, DOI 10.1016/j.carbpol.2013.01.033
   BUDINOVA TK, 1994, J CHEM TECHNOL BIOT, V60, P177, DOI 10.1002/jctb.280600210
   Carpenter AW, 2015, ENVIRON SCI TECHNOL, V49, P5277, DOI 10.1021/es506351r
   Chandrasekaran T., 2013, IJIRI, V1, P26
   Chen CX, 2012, BIORESOURCES, V7, P5109
   Chiang YC, 2001, CARBON, V39, P523, DOI 10.1016/S0008-6223(00)00161-5
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   De Ridder D. J., 2012, THESIS
   Herzfeld J, 2011, J PHYS CHEM B, V115, P5741, DOI 10.1021/jp1119662
   Hu JY, 2015, J ENVIRON MANAGE, V160, P98, DOI 10.1016/j.jenvman.2015.06.011
   Huang MC, 2002, AICHE J, V48, P1804, DOI 10.1002/aic.690480820
   Jorfi M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41719
   Khalkhali RA, 2005, POL J ENVIRON STUD, V14, P185
   Li YH, 2003, FUEL, V82, P451, DOI 10.1016/S0016-2361(02)00307-1
   Ma Y, 2013, FRONT ENV SCI ENG, V7, P158, DOI 10.1007/s11783-012-0479-7
   Martens DA, 2002, SOIL BIOL BIOCHEM, V34, P1393, DOI 10.1016/S0038-0717(02)00082-2
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   Moreno-Castilla C, 2004, CARBON, V42, P83, DOI 10.1016/j.carbon.2003.09.022
   Patravale V, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818195
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Qing Q, 2013, AQUEOUS PRETREATMENT, P391
   Qing WX, 2016, APPL SURF SCI, V366, P404, DOI 10.1016/j.apsusc.2016.01.133
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Ruhl AS, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1877-1
   Saad ME, 2014, ARAB J CHEM, V7, P109, DOI 10.1016/j.arabjc.2013.11.002
   Shokri J., 2013, CELLULOSE MED PHARMA
   Tansel B, 2004, ADV ENVIRON RES, V8, P411, DOI 10.1016/S1093-0191(02)00126-0
   Teka T., 2014, INT J INNOV SCI RES, V8, P106
   Tessmer CH, 1997, ENVIRON SCI TECHNOL, V31, P1872, DOI 10.1021/es960474r
   van Zandvoort I, 2015, GREEN CHEM, V17, P4383, DOI 10.1039/c5gc00327j
   van Zandvoort I, 2013, CHEMSUSCHEM, V6, P1745, DOI 10.1002/cssc.201300332
   Yan H, 2011, COLLOID SURFACE A, V380, P143, DOI 10.1016/j.colsurfa.2011.02.045
NR 33
TC 3
Z9 3
U1 4
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 20
PY 2017
VL 156
BP 26
EP 33
DI 10.1016/j.carbpol.2016.09.009
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA EC4OA
UT WOS:000388110900004
PM 27842822
DA 2018-10-20
ER

PT J
AU Liu, XB
   Souzandeh, H
   Zheng, YD
   Xie, YJ
   Zhong, WH
   Wang, C
AF Liu, Xiaobing
   Souzandeh, Harnid
   Zheng, Yudong
   Xie, Yajie
   Zhong, Wei-Hong
   Wang, Cai
TI Soy protein isolate/bacterial cellulose composite membranes for high
   efficiency particulate air filtration
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bio-material; Biocomposite film; Soy protein; Cellulose; Filtration
   mechanism
ID MICROBIAL CELLULOSE; MECHANICAL-PROPERTIES; BACTERIAL CELLULOSE;
   NANOPARTICLES; IMPROVEMENT; NANOFIBERS; ISOLATE; FILTERS; FILMS
AB Particulate matter (PM) and toxic chemical pollutants are pervasive in the air. However, conventional petroleum-based and chemically synthesized polymers providing commercial air filters are not eco-friendly materials and can cause secondary environmental pollution. To address this serious issue, developing an environmentally friendly and multi-functional air filtering material is in critical need. In this study, soy protein isolate (SPI) and bacterial cellulose (BC) are employed to study the potential of biomaterials as high efficiency air filtering materials. Soy protein isolate contains many functional groups on its structure and these functional groups were exposed for interactions with pollutants via denaturation process using acrylic acid treatment. The 3D nano-network of BC contributes to the preliminary physical capturing of PM particles, while the functional groups of SPI further attract the PM particles via electrostatic attraction and dipole interaction between the filter materials and the PM particles. It is found that the resulting SPI/BC composite with the appropriately modified SPI possesses extremely high removal efficiencies for particulate pollutants with a broad range of sizes: 99.94% and 99.95% for PM2.5 removal efficiency and Ph-10, respectively, under extremely hazardous air conditions, while maintaining a very high air penetration rate of 92.63%. The mechanism responsible for this high filtration performance of the SPI/BC composite material is analyzed. These study results reveal that functional structures of the biomaterial provide a huge potential for applications in green multi-functional air filters. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Liu, Xiaobing; Zheng, Yudong; Xie, Yajie; Wang, Cai] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Biomed Mat Res Ctr, Beijing 100083, Peoples R China.
   [Souzandeh, Harnid; Zhong, Wei-Hong] Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
RP Zheng, YD (reprint author), Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Biomed Mat Res Ctr, Beijing 100083, Peoples R China.
EM zhengyudong@mater.ustb.edu.cn
FU National Natural Science Foundation of China Project [51473019]; Beijing
   Municipal Science and Technology Plan projects [Z161100000116003]
FX This study is financially supported by the National Natural Science
   Foundation of China Project (Grant number 51473019), Beijing Municipal
   Science and Technology Plan projects (No. Z161100000116003).
CR Cheng B., 2014, LEATHER SCI TECHNOL, V24
   Chien KB, 2012, ACTA BIOMATER, V8, P694, DOI 10.1016/j.actbio.2011.09.036
   Cho D, 2013, POLYMER, V54, P2364, DOI 10.1016/j.polymer.2013.02.034
   Cho SY, 2007, LWT-FOOD SCI TECHNOL, V40, P418, DOI 10.1016/j.lwt.2006.02.003
   Chong L., 2015, NAT COMMUN, V6
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464485
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DAVIES CN, 1983, J AEROSOL SCI, V14, P147, DOI 10.1016/0021-8502(83)90039-3
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Gu Z., 2000, J CHIN CEREALS OILS, V15
   Harrison RM, 2000, SCI TOTAL ENVIRON, V249, P85, DOI 10.1016/S0048-9697(99)00513-6
   Hu J, 2015, CERAM INT, V41, P7080, DOI 10.1016/j.ceramint.2015.02.016
   Huang W, 2012, AM J EPIDEMIOL, V176, P117, DOI 10.1093/aje/kwr511
   Islam M. UI-, 2012, CELLULOSE, V20, P589
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Lin T.C., 2008, CLIN MOL ALLERGY, V6, P1
   Liu K, 2015, RSC ADV, V5, P87924, DOI 10.1039/c5ra15620c
   Liu R, 2012, J WUHAN UNIV TECHNOL, V27, P852, DOI 10.1007/s11595-012-0561-9
   Liu Y, 2015, FIBER POLYM, V16, P629, DOI 10.1007/s12221-015-0629-1
   Lubasova D, 2014, J NANOSCI NANOTECHNO, V14, P4891, DOI 10.1166/jnn.2014.8729
   Maricq MM, 2007, J AEROSOL SCI, V38, P1079, DOI 10.1016/j.jaerosci.2007.08.001
   Marshak DR, 1996, STRATEGIES PROTEIN P
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   Park S.H., 2015, J MEMBR SCI, V499
   Peles Z, 2012, ACTA BIOMATER, V8, P209, DOI 10.1016/j.actbio.2011.08.022
   Pollution I.A., 2014, AIR QUAL CLIM CHANGE, V48
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Raghu B., 2014, ENVIRON SCI TECHNOL, V48, P4327
   Salas C, 2014, REACT FUNCT POLYM, V85, P221, DOI 10.1016/j.reactfunctpolym.2014.09.022
   Sasmal A, 2009, INT J PLAST TECHNOL, V13, P8, DOI 10.1007/s12588-009-0003-5
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Tian HF, 2011, J FOOD ENG, V107, P21, DOI 10.1016/j.jfoodeng.2011.06.008
   Urbina L, 2016, BIODEGRADABLE COMPOS, V133
   Wang N, 2014, SEP PURIF TECHNOL, V126, P44, DOI 10.1016/j.seppur.2014.02.017
   Wang Z, 2014, FOOD HYDROCOLLOID, V35, P51, DOI 10.1016/j.foodhyd.2013.07.006
   Yun H.J., 2014, KIDNEY INT, V280, P356
   Zhang H., 2015, J CLEAN PROD, V112
   Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013
   Zhao S, 2013, MATER LETT, V95, P142, DOI 10.1016/j.matlet.2012.12.106
   Zhao Y., 2016, ACS APPL MAT INTERFA, V8
   Zhong Z., 2015, ACS APPL MAT INTERFA, V7
NR 44
TC 9
Z9 10
U1 16
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
EI 1879-1050
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JAN 18
PY 2017
VL 138
BP 124
EP 133
DI 10.1016/j.compscitech.2016.11.022
PG 10
WC Materials Science, Composites
SC Materials Science
GA EI8SP
UT WOS:000392778500015
DA 2018-10-20
ER

PT J
AU Ghezzi, CE
   Marelli, B
   Omenetto, FG
   Funderburgh, JL
   Kaplan, DL
AF Ghezzi, Chiara E.
   Marelli, Benedetto
   Omenetto, Fiorenzo G.
   Funderburgh, James L.
   Kaplan, David L.
TI 3D Functional Corneal Stromal Tissue Equivalent Based on Corneal Stromal
   Stem Cells and Multi-Layered Silk Film Architecture
SO PLOS ONE
LA English
DT Article
ID EXTRACELLULAR-MATRIX; FIBROUS PROTEINS; EPITHELIAL-CELLS; KERATAN
   SULFATE; IN-VITRO; TRANSPLANTATION; CONSTRUCTION; RECONSTRUCTION;
   BIOMATERIALS; TRANSPARENCY
AB The worldwide need for human cornea equivalents continues to grow. Few clinical options are limited to allogenic and synthetic material replacements. We hypothesized that tissue engineered human cornea systems based on mechanically robust, patterned, porous, thin, optically clear silk protein films, in combination with human corneal stromal stem cells (hCSSCs), would generate 3D functional corneal stroma tissue equivalents, in comparison to previously developed 2D approaches. Silk film contact guidance was used to control the alignment and distribution of hCSSCs on RGD-treated single porous silk films, which were then stacked in an orthogonally, multi-layered architecture and cultured for 9 weeks. These systems were compared similar systems generated with human corneal fibroblasts (hCFs). Both cell types were viable and preferentially aligned along the biomaterial patterns for up to 9 weeks in culture. H&E histological sections showed that the systems seeded with the hCSSCs displayed ECM production throughout the entire thickness of the constructs. In addition, the ECM proteins tested positive for keratocyte-specific tissue markers, including keratan sulfate, lumican, and keratocan. The quantification of hCSSC gene expression of keratocyte-tissue markers, including keratocan, lumican, human aldehyde dehydrogenase 3A1 (ALDH3A1), prostaglandin D2 synthase (PTDGS), and pyruvate dehydrogenase kinase, isozyme 4 (PDK4), within the 3D tissue systems demonstrated upregulation when compared to 2D single silk films and to the systems generated with the hCFs. Furthermore, the production of ECM from the hCSSC seeded systems and subsequent remodeling of the initial matrix significantly improved cohesiveness and mechanical performance of the constructs, while maintaining transparency after 9 weeks.
C1 [Ghezzi, Chiara E.; Marelli, Benedetto; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Ghezzi, Chiara E/0000-0002-9800-4397
FU NIH [R01 EY020856, P41 EB002520, EY016415]
FX We thank the NIH (R01 EY020856, P41 EB002520, and EY016415 (to JLF)) for
   support for this work.
CR Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013
   Akhtar S, 2011, GRAEF ARCH CLIN EXP, V249, P413, DOI 10.1007/s00417-010-1512-9
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   [Anonymous], 2013, 2013 EYE BANK STAT R
   Behlau I, 2014, ACTA OPHTHALMOL, V92, pe546, DOI 10.1111/aos.12309
   BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999
   BIRK DE, 1990, J CELL SCI, V95, P649
   BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   BRYANT MR, 1994, INVEST OPHTH VIS SCI, V35, P3022
   Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037
   Diao JM, 2015, EXP EYE RES, V132, P216, DOI 10.1016/j.exer.2015.01.015
   DONOHUE DJ, 1995, J OPT SOC AM A, V12, P1425, DOI 10.1364/JOSAA.12.001425
   Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256
   Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91
   Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951
   George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x
   Ghezzi C, 2014, TISSUE ENG B
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI DOI 10.1038/NRM1858
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Griffith M, 2014, CURR OPIN OPHTHALMOL, V25, P240, DOI 10.1097/ICU.0000000000000049
   Griffith M, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P911, DOI 10.1016/B978-0-12-381422-7.10049-5
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Jacobs J, 2005, EMEDICINE, P1
   Jester JV, 1996, CORNEA, V15, P505
   Kao WWY, 2003, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169
   Kim MJ, 2013, OPHTHALMOLOGY
   Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Levis HJ, 2013, BIOMATERIALS, V34, P8860, DOI 10.1016/j.biomaterials.2013.08.002
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luo HL, 2013, BIOMATERIALS, V34, P6748, DOI 10.1016/j.biomaterials.2013.05.045
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020
   Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539
   Phu D, 2011, TISSUE ENG PT A, V17, P799, DOI [10.1089/ten.tea.2009.0724, 10.1089/ten.TEA.2009.0724]
   Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ronge L., 1994, CORNEA, P379
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243
   Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2
   Tan XW, 2012, J MATER SCI-MATER M, V23, P1063, DOI 10.1007/s10856-012-4578-6
   Teichmann J, 2013, ACTA BIOMATER, V9, P5031, DOI 10.1016/j.actbio.2012.10.023
   Wang L, 2014, J BIOMEDICAL MAT R B
   Wilson SL, 2012, ADV FUNCT MATER, V22, P3641, DOI 10.1002/adfm.201200655
   Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.tea.2012.0545, 10.1089/ten.TEA.2012.0545]
   Wu JW, 2014, APPL MATH COMPUT, V227, P701, DOI 10.1016/j.amc.2013.11.026
NR 60
TC 8
Z9 8
U1 4
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 18
PY 2017
VL 12
IS 1
AR e0169504
DI 10.1371/journal.pone.0169504
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3HH
UT WOS:000392380100026
PM 28099503
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Alalwiat, A
   Tang, W
   Gerislioglu, S
   Becker, ML
   Wesdemiotis, C
AF Alalwiat, Ahlam
   Tang, Wen
   Gerislioglu, Selim
   Becker, Matthew L.
   Wesdemiotis, Chrys
TI Mass Spectrometry and Ion Mobility Characterization of Bioactive
   Peptide-Synthetic Polymer Conjugates
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; LASER-DESORPTION IONIZATION; COLLISION
   CROSS-SECTIONS; GAS-PHASE; ELECTROSPRAY-IONIZATION; OSTEOGENIC
   DIFFERENTIATION; PROTONATED PEPTIDES; PROTEIN COMPLEXES; MODULAR
   PEPTIDE; IN-VACUO
AB The bioconjugate BMP2-(PEO-HA)(2), composed of a dendron with two monodisperse poly(ethylene oxide) (PEO) branches terminated by a hydroxyapatite binding peptide (HA), and a focal point substituted with a bone growth stimulating peptide (BMP2), has been comprehensively characterized by mass spectrometry (MS) methods, encompassing matrix assisted laser desorption ionization (MALDI), electrospray ionization (ESI), tandem mass spectrometry (MS2), and ion mobility mass spectrometry (IM-MS). MS2 experiments using different ion activation techniques validated the sequences of the synthetic, bioactive peptides HA and BMP2, which contained highly basic amino acid residues either at the N-terminus (BMP2) or C-terminus (HA). Application of MALDI-MS, ESI-MS, and IM-MS to the polymer peptide biomaterial confirmed its composition. Collision cross-section measurements and molecular modeling indicated that BMP2-(PEO-HA)(2) exists in several folded and extended conformations, depending on the degree of protonation. Protonation of all basic sites of the hybrid material nearly doubles its conformational space and accessible surface area.
C1 [Alalwiat, Ahlam; Gerislioglu, Selim; Wesdemiotis, Chrys] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Tang, Wen; Becker, Matthew L.; Wesdemiotis, Chrys] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
RP Wesdemiotis, C (reprint author), Univ Akron, Dept Chem, Akron, OH 44325 USA.; Wesdemiotis, C (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM wesdemiotis@uakron.edu
OI Gerislioglu, Selim/0000-0003-3505-3180
FU National Science Foundation [CHE-1308307, DMR-BMAT-1507420]
FX We thank the National Science Foundation for supporting this research
   (Grants CHE-1308307 to C.W. and DMR-BMAT-1507420 to M.L.B.). We thank
   Professor Alper Buldum (The University of Akron) for valuable assistance
   in the use of the Materials Studio software.
CR Abboud JLM, 2001, EUR J ORG CHEM, P3013
   Alalwiat A, 2015, ANALYST, V140, P7550, DOI 10.1039/c5an01600b
   Anupriya, 2016, J AM SOC MASS SPECTR, V27, P1366, DOI 10.1007/s13361-016-1409-x
   BOWERS MT, 1993, SCIENCE, V260, P1446, DOI 10.1126/science.260.5113.1446
   Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i
   Brounts SH, 2013, MOL PHARMACEUT, V10, P2086, DOI 10.1021/mp300662r
   Carbeck JD, 1998, J PHYS CHEM B, V102, P10596, DOI 10.1021/jp980768u
   Clemmer DE, 1997, J MASS SPECTROM, V32, P577
   Ehrmann BM, 2008, J AM SOC MASS SPECTR, V19, P719, DOI 10.1016/j.jasms.2008.01.003
   FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315
   Ferguson PL, 2009, CURR ANAL CHEM, V5, P186, DOI 10.2174/157341109787846180
   Fiori J, 2013, EUR J MASS SPECTROM, V19, P483, DOI 10.1255/ejms.1255
   Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s
   Grewal RN, 2004, J PHYS CHEM B, V108, P4899, DOI 10.1021/jp031093k
   Hewitt D, 2014, J PHYS CHEM B, V118, P8489, DOI 10.1021/jp501950d
   Jarrold MF, 2007, PHYS CHEM CHEM PHYS, V9, P1659, DOI 10.1039/b612615d
   Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e
   Kanu AB, 2008, J MASS SPECTROM, V43, P1, DOI 10.1002/jms.1383
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   Kiselar JG, 2000, J AM SOC MASS SPECTR, V11, P746, DOI 10.1016/S1044-0305(00)00144-6
   Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940
   Lee JS, 2009, ANGEW CHEM INT EDIT, V48, P6266, DOI 10.1002/anie.200901618
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li XP, 2011, MACROMOLECULES, V44, P4555, DOI 10.1021/ma200542p
   Marklund EG, 2015, STRUCTURE, V23, P791, DOI 10.1016/j.str.2015.02.010
   Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v
   NIST Chemistry WebBook, NIST STANDARD REFERE, V69
   Owens K.G., 2010, MALDI MASS SPECTROME, P129
   Paizs B, 2005, MASS SPECTROM REV, V24, P508, DOI 10.1002/mas.20024
   Pitteri SJ, 2005, MASS SPECTROM REV, V24, P931, DOI 10.1002/mas.20048
   Policastro GM, 2016, WIRES NANOMED NANOBI, V8, P449, DOI 10.1002/wnan.1376
   Policastro GM, 2015, BIOMACROMOLECULES, V16, P1358, DOI 10.1021/acs.biomac.5b00153
   Polini A, 2014, BIOMATER SCI-UK, V2, P1779, DOI 10.1039/c4bm00164h
   Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021
   Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322
   Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Salbo R, 2012, RAPID COMMUN MASS SP, V26, P1181, DOI 10.1002/rcm.6211
   Shelimov KB, 1997, J AM CHEM SOC, V119, P2240, DOI 10.1021/ja9619059
   Sleno L, 2004, J MASS SPECTROM, V39, P1091, DOI 10.1002/jms.703
   Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107
   Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947
   Song Y, 2015, ACS CENTRAL SCI, V1, P477, DOI 10.1021/acscentsci.5b00251
   Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0
   Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101
   Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI DOI 10.1002/RCM.1290020802
   Tang W, 2013, BIOMACROMOLECULES, V14, P3304, DOI 10.1021/bm400908c
   Theory/Analysis, THEOR COLL CROSS SEC
   Vaisar T, 1996, J MASS SPECTROM, V31, P1185, DOI 10.1002/(SICI)1096-9888(199610)31:10<1185::AID-JMS396>3.0.CO;2-Q
   Valentine SJ, 1997, J AM SOC MASS SPECTR, V8, P954, DOI 10.1016/S1044-0305(97)00085-8
   Williams JP, 2009, J AM SOC MASS SPECTR, V20, P1119, DOI 10.1016/j.jasms.2009.02.016
   Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R
NR 53
TC 11
Z9 11
U1 7
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JAN 17
PY 2017
VL 89
IS 2
BP 1170
EP 1177
DI 10.1021/acs.analchem.6b03553
PG 8
WC Chemistry, Analytical
SC Chemistry
GA EI4IX
UT WOS:000392458100022
PM 27936608
DA 2018-10-20
ER

PT J
AU Adil, MM
   Rodrigues, GMC
   Kulkarni, RU
   Rao, AT
   Chernavsky, NE
   Miller, EW
   Schaffer, DV
AF Adil, Maroof M.
   Rodrigues, Gonalo M. C.
   Kulkarni, Rishikesh U.
   Rao, Antara T.
   Chernavsky, Nicole E.
   Miller, Evan W.
   Schaffer, David V.
TI Efficient generation of hPSC-derived midbrain dopaminergic neurons in a
   fully defined, scalable, 3D biomaterial platform
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; HUMAN ES CELLS; PARKINSONS-DISEASE;
   SUSPENSION-CULTURE; NEURAL DIFFERENTIATION; RAT MODEL; EXPANSION;
   PROGENITORS; TRANSPLANTATION; BEHAVIOR
AB Pluripotent stem cells (PSCs) have major potential as an unlimited source of functional cells for many biomedical applications; however, the development of cell manufacturing systems to enable this promise faces many challenges. For example, there have been major recent advances in the generation of midbrain dopaminergic (mDA) neurons from stem cells for Parkinson's Disease (PD) therapy; however, production of these cells typically involves undefined components and difficult to scale 2D culture formats. Here, we used a fully defined, 3D, thermoresponsive biomaterial platform to rapidly generate large numbers of action-potential firing mDA neurons after 25 days of differentiation (similar to 40% tyrosine hydroxylase (TH) positive, maturing into 25% cells exhibiting mDA neuron-like spiking behavior). Importantly, mDA neurons generated in 3D exhibited a 30-fold increase in viability upon implantation into rat striatum compared to neurons generated on 2D, consistent with the elevated expression of survival markers FOXA2 and EN1 in 3D. A defined, scalable, and resource-efficient cell culture platform can thus rapidly generate high quality differentiated cells, both neurons and potentially other cell types, with strong potential to accelerate both basic and translational research.
C1 [Adil, Maroof M.; Rodrigues, Gonalo M. C.; Rao, Antara T.; Chernavsky, Nicole E.; Schaffer, David V.] Univ Calif Berkeley, Dept Biomol & Chem Engn, Berkeley, CA 94720 USA.
   [Kulkarni, Rishikesh U.; Miller, Evan W.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   [Miller, Evan W.; Schaffer, David V.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.
   [Miller, Evan W.; Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Biomol & Chem Engn, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM schaffer@berkeley.edu
RI Adil, Maroof/E-6881-2017
FU California Institute for Regenerative Medicine [RT3-07800]; CIRM
   Training Grant [TG2-01164]; Fundacao para a Ciencia e a Tecnologia
   (FCT), Portugal [SFRH/BD/89374/2012]; NIH [GMT32GM066698]
FX This work was supported by the California Institute for Regenerative
   Medicine grant RT3-07800. MMA was supported in part by CIRM Training
   Grant TG2-01164. GMCR was supported by Fundacao para a Ciencia e a
   Tecnologia (FCT), Portugal (SFRH/BD/89374/2012). RUK was supported in
   part by an NIH Training Grant (GMT32GM066698). EWM thanks UC Berkeley
   Hellman Fellows Fund, Alzheimer's Association (2016-NIRG-394290), and
   the NIH.
CR Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032
   Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325
   Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501
   Arenas E, 2015, DEVELOPMENT, V142, P1918, DOI 10.1242/dev.097394
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bye CR, 2015, P NATL ACAD SCI USA, V112, pE1946, DOI 10.1073/pnas.1501989112
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chan LY, 2013, BIOMATERIALS, V34, P382, DOI 10.1016/j.biomaterials.2012.09.033
   Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007
   Chen VC, 2012, STEM CELL RES, V8, P388, DOI 10.1016/j.scr.2012.02.001
   Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895
   Grace A. A., 1995, PSYCHOPHARMACOLOGY
   GRACE AA, 1984, J NEUROSCI, V4, P2877
   GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5
   Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017
   Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328
   Hartfield EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087388
   Hegarty SV, 2013, DEV BIOL, V379, P123, DOI 10.1016/j.ydbio.2013.04.014
   Huang YL, 2015, J AM CHEM SOC, V137, P10767, DOI 10.1021/jacs.5b06644
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Keung AJ, 2012, INTEGR BIOL-UK, V4, P1049, DOI 10.1039/c2ib20083j
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim J, 2013, STEM CELL RES, V11, P978, DOI 10.1016/j.scr.2013.06.005
   Kirkeby A., 2016, CELL STEM CELL, P1, DOI DOI 10.1016/J.STEM.2016.09.004
   Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009
   Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325
   Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010
   Lee CT, 2015, CELL REP, V10, P616, DOI 10.1016/j.celrep.2014.12.050
   Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110
   Lindvall O, 2012, NAT BIOTECHNOL, V30, P56, DOI 10.1038/nbt.2077
   Liu QY, 2013, CYTOTHERAPY, V15, P999, DOI 10.1016/j.jcyt.2013.03.006
   Maria S., 2014, IMPROVED CELL THERAP, V31, P1548
   McNeish J, 2010, J BIOL CHEM, V285, P17209, DOI 10.1074/jbc.M109.098814
   Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI [10.1021/bp.110, 10.1002/btpr.110]
   Oh S., 2015, EMBO MOL MED, V7, P1, DOI DOI 10.15252/EMMM.201404610
   Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976
   Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194
   Pristera A, 2015, P NATL ACAD SCI USA, V112, pE4929, DOI 10.1073/pnas.1503911112
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sanchez-Danes A, 2012, HUM GENE THER, V23, P56, DOI 10.1089/hum.2011.054
   Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003
   Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001
   Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Veenvliet JV, 2013, DEVELOPMENT, V140, P3373, DOI 10.1242/dev.094565
   Woodford CR, 2015, J AM CHEM SOC, V137, P1817, DOI 10.1021/ja510602z
   Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318
NR 53
TC 8
Z9 8
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 16
PY 2017
VL 7
AR 40573
DI 10.1038/srep40573
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH6IU
UT WOS:000391877300001
PM 28091566
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ng, CH
   Chan, CW
   Man, HC
   Waugh, DG
   Lawrence, J
AF Ng, C. H.
   Chan, C. W.
   Man, H. C.
   Waugh, D. G.
   Lawrence, J.
TI NiTi shape memory alloy with enhanced wear performance by laser
   selective area nitriding for orthopaedic applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Shape memory alloys. NiTi; laser gas nitriding; Wear; Taguchi experiment
ID CORROSION BEHAVIOR; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; THIN-FILMS;
   SURFACE; PLASMA; RESISTANCE; MICROSTRUCTURE; UHMWPE; REPLACEMENT
AB In recent years, near-equiatomic NiTi alloy has been identified as a sound alternative to replace the conventional Ti6AI4V alloy as the next generation orthopaedic biomaterial because of its lower young modulus and unique shape memory effect. The potential problem of using NiTi alloy is the generation of Ni-rich debris when wear occurs. Surface treatment is therefore needed to improve the wear resistance in order to alleviate the impact of the wear. This paper details the surface treatment of NiTi by laser selective area nitriding for enhancing the wear resistance. This was done by a systematic two-step optimization approach: (1) selecting the appropriate set of laser parameters with an L9 Taguchi experiment to optimize the nitride properties and (2) identifying the optimized surface coverage ratio to maximize the wear resistance. The microstructure and surface profiles of the optimized nitride surface was characterized by scanning electron microscopy (SEM) and X-ray diffraction (XRD), and 3-D profile measurement, respectively. The wear resistance of nitrided surfaces with different coverage ratios were then evaluated using reciprocating wear testing against ultra-high-molecular-weight polyethylene (UHMWPE) in simulated body fluid, i.e., Hanks' solution. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ng, C. H.; Waugh, D. G.; Lawrence, J.] Univ Chester, Fac Sci & Engn, Laser Engn & Mfg Res Ctr, Parkgate Rd, Chester CH1 4BJ, Cheshire, England.
   [Chan, C. W.] Queens Univ, Sch Mech & Aerosp Engn, Belfast BT9 5AH, Antrim, North Ireland.
   [Man, H. C.] Hong Kong Polytech Univ, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
RP Waugh, DG (reprint author), Univ Chester, Fac Sci & Engn, Laser Engn & Mfg Res Ctr, Parkgate Rd, Chester CH1 4BJ, Cheshire, England.
EM d.waugh@chester.ac.uk
OI Chan, Chi-Wai/0000-0003-4953-1024; Lawrence,
   Jonathan/0000-0002-1649-9948; Waugh, David/0000-0002-7186-2797
FU Hong Kong Polytechnic University, Hong Kong Special Administration
   Region, China research [G-YK36, G-YM75]; University of Chester, UK
FX The work was supported by the visiting research associateship provided
   by the School of Mechanical and Aerospace Engineering, Queen's
   University, Belfast, UK, and by the Hong Kong Polytechnic University,
   Hong Kong Special Administration Region, China research (Grant
   Nos.G-YK36 and G-YM75). The PhD funding from University of Chester, UK
   as international studentship is gratefully acknowledged.
CR [Anonymous], 1956, Q J ROYAL METEOROLOG, V82, P119
   Antony J., 2001, WORK STUDY, V50, P141, DOI DOI 10.1108/00438020110391873
   Bahraminasab M, 2011, MATER DESIGN, V32, P4471, DOI 10.1016/j.matdes.2011.03.046
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   Chan CW, 2014, MAT SCI ENG C-MATER, V42, P254, DOI 10.1016/j.msec.2014.05.022
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Fu Y, 2000, APPL SURF SCI, V157, P167, DOI 10.1016/S0169-4332(99)00494-8
   Galvin A, 2008, P I MECH ENG H, V222, P1073, DOI 10.1243/09544119JEIM407
   Jianglong L., 1993, SURF COAT TECH, V57, P191
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lawrence J, 2015, WOODH PUB SER ELECT, P1
   Li BE, 2016, MATER LETT, V182, P43, DOI 10.1016/j.matlet.2016.06.079
   Lin NM, 2012, SURF COAT TECH, V209, P212, DOI 10.1016/j.surfcoat.2012.07.046
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Man HC, 2011, APPL SURF SCI, V258, P436, DOI 10.1016/j.apsusc.2011.08.114
   Man HC, 2006, SURF COAT TECH, V200, P5598, DOI 10.1016/j.surfcoat.2005.07.079
   Man HC, 2002, J LASER APPL, V14, P242, DOI 10.2351/1.1514236
   Mihalcz I., 2001, PERIOD POLYTECH, V45, P75
   Naghibi SA, 2014, MATER CHEM PHYS, V148, P614, DOI 10.1016/j.matchemphys.2014.08.025
   Nalbant M, 2007, MATER DESIGN, V28, P1379, DOI 10.1016/j.matdes.2006.01.008
   Ng CH, 2016, J MATER SCI TECHNOL, V32, P459, DOI 10.1016/j.jmst.2016.01.012
   Nolan D, 2006, SURF COAT TECH, V200, P5698, DOI 10.1016/j.surfcoat.2005.08.110
   Peace G.S., 1992, TAGUCHI METHODS HAND
   Schaaf P., 2014, COMPREHENSIVE MAT PR, P261
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shi W, 2000, MAT SCI ENG A-STRUCT, V291, P27, DOI 10.1016/S0921-5093(00)00972-2
   Silva MM, 2012, SURF COAT TECH, V211, P209, DOI 10.1016/j.surfcoat.2011.07.069
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Vaz F, 2004, THIN SOLID FILMS, V447, P449, DOI 10.1016/S0040-6090(03)01123-4
   Xavior M. A., 2014, P ENG, V97, P1637
   Xiong DS, 2007, SURF COAT TECH, V201, P6847, DOI 10.1016/j.surfcoat.2006.09.043
   Yibas BS, 2006, APPL SURF SCI, V252, P8557, DOI 10.1016/j.apsusc.2005.11.076
   Zhang J, 2013, APPL SURF SCI, V280, P626, DOI 10.1016/j.apsusc.2013.05.037
   Zhecheva A, 2005, SURF COAT TECH, V200, P2192, DOI 10.1016/j.surfcoat.2004.07.115
NR 38
TC 3
Z9 3
U1 3
U2 23
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 15
PY 2017
VL 309
BP 1015
EP 1022
DI 10.1016/j.surfcoat.2016.10.042
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA EN7LN
UT WOS:000396184400118
OA Green Published
DA 2018-10-20
ER

PT J
AU Xue, YF
   Sant, V
   Phillippi, J
   Sant, S
AF Xue, Yingfei
   Sant, Vinayak
   Phillippi, Julie
   Sant, Shilpa
TI Biodegradable and biomimetic elastomeric scaffolds for tissue engineered
   heart valves
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biodegradable elastomers; Heart valve tissue engineering; Anisotropy;
   Microarchitecture; Biomaterial property; Biocompatibility; Synthetic
   elastomers
ID INTERSTITIAL CELL PHENOTYPE; POLY(GLYCEROL SEBACATE) SCAFFOLDS;
   AMPHIPHILIC BLOCK-COPOLYMERS; IN-VITRO MODEL; AORTIC-VALVE;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; DRUG-DELIVERY;
   CARDIAC-VALVE; BIOMEDICAL APPLICATIONS
AB Valvular heart diseases are the third leading cause of cardiovascular disease, resulting in more than 25,000 deaths annually in the United States. Heart valve tissue engineering (HVTE) has emerged as a putative treatment strategy such that the designed construct would ideally withstand native dynamic mechanical environment, guide regeneration of the diseased tissue and more importantly, have the ability to grow with the patient. These desired functions could be achieved by biomimetic design of tissue engineered constructs that recapitulate in vivo heart valve microenvironment with biomimetic architecture, optimal mechanical properties and possess suitable biodegradability and biocompatibility. Synthetic biodegradable elastomers have gained interest in HVTE due to their excellent mechanical compliance, controllable chemical structure and tunable degradability. This review focuses on the state-of-art strategies to engineer biomimetic elastomeric scaffolds for HVTE. We first discuss the various types of biodegradable synthetic elastomers and their key properties. We then highlight tissue engineering approaches to recreate some of the features in the heart valve microenvironment such as anisotropic and hierarchical tri-layered architecture, mechanical anisotropy and biocompatibility.
   Statement of Significance
   Heart valve tissue engineering (HVTE) is of special significance to overcome the drawbacks of current valve replacements. Although biodegradable synthetic elastomers have emerged as promising materials for HVTE, a mature HVTE construct made from synthetic elastomers for clinical use remains to be developed. Hence, this review summarized various types of biodegradable synthetic elastomers and their key properties. The major focus that distinguishes this review from the current literature is the thorough discussion on the key features of native valve microenvironments and various up-and-coming approaches to engineer synthetic elastomers to recreate these features such as anisotropic tri-layered architecture, mechanical anisotropy, biodegradability and biocompatibility. This review is envisioned to inspire and instruct the design of functional HVTE constructs and facilitate their clinical translation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xue, Yingfei; Sant, Vinayak; Sant, Shilpa] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
   [Phillippi, Julie; Sant, Shilpa] Univ Pittsburgh, Dept Bioengn, Swanson Sch Engn, Pittsburgh, PA 15219 USA.
   [Phillippi, Julie] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA.
   [Phillippi, Julie; Sant, Shilpa] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Phillippi, Julie] Univ Pittsburgh, Ctr Vasc Remodeling & Regenerat, Pittsburgh, PA 15219 USA.
RP Sant, S (reprint author), 808A Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.
EM shs149@pitt.edu
OI Xue, Yingfei/0000-0002-4551-3702
FU University of Pittsburgh School of Pharmacy
FX This work is supported by the seed funding (SS) and Graduate Student
   Research Scholarship (YX) from University of Pittsburgh School of
   Pharmacy.
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Aleksieva G, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-92
   Amoroso NJ, 2012, ACTA BIOMATER, V8, P4268, DOI 10.1016/j.actbio.2012.08.002
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Badrossamay MR, 2014, BIOMATERIALS, V35, P3188, DOI 10.1016/j.biomaterials.2013.12.072
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Barrett DG, 2009, MOLECULES, V14, P4022, DOI 10.3390/molecules14104022
   Basude S, 2012, BJOG-INT J OBSTET GY, V119, P1008, DOI 10.1111/j.1471-0528.2012.03359.x
   Bat E, 2014, REGEN MED, V9, P385, DOI [10.2217/rme.14.4, 10.2217/RME.14.4]
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Bettinger CJ, 2011, PURE APPL CHEM, V83, P9, DOI 10.1351/PAC-CON-10-08-18
   Bongio M, 2010, J MATER CHEM, V20, P8747, DOI 10.1039/c0jm00795a
   Boon NA, 2002, HEART, V87, P395, DOI 10.1136/heart.87.4.395
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Brody S, 2007, J BIOMED MATER RES B, V83B, P16, DOI 10.1002/jbm.b.30763
   Brody S, 2007, BIOMATERIALS, V28, P1461, DOI 10.1016/j.biomaterials.2006.11.030
   Brugmans M. M. C. P., 2013, J TISSUE ENG REGENER
   Brugmans M. M. C. P., 2015, TISSUE ENG A
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Capps SB, 2000, J THORAC CARDIOV SUR, V119, P975, DOI 10.1016/S0022-5223(00)70092-4
   Capulli AK, 2016, ADV DRUG DELIVER REV, V96, P83, DOI 10.1016/j.addr.2015.11.020
   Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cheung DY, 2015, EXPERT OPIN BIOL TH, V15, P1155, DOI 10.1517/14712598.2015.1051527
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Cox MAJ, 2010, TISSUE ENG PT A, V16, P1527, DOI 10.1089/ten.TEA.2009.0263
   d'Arcy JL, 2011, HEART, V97, P91, DOI 10.1136/hrt.2010.205096
   Daebritz SH, 2003, CIRCULATION, V108, P134, DOI 10.1161/01.cir.0000087655.41288.dc
   Del Gaudio C, 2008, INT J ARTIF ORGANS, V31, P68
   Del Gaudio C, 2008, ANN I SUPER SANITA, V44, P178
   Duan B, 2013, ACTA BIOMATER, V9, P7640, DOI 10.1016/j.actbio.2013.04.050
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Emmert MY, 2012, JACC-CARDIOVASC INTE, V5, P874, DOI 10.1016/j.jcin.2012.04.010
   Endo M, 2005, NANO LETT, V5, P101, DOI [10.1021/nl0482635, 10.1012/nl0482635]
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Eslami M, 2015, CELL J, V17, P478
   Eslami M, 2014, J BIOMATER APPL, V29, P399, DOI 10.1177/0885328214530589
   Fan R, 2013, J BIOMECH, V46, P662, DOI 10.1016/j.jbiomech.2012.11.046
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI [10.1089/ten.tea.2009.0018, 10.1089/ten.TEA.2009.0018]
   Freier T, 2006, ADV POLYM SCI, P1, DOI 10.1007/12_073
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Gottlieb D, 2010, J THORAC CARDIOV SUR, V139, P723, DOI 10.1016/j.jtcvs.2009.11.006
   Gould RA, 2012, ACTA BIOMATER, V8, P1710, DOI 10.1016/j.actbio.2012.01.006
   Grabow N, 2004, ARTIF ORGANS, V28, P971, DOI 10.1111/j.1525-1594.2004.00007.x
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hinderer S., 2015, ADV HEALTHCARE MAT
   Hinderer S, 2014, BIOMATERIALS, V35, P2130, DOI 10.1016/j.biomaterials.2013.10.080
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hobson CM, 2015, J BIOMED MATER RES A, V103, P3101, DOI 10.1002/jbm.a.35450
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05
   Hong H, 2008, ASAIO J, V54, P627, DOI 10.1097/MAT.0b013e31818965d3
   Hong H, 2009, ARTIF ORGANS, V33, P554, DOI 10.1111/j.1525-1594.2009.00742.x
   Iatridis JC, 2009, NAT MATER, V8, P923, DOI 10.1038/nmat2577
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   Jahnavi S, 2015, MAT SCI ENG C-MATER, V51, P263, DOI 10.1016/j.msec.2015.03.009
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Jana S., 2015, J TISSUE ENG REGENER
   Jana S, 2015, BIOTECHNOL ADV, V33, P1503, DOI 10.1016/j.biotechadv.2015.07.006
   Jana S, 2015, ACS APPL MATER INTER, V7, P20012, DOI 10.1021/acsami.5b04805
   Jana S, 2014, J CONTROL RELEASE, V196, P307, DOI 10.1016/j.jconrel.2014.10.009
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kheradvar A, 2015, ANN BIOMED ENG, V43, P833, DOI 10.1007/s10439-014-1209-z
   Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Kortsmit J, 2009, TISSUE ENG PT A, V15, P797, DOI 10.1089/ten.tea.2008.0197
   Kutikov AB, 2015, ACS BIOMATER SCI ENG, V1, P463, DOI 10.1021/acsbiomaterials.5b00122
   Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lapiodot S, 2012, NANOMEDICINE-UK, V7, P1409, DOI 10.2217/NNM.12.107
   Lau TT, 2013, NANOMEDICINE-UK, V8, P655, DOI [10.2217/NNM.13.32, 10.2217/nnm.13.32]
   Lee LY, 2009, EUR POLYM J, V45, P3247, DOI 10.1016/j.eurpolymj.2009.07.016
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma B, 2014, REGEN BIOMATER, V1, P81, DOI 10.1093/rb/rbu009
   Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035
   Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Mason B. N., 2012, MATRIX STIFFNESS REG, P19
   Masoumi N., 2014, BIOMATERIALS
   Masoumi N, 2014, ADV HEALTHC MATER, V3, P929, DOI 10.1002/adhm.201300505
   Masoumi N, 2013, ACTA BIOMATER, V9, P5974, DOI 10.1016/j.actbio.2013.01.001
   Masoumi N, 2013, J BIOMED MATER RES A, V101, P104, DOI 10.1002/jbm.a.34305
   Mathapati S, 2011, INTERACT CARDIOV TH, V12, P360, DOI 10.1510/icvts.2010.256719
   MAVRILAS D, 1991, J BIOMECH, V24, P331, DOI 10.1016/0021-9290(91)90351-M
   Mazzitelli D, 2015, ANN THORAC SURG, V100, P1923, DOI 10.1016/j.athoracsur.2015.04.056
   Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315
   Merryman WD, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0355-5
   Morsi YS, 2014, INT J ARTIF ORGANS, V37, P651, DOI 10.5301/ijao.5000339
   Nagura M, 2009, J APPL POLYM SCI, V113, P2462, DOI 10.1002/app.30027
   Nejad SP, 2016, ADV DRUG DELIVER REV, V96, P161, DOI 10.1016/j.addr.2015.11.003
   Neumann A., 2013, BIOMEDIZINISCHE TECH, V58
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Patel A, 2013, BIOMATERIALS, V34, P3970, DOI 10.1016/j.biomaterials.2013.01.045
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Ratner B. D., 2012, SCIENCE
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Reimer J., 2016, ANN BIOMED ENG
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Rodriguez KJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-29
   Rush MN, 2015, ACTA BIOMATER, V28, P76, DOI 10.1016/j.actbio.2015.09.031
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Sant S, 2013, ACTA BIOMATER, V9, P5963, DOI 10.1016/j.actbio.2012.11.014
   Sant S, 2011, J TISSUE ENG REGEN M, V5, P283, DOI 10.1002/term.313
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sanz-Garcia A, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.15
   Schaefermeier PK, 2009, EUR SURG RES, V42, P49, DOI 10.1159/000168317
   Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Schmidt D, 2006, TISSUE ENG, V12, P3223, DOI 10.1089/ten.2006.12.3223
   Schmidt D, 2010, J AM COLL CARDIOL, V56, P510, DOI 10.1016/j.jacc.2010.04.024
   Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257
   Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004
   Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Simionescu DT, 2012, J HEALTHC ENG, V3, P179, DOI 10.1260/2040-2295.3.2.179
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Sodian R, 2000, CIRCULATION, V102, P22
   Sodian R, 2010, ANN THORAC SURG, V89, P819, DOI 10.1016/j.athoracsur.2009.11.058
   Sohier J, 2014, BIOMATERIALS, V35, P1833, DOI 10.1016/j.biomaterials.2013.10.061
   Spoon D.B., 2013, INTERV CARDIOL, V5, P319
   Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Stella JA, 2007, J BIOMECH, V40, P3169, DOI 10.1016/j.jbiomech.2007.04.001
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Syedain Z, 2015, BIOMATERIALS, V73, P175, DOI 10.1016/j.biomaterials.2015.09.016
   Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]
   Thierfelder N, 2013, ASAIO J, V59, P309, DOI 10.1097/MAT.0b013e318289b95e
   Tillquist MN, 2011, PATIENT PREFER ADHER, V5, P91, DOI 10.2147/PPA.S16420
   Tseng H, 2014, TISSUE ENG PT A, V20, P2634, DOI [10.1089/ten.tea.2013.0397, 10.1089/ten.TEA.2013.0397]
   Vacanti JP, 1999, LANCET, V354, pSI32
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   Van Lieshout MI, 2006, J BIOMAT SCI-POLYM E, V17, P77, DOI 10.1163/156856206774879153
   van Wachem PB, 2000, J BIOMED MATER RES, V53, P18, DOI 10.1002/(SICI)1097-4636(2000)53:1<18::AID-JBM3>3.3.CO;2-A
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Weber B, 2012, BIOMATERIALS, V33, P4031, DOI 10.1016/j.biomaterials.2011.11.087
   Weber B, 2011, EUR HEART J, V32, P2830, DOI 10.1093/eurheartj/ehr059
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
   Wu S, 2007, ARTIF ORGANS, V31, P689, DOI 10.1111/j.1525-1594.2007.00442.x
   Xue YF, 2016, MACROMOL MATER ENG, V301, P296, DOI 10.1002/mame.201500190
   Xue YF, 2015, EUR POLYM J, V72, P163, DOI 10.1016/j.eurpolymj.2015.09.013
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Ye Q, 2000, ASAIO J, V46, P730, DOI 10.1097/00002480-200011000-00014
   Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054622
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang X, 2015, ACTA BIOMATER, V14, P11, DOI 10.1016/j.actbio.2014.11.042
NR 170
TC 15
Z9 14
U1 15
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 2
EP 19
DI 10.1016/j.actbio.2016.10.032
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000001
PM 27780764
DA 2018-10-20
ER

PT J
AU Rufaihah, AJ
   Johari, NA
   Vaibavi, SR
   Plotkin, M
   Thien, DTD
   Kofidis, T
   Seliktar, D
AF Rufaihah, Abdul Jalil
   Johari, Nurul Azizah
   Vaibavi, Srirangam Ramanujam
   Plotkin, Marian
   Do Thi Di Thien
   Kofidis, Theodoros
   Seliktar, Dror
TI Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable
   hydrogel
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Myocardial infarction; Biomaterials; PEG-fibrinogen; Growth factor
   delivery; Heart attack
ID ENDOTHELIAL GROWTH-FACTOR; MYOCARDIAL-INFARCTION; OVEREXPRESSING
   ANGIOPOIETIN-1; SIGNAL-TRANSDUCTION; ANGIOGENIC RESPONSE; MODEL;
   ARTERIOGENESIS; HYPOTENSION; INJECTION; RECEPTOR
AB Acute myocardial infarction (MI) caused by ischemia is the most common cause of cardiac dysfunction. While growth factor therapy is promising, the retention in the highly vascularized myocardium is limited and prevents sustained activation needed for adequate cellular responses. Here, we demonstrated the use of polyethylene glycol-fibrinogen (PF) hydrogels for sustained dual delivery of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ANG-1) to enhance myocardial repair and function. VEGF and ANG-1 were incorporated in PF hydrogels and their in vitro characteristics were studied. Acute MI was generated in a rodent model with rats randomly assigned to 4 groups; sham, saline, PF and PF-VEGF-ANG1 (n =10 each group). Saline or hydrogel was injected in infarct and peri-infarct areas of the myocardium. After 4 weeks, myocardial function was assessed using echocardiography. Tissue samples were harvested for Hematoxylin and Eosin, Masson Trichrome and capillary staining to assess the extent of fibrotic scar and arteriogenesis. Both VEGF and ANG-1 were released in a sustained and controlled manner over 30 days. PF-VEGF-ANG1 treated animals showed the best improvement in cardiac function, highest degree of cardiac muscle preservation, and arteriogenesis. This study demonstrates that PF hydrogels can simultaneously provide mechanical support to attenuate adverse myocardial remodelling, and a pro-angiogenic benefit from the sustained VEGF and ANG1 delivery that culminates in a restorative effect following MI. The utility of this synergistic, biomaterial-based growth factor delivery may have clinical implications in the prevention of post-MI cardiac dysfunction.
   Statement of Significance
   Acute myocardial infarction (MI) caused by ischemia is the most common cause of cardiac dysfunction. Here, we demonstrated the use of polyethylene glycol-fibrinogen (PF) hydrogels for sustained dual delivery of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ANG-1) to enhance myocardial repair and function. Treated animals showed the best improvement in cardiac function, highest degree of cardiac muscle preservation, and arteriogenesis. This study demonstrates that PF hydrogels can simultaneously provide mechanical support to attenuate adverse myocardial remodelling, and a pro-angiogenic benefit from the sustained VEGF and ANG1 delivery that culminates in a restorative effect following MI. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rufaihah, Abdul Jalil; Johari, Nurul Azizah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore.
   [Vaibavi, Srirangam Ramanujam; Plotkin, Marian; Do Thi Di Thien] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Singapore, Singapore.
   [Kofidis, Theodoros] Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Heart, Dept Cardiac Thorac & Vasc Surg, Singapore, Singapore.
   [Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
RP Kofidis, T (reprint author), Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Heart, Dept Cardiac Thorac & Vasc Surg, Singapore, Singapore.; Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
EM surtk@nus.edu.sg; dror@nm.technion.ac.il
RI Abdul Jalil, Rufaihah/A-4572-2012; Kofidis, Theodoros/B-9283-2011
OI Abdul Jalil, Rufaihah/0000-0002-9764-8668; Kofidis,
   Theodoros/0000-0002-9623-6450; Seliktar, Dror/0000-0001-6964-8567
FU Regenerative Medicine Initiative in Cardiac Restoration Therapy
FX The authors would like to acknowledge funding support from for
   Regenerative Medicine Initiative in Cardiac Restoration Therapy.
CR Anisimov A, 2013, CIRCULATION, V127, P424, DOI 10.1161/CIRCULATIONAHA.112.127472
   Anyanwu AC, 2007, ANN THORAC SURG, V84, P1405, DOI 10.1016/j.athoracsur.2007.02.004
   Berdichevski A, 2015, P NATL ACAD SCI USA, V112, P5147, DOI 10.1073/pnas.1502232112
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2
   Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663
   Frisman I, 2010, ACTA BIOMATER, V6, P2518, DOI 10.1016/j.actbio.2009.07.015
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   LEE JH, 2013, J PRIVACY CONFIDENTI, V5, P5, DOI DOI 10.5345/JKIBC.2013.13.5.506
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Makinde T, 2008, J CELL MOL MED, V12, P810, DOI 10.1111/j.1582-4934.2008.00254.x
   MCCARTHY PM, 1994, CIRCULATION, V90, P83
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Siddiqui AJ, 2003, BIOCHEM BIOPH RES CO, V310, P1002, DOI 10.1016/j.bbrc.2003.09.111
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94
   Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108
   THOMPSON WD, 1985, J PATHOL, V145, P27, DOI 10.1002/path.1711450103
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Yamauchi A, 2003, J GENE MED, V5, P994, DOI 10.1002/jgm.439
NR 37
TC 9
Z9 10
U1 7
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 58
EP 67
DI 10.1016/j.actbio.2016.10.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000004
PM 27756647
DA 2018-10-20
ER

PT J
AU Chouhan, D
   Chakraborty, B
   Nandi, SK
   Mandal, BB
AF Chouhan, Dimple
   Chakraborty, Bijayshree
   Nandi, Samit K.
   Mandal, Biman B.
TI Role of non-mulberry silk fibroin in deposition and regulation of
   extracellular matrix towards accelerated wound healing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Non-mulberry silk; Biomaterial; Electrospinning; Wound dressing; Wound
   healing
ID EPIDERMAL-GROWTH-FACTOR; IN-VITRO; SKIN REGENERATION; ANTHERAEA-ASSAMA;
   ELASTIC FIBERS; BOMBYX-MORI; SCAR TISSUE; COLLAGEN; BIOMATERIALS; FILMS
AB Bombyx mori silk fibroin (BMSF) as biopolymer has been extensively explored in wound healing applications. However, limited study is available on the potential of silk fibroin (SF) from non-mulberry (Antheraea assama and Philosamia ricini) silk variety. Herein, we have developed non-mulberry SF (NMSF) based electrospun mats functionalized with epidermal growth factor (EGF) and ciprofloxacin HCI as potential wound dressing. The NMSF based mats exhibited essential properties of wound dressing like biocompatibility, high water retention capacity (440%), water vapor transmission rate (similar to 2330 g m(-2) day(-1)), high elasticity (similar to 2.6 MPa), sustained drug release and antibacterial activity. Functionalized NMSF mats enhanced the proliferation of human dermal fibroblasts and HaCaT cells in vitro as compared to non-functionalized mats (p <= 0.01) showing effective delivery of EGF. Extensive in vivo wound healing assesment demonstrated accelerated wound healing, enhanced reepithelialization, highly vascularized granulation tissue and higher wound maturity as compared to BMSF based mats. NMSF mats treated wounds showed regulated deposition of mature elastin, collagen and reticulin fibers in the extracellular matrix of skin. Presence of skin appendages and isotropic collagen fibers in the regenerated skin also demonstrated scar-less healing and aesthetic wound repair.
   Statement of Significance
   A facile fabrication of a ready-to-use bioactive wound dressing capable of concomitantly accelerating the healing process as well as deposition of the extracellular matrix (ECM) to circumvent further scarring complicacies has become a focal point of research. In this backdrop, our present work is based on non mulberry silk fibroin (NMSF) electrospun antibiotic loaded semi-occlusive mats, mimicking the ECM of skin in terms of morphology, topology, microporous structure and mechanical stiffness. Regulation of ECM deposition and isotropic orientation evinced the potential of the mat as an instructive platform for skin regeneration. The unique peptide motifs of NMSF assisted the augmented recruitment of fibroblast, keratinocytes and endothelial cells leading to accelerated wound healing. Early progression of mature granulation, faster re-epithelialization and angiogenesis in the wounds in in vivo rabbit model forwarded the blended nanofibrous mats of NMSF and PVA ferrying EGF, apt for scarless healing. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chouhan, Dimple; Mandal, Biman B.] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
   [Chakraborty, Bijayshree; Nandi, Samit K.] West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, W Bengal, India.
RP Mandal, BB (reprint author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM biman.mandal@iitg.ernet.in
FU Department of Biotechnology, DBT, Government of India
   [BT/IN/Sweden/38/BBM/2013, BT/505/NE/TBP/2013, BT/548/NE/U-Excel/2014];
   Department of Science and Technology, DST, Government of India
   [DST/INT/UK/P-110/2014]
FX BBM greatly acknowledges Department of Biotechnology, DBT
   (BT/IN/Sweden/38/BBM/2013, BT/505/NE/TBP/2013, BT/548/NE/U-Excel/2014),
   and Department of Science and Technology, DST (DST/INT/UK/P-110/2014),
   Government of India for generous funding. Central Instruments Facility,
   IITG is acknowledged for high end instruments. Prof. Niranjan Karak,
   Tezpur University is acknowledged for help with Universal Testing
   Machine. DC wish to thank Prerak Gupta for his help in ELISA experiments
   and Dr. Rocktotpal Konwarh, IITG for his valuable suggestions.
CR Abrigo M, 2014, MACROMOL BIOSCI, V14, P772, DOI 10.1002/mabi.201300561
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   BHANGOO KS, 1976, PLAST RECONSTR SURG, V57, P308, DOI 10.1097/00006534-197603000-00005
   Bhardwaj N, 2015, INTEGR BIOL-UK, V7, P53, DOI 10.1039/c4ib00208c
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Bygd HC, 2015, BIOMATERIALS, V63, P47, DOI 10.1016/j.biomaterials.2015.05.045
   CELEBI N, 1994, J PHARM PHARMACOL, V46, P386, DOI 10.1111/j.2042-7158.1994.tb03820.x
   Cheng W, 2011, AFR J BIOTECHNOL, V10, P2524
   Chiellini E, 2006, POLYM DEGRAD STABIL, V91, P3397, DOI 10.1016/j.polymdegradstab.2006.05.021
   Choi JK, 2012, BIOMATERIALS, V33, P8579, DOI 10.1016/j.biomaterials.2012.07.061
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Coates J., 2006, ENCY ANAL CHEM
   Dado D, 2012, REGEN MED, V7, P101, DOI [10.2217/RME.11.99, 10.2217/rme.11.99]
   ELIOPOULOS GM, 1984, ANTIMICROB AGENTS CH, V25, P331, DOI 10.1128/AAC.25.3.331
   Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048
   GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X
   Geerligs M, 2011, J BIOMECH, V44, P1176, DOI 10.1016/j.jbiomech.2011.01.015
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Godwin J, 2014, INT J BIOCHEM CELL B, V56, P47, DOI 10.1016/j.biocel.2014.10.011
   Gogoi D, 2014, BIOPOLYMERS, V101, P355, DOI 10.1002/bip.22369
   GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237
   Gorouhi F, 2014, J INVEST DERMATOL, V134, P1757, DOI 10.1038/jid.2014.7
   GREENHALGH DG, 1990, AM J PATHOL, V136, P1235
   GRIDLEY MF, 1951, AM J CLIN PATHOL, V21, P897
   Gupta Adarsh K., 2015, Scientific Reports, V5, P12706, DOI 10.1038/srep12706
   Gupta P, 2016, ACS APPL MATER INTER, V8, P15874, DOI 10.1021/acsami.6b00783
   HECK DE, 1992, J BIOL CHEM, V267, P21277
   Heo YS, 2011, ANN DERMATOL, V23, P44, DOI 10.5021/ad.2011.23.1.44
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang R, 2015, BIOMATERIALS, V53, P58, DOI 10.1016/j.biomaterials.2015.02.076
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Kim YS, 2010, J KOREAN MED SCI, V25, P589, DOI 10.3346/jkms.2010.25.4.589
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417
   Li MZ, 2001, MACROMOL MATER ENG, V286, P529
   Li WL, 2012, J APPL POLYM SCI, V123, P20, DOI 10.1002/app.34434
   Luo Q, 2013, INT J BIOL MACROMOL, V61, P135, DOI 10.1016/j.ijbiomac.2013.06.050
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Marchesan S, 2013, BIOMATERIALS, V34, P3678, DOI 10.1016/j.biomaterials.2013.01.096
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mimura Y, 2006, MATRIX BIOL, V25, P202, DOI 10.1016/j.matbio.2005.12.002
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   PROCTOR GB, 1988, STAIN TECHNOL, V63, P101, DOI 10.3109/10520298809107169
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Schunck M, 2005, J INVEST DERMATOL, V125, P1063, DOI 10.1111/j.0022-202X.2005.23890.x
   Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540
   Shankhwar N, 2016, J BIOMAT SCI-POLYM E, V27, P247, DOI 10.1080/09205063.2015.1120474
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   SMITH SM, 1985, ANTIMICROB AGENTS CH, V27, P688, DOI 10.1128/AAC.27.5.688
   Sood A, 2014, ADV WOUND CARE, V3, P511, DOI 10.1089/wound.2012.0401
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tanaka T, 2002, J THERM ANAL CALORIM, V70, P825, DOI 10.1023/A:1022256203778
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Urtreger A, 1998, INT J CANCER, V78, P233, DOI 10.1002/(SICI)1097-0215(19981005)78:2<233::AID-IJC18>3.0.CO;2-B
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   van Zuijlen PPM, 2003, BURNS, V29, P423, DOI 10.1016/S0305-4179(03)00052-4
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Wang QN, 2015, BIOMATERIALS, V53, P659, DOI 10.1016/j.biomaterials.2015.03.011
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Widhe M, 2016, BIOMATERIALS, V74, P256, DOI 10.1016/j.biomaterials.2015.10.013
   Xu R, 2015, BIOMATERIALS, V40, P1, DOI 10.1016/j.biomaterials.2014.10.077
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
NR 73
TC 23
Z9 24
U1 18
U2 118
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 157
EP 174
DI 10.1016/j.actbio.2016.10.019
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000013
PM 27746359
DA 2018-10-20
ER

PT J
AU Dan, P
   Velot, E
   Francius, G
   Menu, P
   Decot, V
AF Dan, Pan
   Velot, Emilie
   Francius, Gregory
   Menu, Patrick
   Decot, Veronique
TI Human-derived extracellular matrix from Wharton's jelly: An untapped
   substrate to build up a standardized and homogeneous coating for
   vascular engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomimetic materials; Vascular tissue engineering; Wharton's jelly; ECM
   (extracellular matrix); Coating
ID MESENCHYMAL STEM-CELLS; SHEAR-STRESS; IN-VITRO; ENDOTHELIALIZATION;
   DIFFERENTIATION; ENDOTHELIUM; RETENTION; SCAFFOLD; COLLAGEN; FILMS
AB One of the outstanding goals in tissue engineering is to develop a natural coating surface which is easy to manipulate, effective for cell adhesion and fully biocompatible. The ideal surface would be derived from human tissue, perfectly controllable, and pathogen-free, thereby satisfying all of the standards of the health authorities. This paper reports an innovative approach to coating surfaces using a natural extracellular matrix (ECM) extracted from the Wharton's jelly (WJ) of the umbilical cord (referred to as WJ-ECM). We have shown by atomic force microscopy (AFM), that the deposition of WJ-ECM on surfaces is homogenous with a controllable thickness, and that this easily-prepared coating is appropriate for both the adhesion and proliferation of human mesenchymal stem cells and mature endothelial cells. Furthermore, under physiological shear stress conditions, a larger number of cells remained adhered to WJ-ECM than to a conventional coating such as collagen - a result supported by the higher expression of both integrins alpha 2 and beta 1 in cells cultured on WJ-ECM. Our data clearly show that Wharton's jelly is a highly promising coating for the design of human biocompatible surfaces in tissue engineering as well as in regenerative medicine.
   Statement of Significance
   Discovery and design of biomaterial surface are a hot spot in the tissue engineering field. Natural matrix is preferred to mimic native cell microenvironment but its use is limited due to poor resource availability. Moreover, current studies often use single or several components of natural polymers, which is not the case in human body. This paper reports a natural extracellular matrix with full components derived from healthy human tissue: Wharton's jelly of umbilical cord. Reconstituting this matrix as a culture surface, our easily-prepared coating provides superior biocompatibility for stem and mature cells. Furthermore, we observed improved cell performance on this coating under both static and dynamic condition. This novel human derived ECM would be a promising choice for regenerative medicine. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dan, Pan; Velot, Emilie; Menu, Patrick; Decot, Veronique] Univ Lorraine, Ingn Mol & Physiopathol Articulaire, CNRS, UMR 7365, F-54505 Vandceuvre Les Nancy Ced, France.
   [Francius, Gregory] Univ Lorraine, Lab Chim Phys & Microbiol Environm, UMR 7564, F-54600 Villers Les Nancy, France.
   [Decot, Veronique] CHRU Nancy, Unite Therapie Cellulaire & Tissulaire, F-54511 Vandoeuvre Les Nancy, France.
RP Menu, P (reprint author), Univ Lorraine, Ingn Mol & Physiopathol Articulaire, CNRS, UMR 7365, F-54505 Vandceuvre Les Nancy Ced, France.
EM patrick.menu@univ-Iorraine.fr
CR Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816
   Benrashid E, 2016, METHODS, V99, P13, DOI 10.1016/j.ymeth.2015.07.014
   Berthelemy N, 2008, ADV MATER, V20, P2674, DOI 10.1002/adma.200702418
   Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417
   Chlupac J, 2014, TISSUE ENG PT A, V20, P2253, DOI [10.1089/ten.TEA.2013.0153, 10.1089/ten.tea.2013.0153]
   Coakley DN, 2016, INT J SURG, V25, P31, DOI 10.1016/j.ijsu.2015.11.008
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720
   El Omar R, 2016, IMMUNOL CELL BIOL, V94, P342, DOI 10.1038/icb.2015.94
   Frendl CM, 2014, BIOMATERIALS, V35, P7714, DOI 10.1016/j.biomaterials.2014.05.075
   Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/NNANO.2012.163, 10.1038/nnano.2012.163]
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   Gong XH, 2014, BIOMATERIALS, V35, P4782, DOI [10.1016/j.biomaterials2014.02.050, 10.1016/j.biomaterials.2014.02.050]
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Han YF, 2013, CYTOTECHNOLOGY, V65, P819, DOI 10.1007/s10616-012-9528-0
   Han YL, 2013, COLLOID SURFACE B, V111, P479, DOI 10.1016/j.colsurfb.2013.06.042
   Hao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058314
   Koobatian MT, 2016, BIOMATERIALS, V76, P344, DOI 10.1016/j.biomaterials.2015.10.020
   Krawiec JT, 2012, BIOMATERIALS, V33, P3388, DOI 10.1016/j.biomaterials.2012.01.014
   Martino Mikael M, 2015, Front Bioeng Biotechnol, V3, P45, DOI 10.3389/fbioe.2015.00045
   McIlhenny SE, 2010, TISSUE ENG PT A, V16, P245, DOI 10.1089/ten.TEA.2009.0238
   Moore MC, 2015, BIOMATERIALS, V49, P37, DOI 10.1016/j.biomaterials.2015.01.022
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Polyakov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018887
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Ringe J, 2014, NAT REV RHEUMATOL, V10, P388, DOI 10.1038/nrrheum.2014.79
   Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Sobolewski K, 2005, PLACENTA, V26, P747, DOI 10.1016/j.placenta.2004.10.008
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Turner NJ, 2006, CIRCULATION, V114, P820, DOI 10.1161/CIRCULATIONHA.106.635292
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Warstat K, 2010, STEM CELLS DEV, V19, P645, DOI 10.1089/scd.2009.0208
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Zhao YL, 2010, BIOMATERIALS, V31, P296, DOI 10.1016/j.biomaterials.2009.09.049
NR 42
TC 3
Z9 3
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 227
EP 237
DI 10.1016/j.actbio.2016.10.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000019
PM 27769940
DA 2018-10-20
ER

PT J
AU Brockman, KS
   Kizhakkedathu, JN
   Santerre, JP
AF Brockman, Kathryne S.
   Kizhakkedathu, Jayachandran N.
   Santerre, J. Paul
TI Hemocompatibility studies on a degradable polar hydrophobic ionic
   polyurethane (D-PHI)
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterials; Thrombosis; Complement activation; Polyurethane;
   Platelets; Leukocytes
ID TISSUE FACTOR ACTIVITY; IN-VITRO; BLOOD COMPATIBILITY; CONTACT
   ACTIVATION; CELL COCULTURES; VASCULAR GRAFTS; PLASMA-PROTEINS;
   BIOMATERIAL; COAGULATION; COMPLEMENT
AB Biomaterial blood compatibility is a complex process that involves four key pathways, including the coagulation cascade, the complement system, platelets, and leukocytes. While many studies have addressed the initial contact of blood with homopolymeric (e.g. Teflon) or simple copolymeric (e.g. Dacron) biomaterials, relatively less attention has been given to investigating blood coagulation with respect to complex copolymeric systems containing well defined and diverse function. The current study sought to assess the hemocompatibility of a complex polyurethane (PU) containing a unique combination of polar, hydrophobic, and ionic domains (D-PHI). This included a whole blood (WB) study, followed by tests on the intrinsic and extrinsic coagulation pathways, complement activation, platelet activation, and an assessment of the effect of leukocytes on platelet-biomaterial interactions. A small increase in blood clot formation was observed on D-PHI in WB; however, there was no significant increase in clotting via the intrinsic coagulation cascade. No significant increase in platelet adhesion and only a very slight increase in platelet activation were observed in comparison to albumin-coated substrates (negative control). D-PHI showed mild complement activation and increased initiation of the extrinsic pathway of coagulation, along with the observation that leukocytes were important in mediating platelet-biomaterial interactions. It is proposed that complement is responsible for activating coagulation by inciting leukocytes to generate tissue factor (TF), which causes extrinsic pathway activation. This low level of blood clotting on D-PHI's surface may be necessary for the beneficial wound healing of vascular constructs that has been previously reported for this material.
   Statement of Significance
   Understanding the hemocompatibility of devices intended for blood-contacting applications is important for predicting device failure. Hemocompatibility is a complex parameter (affected by at least four different mechanisms) that measures the level of thrombus generation and immune system activation resulting from blood-biomaterial contact. The complexity of hemocompatibility implies that homopolymers are unlikely to solve the clotting challenges that face most biomaterials. Diversity in surface chemistry (containing hydrophobic, ionic, and polar domains) obtained from engineered polyurethanes can lead to favourable interactions with blood. The current research considered the effect of a highly functionalized polyurethane biomaterial on all four mechanisms in order to provide a comprehensive in vitro measure of the hemocompatibility of this unique material and the important mechanisms at play. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Brockman, Kathryne S.; Santerre, J. Paul] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3R5, Canada.
   [Brockman, Kathryne S.; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada.
   [Kizhakkedathu, Jayachandran N.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada.
   [Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
   [Santerre, J. Paul] Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.; Santerre, JP (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU Natural Sciences and Engineering Research Council (NSERC) [Syn 430828];
   NSERC Canada Graduate Scholarship-Masters (CGSM); Queen Elizabeth II
   Graduate Scholarship in Science and Technology; NSERC Collaborative
   Research and Training Experience Program (CREATE); Michael Smith
   Foundation for Health Research (MSFHR); NSERC; Canada Foundation for
   Innovation; British Columbia Knowledge Development Fund
FX The study was supported by the Natural Sciences and Engineering Research
   Council (NSERC) # Syn 430828, NSERC Canada Graduate Scholarship-Masters
   (CGSM), Queen Elizabeth II Graduate Scholarship in Science and
   Technology, and NSERC Collaborative Research and Training Experience
   Program (CREATE). Thank-you to Kai Yu and Jian Wang for help with SEM.
   Benjamin Lai for help with blood compatibility analysis. JNK holds a
   Career Investigator Scholar award from the Michael Smith Foundation for
   Health Research (MSFHR). JNK also acknowledges NSERC discovery grant
   support. The authors thank the LMB Macromolecular Hub at the UBC Center
   for Blood Research for the use of their research facilities. These
   facilities are supported in part by grants from the Canada Foundation
   for Innovation and British Columbia Knowledge Development Fund.
CR Ahmed M, 2012, BIOCONJUGATE CHEM, V23, P1050, DOI 10.1021/bc3000723
   Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Battiston KG, 2015, ACTA BIOMATER, V24, P74, DOI 10.1016/j.actbio.2015.05.038
   Battiston KG, 2015, ACTA BIOMATER, V24, P35, DOI 10.1016/j.actbio.2015.06.003
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Berends ETM, 2014, FEMS MICROBIOL REV, V38, P1146, DOI 10.1111/1574-6976.12080
   Bergmeister H, 2013, EUR SURG, V45, P187, DOI 10.1007/s10353-013-0224-x
   Canada S., 2011, 10 LEADING CAUSES DE
   De Mel A., 2012, INT J BIOMATER, V2012
   Fischer M, 2010, BIOMATERIALS, V31, P2498, DOI 10.1016/j.biomaterials.2009.12.016
   Freitas S.C., 2012, ACTA BIOMATER
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Green D, 2010, BLOOD COAGUL FIBRIN, V21, pS3, DOI 10.1097/01.mbc.0000388935.77612.d0
   Hamad OA, 2012, ADV EXP MED BIOL, V946, P185, DOI 10.1007/978-1-4614-0106-3_11
   Hanson S., 2004, BIOMATERIALS SCI INT, P332
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422
   Hoshikawa Y, 2012, MAT SCI ENG C-MATER, V32, P1627, DOI 10.1016/j.msec.2012.04.053
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jaganathan SK, 2014, BIOMED RES INT, DOI 10.1155/2014/459465
   Jiang H, 2011, LANGMUIR, V27, P11575, DOI 10.1021/la202101q
   Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193
   Kainthan RK, 2006, BIOMATERIALS, V27, P5377, DOI 10.1016/j.biomaterials.2006.06.021
   Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882
   Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864
   Konings J, 2013, THROMB RES, V132, P138, DOI 10.1016/j.thromres.2013.05.016
   Lai BFL, 2010, BIOMATERIALS, V31, P6710, DOI 10.1016/j.biomaterials.2010.05.052
   LAWSON JH, 1994, J BIOL CHEM, V269, P23357
   Lieder R., 2013, TISSUE ENG, V19
   Maitz M.F., 2008, SURFACE ENDOTOXIN CO, P18
   Marlar RA, 2008, ONE STAGE PROTHROMBI
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McDonald SM, 2011, J CELL BIOCHEM, V112, P3762, DOI 10.1002/jcb.23307
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Monroe D. M., 2009, PRACTICAL HEMOSTASIS, P1
   MUHLFELDER TW, 1979, J CLIN INVEST, V63, P147, DOI 10.1172/JCI109269
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   NIEMETZ J, 1972, J CLIN INVEST, V51, P307, DOI 10.1172/JCI106815
   Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5
   Peng HT, 2010, J BIOMED MATER RES B, V94B, P469, DOI 10.1002/jbm.b.31626
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Rossi NAA, 2009, BIOMATERIALS, V30, P638, DOI 10.1016/j.biomaterials.2008.09.057
   Sakiyama-Elbert SE, 2014, ACTA BIOMATER, V10, P1581, DOI 10.1016/j.actbio.2013.08.045
   Schoen F. J., 2011, BIOMATER SCI INTRO M, P771
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   Sefton M.V., 2012, NONTHROMBOGENIC TREA, DOI [10.1016/B978-0-08-087780-8.00155-8., DOI 10.1016/B978-0-08-087780-8.00155-8]
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Sydow-Plum G, 2008, MATER SCI TECH-LOND, V24, P1127, DOI 10.1179/174328408X341816
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   ul-Haq MI, 2012, BIOMATERIALS, V33, P9135, DOI 10.1016/j.biomaterials.2012.09.007
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yu K, 2015, BIOMATERIALS, V69, P201, DOI 10.1016/j.biomaterials.2015.08.003
   Zhu S, 2014, THROMB RES, V134, P1335, DOI 10.1016/j.thromres.2014.09.030
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 61
TC 5
Z9 5
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 368
EP 377
DI 10.1016/j.actbio.2016.11.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000030
PM 27818307
DA 2018-10-20
ER

PT J
AU Cipriano, AF
   Sallee, A
   Tayoba, M
   Alcaraz, MCC
   Lin, A
   Guan, RG
   Zhao, ZY
   Liu, HN
AF Cipriano, Aaron F.
   Sallee, Amy
   Tayoba, Myla
   Alcaraz, Mayra C. Cortez
   Lin, Alan
   Guan, Ren-Guo
   Zhao, Zhan-Yong
   Liu, Huinan
TI Cytocompatibility and early inflammatory response of human endothelial
   cells in direct culture with Mg-Zn-Sr alloys
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradable Magnesium Zinc Strontium alloy; Mg-Zn-Sr alloy; Human
   umbilical vein endothelial cells (HUVEC); Induction of vascular cell
   adhesion molecule-1 (VCAM-1); Early inflammatory response; Biomedical
   implants
ID NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INTERCELLULAR-ADHESION MOLECULE-1;
   ZINC-STRONTIUM ALLOYS; IN-VITRO DEGRADATION; HEAVY-METAL IONS; MAGNESIUM
   IMPLANTS; GENE-EXPRESSION; ORTHOPEDIC BIOMATERIALS; VIVO CORROSION
AB Crystalline Mg-Zinc (Zn)-Strontium (Sr) ternary alloys consist of elements naturally present in the human body and provide attractive mechanical and biodegradable properties for a variety of biomedical applications. The first objective of this study was to investigate the degradation and cytocompatibility of four Mg-4Zn-xSr alloys (x = 0.15, 0.5,1.0, 1.5 wt%; designated as ZSr41A, B, C, and D respectively) in the direct culture with human umbilical vein endothelial cells (HUVEC) in vitro. The second objective was to investigate, for the first time, the early-stage inflammatory response in cultured HUVECs as indicated by the induction of vascular cellular adhesion molecule-1 (VCAM-1). The results showed that the 24-h in vitro degradation of the ZSr41 alloys containing a beta-phase with a Zn/Sr at% ratio similar to 1.5 was significantly faster than the ZSr41 alloys with Zn/Sr at% similar to 1. Additionally, the adhesion density of HUVECs in the direct culture but not in direct contact with the ZSr41 alloys for up to 24 h was not adversely affected by the degradation of the alloys. Importantly, neither culture media supplemented with up to 27.6 mM Mg2+ ions nor media intentionally adjusted up to alkaline pH 9 induced any detectable adverse effects on HUVEC responses. In contrast, the significantly higher, yet non-cytotoxic, Zn2+ ion concentration from the degradation of ZSr41D alloy was likely the cause for the initially higher VCAM-1 expression on cultured HUVECs. Lastly, analysis of the HUVEC-ZSr41 interface showed near-complete absence of cell adhesion directly on the sample surface, most likely caused by either a high local alkalinity, change in surface topography, and/or surface composition. The direct culture method used in this study was proposed as a valuable tool for studying the design aspects of Zn-containing Mg-based biomaterials in vitro, in order to engineer solutions to address current shortcomings of Mg alloys for vascular device applications.
   Statement of Significance
   Magnesium (Mg) alloys specifically designed for biodegradable implant applications have been the focus of biomedical research since the early 2000s. Physicochemical properties of Mg alloys make these metallic biomaterials excellent candidates for temporary biodegradable implants in orthopedic and cardiovascular applications. As Mg alloys continue to be investigated for biomedical applications, it is necessary to understand whether Mg-based materials or the alloying elements have the intrinsic ability to direct an immune response to improve implant integration while avoiding cell-biomaterial interactions leading to chronic inflammation and/or foreign body reactions. The present study utilized the direct culture method to investigate for the first time the in vitro transient inflammatory activation of endothelial cells induced by the degradation products of Zn-containing Mg alloys. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Cipriano, Aaron F.; Sallee, Amy; Tayoba, Myla; Alcaraz, Mayra C. Cortez; Lin, Alan; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
   [Cipriano, Aaron F.; Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Guan, Ren-Guo; Zhao, Zhan-Yong] Northeastern Univ, Sch Met & Mat, Shenyang 110004, Peoples R China.
   [Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU American Heart Association [12SDG12220014]; Hellman Faculty Fellowship;
   University of California Regents Faculty Fellowship; Graduate Division
   at UC Riverside
FX The authors would like to thank the American Heart Association
   (12SDG12220014), Hellman Faculty Fellowship (Huinan Liu), and the
   University of California Regents Faculty Fellowship (Huinan Liu) for
   financial support. Aaron F. Cipriano would like to thank the Graduate
   Division at UC Riverside for the Dissertation Year Program fellowship.
   The authors thank the Central Facility for Advanced Microscopy and
   Microanalysis (CFAMM) at the University of California, Riverside.
CR Aljarrah M, 2007, INTERMETALLICS, V15, P93, DOI 10.1016/j.intermet.2006.03.011
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   Amini Ami R, 2011, J Long Term Eff Med Implants, V21, P93
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ARSALANE K, 1994, J APPL TOXICOL, V14, P375, DOI 10.1002/jat.2550140510
   Badar M, 2013, ACTA BIOMATER, V9, P7580, DOI 10.1016/j.actbio.2013.03.012
   Bao B, 2007, FEBS LETT, V581, P4507, DOI 10.1016/j.febslet.2007.08.030
   Bayata S, 2010, ANADOLU KARDIYOL DER, V10, P405, DOI 10.5152/akd.2010.137
   Bondarenko A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-32
   Bowen PK, 2014, ACTA BIOMATER, V10, P1475, DOI 10.1016/j.actbio.2013.11.021
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   Cha P.-R., 2013, SCI REP, V3
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   Cortese-Krott MM, 2014, REDOX BIOL, V2, P945, DOI 10.1016/j.redox.2014.06.011
   Cui T., 2013, ADV SCI LETT, V19, P1082
   Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871
   Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0
   Feser K, 2011, J BIOMATER APPL, V25, P685, DOI 10.1177/0885328209360424
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P1773, DOI 10.1016/j.mseb.2011.06.002
   Franco D, 2011, SOFT MATTER, V7, P7313, DOI 10.1039/c1sm05191a
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   GOEBELER M, 1993, J INVEST DERMATOL, V100, P759, DOI 10.1111/1523-1747.ep12476328
   GOEBELER M, 1995, J IMMUNOL, V155, P2459
   Grillo CA, 2011, COLLOID SURFACE B, V88, P471, DOI 10.1016/j.colsurfb.2011.07.035
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065011
   Guan A.G., 2013, MICROSTRUCT MECH P C, V33, P3661
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290
   Jung O, 2015, ACTA BIOMATER, V23, P354, DOI 10.1016/j.actbio.2015.06.005
   Kelly RG, 2002, ELECTROCHEMICAL TECH
   Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KNEDLER A, 1987, IN VITRO CELL DEV B, V23, P481
   Kocaturk PA, 2004, BIOL TRACE ELEM RES, V102, P51, DOI 10.1385/BTER:102:1-3:051
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543
   Lelong IH, 1998, J PHARMACOL TOXICOL, V39, P203, DOI 10.1016/S1056-8719(98)00019-7
   [李海伟 Li Haiwei], 2010, [介入放射学杂志, Journal of Interventional Radiology], V19, P315
   Li H, 2014, MATER DESIGN, V58, P43, DOI 10.1016/j.matdes.2014.01.031
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Liu L, 2014, MED SCI MONITOR, V20, P1056
   Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P13, DOI 10.1016/j.bbadis.2004.01.002
   Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P6, DOI 10.1016/j.bbadis.2004.02.004
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Martinesi M, 2005, J BIOMED MATER RES A, V74A, P197, DOI 10.1002/jbm.a.30366
   McLucas E, 2008, J MATER SCI-MATER M, V19, P975, DOI 10.1007/s10856-006-0087-9
   Messer Regina L W, 2005, J Long Term Eff Med Implants, V15, P39, DOI 10.1615/JLongTermEffMedImplants.v15.i1.50
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Nguyen TY, 2015, J BIOMED MATER RES A, V103, P2974, DOI 10.1002/jbm.a.35429
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Ninomiya JT, 2013, J ORTHOP RES, V31, P1484, DOI 10.1002/jor.22377
   OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7
   Persaud-Sharma D., 2013, J BIOMIMETICS BIOMAT, V18
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   POBER JS, 1986, J IMMUNOL, V136, P1680
   POBER JS, 1986, J IMMUNOL, V137, P1893
   Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599
   Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013
   Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019
   Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956
   Prasad AS, 2001, J LAB CLIN MED, V138, P250, DOI 10.1067/mlc.2001.118108
   Rochelson B, 2007, J REPROD IMMUNOL, V73, P101, DOI 10.1016/j.jri.2006.06.004
   Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Roth I., 2014, PROG BIOMATER, P1
   Ruygrok PN, 1996, CIRCULATION, V94, P882, DOI 10.1161/01.CIR.94.5.882
   Sands JM, 2009, SEMIN NEPHROL, V29, P178, DOI 10.1016/j.semnephrol.2009.03.008
   Sobieszczanska B., 2012, BIOL INTERACTIONS SU, P161
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Strlic M, 2003, ACTA CHIM SLOV, V50, P619
   Nguyen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076547
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135
   Wang JL, 2015, ACTA BIOMATER, V21, P237, DOI 10.1016/j.actbio.2015.04.011
   Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x
   Wilham J.M., 2007, ROLE ZINC REACTIVE O, P190
   Willbold E, 2011, MATER SCI ENG B-ADV, V176, P1835, DOI 10.1016/j.mseb.2011.02.010
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xia X, 2015, CORROSION, V71, P38, DOI 10.5006/1417
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yang CX, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045005
   Zhai ZJ, 2014, BIOMATERIALS, V35, P6299, DOI 10.1016/j.biomaterials.2014.04.044
   Zhang BP, 2011, BIOMATERIALS - PHYSICS AND CHEMISTRY, P183
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang WJ, 2003, FREE RADICAL BIO MED, V34, P674, DOI 10.1016/S0891-5849(02)01375-8
   Zhang XB, 2012, MATER LETT, V66, P209, DOI 10.1016/j.matlet.2011.08.079
   Zhao N, 2015, METALLOMICS, V7, P113, DOI 10.1039/c4mt00244j
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 107
TC 14
Z9 14
U1 11
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2017
VL 48
BP 499
EP 520
DI 10.1016/j.actbio.2016.10.020
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EJ5GY
UT WOS:000393247000043
PM 27746360
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Guo, GY
   Zhou, HJ
   Wang, QJ
   Wang, JX
   Tan, JQ
   Li, JH
   Jin, P
   Shen, H
AF Guo, Geyong
   Zhou, Huaijuan
   Wang, Qiaojie
   Wang, Jiaxing
   Tan, Jiaqi
   Li, Jinhua
   Jin, Ping
   Shen, Hao
TI Nano-layered magnesium fluoride reservoirs on biomaterial surfaces
   strengthen polymorphonuclear leukocyte resistance to bacterial pathogens
SO NANOSCALE
LA English
DT Article
ID ZN-ZR ALLOY; STAPHYLOCOCCUS-AUREUS; IN-VITRO; REAL-TIME; MECHANICAL
   CHARACTERIZATION; ANTIBACTERIAL PROPERTIES; VIRULENCE DETERMINANT;
   ANTIBIOFILM ACTIVITY; HUMAN NEUTROPHILS; INFECTION MODEL
AB Biomaterial-related bacterial infections cause patient suffering, mortality and extended periods of hospitalization, imposing a substantial burden on medical systems. In this context, understanding of nanomaterials-bacteria-cells interactions is of both fundamental and clinical significance. Herein, nano-MgF2 films were deposited on titanium substrate via magnetron sputtering. Using this platform, the antibacterial behavior and mechanism of the nano-MgF2 films were investigated in vitro and in vivo. It was found that, for S. aureus (CA-MRSA, USA300) and S. epidermidis (RP62A), the nano-MgF2 films possessed excellent anti-biofilm activity, but poor anti-planktonic bacteria activity in vitro. Nevertheless, both the traditional SD rat osteomyelitis model and the novel stably luminescent mouse infection model demonstrated that nano-MgF2 films exerted superior anti-infection effect in vivo, which cannot be completely explained by the antibacterial activity of the nanomaterial itself. Further, using polymorphonuclear leukocytes (PMNs), the critical immune cells of innate immunity, a complementary investigation of MgF2-bacteria-PMNs co-culturing revealed that the nano-MgF2 films improved the antibacterial effect of PMNs through enhancing their phagocytosis and stability. To our knowledge, this is the first time of exploring the antimicrobial mechanism of nano-MgF2 from the perspective of innate immunity both in vitro and in vivo. Based on the research results, a plausible mechanism is put forward for the predominant antibacterial effect of nano-MgF2 in vivo, which may originate from the indirect immune enhancement effect of nano-MgF2 films. In summary, this study of surface antibacterial design using MgF2 nanolayer is a meaningful attempt, which can promote the host innate immune response to bacterial pathogens. This may give us a new understanding towards the antibacterial behavior and mechanism of nano-MgF2 films and pave the way towards their clinical applications.
C1 [Guo, Geyong; Wang, Qiaojie; Wang, Jiaxing; Tan, Jiaqi; Shen, Hao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Zhou, Huaijuan; Li, Jinhua; Jin, Ping] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Li, Jinhua] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Shen, H (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.; Li, JH; Jin, P (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Li, JH (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
EM lijinhua429@gmail.com; p-jin@mail.sic.ac.cn; shenhao7212@sina.com
OI Li, Alex Jinhua/0000-0003-1110-7471; Zhou, Huaijuan/0000-0002-9289-3613
FU National Natural Science Foundation of China [81472108]; MOST
   [2014AA032802]; Science and Technology Commission of Shanghai
   Municipality (STCSM) [14DZ2261203]
FX This work was jointly supported by a grant from the National Natural
   Science Foundation of China (no. 81472108), the high-tech project of
   MOST (2014AA032802) and the Science and Technology Commission of
   Shanghai Municipality (STCSM, no. 14DZ2261203).
CR Ahmad Z, 2006, FEBS LETT, V580, P517, DOI 10.1016/j.feblset.2005.12.057
   Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P771, DOI 10.5301/ijao.5000046
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arita NK, 2006, DENT MATER J, V25, P684
   Bober J, 2000, FLUORIDE, V33, P108
   Bodelon OG, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/4/045015
   Bose JL, 2014, METHODS MOL BIOL, V1106, P101, DOI 10.1007/978-1-62703-736-5_8
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11
   GABLER WL, 1979, J DENT RES, V58, P1933, DOI 10.1177/00220345790580092101
   Gazzano E, 2010, CURR MED CHEM, V17, P2431, DOI 10.2174/092986710791698503
   Gentleman E, 2013, ACTA BIOMATER, V9, P5771, DOI 10.1016/j.actbio.2012.10.043
   Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907
   GuhaChowdhury N, 1997, ORAL MICROBIOL IMMUN, V12, P91, DOI 10.1111/j.1399-302X.1997.tb00623.x
   GuhaChowdhury N, 1997, CARIES RES, V31, P373, DOI 10.1159/000262421
   GUTIERREZ J, 1994, J DENT, V22, P279, DOI 10.1016/0300-5712(94)90060-4
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Kim HJ, 2004, J LIPOSOME RES, V14, P123, DOI 10.1081/LPR-200029887
   Klaus E., 2000, J PHYS D, V33, pR17
   Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lellouche J, 2012, NANOMED-NANOTECHNOL, V8, P702, DOI 10.1016/j.nano.2011.09.002
   Lellouche J, 2012, INT J NANOMED, V7, P1175, DOI 10.2147/IJN.S26770
   Lellouche J, 2009, BIOMATERIALS, V30, P5969, DOI 10.1016/j.biomaterials.2009.07.037
   LESHER RJ, 1977, ANTIMICROB AGENTS CH, V12, P339, DOI 10.1128/AAC.12.3.339
   Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692
   Lichtenberger C, 1999, J IMMUNOL METHODS, V227, P75, DOI 10.1016/S0022-1759(99)00076-9
   Mao L, 2015, ACS APPL MATER INTER, V7, P5320, DOI 10.1021/am5086885
   Mao L, 2013, MAT SCI ENG C-MATER, V33, P242, DOI 10.1016/j.msec.2012.08.036
   Lozano RM, 2013, J BIOMED MATER RES A, V101, P2753, DOI 10.1002/jbm.a.34579
   Mihailescu N, 2016, MAT SCI ENG C-MATER, V59, P863, DOI 10.1016/j.msec.2015.10.078
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Pardun K, 2015, J BIOMATER APPL, V30, P104, DOI 10.1177/0885328215572428
   Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09
   Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232
   Prasad C. Subhankari, 2010, NANOTECHNOLOGY, V21
   Qin H, 2015, BIOMATERIALS, V53, P211, DOI 10.1016/j.biomaterials.2015.02.096
   Sales D, 2003, BIOMATERIALS, V24, P1687, DOI 10.1016/S0142-9612(02)00545-8
   Seitz JM, 2015, J BIOMED MATER RES A, V103, P2427, DOI 10.1002/jbm.a.35382
   Shirwaiker RA, 2015, J AM ACAD ORTHOP SUR, V23, pS44, DOI 10.5435/JAAOS-D-14-00379
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   STURR MG, 1990, ARCH MICROBIOL, V155, P22, DOI 10.1007/BF00291269
   Sun JE, 2013, MAT SCI ENG C-MATER, V33, P3263, DOI 10.1016/j.msec.2013.04.006
   Suresh AK, 2013, NANOSCALE, V5, P463, DOI 10.1039/c2nr32447d
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907
   Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506
   WAGNER CD, 1980, J ELECTRON SPECTROSC, V18, P345, DOI 10.1016/0368-2048(80)80022-3
   Wang JX, 2016, ACS APPL MATER INTER, V8, P11162, DOI 10.1021/acsami.6b02803
   Wang LX, 2014, BIOMATERIALS, V35, P6758, DOI 10.1016/j.biomaterials.2014.04.085
   Weber CM, 2015, ACTA BIOMATER, V18, P249, DOI 10.1016/j.actbio.2015.03.003
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zhang H, 2008, IN VIVO, V22, P667
   Zhang J, 2014, J MATER SCI-MATER M, V25, P791, DOI 10.1007/s10856-013-5106-z
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 65
TC 4
Z9 4
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PD JAN 14
PY 2017
VL 9
IS 2
BP 875
EP 892
DI 10.1039/c6nr07729c
PG 18
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EL7DB
UT WOS:000394780200048
PM 27995243
DA 2018-10-20
ER

PT J
AU Wang, Z
   Sheng, RL
   Luo, T
   Sun, JJ
   Cao, A
AF Wang, Zhao
   Sheng, Ruilong
   Luo, Ting
   Sun, Jingjing
   Cao, Amin
TI Synthesis and self-assembly of diblock glycopolypeptide analogues
   PMAgala-b-PBLG as multifunctional biomaterials for protein recognition,
   drug delivery and hepatoma cell targeting
SO POLYMER CHEMISTRY
LA English
DT Article
ID BLOCK-COPOLYMERS; CLICK CHEMISTRY; INTRACELLULAR DELIVERY; DOXORUBICIN
   DELIVERY; RAFT-POLYMERIZATION; ANTICANCER DRUGS; CANCER-CELLS;
   TUMOR-CELLS; IN-VIVO; MICELLES
AB A series of diblock amphiphilic glycopolypeptide analogues poly(6-O-methacryloyl-D-galactopyranose)-SS-poly(gamma-benzyl-L-glutamate) (PMAgala-SS-PBLG) with well-defined and tunable structure, and redox-responsive disulfide linkage were prepared through a combination of modulated reactions including RAFT polymerization, ring-opening polymerization, "click" coupling reaction and following TFA-mediated deprotection, and a non-disulfide analogue PMAgala(27)-CC-PBLG(30) was prepared as a control. Molecular structures of the above prepared PMAgala-b-PBLG glycopolypeptide analogues were further characterized and their self-assembly properties were examined. The glycopolypeptide analogues were able to form stabilized micelles (with alpha-helix PBLG cores) and the uniform-sized PMAgala-SS-PBLG micelles exhibited obvious redox-responsive features in the presence of glutathione (GSH), whereas the non-disulfide control did not show such change. For biological applications, the lectin recognition properties, doxorubicin (DOX) delivery manner and human hepatoma cell receptor targeting capabilities were further evaluated. The results illustrated that the PMAgala-b-PBLG glycopolypeptide analogues might serve as redox-responsive, highly biocompatible multifunctional biomaterial platforms for practical applications.
C1 [Wang, Zhao; Sheng, Ruilong; Luo, Ting; Sun, Jingjing; Cao, Amin] Chinese Acad Sci, Shanghai Inst Organ Chem, CAS Key Lab Synthet & Self Assembly Chem Organ Fu, 345 Lingling Rd, Shanghai 200032, Peoples R China.
   [Sheng, Ruilong] Univ Montreal, Dept Chem, Succursale Cent Ville, Montreal, PQ H3C 3J7, Canada.
RP Sheng, RL; Cao, A (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, CAS Key Lab Synthet & Self Assembly Chem Organ Fu, 345 Lingling Rd, Shanghai 200032, Peoples R China.; Sheng, RL (reprint author), Univ Montreal, Dept Chem, Succursale Cent Ville, Montreal, PQ H3C 3J7, Canada.
EM rlsheng@mail.sioc.ac.cn; acao@mail.sioc.ac.cn
RI Sun, Jingjing/N-5245-2017; zhao, wang/T-1070-2018
OI Sun, Jingjing/0000-0002-6230-1015; Sheng, Ruilong/0000-0002-3303-3832
FU National Natural Science Foundation of China [21174160, 21372251];
   Chinese Academy of Sciences (CAS); Youth Innovation Promotion
   Association (YIPA) [2012204]
FX The authors are indebted to the financial support partially from the
   National Natural Science Foundation of China (21174160 and 21372251).
   The authors are also grateful to Prof. X. Shi and Assoc. Prof. X. Cao of
   Donghua University for their kind assistance in FACS measurements. Dr
   Ruilong Sheng also appreciates the Chinese Academy of Sciences (CAS) for
   the CAS-Canada Young Visiting Scientist Scholarship and Youth Innovation
   Promotion Association (YIPA, No 2012204) Scholarship.
CR Agut W, 2007, MACROMOLECULES, V40, P5653, DOI 10.1021/ma070579m
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Bonduelle C, 2016, CHEM COMMUN, V52, P11251, DOI 10.1039/c6cc06437j
   Bonduelle C, 2014, CHEM COMMUN, V50, P3350, DOI 10.1039/c3cc48190e
   Bonduelle C, 2013, FARADAY DISCUSS, V166, P137, DOI 10.1039/c3fd00082f
   Bonduelle C, 2013, BIOMACROMOLECULES, V14, P2973, DOI 10.1021/bm4008088
   Bonduelle C, 2012, CHEM COMMUN, V48, P8353, DOI 10.1039/c2cc32970k
   Byrne M, 2015, MACROMOL BIOSCI, V15, P74, DOI 10.1002/mabi.201400371
   Chen W, 2015, J MATER CHEM B, V3, P2308, DOI 10.1039/c4tb01962h
   Chen W, 2014, BIOMACROMOLECULES, V15, P900, DOI 10.1021/bm401749t
   Cheng YL, 2013, POLYM CHEM-UK, V4, P3851, DOI 10.1039/c3py00364g
   Das S, 2015, LANGMUIR, V31, P3402, DOI 10.1021/la503993e
   Das S, 2012, BIOMACROMOLECULES, V13, P3695, DOI 10.1021/bm301170u
   Ding JX, 2013, J CONTROL RELEASE, V169, P193, DOI 10.1016/j.jconrel.2012.12.006
   Ding JX, 2013, J MATER CHEM B, V1, P69, DOI 10.1039/c2tb00063f
   Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390
   Hu YW, 2015, J CONTROL RELEASE, V206, P91, DOI 10.1016/j.jconrel.2015.03.018
   Huang J, 2013, MACROMOL RAPID COMM, V34, P1542, DOI 10.1002/marc.201300439
   Huang J, 2012, J AM CHEM SOC, V134, P119, DOI 10.1021/ja209676p
   Huo M, 2014, POLYM CHEM-UK, V5, P1519, DOI 10.1039/c3py01192e
   Ji W, 2015, MACROMOL CHEM PHYS, V216, P1945, DOI 10.1002/macp.201500210
   Kramer JR, 2014, POLYM CHEM-UK, V5, P671, DOI 10.1039/c3py01081c
   Krannig KS, 2014, SOFT MATTER, V10, P4228, DOI 10.1039/c4sm00352g
   Lee ALZ, 2012, BIOMATERIALS, V33, P1921, DOI 10.1016/j.biomaterials.2011.11.032
   Li H, 2013, BIOMATERIALS, V34, P7923, DOI 10.1016/j.biomaterials.2013.06.064
   Li X, 2015, POLYM CHEM-UK, V6, P1417, DOI 10.1039/c4py01740d
   Lin JP, 2008, POLYMER, V49, P1132, DOI 10.1016/j.polymer.2008.01.021
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038
   Mildner R, 2014, BIOMACROMOLECULES, V15, P4528, DOI 10.1021/bm501325n
   Moad G, 2005, POLYMER, V46, P8458, DOI 10.1016/j.polymer.2004.12.061
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Papadopoulos P, 2004, BIOMACROMOLECULES, V5, P81, DOI 10.1021/bm034291q
   Pati D, 2016, BIOMACROMOLECULES, V17, P466, DOI 10.1021/acs.biomac.5b01354
   Pati D, 2012, BIOMACROMOLECULES, V13, P1287, DOI 10.1021/bm201813s
   Pati D, 2012, J AM CHEM SOC, V134, P7796, DOI 10.1021/ja300065f
   Poche DS, 1999, SYNTHETIC COMMUN, V29, P843, DOI 10.1080/00397919908086042
   Ren KX, 2015, BIOMATERIALS, V51, P238, DOI 10.1016/j.biomaterials.2015.02.026
   Schatz C, 2009, ANGEW CHEM INT EDIT, V48, P2572, DOI 10.1002/anie.200805895
   Sheng RL, 2011, BIOMATERIALS, V32, P3507, DOI 10.1016/j.biomaterials.2011.01.055
   Shi CL, 2014, BIOMATERIALS, V35, P8711, DOI 10.1016/j.biomaterials.2014.06.036
   Song NJ, 2013, BIOMACROMOLECULES, V14, P4407, DOI 10.1021/bm401342t
   Sun HL, 2010, BIOMACROMOLECULES, V11, P848, DOI 10.1021/bm1001069
   Sun HL, 2009, BIOMATERIALS, V30, P6358, DOI 10.1016/j.biomaterials.2009.07.051
   Sun JJ, 2016, J MATER CHEM B, V4, P4696, DOI 10.1039/c6tb00969g
   Tang HY, 2010, BIOMACROMOLECULES, V11, P1585, DOI 10.1021/bm1002174
   Tang LY, 2009, BIOCONJUGATE CHEM, V20, P1095, DOI 10.1021/bc900144m
   Tappertzhofen K, 2016, MACROMOL BIOSCI, V16, P106, DOI 10.1002/mabi.201500212
   Thambi T, 2013, MACROMOL RES, V21, P100, DOI 10.1007/s13233-013-1014-9
   Tibbitt MW, 2016, J AM CHEM SOC, V138, P704, DOI 10.1021/jacs.5b09974
   Upadhyay KK, 2009, BIOMACROMOLECULES, V10, P2802, DOI 10.1021/bm9006419
   Upadhyay KK, 2010, MACROMOL BIOSCI, V10, P503, DOI 10.1002/mabi.200900415
   Wang J, 2014, BIOMATERIALS, V35, P3080, DOI 10.1016/j.biomaterials.2013.12.025
   Wang YC, 2011, BIOCONJUGATE CHEM, V22, P1939, DOI 10.1021/bc200139n
   Wang Z, 2016, BIOMACROMOLECULES, V17, P98, DOI 10.1021/acs.biomac.5b01227
   Wu XM, 2014, J AM CHEM SOC, V136, P3579, DOI 10.1021/ja412380j
   Xu XD, 2016, BIOMATERIALS, V76, P238, DOI 10.1016/j.biomaterials.2015.10.056
   Yan Q, 2014, ACS MACRO LETT, V3, P472, DOI 10.1021/mz500181q
   Yin SP, 2015, ACTA BIOMATER, V26, P274, DOI 10.1016/j.actbio.2015.08.029
   Zhang AP, 2013, MACROMOL BIOSCI, V13, P1249, DOI 10.1002/mabi.201300175
   Zhang JC, 2012, LANGMUIR, V28, P2056, DOI 10.1021/la203843m
   Zhong YN, 2013, BIOMACROMOLECULES, V14, P3723, DOI 10.1021/bm401098w
   Zhu Y, 2016, J CONTROL RELEASE, V233, P29, DOI 10.1016/j.jconrel.2016.05.014
NR 63
TC 6
Z9 6
U1 9
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PD JAN 14
PY 2017
VL 8
IS 2
BP 472
EP 484
DI 10.1039/c6py01526c
PG 13
WC Polymer Science
SC Polymer Science
GA EI7JI
UT WOS:000392673200016
DA 2018-10-20
ER

PT J
AU Fujii, T
   Tohgo, K
   Isono, H
   Shimamura, Y
AF Fujii, Tomoyuki
   Tohgo, Keiichiro
   Isono, Hiroshi
   Shimamura, Yoshinobu
TI Fabrication of a PSZ-Ti functionally graded material by spark plasma
   sintering and its fracture toughness
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Powder metallurgy; Spark plasma sintering; Functionally graded
   materials; Fracture toughness
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE; BIOCOMPATIBILITY; BIOMATERIAL;
   COMPOSITES; STRENGTH; BEHAVIOR
AB This paper deals with fracture behavior of a partially stabilized zirconia (PSZ) - pure titanium (Ti) functionally graded material (FGM) fabricated by spark plasma sintering (SPS) technique. The PSZ-Ti FGM in which PSZ content is reduced from PSZ surface to Ti substrate in a stepwise manner was fabricated, and its fracture toughness distribution was evaluated. Large voids and delamination were not observed in the graded layer of the fabricated FGM. The Ti substrate and PSZ surface maintained original hardness of the monolithic Ti and PSZ fabricated by SPS respectively, and the hardness in the graded layer decreased with increasing Ti volume fraction. In fracture toughness tests, unstable crack growth occurred from a small starter-crack in the PSZ surface through the graded layer and stable crack growth occurred in the Ti substrate. The fracture toughness in the Ti substrate increased with being apart from the interface between the graded layer and Ti substrate. These results revealed that the PSZ-Ti FGM had an ability to arrest crack propagation in the Ti substrate.
C1 [Fujii, Tomoyuki; Tohgo, Keiichiro; Isono, Hiroshi; Shimamura, Yoshinobu] Shizuoka Univ, Dept Mech Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.
RP Fujii, T (reprint author), Shizuoka Univ, Dept Mech Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.
EM fujii.tomoyuki@shizuoka.ac.jp
RI Shimamura, Yoshinbou/C-5280-2014
OI Shimamura, Yoshinbou/0000-0003-1698-9012
FU Ministry of Education, Science, Sports and Culture of Japan [23360053]
FX The present work was supported by the Grant-in-Aid for Scientific
   Research ((B) 23360053) from the Ministry of Education, Science, Sports
   and Culture of Japan.
CR Afzal MAF, 2012, MAT SCI ENG C-MATER, V32, P1164, DOI 10.1016/j.msec.2012.03.003
   Askari E, 2012, J MECH BEHAV BIOMED, V12, P144, DOI 10.1016/j.jmbbm.2012.02.029
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chu CL, 2001, MAT SCI ENG A-STRUCT, V316, P205, DOI 10.1016/S0921-5093(01)01239-4
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Farnoush H, 2015, SURF COAT TECH, V265, P7, DOI 10.1016/j.surfcoat.2015.01.069
   FETT T, 1991, ENG FRACT MECH, V40, P683, DOI 10.1016/0013-7944(91)90161-S
   Fujii T., 2010, KEY ENG MATER, V4, P1699
   Fukui Y, 2014, COMP MATER SCI, V95, P29, DOI 10.1016/j.commatsci.2014.06.037
   Hussain MA, 2015, CERAM INT, V41, P10125, DOI 10.1016/j.ceramint.2015.04.110
   Kanchana S., 2013, J DENT MED SCI, V12, P66
   Koizumi M, 1997, COMPOS PART B-ENG, V28, P1, DOI 10.1016/S1359-8368(96)00016-9
   Li LH, 2005, J BIOMED MATER RES A, V73A, P48, DOI 10.1002/jbm.a.30244
   Mehrali M, 2013, J BIOMED MATER RES A, V101, P3046, DOI 10.1002/jbm.a.34588
   Nindhia T.G.T., 2008, TRENDS BIOMATER ARTI, V22, P28
   Oshkour AA, 2015, J MECH BEHAV BIOMED, V49, P321, DOI 10.1016/j.jmbbm.2015.05.020
   Prabakaran K., 2005, ARTIF ORGANS, V18, P114
   Shahrjerdi A, 2011, INT J PHYS SCI, V6, P2258
   Song HJ, 2007, SURF COAT TECH, V201, P8738, DOI 10.1016/j.surfcoat.2006.11.022
   Tohgo K, 2005, ENG FRACT MECH, V72, P2359, DOI 10.1016/j.engfracmech.2005.03.006
   Tohgo K, 2008, ENG FRACT MECH, V75, P4529, DOI 10.1016/j.engfracmech.2008.05.005
   Tohgo K, 2015, MAT SCI ENG A-STRUCT, V621, P166, DOI 10.1016/j.msea.2014.10.062
   Tsukada G, 2014, J DENT, V42, P1569, DOI 10.1016/j.jdent.2014.09.012
   Zhang Y, 2012, ACTA BIOMATER, V8, P1101, DOI 10.1016/j.actbio.2011.11.033
   Zhou CC, 2015, J MECH BEHAV BIOMED, V48, P1, DOI 10.1016/j.jmbbm.2015.04.002
NR 26
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 13
PY 2017
VL 682
BP 656
EP 663
DI 10.1016/j.msea.2016.11.091
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA EJ1XM
UT WOS:000393003800076
DA 2018-10-20
ER

PT J
AU Huo, WT
   Zhao, LZ
   Yu, S
   Yu, ZT
   Zhang, PX
   Zhang, YS
AF Huo, W. T.
   Zhao, L. Z.
   Yu, S.
   Yu, Z. T.
   Zhang, P. X.
   Zhang, Y. S.
TI Significantly enhanced osteoblast response to nano-grained pure tantalum
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VITRO BIOCOMPATIBILITY; HIGH-PRESSURE TORSION; 316L STAINLESS-STEEL;
   CORROSION-RESISTANCE; TI-25NB-3MO-3ZR-2SN ALLOY; SLIDING FRICTION;
   CELLULAR-RESPONSE; MAGNESIUM ALLOY; BONE-FORMATION; TI ALLOY
AB Tantalum (Ta) metal is receiving increasing interest as biomaterial for load-bearing orthopedic applications and the synthetic properties of Ta can be tailored by altering its grain structures. This study evaluates the capability of sliding friction treatment (SFT) technique to modulate the comprehensive performances of pure Ta. Specifically, novel nanocrystalline (NC) surface with extremely small grains (average grain size of <= 20 nm) was fabricated on conventional coarse-grained (CG) Ta by SFT. It shows that NC surface possessed higher surface hydrophilicity and enhanced corrosion resistance than CG surface. Additionally, the NC surface adsorbed a notably higher percentage of protein as compared to CG surface. The in vitro results indicated that in the initial culture stages (up to 24 h), the NC surface exhibited considerably enhanced osteoblast adherence and spreading, consistent with demonstrated superior hydrophilicity on NC surface. Furthermore, within the 14 days culture period, NC Ta surface exhibited a remarkable enhancement in osteoblast cell proliferation, maturation and mineralization as compared to CG surface. Ultimately, the improved osteoblast functions together with the good mechanical and anti-corrosion properties render the SFT-processed Ta a promising alternative for the load-bearing bone implant applications.
C1 [Huo, W. T.; Yu, S.; Yu, Z. T.; Zhang, P. X.; Zhang, Y. S.] Northwest Inst Nonferrous Met Res, Xian 710016, Peoples R China.
   [Zhao, L. Z.] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
RP Zhang, YS (reprint author), Northwest Inst Nonferrous Met Res, Xian 710016, Peoples R China.; Zhao, LZ (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
EM zhaolingzhou1983@hotmail.com; y.sh.zhang@163.com
FU National Natural Science Foundation of China [51271152, 31400821,
   31570954]; Innovation team in key areas of Shaanxi Province
   [2016KCT-30]; International Science and Technology Cooperation of China
   [2014DFA30880]; National High Technology Research and Development
   Program of China [SS2015AA020921]; Foundation for the Author of National
   Excellent Doctoral Dissertation of PR China (FANEDD) [201483]; Natural
   Science Foundation of Shaanxi Province [2015JM8387]
FX This work was supported by National Natural Science Foundation of China
   (Grant No. 51271152, 31400821 and 31570954), Innovation team in key
   areas of Shaanxi Province (2016KCT-30), International Science and
   Technology Cooperation of China (2014DFA30880), National High Technology
   Research and Development Program of China (SS2015AA020921), A Foundation
   for the Author of National Excellent Doctoral Dissertation of PR China
   (FANEDD, No. 201483), and Natural Science Foundation of Shaanxi Province
   (2015JM8387).
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bagherifard S, 2015, BIOMATERIALS, V73, P185, DOI 10.1016/j.biomaterials.2015.09.019
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Balyanov A, 2004, SCRIPTA MATER, V51, P225, DOI 10.1016/j.scriptamat.2004.04.011
   Cheng Y T, 2005, APPL PHYS LETT, V86, DOI DOI 10.1063/1.1895487
   Estrin Y, 2011, ACTA BIOMATER, V7, P900, DOI 10.1016/j.actbio.2010.09.033
   Faghihi S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485703
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Faghihi S, 2007, ADV MATER, V19, P1069, DOI 10.1002/adma.200602276
   Faghihi S, 2012, TISSUE CELL, V44, P365, DOI 10.1016/j.tice.2012.06.002
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Gnedenkov AS, 2016, CORROS SCI, V102, P348, DOI 10.1016/j.corsci.2015.10.026
   Ha SW, 2015, BIOMATERIALS, V65, P32, DOI 10.1016/j.biomaterials.2015.06.039
   Huang R, 2014, MAT SCI ENG C-MATER, V35, P144, DOI 10.1016/j.msec.2013.10.037
   Huang R, 2013, COLLOID SURFACE B, V111, P232, DOI 10.1016/j.colsurfb.2013.06.007
   Huang R, 2013, MAT SCI ENG C-MATER, V33, P2353, DOI 10.1016/j.msec.2013.01.068
   Jiang PL, 2013, ELECTROCHIM ACTA, V107, P16, DOI 10.1016/j.electacta.2013.05.120
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Li HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24414
   Liu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27374
   Liu XC, 2015, ACTA MATER, V96, P24, DOI 10.1016/j.actamat.2015.06.014
   Liu XC, 2013, SCIENCE, V342, P337, DOI 10.1126/science.1242578
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lu T, 2015, BIOMATERIALS, V51, P173, DOI 10.1016/j.biomaterials.2015.02.018
   Martines E, 2005, NANO LETT, V5, P2097, DOI [10.1021/nl051435t, 10.1021/nt051435t]
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nie FL, 2014, J BIOMED MATER RES B, V102, P221, DOI 10.1002/jbm.b.32998
   Nie FL, 2013, J BIOMED MATER RES A, V101, P1694, DOI 10.1002/jbm.a.34472
   Nie FL, 2012, J BIOMED MATER RES B, V100B, P1404, DOI 10.1002/jbm.b.32713
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   Orlov D, 2011, ACTA MATER, V59, P6176, DOI 10.1016/j.actamat.2011.06.033
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Seong JW, 2015, ACTA BIOMATER, V11, P531, DOI 10.1016/j.actbio.2014.09.029
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044
   Vinogradov A, 1999, SCRIPTA MATER, V41, P319, DOI 10.1016/S1359-6462(99)00170-0
   Wang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep26248
   Wang W, 2012, BIOMATERIALS, V33, P7993, DOI 10.1016/j.biomaterials.2012.07.064
   Xie KY, 2013, MAT SCI ENG C-MATER, V33, P3530, DOI 10.1016/j.msec.2013.04.044
   Xu WQ, 2015, NAT MATER, V14, P1229, DOI 10.1038/NMAT4435
   Zhang YS, 2014, MATER LETT, V127, P4, DOI 10.1016/j.matlet.2014.04.079
   Zhang YS, 2014, MAT SCI ENG A-STRUCT, V607, P351, DOI 10.1016/j.msea.2014.03.089
   Zhang YS, 2014, INT J REFRACT MET H, V45, P71, DOI 10.1016/j.ijrmhm.2014.03.011
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
   Zhao LZ, 2010, BIOMATERIALS, V31, P8341, DOI 10.1016/j.biomaterials.2010.07.036
   Zhao Y, 2012, CORROS SCI, V59, P360, DOI 10.1016/j.corsci.2012.03.020
   Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29069
   Zhou JH, 2016, NANOMED-NANOTECHNOL, V12, P1161, DOI 10.1016/j.nano.2016.01.011
   Zhou JH, 2013, ACS APPL MATER INTER, V5, P5358, DOI 10.1021/am401339n
NR 52
TC 7
Z9 7
U1 2
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 13
PY 2017
VL 7
AR 40868
DI 10.1038/srep40868
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH7CS
UT WOS:000391931100001
PM 28084454
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Knight, VB
   Serrano, EE
AF Knight, V. Bleu
   Serrano, Elba E.
TI Hydrogel scaffolds promote neural gene expression and structural
   reorganization in human astrocyte cultures
SO PEERJ
LA English
DT Article
DE 3D culture; RNA-seq; Tissue engineering; Transcriptome; Hydrogel;
   Astrocyte; Gene expression
ID SPINAL-CORD-INJURY; NEURONAL MATURATION; BRAIN-DEVELOPMENT; HEME
   OXYGENASE-1; CELL-CULTURE; STEM-CELLS; DIFFERENTIATION; MODEL;
   RESOURCES; SURVIVAL
AB Biomaterial scaffolds have the potential to enhance neuronal development and regeneration. Understanding the genetic responses of astrocytes and neurons to biomaterials could facilitate the development of synthetic environments that enable the specification of neural tissue organization with engineered scaffolds. In this study, we used high throughput transcriptomic and imaging methods to determine the impact of a hydrogel, PuraMatri (TM), on human glial cells in vitro. Parallel studies were undertaken with cells grown in a monolayer environment on tissue culture polystyrene. When the Normal Human Astrocyte (NHA) cell line is grown in a hydrogel matrix environment, the glial cells adopt a structural organization that resembles that of neuronal-glial cocultures, where neurons form clusters that are distinct from the surrounding glia. Statistical analysis of next generation RNA sequencing data uncovered a set of genes that are differentially expressed in the monolayer and matrix hydrogel environments. Functional analysis demonstrated that hydrogel-upregulated genes can be grouped into three broad categories: neuronal differentiation and/or neural plasticity, response to neural insult, and sensory perception. Our results demonstrate that hydrogel biomaterials have the potential to transform human glial cell identity, and may have applications in the repair of damaged brain tissue.
C1 [Serrano, Elba E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   MIT, Cell Decis Proc Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Serrano, EE (reprint author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM serrano@nmsu.edu
OI Serrano, Elba/0000-0001-7804-4212
FU National Institutes of Health [P50GM068762]; New Mexico State University
   (Manasse Endowment Fund); UTEP RCMI Border Biomedical Core Facility [NIH
   5G12MD007592]
FX This research was supported by awards from the National Institutes of
   Health (P50GM068762) and New Mexico State University (Manasse Endowment
   Fund) to EES, and the UTEP RCMI Border Biomedical Core Facility (NIH
   5G12MD007592). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abd-el-basset EM, 2013, ADV BIOSCIENCE BIOTE, V4, P7380
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983
   Azizi SA, 2013, METHODS MOL BIOL, V1078, P89, DOI 10.1007/978-1-62703-640-5_8
   Benito-Gonzalez A, 2014, JOURNAL OF NEUROSCIE, V34, DOI [10.1523/JNEUROSCI, DOI 10.1523/JNEUROSCI]
   Bjornbak C, 2014, J HISTOCHEM CYTOCHEM, V62, P369, DOI 10.1369/0022155414528514
   Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026
   Bozza A, 2014, BIOMATERIALS, V35, P4636, DOI 10.1016/j.biomaterials.2014.02.039
   Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008
   Chatzi C, 2013, DEV DYNAM, V242, P1056, DOI 10.1002/dvdy.23999
   Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042
   Clarkson BDS, 2014, J EXP MED, V211, P595, DOI 10.1084/jem.20131377
   Decleves X, 2011, CURR DRUG METAB, V12, P732, DOI 10.2174/138920011798357024
   Feinberg J, 2014, WORDLE BEAUTIFUL WOR
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Girotto G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085352
   Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071
   Hartmann U, 2013, J NEUROCHEM, V125, P399, DOI 10.1111/jnc.12212
   Hascalovici JR, 2009, J NEUROCHEM, V108, P72, DOI 10.1111/j.1471-4159.2008.05741.x
   Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28
   Hjelm BE, 2013, HUM MOL GENET, V22, P3534, DOI 10.1093/hmg/ddt208
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Jeffery AF, 2014, BIOMACROMOLECULES, V15, P2157, DOI 10.1021/bm500318d
   Kanazawa T, 2013, AM J MED GENET B, V162, P679, DOI 10.1002/ajmg.b.32164
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Kaur S, 2007, GENE EXPRESSION, V13, P321
   Kolde R., 2015, PHEATMAP PRETTY HEAT
   Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Levy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092165
   Li H, 2014, BIOMATERIALS, V35, P9049, DOI 10.1016/j.biomaterials.2014.07.038
   Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81
   Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065
   NIH (National Institutes of Health), 2016, PRINC GUID REP PRECL
   Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70
   Pfeiffer S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.426
   Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Schipper H, 2014, BRAIN RES, V1116, P5400, DOI [10.1016/j.neuroscience.2014.06.065, DOI 10.1016/J.NEUROSCIENCE.2014.06.065]
   Schipper HM, 2015, INT J MOL SCI, V16, P5400, DOI 10.3390/ijms16035400
   Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a
   SERRANO EE, 1990, GLIA, V3, P539, DOI 10.1002/glia.440030613
   Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346
   Spencer NJ, 2008, BIOMATERIALS, V29, P1028, DOI 10.1016/j.biomaterials.2007.11.006
   Sur S, 2013, BIOMATERIALS, V34, P4749, DOI 10.1016/j.biomaterials.2013.03.025
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158
   Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065701
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhang S, 2005, SQL SERVER DATABASE, P1
NR 71
TC 2
Z9 2
U1 2
U2 10
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JAN 11
PY 2017
VL 5
AR e2829
DI 10.7717/peerj.2829
PG 33
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5YK
UT WOS:000394697300001
PM 28097054
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, LS
   Duncan, B
   Tang, R
   Lee, YW
   Creran, B
   Elci, SG
   Zhu, J
   Tonga, GY
   Doble, J
   Fessenden, M
   Bayat, M
   Nonnenmann, S
   Vachet, RW
   Rotello, VM
AF Wang, Li-Sheng
   Duncan, Bradley
   Tang, Rui
   Lee, Yi-Wei
   Creran, Brian
   Elci, Sukru Gokhan
   Zhu, Jiaxin
   Tonga, Gulen Yesilbag
   Doble, Jesse
   Fessenden, Matthew
   Bayat, Mahin
   Nonnenmann, Stephen
   Vachet, Richard W.
   Rotello, Vincent M.
TI Gradient and Patterned Protein Films Stabilized via Nanoimprint
   Lithography for Engineered Interactions with Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterial; nanoimprint lithography; inkjet printing; cell patterning
   thin films
ID SILK FIBROIN; INKJET; BIOMATERIALS; DIFFERENTIATION; COCULTURES;
   CHEMISTRY; ADHESION
AB Protein-based biomaterials provide versatile scaffolds for generating functional surfaces for biomedical applications. However, tailoring the functional and biological properties of protein films remains a challenge. Here, we describe a high-throughput method to designing stable, functional biomaterials by combining inkjet deposition of protein inks with a nano imprint lithography based methodology. The translation of the intrinsically charged proteins into functional materials properties was demonstrated through controlled cellular adhesion. This modular strategy offers a rapid method to produce customizable biomaterials.
C1 [Wang, Li-Sheng; Duncan, Bradley; Tang, Rui; Lee, Yi-Wei; Creran, Brian; Elci, Sukru Gokhan; Tonga, Gulen Yesilbag; Doble, Jesse; Fessenden, Matthew; Bayat, Mahin; Vachet, Richard W.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA.
   [Zhu, Jiaxin; Nonnenmann, Stephen] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.
RP Rotello, VM (reprint author), Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA.
EM rotello@chem.umass.edu
RI Wang, Li-Sheng/D-6455-2018; Tang, Rui/J-2444-2013
OI Wang, Li-Sheng/0000-0001-6202-5463; Tang, Rui/0000-0002-3161-801X;
   Nonnenmann, Stephen/0000-0002-5369-9279; ELCI, SUKRU
   GOKHAN/0000-0002-6833-6083
FU NSF [CHE-1307021, CMMI-1025020]
FX The authors thank Professor Kenneth R. Carter, from the Department of
   Polymer Science and Engineering at University of Massachusetts Amherst,
   for the use of the nanoimprinter. This research was supported by the NSF
   (CHE-1307021 and CMMI-1025020).
CR Chen XY, 2012, CELL MOL BIOENG, V5, P307, DOI 10.1007/s12195-012-0237-8
   Creran B, 2014, ACS APPL MATER INTER, V6, P19525, DOI 10.1021/am505689g
   de Gans BJ, 2004, LANGMUIR, V20, P7789, DOI 10.1021/la049469o
   Delaney JT, 2009, SOFT MATTER, V5, P4866, DOI 10.1039/b909878j
   Derby B, 2010, ANNU REV MATER RES, V40, P395, DOI 10.1146/annurev-matsci-070909-104502
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Har-el Y., 2014, WOUND MED, V5, P9, DOI DOI 10.1016/J.WNDM.2014.04.007
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Jeoung E, 2015, ADV MATER, V27, P6251, DOI 10.1002/adma.201502457
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]
   Liou YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089767
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Perelaer J, 2009, MACROMOL CHEM PHYSIC, V210, P387, DOI 10.1002/macp.200800537
   Saunders RE, 2014, INT MATER REV, V59, P430, DOI 10.1179/1743280414Y.0000000040
   Silva NHCS, 2014, J MATER CHEM B, V2, P3715, DOI 10.1039/c4tb00168k
   Tao H, 2015, ADV MATER, V27, P4273, DOI 10.1002/adma.201501425
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Yoon SH, 2012, LAB CHIP, V12, P2391, DOI [10.1039/c2lc40084g, 10.1039/c21c40084g]
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
NR 28
TC 4
Z9 4
U1 4
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JAN 11
PY 2017
VL 9
IS 1
BP 42
EP 46
DI 10.1021/acsami.6b13815
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EH8QM
UT WOS:000392037400007
PM 28009164
DA 2018-10-20
ER

PT J
AU Gu, J
   Su, YJ
   Liu, P
   Li, P
   Yang, P
AF Gu, Jin
   Su, Yajuan
   Liu, Peng
   Li, Peng
   Yang, Peng
TI An Environmentally Benign Antimicrobial Coating Based on a Protein
   Supramolecular Assembly
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE surface coating; antimicrobial; biocompatibility; protein phase
   transition; lysozyme
ID GRAM-NEGATIVE BACTERIA; EGG-WHITE LYSOZYME; WALLED CARBON NANOTUBES;
   BIOFILM FORMATION; ANTIBACTERIAL; SURFACE; ACID; NANOPARTICLES;
   TITANIUM; BIOMATERIALS
AB The use of antimicrobial materials, for example, silver nanoparticles, has been a cause for concern because they often exert an adverse effect on environmental and safety during their preparation and use. In this study, we report a class of green antimicrobial coating based on a supramolecular assembly of a protein extracted from daily food, without the addition of any other hazardous agents. It is found that a self-assembled nanofilm by mere hen egg white lysozyme has durable in vitro and in vivo broad-spectrum antimicrobial efficacy against Gram-positive/negative and fungi. Such enhanced antimicrobial capability over native lysozyme is attributed to a synergistic combination of positive charge and hydrophobic amino acid residues enriched on polymeric aggregates in the lysozyme nanofilm. Accompanied with high antimicrobial activity, this protein-based PTL material simultaneously exhibits the integration of multiple functions including antifouling, antibiofilm, blood compatibility, and low cytotoxicity due to the existence of surface hydration effect. Moreover, the bioinspired adhesion mediated by the amyloid structure contained in the nanofilm induces robust transfer and self-adhesion of the material onto virtually arbitrary substrates by a simple one-step aqueous coating or solvent-free printing in 1 min, thereby allowing an ultrafast route into practical implications for surface-functionalized commodity and biomedical devices. Our results demonstrate that the application of pure proteinaceous substance may afford a cost-effective green biomaterial that has high antimicrobial activity and low environmental impact.
C1 [Gu, Jin; Yang, Peng] Shaanxi Normal Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Appl Surface & Colloids Chem, Xian 710119, Peoples R China.
   [Su, Yajuan; Li, Peng] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Biomed Engn & Regenerat Med, Xian 710049, Peoples R China.
   [Liu, Peng] Chongqing Univ, Coll Biomed Engn, Chongqing 400044, Peoples R China.
   [Li, Peng] Nanjing Tech Univ NanjingTech, Key Lab Flexible Elect KLOFE, Nanjing 210009, Jiangsu, Peoples R China.
   [Li, Peng] Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Inst Adv Mat IAM, Nanjing 210009, Jiangsu, Peoples R China.
RP Yang, P (reprint author), Shaanxi Normal Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Appl Surface & Colloids Chem, Xian 710119, Peoples R China.; Li, P (reprint author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Biomed Engn & Regenerat Med, Xian 710049, Peoples R China.; Liu, P (reprint author), Chongqing Univ, Coll Biomed Engn, Chongqing 400044, Peoples R China.; Li, P (reprint author), Nanjing Tech Univ NanjingTech, Key Lab Flexible Elect KLOFE, Nanjing 210009, Jiangsu, Peoples R China.; Li, P (reprint author), Nanjing Tech Univ NanjingTech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Inst Adv Mat IAM, Nanjing 210009, Jiangsu, Peoples R China.
EM liupeng79@cqu.edu.cn; iampli@njtech.edu.cn; yangpeng@snnu.edu.cn
RI Li, Peng/G-9033-2012; Yang, Peng/F-5519-2010
OI Li, Peng/0000-0002-5876-2177; Yang, Peng/0000-0002-0463-1024
FU National Natural Science Foundation of China [21374057, 51303100,
   51673112, 51403173]; Fundamental Research Funds for the Central
   Universities [GK201502001, GK201301006]; 111 Project [B14041]; Program
   for Changjiang Scholars and Innovative Research Team in University
   [IRT_14R33]; Natural Science Basic Research Plan in Shaanxi Province of
   China [2015JM2048, 2015JQ5139]; State Key Laboratory of Supramolecular
   Structure and Materials [sklssm201626]; Fundamental Research Funds for
   the Central Universities; State Key Project of Research and Development
   [2016YFC1100300]; Natural Science Foundation of China [51303218]
FX P.Y. is thankful for the funding from the National Natural Science
   Foundation of China (nos. 21374057, 51303100, and 51673112), the
   Fundamental Research Funds for the Central Universities (nos.
   GK201502001, GK201301006), the 111 Project (no. B14041) and Program for
   Changjiang Scholars and Innovative Research Team in University (no.
   IRT_14R33), the Natural Science Basic Research Plan in Shaanxi Province
   of China (no. 2015JM2048), as well as the Open Project of State Key
   Laboratory of Supramolecular Structure and Materials (no. sklssm201626).
   P.Li and Y.S. are thankful for the funding from the National Natural
   Science Foundation of China (no. 51403173), the Natural Science Basic
   Research Plan in Shaanxi Province of China (no. 2015JQ5139), and the
   Fundamental Research Funds for the Central Universities. P.Liu is
   thankful for the funding from the State Key Project of Research and
   Development (Grant no. 2016YFC1100300) and the Natural Science
   Foundation of China (51303218).
CR CABRINI G, 1986, J MEMBRANE BIOL, V92, P171, DOI 10.1007/BF01870706
   Calfee DP, 2012, ANNU REV MED, V63, P359, DOI 10.1146/annurev-med-081210-144458
   Cegielska-Radziejewska R, 2010, EUR FOOD RES TECHNOL, V231, P959, DOI 10.1007/s00217-010-1347-y
   Cegielska-Radziejewska R, 2009, EUR FOOD RES TECHNOL, V228, P841, DOI 10.1007/s00217-008-0997-5
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen WY, 2015, ADV FUNCT MATER, V25, P7189, DOI 10.1002/adfm.201503248
   Corrigan AM, 2006, J AM CHEM SOC, V128, P14740, DOI 10.1021/ja064455l
   Durmus NG, 2013, ADV MATER, V25, P5706, DOI 10.1002/adma.201302627
   Gao AT, 2016, ADV MATER, V28, P579, DOI 10.1002/adma.201504769
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Ha H. B., 2011, ASIAN J ANIM VET ADV, V6, P667
   Hadjesfandiari N, 2014, J MATER CHEM B, V2, P4968, DOI 10.1039/c4tb00550c
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hartleb W, 2016, MACROMOL CHEM PHYS, V217, P225, DOI 10.1002/macp.201500266
   He WW, 2014, J AM CHEM SOC, V136, P750, DOI 10.1021/ja410800y
   Hoq MI, 2009, FOOD RES INT, V42, P298, DOI 10.1016/j.foodres.2008.12.004
   Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x
   IBRAHIM HR, 1991, J AGR FOOD CHEM, V39, P2077, DOI 10.1021/jf00011a039
   Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P1416, DOI 10.1021/jf9507147
   Inzana JA, 2016, BIOMATERIALS, V81, P58, DOI 10.1016/j.biomaterials.2015.12.012
   Irwansyah I, 2015, ADV MATER, V27, P648, DOI 10.1002/adma.201403339
   Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838
   Julian TR, 2010, J APPL MICROBIOL, V109, P1868, DOI 10.1111/j.1365-2672.2010.04814.x
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Kuijpers AJ, 2000, J CONTROL RELEASE, V67, P323, DOI 10.1016/S0168-3659(00)00221-2
   Kushner AM, 2011, ANGEW CHEM INT EDIT, V50, P9026, DOI 10.1002/anie.201006496
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lesnierowski G, 2009, INT J FOOD SCI TECH, V44, P305, DOI 10.1111/j.1365-2621.2008.01713.x
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   Li M, 2014, ADV FUNCT MATER, V24, P1631, DOI 10.1002/adfm.201302242
   Li P, 2012, ADV MATER, V24, P4130, DOI 10.1002/adma.201104186
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Lian ZX, 2012, PROCESS BIOCHEM, V47, P201, DOI 10.1016/j.procbio.2011.10.031
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lu Y, 2015, FRONT CHEM SCI ENG, V9, P324, DOI 10.1007/s11705-015-1529-z
   Lv HB, 2014, J DENT, V42, P1464, DOI 10.1016/j.jdent.2014.06.003
   Martins AM, 2009, ACTA BIOMATER, V5, P3328, DOI 10.1016/j.actbio.2009.05.027
   MILLER TE, 1969, J BACTERIOL, V98, P949
   Muriel-Galet V, 2013, J AGR FOOD CHEM, V61, P6720, DOI 10.1021/jf401818u
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Natalio F, 2012, NAT NANOTECHNOL, V7, P530, DOI [10.1038/NNANO.2012.91, 10.1038/nnano.2012.91]
   Nepal D, 2008, NANO LETT, V8, P1896, DOI 10.1021/nl080522t
   Nyankima AG, 2014, ACS MACRO LETT, V3, P77, DOI 10.1021/mz400395j
   Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124
   Richter AP, 2015, NAT NANOTECHNOL, V10, P817, DOI [10.1038/NNANO.2015.141, 10.1038/nnano.2015.141]
   Shi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16336
   Souza BWS, 2010, FOOD HYDROCOLLOID, V24, P330, DOI 10.1016/j.foodhyd.2009.10.011
   Stein MJ, 2009, J PHYS CHEM B, V113, P11550, DOI 10.1021/jp9015867
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tao Y, 2015, ADV MATER, V27, P1097, DOI 10.1002/adma.201405105
   Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451
   Voinescu AE, 2007, LANGMUIR, V23, P12269, DOI 10.1021/la701892v
   Wang D., 2016, ADV MATER, V34, P7413
   Wang DH, 2015, SOFT MATTER, V11, P3094, DOI 10.1039/c5sm00049a
   Wang SY, 2005, BIOCHEM BIOPH RES CO, V327, P820, DOI 10.1016/j.bbrc.2004.12.077
   Wen P, 2016, FOOD CHEM, V196, P996, DOI 10.1016/j.foodchem.2015.10.043
   Wong GCL, 2011, MRS BULL, V36, P339, DOI 10.1557/mrs.2011.64
   Wu Z., 2015, ADV MATER INTERFACES, V2, P1
   Xie JB, 2011, PROTEINS, V79, P2505, DOI 10.1002/prot.23074
   Xiong M, 2015, P NATL ACAD SCI USA, V112, P13155, DOI 10.1073/pnas.1507893112
   Yang C, 2014, ADV MATER, V26, P7346, DOI 10.1002/adma.201402059
   Yang P, 2012, MACROMOL BIOSCI, V12, P1053, DOI 10.1002/mabi.201200092
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Yuan SS, 2014, ACS APPL MATER INTER, V6, P18078, DOI 10.1021/am504955g
   Yuan Y, 2013, ADV MATER, V25, P6619, DOI 10.1002/adma.201301955
   Zhao L, 2014, COLLOID SURFACE B, V119, P115, DOI 10.1016/j.colsurfb.2014.05.002
   Zhu CL, 2011, ADV MATER, V23, P4805, DOI 10.1002/adma.201102850
NR 69
TC 41
Z9 41
U1 44
U2 213
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JAN 11
PY 2017
VL 9
IS 1
BP 198
EP 210
DI 10.1021/acsami.6b13552
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EH8QM
UT WOS:000392037400026
PM 27982574
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Scott, JB
   Ward, CL
   Corona, BT
   Deschenes, MR
   Harrison, BS
   Saul, JM
   Christ, GJ
AF Scott, John B.
   Ward, Catherine L.
   Corona, Benjamin T.
   Deschenes, Michael R.
   Harrison, Benjamin S.
   Saul, Justin M.
   Christ, George J.
TI Achieving Acetylcholine Receptor Clustering in Tissue-Engineered
   Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin
   Delivery Approach
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE bioreactor; drug delivery; fibrin; microspheres; tissue engineering;
   regenerative medicine
ID MESENCHYMAL STEM-CELLS; ALTERNATIVELY SPLICED ISOFORMS;
   NEUROMUSCULAR-JUNCTION; SATELLITE CELLS; MURINE MODEL; LOSS INJURY;
   EXTRACELLULAR-MATRIX; MOLECULAR REGULATION; FUNCTIONAL RECOVERY; REPAIR
   CONSTRUCT
AB Volumetric muscle loss (VML) can result from trauma, infection, congenital anomalies, or surgery, and produce permanent functional and cosmetic deficits. There are no effective treatment options for VML injuries, and recent advances toward development of muscle constructs lack the ability to achieve innervation necessary for long-term function. We sought to develop a proof-of-concept biomaterial construct that could achieve acetylcholine receptor (AChR) clustering on muscle-derived cells (MDCs) in vitro. The approach consisted of the presentation of neural (Z+) agrin from the surface of microspheres embedded with a fibrin hydrogel to muscle cells (C2C12 cell line or primary rat MDCs). AChR clustering was spatially restricted to areas of cell (C2C12)-microsphere contact when the microspheres were delivered in suspension or when they were incorporated into a thin (2D) fibrin hydrogel. AChR clusters were observed from 16 to 72 h after treatment when Z+ agrin was adsorbed to the microspheres, and for greater than 120 h when agrin was covalently coupled to the microspheres. Little to no AChR clustering was observed when agrin-coated microspheres were delivered from specially designed 3D fibrin constructs. However, cyclic stretch in combination with agrin-presenting microspheres led to dramatic enhancement of AChR clustering in cells cultured on these 3D fibrin constructs, suggesting a synergistic effect between mechanical strain and agrin stimulation of AChR clustering in vitro. These studies highlight a strategy for maintaining a physiological phenotype characterized by motor endplates of muscle cells used in tissue engineering strategies for muscle regeneration. As such, these observations may provide an important first step toward improving function of tissue-engineered constructs for treatment of VML injuries.
C1 [Scott, John B.; Ward, Catherine L.; Corona, Benjamin T.; Harrison, Benjamin S.; Christ, George J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Scott, John B.; Harrison, Benjamin S.] Wake Forest Univ Biomed Engn, Wake Forest Univ, Sch Biomed Engn, Virginia Tech, Winston Salem, NC USA.
   [Ward, Catherine L.; Corona, Benjamin T.] US Army Inst Surg Res, San Antonio, TX USA.
   [Deschenes, Michael R.] Coll William & Mary, Dept Neurosci, Williamsburg, VA USA.
   [Saul, Justin M.] Miami Univ, Dept Chem Paper & Biomed Engn, Oxford, OH 45056 USA.
   [Christ, George J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.
   [Christ, George J.] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA.
RP Saul, JM (reprint author), Miami Univ, Dept Chem Paper & Biomed Engn, Oxford, OH 45056 USA.
EM sauljm@MiamiOH.edu
FU Telemedicine and Advanced Technology Research Center [W81XWH-12-1-0422];
   National Institutes of Health [R01AR061391]; Wake Forest University
   Department of Biomedical Engineering; Wake Forest Institute for
   Regenerative Medicine
FX This work was funded by an award from the Telemedicine and Advanced
   Technology Research Center (W81XWH-12-1-0422, GC). This work was also
   supported by the National Institutes of Health (JMS; R01AR061391) and
   the content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. This work was also partially funded by the Wake Forest
   University Department of Biomedical Engineering, and by the Wake Forest
   Institute for Regenerative Medicine. The authors gratefully acknowledge
   the assistance of Hannah Baker, Christopher Bergman, Hayden Holbrook,
   Venu Kesireddy, Juliana Passipieri, Pooja Patil, Mevan Siriwardane,
   Claire Staley, and Taylor Zak in performing experiments; Cathy Mathis
   and Cynthia Zimmerman for their assistance with histology; Christopher
   Booth for his assistance in confocal microscopy; Judy Bohnert and
   Michael Rariden for blinded image analysis; and Dr. Frank Marini for
   critique of confocal micrographs.
CR Ambrosio F, 2009, AM J PHYS MED REHAB, V88, P145, DOI 10.1097/PHM.0b013e3181951fc5
   Bach AD, 2006, J CELL MOL MED, V10, P716, DOI 10.2755/jcmm010.003.14
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bian WN, 2012, FASEB J, V26, P955, DOI 10.1096/fj.11-187575
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   CARLSON BM, 1988, EXP NEUROL, V102, P50, DOI 10.1016/0014-4886(88)90077-5
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Christ G. J., 2015, STEM CELL BIOL TISSU
   Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453
   Cleland JL, 2001, CURR OPIN BIOTECH, V12, P212, DOI 10.1016/S0958-1669(00)00202-0
   Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761
   Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Crow BD, 2007, J ORTHOP RES, V25, P396, DOI 10.1002/jor.20232
   Daggett DF, 1996, MOL CELL NEUROSCI, V8, P272, DOI 10.1006/mcne.1996.0063
   DAVIS BK, 1974, P NATL ACAD SCI USA, V71, P3120, DOI 10.1073/pnas.71.8.3120
   Dedkov EI, 2002, ACTA NEUROPATHOL, V103, P565, DOI 10.1007/s00401-001-0504-6
   Dhawan V, 2007, TISSUE ENG, V13, P2813, DOI 10.1089/ten.2007.0003
   Du XW, 2013, NEUROUROL URODYNAM, V32, P281, DOI 10.1002/nau.22291
   Dufrane D, 2008, BIOMATERIALS, V29, P2237, DOI 10.1016/j.biomaterials.2008.01.027
   Dumont NA, 2013, AM J PATHOL, V182, P505, DOI 10.1016/j.ajpath.2012.10.010
   Falco EE, 2011, PHARM RES-DORDR, V28, P1306, DOI 10.1007/s11095-010-0358-5
   FRANK E, 1975, J PHYSIOL-LONDON, V247, P725, DOI 10.1113/jphysiol.1975.sp010954
   Fujita H, 2010, J TISSUE ENG REGEN M, V4, P437, DOI 10.1002/term.253
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Gutmann E, 1942, J EXP BIOL, V19, P14
   Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Horie M, 2014, J APPL PHYSIOL, V116, P149, DOI 10.1152/japplphysiol.00235.2013
   Jang JH, 2006, J CONTROL RELEASE, V112, P120, DOI 10.1016/j.jconrel.2006.01.013
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Juhas M, 2014, BIOMATERIALS, V35, P9438, DOI 10.1016/j.biomaterials.2014.07.035
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013
   Khodabukus A, 2009, TISSUE ENG PART C-ME, V15, P501, DOI [10.1089/ten.tec.2008.0286, 10.1089/ten.TEC.2008.0286]
   Khouri RK, 1998, PLAST RECONSTR SURG, V102, P711, DOI 10.1097/00006534-199809030-00015
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Ko IK, 2013, BIOMATERIALS, V34, P3246, DOI 10.1016/j.biomaterials.2013.01.029
   Kobayashi T, 2013, J APPL PHYSIOL, V114, P262, DOI 10.1152/japplphysiol.00140.2011
   Koning M, 2012, TISSUE ENG PT A, V18, P889, DOI [10.1089/ten.TEA.2011.0191, 10.1089/ten.tea.2011.0191]
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Lanza R, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1
   Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75
   Lawson R, 2007, J AM ACAD ORTHOP SUR, V15, P290, DOI 10.5435/00124635-200705000-00007
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   LEVINSON SF, 1995, J BIOMECH, V28, P1145, DOI 10.1016/0021-9290(94)00173-2
   Lew TA, 2010, J ORAL MAXIL SURG, V68, P3, DOI 10.1016/j.joms.2009.06.006
   Lin CH, 1999, PLAST RECONSTR SURG, V104, P1070, DOI 10.1097/00006534-199909040-00027
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]
   Madhavan R, 2005, IUBMB LIFE, V57, P719, DOI 10.1080/15216540500338739
   Marques MJ, 2000, J NEUROSCI, V20, P3663
   Martin NRW, 2015, TISSUE ENG PT A, V21, P2595, DOI [10.1089/ten.tea.2015.0146, 10.1089/ten.TEA.2015.0146]
   Martin NRW, 2013, BIOMATERIALS, V34, P5759, DOI 10.1016/j.biomaterials.2013.04.002
   Mazurek Michael T, 2006, J Am Acad Orthop Surg, V14, pS18
   McKeon-Fischer KD, 2011, J BIOMED MATER RES A, V99A, P493, DOI 10.1002/jbm.a.33116
   Megeath LJ, 1998, J NEUROSCI, V18, P672
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   Ni XC, 2014, CELL REPROGRAM, V16, P140, DOI 10.1089/cell.2013.0056
   Oshima S, 2014, J ORTHOP SCI, V19, P478, DOI 10.1007/s00776-014-0548-9
   Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Sato M, 2011, J BIOSCI BIOENG, V112, P273, DOI 10.1016/j.jbiosc.2011.05.007
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274
   Scott JB, 2011, BIOMATERIALS, V32, P4830, DOI 10.1016/j.biomaterials.2011.03.037
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   Sun Y, 2013, ACTA BIOMATER, V9, P7885, DOI 10.1016/j.actbio.2013.04.036
   Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200
   Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   VANDENBURGH HH, 1989, AM J PHYSIOL, V256, pC674
   VANDENBURGH HH, 1991, J BIOMECH, V24, P91, DOI 10.1016/0021-9290(91)90380-6
   VANDENBURGH HH, 1989, IN VITRO CELL DEV B, V25, P607
   VanDusen KW, 2014, TISSUE ENG PT A, V20, P2920, DOI [10.1089/ten.tea.2014.0060, 10.1089/ten.TEA.2014.0060]
   Vignaud A, 2005, EXP PHYSIOL, V90, P487, DOI 10.1113/expphysiol.2005.029835
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wang L, 2013, MOL NEUROBIOL, V48, P397, DOI 10.1007/s12035-013-8412-z
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Williams ML, 2013, J TISSUE ENG REGEN M, V7, P434, DOI 10.1002/term.537
   Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x
   Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711
   Yun YR, 2012, BIOTECHNOL LETT, V34, P771, DOI 10.1007/s10529-011-0812-4
NR 98
TC 0
Z9 0
U1 3
U2 18
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JAN 11
PY 2017
VL 7
AR 508
DI 10.3389/fphar.2016.00508
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EH3LB
UT WOS:000391672000001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dennis, SC
   Whitlow, J
   Detamore, MS
   Kieweg, SL
   Berkland, CJ
AF Dennis, S. Connor
   Whitlow, Jonathan
   Detamore, Michael S.
   Kieweg, Sarah L.
   Berkland, Cory J.
TI Hyaluronic-Acid-Hydroxyapatite Colloidal Gels Combined with Micronized
   Native ECM as Potential Bone Defect Fillers
SO LANGMUIR
LA English
DT Article
ID IN-VIVO; DECELLULARIZED CARTILAGE; DRUG-DELIVERY; GELATIN GELS;
   HYDROGELS; MATRIX; RHEOLOGY; BEHAVIOR; FORCES; CELLS
AB One of the grand challenges in translational regenerative medicine is the surgical placement of biomaterials. For bone regeneration in particular, malleable and injectable colloidal gels are frequently designed to exhibit self-assembling and shear-response behavior which facilitates biomaterial placement in tissue defects. The current study demonstrated that by combining native extracellular matrix (ECM) microparticles, i.e., demineralized bone matrix (DBM) and decellularized cartilage (DCC), with hyaluronic acid (HA) and hydroxyapatite (HAP) nanoparticles, a viscoelastic colloidal gel consisting exclusively of natural materials was achieved. Rheological testing of HA-ECM suspensions and HA-HAP-ECM colloidal gels concluded either equivalent or substantially higher storage moduli (G' approximate to 100-10 000 Pa), yield stresses (tau(y) approximate to 100-1000 Pa), and viscoelastic recoveries (G'(recovery) >= 87%) in comparison with controls formulated without ECM, which indicated a previously unexplored synergy in fluid properties between ECM microparticles and HA-HAP colloidal networks. Notable rheological differences were observed between respective DBM and DCC formulations, specifically in HA-HAP-DBM mixtures, which displayed a mean 3-fold increase in G' and a mean 4-fold increase in tau(y) from corresponding DCC mixtures. An initial in vitro assessment of these potential tissue fillers as substrates for cell growth revealed that all formulations of HA-ECM and HA-HAP-ECM showed no signs of cytotoxicity and appeared to promote cell viability. Both DBM and DCC colloidal gels represent promising platforms for future studies in bone and cartilage tissue engineering. Overall, the current study identified colloidal gels constructed exclusively of natural materials, with viscoelastic properties that may facilitate surgical placement for a wide variety of therapeutic applications.
C1 [Dennis, S. Connor; Whitlow, Jonathan; Kieweg, Sarah L.; Berkland, Cory J.] Univ Kansas, Bioengn Program, Lawrence, KS 66045 USA.
   [Dennis, S. Connor; Whitlow, Jonathan; Berkland, Cory J.] Univ Kansas, Chem & Petr Engn Dept, Lawrence, KS 66045 USA.
   [Kieweg, Sarah L.] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
   [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.
   [Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.
RP Berkland, CJ (reprint author), 2030 Becker Dr, Lawrence, KS 66047 USA.
EM Berkland@ku.edu
FU National Institute of Dental and Craniofacial Research of the National
   Institutes of Health (NIH) [R01 DE022471]; NIGMS Predoctoral Training
   Grant Program (NIH/NIGMS) [T32-GM08359]
FX We acknowledge the National Institute of Dental and Craniofacial
   Research of the National Institutes of Health (NIH R01 DE022471) and the
   NIGMS Predoctoral Training Grant Program (NIH/NIGMS T32-GM08359).
CR Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010
   Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   BERRIAUD N, 1994, INT J BIOL MACROMOL, V16, P137, DOI 10.1016/0141-8130(94)90040-X
   BUSCALL R, 1986, COLLOID SURFACE, V18, P341, DOI 10.1016/0166-6622(86)80322-5
   BUSCALL R, 1993, J RHEOL, V37, P621, DOI 10.1122/1.550387
   Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047
   Dennis SC, 2014, LANGMUIR, V30, P3528, DOI 10.1021/la4041985
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Fakhari A, 2014, J BIOMED MATER RES B, V102, P612, DOI 10.1002/jbm.b.33041
   GARBOCZI EJ, 1995, PHYS REV E, V52, P819, DOI 10.1103/PhysRevE.52.819
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Habib M, 2010, ACTA BIOMATER, V6, P250, DOI 10.1016/j.actbio.2009.06.012
   Hamed E, 2012, ACTA BIOMATER, V8, P1080, DOI 10.1016/j.actbio.2011.11.010
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   ISRAELACHVILI JN, 1991, ABSTR PAP AM CHEM S, V201, P245
   KHAN SA, 1987, RHEOL ACTA, V26, P144, DOI 10.1007/BF01331972
   Lamboni L, 2015, BIOTECHNOL ADV, V33, P1855, DOI 10.1016/j.biotechadv.2015.10.014
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   LEONG YK, 1993, J CHEM SOC CHEM COMM, P639, DOI 10.1039/c39930000639
   Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310
   Matteini P, 2009, BIOMACROMOLECULES, V10, P1516, DOI 10.1021/bm900108z
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mellott AJ, 2015, TISSUE ENG PT A, V21, P1795, DOI [10.1089/ten.tea.2014.0340, 10.1089/ten.TEA.2014.0340]
   Meyer U., 2006, BONE CARTILAGE ENG, P7
   Oakes DA, 2003, CLIN ORTHOP RELAT R, P281, DOI 10.1097/01.blo.0000073347.50837.16
   Ozbas B, 2007, J PHYS CHEM B, V111, P13901, DOI 10.1021/jp075117p
   Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f
   Rabie ABM, 2000, AM J ORTHOD DENTOFAC, V117, P288, DOI 10.1016/S0889-5406(00)70233-2
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Sfeir C, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P21, DOI 10.1385/1-59259-863-3:021
   Shih WY, 1999, J AM CERAM SOC, V82, P616, DOI 10.1111/j.1151-2916.1999.tb01809.x
   Song FF, 2015, J BIOMED NANOTECHNOL, V11, P40, DOI 10.1166/jbn.2015.1962
   Sutherland AJ, 2015, MACROMOL BIOSCI, V15, P979, DOI 10.1002/mabi.201400472
   Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Van Tomme SR, 2006, BIOMATERIALS, V27, P4141, DOI 10.1016/j.biomaterials.2006.03.023
   Verma NP, 2013, J MATER SCI-MATER M, V24, P53, DOI 10.1007/s10856-012-4790-4
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wang HA, 2012, BIOMATERIALS, V33, P8695, DOI 10.1016/j.biomaterials.2012.08.024
   Wang J, 1998, BONE, V22, P621, DOI 10.1016/S8756-3282(98)00057-X
   Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]
   Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052
NR 50
TC 5
Z9 5
U1 3
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 10
PY 2017
VL 33
IS 1
BP 206
EP 218
DI 10.1021/acs.langmuir.6b03529
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA EH6QD
UT WOS:000391898100026
PM 28005380
DA 2018-10-20
ER

PT J
AU Wang, D
   Wang, AJ
   Wu, F
   Qiu, XF
   Li, Y
   Chu, J
   Huang, WC
   Xu, K
   Gong, XH
   Li, S
AF Wang, Dong
   Wang, Aijun
   Wu, Fan
   Qiu, Xuefeng
   Li, Ye
   Chu, Julia
   Huang, Wen-Chin
   Xu, Kang
   Gong, Xiaohua
   Li, Song
TI Sox10(+) adult stem cells contribute to biomaterial encapsulation and
   microvascularization
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; VASCULAR GRAFTS;
   MECHANISMS; FIBROSIS; DIFFERENTIATION; MYOFIBROBLASTS; SCAFFOLDS;
   DISEASES; INFILTRATION
AB Implanted biomaterials and biomedical devices generally induce foreign body reaction and end up with encapsulation by a dense avascular fibrous layer enriched in extracellular matrix. Fibroblasts/myofibroblasts are thought to be the major cell type involved in encapsulation, but it is unclear whether and how stem cells contribute to this process. Here we show, for the first time, that Sox10(+) adult stem cells contribute to both encapsulation and microvessel formation. Sox10(+) adult stem cells were found sparsely in the stroma of subcutaneous loose connective tissues. Upon subcutaneous biomaterial implantation, Sox10(+) stem cells were activated and recruited to the biomaterial scaffold, and differentiated into fibroblasts and then myofibroblasts. This differentiation process from Sox10(+) stem cells to myofibroblasts could be recapitulated in vitro. On the other hand, Sox10(+) stem cells could differentiate into perivascular cells to stabilize newly formed microvessels. Sox10(+) stem cells and endothelial cells in three-dimensional co-culture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on Sox10(+) stem cells. Transplanted Sox10(+) stem cells differentiated into smooth muscle cells to stabilize functional microvessels. These findings demonstrate the critical role of adult stem cells in tissue remodeling and unravel the complexity of stem cell fate determination.
C1 [Wang, Dong; Wang, Aijun; Wu, Fan; Chu, Julia; Huang, Wen-Chin; Xu, Kang; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Wang, Dong; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.
   [Wang, Dong; Qiu, Xuefeng; Xu, Kang; Li, Song] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Wang, Aijun] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA.
   [Qiu, Xuefeng] Huazhong Univ Sci & Technol, Tongji Med Sch, Union Hosp, Dept Cardiovasc Surg, Wuhan 430022, Peoples R China.
   [Li, Ye] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA.
   [Li, Ye] Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Hangzhou 310016, Zhejiang, Peoples R China.
RP Li, S (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Li, S (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
EM songli@ucla.edu
RI Wang, Aijun/C-7559-2013
OI Wang, Aijun/0000-0002-2985-3627; Xu, Kang/0000-0002-8492-2058
FU NIH [HL117213, HL121450]; UCLA startup fund; Siebel Fellowship
FX This work was supported by the grants from NIH (HL117213 and HL121450 to
   S.L.), UCLA startup fund (to S.L.) and Siebel Fellowship (to D.W.). X.G.
   as endowed Pamela and Kenneth Fong Chair. We thank Mary West in CIRM/QB3
   Shared Stem Cell Facility of UC Berkeley for her technical assistance.
   Some of the confocal microscopy (Leica SP5-Blue) was performed at the
   CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at
   UCLA. We also thank Dr. Fan Yuan at Duke University for his help on
   skinfold chamber model and Dr. Yang Dan at UC Berkeley for her help on
   two-photon microscopy.
CR Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636
   Bockmeyer CL, 2012, NEPHROL DIAL TRANSPL, V27, P3493, DOI 10.1093/ndt/gfr811
   BRONNERFRASER M, 1993, BIOESSAYS, V15, P221, DOI 10.1002/bies.950150402
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882
   Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5
   Dravis C, 2015, CELL REP, V12, P2035, DOI 10.1016/j.celrep.2015.08.040
   Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831
   Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348
   Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419
   Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004
   Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005
   Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004
   Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253
   Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595
   Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062
   Lee BLP, 2013, ACTA BIOMATER, V9, P7264, DOI 10.1016/j.actbio.2013.03.009
   Lee BLP, 2012, ACTA BIOMATER, V8, P2648, DOI 10.1016/j.actbio.2012.04.023
   Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696
   Lee VK, 2017, ANN BIOMED ENG, V45, P115, DOI 10.1007/s10439-016-1613-7
   Li MY, 2014, BIOMED RES INT, DOI 10.1155/2014/186239
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Nichols SP, 2013, CHEM REV, V113, P2528, DOI 10.1021/cr300387j
   Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563
   Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Schmidt-Hansen B, 2004, ONCOGENE, V23, P5487, DOI 10.1038/sj.onc.1207720
   Schneider M, 2008, J MOL MED-JMM, V86, P507, DOI 10.1007/s00109-007-0301-3
   Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200
   Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535
   STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393
   Tang ZY, 2013, CIRC RES, V112, P23, DOI 10.1161/CIRCRESAHA.112.281055
   Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867
   TARIN D, 1970, J ANAT, V106, P79
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tomokiyo A, 2012, J CELL PHYSIOL, V227, P2040, DOI 10.1002/jcp.22933
   vanderLoop FTL, 1996, J CELL BIOL, V134, P401, DOI 10.1083/jcb.134.2.401
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Wang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10081
   Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510
   Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1
   Yu J, 2012, BIOMATERIALS, V33, P8062, DOI 10.1016/j.biomaterials.2012.07.042
   Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012
NR 50
TC 4
Z9 4
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 10
PY 2017
VL 7
AR 40295
DI 10.1038/srep40295
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH5SH
UT WOS:000391832700001
PM 28071739
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Duminis, T
   Shahid, S
   Hill, RG
AF Duminis, Tomas
   Shahid, Saroash
   Hill, Robert Graham
TI Apatite Glass-Ceramics: A Review
SO FRONTIERS IN MATERIALS
LA English
DT Review
DE apatite; glass; glass-ceramic; biomaterial; fluorapatite; chlorapatite;
   nucleation and crystallization; orthopedic
ID AMORPHOUS PHASE-SEPARATION; CRYSTAL NUCLEATION KINETICS; TRANSMISSION
   ELECTRON-MICROSCOPY; SIMULATED BODY-FLUID; BIOACTIVE GLASS; BAO-SIO2
   GLASSES; CA-5(PO4)(3)F NANOCRYSTALS; SPECTROSCOPIC PROPERTIES; CALCIUM
   FLUOROPHOSPHATE; NEUTRON-DIFFRACTION
AB This article is a review of the published literature on apatite glass-ceramics (GCs). Topics covered include crystallization mechanisms of the various families of apatite GCs and an update on research and development on apatite GCs for applications in orthopedics, dentistry, optoelectronics, and nuclear waste management. Most apatite GCs crystallize through a homogenous nucleation and crystallization mechanism, which is aided by a prior liquid-liquid phase separation. Careful control of the base glass composition and heat-treatment conditions, which determine the nature and morphology of the crystal phases in the GC can produce GC materials with exceptional thermal, mechanical, optical, and biological properties. The GCs reviewed for orthopedic applications exhibit suitable mechanical properties and can chemically bond to bone and stimulate its regeneration. The most commercially successful apatite GCs are those developed for dental veneering. These materials exhibit excellent translucency and clinical esthetics and mimic the natural tooth mineral. Due to the ease of solid solution of the apatite lattice, rare earth doped apatite GCs are discussed for potential applications in optoelectronics and nuclear waste management. One of the drawbacks of the commercial apatite GCs used in orthopedics is the lack of resorbability; therefore, the review provides a direction for future research in the field.
C1 [Duminis, Tomas; Shahid, Saroash; Hill, Robert Graham] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Oral Growth & Dev,Unit Dent Phys Sci, London, England.
RP Duminis, T (reprint author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Oral Growth & Dev,Unit Dent Phys Sci, London, England.
EM t.duminis@qmul.ac.uk
OI Duminis, Tomas/0000-0002-4959-3199
FU Cera Dynamics Limited; James Kent Group; Institute of Dentistry (Queen
   Mary University of London)
FX The authors would like to thank Cera Dynamics Limited, part of the James
   Kent Group and the Institute of Dentistry (Queen Mary University of
   London) for jointly funding TD.
CR An Y. H., 2000, MECH TESTING BONE BO
   Blades MC, 1998, J MATER SCI-MATER M, V9, P701, DOI 10.1023/A:1008990516159
   BLUMENTHAL NC, 1975, CALC TISS RES, V18, P81, DOI 10.1007/BF02546228
   CAHN JW, 1969, J AM CERAM SOC, V52, P118, DOI 10.1111/j.1151-2916.1969.tb11194.x
   Calver A, 2004, J MATER SCI, V39, P2601, DOI 10.1023/B:JMSC.0000020038.79675.0f
   Chen XJ, 2014, INT J APPL GLASS SCI, V5, P207, DOI 10.1111/ijag.12082
   Chen XJ, 2014, J NON-CRYST SOLIDS, V402, P172, DOI 10.1016/j.jnoncrysol.2014.05.025
   Chen XJ, 2014, MATERIALS, V7, P5470, DOI 10.3390/ma7085470
   Clifford A, 1996, J NON-CRYST SOLIDS, V196, P346, DOI 10.1016/0022-3093(95)00611-7
   Clifford A, 2001, J MATER SCI-MATER M, V12, P461, DOI 10.1023/A:1011213406951
   Clifford A, 2001, J MATER SCI, V36, P3955, DOI 10.1023/A:1017974306184
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504
   DELOACH LD, 1994, J OPT SOC AM B, V11, P269, DOI 10.1364/JOSAB.11.000269
   Denry I, 2012, J BIOMED MATER RES B, V100B, P1198, DOI 10.1002/jbm.b.32684
   Donald IW, 2007, J NUCL MATER, V361, P78, DOI 10.1016/j.jnucmat.2006.11.011
   Ducheyne P., 2011, COMPREHENSIVE BIOMAT
   ELLIOTT JC, 1967, NATURE, V214, P904, DOI 10.1038/214904b0
   Fang YN, 2014, DALTON T, V43, P16031, DOI 10.1039/c4dt02088j
   Fechtelkord M, 2003, AM MINERAL, V88, P47
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Frank M., 1994, GLASTECH BER GLASS C, V67, P117
   Freeman CO, 2003, J MATER SCI-MATER M, V14, P985, DOI 10.1023/A:1026306901058
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gerth K., 1962, 63 ANN AM CER SOC S, P11
   Goodridge RD, 2007, ACTA BIOMATER, V3, P221, DOI 10.1016/j.actbio.2006.10.005
   GROSSMAN DG, 1972, J AM CERAM SOC, V55, P446, DOI 10.1111/j.1151-2916.1972.tb11337.x
   Hill R, 2006, KEY ENG MAT, V309-311, P305, DOI 10.4028/www.scientific.net/KEM.309-311.305
   HILL R, 1995, J MATER SCI-MATER M, V6, P311, DOI 10.1007/BF00120298
   Hill R., 1991, 4 INT S CER MED
   Hill RG, 2004, J NON-CRYST SOLIDS, V336, P223, DOI 10.1016/j.jnoncrysol.2004.02.005
   Hill R, 2007, J AM CERAM SOC, V90, P763, DOI 10.1111/j.1551-2916.2006.01474.x
   Hill RG, 2010, J NON-CRYST SOLIDS, V356, P2935, DOI 10.1016/j.jnoncrysol.2010.05.102
   Holand W, 2008, WOODHEAD PUBL MATER, P548, DOI 10.1533/9781845694227.2.548
   Holand W, 2000, J MATER SCI-MATER M, V11, P11, DOI 10.1023/A:1008977416834
   Holand W., 2012, GLASS CERAMIC TECHNO
   Holand Wolfram, 2015, Front Bioeng Biotechnol, V3, P149, DOI 10.3389/fbioe.2015.00149
   HOPKINS RH, 1971, J APPL PHYS, V42, P272, DOI 10.1063/1.1659583
   JAMES PF, 1981, AM CERAM SOC BULL, V60, P352
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KITSUGI T, 1990, J BIOMED MATER RES, V24, P259, DOI 10.1002/jbm.820240211
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T, 2008, WOODHEAD PUBL MATER, P284, DOI 10.1533/9781845694227.2.284
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6
   LEGEROS RZ, 1980, 2ND P INT C PHOSPH C, P89
   McCubbin FM, 2008, AM MINERAL, V93, P676, DOI 10.2138/am.2008.2558
   McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107
   Montazerian M, 2016, J BIOMED MATER RES A, V104, P1231, DOI 10.1002/jbm.a.35639
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   O'Donnell MD, 2010, J NON-CRYST SOLIDS, V356, P2693, DOI 10.1016/j.jnoncrysol.2010.08.038
   OHLMANN RC, 1968, APPL OPTICS, V7, P905, DOI 10.1364/AO.7.000905
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   PAYNE SA, 1994, IEEE J QUANTUM ELECT, V30, P170, DOI 10.1109/3.272077
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Pinckney L. R., 1998, Transparent Apatite Glass-Ceramics, Patent No. [WO 1998043922 A1, 1998043922]
   PIPER WW, 1965, PHYS REV, V138, P1802, DOI 10.1103/PhysRev.138.A1802
   Rafferty A, 2000, J AM CERAM SOC, V83, P2833
   Rafferty A, 2000, J MATER SCI, V35, P3863, DOI 10.1023/A:1004885531712
   Rafferty A, 2003, J MATER SCI, V38, P2311, DOI 10.1023/A:1023972127593
   RAMSDEN AH, 1984, J MATER SCI, V19, P2894, DOI 10.1007/BF01026965
   RAMSDEN AH, 1984, J MATER SCI, V19, P1406, DOI 10.1007/BF00563035
   Ranu H S, 1987, Eng Med, V16, P175
   Reusche E, 2001, HUM PATHOL, V32, P1136, DOI 10.1053/hupa.2001.28251
   Robert H, 2000, GLASS SCI TECHNOL, V73, P146
   RODRIGUEZ M, 1990, J BONE MINER RES, V5, P59, DOI 10.1002/jbmr.5650050110
   Sabareeswaran A, 2013, BIOMATERIALS, V34, P9278, DOI 10.1016/j.biomaterials.2013.08.070
   Samuneva B, 1998, J SOL-GEL SCI TECHN, V13, P951, DOI 10.1023/A:1008691711234
   SEGALL B, 1962, PHYS REV, V128, P76, DOI 10.1103/PhysRev.128.76
   Siriphannon P, 2000, J BIOMED MATER RES, V52, P30, DOI 10.1002/1097-4636(200010)52:1<30::AID-JBM5>3.0.CO;2-Z
   Soulet S, 2001, NUCL INSTRUM METH B, V184, P383, DOI 10.1016/S0168-583X(01)00764-9
   Stamboulis A, 2006, KEY ENG MAT, V309-311, P309, DOI 10.4028/www.scientific.net/KEM.309-311.309
   Stamboulis A., 2004, BIOCERAMICS, V16, P254, DOI [10.4028/www.scientific.net/KEM.254-256.99, DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.254-256.99]
   Stanton KT, 2005, J CRYST GROWTH, V275, pE2061, DOI 10.1016/j.jcrysgro.2004.11.266
   Stanton KT, 2010, J NON-CRYST SOLIDS, V356, P1802, DOI 10.1016/j.jnoncrysol.2010.07.006
   Stanton KT, 2009, J MATER SCI-MATER M, V20, P851, DOI 10.1007/s10856-008-3650-8
   STRNAD Z, 1992, BIOMATERIALS, V13, P317, DOI 10.1016/0142-9612(92)90056-T
   TOMOZAWA M, 1972, PHYS CHEM GLASSES, V13, P161
   Tulyaganov DU, 2000, J AM CERAM SOC, V83, P3141, DOI 10.1111/j.1151-2916.2000.tb01695.x
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   VOGEL W, 1986, J NON-CRYST SOLIDS, V80, P34, DOI 10.1016/0022-3093(86)90377-7
   Vogel W., 2013, INTRO BIOCERAMICS, P215
   Weber W. J., 1979, CERAMICS NUCLEAR WAS, P294
   WEBER WJ, 1993, J AM CERAM SOC, V76, P1729, DOI 10.1111/j.1151-2916.1993.tb06641.x
   White T, 2005, REV MINERAL GEOCHEM, V57, P307, DOI 10.2138/rmg.2005.57.10
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
   ZANOTTO ED, 1986, J MATER SCI, V21, P3050, DOI 10.1007/BF00553336
   Zanotto ED, 2010, AM CERAM SOC BULL, V89, P19
   Zeng Q, 2000, AM MINERAL, V85, P863, DOI 10.2138/am-2000-5-630
   Zhang SN, 2013, OPT MATER EXPRESS, V3, P868, DOI 10.1364/OME.3.000868
   Zhang SN, 2013, J NON-CRYST SOLIDS, V366, P35, DOI 10.1016/j.jnoncrysol.2013.01.048
   Zhang SN, 2012, J NON-CRYST SOLIDS, V358, P2835, DOI 10.1016/j.jnoncrysol.2012.07.005
NR 98
TC 3
Z9 3
U1 5
U2 23
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 2296-8016
J9 FRONT MATER
JI Front. Mater.
PD JAN 9
PY 2017
VL 3
AR UNSP 59
DI 10.3389/fmats.2016.00059
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA EK0WM
UT WOS:000393647800001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, ZX
   Yao, SL
   Xie, S
   Wang, XM
   Chang, FY
   Luo, J
   Wang, JM
   Fu, J
AF Zhang, Zhenxia
   Yao, Shenglian
   Xie, Sheng
   Wang, Xiumei
   Chang, Feiyan
   Luo, Jie
   Wang, Jingming
   Fu, Jun
TI Effect of hierarchically aligned fibrin hydrogel in regeneration of
   spinal cord injury demonstrated by tractography: A pilot study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DIFFUSION-TENSOR MRI; FUNCTIONAL RECOVERY; FIBER TRACKING; MONODOMAIN
   GELS; STEM-CELLS; RAT MODEL; FEASIBILITY; OUTCOMES; TRAUMA; CANINE
AB Some studies have reported that scaffold or cell-based transplantation may improve functional recovery following SCI, but no imaging information regarding regeneration has been provided to date. This study used tractography to show the regenerating process induced by a new biomaterial-aligned fibrin hydrogel (AFG). A total of eight canines subjected to SCI procedures were assigned to the control or the AFG group. AFG was implanted into the SCI lesion immediately after injury in 5 canines. A follow-up was performed at 12 weeks to evaluate the therapeutic effect including the hindlimb functional recovery, anisotropy and continuity of fibers on tractography. Using tractography, we found new fibers running across the SCI in three canines of the AFG group. Further histological examination confirmed limited glial scarring and regenerated nerve fibers in the lesions. Moreover, Repeated Measures Analysis revealed a significantly different change in fractional anisotropy (FA) between the two groups during the follow-up interval. An increase in FA during the post injury time interval was detected in the AFG group, indicating a beneficial effect of AFG in the rehabilitation of injured axons. Using tractography, AFG was suggested to be helpful in the restoration of fibers in SCI lesions, thus leading to promoted functional recovery.
C1 [Zhang, Zhenxia; Xie, Sheng] Peking Univ, Dept Radiol, China Japan Friendship Sch Clin Med, Beijing 100029, Peoples R China.
   [Yao, Shenglian; Wang, Xiumei] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Xie, Sheng; Chang, Feiyan] China Japan Friendship Hosp, Dept Radiol, Beijing 100029, Peoples R China.
   [Luo, Jie] China Japan Friendship Hosp, Dept Pathol, Beijing 100029, Peoples R China.
   [Wang, Jingming; Fu, Jun] Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing 100853, Peoples R China.
RP Xie, S (reprint author), Peking Univ, Dept Radiol, China Japan Friendship Sch Clin Med, Beijing 100029, Peoples R China.; Wang, XM (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.; Xie, S (reprint author), China Japan Friendship Hosp, Dept Radiol, Beijing 100029, Peoples R China.
EM xs_mri@126.com; wxm@mail.tsinghua.edu.cn
FU Tsinghua University Initiative Scientific Research Program of China
   [20121087982, 20131089199]; Tsinghua University Initiative Scientific
   Research Program [20121087982, 20131089199]
FX This work was supported by the Tsinghua University Initiative Scientific
   Research Program of China (20121087982 and 20131089199). We would like
   to gratefully thank Kaining Shi of the Philips Healthcare China Research
   Team for his critical comments on the manuscript and for his revision of
   the manuscript. This work was supported by the Tsinghua University
   Initiative Scientific Research Program [No. 20121087982 and 20131089199
   to Xiumei Wang].
CR Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105
   Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9
   Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Cao HQ, 2013, NEUROSCI BULL, V29, P94, DOI 10.1007/s12264-012-1277-8
   Chau C, 1998, J NEUROPHYSIOL, V79, P392
   Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484
   Facon D, 2005, AM J NEURORADIOL, V26, P1587
   Fujiyoshi K, 2013, EXP NEUROL, V242, P74, DOI 10.1016/j.expneurol.2012.07.015
   GRILLNER S, 1973, ACTA PHYSIOL SCAND, V87, P320, DOI 10.1111/j.1748-1716.1973.tb05396.x
   Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031
   Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481
   Hobert MK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-36
   Kelley BJ, 2014, J NEUROTRAUM, V31, P1362, DOI 10.1089/neu.2013.3238
   Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784
   Kim JH, 2012, EXP NEUROL, V235, P188, DOI 10.1016/j.expneurol.2011.11.015
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   Konomi T, 2012, NEUROIMAGE, V63, P1841, DOI 10.1016/j.neuroimage.2012.08.040
   Li A, 2014, BIOMATERIALS, V35, P8780, DOI 10.1016/j.biomaterials.2014.06.049
   Li XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12639
   LOVELY RG, 1990, BRAIN RES, V514, P206, DOI 10.1016/0006-8993(90)91417-F
   Mondragon-Lozano R, 2013, SPINE, V38, pE1242, DOI 10.1097/BRS.0b013e31829ef69c
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913
   Rao JS, 2013, J NEURORADIOLOGY, V40, P181, DOI 10.1016/j.neurad.2012.08.008
   Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007
   Sasiadek MJ, 2012, MED SCI MONITOR, V18, pRA73
   Schwartz ED, 2005, J NEUROTRAUM, V22, P1388, DOI 10.1089/neu.2005.22.1388
   Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916
   van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721
   Wang F, 2014, NEUROREPORT, V25, P1386, DOI 10.1097/WNR.0000000000000278
   Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022
   Yao SL, 2016, NANOSCALE, V8, P10252, DOI 10.1039/c6nr01169a
   Zhang D, 2015, NEURAL REGEN RES, V10, P412, DOI 10.4103/1673-5374.153689
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
NR 38
TC 6
Z9 6
U1 3
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 9
PY 2017
VL 7
AR 40017
DI 10.1038/srep40017
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG9ZK
UT WOS:000391421400001
PM 28067245
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Taylor, JO
   Yang, L
   Deutsch, S
   Manning, KB
AF Taylor, Joshua O.
   Yang, Ling
   Deutsch, Steven
   Manning, Keefe B.
TI Development of a platelet adhesion transport equation for a
   computational thrombosis model
SO JOURNAL OF BIOMECHANICS
LA English
DT Article; Proceedings Paper
CT 8th International Biofluid Mechanics Symposium
CY MAR, 2016
CL Calif Inst Technol, Pasadena, CA
HO Calif Inst Technol
DE Thrombosis; Platelets; Modeling; Laser Doppler velocimetry; Adhesion;
   Computations
ID BLOOD-VISCOSITY; FLOW; AGGREGATION; ACTIVATION; SIMULATION; SUSPENSION;
   DEPOSITION; PLASMA; GROWTH
AB Thrombosis is a significant issue for cardiovascular device development and use. While thrombosis models are available, very few are device-related and none have been thoroughly validated experimentally. Here, we introduce a surface adherent platelet transport equation into a continuum model to account for the biomaterial interface/blood interaction. Using a rotating disc system and polyurethane urea material, we characterize steady and pulsatile flow fields using laser Doppler velocimetry. In vitro measurements of platelet adhesion are used in combination with the LDV data to provide further experimental validation. The rotating disc system is computationally studied using the device-induced thrombosis model with the surface platelet adherent transport equation. The results indicate that the flow field is in excellent agreement to the experimental LDV data and that the platelet adhesion simulations are in good agreement with the in vitro platelet data. These results provide good evidence that this transport equation can be used to express the relationship between blood and a biomaterial if the correct platelet adhesion characteristics are known for the biomaterial. Further validation is necessary with other materials. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Taylor, Joshua O.; Yang, Ling; Manning, Keefe B.] Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.
   [Taylor, Joshua O.; Deutsch, Steven] Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.
   [Manning, Keefe B.] Penn State Hershey, Med Ctr, Dept Surg, Hershey, PA USA.
RP Manning, KB (reprint author), Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.
EM kbm10@psu.edu
FU Applied Research Laboratory at the Pennsylvania State University; Penn
   State Grace Woodward Foundation
FX A Walker Graduate Assistantship from the Applied Research Laboratory at
   the Pennsylvania State University and a Penn State Grace Woodward
   Foundation grant supported this work.
CR Bark DL, 2012, BIOTECHNOL BIOENG, V109, P2642, DOI 10.1002/bit.24537
   Bludszuweit C., 1994, THESIS
   Cito S, 2013, THROMB RES, V131, P116, DOI 10.1016/j.thromres.2012.11.020
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   de Biasi AR, 2015, J THORAC CARDIOV SUR, V149, P667, DOI 10.1016/j.jtcvs.2014.11.041
   Fogelson AL, 2008, COMPUT METHOD APPL M, V197, P2087, DOI 10.1016/j.cma.2007.06.030
   FOGELSON AL, 1992, SIAM J APPL MATH, V52, P1089, DOI 10.1137/0152064
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Good BC, 2016, ANN BIOMED ENG, V44, P1019, DOI 10.1007/s10439-015-1370-z
   Goodman PD, 2005, ANN BIOMED ENG, V33, P780, DOI 10.1007/s10439-005-2951-z
   Grunenwald LE., 2013, THESIS
   Jurk K, 2003, FASEB J, V17, P1490, DOI 10.1096/fj.02-0830fje
   Kennedy SD, 1997, AM J CLIN PATHOL, V107, P99
   Leiderman K, 2014, THROMB RES, V133, pS12, DOI 10.1016/j.thromres.2014.03.005
   LINDERKAMP O, 1984, PEDIATRICS, V74, P45
   Marchena E.D., 2015, JACC-CARDIOVASC INTE, V8, P728
   Mehra MR, 2014, J HEART LUNG TRANSPL, V33, P1, DOI 10.1016/j.healun.2013.12.002
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Mori D, 2008, THROMB HAEMOSTASIS, V99, P108, DOI 10.1160/TH07-08-0490
   Navitsky MA, 2014, ARTIF ORGANS, V38, P1046, DOI 10.1111/aor.12296
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551
   Soares JS, 2013, BIOMECH MODEL MECHAN, V12, P1127, DOI 10.1007/s10237-013-0469-0
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201
   STEWART S, 2013, CARDIOVASC ENG TECHN, V4, P374
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   Taylor J.O., 2014, J BIOMECH ENG, V136
   Taylor J.O., 2016, BIOMECH MODEL MECH B
   Tokarev AA, 2011, BIOPHYS J, V100, P799, DOI 10.1016/j.bpj.2010.12.3740
   Topper SR, 2014, CARDIOVASC ENG TECHN, V5, P54, DOI 10.1007/s13239-014-0174-x
   Wang WW, 2012, ANN BIOMED ENG, V40, P2345, DOI 10.1007/s10439-012-0558-8
   Windberger U, 2003, EXP PHYSIOL, V88, P431, DOI 10.1113/eph8802496
   Xu ZL, 2011, ARTERIOSCL THROM VAS, V31, P500, DOI 10.1161/ATVBAHA.110.213397
   Yamanaka H, 2005, ASAIO J, V51, P567, DOI 10.1097/01.mat.0000181707.06225.a0
   ZYDNEY AL, 1988, PHYSICOCHEM HYDRODYN, V10, P77
NR 36
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JAN 4
PY 2017
VL 50
SI SI
BP 114
EP 120
DI 10.1016/j.jbiomech.2016.11.012
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA EI8WQ
UT WOS:000392789300017
PM 27855988
DA 2018-10-20
ER

PT J
AU He, XR
   Wang, XX
   Fang, JC
   Zhao, ZF
   Huang, LH
   Guo, H
   Zheng, XH
AF He, Xirui
   Wang, Xiaoxiao
   Fang, Jiacheng
   Zhao, Zefeng
   Huang, Linhong
   Guo, Hao
   Zheng, Xiaohui
TI Bletilla striata: Medicinal uses, phytochemistry and pharmacological
   activities
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Review
DE Bletilla striata; Polysaccharides; Phenanthrenes; Wound healing;
   Biomaterials
ID SPIROSTANE-STEROIDAL SAPONINS; ULCERATIVE-COLITIS; NONPOLAR
   CONSTITUENTS; POLYSACCHARIDE; BIPHENANTHRENES; INFLAMMATION;
   STILBENOIDS; MACROPHAGES; GLUCOMANNAN; EXPRESSION
AB Ethnopharmacological relevance: Bletilla striata (Thunb.) Reichb. f. (Orchidaceae), also known as Hyacinth Orchid and Baiji (Simplified Chinese: ), not only has been widely used for the treatment of hematemesis, hemoptysis, and traumatic bleeding due to the efficacy of arresting bleeding with astringent action, but also has been applied topically to overcome ulcers, sores, swellings, and chapped skin due to the efficacy of dispersing swelling and promoting tissue regeneration. Additional medical applications include the treatment of tuberculosis, malignant ulcers, hemorrhoids, anthrax, eye diseases, and silicosis.
   Aim of this review: This review aims to provide up-to-date information on the botanical characterization, medicinal uses, chemical constituents, pharmacological activities, and toxicity of B. striata. In addition, this paper also focuses on the possible exploitation of this plant for the treatment of different diseases, and uncovers opportunities for future research.
   Materials and methods: The relevant information on B. striata was gathered from worldwide accepted scientific databases via an electronic search (Google Scholar, Web of Science, ScienceDirect, ACS Publications, PubMed, Wiley Online Library, SciFinder, CNKI). Information was also obtained from The Plant List, Chinese pharmacopoeia, Chinese herbal classics books, PhD and MSc dissertations, etc.
   Results: A comprehensive analysis of the literature obtained through the above-mentioned sources confirmed that the ethnomedical usages of B. striata have been recorded in Mongolia, Korea, Japan, and China. Phytochemical investigations revealed that the major chemical constituents of B. striata are polysaccharides, bibenzyls, phenanthrenes, triterpenoids and its saponins, steroids and its saponins, which also have been proven to be the main bioactive substances capable of exhibiting numerous pharmacological activities including wound healing, antiulcer, hemostasis, cytotoxicity, antimicrobial, anti-inflammation, anti-oxidation, immuno-modulation, anti-fibrosis, antiaging, anti-allergy, and anti-itch.
   Conclusions: Preliminary investigations on pharmacological properties of B. striata have shown that B. striata is an outstanding astringent hemostatic medicinal, B. striata polysaccharides (BSP) as the major bioactive components not only capable of promoting wound healing, but also show good performance as a kind of promising natural biomaterial. More importantly, BSP are also reported to be excellent embolic material. However, further investigations need to be carried out to fully clarify its efficacy of dispersing swelling and promoting tissue regeneration. Moreover, this plant also needs a lot more investigations to clarify the pathways of absorption, distribution, metabolism and excretion, and to evaluate its long-term in vivo chronic toxicity before proceeding to the development of pharmaceutical formulation.
C1 [He, Xirui; Huang, Linhong; Guo, Hao] Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Xian 710054, Peoples R China.
   [He, Xirui; Wang, Xiaoxiao; Fang, Jiacheng; Zhao, Zefeng; Zheng, Xiaohui] Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian 710069, Peoples R China.
RP Huang, LH (reprint author), Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Xian 710054, Peoples R China.; Zheng, XH (reprint author), Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian 710069, Peoples R China.
EM hxrhist@163.com; zhengxh@nwu.edu.cn
FU Administration of Traditional Chinese Medicine of Shaanxi Province
   [13-JC-030]; Xi'an Foundation for Development of Science and Technology,
   China [SF1423(3)]
FX This work was supported by Administration of Traditional Chinese
   Medicine of Shaanxi Province (13-JC-030); Xi'an Foundation for
   Development of Science and Technology, China (No. SF1423(3)).
CR Agyare C, 2016, J ETHNOPHARMACOL, V177, P85, DOI 10.1016/j.jep.2015.11.008
   BAI L, 1990, PHYTOCHEMISTRY, V29, P1259, DOI 10.1016/0031-9422(90)85437-K
   BAI L, 1991, PHYTOCHEMISTRY, V30, P2733, DOI 10.1016/0031-9422(91)85133-K
   BAI L, 1993, PHYTOCHEMISTRY, V33, P1481, DOI 10.1016/0031-9422(93)85115-8
   Bown D., 1995, ENCY HERBS THEIR USE, P126
   Brewer MS, 2011, COMPR REV FOOD SCI F, V10, P221, DOI 10.1111/j.1541-4337.2011.00156.x
   Calaway H. D., 1997, ORCHID BIOL REV PERS, VVII, P258
   Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006
   China Pharmacopoeia Commission, 2015, CHIN PHARM, P103
   Chinese Herbalism Editorial Board, 1999, ZHONGH BENC, P7803
   Diao HJ, 2008, J BIOSCI BIOENG, V105, P85, DOI 10.1263/jbb.105.85
   Dong JW, 2015, PROCESS BIOCHEM, V50, P8, DOI 10.1016/j.procbio.2014.09.008
   Dong L, 2009, J CONTROL RELEASE, V134, P214, DOI 10.1016/j.jconrel.2008.11.013
   Dreifke MB, 2015, MAT SCI ENG C-MATER, V48, P651, DOI 10.1016/j.msec.2014.12.068
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   Feng Gan-Sheng, 2003, Zhonghua Yi Xue Za Zhi, V83, P412
   Feng JQ, 2008, HELV CHIM ACTA, V91, P520, DOI 10.1002/hlca.200890056
   Feng WW, 2015, LAT AM J PHARM, V34, P907
   Flora of China Editorial Committee, 2009, FLORA CHINA, P210
   Han G. X., 2001, J PHARM PRACTICE, V19, P360
   Han Guang-xuan, 2002, Yao Xue Xue Bao, V37, P194
   [韩广轩 Han Guangxuan], 2002, [第二军医大学学报, Academic Journal of Second Military Medical University], V23, P1029
   Han GX, 2002, ACAD J SEC MIL MED U, V23, P443
   [何海玲 HE Hailing], 2007, [食品科学, Food Science], V28, P336
   Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46
   Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002
   Hossain MM, 2011, FITOTERAPIA, V82, P102, DOI 10.1016/j.fitote.2010.09.007
   Jiang FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058004
   [柯昌毅 KE Changyi], 2011, [中国药房, China Pharmacy], V22, P2132
   Koo H. C., 1955, ACTA PHARMACOL SIN, V3, P257
   Koon J. M., 2003, ACTA PHARMACOL SIN, V24, P7
   Kubo Michinori, 2003, Natural Medicines, V57, P55
   Lawler L. J., 1984, ORCHID BIOL REV PERS, VIII, P256
   Lee J.H., 2013, KOREAN J HERBOL, V28, P9
   Lei Z. Q., 2012, SCI CHINESE MATERIA, P191
   Li Q, 2014, ASIAN J CHEM, V26, P3574
   [李嵘 LI Rong], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1751
   Lin J. H., 2012, J NANOMATER, V2012, P703
   Liu BS, 2010, POLYM COMPOSITE, V31, P1037, DOI 10.1002/pc.20890
   Liu Ming Zhi, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P383
   Liu R, 2011, AM J CHINESE MED, V39, P261, DOI 10.1142/S0192415X11008804
   Liu SL, 2014, AQUAC RES, V45, P1402, DOI 10.1111/are.12086
   Liu W. J., 1992, CHIN TRADIT PAT MED, V14, P18
   [刘莹 LIU Ying], 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P397
   Lu B., 2005, PHARM J CHIN PEOPLES, V21, P330
   Luo S. H., 2015, ALTERN MED ECAM, V2015, P1
   Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711
   Ma YN, 2016, MOLECULES, V21, DOI 10.3390/molecules21030265
   Morita H, 2005, BIOORG MED CHEM LETT, V15, P1051, DOI 10.1016/j.bmcl.2004.12.026
   Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0
   Park JE, 2014, HELV CHIM ACTA, V97, P56, DOI 10.1002/hlca.201300102
   Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004
   Peng Q, 2014, CARBOHYD POLYM, V107, P119, DOI 10.1016/j.carbpol.2014.02.042
   Perry L. M., 1990, MED PLANTS E SE ASIA, P168
   Qian CD, 2015, J NAT PROD, V78, P939, DOI 10.1021/np501012n
   Qiu Hong-mei, 2011, Chinese Journal of Biologicals, V24, P676
   Qu Y, 2016, CARBOHYD POLYM, V148, P345, DOI 10.1016/j.carbpol.2016.04.081
   REINECKE T, 1994, PHYTOCHEMISTRY, V35, P63
   SAITO N, 1995, PHYTOCHEMISTRY, V40, P1523, DOI 10.1016/0031-9422(95)00479-Q
   Sakuno E, 2010, WEED BIOL MANAG, V10, P202, DOI 10.1111/j.1445-6664.2010.00385.x
   Shi Song, 2012, Journal of China Pharmaceutical University, V43, P535
   Su Shu-lan, 2010, CHIN J EXP TRADIT ME, V16, P123
   Sun AJ, 2016, BIOORG MED CHEM LETT, V26, P2375, DOI 10.1016/j.bmcl.2016.01.076
   [孙爱静 Sun Aijing], 2016, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V47, P35
   [孙爱静 Sun Aijing], 2016, [中国药学杂志, Chinese Pharmaceutical Journal], V51, P101
   TAKAGI S, 1983, PHYTOCHEMISTRY, V22, P1011, DOI 10.1016/0031-9422(83)85044-4
   Tatsuzawa F, 2010, J JPN SOC HORTIC SCI, V79, P215, DOI 10.2503/jjshs1.79.215
   TOMODA M, 1974, CHEM PHARM BULL, V22, P2710
   Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x
   [王如平 WANG Ruping], 2008, [食品科学, Food Science], V29, P645
   Wang W., 2016, J PHARM PRACT, V34, P32
   Wang W, 2015, FITOTERAPIA, V101, P12, DOI 10.1016/j.fitote.2014.11.005
   Wang Y, 2014, FITOTERAPIA, V92, P72, DOI 10.1016/j.fitote.2013.10.008
   Wang Y, 2015, BIOTECHNOL LETT, V37, P1, DOI 10.1007/s10529-014-1647-6
   [翁小刚 Weng Xiaogang], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P57
   Wiart C, 2012, MEDICINAL PLANTS OF CHINA, KOREA, AND JAPAN: BIORESOURCES FOR TOMORROW'S DRUGS AND COSMETICS, P1, DOI 10.1201/b12046
   Woo Kyeong Wan, 2014, Natural Product Sciences, V20, P91
   Wu J. N., 2005, ILLUSTRATED CHINESE, P136
   Wu XG, 2010, J PHARM PHARMACOL, V62, P1152, DOI 10.1111/j.2042-7158.2010.01137.x
   Wu XG, 2012, J OCUL PHARMACOL TH, V28, P369, DOI 10.1089/jop.2011.0200
   Xiang YL, 2014, MATER LETT, V117, P208, DOI 10.1016/j.matlet.2013.05.098
   YAMAKI M, 1992, PHYTOCHEMISTRY, V31, P3985, DOI 10.1016/S0031-9422(00)97568-X
   YAMAKI M, 1993, PHYTOCHEMISTRY, V34, P535, DOI 10.1016/0031-9422(93)80041-P
   YAMAKI M, 1990, PHYTOCHEMISTRY, V29, P2285, DOI 10.1016/0031-9422(90)83053-4
   YAMAKI M, 1993, PHYTOCHEMISTRY, V33, P1497, DOI 10.1016/0031-9422(93)85119-C
   YAMAKI M, 1993, PHYTOCHEMISTRY, V32, P427, DOI 10.1016/S0031-9422(00)95008-8
   YAMAKI M, 1989, PHYTOCHEMISTRY, V28, P3503, DOI 10.1016/0031-9422(89)80373-5
   YAMAKI M, 1991, PHYTOCHEMISTRY, V30, P2759, DOI 10.1016/0031-9422(91)85139-Q
   Yamaki Masae, 1997, Natural Medicines, V51, P493
   Yan Y, 2014, CHIN J EXP TRADITI M, V20, P57
   Yang L, 2014, BIOCHEM SYST ECOL, V57, P238, DOI 10.1016/j.bse.2014.08.020
   Yang XZ, 2012, PLANTA MED, V78, P606, DOI 10.1055/s-0031-1298264
   Yeung H. C., 1985, I CHIN MED, V206
   Yoon J. H., 2013, J LIFE SCI, V23, P1073
   Yu Hang-su, 2016, Zhong Yao Cai, V39, P544
   Yu Linhua, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1487
   Yue L, 2016, INT J BIOL MACROMOL, V89, P376, DOI 10.1016/j.ijbiomac.2016.05.002
   Zhan XD, 2014, BIOMATERIALS, V35, P10046, DOI 10.1016/j.biomaterials.2014.09.007
   Zhang Q, 2015, MATER LETT, V161, P576, DOI 10.1016/j.matlet.2015.09.031
   Zhang W. M., 2003, CHINESE WILD PLANT R, V22, P59
   Zhang Y. W., 2012, CHIN ARCH TRADIT CHI, V30, P2264
   Zhang YS, 2015, PHARMACOGN MAG, V11, P449, DOI [10.4103/0973-1296.160447, 10.4103/0973-1296.1604471]
   Zheng CS, 1998, CHINESE MED J-PEKING, V111, P1060
NR 103
TC 13
Z9 16
U1 12
U2 80
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JAN 4
PY 2017
VL 195
BP 20
EP 38
DI 10.1016/j.jep.2016.11.026
PG 19
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA EJ0KM
UT WOS:000392897300003
PM 27865796
DA 2018-10-20
ER

PT J
AU Wan, L
   Chen, Y
   Wang, ZH
   Wang, WJ
   Schmull, S
   Dong, J
   Xue, S
   Imboden, H
   Li, J
AF Wan, Long
   Chen, Yao
   Wang, Zhenhua
   Wang, Weijun
   Schmull, Sebastian
   Dong, Jun
   Xue, Song
   Imboden, Hans
   Li, Jun
TI Human heart valve-derived scaffold improves cardiac repair in a murine
   model of myocardial infarction
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEMATOPOIETIC STEM-CELLS; C-KIT; EXTRACELLULAR-MATRIX;
   MONONUCLEAR-CELLS; IN-VITRO; PATCH; TRANSPLANTATION; CARDIOMYOCYTES;
   RECONSTRUCTION; MOBILIZATION
AB Cardiac tissue engineering using biomaterials with or without combination of stem cell therapy offers a new option for repairing infarcted heart. However, the bioactivity of biomaterials remains to be optimized because currently available biomaterials do not mimic the biochemical components as well as the structural properties of native myocardial extracellular matrix. Here we hypothesized that human heart valve-derived scaffold (hHVS), as a clinically relevant novel biomaterial, may provide the proper microenvironment of native myocardial extracellular matrix for cardiac repair. In this study, human heart valve tissue was sliced into 100 mu m tissue sheet by frozen-sectioning and then decellularized to form the hHVS. Upon anchoring onto the hHVS, post-infarct murine BM c-kit+ cells exhibited an increased capacity for proliferation and cardiomyogenic differentiation in vitro. When used to patch infarcted heart in a murine model of myocardial infarction, either implantation of the hHVS alone or c-kit+ cell-seeded hHVS significantly improved cardiac function and reduced infarct size; while c-kit+ cell-seeded hHVS was even superior to the hHVS alone. Thus, we have successfully developed a hHVS for cardiac repair. Our in vitro and in vivo observations provide the first clinically relevant evidence for translating the hHVS-based biomaterials into clinical strategies to treat myocardial infarction.
C1 [Wan, Long; Chen, Yao; Schmull, Sebastian; Li, Jun] Shanghai Jiao Tong Univ, Renji Med Clin Stem Cell Res Ctr X, Lab Cardiovasc Sci, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.
   [Wang, Zhenhua; Wang, Weijun; Xue, Song; Li, Jun] Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Sch Med, Ren Ji Hosp, Shanghai, Peoples R China.
   [Dong, Jun] German Rheumatism Res Ctr, Berlin, Germany.
   [Imboden, Hans] Univ Bern, Inst Cell Biol, Bern, Switzerland.
RP Li, J (reprint author), Shanghai Jiao Tong Univ, Renji Med Clin Stem Cell Res Ctr X, Lab Cardiovasc Sci, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.; Li, J (reprint author), Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Sch Med, Ren Ji Hosp, Shanghai, Peoples R China.
EM jun.li@sjtu.edu.cn
FU National Natural Science Foundation of China [81370321, 81300088];
   Shanghai International Cooperation Foundation of Science and Technology
   [14430721500]; Major Program of Development Fund for Shanghai Zhangjiang
   National Innovtaion Demonstration Zone [ZJ2014-ZD-002]
FX This study was funded by grants from the National Natural Science
   Foundation of China (81370321, 81300088), Shanghai International
   Cooperation Foundation of Science and Technology (14430721500), and
   Major Program of Development Fund for Shanghai Zhangjiang National
   Innovtaion Demonstration Zone (ZJ2014-ZD-002).
CR Alberti KA, 2013, ADV HEALTHC MATER, V2, P817, DOI 10.1002/adhm.201200319
   Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Cimini M, 2007, CIRCULATION, V116, pI77, DOI 10.1161/CIRCULATIONAHA.107.708107
   Curato C, 2010, J IMMUNOL, V185, P6286, DOI 10.4049/jimmunol.0903681
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fazel SS, 2008, FASEB J, V22, P930, DOI 10.1096/fj.07-8636com
   Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Limbourg FP, 2005, EUR J HEART FAIL, V7, P722, DOI 10.1016/j.ejheart.2005.06.005
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Ludwig M, 2012, CAN J PHYSIOL PHARM, V90, P287, DOI [10.1139/y11-108, 10.1139/Y11-108]
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Xaymardan M, 2009, STEM CELLS, V27, P1911, DOI 10.1002/stem.106
   Xu YC, 2013, INT J CARDIOL, V168, P4551, DOI 10.1016/j.ijcard.2013.06.087
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 34
TC 1
Z9 1
U1 3
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 4
PY 2017
VL 7
AR 39988
DI 10.1038/srep39988
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH0HM
UT WOS:000391444700001
PM 28051180
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kim, JJ
   Bennett, NK
   Devita, MS
   Chahar, S
   Viswanath, S
   Lee, EA
   Jung, G
   Shao, PP
   Childers, EP
   Liu, SC
   Kulesa, A
   Garcia, BA
   Becker, ML
   Hwang, NS
   Madabhushi, A
   Verzi, MP
   Moghe, PV
AF Kim, Joseph J.
   Bennett, Neal K.
   Devita, Mitchel S.
   Chahar, Sanjay
   Viswanath, Satish
   Lee, Eunjee A.
   Jung, Giyoung
   Shao, Paul P.
   Childers, Erin P.
   Liu, Shichong
   Kulesa, Anthony
   Garcia, Benjamin A.
   Becker, Matthew L.
   Hwang, Nathaniel S.
   Madabhushi, Anant
   Verzi, Michael P.
   Moghe, Prabhas V.
TI Optical High Content Nanoscopy of Epigenetic Marks Decodes Phenotypic
   Divergence in Stem Cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENE-EXPRESSION; MASS-SPECTROMETRY; FLUORESCENCE NANOSCOPY; LINEAGE
   SPECIFICATION; BIOIMAGE INFORMATICS; CHROMATIN-STRUCTURE; HISTONE CODE;
   HETEROCHROMATIN; DIFFERENTIATION; PLURIPOTENCY
AB While distinct stem cell phenotypes follow global changes in chromatin marks, single-cell chromatin technologies are unable to resolve or predict stem cell fates. We propose the first such use of optical high content nanoscopy of histone epigenetic marks (epi-marks) in stem cells to classify emergent cell states. By combining nanoscopy with epi-mark textural image informatics, we developed a novel approach, termed EDICTS (Epi-mark Descriptor Imaging of Cell Transitional States), to discern chromatin organizational changes, demarcate lineage gradations across a range of stem cell types and robustly track lineage restriction kinetics. We demonstrate the utility of EDICTS by predicting the lineage progression of stem cells cultured on biomaterial substrates with graded nanotopographies and mechanical stiffness, thus parsing the role of specific biophysical cues as sensitive epigenetic drivers. We also demonstrate the unique power of EDICTS to resolve cellular states based on epi-marks that cannot be detected via mass spectrometry based methods for quantifying the abundance of histone post-translational modifications. Overall, EDICTS represents a powerful new methodology to predict single cell lineage decisions by integrating high content super-resolution nanoscopy and imaging informatics of the nuclear organization of epi-marks.
C1 [Kim, Joseph J.; Bennett, Neal K.; Kulesa, Anthony; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Kim, Joseph J.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA.
   [Devita, Mitchel S.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA.
   [Chahar, Sanjay; Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA.
   [Viswanath, Satish; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Lee, Eunjee A.; Jung, Giyoung; Hwang, Nathaniel S.] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea.
   [Jung, Giyoung] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Shao, Paul P.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA.
   [Childers, Erin P.; Becker, Matthew L.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Program, Philadelphia, PA 19104 USA.
   [Kulesa, Anthony] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.; Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
EM moghe@rutgers.edu
OI Madabhushi, Anant/0000-0002-5741-0399; Viswanath,
   Satish/0000-0003-4550-8337
FU NIH [P41EB001046, GM110174]; NSF [DGE 0801620]; NJ Stem Cell Technology
   CORE; Leukemia and Lymphoma Robert Arceci Scholar award
   [1U24CA199374-01, R21CA167811-01, R21CA179327-01, 1R01CA190558-01A1]
FX The authors gratefully acknowledge critical feedback from Drs. Geeta
   Narlikar (UCSF), Donald Ingber (Harvard), and Vincent Pirrotta
   (Rutgers), and financial support from the following grants: NIH
   P41EB001046 (PVM, MLB), NSF DGE 0801620 (PVM, JJK, NKB), NJ Stem Cell
   Technology CORE (PVM), NIH GM110174 and a Leukemia and Lymphoma Robert
   Arceci Scholar award (BAG), 1U24CA199374-01, R21CA167811-01,
   R21CA179327-01 (AM); and 1R01CA190558-01A1 (MPV).
CR Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157
   Brown CR, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001621
   Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461
   Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885
   Callahan LAS, 2013, ACTA BIOMATER, V9, P6095, DOI 10.1016/j.actbio.2012.12.028
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033
   Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607
   Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158
   Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359
   Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799
   Dickel DE, 2014, NAT METHODS, V11, P566, DOI [10.1038/NMETH.2886, 10.1038/nmeth.2886]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106
   Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036
   Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052
   Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895
   HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780
   Hinde E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12001
   Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911
   Iyer KV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046628
   JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7
   Jacob Y, 2014, SCIENCE, V343, P1249, DOI 10.1126/science.1248357
   Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342
   Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052
   Kingston RE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019349
   Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558
   Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   May G, 2013, CELL STEM CELL, V13, P754, DOI 10.1016/j.stem.2013.09.003
   Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]
   Murphy RF, 2014, BIOINFORMATICS, V30, P1353, DOI 10.1093/bioinformatics/btu158
   Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106
   Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043
   Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44
   Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013
   Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570
   Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103
   Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109
   Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110
   Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x
   Shedden K, 2002, P NATL ACAD SCI USA, V99, P4379, DOI 10.1073/pnas.062569899
   Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114
   Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768
   Swedlow JR, 2009, ANNU REV BIOPHYS, V38, P327, DOI 10.1146/annurev.biophys.050708.133641
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045
   Xing YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17463
   Zhou F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3171
NR 60
TC 1
Z9 1
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 4
PY 2017
VL 7
AR 39406
DI 10.1038/srep39406
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG5PS
UT WOS:000391097100001
PM 28051095
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Buzatu, O
   Buzatu, T
AF Buzatu, Ormihai
   Buzatu, Traian
GP IEEE
TI Contributions Regarding the Obtaining and Characterization of New
   Titanium Based Alloys for Medical Applications
SO 2017 IEEE INTERNATIONAL CONFERENCE ON E-HEALTH AND BIOENGINEERING
   CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT 6th IEEE International Conference on E-Health and Bioengineering (EHB)
CY JUN 22-24, 2017
CL Sinaia, ROMANIA
SP IEEE, IEEE EMB Romania Chapter, Romanian Acad, Iasi Branch, Inst Comp Sci, Grigore T Popa Univ Med & Pharmacy, IEEE Romania Sect, Inst Informatica Teoretica, ESC Working Grp e Cardiol, Romanian Soc Med Bioengineering, Grigore T Popa Univ Med & Pharmacy, Fac Med Bioengineering, IEEE EMC Romania Chapter
DE metallic biomaterial; titanium; Young modulus
ID DEFORMATION-BEHAVIOR; CORROSION
AB This paper presents the design of a new titanium alloy - TiMoW- for medical applications with high mechanical and corrosion characteristics and a modulus of elasticity similar to that of bone material. While working on the alloy, a certain series of parameters was taken into consideration, such as the bond ordinator (Bo), the energy level of metal d-orbital (Md), the electron density defined by the raport between electron's valence and atoms (e/a) and the Mo equivalent. These parameters can predict the domain from the faze equilibrium diagram. The stability of faze beta in titan based alloys, especially Ti-15Mo, is defined by the growth of Bo and the drop of Md and through an increase in electronic density, e/a and the Mo equivalent.
C1 [Buzatu, Ormihai] MedLife, Bucharest, Romania.
   [Buzatu, Traian] Remat Bucuresti Sud SA, Bucharest, Romania.
RP Buzatu, O (reprint author), MedLife, Bucharest, Romania.
EM mihaibuzatu23@gmail.com; traian16831@gmail.com
CR Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Furuta T, 2005, MATER TRANS, V46, P3001, DOI 10.2320/matertrans.46.3001
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Marteleur M, 2012, SCRIPTA MATER, V66, P749, DOI 10.1016/j.scriptamat.2012.01.049
   Min XH, 2011, MATER TRANS, V52, P1611, DOI 10.2320/matertrans.M2011124
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Nishimura T., 2008, J POWER ENERGY SYST, V2, P530
   Nitta K., 2001, STRUCTURAL BIOMATERI, V2012, P25
   Tamilselvi S, 2009, MATER TRANS, V50, P2545, DOI 10.2320/matertrans.M2009267
NR 10
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-5386-0358-1
J9 E-HEALTH BIOENG CONF
PY 2017
BP 133
EP 136
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA BL0BL
UT WOS:000445457500034
DA 2018-10-20
ER

PT S
AU Mate, S
   Kadioglu, D
   Majeed, RW
   Stohr, MR
   Folz, M
   Vormstein, P
   Storf, H
   Brucker, DP
   Keune, D
   Zerbe, N
   Hummel, M
   Senghas, K
   Prokosch, HU
   Lablans, M
AF Mate, Sebastian
   Kadioglu, Dennis
   Majeed, Raphael W.
   Stoehr, Mark R.
   Folz, Michael
   Vormstein, Patric
   Storf, Holger
   Brucker, Daniel P.
   Keune, Dietmar
   Zerbe, Norman
   Hummel, Michael
   Senghas, Karsten
   Prokosch, Hans-Ulrich
   Lablans, Martin
BE Rohrig, R
   Timmer, A
   Binder, H
   Sax, U
TI Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures
   into a Hybrid Biobanking Network
SO GERMAN MEDICAL DATA SCIENCES: VISIONS AND BRIDGES
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 62nd Annual Meeting of the
   German-Association-of-Medical-Informatics-Biometry-and-Epidemiology
CY SEP, 2017
CL Oldenburg, GERMANY
SP German Assoc Med Informat Biometry & Epidemiol
DE Translational medical research; biobank network; federated queries;
   cohort identification; German Biobank Node
ID INFORMATICS; SAMPLES; SUITE
AB Cross-institutional biobank networks hold the promise of supporting medicine by enabling the exchange of associated samples for research purposes. Various initiatives, such as BBMRI-ERIC and German Biobank Node (GBN), aim to interconnect biobanks for enabling the compilation of joint biomaterial collections. However, building software platforms to facilitate such collaboration is challenging due to the heterogeneity of existing biobank IT infrastructures and the necessary efforts for installing and maintaining additional software components. As a remedy, this paper presents the concept of a hybrid network for interconnecting already existing software components commonly found in biobanks and a proof-of-concept implementation of two prototypes involving four biobanks of the German Biobank Node. Here we demonstrate the successful bridging of two IT systems found in many German biobanks - Samply and i2b2.
C1 [Mate, Sebastian; Kadioglu, Dennis; Prokosch, Hans-Ulrich] Univ Erlangen Nurnberg, Med Informat, Erlangen, Germany.
   [Kadioglu, Dennis] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, Mainz, Germany.
   [Majeed, Raphael W.; Stoehr, Mark R.] Justus Liebig Univ, German Ctr Lung Res DZL, UGMLC, Giessen, Germany.
   [Folz, Michael; Vormstein, Patric; Storf, Holger] Univ Hosp Frankfurt, Med Informat Grp, Frankfurt, Germany.
   [Vormstein, Patric; Storf, Holger; Brucker, Daniel P.] German Canc Consortium DKTK, Partner Site Frankfurt, Heidelberg, Germany.
   [Vormstein, Patric; Storf, Holger; Brucker, Daniel P.] German Canc Res Ctr, Heidelberg, Germany.
   [Brucker, Daniel P.] Univ Hosp Frankfurt, Univ Canc Ctr UCT Frankfurt, Frankfurt, Germany.
   [Keune, Dietmar] Charite Comprehens Canc Ctr, Clin Canc Registry, Berlin, Germany.
   [Zerbe, Norman; Hummel, Michael] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany.
   [Zerbe, Norman; Hummel, Michael] Cent Biobank Charite ZeBanC, Berlin, Germany.
   [Hummel, Michael] German Canc Res Ctr, German Biobank Node, Heidelberg, Germany.
   [Senghas, Karsten; Lablans, Martin] German Canc Res Ctr, Med Informat Translat Oncol, Heidelberg, Germany.
RP Mate, S (reprint author), Wetterkreuz 13, D-91058 Erlangen, Germany.
EM Sebastian.Mate@fau.de
FU Federal Ministry of Education and Research of Germany within the project
   German Biobank Node [01EY1301]
FX The present work has been funded by the Federal Ministry of Education
   and Research of Germany within the project German Biobank Node (project
   number 01EY1301). It was performed in (partial) fulfillment of the
   requirements for obtaining the degree "Dr. rer. biol. hum." from the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg (SM).
CR Bauer CRKD, 2016, METHOD INFORM MED, V55, P125, DOI 10.3414/ME15-01-0082
   Eminaga O, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9975-y
   Gainer Vivian S, 2016, J Pers Med, V6, DOI 10.3390/jpm6010011
   Hummel M, 2015, BUNDESGESUNDHEITSBLA, V58, P127, DOI 10.1007/s00103-014-2090-5
   Lablans M, 2015, METHOD INFORM MED, V54, P346, DOI 10.3414/ME14-01-0137
   Lablans M, 2016, BUNDESGESUNDHEITSBLA, V59, P373, DOI 10.1007/s00103-015-2299-y
   Lablans M, 2011, STUD HEALTH TECHNOL, V169, P644, DOI 10.3233/978-1-60750-806-9-644
   Mabile L, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-7
   McIntosh LD, 2015, J BIOMED INFORM, V57, P456, DOI 10.1016/j.jbi.2015.08.020
   McMurry AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055811
   Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893
   Oberlander M, 2013, LANGENBECK ARCH SURG, V398, P251, DOI 10.1007/s00423-012-1043-4
   Olson JE, 2014, CLIN GENET, V86, P50, DOI 10.1111/cge.12370
   Pang C, 2015, J AM MED INFORM ASSN, V22, P65, DOI 10.1136/amiajnl-2013-002577
   Quinlan PR, 2015, BIOPRESERV BIOBANK, V13, P363, DOI 10.1089/bio.2014.0099
   Quinlan PR, 2015, ADV EXP MED BIOL, V864, P165, DOI 10.1007/978-3-319-20579-3_13
   Quinlan PR, 2014, BIOPRESERV BIOBANK, V12, P184, DOI 10.1089/bio.2013.0089
   von Laffert M, 2014, J THORAC ONCOL, V9, P1464, DOI 10.1097/JTO.0000000000000307
NR 18
TC 3
Z9 3
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
EI 1879-8365
BN 978-1-61499-808-2; 978-1-61499-807-5
J9 STUD HEALTH TECHNOL
PY 2017
VL 243
BP 100
EP 104
DI 10.3233/978-1-61499-808-2-100
PG 5
WC Computer Science, Information Systems; Medical Informatics
SC Computer Science; Medical Informatics
GA BK8FY
UT WOS:000442654900019
PM 28883179
DA 2018-10-20
ER

PT S
AU Moudgil, A
   Kalyani, N
   Das, S
   Mishra, P
AF Moudgil, Akshay
   Kalyani, Neeti
   Das, Samaresh
   Mishra, Prashant
GP IEEE
TI Azurin based Flexible Device for Resistive Switching Memory application
SO 2017 IEEE 17TH INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY (IEEE-NANO)
SE IEEE International Conference on Nanotechnology
LA English
DT Proceedings Paper
CT 17th IEEE International Conference on Nanotechnology (IEEE NANO)
CY JUL 25-28, 2017
CL Pittsburgh, PA
SP IEEE, IEEE Nanotechnol Council, W Virginia Univ
DE Azurin; Memory; Flexible; Resistive Switching; Redox pair
ID COPPER PROTEIN AZURIN; ELECTRON-TRANSFER; ACTIVE-SITES; METALLOPROTEINS;
   BIOMEMORY
AB Resistive switching memory devices is a promising candidate for next generation data storage. The use of nontoxic and natural available biomaterials are prospective building block for environment friendly, biocompatible and biodegradable electronic devices. The fabrication and characterization of protein based Al/Azurin/ITO/PET flexible memory device is presented here. We observed significant bistable resistive switching behavior with long retention time and very good stability under bending stress at room temperature. The memory behavior originates due to the redox pair formation in the azurin, which corresponds to the low and high resistive states. This demonstration implies that the azurin protein is an active and useful biomaterial for nonvolatile memory and sustainable bioelectronics applications.
C1 [Moudgil, Akshay; Das, Samaresh] Indian Inst Technol Delhi, Ctr Appl Res Elect, New Delhi 110016, India.
   [Kalyani, Neeti; Mishra, Prashant] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India.
RP Das, S (reprint author), Indian Inst Technol Delhi, Ctr Appl Res Elect, New Delhi 110016, India.
EM samareshdas@care.iitd.ac.in
OI Das, Samaresh/0000-0003-4159-1962
FU Department of Electronics and Information Technology (DeitY), Government
   of India; Department of Electronics and Information Technology, New
   Delhi; Council of Scientific and Industrial Research, New Delhi
FX The work was partially supported by the Department of Electronics and
   Information Technology (DeitY), Government of India. Akshay Moudgil
   received financial support from Department of Electronics and
   Information Technology, New Delhi and Neeti Kalyani acknowledges
   financial support from Council of Scientific and Industrial Research,
   New Delhi.
CR Bonanni B, 2007, J PHYS CHEM B, V111, P5062, DOI 10.1021/jp070035m
   Cascella M, 2006, P NATL ACAD SCI USA, V103, P19641, DOI 10.1073/pnas.0607890103
   Dsm T., 2004, J INORG BIOCHEM, V98, P276
   Farver O, 2000, EUR J BIOCHEM, V267, P3123, DOI 10.1046/j.1432-1327.2000.01317.x
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Rinaldi R, 2002, ADV MATER, V14, P1453, DOI 10.1002/1521-4095(20021016)14:20<1453::AID-ADMA1453>3.0.CO;2-C
   Rizzuti B, 2007, BIOPHYS CHEM, V125, P532, DOI 10.1016/j.bpc.2006.11.003
   Solomon EI, 2000, COORDIN CHEM REV, V200, P595, DOI 10.1016/S0010-8545(00)00332-5
   Willner B, 2006, CURR OPIN BIOTECH, V17, P589, DOI 10.1016/j.copbio.2006.10.008
   Wilson TD, 2013, COORDIN CHEM REV, V257, P260, DOI 10.1016/j.ccr.2012.06.015
   Winkler JR, 1997, P NATL ACAD SCI USA, V94, P4246, DOI 10.1073/pnas.94.9.4246
   Yagati AK, 2013, BIOSENS BIOELECTRON, V40, P283, DOI 10.1016/j.bios.2012.07.055
   Yagati AK, 2009, BIOSENS BIOELECTRON, V24, P1503, DOI 10.1016/j.bios.2008.07.080
   Zhang WJ, 2004, ANAL SCI, V20, P603, DOI 10.2116/analsci.20.603
NR 14
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1944-9399
EI 1944-9380
BN 978-1-5090-3029-3; 978-1-5090-3028-6
J9 IEEE CONF NANOTECH
PY 2017
BP 735
EP 738
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BK3BT
UT WOS:000434647500170
DA 2018-10-20
ER

PT S
AU Carreon, H
   Barriuso, S
   Carreon, M
   Asensio, A
   Montealegre, MA
   Jimenez, JA
   Gonzalez-Carrasco, JL
AF Carreon, H.
   Barriuso, S.
   Carreon, M.
   Asensio, A.
   Montealegre, M. A.
   Jimenez, J. A.
   Gonzalez-Carrasco, J. L.
BE Exarhos, GJ
   Gruzdev, VE
   Menapace, JA
   Ristau, D
   Soileau, MJ
TI Superficial modification of a Ti-6Al-4V alloy by laser peening
SO LASER-INDUCED DAMAGE IN OPTICAL MATERIALS 2017
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Annual Laser Damage Symposium / 49th Annual Symposium on Optical
   Materials for High Power Lasers
CY SEP 24-27, 2017
CL Boulder, CO
SP SPIE, Spica Technologies Inc, Lawrence Livermore Natl Lab, Mater Corporat, ZC Optoelectron Technologies Ltd
DE Laser Peening; Pulse Density; Wave Length; Residual Stresses;
   Biomaterial
ID THERMOELECTRIC-POWER; SURFACE; STEEL
AB This research work was focused on the laser peening surface process in a metallic Ti-6Al-4V biomaterial. The Ti-6Al-4V samples were surface treated at different laser conditions varying parameters such as pulse density and wave length. Laser peening induced effects were evaluated by synchrotron radiation X-ray diffraction (SR-XRD) to determine the residual stress state; scanning electron microscopy (SEM) to assess microstructural changes and thermoelectric testing (TEP) to sense the subtle material variations such as local texture, increased dislocation density, hardening and residual stresses degree. The TEP measurements demonstrate that the non-contact technique is very sensitive to the compressive residual stresses with increasing the severity of the laser treatment parameters, while the TEP contact results are closely related to grain size, cracks, anisotropy, and work hardening.
C1 [Carreon, H.] Inst Invest Met UMSNH, Ciudad Univ, Morelia, Michoacan, Mexico.
   [Barriuso, S.; Jimenez, J. A.; Gonzalez-Carrasco, J. L.] Ctr Nacl Invest Met CENIM CSIC, Gregorio Amo 8, Madrid 28040, Spain.
   [Carreon, M.] Inst Invest Quim Biol UMSNH, Ciudad Univ, Morelia, Michoacan, Mexico.
   [Asensio, A.; Montealegre, M. A.] Ctr Tecnol AIMEN, Relva 27A Torneiros, Porrino 36410, Pontevedra, Spain.
   [Gonzalez-Carrasco, J. L.] CIBER BBN, Ctr Bioingn Biomat & Nanomed, Madrid, Spain.
RP Carreon, H (reprint author), Inst Invest Met UMSNH, Ciudad Univ, Morelia, Michoacan, Mexico.
OI MARIA, CARREON/0000-0002-9589-4515; CARREON, HECTOR/0000-0002-4803-0650
FU CONACYT (Mexico) [CB-256013]; CSIC; ESF
FX This work was partially supported by CONACYT (Mexico) CB-256013. S.
   Barriuso thanks the CSIC for the JAE-I3P grant, co-financed by the ESF.
CR Aparicio C, 2004, KEY ENG MAT, V254-2, P737, DOI 10.4028/www.scientific.net/KEM.254-256.737
   Barriuso S, 2011, WEAR, V270, P634, DOI 10.1016/j.wear.2011.01.024
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Carreon H, 2013, MAT SCI ENG C-MATER, V33, P1417, DOI 10.1016/j.msec.2012.12.045
   Carreon H, 2002, RES NONDESTRUCT EVAL, V14, P59, DOI 10.1007/s00164-002-0001-x
   Carreon H., 2012, SURF COAT TECH, V206, P2942
   Carreon H, 2017, AIP ADV, V7, DOI 10.1063/1.4973391
   Carreon H, 2014, RUSS J NONDESTRUCT+, V50, P684, DOI 10.1134/S1061830914110102
   Carreon H, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.12.122502
   Kalainathan S, 2012, OPT LASER ENG, V50, P1740, DOI 10.1016/j.optlaseng.2012.07.007
   KANG X, 2010, J ENG MANUFACTURE, V224, P689, DOI DOI 10.1243/09544054JEM1672
   Kleber X, 2008, NDT&E INT, V41, P364, DOI 10.1016/j.ndteint.2008.01.003
   Ocana JL, 2007, P SOC PHOTO-OPT INS, V6346, pP3461, DOI 10.1117/12.738836
   Peyre P, 1997, P SOC PHOTO-OPT INS, V3097, P558
   Prevey P. S., 2005, P 9 INT C SHOT PEEN, P267
NR 15
TC 0
Z9 0
U1 2
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-5106-1363-8; 978-1-5106-1362-1
J9 PROC SPIE
PY 2017
VL 10447
AR UNSP 104471T
DI 10.1117/12.2280638
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BK2BC
UT WOS:000432478700032
DA 2018-10-20
ER

PT S
AU Sederaviciute, F
   Domskiene, J
   Puiso, J
   Vaitkeviciene, V
AF Sederaviciute, Florentina
   Domskiene, Jurgita
   Puiso, Judita
   Vaitkeviciene, Viktorija
BE Adliene, D
TI INFLUENCE OF DRYING TEMPERATURE ON MECHANICAL PROPERTIES OF BACTERIAL
   CELLULOSE
SO MEDICAL PHYSICS IN THE BALTIC STATES
SE Medical Physics in the Baltic States
LA English
DT Proceedings Paper
CT 13th International Conference on Medical Physics
CY NOV 09-11, 2017
CL Kaunas, LITHUANIA
SP Kaunas Univ Technol, Lund Univ, Skane Univ Hosp, Med Physicists Soc, Lithuanian Univ Hlth Sci, Univ Hosp
DE Bacterial cellulose; biofilm; mechanical properties; tensile strength;
   drying temperature
AB Bacterial cellulose is biodegradable and nontoxic material that possesses broad range of applications due to attractive physico-mechanical properties. The aim of the research is to investigate the mechanical properties of wet bacterial cellulose film and to examine the influence of drying conditions on the tensile properties of biomaterial. Produced biofilm is characterized by density (1.3 - 4.5 g/cm(3)) and yield (0.2 g/L). According to the results of DSC and FTIR chemical composition of produced BC is very close to the pure plant cellulose. SEM has revealed the porous BC structure with 100 nm fibrils. Four drying temperatures (21 degrees C, 25 degrees C, 50 degrees C and 75 degrees C) are applied for gel like biofilm to obtain solid and dense dry biomaterial. The best tensile properties are obtained for the sample dried at 50 degrees C temperature: the highest tensile strength (21.6 MPa) and elongation (55.0 %) was recorded. The non-dried biofilm has excellent elongation properties (37.9 %) while the tensile strength is low (0.4 MPa).
C1 [Sederaviciute, Florentina] Kaunas Univ Technol, Dept Mat Engn, Kaunas, Lithuania.
   [Domskiene, Jurgita] Kaunas Univ Technol, Dept Prod Engn, Kaunas, Lithuania.
   [Puiso, Judita] Kaunas Univ Technol, Dept Phys, Kaunas, Lithuania.
   [Vaitkeviciene, Viktorija] Klaipeda Univ, Klaipeda, Lithuania.
RP Sederaviciute, F (reprint author), Kaunas Univ Technol, Dept Mat Engn, Kaunas, Lithuania.
EM florentina.sederaviciute@ktu.edu; jurgita.domskiene@ktu.lt;
   judita.puiso@ktu.lt; viktorija.vaitkeviciene@ku.lt
CR Barud HS, 2013, POLIMEROS, V23, P135, DOI 10.1590/S0104-14282013005000018
   Chen P, 2009, CURR APPL PHYS, V9, pE96, DOI 10.1016/j.cap.2008.12.038
   Gao WH, 2011, BIORESOURCES, V6, P144
   Gayathry G, 2014, INDIAN J FIBRE TEXT, V39, P93
   Hassan I. A., 2014, BAGHDAD SCI J, V11, P1420
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Oster G. A., United States Patent, Patent No. [60/252, 60252]
   Sameshima K., AFRICAN J BIOTECHNOL, V4
   Sanchis MJ, 2017, CARBOHYD POLYM, V157, P353, DOI 10.1016/j.carbpol.2016.10.001
   Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Sim K, 2015, FIBER POLYM, V16, P294, DOI 10.1007/s12221-015-0294-4
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7
NR 17
TC 0
Z9 0
U1 0
U2 0
PU KAUNAS UNIV TECHNOLOGY PRESS
PI KAUNAS
PA K DONELAICIO 73, KAUNAS LT 3006, LITHUANIA
SN 1822-5721
J9 MED PHYS BALTIC STAT
PY 2017
BP 99
EP 103
PG 5
WC Biophysics
SC Biophysics
GA BK0YW
UT WOS:000431393200023
DA 2018-10-20
ER

PT J
AU Zatkalikova, V
   Oravcova, M
   Palcek, P
   Markovicova, L
AF Zatkalikova, Viera
   Oravcova, Monika
   Palcek, Peter
   Markovicova, Lenka
TI THE EFFECT OF SURFACE TREATMENT ON CORROSION RESISTANCE OF AUSTENITIC
   BIOMATERIAL
SO TRANSACTIONS OF FAMENA
LA English
DT Article
DE austenitic biomaterial; pitting corrosion; electrochemical polishing;
   sensitization
ID STAINLESS-STEEL; ROUGHNESS; BEHAVIOR
AB This paper focuses on the effect of surface treatment (grinding, electrochemical polishing) on the corrosion resistance of AISI 316L, a Cr-Ni-Mo low-carbon austenitic surgical stainless steel, in a physiological solution at the temperature of 37 degrees C. The influence of a surface defect and of sensitization by heat treatment on the corrosion behaviour of electrochemically polished surface is also studied. The evaluation is based on the results of cyclic potentiodynamic polarization tests and on the microscopic observation of specimen surfaces after performed tests. The analysis of cyclic potentiodynamic curves showed the highest pitting corrosion resistance of electrochemically polished specimens regardless of the previous sensitization. The as-received specimen showed the highest susceptibility to pitting, which was microscopically confirmed. Based on the performed experiments we can conclude that electrochemical polishing is an efficient chemical surface treatment to increase the resistance of AISI 316L to pitting corrosion; the resistance to pitting corrosion of electrochemically polished surface can by markedly decreased by the presence of mechanical defects; the as-received surface and the ground surface showed lower resistance to pitting corrosion than electrochemically polished ones; sensitization induced by heat treatment (700 degrees C/10 hours) does not decrease resistance to pitting corrosion.
C1 [Zatkalikova, Viera; Oravcova, Monika; Palcek, Peter; Markovicova, Lenka] Univ Zilina, Fac Mech Engn, Dept Mat Engn, Univ 1, Zilina 01026, Slovakia.
RP Zatkalikova, V (reprint author), Univ Zilina, Fac Mech Engn, Dept Mat Engn, Univ 1, Zilina 01026, Slovakia.
EM viera.zatkalikova@fstroj.uniza.sk
FU Scientific Grant Agency of the Ministry of Education, Science and Sport
   of the Slovak Republic; Slovak Academy of Science grant VEGA
   [1/0683/15]; project KEGA [044ZU-4/2017]
FX The research was supported partially by the Scientific Grant Agency of
   the Ministry of Education, Science and Sport of the Slovak Republic, by
   the Slovak Academy of Science grant VEGA No. 1/0683/15, and by the
   project KEGA No. 044ZU-4/2017.
CR BURSTEIN GT, 1995, CORROSION, V51, P380, DOI 10.5006/1.3293603
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Hadzima B., 2008, ZAKLADY ELEKTROCHEMI, P114
   Han YL, 2015, CORROS SCI, V98, P72, DOI 10.1016/j.corsci.2015.05.026
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Ladwein T. L., 2011, CORROSION
   Lee H. S., 2003, J MATER PROCESS TECH, V140, P206, DOI [10.1016/S0924-0136(03)00785-4, DOI 10.1016/S0924-0136(03)00785-4]
   Liptakova T, 2009, BODOVA KOROZIA NEHRD, P67
   Marek P., 2006, MEDZIKRYSTALOVA KORO
   Nagase M, 1995, HOST REACTIONS PARTI, V1
   Pardo A, 2007, ACTA MATER, V55, P2239, DOI 10.1016/j.actamat.2006.11.021
   Ratner B.D., 2004, BIOMATERIALS SCI
   Rokosz K, 2015, TEH VJESN, V22, P125, DOI 10.17559/TV-20140211130812
   Sasaki K, 1996, CORROS SCI, V38, P2111, DOI 10.1016/S0010-938X(96)00066-2
   Szklarska-Smialowska Z, 2005, PITTING CREVICE CORR, P590
   Vana D., 2014, POROVNANIE TECHNOLOG, P101
   Ziemniak SE, 2008, CORROS SCI, V50, P2465, DOI 10.1016/j.corsci.2008.06.032
   Zuo Y, 2002, CORROS SCI, V44, P25, DOI 10.1016/S0010-938X(01)00039-7
NR 18
TC 0
Z9 0
U1 2
U2 2
PU UNIV ZAGREB FAC MECHANICAL ENGINEERING & NAVAL ARCHITECTURE
PI ZAGREB
PA IVANA LUCICA 5, ZAGREB, 10002, CROATIA
SN 1333-1124
J9 T FAMENA
JI Trans. FAMENA
PY 2017
VL 41
IS 4
BP 25
EP 34
DI 10.21278/TOF.41403
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA GF2YS
UT WOS:000431808800003
OA Bronze
DA 2018-10-20
ER

PT J
AU Lopes, NID
   Silva, LAD
   Santos, LD
   Buono, VTL
AF de Azevedo Lopes, Natalia Isabel
   de Oliveira Silva, Lais Avila
   Santos, Leandro de Arruda
   Lopes Buono, Vicente Tadeu
TI Surface Characterization of NiTi Superelastic and Shape Memory Alloys
   After Electrolytic Polishing
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE NiTi; superelasticity; shape memory effect; electrolytic polishing;
   biomaterial
ID MEDICAL APPLICATIONS; CORROSION BEHAVIOR
AB For the biomedical application of NiTi alloys, an excellent surface finishing process is required to guarantee high corrosion resistance and biocompatibility, eliminating the allergenic and toxic effects associated with the release of nickel ions in the body. Electropolishing is a process that can reduce surface imperfections and form a thin protective layer of TiO2, even in complex-shaped devices. The main objective of our study was to find and report suitable parameters for electrolytic polishing of NiTi wires, in both the superelastic and shape memory states. The results indicate that electropolishing in a 3.5 mol.L-1 methanolic H2SO4 electrolyte at 20 degrees C can effectively reduce surface roughness, remove superficial nickel-rich layers and improve corrosion resistance for austenitic and martensitic NiTi alloys.
C1 [de Azevedo Lopes, Natalia Isabel; de Oliveira Silva, Lais Avila; Santos, Leandro de Arruda; Lopes Buono, Vicente Tadeu] Univ Fed Minas Gerais, Dept Engn Met & Mat, Belo Horizonte, MG, Brazil.
RP Lopes, NID (reprint author), Univ Fed Minas Gerais, Dept Engn Met & Mat, Belo Horizonte, MG, Brazil.
EM natalia.ial@gmail.com
RI Lopes, Natalia/H-6685-2016; Buono, Vicente/I-8474-2012; Santos,
   Leandro/H-9507-2018
OI Lopes, Natalia/0000-0002-4613-6152; Buono, Vicente/0000-0002-0574-5218;
   Santos, Leandro/0000-0001-9172-6429
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brasilia, DF, Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/PROEX), Brasilia, DF, Brazil
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brasilia, DF, Brazil; and Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PROEX), Brasilia,
   DF, Brazil.
CR Armitage DA, 2003, MAT SCI ENG A-STRUCT, V349, P89, DOI 10.1016/S0921-5093(02)00818-3
   ASM International, 2009, MAT COAT MED DEV CAR
   ASTM International, 2004, F212904 ASTM INT
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   da Silva MAC, 2013, AUST ENDOD J, V39, P73, DOI 10.1111/j.1747-4477.2011.00308.x
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Frenzel J, 2004, J ALLOY COMPD, V385, P214, DOI 10.1016/j.jallcom.2004.05.002
   Fushimi K, 2006, ELECTROCHIM ACTA, V52, P1290, DOI 10.1016/j.electacta.2006.07.030
   Gutmann JL, 2012, INT ENDOD J, V45, P113, DOI 10.1111/j.1365-2591.2011.01957.x
   Hansen AW, 2015, MATER RES-IBERO-AM J, V18, P184, DOI 10.1590/1516-1439.305614
   Hassel AW, 2004, MINIM INVASIV THER, V13, P240, DOI 10.1080/13645700410020278
   Neelakantan L, 2007, ELECTROCHIM ACTA, V53, P915, DOI 10.1016/j.electacta.2007.08.007
   Okazaki S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.098002
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Patel MM, 2006, SMST 2006 P INT C SH, P1
   Pohl M, 2004, MAT SCI ENG A-STRUCT, V378, P191, DOI 10.1016/j.msea.2003.11.080
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Wichelhaus A, 2005, DENT MATER, V21, P938, DOI 10.1016/j.dental.2004.11.011
   Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085
   Yang G, 2017, SURF ENG, V33, P149, DOI 10.1080/02670844.2016.1198452
   Zhu L, 2003, SMST 2003 P INT C SH, P357
NR 26
TC 2
Z9 2
U1 0
U2 0
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PY 2017
VL 20
SU 2
BP 572
EP 579
DI 10.1590/1980-5373-MR-2016-0933
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA GD0JR
UT WOS:000430187600085
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU de Sousa, LL
   Ricci, VP
   Prado, DG
   Apolinario, RC
   Vercik, LCD
   Rigo, ECD
   Fernandes, MCD
   Mariano, NA
AF de Sousa, Luciola Lucena
   Ricci, Virgilio Pereira
   Prado, Deborah Gouvea
   Apolinario, Raira Chefer
   de Oliveira Vercik, Luci Cristina
   da Silva Rigo, Eliana Cristina
   dos Santos Fernandes, Merlin Cristina
   Mariano, Neide Aparecida
TI Titanium Coating with Hydroxyapatite and Chitosan Doped with Silver
   Nitrate
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE Chitosan; Titanium; Biomimetic Method; Biomaterial
ID SIMULATED BODY-FLUID; CORROSION BEHAVIOR; COMPOSITE COATINGS;
   BIOCOMPATIBILITY; FABRICATION; CERAMICS; METAL
AB Biomaterials are effective alternatives for tissue substitution, including the bone tissue, since they do not pose risks of transmission of diseases or immune rejection. Nowadays, there is an interest in new materials capable of being associated with other substances which favor bone formation, especially natural biopolymers, in particular chitosan, which may present a potential for repairing bone defects and forms films that adhere to metal surfaces. Titanium, despite being a material greatly employed in implants because of its excellent physical properties, does not present bioactive characteristics, making it necessary to use methods of surface modification to enhance its biological response, favoring bone formation. This work aims at studying commercially pure titanium (cp-Ti) coating with chitosan using the biomimetic method and the evaluation of the effects of process variables as substrate surface conditions. Subsequently, the incorporation of AgNO3 was studied and its effects on corrosion resistance were evaluated. To evaluate the coating process, several tests were conducted, such as scanning electron microscopy, X-ray diffraction and infrared spectroscopy. From the results obtained, the efficacy of the chitosan film in inhibiting the corrosion of the metals is concluded, which was the target of this study, thus justifying its use for osseointegration and in several implants.
C1 [de Sousa, Luciola Lucena; Ricci, Virgilio Pereira; Prado, Deborah Gouvea; Apolinario, Raira Chefer; Mariano, Neide Aparecida] Univ Fed Alfenas UNIFAL, Campus Avancado Pocos de Caldas, BR-37701540 Pocos De Caldas, MG, Brazil.
   [de Oliveira Vercik, Luci Cristina; da Silva Rigo, Eliana Cristina] Univ Sao Paulo, FZEA, Dept Ciencias Basicas, Ave Duque de Caxias Norte 225, BR-13635900 Pirassununga, SP, Brazil.
   [dos Santos Fernandes, Merlin Cristina] Univ Estadual Paulista Julio de Mesquita Filho UN, Campus Itapeva,Rua Geraldo Alckmin 519, BR-18409010 Itapeva, SP, Brazil.
RP de Sousa, LL (reprint author), Univ Fed Alfenas UNIFAL, Campus Avancado Pocos de Caldas, BR-37701540 Pocos De Caldas, MG, Brazil.
EM luciolalucena@gmail.com
FU Brazilian research funding agency FAPEMIG (Minas Gerais State Research
   Foundation); Brazilian research funding agency CNPq (National Council
   for Scientific and Technological Development); Brazilian research
   funding agency CAPES (Federal Agency for the Support and Improvement of
   Higher Education)
FX The authors gratefully acknowledge the Brazilian research funding
   agencies FAPEMIG (Minas Gerais State Research Foundation), CNPq
   (National Council for Scientific and Technological Development) and
   CAPES (Federal Agency for the Support and Improvement of Higher
   Education) for their financial and material support.
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Adawy A., 2009, OPEN MED DEVICES J, V1, P19
   Agrawal C. M, 2014, INTRO BIOMATERIALS B
   ASTM International, 2001, E395 ASTM INT, DOI [10.1520/E0003-95, DOI 10.1520/E0003-95]
   ASTM International, 2006, F67 ASTM, DOI [10.1520/F0067-06, DOI 10.1520/F0067-06]
   Coelho Mariny F. C., 2014, Materials Science Forum, V802, P440, DOI 10.4028/www.scientific.net/MSF.802.440
   Erakovic S, 2013, J PHYS CHEM B, V117, P1633, DOI 10.1021/jp305252a
   Fraga AF, 2011, APPL SURF SCI, V257, P3888, DOI 10.1016/j.apsusc.2010.11.104
   Hazra M, 2015, SAUDI PHARM J, V23, P429, DOI 10.1016/j.jsps.2015.01.007
   Kokubo T, 2016, ACTA BIOMATER, V44, P16, DOI 10.1016/j.actbio.2016.08.013
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   Liu YT, 2014, MATER LETT, V128, P31, DOI 10.1016/j.matlet.2014.04.117
   Majumdar P, 2011, J MECH BEHAV BIOMED, V4, P1132, DOI 10.1016/j.jmbbm.2011.03.023
   Manera RS, 2009, 5 C BRAS ENG FABR AP
   Mariano NA, 2009, MATERIA, V14, P878, DOI 10.1590/S1517-70762009000200010
   Mishra SK, 2014, J MECH BEHAV BIOMED, V40, P314, DOI 10.1016/j.jmbbm.2014.08.014
   Podporska-Carroll J, 2013, MATER LETT, V112, P54, DOI 10.1016/j.matlet.2013.08.112
   Song L, 2011, MATER LETT, V65, P974, DOI 10.1016/j.matlet.2010.12.051
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Tang S, 2014, SURF COAT TECH, V251, P210, DOI 10.1016/j.surfcoat.2014.04.028
   Tiyyagura HR, 2016, PROG ORG COAT, V99, P147, DOI 10.1016/j.porgcoat.2016.05.019
   Vercik LCD, 2003, ECLET QUIM, V28, P25
   Zhou JB, 2011, THIN SOLID FILMS, V519, P4658, DOI 10.1016/j.tsf.2011.01.012
NR 23
TC 0
Z9 0
U1 4
U2 4
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PY 2017
VL 20
SU 2
BP 863
EP 868
DI 10.1590/1980-5373-MR-2017-0021
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA GD0JR
UT WOS:000430187600123
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU O'Neill, JJ
   Johnson, RA
   Dockter, RL
   Kowalewski, TM
AF O'Neill, John J.
   Johnson, Reed A.
   Dockter, Rodney L.
   Kowalewski, Timothy M.
BE Bicchi, A
   Okamura, A
TI 3D Bioprinting Directly Onto Moving Human Anatomy
SO 2017 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS
   (IROS)
SE IEEE International Conference on Intelligent Robots and Systems
LA English
DT Proceedings Paper
CT IEEE/RSJ International Conference on Intelligent Robots and Systems
   (IROS)
CY SEP 24-28, 2017
CL Vancouver, CANADA
SP IEEE, RSJ, IEEE Robot & Automat Soc, IEEE IES, SICE, New Technol Fdn
ID FABRICATION; CELLS; SKIN
AB This paper establishes the feasibility of robotically 3D printing biomaterials such as alginate hydrogels onto moving human anatomy and a stationary plane. The alginate hydrogels used are in-vivo compatible and a proven biomaterial for tissue scaffolds. We developed a control scheme for precision material deposition via piezo microjetting while tracking in real-time to continuously sense anatomy location and deposits material in a predefined trajectory derived from two pre-selected target geometries. We show that multilayer 3D structures can be created on a moving human hand with 1.6 mm average error and 87.8 % overall accuracy.
C1 [O'Neill, John J.; Johnson, Reed A.; Dockter, Rodney L.; Kowalewski, Timothy M.] Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55417 USA.
RP O'Neill, JJ (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55417 USA.
EM oneil463@umn.edu
FU MnDRIVE Robotics, Sensors, and Advanced Manufacturing initiative; Army
   Research Laboratory;  [W911NF-14-2-0035]
FX We would like to thank the MnDRIVE Robotics, Sensors, and Advanced
   Manufacturing initiative for financialsupport.; Research was sponsored
   in part by the Army Research Laboratory and was accomplished under
   Cooperative Agreement Number W911NF-14-2-0035. The views and conclusions
   contained in this document are those of the authors and should not be
   interpreted as representing the official policies, either expressed or
   implied, of the Army Research Laboratory or the U.S. Government. The
   U.S. Government is authorized to reproduce and distribute reprints for
   Government purposes notwithstanding any copyright notation herein.
CR Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133
   Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149
   Dockter R, 2014, IEEE INT C INT ROBOT, P1984, DOI 10.1109/IROS.2014.6942826
   French A, 2016, J MED DEVICES, V10, DOI 10.1115/1.4033171
   Haase S, 2013, CURR MED IMAGING REV, V9, P113, DOI 10.2174/1573405611309020006
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee V, 2014, TISSUE ENG PART C-ME, V20, P473, DOI [10.1089/ten.tec.2013.0335, 10.1089/ten.TEC.2013.0335]
   Maier-Hein L, 2013, MED IMAGE ANAL, V17, P974, DOI 10.1016/j.media.2013.04.003
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   O'Neill JJ, 2014, J MED DEVICES, V8, DOI 10.1115/1.4027119
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Quigley M., 2009, ICRA WORKSH OP SOURC, V3, P5
   Risio S.D., 2007, MACROMOL RAPID COMM, V28, P1934
   Seol Y.-J., 2014, EUROPEAN J CARDIOTHO, P148
   Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088
   Weichert F, 2013, SENSORS-BASEL, V13, P6380, DOI 10.3390/s130506380
   Xu T, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035001
NR 18
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2153-0858
BN 978-1-5386-2682-5
J9 IEEE INT C INT ROBOT
PY 2017
BP 934
EP 940
PG 7
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Robotics
SC Computer Science; Robotics
GA BJ6YC
UT WOS:000426978201047
DA 2018-10-20
ER

PT S
AU Pugliese, D
   Boetti, NG
   Ceci-Ginistrelli, E
   Janner, D
   Lousteau, J
   Milanese, D
AF Pugliese, Diego
   Boetti, Nadia G.
   Ceci-Ginistrelli, Edoardo
   Janner, Davide
   Lousteau, Joris
   Milanese, Daniel
GP IEEE
TI Design, Processing and Characterization of Custom Phosphate Glasses for
   Photonic and Biomedical Applications
SO 2017 19TH INTERNATIONAL CONFERENCE ON TRANSPARENT OPTICAL NETWORKS
   (ICTON)
SE International Conference on Transparent Optical Networks-ICTON
LA English
DT Proceedings Paper
CT 19th International Conference on Transparent Optical Networks (ICTON)
CY JUL 02-06, 2017
CL Girona, SPAIN
SP IEEE, IEEE Photon Soc, FYLA, OptoSigma, LIGHT TEC, Ajuntament Girona, AE Tech
DE phosphate glass; rare-earth ion; optical material; biomaterial;
   bioresorbable optics; spectroscopic analysis
ID FIBER; LASER
AB Phosphate glasses (PGs) are promising host materials for the development of compact fiber amplifiers and lasers thanks to their good chemical durability, easy processing, outstanding optical properties, no clustering effect and very high solubility of rare-earth (RE) ions. Furthermore, some particular calcium-phosphate glasses exhibit unique dissolution properties in aqueous media with degradation rates that can be tailored by properly designing the glass composition. This feature makes them attractive biomaterials and allows the engineering of novel biomedical devices for deep-tissue diagnosis and therapy.
   In this work we will report the ongoing activities and the recent results obtained by our research group on the design, processing and characterization of novel custom phosphate glasses for both photonic and biomedical applications.
C1 [Pugliese, Diego; Ceci-Ginistrelli, Edoardo; Janner, Davide; Milanese, Daniel] Politecn Torino, Dipartimento Sci Applicata & Tecnol, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
   [Pugliese, Diego; Ceci-Ginistrelli, Edoardo; Janner, Davide; Milanese, Daniel] INSTM, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
   [Boetti, Nadia G.] Ist Super Mario Boella, Via PC Boggio 61, I-10134 Turin, Italy.
   [Lousteau, Joris] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.
   [Milanese, Daniel] Ist Foton & Nanotecnol, Consiglio Nazl Ric, Via Cascata 56-C, I-38123 Trento, Italy.
RP Pugliese, D (reprint author), Politecn Torino, Dipartimento Sci Applicata & Tecnol, Cso Duca Abruzzi 24, I-10129 Turin, Italy.; Pugliese, D (reprint author), INSTM, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM diego.pugliese@polito.it
FU COST Action "Advanced Fibre Laser and Coherent Source as tools for
   Society, Manufacturing and Lifescience" [MP1401]
FX The authors acknowledge the COST Action MP1401 "Advanced Fibre Laser and
   Coherent Source as tools for Society, Manufacturing and Lifescience" for
   the partial support of this research effort.
CR Bitar M, 2008, J BIOMED MATER RES A, V87A, P1017, DOI 10.1002/jbm.a.31855
   Brancaleon L, 2002, LASER MED SCI, V17, P173, DOI 10.1007/s101030200027
   BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   Ceci-Ginistrelli E, 2016, OPT MATER EXPRESS, V6, P2040, DOI 10.1364/OME.6.002040
   Massera J, 2015, J NON-CRYST SOLIDS, V425, P52, DOI 10.1016/j.jnoncrysol.2015.05.028
   Pugliese D, 2016, J ALLOY COMPD, V657, P678, DOI 10.1016/j.jallcom.2015.10.126
   Stepien R, 2014, MATERIALS, V7, P4723, DOI 10.3390/ma7064723
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2162-7339
BN 978-1-5386-0859-3
J9 INT C TRANS OPT NETW
PY 2017
PG 4
WC Engineering, Electrical & Electronic; Optics; Telecommunications
SC Engineering; Optics; Telecommunications
GA BJ7BW
UT WOS:000427031500119
DA 2018-10-20
ER

PT S
AU Chebodaeva, V
   Sedelnikova, M
   Sharkeev, Y
AF Chebodaeva, V.
   Sedelnikova, M.
   Sharkeev, Yu.
BE Gutmanas, EY
   Naimark, OB
   Sharkeev, YP
TI Influence of Nanoparticles Deposition Conditions on the Microarc
   Coatings Properties
SO PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS
   (PC IPCA)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Physics of Cancer - Interdisciplinary
   Problems and Clinical Applications (PC IPCA)
CY MAY 23-26, 2017
CL Tomsk, RUSSIA
SP Russian Acad Sci, Siberian Branch, Inst Strength Phys & Mat Sci, Tomsk Res Inst Oncol, Russian Acad Sci, UrB, Inst Continuous Media Mech, Natl Res Tomsk Polytechn Univ, Natl Res Tomsk State Univ
ID CALCIUM-PHOSPHATE COATINGS; NIOBIUM ALLOY; PRECURSOR; BOEHMITE; TITANIUM
AB The surface charge of biomaterials significantly contributes to such processes as protein adsorption or biofilm formation and consequently osseointegration bone tissue and implant. There are a set of methods to create a charge on dielectric biomaterials surface. One of the perspective methods of materials electrization is an introduction of the nanoparticles with appropriate biomedical properties into biomaterial. Boehmite AlO(OH) nanoparticles is perspective for the biomaterials surface modification due to its high surface area and positive charge. In this work, the investigations of microarc calcium phosphate biocoatings modified by boehmite nanoparticles on the Ti substrate were presented. A variation of the nanoparticles deposition parameters allowed producing calcium phosphate coatings with different morphology and boehmite nanoparticles size distribution. The investigations of the modified coatings by the transmission and scanning electron microscopy methods are presented in the work.
C1 [Chebodaeva, V.; Sharkeev, Yu.] Natl Res Tomsk Polytech Univ, Tomsk 634050, Russia.
   [Sedelnikova, M.; Sharkeev, Yu.] RAS, Inst Strength Phys & Mat Sci SB, Tomsk 634055, Russia.
RP Chebodaeva, V (reprint author), Natl Res Tomsk Polytech Univ, Tomsk 634050, Russia.
EM vtina5@mail.ru; smasha5@yandex.ru; sharkeev@ispms.tsc.ru
FU ISPMS SB RAS [23.2.5]
FX The work was carried out in the frame of ISPMS SB RAS state task,
   project No. 23.2.5.
CR Bakina OV, 2015, RUSS PHYS J+, V57, P1669, DOI 10.1007/s11182-015-0436-6
   Bokhimi X, 2001, J SOLID STATE CHEM, V159, P32, DOI 10.1006/jssc.2001.9124
   Chebodaeva Valentina, 2017, Key Engineering Materials, V743, P124, DOI 10.4028/www.scientific.net/KEM.743.124
   Gobichon AE, 2001, MATER SCI FORUM, V378-3, P523, DOI 10.4028/www.scientific.net/MSF.378-381.523
   Kazantsev SO, 2016, AIP CONF PROC, V1760, DOI 10.1063/1.4960244
   Komarova Ekaterina G., 2016, Key Engineering Materials, V683, P370, DOI 10.4028/www.scientific.net/KEM.683.370
   Legostaeva EV, 2013, MATERIALWISS WERKST, V44, P188, DOI 10.1002/mawe.201300107
   Lozhkomoev AS, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/20/205603
   Sedelnikova MB, 2016, SURF COAT TECH, V307, P1274, DOI 10.1016/j.surfcoat.2016.08.062
   Shirai T, 2009, ANN REP CERAM RES LA, V9, P23
   TETTENHORST R, 1980, CLAY CLAY MINER, V28, P373, DOI 10.1346/CCMN.1980.0280507
   Wefers K., 1987, 19 ALC LAB, V19
NR 12
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1562-1
J9 AIP CONF PROC
PY 2017
VL 1882
AR UNSP 020012-1
DI 10.1063/1.5001591
PG 4
WC Oncology; Physics, Applied
SC Oncology; Physics
GA BJ6QG
UT WOS:000426914800012
DA 2018-10-20
ER

PT S
AU Sergeeva, NS
   Sviridova, IK
   Komlev, VS
   Karalkin, PA
   Kirsanova, VA
   Akhmedova, SA
   Shanskij, YD
   Kuvshinova, EA
   Fedotov, AY
   Teterina, AY
   Barinov, SM
AF Sergeeva, N. S.
   Sviridova, I. K.
   Komlev, V. S.
   Karalkin, P. A.
   Kirsanova, V. A.
   Akhmedova, S. A.
   Shanskij, Ya. D.
   Kuvshinova, E. A.
   Fedotov, A. Yu.
   Teterina, A. Yu.
   Barinov, S. M.
BE Gutmanas, EY
   Naimark, OB
   Sharkeev, YP
TI 3D Printed Constructs with Antibacterial or Antitumor Activity for
   Surgical Treatment of Bone Defects in Cancer Patients
SO PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS
   (PC IPCA)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Physics of Cancer - Interdisciplinary
   Problems and Clinical Applications (PC IPCA)
CY MAY 23-26, 2017
CL Tomsk, RUSSIA
SP Russian Acad Sci, Siberian Branch, Inst Strength Phys & Mat Sci, Tomsk Res Inst Oncol, Russian Acad Sci, UrB, Inst Continuous Media Mech, Natl Res Tomsk Polytechn Univ, Natl Res Tomsk State Univ
ID OCTACALCIUM PHOSPHATE; REGENERATION; BIOCERAMICS
AB The concept of functionalization with bioactive molecules and drugs is one of the most advanced areas of modern bone tissue biomaterial science in terms of enhancement of their osteoconductive and therapeutic properties. The purpose of this study was to develop the approaches for 3D printing of sodium alginate /gelatin /octacalcium phosphate-based constructs with antibacterial and antitumor activity intended for bone defects replacement in the patients with malignant diseases. In this work, we evaluated the drug release kinetic and physicochemical characteristics of the constructs, as well as their specific activity, biocompatibility and osteoplastic properties in in vitro and in vivo tests. The experimental results proved the principal possibility of creating the biocompatible bone substitutes with antibacterial /antitumor activity and maintaining osteoconductive properties by means of 3D printing method.
C1 [Sergeeva, N. S.; Sviridova, I. K.; Karalkin, P. A.; Kirsanova, V. A.; Akhmedova, S. A.; Shanskij, Ya. D.; Kuvshinova, E. A.] Minist Hlth Care Russian Federat, Natl Med Res Radiol Ctr, PA Herzen Moscow Oncol Res Inst Branch, Moscow 125284, Russia.
   [Sergeeva, N. S.] Russian Acad Sci, AA Baikov Inst Met & Mat Sci, Moscow 119334, Russia.
   [Komlev, V. S.; Fedotov, A. Yu.; Teterina, A. Yu.; Barinov, S. M.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia.
RP Sergeeva, NS (reprint author), Minist Hlth Care Russian Federat, Natl Med Res Radiol Ctr, PA Herzen Moscow Oncol Res Inst Branch, Moscow 125284, Russia.; Sergeeva, NS (reprint author), Russian Acad Sci, AA Baikov Inst Met & Mat Sci, Moscow 119334, Russia.
EM prognoz.06@mail.ru; komlev@mail.ru
RI Shansky, Yaroslav/I-2007-2014
OI Shansky, Yaroslav/0000-0003-4672-2474
FU Russian Science Foundation [15-13-00108]
FX This work was financially supported by the Russian Science Foundation
   (project No. 15-13-00108).
CR Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Inzana JA, 2015, EUR CELLS MATER, V30, P232, DOI 10.22203/eCM.v030a16
   Karalkin P. A., 2016, GENES CELLS, V11, P94
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Komlev VS, 2014, ACS APPL MATER INTER, V6, P16610, DOI 10.1021/am502583p
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Pertici G, 2015, J BIOL REG HOMEOS AG, V29, P136
   Sergeeva NS, 2015, GENES CELLS, V10, P39
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
NR 9
TC 0
Z9 0
U1 1
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1562-1
J9 AIP CONF PROC
PY 2017
VL 1882
AR UNSP 020063-1
DI 10.1063/1.5001642
PG 5
WC Oncology; Physics, Applied
SC Oncology; Physics
GA BJ6QG
UT WOS:000426914800063
DA 2018-10-20
ER

PT B
AU Sahu, S
   Singh, G
AF Sahu, Sourabh
   Singh, Ghanshyam
GP IEEE
TI Modeling of Grating Slot Waveguide for High-Q based Refractive Index
   Sensor
SO 2017 INTERNATIONAL CONFERENCE ON COMPUTER, COMMUNICATIONS AND
   ELECTRONICS (COMPTELIX)
LA English
DT Proceedings Paper
CT International Conference on Computer Communications and Electronics
   (Comptelix)
CY JUL 01-02, 2017
CL jaipur, INDIA
SP IRIS World, IEEE Delhi Sect, Inst Elect & Telecommunications Engn India, Malaviya Natl Inst Technol Student Chapter, Manipal Univ Jaipur Student Chapter, Malaviya Natl Inst Technol Student Chapter Jaipur, Altair, FEKO
DE refractive index sensor; slot waveguide; transfer matrix
AB The grating slot waveguide is designed and numerically simulated to obtain a narrow resonant band at a stop-band of the transmission spectra for a realization of a refractive index sensor. The sensing principle has depended on a detection of the shift in the resonant band for a change in the refractive index of a biomaterial. The Q factor of the resonant peak is found out to be 21637. The theoretical value of the limit of detection has calculated as 3.684 x 10(-4) RIU.
C1 [Sahu, Sourabh; Singh, Ghanshyam] Malaviya Natl Inst Technol Jaipur, Dept Elect & Commun Engn, Jaipur, Rajasthan, India.
RP Sahu, S (reprint author), Malaviya Natl Inst Technol Jaipur, Dept Elect & Commun Engn, Jaipur, Rajasthan, India.
EM sourabh.ggits@gmail.com; gsingh.ece@mnit.ac.in
CR Chrostowski L, 2015, SILICON PHOTONICS DESIGN, P1
   Dell'Olio F, 2007, OPT EXPRESS, V15, P4977, DOI 10.1364/OE.15.004977
   Fard ST, 2013, PROC SPIE, V8629, DOI 10.1117/12.2005832
   Hosseini A, 2006, OPT EXPRESS, V14, P11318, DOI 10.1364/OE.14.011318
   Olyaee S, 2015, OPTIK, V126, P2560, DOI 10.1016/j.ijleo.2015.06.037
   Prabhathan P, 2009, OPT EXPRESS, V17, P15330, DOI 10.1364/OE.17.015330
   Sahu S., 2016, 13 INT C FIB OPT PHO
   Sahu S., OPTICA APPL IN PRESS
   Sahu S., 2016, 2016 INT C REC ADV I, P1, DOI DOI 10.1109/ICRAIE.2016.7939565
   Sahu S, 2017, OPT COMMUN, V402, P408, DOI 10.1016/j.optcom.2017.06.051
   Shu XW, 2002, J LIGHTWAVE TECHNOL, V20, P255, DOI 10.1109/50.983240
   Wang X, 2013, OPT EXPRESS, V21, P19029, DOI 10.1364/OE.21.019029
NR 12
TC 2
Z9 2
U1 2
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-4708-6
PY 2017
BP 394
EP 396
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ6LL
UT WOS:000426812500075
DA 2018-10-20
ER

PT B
AU Bensalem, M
   Mindeguia, JC
   Sommier, A
   Batsale, JC
   Pradere, C
AF Bensalem, M.
   Mindeguia, J. C.
   Sommier, A.
   Batsale, J. C.
   Pradere, C.
BE Vandamme, M
   Dangla, P
   Pereira, JM
   Ghabezloo, S
TI Measurement of Water Content in a Wood Sample by Terahertz Imaging
SO POROMECHANICS VI: PROCEEDINGS OF THE SIXTH BIOT CONFERENCE ON
   POROMECHANICS
LA English
DT Proceedings Paper
CT 6th Biot Conference on Poromechanics
CY JUL 09-13, 2017
CL Paris, FRANCE
SP Ecole Ponts ParisTech, Inst Francais Sci Technologies Transports Amenagement Reseaux, Ctr Natl Rech Sci, Agence Natl Rech, Amer Soc Civil Engineers, Engn Mech Inst, Amer Soc Civil Engineers
AB Recently, THz waves shows to be a good technique to investigate the water diffusion within porous media such as biomaterial or insulation materials. This is due to the sufficient resolution for such applications and safe radiation. In this study, a calibration method is developed in order to demonstrate the relationship between the absorption coefficient of maritime pine sample and its water content. An analytical model is built, based on the Beer-Lambert law, linking the absorption coefficient, the density of solid and its water content.
C1 [Bensalem, M.; Sommier, A.; Batsale, J. C.; Pradere, C.] Esplanade Arts & Metiers, UMR 5295, I2M, ENSAM, F-33405 Talence, France.
   [Mindeguia, J. C.] Univ Bordeaux, I2M, UMR 5295, 351 Cours Liberat, F-33405 Talence, France.
RP Bensalem, M (reprint author), Esplanade Arts & Metiers, UMR 5295, I2M, ENSAM, F-33405 Talence, France.
CR Bertie JE, 1996, APPL SPECTROSC, V50, P1047, DOI 10.1366/0003702963905385
   Federici JF, 2005, SEMICOND SCI TECH, V20, pS266, DOI 10.1088/0268-1242/20/7/018
   Hameury S, 2006, WOOD MATER SCI ENG, V1, P116, DOI 10.1080/17480270601150578
   Jansen Christian, OPTICAL SOC AM
   Jordens C, 2009, J BIOL PHYS, V35, P255, DOI 10.1007/s10867-009-9161-0
   Sandberg Karin, 2006, New Zealand Journal of Forestry Science, V36, P347
   Sedighi-Gilani M, 2012, INT J HEAT MASS TRAN, V55, P6211, DOI 10.1016/j.ijheatmasstransfer.2012.06.045
   Skry Anton S., 2014, 2014 OPTICAL SOCIETY, V53
   White Jeffrey, 2007, OPTICAL SOC AM
   Zhang HB, 2008, JPN J APPL PHYS, V47, P8065, DOI 10.1143/JJAP.47.8065
   Zhang XB, 2015, BUILD ENVIRON, V92, P387, DOI 10.1016/j.buildenv.2015.05.021
NR 11
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC CIVIL ENGINEERS
PI NEW YORK
PA UNITED ENGINEERING CENTER, 345 E 47TH ST, NEW YORK, NY 10017-2398 USA
BN 978-0-7844-8077-9
PY 2017
BP 847
EP 854
PG 8
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary;
   Physics, Applied
SC Engineering; Materials Science; Physics
GA BJ5RL
UT WOS:000426216300105
DA 2018-10-20
ER

PT J
AU Burca, S
   Indolean, C
   Maicaneanu, A
AF Burca, Silvia
   Indolean, Cerasella
   Maicaneanu, Andrada
TI MALACHITE GREEN DYE ADSORPTION FROM MODEL AQUEOUS SOLUTIONS USING CORN
   COB ACTIVATED CARBON (CCAC)
SO STUDIA UNIVERSITATIS BABES-BOLYAI CHEMIA
LA English
DT Article
DE corn cob biomass; activated carbon; malachite green; aqueous phase;
   characterization techniques; kinetics
ID WASTE-WATER; REMOVAL; BIOMASS; DEGRADATION; AEROGELS; BLUE
AB This paper presents a report on kinetics of malachite green (MG) dye removal from model aqueous solutions using a biomaterial formed by corn cob activated carbon (CCAC). The sorbent was characterized using specific surface area and pore size distribution (Brunauer-Emmett-Teller, BET) analysis. The BET analysis confirmed the macro-porosity of the adsorbent. Effects of initial concentration of MG dye and CCAC quantity, particle size and stirring rate on adsorption capacities and efficiency were monitored through pseudo first-and second-order models, intra-particle and film diffusion models to present adsorption rate parameters. The removal efficiency of MG increased with the adsorbent quantity and particle size.
C1 [Burca, Silvia; Indolean, Cerasella] Babes Bolyai Univ, Fac Chem & Chem Engn, Dept Chem Engn, 11 Arany Janos St, RO-400028 Cluj Napoca, Romania.
   [Maicaneanu, Andrada] Indiana Univ Penn, Dept Chem, Indiana, PA 15705 USA.
RP Indolean, C (reprint author), Babes Bolyai Univ, Fac Chem & Chem Engn, Dept Chem Engn, 11 Arany Janos St, RO-400028 Cluj Napoca, Romania.
EM cella@chem.ubbcluj.ro
RI INDOLEAN (AFLOROAEI), Liliana - Cerasella/D-6852-2012
OI INDOLEAN (AFLOROAEI), Liliana - Cerasella/0000-0003-0106-5191
CR Acharya J, 2009, CHEM ENG J, V150, P25, DOI 10.1016/j.cej.2008.11.035
   Ai LH, 2014, APPL CATAL B-ENVIRON, V148, P191, DOI 10.1016/j.apcatb.2013.10.056
   Akar E, 2013, ECOL ENG, V52, P19, DOI 10.1016/j.ecoleng.2012.12.032
   Aljeboree AM, 2017, ARAB J CHEM, V10, pS3381, DOI 10.1016/j.arabjc.2014.01.020
   Auta M, 2011, CHEM ENG J, V171, P502, DOI 10.1016/j.cej.2011.04.017
   Bellona C, 2004, WATER RES, V38, P2795, DOI 10.1016/j.watres.2004.03.034
   BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066
   Burca S, 2016, REV ROUM CHIM, V61, P541
   Chang CF, 2000, J COLLOID INTERF SCI, V232, P45, DOI 10.1006/jcis.2000.7171
   Concalves M., 2013, WASTE BIOMASS VALORI, V4, P395
   Dawood S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1818-4
   Devaraj M, 2016, J MOL LIQ, V221, P930, DOI 10.1016/j.molliq.2016.06.028
   Djilani C, 2015, J TAIWAN INST CHEM E, V53, P112, DOI 10.1016/j.jtice.2015.02.025
   Fernandez ME, 2014, IND CROP PROD, V62, P437, DOI 10.1016/j.indcrop.2014.09.015
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Goswami M, 2017, J ENVIRON CHEM ENG, V5, P3508, DOI 10.1016/j.jece.2017.07.016
   Ho Y.S., 2006, PROCESS BIOCHEM, V136, P681
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Indolean C, 2017, ACTA CHIM SLOV, V64, P513, DOI 10.17344/acsi.2017.3271
   Jiang F, 2017, CARBOHYD POLYM, V173, P286, DOI 10.1016/j.carbpol.2017.05.097
   Khataee AR, 2010, J HAZARD MATER, V181, P886, DOI 10.1016/j.jhazmat.2010.05.096
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Li KM, 2016, J MATER CHEM A, V4, P5223, DOI 10.1039/c5ta09908k
   Li ZY, 2017, J MOL LIQ, V242, P747, DOI 10.1016/j.molliq.2017.07.062
   Majdik C., 2015, ACTA CHIM SLOV, V62, P452
   Majdik C, 2010, REV ROUM CHIM, V55, P871
   Moreno-Castilla C, 1998, CARBON, V36, P145, DOI 10.1016/S0008-6223(97)00171-1
   Nagy B, 2017, ARAB J CHEM, V10, pS3569, DOI 10.1016/j.arabjc.2014.03.004
   Njimou JR, 2016, ENVIRON TECHNOL, V37, P1369, DOI 10.1080/09593330.2015.1116609
   Sacara AM, 2016, STUD U BABES-BOL CHE, V61, P183
   Saravanan R, 2014, J MOL LIQ, V193, P160, DOI 10.1016/j.molliq.2013.12.029
   Saygih H, 2015, CHEM ENG RES DES, V100, P27, DOI 10.1016/j.cherd.2015.05.014
   Stanca M., 2007, CARACTERIZAREA VALOR
   Tsang DCW, 2007, WATER AIR SOIL POLL, V184, P141, DOI 10.1007/s11270-007-9404-2
   Vuono D, 2017, CHINESE J CHEM ENG, V25, P523, DOI 10.1016/j.cjche.2016.10.021
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yagub MT, 2014, ADV COLLOID INTERFAC, V209, P172, DOI 10.1016/j.cis.2014.04.002
   Zhang CH, 2016, J MOL LIQ, V221, P1145, DOI 10.1016/j.molliq.2016.06.093
NR 38
TC 0
Z9 0
U1 1
U2 1
PU UNIV BABES-BOLYAI
PI CLUJ-NAPOCA
PA MIHAIL KOGALNICEANU NR. 1, CLUJ-NAPOCA RO-3400, ROMANIA
SN 1224-7154
J9 STUD U BABES-BOL CHE
JI Stud. Univ. Babes-Bolyai Chem.
PY 2017
VL 62
IS 4
BP 293
EP 307
DI 10.24193/subbchem.2017.4.25
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA FX3ID
UT WOS:000425964800026
OA Bronze
DA 2018-10-20
ER

PT B
AU Bhardwaj, T
   Singh, SP
   Shukla, M
AF Bhardwaj, Tarun
   Singh, Surya Pratap
   Shukla, Mukul
BE Agarwal, PK
   Gupta, M
TI Finite Element Modeling and Analysis of Implant Scaffolds
SO 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN MECHANICAL, INDUSTRIAL,
   AUTOMATION AND MANAGEMENT SYSTEMS (AMIAMS) - PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Advances in Mechanical, Industrial,
   Automation and Management Systems (AMIAMS)
CY FEB 03-05, 2017
CL Allahabad, INDIA
SP IEEE, Motilal Nehru Natl Inst Technol, Dept Mech Engn, IEEE Uttar Pradesh Sect, IEEE Robot& Automat Soc
DE Orthopaedic implants; FEA; Additive manufacturing; Porous scaffolds
ID REGULAR POROUS BIOMATERIALS; MECHANICAL-PROPERTIES; METALS
AB Design of porous scaffolds is a critical issue in orthopaedic applications. Porous biomaterial scaffolds are suitable for repairing the damaged bones. They promote proliferation and osseointegration of bone tissues. To fabricate the porous scaffolds, Additive Manufacturing (AM) techniques have been widely used. Modeling and Finite Element Analysis (FEA) allows investigating the mechanical and biological behaviour of patient specific implants at reduced cost. In this study, modeling of Hollow Cube and Truncated Hexahedron (THH) unit cells has been done using the SolidWorks 2016 CAD software and FEA of their compressive strength has been done using the Abaqus 6.14 FEA package. The compressive strength of various structures based on these two unit cells have been analyzed for different strut size for the biocompatible grade 5 titanium alloy (Ti-6Al-4V). Compressive strength of 162 MPa for THH 2 for strut size of 0.5 found to be in desirable range of cortical bone.
C1 [Bhardwaj, Tarun; Singh, Surya Pratap; Shukla, Mukul] Motilal Nehru Natl Inst Technol, Mech Engn Dept, Allahabad, Uttar Pradesh, India.
   [Shukla, Mukul] Univ Johannesburg, Dept Mech Engn Technol, Doornfontein Campus, ZA-2028 Johannesburg, South Africa.
RP Bhardwaj, T (reprint author), Motilal Nehru Natl Inst Technol, Mech Engn Dept, Allahabad, Uttar Pradesh, India.
EM tarunbhardwaj97@gmail.com; suryapratap.me@gmail.com;
   mukulshukla@mnnit.ac.in
OI SHUKLA, MUKUL/0000-0002-9981-4690
CR Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Hedayati R, 2016, MAT SCI ENG C-MATER, V60, P163, DOI 10.1016/j.msec.2015.11.001
   Hedayati R, 2016, MATER DESIGN, V89, P9, DOI 10.1016/j.matdes.2015.09.052
   Leary M, 2016, MATER DESIGN, V98, P344, DOI 10.1016/j.matdes.2016.02.127
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 8
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-5674-3
PY 2017
BP 358
EP 362
PG 5
WC Engineering, Industrial; Engineering, Manufacturing; Engineering,
   Mechanical
SC Engineering
GA BJ5HT
UT WOS:000425926000060
DA 2018-10-20
ER

PT B
AU Smetana, M
   Chudacik, V
   Behun, L
AF Smetana, Milan
   Chudacik, Vladimir
   Behun, Lukas
GP IEEE
TI Investigation of Artificial Fatigue Cracks by Eddy Current Technique
SO PROCEEDINGS OF 2017 18TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL
   PROBLEMS OF ELECTRICAL ENGINEERING (CPEE)
LA English
DT Proceedings Paper
CT 18th International Conference on Computational Problems of Electrical
   Engineering (CPEE)
CY SEP 11-13, 2017
CL Kutna Hora, CZECH REPUBLIC
SP IEEE, Czechoslovakia Sect, Univ W Bohemia, Fac Elect Engn, Lodz Univ Technol, Inst Comp Sci, Lviv Polytechn Natl Univ, Univ Zilina, Warsaw Univ Life Sci, Warsaw Univ Technol
DE component; nondestructive evaluation; eddy current testing;
   giant-magneto-resistive sensor
AB This paper deals with evaluation of the artificial biomaterial fatigue cracks by eddy current testing method. New modular eddy current probe is used for this evaluation. Harmonic excitation is applied for the eddy current induction. Austenitic biomaterial of the grade 316L with presence of fatigue cracks is inspected. Gained results are discussed and presented in the paper.
C1 [Smetana, Milan; Chudacik, Vladimir; Behun, Lukas] Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina, Slovakia.
RP Smetana, M (reprint author), Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina, Slovakia.
CR Dogaru T, 2000, NONDESTRUCT TEST EVA, V16, P31
   Douglas E., 2007, HLTH MONITORING STRU
   Janousek L., 2013, COMMUNICATIONS, V15, P102
   Leary M., 2009, QUALITY RELIABILITY, V25
   McGuire M. F., 2008, STAINLESS STEELS DES, P296
   Palcek P., 2015, MAT BIOMEDICAL ENG
   Skocovsky P., 1996, MAT SCI
   Smetana M., 2015, ENDE 2015
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-1040-4
PY 2017
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ4PA
UT WOS:000425270900025
DA 2018-10-20
ER

PT S
AU Tan, CH
   Muhamad, N
   Abdullah, MMAB
AF Tan, C. H.
   Muhamad, N.
   Abdullah, M. M. A. B.
BE Sandu, AV
   Abdullah, MMA
   Vizureanu, P
   Ghazali, CMR
   Sandu, I
TI Surface Topographical Modification of Coronary Stent: A Review
SO INTERNATIONAL CONFERENCE ON INNOVATIVE RESEARCH - ICIR EUROINVENT 2017
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT International Conference on Innovative Research (ICIR Euroinvent)
CY MAY 25-26, 2017
CL Iasi, ROMANIA
SP Romanian Inventors Forum, Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Alexandru Ioan Cuza Univ Iasi, ARHEOINVEST Platform, Univ Malaysia Perlis, Ctr Excellence Geopolymer & Green Technol, Malaysian Res & Innovat Soc, EUROINVENT
ID DRUG-ELUTING STENT; STAINLESS-STEEL; ANTIPLATELET THERAPY; CELL
   ADHESION; IN-VITRO; ENDOTHELIALIZATION; THROMBOSIS; MICRO;
   PROLIFERATION; NITINOL
AB Driven by the urge of mediating the inflammatory response from coronary stent implant to improve patency rates of the current coronary stent, concern has been focusing on reducing the risk of in-stent restenosis and thrombosis for long-term safety. Surface modification approach has been found to carry great potential due to the surface is the vital parts that act as a buffer layer between the biomaterial and the organic material like blood and vessel tissues. Nevertheless, manipulating cell response in situ using physical patterning is very complex as the exact mechanism were yet elucidated. Thus, the aim of this review is to summarise the recent efforts on modifying the surface topography of coronary stent at the micro-and nanometer scale with the purpose of inducing rapid in situ endothelialization to regenerate a healthy endothelium layer on biomaterial surface. In particular, a discussion on the surface patterns that have been investigated on cell selective behaviour together with the methods used to generate them are presented. Furthermore, the probable future work involving the surface modification of coronary stent were indicated.
C1 [Tan, C. H.; Muhamad, N.] Univ Malaysia Perlis, Sch Mfg Engn, Pauh Putra Main Campus, Perlis, Malaysia.
   [Tan, C. H.; Muhamad, N.; Abdullah, M. M. A. B.] Univ Malaysia Perlis, Sch Mat Engn, Ctr Excellence Geopolymer & Green Technol, Perlis, Malaysia.
   [Abdullah, M. M. A. B.] Univ Malaysia Perlis, Fac Engn Technol, Uniciti Alam Campus, Perlis, Malaysia.
RP Tan, CH (reprint author), Univ Malaysia Perlis, Sch Mfg Engn, Pauh Putra Main Campus, Perlis, Malaysia.; Tan, CH (reprint author), Univ Malaysia Perlis, Sch Mat Engn, Ctr Excellence Geopolymer & Green Technol, Perlis, Malaysia.
EM jimmyhao91@gmail.com; noorhafiza@unimap.edu.my
OI Abdullah, Mohd Mustafa Al Bakri/0000-0002-9779-8586
FU School of Manufacturing Engineering, UniMAP; Fundamental Research Grant
   Scheme under Ministry of Education Malaysia (MOE) [FRGS-9003-00584]
FX The authors gratefully acknowledge School of Manufacturing Engineering,
   UniMAP for their expertise and support. The authors would also like to
   thank for the funding support from the Fundamental Research Grant Scheme
   (FRGS-9003-00584) under Ministry of Education Malaysia (MOE).
CR Aktas C, 2012, MAT SCI ENG C-MATER, V32, P1017, DOI 10.1016/j.msec.2012.02.032
   Bhatia V, 2008, MED UPDATE, P70
   Chong DST, 2014, EUR J VASC ENDOVASC, V47, P566, DOI 10.1016/j.ejvs.2014.02.007
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Giacoppo D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5392
   Grabow N, 2010, J CHEM TECHNOL BIOT, V85, P744, DOI 10.1002/jctb.2282
   Iqbal J, 2013, BRIT MED BULL, V106, P193, DOI 10.1093/bmb/ldt009
   Istrate B, 2016, ENVIRON ENG MANAG J, V15, P955
   Jeewandara TM, 2014, MATERIALS, V7, P769, DOI 10.3390/ma7020769
   Kereiakes DJ, 2015, JACC-CARDIOVASC INTE, V8, P1552, DOI 10.1016/j.jcin.2015.05.026
   Kiefer K, 2016, RSC ADV, V6, P17460, DOI 10.1039/c5ra21775j
   Lee PP, 2014, NANO LETT, V14, P5021, DOI 10.1021/nl501523v
   Li L, 2013, LASER SURG MED, V45, P608, DOI 10.1002/lsm.22180
   Liang CY, 2016, BIOMATERIALS, V103, P170, DOI 10.1016/j.biomaterials.2016.06.042
   Lin CY, 2012, PHYSCS PROC, V39, P661, DOI 10.1016/j.phpro.2012.10.086
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   McDaniel C, 2015, RSC ADV, V5, P42548, DOI 10.1039/c5ra04342e
   Mendis S, 2014, WORLD HLTH ORG
   Minciuna M G, 2016, MATER SCI ENG, V133, P28
   Mohammad RA, 2010, CLIN THER, V32, P2265, DOI 10.1016/j.clinthera.2011.01.003
   Nozaki K, 2015, MAT SCI ENG C-MATER, V57, P1, DOI 10.1016/j.msec.2015.07.028
   Oberringer M, 2013, MAT SCI ENG C-MATER, V33, P901, DOI 10.1016/j.msec.2012.11.018
   Pang JH, 2015, SMALL, V11, P6248, DOI 10.1002/smll.201402579
   Ren XK, 2015, CHEM SOC REV, V44, P5680, DOI 10.1039/c4cs00483c
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Tammareddi S, 2016, MATER DESIGN, V90, P682, DOI 10.1016/j.matdes.2015.10.153
   Tomkin G.H., 2012, J ATHEROSCLER THROMB, V5, P13, DOI DOI 10.2174/18765068012050
   Tugui CA, 2015, J OPTOELECTRON ADV M, V17, P1855
   Vandrangi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111465
   Zhang K, 2014, J BIOMED MATER RES A, V102, P588, DOI 10.1002/jbm.a.34714
NR 31
TC 0
Z9 0
U1 1
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2017
VL 209
AR UNSP 012031
DI 10.1088/1757-899X/209/1/012031
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJ3KA
UT WOS:000423732100031
OA Other Gold
DA 2018-10-20
ER

PT S
AU Dietrich, K
   Brulisauer, M
   Cagin, E
   Bertsch, D
   Luthi, S
   Heeb, P
   Starker, U
   Bernard, A
AF Dietrich, Klaus
   Bruelisauer, Martina
   Cagin, Emine
   Bertsch, Dietmar
   Luethi, Stefan
   Heeb, Peter
   Staerker, Ulrich
   Bernard, Andre
BE Ferraro, P
   Grilli, S
   RitschMarte, M
   Hitzenberger, CK
TI In focal plane characterization of excitation distribution for
   quantitative fluorescence microscopy applications
SO OPTICAL METHODS FOR INSPECTION, CHARACTERIZATION, AND IMAGING OF
   BIOMATERIALS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optical Methods for Inspection, Characterization, and
   Imaging of Biomaterials III
CY JUN 26-28, 2017
CL Munich, GERMANY
SP SPIE
DE fluorescence microscopy; biomaterials; optical metrology; quantitative
   imaging; calibration reference; image linearization; time resolved
   chromatic characterization
ID FLAT-FIELD CORRECTION; CALIBRATION
AB The applications of fluorescence microscopy span medical diagnostics, bioengineering and biomaterial analytics. Full exploitation of fluorescent microscopy is hampered by imperfections in illumination, detection and filtering. Mainly, errors stem from deviations induced by real-world components inducing spatial or angular variations of propagation properties along the optical path, and they can be addressed through consistent and accurate calibration. For many applications, uniform signal to noise ratio (SNR) over the imaging area is required. Homogeneous SNR can be achieved by quantifying and compensating for the signal bias. We present a method to quantitatively characterize novel reference materials as a calibration reference for biomaterials analytics.
   The reference materials under investigation comprise thin layers of fluorophores embedded in polymer matrices. These layers are highly homogeneous in their fluorescence response, where cumulative variations do not exceed 1% over the field of view (1.5 x 1.1 mm). An automated and reproducible measurement methodology, enabling sufficient correction for measurement artefacts, is reported. The measurement setup is equipped with an autofocus system, ensuring that the measured film quality is not artificially increased by out-of-focus reduction of the system modulation transfer function.
   The quantitative characterization method is suitable for analysis of modified bio-materials, especially through patterned protein decoration. The imaging method presented here can be used to statistically analyze protein patterns, thereby increasing both precision and throughput. Further, the method can be developed to include a reference emitter and detector pair on the image surface of the reference object, in order to provide traceable measurements.
C1 [Dietrich, Klaus; Bruelisauer, Martina; Cagin, Emine; Bertsch, Dietmar; Luethi, Stefan; Heeb, Peter; Bernard, Andre] NTB Buchs, Interstaatl Hsch Tech, Inst Micro & Nanotechnol, Werdenbergstr 4, CH-9470 Buchs, Switzerland.
   [Staerker, Ulrich] Volpi, AG, Wiessenstr 33, CH-8952 Schlieren, Switzerland.
RP Dietrich, K (reprint author), NTB Buchs, Interstaatl Hsch Tech, Inst Micro & Nanotechnol, Werdenbergstr 4, CH-9470 Buchs, Switzerland.
EM klaus.dietrich@ntb.ch
FU Commission for Technology and Innovation of Switzerland [KTI 18720.1
   PFNM-NM]
FX We gratefully acknowledge the financial support of the Commission for
   Technology and Innovation of Switzerland, through the project KTI
   18720.1 PFNM-NM. Professor David Norris of ETH Zurich and PD Dr. Dominik
   Bruhwiler of ZHAW contributed with fruitful discussions.
CR Antonini A, 2014, OPT EXPRESS, V22, P14293, DOI 10.1364/OE.22.014293
   Brulisauer M., 2017, P SPIE
   Eichinger CD, 2012, LANGMUIR, V28, P2238, DOI 10.1021/la2039202
   Engel A, 2006, PROC SPIE, V6191, DOI 10.1117/12.663627
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Kask P, 2016, J MICROSC-OXFORD, V263, P328, DOI 10.1111/jmi.12404
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Model MA, 2001, CYTOMETRY, V44, P309, DOI 10.1002/1097-0320(20010801)44:4<309::AID-CYTO1122>3.0.CO;2-3
   Piccinini F, 2012, J MICROSC-OXFORD, V248, P6, DOI 10.1111/j.1365-2818.2012.03645.x
   Resch-Genger U, 2005, J FLUORESC, V15, P337, DOI 10.1007/s10895-005-2630-3
   Royon A., 2017, OPTIK PHOTONIK, V12, P22
   Schrader M., J MICROSCOPY, V191, P135
   Seibert JA, 1998, P SOC PHOTO-OPT INS, V3336, P348, DOI 10.1117/12.317034
   Webb D.J., 2013, METHODS MOL BIOL CLI, V931, P29, DOI DOI 10.1007/978-1-62703-056-4_2.
   Zwier JM, 2004, J MICROSC-OXFORD, V216, P15, DOI 10.1111/j.0022-2720.2004.01390.x
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-5106-1112-2; 978-1-5106-1111-5
J9 PROC SPIE
PY 2017
VL 10333
AR 103330L
DI 10.1117/12.2270316
PG 9
WC Biophysics; Optics; Imaging Science & Photographic Technology
SC Biophysics; Optics; Imaging Science & Photographic Technology
GA BJ3EZ
UT WOS:000423023300013
DA 2018-10-20
ER

PT J
AU Radu, N
   Roman, V
   Bostan, M
   Radu, E
   Tanasescu, C
AF Radu, Nicoleta
   Roman, Viviana
   Bostan, Marinela
   Radu, Elena
   Tanasescu, Ciprian
TI Influence of some spice food based bioproducts on human monocytic cells
   line type THP-1
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Frontiers of Polymers and Advanced
   Materials (ICFPAM)
CY OCT 31-NOV 04, 2016
CL Daejeon, SOUTH KOREA
SP Hannam Univ, LG Chem, BioActs, TecSco, Tavoro
DE Apoptosis cells; NO inhibition; spice food biomaterials; THP-1 cell line
ID ESSENTIAL OIL; CANCER; EXPRESSION; THERAPY; INOS; L.
AB Two biomaterials obtained by hydrodistilation from an indigenous Satureja hortensis plant (SHEO), and from the rhizoms of Zingiber officinale (ZOEO), purchased from Romanian market, were tested in order to evaluate their effect on monocytic cells line type THP-1. The first biomaterial, (SHEO), has practically no biological effect whereas the other bioproduct, (ZOEO) has a better effect in comparison to L-NAME and etoposide. Due to a mechanism which implies cells apoptosis the quantities of nitric oxide (NO) produced by THP-1 cells are reduced under ZOEO action.
C1 [Radu, Nicoleta; Radu, Elena] Natl Inst Res & Dev Chem & Petrochem, Biotechnol Dept, Bucharest, Romania.
   [Roman, Viviana; Bostan, Marinela] Romaniana Acad, IVN Stefan Nicolau, Immunol Ctr, Bucharest, Romania.
   [Tanasescu, Ciprian] Univ Lucian Blaga, Fac Med, Clin Surg Dept, Sibiu, Romania.
RP Radu, N (reprint author), Natl Inst Res & Dev Chem & Petrochem, Biotechnol Dept, Bucharest, Romania.
EM nicolbiotec@yahoo.com
RI Radu, Nicoleta/B-5253-2017
CR Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106
   Aktan F, 2006, PLANTA MED, V72, P727, DOI 10.1055/s-2006-931588
   Ash D, 2015, AM J CANCER RES, V5, P481
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50
   Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9
   Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441
   Habib S, 2011, INDIAN J CLIN BIOCHE, V26, P3, DOI 10.1007/s12291-011-0108-4
   Haloc H, 2014, INT J PHARM PHARM SC, V6, P189
   Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17
   Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200
   Lee Y, 2016, TOX RESEARCH, V32, P225, DOI 10.5487/TR.2016.32.3.225
   Morar S., 2013, METAL INT, V18, P296
   Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161
   Nunes Reginaldo Teixeira, 2016, Revista de Patologia Tropical, V45, P273, DOI 10.5216/rpt.v45i3.43515
   Purnomo H., 2010, International Food Research Journal, V17, P335
   Radu N, 2016, MOL CRYST LIQ CRYST, V628, P115, DOI 10.1080/15421406.2015.1137686
   Roman V, 2000, LEUKEMIA, V14, P696, DOI 10.1038/sj.leu.2401702
   Shahid Marina, 2012, INT J CHEM BIOCH SCI, V2, P101
   Sharifzadeh A, 2016, MICROB PATHOGENESIS, V96, P1, DOI 10.1016/j.micpath.2016.04.014
   Sobral MV, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1155/2014/95345125401162
   Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307
   Wasaporn C, 2012, THESIS
NR 23
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2017
VL 655
IS 1
SI SI
BP 114
EP 123
DI 10.1080/15421406.2017.1361307
PG 10
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA FT4GF
UT WOS:000423110900013
DA 2018-10-20
ER

PT J
AU Dias, OAT
   Negrao, DR
   Fernanda, D
   Goncalves, C
   Cesarino, I
   Leao, AL
AF Titton Dias, Otavio Augusto
   Negrao, Djanira Rodrigues
   Fernanda, Daniele
   Goncalves, Chiarelli
   Cesarino, Ivana
   Leao, Alcides Lopes
TI Recent approaches and future trends for lignin-based materials
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Frontiers of Polymers and Advanced
   Materials (ICFPAM)
CY OCT 31-NOV 04, 2016
CL Daejeon, SOUTH KOREA
SP Hannam Univ, LG Chem, BioActs, TecSco, Tavoro
DE Applications; biomaterial; biopolymer; lignin; properties
ID RADICAL SCAVENGING ACTIVITY; ACACIA-NILOTICA WOOD; ANTIOXIDANT ACTIVITY;
   CARBON-FIBERS; NATURAL ANTIOXIDANTS; KRAFT LIGNIN; RENEWABLE
   THERMOPLASTICS; ENZYMATIC-HYDROLYSIS; BIOACTIVE COMPOUNDS; POLYURETHANE
   FOAMS
AB Known as the main source of aromatic compounds in nature, lignin possesses heterogeneous composition which has high potential to be used in many industrial purposes. Lignin has been used as retardants of fire, thermal stabilizer, hydrophobicity agent, carbon fiber, aerogels and antioxidants. This review summarizes several uses of lignin-based components and their potential applications. We focused on the industrial uses of lignin in order to diminish the dependence of petroleum-based materials.
C1 [Titton Dias, Otavio Augusto; Negrao, Djanira Rodrigues; Fernanda, Daniele; Goncalves, Chiarelli; Cesarino, Ivana; Leao, Alcides Lopes] Sao Paulo State Univ Unesp, Coll Agr Sci, BR-18610307 Botucatu, SP, Brazil.
RP Dias, OAT (reprint author), Sao Paulo State Univ Unesp, Coll Agr Sci, BR-18610307 Botucatu, SP, Brazil.
EM otaviotd@gmail.com
OI Cesarino, Ivana/0000-0002-2296-3671
CR Aadil KR, 2014, INT J BIOL MACROMOL, V67, P220, DOI 10.1016/j.ijbiomac.2014.03.040
   Amaral-Labat G, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015001
   Antonopoulou I, 2016, APPL MICROBIOL BIOT, V100, P6519, DOI 10.1007/s00253-016-7647-9
   Aracri E, 2014, GREEN CHEM, V16, P2597, DOI 10.1039/c4gc00063c
   Arshanitsa A, 2013, J ANAL APPL PYROL, V103, P78, DOI 10.1016/j.jaap.2012.12.023
   Asada C, 2015, INT J BIOL MACROMOL, V74, P413, DOI 10.1016/j.ijbiomac.2014.12.039
   Azadfar M, 2015, INT J BIOL MACROMOL, V75, P58, DOI 10.1016/j.ijbiomac.2014.12.049
   Azadi P, 2013, RENEW SUST ENERG REV, V21, P506, DOI 10.1016/j.rser.2012.12.022
   Bahl K, 2014, POLYMER, V55, P3825, DOI 10.1016/j.polymer.2014.06.061
   Bajwa DS, 2016, INT J BIOL MACROMOL, V89, P265, DOI 10.1016/j.ijbiomac.2016.04.077
   Baker D., J APPL POLYM SCI, V130, P713
   Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042
   Barapatre A, 2015, INT J BIOL MACROMOL, V75, P81, DOI 10.1016/j.ijbiomac.2015.01.012
   Bedoya LM, 2005, BIOORG MED CHEM LETT, V15, P4447, DOI 10.1016/j.bmcl.2005.07.041
   Bova T, 2016, GREEN CHEM, V18, P5423, DOI [10.1039/c6gc01067a, 10.1039/C6GC01067A]
   Bozsodi B, 2016, MATER DESIGN, V103, P32, DOI 10.1016/j.matdes.2016.04.061
   Brewer MS, 2011, COMPR REV FOOD SCI F, V10, P221, DOI 10.1111/j.1541-4337.2011.00156.x
   Buono P, 2016, ACS SUSTAIN CHEM ENG, V4, P5212, DOI 10.1021/acssuschemeng.6b00903
   Carrico CS, 2016, EUR POLYM J, V85, P53, DOI 10.1016/j.eurpolymj.2016.10.012
   Cateto CA, 2014, J CELL PLAST, V50, P81, DOI 10.1177/0021955X13504774
   Chaiyasit W, 2007, CRIT REV FOOD SCI, V47, P299, DOI 10.1080/10408390600754248
   Chatgilialoglu C, 2009, ANGEW CHEM INT EDIT, V48, P2214, DOI 10.1002/anie.200805372
   Chen F, 2011, BIORESOURCES, V6, P1262
   Chen MJ, 2016, CELLULOSE, V23, P1325, DOI 10.1007/s10570-015-0814-9
   Chen YR, 2010, PHYTOCHEMISTRY, V71, P453, DOI 10.1016/j.phytochem.2009.11.012
   Chowdhury MA, 2014, INT J BIOL MACROMOL, V65, P136, DOI 10.1016/j.ijbiomac.2014.01.012
   Clark JH, 2012, ANNU REV CHEM BIOMOL, V3, P183, DOI 10.1146/annurev-chembioeng-062011-081014
   Dias OAT, 2016, MOL CRYST LIQ CRYST, V628, P72, DOI 10.1080/15421406.2015.1137677
   Ding R, 2016, CARBON, V100, P126, DOI 10.1016/j.carbon.2015.12.078
   Dizhbite T, 2004, BIORESOURCE TECHNOL, V95, P309, DOI 10.1016/j.biortech.2004.02.024
   Egues I, 2012, IND CROP PROD, V36, P164, DOI 10.1016/j.indcrop.2011.08.017
   Ferdosian F, 2014, RSC ADV, V4, P31745, DOI 10.1039/c4ra03978e
   Fernandez-Perez M, 2011, CARBOHYD POLYM, V83, P1672, DOI 10.1016/j.carbpol.2010.10.024
   Fortunati E, 2016, EUR POLYM J, V80, P295, DOI 10.1016/j.eurpolymj.2016.04.013
   Frank E, 2014, ANGEW CHEM INT EDIT, V53, P5262, DOI 10.1002/anie.201306129
   Galano A, 2016, ANNU REV FOOD SCI T, V7, P335, DOI 10.1146/annurev-food-041715-033206
   Gordobil O, 2015, IND CROP PROD, V72, P46, DOI 10.1016/j.indcrop.2015.01.055
   Grishechko LI, 2013, MICROPOR MESOPOR MAT, V168, P19, DOI 10.1016/j.micromeso.2012.09.024
   Grishechko LI, 2013, IND CROP PROD, V41, P347, DOI 10.1016/j.indcrop.2012.04.052
   Hemanth R, 2014, INDIAN J ADV CHEM SC, V2, P28
   Hilburg SL, 2014, POLYMER, V55, P995, DOI 10.1016/j.polymer.2013.12.070
   Hu L, 2015, J APPL POLYM SCI, V131, P21
   Husman G, 2012, 2012 DOE HYDR FUEL C
   Jones S. M., 2011, AEROGELS HDB, P721
   Kovalcik A, 2015, REACT FUNCT POLYM, V94, P25, DOI 10.1016/j.reactfunctpolym.2015.07.001
   Kubo S, 2005, J POLYM ENVIRON, V13, P97, DOI 10.1007/s10924-005-2941-0
   Kwan-Woo K, 2015, CARBON LETT, V16, P62
   Labaj J, 2004, NUTR CANCER, V50, P198, DOI 10.1207/s15327914nc5002_10
   Leopoldini M, 2011, J CHEM THEORY COMPUT, V7, P4218, DOI 10.1021/ct200572p
   Li CZ, 2015, CHEM REV, V115, P11559, DOI 10.1021/acs.chemrev.5b00155
   Liu C, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42182
   Liu HC, 2016, CARBON, V101, P382, DOI 10.1016/j.carbon.2016.01.096
   Liu YD, 2012, POLYM REV, V52, P234, DOI 10.1080/15583724.2012.705410
   Luo SP, 2016, ACS SUSTAIN CHEM ENG, V4, P3465, DOI 10.1021/acssuschemeng.6b00495
   Mahmood N, 2015, EUR POLYM J, V68, P1, DOI 10.1016/j.eurpolymj.2015.04.030
   Maldaner A. O., 2015, J THERMOPLAST COMPOS, P1
   Maleki H, 2016, ADV COLLOID INTERFAC, V236, P1, DOI 10.1016/j.cis.2016.05.011
   Martins M, 2015, J SUPERCRIT FLUID, V106, P152, DOI 10.1016/j.supflu.2015.05.010
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   Naskar A. K, 2014, U. S. Patent Application, Patent No. [13/288,360, 13288360]
   Oroumei A, 2015, ACS SUSTAIN CHEM ENG, V3, P758, DOI 10.1021/acssuschemeng.5b00097
   Perez-Cantu L, 2014, MICROPOR MESOPOR MAT, V195, P303, DOI 10.1016/j.micromeso.2014.04.018
   Phakkeeree T, 2016, J FIBER SCI TECHNOL, V72, P160, DOI 10.2115/fiberst.2016-0023
   Popa V, 2013, POLYM BIOMATERIALS S, P709
   Popa VI, 2011, CELL CHEM TECHNOL, V45, P221
   Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0
   PRYOR WA, 1988, FREE RADICAL BIO MED, V4, P219, DOI 10.1016/0891-5849(88)90043-3
   PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301
   Qiao W, 2015, J IND ENG CHEM, V21, P1417, DOI 10.1016/j.jiec.2014.06.016
   Quraishi S, 2015, J SUPERCRIT FLUID, V105, P1, DOI 10.1016/j.supflu.2014.12.026
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Sadeghifar H, 2016, ACS SUSTAIN CHEM ENG, V4, P5230, DOI 10.1021/acssuschemeng.6b00848
   Sain M, 2015, LIGNIN POLYM COMPOSI
   Sallem-Idrissi N, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42963
   Sameni J., 2015, INT J ENG INNOV TECH, V4, P102
   Santos OSH, 2017, J HAZARD MATER, V324, P406, DOI 10.1016/j.jhazmat.2016.11.004
   SARKANEN KV, 1971, LIGNINS OCCURRENCE F, P43
   Schorr D., 2015, J MATER RES, V4, P63, DOI [10.5539/jmsr.v4n1p63, DOI 10.5539/JMSR.V4N1P63]
   Spiridon I, 2015, COMPOS PART B-ENG, V69, P342, DOI 10.1016/j.compositesb.2014.10.006
   Stucker A, 2016, IND CROP PROD, V85, P300, DOI 10.1016/j.indcrop.2016.02.062
   Su L, 2013, BIORESOURCES, V8, P3532
   Sun JT, 2016, MACROMOL MATER ENG, V301, P328, DOI 10.1002/mame.201500310
   Sun Y, 2015, J MATER CHEM A, V3, P3699, DOI 10.1039/c4ta05991c
   Tan ZL, 2012, FOOD CHEM, V133, P1427, DOI 10.1016/j.foodchem.2012.02.030
   Tavares LB, 2016, EXPRESS POLYM LETT, V10, P927, DOI 10.3144/expresspolymlett.2016.86
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Tran CD, 2016, ADV FUNCT MATER, V26, P2677, DOI 10.1002/adfm.201504990
   Ugartondo V, 2009, IND CROP PROD, V30, P184, DOI 10.1016/j.indcrop.2009.03.001
   Vijayalaxmi, 2004, INT J RADIAT ONCOL, V59, P639, DOI 10.1016/j.ijrobp.2004.02.006
   Vinay Kumar, 2013, Free Radicals and Antioxidants, V3, P55, DOI 10.1016/j.fra.2013.07.001
   Vishtal A, 2011, BIORESOURCES, V6, P3547
   Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32383
   Wang C, 2016, CHEMSUSCHEM, V9, P770, DOI 10.1002/cssc.201501531
   Wang MC, 2009, EUR POLYM J, V45, P3380, DOI 10.1016/j.eurpolymj.2009.10.003
   Wang SC, 2016, COMPOS SCI TECHNOL, V128, P116, DOI 10.1016/j.compscitech.2016.03.018
   Wootton-Beard PC, 2011, FOOD RES INT, V44, P217, DOI 10.1016/j.foodres.2010.10.033
   Xu XZ, 2015, ADV FUNCT MATER, V25, P3193, DOI 10.1002/adfm.201500538
   Xu XZ, 2014, CARBON, V80, P91, DOI 10.1016/j.carbon.2014.08.042
   Youe WJ, 2016, INT J BIOL MACROMOL, V82, P497, DOI 10.1016/j.ijbiomac.2015.10.022
   Yu P, 2016, POLYM TEST, V54, P176, DOI 10.1016/j.polymertesting.2016.07.014
   Zhang CQ, 2015, POLYMER, V69, P52, DOI 10.1016/j.polymer.2015.05.046
   Zhang M, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43663
NR 102
TC 1
Z9 1
U1 8
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2017
VL 655
IS 1
SI SI
BP 204
EP 223
DI 10.1080/15421406.2017.1360713
PG 20
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA FT4GF
UT WOS:000423110900023
DA 2018-10-20
ER

PT J
AU Radu, N
   Voicescu, M
   Radu, E
   Tanasescu, C
AF Radu, Nicoleta
   Voicescu, Mariana
   Radu, Elena
   Tanasescu, Ciprian
TI Biomaterial with antioxidant and antifungal activities, obtained from
   romanian indigenous plants
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Frontiers of Polymers and Advanced
   Materials (ICFPAM)
CY OCT 31-NOV 04, 2016
CL Daejeon, SOUTH KOREA
SP Hannam Univ, LG Chem, BioActs, TecSco, Tavoro
DE Antifungal activities; antioxidant; essential oils; Satureja hortensis
ID L. ESSENTIAL OIL; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION;
   HORTENSIS; THYMOL; GROWTH; BLIGHT
AB Studies performed with the bioproduct obtained by hydrodistilation of Satureja hortensis, a Romanian indigenous plant, showed the presence of Tymol (47.18%), o-Cymene (22.38%) and Eucalyptol (7.59%). The bioproduct contains macro and microelements like Ca (42.6 ppm) and Fe (0.001 ppm). Studies regarding antioxidant properties, indicated a total antioxidant activity ranged between 99.4-99.9% for this bioproduct. Biological tests reveal the antifungal activities against Rhizoctonia solany (DL50= 219 mu L.L-1), Botrytis allii (DL50= 175 mu L.L-1), Sclerotinia sclerotiorum (DL50= 222 mu L.L-1) and Fusarium graminearum (DL50= 165 mu L.L-1). In conclusion, the bioproduct obtained from SH represents a bioproduct with antioxidant and biological activities against some phytopatogens.
C1 [Radu, Nicoleta; Radu, Elena] Nat Inst Res & Dev Chem & Petrochem, Biotechnol Dept, 202 Splaiul Independentei St,Dist 6, Bucharest 060021, Romania.
   [Voicescu, Mariana] Romanian Acad, ICF Ilie Murgulescu, Lab Quantum Chem & Mol Struct, Bucharest, Romania.
   [Tanasescu, Ciprian] Univ Lucian Blaga, Clin Surg Dept, Fac Med, Sibiu, Romania.
RP Radu, N (reprint author), Nat Inst Res & Dev Chem & Petrochem, Biotechnol Dept, 202 Splaiul Independentei St,Dist 6, Bucharest 060021, Romania.
EM nicolbiotec@yahoo.com
RI Radu, Nicoleta/B-5253-2017
FU National Authority for Scientific Research and Innovation from Romania
   [PN 16.31.03./2016]
FX This work has been supported by the National Authority for Scientific
   Research and Innovation from Romania, through the Core Projects no PN
   16.31.03./2016.
CR Ahmad A, 2010, FITOTERAPIA, V81, P1157, DOI 10.1016/j.fitote.2010.07.020
   Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI [10.1111/j.1364-3703.2005.00316.x, 10.1111/J.1364-3703.2005.00316.X]
   de Oliveira TLC, 2011, INT J FOOD MICROBIOL, V144, P546, DOI 10.1016/j.ijfoodmicro.2010.11.022
   Darvishi E, 2013, MED MYCOL, V51, P826, DOI 10.3109/13693786.2013.795664
   Djenane D, 2011, FOOD CONTROL, V22, P1046, DOI 10.1016/j.foodcont.2010.12.015
   Farzaneh M, 2015, POSTHARVEST BIOL TEC, V109, P145, DOI 10.1016/j.postharvbio.2015.06.014
   Fereshteh J, 2016, J ACUPUNCTURE MERIDI, V9, P118
   Haloc H, 2014, INT J PHARM PHARM SC, V6, P189
   Jorjandi M., 2009, American Journal of Agricultural and Biological Sciences, V4, P72
   Khan A, 2011, FEMS YEAST RES, V11, P114, DOI 10.1111/j.1567-1364.2010.00697.x
   Laleh Y, 2014, J EXP BIOL, V4, P399
   Mahboubi M, 2011, Iran J Microbiol, V3, P194
   Miguel MG, 2010, ACTA HORTIC, V853, P363
   Mihajilov-Krstev T, 2009, BIOTECHNOL BIOTEC EQ, V23, P1492, DOI 10.2478/V10133-009-0018-2
   Mihajilov-Krstev T, 2009, CENT EUR J BIOL, V4, P411, DOI 10.2478/s11535-009-0027-z
   Miladi H, 2013, J CHEM-NY, DOI 10.1155/2013/275698
   Moghadam ARL, 2015, J ESSENT OIL BEAR PL, V18, P455, DOI 10.1080/0972060X.2014.1002014
   Morar S., 2013, METAL INT, V18, P296
   Mumivand H, 2011, J MED PLANTS RES, V5, P1859
   Najafi F., 2010, J STRESS PHYSL BIOCH, V6, P13
   Nunes Reginaldo Teixeira, 2016, Revista de Patologia Tropical, V45, P273, DOI 10.5216/rpt.v45i3.43515
   Oussalah M, 2007, FOOD CONTROL, V18, P414, DOI 10.1016/j.foodcont.2005.11.009
   PANIZZI L, 1993, J ETHNOPHARMACOL, V39, P167, DOI 10.1016/0378-8741(93)90032-Z
   Pascual CB, 2000, PLANT PATHOL, V49, P108, DOI 10.1046/j.1365-3059.2000.00429.x
   Schulz H, 2005, VIB SPECTROSC, V39, P249, DOI 10.1016/j.vibspec.2005.04.009
   Sharifzadeh A, 2016, MICROB PATHOGENESIS, V96, P1, DOI 10.1016/j.micpath.2016.04.014
   Valizadeh S, 2014, BIOTECH HLTH SCI, V1, P24
NR 29
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2017
VL 655
IS 1
SI SI
BP 243
EP 249
DI 10.1080/15421406.2017.1361732
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA FT4GF
UT WOS:000423110900026
DA 2018-10-20
ER

PT J
AU Blasko, J
   Szekiova, E
   Slovinska, L
   Kafka, J
   Cizkova, D
AF Blasko, Juraj
   Szekiova, Eva
   Slovinska, Lucia
   Kafka, Jozef
   Cizkova, Dasa
TI Axonal outgrowth stimulation after alginate/mesenchymal stem cell
   therapy in injured rat spinal cord
SO ACTA NEUROBIOLOGIAE EXPERIMENTALIS
LA English
DT Article
DE spinal cord injury; mesenchymal stem cells; alginate; biomaterials;
   axonal outgrowth
ID QUANTITATIVE GAIT ANALYSIS; FUNCTIONAL RECOVERY; LOCOMOTOR RECOVERY;
   REGENERATION; INFLAMMATION; ALGINATE; CONTUSION; MICROGLIA; RESPONSES;
   NEURONS
AB Despite strong efforts in the field, spinal cord trauma still belongs among the untreatable neurological conditions at present. Given the complexity of the nervous system, an effective therapy leading to complete recovery has still not been found. One of the potential tools for supporting tissue regeneration may be found in mesenchymal stem cells, which possess anti-inflammatory and trophic factor-producing properties. In the context of transplantations, application of degradable biomaterials which could form a supportive environment and scaffold to bridge the lesion area represents another attractive strategy. In the present study, through a combination of these two approaches we applied both alginate hydrogel biomaterial alone or allogenic transplants of MSCs isolated from bone marrow seeded in alginate biomaterial into injured rat spinal cord at three weeks after spinal cord compression performed at Th8-9 level. Following three-week survival, using immunohistochemistry we studied axonal growth (GAP-43 expression) and both microglia (lba-1) and astrocyte (GFAP) reactions at the lesion site and in the segments below and above the lesion. To detect functional improvement, during whole survival period we performed behavioral analyses of locomotor abilities using a classical open field test (BBB score) and a Catwalk automated gait analyzing device (Noldus). We found that despite the absence of locomotor improvement, application of both alginate and MSCs caused significant increase in the number of GAP-43 positive axons.
C1 [Blasko, Juraj; Szekiova, Eva; Slovinska, Lucia] Slovak Acad Sci, Inst Neurobiol, Kosice, Slovakia.
   [Kafka, Jozef; Cizkova, Dasa] Univ Vet Med & Pharm, Kosice, Slovakia.
   [Cizkova, Dasa] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia.
RP Blasko, J (reprint author), Slovak Acad Sci, Inst Neurobiol, Kosice, Slovakia.
EM jblasko@saske.sk
FU VEGA [2/0125/15, 2/0145/16]; APVV [15-0613]; ERANET Neuron JTC
   AxonRepair
FX This study was supported by grants VEGA 2/0125/15, 2/0145/16, APVV
   15-0613 and ERANET Neuron JTC 2016 AxonRepair.
CR Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Blight A R, 2001, Curr Opin Investig Drugs, V2, P801
   Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004
   Brock JH, 2016, J NEUROTRAUM, V33, P1103, DOI 10.1089/neu.2015.4009
   Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1
   CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Foret A, 2010, J NEUROCHEM, V112, P762, DOI 10.1111/j.1471-4159.2009.06500.x
   Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008
   Grulova I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13702
   Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073
   Gunther MI, 2015, ACTA BIOMATER, V27, P140, DOI 10.1016/j.actbio.2015.09.001
   Gunther MI, 2015, J NEUROSCI METH, V251, P143, DOI 10.1016/j.jneumeth.2015.05.021
   Hamano K, 2000, CELL TRANSPLANT, V9, P439, DOI 10.1177/096368970000900315
   Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613
   Hendricks WA, 2006, MOL MED, V12, P34, DOI 10.2119/2006-00014.Hendricks
   Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731
   Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x
   Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016
   Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018
   Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125
   LINDA H, 1992, EXP BRAIN RES, V91, P284
   Nagyova M, 2014, IN VITRO CELL DEV-AN, V50, P656, DOI 10.1007/s11626-014-9750-5
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Novotna I, 2011, CELL MOL NEUROBIOL, V31, P1129, DOI 10.1007/s10571-011-9714-1
   Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9
   Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014
   Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119
   Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484
   Sandner B, 2016, CELL TRANSPLANT, V25, P125, DOI 10.3727/096368915X687679
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   van Middendorp JJ, 2012, SPINAL CORD, V50, P686, DOI 10.1038/sc.2012.34
   van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010
   Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687
   Voulgari-Kokota A, 2012, EXP NEUROL, V236, P161, DOI 10.1016/j.expneurol.2012.04.011
   Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2
   Wallace PK, 2008, CYTOM PART A, V73A, P1019, DOI 10.1002/cyto.a.20619
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Yan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084116
   Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057
   Zhang Xian-Yang, 2003, Methods Mol Biol, V229, P131
NR 51
TC 1
Z9 1
U1 1
U2 2
PU NENCKI INST EXPERIMENTAL BIOLOGY
PI WARSAW
PA UL PASTEURA 3, 02-093 WARSAW, POLAND
SN 0065-1400
EI 1689-0035
J9 ACTA NEUROBIOL EXP
JI Acta Neurobiol. Exp.
PY 2017
VL 77
IS 4
BP 337
EP 350
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA FT0JL
UT WOS:000422811200006
PM 29369299
DA 2018-10-20
ER

PT S
AU Soon, KS
   Hii, SL
   Wong, CL
   Leong, LK
   Woo, KK
AF Soon, K. S.
   Hii, S. L.
   Wong, C. L.
   Leong, L. K.
   Woo, K. K.
BE Ibrahim, SM
   Noorsal, K
TI Physicochemical Properties of Marine Collagen-Alginate Biomaterial
SO ADVANCED MATERIALS FOR SUSTAINABILITY AND GROWTH
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 3rd Advanced Materials Conference (AMC)
CY NOV 28-29, 2016
CL Langkawi, MALAYSIA
SP SIRIM Berhad
ID COMPOSITE; SCAFFOLDS
AB Collagen base biomaterials are widely applied in the field of tissue engineering. However, these fibrous proteins in animal connective tissues are insufficient to fulfill the mechanical properties for such applications. Therefore, alginate as a natural polysaccharide was incorporated. In this study, Smooth wolf herring skins was collected from the local fish ball processing industry for collagen extraction using acid solubilisation method. On the other hand, alginate from brown seaweed (Sargassum polycystum) was extracted with calcium carbonate at 50 degrees C. The composite films of different collagen and alginate ratio were prepared by lyophilisation with pure collagen film as control. The effects of alginate on swelling behaviour, porosity, collagenase degradation and tensile strength of the composite films were investigated. Swelling behaviour increased with alginate content, 50 % alginate film achieved 1254.75 % swelling after 24 h. All composite films achieved more than 80 % porosity except the film with 80 % collagen (65.41 %). Porosity was highest in 100 % alginate (94.30 %). Highest tensile strength (1585.87 kPa) and young modulus (27.05 MPa) was found in 50 % alginate film. In addition, resistance to collagenase degradation was improved with alginate content, lowest degradation rate was determined in 80 % alginate film. Results indicated alginate is efficient in improving some mechanical properties of the composite film.
C1 [Soon, K. S.; Leong, L. K.; Woo, K. K.] Univ Tunku Abdul Rahman, Lee Kong Chian Fac Engn & Sci, Dept Chem Engn, Jalan Sungai Long, Kajang 43000, Selangor, Malaysia.
   [Hii, S. L.] Kolej Univ Teknol Sarawak, Sch Engn & Technol, Sibu 96000, Sarawak, Malaysia.
   [Wong, C. L.] Taylors Univ, Sch Biosci, Taylors Lakeside Campus,1,Jalan Taylors, Subang Jaya 47500, Selangor Darul, Malaysia.
RP Woo, KK (reprint author), Univ Tunku Abdul Rahman, Lee Kong Chian Fac Engn & Sci, Dept Chem Engn, Jalan Sungai Long, Kajang 43000, Selangor, Malaysia.
EM jasonkeanseng90@gmail.com; hiisl@ucts.edu.my;
   chinglee.wong@taylors.edu.my; eonglk@utar.edu.my; wookk@utar.edu.my
FU Ministry of Higher Education, Malaysia
FX This study is financially supported by the Fundamental Research Grant
   Scheme (FRGS), Ministry of Higher Education, Malaysia.
CR Antiszko M, 1996, Polim Med, V26, P21
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Chee S., 2010, J APPL PHYSIOL, V23, P191
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Feng WP, 2015, INT J BIOL MACROMOL, V74, P218, DOI 10.1016/j.ijbiomac.2014.11.031
   Foegeding E., 1996, FOOD CHEM, V3, P849
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Perumal S, 2015, J MECH BEHAV BIOMED, V52, P131, DOI 10.1016/j.jmbbm.2015.04.006
   Sang L, 2011, MAT SCI ENG C-MATER, V31, P262, DOI 10.1016/j.msec.2010.09.008
   Wang H, 2013, PLOS ONE, V8
   Wang LF, 2015, INT J BIOL MACROMOL, V80, P460, DOI 10.1016/j.ijbiomac.2015.07.007
NR 14
TC 0
Z9 0
U1 2
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1589-8
J9 AIP CONF PROC
PY 2017
VL 1901
AR UNSP 100011
DI 10.1063/1.5010533
PG 6
WC Physics, Applied
SC Physics
GA BJ2RJ
UT WOS:000419832900096
DA 2018-10-20
ER

PT S
AU Prevot, ME
   Bergquist, LE
   Sharma, A
   Mori, T
   Gao, Y
   Bera, T
   Zhu, C
   Leslie, MT
   Cukelj, R
   Korley, LTJ
   Freeman, EJ
   McDonough, JA
   Clements, RJ
   Hegmann, E
AF Prevot, Marianne E.
   Bergquist, Leah E.
   Sharma, Anshul
   Mori, Taizo
   Gao, Yunxiang
   Bera, Tanmay
   Zhu, Chenhui
   Leslie, Michelle T.
   Cukelj, Richard
   Korley, LaShanda T. J.
   Freeman, Ernest J.
   McDonough, Jennifer A.
   Clements, Robert J.
   Hegmann, Elda
BE Khoo, IC
TI New developments in 3D liquid crystal elastomers scaffolds for tissue
   engineering: from physical template to responsive substrate
SO LIQUID CRYSTALS XXI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Liquid Crystals XXI
CY AUG 06-07, 2017
CL San Diego, CA
SP SPIE, Kolon Ind Inc
DE Liquid crystal elastomer; 3D scaffold; microspheres; tissue engineering;
   biocompatible; biodegradable; cell proliferation; cell alignment
ID POLYMER; MODULUS
AB We report here on cell growth and proliferation within a 3D architecture created using smectic liquid crystal elastomers (LCEs) leading to a responsive scaffold for tissue engineering. The investigated LCE scaffolds exhibit biocompatibility, controlled degradability, with mechanical properties and morphologies that can match development of the extracellular matrix. Moreover, the synthetic pathway and scaffold design offer a versatility of processing, allowing modifications of the surface such as adjusting the hydrophilic/hydrophobic balance and the mobility of the LC moieties to enhance the biomaterial performance. First, we succeeded in generating LCEs whose mechanical properties mimic muscle tissue. In films, our LCEs showed cell adhesion, proliferation, and alignment. We also achieved creating 3D LCE structures using either metallic template or microsphere scaffolds. Finally, we recorded a four times higher cell proliferation capability in comparison to conventional porous films and, most importantly, anisotropic cell growth that highlights the tremendous effect of liquid crystal moieties within LCEs on the cell environment.
C1 [Prevot, Marianne E.; Bergquist, Leah E.; Sharma, Anshul; Mori, Taizo; Gao, Yunxiang; Bera, Tanmay; Hegmann, Elda] Kent State Univ, Liquid Crystal Inst, 1425 Lefton Esplanade, Kent, OH 44242 USA.
   [Zhu, Chenhui] Lawrence Berkeley Natl Lab, Adv Light Source, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
   [Leslie, Michelle T.; Korley, LaShanda T. J.] Case Western Reserve, Macromol Sci & Engn Dept, 2100 Adelbert Rd, Cleveland, OH 44106 USA.
   [Cukelj, Richard; Freeman, Ernest J.; McDonough, Jennifer A.; Clements, Robert J.; Hegmann, Elda] Kent State Univ, Dept Biol Sci, 1425 Lefton Esplanade, Kent, OH 44242 USA.
   [Hegmann, Elda] Kent State Univ, Chem Phys Interdisciplinary Program, 1425 Lefton Esplanade, Kent, OH 44242 USA.
RP Hegmann, E (reprint author), Kent State Univ, Liquid Crystal Inst, 1425 Lefton Esplanade, Kent, OH 44242 USA.; Hegmann, E (reprint author), Kent State Univ, Dept Biol Sci, 1425 Lefton Esplanade, Kent, OH 44242 USA.; Hegmann, E (reprint author), Kent State Univ, Chem Phys Interdisciplinary Program, 1425 Lefton Esplanade, Kent, OH 44242 USA.
EM ehegmann@kent.edu
OI Gao, Yunxiang/0000-0002-3522-5838
FU KSU; Office of Science, Office of Basic Energy Sciences, of the U.S.
   Department of Energy [DE-AC02-05CH11231]
FX Authors would like to thank KSU for financial support of the
   Collaborative Research Grant. The authors are also thankful to Dr. C.
   Zhu and Dr. E. Schaible for help with SAXD measurements at Advanced
   Light Source, Berkeley. Beamline 7.3.3 of the Advanced Light Source is
   supported by the Director of the Office of Science, Office of Basic
   Energy Sciences, of the U.S. Department of Energy under Contract No.
   DE-AC02-05CH11231. The authors declare no competing financial interest.
CR Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Bera T, 2016, FRONT MATER, V3, DOI 10.3389/fmats.2016.00031
   Bera T, 2015, ACS APPL MATER INTER, V7, P14528, DOI 10.1021/acsami.5b04208
   Berkland C, 2003, PHARMACEUT RES, V20, P1055, DOI 10.1023/A:1024466407849
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   deGennes PG, 1997, CR ACAD SCI II B, V324, P343, DOI 10.1016/S1251-8069(99)80044-X
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Gao YX, 2016, ACS MACRO LETT, V5, P14, DOI 10.1021/acsmacrolett.5b00729
   Harris KD, 2005, J MATER CHEM, V15, P5043, DOI 10.1039/b512655j
   Lehmann O., 1909, J PHYS, V8, P713
   Lub J, 2005, MOL CRYST LIQ CRYST, V429, P77, DOI [10.1080/15421400590930773, 10.1080/15421400590937003]
   McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Sakai T, 2014, POLYM J, V46, P517, DOI 10.1038/pj.2014.28
   Sharma A, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600278
   Sharma A, 2015, MACROMOL BIOSCI, V15, P200, DOI 10.1002/mabi.201400325
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
NR 17
TC 0
Z9 0
U1 1
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-5106-1180-1; 978-1-5106-1180-1
J9 PROC SPIE
PY 2017
VL 10361
AR UNSP 103610T
DI 10.1117/12.2275338
PG 11
WC Crystallography; Materials Science, Multidisciplinary; Optics
SC Crystallography; Materials Science; Optics
GA BJ2SP
UT WOS:000419984000007
DA 2018-10-20
ER

PT S
AU Hospodarova, V
   Stevulova, N
   Vaclavik, V
   Dvorsky, T
AF Hospodarova, V.
   Stevulova, N.
   Vaclavik, V.
   Dvorsky, T.
BE Rucevskis, S
   Bajare, D
   Erdmane, D
   Vitola, L
TI Influence of Cellulosic Fibres on the Physical Properties of Fibre
   Cement Composites
SO 3RD INTERNATIONAL CONFERENCE ON INNOVATIVE MATERIALS, STRUCTURES AND
   TECHNOLOGIES (IMST 2017)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 3rd International Conference on Innovative Materials, Structures and
   Technologies (IMST)
CY SEP 27-29, 2017
CL Riga, LATVIA
SP Riga Tech Univ, Fac Civil Engn, Natl Res Programme Innovat Mat & Smart Technologies Environm Safety, Brno Univ Technol
ID MECHANICAL-BEHAVIOR; JUTE FIBER; MORTAR
AB Nowadays, there are new approaches directing to processing of non-conventional fibre-cement composites for application in the housing construction. Vegetable cellulosic fibres coming from natural resources used as reinforcement in cost-effective and environmental friendly building products are in the spotlight. The applying of natural fibres in cement based composites is narrowly linked to the ecological building sector, where a choice of materials is based on components including recyclable, renewable raw materials and low-resource manufacture techniques. In this paper, two types of cellulosic fibres coming from wood pulp and recycled waste paper with 0.2%; 0.3% and 0.5% of fibre addition into cement mixtures were used. Differences in the physical characteristics (flowability, density, coefficient of thermal conductivity and water absorbability) of 28 days hardened fibre-cement composites are investigated. Addition of cellulosic fibres to cement mixture caused worsening the workability of fresh mixture as well as absorbability of hardened composites due to hydrophilic nature of biomaterial, whereas density and thermal conductivity of manufactured cement based fibre plaster are enhanced. The physical properties of cement plasters based on cellulosic fibres depend on structural, physical characteristics of cellulosic fibres, their nature and processing.
C1 [Hospodarova, V.; Stevulova, N.] Tech Univ Kosice, Fac Civil Engn, Inst Environm Engn, Kosice, Slovakia.
   [Vaclavik, V.; Dvorsky, T.] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Environm Engn, Ostrava, Czech Republic.
RP Hospodarova, V (reprint author), Tech Univ Kosice, Fac Civil Engn, Inst Environm Engn, Kosice, Slovakia.
EM viola.hospodarova@tuke.sk
RI Dvorsky, Tomas/J-2386-2012
OI Dvorsky, Tomas/0000-0001-8364-1329; Stevulova,
   Nadezda/0000-0003-1093-044X
FU Slovak VEGA Grant Agency [VEGA 1/0277/15, LO1406]
FX The authors are grateful to the Slovak VEGA Grant Agency for financial
   support of the project VEGA 1/0277/15 and Project Institute of Clean
   Technologies for Mining and Utilization of Raw Materials for Energy Use.
   Reg. No. LO1406.
CR Akinwumi II, 2014, CIVIL ENV RES, V6, P160
   [Anonymous], 7313161989 STN
   [Anonymous], 19612016 STN EN
   [Anonymous], 10082003 STN EN
   [Anonymous], 101532000 STN EN
   Ardanuy M, 2015, CONSTR BUILD MATER, V79, P115, DOI 10.1016/j.conbuildmat.2015.01.035
   Ashour T, 2010, MATER DESIGN, V31, P4676, DOI 10.1016/j.matdes.2010.05.026
   Binici H, 2017, MATER TODAY COMMUN, V10, P14, DOI 10.1016/j.mtcomm.2016.09.004
   Boumhaout M, 2017, CONSTR BUILD MATER, V135, P241, DOI 10.1016/j.conbuildmat.2016.12.217
   Celino A, 2013, J APPL POLYM SCI, V130, P297, DOI 10.1002/app.39148
   Chakraborty S, 2013, CONSTR BUILD MATER, V49, P214, DOI 10.1016/j.conbuildmat.2013.08.025
   Chakraborty S, 2013, CONSTR BUILD MATER, V38, P776, DOI 10.1016/j.conbuildmat.2012.09.067
   Cigasova J, 2015, 2015 IOP C S MAT SCI, V96, P1
   Hospodarova V, 2015, 2015 IOP C SER MAT S, V96, P1
   Karade SR, 2010, CONSTR BUILD MATER, V24, P1323, DOI 10.1016/j.conbuildmat.2010.02.003
   Khedari J, 2001, CEMENT CONCRETE COMP, V23, P65, DOI 10.1016/S0958-9465(00)00072-X
   Kusnerova M, 2016, DEF DIFF FORUM, V370, P68
   Marmol G, 2013, IND CROP PROD, V49, P422, DOI 10.1016/j.indcrop.2013.04.051
   Savastano H, 2006, J MATER SCI, V41, P6938, DOI 10.1007/s10853-006-0218-1
   Sawsen C, 2015, CONSTR BUILD MATER, V79, P229, DOI 10.1016/j.conbuildmat.2014.12.091
   Shoukry H, 2016, CONSTR BUILD MATER, V102, P167, DOI 10.1016/j.conbuildmat.2015.10.188
   Sinka M, 2015, 2015 IOP C S MAT SCI, V96, P1
   Stevulova N, 2015, MATERIALS, V8, P2243, DOI 10.3390/ma8052243
NR 23
TC 0
Z9 0
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2017
VL 251
AR UNSP 012015
DI 10.1088/1757-899X/251/1/012015
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJ2HP
UT WOS:000419383500015
OA Other Gold
DA 2018-10-20
ER

PT J
AU Horikawa, A
   Maegawa, S
   Hasebe, T
   Matsumoto, T
   Tanaka, M
   Takahashi, K
   Suzuki, T
AF Horikawa, Ayumi
   Maegawa, Shunto
   Hasebe, Terumitsu
   Matsumoto, Tomohiro
   Tanaka, Minoru
   Takahashi, Koki
   Suzuki, Tetsuya
TI Fluorine-Incorporated Amorphous Carbon Coating Inhibits Adhesion of
   Blood Cells to Biomaterials
SO SENSORS AND MATERIALS
LA English
DT Article
DE amorphous carbon; fluorine doping; biomaterial; antithrombogenic;
   anti-inflammation
ID DIAMOND-LIKE CARBON; PLATELET ACTIVATION; P-SELECTIN; NEUTROPHILS;
   INFLAMMATION; PROTEIN; THROMBOSIS; RESPONSES; DLC
AB When the surfaces of biomaterials come into contact with human blood, the contact can induce adhesion and activation of platelets and leukocytes following protein adhesion, and these complex reactions cause responses in the body including biomaterial-associated thrombosis and inflammation. Fluorine-incorporated amorphous carbon (a-C:H:F) is widely known as an antithrombogenic thin film and is regarded as a promising coating that can solve the problem of blood-contacting medical devices. However, the anti-inflammatory properties of a-C:H:F have not yet been elucidated. Polymorphonuclear neutrophil leukocytes (neutrophils) play important roles in thrombosis and inflammation, and platelets that adhere to and become activated on biomaterial, which are also key factors of thrombus formation, promote adhesion of neutrophils in an inflammatory process. In this study, to evaluate the antithrombogenic and anti-inflammatory properties of a-C:H:F coating, we analyzed the platelets that had adhered to and become activated on, as well as neutrophils that had adhered to, a-C:H:F-coated SUS316L, which is a conventional material used for medical devices. The a-C:H:F-coated SUS316L suppressed platelet adhesion and activation and neutrophil adhesion to a greater extent than uncoated SUS316L. These results showed that a-C:H:F coating is a suitable and biocompatible coating for implanted devices because it controls the initial thrombotic and inflammatory reactions of biomaterials.
C1 [Horikawa, Ayumi] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.
   [Horikawa, Ayumi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.
   [Horikawa, Ayumi; Tanaka, Minoru; Takahashi, Koki] Univ Tokyo, Dept Transfus Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
   [Horikawa, Ayumi; Tanaka, Minoru; Takahashi, Koki] Univ Tokyo, Inst Med Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
   [Maegawa, Shunto; Hasebe, Terumitsu; Matsumoto, Tomohiro; Suzuki, Tetsuya] Keio Univ, Grad Sch Sci & Technol, Ctr Sci Environm Resources & Energy, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
   [Hasebe, Terumitsu; Matsumoto, Tomohiro] Tokai Univ, Sch Med, Hachioji Hosp, Dept Radiol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.
   [Tanaka, Minoru] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr,Div Innovat Canc Therapy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
   [Takahashi, Koki] Japanese Red Cross Soc, Dept Blood Serv Board Management, Minato Ku, 1-3 Shiba Daimon 1 Chome, Tokyo 1058521, Japan.
RP Hasebe, T (reprint author), Keio Univ, Grad Sch Sci & Technol, Ctr Sci Environm Resources & Energy, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.; Hasebe, T (reprint author), Tokai Univ, Sch Med, Hachioji Hosp, Dept Radiol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.
EM hasebe@tokai-u.jp
FU Nanotech Challenge Program research grant of the Research and
   Development Organization (NEDO) in Japan; Kawasumi Laboratories, Inc.
FX This work was supported by the Nanotech Challenge Program research grant
   of the Research and Development Organization (NEDO) in Japan and funded
   partly by Kawasumi Laboratories, Inc. We greatly appreciate the
   discussions with and helpful comments made by Haruko Ogawa of the
   Graduate School of Humanities and Science and the Glycoscience
   Institute, Ochanomizu University; Hitoshi Okazaki, Mika Matsuhashi, and
   Madoka Nishimori of the Department of Transfusion Medicine and the
   Institute of Medical Science of the University of Tokyo; and Yoshiharu
   Yoshikawa, Akira Ihara, Toshiyasu Yuba, Mai Teranishi, Kazunori
   Murakaini, and Akira Bonkohara of Kawasumi Laboratories, Inc.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   CROVELLO CS, 1993, J BIOL CHEM, V268, P14590
   FORBES CD, 1978, BRIT MED BULL, V34, P201, DOI 10.1093/oxfordjournals.bmb.a071492
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HAMBURGER SA, 1990, BLOOD, V75, P550
   HANSON SR, 1993, CARDIOVASC PATHOL, V2, pS157
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hasebe T, 2011, DIAM RELAT MATER, V20, P902, DOI 10.1016/j.diamond.2011.04.014
   Hasebe T, 2007, THIN SOLID FILMS, V516, P299, DOI 10.1016/j.tsf.2007.06.033
   Hasebe T, 2007, J BIOMED MATER RES A, V83A, P1192, DOI 10.1002/jbm.a.31340
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Inoue T, 1996, CIRCULATION, V94, P1523
   Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515
   LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4
   Maegawa S, 2016, DIAM RELAT MATER, V70, P33, DOI 10.1016/j.diamond.2016.09.021
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Neumann A W, 1979, Cell Biophys, V1, P79
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970
   Schwarz C, 2008, DIAM RELAT MATER, V17, P1685, DOI 10.1016/j.diamond.2008.02.039
   SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TSCHOEPE D, 1993, CIRCULATION, V88, P37, DOI 10.1161/01.CIR.88.1.37
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yokoyama S, 2005, J AM COLL CARDIOL, V45, P1280, DOI 10.1016/j.jacc.2004.12.071
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
NR 31
TC 0
Z9 0
U1 4
U2 7
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2017
VL 29
IS 6
SU 2
SI SI
BP 795
EP 803
DI 10.18494/SAM.2017.1558
PG 9
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA FS4HE
UT WOS:000419748900004
OA Bronze
DA 2018-10-20
ER

PT J
AU Yamato, Y
   Maegawa, S
   Hasebe, T
   Bito, K
   Matsumoto, T
   Mine, T
   Hayashi, T
   Hotta, A
   Suzukil, T
AF Yamato, Yuya
   Maegawa, Shunto
   Hasebe, Terumitsu
   Bito, Kenta
   Matsumoto, Tomohiro
   Mine, Takahiko
   Hayashi, Toshihiko
   Hotta, Asushi
   Suzukil, Tetsuya
TI Biocompatibility Tests and Adhesion Improvements for Hydrogen-Free
   Amorphous Carbon for Blood-Contacting Medical Devices
SO SENSORS AND MATERIALS
LA English
DT Article
DE amorphous carbon; biomaterial; adhesive properties; biocompatibility
ID DIAMOND-LIKE CARBON; ION IMPLANTATION-DEPOSITION; PROTEIN ADSORPTION;
   PLATELET-ADHESION; DLC COATINGS; SHAPE CHANGE; FILMS; PLASMA; PTFE;
   ACTIVATION
AB The hydrogenated amorphous carbon (a-C:H) film has been known as a coating material that imparts improved biocompatibility to base materials and has been used for many clinical applications. Recent studies have revealed that hydrogen-free amorphous carbon (H-free a-C) on stainless steel (SUS) has beneficial antibacterial properties, which allow avoidance of the risk of bacterial infection. In our study, to evaluate the biocompatibility of H-free a-C itself for blood-contacting devices, we investigated not only the ability to grow bacteria but also platelet aggregation on the surfaces of H-free a-C. Moreover, to apply H-free a-C to polytetrafluoroethylene (PTFE), we evaluated the adhesive properties of H-free a-C deposited after Ar or O-2 plasma pre-treatment and fluorine-incorporated a-C:H (a-C:H:F) interlayer deposition. Antibacterial tests and antithrombogenic tests indicated that H-free a-C coating reduced bacterial adhesion and platelet activation in comparison with a-C:H coating. The adhesive strength of plasma-treated Ar and the interlayer deposited PTFE was five times larger than those of untreated PTFE from film adhesion tests. These results indicated that the pre-treated PTFE coated with H-free a-C is a promising candidate biomaterial for medical devices.
C1 [Yamato, Yuya; Maegawa, Shunto; Hasebe, Terumitsu; Bito, Kenta; Matsumoto, Tomohiro; Hotta, Asushi; Suzukil, Tetsuya] Keio Univ, Grad Sch Sci & Technol, Ctr Sci Environm Resource & Energy, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
   [Hasebe, Terumitsu; Matsumoto, Tomohiro; Mine, Takahiko; Hayashi, Toshihiko] Tokai Univ, Sch Med, Hachioji Hosp, Dept Radiol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.
RP Hasebe, T (reprint author), Keio Univ, Grad Sch Sci & Technol, Ctr Sci Environm Resource & Energy, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.; Hasebe, T (reprint author), Tokai Univ, Sch Med, Hachioji Hosp, Dept Radiol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.
EM hasebe@tokai-u.jp
CR ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   Baba K, 2006, THIN SOLID FILMS, V506, P55, DOI 10.1016/j.tsf.2005.08.072
   Barrio J, 2005, EUR J RADIOL, V55, P120, DOI 10.1016/j.ejrad.2004.10.007
   Basak GC, 2011, APPL SURF SCI, V257, P2891, DOI 10.1016/j.apsusc.2010.10.087
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Guo YB, 2003, DIAM RELAT MATER, V12, P946, DOI 10.1016/S0925-9635(02)00320-5
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hasebe T, 2007, NEW DIAM FRONT C TEC, V17, P263
   Hasebe T, 2007, THIN SOLID FILMS, V516, P299, DOI 10.1016/j.tsf.2007.06.033
   Hasebe T, 2007, J BIOMED MATER RES A, V83A, P1192, DOI 10.1002/jbm.a.31340
   Hatzidakis A, 2007, CARDIOVASC INTER RAD, V30, P950, DOI 10.1007/s00270-007-9049-y
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kim HG, 2005, THIN SOLID FILMS, V482, P299, DOI 10.1016/j.tsf.2004.11.164
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Marciano FR, 2009, DIAM RELAT MATER, V18, P1010, DOI 10.1016/j.diamond.2009.02.014
   Meunier C, 2005, SURF COAT TECH, V200, P1976, DOI 10.1016/j.surfcoat.2005.08.013
   Nagashima S, 2010, DIAM RELAT MATER, V19, P861, DOI 10.1016/j.diamond.2010.02.003
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Ozeki K, 2008, APPL SURF SCI, V254, P1614, DOI 10.1016/j.apsusc.2007.07.129
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   Steffen HJ, 2000, SURF INTERFACE ANAL, V29, P386, DOI 10.1002/1096-9918(200006)29:6<386::AID-SIA882>3.0.CO;2-0
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P661, DOI 10.1002/sia.2691
   Wilson DJ, 2001, SURF INTERFACE ANAL, V31, P385, DOI 10.1002/sia.1065
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
NR 32
TC 1
Z9 1
U1 4
U2 8
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2017
VL 29
IS 6
SU 2
SI SI
BP 843
EP 854
DI 10.18494/SAM.2017.1573
PG 12
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA FS4HE
UT WOS:000419748900009
OA Bronze
DA 2018-10-20
ER

PT S
AU Zatkalikova, V
   Markovicova, L
   Skorvanova, M
AF Zatkalikova, V.
   Markovicova, L.
   Skorvanova, M.
GP IOP
TI Corrosion behaviour of electropolished AISI 316L austenitic biomaterial
   in physiological solution
SO 27TH JOINT SEMINAR DEVELOPMENT OF MATERIALS SCIENCE IN RESEARCH AND
   EDUCATION
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 27th Joint Seminar on Development of Materials Science in Research and
   Education
CY SEP 04-08, 2017
CL SLOVAKIA
SP Slovak Expert Grp Solid State Chem & Phys, Czechoslovak Assoc Crystal Growth, Crystallogr Soc, STU, Fac Chem & Food Technol, Slovak Soc Ind Chem, STU, Fac Mat Sci & Technol Trnava, Czech & Slovak Crystallographers, Reg Comm, Inst Phys, Czech Acad Sci, European Reg Dev Fund
ID STAINLESS-STEEL; SURFACE-ROUGHNESS
AB Due to suitable mechanical properties, satisfactory corrosion resistance and relatively low cost, austenitic stainless steels are important biomaterials for manufacture of implants and various medical instruments and devices. Their corrosion properties and biocompatibility are significantly affected by protective passive surface film quality, which depends on used mechanical and chemical surface treatment. This article deals with corrosion resistance of AISI 316L stainless steel, which is the most widely used Cr-Ni-Mo austenitic biomaterial. Corrosion behaviour of five various surfaces (original, electropolished, three surfaces with combined treatment finished by electropolishing) is evaluated on the bases of cyclic potentiodynamic polarization tests performed in physiological solution at the temperature of 37 +/- 0.5 degrees C.
C1 [Zatkalikova, V.; Markovicova, L.] Univ Zilina, Fac Mech Engn, Dept Mat Engn, Univ 8215-1, Zilina 01026, Slovakia.
   [Skorvanova, M.] Comenius Univ, Jessenius Fac Med Martin, Mala Hora 10701-4A, Martin 03601, Slovakia.
RP Zatkalikova, V (reprint author), Univ Zilina, Fac Mech Engn, Dept Mat Engn, Univ 8215-1, Zilina 01026, Slovakia.
EM viera.zatkalikova@fstroj.uniza.sk
FU Scientific Grant Agency of Ministry of Education, Science and Sport of
   Slovak Republic; Slovak Academy of Sciences, grant VEGA [1/0683/15];
   Slovak Academy of Sciences, grant KEGA [049ZU-4/2017]
FX The research was supported partially by Scientific Grant Agency of
   Ministry of Education, Science and Sport of Slovak Republic and Slovak
   Academy of Sciences, grant VEGA No. 1/0683/15 and grant KEGA No.
   049ZU-4/2017.
CR Ghanavati S, 2015, IRANIAN J OIL GAS SC, V5, P65
   Hadzima B, 2008, ZAKLADY ELEKTROCHEMI
   Hashimoto K, 2007, CORROS SCI, V49, P42, DOI 10.1016/j.corsci.2006.05.003
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Lee SJ, 2003, J MATER PROCESS TECH, V140, P206, DOI 10.1016/S0924-0136(03)00785-4
   Liptakova T, 2012, PERIOD POLYTECH, V41, P143
   Liptakova T, 2009, BODOVA KOROZIA NEHRD
   Nagase M, 1995, HOST REACTIONS PAR A, V1
   Nunez PJ, 2013, PROCEDIA ENGINEER, V63, P771, DOI 10.1016/j.proeng.2013.08.255
   Oravcova M, 2017, IOP C SERIES MAT SCI, V175, P1
   Ratner B.D., 2004, BIOMATERIALS SCI
   Sasaki K, 1996, CORROS SCI, V38, P2111, DOI 10.1016/S0010-938X(96)00066-2
   Szklarska-Smialowska Z., 2005, PITTING CREVICE CORR
   Uhricik M, 2016, EAN 2016 54 INT C EX
   Vana D, 2014, POROVNANIE TECHNOLOG
   Zhao H, 2002, J MATER SCI-MATER M, V13, P911, DOI 10.1023/A:1019831808503
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2017
VL 266
AR UNSP 012016
DI 10.1088/1757-899X/266/1/012016
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJ2EP
UT WOS:000419228900016
OA Other Gold
DA 2018-10-20
ER

PT S
AU Suzuki, H
   He, JM
AF Suzuki, Hiromichi
   He, Jianmei
GP IOP
TI Evaluation on Bending Properties of Biomaterial GUM Metal Meshed Plates
   for Bone Graft Applications
SO 2017 4TH INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS, MECHANICS AND
   STRUCTURAL ENGINEERING (4TH AMMSE 2017)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Advanced Materials, Mechanics and
   Structural Engineering (AMMSE)
CY SEP 22-24, 2017
CL Tianjin, PEOPLES R CHINA
SP Incheon Natl Univ, Incheon Disaster Prevent Res Ctr, Incheon Natl Univ
AB There are three bone graft methods for bone defects caused by diseases such as cancer and accident injuries: Autogenous bone grafts, Allografts and Artificial bone grafts. In this study, meshed GUM Metal plates with lower elasticity, high strength and high biocompatibility are introduced to solve the over stiffness & weight problems of ready-used metal implants. Basic mesh shapes are designed and applied to GUM Metal plates using 3D CAD modeling tools. Bending properties of prototype meshed GUM Metal plates are evaluated experimentally and analytically. Meshed plate specimens with 180 degrees, 120 degrees and 60 degrees axis-symmetrical types were fabricated for 3-point bending tests. The pseudo bending elastic moduli of meshed plate specimens obtained from 3-point bending test are ranged from 4.22 GPa to 16.07 GPa, within the elasticity range of natural cortical bones from 2.0 GPa to 30.0 GPa. Analytical approach method is validated by comparison with experimental and analytical results for evaluation on bending property of meshed plates.
C1 [Suzuki, Hiromichi; He, Jianmei] Kogakuin Univ, Dept Mech Engn, Shinjuku Ku, 1-24-2,Nishi Shinjuku, Tokyo 1638677, Japan.
RP Suzuki, H (reprint author), Kogakuin Univ, Dept Mech Engn, Shinjuku Ku, 1-24-2,Nishi Shinjuku, Tokyo 1638677, Japan.
CR Kokubo K, MECH ENG BASIC COURS
   Ohara H, 2017, STUDY BENDING PROPER
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2017
VL 269
AR UNSP 012078
DI 10.1088/1757-899X/269/1/012078
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BJ2EO
UT WOS:000419228000078
OA Other Gold
DA 2018-10-20
ER

PT S
AU Prevot, M
   Hegmann, E
AF Prevot, M.
   Hegmann, E.
BE Ito, Y
   Chen, X
   Kang, IK
TI From Biomaterial, Biomimetic, and Polymer to Biodegradable and
   Biocompatible Liquid Crystal Elastomer Cell Scaffolds
SO ADVANCES IN BIOINSPIRED AND BIOMEDICAL MATERIALS, VOL 2
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT International Symposium on Advanced in Bioinspired and Medical Materials
   / PacifiChen 2015
CY DEC 15-20, 2015
CL Amer Chem Soc, Honolulu, HI
SP Amer Chem Soc
HO Amer Chem Soc
ID TISSUE ENGINEERING APPLICATIONS; IN-VIVO DEGRADATION; POLY(GLYCEROL
   SEBACATE); MECHANICAL-PROPERTIES; REGENERATIVE MEDICINE; ARTIFICIAL
   MUSCLES; POROUS SCAFFOLDS; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS;
   EXTRACELLULAR-MATRIX
AB 3D scaffolds are no longer simply physical templates for cell growth and tissue formation; they also have to provide chemical, biomolecular, mechanical and geometrical signals to cells.
   Liquid crystals (LCs) can be of significant importance in tissue engineering because they are able to report anisotropic growth of expanding cell lines back to the observer with an easily discernable optical response such as a change in birefringence or via the alignment of the LC molecules. The real challenge is to design materials that can direct or guide the behavior of biological materials.
   After a brief survey of several materials classes intensively investigated for the use as 3D cell scaffolds, we summarize recent research on a particular class of LC materials, liquid crystal elastomers (LCEs), that can serve as unique, longitudinal and multi-responsive cell scaffolds suitable for cell attachment, cell proliferation and cell alignment. Several types of biocompatible, biodegradable LCE scaffolds with specially engineered porous architectures will be introduced and their advantages discussed.
C1 [Prevot, M.; Hegmann, E.] Kent State Univ, Liquid Crystal Inst, Kent, OH 44242 USA.
   [Hegmann, E.] Kent State Univ, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA.
   [Hegmann, E.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
RP Hegmann, E (reprint author), Kent State Univ, Liquid Crystal Inst, Kent, OH 44242 USA.; Hegmann, E (reprint author), Kent State Univ, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA.; Hegmann, E (reprint author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
EM ehegmann@kent.edu
CR Agarwal A, 2008, ADV MATER, V20, P4804, DOI 10.1002/adma.200800932
   Agrawal A, 2014, SOFT MATTER, V10, P1411, DOI 10.1039/c3sm51654g
   Agrawal A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2772
   Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1
   Alge DL, 2013, BIOMACROMOLECULES, V14, P949, DOI 10.1021/bm4000508
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Artal C, 2001, MACROMOLECULES, V34, P4244, DOI 10.1021/ma001928e
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Barrioni BR, 2015, MAT SCI ENG C-MATER, V52, P22, DOI 10.1016/j.msec.2015.03.027
   Bera T, 2016, FRONT MATER, V3, DOI 10.3389/fmats.2016.00031
   Bera T, 2015, ACS APPL MATER INTER, V7, P14528, DOI 10.1021/acsami.5b04208
   Bergmann GHF, 1997, MACROMOL RAPID COMM, V18, P353, DOI 10.1002/marc.1997.030180501
   Berkland C, 2003, PHARMACEUT RES, V20, P1055, DOI 10.1023/A:1024466407849
   Boccaccini AR, 2014, TISSUE ENG USING CER
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Brommel F, 2012, ADV POLYM SCI, V250, P1, DOI 10.1007/12_2012_168
   Buguin A, 2006, J AM CHEM SOC, V128, P1088, DOI 10.1021/ja0575070
   Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118
   CARDY RH, 1979, J NATL CANCER I, V62, P1107
   Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Cheng H, 2011, ADV MATER, V23, pH95, DOI 10.1002/adma.201003482
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   de Jeu WH, 2007, EUR PHYS J E, V24, P399, DOI 10.1140/epje/i2007-10254-8
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   deGennes PG, 1997, CR ACAD SCI II B, V324, P343, DOI 10.1016/S1251-8069(99)80044-X
   deGennes PG, 1997, MACROMOL SYMP, V113, P39, DOI 10.1002/masy.19971130107
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Divya P, 2009, J TISSUE ENG REGEN M, V3, P377, DOI 10.1002/term.174
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Eirich F. R., 1994, SCI TECHNOLOGY RUBBE
   El-Laboudy H, 2011, SOFT MATER, V9, P409, DOI 10.1080/1539445X.2010.528726
   FIELDS RD, 1974, J APPL POLYM SCI, V18, P3571, DOI 10.1002/app.1974.070181207
   Finkelmann H, 2001, ADV MATER, V13, P1069, DOI 10.1002/1521-4095(200107)13:14<1069::AID-ADMA1069>3.0.CO;2-6
   Finkelmann H, 2002, P SOC PHOTO-OPT INS, V4695, P459, DOI 10.1117/12.475190
   Fleischmann E.-K., 2012, NAT COMMUN, P3
   Fleischmann EK, 2013, ANGEW CHEM INT EDIT, V52, P8810, DOI 10.1002/anie.201300371
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gao YX, 2016, ACS MACRO LETT, V5, P14, DOI 10.1021/acsmacrolett.5b00729
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gerecht S, 2007, BIOMATERIALS, V28, P4826, DOI 10.1016/j.biomaterials.2007.07.039
   Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292
   Ginebra MP, 2007, J BIOMED MATER RES A, V80A, P351, DOI 10.1002/jbm.a.30886
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Guo BL, 2014, SCI CHINA CHEM, V57, P490, DOI 10.1007/s11426-014-5086-y
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Harris KD, 2005, J MATER CHEM, V15, P5043, DOI 10.1039/b512655j
   Hashimoto S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917465
   Herzer N, 2012, J AM CHEM SOC, V134, P7608, DOI 10.1021/ja301845n
   Hiljanen Vainio M. P., 1997, J BIOMED MATER RES, V34, P39
   Hiob MA, 2016, CURR OPIN BIOTECH, V40, P149, DOI 10.1016/j.copbio.2016.04.008
   Hollister SJ, 2006, NAT MATER, V5, P590, DOI 10.1038/nmat1683
   Jayakumar R, 2011, ADV POLYM SCI, V244, P1, DOI 10.1007/978-3-642-24061-4
   Jing DY, 2006, MACROMOL BIOSCI, V6, P747, DOI 10.1002/mabi.200600079
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Kerativitayanan P, 2015, ACTA BIOMATER, V26, P34, DOI 10.1016/j.actbio.2015.08.025
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kim HY, 2016, J VIS EXP
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Krol P, 2007, PROG MATER SCI, V52, P915, DOI 10.1016/j.pmatsci.2006.11.001
   Kucinska-Lipka J, 2015, MAT SCI ENG C-MATER, V46, P166, DOI 10.1016/j.msec.2014.10.027
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lewandowska K, 2014, MOL CRYST LIQ CRYST, V590, P193, DOI 10.1080/15421406.2013.874718
   Lewis KJR, 2013, MRS BULL, V38, P260, DOI 10.1557/mrs.2013.54
   Li MH, 2006, PHILOS T R SOC A, V364, P2763, DOI 10.1098/rsta.2006.1853
   Li XD, 2015, BIOMACROMOLECULES, V16, P1525, DOI 10.1021/acs.biomac.5b00018
   Li Y, 2013, POLYM INT, V62, P534, DOI 10.1002/pi.4419
   Liu XH, 2010, BIOMATERIALS, V31, P259, DOI 10.1016/j.biomaterials.2009.09.046
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lowe AM, 2012, CHEM MATER, V24, P746, DOI 10.1021/cm202632m
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Lub J, 2005, MOL CRYST LIQ CRYST, V429, P77, DOI [10.1080/15421400590930773, 10.1080/15421400590937003]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Marshall JE, 2014, J AM CHEM SOC, V136, P474, DOI 10.1021/ja410930g
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Martinoty P, 2004, EUR PHYS J E, V14, P311, DOI 10.1140/epje/i2003-10154-y
   Masoumi N, 2013, ACTA BIOMATER, V9, P5974, DOI 10.1016/j.actbio.2013.01.001
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matassi F, 2011, CLIN CASES MINER BON, V8, P21
   Mathias EV, 2010, COLLOID POLYM SCI, V288, P1655, DOI 10.1007/s00396-010-2304-9
   Mayer S, 2002, CURR OPIN SOLID ST M, V6, P545, DOI 10.1016/S1359-0286(03)00011-1
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520
   Mitov M, 2006, NAT MATER, V5, P361, DOI 10.1038/nmat1619
   Mondal D, 2016, INT J POLYM MATER PO, V65, P255, DOI 10.1080/00914037.2015.1103241
   Neuss S, 2009, BIOMATERIALS, V30, P1697, DOI 10.1016/j.biomaterials.2008.12.027
   Ning LQ, 2016, J BIOMAT SCI-POLYM E, V27, P898, DOI 10.1080/09205063.2016.1170415
   Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H
   Nottelet B, 2010, J POLYM SCI POL CHEM, V48, P3244, DOI 10.1002/pola.24100
   Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Ohm C, 2012, ADV POLYM SCI, V250, P49, DOI 10.1007/12_2011_164
   Ohm C, 2010, ADV MATER, V22, P3366, DOI 10.1002/adma.200904059
   Olsen BD, 2010, MACROMOLECULES, V43, P9094, DOI 10.1021/ma101434a
   Palffy-Muhoray P, 2004, NAT MATER, V3, P139, DOI 10.1038/nmat1083
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Patel A, 2013, BIOMATERIALS, V34, P3970, DOI 10.1016/j.biomaterials.2013.01.045
   Patricio T, 2013, PROC CIRP, V5, P110, DOI 10.1016/j.procir.2013.01.022
   Peltzer J, 2008, DEV DYNAM, V237, P1412, DOI 10.1002/dvdy.21543
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Qutachi O, 2014, ACTA BIOMATER, V10, P5090, DOI 10.1016/j.actbio.2014.08.015
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Reinitzer F, 1908, ANN PHYS-BERLIN, V27, P213
   Reinitzer F., 1888, MONATSH CHEM, V9, P20
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   ROWLANDS AS, 2007, J BIOMATERIALS, V28, P2109, DOI DOI 10.1016/J.BIOMATERIALS.2006.12.032
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Saed M. O., 2016, J VIS EXP
   Sanchez-Ferrer A, 2011, ADV MATER, V23, P4526, DOI 10.1002/adma.201102277
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SCOTT JE, 1995, J ANAT, V187, P259
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Seunarine K, 2006, NANOMEDICINE-UK, V1, P281, DOI 10.2217/17435889.1.3.281
   Sharma A, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600278
   Sharma A, 2015, MACROMOL BIOSCI, V15, P200, DOI 10.1002/mabi.201400325
   Shin YC, 2015, J NANOSCI NANOTECHNO, V15, P7907, DOI 10.1166/jnn.2015.11214
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Stein P, 2001, EUR PHYS J E, V4, P255, DOI 10.1007/s101890170107
   Stewart GT, 2003, LIQ CRYST, V30, P751, DOI 10.1080/0267829031000138514
   Storey RF, 1997, POLYMER, V38, P6295, DOI 10.1016/S0032-3861(97)00208-5
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Teppola H, 2016, NEUROCHEM RES, V41, P731, DOI 10.1007/s11064-015-1743-6
   Thomsen DL, 2001, MACROMOLECULES, V34, P5868, DOI 10.1021/ma001639q
   Tremblay D, 2013, CYTOSKELETON, V70, P837, DOI 10.1002/cm.21148
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   Vieira AC, 2010, MATER SCI FORUM, V636-637, P825, DOI 10.4028/www.scientific.net/MSF.636-637.825
   Wang Y, 2011, JOVE-J VIS EXP, V50, pe2691, DOI DOI 10.3791/2691)
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WARD IM, 1966, BRIT J APPL PHYS, V17, P3, DOI 10.1088/0508-3443/17/1/302
   Wheeler DL, 1997, J BIOMED MATER RES, V35, P249, DOI 10.1002/(SICI)1097-4636(199705)35:2<249::AID-JBM12>3.0.CO;2-C
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   Wise SG, 2016, TISSUE ENG PT A, V22, P524, DOI [10.1089/ten.TEA.2015.0409, 10.1089/ten.tea.2015.0409]
   Woltman SJ, 2007, NAT MATER, V6, P929, DOI 10.1038/nmat2010
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Wu LB, 2005, TISSUE ENG, V11, P1105, DOI 10.1089/ten.2005.11.1105
   Xing I., 2016, ACS BIOMATER SCI ENG, DOI [10.1021/acsbiomaterials.6b00235, DOI 10.1021/ACSBIOMATERIALS.6B00235]
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yakacki CM, 2015, RSC ADV, V5, P18997, DOI 10.1039/c5ra01039j
   Yakacki CM, 2008, ADV FUNCT MATER, V18, P2428, DOI 10.1002/adfm.200701049
   Yamada M, 2008, ANGEW CHEM INT EDIT, V47, P4986, DOI 10.1002/anie.200800760
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang C G, 2006, THESIS
   Zhang XL, 2016, POLYM TEST, V54, P118, DOI 10.1016/j.polymertesting.2016.07.006
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhou L, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42196
   Zilla P. P., 1999, TISSUE ENG VASCULAR
NR 186
TC 2
Z9 2
U1 4
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-3222-8
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2017
VL 1253
BP 3
EP 45
PG 43
WC Biotechnology & Applied Microbiology; Chemistry, Applied; Engineering,
   Biomedical; Materials Science, Biomaterials
SC Biotechnology & Applied Microbiology; Chemistry; Engineering; Materials
   Science
GA BJ2AY
UT WOS:000418627300001
DA 2018-10-20
ER

PT J
AU Zhao, HK
   Li, JL
   Wang, P
   Zeng, SQ
   Xie, YM
AF Zhao, Houkuan
   Li, Jinling
   Wang, Peng
   Zeng, Shaoqiong
   Xie, Yimin
TI Lignin-Carbohydrate Complexes Based Spherical Biocarriers: Preparation,
   Characterization, and Biocompatibility
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID SYNTHETIC EXTRACELLULAR-MATRIX; HEPATOCYTE ATTACHMENT; CELLS; LINKAGES;
   ALGINATE; CHITOSAN; SCAFFOLD; SPRUCE; WOOD; C-13
AB Spherical biocarriers were prepared with lignin-carbohydrate complexes isolated from ginkgo (Ginkgo biloba L.) xylem. The specific surface and average pore size of the biocarriers were 17.15 m(2) g(-1) and 21.59 nm, respectively. The carriers were stable in solution at pH 4.0 similar to 9.5. Fourier transform infrared (FT-IR) spectrum indicated that the spherical carrier was composed of lignin and polysaccharides and had a typical lignin-carbohydrate complex (LCC) structure. The contents of galactose, lignin, and total sugar were 3.30%, 23.9%, and 64.62%, respectively, making the spherical biocarriers have good physical strength and compatible with hepatocytes. It was observed using a scanning electron microscopy (SEM) that liver cells adhered to the spherical biocarriers during culture. Cell counting indicated that the proliferation of liver cells in the experimental group was significantly higher than that of the control group. The albumin secretion (ALB) value and glucose consumption of the human hepatocytes were increased by 51.7% and 38.6%, respectively, by the fourth day when cultivated on the biocarriers. The results indicate that ginkgo LCC is very biocompatible and shows promise for the use as a biomaterial in the culture of human hepatocytes.
C1 [Zhao, Houkuan; Li, Jinling; Wang, Peng; Zeng, Shaoqiong; Xie, Yimin] Hubei Univ Technol, Res Inst Pulp & Paper Engn, Wuhan 430068, Hubei, Peoples R China.
   [Wang, Peng; Xie, Yimin] Hubei Univ Technol, Hubei Prov Key Lab Green Mat Light Ind, Wuhan 430068, Hubei, Peoples R China.
RP Xie, YM (reprint author), Hubei Univ Technol, Res Inst Pulp & Paper Engn, Wuhan 430068, Hubei, Peoples R China.; Xie, YM (reprint author), Hubei Univ Technol, Hubei Prov Key Lab Green Mat Light Ind, Wuhan 430068, Hubei, Peoples R China.
EM ppymxie@scut.edu.cn
FU National Natural Science Foundation of China [31370574, 31300494]; Hubei
   Provincial Key Laboratory of Green Materials for Light Industry
   [Q20131402]
FX The authors are grateful for the support of the National Natural Science
   Foundation of China (Grants no. 31370574 and no. 31300494) and Hubei
   Provincial Key Laboratory of Green Materials for Light Industry
   (Q20131402). The authors thank Professor Xue-Feng Li for his help in the
   preparation of the biocarriers.
CR AZUMA JI, 1988, METHOD ENZYMOL, V161, P12
   Bjorkman A., 1957, IND ENG CHEM RES, V60, P243
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chirkova J, 2011, HOLZFORSCHUNG, V65, P497, DOI 10.1515/HF.2011.092
   Cho CS, 2001, BIOMATERIALS, V22, P45, DOI 10.1016/S0142-9612(00)00143-5
   Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   Chung HY, 2013, GREEN MATER, V1, P137, DOI 10.1680/gmat.12.00009
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Du XY, 2014, PLANTA, V239, P1079, DOI 10.1007/s00425-014-2037-y
   Erakovic S., 2009, INT J CHEM REACT ENG, V7, P113
   GEFFEN I, 1992, INT REV CYTOL, V137B, P181
   Ghanem A, 2000, BIOTECHNOL PROGR, V16, P471, DOI 10.1021/bp000047o
   Hansmann C, 2004, HOLZFORSCHUNG, V58, P483, DOI 10.1515/HF.2004.073
   Lee JB, 2011, BIOSCI BIOTECH BIOCH, V75, P459, DOI 10.1271/bbb.100645
   LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323
   Mansur HS, 2005, KEY ENG MAT, V284-286, P745, DOI 10.4028/www.scientific.net/KEM.284-286.745
   Mastoby-Martinez M, 2009, REV MVZ CORDOBA, V14, P1624
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Raymundo-Pinero E., 2007, J ELECTROCHEMICAL SO, V142, P325
   Roopan SM, 2017, INT J BIOL MACROMOL, V103, P508, DOI 10.1016/j.ijbiomac.2017.05.103
   Sakagami H, 2005, PHYTOCHEMISTRY, V66, P2108, DOI 10.1016/j.phytochem.2005.05.013
   Sakagami H, 2011, IN VIVO, V25, P229
   Sakagami H, 2010, PHARMACOL THERAPEUT, V128, P91, DOI 10.1016/j.pharmthera.2010.05.004
   Seo SJ, 2005, BIOMATERIALS, V26, P3607, DOI 10.1016/j.biomaterials.2004.09.025
   Singh R, 2005, CARBOHYD POLYM, V62, P57, DOI 10.1016/j.carbpol.2005.07.011
   Sipponen MH, 2013, BIORESOURCE TECHNOL, V133, P522, DOI 10.1016/j.biortech.2013.01.175
   Vasanthan KS, 2012, BIOTECHNOL ADV, V30, P742, DOI 10.1016/j.biotechadv.2012.01.004
   Wang JY, 2010, CARBOHYD POLYM, V82, P578, DOI 10.1016/j.carbpol.2010.05.011
   Wellner N, 1998, CARBOHYD RES, V308, P123, DOI 10.1016/S0008-6215(98)00065-2
   Xie YM, 2000, J WOOD SCI, V46, P130, DOI 10.1007/BF00777359
   Yan J, 2010, CARBON, V48, P3825, DOI 10.1016/j.carbon.2010.06.047
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Yang N, 2012, CARBOHYD POLYM, V88, P509, DOI 10.1016/j.carbpol.2011.12.036
   You TT, 2015, IND CROP PROD, V71, P65, DOI 10.1016/j.indcrop.2015.03.070
   Yuan TQ, 2011, J AGR FOOD CHEM, V59, P10604, DOI 10.1021/jf2031549
   Zahedifar M, 2002, ANIM FEED SCI TECH, V95, P83, DOI 10.1016/S0377-8401(01)00305-4
NR 36
TC 1
Z9 1
U1 3
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9422
EI 1687-9430
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2017
AR 4915185
DI 10.1155/2017/4915185
PG 9
WC Polymer Science
SC Polymer Science
GA FR1QE
UT WOS:000418841300001
OA DOAJ Gold
DA 2018-10-20
ER

EF